,cmap_name,moa,target,canonical_smiles,inchi_key,compound_aliases,target_new
0,meclizine,CAR agonist,NR1I3,Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1,OCJYIGYOJCODJL-UHFFFAOYSA-N,meclozine,NR1I3
1,TCPOBOP,CAR agonist,NR1I3,Clc1cnc(Oc2ccc(Oc3ncc(Cl)cc3Cl)cc2)c(Cl)c1,BAFKRPOFIYPKBQ-UHFFFAOYSA-N,tcpobop,NR1I3
2,DMH1,ALK inhibitor,ACVR1,CC(C)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12,JMIFGARJSWXZSH-UHFFFAOYSA-N,DMH-1,ACVR1
3,GDC-0068,Akt inhibitor,AKT3,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,GRZXWCHAXNAUHY-NSISKUIASA-N,ipatasertib,AKT3
4,GDC-0068,Akt inhibitor,AKT1,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,GRZXWCHAXNAUHY-NSISKUIASA-N,ipatasertib,AKT1
5,GDC-0068,Akt inhibitor,AKT2,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,GRZXWCHAXNAUHY-NSISKUIASA-N,ipatasertib,AKT2
6,palomid-529,Akt inhibitor,MTOR,COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,YEAHTLOYHVWAKW-UHFFFAOYSA-N,PALOMID-529,MTOR
7,BCL2-inhibitor,BCL inhibitor,BCL2,COc1ccc([N+][O-])c(CCc2cc(OC)ccc2[N+][O-])c1,YPSXFMHXRZAGTG-UHFFFAOYSA-N,BCL-2-INHIBITOR,BCL2
8,ibrutinib,BTK inhibitor,BTK,Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C,XYFPWWZEPKGCCK-GOSISDBHSA-N,PCI-32765,BTK
9,7-hydroxystaurosporine,CDK inhibitor,CDK4,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK4
10,7-hydroxystaurosporine,CDK inhibitor,CHEK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK1
11,7-hydroxystaurosporine,CDK inhibitor,CHEK2,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK2
12,7-hydroxystaurosporine,CDK inhibitor,PDPK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PDPK1
13,7-hydroxystaurosporine,CDK inhibitor,PRKCA,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PRKCA
14,7-hydroxystaurosporine,CDK inhibitor,CDK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK1
15,Ro-3306,CDK inhibitor,CDK1,O=C1N=C(NCc2cccs2)SC1=C/c1ccc2ncccc2c1,XOLMRFUGOINFDQ-YBEGLDIGSA-N,RO-3306,CDK1
16,7-hydroxystaurosporine,CHK inhibitor,CDK4,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK4
17,7-hydroxystaurosporine,CHK inhibitor,CHEK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK1
18,7-hydroxystaurosporine,CHK inhibitor,CHEK2,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK2
19,7-hydroxystaurosporine,CHK inhibitor,PDPK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PDPK1
20,7-hydroxystaurosporine,CHK inhibitor,PRKCA,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PRKCA
21,7-hydroxystaurosporine,CHK inhibitor,CDK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK1
22,CCT-018159,HSP inhibitor,HSP90AA1,CCc1cc(-c2n[nH]c(C)c2-c2ccc3OCCOc3c2)c(O)cc1O,OWPMENVYXDJDOW-UHFFFAOYSA-N,HSP-90-INHIBITOR,HSP90AA1
23,KIN001-127,ITK inhibitor,ITK,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)C)cc3)s2)cc1C(=O)N1CCN(CC1)C(C)=O,RRHONYZEMUNMJX-UHFFFAOYSA-N,KIN-001-127,ITK
24,KIN001-055,JAK inhibitor,JAK3,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,YVCXQRVVNQMZEI-UHFFFAOYSA-N,KIN-001-055,JAK3
25,sunitinib,KIT inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT1
26,sunitinib,KIT inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT3
27,sunitinib,KIT inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT4
28,sunitinib,KIT inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KDR
29,sunitinib,KIT inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KIT
30,sunitinib,KIT inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRA
31,sunitinib,KIT inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRB
32,sunitinib,KIT inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,RET
33,MDM2-inhibitor,MDM inhibitor,MDM2,OB(O)c1ccc(cc1)C(=O)/C=C/c2ccc(I)cc2,BYMGWCQXSPGCMW-XCVCLJGOSA-N,MDM-2-INHIBITOR,MDM2
34,nutlin-3,MDM inhibitor,MDM2,COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,BDUHCSBCVGXTJM-UHFFFAOYSA-N,NUTLIN-3A,MDM2
35,RITA,MDM inhibitor,MDM2,OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1,KZENBFUSKMWCJF-UHFFFAOYSA-N,rita,MDM2
36,Ro-4987655,MEK inhibitor,MAP2K1,OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,FIMYFEGKMOCQKT-UHFFFAOYSA-N,RO-4987655,MAP2K1
37,7-hydroxystaurosporine,PKC inhibitor,CDK4,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK4
38,7-hydroxystaurosporine,PKC inhibitor,CHEK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK1
39,7-hydroxystaurosporine,PKC inhibitor,CHEK2,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CHEK2
40,7-hydroxystaurosporine,PKC inhibitor,PDPK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PDPK1
41,7-hydroxystaurosporine,PKC inhibitor,PRKCA,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,PRKCA
42,7-hydroxystaurosporine,PKC inhibitor,CDK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,7-HYDROXYSTAUROSPORINE,CDK1
43,PKCbeta-inhibitor,PKC inhibitor,PRKCB,O=C1NC(=O)C(=C1Nc1ccccc1)c1cn(CCCn2ccnc2)c2ccccc12,KIWODJBCHRADND-UHFFFAOYSA-N,pkcbeta-inhibitor,PRKCB
44,AICA-ribonucleotide,AMPK activator,PRKAA1,NC(=O)c1ncn(C2OC(COP(O)(O)=O)C(O)C2O)c1N,NOTGFIUVDGNKRI-UHFFFAOYSA-N,aica-ribonucleotide,PRKAA1
45,PTB1,AMPK activator,PTPN1,OP(O)(=O)C(F)(F)c1cc2cc(ccc2cc1Br)C#N,BWJOQFMMTKEZGA-UHFFFAOYSA-N,PTB-1,PTPN1
46,KIN001-055,EGFR inhibitor,JAK3,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,YVCXQRVVNQMZEI-UHFFFAOYSA-N,KIN-001-055,JAK3
47,tyrphostin-47,EGFR inhibitor,EGFR,NC(=S)/C(=C/c1ccc(O)c(O)c1)/C#N,ZGHQGWOETPXKLY-XVNBXDOJSA-N,TYRPHOSTIN-47,EGFR
48,sunitinib,FLT3 inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT1
49,sunitinib,FLT3 inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT3
50,sunitinib,FLT3 inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT4
51,sunitinib,FLT3 inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KDR
52,sunitinib,FLT3 inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KIT
53,sunitinib,FLT3 inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRA
54,sunitinib,FLT3 inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRB
55,sunitinib,FLT3 inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,RET
56,HDAC3-selective,HDAC inhibitor,HDAC3,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccc(F)cc1N,RRJDFENBXIEAPD-UHFFFAOYSA-N,HDAC-3-SELECTIVE,HDAC3
57,HNHA,HDAC inhibitor,HDAC1,ONC(=O)CCCCCCSc1ccc2ccccc2c1,KPNNXHVGOKRBEF-UHFFFAOYSA-N,hnha,HDAC1
58,ISOX,HDAC inhibitor,HDAC6,CC(C)(C)OC(=O)Nc1ccc(cc1)-c1cc(no1)C(=O)NCCCCCCC(=O)NO,WWGBHDIHIVGYLZ-UHFFFAOYSA-N,isox,HDAC6
59,JNJ-26481585,HDAC inhibitor,HDAC1,Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12,PAWIYAYFNXQGAP-UHFFFAOYSA-N,JNJ-26854165,HDAC1
60,JNJ-26481585,HDAC inhibitor,MDM2,Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12,PAWIYAYFNXQGAP-UHFFFAOYSA-N,JNJ-26854165,MDM2
61,Merck60,HDAC inhibitor,HDAC1,CC(=O)Nc1ccc(cc1)C(=O)Nc2cc(ccc2N)c3cccs3,ABZSPJVXTTUFAA-UHFFFAOYSA-N,MERCK-60,HDAC1
62,Merck60,HDAC inhibitor,HDAC2,CC(=O)Nc1ccc(cc1)C(=O)Nc2cc(ccc2N)c3cccs3,ABZSPJVXTTUFAA-UHFFFAOYSA-N,MERCK-60,HDAC2
63,NVP-BEZ235,MTOR inhibitor,MTOR,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,MTOR
64,NVP-BEZ235,MTOR inhibitor,PIK3CA,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CA
65,NVP-BEZ235,MTOR inhibitor,PIK3CD,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CD
66,NVP-BEZ235,MTOR inhibitor,PIK3CG,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CG
67,palomid-529,MTOR inhibitor,MTOR,COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,YEAHTLOYHVWAKW-UHFFFAOYSA-N,PALOMID-529,MTOR
68,torin-1,MTOR inhibitor,MTOR,CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1,AKCRNFFTGXBONI-UHFFFAOYSA-N,TORIN-1,MTOR
69,torin-2,MTOR inhibitor,MTOR,Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4cccc(c4)C(F)(F)F)c3c2c1,GUXXEUUYCAYESJ-UHFFFAOYSA-N,TORIN-2,MTOR
70,NVP-BEZ235,PI3K inhibitor,MTOR,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,MTOR
71,NVP-BEZ235,PI3K inhibitor,PIK3CA,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CA
72,NVP-BEZ235,PI3K inhibitor,PIK3CD,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CD
73,NVP-BEZ235,PI3K inhibitor,PIK3CG,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,dactolisib,PIK3CG
74,TG-100115,PI3K inhibitor,PIK3CG,Nc1nc(N)c2nc(-c3cccc(O)c3)c(nc2n1)-c1cccc(O)c1,UJIAQDJKSXQLIT-UHFFFAOYSA-N,TG-100-115,PIK3CG
75,torin-1,PI3K inhibitor,MTOR,CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1,AKCRNFFTGXBONI-UHFFFAOYSA-N,TORIN-1,MTOR
76,necrostatin-1,RIPK inhibitor,RIPK1,CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O,TXUWMXQFNYDOEZ-UHFFFAOYSA-N,NECROSTATIN-1,RIPK1
77,tenovin-6,SIRT inhibitor,SIRT2,CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1,BVJSXSQRIUSRCO-UHFFFAOYSA-N,TENOVIN-6,SIRT2
78,tenovin-6,SIRT inhibitor,SIRT3,CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1,BVJSXSQRIUSRCO-UHFFFAOYSA-N,TENOVIN-6,SIRT3
79,tenovin-6,SIRT inhibitor,SIRT1,CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1,BVJSXSQRIUSRCO-UHFFFAOYSA-N,TENOVIN-6,SIRT1
80,PRIMA1,TP53 inhibitor,ACHE,OCC1(CO)N2CCC(CC2)C1=O,RFBVBRVVOPAAFS-UHFFFAOYSA-N,PRIMA-1,ACHE
81,DMBI,PDGFR inhibitor,PDGFRB,CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc23)cc1,UAKWLVYMKBWHMX-RVDMUPIBSA-N,dmbi,PDGFRB
82,sunitinib,PDGFR inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT1
83,sunitinib,PDGFR inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT3
84,sunitinib,PDGFR inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT4
85,sunitinib,PDGFR inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KDR
86,sunitinib,PDGFR inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KIT
87,sunitinib,PDGFR inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRA
88,sunitinib,PDGFR inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRB
89,sunitinib,PDGFR inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,RET
90,IU1,USP14 inhibitor,USP14,Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1,JUWDSDKJBMFLHE-UHFFFAOYSA-N,IU-1,USP14
91,DMBI,VEGFR inhibitor,PDGFRB,CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc23)cc1,UAKWLVYMKBWHMX-RVDMUPIBSA-N,dmbi,PDGFRB
92,oxindole-I,VEGFR inhibitor,KDR,O=C/1Nc2ccccc2C1=Cc3ccc[nH]3,SEZFNTZQMWJIAI-FLIBITNWSA-N,oxindole-i,KDR
93,palomid-529,VEGFR inhibitor,MTOR,COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,YEAHTLOYHVWAKW-UHFFFAOYSA-N,PALOMID-529,MTOR
94,sunitinib,VEGFR inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT1
95,sunitinib,VEGFR inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT3
96,sunitinib,VEGFR inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT4
97,sunitinib,VEGFR inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KDR
98,sunitinib,VEGFR inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KIT
99,sunitinib,VEGFR inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRA
100,sunitinib,VEGFR inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRB
101,sunitinib,VEGFR inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,RET
102,DBeQ,ATPase inhibitor,CASP3,C(Nc1nc(NCc2ccccc2)c2ccccc2n1)c1ccccc1,QAIMUUJJAJBPCL-UHFFFAOYSA-N,dbeq,CASP3
103,mdivi-1,Dynamin inhibitor,DNM1,COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O,NZJKEVWTYMOYOR-UHFFFAOYSA-N,MDIVI-1,DNM1
104,docetaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,docetaxil,TUBB
105,inhibitor-BEC,Arginase inhibitor,ARG1,N[C@H](CSCCB(O)O)C(=O)O,OTJHLDXXJHAZTN-SCSAIBSYSA-N,inhibitor-bec,ARG1
106,inhibitor-BEC,Arginase inhibitor,ARG2,N[C@H](CSCCB(O)O)C(=O)O,OTJHLDXXJHAZTN-SCSAIBSYSA-N,inhibitor-bec,ARG2
107,7b-cis,Exportin antagonist,XPO1,CCOC(=O)C=C/n1nnc(n1)-c1cccc(Cl)c1,AICKZRPQDLFSPA-SREVYHEPSA-N,7B-CIS,XPO1
108,DCPIB,Glutamate inhibitor,SLC1A2,CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1,KHKGTPJPBOQECW-UHFFFAOYSA-N,dcpib,SLC1A2
109,wnt-c59,Porcupine inhibitor,PORCN,Cc1cc(ccn1)-c1ccc(CC(=O)Nc2ccc(cc2)-c2cccnc2)cc1,KHZOJCQBHJUJFY-UHFFFAOYSA-N,WNT-C59,PORCN
110,4-chlorophenylguanidine,Urokinase inhibitor,PLAUR,NC(=N)Nc1ccc(Cl)cc1,ZSJNJAJDBNFVCA-UHFFFAOYSA-N,4-CHLOROPHENYLGUANIDINE,PLAUR
111,GNF-2,Abl kinase inhibitor,ABL1,NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1,WEVYNIUIFUYDGI-UHFFFAOYSA-N,HY-11007,ABL1
112,GNF-2,Abl kinase inhibitor,BCR,NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1,WEVYNIUIFUYDGI-UHFFFAOYSA-N,HY-11007,BCR
113,KBG,Neprilysin inhibitor,MME,OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)c1ccccc1,FOLRUCXBTYDAQK-SFZUHQLGSA-N,kbg,MME
114,SMI-4a,Pim kinase inhibitor,PIM1,FC(F)(F)c1cccc(c1)C=C1SC(=O)NC1=O,NGJLOFCOEOHFKQ-VMPITWQZSA-N,SMI-4A,PIM1
115,ixazomib,Proteasome inhibitor,PSMB1,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,MXAYKZJJDUDWDS-LBPRGKRZSA-N,MLN-2238,PSMB1
116,I-BET-762,Bromodomain inhibitor,BRD4,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12,AAAQFGUYHFJNHI-SFHVURJKSA-N,GSK-525762A,BRD4
117,I-BET-762,Bromodomain inhibitor,BRD2,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12,AAAQFGUYHFJNHI-SFHVURJKSA-N,GSK-525762A,BRD2
118,I-BET-762,Bromodomain inhibitor,BRD3,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12,AAAQFGUYHFJNHI-SFHVURJKSA-N,GSK-525762A,BRD3
119,KIN001-055,Leukotriene inhibitor,JAK3,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,YVCXQRVVNQMZEI-UHFFFAOYSA-N,KIN-001-055,JAK3
120,D-64131,Microtubule inhibitor,TUBB,COc1ccc2[nH]c(cc2c1)C(=O)c1ccccc1,ICMIJSRDISNKOC-UHFFFAOYSA-N,SA-792574,TUBB
121,nTZDpa,PPAR receptor agonist,PPARG,OC(=O)c1n(Cc2ccc(Cl)cc2)c2ccc(Cl)cc2c1Sc1ccccc1,VUPOTURDKDMIGQ-UHFFFAOYSA-N,ntzdpa,PPARG
122,DCPIB,Gap junction modulator,SLC1A2,CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1,KHKGTPJPBOQECW-UHFFFAOYSA-N,dcpib,SLC1A2
123,CDC,Lipoxygenase inhibitor,ALOX12,Oc1ccc(/C=C(/C#N)C(=O)OCC=Cc2ccccc2)cc1O,XGHYFEJMJXGPGN-CHLGNXTCSA-N,cdc,ALOX12
124,barasertib-HQPA,Aurora kinase inhibitor,AURKB,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,QYZOGCMHVIGURT-UHFFFAOYSA-N,barasertib-hqpa,AURKB
125,IC-261,Casein kinase inhibitor,CSNK1E,COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc23)c(OC)c1,JBJYTZXCZDNOJW-JLHYYAGUSA-N,SA-63133,CSNK1E
126,trap-101,NOP receptor antagonist,OPRL1,CCn1c2ccccc2n(C2=C(CO)CN(CC3CCCCCCC3)CC2)c1=O,DCRGHMJXEBSRQG-UHFFFAOYSA-N,TRAP-101,OPRL1
127,FIT,Opioid receptor agonist,OPRD1,CCC(=O)N(C1CCN(CCc2ccc(cc2)N=C=S)CC1)c1ccccc1,VDKBIFPJULZUPU-UHFFFAOYSA-N,fit,OPRD1
128,m-3M3FBS,Phospholipase activator,PLCB2,Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,M-3M3FBS,PLCB2
129,m-3M3FBS,Phospholipase activator,PLCB3,Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,M-3M3FBS,PLCB3
130,m-3M3FBS,Phospholipase activator,PLCD1,Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,M-3M3FBS,PLCD1
131,m-3M3FBS,Phospholipase activator,PLCG1,Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,M-3M3FBS,PLCG1
132,m-3M3FBS,Phospholipase activator,PLCG2,Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,M-3M3FBS,PLCG2
133,epirubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-VTZDEGQISA-N,pidorubicine,TOP2A
134,genz-644282,Topoisomerase inhibitor,TOP1,CNCCn1c2c(cnc3cc4OCOc4cc23)c2cc(OC)c(OC)cc2c1=O,BAORCAMWLWRZQG-UHFFFAOYSA-N,GENZ-644282,TOP1
135,NO-ASA,Cyclooxygenase inhibitor,PTGS2,CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+]([O-])=O)c1,IOJUJUOXKXMJNF-UHFFFAOYSA-N,no-asa,PTGS2
136,salicylic-acid,Cyclooxygenase inhibitor,PTGS1,OC(=O)c1ccccc1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,sodium-salicylate,PTGS1
137,3'-fluorobenzylspiperone,Dopamine receptor ligand,DRD2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(Cc1cccc(F)c1)C2=O)c1ccccc1,DXZKTRNEOISOCA-UHFFFAOYSA-N,3'-FLUOROBENZYLSPIPERONE,DRD2
138,1-monopalmitin,P-glycoprotein inhibitor,ABCB1,CCCCCCCCCCCCCCCC(=O)OCC(O)CO,QHZLMUACJMDIAE-UHFFFAOYSA-N,1-MONOPALMITIN,ABCB1
139,BADGE,PPAR receptor antagonist,PPARG,CC(C)(c1ccc(OCC2CO2)cc1)c3ccc(OCC4CO4)cc3,LCFVJGUPQDGYKZ-UHFFFAOYSA-N,badge,PPARG
140,KIN001-242,Protein kinase inhibitor,RPS6KA3,COCCNCCCn1c(C(=O)CF)c(-c2ccc(C)cc2)c2c(N)ncnc12,UPTQGXMIZXGVSC-UHFFFAOYSA-N,KIN-001-242,RPS6KA3
141,BP-897,Dopamine receptor agonist,DRD3,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,MNHDKMDLOJSCGN-UHFFFAOYSA-N,PRESTWICK-559,DRD3
142,L-stepholidine,Dopamine receptor agonist,DRD1,COc1cc2CCN3Cc4c(OC)c(O)ccc4CC3c2cc1O,JKPISQIIWUONPB-UHFFFAOYSA-N,l-stepholidine,DRD1
143,L-stepholidine,Dopamine receptor agonist,DRD2,COc1cc2CCN3Cc4c(OC)c(O)ccc4CC3c2cc1O,JKPISQIIWUONPB-UHFFFAOYSA-N,l-stepholidine,DRD2
144,PPT,Estrogen receptor agonist,ESR1,CCCc1c(nn(c1-c1ccc(O)cc1)-c1ccc(O)cc1)-c1ccc(O)cc1,IOTXSIGGFRQYKW-UHFFFAOYSA-N,ppt,ESR1
145,BAPTA-AM,Potassium channel blocker,KCNA3,CC(=O)OCOC(=O)CN(CC(=O)OCOC(=O)C)c1ccccc1OCCOc2ccccc2N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,YJIYWYAMZFVECX-UHFFFAOYSA-N,bapta-am,KCNA3
146,BAPTA-AM,Potassium channel blocker,KCNA5,CC(=O)OCOC(=O)CN(CC(=O)OCOC(=O)C)c1ccccc1OCCOc2ccccc2N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,YJIYWYAMZFVECX-UHFFFAOYSA-N,bapta-am,KCNA5
147,BAPTA-AM,Potassium channel blocker,KCNH2,CC(=O)OCOC(=O)CN(CC(=O)OCOC(=O)C)c1ccccc1OCCOc2ccccc2N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,YJIYWYAMZFVECX-UHFFFAOYSA-N,bapta-am,KCNH2
148,5-iodotubercidin,Adenosine kinase inhibitor,MAPK3,Nc1ncnc2n(cc(I)c12)C3OC(CO)C(O)C3O,WHSIXKUPQCKWBY-UHFFFAOYSA-N,5-IODOTUBERCIDIN,MAPK3
149,EBPC,Aldose reductase inhibitor,AKR1B1,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1=O,FQMSSTZJKSWSMP-UHFFFAOYSA-N,ebpc,AKR1B1
150,ATPA,Glutamate receptor agonist,GRIK1,CC(C)(C)c1onc(O)c1CC(N)C(O)=O,PIXJURSCCVBKRF-UHFFFAOYSA-N,atpa,GRIK1
151,ODQ,Guanylyl cyclase inhibitor,GUCY1A2,O=c1onc2cnc3ccccc3n12,LZMHWZHOZLVYDL-UHFFFAOYSA-N,odq,GUCY1A2
152,KIN001-055,Mediator release inhibitor,JAK3,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,YVCXQRVVNQMZEI-UHFFFAOYSA-N,KIN-001-055,JAK3
153,2-iodomelatonin,Melatonin receptor agonist,MTNR1A,COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,2-IODOMELATONIN,MTNR1A
154,2-iodomelatonin,Melatonin receptor agonist,MTNR1B,COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,2-IODOMELATONIN,MTNR1B
155,2-iodomelatonin,Melatonin receptor agonist,NQO2,COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,2-IODOMELATONIN,NQO2
156,2-phenylmelatonin,Melatonin receptor agonist,MTNR1A,COc1ccc2[nH]c(c(CCNC(C)=O)c2c1)-c1ccccc1,OFCLARYYBGKCHN-UHFFFAOYSA-N,2-PHENYLMELATONIN,MTNR1A
157,2-phenylmelatonin,Melatonin receptor agonist,MTNR1B,COc1ccc2[nH]c(c(CCNC(C)=O)c2c1)-c1ccccc1,OFCLARYYBGKCHN-UHFFFAOYSA-N,2-PHENYLMELATONIN,MTNR1B
158,5'-guanidinonaltrindole,Opioid receptor antagonist,OPRK1,NC(=N)Nc1ccc2[nH]c3C4Oc5c6c(CC7N(CC8CC8)CCC46C7(O)Cc3c2c1)ccc5O,VLNHDKDBGWXJEE-UHFFFAOYSA-N,5'-GUANIDINONALTRINDOLE,OPRK1
159,BNTX,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)C(C[C@@]35O)=Cc1ccccc1,WXOUFNFMPVMGFZ-WLNGDWEISA-N,bntx,OPRD1
160,JDTic,Opioid receptor antagonist,OPRK1,CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c1cccc(O)c1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1,ZLVXBBHTMQJRSX-VMGNSXQWSA-N,jdtic,OPRK1
161,trap-101,Opioid receptor antagonist,OPRL1,CCn1c2ccccc2n(C2=C(CO)CN(CC3CCCCCCC3)CC2)c1=O,DCRGHMJXEBSRQG-UHFFFAOYSA-N,TRAP-101,OPRL1
162,5-methoxytryptamine,Serotonin receptor agonist,HTR2A,COc1ccc2[nH]cc(CCN)c2c1,JTEJPPKMYBDEMY-UHFFFAOYSA-N,5-METHOXYTRYPTAMINE,HTR2A
163,5-methoxytryptamine,Serotonin receptor agonist,HTR6,COc1ccc2[nH]cc(CCN)c2c1,JTEJPPKMYBDEMY-UHFFFAOYSA-N,5-METHOXYTRYPTAMINE,HTR6
164,mCPP,Serotonin receptor agonist,HTR1D,Clc1cccc(c1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,mcpp,HTR1D
165,mCPP,Serotonin receptor agonist,HTR2A,Clc1cccc(c1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,mcpp,HTR2A
166,mCPP,Serotonin receptor agonist,HTR2B,Clc1cccc(c1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,mcpp,HTR2B
167,mCPP,Serotonin receptor agonist,HTR2C,Clc1cccc(c1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,mcpp,HTR2C
168,N-methylquipazine,Serotonin receptor agonist,HTR2A,CN1CCN(CC1)c1ccc2ccccc2n1,HOMWNUXPSJQSSU-UHFFFAOYSA-N,n-methylquipazine,HTR2A
169,N-methylquipazine,Serotonin receptor agonist,HTR3A,CN1CCN(CC1)c1ccc2ccccc2n1,HOMWNUXPSJQSSU-UHFFFAOYSA-N,n-methylquipazine,HTR3A
170,N-methylquipazine,Serotonin receptor agonist,HTR3B,CN1CCN(CC1)c1ccc2ccccc2n1,HOMWNUXPSJQSSU-UHFFFAOYSA-N,n-methylquipazine,HTR3B
171,TCB2,Serotonin receptor agonist,HTR2A,COc1cc(Br)c(OC)c2CC(CN)c21,MPBCKKVERDTCEL-UHFFFAOYSA-N,TCB-2,HTR2A
172,TFMPP,Serotonin receptor agonist,HTR1D,FC(F)(F)c1cccc(c1)N2CCNCC2,KKIMDKMETPPURN-UHFFFAOYSA-N,tfmpp,HTR1D
173,TFMPP,Serotonin receptor agonist,HTR2A,FC(F)(F)c1cccc(c1)N2CCNCC2,KKIMDKMETPPURN-UHFFFAOYSA-N,tfmpp,HTR2A
174,DMAB-anabaseine,Adrenergic receptor agonist,CHRNA7,CN(C)c1ccc(cc1)C=C1CCCN=C/1c1cccnc1,KHUUTHZSRXABAC-DTQAZKPQSA-N,dmab-anabaseine,CHRNA7
175,CFTRinh-172,Chloride channel antagonist,CFTR,OC(=O)c1ccc(cc1)C=C1SC(=S)N(C1=O)c1cccc(c1)C(F)(F)F,JIMHYXZZCWVCMI-RIYZIHGNSA-N,CFTRINH-172,CFTR
176,DCPIB,Chloride channel antagonist,SLC1A2,CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1,KHKGTPJPBOQECW-UHFFFAOYSA-N,dcpib,SLC1A2
177,MBCQ,Phosphodiesterase inhibitor,PDE5A,Clc1ccc2ncnc(NCc3ccc4OCOc4c3)c2c1,CNODHOSDWZLJGA-UHFFFAOYSA-N,mbcq,PDE5A
178,GP-1a,Cannabinoid receptor agonist,CNR2,Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1,FNOMTMVRTBHRET-UHFFFAOYSA-N,GP-1A,CNR2
179,GP-2a,Cannabinoid receptor agonist,CNR2,Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1,SPEFJYZGXZENAF-UHFFFAOYSA-N,GP-2A,CNR2
180,quetiapine,Dopamine receptor antagonist,DRD1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,DRD1
181,quetiapine,Dopamine receptor antagonist,DRD2,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,DRD2
182,quetiapine,Dopamine receptor antagonist,HRH1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HRH1
183,quetiapine,Dopamine receptor antagonist,HTR1A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1A
184,quetiapine,Dopamine receptor antagonist,HTR1D,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1D
185,quetiapine,Dopamine receptor antagonist,HTR1E,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1E
186,quetiapine,Dopamine receptor antagonist,HTR2A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR2A
187,L-stepholidine,Dopamine receptor antagonist,DRD1,COc1cc2CCN3Cc4c(OC)c(O)ccc4CC3c2cc1O,JKPISQIIWUONPB-UHFFFAOYSA-N,l-stepholidine,DRD1
188,L-stepholidine,Dopamine receptor antagonist,DRD2,COc1cc2CCN3Cc4c(OC)c(O)ccc4CC3c2cc1O,JKPISQIIWUONPB-UHFFFAOYSA-N,l-stepholidine,DRD2
189,PHTPP,Estrogen receptor antagonist,ESR2,Oc1ccc(cc1)-c1c(nn2c(cc(nc12)C(F)(F)F)C(F)(F)F)-c1ccccc1,AEZPAUSGTAHLOQ-UHFFFAOYSA-N,phtpp,ESR2
190,SKI-II,Sphingosine kinase inhibitor,SPHK1,Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1,ZFGXZJKLOFCECI-UHFFFAOYSA-N,SA-792728,SPHK1
191,EHNA,Adenosine deaminase inhibitor,ADA,CCCCCC[C@@H]([C@@H](C)O)n1cnc2c(N)ncnc12,IOSAAWHGJUZBOG-MNOVXSKESA-N,ehna,ADA
192,EHNA,Adenosine deaminase inhibitor,PDE2A,CCCCCC[C@@H]([C@@H](C)O)n1cnc2c(N)ncnc12,IOSAAWHGJUZBOG-MNOVXSKESA-N,ehna,PDE2A
193,DPCPX,Adenosine receptor antagonist,ADORA1,CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCCC1,FFBDFADSZUINTG-UHFFFAOYSA-N,dpcpx,ADORA1
194,tipifarnib-P2,Farnesyltransferase inhibitor,FNTA,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1,PLHJCIYEEKOWNM-HHHXNRCGSA-N,TIPIFARNIB-P2,FNTA
195,tipifarnib-P2,Farnesyltransferase inhibitor,FNTB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1,PLHJCIYEEKOWNM-HHHXNRCGSA-N,TIPIFARNIB-P2,FNTB
196,DL-PDMP,Glucosyltransferase inhibitor,ASAH1,CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c2ccccc2,UYNCFCUHRNOSCN-FYYLOGMGSA-N,dl-pdmp,ASAH1
197,DL-PDMP,Glucosyltransferase inhibitor,UGCG,CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c2ccccc2,UYNCFCUHRNOSCN-FYYLOGMGSA-N,dl-pdmp,UGCG
198,3-matida,Glutamate receptor antagonist,GRM1,Cc1cc(sc1C(N)C(=O)O)C(=O)O,KOMWRBFEDDEWEP-UHFFFAOYSA-N,3-MATIDA,GRM1
199,CPCCOEt,Glutamate receptor antagonist,GRM1,CCOC(=O)C12CC2C(=NO)c3ccccc3O1,FXCTZFMSAHZQTR-UHFFFAOYSA-N,cpccoet,GRM1
200,CTEP,Glutamate receptor antagonist,GRM5,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1,GOHCTCOGYKAJLZ-UHFFFAOYSA-N,ctep,GRM5
201,MPEP,Glutamate receptor antagonist,GRM5,Cc1cccc(n1)C#Cc1ccccc1,NEWKHUASLBMWRE-UHFFFAOYSA-N,mpep,GRM5
202,salicylic-acid,Prostanoid receptor inhibitor,PTGS1,OC(=O)c1ccccc1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,sodium-salicylate,PTGS1
203,BCI-hydrochloride,Protein phosphatase inhibitor,DUSP1,O=C1c2ccccc2C(NC2CCCCC2)C1=Cc1ccccc1,XJDKPLZUXCIMIS-HKWRFOASSA-N,bci-hydrochloride,DUSP1
204,BCI-hydrochloride,Protein phosphatase inhibitor,DUSP6,O=C1c2ccccc2C(NC2CCCCC2)C1=Cc1ccccc1,XJDKPLZUXCIMIS-HKWRFOASSA-N,bci-hydrochloride,DUSP6
205,sunitinib,RET tyrosine kinase inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT1
206,sunitinib,RET tyrosine kinase inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT3
207,sunitinib,RET tyrosine kinase inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,FLT4
208,sunitinib,RET tyrosine kinase inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KDR
209,sunitinib,RET tyrosine kinase inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,KIT
210,sunitinib,RET tyrosine kinase inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRA
211,sunitinib,RET tyrosine kinase inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,PDGFRB
212,sunitinib,RET tyrosine kinase inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,sunitinib-malate,RET
213,quetiapine,Serotonin receptor antagonist,DRD1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,DRD1
214,quetiapine,Serotonin receptor antagonist,DRD2,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,DRD2
215,quetiapine,Serotonin receptor antagonist,HRH1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HRH1
216,quetiapine,Serotonin receptor antagonist,HTR1A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1A
217,quetiapine,Serotonin receptor antagonist,HTR1D,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1D
218,quetiapine,Serotonin receptor antagonist,HTR1E,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR1E
219,quetiapine,Serotonin receptor antagonist,HTR2A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,quetiapine-fumarate,HTR2A
220,MM77,Serotonin receptor antagonist,HTR1A,COc1ccccc1N1CCN(CCCCN2C(=O)CCC2=O)CC1,MQHOGPLXAXSQAJ-UHFFFAOYSA-N,MM-77,HTR1A
221,SDZ-21009,Serotonin receptor antagonist,HTR1A,CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1,SJYFDORQYYEJLB-UHFFFAOYSA-N,carpindolol,HTR1A
222,SDZ-21009,Serotonin receptor antagonist,HTR1B,CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1,SJYFDORQYYEJLB-UHFFFAOYSA-N,carpindolol,HTR1B
223,TFMPP,Serotonin receptor antagonist,HTR1D,FC(F)(F)c1cccc(c1)N2CCNCC2,KKIMDKMETPPURN-UHFFFAOYSA-N,tfmpp,HTR1D
224,TFMPP,Serotonin receptor antagonist,HTR2A,FC(F)(F)c1cccc(c1)N2CCNCC2,KKIMDKMETPPURN-UHFFFAOYSA-N,tfmpp,HTR2A
225,SDZ-21009,Adrenergic receptor antagonist,HTR1A,CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1,SJYFDORQYYEJLB-UHFFFAOYSA-N,carpindolol,HTR1A
226,SDZ-21009,Adrenergic receptor antagonist,HTR1B,CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1,SJYFDORQYYEJLB-UHFFFAOYSA-N,carpindolol,HTR1B
227,timolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1,BLJRIMJGRPQVNF-SNVBAGLBSA-N,timolol-maleate,ADRB1
228,timolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1,BLJRIMJGRPQVNF-SNVBAGLBSA-N,timolol-maleate,ADRB2
229,Z160,N-type calcium channel blocker,CACNA1B,O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Z-160,CACNA1B
230,salicylic-acid,Prostanoid receptor antagonist,PTGS1,OC(=O)c1ccccc1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,sodium-salicylate,PTGS1
231,PIT,Purinergic receptor antagonist,P2RY1,[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1,LXEZPPZLNVOLDI-UHFFFAOYSA-N,pit,P2RY1
232,sonidegib,Smoothened receptor antagonist,SMO,C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1,VZZJRYRQSPEMTK-CALCHBBNSA-N,erismodegib,SMO
233,2-iminobiotin,Nitric oxide synthase inhibitor,NOS1,OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12,WWVANQJRLPIHNS-ZKWXMUAHSA-N,2-IMINOBIOTIN,NOS1
234,2-iminobiotin,Nitric oxide synthase inhibitor,NOS2,OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12,WWVANQJRLPIHNS-ZKWXMUAHSA-N,2-IMINOBIOTIN,NOS2
235,3-deazaadenosine,Adenosylhomocysteinase inhibitor,AHCY,Nc1nccc2n(cnc12)[C@@H]1O[C@H](CO)C(O)C1O,DBZQFUNLCALWDY-JXACCQRMSA-N,3-DEAZAADENOSINE,AHCY
236,alda-1,Aldehyde dehydrogenase activator,ALDH2,Clc1cccc(Cl)c1C(=O)NCc2ccc3OCOc3c2,NMKJFZCBCIUYHI-UHFFFAOYSA-N,ALDA-1,ALDH2
237,methscopolamine,Acetylcholine receptor antagonist,CHRM1,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,LZCOQTDXKCNBEE-IKIFYQGPSA-N,methylscopolamine,CHRM1
238,methscopolamine,Acetylcholine receptor antagonist,CHRM2,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,LZCOQTDXKCNBEE-IKIFYQGPSA-N,methylscopolamine,CHRM2
239,methscopolamine,Acetylcholine receptor antagonist,CHRM3,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,LZCOQTDXKCNBEE-IKIFYQGPSA-N,methylscopolamine,CHRM3
240,ipratropium,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-BHIXFJMTSA-N,ipratropium-br,CHRM1
241,ipratropium,Acetylcholine receptor antagonist,CHRM2,CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-BHIXFJMTSA-N,ipratropium-br,CHRM2
242,ipratropium,Acetylcholine receptor antagonist,CHRM3,CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-BHIXFJMTSA-N,ipratropium-br,CHRM3
243,ipratropium,Acetylcholine receptor antagonist,CHRM4,CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-BHIXFJMTSA-N,ipratropium-br,CHRM4
244,rocuronium,Acetylcholine receptor antagonist,CHRNA2,CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,YXRDKMPIGHSVRX-OOJCLDBCSA-N,rocuronium-bromide,CHRNA2
245,ITE,Aryl hydrocarbon receptor agonist,AHR,COC(=O)c1csc(n1)C(=O)c2c[nH]c3ccccc23,KDDXOGDIPZSCTM-UHFFFAOYSA-N,ite,AHR
246,methotrexate,Dihydrofolate reductase inhibitor,DHFR,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-UHFFFAOYSA-N,methrotrexate,DHFR
247,palomid-529,Fibroblast growth factor inhibitor,MTOR,COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,YEAHTLOYHVWAKW-UHFFFAOYSA-N,PALOMID-529,MTOR
248,stemregenin-1,Aryl hydrocarbon receptor antagonist,AHR,CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)-c1csc2ccccc12,BGFHMYJZJZLMHW-UHFFFAOYSA-N,STEMREGENIN-1,AHR
249,JIB04,Histone lysine demethylase inhibitor,KDM4E,Clc1ccc(NN=C(/c2ccccc2)c2ccccn2)nc1,YHHFKWKMXWRVTJ-OQKWZONESA-N,JIB-04,KDM4E
250,K-858,Kinesin-like spindle protein inhibitor,KIF11,CC(=O)NC1=NN(C(C)=O)C(C)(S1)c1ccccc1,JEFVYQYZCAVNTP-UHFFFAOYSA-N,K-3644,KIF11
251,fumonisin-b1,Sphingosine N acyltransferase inhibitor,CERS1,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(O)=O)C(O)=O)[C@H](CC(C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(O)=O)C(O)=O,UVBUBMSSQKOIBE-YPCSWJJOSA-N,FUMONISIN-B1,CERS1
252,KIN001-244,Phosphoinositide dependent kinase inhibitor,PDPK1,Fc1ccc(Cn2cccc(C(=O)N[C@@H](COc3ccc4[nH]c(=O)[nH]c4c3)c3ccccc3)c2=O)cc1F,AHMXYULEXZAPCS-VWLOTQADSA-N,KIN-001-244,PDPK1
253,clocortolone-pivalate,Steroid,NR3C1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,SXYZQZLHAIHKKY-GSTUPEFVSA-N,,NR3C1
254,chlorothiazide,Diuretic,SLC12A3,NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O,JBMKAUGHUNFTOL-UHFFFAOYSA-N,,SLC12A3
255,chlorothiazide,Diuretic,CA2,NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O,JBMKAUGHUNFTOL-UHFFFAOYSA-N,,CA2
256,furosemide,Diuretic,SLC12A1,NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,,SLC12A1
257,furosemide,Diuretic,SLC12A2,NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,,SLC12A2
258,ribavirin,Antiviral,IMPDH1,NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IWUCXVSUMQZMFG-AFCXAGJDSA-N,,IMPDH1
259,ribavirin,Antiviral,IMPDH1,NC(=O)c1ncn(n1)[C@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IWUCXVSUMQZMFG-DJSMDIAISA-N,,IMPDH1
260,ribavirin,Antiviral,IMPDH1,NC(=O)c1ncn(n1)C1OC(CO)C(O)C1O,IWUCXVSUMQZMFG-UHFFFAOYSA-N,,IMPDH1
261,vidarabine,Antiviral,ADA,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,OIRDTQYFTABQOQ-UHTZMRCNSA-N,,ADA
262,taurocholic-acid,Bile acid,CEL,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,WBWWGRHZICKQGZ-IECFWMJSSA-N,,CEL
263,cholic-acid,Bile acid,CES1,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,,CES1
264,cholic-acid,Bile acid,FECH,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,,FECH
265,cholic-acid,Bile acid,PLA2G1B,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,,PLA2G1B
266,cyanocobalamin,Vitamin B,MMUT,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12,FMCRMSOQAVOHRD-SBGISONWSA-M,,MMUT
267,cyanocobalamin,Vitamin B,MMUT,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@@H]2N=C1C(C)=C1N=C(C=C3N=C(C(C)=C4[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12,RMRCNWBMXRMIRW-WDJKBINPSA-M,,MMUT
268,niacin,Vitamin B,HCAR2,OC(=O)c1cccnc1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,,HCAR2
269,niacin,Vitamin B,HCAR3,OC(=O)c1cccnc1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,,HCAR3
270,niacin,Vitamin B,HCAR2,OC(=O)c1cccnc1SCCc2ccccc2,UZERZZRWECLIKE-UHFFFAOYSA-N,,HCAR2
271,niacin,Vitamin B,HCAR3,OC(=O)c1cccnc1SCCc2ccccc2,UZERZZRWECLIKE-UHFFFAOYSA-N,,HCAR3
272,thiamine,Vitamin B,SLC19A2,Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N,JZRWCGZRTZMZEH-UHFFFAOYSA-N,,SLC19A2
273,metitepine,Anti-HCVE2,HTR5A,CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1,RLJFTICUTYVZDG-UHFFFAOYSA-N,,HTR5A
274,metitepine,Anti-HCVE2,HTR6,CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1,RLJFTICUTYVZDG-UHFFFAOYSA-N,,HTR6
275,metitepine,Anti-HCVE2,HTR7,CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1,RLJFTICUTYVZDG-UHFFFAOYSA-N,,HTR7
276,ascorbic-acid,Antioxidant,SLC23A1,CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@@H]1OC(=O)C(=O)C1O,CYJPUZLKFAUFHF-YIXKLDTESA-N,,SLC23A1
277,ascorbic-acid,Antioxidant,SLC23A1,OCC(O)C1OC(=O)C(=O)C1O,KRGQEOSDQHTZMX-UHFFFAOYSA-N,,SLC23A1
278,benfotiamine,Antioxidant,AGER,CC(N(Cc1cnc(C)nc1N)C=O)=C(CCOP(O)(O)=O)SC(=O)c1ccccc1,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,,AGER
279,rutin,Antioxidant,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-NVPNHPEKSA-N,,AKR1C3
280,rutin,Antioxidant,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-KUKMIBIMSA-N,,AKR1C3
281,rutin,Antioxidant,AKR1C3,CC1OC(OCC2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O,IKGXIBQEEMLURG-UHFFFAOYSA-N,,AKR1C3
282,farnesol,FXR agonist,MAOB,CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C,CRDAMVZIKSXKFV-YFVJMOTDSA-N,,MAOB
283,fexaramine,FXR agonist,NR1H4,COC(=O)C=Cc1cccc(c1)N(Cc2ccc(cc2)c3ccc(cc3)N(C)C)C(=O)C4CCCCC4,VLQTUNDJHLEFEQ-UHFFFAOYSA-N,,NR1H4
284,GW-4064,FXR agonist,NR1H4,CC(C)c1onc(c1COc1ccc(C=Cc2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl,BYTNEISLBIENSA-MDZDMXLPSA-N,,NR1H4
285,GW-4064,FXR agonist,NR1H4,CC(C)c1onc(c1COc2ccc(C=Cc3cccc(c3)C(=O)O)c(Cl)c2)c4c(Cl)cccc4Cl,BYTNEISLBIENSA-UHFFFAOYSA-N,,NR1H4
286,SR-12813,FXR agonist,NR1I2,CCOP(=O)(OCC)C(=Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)P(=O)(OCC)OCC,YQLJDECYQDRSBI-UHFFFAOYSA-N,,NR1I2
287,WAY-362450,FXR agonist,NR1H4,CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c1ccccc21)C(=O)c1ccc(F)c(F)c1,INASOKQDNHHMRE-UHFFFAOYSA-N,,NR1H4
288,KU-C103871,GSP agonist,SMAD3,Fc1ccc2sn(-c3ccccc3Cl)c(=O)c2c1,LULUFYSNKNUYNX-UHFFFAOYSA-N,,SMAD3
289,epoxycholesterol,LXR agonist,NR1H3,C[C@H](CC[C@@H]1OC1(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,OSENKJZWYQXHBN-XVYZBDJZSA-N,,NR1H3
290,epoxycholesterol,LXR agonist,NR1H2,C[C@H](CC[C@@H]1OC1(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,OSENKJZWYQXHBN-XVYZBDJZSA-N,,NR1H2
291,GW-3965,LXR agonist,NR1H3,OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,,NR1H3
292,GW-3965,LXR agonist,NR1H2,OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,,NR1H2
293,T-0901317,LXR agonist,NR1H3,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H3
294,T-0901317,LXR agonist,NR1H2,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H2
295,AC-264613,PAR agonist,F2RL1,CC(=N/NC(=O)[C@H]1[C@@H](CNC1=O)c1ccccc1)c1cccc(Br)c1,RQKXQCSEZPQBNZ-QSBCOWLBSA-N,,F2RL1
296,imiquimod,TLR agonist,TLR7,CC(C)Cn1cnc2c(N)nc3ccccc3c12,DOUYETYNHWVLEO-UHFFFAOYSA-N,,TLR7
297,imiquimod,TLR agonist,TLR8,CC(C)Cn1cnc2c(N)nc3ccccc3c12,DOUYETYNHWVLEO-UHFFFAOYSA-N,,TLR8
298,RWJ-21757,TLR agonist,TLR7,Nc1nc2n(C3OC(CO)C(O)C3O)c(=O)n(CC=C)c2c(=O)[nH]1,VDCRFBBZFHHYGT-UHFFFAOYSA-N,,TLR7
299,minoxidil,Vasodilator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
300,minoxidil,Vasodilator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
301,minoxidil,Vasodilator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
302,minoxidil,Vasodilator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
303,minoxidil,Vasodilator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
304,minoxidil,Vasodilator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
305,T-5224,AP inhibitor,JUN,OC(=O)CCc1cc(ccc1OCc1ccc2c(O)noc2c1)C(=O)c1ccc(OC2CCCC2)cc1O,DALCQQSLNPLQFZ-UHFFFAOYSA-N,,JUN
306,VU-0365114-2,M5 modulator,CHRM5,FC(F)(F)Oc1ccc2N(Cc3ccc(cc3)-c3ccccc3)C(=O)C(=O)c2c1,SPBGRXOPAXZSER-UHFFFAOYSA-N,,CHRM5
307,glibenclamide,Sulfonylurea,CFTR,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,CFTR
308,glibenclamide,Sulfonylurea,KCNJ5,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ5
309,glibenclamide,Sulfonylurea,KCNJ8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ8
310,glibenclamide,Sulfonylurea,KCNJ11,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ11
311,glibenclamide,Sulfonylurea,ABCC8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,ABCC8
312,glipizide,Sulfonylurea,KCNJ11,Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,,KCNJ11
313,glipizide,Sulfonylurea,ABCC8,Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,,ABCC8
314,gliquidone,Sulfonylurea,ABCC8,COc1ccc2c(c1)C(=O)N(CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C,LLJFMFZYVVLQKT-UHFFFAOYSA-N,,ABCC8
315,arvanil,TRPV agonist,CNR1,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCc1ccc(O)c(OC)c1,QVLMCRFQGHWOPM-ZKWNWVNESA-N,,CNR1
316,arvanil,TRPV agonist,TRPV1,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCc1ccc(O)c(OC)c1,QVLMCRFQGHWOPM-ZKWNWVNESA-N,,TRPV1
317,capsaicin,TRPV agonist,TRPV1,COc1cc(CNC(=O)CCCC/C=CC(C)C)ccc1O,YKPUWZUDDOIDPM-VURMDHGXSA-N,,TRPV1
318,capsaicin,TRPV agonist,TRPV1,COc1cc(CNC(=O)CCCCC=CC(C)C)ccc1O,YKPUWZUDDOIDPM-SOFGYWHQSA-N,,TRPV1
319,capsazepine,TRPV agonist,TRPV1,Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1,DRCMAZOSEIMCHM-UHFFFAOYSA-N,,TRPV1
320,disulfiram,TRPV agonist,ALDH2,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,,ALDH2
321,evodiamine,TRPV agonist,TRPV1,CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12,TXDUTHBFYKGSAH-UHFFFAOYSA-N,,TRPV1
322,icilin,TRPV agonist,TRPM8,Oc1ccccc1N1CC=C(NC1=O)c1cccc(c1)[N+]([O-])=O,RCEFMOGVOYEGJN-UHFFFAOYSA-N,,TRPM8
323,icilin,TRPV agonist,TRPA1,Oc1ccccc1N1CC=C(NC1=O)c1cccc(c1)[N+]([O-])=O,RCEFMOGVOYEGJN-UHFFFAOYSA-N,,TRPA1
324,olvanil,TRPV agonist,CNR1,CCCCCCCCC=CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1,OPZKBPQVWDSATI-UHFFFAOYSA-N,,CNR1
325,olvanil,TRPV agonist,TRPV1,CCCCCCCCC=CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1,OPZKBPQVWDSATI-UHFFFAOYSA-N,,TRPV1
326,lomeguatrib,AGT inhibitor,MGMT,Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1,JUJPKFNFCWJBCX-UHFFFAOYSA-N,,MGMT
327,alectinib,ALK inhibitor,ALK,CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1,KDGFLJKFZUIJMX-UHFFFAOYSA-N,,ALK
328,CEP-37440,ALK inhibitor,ALK,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl,BCSHRERPHLTPEE-NRFANRHFSA-N,,ALK
329,ceritinib,ALK inhibitor,ALK,CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,VERWOWGGCGHDQE-UHFFFAOYSA-N,,ALK
330,crizotinib,ALK inhibitor,ALK,C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,,ALK
331,crizotinib,ALK inhibitor,MET,C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,,MET
332,NVP-TAE684,ALK inhibitor,ALK,COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1,QQWUGDVOUVUTOY-UHFFFAOYSA-N,,ALK
333,SB-505124,ALK inhibitor,TGFBR1,Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2OCOc2c1)C(C)(C)C,WGZOTBUYUFBEPZ-UHFFFAOYSA-N,,TGFBR1
334,pyrvinium-pamoate,Akt inhibitor,AR,CN(C)c1ccc2[n+](C)c(CCc3cc(C)n(c3C)-c3ccccc3)ccc2c1,JSZNAPGSRFTCQR-UHFFFAOYSA-N,,AR
335,pyrvinium-pamoate,Akt inhibitor,AR,CN(C)c1ccc2[n+](C)c(CCc3cc(C)n(c3C)-c3ccccc3)ccc2c1,JSZNAPGSRFTCQR-UHFFFAOYSA-N,,AR
336,10-DEBC,Akt inhibitor,PIM1,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc12,GYBXAGDWMCJZJK-UHFFFAOYSA-N,,PIM1
337,BML-257,Akt inhibitor,AKT1,OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4,LFWGZXMTCUOPFI-UHFFFAOYSA-N,,AKT1
338,GDC-0068,Akt inhibitor,AKT3,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1,GRZXWCHAXNAUHY-AHRSYUTCSA-N,,AKT3
339,GDC-0068,Akt inhibitor,AKT1,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1,GRZXWCHAXNAUHY-AHRSYUTCSA-N,,AKT1
340,GDC-0068,Akt inhibitor,AKT2,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1,GRZXWCHAXNAUHY-AHRSYUTCSA-N,,AKT2
341,GSK-690693,Akt inhibitor,AKT3,CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,,AKT3
342,GSK-690693,Akt inhibitor,AKT1,CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,,AKT1
343,GSK-690693,Akt inhibitor,AKT2,CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,,AKT2
344,GSK-690693,Akt inhibitor,PRKCQ,CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,,PRKCQ
345,GSK-690693,Akt inhibitor,AKT3,CCn1c(nc2c(ncc(OCC3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-UHFFFAOYSA-N,,AKT3
346,GSK-690693,Akt inhibitor,AKT1,CCn1c(nc2c(ncc(OCC3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-UHFFFAOYSA-N,,AKT1
347,GSK-690693,Akt inhibitor,AKT2,CCn1c(nc2c(ncc(OCC3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-UHFFFAOYSA-N,,AKT2
348,GSK-690693,Akt inhibitor,PRKCQ,CCn1c(nc2c(ncc(OCC3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,KGPGFQWBCSZGEL-UHFFFAOYSA-N,,PRKCQ
349,MK-2206,Akt inhibitor,AKT1,NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1,ULDXWLCXEDXJGE-UHFFFAOYSA-N,,AKT1
350,triciribine,Akt inhibitor,AKT3,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-HTVVRFAVSA-N,,AKT3
351,triciribine,Akt inhibitor,AKT1,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-HTVVRFAVSA-N,,AKT1
352,triciribine,Akt inhibitor,AKT2,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-HTVVRFAVSA-N,,AKT2
353,triciribine,Akt inhibitor,AKT3,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)C(O)[C@@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-XVCUJNKASA-N,,AKT3
354,triciribine,Akt inhibitor,AKT1,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)C(O)[C@@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-XVCUJNKASA-N,,AKT1
355,triciribine,Akt inhibitor,AKT2,Cn1nc(N)c2cn([C@@H]3O[C@H](CO)C(O)[C@@H]3O)c3ncnc1c23,HOGVTUZUJGHKPL-XVCUJNKASA-N,,AKT2
356,triciribine,Akt inhibitor,AKT3,Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c4ncnc1c24,HOGVTUZUJGHKPL-UHFFFAOYSA-N,,AKT3
357,triciribine,Akt inhibitor,AKT1,Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c4ncnc1c24,HOGVTUZUJGHKPL-UHFFFAOYSA-N,,AKT1
358,triciribine,Akt inhibitor,AKT2,Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c4ncnc1c24,HOGVTUZUJGHKPL-UHFFFAOYSA-N,,AKT2
359,antazoline,Antihistamine,HRH1,C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1,REYFJDPCWQRWAA-UHFFFAOYSA-N,,HRH1
360,homochlorcyclizine,Antihistamine,HRH1,CN1CCCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,WEUCDJCFJHYFRL-UHFFFAOYSA-N,,HRH1
361,hydroxyzine,Antihistamine,HRH1,OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,,HRH1
362,ABT-737,BCL inhibitor,BCL2,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,HPLNQCPCUACXLM-PGUFJCEWSA-N,,BCL2
363,ABT-737,BCL inhibitor,BCL2L1,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,HPLNQCPCUACXLM-PGUFJCEWSA-N,,BCL2L1
364,ABT-737,BCL inhibitor,BCL2L2,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,HPLNQCPCUACXLM-PGUFJCEWSA-N,,BCL2L2
365,BH3I-1,BCL inhibitor,BCL2L1,CC(C)C(N1C(=O)/C(=C/c2ccc(Br)cc2)/SC1=S)C(=O)O,COHIEJLWRGREHV-XFFZJAGNSA-N,,BCL2L1
366,BH3I-1,BCL inhibitor,BCL2L1,CC(C)C(N1C(=O)/C(=C/c2ccccc2)/SC1=S)C(=O)O,JZLLRVWRJBPACN-FLIBITNWSA-N,,BCL2L1
367,BRD-K01265221,BCL inhibitor,BCL2,CN(C)C1=C(Cl)C(=O)N(C1=O)c2ccc(Cl)c(Cl)c2,UJVSRUOVYSHYAG-UHFFFAOYSA-N,,BCL2
368,gossypol,BCL inhibitor,MCL1,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,MCL1
369,gossypol,BCL inhibitor,BCL2,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,BCL2
370,gossypol,BCL inhibitor,BCL2L1,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,BCL2L1
371,HA-14-1,BCL inhibitor,BCL2,CCOC(=O)[C@@H](C#N)[C@@H]1c2cc(Br)ccc2OC(N)=C1C(=O)OCC,SXJDCULZDFWMJC-AAEUAGOBSA-N,,BCL2
372,HA-14-1,BCL inhibitor,BCL2,CCOC(=O)C(C#N)C1c2cc(Br)ccc2OC(N)=C1C(=O)OCC,SXJDCULZDFWMJC-UHFFFAOYSA-N,,BCL2
373,navitoclax,BCL inhibitor,BCL2,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,JLYAXFNOILIKPP-KXQOOQHDSA-N,,BCL2
374,navitoclax,BCL inhibitor,BCL2L1,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,JLYAXFNOILIKPP-KXQOOQHDSA-N,,BCL2L1
375,navitoclax,BCL inhibitor,BCL2L2,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,JLYAXFNOILIKPP-KXQOOQHDSA-N,,BCL2L2
376,obatoclax,BCL inhibitor,BCL2,COC1=CC(=NC1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1,RFTSSZJZXOSICM-GRSHGNNSSA-N,,BCL2
377,TW-37,BCL inhibitor,MCL1,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,PQAPVTKIEGUPRN-UHFFFAOYSA-N,,MCL1
378,TW-37,BCL inhibitor,BCL2,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,PQAPVTKIEGUPRN-UHFFFAOYSA-N,,BCL2
379,TW-37,BCL inhibitor,BCL2L1,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,PQAPVTKIEGUPRN-UHFFFAOYSA-N,,BCL2L1
380,AVL-292,BTK inhibitor,BTK,COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1,KXBDTLQSDKGAEB-UHFFFAOYSA-N,,BTK
381,CNX-774,BTK inhibitor,BTK,CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1,VVLHQJDAUIPZFH-UHFFFAOYSA-N,,BTK
382,GDC-0834,BTK inhibitor,BTK,CN1CCN(C)C(=O)C1c1ccc(Nc2nc(cn(C)c2=O)-c2cccc(NC(=O)c3cc4CCCCc4s3)c2C)cc1,CDOOFZZILLRUQH-UHFFFAOYSA-N,,BTK
383,ibrutinib,BTK inhibitor,BTK,Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCN(C1)C(=O)C=C,XYFPWWZEPKGCCK-UHFFFAOYSA-N,,BTK
384,LFM-A13,BTK inhibitor,BTK,CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br,BQLDGDMKDYAGNE-UHFFFAOYSA-N,,BTK
385,KU-C103428N,CDC inhibitor,NFE2,NS(=O)(=O)c1ccc(cc1)N1N=C(CC1c1cccc(Br)c1)c1ccccc1,YTYYWJOOCWVVKJ-UHFFFAOYSA-N,,NFE2
386,NSC-663284,CDC inhibitor,CDC25A,ClC1=C(NCCN2CCOCC2)C(=O)c2ncccc2C1=O,BMKPVDQDJQWBPD-UHFFFAOYSA-N,,CDC25A
387,NSC-663284,CDC inhibitor,CDC25B,ClC1=C(NCCN2CCOCC2)C(=O)c2ncccc2C1=O,BMKPVDQDJQWBPD-UHFFFAOYSA-N,,CDC25B
388,NSC-693868,CDK inhibitor,CDK5,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK5
389,NSC-693868,CDK inhibitor,GSK3A,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,GSK3A
390,NSC-693868,CDK inhibitor,CDK1,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK1
391,aloisine,CDK inhibitor,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(O)cc3,PRIGRJPRGZCFAS-UHFFFAOYSA-N,,CDK2
392,aloisine,CDK inhibitor,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(OC)cc3,WVMANZPBOBRWCB-UHFFFAOYSA-N,,CDK2
393,alvocidib,CDK inhibitor,CDK2,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK2
394,alvocidib,CDK inhibitor,CDK4,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK4
395,alvocidib,CDK inhibitor,CDK5,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK5
396,alvocidib,CDK inhibitor,CDK6,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK6
397,alvocidib,CDK inhibitor,CDK7,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK7
398,alvocidib,CDK inhibitor,CDK8,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK8
399,alvocidib,CDK inhibitor,CDK9,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK9
400,alvocidib,CDK inhibitor,EGFR,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,EGFR
401,alvocidib,CDK inhibitor,PYGM,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,PYGM
402,alvocidib,CDK inhibitor,CDK1,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,,CDK1
403,aminopurvalanol-a,CDK inhibitor,CDK2,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK2
404,aminopurvalanol-a,CDK inhibitor,CDK5,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK5
405,aminopurvalanol-a,CDK inhibitor,CDK1,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK1
406,arcyriaflavin-a,CDK inhibitor,CDK4,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21,KAJXOWFGKYKMMZ-UHFFFAOYSA-N,,CDK4
407,arcyriaflavin-a,CDK inhibitor,CCND1,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21,KAJXOWFGKYKMMZ-UHFFFAOYSA-N,,CCND1
408,AT-7519,CDK inhibitor,CDK2,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK2
409,AT-7519,CDK inhibitor,CDK4,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK4
410,AT-7519,CDK inhibitor,CDK5,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK5
411,AT-7519,CDK inhibitor,CDK6,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK6
412,AT-7519,CDK inhibitor,CDK9,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK9
413,AT-7519,CDK inhibitor,CDK1,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK1
414,BML-259,CDK inhibitor,CDK2,CC(C)c1cnc(NC(=O)Cc2ccccc2)s1,IGRZXNLKVUEFDM-UHFFFAOYSA-N,,CDK2
415,BML-259,CDK inhibitor,CDK5,CC(C)c1cnc(NC(=O)Cc2ccccc2)s1,IGRZXNLKVUEFDM-UHFFFAOYSA-N,,CDK5
416,BMS-265246,CDK inhibitor,CDK2,CCCCOc1c(cnc2[nH]ncc12)C(=O)c1c(F)cc(C)cc1F,SCFMWQIQBVZOQR-UHFFFAOYSA-N,,CDK2
417,BMS-265246,CDK inhibitor,CDK1,CCCCOc1c(cnc2[nH]ncc12)C(=O)c1c(F)cc(C)cc1F,SCFMWQIQBVZOQR-UHFFFAOYSA-N,,CDK1
418,BMS-387032,CDK inhibitor,CDK2,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK2
419,BMS-387032,CDK inhibitor,CDK7,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK7
420,BMS-387032,CDK inhibitor,CDK9,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK9
421,BRD-K71726959,CDK inhibitor,CDK5,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc12,WHDJEAZLMYPLGL-UHFFFAOYSA-N,,CDK5
422,BRD-K71726959,CDK inhibitor,CDK1,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc12,WHDJEAZLMYPLGL-UHFFFAOYSA-N,,CDK1
423,BS-181,CDK inhibitor,CDK7,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,DNYBIOICMDTDAP-UHFFFAOYSA-N,,CDK7
424,CGP-60474,CDK inhibitor,CDK1,OCCCNc1cc(ccn1)c2ccnc(Nc3cccc(Cl)c3)n2,IYNDTACKOAXKBJ-UHFFFAOYSA-N,,CDK1
425,dinaciclib,CDK inhibitor,CDK2,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,,CDK2
426,dinaciclib,CDK inhibitor,CDK5,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,,CDK5
427,dinaciclib,CDK inhibitor,CDK9,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,,CDK9
428,dinaciclib,CDK inhibitor,CDK1,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,,CDK1
429,indirubin,CDK inhibitor,CDK5,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,CDK5
430,indirubin,CDK inhibitor,GSK3A,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,GSK3A
431,indirubin,CDK inhibitor,CDK1,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,CDK1
432,indirubin,CDK inhibitor,CDK5,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,CDK5
433,indirubin,CDK inhibitor,GSK3A,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,GSK3A
434,indirubin,CDK inhibitor,CDK1,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,CDK1
435,JNJ-7706621,CDK inhibitor,CDK2,Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F,KDKUVYLMPJIGKA-UHFFFAOYSA-N,,CDK2
436,JNJ-7706621,CDK inhibitor,AURKA,Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F,KDKUVYLMPJIGKA-UHFFFAOYSA-N,,AURKA
437,JNJ-7706621,CDK inhibitor,AURKB,Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F,KDKUVYLMPJIGKA-UHFFFAOYSA-N,,AURKB
438,JNJ-7706621,CDK inhibitor,CDK1,Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F,KDKUVYLMPJIGKA-UHFFFAOYSA-N,,CDK1
439,kenpaullone,CDK inhibitor,CDK5,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,CDK5
440,kenpaullone,CDK inhibitor,GSK3B,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,GSK3B
441,kenpaullone,CDK inhibitor,CDK1,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,CDK1
442,NSC-693868,CDK inhibitor,CDK5,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK5
443,NSC-693868,CDK inhibitor,GSK3A,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,GSK3A
444,NSC-693868,CDK inhibitor,CDK1,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK1
445,olomoucine,CDK inhibitor,CDK2,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12,GTVPOLSIJWJJNY-UHFFFAOYSA-N,,CDK2
446,olomoucine,CDK inhibitor,CDK5,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12,GTVPOLSIJWJJNY-UHFFFAOYSA-N,,CDK5
447,olomoucine,CDK inhibitor,CDK1,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12,GTVPOLSIJWJJNY-UHFFFAOYSA-N,,CDK1
448,palbociclib,CDK inhibitor,CDK4,CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O,AHJRHEGDXFFMBM-UHFFFAOYSA-N,,CDK4
449,palbociclib,CDK inhibitor,CDK6,CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O,AHJRHEGDXFFMBM-UHFFFAOYSA-N,,CDK6
450,PHA-793887,CDK inhibitor,CDK2,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK2
451,PHA-793887,CDK inhibitor,CDK4,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK4
452,PHA-793887,CDK inhibitor,CDK5,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK5
453,PHA-793887,CDK inhibitor,CDK7,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK7
454,PHA-793887,CDK inhibitor,CDK9,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK9
455,PHA-793887,CDK inhibitor,CDK1,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,,CDK1
456,PHA-848125,CDK inhibitor,CDK2,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK2
457,PHA-848125,CDK inhibitor,CDK4,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK4
458,PHA-848125,CDK inhibitor,NTRK1,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,NTRK1
459,PHA-848125,CDK inhibitor,CDK1,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK1
460,purvalanol-a,CDK inhibitor,CDK2,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK2
461,purvalanol-a,CDK inhibitor,CDK4,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK4
462,purvalanol-a,CDK inhibitor,CDK5,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK5
463,purvalanol-a,CDK inhibitor,CDK1,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK1
464,roscovitine,CDK inhibitor,CDK2,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,,CDK2
465,roscovitine,CDK inhibitor,CDK7,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,,CDK7
466,roscovitine,CDK inhibitor,CDK9,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,,CDK9
467,TG-02,CDK inhibitor,CDK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK2
468,TG-02,CDK inhibitor,CDK7,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK7
469,TG-02,CDK inhibitor,CDK9,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK9
470,TG-02,CDK inhibitor,FLT3,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,FLT3
471,TG-02,CDK inhibitor,JAK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,JAK2
472,TG-02,CDK inhibitor,CDK1,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK1
473,AZD-7762,CHK inhibitor,CHEK1,C1C[C@H](CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,IAYGCINLNONXHY-GFCCVEGCSA-N,,CHEK1
474,AZD-7762,CHK inhibitor,CHEK2,C1C[C@H](CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,IAYGCINLNONXHY-GFCCVEGCSA-N,,CHEK2
475,AZD-7762,CHK inhibitor,CHEK1,NC(=O)Nc1cc(sc1C(=O)N[C@@H]1CCCNC1)-c1cccc(F)c1,IAYGCINLNONXHY-GFCCVEGCSA-N,,CHEK1
476,AZD-7762,CHK inhibitor,CHEK2,NC(=O)Nc1cc(sc1C(=O)N[C@@H]1CCCNC1)-c1cccc(F)c1,IAYGCINLNONXHY-GFCCVEGCSA-N,,CHEK2
477,AZD-7762,CHK inhibitor,CHEK1,NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1,IAYGCINLNONXHY-LBPRGKRZSA-N,,CHEK1
478,AZD-7762,CHK inhibitor,CHEK2,NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1,IAYGCINLNONXHY-LBPRGKRZSA-N,,CHEK2
479,CHIR-124,CHK inhibitor,CHEK1,Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1,MOVBBVMDHIRCTG-LJQANCHMSA-N,,CHEK1
480,PF-477736,CHK inhibitor,CHEK1,Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O,NDEXUOWTGYUVGA-LJQANCHMSA-N,,CHEK1
481,SB-218078,CHK inhibitor,CHEK1,O=C1NC(=O)c2c1c1c3ccccc3n3C4CCC(O4)n4c5ccccc5c2c4c13,OTPNDVKVEAIXTI-UHFFFAOYSA-N,,CHEK1
482,SCH-900776,CHK inhibitor,CHEK1,Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1,GMIZZEXBPRLVIV-SECBINFHSA-N,,CHEK1
483,BRD-A81377415,CLK inhibitor,CLK1,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,CLK1
484,BRD-A81377415,CLK inhibitor,DYRK1A,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,DYRK1A
485,BRD-A81377415,CLK inhibitor,CLK4,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,CLK4
486,BRD-A81377415,CLK inhibitor,DYRK1B,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,DYRK1B
487,BRD-K68783079,CLK inhibitor,CLK1,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,CLK1
488,BRD-K68783079,CLK inhibitor,DYRK1A,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,DYRK1A
489,BRD-K68783079,CLK inhibitor,CLK4,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,CLK4
490,ML-167,CLK inhibitor,CLK1,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,CLK1
491,ML-167,CLK inhibitor,DYRK1A,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,DYRK1A
492,ML-167,CLK inhibitor,CLK4,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,CLK4
493,ML-167,CLK inhibitor,DYRK1B,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,DYRK1B
494,TG-003,CLK inhibitor,CLK1,CCN1C(Sc2ccc(OC)cc12)=CC(C)=O,BGVLELSCIHASRV-QPEQYQDCSA-N,,CLK1
495,TG-003,CLK inhibitor,DYRK1A,CCN1C(Sc2ccc(OC)cc12)=CC(C)=O,BGVLELSCIHASRV-QPEQYQDCSA-N,,DYRK1A
496,TG-003,CLK inhibitor,CLK4,CCN1C(Sc2ccc(OC)cc12)=CC(C)=O,BGVLELSCIHASRV-QPEQYQDCSA-N,,CLK4
497,TG-003,CLK inhibitor,DYRK1B,CCN1C(Sc2ccc(OC)cc12)=CC(C)=O,BGVLELSCIHASRV-QPEQYQDCSA-N,,DYRK1B
498,WZ-3105,CLK inhibitor,CLK2,CC(C)n1cnc2c(Nc3cccc(NC(=O)C=C)c3)nc(N[C@H]3CC[C@@H](CC3)N(C)C)nc12,DGEBYERMQBTMHV-IRJFHVNHSA-N,,CLK2
499,WZ-3105,CLK inhibitor,CSNK1E,CC(C)n1cnc2c(Nc3cccc(NC(=O)C=C)c3)nc(N[C@H]3CC[C@@H](CC3)N(C)C)nc12,DGEBYERMQBTMHV-IRJFHVNHSA-N,,CSNK1E
500,WZ-3105,CLK inhibitor,FLT3,CC(C)n1cnc2c(Nc3cccc(NC(=O)C=C)c3)nc(N[C@H]3CC[C@@H](CC3)N(C)C)nc12,DGEBYERMQBTMHV-IRJFHVNHSA-N,,FLT3
501,WZ-3105,CLK inhibitor,ULK1,CC(C)n1cnc2c(Nc3cccc(NC(=O)C=C)c3)nc(N[C@H]3CC[C@@H](CC3)N(C)C)nc12,DGEBYERMQBTMHV-IRJFHVNHSA-N,,ULK1
502,megestrol-acetate,DNA inhibitor,PGR,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,,PGR
503,carmustine,DNA inhibitor,GSR,[O-][N+]N(CCCl)C(=O)NCCCl,DLGOEMSEDOSKAD-UHFFFAOYSA-N,,GSR
504,estramustine-phosphate,DNA inhibitor,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR1
505,estramustine-phosphate,DNA inhibitor,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR2
506,estramustine-phosphate,DNA inhibitor,MAP1A,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP1A
507,estramustine-phosphate,DNA inhibitor,MAP2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP2
508,megestrol-acetate,DNA inhibitor,PGR,CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,RQZAXGRLVPAYTJ-VSUSFZLSSA-N,,PGR
509,metronidazole,DNA inhibitor,CYP2C9,Cc1ncc(n1CCO)[N+]([O-])=O,VAOCPAMSLUNLGC-UHFFFAOYSA-N,,CYP2C9
510,metronidazole,DNA inhibitor,CYP3A4,Cc1ncc(n1CCO)[N+]([O-])=O,VAOCPAMSLUNLGC-UHFFFAOYSA-N,,CYP3A4
511,valrubicin,DNA inhibitor,TOP2A,CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,,TOP2A
512,CI-966,GAT inhibitor,SLC6A1,OC(=O)C1=CCCN(CCOC(c2ccc(cc2)C(F)(F)F)c2ccc(cc2)C(F)(F)F)C1,CMHQDSBIBSKHFP-UHFFFAOYSA-N,,SLC6A1
513,NNC-05-2090,GAT inhibitor,SLC6A12,COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc23)CC1,XZZYCJOGZYEPPW-UHFFFAOYSA-N,,SLC6A12
514,NNC-711,GAT inhibitor,SLC6A1,OC(=O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1,NGNALWDRPKNJGR-UHFFFAOYSA-N,,SLC6A1
515,BML-257,HCV inhibitor,AKT1,OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4,LFWGZXMTCUOPFI-UHFFFAOYSA-N,,AKT1
516,ellagic-acid,HCV inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
517,ellagic-acid,HCV inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
518,ellagic-acid,HCV inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
519,ellagic-acid,HCV inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
520,ellagic-acid,HCV inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
521,ellagic-acid,HCV inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
522,ellagic-acid,HCV inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
523,ellagic-acid,HCV inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
524,embelin,HCV inhibitor,XIAP,CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O,FNQDSLSOLMXCMU-UHFFFAOYSA-N,,XIAP
525,simeprevir,HCV inhibitor,CYP1A2,COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCCC=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C,JTZZSQYMACOLNN-SNWGISBASA-N,,CYP1A2
526,simeprevir,HCV inhibitor,CYP3A4,COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCCC=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C,JTZZSQYMACOLNN-SNWGISBASA-N,,CYP3A4
527,BAY-87-2243,HIF inhibitor,HIF1A,Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1,CDJNNOJINJAXPV-UHFFFAOYSA-N,,HIF1A
528,CAY-10585,HIF modulator,HIF1A,COC(=O)c1ccc(O)c(NC(=O)COc2ccc(cc2)C2C3CC4CC(C3)CC2C4)c1,CSCOJWVRGOZGPK-UHFFFAOYSA-N,,HIF1A
529,VU-0418946-1,HIF modulator,HIF1A,C(Nc1nc(nnc1-c1ccccc1)-c1ccccn1)c1ccc(cc1)-c1ccccc1,QNRODODTMXCRKU-UHFFFAOYSA-N,,HIF1A
530,alvespimycin,HSP inhibitor,HSP90AA1,CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)C(C)=C/C=C[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,KUFRQPKVAWMTJO-TYVPZVKISA-N,,HSP90AA1
531,alvespimycin,HSP inhibitor,HSP90AA1,CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)C(C)=CC=C/[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,KUFRQPKVAWMTJO-LMZWQJSESA-N,,HSP90AA1
532,alvespimycin,HSP inhibitor,HSP90AA1,COC1CC(C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)C(C)=CC=CC(OC)C(OC(N)=O)C(C)=CC(C)C1O)C2=O,KUFRQPKVAWMTJO-UBRRALEVSA-N,,HSP90AA1
533,BIIB-021,HSP inhibitor,HSP90AA1,COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C,QULDDKSCVCJTPV-UHFFFAOYSA-N,,HSP90AA1
534,ganetespib,HSP inhibitor,HSP90AA1,CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3n(C)ccc3c2)c(O)cc1O,RVAQIUULWULRNW-UHFFFAOYSA-N,,HSP90AA1
535,gedunin,HSP inhibitor,HSP90AA1,CC1(C)C=CC(=O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6,VOKBOMKQXKLQSI-UMZYLEKASA-N,,HSP90AA1
536,geldanamycin,HSP inhibitor,HSP90AA1,CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)C(C)=CC=C/[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,QTQAWLPCGQOSGP-KSRBKZBZSA-N,,HSP90AA1
537,geldanamycin,HSP inhibitor,HSP90AA1,COC1CC(C)CC2=C(OC)C(=O)C=C(NC(=O)C(C)=CC=CC(OC)C(OC(N)=O)C(C)=CC(C)C1O)C2=O,QTQAWLPCGQOSGP-VDYWNIEOSA-N,,HSP90AA1
538,NVP-AUY922,HSP inhibitor,HSP90AA1,CCNC(=O)C1=C(C(=C2C=C(C(=CC2=O)O)C(C)C)ON1)C3=CC=C(C=C3)CN4CCOCC4,SWDZPNJZKUGIIH-UHFFFAOYSA-N,,HSP90AA1
539,NVP-AUY922,HSP inhibitor,HSP90AB1,CCNC(=O)C1=C(C(=C2C=C(C(=CC2=O)O)C(C)C)ON1)C3=CC=C(C=C3)CN4CCOCC4,SWDZPNJZKUGIIH-UHFFFAOYSA-N,,HSP90AB1
540,NVP-AUY922,HSP inhibitor,HSP90AA1,CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O,NDAZATDQFDPQBD-UHFFFAOYSA-N,,HSP90AA1
541,NVP-AUY922,HSP inhibitor,HSP90AB1,CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O,NDAZATDQFDPQBD-UHFFFAOYSA-N,,HSP90AB1
542,pifithrin-mu,HSP inhibitor,HSPA1A,NS(=O)(=O)C#Cc1ccccc1,ZZUZYEMRHCMVTB-UHFFFAOYSA-N,,HSPA1A
543,pifithrin-mu,HSP inhibitor,TP53,NS(=O)(=O)C#Cc1ccccc1,ZZUZYEMRHCMVTB-UHFFFAOYSA-N,,TP53
544,PU-H71,HSP inhibitor,HSP90AA1,CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12,SUPVGFZUWFMATN-UHFFFAOYSA-N,,HSP90AA1
545,tanespimycin,HSP inhibitor,HSP90AA1,CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(C)=CC=C/[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,AYUNIORJHRXIBJ-TXHRRWQRSA-N,,HSP90AA1
546,tanespimycin,HSP inhibitor,HSP90AA1,COC1CC(C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(C)=CC=CC(OC)C(OC(N)=O)C(C)=CC(C)C1O)C2=O,AYUNIORJHRXIBJ-ZGQRYRSUSA-N,,HSP90AA1
547,VER-155008,HSP inhibitor,HSPA1A,Nc1ncnc2n([C@@H]3O[C@H](COCc4ccc(cc4)C#N)[C@@H](O)[C@H]3O)c(NCc3ccc(Cl)c(Cl)c3)nc12,ZXGGCBQORXDVTE-UMCMBGNQSA-N,,HSPA1A
548,gambogic-acid,HSP inhibitor,BCL2,CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(CC=C(C)C(O)=O)OC6(C)C,GEZHEQNLKAOMCA-RRZNCOCZSA-N,,BCL2
549,BMS-345541,IKK inhibitor,IKBKB,Cc1cnc2c(NCCN)nc3ccc(C)cc3n12,PSPFQEBFYXJZEV-UHFFFAOYSA-N,,IKBKB
550,BX-795,IKK inhibitor,PDK1,Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1,VAVXGGRQQJZYBL-UHFFFAOYSA-N,,PDK1
551,BX-795,IKK inhibitor,PDPK1,Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1,VAVXGGRQQJZYBL-UHFFFAOYSA-N,,PDPK1
552,guggulsterone,IKK inhibitor,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
553,guggulsterone,IKK inhibitor,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
554,guggulsterone,IKK inhibitor,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
555,guggulsterone,IKK inhibitor,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
556,guggulsterone,IKK inhibitor,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
557,guggulsterone,IKK inhibitor,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
558,guggulsterone,IKK inhibitor,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
559,guggulsterone,IKK inhibitor,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
560,guggulsterone,IKK inhibitor,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
561,guggulsterone,IKK inhibitor,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
562,hypoestoxide,IKK inhibitor,IKBKB,CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C,HNPAHGHFONBTLV-UOAZVOCOSA-N,,IKBKB
563,hypoestoxide,IKK inhibitor,IL1B,CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C,HNPAHGHFONBTLV-UOAZVOCOSA-N,,IL1B
564,hypoestoxide,IKK inhibitor,TNF,CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C,HNPAHGHFONBTLV-UOAZVOCOSA-N,,TNF
565,IKK-16,IKK inhibitor,IKBKB,O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1,BWZJBXAPRCVCKQ-UHFFFAOYSA-N,,IKBKB
566,TPCA-1,IKK inhibitor,IKBKB,NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1,SAYGKHKXGCPTLX-UHFFFAOYSA-N,,IKBKB
567,withaferin-a,IKK inhibitor,NAMPT,C[C@@H]([C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45[C@@H](O)C=CC(=O)[C@]5(C)[C@H]3CC[C@]12C)[C@H]6CC(=C(CO)C(=O)O6)C,DBRXOUCRJQVYJQ-CKNDUULBSA-N,,NAMPT
568,withaferin-a,IKK inhibitor,IKBKB,C[C@@H]([C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45[C@@H](O)C=CC(=O)[C@]5(C)[C@H]3CC[C@]12C)[C@H]6CC(=C(CO)C(=O)O6)C,DBRXOUCRJQVYJQ-CKNDUULBSA-N,,IKBKB
569,withaferin-a,IKK inhibitor,NAMPT,CC([C@H]1CC[C@@H]2[C@H]3C[C@H]4O[C@@]44[C@@H](O)C=CC(=O)[C@@]4(C)C3CC[C@@]12C)[C@@H]1CC(C)=C(CO)C(=O)O1,DBRXOUCRJQVYJQ-MZNHJNIISA-N,,NAMPT
570,withaferin-a,IKK inhibitor,IKBKB,CC([C@H]1CC[C@@H]2[C@H]3C[C@H]4O[C@@]44[C@@H](O)C=CC(=O)[C@@]4(C)C3CC[C@@]12C)[C@@H]1CC(C)=C(CO)C(=O)O1,DBRXOUCRJQVYJQ-MZNHJNIISA-N,,IKBKB
571,YM-90709,IL5 inhibitor,IL5RA,COc1cc2CC(C)(C)n3c(cc4nc5ccccc5nc34)-c2cc1OC,HIXSPVQXXDULHS-UHFFFAOYSA-N,,IL5RA
572,AG-490,JAK inhibitor,JAK2,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK2
573,AG-490,JAK inhibitor,JAK3,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK3
574,AG-490,JAK inhibitor,JAK2,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK2
575,AG-490,JAK inhibitor,JAK3,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK3
576,AT-9283,JAK inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
577,AT-9283,JAK inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
578,AT-9283,JAK inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
579,AT-9283,JAK inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
580,AZD-1480,JAK inhibitor,JAK1,C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1,PDOQBOJDRPLBQU-QMMMGPOBSA-N,,JAK1
581,AZD-1480,JAK inhibitor,JAK2,C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1,PDOQBOJDRPLBQU-QMMMGPOBSA-N,,JAK2
582,AZD-1480,JAK inhibitor,JAK1,CC(Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1,PDOQBOJDRPLBQU-UHFFFAOYSA-N,,JAK1
583,AZD-1480,JAK inhibitor,JAK2,CC(Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1,PDOQBOJDRPLBQU-UHFFFAOYSA-N,,JAK2
584,baricitinib,JAK inhibitor,JAK1,CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12,XUZMWHLSFXCVMG-UHFFFAOYSA-N,,JAK1
585,baricitinib,JAK inhibitor,JAK2,CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12,XUZMWHLSFXCVMG-UHFFFAOYSA-N,,JAK2
586,CEP-33779,JAK inhibitor,JAK2,CN1CCN(CC1)c1cccc(Nc2nc3c(cccn3n2)-c2ccc(cc2)S(C)(=O)=O)c1,RFZKSQIFOZZIAQ-UHFFFAOYSA-N,,JAK2
587,filgotinib,JAK inhibitor,JAK1,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,RIJLVEAXPNLDTC-UHFFFAOYSA-N,,JAK1
588,filgotinib,JAK inhibitor,JAK2,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,RIJLVEAXPNLDTC-UHFFFAOYSA-N,,JAK2
589,lestaurtinib,JAK inhibitor,FLT3,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
590,lestaurtinib,JAK inhibitor,NTRK1,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
591,lestaurtinib,JAK inhibitor,FLT3,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
592,lestaurtinib,JAK inhibitor,NTRK1,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
593,NVP-BSK805,JAK inhibitor,JAK2,Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1,IBPVXAOOVUAOKJ-UHFFFAOYSA-N,,JAK2
594,pacritinib,JAK inhibitor,FLT3,C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COCC=CCOCc1c2)c3,HWXVIOGONBBTBY-ONEGZZNKSA-N,,FLT3
595,pacritinib,JAK inhibitor,JAK2,C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COCC=CCOCc1c2)c3,HWXVIOGONBBTBY-ONEGZZNKSA-N,,JAK2
596,TG-02,JAK inhibitor,CDK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK2
597,TG-02,JAK inhibitor,CDK7,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK7
598,TG-02,JAK inhibitor,CDK9,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK9
599,TG-02,JAK inhibitor,FLT3,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,FLT3
600,TG-02,JAK inhibitor,JAK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,JAK2
601,TG-02,JAK inhibitor,CDK1,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK1
602,TG-101209,JAK inhibitor,JAK2,CN1CCN(CC1)c1ccc(Nc2ncc(C)c(Nc3cccc(c3)S(=O)(=O)NC(C)(C)C)n2)cc1,JVDOKQYTTYUYDV-UHFFFAOYSA-N,,JAK2
603,TG-101209,JAK inhibitor,JAK3,CN1CCN(CC1)c1ccc(Nc2ncc(C)c(Nc3cccc(c3)S(=O)(=O)NC(C)(C)C)n2)cc1,JVDOKQYTTYUYDV-UHFFFAOYSA-N,,JAK3
604,TG-101348,JAK inhibitor,FLT3,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,,FLT3
605,TG-101348,JAK inhibitor,JAK2,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,,JAK2
606,tofacitinib,JAK inhibitor,JAK1,C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,,JAK1
607,tofacitinib,JAK inhibitor,JAK2,C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,,JAK2
608,tofacitinib,JAK inhibitor,JAK3,C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,,JAK3
609,tofacitinib,JAK inhibitor,JAK1,C[C@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-AAEUAGOBSA-N,,JAK1
610,tofacitinib,JAK inhibitor,JAK2,C[C@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-AAEUAGOBSA-N,,JAK2
611,tofacitinib,JAK inhibitor,JAK3,C[C@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,UJLAWZDWDVHWOW-AAEUAGOBSA-N,,JAK3
612,tozasertib,JAK inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
613,tozasertib,JAK inhibitor,ABL1,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
614,tozasertib,JAK inhibitor,JAK2,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
615,tozasertib,JAK inhibitor,BCR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
616,tozasertib,JAK inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
617,tozasertib,JAK inhibitor,AURKC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
618,tozasertib,JAK inhibitor,AURKB,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
619,tozasertib,JAK inhibitor,FLT3,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
620,tozasertib,JAK inhibitor,ABL1,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
621,tozasertib,JAK inhibitor,JAK2,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
622,tozasertib,JAK inhibitor,BCR,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
623,tozasertib,JAK inhibitor,AURKA,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
624,tozasertib,JAK inhibitor,AURKC,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
625,tozasertib,JAK inhibitor,AURKB,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
626,WHI-P154,JAK inhibitor,EGFR,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CBIAKDAYHRWZCU-UHFFFAOYSA-N,,EGFR
627,WHI-P154,JAK inhibitor,JAK3,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CBIAKDAYHRWZCU-UHFFFAOYSA-N,,JAK3
628,WHI-P154,JAK inhibitor,EGFR,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CBIAKDAYHRWZCU-UHFFFAOYSA-N,,EGFR
629,WHI-P154,JAK inhibitor,JAK3,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CBIAKDAYHRWZCU-UHFFFAOYSA-N,,JAK3
630,AS-601245,JNK inhibitor,MAPK8,N#CC(c1nc2ccccc2s1)c1ccnc(NCCc2cccnc2)n1,RCYPVQCPYKNSTG-UHFFFAOYSA-N,,MAPK8
631,AS-601245,JNK inhibitor,MAPK9,N#CC(c1nc2ccccc2s1)c1ccnc(NCCc2cccnc2)n1,RCYPVQCPYKNSTG-UHFFFAOYSA-N,,MAPK9
632,AS-601245,JNK inhibitor,MAPK10,N#CC(c1nc2ccccc2s1)c1ccnc(NCCc2cccnc2)n1,RCYPVQCPYKNSTG-UHFFFAOYSA-N,,MAPK10
633,BI-78D3,JNK inhibitor,MAPK8,Oc1nnc(Sc2ncc(s2)[N+]([O-])=O)n1-c1ccc2OCCOc2c1,QFRLDZGQEZCCJZ-UHFFFAOYSA-N,,MAPK8
634,CG-930,JNK inhibitor,MAPK8,C1COC[C@@H]1N2C3=NC(=NC=C3N=C2NC4=C(C=C(C=C4F)F)F)NC5CCC(CC5)O,IBGLGMOPHJQDJB-ROKHWSDSSA-N,,MAPK8
635,CG-930,JNK inhibitor,MAPK8,O[C@H]1CC[C@H](CC1)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@@H]3CCOC3)c2n1,IBGLGMOPHJQDJB-MCIONIFRSA-N,,MAPK8
636,JNK-9L,JNK inhibitor,MAPK8,N#Cc1cc(cc(c1)-c1ccnc(Nc2ccc(cc2)-n2cnc(n2)-c2cccnc2)n1)N1CCOCC1,VCUNSUCAAIMDKU-UHFFFAOYSA-N,,MAPK8
637,pyrazolanthrone,JNK inhibitor,MAPK8,O=C1c2ccccc2-c2n[nH]c3cccc1c23,ACPOUJIDANTYHO-UHFFFAOYSA-N,,MAPK8
638,pyrazolanthrone,JNK inhibitor,MAPK9,O=C1c2ccccc2-c2n[nH]c3cccc1c23,ACPOUJIDANTYHO-UHFFFAOYSA-N,,MAPK9
639,pyrazolanthrone,JNK inhibitor,MAPK10,O=C1c2ccccc2-c2n[nH]c3cccc1c23,ACPOUJIDANTYHO-UHFFFAOYSA-N,,MAPK10
640,pyrazolanthrone,JNK inhibitor,TTK,O=C1c2ccccc2-c2n[nH]c3cccc1c23,ACPOUJIDANTYHO-UHFFFAOYSA-N,,TTK
641,amuvatinib,KIT inhibitor,FLT3,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,FLT3
642,amuvatinib,KIT inhibitor,KIT,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,KIT
643,amuvatinib,KIT inhibitor,MET,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,MET
644,amuvatinib,KIT inhibitor,PDGFRA,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,PDGFRA
645,cediranib,KIT inhibitor,FLT1,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,FLT1
646,cediranib,KIT inhibitor,FLT4,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,FLT4
647,cediranib,KIT inhibitor,KDR,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,KDR
648,cediranib,KIT inhibitor,KIT,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,KIT
649,cediranib,KIT inhibitor,PDGFRB,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,PDGFRB
650,dasatinib,KIT inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
651,dasatinib,KIT inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
652,dasatinib,KIT inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
653,dasatinib,KIT inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
654,dasatinib,KIT inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
655,dasatinib,KIT inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
656,dasatinib,KIT inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
657,dasatinib,KIT inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
658,dasatinib,KIT inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
659,dasatinib,KIT inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
660,imatinib,KIT inhibitor,CSF1R,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,CSF1R
661,imatinib,KIT inhibitor,ABL1,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,ABL1
662,imatinib,KIT inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,KIT
663,imatinib,KIT inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRA
664,imatinib,KIT inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRB
665,imatinib,KIT inhibitor,BCR,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,BCR
666,KI-8751,KIT inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC,LFKQSJNCVRGFCC-UHFFFAOYSA-N,,KDR
667,lenvatinib,KIT inhibitor,FGFR1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FGFR1
668,lenvatinib,KIT inhibitor,FLT1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT1
669,lenvatinib,KIT inhibitor,FLT4,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT4
670,lenvatinib,KIT inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KDR
671,lenvatinib,KIT inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KIT
672,masitinib,KIT inhibitor,FGFR3,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,FGFR3
673,masitinib,KIT inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,KIT
674,masitinib,KIT inhibitor,LYN,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,LYN
675,masitinib,KIT inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRA
676,masitinib,KIT inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRB
677,midostaurin,KIT inhibitor,FLT3,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,FLT3
678,midostaurin,KIT inhibitor,KIT,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,KIT
679,motesanib,KIT inhibitor,FLT1,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT1
680,motesanib,KIT inhibitor,FLT4,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT4
681,motesanib,KIT inhibitor,KDR,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KDR
682,motesanib,KIT inhibitor,KIT,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KIT
683,OSI-930,KIT inhibitor,KDR,FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1,FGTCROZDHDSNIO-UHFFFAOYSA-N,,KDR
684,OSI-930,KIT inhibitor,KIT,FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1,FGTCROZDHDSNIO-UHFFFAOYSA-N,,KIT
685,pazopanib,KIT inhibitor,FLT1,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT1
686,pazopanib,KIT inhibitor,FLT4,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT4
687,pazopanib,KIT inhibitor,KDR,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KDR
688,pazopanib,KIT inhibitor,KIT,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KIT
689,pazopanib,KIT inhibitor,PDGFRA,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRA
690,pazopanib,KIT inhibitor,PDGFRB,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRB
691,regorafenib,KIT inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
692,regorafenib,KIT inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
693,regorafenib,KIT inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
694,regorafenib,KIT inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
695,regorafenib,KIT inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
696,regorafenib,KIT inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
697,regorafenib,KIT inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
698,regorafenib,KIT inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
699,regorafenib,KIT inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
700,regorafenib,KIT inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
701,regorafenib,KIT inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
702,regorafenib,KIT inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
703,regorafenib,KIT inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
704,regorafenib,KIT inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
705,regorafenib,KIT inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
706,regorafenib,KIT inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
707,sorafenib,KIT inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
708,sorafenib,KIT inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
709,sorafenib,KIT inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
710,sorafenib,KIT inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
711,sorafenib,KIT inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
712,sorafenib,KIT inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
713,sorafenib,KIT inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
714,sorafenib,KIT inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
715,sorafenib,KIT inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
716,sorafenib,KIT inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
717,sorafenib,KIT inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
718,sorafenib,KIT inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
719,sorafenib,KIT inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
720,sorafenib,KIT inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
721,sorafenib,KIT inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
722,sorafenib,KIT inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
723,sorafenib,KIT inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
724,sorafenib,KIT inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
725,sorafenib,KIT inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
726,sorafenib,KIT inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
727,sorafenib,KIT inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
728,sorafenib,KIT inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
729,sunitinib,KIT inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT1
730,sunitinib,KIT inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT3
731,sunitinib,KIT inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT4
732,sunitinib,KIT inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KDR
733,sunitinib,KIT inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KIT
734,sunitinib,KIT inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRA
735,sunitinib,KIT inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRB
736,sunitinib,KIT inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,RET
737,tandutinib,KIT inhibitor,FLT3,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,FLT3
738,tandutinib,KIT inhibitor,KIT,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,KIT
739,tandutinib,KIT inhibitor,PDGFRA,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRA
740,tandutinib,KIT inhibitor,PDGFRB,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRB
741,telatinib,KIT inhibitor,KDR,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,QFCXANHHBCGMAS-UHFFFAOYSA-N,,KDR
742,vatalanib,KIT inhibitor,FLT1,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT1
743,vatalanib,KIT inhibitor,FLT4,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT4
744,vatalanib,KIT inhibitor,KDR,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KDR
745,vatalanib,KIT inhibitor,KIT,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KIT
746,vatalanib,KIT inhibitor,PDGFRB,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,PDGFRB
747,AMG-232,MDM inhibitor,MDM2,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,DRLCSJFKKILATL-YWCVFVGNSA-N,,MDM2
748,HLI-373,MDM inhibitor,MDM2,CN(C)CCCNc1c2ccccc2n(C)c2nc(=O)n(C)c(=O)c12,LNRUPMPQQGPSQT-UHFFFAOYSA-N,,MDM2
749,serdemetan,MDM inhibitor,MDM2,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,CEGSUKYESLWKJP-UHFFFAOYSA-N,,MDM2
750,serdemetan,MDM inhibitor,MDM2,C(Cc1c[nH]c2ccccc12)Nc1cccc(Nc2ccncc2)c1,JCKLHFMOFAYQHE-UHFFFAOYSA-N,,MDM2
751,SJ-172550,MDM inhibitor,MDM4,CCOc1cc(cc(Cl)c1OCC(=O)OC)C=C1C(=O)N(N=C/1C)c1ccccc1,RKKFQJXGAQWHBZ-YVLHZVERSA-N,,MDM4
752,SAR405838,MDM inhibitor,MDM2,CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1,IDKAKZRYYDCJDU-UHFFFAOYSA-N,,MDM2
753,nutlin-3,MDM inhibitor,MDM2,COc1ccc(C2=N[C@@H]([C@@H](N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,BDUHCSBCVGXTJM-IZLXSDGUSA-N,,MDM2
754,arctigenin,MEK inhibitor,CHUK,COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O,NQWVSMVXKMHKTF-JKSUJKDBSA-N,,CHUK
755,arctigenin,MEK inhibitor,MAP2K1,COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O,NQWVSMVXKMHKTF-JKSUJKDBSA-N,,MAP2K1
756,AS-703026,MEK inhibitor,MAP2K1,OC[C@@H](O)CNC(=O)c1ccncc1Nc1ccc(I)cc1F,VIUAUNHCRHHYNE-JTQLQIEISA-N,,MAP2K1
757,AS-703026,MEK inhibitor,MAP2K2,OC[C@@H](O)CNC(=O)c1ccncc1Nc1ccc(I)cc1F,VIUAUNHCRHHYNE-JTQLQIEISA-N,,MAP2K2
758,BIX-02189,MEK inhibitor,MAPK7,CN(C)Cc1cccc(NC(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1,HOMJAAIVTDVQJA-IZHYLOQSSA-N,,MAPK7
759,BIX-02189,MEK inhibitor,MAP2K5,CN(C)Cc1cccc(NC(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1,HOMJAAIVTDVQJA-IZHYLOQSSA-N,,MAP2K5
760,nobiletin,MEK inhibitor,MAP2K1,COc1ccc(cc1OC)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1,MRIAQLRQZPPODS-UHFFFAOYSA-N,,MAP2K1
761,PD-0325901,MEK inhibitor,MAP2K1,OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-SECBINFHSA-N,,MAP2K1
762,PD-0325901,MEK inhibitor,MAP2K1,OCC(O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-UHFFFAOYSA-N,,MAP2K1
763,PD-184352,MEK inhibitor,MAP2K1,Fc1ccc(C(=O)NOCC2CC2)c(Nc2ccc(I)cc2Cl)c1F,GFMMXOIFOQCCGU-UHFFFAOYSA-N,,MAP2K1
764,PD-198306,MEK inhibitor,MAP2K1,Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1,UHAXDAKQGVISBZ-UHFFFAOYSA-N,,MAP2K1
765,PD-198306,MEK inhibitor,MAP2K2,Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1,UHAXDAKQGVISBZ-UHFFFAOYSA-N,,MAP2K2
766,PD-98059,MEK inhibitor,MAP2K1,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,QFWCYNPOPKQOKV-UHFFFAOYSA-N,,MAP2K1
767,refametinib,MEK inhibitor,MAP2K1,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,RDSACQWTXKSHJT-NSHDSACASA-N,,MAP2K1
768,refametinib,MEK inhibitor,MAP2K2,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,RDSACQWTXKSHJT-NSHDSACASA-N,,MAP2K2
769,selumetinib,MEK inhibitor,MAP2K1,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO,CYOHGALHFOKKQC-UHFFFAOYSA-N,,MAP2K1
770,TAK-733,MEK inhibitor,MAP2K1,Cn1c2ncn(C[C@@H](O)CO)c(=O)c2c(Nc2ccc(I)cc2F)c(F)c1=O,RCLQNICOARASSR-SECBINFHSA-N,,MAP2K1
771,trametinib,MEK inhibitor,MAP2K1,CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,,MAP2K1
772,trametinib,MEK inhibitor,MAP2K2,CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,,MAP2K2
773,U-0126,MEK inhibitor,MAP2K1,NC(Sc1ccccc1N)=C(C#N)/C(C#N)=C(/N)Sc1ccccc1N,DVEXZJFMOKTQEZ-MJZABRMRSA-N,,MAP2K1
774,U-0126,MEK inhibitor,MAP2K2,NC(Sc1ccccc1N)=C(C#N)/C(C#N)=C(/N)Sc1ccccc1N,DVEXZJFMOKTQEZ-MJZABRMRSA-N,,MAP2K2
775,U-0126,MEK inhibitor,MAP2K1,NC(Sc1ccccc1N)=C(C#N)/C(C#N)=C(N)Sc1ccccc1N,DVEXZJFMOKTQEZ-JYFOCSDGSA-N,,MAP2K1
776,U-0126,MEK inhibitor,MAP2K2,NC(Sc1ccccc1N)=C(C#N)/C(C#N)=C(N)Sc1ccccc1N,DVEXZJFMOKTQEZ-JYFOCSDGSA-N,,MAP2K2
777,U-0126,MEK inhibitor,MAP2K1,NC(=C(C#N)C(=C(N)Sc1ccccc1N)C#N)Sc2ccccc2N,DVEXZJFMOKTQEZ-UHFFFAOYSA-N,,MAP2K1
778,U-0126,MEK inhibitor,MAP2K2,NC(=C(C#N)C(=C(N)Sc1ccccc1N)C#N)Sc2ccccc2N,DVEXZJFMOKTQEZ-UHFFFAOYSA-N,,MAP2K2
779,dofequidar,MRP inhibitor,ABCC1,OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1,KLWUUPVJTLHYIM-UHFFFAOYSA-N,,ABCC1
780,dofequidar,MRP inhibitor,ABCB1,OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1,KLWUUPVJTLHYIM-UHFFFAOYSA-N,,ABCB1
781,8-bromo-cGMP,PKA activator,PRKG1,Nc1nc(O)c2nc(Br)n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c2n1,YUFCOOWNNHGGOD-UMMCILCDSA-N,,PRKG1
782,H-89,PKA inhibitor,PRKACA,Brc1ccc(C=CCNCCNS(=O)(=O)c2cccc3cnccc23)cc1,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,,PRKACA
783,H-9,PKA inhibitor,PRKACA,NCCNCc1cccc2cnccc12,YVVIHNCTCNPFJM-UHFFFAOYSA-N,,PRKACA
784,H-9,PKA inhibitor,PRKACA,NCCNS(=O)(=O)c1cccc2cnccc12,DCVZSHVZGVWQKV-UHFFFAOYSA-N,,PRKACA
785,ingenol,PKC activator,PRKCD,CC1CC2C(C3C=C(COC(=O)c4ccccc4)C(O)C4(O)C(OC(=O)c5ccccc5)C(C)=CC14C3=O)C2(C)C,GIMKEHNOTHXONN-UHFFFAOYSA-N,,PRKCD
786,ingenol,PKC activator,PRKCE,CC1CC2C(C3C=C(COC(=O)c4ccccc4)C(O)C4(O)C(OC(=O)c5ccccc5)C(C)=CC14C3=O)C2(C)C,GIMKEHNOTHXONN-UHFFFAOYSA-N,,PRKCE
787,ingenol-mebutate,PKC activator,PRKCA,CC=C(C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,VDJHFHXMUKFKET-WDUFCVPESA-N,,PRKCA
788,ingenol-mebutate,PKC activator,PRKCD,CC=C(C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,VDJHFHXMUKFKET-WDUFCVPESA-N,,PRKCD
789,bisindolylmaleimide-ix,PKC inhibitor,SIRT1,Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCSC(N)=N)c3ccccc23)c2ccccc12,DSXXEELGXBCYNQ-UHFFFAOYSA-N,,SIRT1
790,CGP-53353,PKC inhibitor,EGFR,Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1,RONQPWQYDRPRGG-UHFFFAOYSA-N,,EGFR
791,EI-273,PKC inhibitor,PRKCA,COCc1cc(O)c(O)c(O)c1c2c(O)c(O)c(O)cc2COC,NEBCAMAQXZIVRE-UHFFFAOYSA-N,,PRKCA
792,EI-273,PKC inhibitor,PRKCG,COCc1cc(O)c(O)c(O)c1c2c(O)c(O)c(O)cc2COC,NEBCAMAQXZIVRE-UHFFFAOYSA-N,,PRKCG
793,enzastaurin,PKC inhibitor,PRKCB,Cn1cc(C2=C(C(=O)NC2=O)c2cn(C3CCN(Cc4ccccn4)CC3)c3ccccc23)c2ccccc12,AXRCEOKUDYDWLF-UHFFFAOYSA-N,,PRKCB
794,hispidin,PKC inhibitor,PRKCB,Oc1cc(/C=C/c2ccc(O)c(O)c2)oc(=O)c1,SGJNQVTUYXCBKH-HNQUOIGGSA-N,,PRKCB
795,midostaurin,PKC inhibitor,FLT3,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,FLT3
796,midostaurin,PKC inhibitor,KIT,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,KIT
797,sotrastaurin,PKC inhibitor,PRKCA,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCA
798,sotrastaurin,PKC inhibitor,PRKCB,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCB
799,sotrastaurin,PKC inhibitor,PRKCD,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCD
800,sotrastaurin,PKC inhibitor,PRKCE,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCE
801,sotrastaurin,PKC inhibitor,PRKCH,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCH
802,sotrastaurin,PKC inhibitor,PRKCQ,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,,PRKCQ
803,staurosporine,PKC inhibitor,CDK2,CN[C@@H]1C[C@@]2(C)O[C@@H]([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35,XTGJCWHCHWNXSE-WQGXBGQBSA-N,,CDK2
804,staurosporine,PKC inhibitor,GSK3B,CN[C@@H]1C[C@@]2(C)O[C@@H]([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35,XTGJCWHCHWNXSE-WQGXBGQBSA-N,,GSK3B
805,staurosporine,PKC inhibitor,CDK2,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35,HKSZLNNOFSGOKW-FYTWVXJKSA-N,,CDK2
806,staurosporine,PKC inhibitor,GSK3B,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35,HKSZLNNOFSGOKW-FYTWVXJKSA-N,,GSK3B
807,BI-2536,PLK inhibitor,PLK1,CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,XQVVPGYIWAGRNI-JOCHJYFZSA-N,,PLK1
808,BI-2536,PLK inhibitor,PLK1,CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O,XQVVPGYIWAGRNI-JOCHJYFZSA-N,,PLK1
809,GSK-461364,PLK inhibitor,PLK1,C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F,ZHJGWYRLJUCMRT-QGZVFWFLSA-N,,PLK1
810,GW-843682X,PLK inhibitor,PLK3,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC,JSKUWFIZUALZLX-UHFFFAOYSA-N,,PLK3
811,GW-843682X,PLK inhibitor,PLK1,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC,JSKUWFIZUALZLX-UHFFFAOYSA-N,,PLK1
812,HMN-214,PLK inhibitor,CSF1R,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,CSF1R
813,HMN-214,PLK inhibitor,FLT1,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,FLT1
814,HMN-214,PLK inhibitor,FLT3,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,FLT3
815,HMN-214,PLK inhibitor,FLT4,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,FLT4
816,HMN-214,PLK inhibitor,KDR,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,KDR
817,HMN-214,PLK inhibitor,KIT,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,KIT
818,HMN-214,PLK inhibitor,PDGFRB,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,PDGFRB
819,HMN-214,PLK inhibitor,RET,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,OCKHRKSTDPOHEN-BQYQJAHWSA-N,,RET
820,LY-294002,PLK inhibitor,MTOR,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,MTOR
821,LY-294002,PLK inhibitor,PIK3CA,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CA
822,LY-294002,PLK inhibitor,PIK3CB,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CB
823,LY-294002,PLK inhibitor,PIK3CD,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CD
824,LY-294002,PLK inhibitor,PIK3CG,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CG
825,LY-294002,PLK inhibitor,PLK1,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PLK1
826,LY-294002,PLK inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PRKDC
827,NMS-1286937,PLK inhibitor,PLK1,CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,,PLK1
828,ON-01910,PLK inhibitor,PLK2,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,PLK2
829,ON-01910,PLK inhibitor,FLT1,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,FLT1
830,ON-01910,PLK inhibitor,FYN,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,FYN
831,ON-01910,PLK inhibitor,PDGFRA,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,PDGFRA
832,ON-01910,PLK inhibitor,PLK1,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,PLK1
833,ON-01910,PLK inhibitor,SRC,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,SRC
834,ON-01910,PLK inhibitor,CDK1,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC=O)c2)c(OC)c1,POSHWWRILMRTTE-JXMROGBWSA-N,,CDK1
835,rigosertib,PLK inhibitor,PLK1,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1,OWBFCJROIKNMGD-BQYQJAHWSA-N,,PLK1
836,volasertib,PLK inhibitor,PLK1,CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2N(C)C1=O,SXNJFOWDRLKDSF-STROYTFGSA-N,,PLK1
837,AZ-628,RAF inhibitor,RAF1,Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1,ZGBGPEDJXCYQPH-UHFFFAOYSA-N,,RAF1
838,AZ-628,RAF inhibitor,BRAF,Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1,ZGBGPEDJXCYQPH-UHFFFAOYSA-N,,BRAF
839,CEP-32496,RAF inhibitor,BRAF,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC,DKNUPRMJNUQNHR-UHFFFAOYSA-N,,BRAF
840,dabrafenib,RAF inhibitor,BRAF,CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F,BFSMGDJOXZAERB-UHFFFAOYSA-N,,BRAF
841,GDC-0879,RAF inhibitor,BRAF,OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CCC2=N/O)c1,DEZZLWQELQORIU-RELWKKBWSA-N,,BRAF
842,GW-5074,RAF inhibitor,RAF1,Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br,LMXYVLFTZRPNRV-UHFFFAOYSA-N,,RAF1
843,GW-5074,RAF inhibitor,RAF1,Oc1c(Br)cc(cc1Br)C=C1/C(=O)Nc2ccc(I)cc12,LMXYVLFTZRPNRV-KMKOMSMNSA-N,,RAF1
844,PLX-4720,RAF inhibitor,BRAF,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,YZDJQTHVDDOVHR-UHFFFAOYSA-N,,BRAF
845,PP-30,RAF inhibitor,RAF1,CC(C)n1nc(-c2cccc(c2)C(=O)NC2=NCCC2)c2c(N)ncnc12,RWRBSEISHUTNQL-UHFFFAOYSA-N,,RAF1
846,regorafenib,RAF inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
847,regorafenib,RAF inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
848,regorafenib,RAF inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
849,regorafenib,RAF inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
850,regorafenib,RAF inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
851,regorafenib,RAF inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
852,regorafenib,RAF inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
853,regorafenib,RAF inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
854,regorafenib,RAF inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
855,regorafenib,RAF inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
856,regorafenib,RAF inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
857,regorafenib,RAF inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
858,regorafenib,RAF inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
859,regorafenib,RAF inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
860,regorafenib,RAF inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
861,regorafenib,RAF inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
862,SB-590885,RAF inhibitor,BRAF,CN(C)CCOC1=CC=C(C=C1)C2=NC(=C3C=CC4=C(CCC4=C3)N=O)C(=C5C=CNC=C5)N2,DPCXEUSDRQOOGZ-UHFFFAOYSA-N,,BRAF
863,SB-590885,RAF inhibitor,BRAF,CN(C)CCOc1ccc(cc1)-c1nc(c([nH]1)-c1ccc2c(CCC2=NO)c1)-c1ccncc1,MLSAQOINCGAULQ-QLTSDVKISA-N,,BRAF
864,sorafenib,RAF inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
865,sorafenib,RAF inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
866,sorafenib,RAF inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
867,sorafenib,RAF inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
868,sorafenib,RAF inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
869,sorafenib,RAF inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
870,sorafenib,RAF inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
871,sorafenib,RAF inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
872,sorafenib,RAF inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
873,sorafenib,RAF inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
874,sorafenib,RAF inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
875,sorafenib,RAF inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
876,sorafenib,RAF inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
877,sorafenib,RAF inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
878,sorafenib,RAF inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
879,sorafenib,RAF inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
880,sorafenib,RAF inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
881,sorafenib,RAF inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
882,sorafenib,RAF inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
883,sorafenib,RAF inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
884,sorafenib,RAF inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
885,sorafenib,RAF inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
886,vemurafenib,RAF inhibitor,BRAF,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F,GPXBXXGIAQBQNI-UHFFFAOYSA-N,,BRAF
887,tolimidone,Src activator,LYN,Cc1cccc(Oc2cnc(=O)[nH]c2)c1,HJQILFPVRNHTIG-UHFFFAOYSA-N,,LYN
888,tolimidone,Src activator,SRC,Cc1cccc(Oc2cnc(=O)[nH]c2)c1,HJQILFPVRNHTIG-UHFFFAOYSA-N,,SRC
889,aminogenistein,Src inhibitor,LCK,Nc1ccc(cc1)c2cc(=O)c3cc(O)ccc3o2,YBQRUOMICVULNM-UHFFFAOYSA-N,,LCK
890,bosutinib,Src inhibitor,ABL1,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,ABL1
891,bosutinib,Src inhibitor,HCK,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,HCK
892,bosutinib,Src inhibitor,LYN,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,LYN
893,bosutinib,Src inhibitor,BCR,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,BCR
894,bosutinib,Src inhibitor,SRC,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,SRC
895,bosutinib,Src inhibitor,CAMK2G,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,CAMK2G
896,butein,Src inhibitor,ACE,Oc1ccc(C(=O)C=Cc2ccc(O)c(O)c2)c(O)c1,AYMYWHCQALZEGT-ORCRQEGFSA-N,,ACE
897,dasatinib,Src inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
898,dasatinib,Src inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
899,dasatinib,Src inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
900,dasatinib,Src inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
901,dasatinib,Src inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
902,dasatinib,Src inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
903,dasatinib,Src inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
904,dasatinib,Src inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
905,dasatinib,Src inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
906,dasatinib,Src inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
907,masitinib,Src inhibitor,FGFR3,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,FGFR3
908,masitinib,Src inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,KIT
909,masitinib,Src inhibitor,LYN,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,LYN
910,masitinib,Src inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRA
911,masitinib,Src inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRB
912,PP-2,Src inhibitor,LCK,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12,PBBRWFOVCUAONR-UHFFFAOYSA-N,,LCK
913,PP-2,Src inhibitor,SRC,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12,PBBRWFOVCUAONR-UHFFFAOYSA-N,,SRC
914,saracatinib,Src inhibitor,ABL1,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,OUKYUETWWIPKQR-UHFFFAOYSA-N,,ABL1
915,saracatinib,Src inhibitor,SRC,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,OUKYUETWWIPKQR-UHFFFAOYSA-N,,SRC
916,saracatinib,Src inhibitor,ABL1,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N,,ABL1
917,saracatinib,Src inhibitor,SRC,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N,,SRC
918,SU-6656,Src inhibitor,LYN,CN(C)S(=O)(=O)c1ccc2NC(=O)/C(=Cc3cc4CCCCc4[nH]3)/c2c1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,,LYN
919,TG-100801,Src inhibitor,FGFR1,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,FGFR1
920,TG-100801,Src inhibitor,FLT1,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,FLT1
921,TG-100801,Src inhibitor,KDR,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,KDR
922,TG-100801,Src inhibitor,SRC,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,SRC
923,ZM-306416,Src inhibitor,FLT1,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,FLT1
924,ZM-306416,Src inhibitor,KDR,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,KDR
925,fostamatinib,Syk inhibitor,SYK,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,NHHQJBCNYHBUSI-UHFFFAOYSA-N,,SYK
926,ER-27319,Syk inhibitor,SYK,Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O,CFPDEQBPNROZDC-UHFFFAOYSA-N,,SYK
927,GS-9973,Syk inhibitor,SYK,C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,,SYK
928,SYK-inhibitor,Syk inhibitor,SYK,Cn1cc(/C=C/2C(=O)Nc3ccc(cc23)S(=O)(=O)N)c4ccccc14,MLKHXLFEYOOYEY-NVNXTCNLSA-N,,SYK
929,CI-976,ACAT inhibitor,ACAT1,CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC,WAFNZAURAWBNDZ-UHFFFAOYSA-N,,ACAT1
930,KD-023,ACAT inhibitor,ACACA,CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O,CZRCFAOMWRAFIC-UHFFFAOYSA-N,,ACACA
931,KD-023,ACAT inhibitor,ACACB,CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O,CZRCFAOMWRAFIC-UHFFFAOYSA-N,,ACACB
932,linoleamide,ACAT inhibitor,SOAT1,CCCCC/C=CC/C=CCCCCCCCC(=O)N,SFIHQZFZMWZOJV-HZJYTTRNSA-N,,SOAT1
933,linoleamide,ACAT inhibitor,SOAT2,CCCCC/C=CC/C=CCCCCCCCC(=O)N,SFIHQZFZMWZOJV-HZJYTTRNSA-N,,SOAT2
934,dorsomorphin,AMPK inhibitor,PRKAA1,C(CN1CCCCC1)Oc2ccc(cc2)c3cnc4c(cnn4c3)c5ccncc5,XHBVYDAKJHETMP-UHFFFAOYSA-N,,PRKAA1
935,dorsomorphin,AMPK inhibitor,BMPR1A,C(CN1CCCCC1)Oc2ccc(cc2)c3cnc4c(cnn4c3)c5ccncc5,XHBVYDAKJHETMP-UHFFFAOYSA-N,,BMPR1A
936,dorsomorphin,AMPK inhibitor,BMPR1B,C(CN1CCCCC1)Oc2ccc(cc2)c3cnc4c(cnn4c3)c5ccncc5,XHBVYDAKJHETMP-UHFFFAOYSA-N,,BMPR1B
937,BRD-K00313977,APEX inhibitor,APEX1,CC(C)N1Cc2sc(NC(C)=O)c(-c3nc4ccccc4s3)c2C1,CZIACNCULOWAAI-UHFFFAOYSA-N,,APEX1
938,BRD-K30351863,APEX inhibitor,APEX1,CC(=O)Nc1sc2CNCc2c1-c1nc2ccccc2s1,MODNMLYGANOZDZ-UHFFFAOYSA-N,,APEX1
939,propafenone,Antiarrhythmic,KCNH2,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,JWHAUXFOSRPERK-UHFFFAOYSA-N,,KCNH2
940,propafenone,Antiarrhythmic,SCN5A,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,JWHAUXFOSRPERK-UHFFFAOYSA-N,,SCN5A
941,bucladesine,CAMP stimulant,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC,CJGYSWNGNKCJSB-YVLZZHOMSA-N,,PRKACA
942,bucladesine,CAMP stimulant,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2OP(O)(=O)OC[C@@H]2[C@H]1OC(=O)CCC,ZKSUYDZTGVUZGX-BKCXMMJFSA-N,,PRKACA
943,bucladesine,CAMP stimulant,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]3O[C@@H]4OP(=O)(O)OC[C@H]4[C@H]3OC(=O)CCC,ZKSUYDZTGVUZGX-VBJMPTANSA-N,,PRKACA
944,bucladesine,CAMP stimulant,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC,CJGYSWNGNKCJSB-ZBSNKJFMSA-N,,PRKACA
945,bucladesine,CAMP stimulant,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)C3OC4COP(=O)(O)OC4C3OC(=O)CCC,CJGYSWNGNKCJSB-UHFFFAOYSA-N,,PRKACA
946,RS-102895,CCR antagonist,CCR2,FC(F)(F)c1ccc(CCN2CCC3(CC2)OC(=O)Nc2ccccc32)cc1,HIDWEYPGMLIQSN-UHFFFAOYSA-N,,CCR2
947,BRD-A81377415,DYRK inhibitor,CLK1,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,CLK1
948,BRD-A81377415,DYRK inhibitor,DYRK1A,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,DYRK1A
949,BRD-A81377415,DYRK inhibitor,CLK4,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,CLK4
950,BRD-A81377415,DYRK inhibitor,DYRK1B,C(Nc1ncnc2ccc(cc12)-c1ccc2OCOc2c1)C1CCOC1,ADJWQFUAOONPHD-UHFFFAOYSA-N,,DYRK1B
951,BRD-K06217810,DYRK inhibitor,CLK1,CN(Cc1csc(C)n1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,PMDAVRLCSZSLRH-UHFFFAOYSA-N,,CLK1
952,BRD-K06217810,DYRK inhibitor,DYRK1A,CN(Cc1csc(C)n1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,PMDAVRLCSZSLRH-UHFFFAOYSA-N,,DYRK1A
953,BRD-K06217810,DYRK inhibitor,CLK4,CN(Cc1csc(C)n1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,PMDAVRLCSZSLRH-UHFFFAOYSA-N,,CLK4
954,BRD-K06217810,DYRK inhibitor,DYRK1B,CN(Cc1csc(C)n1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,PMDAVRLCSZSLRH-UHFFFAOYSA-N,,DYRK1B
955,BRD-K59222562,DYRK inhibitor,CLK1,CN(Cc1cccs1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,LXDHFJUOCGKVAV-UHFFFAOYSA-N,,CLK1
956,BRD-K59222562,DYRK inhibitor,DYRK1A,CN(Cc1cccs1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,LXDHFJUOCGKVAV-UHFFFAOYSA-N,,DYRK1A
957,BRD-K59222562,DYRK inhibitor,CLK4,CN(Cc1cccs1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,LXDHFJUOCGKVAV-UHFFFAOYSA-N,,CLK4
958,BRD-K59222562,DYRK inhibitor,DYRK1B,CN(Cc1cccs1)c1ncnc2ccc(cc12)-c1ccc2OCOc2c1,LXDHFJUOCGKVAV-UHFFFAOYSA-N,,DYRK1B
959,BRD-K68783079,DYRK inhibitor,CLK1,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,CLK1
960,BRD-K68783079,DYRK inhibitor,DYRK1A,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,DYRK1A
961,BRD-K68783079,DYRK inhibitor,CLK4,Cc1nc(CNc2ncnc3ccc(cc23)-c2ccc3OCOc3c2)cs1,LELRIWOVACJYND-UHFFFAOYSA-N,,CLK4
962,BRD-K70693222,DYRK inhibitor,CLK1,C(Nc1ncnc2ccc(cc12)c3ccc4OCOc4c3)c5cccs5,QFBOPHGXTBOQRN-UHFFFAOYSA-N,,CLK1
963,BRD-K70693222,DYRK inhibitor,DYRK1A,C(Nc1ncnc2ccc(cc12)c3ccc4OCOc4c3)c5cccs5,QFBOPHGXTBOQRN-UHFFFAOYSA-N,,DYRK1A
964,BRD-K70693222,DYRK inhibitor,CLK4,C(Nc1ncnc2ccc(cc12)c3ccc4OCOc4c3)c5cccs5,QFBOPHGXTBOQRN-UHFFFAOYSA-N,,CLK4
965,harmine,DYRK inhibitor,MAOA,COc1ccc2c(c1)[nH]c3c(C)nccc23,BXNJHAXVSOCGBA-UHFFFAOYSA-N,,MAOA
966,ML-167,DYRK inhibitor,CLK1,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,CLK1
967,ML-167,DYRK inhibitor,DYRK1A,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,DYRK1A
968,ML-167,DYRK inhibitor,CLK4,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,CLK4
969,ML-167,DYRK inhibitor,DYRK1B,Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,,DYRK1B
970,purvalanol-a,DYRK inhibitor,CDK2,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK2
971,purvalanol-a,DYRK inhibitor,CDK4,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK4
972,purvalanol-a,DYRK inhibitor,CDK5,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK5
973,purvalanol-a,DYRK inhibitor,CDK1,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,PMXCMJLOPOFPBT-HNNXBMFYSA-N,,CDK1
974,afatinib,EGFR inhibitor,EGFR,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,,EGFR
975,afatinib,EGFR inhibitor,ERBB2,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,,ERBB2
976,afatinib,EGFR inhibitor,ERBB4,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,,ERBB4
977,afatinib,EGFR inhibitor,EGFR,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1,ULXXDDBFHOBEHA-ONEGZZNKSA-N,,EGFR
978,afatinib,EGFR inhibitor,ERBB2,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1,ULXXDDBFHOBEHA-ONEGZZNKSA-N,,ERBB2
979,afatinib,EGFR inhibitor,ERBB4,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1,ULXXDDBFHOBEHA-ONEGZZNKSA-N,,ERBB4
980,AG-490,EGFR inhibitor,JAK2,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK2
981,AG-490,EGFR inhibitor,JAK3,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK3
982,AG-490,EGFR inhibitor,JAK2,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK2
983,AG-490,EGFR inhibitor,JAK3,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK3
984,AG-494,EGFR inhibitor,EGFR,Oc1ccc(C=C(C#N)C(=O)Nc2ccccc2)cc1O,HKHOVJYOELRGMV-UHFFFAOYSA-N,,EGFR
985,ARRY-334543,EGFR inhibitor,EGFR,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,,EGFR
986,ARRY-334543,EGFR inhibitor,ERBB2,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,,ERBB2
987,AST-1306,EGFR inhibitor,EGFR,Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=O)C=C)cc34)cc2Cl)c1,MVZGYPSXNDCANY-UHFFFAOYSA-N,,EGFR
988,AST-1306,EGFR inhibitor,ERBB2,Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=O)C=C)cc34)cc2Cl)c1,MVZGYPSXNDCANY-UHFFFAOYSA-N,,ERBB2
989,BIBU-1361,EGFR inhibitor,EGFR,CCN(CC)CC1CCN(CC1)c1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,JUGSLZCFNSTKBN-UHFFFAOYSA-N,,EGFR
990,BIBX-1382,EGFR inhibitor,EGFR,CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,FTFRZXFNZVCRSK-UHFFFAOYSA-N,,EGFR
991,bis-tyrphostin,EGFR inhibitor,EGFR,Oc1ccc(/C=C(C#N)/C(=O)NCCCNC(=O)C(=Cc2ccc(O)c(O)c2)C#N)cc1O,ZHOKHSGWBNPFQU-GONBZBRSSA-N,,EGFR
992,BMS-599626,EGFR inhibitor,EGFR,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,EGFR
993,BMS-599626,EGFR inhibitor,ERBB2,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,ERBB2
994,BMS-599626,EGFR inhibitor,ERBB4,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,ERBB4
995,butein,EGFR inhibitor,ACE,Oc1ccc(C(=O)C=Cc2ccc(O)c(O)c2)c(O)c1,AYMYWHCQALZEGT-ORCRQEGFSA-N,,ACE
996,canertinib,EGFR inhibitor,EGFR,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,,EGFR
997,canertinib,EGFR inhibitor,ERBB2,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,,ERBB2
998,canertinib,EGFR inhibitor,ERBB4,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,,ERBB4
999,CGP-52411,EGFR inhibitor,EGFR,O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc12,AAALVYBICLMAMA-UHFFFAOYSA-N,,EGFR
1000,CGP-53353,EGFR inhibitor,EGFR,Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1,RONQPWQYDRPRGG-UHFFFAOYSA-N,,EGFR
1001,chrysophanic-acid,EGFR inhibitor,EGFR,Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1,LQGUBLBATBMXHT-UHFFFAOYSA-N,,EGFR
1002,chrysophanic-acid,EGFR inhibitor,MTOR,Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1,LQGUBLBATBMXHT-UHFFFAOYSA-N,,MTOR
1003,CP-724714,EGFR inhibitor,ERBB2,COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,LLVZBTWPGQVVLW-SNAWJCMRSA-N,,ERBB2
1004,dacomitinib,EGFR inhibitor,EGFR,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN1CCCCC1,LVXJQMNHJWSHET-AATRIKPKSA-N,,EGFR
1005,dacomitinib,EGFR inhibitor,ERBB2,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN1CCCCC1,LVXJQMNHJWSHET-AATRIKPKSA-N,,ERBB2
1006,dacomitinib,EGFR inhibitor,ERBB4,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN1CCCCC1,LVXJQMNHJWSHET-AATRIKPKSA-N,,ERBB4
1007,dovitinib,EGFR inhibitor,EGFR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,EGFR
1008,dovitinib,EGFR inhibitor,FGFR1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR1
1009,dovitinib,EGFR inhibitor,FGFR3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR3
1010,dovitinib,EGFR inhibitor,FGFR2,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR2
1011,dovitinib,EGFR inhibitor,FLT1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT1
1012,dovitinib,EGFR inhibitor,FLT3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT3
1013,dovitinib,EGFR inhibitor,FLT4,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT4
1014,dovitinib,EGFR inhibitor,KDR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KDR
1015,dovitinib,EGFR inhibitor,KIT,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KIT
1016,dovitinib,EGFR inhibitor,PDGFRB,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,PDGFRB
1017,erbstatin-analog,EGFR inhibitor,EGFR,COC(=O)C=Cc1cc(O)ccc1O,BQCNSTFWSKOWMA-GORDUTHDSA-N,,EGFR
1018,erlotinib,EGFR inhibitor,EGFR,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC,AAKJLRGGTJKAMG-UHFFFAOYSA-N,,EGFR
1019,gefitinib,EGFR inhibitor,EGFR,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,XGALLCVXEZPNRQ-UHFFFAOYSA-N,,EGFR
1020,GW-583340,EGFR inhibitor,EGFR,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,EGFR
1021,GW-583340,EGFR inhibitor,ERBB2,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,ERBB2
1022,lapatinib,EGFR inhibitor,EGFR,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,EGFR
1023,lapatinib,EGFR inhibitor,ERBB2,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,ERBB2
1024,lapatinib,EGFR inhibitor,EGFR,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,EGFR
1025,lapatinib,EGFR inhibitor,ERBB2,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,ERBB2
1026,lavendustin-c,EGFR inhibitor,EGFR,OC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,LULATDWLDJOKCX-UHFFFAOYSA-N,,EGFR
1027,lavendustin-c,EGFR inhibitor,SRC,OC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,LULATDWLDJOKCX-UHFFFAOYSA-N,,SRC
1028,lavendustin-c,EGFR inhibitor,CAMK2A,OC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,LULATDWLDJOKCX-UHFFFAOYSA-N,,CAMK2A
1029,LFM-A12,EGFR inhibitor,EGFR,CC(=O)C(C#N)C(=O)Nc1ccc(OC(F)(F)F)cc1,XXNKCLVHOZOIOC-UHFFFAOYSA-N,,EGFR
1030,neratinib,EGFR inhibitor,EGFR,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,JWNPDZNEKVCWMY-VQHVLOKHSA-N,,EGFR
1031,neratinib,EGFR inhibitor,ERBB2,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,JWNPDZNEKVCWMY-VQHVLOKHSA-N,,ERBB2
1032,neratinib,EGFR inhibitor,ERBB4,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,JWNPDZNEKVCWMY-VQHVLOKHSA-N,,ERBB4
1033,PD-158780,EGFR inhibitor,EGFR,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,KFHMLBXBRCITHF-UHFFFAOYSA-N,,EGFR
1034,pelitinib,EGFR inhibitor,EGFR,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,WVUNYSQLFKLYNI-AATRIKPKSA-N,,EGFR
1035,RG-14620,EGFR inhibitor,EGFR,Clc1cc(Cl)cc(/C=C(C#N)/c2cccnc2)c1,TYXIVBJQPBWBHO-UUILKARUSA-N,,EGFR
1036,rociletinib,EGFR inhibitor,EGFR,COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,,EGFR
1037,TAK-285,EGFR inhibitor,ERBB2,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12,ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,,ERBB2
1038,tyrphostin,EGFR inhibitor,ERBB2,COc1cc(C=C(C#N)C(=O)N)cc(CSc2nc3ccccc3s2)c1O,KXDONFLNGBQLTN-UHFFFAOYSA-N,,ERBB2
1039,vandetanib,EGFR inhibitor,EGFR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,EGFR
1040,vandetanib,EGFR inhibitor,FLT1,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT1
1041,vandetanib,EGFR inhibitor,FLT4,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT4
1042,vandetanib,EGFR inhibitor,KDR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,KDR
1043,vandetanib,EGFR inhibitor,PTK6,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,PTK6
1044,vandetanib,EGFR inhibitor,RET,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,RET
1045,vandetanib,EGFR inhibitor,TEK,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,TEK
1046,WZ-3146,EGFR inhibitor,EGFR,CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)cc1,APHGZZPEOCCYNO-UHFFFAOYSA-N,,EGFR
1047,WZ-4002,EGFR inhibitor,EGFR,COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1,ITTRLTNMFYIYPA-UHFFFAOYSA-N,,EGFR
1048,WZ-4002,EGFR inhibitor,ERBB2,COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1,ITTRLTNMFYIYPA-UHFFFAOYSA-N,,ERBB2
1049,LY-2183240,FAAH inhibitor,FAAH,CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1,GZNIYOXWFCDBBJ-UHFFFAOYSA-N,,FAAH
1050,AM-404,FAAH inhibitor,TRPV1,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-DOFZRALJSA-N,,TRPV1
1051,AM-404,FAAH inhibitor,TRPV1,CCCCCC=CCC=CCC=CCC=CCCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-UHFFFAOYSA-N,,TRPV1
1052,JNJ-1661010,FAAH inhibitor,FAAH,O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1,BHBOSTKQCZEAJM-UHFFFAOYSA-N,,FAAH
1053,PF-04457845,FAAH inhibitor,FAAH,FC(F)(F)c1ccc(Oc2cccc(C=C3CCN(CC3)C(=O)Nc3cccnn3)c2)nc1,BATCTBJIJJEPHM-UHFFFAOYSA-N,,FAAH
1054,PF-3845,FAAH inhibitor,FAAH,FC(F)(F)c1ccc(Oc2cccc(CC3CCN(CC3)C(=O)Nc3cccnc3)c2)nc1,NBOJHRYUGLRASX-UHFFFAOYSA-N,,FAAH
1055,PF-750,FAAH inhibitor,FAAH,O=C(Nc1ccccc1)N2CCC(Cc3cnc4ccccc4c3)CC2,BIODYGOZWZNCAG-UHFFFAOYSA-N,,FAAH
1056,brivanib,FGFR inhibitor,FGFR1,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,FGFR1
1057,brivanib,FGFR inhibitor,FLT1,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,FLT1
1058,brivanib,FGFR inhibitor,KDR,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,KDR
1059,brivanib,FGFR inhibitor,FGFR1,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,FGFR1
1060,brivanib,FGFR inhibitor,FLT1,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,FLT1
1061,brivanib,FGFR inhibitor,KDR,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,KDR
1062,dovitinib,FGFR inhibitor,EGFR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,EGFR
1063,dovitinib,FGFR inhibitor,FGFR1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR1
1064,dovitinib,FGFR inhibitor,FGFR3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR3
1065,dovitinib,FGFR inhibitor,FGFR2,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR2
1066,dovitinib,FGFR inhibitor,FLT1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT1
1067,dovitinib,FGFR inhibitor,FLT3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT3
1068,dovitinib,FGFR inhibitor,FLT4,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT4
1069,dovitinib,FGFR inhibitor,KDR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KDR
1070,dovitinib,FGFR inhibitor,KIT,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KIT
1071,dovitinib,FGFR inhibitor,PDGFRB,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,PDGFRB
1072,lenvatinib,FGFR inhibitor,FGFR1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FGFR1
1073,lenvatinib,FGFR inhibitor,FLT1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT1
1074,lenvatinib,FGFR inhibitor,FLT4,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT4
1075,lenvatinib,FGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KDR
1076,lenvatinib,FGFR inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KIT
1077,lucitanib,FGFR inhibitor,FGFR1,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FGFR1
1078,lucitanib,FGFR inhibitor,FGFR2,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FGFR2
1079,lucitanib,FGFR inhibitor,FLT1,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FLT1
1080,lucitanib,FGFR inhibitor,FLT4,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FLT4
1081,lucitanib,FGFR inhibitor,KDR,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,KDR
1082,MK-2461,FGFR inhibitor,FGFR1,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR1
1083,MK-2461,FGFR inhibitor,FGFR3,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR3
1084,MK-2461,FGFR inhibitor,FGFR2,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR2
1085,MK-2461,FGFR inhibitor,FLT1,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FLT1
1086,MK-2461,FGFR inhibitor,FLT3,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FLT3
1087,MK-2461,FGFR inhibitor,MET,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,MET
1088,nintedanib,FGFR inhibitor,FGFR1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR1
1089,nintedanib,FGFR inhibitor,FGFR3,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR3
1090,nintedanib,FGFR inhibitor,FLT1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT1
1091,nintedanib,FGFR inhibitor,FLT4,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT4
1092,nintedanib,FGFR inhibitor,KDR,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,KDR
1093,nintedanib,FGFR inhibitor,PDGFRA,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRA
1094,nintedanib,FGFR inhibitor,PDGFRB,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRB
1095,NVP-BGJ398,FGFR inhibitor,FGFR1,CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1,QADPYRIHXKWUSV-UHFFFAOYSA-N,,FGFR1
1096,NVP-BGJ398,FGFR inhibitor,FGFR3,CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1,QADPYRIHXKWUSV-UHFFFAOYSA-N,,FGFR3
1097,NVP-BGJ398,FGFR inhibitor,FGFR2,CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1,QADPYRIHXKWUSV-UHFFFAOYSA-N,,FGFR2
1098,NVP-BGJ398,FGFR inhibitor,FGFR4,CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1,QADPYRIHXKWUSV-UHFFFAOYSA-N,,FGFR4
1099,orantinib,FGFR inhibitor,FGFR1,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR1
1100,orantinib,FGFR inhibitor,FGFR2,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR2
1101,orantinib,FGFR inhibitor,KDR,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,KDR
1102,orantinib,FGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRA
1103,orantinib,FGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRB
1104,orantinib,FGFR inhibitor,AURKA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKA
1105,orantinib,FGFR inhibitor,AURKB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKB
1106,orantinib,FGFR inhibitor,FGFR1,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR1
1107,orantinib,FGFR inhibitor,FGFR2,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR2
1108,orantinib,FGFR inhibitor,KDR,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,KDR
1109,orantinib,FGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRA
1110,orantinib,FGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRB
1111,orantinib,FGFR inhibitor,AURKA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKA
1112,orantinib,FGFR inhibitor,AURKB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKB
1113,PD-173074,FGFR inhibitor,FGFR1,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,DXCUKNQANPLTEJ-UHFFFAOYSA-N,,FGFR1
1114,PD-173074,FGFR inhibitor,FGFR3,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,DXCUKNQANPLTEJ-UHFFFAOYSA-N,,FGFR3
1115,regorafenib,FGFR inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
1116,regorafenib,FGFR inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
1117,regorafenib,FGFR inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
1118,regorafenib,FGFR inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
1119,regorafenib,FGFR inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
1120,regorafenib,FGFR inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
1121,regorafenib,FGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
1122,regorafenib,FGFR inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
1123,regorafenib,FGFR inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
1124,regorafenib,FGFR inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
1125,regorafenib,FGFR inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
1126,regorafenib,FGFR inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
1127,regorafenib,FGFR inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
1128,regorafenib,FGFR inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
1129,regorafenib,FGFR inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
1130,regorafenib,FGFR inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
1131,fostamatinib,FLT3 inhibitor,SYK,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,NHHQJBCNYHBUSI-UHFFFAOYSA-N,,SYK
1132,amuvatinib,FLT3 inhibitor,FLT3,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,FLT3
1133,amuvatinib,FLT3 inhibitor,KIT,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,KIT
1134,amuvatinib,FLT3 inhibitor,MET,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,MET
1135,amuvatinib,FLT3 inhibitor,PDGFRA,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,PDGFRA
1136,AT-9283,FLT3 inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
1137,AT-9283,FLT3 inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
1138,AT-9283,FLT3 inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
1139,AT-9283,FLT3 inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
1140,BMS-777607,FLT3 inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
1141,BMS-777607,FLT3 inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
1142,BMS-777607,FLT3 inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
1143,BMS-777607,FLT3 inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
1144,BMS-777607,FLT3 inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
1145,dovitinib,FLT3 inhibitor,EGFR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,EGFR
1146,dovitinib,FLT3 inhibitor,FGFR1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR1
1147,dovitinib,FLT3 inhibitor,FGFR3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR3
1148,dovitinib,FLT3 inhibitor,FGFR2,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR2
1149,dovitinib,FLT3 inhibitor,FLT1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT1
1150,dovitinib,FLT3 inhibitor,FLT3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT3
1151,dovitinib,FLT3 inhibitor,FLT4,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT4
1152,dovitinib,FLT3 inhibitor,KDR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KDR
1153,dovitinib,FLT3 inhibitor,KIT,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KIT
1154,dovitinib,FLT3 inhibitor,PDGFRB,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,PDGFRB
1155,ENMD-2076,FLT3 inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,FLT3
1156,ENMD-2076,FLT3 inhibitor,KDR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,KDR
1157,ENMD-2076,FLT3 inhibitor,PDGFRA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,PDGFRA
1158,ENMD-2076,FLT3 inhibitor,SRC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,SRC
1159,ENMD-2076,FLT3 inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,AURKA
1160,GTP-14564,FLT3 inhibitor,FLT3,c1ccc(cc1)-c1n[nH]c2c1oc1ccccc21,DZQLVVLATXPWBK-UHFFFAOYSA-N,,FLT3
1161,KW-2449,FLT3 inhibitor,FGFR1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FGFR1
1162,KW-2449,FLT3 inhibitor,FLT3,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FLT3
1163,KW-2449,FLT3 inhibitor,ABL1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,ABL1
1164,KW-2449,FLT3 inhibitor,AURKA,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,AURKA
1165,lestaurtinib,FLT3 inhibitor,FLT3,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
1166,lestaurtinib,FLT3 inhibitor,NTRK1,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
1167,lestaurtinib,FLT3 inhibitor,FLT3,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
1168,lestaurtinib,FLT3 inhibitor,NTRK1,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
1169,midostaurin,FLT3 inhibitor,FLT3,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,FLT3
1170,midostaurin,FLT3 inhibitor,KIT,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,KIT
1171,pacritinib,FLT3 inhibitor,FLT3,C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COCC=CCOCc1c2)c3,HWXVIOGONBBTBY-ONEGZZNKSA-N,,FLT3
1172,pacritinib,FLT3 inhibitor,JAK2,C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COCC=CCOCc1c2)c3,HWXVIOGONBBTBY-ONEGZZNKSA-N,,JAK2
1173,ponatinib,FLT3 inhibitor,FGFR1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR1
1174,ponatinib,FLT3 inhibitor,FGFR3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR3
1175,ponatinib,FLT3 inhibitor,FGFR2,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR2
1176,ponatinib,FLT3 inhibitor,FGFR4,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR4
1177,ponatinib,FLT3 inhibitor,FLT3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FLT3
1178,ponatinib,FLT3 inhibitor,ABL1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,ABL1
1179,ponatinib,FLT3 inhibitor,KIT,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,KIT
1180,ponatinib,FLT3 inhibitor,RET,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,RET
1181,ponatinib,FLT3 inhibitor,BCR,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,BCR
1182,ponatinib,FLT3 inhibitor,TEK,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,TEK
1183,quizartinib,FLT3 inhibitor,CSF1R,CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1,CVWXJKQAOSCOAB-UHFFFAOYSA-N,,CSF1R
1184,quizartinib,FLT3 inhibitor,FLT3,CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1,CVWXJKQAOSCOAB-UHFFFAOYSA-N,,FLT3
1185,quizartinib,FLT3 inhibitor,KIT,CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1,CVWXJKQAOSCOAB-UHFFFAOYSA-N,,KIT
1186,quizartinib,FLT3 inhibitor,RET,CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1,CVWXJKQAOSCOAB-UHFFFAOYSA-N,,RET
1187,sorafenib,FLT3 inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
1188,sorafenib,FLT3 inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
1189,sorafenib,FLT3 inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
1190,sorafenib,FLT3 inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
1191,sorafenib,FLT3 inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
1192,sorafenib,FLT3 inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
1193,sorafenib,FLT3 inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
1194,sorafenib,FLT3 inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
1195,sorafenib,FLT3 inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
1196,sorafenib,FLT3 inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
1197,sorafenib,FLT3 inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
1198,sorafenib,FLT3 inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
1199,sorafenib,FLT3 inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
1200,sorafenib,FLT3 inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
1201,sorafenib,FLT3 inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
1202,sorafenib,FLT3 inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
1203,sorafenib,FLT3 inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
1204,sorafenib,FLT3 inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
1205,sorafenib,FLT3 inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
1206,sorafenib,FLT3 inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
1207,sorafenib,FLT3 inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
1208,sorafenib,FLT3 inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
1209,sunitinib,FLT3 inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT1
1210,sunitinib,FLT3 inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT3
1211,sunitinib,FLT3 inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT4
1212,sunitinib,FLT3 inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KDR
1213,sunitinib,FLT3 inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KIT
1214,sunitinib,FLT3 inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRA
1215,sunitinib,FLT3 inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRB
1216,sunitinib,FLT3 inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,RET
1217,tandutinib,FLT3 inhibitor,FLT3,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,FLT3
1218,tandutinib,FLT3 inhibitor,KIT,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,KIT
1219,tandutinib,FLT3 inhibitor,PDGFRA,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRA
1220,tandutinib,FLT3 inhibitor,PDGFRB,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRB
1221,TCS-359,FLT3 inhibitor,FLT3,COc1ccc(cc1OC)C(=O)Nc1sc2CCCCc2c1C(N)=O,FSPQCTGGIANIJZ-UHFFFAOYSA-N,,FLT3
1222,TG-02,FLT3 inhibitor,CDK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK2
1223,TG-02,FLT3 inhibitor,CDK7,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK7
1224,TG-02,FLT3 inhibitor,CDK9,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK9
1225,TG-02,FLT3 inhibitor,FLT3,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,FLT3
1226,TG-02,FLT3 inhibitor,JAK2,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,JAK2
1227,TG-02,FLT3 inhibitor,CDK1,CN1CC=CCCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,,CDK1
1228,TG-101348,FLT3 inhibitor,FLT3,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,,FLT3
1229,TG-101348,FLT3 inhibitor,JAK2,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,,JAK2
1230,tozasertib,FLT3 inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
1231,tozasertib,FLT3 inhibitor,ABL1,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
1232,tozasertib,FLT3 inhibitor,JAK2,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
1233,tozasertib,FLT3 inhibitor,BCR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
1234,tozasertib,FLT3 inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
1235,tozasertib,FLT3 inhibitor,AURKC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
1236,tozasertib,FLT3 inhibitor,AURKB,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
1237,tozasertib,FLT3 inhibitor,FLT3,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
1238,tozasertib,FLT3 inhibitor,ABL1,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
1239,tozasertib,FLT3 inhibitor,JAK2,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
1240,tozasertib,FLT3 inhibitor,BCR,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
1241,tozasertib,FLT3 inhibitor,AURKA,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
1242,tozasertib,FLT3 inhibitor,AURKC,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
1243,tozasertib,FLT3 inhibitor,AURKB,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
1244,GR-235,FXR antagonist,NR1H4,CC=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-OSJVMJFVSA-N,,NR1H4
1245,guggulsterone,FXR antagonist,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
1246,guggulsterone,FXR antagonist,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
1247,guggulsterone,FXR antagonist,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
1248,guggulsterone,FXR antagonist,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
1249,guggulsterone,FXR antagonist,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
1250,guggulsterone,FXR antagonist,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
1251,guggulsterone,FXR antagonist,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
1252,guggulsterone,FXR antagonist,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
1253,guggulsterone,FXR antagonist,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
1254,guggulsterone,FXR antagonist,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
1255,z-guggulsterone,FXR antagonist,NR1H4,CC=C1C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-AUKWTSKRSA-N,,NR1H4
1256,sanguinarium-chloride,FtsZ inhibitor,CASP3,C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12,INVGWHRKADIJHF-UHFFFAOYSA-N,,CASP3
1257,GANT-58,GLI antagonist,GLI1,c1cc(ccn1)-c1sc(c(c1-c1ccncc1)-c1ccncc1)-c1ccncc1,USWLOKMMUTWFMD-UHFFFAOYSA-N,,GLI1
1258,GANT-61,GLI antagonist,GLI1,CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1,KVQOGDQTWWCZFX-UHFFFAOYSA-N,,GLI1
1259,GANT-61,GLI antagonist,GLI2,CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1,KVQOGDQTWWCZFX-UHFFFAOYSA-N,,GLI2
1260,ACY-1215,HDAC inhibitor,HDAC6,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1,QGZYDVAGYRLSKP-UHFFFAOYSA-N,,HDAC6
1261,apicidin,HDAC inhibitor,HDAC6,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC6
1262,apicidin,HDAC inhibitor,HDAC5,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC5
1263,apicidin,HDAC inhibitor,HDAC1,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC1
1264,apicidin,HDAC inhibitor,HDAC2,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC2
1265,apicidin,HDAC inhibitor,HDAC7,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC7
1266,apicidin,HDAC inhibitor,HDAC8,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC8
1267,apicidin,HDAC inhibitor,HDAC11,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC11
1268,apicidin,HDAC inhibitor,HDAC10,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC10
1269,apicidin,HDAC inhibitor,HDAC3,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC3
1270,apicidin,HDAC inhibitor,HDAC9,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC9
1271,apicidin,HDAC inhibitor,HDAC4,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O,JWOGUUIOCYMBPV-VWIQTCEGSA-N,,HDAC4
1272,apicidin,HDAC inhibitor,HDAC6,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC6
1273,apicidin,HDAC inhibitor,HDAC5,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC5
1274,apicidin,HDAC inhibitor,HDAC1,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC1
1275,apicidin,HDAC inhibitor,HDAC2,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC2
1276,apicidin,HDAC inhibitor,HDAC7,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC7
1277,apicidin,HDAC inhibitor,HDAC8,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC8
1278,apicidin,HDAC inhibitor,HDAC11,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC11
1279,apicidin,HDAC inhibitor,HDAC10,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC10
1280,apicidin,HDAC inhibitor,HDAC3,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC3
1281,apicidin,HDAC inhibitor,HDAC9,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC9
1282,apicidin,HDAC inhibitor,HDAC4,CCC(C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O,JWOGUUIOCYMBPV-LQJYRIKDSA-N,,HDAC4
1283,belinostat,HDAC inhibitor,HDAC6,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC6
1284,belinostat,HDAC inhibitor,HDAC5,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC5
1285,belinostat,HDAC inhibitor,HDAC1,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC1
1286,belinostat,HDAC inhibitor,HDAC2,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC2
1287,belinostat,HDAC inhibitor,HDAC7,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC7
1288,belinostat,HDAC inhibitor,HDAC8,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC8
1289,belinostat,HDAC inhibitor,HDAC3,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC3
1290,belinostat,HDAC inhibitor,HDAC9,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC9
1291,belinostat,HDAC inhibitor,HDAC4,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,,HDAC4
1292,dacinostat,HDAC inhibitor,HDAC1,OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(C=CC(=O)NO)cc1,BWDQBBCUWLSASG-MDZDMXLPSA-N,,HDAC1
1293,droxinostat,HDAC inhibitor,HDAC6,Cc1cc(Cl)ccc1OCCCC(=O)NO,JHSXDAWGLCZYSM-UHFFFAOYSA-N,,HDAC6
1294,droxinostat,HDAC inhibitor,HDAC8,Cc1cc(Cl)ccc1OCCCC(=O)NO,JHSXDAWGLCZYSM-UHFFFAOYSA-N,,HDAC8
1295,entinostat,HDAC inhibitor,HDAC1,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,INVTYAOGFAGBOE-UHFFFAOYSA-N,,HDAC1
1296,givinostat,HDAC inhibitor,HDAC2,CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(cc3)C(=O)NO)ccc2c1,YALNUENQHAQXEA-UHFFFAOYSA-N,,HDAC2
1297,MC1568,HDAC inhibitor,HDAC2,CN1C=C(C=C1C=CC(=O)NO)C=CC(=O)C2=CC(=CC=C2)F,QRDAPCMJAOQZSU-UHFFFAOYSA-N,,HDAC2
1298,mocetinostat,HDAC inhibitor,HDAC1,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1,HRNLUBSXIHFDHP-UHFFFAOYSA-N,,HDAC1
1299,mocetinostat,HDAC inhibitor,HDAC2,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1,HRNLUBSXIHFDHP-UHFFFAOYSA-N,,HDAC2
1300,mocetinostat,HDAC inhibitor,HDAC11,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1,HRNLUBSXIHFDHP-UHFFFAOYSA-N,,HDAC11
1301,mocetinostat,HDAC inhibitor,HDAC3,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1,HRNLUBSXIHFDHP-UHFFFAOYSA-N,,HDAC3
1302,NCH-51,HDAC inhibitor,HDAC6,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC6
1303,NCH-51,HDAC inhibitor,HDAC5,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC5
1304,NCH-51,HDAC inhibitor,HDAC1,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC1
1305,NCH-51,HDAC inhibitor,HDAC2,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC2
1306,NCH-51,HDAC inhibitor,HDAC7,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC7
1307,NCH-51,HDAC inhibitor,HDAC8,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC8
1308,NCH-51,HDAC inhibitor,HDAC11,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC11
1309,NCH-51,HDAC inhibitor,HDAC10,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC10
1310,NCH-51,HDAC inhibitor,HDAC3,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC3
1311,NCH-51,HDAC inhibitor,HDAC9,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC9
1312,NCH-51,HDAC inhibitor,HDAC4,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1,MDYDGUOQFUQOGE-UHFFFAOYSA-N,,HDAC4
1313,NSC-3852,HDAC inhibitor,HDAC1,Oc1ccc([N+][O-])c2cccnc12,RZWRYPGAUIOOMK-UHFFFAOYSA-N,,HDAC1
1314,panobinostat,HDAC inhibitor,HDAC1,Cc1[nH]c2ccccc2c1CCNCc1ccc(C=CC(=O)NO)cc1,FPOHNWQLNRZRFC-ZHACJKMWSA-N,,HDAC1
1315,panobinostat,HDAC inhibitor,HDAC2,Cc1[nH]c2ccccc2c1CCNCc1ccc(C=CC(=O)NO)cc1,FPOHNWQLNRZRFC-ZHACJKMWSA-N,,HDAC2
1316,PCI-24781,HDAC inhibitor,HDAC6,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N,,HDAC6
1317,PCI-24781,HDAC inhibitor,HDAC1,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N,,HDAC1
1318,PCI-24781,HDAC inhibitor,HDAC2,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N,,HDAC2
1319,PCI-24781,HDAC inhibitor,HDAC10,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N,,HDAC10
1320,PCI-24781,HDAC inhibitor,HDAC3,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N,,HDAC3
1321,PCI-34051,HDAC inhibitor,HDAC6,COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1,AJRGHIGYPXNABY-UHFFFAOYSA-N,,HDAC6
1322,PCI-34051,HDAC inhibitor,HDAC1,COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1,AJRGHIGYPXNABY-UHFFFAOYSA-N,,HDAC1
1323,PCI-34051,HDAC inhibitor,HDAC8,COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1,AJRGHIGYPXNABY-UHFFFAOYSA-N,,HDAC8
1324,PCI-34051,HDAC inhibitor,HDAC10,COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1,AJRGHIGYPXNABY-UHFFFAOYSA-N,,HDAC10
1325,resminostat,HDAC inhibitor,HDAC1,CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)C=CC(=O)NO,FECGNJPYVFEKOD-VMPITWQZSA-N,,HDAC1
1326,RGFP-966,HDAC inhibitor,ALOX5,Nc1cc(F)ccc1NC(=O)C=Cc1cnn(CC=Cc2ccccc2)c1,BLVQHYHDYFTPDV-VCABWLAWSA-N,,ALOX5
1327,RGFP-966,HDAC inhibitor,HDAC3,Nc1cc(F)ccc1NC(=O)C=Cc1cnn(CC=Cc2ccccc2)c1,BLVQHYHDYFTPDV-VCABWLAWSA-N,,HDAC3
1328,romidepsin,HDAC inhibitor,HDAC1,CC=C1/NC(=O)[C@H]2CSSCCC=C[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N,,HDAC1
1329,romidepsin,HDAC inhibitor,HDAC2,CC=C1/NC(=O)[C@H]2CSSCCC=C[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N,,HDAC2
1330,SB-939,HDAC inhibitor,HDAC5,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC5
1331,SB-939,HDAC inhibitor,HDAC1,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC1
1332,SB-939,HDAC inhibitor,HDAC2,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC2
1333,SB-939,HDAC inhibitor,HDAC10,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC10
1334,SB-939,HDAC inhibitor,HDAC3,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC3
1335,SB-939,HDAC inhibitor,HDAC9,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC9
1336,SB-939,HDAC inhibitor,HDAC4,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,,HDAC4
1337,scriptaid,HDAC inhibitor,HDAC1,ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23,JTDYUFSDZATMKU-UHFFFAOYSA-N,,HDAC1
1338,sodium-butyrate,HDAC inhibitor,HDAC1,CCCC(O)=O,FERIUCNNQQJTOY-UHFFFAOYSA-N,,HDAC1
1339,tubacin,HDAC inhibitor,HDAC6,OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)O[C@@H](O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6,BHUZLJOUHMBZQY-YXQOSMAKSA-N,,HDAC6
1340,tubastatin-a,HDAC inhibitor,HDAC6,CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO,GOVYBPLHWIEHEJ-UHFFFAOYSA-N,,HDAC6
1341,valproic-acid,HDAC inhibitor,ABAT,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ABAT
1342,valproic-acid,HDAC inhibitor,HDAC1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,HDAC1
1343,valproic-acid,HDAC inhibitor,SCN1A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN1A
1344,valproic-acid,HDAC inhibitor,SCN3A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN3A
1345,valproic-acid,HDAC inhibitor,ALDH5A1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ALDH5A1
1346,vorinostat,HDAC inhibitor,HDAC6,ONC(=O)CCCCCCC(=O)Nc1ccccc1,WAEXFXRVDQXREF-UHFFFAOYSA-N,,HDAC6
1347,vorinostat,HDAC inhibitor,HDAC1,ONC(=O)CCCCCCC(=O)Nc1ccccc1,WAEXFXRVDQXREF-UHFFFAOYSA-N,,HDAC1
1348,vorinostat,HDAC inhibitor,HDAC2,ONC(=O)CCCCCCC(=O)Nc1ccccc1,WAEXFXRVDQXREF-UHFFFAOYSA-N,,HDAC2
1349,vorinostat,HDAC inhibitor,HDAC8,ONC(=O)CCCCCCC(=O)Nc1ccccc1,WAEXFXRVDQXREF-UHFFFAOYSA-N,,HDAC8
1350,vorinostat,HDAC inhibitor,HDAC3,ONC(=O)CCCCCCC(=O)Nc1ccccc1,WAEXFXRVDQXREF-UHFFFAOYSA-N,,HDAC3
1351,WT-171,HDAC inhibitor,HDAC6,ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3,KXWWYFKVBFUVIZ-SGWCAAJKSA-N,,HDAC6
1352,4-mu-8C,IRE1 inhibitor,ERN1,Cc1cc(=O)oc2c(C=O)c(O)ccc12,RTHHSXOVIJWFQP-UHFFFAOYSA-N,,ERN1
1353,minoxidil,KATP activator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
1354,minoxidil,KATP activator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
1355,minoxidil,KATP activator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
1356,minoxidil,KATP activator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
1357,minoxidil,KATP activator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
1358,minoxidil,KATP activator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
1359,BMS-387032,MCL1 inhibitor,CDK2,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK2
1360,BMS-387032,MCL1 inhibitor,CDK7,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK7
1361,BMS-387032,MCL1 inhibitor,CDK9,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK9
1362,gossypol,MCL1 inhibitor,MCL1,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,MCL1
1363,gossypol,MCL1 inhibitor,BCL2,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,BCL2
1364,gossypol,MCL1 inhibitor,BCL2L1,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,QBKSWRVVCFFDOT-UHFFFAOYSA-N,,BCL2L1
1365,AZD-8055,MTOR inhibitor,MTOR,COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,KVLFRAWTRWDEDF-IRXDYDNUSA-N,,MTOR
1366,deforolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O,BUROJSBIWGDYCN-LWCFFJEVSA-N,,MTOR
1367,deforolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OP(C)(C)=O,BUROJSBIWGDYCN-HSPIJORXSA-N,,MTOR
1368,everolimus,MTOR inhibitor,MTOR,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,HKVAMNSJSFKALM-UHFFFAOYSA-N,,MTOR
1369,everolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO,HKVAMNSJSFKALM-GKUWKFKPSA-N,,MTOR
1370,everolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO,HKVAMNSJSFKALM-MUKRYTAKSA-N,,MTOR
1371,GDC-0980,MTOR inhibitor,MTOR,C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,,MTOR
1372,GDC-0980,MTOR inhibitor,PIK3CG,C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,,PIK3CG
1373,GDC-0980,MTOR inhibitor,MTOR,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,YOVVNQKCSKSHKT-UHFFFAOYSA-N,,MTOR
1374,GDC-0980,MTOR inhibitor,PIK3CG,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,YOVVNQKCSKSHKT-UHFFFAOYSA-N,,PIK3CG
1375,kawain,MTOR inhibitor,MTOR,COC1=CC(=O)O[C@H](C1)/C=C/c2ccccc2,XEAQIWGXBXCYFX-GUOLPTJISA-N,,MTOR
1376,KU-0063794,MTOR inhibitor,MTOR,COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1,RFSMUFRPPYDYRD-CALCHBBNSA-N,,MTOR
1377,LY-294002,MTOR inhibitor,MTOR,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,MTOR
1378,LY-294002,MTOR inhibitor,PIK3CA,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CA
1379,LY-294002,MTOR inhibitor,PIK3CB,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CB
1380,LY-294002,MTOR inhibitor,PIK3CD,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CD
1381,LY-294002,MTOR inhibitor,PIK3CG,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CG
1382,LY-294002,MTOR inhibitor,PLK1,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PLK1
1383,LY-294002,MTOR inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PRKDC
1384,NU-7026,MTOR inhibitor,PRKDC,O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1,KKTZALUTXUZPSN-UHFFFAOYSA-N,,PRKDC
1385,OSI-027,MTOR inhibitor,MTOR,COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21,CDNMDRUIGNHEMR-UHFFFAOYSA-N,,MTOR
1386,OSI-027,MTOR inhibitor,MTOR,COc1cccc2cc([nH]c12)-c1nc([C@@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12,JROFGZPOBKIAEW-TXEJJXNPSA-N,,MTOR
1387,OSI-027,MTOR inhibitor,MTOR,COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12,JROFGZPOBKIAEW-HAQNSBGRSA-N,,MTOR
1388,PF-04691502,MTOR inhibitor,MTOR,COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O,XDLYKKIQACFMJG-WKILWMFISA-N,,MTOR
1389,PF-04691502,MTOR inhibitor,PIK3CA,COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O,XDLYKKIQACFMJG-WKILWMFISA-N,,PIK3CA
1390,PF-05212384,MTOR inhibitor,MTOR,CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,,MTOR
1391,PF-05212384,MTOR inhibitor,PIK3CA,CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,,PIK3CA
1392,PI-103,MTOR inhibitor,MTOR,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,MTOR
1393,PI-103,MTOR inhibitor,PIK3CA,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CA
1394,PI-103,MTOR inhibitor,PIK3CB,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CB
1395,PI-103,MTOR inhibitor,PIK3CD,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CD
1396,PI-103,MTOR inhibitor,PIK3CG,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CG
1397,PKI-179,MTOR inhibitor,MTOR,O=C(Nc1ccncc1)Nc1ccc(cc1)-c1nc(nc(n1)N1CCOCC1)N1C2CCC1COC2,WXUUCRLKXQMWRY-UHFFFAOYSA-N,,MTOR
1398,salirasib,MTOR inhibitor,TRPA1,CC(C)=CCCC(C)=CCCC(C)=CCSc1ccccc1C(O)=O,WUILNKCFCLNXOK-CFBAGHHKSA-N,,TRPA1
1399,SB-2343,MTOR inhibitor,MTOR,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,MTOR
1400,SB-2343,MTOR inhibitor,PIK3CA,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CA
1401,SB-2343,MTOR inhibitor,PIK3CB,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CB
1402,SB-2343,MTOR inhibitor,PIK3CD,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CD
1403,SB-2343,MTOR inhibitor,PIK3CG,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CG
1404,sirolimus,MTOR inhibitor,FKBP1A,CC[C@@H]1C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(C)=C[C@@H]1CC[C@@H](O)[C@@H](C1)OC,ZDQSOHOQTUFQEM-NURRSENYSA-N,,FKBP1A
1405,sirolimus,MTOR inhibitor,MTOR,CC[C@@H]1C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(C)=C[C@@H]1CC[C@@H](O)[C@@H](C1)OC,ZDQSOHOQTUFQEM-NURRSENYSA-N,,MTOR
1406,sirolimus,MTOR inhibitor,FKBP1A,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-HPLJOQBZSA-N,,FKBP1A
1407,sirolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-HPLJOQBZSA-N,,MTOR
1408,sirolimus,MTOR inhibitor,FKBP1A,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-HPLJOQBZSA-N,,FKBP1A
1409,sirolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-HPLJOQBZSA-N,,MTOR
1410,sirolimus,MTOR inhibitor,FKBP1A,CO[C@@H]1C[C@H](CC(C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-DENUVPQMSA-N,,FKBP1A
1411,sirolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](CC(C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-DENUVPQMSA-N,,MTOR
1412,sirolimus,MTOR inhibitor,FKBP1A,CO[C@@H]1CC(CC(C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@@H](C)C[C@H](C)C=CC=CC=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-GWUMUYGYSA-N,,FKBP1A
1413,sirolimus,MTOR inhibitor,MTOR,CO[C@@H]1CC(CC(C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@@H](C)C[C@H](C)C=CC=CC=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,QFJCIRLUMZQUOT-GWUMUYGYSA-N,,MTOR
1414,sirolimus,MTOR inhibitor,FKBP1A,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O,QFJCIRLUMZQUOT-XWBLMERNSA-N,,FKBP1A
1415,sirolimus,MTOR inhibitor,MTOR,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O,QFJCIRLUMZQUOT-XWBLMERNSA-N,,MTOR
1416,temsirolimus,MTOR inhibitor,MTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO,CBPNZQVSJQDFBE-SREVRWKESA-N,,MTOR
1417,temsirolimus,MTOR inhibitor,MTOR,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1OC(=O)C(C)(CO)CO,CBPNZQVSJQDFBE-WEDGMEQVSA-N,,MTOR
1418,voxtalisib,MTOR inhibitor,MTOR,CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O,RGHYDLZMTYDBDT-UHFFFAOYSA-N,,MTOR
1419,voxtalisib,MTOR inhibitor,PIK3CA,CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O,RGHYDLZMTYDBDT-UHFFFAOYSA-N,,PIK3CA
1420,WYE-125132,MTOR inhibitor,MTOR,CNC(=O)Nc1ccc(cc1)-c1nc(N2CC3CCC(C2)O3)c2cnn(C3CCC4(CC3)OCCO4)c2n1,QLHHRYZMBGPBJG-UHFFFAOYSA-N,,MTOR
1421,WYE-354,MTOR inhibitor,MTOR,COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(CC3)C(=O)OC)c2n1,IMXHGCRIEAKIBU-UHFFFAOYSA-N,,MTOR
1422,BRD-K91781484,NRF2 activator,NFE2L2,S=c1ccss1,LZENMJMJWQSSNJ-UHFFFAOYSA-N,,NFE2L2
1423,dimethyl-fumarate,NRF2 activator,NFE2L2,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,NFE2L2
1424,dimethyl-fumarate,NRF2 activator,KEAP1,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,KEAP1
1425,4-HQN,PARP inhibitor,PARP1,Oc1ncnc2ccccc12,QMNUDYFKZYBWQX-UHFFFAOYSA-N,,PARP1
1426,AG-14361,PARP inhibitor,PARP1,CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23,SEKJSSBJKFLZIT-UHFFFAOYSA-N,,PARP1
1427,BYK-204165,PARP inhibitor,PARP1,Cn1cccc1C=C1/C(=O)NC(=O)c2ccccc12,BTYSIDSTHDDAJW-LCYFTJDESA-N,,PARP1
1428,CS-1657,PARP inhibitor,PARP1,Nc1ccc2C(=O)NC(=O)c3cccc1c32,SSMIFVHARFVINF-UHFFFAOYSA-N,,PARP1
1429,endo-IWR-1,PARP inhibitor,TNKS2,O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O,ZGSXEXBYLJIOGF-ALFLXDJESA-N,,TNKS2
1430,endo-IWR-1,PARP inhibitor,TNKS,O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O,ZGSXEXBYLJIOGF-ALFLXDJESA-N,,TNKS
1431,hypoxanthine,PARP inhibitor,PNP,O=c1[nH]cnc2nc[nH]c12,FDGQSTZJBFJUBT-UHFFFAOYSA-N,,PNP
1432,iniparib,PARP inhibitor,PARP1,NC(=O)c1ccc(I)c(c1)[N+]([O-])=O,MDOJTZQKHMAPBK-UHFFFAOYSA-N,,PARP1
1433,NU-1025,PARP inhibitor,PARP1,Cc1nc2c(O)cccc2c(=O)[nH]1,YJDAOHJWLUNFLX-UHFFFAOYSA-N,,PARP1
1434,olaparib,PARP inhibitor,PARP2,Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N,,PARP2
1435,olaparib,PARP inhibitor,PARP1,Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N,,PARP1
1436,phenanthridone,PARP inhibitor,PARP1,O=c1[nH]c2ccccc2c3ccccc13,RZFVLEJOHSLEFR-UHFFFAOYSA-N,,PARP1
1437,rucaparib,PARP inhibitor,PARP2,CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23,HMABYWSNWIZPAG-UHFFFAOYSA-N,,PARP2
1438,rucaparib,PARP inhibitor,PARP1,CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23,HMABYWSNWIZPAG-UHFFFAOYSA-N,,PARP1
1439,S-111,PARP inhibitor,PARP1,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C,PYXFVCFISTUSOO-HKUCOEKDSA-N,,PARP1
1440,talazoparib,PARP inhibitor,PARP2,Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N,,PARP2
1441,talazoparib,PARP inhibitor,PARP1,Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N,,PARP1
1442,UPF-1069,PARP inhibitor,PARP2,O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1,JJWMRRNGWSITSQ-UHFFFAOYSA-N,,PARP2
1443,veliparib,PARP inhibitor,PARP2,C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-ZDUSSCGKSA-N,,PARP2
1444,veliparib,PARP inhibitor,PARP1,C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-ZDUSSCGKSA-N,,PARP1
1445,veliparib,PARP inhibitor,PARP2,C[C@@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,,PARP2
1446,veliparib,PARP inhibitor,PARP1,C[C@@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,,PARP1
1447,veliparib,PARP inhibitor,PARP2,CC1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-UHFFFAOYSA-N,,PARP2
1448,veliparib,PARP inhibitor,PARP1,CC1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,JNAHVYVRKWKWKQ-UHFFFAOYSA-N,,PARP1
1449,alpelisib,PI3K inhibitor,PIK3CA,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F,STUWGJZDJHPWGZ-LBPRGKRZSA-N,,PIK3CA
1450,AS-604850,PI3K inhibitor,PIK3CG,FC1(F)Oc2ccc(cc2O1)C=C1/SC(=O)NC1=O,SRLVNYDXMUGOFI-YWEYNIOJSA-N,,PIK3CG
1451,AS-605240,PI3K inhibitor,PIK3CG,O=C1NC(=O)C(S1)=C/c1ccc2nccnc2c1,SQWZFLMPDUSYGV-UXBLZVDNSA-N,,PIK3CG
1452,AS-605240,PI3K inhibitor,PIK3CG,O=C1NC(=O)C(S1)=Cc1ccc2nccnc2c1,SQWZFLMPDUSYGV-POHAHGRESA-N,,PIK3CG
1453,AZD-6482,PI3K inhibitor,PIK3CB,C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,IRTDIKMSKMREGO-OAHLLOKOSA-N,,PIK3CB
1454,AZD-6482,PI3K inhibitor,PIK3CD,C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,IRTDIKMSKMREGO-OAHLLOKOSA-N,,PIK3CD
1455,AZD-6482,PI3K inhibitor,PIK3CG,C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,IRTDIKMSKMREGO-OAHLLOKOSA-N,,PIK3CG
1456,BRD-K75430629,PI3K inhibitor,PIK3CD,Cc1ccccc1n2c(Cn3cnc4c(N)ncnc34)nc5cccc(C)c5c2=O,GNWHRHGTIBRNSM-UHFFFAOYSA-N,,PIK3CD
1457,buparlisib,PI3K inhibitor,PIK3CA,Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F,CWHUFRVAEUJCEF-UHFFFAOYSA-N,,PIK3CA
1458,copanlisib,PI3K inhibitor,PIK3CA,COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12,PZBCKZWLPGJMAO-UHFFFAOYSA-N,,PIK3CA
1459,copanlisib,PI3K inhibitor,PIK3CD,COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12,PZBCKZWLPGJMAO-UHFFFAOYSA-N,,PIK3CD
1460,GDC-0941,PI3K inhibitor,PIK3CG,CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1,LHNIIDJUOCFXAP-UHFFFAOYSA-N,,PIK3CG
1461,GDC-0980,PI3K inhibitor,MTOR,C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,,MTOR
1462,GDC-0980,PI3K inhibitor,PIK3CG,C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,,PIK3CG
1463,GDC-0980,PI3K inhibitor,MTOR,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,YOVVNQKCSKSHKT-UHFFFAOYSA-N,,MTOR
1464,GDC-0980,PI3K inhibitor,PIK3CG,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,YOVVNQKCSKSHKT-UHFFFAOYSA-N,,PIK3CG
1465,idelalisib,PI3K inhibitor,PIK3CD,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,IFSDAJWBUCMOAH-HNNXBMFYSA-N,,PIK3CD
1466,idelalisib,PI3K inhibitor,PIK3CG,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,IFSDAJWBUCMOAH-HNNXBMFYSA-N,,PIK3CG
1467,IPI-145,PI3K inhibitor,PIK3CD,C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,SJVQHLPISAIATJ-ZDUSSCGKSA-N,,PIK3CD
1468,IPI-145,PI3K inhibitor,PIK3CG,C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,SJVQHLPISAIATJ-ZDUSSCGKSA-N,,PIK3CG
1469,KU-0060648,PI3K inhibitor,PIK3CA,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CA
1470,KU-0060648,PI3K inhibitor,PIK3CB,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CB
1471,KU-0060648,PI3K inhibitor,PIK3CD,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CD
1472,KU-0060648,PI3K inhibitor,PRKDC,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PRKDC
1473,LY-303511,PI3K inhibitor,BRD4,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD4
1474,LY-303511,PI3K inhibitor,BRD2,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD2
1475,LY-303511,PI3K inhibitor,BRD3,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD3
1476,NU-7026,PI3K inhibitor,PRKDC,O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1,KKTZALUTXUZPSN-UHFFFAOYSA-N,,PRKDC
1477,PF-04691502,PI3K inhibitor,MTOR,COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O,XDLYKKIQACFMJG-WKILWMFISA-N,,MTOR
1478,PF-04691502,PI3K inhibitor,PIK3CA,COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O,XDLYKKIQACFMJG-WKILWMFISA-N,,PIK3CA
1479,PF-05212384,PI3K inhibitor,MTOR,CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,,MTOR
1480,PF-05212384,PI3K inhibitor,PIK3CA,CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,,PIK3CA
1481,PI-103,PI3K inhibitor,MTOR,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,MTOR
1482,PI-103,PI3K inhibitor,PIK3CA,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CA
1483,PI-103,PI3K inhibitor,PIK3CB,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CB
1484,PI-103,PI3K inhibitor,PIK3CD,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CD
1485,PI-103,PI3K inhibitor,PIK3CG,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,TUVCWJQQGGETHL-UHFFFAOYSA-N,,PIK3CG
1486,PIK-75,PI3K inhibitor,PIK3CA,CN(N=Cc1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,,PIK3CA
1487,PIK-75,PI3K inhibitor,PIK3CA,CN(N=Cc1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,,PIK3CA
1488,PIK-93,PI3K inhibitor,PI4KB,CC(=O)Nc1nc(C)c(s1)-c1ccc(Cl)c(c1)S(=O)(=O)NCCO,JFVNFXCESCXMBC-UHFFFAOYSA-N,,PI4KB
1489,PKI-179,PI3K inhibitor,MTOR,O=C(Nc1ccncc1)Nc1ccc(cc1)-c1nc(nc(n1)N1CCOCC1)N1C2CCC1COC2,WXUUCRLKXQMWRY-UHFFFAOYSA-N,,MTOR
1490,SB-2343,PI3K inhibitor,MTOR,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,MTOR
1491,SB-2343,PI3K inhibitor,PIK3CA,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CA
1492,SB-2343,PI3K inhibitor,PIK3CB,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CB
1493,SB-2343,PI3K inhibitor,PIK3CD,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CD
1494,SB-2343,PI3K inhibitor,PIK3CG,CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1,QYBGBLQCOOISAR-UHFFFAOYSA-N,,PIK3CG
1495,taselisib,PI3K inhibitor,PIK3CA,CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,,PIK3CA
1496,TGX-221,PI3K inhibitor,PIK3CB,CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,CPRAGQJXBLMUEL-UHFFFAOYSA-N,,PIK3CB
1497,voxtalisib,PI3K inhibitor,MTOR,CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O,RGHYDLZMTYDBDT-UHFFFAOYSA-N,,MTOR
1498,voxtalisib,PI3K inhibitor,PIK3CA,CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O,RGHYDLZMTYDBDT-UHFFFAOYSA-N,,PIK3CA
1499,wortmannin,PI3K inhibitor,PIK3CA,COC[C@H]1OC(=O)c2coc3C(=O)C4=C([C@@H](C[C@@]5(C)C4CCC5=O)OC(=O)C)[C@]1(C)c23,QDLHCMPXEPAAMD-ZGSWIPFCSA-N,,PIK3CA
1500,wortmannin,PI3K inhibitor,PIK3CG,COC[C@H]1OC(=O)c2coc3C(=O)C4=C([C@@H](C[C@@]5(C)C4CCC5=O)OC(=O)C)[C@]1(C)c23,QDLHCMPXEPAAMD-ZGSWIPFCSA-N,,PIK3CG
1501,wortmannin,PI3K inhibitor,PLK1,COC[C@H]1OC(=O)c2coc3C(=O)C4=C([C@@H](C[C@@]5(C)C4CCC5=O)OC(=O)C)[C@]1(C)c23,QDLHCMPXEPAAMD-ZGSWIPFCSA-N,,PLK1
1502,wortmannin,PI3K inhibitor,PIK3CA,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O,QDLHCMPXEPAAMD-QAIWCSMKSA-N,,PIK3CA
1503,wortmannin,PI3K inhibitor,PIK3CG,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O,QDLHCMPXEPAAMD-QAIWCSMKSA-N,,PIK3CG
1504,wortmannin,PI3K inhibitor,PLK1,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O,QDLHCMPXEPAAMD-QAIWCSMKSA-N,,PLK1
1505,wortmannin,PI3K inhibitor,PIK3CA,COCC1OC(=O)c2coc3c2C1(C)C1=C(C2CCC(=O)C2(C)CC1OC(C)=O)C3=O,QDLHCMPXEPAAMD-UHFFFAOYSA-N,,PIK3CA
1506,wortmannin,PI3K inhibitor,PIK3CG,COCC1OC(=O)c2coc3c2C1(C)C1=C(C2CCC(=O)C2(C)CC1OC(C)=O)C3=O,QDLHCMPXEPAAMD-UHFFFAOYSA-N,,PIK3CG
1507,wortmannin,PI3K inhibitor,PLK1,COCC1OC(=O)c2coc3c2C1(C)C1=C(C2CCC(=O)C2(C)CC1OC(C)=O)C3=O,QDLHCMPXEPAAMD-UHFFFAOYSA-N,,PLK1
1508,XL-147,PI3K inhibitor,PIK3CA,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1,MQMKRQLTIWPEDM-UHFFFAOYSA-N,,PIK3CA
1509,XL-147,PI3K inhibitor,PIK3CD,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1,MQMKRQLTIWPEDM-UHFFFAOYSA-N,,PIK3CD
1510,XL-147,PI3K inhibitor,PIK3CG,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1,MQMKRQLTIWPEDM-UHFFFAOYSA-N,,PIK3CG
1511,ZSTK-474,PI3K inhibitor,PIK3CG,FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1,HGVNLRPZOWWDKD-UHFFFAOYSA-N,,PIK3CG
1512,BRD-A32917072,ROR antagonist,RORC,COc1cc(O)c(C(CC(=O)N2CCCC(C)C2)c3ccc4OCOc4c3)c(OC)c1,ISXDTMVXKAPUDE-UHFFFAOYSA-N,,RORC
1513,BRD-A38793261,ROR antagonist,RORC,COc1cc(O)c([C@@H](CC(=O)N2CC(C)CC(C)C2)c2ccc3OCOc3c2)c(OC)c1,YEKVAIMYYCZDLI-RJYAGPCLSA-N,,RORC
1514,acexamic-acid,Reducing agent,GAST,CC(=O)NCCCCCC(O)=O,WDSCBUNMANHPFH-UHFFFAOYSA-N,,GAST
1515,ginkgolide-b,Reducing agent,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
1516,ginkgolide-b,Reducing agent,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
1517,ginkgolide-b,Reducing agent,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
1518,ginkgolide-b,Reducing agent,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
1519,ginkgolide-b,Reducing agent,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
1520,ginkgolide-b,Reducing agent,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
1521,amitifadine,SERT inhibitor,SLC6A2,Clc1ccc(cc1Cl)C12CC1CNC2,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,,SLC6A2
1522,amitifadine,SERT inhibitor,SLC6A3,Clc1ccc(cc1Cl)C12CC1CNC2,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,,SLC6A3
1523,amitifadine,SERT inhibitor,SLC6A4,Clc1ccc(cc1Cl)C12CC1CNC2,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,,SLC6A4
1524,clomipramine,SERT inhibitor,SLC6A2,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12,GDLIGKIOYRNHDA-UHFFFAOYSA-N,,SLC6A2
1525,clomipramine,SERT inhibitor,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12,GDLIGKIOYRNHDA-UHFFFAOYSA-N,,SLC6A4
1526,SRT-1720,SIRT activator,SIRT1,O=C(Nc1cc(CN2CCNCC2)cc(c1)-c1nc2ccccc2[nH]1)c1cnc2ccccc2n1,GXDSSUIUJKSVED-UHFFFAOYSA-N,,SIRT1
1527,resveratrol,SIRT activator,SIRT1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,SIRT1
1528,resveratrol,SIRT activator,PTGS1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,PTGS1
1529,resveratrol,SIRT activator,PTGS2,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,PTGS2
1530,resveratrol,SIRT activator,SIRT1,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,SIRT1
1531,resveratrol,SIRT activator,PTGS1,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,PTGS1
1532,resveratrol,SIRT activator,PTGS2,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,PTGS2
1533,AGK-2,SIRT inhibitor,SIRT2,Clc1ccc(Cl)c(c1)c2ccc(/C=C(C#N)/C(=O)Nc3cccc4ncccc34)o2,SVENPFFEMUOOGK-SDNWHVSQSA-N,,SIRT2
1534,EX-527,SIRT inhibitor,SIRT1,NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21,FUZYTVDVLBBXDL-VIFPVBQESA-N,,SIRT1
1535,EX-527,SIRT inhibitor,SIRT1,NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21,FUZYTVDVLBBXDL-UHFFFAOYSA-N,,SIRT1
1536,salermide,SIRT inhibitor,SIRT2,CC(C(=O)Nc1cccc(c1)N=Cc1c(O)ccc2ccccc12)c1ccccc1,HQSSEGBEYORUBY-WPWMEQJKSA-N,,SIRT2
1537,salermide,SIRT inhibitor,SIRT1,CC(C(=O)Nc1cccc(c1)N=Cc1c(O)ccc2ccccc12)c1ccccc1,HQSSEGBEYORUBY-WPWMEQJKSA-N,,SIRT1
1538,sirtinol,SIRT inhibitor,SIRT2,CC(NC(=O)c1ccccc1N=Cc1c(O)ccc2ccccc12)c1ccccc1,UXJFDYIHRJGPFS-WPWMEQJKSA-N,,SIRT2
1539,sirtinol,SIRT inhibitor,SIRT1,CC(NC(=O)c1ccccc1N=Cc1c(O)ccc2ccccc12)c1ccccc1,UXJFDYIHRJGPFS-WPWMEQJKSA-N,,SIRT1
1540,cryptotanshinone,STAT inhibitor,STAT3,C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C,GVKKJJOMQCNPGB-JTQLQIEISA-N,,STAT3
1541,meisoindigo,STAT inhibitor,STAT3,CN1C(=O)C(c2ccccc12)=C1C(=O)Nc2ccccc12,QNOCRUSVMMAKSC-CCEZHUSRSA-N,,STAT3
1542,niclosamide,STAT inhibitor,STAT3,Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,,STAT3
1543,ursolic-acid,STAT inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
1544,ursolic-acid,STAT inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
1545,ursolic-acid,STAT inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
1546,ursolic-acid,STAT inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
1547,mepacrine,TP53 activator,TP53,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,GPKJTRJOBQGKQK-UHFFFAOYSA-N,,TP53
1548,securinine,TP53 activator,GABRA1,O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31,SWZMSZQQJRKFBP-WZRBSPASSA-N,,GABRA1
1549,securinine,TP53 activator,GABRA1,O=C1OC2(C[C@H]3C=CC2=C1)[C@H]4CCCCN34,SWZMSZQQJRKFBP-KKPNGEORSA-N,,GABRA1
1550,pifithrin-alpha,TP53 inhibitor,TP53,Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N,OLTZHXYLLRJLST-UHFFFAOYSA-N,,TP53
1551,birinapant,XIAP inhibitor,BIRC2,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC,PKWRMUKBEYJEIX-DXXQBUJASA-N,,BIRC2
1552,birinapant,XIAP inhibitor,XIAP,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC,PKWRMUKBEYJEIX-DXXQBUJASA-N,,XIAP
1553,BRD-A05680309,XIAP inhibitor,XIAP,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2CCCc3ccccc23,POKZVJVCUGVHME-UHFFFAOYSA-N,,XIAP
1554,BRD-A05680309,XIAP inhibitor,CASP8,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2CCCc3ccccc23,POKZVJVCUGVHME-UHFFFAOYSA-N,,CASP8
1555,BRD-A61189834,XIAP inhibitor,XIAP,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)Nc1ccc2[nH]ccc2c1,CPJCDIAPGXTNBU-UHFFFAOYSA-N,,XIAP
1556,BRD-A69470004,XIAP inhibitor,XIAP,CC(C)C(NC(=O)C(C)N)C(=O)N1CCCC1C(=O)NC(c2ccccc2)c3ccccc3,WKJJKOCFFPMSNU-UHFFFAOYSA-N,,XIAP
1557,BRD-A94297859,XIAP inhibitor,XIAP,CNC(C)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)Nc1cccc2ccccc12,JSZPIOJRNMIRQD-UHFFFAOYSA-N,,XIAP
1558,BRD-A97035593,XIAP inhibitor,XIAP,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NNc2ccccc2,OIAFZXFQHCIAJL-UHFFFAOYSA-N,,XIAP
1559,BRD-K71427192,XIAP inhibitor,XIAP,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)Nc1cccc2ccccc12,NUXOKPCTWFCPBI-DEYYWGMASA-N,,XIAP
1560,embelin,XIAP inhibitor,XIAP,CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O,FNQDSLSOLMXCMU-UHFFFAOYSA-N,,XIAP
1561,BMS-777607,C-Met inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
1562,BMS-777607,C-Met inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
1563,BMS-777607,C-Met inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
1564,BMS-777607,C-Met inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
1565,BMS-777607,C-Met inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
1566,MK-8033,C-Met inhibitor,MET,Cn1cc(cn1)-c1cnc2ccc3ccc(CS(=O)(=O)NCc4ccccn4)cc3c(=O)c2c1,VMJFTOSOFDEKTM-UHFFFAOYSA-N,,MET
1567,PF-04217903,C-Met inhibitor,MET,OCCn1cc(cn1)-c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,PDMUGYOXRHVNMO-UHFFFAOYSA-N,,MET
1568,PHA-665752,C-Met inhibitor,MET,Cc1[nH]c(C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,OYONTEXKYJZFHA-SSHUPFPWSA-N,,MET
1569,WZ-7043,CSF1R inhibitor,CSF1R,CCN(CC)CCCCNc1ncc2CN(C(=O)N(C)c2n1)c1c(Cl)c(OC)cc(OC)c1Cl,NHOUHWHGHAFDOP-UHFFFAOYSA-N,,CSF1R
1570,deferasirox,Chelating agent,CYP3A4,OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O,BOFQWVMAQOTZIW-UHFFFAOYSA-N,,CYP3A4
1571,deferiprone,Chelating agent,UGT1A6,Cc1c(O)c(=O)ccn1C,TZXKOCQBRNJULO-UHFFFAOYSA-N,,UGT1A6
1572,thenoyltrifluoroacetone,Chelating agent,CES1,FC(F)(F)C(=O)CC(=O)c1cccs1,TXBBUSUXYMIVOS-UHFFFAOYSA-N,,CES1
1573,EPZ-5676,DOT1L inhibitor,DOT1L,CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1,LXFOLMYKSYSZQS-LURJZOHASA-N,,DOT1L
1574,EPZ-5676,DOT1L inhibitor,DOT1L,CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)C1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1,LXFOLMYKSYSZQS-JTBNCTPPSA-N,,DOT1L
1575,XMD-1499,EPHB3 inhibitor,EPHB3,COc1cc(ccc1Nc1nc(N)c(s1)C(=O)c1c(Cl)cccc1Cl)N1CCN(C)CC1,UISRWLSAXIOCND-UHFFFAOYSA-N,,EPHB3
1576,AG-490,ErbB2 inhibitor,JAK2,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK2
1577,AG-490,ErbB2 inhibitor,JAK3,Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O,TUCIOBMMDDOEMM-UHFFFAOYSA-N,,JAK3
1578,AG-490,ErbB2 inhibitor,JAK2,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK2
1579,AG-490,ErbB2 inhibitor,JAK3,Oc1ccc(cc1O)C=C(/C#N)C(=O)NCc1ccccc1,TUCIOBMMDDOEMM-RIYZIHGNSA-N,,JAK3
1580,GW-583340,ErbB2 inhibitor,EGFR,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,EGFR
1581,GW-583340,ErbB2 inhibitor,ERBB2,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,ERBB2
1582,lapatinib,ErbB2 inhibitor,EGFR,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,EGFR
1583,lapatinib,ErbB2 inhibitor,ERBB2,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,ERBB2
1584,lapatinib,ErbB2 inhibitor,EGFR,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,EGFR
1585,lapatinib,ErbB2 inhibitor,ERBB2,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,BCFGMOOMADDAQU-UHFFFAOYSA-N,,ERBB2
1586,thiostrepton,FOXM1 inhibitor,FOXM1,CCC(C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=CC)[C@@](C)(O)[C@@H](C)O)[C@H](C)O,NSFFHOGKXHRQEW-MWCLUCFNSA-N,,FOXM1
1587,thiostrepton,FOXM1 inhibitor,FOXM1,CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O,NSFFHOGKXHRQEW-DVRIZHICSA-N,,FOXM1
1588,NSC-693868,GSK-3 inhibitor,CDK5,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK5
1589,NSC-693868,GSK-3 inhibitor,GSK3A,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,GSK3A
1590,NSC-693868,GSK-3 inhibitor,CDK1,Nc1n[nH]c2nc3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK1
1591,aloisine,GSK-3 inhibitor,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(O)cc3,PRIGRJPRGZCFAS-UHFFFAOYSA-N,,CDK2
1592,aloisine,GSK-3 inhibitor,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(OC)cc3,WVMANZPBOBRWCB-UHFFFAOYSA-N,,CDK2
1593,AR-A014418,GSK-3 inhibitor,GSK3B,COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1,YAEMHJKFIIIULI-UHFFFAOYSA-N,,GSK3B
1594,IM-12,GSK-3 inhibitor,GSK3B,CN1C(=O)C(NCCc2ccc(F)cc2)=C(C1=O)c1c(C)[nH]c2ccccc12,ZKJAZFUFPPSFCO-UHFFFAOYSA-N,,GSK3B
1595,indirubin,GSK-3 inhibitor,CDK5,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,CDK5
1596,indirubin,GSK-3 inhibitor,GSK3A,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,GSK3A
1597,indirubin,GSK-3 inhibitor,CDK1,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N,,CDK1
1598,indirubin,GSK-3 inhibitor,CDK5,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,CDK5
1599,indirubin,GSK-3 inhibitor,GSK3A,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,GSK3A
1600,indirubin,GSK-3 inhibitor,CDK1,ON=C1C(=C2C(=O)Nc3ccccc23)Nc4ccccc14,HBDSHCUSXQATPO-UHFFFAOYSA-N,,CDK1
1601,kenpaullone,GSK-3 inhibitor,CDK5,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,CDK5
1602,kenpaullone,GSK-3 inhibitor,GSK3B,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,GSK3B
1603,kenpaullone,GSK-3 inhibitor,CDK1,Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1,QQUXFYAWXPMDOE-UHFFFAOYSA-N,,CDK1
1604,NSC-693868,GSK-3 inhibitor,CDK5,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK5
1605,NSC-693868,GSK-3 inhibitor,GSK3A,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,GSK3A
1606,NSC-693868,GSK-3 inhibitor,CDK1,Nc1nnc2[nH]c3ccccc3nc12,DWHVZCLBMTZRQM-UHFFFAOYSA-N,,CDK1
1607,SB-216763,GSK-3 inhibitor,GSK3B,Cn1cc(C2=C(C(=O)NC2=O)c2ccc(Cl)cc2Cl)c2ccccc12,JCSGFHVFHSKIJH-UHFFFAOYSA-N,,GSK3B
1608,SB-415286,GSK-3 inhibitor,GSK3B,Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl,PQCXVIPXISBFPN-UHFFFAOYSA-N,,GSK3B
1609,TWS-119,GSK-3 inhibitor,GSK3B,Nc1cccc(c1)-c1cc2c(Oc3cccc(O)c3)ncnc2[nH]1,VPVLEBIVXZSOMQ-UHFFFAOYSA-N,,GSK3B
1610,atorvastatin,HMGCR inhibitor,DPP4,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-KAYWLYCHSA-N,,DPP4
1611,atorvastatin,HMGCR inhibitor,HMGCR,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-KAYWLYCHSA-N,,HMGCR
1612,atorvastatin,HMGCR inhibitor,DPP4,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-UHFFFAOYSA-N,,DPP4
1613,atorvastatin,HMGCR inhibitor,HMGCR,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-UHFFFAOYSA-N,,HMGCR
1614,atorvastatin,HMGCR inhibitor,DPP4,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-UHFFFAOYSA-N,,DPP4
1615,atorvastatin,HMGCR inhibitor,HMGCR,CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1,XUKUURHRXDUEBC-UHFFFAOYSA-N,,HMGCR
1616,cerivastatin,HMGCR inhibitor,HMGCR,COCc1c(nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1c2ccc(F)cc2)C(C)C,SEERZIQQUAZTOL-ANMDKAQQSA-N,,HMGCR
1617,fluvastatin,HMGCR inhibitor,HMGCR,CC(C)n1c(C=C[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12,FJLGEFLZQAZZCD-MCBHFWOFSA-N,,HMGCR
1618,fluvastatin,HMGCR inhibitor,HMGCR,CC(C)n1c(C=C[C@H](O)C[C@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12,FJLGEFLZQAZZCD-OALUTQOASA-N,,HMGCR
1619,lovastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,PCZOHLXUXFIOCF-BXMDZJJMSA-N,,HMGCR
1620,lovastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]12,PCZOHLXUXFIOCF-ZZUUWIQOSA-N,,HMGCR
1621,lovastatin,HMGCR inhibitor,HMGCR,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C12,QLJODMDSTUBWDW-UHFFFAOYSA-N,,HMGCR
1622,mevastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,AJLFOPYRIVGYMJ-INTXDZFKSA-N,,HMGCR
1623,mevastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]12,AJLFOPYRIVGYMJ-GJYIOPSLSA-N,,HMGCR
1624,mevastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CCO3)[C@@H]12,PCRLJXQATRCBPW-SOWWUCBVSA-N,,HMGCR
1625,pitavastatin,HMGCR inhibitor,HMGCR,O[C@H](C[C@H](O)/C=C/c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC(=O)O[Ca]OC(=O)C[C@H](O)C[C@H](O)/C=C/c5c(nc6ccccc6c5c7ccc(F)cc7)C8CC8,RHGYHLPFVJEAOC-FFNUKLMVSA-L,,HMGCR
1626,pitavastatin,HMGCR inhibitor,HMGCR,O[C@H](C[C@H](O)C=Cc1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O,VGYFMXBACGZSIL-MCBHFWOFSA-N,,HMGCR
1627,pravastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@@H]1C[C@H](O)C=C2C=C[C@H](C)[C@@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12,TUZYXOIXSAXUGO-QBHFJHEUSA-N,,HMGCR
1628,pravastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12,TUZYXOIXSAXUGO-PZAWKZKUSA-N,,HMGCR
1629,pravastatin,HMGCR inhibitor,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]12,TUZYXOIXSAXUGO-SDYRHPPTSA-N,,HMGCR
1630,pravastatin,HMGCR inhibitor,HMGCR,CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12,TUZYXOIXSAXUGO-XYLZAPOUSA-N,,HMGCR
1631,pravastatin,HMGCR inhibitor,HMGCR,CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(O)=O)C12,TUZYXOIXSAXUGO-UHFFFAOYSA-N,,HMGCR
1632,procaine,HMGCR inhibitor,HTR3A,CCN(CC)CCOC(=O)c1ccc(N)cc1,MFDFERRIHVXMIY-UHFFFAOYSA-N,,HTR3A
1633,rosuvastatin,HMGCR inhibitor,HMGCR,CC(C)c1nc(nc(-c2ccc(F)cc2)c1C=C[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O,BPRHUIZQVSMCRT-VEUZHWNKSA-N,,HMGCR
1634,simvastatin,HMGCR inhibitor,HMGCR,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]12,RYMZZMVNJRMUDD-HFFZACBOSA-N,,HMGCR
1635,simvastatin,HMGCR inhibitor,HMGCR,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,RYMZZMVNJRMUDD-HGQWONQESA-N,,HMGCR
1636,simvastatin,HMGCR inhibitor,HMGCR,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C12,RYMZZMVNJRMUDD-UHFFFAOYSA-N,,HMGCR
1637,AG-1024,IGF-1 inhibitor,IGF1R,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,ABBADGFSRBWENF-UHFFFAOYSA-N,,IGF1R
1638,BMS-536924,IGF-1 inhibitor,IGF1R,Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1,FDBVBFZVZLTNFJ-KKPVDXMRSA-N,,IGF1R
1639,BMS-754807,IGF-1 inhibitor,IGF1R,C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1,LQVXSNNAFNGRAH-QHCPKHFHSA-N,,IGF1R
1640,EI-247,IGF-1 inhibitor,INSR,O[C@H](c1ccc2ccccc2c1)P(O)(O)=O,AMJJLDJPDLKNJA-NSHDSACASA-N,,INSR
1641,GSK-1904529A,IGF-1 inhibitor,IGF1R,CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,MOSKATHMXWSZTQ-UHFFFAOYSA-N,,IGF1R
1642,GSK-1904529A,IGF-1 inhibitor,INSR,CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,MOSKATHMXWSZTQ-UHFFFAOYSA-N,,INSR
1643,linsitinib,IGF-1 inhibitor,IGF1R,C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,PKCDDUHJAFVJJB-VLZXCDOPSA-N,,IGF1R
1644,linsitinib,IGF-1 inhibitor,INSR,C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,PKCDDUHJAFVJJB-VLZXCDOPSA-N,,INSR
1645,linsitinib,IGF-1 inhibitor,IGF1R,C[C@@]1(O)CC(C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,PKCDDUHJAFVJJB-FQFBAAABSA-N,,IGF1R
1646,linsitinib,IGF-1 inhibitor,INSR,C[C@@]1(O)CC(C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,PKCDDUHJAFVJJB-FQFBAAABSA-N,,INSR
1647,linsitinib,IGF-1 inhibitor,IGF1R,CC1(C)CC(C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,RGLPLEBXLNEXKU-UHFFFAOYSA-N,,IGF1R
1648,linsitinib,IGF-1 inhibitor,INSR,CC1(C)CC(C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,RGLPLEBXLNEXKU-UHFFFAOYSA-N,,INSR
1649,NVP-ADW742,IGF-1 inhibitor,IGF1R,Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@H]1C[C@H](CN2CCCC2)C1,LSFLAQVDISHMNB-AFARHQOCSA-N,,IGF1R
1650,NVP-AEW541,IGF-1 inhibitor,IGF1R,C1CN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6,AECDBHGVIIRMOI-UHFFFAOYSA-N,,IGF1R
1651,NVP-AEW541,IGF-1 inhibitor,IGF1R,Nc1ncnc2n(cc(-c3ccc(OCc4ccccc4)cc3)c12)[C@H]1C[C@H](CN2CCC2)C1,MJEHBQIPZHTMNZ-AQYVVDRMSA-N,,IGF1R
1652,NVP-AEW541,IGF-1 inhibitor,IGF1R,Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1,AECDBHGVIIRMOI-GRGXKFILSA-N,,IGF1R
1653,PQ-401,IGF-1 inhibitor,IGF1R,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,YBLWOZUPHDKFOT-UHFFFAOYSA-N,,IGF1R
1654,AVN-944,IMPDH inhibitor,IMPDH1,CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1,GYCPCOJTCINIFZ-OXJNMPFZSA-N,,IMPDH1
1655,AVN-944,IMPDH inhibitor,IMPDH2,CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1,GYCPCOJTCINIFZ-OXJNMPFZSA-N,,IMPDH2
1656,merimepodib,IMPDH inhibitor,IMPDH1,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1,JBPUGFODGPKTDW-SFHVURJKSA-N,,IMPDH1
1657,mycophenolate-mofetil,IMPDH inhibitor,IMPDH1,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH1
1658,mycophenolate-mofetil,IMPDH inhibitor,IMPDH2,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH2
1659,mepazine,MALT1 inhibitor,MALT1,CN1CCCC(CN2c3ccccc3Sc3ccccc23)C1,CBHCDHNUZWWAPP-UHFFFAOYSA-N,,MALT1
1660,methocarbamol,Muscle relaxant,CA1,COc1ccccc1OCC(O)COC(N)=O,GNXFOGHNGIVQEH-UHFFFAOYSA-N,,CA1
1661,BRD-K26947839,NADPH inhibitor,NOX1,CC(=O)c1ccc2Sc3ccccc3Nc2c1,JWGBOHJGWOPYCL-UHFFFAOYSA-N,,NOX1
1662,dicoumarol,NADPH inhibitor,NQO1,Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,,NQO1
1663,dicoumarol,NADPH inhibitor,VKORC1,Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,,VKORC1
1664,GMX-1778,NAMPT inhibitor,NAMPT,Clc1ccc(OCCCCCCN=C(NC#N)Nc2ccncc2)cc1,BOIPLTNGIAPDBY-UHFFFAOYSA-N,,NAMPT
1665,CAY-10618,NAMPT inhibitor,NAMPT,O=C(CCCCCCCn1cc(nn1)-c1cccnc1)Nc1ccccc1-c1ccccc1,SJOLTIOPWDLDEB-UHFFFAOYSA-N,,NAMPT
1666,exifone,Nootropic agent,TYR,Oc1ccc(C(=O)c2cc(O)c(O)c(O)c2)c(O)c1O,XEDWWPGWIXPVRQ-UHFFFAOYSA-N,,TYR
1667,AG-370,PDGFR inhibitor,PDGFRB,NC(=C(C#N)C#N)/C(=C/c1ccc2[nH]ccc2c1)/C#N,CMMDWEJTQUTCKG-WUXMJOGZSA-N,,PDGFRB
1668,amuvatinib,PDGFR inhibitor,FLT3,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,FLT3
1669,amuvatinib,PDGFR inhibitor,KIT,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,KIT
1670,amuvatinib,PDGFR inhibitor,MET,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,MET
1671,amuvatinib,PDGFR inhibitor,PDGFRA,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,PDGFRA
1672,axitinib,PDGFR inhibitor,FLT1,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,FLT1
1673,axitinib,PDGFR inhibitor,FLT4,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,FLT4
1674,axitinib,PDGFR inhibitor,KDR,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,KDR
1675,CP-673451,PDGFR inhibitor,PDGFRB,COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1,DEEOXSOLTLIWMG-UHFFFAOYSA-N,,PDGFRB
1676,crenolanib,PDGFR inhibitor,PDGFRA,CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1,DYNHJHQFHQTFTP-UHFFFAOYSA-N,,PDGFRA
1677,crenolanib,PDGFR inhibitor,PDGFRB,CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1,DYNHJHQFHQTFTP-UHFFFAOYSA-N,,PDGFRB
1678,dasatinib,PDGFR inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
1679,dasatinib,PDGFR inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
1680,dasatinib,PDGFR inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
1681,dasatinib,PDGFR inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
1682,dasatinib,PDGFR inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
1683,dasatinib,PDGFR inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
1684,dasatinib,PDGFR inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
1685,dasatinib,PDGFR inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
1686,dasatinib,PDGFR inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
1687,dasatinib,PDGFR inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
1688,dovitinib,PDGFR inhibitor,EGFR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,EGFR
1689,dovitinib,PDGFR inhibitor,FGFR1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR1
1690,dovitinib,PDGFR inhibitor,FGFR3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR3
1691,dovitinib,PDGFR inhibitor,FGFR2,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR2
1692,dovitinib,PDGFR inhibitor,FLT1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT1
1693,dovitinib,PDGFR inhibitor,FLT3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT3
1694,dovitinib,PDGFR inhibitor,FLT4,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT4
1695,dovitinib,PDGFR inhibitor,KDR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KDR
1696,dovitinib,PDGFR inhibitor,KIT,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KIT
1697,dovitinib,PDGFR inhibitor,PDGFRB,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,PDGFRB
1698,imatinib,PDGFR inhibitor,CSF1R,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,CSF1R
1699,imatinib,PDGFR inhibitor,ABL1,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,ABL1
1700,imatinib,PDGFR inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,KIT
1701,imatinib,PDGFR inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRA
1702,imatinib,PDGFR inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRB
1703,imatinib,PDGFR inhibitor,BCR,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,BCR
1704,KI-8751,PDGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC,LFKQSJNCVRGFCC-UHFFFAOYSA-N,,KDR
1705,leflunomide,PDGFR inhibitor,DHODH,Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F,VHOGYURTWQBHIL-UHFFFAOYSA-N,,DHODH
1706,lenvatinib,PDGFR inhibitor,FGFR1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FGFR1
1707,lenvatinib,PDGFR inhibitor,FLT1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT1
1708,lenvatinib,PDGFR inhibitor,FLT4,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT4
1709,lenvatinib,PDGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KDR
1710,lenvatinib,PDGFR inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KIT
1711,linifanib,PDGFR inhibitor,CSF1R,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,CSF1R
1712,linifanib,PDGFR inhibitor,FLT1,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT1
1713,linifanib,PDGFR inhibitor,FLT3,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT3
1714,linifanib,PDGFR inhibitor,FLT4,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT4
1715,linifanib,PDGFR inhibitor,KDR,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,KDR
1716,linifanib,PDGFR inhibitor,PDGFRB,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,PDGFRB
1717,masitinib,PDGFR inhibitor,FGFR3,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,FGFR3
1718,masitinib,PDGFR inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,KIT
1719,masitinib,PDGFR inhibitor,LYN,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,LYN
1720,masitinib,PDGFR inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRA
1721,masitinib,PDGFR inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,,PDGFRB
1722,motesanib,PDGFR inhibitor,FLT1,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT1
1723,motesanib,PDGFR inhibitor,FLT4,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT4
1724,motesanib,PDGFR inhibitor,KDR,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KDR
1725,motesanib,PDGFR inhibitor,KIT,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KIT
1726,nintedanib,PDGFR inhibitor,FGFR1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR1
1727,nintedanib,PDGFR inhibitor,FGFR3,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR3
1728,nintedanib,PDGFR inhibitor,FLT1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT1
1729,nintedanib,PDGFR inhibitor,FLT4,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT4
1730,nintedanib,PDGFR inhibitor,KDR,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,KDR
1731,nintedanib,PDGFR inhibitor,PDGFRA,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRA
1732,nintedanib,PDGFR inhibitor,PDGFRB,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRB
1733,orantinib,PDGFR inhibitor,FGFR1,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR1
1734,orantinib,PDGFR inhibitor,FGFR2,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR2
1735,orantinib,PDGFR inhibitor,KDR,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,KDR
1736,orantinib,PDGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRA
1737,orantinib,PDGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRB
1738,orantinib,PDGFR inhibitor,AURKA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKA
1739,orantinib,PDGFR inhibitor,AURKB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKB
1740,orantinib,PDGFR inhibitor,FGFR1,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR1
1741,orantinib,PDGFR inhibitor,FGFR2,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR2
1742,orantinib,PDGFR inhibitor,KDR,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,KDR
1743,orantinib,PDGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRA
1744,orantinib,PDGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRB
1745,orantinib,PDGFR inhibitor,AURKA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKA
1746,orantinib,PDGFR inhibitor,AURKB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKB
1747,pazopanib,PDGFR inhibitor,FLT1,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT1
1748,pazopanib,PDGFR inhibitor,FLT4,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT4
1749,pazopanib,PDGFR inhibitor,KDR,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KDR
1750,pazopanib,PDGFR inhibitor,KIT,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KIT
1751,pazopanib,PDGFR inhibitor,PDGFRA,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRA
1752,pazopanib,PDGFR inhibitor,PDGFRB,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRB
1753,ponatinib,PDGFR inhibitor,FGFR1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR1
1754,ponatinib,PDGFR inhibitor,FGFR3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR3
1755,ponatinib,PDGFR inhibitor,FGFR2,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR2
1756,ponatinib,PDGFR inhibitor,FGFR4,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR4
1757,ponatinib,PDGFR inhibitor,FLT3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FLT3
1758,ponatinib,PDGFR inhibitor,ABL1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,ABL1
1759,ponatinib,PDGFR inhibitor,KIT,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,KIT
1760,ponatinib,PDGFR inhibitor,RET,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,RET
1761,ponatinib,PDGFR inhibitor,BCR,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,BCR
1762,ponatinib,PDGFR inhibitor,TEK,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,TEK
1763,regorafenib,PDGFR inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
1764,regorafenib,PDGFR inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
1765,regorafenib,PDGFR inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
1766,regorafenib,PDGFR inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
1767,regorafenib,PDGFR inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
1768,regorafenib,PDGFR inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
1769,regorafenib,PDGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
1770,regorafenib,PDGFR inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
1771,regorafenib,PDGFR inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
1772,regorafenib,PDGFR inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
1773,regorafenib,PDGFR inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
1774,regorafenib,PDGFR inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
1775,regorafenib,PDGFR inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
1776,regorafenib,PDGFR inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
1777,regorafenib,PDGFR inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
1778,regorafenib,PDGFR inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
1779,sorafenib,PDGFR inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
1780,sorafenib,PDGFR inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
1781,sorafenib,PDGFR inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
1782,sorafenib,PDGFR inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
1783,sorafenib,PDGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
1784,sorafenib,PDGFR inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
1785,sorafenib,PDGFR inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
1786,sorafenib,PDGFR inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
1787,sorafenib,PDGFR inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
1788,sorafenib,PDGFR inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
1789,sorafenib,PDGFR inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
1790,sorafenib,PDGFR inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
1791,sorafenib,PDGFR inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
1792,sorafenib,PDGFR inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
1793,sorafenib,PDGFR inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
1794,sorafenib,PDGFR inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
1795,sorafenib,PDGFR inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
1796,sorafenib,PDGFR inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
1797,sorafenib,PDGFR inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
1798,sorafenib,PDGFR inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
1799,sorafenib,PDGFR inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
1800,sorafenib,PDGFR inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
1801,SU-4312,PDGFR inhibitor,KDR,CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)cc1,UAKWLVYMKBWHMX-UHFFFAOYSA-N,,KDR
1802,SU-4312,PDGFR inhibitor,KDR,CN(C)c1ccc(cc1)C=C1/C(=O)Nc2ccccc12,UAKWLVYMKBWHMX-PTNGSMBKSA-N,,KDR
1803,sunitinib,PDGFR inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT1
1804,sunitinib,PDGFR inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT3
1805,sunitinib,PDGFR inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT4
1806,sunitinib,PDGFR inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KDR
1807,sunitinib,PDGFR inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KIT
1808,sunitinib,PDGFR inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRA
1809,sunitinib,PDGFR inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRB
1810,sunitinib,PDGFR inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,RET
1811,tandutinib,PDGFR inhibitor,FLT3,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,FLT3
1812,tandutinib,PDGFR inhibitor,KIT,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,KIT
1813,tandutinib,PDGFR inhibitor,PDGFRA,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRA
1814,tandutinib,PDGFR inhibitor,PDGFRB,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,,PDGFRB
1815,telatinib,PDGFR inhibitor,KDR,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,QFCXANHHBCGMAS-UHFFFAOYSA-N,,KDR
1816,trapidil,PDGFR inhibitor,PDGFRA,CCN(CC)c1cc(C)nc2ncnn12,GSNOZLZNQMLSKJ-UHFFFAOYSA-N,,PDGFRA
1817,vatalanib,PDGFR inhibitor,FLT1,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT1
1818,vatalanib,PDGFR inhibitor,FLT4,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT4
1819,vatalanib,PDGFR inhibitor,KDR,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KDR
1820,vatalanib,PDGFR inhibitor,KIT,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KIT
1821,vatalanib,PDGFR inhibitor,PDGFRB,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,PDGFRB
1822,amuvatinib,RAD51 inhibitor,FLT3,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,FLT3
1823,amuvatinib,RAD51 inhibitor,KIT,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,KIT
1824,amuvatinib,RAD51 inhibitor,MET,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,MET
1825,amuvatinib,RAD51 inhibitor,PDGFRA,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,PDGFRA
1826,aliskiren,Renin inhibitor,REN,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC,UXOWGYHJODZGMF-QORCZRPOSA-N,,REN
1827,VTP-27999,Renin inhibitor,REN,CN[C@H](CNC(=O)N1CCC[C@H](C1)[C@@H](OCCNC(=O)OC)c1cccc(Cl)c1)C[C@H]1CCCOC1,NXWASIVXQMMPLM-ZXMXYHOLSA-N,,REN
1828,fatostatin,SREBP inhibitor,SREBF1,CCCc1cc(ccn1)c2nc(cs2)c3ccc(C)cc3,ZROSUBKIGBSZCG-UHFFFAOYSA-N,,SREBF1
1829,fatostatin,SREBP inhibitor,SREBF2,CCCc1cc(ccn1)c2nc(cs2)c3ccc(C)cc3,ZROSUBKIGBSZCG-UHFFFAOYSA-N,,SREBF2
1830,AM-404,TRPV antagonist,TRPV1,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-DOFZRALJSA-N,,TRPV1
1831,AM-404,TRPV antagonist,TRPV1,CCCCCC=CCC=CCC=CCC=CCCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-UHFFFAOYSA-N,,TRPV1
1832,AMG-517,TRPV antagonist,TRPV1,CC(=O)Nc1nc2c(Oc3cc(ncn3)-c3ccc(cc3)C(F)(F)F)cccc2s1,YUTIXVXZQIQWGY-UHFFFAOYSA-N,,TRPV1
1833,AMG-9810,TRPV antagonist,TRPV1,CC(C)(C)c1ccc(C=CC(=O)Nc2ccc3OCCOc3c2)cc1,GZTFUVZVLYUPRG-UHFFFAOYSA-N,,TRPV1
1834,AMG-9810,TRPV antagonist,TRPV1,CC(C)(C)c1ccc(cc1)C=CC(=O)Nc1ccc2OCCOc2c1,GZTFUVZVLYUPRG-IZZDOVSWSA-N,,TRPV1
1835,JNJ-17203212,TRPV antagonist,TRPV1,FC(F)(F)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2C(F)(F)F)nc1,JFRYYGVYCWYIDQ-UHFFFAOYSA-N,,TRPV1
1836,naringenin,TRPV antagonist,CYP19A1,Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,FTVWIRXFELQLPI-ZDUSSCGKSA-N,,CYP19A1
1837,naringenin,TRPV antagonist,ESR2,Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,FTVWIRXFELQLPI-ZDUSSCGKSA-N,,ESR2
1838,naringenin,TRPV antagonist,CYP19A1,Oc1ccc(cc1)C2CC(=O)c3c(O)cc(O)cc3O2,FTVWIRXFELQLPI-UHFFFAOYSA-N,,CYP19A1
1839,naringenin,TRPV antagonist,ESR2,Oc1ccc(cc1)C2CC(=O)c3c(O)cc(O)cc3O2,FTVWIRXFELQLPI-UHFFFAOYSA-N,,ESR2
1840,phenamil,TRPV antagonist,PKD2L1,Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2,NIOHELZQFBGCEO-UHFFFAOYSA-N,,PKD2L1
1841,RN-1734,TRPV antagonist,TRPV4,CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl,IHYZMEAZAIFMTN-UHFFFAOYSA-N,,TRPV4
1842,SB-366791,TRPV antagonist,TRPV1,COc1cccc(NC(=O)C=Cc2ccc(Cl)cc2)c1,RYAMDQKWNKKFHD-JXMROGBWSA-N,,TRPV1
1843,SB-366791,TRPV antagonist,TRPV1,COc1cccc(NC(=O)C=Cc2ccc(Cl)cc2)c1,RYAMDQKWNKKFHD-UHFFFAOYSA-N,,TRPV1
1844,SB-705498,TRPV antagonist,TRPV1,FC(F)(F)c1ccc(nc1)N1CC[C@H](C1)NC(=O)Nc1ccccc1Br,JYILLRHXRVTRSH-GFCCVEGCSA-N,,TRPV1
1845,axitinib,VEGFR inhibitor,FLT1,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,FLT1
1846,axitinib,VEGFR inhibitor,FLT4,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,FLT4
1847,axitinib,VEGFR inhibitor,KDR,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,KDR
1848,BRD-K97951054,VEGFR inhibitor,PIM1,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,PIM1
1849,BRD-K97951054,VEGFR inhibitor,AURKB,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,AURKB
1850,brivanib,VEGFR inhibitor,FGFR1,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,FGFR1
1851,brivanib,VEGFR inhibitor,FLT1,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,FLT1
1852,brivanib,VEGFR inhibitor,KDR,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,,KDR
1853,brivanib,VEGFR inhibitor,FGFR1,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,FGFR1
1854,brivanib,VEGFR inhibitor,FLT1,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,FLT1
1855,brivanib,VEGFR inhibitor,KDR,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,WCWUXEGQKLTGDX-UHFFFAOYSA-N,,KDR
1856,cabozantinib,VEGFR inhibitor,FLT3,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,FLT3
1857,cabozantinib,VEGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,KDR
1858,cabozantinib,VEGFR inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,KIT
1859,cabozantinib,VEGFR inhibitor,MET,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,MET
1860,cabozantinib,VEGFR inhibitor,RET,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,RET
1861,cabozantinib,VEGFR inhibitor,TEK,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,TEK
1862,cediranib,VEGFR inhibitor,FLT1,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,FLT1
1863,cediranib,VEGFR inhibitor,FLT4,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,FLT4
1864,cediranib,VEGFR inhibitor,KDR,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,KDR
1865,cediranib,VEGFR inhibitor,KIT,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,KIT
1866,cediranib,VEGFR inhibitor,PDGFRB,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,,PDGFRB
1867,dovitinib,VEGFR inhibitor,EGFR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,EGFR
1868,dovitinib,VEGFR inhibitor,FGFR1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR1
1869,dovitinib,VEGFR inhibitor,FGFR3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR3
1870,dovitinib,VEGFR inhibitor,FGFR2,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FGFR2
1871,dovitinib,VEGFR inhibitor,FLT1,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT1
1872,dovitinib,VEGFR inhibitor,FLT3,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT3
1873,dovitinib,VEGFR inhibitor,FLT4,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,FLT4
1874,dovitinib,VEGFR inhibitor,KDR,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KDR
1875,dovitinib,VEGFR inhibitor,KIT,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,KIT
1876,dovitinib,VEGFR inhibitor,PDGFRB,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,BAWMTQUBRCAWFL-ZZEZOPTASA-N,,PDGFRB
1877,ENMD-2076,VEGFR inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,FLT3
1878,ENMD-2076,VEGFR inhibitor,KDR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,KDR
1879,ENMD-2076,VEGFR inhibitor,PDGFRA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,PDGFRA
1880,ENMD-2076,VEGFR inhibitor,SRC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,SRC
1881,ENMD-2076,VEGFR inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,AURKA
1882,foretinib,VEGFR inhibitor,KDR,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,CXQHYVUVSFXTMY-UHFFFAOYSA-N,,KDR
1883,foretinib,VEGFR inhibitor,MET,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,CXQHYVUVSFXTMY-UHFFFAOYSA-N,,MET
1884,golvatinib,VEGFR inhibitor,KDR,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1,UQRCJCNVNUFYDX-UHFFFAOYSA-N,,KDR
1885,golvatinib,VEGFR inhibitor,MET,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1,UQRCJCNVNUFYDX-UHFFFAOYSA-N,,MET
1886,KI-8751,VEGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC,LFKQSJNCVRGFCC-UHFFFAOYSA-N,,KDR
1887,lenvatinib,VEGFR inhibitor,FGFR1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FGFR1
1888,lenvatinib,VEGFR inhibitor,FLT1,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT1
1889,lenvatinib,VEGFR inhibitor,FLT4,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,FLT4
1890,lenvatinib,VEGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KDR
1891,lenvatinib,VEGFR inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,,KIT
1892,linifanib,VEGFR inhibitor,CSF1R,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,CSF1R
1893,linifanib,VEGFR inhibitor,FLT1,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT1
1894,linifanib,VEGFR inhibitor,FLT3,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT3
1895,linifanib,VEGFR inhibitor,FLT4,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,FLT4
1896,linifanib,VEGFR inhibitor,KDR,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,KDR
1897,linifanib,VEGFR inhibitor,PDGFRB,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,,PDGFRB
1898,lucitanib,VEGFR inhibitor,FGFR1,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FGFR1
1899,lucitanib,VEGFR inhibitor,FGFR2,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FGFR2
1900,lucitanib,VEGFR inhibitor,FLT1,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FLT1
1901,lucitanib,VEGFR inhibitor,FLT4,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,FLT4
1902,lucitanib,VEGFR inhibitor,KDR,CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N,,KDR
1903,MAZ-51,VEGFR inhibitor,FLT4,CN(C)c1ccc(/C=C/2C(=O)Nc3ccccc23)c4ccccc14,VFCXONOPGCDDBQ-AQTBWJFISA-N,,FLT4
1904,methylnorlichexanthone,VEGFR inhibitor,PIM1,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,PIM1
1905,methylnorlichexanthone,VEGFR inhibitor,AURKB,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,AURKB
1906,MGCD-265,VEGFR inhibitor,MET,Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,UFICVEHDQUKCEA-UHFFFAOYSA-N,,MET
1907,MGCD-265,VEGFR inhibitor,AXL,Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,UFICVEHDQUKCEA-UHFFFAOYSA-N,,AXL
1908,MK-2461,VEGFR inhibitor,FGFR1,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR1
1909,MK-2461,VEGFR inhibitor,FGFR3,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR3
1910,MK-2461,VEGFR inhibitor,FGFR2,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FGFR2
1911,MK-2461,VEGFR inhibitor,FLT1,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FLT1
1912,MK-2461,VEGFR inhibitor,FLT3,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,FLT3
1913,MK-2461,VEGFR inhibitor,MET,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,,MET
1914,motesanib,VEGFR inhibitor,FLT1,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT1
1915,motesanib,VEGFR inhibitor,FLT4,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,FLT4
1916,motesanib,VEGFR inhibitor,KDR,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KDR
1917,motesanib,VEGFR inhibitor,KIT,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,KIT
1918,nintedanib,VEGFR inhibitor,FGFR1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR1
1919,nintedanib,VEGFR inhibitor,FGFR3,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FGFR3
1920,nintedanib,VEGFR inhibitor,FLT1,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT1
1921,nintedanib,VEGFR inhibitor,FLT4,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,FLT4
1922,nintedanib,VEGFR inhibitor,KDR,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,KDR
1923,nintedanib,VEGFR inhibitor,PDGFRA,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRA
1924,nintedanib,VEGFR inhibitor,PDGFRB,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,XZXHXSATPCNXJR-ZIADKAODSA-N,,PDGFRB
1925,orantinib,VEGFR inhibitor,FGFR1,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR1
1926,orantinib,VEGFR inhibitor,FGFR2,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,FGFR2
1927,orantinib,VEGFR inhibitor,KDR,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,KDR
1928,orantinib,VEGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRA
1929,orantinib,VEGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,PDGFRB
1930,orantinib,VEGFR inhibitor,AURKA,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKA
1931,orantinib,VEGFR inhibitor,AURKB,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,,AURKB
1932,orantinib,VEGFR inhibitor,FGFR1,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR1
1933,orantinib,VEGFR inhibitor,FGFR2,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,FGFR2
1934,orantinib,VEGFR inhibitor,KDR,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,KDR
1935,orantinib,VEGFR inhibitor,PDGFRA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRA
1936,orantinib,VEGFR inhibitor,PDGFRB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,PDGFRB
1937,orantinib,VEGFR inhibitor,AURKA,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKA
1938,orantinib,VEGFR inhibitor,AURKB,Cc1[nH]c(C=C2C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,NHFDRBXTEDBWCZ-NTEUORMPSA-N,,AURKB
1939,OSI-930,VEGFR inhibitor,KDR,FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1,FGTCROZDHDSNIO-UHFFFAOYSA-N,,KDR
1940,OSI-930,VEGFR inhibitor,KIT,FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1,FGTCROZDHDSNIO-UHFFFAOYSA-N,,KIT
1941,pazopanib,VEGFR inhibitor,FLT1,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT1
1942,pazopanib,VEGFR inhibitor,FLT4,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,FLT4
1943,pazopanib,VEGFR inhibitor,KDR,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KDR
1944,pazopanib,VEGFR inhibitor,KIT,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,KIT
1945,pazopanib,VEGFR inhibitor,PDGFRA,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRA
1946,pazopanib,VEGFR inhibitor,PDGFRB,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,CUIHSIWYWATEQL-UHFFFAOYSA-N,,PDGFRB
1947,PD-173074,VEGFR inhibitor,FGFR1,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,DXCUKNQANPLTEJ-UHFFFAOYSA-N,,FGFR1
1948,PD-173074,VEGFR inhibitor,FGFR3,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,DXCUKNQANPLTEJ-UHFFFAOYSA-N,,FGFR3
1949,rebastinib,VEGFR inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,FLT3
1950,rebastinib,VEGFR inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,ABL1
1951,rebastinib,VEGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,KDR
1952,rebastinib,VEGFR inhibitor,BCR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,BCR
1953,rebastinib,VEGFR inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,TEK
1954,regorafenib,VEGFR inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
1955,regorafenib,VEGFR inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
1956,regorafenib,VEGFR inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
1957,regorafenib,VEGFR inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
1958,regorafenib,VEGFR inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
1959,regorafenib,VEGFR inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
1960,regorafenib,VEGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
1961,regorafenib,VEGFR inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
1962,regorafenib,VEGFR inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
1963,regorafenib,VEGFR inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
1964,regorafenib,VEGFR inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
1965,regorafenib,VEGFR inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
1966,regorafenib,VEGFR inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
1967,regorafenib,VEGFR inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
1968,regorafenib,VEGFR inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
1969,regorafenib,VEGFR inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
1970,semaxanib,VEGFR inhibitor,FLT1,Cc1cc(C)c(C=C2/C(=O)Nc3ccccc23)[nH]1,WUWDLXZGHZSWQZ-WQLSENKSSA-N,,FLT1
1971,semaxanib,VEGFR inhibitor,KDR,Cc1cc(C)c(C=C2/C(=O)Nc3ccccc23)[nH]1,WUWDLXZGHZSWQZ-WQLSENKSSA-N,,KDR
1972,semaxanib,VEGFR inhibitor,KIT,Cc1cc(C)c(C=C2/C(=O)Nc3ccccc23)[nH]1,WUWDLXZGHZSWQZ-WQLSENKSSA-N,,KIT
1973,semaxanib,VEGFR inhibitor,PDGFRB,Cc1cc(C)c(C=C2/C(=O)Nc3ccccc23)[nH]1,WUWDLXZGHZSWQZ-WQLSENKSSA-N,,PDGFRB
1974,sorafenib,VEGFR inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
1975,sorafenib,VEGFR inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
1976,sorafenib,VEGFR inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
1977,sorafenib,VEGFR inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
1978,sorafenib,VEGFR inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
1979,sorafenib,VEGFR inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
1980,sorafenib,VEGFR inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
1981,sorafenib,VEGFR inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
1982,sorafenib,VEGFR inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
1983,sorafenib,VEGFR inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
1984,sorafenib,VEGFR inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
1985,sorafenib,VEGFR inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
1986,sorafenib,VEGFR inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
1987,sorafenib,VEGFR inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
1988,sorafenib,VEGFR inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
1989,sorafenib,VEGFR inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
1990,sorafenib,VEGFR inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
1991,sorafenib,VEGFR inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
1992,sorafenib,VEGFR inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
1993,sorafenib,VEGFR inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
1994,sorafenib,VEGFR inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
1995,sorafenib,VEGFR inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
1996,SU-1498,VEGFR inhibitor,ERBB2,CC(C)c1cc(/C=C(C#N)/C(=O)NCCCc2ccccc2)cc(C(C)C)c1O,JANPYFTYAGTSIN-FYJGNVAPSA-N,,ERBB2
1997,SU-4312,VEGFR inhibitor,KDR,CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)cc1,UAKWLVYMKBWHMX-UHFFFAOYSA-N,,KDR
1998,SU-4312,VEGFR inhibitor,KDR,CN(C)c1ccc(cc1)C=C1/C(=O)Nc2ccccc12,UAKWLVYMKBWHMX-PTNGSMBKSA-N,,KDR
1999,sunitinib,VEGFR inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT1
2000,sunitinib,VEGFR inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT3
2001,sunitinib,VEGFR inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT4
2002,sunitinib,VEGFR inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KDR
2003,sunitinib,VEGFR inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KIT
2004,sunitinib,VEGFR inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRA
2005,sunitinib,VEGFR inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRB
2006,sunitinib,VEGFR inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,RET
2007,telatinib,VEGFR inhibitor,KDR,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,QFCXANHHBCGMAS-UHFFFAOYSA-N,,KDR
2008,TG-100801,VEGFR inhibitor,FGFR1,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,FGFR1
2009,TG-100801,VEGFR inhibitor,FLT1,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,FLT1
2010,TG-100801,VEGFR inhibitor,KDR,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,KDR
2011,TG-100801,VEGFR inhibitor,SRC,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,,SRC
2012,tivozanib,VEGFR inhibitor,FLT1,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,FLT1
2013,tivozanib,VEGFR inhibitor,FLT4,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,FLT4
2014,tivozanib,VEGFR inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,KDR
2015,tivozanib,VEGFR inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,KIT
2016,tivozanib,VEGFR inhibitor,PDGFRA,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,PDGFRA
2017,tivozanib,VEGFR inhibitor,PDGFRB,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N,,PDGFRB
2018,vandetanib,VEGFR inhibitor,EGFR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,EGFR
2019,vandetanib,VEGFR inhibitor,FLT1,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT1
2020,vandetanib,VEGFR inhibitor,FLT4,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT4
2021,vandetanib,VEGFR inhibitor,KDR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,KDR
2022,vandetanib,VEGFR inhibitor,PTK6,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,PTK6
2023,vandetanib,VEGFR inhibitor,RET,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,RET
2024,vandetanib,VEGFR inhibitor,TEK,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,TEK
2025,vatalanib,VEGFR inhibitor,FLT1,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT1
2026,vatalanib,VEGFR inhibitor,FLT4,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,FLT4
2027,vatalanib,VEGFR inhibitor,KDR,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KDR
2028,vatalanib,VEGFR inhibitor,KIT,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,KIT
2029,vatalanib,VEGFR inhibitor,PDGFRB,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,,PDGFRB
2030,ZM-306416,VEGFR inhibitor,FLT1,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,FLT1
2031,ZM-306416,VEGFR inhibitor,KDR,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,KDR
2032,ZM-323881,VEGFR inhibitor,KDR,Cc1cc(F)c(Nc2ncnc3cc(OCc4ccccc4)ccc23)cc1O,NVBNDZZLJRYRPD-UHFFFAOYSA-N,,KDR
2033,QS-11,ARFGAP inhibitor,ARFGAP1,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3CCCc3c2)nc2n(Cc3ccc(cc3)-c3ccccc3)cnc12,DOKZLKDGUQWMSX-HKBQPEDESA-N,,ARFGAP1
2034,esomeprazole,ATPase inhibitor,ATP4A,COc1ccc2n([Mg]n3c(nc4cc(OC)ccc34)S(=O)Cc5ncc(C)c(OC)c5C)c(nc2c1)S(=O)Cc6ncc(C)c(OC)c6C,KWORUUGOSLYAGD-UHFFFAOYSA-N,,ATP4A
2035,blebbistatin,ATPase inhibitor,MYH2,Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c1ccccc1,LZAXPYOBKSJSEX-UHFFFAOYSA-N,,MYH2
2036,bufalin,ATPase inhibitor,ATP1A1,C[C@@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)CC[C@@H]1c5ccc(=O)oc5,QEEBRPGZBVVINN-BMPKRDENSA-N,,ATP1A1
2037,cinobufagin,ATPase inhibitor,ATP1A1,C[C@@H]1C[C@H]2[C@@H](CC[C@@H]3C[C@@H](O)CC[C@@]32C)[C@]45O[C@@H]5[C@H](OC(=O)C)[C@@H](C14)c6ccc(=O)oc6,XSIZUTIZDQZYMA-SBWPMOMYSA-N,,ATP1A1
2038,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O,TZCOBUQKVNFIQF-ARUUDZKJSA-N,,ATP2A1
2039,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,CC(=O)C1C(=O)C2C3C(Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O,TZCOBUQKVNFIQF-UHFFFAOYSA-N,,ATP2A1
2040,cymarin,ATPase inhibitor,ATP1A1,CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@H]1O,XQCGNURMLWFQJR-ZNDDOCHDSA-N,,ATP1A1
2041,cymarin,ATPase inhibitor,ATP1A1,COC1CC(O[C@H]2CC[C@]3(C=O)C4CC[C@]5(C)C(CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)OC(C)C1O,XQCGNURMLWFQJR-LZLVDNNYSA-N,,ATP1A1
2042,digitoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@@H](O[C@H]2[C@@H](O)C[C@@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,WDJUZGPOPHTGOT-DTLXFLGHSA-N,,ATP1A1
2043,digitoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,WDJUZGPOPHTGOT-KSVSUYAUSA-N,,ATP1A1
2044,digoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4,LTMHDMANZUZIPE-PUGKRICDSA-N,,ATP1A1
2045,digoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,LTMHDMANZUZIPE-JEJJVJTCSA-N,,ATP1A1
2046,digoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)C(CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,LTMHDMANZUZIPE-YUICGFAKSA-N,,ATP1A1
2047,digoxin,ATPase inhibitor,ATP1A1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,LTMHDMANZUZIPE-QVYPYPLASA-N,,ATP1A1
2048,omeprazole,ATPase inhibitor,ATP4A,COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C,SUBDBMMJDZJVOS-UHFFFAOYSA-N,,ATP4A
2049,evodiamine,ATPase inhibitor,TRPV1,CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12,TXDUTHBFYKGSAH-UHFFFAOYSA-N,,TRPV1
2050,gitoxigenin,ATPase inhibitor,ATP1A1,C[C@@]12CCC3C(CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)C[C@H](O)[C@@H]1C5=CC(=O)OC5,PVAMXWLZJKTXFW-YOUFMJPESA-N,,ATP1A1
2051,istaroxime,ATPase inhibitor,ATP1A1,C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4CC(CC[C@]34C)=NOCCN)[C@@H]1CCC2=O,MPYLDWFDPHRTEG-PAAYLBSLSA-N,,ATP1A1
2052,lansoprazole,ATPase inhibitor,ATP4A,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,MJIHNNLFOKEZEW-UHFFFAOYSA-N,,ATP4A
2053,oligomycin-a,ATPase inhibitor,ATP5F1A,CC[C@H]1CC[C@@H]2O[C@]3(CC[C@@H](C)[C@@H](C[C@@H](C)O)O3)[C@H](C)[C@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-JBMMDCLPSA-N,,ATP5F1A
2054,oligomycin-a,ATPase inhibitor,ATP5F1A,CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-WMBHJXFZSA-N,,ATP5F1A
2055,oligomycin-a,ATPase inhibitor,ATP5F1A,CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-VVXVDZGXSA-N,,ATP5F1A
2056,oligomycin-c,ATPase inhibitor,ATP5F1A,CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,CMMLZMMKTYEOKV-JEKNLLRFSA-N,,ATP5F1A
2057,ouabain,ATPase inhibitor,ATP1A1,C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O,LPMXVESGRSUGHW-VGFRVVOQSA-N,,ATP1A1
2058,ouabain,ATPase inhibitor,ATP1A1,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O,LPMXVESGRSUGHW-CIMHIGIKSA-N,,ATP1A1
2059,ouabain,ATPase inhibitor,ATP1A1,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)C4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O,LPMXVESGRSUGHW-XPXORLBYSA-N,,ATP1A1
2060,ouabain,ATPase inhibitor,ATP1A1,CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(CCC5(O)C4CCC3(O)C2)C6=CC(=O)OC6)C(O)C(O)C1O,LPMXVESGRSUGHW-UHFFFAOYSA-N,,ATP1A1
2061,pantoprazole,ATPase inhibitor,ATP4A,COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,IQPSEEYGBUAQFF-UHFFFAOYSA-N,,ATP4A
2062,proscillaridin,ATPase inhibitor,ATP1A1,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c6ccc(=O)oc6)[C@H](O)[C@H](O)[C@H]1O,MYEJFUXQJGHEQK-BVLCKXLMSA-N,,ATP1A1
2063,rabeprazole,ATPase inhibitor,ATP4A,COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,YREYEVIYCVEVJK-UHFFFAOYSA-N,,ATP4A
2064,SCH-28080,ATPase inhibitor,ATP4A,Cc1nc2c(OCc3ccccc3)cccn2c1CC#N,PYKJFEPAUKAXNN-UHFFFAOYSA-N,,ATP4A
2065,strophanthidin,ATPase inhibitor,ATP1A1,C[C@@]12CC[C@H]3[C@@H](CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]2(O)CC[C@@H]1C5=CC(=O)OC5,ODJLBQGVINUMMR-HZXDTFASSA-N,,ATP1A1
2066,tenatoprazole,ATPase inhibitor,IDO1,COc1ccc2[nH]c(nc2n1)S(=O)Cc1ncc(C)c(OC)c1C,ZBFDAUIVDSSISP-UHFFFAOYSA-N,,IDO1
2067,thapsigargin,ATPase inhibitor,ATP2A1,CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)/C(=CC)/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(=O)C)[C@@H]12)OC(=O)CCC)C,IXFPJGBNCFXKPI-FSIHEZPISA-N,,ATP2A1
2068,thapsigargin,ATPase inhibitor,ATP2A1,CCCCCCCC(=O)OC1C(OC(=O)/C(=C/C)/C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C,IXFPJGBNCFXKPI-YBFXNURJSA-N,,ATP2A1
2069,ursolic-acid,ATPase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
2070,ursolic-acid,ATPase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
2071,ursolic-acid,ATPase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
2072,ursolic-acid,ATPase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
2073,xanthohumol,ATPase inhibitor,VCP,COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c2ccc(O)cc2,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,,VCP
2074,tranexamic-acid,Antifibrinolytic,PLG,NC[C@H]1CC[C@@H](CC1)C(O)=O,GYDJEQRTZSCIOI-LJGSYFOKSA-N,,PLG
2075,diminazene-aceturate,DNA intercalator,AOC1,NC(=N)c1ccc(NN=Nc2ccc(cc2)C(N)=N)cc1,XNYZHCFCZNMTFY-UHFFFAOYSA-N,,AOC1
2076,ALW-II-38-3,Ephrin inhibitor,DDR1,Cc1cn(cn1)-c1cc(cc(c1)C(F)(F)F)C(=O)Nc1ccc(C)c(NC(=O)c2ccno2)c1,IYUFHBXMTTXZBE-UHFFFAOYSA-N,,DDR1
2077,ALW-II-49-7,Ephrin inhibitor,DDR1,Cc1ccc(cc1Nc1cncc(c1)C(N)=O)C(=O)Nc1cccc(c1)C(F)(F)F,SAAYRHKJHDIDPH-UHFFFAOYSA-N,,DDR1
2078,dasatinib,Ephrin inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
2079,dasatinib,Ephrin inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
2080,dasatinib,Ephrin inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
2081,dasatinib,Ephrin inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
2082,dasatinib,Ephrin inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
2083,dasatinib,Ephrin inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
2084,dasatinib,Ephrin inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
2085,dasatinib,Ephrin inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
2086,dasatinib,Ephrin inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
2087,dasatinib,Ephrin inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
2088,NVP-BHG712,Ephrin inhibitor,EPHB4,Cc1ccc(cc1Nc1nc(nc2n(C)ncc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F,ZCCPLJOKGAACRT-UHFFFAOYSA-N,,EPHB4
2089,GGTI-298,GGTase inhibitor,CDKN1A,COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12,XVWPFYDMUFBHBF-CLOONOSVSA-N,,CDKN1A
2090,FGIN-1-27,IMPase inhibitor,TSPO,CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1,VUWXAQFLTSBUDB-UHFFFAOYSA-N,,TSPO
2091,L-690330,IMPase inhibitor,IMPA1,CC(Oc1ccc(O)cc1)(P(O)(O)=O)P(O)(O)=O,JKOCAAWWDVHWKB-UHFFFAOYSA-N,,IMPA1
2092,L-690488,IMPase inhibitor,IMPA1,CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)C(C)(Oc1ccc(O)cc1)P(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C,LOTSPVPQHAUHCE-UHFFFAOYSA-N,,IMPA1
2093,mycophenolate-mofetil,IMPase inhibitor,IMPDH1,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH1
2094,mycophenolate-mofetil,IMPase inhibitor,IMPDH2,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH2
2095,ebelactone-b,Lipase inhibitor,PNLIP,CC[C@@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)C=C(/C)C[C@H](C)[C@H]1OC(=O)[C@H]1CC,UNBMQQNYLCPCHS-MGTGEOTMSA-N,,PNLIP
2096,orlistat,Lipase inhibitor,FASN,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,,FASN
2097,orlistat,Lipase inhibitor,PNLIP,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,,PNLIP
2098,orlistat,Lipase inhibitor,DAGLA,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,,DAGLA
2099,orlistat,Lipase inhibitor,LIPF,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,,LIPF
2100,benzonatate,Local anesthetic,SCN5A,CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,MAFMQEKGGFWBAB-UHFFFAOYSA-N,,SCN5A
2101,prilocaine,Local anesthetic,SCN5A,CCCNC(C)C(=O)Nc1ccccc1C,MVFGUOIZUNYYSO-UHFFFAOYSA-N,,SCN5A
2102,epinephrine,Neurotransmitter,ADRA1D,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1D
2103,epinephrine,Neurotransmitter,ADRA1B,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1B
2104,epinephrine,Neurotransmitter,ADRA1A,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1A
2105,epinephrine,Neurotransmitter,ADRA2A,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2A
2106,epinephrine,Neurotransmitter,ADRA2B,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2B
2107,epinephrine,Neurotransmitter,ADRA2C,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2C
2108,epinephrine,Neurotransmitter,ADRB1,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB1
2109,epinephrine,Neurotransmitter,ADRB2,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB2
2110,epinephrine,Neurotransmitter,ADRB3,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB3
2111,tasquinimod,S100A9 inhibitor,S100A9,COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12,ONDYALNGTUAJDX-UHFFFAOYSA-N,,S100A9
2112,tasquinimod,S100A9 inhibitor,HDAC4,COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12,ONDYALNGTUAJDX-UHFFFAOYSA-N,,HDAC4
2113,flavokavain-b,Anti-cancer agent,IKBKB,COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1,QKQLSQLKXBHUSO-CMDGGOBGSA-N,,IKBKB
2114,lenalidomide,Anti-cancer agent,CRBN,Nc1cccc2C(=O)N(Cc12)[C@@H]1CCC(=O)NC1=O,GOTYRUGSSMKFNF-SNVBAGLBSA-N,,CRBN
2115,lenalidomide,Anti-cancer agent,TNF,Nc1cccc2C(=O)N(Cc12)[C@@H]1CCC(=O)NC1=O,GOTYRUGSSMKFNF-SNVBAGLBSA-N,,TNF
2116,lenalidomide,Anti-cancer agent,CRBN,Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,,CRBN
2117,lenalidomide,Anti-cancer agent,TNF,Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,,TNF
2118,phenethyl-isothiocyanate,Anti-cancer agent,CYP2E1,S=C=NCCc1ccccc1,IZJDOKYDEWTZSO-UHFFFAOYSA-N,,CYP2E1
2119,sulforaphane,Anti-cancer agent,NFE2L2,CS(=O)CCCCN=C=S,SUVMJBTUFCVSAD-UHFFFAOYSA-N,,NFE2L2
2120,MDL-28170,Calpain inhibitor,CTSB,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C=O,NGBKFLTYGSREKK-PMACEKPBSA-N,,CTSB
2121,MDL-28170,Calpain inhibitor,CAPN1,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C=O,NGBKFLTYGSREKK-PMACEKPBSA-N,,CAPN1
2122,amygdalin,Caspase activator,CASP3,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,XUCIJNAGGSZNQT-JHSLDZJXSA-N,,CASP3
2123,betulinic-acid,Caspase activator,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
2124,betulinic-acid,Caspase activator,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
2125,BRD-A05680309,Caspase activator,XIAP,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2CCCc3ccccc23,POKZVJVCUGVHME-UHFFFAOYSA-N,,XIAP
2126,BRD-A05680309,Caspase activator,CASP8,CNC(C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2CCCc3ccccc23,POKZVJVCUGVHME-UHFFFAOYSA-N,,CASP8
2127,BRD-K30064966,Caspase activator,CASP3,Oc1cccc2cc(C(=O)Nc3cccc(c3)-c3cn4ccccc4n3)c(=O)oc12,FCODPGUEFHCCIA-UHFFFAOYSA-N,,CASP3
2128,MT-21,Caspase activator,CYCS,CCCCCCCCN1C(=O)C(=C(C)C1(C)O)C(=O)C,IWFCPVZRZLDTPI-UHFFFAOYSA-N,,CYCS
2129,PAC-1,Caspase activator,CASP3,Oc1c(CC=C)cccc1C=NNC(=O)CN1CCN(Cc2ccccc2)CC1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,,CASP3
2130,PAC-1,Caspase activator,CASP3,Oc1c(CC=C)cccc1C=NNC(=O)CN2CCN(Cc3ccccc3)CC2,YQNRVGJCPCNMKT-UHFFFAOYSA-N,,CASP3
2131,sanguinarium-chloride,Caspase activator,CASP3,C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12,INVGWHRKADIJHF-UHFFFAOYSA-N,,CASP3
2132,gambogic-acid,Caspase activator,BCL2,CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(CC=C(C)C(O)=O)OC6(C)C,GEZHEQNLKAOMCA-RRZNCOCZSA-N,,BCL2
2133,AZ-10417808,Caspase inhibitor,CASP3,[O-][N+](=O)c1cc(C(=O)NCC=C)c2nc(Nc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1,VUBILPOZTRGZJK-UHFFFAOYSA-N,,CASP3
2134,BRD-K48969316,Caspase inhibitor,CASP1,CC(C)(C)[C@H](NC(=O)c1ccc(N)c(Cl)c1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C#N,KENKPOUHXLJLEY-QANKJYHBSA-N,,CASP1
2135,BRD-K87426499,Caspase inhibitor,CASP3,COc1ccc(cc1C)S(=O)(=O)N(C)C[C@@H]2Oc3c(NC(=O)Nc4cccc5ccccc45)cccc3C(=O)N(C[C@H]2C)[C@@H](C)CO,APTVJNKPZZAJMD-FXZPAHAQSA-N,,CASP3
2136,EMF-BCA1-57,Caspase inhibitor,CASP3,COc1ccc(cc1)S(=O)(=O)N(C)C[C@@H]2Oc3c(NC(=O)Nc4cccc5ccccc45)cccc3C(=O)N(C[C@H]2C)[C@@H](C)CO,FXIXTIXYCSOXIT-UDKTZTBJSA-N,,CASP3
2137,EMF-BCA1-64,Caspase inhibitor,STAT1,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc3OCCOc3c2)Oc4c(NC(=O)Nc5cccc6ccccc56)cccc4C1=O,YDFFDCBBGWXONN-MODXFSQWSA-N,,STAT1
2138,EMF-BCA1-64,Caspase inhibitor,CASP3,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc3OCCOc3c2)Oc4c(NC(=O)Nc5cccc6ccccc56)cccc4C1=O,YDFFDCBBGWXONN-MODXFSQWSA-N,,CASP3
2139,ivachtin,Caspase inhibitor,CASP3,CC(=O)OCCN1C(=O)c2c(C1=O)c3cc(ccc3nc2C)S(=O)(=O)N4CCOCC4,MWXJJTMEUGWKKY-UHFFFAOYSA-N,,CASP3
2140,SA-94315,Caspase inhibitor,CASP3,COc1ccc(cc1)S(=O)(=O)N(C)C[C@H]2Oc3c(NC(=O)Nc4cccc5ccccc45)cccc3C(=O)N(C[C@@H]2C)[C@@H](C)CO,FXIXTIXYCSOXIT-WDCWYOMISA-N,,CASP3
2141,ursolic-acid,Caspase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
2142,ursolic-acid,Caspase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
2143,ursolic-acid,Caspase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
2144,ursolic-acid,Caspase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
2145,VX-765,Caspase inhibitor,CASP1,CCO[C@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,SJDDOCKBXFJEJB-QQSSDERHSA-N,,CASP1
2146,bisbenzimide,DNA binding agent,TOP1,CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6,KTHLBVBTGUUEFS-DIBXZPPDSA-N,,TOP1
2147,dynasore,Dynamin inhibitor,DNM1L,Oc1ccc(C=NNC(=O)c2cc3ccccc3cc2O)cc1O,SYNDQCRDGGCQRZ-VXLYETTFSA-N,,DNM1L
2148,dynasore,Dynamin inhibitor,DNM1,Oc1ccc(C=NNC(=O)c2cc3ccccc3cc2O)cc1O,SYNDQCRDGGCQRZ-VXLYETTFSA-N,,DNM1
2149,dynasore,Dynamin inhibitor,DNM2,Oc1ccc(C=NNC(=O)c2cc3ccccc3cc2O)cc1O,SYNDQCRDGGCQRZ-VXLYETTFSA-N,,DNM2
2150,acexamic-acid,Gastrin inhibitor,GAST,CC(=O)NCCCCCC(O)=O,WDSCBUNMANHPFH-UHFFFAOYSA-N,,GAST
2151,rabeprazole,Gastrin inhibitor,ATP4A,COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,YREYEVIYCVEVJK-UHFFFAOYSA-N,,ATP4A
2152,beclomethasone-dipropionate,Immunosuppressant,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,KUVIULQEHSCUHY-XYWKZLDCSA-N,,NR3C1
2153,beclomethasone-dipropionate,Immunosuppressant,NR3C1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC12C,KUVIULQEHSCUHY-UHFFFAOYSA-N,,NR3C1
2154,fingolimod,Immunosuppressant,S1PR1,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR1
2155,fingolimod,Immunosuppressant,S1PR3,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR3
2156,fingolimod,Immunosuppressant,S1PR5,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR5
2157,fingolimod,Immunosuppressant,S1PR4,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR4
2158,ginkgolide-b,Immunosuppressant,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
2159,ginkgolide-b,Immunosuppressant,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
2160,ginkgolide-b,Immunosuppressant,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
2161,ginkgolide-b,Immunosuppressant,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
2162,ginkgolide-b,Immunosuppressant,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
2163,ginkgolide-b,Immunosuppressant,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
2164,mycophenolate-mofetil,Immunosuppressant,IMPDH1,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH1
2165,mycophenolate-mofetil,Immunosuppressant,IMPDH2,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH2
2166,BRD-K89329876,Kinesin inhibitor,KIF11,CC(C)(C)c1ccc2cc(C#N)c(C#N)cc2c1,MKILROQBJOOZKC-UHFFFAOYSA-N,,KIF11
2167,filanesib,Kinesin inhibitor,KIF11,CON(C)C(=O)N1N=C(S[C@@]1(CCCN)c1ccccc1)c1cc(F)ccc1F,LLXISKGBWFTGEI-FQEVSTJZSA-N,,KIF11
2168,ispinesib,Kinesin inhibitor,KIF11,CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1nc2cc(Cl)ccc2c(=O)n1Cc1ccccc1,QJZRFPJCWMNVAV-HHHXNRCGSA-N,,KIF11
2169,monastrol,Kinesin inhibitor,KIF11,CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1,LOBCDGHHHHGHFA-UHFFFAOYSA-N,,KIF11
2170,arbutin,Melanin inhibitor,TYR,OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,BJRNKVDFDLYUGJ-RMPHRYRLSA-N,,TYR
2171,monobenzone,Melanin inhibitor,TYR,Oc1ccc(OCc2ccccc2)cc1,VYQNWZOUAUKGHI-UHFFFAOYSA-N,,TYR
2172,AT-9283,Mitotic inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
2173,AT-9283,Mitotic inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
2174,AT-9283,Mitotic inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
2175,AT-9283,Mitotic inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
2176,MLN-8054,Mitotic inhibitor,AURKA,OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1,HHFBDROWDBDFBR-UHFFFAOYSA-N,,AURKA
2177,PSB-06126,NTPDase inhibitor,ENTPD3,Nc1c2C(=O)c3ccccc3C(=O)c2c(Nc2cccc3ccccc23)cc1S(O)(=O)=O,ZHQRPIRGSWEALJ-UHFFFAOYSA-N,,ENTPD3
2178,PSB-069,NTPDase inhibitor,ENTPD1,Nc1c(cc(Nc2ccc(Cl)cc2)c3C(=O)c4ccccc4C(=O)c13)S(=O)(=O)O,MHSMKEQLFFWYOS-UHFFFAOYSA-N,,ENTPD1
2179,PSB-069,NTPDase inhibitor,ENTPD2,Nc1c(cc(Nc2ccc(Cl)cc2)c3C(=O)c4ccccc4C(=O)c13)S(=O)(=O)O,MHSMKEQLFFWYOS-UHFFFAOYSA-N,,ENTPD2
2180,PSB-069,NTPDase inhibitor,ENTPD3,Nc1c(cc(Nc2ccc(Cl)cc2)c3C(=O)c4ccccc4C(=O)c13)S(=O)(=O)O,MHSMKEQLFFWYOS-UHFFFAOYSA-N,,ENTPD3
2181,levallorphan,Opioid antagonist,OPRM1,Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1,OZYUPQUCAUTOBP-QXAKKESOSA-N,,OPRM1
2182,fludarabine-phosphate,Purine antagonist,POLA1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,POLA1
2183,fludarabine-phosphate,Purine antagonist,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,RRM1
2184,thioguanine,Purine antagonist,IMPDH1,Nc1nc2nc[nH]c2c(=S)[nH]1,WYWHKKSPHMUBEB-UHFFFAOYSA-N,,IMPDH1
2185,thioguanine,Purine antagonist,IMPDH2,Nc1nc2nc[nH]c2c(=S)[nH]1,WYWHKKSPHMUBEB-UHFFFAOYSA-N,,IMPDH2
2186,hydrochlorothiazide,Thiazide diuretic,SLC12A3,NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl,JZUFKLXOESDKRF-UHFFFAOYSA-N,,SLC12A3
2187,indapamide,Thiazide diuretic,KCNQ1,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O,NDDAHWYSQHTHNT-UHFFFAOYSA-N,,KCNQ1
2188,indapamide,Thiazide diuretic,SLC12A3,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O,NDDAHWYSQHTHNT-UHFFFAOYSA-N,,SLC12A3
2189,quinethazone,Thiazide diuretic,SLC12A3,CCC1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,,SLC12A3
2190,camostat-mesilate,Trypsin inhibitor,PRSS1,CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1,XASIMHXSUQUHLV-UHFFFAOYSA-N,,PRSS1
2191,CYT-997,Tubulin inhibitor,TUBB,CCC[C@H](Nc1nc(ncc1C)-c1ccc(NC(=O)NCC)c(OC)c1)c1cccnc1,MTJHLONVHHPNSI-IBGZPJMESA-N,,TUBB
2192,docetaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C,ZDZOTLJHXYCWBA-AWAZFWMNSA-N,,TUBB
2193,docetaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@]12CO[C@@H]2C[C@H](O)[C@]3(C)[C@@H]1[C@H](OC(=O)c4ccccc4)[C@@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,ZDZOTLJHXYCWBA-VJAAGMARSA-N,,TUBB
2194,docetaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)C2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C,ZDZOTLJHXYCWBA-JXHJHTFNSA-N,,TUBB
2195,docetaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@]12CO[C@H]1C[C@H](O)[C@]1(C)[C@H]2[C@H](OC(=O)c2ccccc2)[C@@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C,ZDZOTLJHXYCWBA-FNKMKNBQSA-N,,TUBB
2196,epothilone-b,Tubulin inhibitor,TUBB,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,QXRSDHAAWVKZLJ-AXCXJGFASA-N,,TUBB
2197,fenbendazole,Tubulin inhibitor,TUBB,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,HDDSHPAODJUKPD-UHFFFAOYSA-N,,TUBB
2198,flubendazole,Tubulin inhibitor,TUBB,COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1,CPEUVMUXAHMANV-UHFFFAOYSA-N,,TUBB
2199,noscapine,Tubulin inhibitor,SIGMAR1,COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-QZTJIDSGSA-N,,SIGMAR1
2200,noscapine,Tubulin inhibitor,SIGMAR1,COc1ccc2[C@@H](OC(=O)c2c1OC)[C@H]1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-ZENAZSQFSA-N,,SIGMAR1
2201,noscapine,Tubulin inhibitor,SIGMAR1,COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5c(OC)c34,AKNNEGZIBPJZJG-QNSVNVJESA-N,,SIGMAR1
2202,noscapine,Tubulin inhibitor,SIGMAR1,COc1ccc2[C@H](OC(=O)c2c1OC)C1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-ZVAWYAOSSA-N,,SIGMAR1
2203,oxibendazole,Tubulin inhibitor,TUBB,CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1,RAOCRURYZCVHMG-UHFFFAOYSA-N,,TUBB
2204,paclitaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(CO[C@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-XINRTLPHSA-N,,TUBB
2205,paclitaxel,Tubulin inhibitor,NR1I2,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(CO[C@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-XINRTLPHSA-N,,NR1I2
2206,paclitaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-WLUSQHPBSA-N,,TUBB
2207,paclitaxel,Tubulin inhibitor,NR1I2,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-WLUSQHPBSA-N,,NR1I2
2208,paclitaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-VAZQATRQSA-N,,TUBB
2209,paclitaxel,Tubulin inhibitor,NR1I2,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-VAZQATRQSA-N,,NR1I2
2210,paclitaxel,Tubulin inhibitor,TUBB,CC(=O)OC1C2=C(C)C(CC(O)(C(OC(=O)c3ccccc3)C4C5(COC5CC(O)C4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)C(O)C(NC(=O)c6ccccc6)c7ccccc7,RCINICONZNJXQF-UHFFFAOYSA-N,,TUBB
2211,paclitaxel,Tubulin inhibitor,NR1I2,CC(=O)OC1C2=C(C)C(CC(O)(C(OC(=O)c3ccccc3)C4C5(COC5CC(O)C4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)C(O)C(NC(=O)c6ccccc6)c7ccccc7,RCINICONZNJXQF-UHFFFAOYSA-N,,NR1I2
2212,parbendazole,Tubulin inhibitor,TUBB,CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1,YRWLZFXJFBZBEY-UHFFFAOYSA-N,,TUBB
2213,vinblastine,Tubulin inhibitor,TUBB,CC[C@]1(O)C[C@@H]2CN(C1)CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@@H]7[C@@]86CCN9CC=C[C@](CC)([C@H]98)[C@@H](OC(=O)C)[C@]7(O)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,,TUBB
2214,vinblastine,Tubulin inhibitor,TUBB,CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,JXLYSJRDGCGARV-XQKSVPLYSA-N,,TUBB
2215,vinblastine,Tubulin inhibitor,TUBB,CC[C@]1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,JXLYSJRDGCGARV-CUGARIAGSA-N,,TUBB
2216,vinblastine,Tubulin inhibitor,TUBB,CCC1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)C(C2)(C(=O)OC)c1cc2c(cc1OC)N(C)C1C22CCN3CC=CC(CC)(C23)C(OC(C)=O)C1(O)C(=O)OC,JXLYSJRDGCGARV-UHFFFAOYSA-N,,TUBB
2217,vinblastine,Tubulin inhibitor,TUBB,CCC1(O)CC2CN(C1)CCc3c([nH]c4ccccc34)C(C2)(C(=O)OC)c5cc6c(cc5OC)N(C)C7C86CCN9CC=CC(CC)(C98)C(C(=O)OC)C7(O)C(=O)OC,SLIRURSWQCRWFG-UHFFFAOYSA-N,,TUBB
2218,vincristine,Tubulin inhibitor,TUBB,CC[C@]1(O)C[C@@H]2CN(C1)CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@@H]7[C@@]86CCN9CC=C[C@](CC)([C@H]98)[C@@H](OC(=O)C)[C@]7(O)C(=O)OC,OGWKCGZFUXNPDA-CFWMRBGOSA-N,,TUBB
2219,vincristine,Tubulin inhibitor,TUBB,CC[C@]1(O)C[C@H]2C[N@@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,OGWKCGZFUXNPDA-YPKBQUEXSA-N,,TUBB
2220,vincristine,Tubulin inhibitor,TUBB,CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,OGWKCGZFUXNPDA-XQKSVPLYSA-N,,TUBB
2221,vincristine,Tubulin inhibitor,TUBB,CC[C@]1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,OGWKCGZFUXNPDA-CUGARIAGSA-N,,TUBB
2222,vincristine,Tubulin inhibitor,TUBB,CCC1(O)CC2CN(C1)CCc3c([nH]c4ccccc34)C(C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)C7C86CCN9CC=CC(CC)(C98)C(C(=O)OC)C7(O)C(=O)OC,KUSGVVPSWLLOSB-UHFFFAOYSA-N,,TUBB
2223,vinorelbine,Tubulin inhibitor,TUBB,CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,GBABOYUKABKIAF-JEEMQKELSA-N,,TUBB
2224,vinorelbine,Tubulin inhibitor,TUBB,CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,GBABOYUKABKIAF-JEEMQKELSA-N,,TUBB
2225,vinorelbine,Tubulin inhibitor,TUBB,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,GBABOYUKABKIAF-IELIFDKJSA-N,,TUBB
2226,vinorelbine,Tubulin inhibitor,TUBB,CCC1=C[C@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,GBABOYUKABKIAF-JKVZWNDSSA-N,,TUBB
2227,paclitaxel,Tubulin inhibitor,TUBB,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-MZXODVADSA-N,,TUBB
2228,paclitaxel,Tubulin inhibitor,NR1I2,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,RCINICONZNJXQF-MZXODVADSA-N,,NR1I2
2229,carbimazole,Anti-thyroid agent,TPO,CCOC(=O)n1ccn(C)c1=S,CFOYWRHIYXMDOT-UHFFFAOYSA-N,,TPO
2230,methimazole,Anti-thyroid agent,TPO,Cn1cc[nH]c1=S,PMRYVIKBURPHAH-UHFFFAOYSA-N,,TPO
2231,levosimendan,Calcium sensitizer,TNNC1,C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,WHXMKTBCFHIYNQ-SECBINFHSA-N,,TNNC1
2232,pimobendan,Calcium sensitizer,PDE3A,COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C,GLBJJMFZWDBELO-UHFFFAOYSA-N,,PDE3A
2233,levodopa,Dopamine precursor,DRD3,N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,,DRD3
2234,DMP-777,Elastase inhibitor,MPO,CCC[C@@H](NC(=O)N1[C@@H](Oc2ccc(cc2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)c1ccc2OCOc2c1,ZSDCIRYNTCVTMF-GIGWZHCTSA-N,,MPO
2235,clotrimazole,Imidazoline ligand,KCNN4,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,,KCNN4
2236,azilsartan-medoxomil,Insulin sensitizer,AGTR2,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,QJFSABGVXDWMIW-UHFFFAOYSA-N,,AGTR2
2237,balaglitazone,Insulin sensitizer,PPARG,Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O,IETKPTYAGKZLKY-UHFFFAOYSA-N,,PPARG
2238,CAY-10415,Insulin sensitizer,INS,CCc1ccc(nc1)C(=O)COc1ccc(CC2SC(=O)NC2=O)cc1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,,INS
2239,GW-0742,Insulin sensitizer,PPARD,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F,HWVNEWGKWRGSRK-UHFFFAOYSA-N,,PPARD
2240,GW-1929,Insulin sensitizer,PPARG,CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1,QTQMRBZOBKYXCG-UHFFFAOYSA-N,,PPARG
2241,GW-501516,Insulin sensitizer,PPARD,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F,YDBLKRPLXZNVNB-UHFFFAOYSA-N,,PPARD
2242,inositol,Insulin sensitizer,CDIPT,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O,CDAISMWEOUEBRE-GPIVLXJGSA-N,,CDIPT
2243,pioglitazone,Insulin sensitizer,PPARG,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,HYAFETHFCAUJAY-UHFFFAOYSA-N,,PPARG
2244,rosiglitazone,Insulin sensitizer,PPARG,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,YASAKCUCGLMORW-UHFFFAOYSA-N,,PPARG
2245,tesaglitazar,Insulin sensitizer,PPARA,CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,,PPARA
2246,tesaglitazar,Insulin sensitizer,PPARG,CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,,PPARG
2247,troglitazone,Insulin sensitizer,PPARG,Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O,GXPHKUHSUJUWKP-UHFFFAOYSA-N,,PPARG
2248,ATN-161,Integrin inhibitor,ITGA5,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,MMHDBUJXLOFTLC-WOYTXXSLSA-N,,ITGA5
2249,ATN-161,Integrin inhibitor,ITGAV,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,MMHDBUJXLOFTLC-WOYTXXSLSA-N,,ITGAV
2250,ATN-161,Integrin inhibitor,ITGB1,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,MMHDBUJXLOFTLC-WOYTXXSLSA-N,,ITGB1
2251,ATN-161,Integrin inhibitor,ITGB3,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,MMHDBUJXLOFTLC-WOYTXXSLSA-N,,ITGB3
2252,cilengitide,Integrin inhibitor,ITGAV,CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O,AMLYAMJWYAIXIA-VWNVYAMZSA-N,,ITGAV
2253,cilengitide,Integrin inhibitor,ITGB3,CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O,AMLYAMJWYAIXIA-VWNVYAMZSA-N,,ITGB3
2254,firategrast,Integrin inhibitor,ITGA4,CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(O)=O)cc2)c(OC)c1,YLFZHHDVRSYTKT-NRFANRHFSA-N,,ITGA4
2255,GR-144053,Integrin inhibitor,ITGB3,NC(=N)c1ccc(cc1)N1CCN(CC1)C1CCN(CC(O)=O)CC1,QGEGSJUSWLLZLH-UHFFFAOYSA-N,,ITGB3
2256,imiquimod,Interferon inducer,TLR7,CC(C)Cn1cnc2c(N)nc3ccccc3c12,DOUYETYNHWVLEO-UHFFFAOYSA-N,,TLR7
2257,imiquimod,Interferon inducer,TLR8,CC(C)Cn1cnc2c(N)nc3ccccc3c12,DOUYETYNHWVLEO-UHFFFAOYSA-N,,TLR8
2258,CMPD-1,P38 MAPK inhibitor,MAPK14,Oc1ccc(NC(=O)CCCc2ccc(cc2)-c2ccccc2F)cc1,ODYAQBDIXCVKAE-UHFFFAOYSA-N,,MAPK14
2259,doramapimod,P38 MAPK inhibitor,MAPK14,Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,,MAPK14
2260,doramapimod,P38 MAPK inhibitor,MAPK11,Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,,MAPK11
2261,doramapimod,P38 MAPK inhibitor,MAPK12,Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,,MAPK12
2262,EO-1428,P38 MAPK inhibitor,MAPK14,Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl,HDCLCHNAEZNGNV-UHFFFAOYSA-N,,MAPK14
2263,EO-1428,P38 MAPK inhibitor,MAPK11,Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl,HDCLCHNAEZNGNV-UHFFFAOYSA-N,,MAPK11
2264,JX-401,P38 MAPK inhibitor,MAPK14,COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1,OMGLGPKQUFSRNN-UHFFFAOYSA-N,,MAPK14
2265,losmapimod,P38 MAPK inhibitor,MAPK14,Cc1c(F)cc(cc1-c1ccc(cn1)C(=O)NCC(C)(C)C)C(=O)NC1CC1,KKYABQBFGDZVNQ-UHFFFAOYSA-N,,MAPK14
2266,LY-364947,P38 MAPK inhibitor,TGFBR1,c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1,IBCXZJCWDGCXQT-UHFFFAOYSA-N,,TGFBR1
2267,ML-3163,P38 MAPK inhibitor,MAPK14,C[S+](O)c1ccc(CSc2nc(c([nH]2)c3ccc(F)cc3)c4ccncc4)cc1,ANMPJJNVRCURIU-UHFFFAOYSA-N,,MAPK14
2268,PH-797804,P38 MAPK inhibitor,MAPK14,CNC(=O)c1ccc(C)c(c1)-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,,MAPK14
2269,SB-202190,P38 MAPK inhibitor,MAPK14,Oc1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,QHKYPYXTTXKZST-UHFFFAOYSA-N,,MAPK14
2270,SB-203580,P38 MAPK inhibitor,MAPK14,CS(=O)(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccncc3)c4ccc(F)cc4,XEOVWJYINDYNSM-UHFFFAOYSA-N,,MAPK14
2271,SB-203580,P38 MAPK inhibitor,MAPK1,CS(=O)(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccncc3)c4ccc(F)cc4,XEOVWJYINDYNSM-UHFFFAOYSA-N,,MAPK1
2272,SB-203580,P38 MAPK inhibitor,MAPK11,CS(=O)(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccncc3)c4ccc(F)cc4,XEOVWJYINDYNSM-UHFFFAOYSA-N,,MAPK11
2273,SB-203580,P38 MAPK inhibitor,MAPK14,CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,CDMGBJANTYXAIV-UHFFFAOYSA-N,,MAPK14
2274,SB-203580,P38 MAPK inhibitor,MAPK1,CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,CDMGBJANTYXAIV-UHFFFAOYSA-N,,MAPK1
2275,SB-203580,P38 MAPK inhibitor,MAPK11,CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,CDMGBJANTYXAIV-UHFFFAOYSA-N,,MAPK11
2276,SB-239063,P38 MAPK inhibitor,MAPK14,COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1,ZQUSFAUAYSEREK-WKILWMFISA-N,,MAPK14
2277,SB-239063,P38 MAPK inhibitor,MAPK11,COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1,ZQUSFAUAYSEREK-WKILWMFISA-N,,MAPK11
2278,SB-239063,P38 MAPK inhibitor,MAPK14,COc1nccc(n1)c2c(ncn2C3CCC(O)CC3)c4ccc(F)cc4,ZQUSFAUAYSEREK-UHFFFAOYSA-N,,MAPK14
2279,SB-239063,P38 MAPK inhibitor,MAPK11,COc1nccc(n1)c2c(ncn2C3CCC(O)CC3)c4ccc(F)cc4,ZQUSFAUAYSEREK-UHFFFAOYSA-N,,MAPK11
2280,SC-68376,P38 MAPK inhibitor,MAPK14,Cc1nc(c(o1)c2ccncc2)c3ccccc3,BHWCZLOXTLWZAQ-UHFFFAOYSA-N,,MAPK14
2281,SD-169,P38 MAPK inhibitor,MAPK14,NC(=O)c1ccc2[nH]ccc2c1,GQMYQEAXTITUAE-UHFFFAOYSA-N,,MAPK14
2282,skepinone-l,P38 MAPK inhibitor,MAPK14,OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1,HXMGCTFLLWPVFM-GOSISDBHSA-N,,MAPK14
2283,TAK-715,P38 MAPK inhibitor,MAPK14,CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1,HEKAIDKUDLCBRU-UHFFFAOYSA-N,,MAPK14
2284,talmapimod,P38 MAPK inhibitor,MAPK14,C[C@H]1CN([C@H](C)CN1Cc1ccc(F)cc1)C(=O)c1cc2c(cn(C)c2cc1Cl)C(=O)C(=O)N(C)C,ZMELOYOKMZBMRB-DLBZAZTESA-N,,MAPK14
2285,VX-702,P38 MAPK inhibitor,MAPK14,NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F,FYSRKRZDBHOFAY-UHFFFAOYSA-N,,MAPK14
2286,VX-745,P38 MAPK inhibitor,MAPK14,Fc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(F)c1,VEPKQEUBKLEPRA-UHFFFAOYSA-N,,MAPK14
2287,aliskiren,Protease inhibitor,REN,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC,UXOWGYHJODZGMF-QORCZRPOSA-N,,REN
2288,camostat-mesilate,Protease inhibitor,PRSS1,CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1,XASIMHXSUQUHLV-UHFFFAOYSA-N,,PRSS1
2289,ginkgolide-b,Protease inhibitor,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
2290,ginkgolide-b,Protease inhibitor,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
2291,ginkgolide-b,Protease inhibitor,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
2292,ginkgolide-b,Protease inhibitor,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
2293,ginkgolide-b,Protease inhibitor,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
2294,ginkgolide-b,Protease inhibitor,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
2295,YM-155,Survivin inhibitor,BIRC5,COCC[n+]1c(C)n(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O,OTSOOHRUMBRSHZ-UHFFFAOYSA-N,,BIRC5
2296,YM-155,Survivin inhibitor,BIRC5,COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C,OTSOOHRUMBRSHZ-UHFFFAOYSA-N,,BIRC5
2297,argatroban,Thrombin inhibitor,F2,C[C@@H]1CCN([C@@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1cccc2CC(C)CNc12,KXNPVXPOPUZYGB-YZYLHUITSA-N,,F2
2298,argatroban,Thrombin inhibitor,F2,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1cccc2CC(C)CNc12,KXNPVXPOPUZYGB-IOVMHBDKSA-N,,F2
2299,dabigatran,Thrombin inhibitor,F2,Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1,YBSJFWOBGCMAKL-UHFFFAOYSA-N,,F2
2300,dabigatran-etexilate,Thrombin inhibitor,F2,CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1,KSGXQBZTULBEEQ-UHFFFAOYSA-N,,F2
2301,skatole,Thrombin inhibitor,CYP2F1,Cc1c[nH]c2ccccc12,ZFRKQXVRDFCRJG-UHFFFAOYSA-N,,CYP2F1
2302,bivalirudin,Thrombin inhibitor,F2,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O,OIRCOABEOLEUMC-GEJPAHFPSA-N,,F2
2303,lesinurad,Uric acid diuretic,SLC22A12,OC(=O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,FGQFOYHRJSUHMR-UHFFFAOYSA-N,,SLC22A12
2304,probenecid,Uricosuric blocker,SLC22A11,CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,,SLC22A11
2305,probenecid,Uricosuric blocker,SLC22A6,CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,,SLC22A6
2306,probenecid,Uricosuric blocker,SLC22A8,CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,,SLC22A8
2307,sulfinpyrazone,Uricosuric blocker,SLC22A12,O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,,SLC22A12
2308,sulfinpyrazone,Uricosuric blocker,ABCC1,O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,,ABCC1
2309,chlorpropamide,ATP channel blocker,ABCC8,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,,ABCC8
2310,glibenclamide,ATP channel blocker,CFTR,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,CFTR
2311,glibenclamide,ATP channel blocker,KCNJ5,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ5
2312,glibenclamide,ATP channel blocker,KCNJ8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ8
2313,glibenclamide,ATP channel blocker,KCNJ11,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ11
2314,glibenclamide,ATP channel blocker,ABCC8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,ABCC8
2315,gliclazide,ATP channel blocker,ABCC8,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,BOVGTQGAOIONJV-UHFFFAOYSA-N,,ABCC8
2316,tolbutamide,ATP channel blocker,KCNJ11,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,JLRGJRBPOGGCBT-UHFFFAOYSA-N,,KCNJ11
2317,tolbutamide,ATP channel blocker,ABCC8,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,JLRGJRBPOGGCBT-UHFFFAOYSA-N,,ABCC8
2318,hydroxychloroquine,Anti-malarial agent,TLR7,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,,TLR7
2319,hydroxychloroquine,Anti-malarial agent,TLR9,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,,TLR9
2320,sulfasalazine,Anti-rheumatic drug,ALOX5,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,ALOX5
2321,sulfasalazine,Anti-rheumatic drug,PTGS1,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,PTGS1
2322,sulfasalazine,Anti-rheumatic drug,PTGS2,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,PTGS2
2323,methyl-angolensate,Apoptosis inhibitor,HTR2B,COC(=O)CC1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C,YNMYHRYTRCKSMI-RPKVDDIGSA-N,,HTR2B
2324,betulinic-acid,Apoptosis stimulant,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
2325,betulinic-acid,Apoptosis stimulant,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
2326,fenretinide,Apoptosis stimulant,RARA,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1,AKJHMTWEGVYYSE-FXILSDISSA-N,,RARA
2327,fenretinide,Apoptosis stimulant,RARA,CC(=CC=CC(=CC(=O)Nc1ccc(O)cc1)C)C=CC2=C(C)CCCC2(C)C,AKJHMTWEGVYYSE-UHFFFAOYSA-N,,RARA
2328,perillyl-alcohol,Apoptosis stimulant,FNTA,CC(=C)C1CCC(CO)=CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,,FNTA
2329,sanguinarium-chloride,Apoptosis stimulant,CASP3,C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12,INVGWHRKADIJHF-UHFFFAOYSA-N,,CASP3
2330,YK-4279,Apoptosis stimulant,DHX9,COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl,HLXSCTYHLQHQDJ-UHFFFAOYSA-N,,DHX9
2331,YK-4279,Apoptosis stimulant,FLI1,COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl,HLXSCTYHLQHQDJ-UHFFFAOYSA-N,,FLI1
2332,anastrozole,Aromatase inhibitor,CYP19A1,CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N,YBBLVLTVTVSKRW-UHFFFAOYSA-N,,CYP19A1
2333,exemestane,Aromatase inhibitor,CYP19A1,C[C@]12CC[C@@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@H]1CCC2=O,BFYIZQONLCFLEV-AFJOWOCMSA-N,,CYP19A1
2334,exemestane,Aromatase inhibitor,CYP19A1,C[C@]12CCC3C(CC(=C)C4=CC(=O)C=C[C@]34C)C1CCC2=O,BFYIZQONLCFLEV-VQIOPMHJSA-N,,CYP19A1
2335,exemestane,Aromatase inhibitor,CYP19A1,C[C@@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]2CCC1=O,BFYIZQONLCFLEV-DAELLWKTSA-N,,CYP19A1
2336,fadrozole,Aromatase inhibitor,CYP19A1,N#Cc1ccc(cc1)C1CCCc2cncn12,CLPFFLWZZBQMAO-UHFFFAOYSA-N,,CYP19A1
2337,formestane,Aromatase inhibitor,CYP19A1,C[C@]12CC[C@@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@H]1CCC2=O,ZMEULISFKSVRLQ-XZTYSOPQSA-N,,CYP19A1
2338,formestane,Aromatase inhibitor,CYP19A1,C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O,ZMEULISFKSVRLQ-AZXRADLDSA-N,,CYP19A1
2339,formestane,Aromatase inhibitor,CYP19A1,CC12CCC3C(CCC4C(=O)C(=O)CCC34C)C2CCC1=O,ZMEULISFKSVRLQ-UHFFFAOYSA-N,,CYP19A1
2340,letrozole,Aromatase inhibitor,CYP19A1,N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1,HPJKCIUCZWXJDR-UHFFFAOYSA-N,,CYP19A1
2341,naringenin,Aromatase inhibitor,CYP19A1,Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,FTVWIRXFELQLPI-ZDUSSCGKSA-N,,CYP19A1
2342,naringenin,Aromatase inhibitor,ESR2,Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,FTVWIRXFELQLPI-ZDUSSCGKSA-N,,ESR2
2343,naringenin,Aromatase inhibitor,CYP19A1,Oc1ccc(cc1)C2CC(=O)c3c(O)cc(O)cc3O2,FTVWIRXFELQLPI-UHFFFAOYSA-N,,CYP19A1
2344,naringenin,Aromatase inhibitor,ESR2,Oc1ccc(cc1)C2CC(=O)c3c(O)cc(O)cc3O2,FTVWIRXFELQLPI-UHFFFAOYSA-N,,ESR2
2345,ZK-756326,CCK receptor ligand,CCR8,OCCOCCN1CCN(Cc2cccc(Oc3ccccc3)c2)CC1,SHDFUNGIHDOLQM-UHFFFAOYSA-N,,CCR8
2346,exherin,Cadherin antagonist,CDH2,CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O,FQVLRGLGWNWPSS-BXBUPLCLSA-N,,CDH2
2347,balicatib,Cathepsin inhibitor,CTSK,CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N,LLCRBOWRJOUJAE-UHFFFAOYSA-N,,CTSK
2348,CA-074-Me,Cathepsin inhibitor,CTSB,CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC,XGWSRLSPWIEMLQ-RQLZCWDZSA-N,,CTSB
2349,odanacatib,Cathepsin inhibitor,CTSK,CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N,FWIVDMJALNEADT-SFTDATJTSA-N,,CTSK
2350,SID-26681509,Cathepsin inhibitor,CTSL,CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C,OTIWAYTTYNFEKL-JOCHJYFZSA-N,,CTSL
2351,KPT-185,Exportin antagonist,XPO1,COc1cc(cc(c1)C(F)(F)F)-c1ncn(C=C/C(=O)OC(C)C)n1,NLNGWFLRRRYNIL-PLNGDYQASA-N,,XPO1
2352,riluzole,Glutamate inhibitor,SCN5A,Nc1nc2ccc(OC(F)(F)F)cc2s1,FTALBRSUTCGOEG-UHFFFAOYSA-N,,SCN5A
2353,safinamide,Glutamate inhibitor,MAOB,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,MAOB
2354,safinamide,Glutamate inhibitor,SLC6A3,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,SLC6A3
2355,safinamide,Glutamate inhibitor,MAOB,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,MAOB
2356,safinamide,Glutamate inhibitor,SLC6A3,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,SLC6A3
2357,WAY-213613,Glutamate inhibitor,SLC1A2,N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(O)=O,BNYDDAAZMBUFRG-ZDUSSCGKSA-N,,SLC1A2
2358,WAY-213613,Glutamate inhibitor,SLC1A2,NC(CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(=O)O,BNYDDAAZMBUFRG-UHFFFAOYSA-N,,SLC1A2
2359,zatebradine,HCN channel blocker,HCN4,COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC,KEDQCFRVSHYKLR-UHFFFAOYSA-N,,HCN4
2360,zatebradine,HCN channel blocker,HCN1,COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC,KEDQCFRVSHYKLR-UHFFFAOYSA-N,,HCN1
2361,zatebradine,HCN channel blocker,HCN3,COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC,KEDQCFRVSHYKLR-UHFFFAOYSA-N,,HCN3
2362,zatebradine,HCN channel blocker,HCN2,COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC,KEDQCFRVSHYKLR-UHFFFAOYSA-N,,HCN2
2363,ZD-7288,HCN channel blocker,HCN4,CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1,JABSKGQQWUDVRU-UHFFFAOYSA-O,,HCN4
2364,ZD-7288,HCN channel blocker,HCN1,CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1,JABSKGQQWUDVRU-UHFFFAOYSA-O,,HCN1
2365,ZD-7288,HCN channel blocker,HCN3,CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1,JABSKGQQWUDVRU-UHFFFAOYSA-O,,HCN3
2366,ZD-7288,HCN channel blocker,HCN2,CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1,JABSKGQQWUDVRU-UHFFFAOYSA-O,,HCN2
2367,aliskiren,Peptidase inhibitor,REN,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC,UXOWGYHJODZGMF-QORCZRPOSA-N,,REN
2368,camostat-mesilate,Peptidase inhibitor,PRSS1,CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1,XASIMHXSUQUHLV-UHFFFAOYSA-N,,PRSS1
2369,ginkgolide-b,Peptidase inhibitor,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
2370,ginkgolide-b,Peptidase inhibitor,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
2371,ginkgolide-b,Peptidase inhibitor,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
2372,ginkgolide-b,Peptidase inhibitor,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
2373,ginkgolide-b,Peptidase inhibitor,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
2374,ginkgolide-b,Peptidase inhibitor,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
2375,tosedostat,Peptidase inhibitor,ANPEP,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1,FWFGIHPGRQZWIW-SQNIBIBYSA-N,,ANPEP
2376,tosedostat,Peptidase inhibitor,LAP3,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1,FWFGIHPGRQZWIW-SQNIBIBYSA-N,,LAP3
2377,tosedostat,Peptidase inhibitor,NPEPPS,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1,FWFGIHPGRQZWIW-SQNIBIBYSA-N,,NPEPPS
2378,IWP-L6,Porcupine inhibitor,PORCN,O=C(CSc1nc2CCSc2c(=O)n1-c1ccccc1)Nc1ccc(cn1)-c1ccccc1,QESQGTFWEQMCMH-UHFFFAOYSA-N,,PORCN
2379,LGK-974,Porcupine inhibitor,PORCN,Cc1cc(ccn1)-c1ncc(CC(=O)Nc2ccc(cn2)-c2cnccn2)cc1C,XXYGTCZJJLTAGH-UHFFFAOYSA-N,,PORCN
2380,norethindrone,Progestogen hormone,PGR,CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@@]21C)C#C,IMONTRJLAWHYGT-FJMAIUEKSA-N,,PGR
2381,altrenogest,Progestogen hormone,PGR,C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C,VWAUPFMBXBWEQY-IVAOSVALSA-N,,PGR
2382,altrenogest,Progestogen hormone,PGR,C[C@]12C=CC3=C4CCC(=O)C=C4CCC3C1CC[C@@]2(O)CC=C,VWAUPFMBXBWEQY-JSRAGOMMSA-N,,PGR
2383,norethindrone,Progestogen hormone,PGR,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@H]1CC[C@@]2(O)C#C,VIKNJXKGJWUCNN-SFUSBHMVSA-N,,PGR
2384,norethindrone,Progestogen hormone,PGR,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,IMONTRJLAWHYGT-ZCPXKWAGSA-N,,PGR
2385,noretynodrel,Progestogen hormone,PGR,C[C@]12CC[C@@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@H]1CC[C@@]2(O)C#C,ICTXHFFSOAJUMG-MDMHHNQBSA-N,,PGR
2386,noretynodrel,Progestogen hormone,PGR,C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C,ICTXHFFSOAJUMG-OQPPHWFISA-N,,PGR
2387,noretynodrel,Progestogen hormone,PGR,C[C@@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]2CC[C@@]1(O)C#C,ICTXHFFSOAJUMG-SLHNCBLASA-N,,PGR
2388,dinoprost,Prostacyclin analog,PTGDR,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,,PTGDR
2389,dinoprost,Prostacyclin analog,PTGER1,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,,PTGER1
2390,dinoprost,Prostacyclin analog,PTGER3,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,,PTGER3
2391,dinoprost,Prostacyclin analog,PTGER4,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,,PTGER4
2392,dinoprost,Prostacyclin analog,PTGFR,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,,PTGFR
2393,dinoprost,Prostacyclin analog,PTGDR,COC(N)(CO)CO.CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O,RLFNJGOHWGRCER-NULUWHCBSA-N,,PTGDR
2394,dinoprost,Prostacyclin analog,PTGER1,COC(N)(CO)CO.CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O,RLFNJGOHWGRCER-NULUWHCBSA-N,,PTGER1
2395,dinoprost,Prostacyclin analog,PTGER3,COC(N)(CO)CO.CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O,RLFNJGOHWGRCER-NULUWHCBSA-N,,PTGER3
2396,dinoprost,Prostacyclin analog,PTGER4,COC(N)(CO)CO.CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O,RLFNJGOHWGRCER-NULUWHCBSA-N,,PTGER4
2397,dinoprost,Prostacyclin analog,PTGFR,COC(N)(CO)CO.CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O,RLFNJGOHWGRCER-NULUWHCBSA-N,,PTGFR
2398,treprostinil,Prostacyclin analog,PTGIR,CCCCC[C@H](O)CC[C@H]1[C@H](O)CC2Cc3c(C)cccc3CC12,OLMBOBKKGZYZNU-OYQUQHOHSA-N,,PTGIR
2399,BRD-K20401833,ROR inverse agonist,RORA,OC(c1ccc(NS(=O)(=O)c2cccs2)cc1)(C(F)(F)F)C(F)(F)F,LZWUNZRMANFRAO-UHFFFAOYSA-N,,RORA
2400,T-0901317,ROR inverse agonist,NR1H3,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H3
2401,T-0901317,ROR inverse agonist,NR1H2,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H2
2402,megestrol-acetate,Steroidal progestin,PGR,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,,PGR
2403,ethynodiol,Steroidal progestin,PGR,CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1,ONKUMRGIYFNPJW-JEJIVWPPSA-N,,PGR
2404,megestrol-acetate,Steroidal progestin,PGR,CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,RQZAXGRLVPAYTJ-VSUSFZLSSA-N,,PGR
2405,XAV-939,Tankyrase inhibitor,TNKS2,Oc1nc(nc2CCSCc12)-c1ccc(cc1)C(F)(F)F,KLGQSVMIPOVQAX-UHFFFAOYSA-N,,TNKS2
2406,XAV-939,Tankyrase inhibitor,TNKS,Oc1nc(nc2CCSCc12)-c1ccc(cc1)C(F)(F)F,KLGQSVMIPOVQAX-UHFFFAOYSA-N,,TNKS
2407,CGK-733,ATM kinase inhibitor,ATM,[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F,HLCDNLNLQNYZTK-UHFFFAOYSA-N,,ATM
2408,CGK-733,ATM kinase inhibitor,ATR,[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F,HLCDNLNLQNYZTK-UHFFFAOYSA-N,,ATR
2409,CP-466722,ATM kinase inhibitor,ATM,COc1cc2ncnc(-n3nc(nc3N)-c3ccccn3)c2cc1OC,ILBRKJBKDGCSCB-UHFFFAOYSA-N,,ATM
2410,KU-55933,ATM kinase inhibitor,ATM,O=c1cc(oc(c1)-c1cccc2Sc3ccccc3Sc12)N1CCOCC1,XRKYMMUGXMWDAO-UHFFFAOYSA-N,,ATM
2411,KU-60019,ATM kinase inhibitor,ATM,CC1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)CC(C)O1,SCELLOWTHJGVIC-UHFFFAOYSA-N,,ATM
2412,CGK-733,ATR kinase inhibitor,ATM,[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F,HLCDNLNLQNYZTK-UHFFFAOYSA-N,,ATM
2413,CGK-733,ATR kinase inhibitor,ATR,[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F,HLCDNLNLQNYZTK-UHFFFAOYSA-N,,ATR
2414,VE-821,ATR kinase inhibitor,ATR,CS(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1ccccc1,DUIHHZKTCSNTGM-UHFFFAOYSA-N,,ATR
2415,VE-822,ATR kinase inhibitor,ATR,CNCc1ccc(cc1)-c1cc(on1)-c1nc(cnc1N)-c1ccc(cc1)S(=O)(=O)C(C)C,JZCWLJDSIRUGIN-UHFFFAOYSA-N,,ATR
2416,BMS-777607,AXL kinase inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
2417,BMS-777607,AXL kinase inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
2418,BMS-777607,AXL kinase inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
2419,BMS-777607,AXL kinase inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
2420,BMS-777607,AXL kinase inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
2421,R-428,AXL kinase inhibitor,AXL,Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1,KXMZDGSRSGHMMK-VWLOTQADSA-N,,AXL
2422,AT-9283,Abl kinase inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
2423,AT-9283,Abl kinase inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
2424,AT-9283,Abl kinase inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
2425,AT-9283,Abl kinase inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
2426,bosutinib,Abl kinase inhibitor,ABL1,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,ABL1
2427,bosutinib,Abl kinase inhibitor,HCK,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,HCK
2428,bosutinib,Abl kinase inhibitor,LYN,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,LYN
2429,bosutinib,Abl kinase inhibitor,BCR,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,BCR
2430,bosutinib,Abl kinase inhibitor,SRC,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,SRC
2431,bosutinib,Abl kinase inhibitor,CAMK2G,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,,CAMK2G
2432,dasatinib,Abl kinase inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
2433,dasatinib,Abl kinase inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
2434,dasatinib,Abl kinase inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
2435,dasatinib,Abl kinase inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
2436,dasatinib,Abl kinase inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
2437,dasatinib,Abl kinase inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
2438,dasatinib,Abl kinase inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
2439,dasatinib,Abl kinase inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
2440,dasatinib,Abl kinase inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
2441,dasatinib,Abl kinase inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
2442,flumatinib,Abl kinase inhibitor,ABL1,CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,BJCJYEYYYGBROF-UHFFFAOYSA-N,,ABL1
2443,flumatinib,Abl kinase inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,BJCJYEYYYGBROF-UHFFFAOYSA-N,,PDGFRB
2444,imatinib,Abl kinase inhibitor,CSF1R,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,CSF1R
2445,imatinib,Abl kinase inhibitor,ABL1,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,ABL1
2446,imatinib,Abl kinase inhibitor,KIT,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,KIT
2447,imatinib,Abl kinase inhibitor,PDGFRA,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRA
2448,imatinib,Abl kinase inhibitor,PDGFRB,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,PDGFRB
2449,imatinib,Abl kinase inhibitor,BCR,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,,BCR
2450,KW-2449,Abl kinase inhibitor,FGFR1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FGFR1
2451,KW-2449,Abl kinase inhibitor,FLT3,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FLT3
2452,KW-2449,Abl kinase inhibitor,ABL1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,ABL1
2453,KW-2449,Abl kinase inhibitor,AURKA,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,AURKA
2454,metatinib,Abl kinase inhibitor,ABL1,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,PDYXPCKITKHFOZ-UHFFFAOYSA-N,,ABL1
2455,metatinib,Abl kinase inhibitor,BCR,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,PDYXPCKITKHFOZ-UHFFFAOYSA-N,,BCR
2456,nilotinib,Abl kinase inhibitor,ABL1,Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N,,ABL1
2457,nilotinib,Abl kinase inhibitor,KIT,Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N,,KIT
2458,nilotinib,Abl kinase inhibitor,BCR,Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N,,BCR
2459,ponatinib,Abl kinase inhibitor,FGFR1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR1
2460,ponatinib,Abl kinase inhibitor,FGFR3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR3
2461,ponatinib,Abl kinase inhibitor,FGFR2,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR2
2462,ponatinib,Abl kinase inhibitor,FGFR4,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FGFR4
2463,ponatinib,Abl kinase inhibitor,FLT3,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,FLT3
2464,ponatinib,Abl kinase inhibitor,ABL1,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,ABL1
2465,ponatinib,Abl kinase inhibitor,KIT,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,KIT
2466,ponatinib,Abl kinase inhibitor,RET,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,RET
2467,ponatinib,Abl kinase inhibitor,BCR,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,BCR
2468,ponatinib,Abl kinase inhibitor,TEK,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,,TEK
2469,rebastinib,Abl kinase inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,FLT3
2470,rebastinib,Abl kinase inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,ABL1
2471,rebastinib,Abl kinase inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,KDR
2472,rebastinib,Abl kinase inhibitor,BCR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,BCR
2473,rebastinib,Abl kinase inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,TEK
2474,tozasertib,Abl kinase inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
2475,tozasertib,Abl kinase inhibitor,ABL1,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
2476,tozasertib,Abl kinase inhibitor,JAK2,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
2477,tozasertib,Abl kinase inhibitor,BCR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
2478,tozasertib,Abl kinase inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
2479,tozasertib,Abl kinase inhibitor,AURKC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
2480,tozasertib,Abl kinase inhibitor,AURKB,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
2481,tozasertib,Abl kinase inhibitor,FLT3,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
2482,tozasertib,Abl kinase inhibitor,ABL1,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
2483,tozasertib,Abl kinase inhibitor,JAK2,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
2484,tozasertib,Abl kinase inhibitor,BCR,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
2485,tozasertib,Abl kinase inhibitor,AURKA,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
2486,tozasertib,Abl kinase inhibitor,AURKC,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
2487,tozasertib,Abl kinase inhibitor,AURKB,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
2488,ZM-306416,Abl kinase inhibitor,FLT1,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,FLT1
2489,ZM-306416,Abl kinase inhibitor,KDR,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,YHUIUSRCUKUUQA-UHFFFAOYSA-N,,KDR
2490,GNF-2,Abl kinase inhibitor,ABL1,,,,ABL1
2491,GNF-2,Abl kinase inhibitor,BCR,,,,BCR
2492,guanadrel,Adrenergic inhibitor,SLC6A2,NC(=N)NCC1COC2(CCCCC2)O1,HPBNRIOWIXYZFK-UHFFFAOYSA-N,,SLC6A2
2493,guanadrel,Adrenergic inhibitor,SLC6A2,NC(=N)NCC1COC2(CCCCC2)O1.NC(=N)NCC1COC2(CCCCC2)O1,SPMDBEGOXXCYHV-UHFFFAOYSA-N,,SLC6A2
2494,nefazodone,Adrenergic inhibitor,HTR2A,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2A
2495,nefazodone,Adrenergic inhibitor,HTR2C,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2C
2496,nefazodone,Adrenergic inhibitor,SLC6A2,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A2
2497,nefazodone,Adrenergic inhibitor,SLC6A4,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A4
2498,venlafaxine,Adrenergic inhibitor,SLC6A2,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A2
2499,venlafaxine,Adrenergic inhibitor,SLC6A4,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A4
2500,dapsone,Bacterial antifolate,DHFR,Nc1ccc(cc1)S(=O)(=O)c1ccc(N)cc1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,,DHFR
2501,ormetoprim,Bacterial antifolate,P2RX2,COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC,KEEYRKYKLYARHO-UHFFFAOYSA-N,,P2RX2
2502,ormetoprim,Bacterial antifolate,P2RX3,COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC,KEEYRKYKLYARHO-UHFFFAOYSA-N,,P2RX3
2503,aloisine,CFTR channel agonist,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(O)cc3,PRIGRJPRGZCFAS-UHFFFAOYSA-N,,CDK2
2504,aloisine,CFTR channel agonist,CDK2,CCCCc1c([nH]c2nccnc12)c3ccc(OC)cc3,WVMANZPBOBRWCB-UHFFFAOYSA-N,,CDK2
2505,ataluren,CFTR channel agonist,DMD,OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F,OOUGLTULBSNHNF-UHFFFAOYSA-N,,DMD
2506,TNP-470,Cell cycle inhibitor,METAP2,CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl,MSHZHSPISPJWHW-MIQCOGSQSA-N,,METAP2
2507,AT-7519,Cell cycle inhibitor,CDK2,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK2
2508,AT-7519,Cell cycle inhibitor,CDK4,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK4
2509,AT-7519,Cell cycle inhibitor,CDK5,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK5
2510,AT-7519,Cell cycle inhibitor,CDK6,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK6
2511,AT-7519,Cell cycle inhibitor,CDK9,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK9
2512,AT-7519,Cell cycle inhibitor,CDK1,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,,CDK1
2513,BMS-387032,Cell cycle inhibitor,CDK2,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK2
2514,BMS-387032,Cell cycle inhibitor,CDK7,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK7
2515,BMS-387032,Cell cycle inhibitor,CDK9,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,,CDK9
2516,perillyl-alcohol,Cell cycle inhibitor,FNTA,CC(=C)C1CCC(CO)=CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,,FNTA
2517,rigosertib,Cell cycle inhibitor,PLK1,COc1cc(OC)c(C=CS(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1,OWBFCJROIKNMGD-BQYQJAHWSA-N,,PLK1
2518,carmustine,DNA alkylating agent,GSR,[O-][N+]N(CCCl)C(=O)NCCCl,DLGOEMSEDOSKAD-UHFFFAOYSA-N,,GSR
2519,cisplatin,DNA alkylating agent,XIAP,Cl[Pt]Cl,CLSUSRZJUQMOHH-UHFFFAOYSA-L,,XIAP
2520,cyclophosphamide,DNA alkylating agent,CYP2A6,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2A6
2521,cyclophosphamide,DNA alkylating agent,CYP3A7,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP3A7
2522,cyclophosphamide,DNA alkylating agent,CYP2B6,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2B6
2523,cyclophosphamide,DNA alkylating agent,CYP2C19,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2C19
2524,cyclophosphamide,DNA alkylating agent,CYP2C8,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2C8
2525,cyclophosphamide,DNA alkylating agent,CYP2C9,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2C9
2526,cyclophosphamide,DNA alkylating agent,CYP2C18,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2C18
2527,cyclophosphamide,DNA alkylating agent,CYP2D6,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP2D6
2528,cyclophosphamide,DNA alkylating agent,CYP3A4,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP3A4
2529,cyclophosphamide,DNA alkylating agent,CYP3A5,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,,CYP3A5
2530,estramustine-phosphate,DNA alkylating agent,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR1
2531,estramustine-phosphate,DNA alkylating agent,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR2
2532,estramustine-phosphate,DNA alkylating agent,MAP1A,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP1A
2533,estramustine-phosphate,DNA alkylating agent,MAP2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP2
2534,ifosfamide,DNA alkylating agent,CYP2A6,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2A6
2535,ifosfamide,DNA alkylating agent,CYP3A7,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP3A7
2536,ifosfamide,DNA alkylating agent,CYP2B6,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2B6
2537,ifosfamide,DNA alkylating agent,CYP2C19,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2C19
2538,ifosfamide,DNA alkylating agent,CYP2C8,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2C8
2539,ifosfamide,DNA alkylating agent,CYP2C9,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2C9
2540,ifosfamide,DNA alkylating agent,CYP2C18,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP2C18
2541,ifosfamide,DNA alkylating agent,CYP3A4,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP3A4
2542,ifosfamide,DNA alkylating agent,CYP3A5,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,CYP3A5
2543,ifosfamide,DNA alkylating agent,PTGS1,ClCCNP1(=O)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,,PTGS1
2544,temozolomide,DNA alkylating agent,MGMT,Cn1nnc2c(ncn2c1=O)C(N)=O,BPEGJWRSRHCHSN-UHFFFAOYSA-N,,MGMT
2545,ataluren,Dystrophin stimulant,DMD,OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F,OOUGLTULBSNHNF-UHFFFAOYSA-N,,DMD
2546,tranexamic-acid,Fibrinogen stimulant,PLG,NC[C@H]1CC[C@@H](CC1)C(O)=O,GYDJEQRTZSCIOI-LJGSYFOKSA-N,,PLG
2547,geniposide,GLP receptor agonist,GLP1R,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]2O)[C@@H]2[C@@H]1CC=C2CO,IBFYXTRXDNAPMM-TYYARJOLSA-N,,GLP1R
2548,BRD-K92980438,Hexokinase inhibitor,HK2,OC(=O)C(=O)CBr,PRRZDZJYSJLDBS-UHFFFAOYSA-N,,HK2
2549,glibenclamide,Insulin secretagogue,CFTR,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,CFTR
2550,glibenclamide,Insulin secretagogue,KCNJ5,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ5
2551,glibenclamide,Insulin secretagogue,KCNJ8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ8
2552,glibenclamide,Insulin secretagogue,KCNJ11,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,KCNJ11
2553,glibenclamide,Insulin secretagogue,ABCC8,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,,ABCC8
2554,gliclazide,Insulin secretagogue,ABCC8,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,BOVGTQGAOIONJV-UHFFFAOYSA-N,,ABCC8
2555,glimepiride,Insulin secretagogue,KCNJ11,CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,,KCNJ11
2556,glimepiride,Insulin secretagogue,ABCC8,CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,,ABCC8
2557,glimepiride,Insulin secretagogue,KCNJ11,CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCC(C)CC3)C1=O,WIGIZIANZCJQQY-UHFFFAOYSA-N,,KCNJ11
2558,glimepiride,Insulin secretagogue,ABCC8,CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCC(C)CC3)C1=O,WIGIZIANZCJQQY-UHFFFAOYSA-N,,ABCC8
2559,mitiglinide,Insulin secretagogue,ABCC8,OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1,WPGGHFDDFPHPOB-BBWFWOEESA-N,,ABCC8
2560,nateglinide,Insulin secretagogue,KCNJ11,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O,OELFLUMRDSZNSF-ULQDDVLXSA-N,,KCNJ11
2561,nateglinide,Insulin secretagogue,ABCC8,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O,OELFLUMRDSZNSF-ULQDDVLXSA-N,,ABCC8
2562,nateglinide,Insulin secretagogue,KCNJ11,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O,OELFLUMRDSZNSF-BRWVUGGUSA-N,,KCNJ11
2563,nateglinide,Insulin secretagogue,ABCC8,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O,OELFLUMRDSZNSF-BRWVUGGUSA-N,,ABCC8
2564,repaglinide,Insulin secretagogue,KCNJ11,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O,FAEKWTJYAYMJKF-QHCPKHFHSA-N,,KCNJ11
2565,repaglinide,Insulin secretagogue,ABCC8,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O,FAEKWTJYAYMJKF-QHCPKHFHSA-N,,ABCC8
2566,TAK-875,Insulin secretagogue,FFAR1,Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3[C@H](CC(O)=O)COc3c2)c1,BZCALJIHZVNMGJ-HSZRJFAPSA-N,,FFAR1
2567,narciclasine,LIM kinase activator,RHOA,O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O,LZAZURSABQIKGB-AEKGRLRDSA-N,,RHOA
2568,XMD-885,MAP kinase inhibitor,LRRK2,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,DDTPGANIPBKTNU-UHFFFAOYSA-N,,LRRK2
2569,XMD-885,MAP kinase inhibitor,MAPK7,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,DDTPGANIPBKTNU-UHFFFAOYSA-N,,MAPK7
2570,CGP-57380,MAP kinase inhibitor,MKNK1,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,UQPMANVRZYYQMD-UHFFFAOYSA-N,,MKNK1
2571,FR-180204,MAP kinase inhibitor,MAPK1,Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1,XVECMUKVOMUNLE-UHFFFAOYSA-N,,MAPK1
2572,FR-180204,MAP kinase inhibitor,MAPK3,Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1,XVECMUKVOMUNLE-UHFFFAOYSA-N,,MAPK3
2573,PD-0325901,MAP kinase inhibitor,MAP2K1,OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-SECBINFHSA-N,,MAP2K1
2574,PD-0325901,MAP kinase inhibitor,MAP2K1,OCC(O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-UHFFFAOYSA-N,,MAP2K1
2575,PD-198306,MAP kinase inhibitor,MAP2K1,Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1,UHAXDAKQGVISBZ-UHFFFAOYSA-N,,MAP2K1
2576,PD-198306,MAP kinase inhibitor,MAP2K2,Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1,UHAXDAKQGVISBZ-UHFFFAOYSA-N,,MAP2K2
2577,PD-98059,MAP kinase inhibitor,MAP2K1,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,QFWCYNPOPKQOKV-UHFFFAOYSA-N,,MAP2K1
2578,XMD-892,MAP kinase inhibitor,MAPK7,CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1,QAPAJIZPZGWAND-UHFFFAOYSA-N,,MAPK7
2579,BMS-777607,Macrophage inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
2580,BMS-777607,Macrophage inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
2581,BMS-777607,Macrophage inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
2582,BMS-777607,Macrophage inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
2583,BMS-777607,Macrophage inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
2584,sacubitril,Neprilysin inhibitor,MME,CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O,PYNXFZCZUAOOQC-UTKZUKDTSA-N,,MME
2585,minodronic-acid,Osteoclast inhibitor,FDPS,OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,,FDPS
2586,risedronate,Osteoclast inhibitor,FDPS,OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O,IIDJRNMFWXDHID-UHFFFAOYSA-N,,FDPS
2587,zoledronic-acid,Osteoclast inhibitor,FDPS,OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,,FDPS
2588,KF-38789,P selectin inhibitor,SELP,COc1ccc(C2CC(=NCCS2)c2c(O)cc(C)oc2=O)c(OC)c1,NHFIAAAMCYVRIW-UHFFFAOYSA-N,,SELP
2589,ammonium-perfluorocaprylate,Pim kinase inhibitor,PIM1,OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,SNGREZUHAYWORS-UHFFFAOYSA-N,,PIM1
2590,BRD-K97951054,Pim kinase inhibitor,PIM1,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,PIM1
2591,BRD-K97951054,Pim kinase inhibitor,AURKB,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,AURKB
2592,GDC-0349,Pim kinase inhibitor,PIK3CA,CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1,RGJOJUGRHPQXGF-INIZCTEOSA-N,,PIK3CA
2593,methylnorlichexanthone,Pim kinase inhibitor,PIM1,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,PIM1
2594,methylnorlichexanthone,Pim kinase inhibitor,AURKB,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,AURKB
2595,quercetagetin,Pim kinase inhibitor,PIM1,COc1ccc(cc1OC)-c1oc2cc(OC)c(OC)c(OC)c2c(=O)c1OC,CHXSDKWBSFDZEU-UHFFFAOYSA-N,,PIM1
2596,SGI-1776,Pim kinase inhibitor,PIM2,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,MHXGEROHKGDZGO-UHFFFAOYSA-N,,PIM2
2597,SGI-1776,Pim kinase inhibitor,FLT3,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,MHXGEROHKGDZGO-UHFFFAOYSA-N,,FLT3
2598,SGI-1776,Pim kinase inhibitor,PIM3,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,MHXGEROHKGDZGO-UHFFFAOYSA-N,,PIM3
2599,SGI-1776,Pim kinase inhibitor,PIM1,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,MHXGEROHKGDZGO-UHFFFAOYSA-N,,PIM1
2600,bortezomib,Proteasome inhibitor,PSMB1,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB1
2601,bortezomib,Proteasome inhibitor,PSMB2,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB2
2602,bortezomib,Proteasome inhibitor,PSMB5,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB5
2603,bortezomib,Proteasome inhibitor,PSMB1,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB1
2604,bortezomib,Proteasome inhibitor,PSMB2,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB2
2605,bortezomib,Proteasome inhibitor,PSMB5,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB5
2606,carfilzomib,Proteasome inhibitor,PSMB1,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB1
2607,carfilzomib,Proteasome inhibitor,PSMB2,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB2
2608,carfilzomib,Proteasome inhibitor,PSMB5,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB5
2609,carfilzomib,Proteasome inhibitor,PSMB8,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB8
2610,carfilzomib,Proteasome inhibitor,PSMB9,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB9
2611,carfilzomib,Proteasome inhibitor,PSMB10,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,,PSMB10
2612,MG-132,Proteasome inhibitor,PSMB1,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O,TZYWCYJVHRLUCT-VABKMULXSA-N,,PSMB1
2613,SCH-79797,Proteasome inhibitor,F2R,CC(C)c1ccc(Cn2ccc3c2ccc4nc(NC5CC5)nc(N)c34)cc1,AVXQPEKZIGPIJW-UHFFFAOYSA-N,,F2R
2614,BIBR-1532,Telomerase inhibitor,TERT,CC(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1,PGFQXGLPJUCTOI-WYMLVPIESA-N,,TERT
2615,MST-312,Telomerase inhibitor,TERT,Oc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(O)c3O)c2)c1O,MIQUEZGHEJGPJB-UHFFFAOYSA-N,,TERT
2616,azelaic-acid,Tyrosinase inhibitor,TYR,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,,TYR
2617,rucinol,Tyrosinase inhibitor,TYR,CCCCc1ccc(O)cc1O,CSHZYWUPJWVTMQ-UHFFFAOYSA-N,,TYR
2618,acenocoumarol,Vitamin K antagonist,VKORC1,CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,,VKORC1
2619,phenindione,Vitamin K antagonist,VKORC1,O=C1C(C(=O)c2ccccc12)c1ccccc1,NFBAXHOPROOJAW-UHFFFAOYSA-N,,VKORC1
2620,phenprocoumon,Vitamin K antagonist,VKORC1,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,DQDAYGNAKTZFIW-UHFFFAOYSA-N,,VKORC1
2621,warfarin,Vitamin K antagonist,VKORC1,CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,PJVWKTKQMONHTI-HNNXBMFYSA-N,,VKORC1
2622,warfarin,Vitamin K antagonist,VKORC1,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,,VKORC1
2623,P-1075,ATP channel activator,KCNJ11,CCC(C)(C)N=C(NC#N)Nc1cccnc1,HKZNADVVGXKQDL-UHFFFAOYSA-N,,KCNJ11
2624,P-1075,ATP channel activator,KCNJ11,CCC(C)(C)NC(=NC#N)Nc1cccnc1,HKZNADVVGXKQDL-UHFFFAOYSA-N,,KCNJ11
2625,pinacidil,ATP channel activator,ABCC9,CC(C(C)(C)C)N=C(/NC#N)Nc1ccncc1,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
2626,pinacidil,ATP channel activator,ABCC8,CC(C(C)(C)C)N=C(/NC#N)Nc1ccncc1,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
2627,pinacidil,ATP channel activator,ABCC9,CC(NC(Nc1ccncc1)=NC#N)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
2628,pinacidil,ATP channel activator,ABCC8,CC(NC(Nc1ccncc1)=NC#N)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
2629,pinacidil,ATP channel activator,ABCC9,CC(NC(=NC#N)Nc1ccncc1)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
2630,pinacidil,ATP channel activator,ABCC8,CC(NC(=NC#N)Nc1ccncc1)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
2631,mitotane,Anti-neoplastic agent,CYP11A1,ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl,JWBOIMRXGHLCPP-UHFFFAOYSA-N,,CYP11A1
2632,mitotane,Anti-neoplastic agent,CYP11B1,ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl,JWBOIMRXGHLCPP-UHFFFAOYSA-N,,CYP11B1
2633,cyclosporin-a,Calcineurin inhibitor,PPIA,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-FVTPFZBWSA-N,,PPIA
2634,cyclosporin-a,Calcineurin inhibitor,PPP3CA,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-FVTPFZBWSA-N,,PPP3CA
2635,cyclosporin-a,Calcineurin inhibitor,PPIA,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CJOIJTDBSA-N,,PPIA
2636,cyclosporin-a,Calcineurin inhibitor,PPP3CA,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CJOIJTDBSA-N,,PPP3CA
2637,cyclosporin-a,Calcineurin inhibitor,PPIA,CCC1NC(=O)C([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-NFOUMSERSA-N,,PPIA
2638,cyclosporin-a,Calcineurin inhibitor,PPP3CA,CCC1NC(=O)C([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-NFOUMSERSA-N,,PPP3CA
2639,cyclosporin-a,Calcineurin inhibitor,PPIA,CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-IMVLJIQESA-N,,PPIA
2640,cyclosporin-a,Calcineurin inhibitor,PPP3CA,CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-IMVLJIQESA-N,,PPP3CA
2641,cyclosporin-a,Calcineurin inhibitor,PPIA,CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-UHFFFAOYSA-N,,PPIA
2642,cyclosporin-a,Calcineurin inhibitor,PPP3CA,CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-UHFFFAOYSA-N,,PPP3CA
2643,INCA-6,Calcineurin inhibitor,NFATC1,O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc12,GCHPUOHXXCNSQL-UHFFFAOYSA-N,,NFATC1
2644,pimecrolimus,Calcineurin inhibitor,FKBP1A,CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(C)=C[C@@H]1CC[C@@H](Cl)[C@@H](C1)OC,KASDHRXLYQOAKZ-RNZHFBRZSA-N,,FKBP1A
2645,tacrolimus,Calcineurin inhibitor,FKBP1A,CO[C@@H]1C[C@@H](CC[C@H]1O)C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)CC(C)=C/[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-LJIGMGMYSA-N,,FKBP1A
2646,tacrolimus,Calcineurin inhibitor,FKBP1A,CO[C@@H]1C[C@@H](CC[C@H]1O)C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-LFZNUXCKSA-N,,FKBP1A
2647,tacrolimus,Calcineurin inhibitor,FKBP1A,CO[C@@H]1C[C@@H](CC[C@H]1O)C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H](C[C@H](C[C@@H](C)CC(C)=C/[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC)[C@H](C[C@H]2C)OC,KDEJOJSUWQBZSP-JWZPFBAESA-N,,FKBP1A
2648,tacrolimus,Calcineurin inhibitor,FKBP1A,CO[C@@H]1C[C@@H](CC[C@H]1O)C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-XTNLUGHASA-N,,FKBP1A
2649,tacrolimus,Calcineurin inhibitor,FKBP1A,CO[C@@H]1CC(CC[C@H]1O)C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-NYOQZLQMSA-N,,FKBP1A
2650,BMS-927711,Calcitonin antagonist,CALCRL,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F,KRNAOFGYEFKHPB-ANJVHQHFSA-N,,CALCRL
2651,BMS-927711,Calcitonin antagonist,CALCA,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F,KRNAOFGYEFKHPB-ANJVHQHFSA-N,,CALCA
2652,MK-3207,Calcitonin antagonist,CALCRL,Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31,AZAANWYREOQRFB-SETSBSEESA-N,,CALCRL
2653,MK-3207,Calcitonin antagonist,CALCA,Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31,AZAANWYREOQRFB-SETSBSEESA-N,,CALCA
2654,telcagepant,Calcitonin antagonist,CALCRL,Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F,CGDZXLJGHVKVIE-DNVCBOLYSA-N,,CALCRL
2655,telcagepant,Calcitonin antagonist,RAMP1,Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F,CGDZXLJGHVKVIE-DNVCBOLYSA-N,,RAMP1
2656,berbamine,Calmodulin antagonist,CALM1,COc1cc2CCN(C)[C@@H]3Cc4ccc(OC(=O)c5ccc(cc5)[N+](=O)[O-])c(Oc6ccc(C[C@@H]7N(C)CCc8cc(OC)c(Oc(c1OC)c32)cc78)cc6)c4,PUAVTDKYTXNVBU-OIDHKYIRSA-N,,CALM1
2657,calmidazolium,Calmodulin antagonist,ATP2B1,Clc1ccc(cc1)C(c2ccc(Cl)cc2)[n+]3ccn(CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,ATP2B1
2658,calmidazolium,Calmodulin antagonist,PDE1A,Clc1ccc(cc1)C(c2ccc(Cl)cc2)[n+]3ccn(CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,PDE1A
2659,calmidazolium,Calmodulin antagonist,ATP2B1,Clc1ccc(cc1)C(c2ccc(Cl)cc2)n3cc[n+](CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,ATP2B1
2660,calmidazolium,Calmodulin antagonist,PDE1A,Clc1ccc(cc1)C(c2ccc(Cl)cc2)n3cc[n+](CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,PDE1A
2661,STO-609,Calmodulin antagonist,CAMKK2,OC(=O)c1ccc2c3nc4ccccc4n3c(=O)c5cccc1c52,MYKOWOGZBMOVBJ-UHFFFAOYSA-N,,CAMKK2
2662,STO-609,Calmodulin antagonist,CAMKK1,OC(=O)c1ccc2c3nc4ccccc4n3c(=O)c5cccc1c52,MYKOWOGZBMOVBJ-UHFFFAOYSA-N,,CAMKK1
2663,W-13,Calmodulin antagonist,MYLK,NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1,JJQKICOADUKSNS-UHFFFAOYSA-N,,MYLK
2664,W-13,Calmodulin antagonist,PDE1A,NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1,JJQKICOADUKSNS-UHFFFAOYSA-N,,PDE1A
2665,W-13,Calmodulin antagonist,CALM1,NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1,JJQKICOADUKSNS-UHFFFAOYSA-N,,CALM1
2666,W-9,Calmodulin antagonist,CALM2,NCCCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1,WAEIMOCPASQBSR-UHFFFAOYSA-N,,CALM2
2667,zaldaride,Calmodulin antagonist,CALM1,CC1(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)OCc2ccccc2-n2cccc12,HTGCJAAPDHZCHL-UHFFFAOYSA-N,,CALM1
2668,bemegride,Chemoreceptor agonist,GABRA1,CCC1(C)CC(=O)NC(=O)C1,ORRZGUBHBVWWOP-UHFFFAOYSA-N,,GABRA1
2669,ezetimibe,Cholesterol inhibitor,NPC1L1,O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1,OLNTVTPDXPETLC-XPWALMASSA-N,,NPC1L1
2670,ezetimibe,Cholesterol inhibitor,NPC1L1,OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1,OLNTVTPDXPETLC-OJVMETQDSA-N,,NPC1L1
2671,guggulsterone,Cholesterol inhibitor,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
2672,guggulsterone,Cholesterol inhibitor,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
2673,guggulsterone,Cholesterol inhibitor,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
2674,guggulsterone,Cholesterol inhibitor,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
2675,guggulsterone,Cholesterol inhibitor,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
2676,guggulsterone,Cholesterol inhibitor,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
2677,guggulsterone,Cholesterol inhibitor,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
2678,guggulsterone,Cholesterol inhibitor,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
2679,guggulsterone,Cholesterol inhibitor,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
2680,guggulsterone,Cholesterol inhibitor,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
2681,timofibrate,Cholesterol inhibitor,LPL,CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(O)=O,QSNOWCXXECLALL-UHFFFAOYSA-N,,LPL
2682,betrixaban,Coagulation inhibitor,F10,COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1,XHOLNRLADUSQLD-UHFFFAOYSA-N,,F10
2683,PD-166793,Collagenase inhibitor,MMP2,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP2
2684,PD-166793,Collagenase inhibitor,MMP3,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP3
2685,PD-166793,Collagenase inhibitor,MMP13,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP13
2686,PD-166793,Collagenase inhibitor,MMP2,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP2
2687,PD-166793,Collagenase inhibitor,MMP3,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP3
2688,PD-166793,Collagenase inhibitor,MMP13,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP13
2689,alfaxalone,GABA receptor agonist,GABBR1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-OLVMNOGESA-N,,GABBR1
2690,alfaxalone,GABA receptor agonist,GABBR1,CC(=O)[C@H]1CC[C@H]2[C@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-KEGGPASISA-N,,GABBR1
2691,baclofen,GABA receptor agonist,GABBR1,NCC(CC(O)=O)c1ccc(Cl)cc1,KPYSYYIEGFHWSV-UHFFFAOYSA-N,,GABBR1
2692,baclofen,GABA receptor agonist,GABBR2,NCC(CC(O)=O)c1ccc(Cl)cc1,KPYSYYIEGFHWSV-UHFFFAOYSA-N,,GABBR2
2693,CL-218872,GABA receptor agonist,GABRA1,Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F,GUOQUXNJZHGPQF-UHFFFAOYSA-N,,GABRA1
2694,eszopiclone,GABA receptor agonist,GABRA1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA1
2695,eszopiclone,GABA receptor agonist,GABRA2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA2
2696,eszopiclone,GABA receptor agonist,GABRA3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA3
2697,eszopiclone,GABA receptor agonist,GABRA4,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA4
2698,eszopiclone,GABA receptor agonist,GABRA5,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA5
2699,eszopiclone,GABA receptor agonist,GABRA6,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRA6
2700,eszopiclone,GABA receptor agonist,GABRB1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRB1
2701,eszopiclone,GABA receptor agonist,GABRB2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRB2
2702,eszopiclone,GABA receptor agonist,GABRB3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRB3
2703,eszopiclone,GABA receptor agonist,GABRD,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRD
2704,eszopiclone,GABA receptor agonist,GABRE,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRE
2705,eszopiclone,GABA receptor agonist,GABRG1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRG1
2706,eszopiclone,GABA receptor agonist,GABRG2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRG2
2707,eszopiclone,GABA receptor agonist,GABRG3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRG3
2708,eszopiclone,GABA receptor agonist,GABRP,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRP
2709,eszopiclone,GABA receptor agonist,GABRQ,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,,GABRQ
2710,fenigam,GABA receptor agonist,GABBR1,NCC(CC(O)=O)c1ccccc1,DAFOCGYVTAOKAJ-UHFFFAOYSA-N,,GABBR1
2711,fenigam,GABA receptor agonist,GABBR2,NCC(CC(O)=O)c1ccccc1,DAFOCGYVTAOKAJ-UHFFFAOYSA-N,,GABBR2
2712,gaboxadol,GABA receptor agonist,GABRD,Oc1noc2CNCCc12,ZXRVKCBLGJOCEE-UHFFFAOYSA-N,,GABRD
2713,indiplon,GABA receptor agonist,GABRA1,CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1,CBIAWPMZSFFRGN-UHFFFAOYSA-N,,GABRA1
2714,loreclezole,GABA receptor agonist,GABRB2,ClC(=Cn1cncn1)c2ccc(Cl)cc2Cl,XGLHZTBDUXXHOM-UHFFFAOYSA-N,,GABRB2
2715,loreclezole,GABA receptor agonist,GABRB3,ClC(=Cn1cncn1)c2ccc(Cl)cc2Cl,XGLHZTBDUXXHOM-UHFFFAOYSA-N,,GABRB3
2716,nefiracetam,GABA receptor agonist,CHRM1,Cc1cccc(C)c1NC(=O)CN1CCCC1=O,NGHTXZCKLWZPGK-UHFFFAOYSA-N,,CHRM1
2717,nimetazepam,GABA receptor agonist,GABRA1,CN1c2ccc(cc2C(=NCC1=O)c1ccccc1)[N+]([O-])=O,GWUSZQUVEVMBPI-UHFFFAOYSA-N,,GABRA1
2718,nimetazepam,GABA receptor agonist,GABRA2,CN1c2ccc(cc2C(=NCC1=O)c1ccccc1)[N+]([O-])=O,GWUSZQUVEVMBPI-UHFFFAOYSA-N,,GABRA2
2719,propofol,GABA receptor agonist,GABRA1,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA1
2720,propofol,GABA receptor agonist,GABRA2,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA2
2721,propofol,GABA receptor agonist,GABRA3,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA3
2722,propofol,GABA receptor agonist,GABRA4,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA4
2723,propofol,GABA receptor agonist,GABRA5,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA5
2724,propofol,GABA receptor agonist,GABRA6,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRA6
2725,propofol,GABA receptor agonist,GABRB1,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRB1
2726,propofol,GABA receptor agonist,GABRB2,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRB2
2727,propofol,GABA receptor agonist,GABRB3,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRB3
2728,propofol,GABA receptor agonist,GABRD,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRD
2729,propofol,GABA receptor agonist,GABRE,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRE
2730,propofol,GABA receptor agonist,GABRG1,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRG1
2731,propofol,GABA receptor agonist,GABRG2,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRG2
2732,propofol,GABA receptor agonist,GABRG3,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRG3
2733,propofol,GABA receptor agonist,GABRP,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRP
2734,propofol,GABA receptor agonist,GABRQ,CC(C)c1cccc(C(C)C)c1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,GABRQ
2735,temazepam,GABA receptor agonist,GABRA1,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA1
2736,temazepam,GABA receptor agonist,GABRA2,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA2
2737,temazepam,GABA receptor agonist,GABRA3,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA3
2738,temazepam,GABA receptor agonist,GABRA4,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA4
2739,temazepam,GABA receptor agonist,GABRA5,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA5
2740,temazepam,GABA receptor agonist,GABRA6,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRA6
2741,temazepam,GABA receptor agonist,GABRB1,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRB1
2742,temazepam,GABA receptor agonist,GABRB2,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRB2
2743,temazepam,GABA receptor agonist,GABRB3,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRB3
2744,temazepam,GABA receptor agonist,GABRD,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRD
2745,temazepam,GABA receptor agonist,GABRE,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRE
2746,temazepam,GABA receptor agonist,GABRG1,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRG1
2747,temazepam,GABA receptor agonist,GABRG2,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRG2
2748,temazepam,GABA receptor agonist,GABRG3,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRG3
2749,temazepam,GABA receptor agonist,GABRP,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRP
2750,temazepam,GABA receptor agonist,GABRQ,CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,,GABRQ
2751,valproic-acid,GABA receptor agonist,ABAT,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ABAT
2752,valproic-acid,GABA receptor agonist,HDAC1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,HDAC1
2753,valproic-acid,GABA receptor agonist,SCN1A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN1A
2754,valproic-acid,GABA receptor agonist,SCN3A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN3A
2755,valproic-acid,GABA receptor agonist,ALDH5A1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ALDH5A1
2756,zopiclone,GABA receptor agonist,GABRA1,CN1CCN(CC1)C(=O)OC2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,GBBSUAFBMRNDJC-UHFFFAOYSA-N,,GABRA1
2757,abamectin,GABA receptor agonist,GABBR1,,,,GABBR1
2758,abamectin,GABA receptor agonist,GABBR2,,,,GABBR2
2759,NNC-05-2090,GABA uptake inhibitor,SLC6A12,COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc23)CC1,XZZYCJOGZYEPPW-UHFFFAOYSA-N,,SLC6A12
2760,SKF-89976A,GABA uptake inhibitor,SLC6A1,OC(=O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1,TXQKSMSLZVKQBI-UHFFFAOYSA-N,,SLC6A1
2761,stiripentol,GABA uptake inhibitor,GABRA3,CC(C)(C)C(O)/C=C/c1ccc2OCOc2c1,IBLNKMRFIPWSOY-FNORWQNLSA-N,,GABRA3
2762,tiagabine,GABA uptake inhibitor,SLC6A1,Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C,PBJUNZJWGZTSKL-MRXNPFEDSA-N,,SLC6A1
2763,Ro-28-1675,Glucokinase activator,GCK,CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1,NEQSWPCDHDQINX-MRXNPFEDSA-N,,GCK
2764,acarbose,Glucosidase inhibitor,GAA,C[C@@H]1O[C@H](O[C@@H]2[C@H](CO)O[C@H](O[C@@H]3[C@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@@H]1O,XUFXOAAUWZOOIT-PCKYEMPFSA-N,,GAA
2765,acarbose,Glucosidase inhibitor,AMY2A,C[C@@H]1O[C@H](O[C@@H]2[C@H](CO)O[C@H](O[C@@H]3[C@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@@H]1O,XUFXOAAUWZOOIT-PCKYEMPFSA-N,,AMY2A
2766,acarbose,Glucosidase inhibitor,MGAM,C[C@@H]1O[C@H](O[C@@H]2[C@H](CO)O[C@H](O[C@@H]3[C@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@@H]1O,XUFXOAAUWZOOIT-PCKYEMPFSA-N,,MGAM
2767,acarbose,Glucosidase inhibitor,GAA,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-SXARVLRPSA-N,,GAA
2768,acarbose,Glucosidase inhibitor,AMY2A,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-SXARVLRPSA-N,,AMY2A
2769,acarbose,Glucosidase inhibitor,MGAM,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-SXARVLRPSA-N,,MGAM
2770,acarbose,Glucosidase inhibitor,GAA,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-UGEKTDRHSA-N,,GAA
2771,acarbose,Glucosidase inhibitor,AMY2A,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-UGEKTDRHSA-N,,AMY2A
2772,acarbose,Glucosidase inhibitor,MGAM,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,XUFXOAAUWZOOIT-UGEKTDRHSA-N,,MGAM
2773,castanospermine,Glucosidase inhibitor,GAA,O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12,JDVVGAQPNNXQDW-TVNFTVLESA-N,,GAA
2774,castanospermine,Glucosidase inhibitor,GBA,O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12,JDVVGAQPNNXQDW-TVNFTVLESA-N,,GBA
2775,miglitol,Glucosidase inhibitor,GAA,OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO,IBAQFPQHRJAVAV-WMEPKMGJSA-N,,GAA
2776,miglitol,Glucosidase inhibitor,MGAM,OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO,IBAQFPQHRJAVAV-WMEPKMGJSA-N,,MGAM
2777,miglitol,Glucosidase inhibitor,GAA,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,,GAA
2778,miglitol,Glucosidase inhibitor,MGAM,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,,MGAM
2779,piceid,Glucosidase inhibitor,XDH,COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1,MFMQRDLLSRLUJY-DXKBKAGUSA-N,,XDH
2780,voglibose,Glucosidase inhibitor,GAA,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,FZNCGRZWXLXZSZ-GENCIFFESA-N,,GAA
2781,voglibose,Glucosidase inhibitor,MGAM,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,FZNCGRZWXLXZSZ-GENCIFFESA-N,,MGAM
2782,BMY-45778,IP receptor activator,PTGIR,OC(=O)COc1cccc(c1)-c1ocnc1-c1nc(c(o1)-c1ccccc1)-c1ccccc1,DSRSEEYZGWTODH-UHFFFAOYSA-N,,PTGIR
2783,carbacyclin,IP receptor activator,PPARD,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2C/C(=CCCCC(=O)O)/C[C@H]12,XZFRIPGNUQRGPI-WBQKLGIQSA-N,,PPARD
2784,carbacyclin,IP receptor activator,PTGIR,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2C/C(=CCCCC(=O)O)/C[C@H]12,XZFRIPGNUQRGPI-WBQKLGIQSA-N,,PTGIR
2785,bergenin,Interleukin inhibitor,IL1B,COc1c(O)cc2C(=O)O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3c2c1O,YWJXCIXBAKGUKZ-BPTACTMOSA-N,,IL1B
2786,bergenin,Interleukin inhibitor,TNF,COc1c(O)cc2C(=O)O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3c2c1O,YWJXCIXBAKGUKZ-BPTACTMOSA-N,,TNF
2787,bergenin,Interleukin inhibitor,IL1B,COc1c(O)cc2C(=O)OC3C(O)C(O)C(CO)OC3c2c1O,YWJXCIXBAKGUKZ-UHFFFAOYSA-N,,IL1B
2788,bergenin,Interleukin inhibitor,TNF,COc1c(O)cc2C(=O)OC3C(O)C(O)C(CO)OC3c2c1O,YWJXCIXBAKGUKZ-UHFFFAOYSA-N,,TNF
2789,diacerein,Interleukin inhibitor,IL1B,CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O,TYNLGDBUJLVSMA-UHFFFAOYSA-N,,IL1B
2790,tanshinone-iia,Interleukin inhibitor,IL1B,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,IL1B
2791,tanshinone-iia,Interleukin inhibitor,TNF,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,TNF
2792,tanshinone-iia,Interleukin inhibitor,NR1I2,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,NR1I2
2793,quiflapon,Leukotriene inhibitor,ALOX5AP,CC(C)(C)Sc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12,NZOONKHCNQFYCI-UHFFFAOYSA-N,,ALOX5AP
2794,ubenimex,Leukotriene inhibitor,LTA4H,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O,VGGGPCQERPFHOB-RDBSUJKOSA-N,,LTA4H
2795,ubenimex,Leukotriene inhibitor,RNPEP,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O,VGGGPCQERPFHOB-RDBSUJKOSA-N,,RNPEP
2796,zileuton,Leukotriene inhibitor,ALOX5,CC(N(O)C(N)=O)c1cc2ccccc2s1,MWLSOWXNZPKENC-UHFFFAOYSA-N,,ALOX5
2797,colchicine,Microtubule inhibitor,TUBB,COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC,IAKHMKGGTNLKSZ-INIZCTEOSA-N,,TUBB
2798,colchicine,Microtubule inhibitor,TUBB1,COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC,IAKHMKGGTNLKSZ-INIZCTEOSA-N,,TUBB1
2799,colchicine,Microtubule inhibitor,TUBB,COc1cc2CCC(NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,,TUBB
2800,colchicine,Microtubule inhibitor,TUBB1,COc1cc2CCC(NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,,TUBB1
2801,epothilone,Microtubule inhibitor,TUBB,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,QXRSDHAAWVKZLJ-PVYNADRNSA-N,,TUBB
2802,estramustine-phosphate,Microtubule inhibitor,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR1
2803,estramustine-phosphate,Microtubule inhibitor,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR2
2804,estramustine-phosphate,Microtubule inhibitor,MAP1A,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP1A
2805,estramustine-phosphate,Microtubule inhibitor,MAP2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP2
2806,triclabendazole,Microtubule inhibitor,DNMT1,CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1,NQPDXQQQCQDHHW-UHFFFAOYSA-N,,DNMT1
2807,vinblastine,Microtubule inhibitor,TUBB,CC[C@]1(O)C[C@@H]2CN(C1)CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@@H]7[C@@]86CCN9CC=C[C@](CC)([C@H]98)[C@@H](OC(=O)C)[C@]7(O)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,,TUBB
2808,vinblastine,Microtubule inhibitor,TUBB,CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,JXLYSJRDGCGARV-XQKSVPLYSA-N,,TUBB
2809,vinblastine,Microtubule inhibitor,TUBB,CC[C@]1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,JXLYSJRDGCGARV-CUGARIAGSA-N,,TUBB
2810,vinblastine,Microtubule inhibitor,TUBB,CCC1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)C(C2)(C(=O)OC)c1cc2c(cc1OC)N(C)C1C22CCN3CC=CC(CC)(C23)C(OC(C)=O)C1(O)C(=O)OC,JXLYSJRDGCGARV-UHFFFAOYSA-N,,TUBB
2811,vinblastine,Microtubule inhibitor,TUBB,CCC1(O)CC2CN(C1)CCc3c([nH]c4ccccc34)C(C2)(C(=O)OC)c5cc6c(cc5OC)N(C)C7C86CCN9CC=CC(CC)(C98)C(C(=O)OC)C7(O)C(=O)OC,SLIRURSWQCRWFG-UHFFFAOYSA-N,,TUBB
2812,epothilone-b,Microtubule stimulant,TUBB,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,QXRSDHAAWVKZLJ-AXCXJGFASA-N,,TUBB
2813,Ro-08-2750,NGF binding inhibitor,NGF,Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O,JDEMVNYMYPJJIM-UHFFFAOYSA-N,,NGF
2814,Ro-08-2750,NGF binding inhibitor,NGFR,Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O,JDEMVNYMYPJJIM-UHFFFAOYSA-N,,NGFR
2815,L-2167,PPAR receptor agonist,PPARD,CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,,PPARD
2816,bezafibrate,PPAR receptor agonist,PPARA,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,,PPARA
2817,bezafibrate,PPAR receptor agonist,PPARD,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,,PPARD
2818,bezafibrate,PPAR receptor agonist,PPARG,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,,PPARG
2819,BRD-K14609189,PPAR receptor agonist,PPARG,COc1ccc(c2nn(cc2/C=C3/SC(=S)N(CCC(=O)O)C3=O)c4ccccc4)c(C)c1,CNMBEYAZXFHTTF-MOSHPQCFSA-N,,PPARG
2820,carbacyclin,PPAR receptor agonist,PPARD,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2C/C(=CCCCC(=O)O)/C[C@H]12,XZFRIPGNUQRGPI-WBQKLGIQSA-N,,PPARD
2821,carbacyclin,PPAR receptor agonist,PTGIR,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2C/C(=CCCCC(=O)O)/C[C@H]12,XZFRIPGNUQRGPI-WBQKLGIQSA-N,,PTGIR
2822,ciglitazone,PPAR receptor agonist,PPARG,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,YZFWTZACSRHJQD-UHFFFAOYSA-N,,PPARG
2823,ciprofibrate,PPAR receptor agonist,PPARA,CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O,KPSRODZRAIWAKH-UHFFFAOYSA-N,,PPARA
2824,clofibrate,PPAR receptor agonist,PPARA,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,KNHUKKLJHYUCFP-UHFFFAOYSA-N,,PPARA
2825,clofibric-acid,PPAR receptor agonist,PPARA,CC(C)(Oc1ccc(Cl)cc1)C(O)=O,TXCGAZHTZHNUAI-UHFFFAOYSA-N,,PPARA
2826,efatutazone,PPAR receptor agonist,PPARG,Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N,JCYNMRJCUYVDBC-UHFFFAOYSA-N,,PPARG
2827,farnesol,PPAR receptor agonist,MAOB,CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C,CRDAMVZIKSXKFV-YFVJMOTDSA-N,,MAOB
2828,fenofibrate,PPAR receptor agonist,PPARA,CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1,YMTINGFKWWXKFG-UHFFFAOYSA-N,,PPARA
2829,gallic-acid,PPAR receptor agonist,CA1,OC(=O)c1cc(O)c(O)c(O)c1,LNTHITQWFMADLM-UHFFFAOYSA-N,,CA1
2830,GW-0742,PPAR receptor agonist,PPARD,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F,HWVNEWGKWRGSRK-UHFFFAOYSA-N,,PPARD
2831,GW-1929,PPAR receptor agonist,PPARG,CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1,QTQMRBZOBKYXCG-UHFFFAOYSA-N,,PPARG
2832,GW-501516,PPAR receptor agonist,PPARD,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F,YDBLKRPLXZNVNB-UHFFFAOYSA-N,,PPARD
2833,GW-7647,PPAR receptor agonist,PPARA,CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O,PKNYXWMTHFMHKD-UHFFFAOYSA-N,,PPARA
2834,HO-013,PPAR receptor agonist,PPARG,CCCCC[C@H](O)/C=C/C=CCCCCCCCC(=O)O,HNICUWMFWZBIFP-IRQZEAMPSA-N,,PPARG
2835,L-165041,PPAR receptor agonist,PPARD,CCCc1c(O)c(CC=O)ccc1OCCCOc2ccc(OCC(=O)O)cc2,YBEZORYMVISYOA-UHFFFAOYSA-N,,PPARD
2836,oleoylethanolamide,PPAR receptor agonist,GPR119,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,GPR119
2837,oleoylethanolamide,PPAR receptor agonist,PPARA,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,PPARA
2838,pioglitazone,PPAR receptor agonist,PPARG,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,HYAFETHFCAUJAY-UHFFFAOYSA-N,,PPARG
2839,pirinixic-acid,PPAR receptor agonist,PPARA,Cc1cccc(Nc2cc(Cl)nc(SCC(O)=O)n2)c1C,SZRPDCCEHVWOJX-UHFFFAOYSA-N,,PPARA
2840,pterostilbene,PPAR receptor agonist,PTGS2,COc1cc(OC)cc(/C=C/c2ccc(O)cc2)c1,VLEUZFDZJKSGMX-ONEGZZNKSA-N,,PTGS2
2841,pterostilbene,PPAR receptor agonist,PTGS2,COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1,VLEUZFDZJKSGMX-UHFFFAOYSA-N,,PTGS2
2842,rosiglitazone,PPAR receptor agonist,PPARG,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,YASAKCUCGLMORW-UHFFFAOYSA-N,,PPARG
2843,tesaglitazar,PPAR receptor agonist,PPARA,CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,,PPARA
2844,tesaglitazar,PPAR receptor agonist,PPARG,CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,,PPARG
2845,troglitazone,PPAR receptor agonist,PPARG,Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O,GXPHKUHSUJUWKP-UHFFFAOYSA-N,,PPARG
2846,4-PPBP,Sigma receptor ligand,SIGMAR1,C(CCc1ccccc1)CN1CCC(CC1)c1ccccc1,HQGDPZPNAXRCSA-UHFFFAOYSA-N,,SIGMAR1
2847,HC-030031,TRPA1 channel blocker,TRPA1,CC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1,HEQDZPHDVAOBLN-UHFFFAOYSA-N,,TRPA1
2848,aprepitant,Tachykinin antagonist,TACR1,C[C@@H](O[C@@H]1OCCN(Cc2nc(=O)[nH][nH]2)[C@@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,NLYKDVVWGQZEED-BYYRLHKVSA-N,,TACR1
2849,aprepitant,Tachykinin antagonist,TACR1,C[C@@H](O[C@H]1OCCN(Cc2nc(=O)[nH][nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,NLYKDVVWGQZEED-OITMNORJSA-N,,TACR1
2850,aprepitant,Tachykinin antagonist,TACR1,C[C@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,ATALOFNDEOCMKK-OCCQLPPTSA-N,,TACR1
2851,AV-608,Tachykinin antagonist,TACR1,FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1Cc1ccc(Cl)cc1)NC(=O)c1ccnc2ccccc12,NXLUTEDAEFXMQR-BJKOFHAPSA-N,,TACR1
2852,FK-888,Tachykinin antagonist,TACR1,CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12,BFNKQTIJVFGCKQ-PDJGWCFMSA-N,,TACR1
2853,GR-159897,Tachykinin antagonist,TAC1,COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1,BANYJBHWTOJQDU-GDLZYMKVSA-N,,TAC1
2854,GR-159897,Tachykinin antagonist,TACR2,COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1,BANYJBHWTOJQDU-GDLZYMKVSA-N,,TACR2
2855,L-732138,Tachykinin antagonist,TACR1,CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,BYYQYXVAWXAYQC-UHFFFAOYSA-N,,TACR1
2856,L-733060,Tachykinin antagonist,TACR1,FC(F)(F)c1cc(CO[C@H]2CCCN[C@H]2c2ccccc2)cc(c1)C(F)(F)F,FCDRFVCGMLUYPG-ROUUACIJSA-N,,TACR1
2857,netupitant,Tachykinin antagonist,TACR1,CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1,WAXQNWCZJDTGBU-UHFFFAOYSA-N,,TACR1
2858,SB-218795,Tachykinin antagonist,TACR3,COC(=O)[C@H](NC(=O)c1cc(nc2ccccc12)-c1ccccc1)c1ccccc1,IUMQXQJZIHWLIN-HSZRJFAPSA-N,,TACR3
2859,SB-222200,Tachykinin antagonist,TACR3,CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c1ccccc1)c1ccccc1,MQNYRKWJSMQECI-QFIPXVFZSA-N,,TACR3
2860,SDZ-NKT-343,Tachykinin antagonist,TACR1,CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1CCCN1C(=O)Nc1ccccc1[N+]([O-])=O,PCVSIMQAFWRUEC-JDXGNMNLSA-N,,TACR1
2861,SDZ-NKT-343,Tachykinin antagonist,TACR1,CN(Cc1ccccc1)C(=O)C(Cc2ccc3ccccc3c2)NC(=O)C4CCCN4C(=O)Nc5ccccc5[N+](=O)[O-],PCVSIMQAFWRUEC-UHFFFAOYSA-N,,TACR1
2862,talnetant,Tachykinin antagonist,TACR3,CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1,BIAVGWDGIJKWRM-FQEVSTJZSA-N,,TACR3
2863,prima-1-met,Thioredoxin inhibitor,TP53,COC[C@]1(CO)[N@@]2CC[C@@H](CC2)C1=O,BGBNULCRKBVAKL-JTQLQIEISA-N,,TP53
2864,PX-12,Thioredoxin inhibitor,TXN,CCC(C)SSc1ncc[nH]1,BPBPYQWMFCTCNG-UHFFFAOYSA-N,,TXN
2865,PX-12,Thioredoxin inhibitor,TXNRD1,CCC(C)SSc1ncc[nH]1,BPBPYQWMFCTCNG-UHFFFAOYSA-N,,TXNRD1
2866,MK-1775,WEE1 kinase inhibitor,WEE1,CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1,BKWJAKQVGHWELA-UHFFFAOYSA-N,,WEE1
2867,adrenosterone,11-beta-HSD1 inhibitor,HSD11B1,C[C@]12CC(=O)[C@@H]3[C@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,RZRPTBIGEANTGU-UUKVCBHOSA-N,,HSD11B1
2868,adrenosterone,11-beta-HSD1 inhibitor,HSD11B2,C[C@]12CC(=O)[C@@H]3[C@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,RZRPTBIGEANTGU-UUKVCBHOSA-N,,HSD11B2
2869,adrenosterone,11-beta-HSD1 inhibitor,HSD11B1,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,RZRPTBIGEANTGU-IRIMSJTPSA-N,,HSD11B1
2870,adrenosterone,11-beta-HSD1 inhibitor,HSD11B2,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,RZRPTBIGEANTGU-IRIMSJTPSA-N,,HSD11B2
2871,carbenoxolone,11-beta-HSD1 inhibitor,HSD11B1,CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O,OBZHEBDUNPOCJG-LTMGWWHLSA-N,,HSD11B1
2872,carbenoxolone,11-beta-HSD1 inhibitor,HSD11B1,CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O)OC(=O)CCC(=O)O,OBZHEBDUNPOCJG-WBXJDKIVSA-N,,HSD11B1
2873,carbenoxolone,11-beta-HSD1 inhibitor,HSD11B1,CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3CC(C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O,OBZHEBDUNPOCJG-XPDVRYJBSA-N,,HSD11B1
2874,carbenoxolone,11-beta-HSD1 inhibitor,HSD11B1,CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)C2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O,OBZHEBDUNPOCJG-YQNKGXRGSA-N,,HSD11B1
2875,chenodiol,11-beta-HSD1 inhibitor,HSD11B1,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C,RUDATBOHQWOJDD-CIKBIKKZSA-N,,HSD11B1
2876,emodin,11-beta-HSD1 inhibitor,CSNK2A1,Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1,RHMXXJGYXNZAPX-UHFFFAOYSA-N,,CSNK2A1
2877,antimycin-a,ATP synthase inhibitor,CYCS,CCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O,ZVYMCLIDNNTNCL-GFRRLMGDSA-N,,CYCS
2878,antimycin-a,ATP synthase inhibitor,CYCS,CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)C(NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O,UIFFUZWRFRDZJC-KSVNMYRZSA-N,,CYCS
2879,antimycin-a,ATP synthase inhibitor,CYCS,CCCCCCC1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O,UIFFUZWRFRDZJC-RBVQMQRASA-N,,CYCS
2880,oligomycin-a,ATP synthase inhibitor,ATP5F1A,CC[C@H]1CC[C@@H]2O[C@]3(CC[C@@H](C)[C@@H](C[C@@H](C)O)O3)[C@H](C)[C@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-JBMMDCLPSA-N,,ATP5F1A
2881,oligomycin-a,ATP synthase inhibitor,ATP5F1A,CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-WMBHJXFZSA-N,,ATP5F1A
2882,oligomycin-a,ATP synthase inhibitor,ATP5F1A,CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,MNULEGDCPYONBU-VVXVDZGXSA-N,,ATP5F1A
2883,oligomycin-c,ATP synthase inhibitor,ATP5F1A,CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C,CMMLZMMKTYEOKV-JEKNLLRFSA-N,,ATP5F1A
2884,angiogenesis-inhibitor,Angiogenesis inhibitor,EGFR,O=C/1Nc2ccccc2C1=C/c3c[nH]cn3,VEEGZPWAAPPXRB-BJMVGYQFSA-N,,EGFR
2885,pomalidomide,Angiogenesis inhibitor,CRBN,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,UVSMNLNDYGZFPF-UHFFFAOYSA-N,,CRBN
2886,pomalidomide,Angiogenesis inhibitor,TNF,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,UVSMNLNDYGZFPF-UHFFFAOYSA-N,,TNF
2887,tasquinimod,Angiogenesis inhibitor,S100A9,COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12,ONDYALNGTUAJDX-UHFFFAOYSA-N,,S100A9
2888,tasquinimod,Angiogenesis inhibitor,HDAC4,COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12,ONDYALNGTUAJDX-UHFFFAOYSA-N,,HDAC4
2889,azilsartan-medoxomil,Angiotensin antagonist,AGTR2,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,QJFSABGVXDWMIW-UHFFFAOYSA-N,,AGTR2
2890,PD-123319,Angiotensin antagonist,AGTR2,CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)cc1C,YSTVFDAKLDMYCR-NDEPHWFRSA-N,,AGTR2
2891,PD-123319,Angiotensin antagonist,AGTR2,CN(C)c1ccc(Cn2cnc3CN(C(Cc32)C(=O)O)C(=O)C(c4ccccc4)c5ccccc5)cc1C,YSTVFDAKLDMYCR-UHFFFAOYSA-N,,AGTR2
2892,gallic-acid,Beta amyloid inhibitor,CA1,OC(=O)c1cc(O)c(O)c(O)c1,LNTHITQWFMADLM-UHFFFAOYSA-N,,CA1
2893,phenserine,Beta amyloid inhibitor,APP,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,APP
2894,phenserine,Beta amyloid inhibitor,ACHE,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,ACHE
2895,phenserine,Beta amyloid inhibitor,BCHE,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,BCHE
2896,Ro-90-7501,Beta amyloid inhibitor,APP,Nc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(N)cc2[nH]1,PAGZCEHLFCJSPV-UHFFFAOYSA-N,,APP
2897,salidroside,Beta amyloid inhibitor,APP,OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,ILRCGYURZSFMEG-RKQHYHRCSA-N,,APP
2898,tramiprosate,Beta amyloid inhibitor,APP,NCCCS(O)(=O)=O,SNKZJIOFVMKAOJ-UHFFFAOYSA-N,,APP
2899,ICG-001,Beta-catenin inhibitor,CTNNB1,Oc1ccc(C[C@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc2ccccc2)cc1,HQWTUOLCGKIECB-LOYHVIPDSA-N,,CTNNB1
2900,PNU-74654,Beta-catenin inhibitor,CTNNB1,Cc1ccc(C=NNC(=O)c2ccccc2Oc2ccccc2)o1,JJEDWBQZCRESJL-DEDYPNTBSA-N,,CTNNB1
2901,PNU-74654,Beta-catenin inhibitor,TCF4,Cc1ccc(C=NNC(=O)c2ccccc2Oc2ccccc2)o1,JJEDWBQZCRESJL-DEDYPNTBSA-N,,TCF4
2902,dexamethasone-acetate,Corticosteroid agonist,NR3C1,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-HIBZCRSPSA-N,,NR3C1
2903,fluocinolone-acetonide,Corticosteroid agonist,NR3C1,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,WJOHZNCJWYWUJD-UUTDCOIBSA-N,,NR3C1
2904,fluocinolone-acetonide,Corticosteroid agonist,NR3C1,CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,FEBLZLNTKCEFIT-AHVBUMMWSA-N,,NR3C1
2905,hydrocortisone-acetate,Corticosteroid agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C,ALEXXDVDDISNDU-KPYZGQEZSA-N,,NR3C1
2906,hydrocortisone-valerate,Corticosteroid agonist,NR3C1,CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO,FZCHYNWYXKICIO-BXLKFAEVSA-N,,NR3C1
2907,folic-acid,Folate receptor ligand,FOLR2,Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1,OVBPIULPVIDEAO-LBPRGKRZSA-N,,FOLR2
2908,enoxolone,Gap junction modulator,HSD11B1,C[C@]12CC[C@@](C)(C[C@@H]1C1=CC(=O)[C@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O,MPDGHEJMBKOTSU-AOLSMHRZSA-N,,HSD11B1
2909,ivabradine,HCN channel antagonist,HCN4,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN4
2910,ivabradine,HCN channel antagonist,HCN1,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN1
2911,ivabradine,HCN channel antagonist,HCN3,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN3
2912,darunavir,HIV protease inhibitor,CYP3A4,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,,CYP3A4
2913,efavirenz,HIV protease inhibitor,CYP1A2,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP1A2
2914,efavirenz,HIV protease inhibitor,CYP2B6,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP2B6
2915,efavirenz,HIV protease inhibitor,CYP2C19,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP2C19
2916,efavirenz,HIV protease inhibitor,CYP2C9,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP2C9
2917,efavirenz,HIV protease inhibitor,CYP2D6,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP2D6
2918,efavirenz,HIV protease inhibitor,CYP3A4,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,,CYP3A4
2919,indinavir,HIV protease inhibitor,CYP3A7,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,CBVCZFGXHXORBI-PXQQMZJSSA-N,,CYP3A7
2920,indinavir,HIV protease inhibitor,CYP3A4,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,CBVCZFGXHXORBI-PXQQMZJSSA-N,,CYP3A4
2921,indinavir,HIV protease inhibitor,CYP3A5,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,CBVCZFGXHXORBI-PXQQMZJSSA-N,,CYP3A5
2922,nelfinavir,HIV protease inhibitor,CYP1A2,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP1A2
2923,nelfinavir,HIV protease inhibitor,CYP3A7,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP3A7
2924,nelfinavir,HIV protease inhibitor,CYP2B6,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP2B6
2925,nelfinavir,HIV protease inhibitor,CYP2C19,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP2C19
2926,nelfinavir,HIV protease inhibitor,CYP2C9,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP2C9
2927,nelfinavir,HIV protease inhibitor,CYP2D6,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP2D6
2928,nelfinavir,HIV protease inhibitor,CYP3A4,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@@H]2CCCC[C@@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-BBDMRMKHSA-N,,CYP3A4
2929,nelfinavir,HIV protease inhibitor,CYP1A2,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP1A2
2930,nelfinavir,HIV protease inhibitor,CYP3A7,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP3A7
2931,nelfinavir,HIV protease inhibitor,CYP2B6,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP2B6
2932,nelfinavir,HIV protease inhibitor,CYP2C19,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP2C19
2933,nelfinavir,HIV protease inhibitor,CYP2C9,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP2C9
2934,nelfinavir,HIV protease inhibitor,CYP2D6,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP2D6
2935,nelfinavir,HIV protease inhibitor,CYP3A4,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,,CYP3A4
2936,ritonavir,HIV protease inhibitor,CYP1A2,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP1A2
2937,ritonavir,HIV protease inhibitor,CYP3A7,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP3A7
2938,ritonavir,HIV protease inhibitor,CYP2B6,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2B6
2939,ritonavir,HIV protease inhibitor,CYP2C19,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2C19
2940,ritonavir,HIV protease inhibitor,CYP2C8,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2C8
2941,ritonavir,HIV protease inhibitor,CYP2C9,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2C9
2942,ritonavir,HIV protease inhibitor,CYP2D6,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2D6
2943,ritonavir,HIV protease inhibitor,CYP2E1,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP2E1
2944,ritonavir,HIV protease inhibitor,CYP3A4,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP3A4
2945,ritonavir,HIV protease inhibitor,CYP3A5,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,,CYP3A5
2946,ritonavir,HIV protease inhibitor,CYP1A2,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP1A2
2947,ritonavir,HIV protease inhibitor,CYP3A7,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP3A7
2948,ritonavir,HIV protease inhibitor,CYP2B6,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2B6
2949,ritonavir,HIV protease inhibitor,CYP2C19,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2C19
2950,ritonavir,HIV protease inhibitor,CYP2C8,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2C8
2951,ritonavir,HIV protease inhibitor,CYP2C9,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2C9
2952,ritonavir,HIV protease inhibitor,CYP2D6,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2D6
2953,ritonavir,HIV protease inhibitor,CYP2E1,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP2E1
2954,ritonavir,HIV protease inhibitor,CYP3A4,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP3A4
2955,ritonavir,HIV protease inhibitor,CYP3A5,CC(C)C(NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)NC(CC(O)C(Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-UHFFFAOYSA-N,,CYP3A5
2956,ursolic-acid,HIV protease inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
2957,ursolic-acid,HIV protease inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
2958,ursolic-acid,HIV protease inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
2959,ursolic-acid,HIV protease inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
2960,erastin,Ion channel antagonist,VDAC2,CCOc1ccccc1-n1c(=O)c2ccccc2nc1C(C)N1CCN(CC1)C(=O)COc1ccc(Cl)cc1,BKQFRNYHFIQEKN-UHFFFAOYSA-N,,VDAC2
2961,berberine,LDL receptor activator,LDLR,COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC,YBHILYKTIRIUTE-UHFFFAOYSA-N,,LDLR
2962,AM-24,Lipoxygenase inhibitor,ALOX5,Oc1c(I)cc(I)cc1I,VAPDZNUFNKUROY-UHFFFAOYSA-N,,ALOX5
2963,BRD-A54632525,Lipoxygenase inhibitor,ALOX12,CC(=O)NC(c1cccs1)c1cc(Br)c2cccnc2c1O,FREDZQWTOHKXRX-UHFFFAOYSA-N,,ALOX12
2964,BRD-K20168484,Lipoxygenase inhibitor,ALOX5AP,CC(C)c1ccc2n(Cc3ccc(Cl)cc3)c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c2c1,QAOAOVKBIIKRNL-UHFFFAOYSA-N,,ALOX5AP
2965,BW-B70C,Lipoxygenase inhibitor,ALOX5,CC(C=Cc1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O,UAIYNMRLUHHRMF-AATRIKPKSA-N,,ALOX5
2966,BW-B70C,Lipoxygenase inhibitor,ALOX5,CC(C=Cc1cccc(Oc2ccc(F)cc2)c1)N(O)C(=O)N,UAIYNMRLUHHRMF-UHFFFAOYSA-N,,ALOX5
2967,caffeic-acid,Lipoxygenase inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
2968,caffeic-acid,Lipoxygenase inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
2969,curcumin,Lipoxygenase inhibitor,PTGS1,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS1
2970,curcumin,Lipoxygenase inhibitor,PTGS2,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS2
2971,curcumin,Lipoxygenase inhibitor,PTGS1,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS1
2972,curcumin,Lipoxygenase inhibitor,PTGS2,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS2
2973,curcumin,Lipoxygenase inhibitor,PTGS1,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS1
2974,curcumin,Lipoxygenase inhibitor,PTGS2,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS2
2975,diethylcarbamazine,Lipoxygenase inhibitor,ALOX5,CCN(CC)C(=O)N1CCN(C)CC1,RCKMWOKWVGPNJF-UHFFFAOYSA-N,,ALOX5
2976,eicosatetraynoic-acid,Lipoxygenase inhibitor,ALOX12,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,ALOX12
2977,eicosatetraynoic-acid,Lipoxygenase inhibitor,PPARA,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PPARA
2978,eicosatetraynoic-acid,Lipoxygenase inhibitor,PPARG,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PPARG
2979,eicosatetraynoic-acid,Lipoxygenase inhibitor,PTGS1,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PTGS1
2980,hyperforin,Lipoxygenase inhibitor,ALOX5,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,ALOX5
2981,hyperforin,Lipoxygenase inhibitor,PTGS1,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,PTGS1
2982,hyperforin,Lipoxygenase inhibitor,NR1I2,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,NR1I2
2983,masoprocol,Lipoxygenase inhibitor,ALOX5,CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1,HCZKYJDFEPMADG-UHFFFAOYSA-N,,ALOX5
2984,mesalazine,Lipoxygenase inhibitor,ALOX5,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,ALOX5
2985,mesalazine,Lipoxygenase inhibitor,PPARG,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PPARG
2986,mesalazine,Lipoxygenase inhibitor,PTGS1,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS1
2987,mesalazine,Lipoxygenase inhibitor,PTGS2,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS2
2988,REV-5901,Lipoxygenase inhibitor,ALOX5,CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1,JRLOEMCOOZSCQP-UHFFFAOYSA-N,,ALOX5
2989,zileuton,Lipoxygenase inhibitor,ALOX5,CC(N(O)C(N)=O)c1cc2ccccc2s1,MWLSOWXNZPKENC-UHFFFAOYSA-N,,ALOX5
2990,cetraxate,Mucus protecting agent,GAST,NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2,FHRSHSOEWXUORL-HDJSIYSDSA-N,,GAST
2991,sofalcone,Mucus protecting agent,CBR1,CC(C)=CCOc1ccc(C=CC(=O)c2ccc(OCC=C(C)C)cc2OCC(O)=O)cc1,GFWRVVCDTLRWPK-KPKJPENVSA-N,,CBR1
2992,BAY-11-7085,NFKB pathway inhibitor,NFKBIA,CC(C)(C)c1ccc(cc1)S(=O)(=O)C=CC#N,VHKZGNPOHPFPER-ONNFQVAWSA-N,,NFKBIA
2993,bindarit,NFKB pathway inhibitor,CCL2,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O,MTHORRSSURHQPZ-UHFFFAOYSA-N,,CCL2
2994,bindarit,NFKB pathway inhibitor,CCL7,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O,MTHORRSSURHQPZ-UHFFFAOYSA-N,,CCL7
2995,bindarit,NFKB pathway inhibitor,CCL8,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O,MTHORRSSURHQPZ-UHFFFAOYSA-N,,CCL8
2996,bortezomib,NFKB pathway inhibitor,PSMB1,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB1
2997,bortezomib,NFKB pathway inhibitor,PSMB2,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB2
2998,bortezomib,NFKB pathway inhibitor,PSMB5,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,RFGAQTOFZHCFHG-NVXWUHKLSA-N,,PSMB5
2999,bortezomib,NFKB pathway inhibitor,PSMB1,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB1
3000,bortezomib,NFKB pathway inhibitor,PSMB2,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB2
3001,bortezomib,NFKB pathway inhibitor,PSMB5,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,,PSMB5
3002,caffeic-acid,NFKB pathway inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
3003,caffeic-acid,NFKB pathway inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
3004,CAY-10470,NFKB pathway inhibitor,NFKB1,Nc1ccc2NCN=C(NCCc3ccc(Oc4ccccc4)cc3)c2c1,GGBVTWRQPMDRCK-UHFFFAOYSA-N,,NFKB1
3005,CAY-10470,NFKB pathway inhibitor,TNF,Nc1ccc2NCN=C(NCCc3ccc(Oc4ccccc4)cc3)c2c1,GGBVTWRQPMDRCK-UHFFFAOYSA-N,,TNF
3006,curcumin,NFKB pathway inhibitor,PTGS1,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS1
3007,curcumin,NFKB pathway inhibitor,PTGS2,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS2
3008,curcumin,NFKB pathway inhibitor,PTGS1,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS1
3009,curcumin,NFKB pathway inhibitor,PTGS2,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS2
3010,curcumin,NFKB pathway inhibitor,PTGS1,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS1
3011,curcumin,NFKB pathway inhibitor,PTGS2,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS2
3012,dimethyl-fumarate,NFKB pathway inhibitor,NFE2L2,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,NFE2L2
3013,dimethyl-fumarate,NFKB pathway inhibitor,KEAP1,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,KEAP1
3014,erythromycin,NFKB pathway inhibitor,MLNR,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,ULGZDMOVFRHVEP-RWJQBGPGSA-N,,MLNR
3015,erythromycin,NFKB pathway inhibitor,MLNR,CCOC(=O)CCC(=O)OC1C(CC(C)OC1OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)N(C)C,NSYZCCDSJNWWJL-UHFFFAOYSA-N,,MLNR
3016,erythromycin-ethylsuccinate,NFKB pathway inhibitor,CYP3A4,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP3A4
3017,erythromycin-ethylsuccinate,NFKB pathway inhibitor,CYP51A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP51A1
3018,erythromycin-ethylsuccinate,NFKB pathway inhibitor,ALB,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ALB
3019,erythromycin-ethylsuccinate,NFKB pathway inhibitor,MLNR,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,MLNR
3020,erythromycin-ethylsuccinate,NFKB pathway inhibitor,KCNH2,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,KCNH2
3021,erythromycin-ethylsuccinate,NFKB pathway inhibitor,ABCB1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ABCB1
3022,erythromycin-ethylsuccinate,NFKB pathway inhibitor,SLC47A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,SLC47A1
3023,iguratimod,NFKB pathway inhibitor,PTGS2,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,ANMATWQYLIFGOK-UHFFFAOYSA-N,,PTGS2
3024,manumycin-a,NFKB pathway inhibitor,FNTA,CCCC[C@@H](C)/C=C(C)/C=C(C)/C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]3O[C@@H]3C1=O,XIZGHTZLVCHYJN-MVTGTTCWSA-N,,FNTA
3025,manumycin-a,NFKB pathway inhibitor,IKBKB,CCCC[C@@H](C)/C=C(C)/C=C(C)/C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]3O[C@@H]3C1=O,XIZGHTZLVCHYJN-MVTGTTCWSA-N,,IKBKB
3026,manumycin-a,NFKB pathway inhibitor,FNTA,CCCC[C@@H](C)C=C(C)C=C(/C)C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]2OC2C1=O,XIZGHTZLVCHYJN-YCWSEAROSA-N,,FNTA
3027,manumycin-a,NFKB pathway inhibitor,IKBKB,CCCC[C@@H](C)C=C(C)C=C(/C)C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]2OC2C1=O,XIZGHTZLVCHYJN-YCWSEAROSA-N,,IKBKB
3028,mepacrine,NFKB pathway inhibitor,TP53,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,GPKJTRJOBQGKQK-UHFFFAOYSA-N,,TP53
3029,pyrrolidine-dithiocarbamate,NFKB pathway inhibitor,HSD11B1,SC(=S)N1CCCC1,VSWDORGPIHIGNW-UHFFFAOYSA-N,,HSD11B1
3030,sasapyrine,NFKB pathway inhibitor,PTGS1,OC(=O)c1ccccc1OC(=O)c1ccccc1O,WVYADZUPLLSGPU-UHFFFAOYSA-N,,PTGS1
3031,sulfasalazine,NFKB pathway inhibitor,ALOX5,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,ALOX5
3032,sulfasalazine,NFKB pathway inhibitor,PTGS1,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,PTGS1
3033,sulfasalazine,NFKB pathway inhibitor,PTGS2,OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,NCEXYHBECQHGNR-QZQOTICOSA-N,,PTGS2
3034,ursolic-acid,NFKB pathway inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
3035,ursolic-acid,NFKB pathway inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
3036,ursolic-acid,NFKB pathway inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
3037,ursolic-acid,NFKB pathway inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
3038,betulinic-acid,NFkB pathway activator,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
3039,betulinic-acid,NFkB pathway activator,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
3040,farnesol,NFkB pathway activator,MAOB,CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C,CRDAMVZIKSXKFV-YFVJMOTDSA-N,,MAOB
3041,cytosporone-b,NUR77 receptor agonist,NR4A1,CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC,UVVWQQKSNZLUQA-UHFFFAOYSA-N,,NR4A1
3042,rutin,Nitric oxide scavenger,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-NVPNHPEKSA-N,,AKR1C3
3043,rutin,Nitric oxide scavenger,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-KUKMIBIMSA-N,,AKR1C3
3044,rutin,Nitric oxide scavenger,AKR1C3,CC1OC(OCC2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O,IKGXIBQEEMLURG-UHFFFAOYSA-N,,AKR1C3
3045,isosorbide-dinitrate,Nitric oxide stimulant,GUCY1A1,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,MOYKHGMNXAOIAT-JGWLITMVSA-N,,GUCY1A1
3046,isosorbide-dinitrate,Nitric oxide stimulant,GUCY1B1,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,MOYKHGMNXAOIAT-JGWLITMVSA-N,,GUCY1B1
3047,tetrahydrobiopterin,Nitric oxide stimulant,PAH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,PAH
3048,tetrahydrobiopterin,Nitric oxide stimulant,TH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,TH
3049,fenoprofen,Prostagladin inhibitor,PTGS1,CC(C(=O)O)c1cccc(Oc2ccccc2)c1.CC(C(=O)O)c1cccc(Oc2ccccc2)c1,HBUGUKMTZDSVIK-UHFFFAOYSA-N,,PTGS1
3050,fenoprofen,Prostagladin inhibitor,PTGS1,CC(C(O)=O)c1cccc(Oc2ccccc2)c1,RDJGLLICXDHJDY-UHFFFAOYSA-N,,PTGS1
3051,4-IBP,Sigma receptor agonist,SIGMAR1,Ic1ccc(cc1)C(=O)NC1CCN(Cc2ccccc2)CC1,HELCSESNNDZLFM-UHFFFAOYSA-N,,SIGMAR1
3052,cutamesine,Sigma receptor agonist,SIGMAR1,COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC,UVSWWUWQVAQPJR-UHFFFAOYSA-N,,SIGMAR1
3053,L-693403,Sigma receptor agonist,SIGMAR1,C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1,GSXJSGMDWKPVBY-UHFFFAOYSA-N,,SIGMAR1
3054,PRE-084,Sigma receptor agonist,SIGMAR1,O=C(OCCN1CCOCC1)C1(CCCCC1)c1ccccc1,RQHKZUBCUZVZEF-UHFFFAOYSA-N,,SIGMAR1
3055,ambroxol,Sodium channel blocker,CYP3A4,Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,JBDGDEWWOUBZPM-XYPYZODXSA-N,,CYP3A4
3056,amiloride,Sodium channel blocker,ASIC2,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,,ASIC2
3057,amiloride,Sodium channel blocker,ASIC1,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,,ASIC1
3058,amiloride,Sodium channel blocker,SCNN1A,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,,SCNN1A
3059,amiloride,Sodium channel blocker,SCNN1B,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,,SCNN1B
3060,amiloride,Sodium channel blocker,SCNN1G,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,,SCNN1G
3061,benzamil,Sodium channel blocker,SCNN1A,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1A
3062,benzamil,Sodium channel blocker,SCNN1B,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1B
3063,benzamil,Sodium channel blocker,SCNN1D,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1D
3064,benzamil,Sodium channel blocker,SCNN1G,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1G
3065,benzamil,Sodium channel blocker,SLC8A1,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SLC8A1
3066,benzamil,Sodium channel blocker,PKD2L1,NC(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,PKD2L1
3067,benzamil,Sodium channel blocker,SCNN1A,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1A
3068,benzamil,Sodium channel blocker,SCNN1B,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1B
3069,benzamil,Sodium channel blocker,SCNN1D,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1D
3070,benzamil,Sodium channel blocker,SCNN1G,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SCNN1G
3071,benzamil,Sodium channel blocker,SLC8A1,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,SLC8A1
3072,benzamil,Sodium channel blocker,PKD2L1,NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N,KXDROGADUISDGY-UHFFFAOYSA-N,,PKD2L1
3073,benzethonium,Sodium channel blocker,SCN10A,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1,SIYLLGKDQZGJHK-UHFFFAOYSA-N,,SCN10A
3074,BRD-K56658166,Sodium channel blocker,CACNA1B,Brc1ccccc1OCC(=O)NCCc2nc3ccccc3[nH]2,XWFRNTHGPRGCNS-UHFFFAOYSA-N,,CACNA1B
3075,cinchocaine,Sodium channel blocker,SCN5A,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,PUFQVTATUTYEAL-UHFFFAOYSA-N,,SCN5A
3076,disopyramide,Sodium channel blocker,SCN5A,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,UVTNFZQICZKOEM-UHFFFAOYSA-N,,SCN5A
3077,flecainide,Sodium channel blocker,SCN5A,FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1,DJBNUMBKLMJRSA-UHFFFAOYSA-N,,SCN5A
3078,hexylcaine,Sodium channel blocker,SCN5A,CC(CNC1CCCCC1)OC(=O)c1ccccc1,DKLKMKYDWHYZTD-UHFFFAOYSA-N,,SCN5A
3079,ivabradine,Sodium channel blocker,HCN4,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN4
3080,ivabradine,Sodium channel blocker,HCN1,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN1
3081,ivabradine,Sodium channel blocker,HCN3,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN3
3082,kavain,Sodium channel blocker,MTOR,COC1=CC(=O)OC(C1)/C=C/c2ccccc2,XEAQIWGXBXCYFX-BQYQJAHWSA-N,,MTOR
3083,kawain,Sodium channel blocker,MTOR,COC1=CC(=O)O[C@H](C1)/C=C/c2ccccc2,XEAQIWGXBXCYFX-GUOLPTJISA-N,,MTOR
3084,lacosamide,Sodium channel blocker,SCN1A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN1A
3085,lacosamide,Sodium channel blocker,SCN3A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN3A
3086,lacosamide,Sodium channel blocker,SCN9A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN9A
3087,lacosamide,Sodium channel blocker,SCN10A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN10A
3088,lamotrigine,Sodium channel blocker,SCN1A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN1A
3089,lamotrigine,Sodium channel blocker,SCN2A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN2A
3090,lamotrigine,Sodium channel blocker,SCN3A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN3A
3091,lupanine,Sodium channel blocker,INS,O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3,JYIJIIVLEOETIQ-RFPFOJJUSA-N,,INS
3092,mexiletine,Sodium channel blocker,SCN5A,CC(N)COc1c(C)cccc1C,VLPIATFUUWWMKC-UHFFFAOYSA-N,,SCN5A
3093,moracizine,Sodium channel blocker,SCN5A,CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN3CCOCC3)c2c1,FUBVWMNBEHXPSU-UHFFFAOYSA-N,,SCN5A
3094,oxcarbazepine,Sodium channel blocker,SCN1A,NC(=O)N1c2ccccc2CC(=O)c2ccccc12,CTRLABGOLIVAIY-UHFFFAOYSA-N,,SCN1A
3095,oxcarbazepine,Sodium channel blocker,SCN3A,NC(=O)N1c2ccccc2CC(=O)c2ccccc12,CTRLABGOLIVAIY-UHFFFAOYSA-N,,SCN3A
3096,oxcarbazepine,Sodium channel blocker,SCN5A,NC(=O)N1c2ccccc2CC(=O)c2ccccc12,CTRLABGOLIVAIY-UHFFFAOYSA-N,,SCN5A
3097,phenacemide,Sodium channel blocker,SCN1A,NC(=O)NC(=O)Cc1ccccc1,XPFRXWCVYUEORT-UHFFFAOYSA-N,,SCN1A
3098,procainamide,Sodium channel blocker,SCN5A,CCN(CC)CCNC(=O)c1ccc(N)cc1,REQCZEXYDRLIBE-UHFFFAOYSA-N,,SCN5A
3099,quinidine,Sodium channel blocker,SCN5A,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-LHHVKLHASA-N,,SCN5A
3100,quinidine,Sodium channel blocker,SCN5A,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-LHHVKLHASA-N,,SCN5A
3101,quinidine,Sodium channel blocker,SCN5A,COc1ccc2nccc(C(O)C3CC4CCN3CC4C=C)c2c1,LOUPRKONTZGTKE-UHFFFAOYSA-N,,SCN5A
3102,ranolazine,Sodium channel blocker,SCN5A,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,,SCN5A
3103,ranolazine,Sodium channel blocker,SCN9A,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,,SCN9A
3104,tocainide,Sodium channel blocker,SCN5A,CC(N)C(=O)Nc1c(C)cccc1C,BUJAGSGYPOAWEI-UHFFFAOYSA-N,,SCN5A
3105,triamterene,Sodium channel blocker,SCNN1A,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,,SCNN1A
3106,triamterene,Sodium channel blocker,SCNN1B,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,,SCNN1B
3107,triamterene,Sodium channel blocker,SCNN1G,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,,SCNN1G
3108,vinpocetine,Sodium channel blocker,PDE1A,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]23)n1c1ccccc41,DDNCQMVWWZOMLN-UNMCSNQZSA-N,,PDE1A
3109,vinpocetine,Sodium channel blocker,PDE1A,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41,DDNCQMVWWZOMLN-IRLDBZIGSA-N,,PDE1A
3110,vinpocetine,Sodium channel blocker,PDE1A,CCOC(=O)C1=CC2(CC)CCCN3CCc4c(C32)n1c5ccccc45,DDNCQMVWWZOMLN-UHFFFAOYSA-N,,PDE1A
3111,zonisamide,Sodium channel blocker,SCN11A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN11A
3112,zonisamide,Sodium channel blocker,SCN1A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN1A
3113,zonisamide,Sodium channel blocker,SCN2A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN2A
3114,zonisamide,Sodium channel blocker,SCN3A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN3A
3115,zonisamide,Sodium channel blocker,SCN4A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN4A
3116,zonisamide,Sodium channel blocker,SCN5A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN5A
3117,zonisamide,Sodium channel blocker,SCN9A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN9A
3118,zonisamide,Sodium channel blocker,CA1,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA1
3119,zonisamide,Sodium channel blocker,CA7,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA7
3120,zonisamide,Sodium channel blocker,CA12,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA12
3121,zonisamide,Sodium channel blocker,SCN11A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN11A
3122,zonisamide,Sodium channel blocker,SCN1A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN1A
3123,zonisamide,Sodium channel blocker,SCN2A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN2A
3124,zonisamide,Sodium channel blocker,SCN3A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN3A
3125,zonisamide,Sodium channel blocker,SCN4A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN4A
3126,zonisamide,Sodium channel blocker,SCN5A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN5A
3127,zonisamide,Sodium channel blocker,SCN9A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN9A
3128,zonisamide,Sodium channel blocker,CA1,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA1
3129,zonisamide,Sodium channel blocker,CA7,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA7
3130,zonisamide,Sodium channel blocker,CA12,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA12
3131,aliskiren,Anti-hypertensive agent,REN,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC,UXOWGYHJODZGMF-QORCZRPOSA-N,,REN
3132,naproxol,Anti-inflammatory agent,PTGS1,COc1ccc2cc(ccc2c1)[C@H](C)CO,LTRANDSQVZFZDG-SNVBAGLBSA-N,,PTGS1
3133,naproxol,Anti-inflammatory agent,PTGS2,COc1ccc2cc(ccc2c1)[C@H](C)CO,LTRANDSQVZFZDG-SNVBAGLBSA-N,,PTGS2
3134,tanshinone-iia,Anti-inflammatory agent,IL1B,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,IL1B
3135,tanshinone-iia,Anti-inflammatory agent,TNF,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,TNF
3136,tanshinone-iia,Anti-inflammatory agent,NR1I2,Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,HYXITZLLTYIPOF-UHFFFAOYSA-N,,NR1I2
3137,probucol,Atherogenesis inhibitor,ABCA1,CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,FYPMFJGVHOHGLL-UHFFFAOYSA-N,,ABCA1
3138,alisertib,Aurora kinase inhibitor,AURKA,COc1cc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2OC)ccc1C(O)=O,ZLHFILGSQDJULK-UHFFFAOYSA-N,,AURKA
3139,AT-9283,Aurora kinase inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
3140,AT-9283,Aurora kinase inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
3141,AT-9283,Aurora kinase inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
3142,AT-9283,Aurora kinase inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
3143,barasertib,Aurora kinase inhibitor,AURKA,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O,GBJVVSCPOBPEIT-UHFFFAOYSA-N,,AURKA
3144,barasertib,Aurora kinase inhibitor,AURKB,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O,GBJVVSCPOBPEIT-UHFFFAOYSA-N,,AURKB
3145,BRD-K97951054,Aurora kinase inhibitor,PIM1,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,PIM1
3146,BRD-K97951054,Aurora kinase inhibitor,AURKB,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,AQZHBCDRWFMXIN-UHFFFAOYSA-N,,AURKB
3147,danusertib,Aurora kinase inhibitor,FGFR1,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,FGFR1
3148,danusertib,Aurora kinase inhibitor,NTRK1,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,NTRK1
3149,danusertib,Aurora kinase inhibitor,RET,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,RET
3150,danusertib,Aurora kinase inhibitor,AURKA,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKA
3151,danusertib,Aurora kinase inhibitor,AURKC,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKC
3152,danusertib,Aurora kinase inhibitor,AURKB,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKB
3153,ENMD-2076,Aurora kinase inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,FLT3
3154,ENMD-2076,Aurora kinase inhibitor,KDR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,KDR
3155,ENMD-2076,Aurora kinase inhibitor,PDGFRA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,PDGFRA
3156,ENMD-2076,Aurora kinase inhibitor,SRC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,SRC
3157,ENMD-2076,Aurora kinase inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,BLQYVHBZHAISJM-CMDGGOBGSA-N,,AURKA
3158,fisetin,Aurora kinase inhibitor,CDK6,Oc1ccc2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O,XHEFDIBZLJXQHF-UHFFFAOYSA-N,,CDK6
3159,GSK-1070916,Aurora kinase inhibitor,AURKC,CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1,QTBWCSQGBMPECM-UHFFFAOYSA-N,,AURKC
3160,GSK-1070916,Aurora kinase inhibitor,AURKB,CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1,QTBWCSQGBMPECM-UHFFFAOYSA-N,,AURKB
3161,JWE-035,Aurora kinase inhibitor,AURKA,CCN1CCN(Cc2ccc(Nc3ncc4N(C)C(=O)c5ccccc5N(C)c4n3)cc2C(F)(F)F)CC1,PXGLIUGVLBRUBV-UHFFFAOYSA-N,,AURKA
3162,KW-2449,Aurora kinase inhibitor,FGFR1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FGFR1
3163,KW-2449,Aurora kinase inhibitor,FLT3,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,FLT3
3164,KW-2449,Aurora kinase inhibitor,ABL1,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,ABL1
3165,KW-2449,Aurora kinase inhibitor,AURKA,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,YYLKKYCXAOBSRM-JXMROGBWSA-N,,AURKA
3166,methylnorlichexanthone,Aurora kinase inhibitor,PIM1,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,PIM1
3167,methylnorlichexanthone,Aurora kinase inhibitor,AURKB,COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1,RFENQGQGMLPVJM-UHFFFAOYSA-N,,AURKB
3168,MK-5108,Aurora kinase inhibitor,AURKA,OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F,LCVIRAZGMYMNNT-VVONHTQRSA-N,,AURKA
3169,MK-5108,Aurora kinase inhibitor,AURKB,OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F,LCVIRAZGMYMNNT-VVONHTQRSA-N,,AURKB
3170,MLN-8054,Aurora kinase inhibitor,AURKA,OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1,HHFBDROWDBDFBR-UHFFFAOYSA-N,,AURKA
3171,reversine,Aurora kinase inhibitor,AURKB,C1CCC(CC1)Nc2nc(Nc3ccc(cc3)N4CCOCC4)nc5[nH]cnc25,ZFLJHSQHILSNCM-UHFFFAOYSA-N,,AURKB
3172,SNS-314,Aurora kinase inhibitor,AURKA,Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,,AURKA
3173,SNS-314,Aurora kinase inhibitor,AURKC,Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,,AURKC
3174,SNS-314,Aurora kinase inhibitor,AURKB,Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,,AURKB
3175,tozasertib,Aurora kinase inhibitor,FLT3,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
3176,tozasertib,Aurora kinase inhibitor,ABL1,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
3177,tozasertib,Aurora kinase inhibitor,JAK2,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
3178,tozasertib,Aurora kinase inhibitor,BCR,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
3179,tozasertib,Aurora kinase inhibitor,AURKA,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
3180,tozasertib,Aurora kinase inhibitor,AURKC,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
3181,tozasertib,Aurora kinase inhibitor,AURKB,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
3182,tozasertib,Aurora kinase inhibitor,FLT3,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,FLT3
3183,tozasertib,Aurora kinase inhibitor,ABL1,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,ABL1
3184,tozasertib,Aurora kinase inhibitor,JAK2,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,JAK2
3185,tozasertib,Aurora kinase inhibitor,BCR,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,BCR
3186,tozasertib,Aurora kinase inhibitor,AURKA,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKA
3187,tozasertib,Aurora kinase inhibitor,AURKC,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKC
3188,tozasertib,Aurora kinase inhibitor,AURKB,CN1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,AURKB
3189,ZM-447439,Aurora kinase inhibitor,AURKA,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,OGNYUTNQZVRGMN-UHFFFAOYSA-N,,AURKA
3190,ZM-447439,Aurora kinase inhibitor,AURKB,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,OGNYUTNQZVRGMN-UHFFFAOYSA-N,,AURKB
3191,AMG-487,CCK receptor antagonist,CXCR3,CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1,WQTKNBPCJKRYPA-OAQYLSRUSA-N,,CXCR3
3192,benzotript,CCK receptor antagonist,CCKAR,OC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1,QJERBBQXOMUURJ-UHFFFAOYSA-N,,CCKAR
3193,benzotript,CCK receptor antagonist,CCKBR,OC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1,QJERBBQXOMUURJ-UHFFFAOYSA-N,,CCKBR
3194,devazepide,CCK receptor antagonist,CCKAR,CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c4ccccc4)c5ccccc15,NFHRQQKPEBFUJK-HSZRJFAPSA-N,,CCKAR
3195,dexloxiglumide,CCK receptor antagonist,CCKAR,CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1,QNQZBKQEIFTHFZ-GOSISDBHSA-N,,CCKAR
3196,lorglumide,CCK receptor antagonist,CCKAR,CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1,IEKOTSCYBBDIJC-UHFFFAOYSA-N,,CCKAR
3197,lorglumide,CCK receptor antagonist,CCKBR,CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1,IEKOTSCYBBDIJC-UHFFFAOYSA-N,,CCKBR
3198,LY-225910,CCK receptor antagonist,CCKBR,CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O,KUECXUACQOYKNB-UHFFFAOYSA-N,,CCKBR
3199,LY-288513,CCK receptor antagonist,CCKBR,Brc1ccc(NC(=O)N2NC(=O)[C@H]([C@@H]2c2ccccc2)c2ccccc2)cc1,LMUQHXHWJWQXSD-PMACEKPBSA-N,,CCKBR
3200,maraviroc,CCK receptor antagonist,CCR5,CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,GSNHKUDZZFZSJB-ILVMPNSOSA-N,,CCR5
3201,MK-0812,CCK receptor antagonist,CCR2,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F,MTMDXAIUENDNDL-RJSMDTJLSA-N,,CCR2
3202,navarixin,CCK receptor antagonist,CXCR1,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1,RXIUEIPPLAFSDF-CYBMUJFWSA-N,,CXCR1
3203,navarixin,CCK receptor antagonist,CXCR2,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1,RXIUEIPPLAFSDF-CYBMUJFWSA-N,,CXCR2
3204,plerixafor,CCK receptor antagonist,CXCR4,C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1,YIQPUIGJQJDJOS-UHFFFAOYSA-N,,CXCR4
3205,proglumide,CCK receptor antagonist,CCKAR,CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1,DGMKFQYCZXERLX-UHFFFAOYSA-N,,CCKAR
3206,proglumide,CCK receptor antagonist,CCKBR,CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1,DGMKFQYCZXERLX-UHFFFAOYSA-N,,CCKBR
3207,reparixin,CCK receptor antagonist,CXCR1,CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O,KQDRVXQXKZXMHP-LLVKDONJSA-N,,CXCR1
3208,reparixin,CCK receptor antagonist,CXCR2,CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O,KQDRVXQXKZXMHP-LLVKDONJSA-N,,CXCR2
3209,RS-504393,CCK receptor antagonist,CCR2,Cc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1,ODNICNWASXKNNQ-UHFFFAOYSA-N,,CCR2
3210,SB-225002,CCK receptor antagonist,CXCR2,Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O,MQBZVUNNWUIPMK-UHFFFAOYSA-N,,CXCR2
3211,SR-27897,CCK receptor antagonist,CCKAR,OC(=O)Cn1c(cc2ccccc12)C(=O)Nc1nc(cs1)-c1ccccc1Cl,ILNRQFBVVQUOLP-UHFFFAOYSA-N,,CCKAR
3212,vicriviroc,CCK receptor antagonist,CCR5,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F,CNPVJJQCETWNEU-CYFREDJKSA-N,,CCR5
3213,vicriviroc,CCK receptor antagonist,CCR5,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F,CNPVJJQCETWNEU-CYFREDJKSA-N,,CCR5
3214,NBI-27914,CRF receptor antagonist,CRHR1,CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl,KNADXBVKFAUMCR-UHFFFAOYSA-N,,CRHR1
3215,cinnarizine,Calcium channel blocker,HRH1,C(/C=C/c1ccccc1)N2CCN(CC2)C(c3ccccc3)c4ccccc4,DERZBLKQOCDDDZ-JLHYYAGUSA-N,,HRH1
3216,amlodipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1C
3217,amlodipine,Calcium channel blocker,CACNA1D,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1D
3218,amlodipine,Calcium channel blocker,CACNA1S,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1S
3219,amlodipine,Calcium channel blocker,CACNA2D1,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA2D1
3220,amlodipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1C
3221,amlodipine,Calcium channel blocker,CACNA1D,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1D
3222,amlodipine,Calcium channel blocker,CACNA1S,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA1S
3223,amlodipine,Calcium channel blocker,CACNA2D1,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,,CACNA2D1
3224,benidipine,Calcium channel blocker,CACNA1C,COC(=O)C1[C@H](C(=C(C)N=C1C)C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-],VATGWEZOSFWWCV-SKWHODKYSA-N,,CACNA1C
3225,benidipine,Calcium channel blocker,CACNA1G,COC(=O)C1[C@H](C(=C(C)N=C1C)C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-],VATGWEZOSFWWCV-SKWHODKYSA-N,,CACNA1G
3226,BRD-K56658166,Calcium channel blocker,CACNA1B,Brc1ccccc1OCC(=O)NCCc2nc3ccccc3[nH]2,XWFRNTHGPRGCNS-UHFFFAOYSA-N,,CACNA1B
3227,buflomedil,Calcium channel blocker,ADRA1A,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,OWYLAEYXIQKAOL-UHFFFAOYSA-N,,ADRA1A
3228,calmidazolium,Calcium channel blocker,ATP2B1,Clc1ccc(cc1)C(c2ccc(Cl)cc2)[n+]3ccn(CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,ATP2B1
3229,calmidazolium,Calcium channel blocker,PDE1A,Clc1ccc(cc1)C(c2ccc(Cl)cc2)[n+]3ccn(CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,PDE1A
3230,calmidazolium,Calcium channel blocker,ATP2B1,Clc1ccc(cc1)C(c2ccc(Cl)cc2)n3cc[n+](CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,ATP2B1
3231,calmidazolium,Calcium channel blocker,PDE1A,Clc1ccc(cc1)C(c2ccc(Cl)cc2)n3cc[n+](CC(OCc4ccc(Cl)cc4Cl)c5ccc(Cl)cc5Cl)c3,CTKNMSVWMRRCPW-UHFFFAOYSA-N,,PDE1A
3232,cilnidipine,Calcium channel blocker,CACNA1B,COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCC=Cc3ccccc3)C,KJEBULYHNRNJTE-UHFFFAOYSA-N,,CACNA1B
3233,cilnidipine,Calcium channel blocker,CACNA1B,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCC=Cc1ccccc1,KJEBULYHNRNJTE-DHZHZOJOSA-N,,CACNA1B
3234,cinnarizine,Calcium channel blocker,HRH1,C(C=Cc1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1,DERZBLKQOCDDDZ-UHFFFAOYSA-N,,HRH1
3235,cleviprex,Calcium channel blocker,CACNA1C,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,,CACNA1C
3236,cleviprex,Calcium channel blocker,CACNA1D,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,,CACNA1D
3237,cleviprex,Calcium channel blocker,CACNA1F,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,,CACNA1F
3238,cleviprex,Calcium channel blocker,CACNA1S,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,,CACNA1S
3239,dantrolene,Calcium channel blocker,RYR1,[O-][N+](=O)c1ccc(cc1)-c1ccc(C=NN2CC(=O)NC2=O)o1,OZOMQRBLCMDCEG-VIZOYTHASA-N,,RYR1
3240,dantrolene,Calcium channel blocker,RYR1,[O-][N+](=O)c1ccc(cc1)c2ccc(C=NN3CC(=O)NC3=O)o2,OZOMQRBLCMDCEG-UHFFFAOYSA-N,,RYR1
3241,diltiazem,Calcium channel blocker,CACNA1C,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,HSUGRBWQSSZJOP-RTWAWAEBSA-N,,CACNA1C
3242,diltiazem,Calcium channel blocker,CACNA1C,COc1ccc(cc1)[C@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@H]2OC(=O)C,HSUGRBWQSSZJOP-LEWJYISDSA-N,,CACNA1C
3243,diltiazem,Calcium channel blocker,CACNA1C,COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O,HSUGRBWQSSZJOP-UHFFFAOYSA-N,,CACNA1C
3244,felodipine,Calcium channel blocker,NR3C2,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,,NR3C2
3245,felodipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,,CACNA1C
3246,felodipine,Calcium channel blocker,CACNA1D,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,,CACNA1D
3247,felodipine,Calcium channel blocker,CACNA1S,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,,CACNA1S
3248,flunarizine,Calcium channel blocker,CACNA1H,Fc1ccc(cc1)C(N1CCN(CC=Cc2ccccc2)CC1)c1ccc(F)cc1,SMANXXCATUTDDT-QPJJXVBHSA-N,,CACNA1H
3249,flunarizine,Calcium channel blocker,CACNA1G,Fc1ccc(cc1)C(N1CCN(CC=Cc2ccccc2)CC1)c1ccc(F)cc1,SMANXXCATUTDDT-QPJJXVBHSA-N,,CACNA1G
3250,flunarizine,Calcium channel blocker,CACNA1H,Fc1ccc(cc1)C(N2CCN(CC=Cc3ccccc3)CC2)c4ccc(F)cc4,SMANXXCATUTDDT-UHFFFAOYSA-N,,CACNA1H
3251,flunarizine,Calcium channel blocker,CACNA1G,Fc1ccc(cc1)C(N2CCN(CC=Cc3ccccc3)CC2)c4ccc(F)cc4,SMANXXCATUTDDT-UHFFFAOYSA-N,,CACNA1G
3252,gabapentin,Calcium channel blocker,CACNA1B,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,,CACNA1B
3253,gabapentin,Calcium channel blocker,CACNA2D1,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,,CACNA2D1
3254,gabapentin,Calcium channel blocker,CACNA2D2,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,,CACNA2D2
3255,isradipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,,CACNA1C
3256,isradipine,Calcium channel blocker,CACNA1D,COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,,CACNA1D
3257,isradipine,Calcium channel blocker,CACNA1F,COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,,CACNA1F
3258,isradipine,Calcium channel blocker,CACNA1S,COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,,CACNA1S
3259,isradipine,Calcium channel blocker,CACNA2D1,COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,,CACNA2D1
3260,isradipine,Calcium channel blocker,CACNA1C,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23,QVGAECMHUSHDCG-UHFFFAOYSA-N,,CACNA1C
3261,isradipine,Calcium channel blocker,CACNA1D,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23,QVGAECMHUSHDCG-UHFFFAOYSA-N,,CACNA1D
3262,isradipine,Calcium channel blocker,CACNA1F,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23,QVGAECMHUSHDCG-UHFFFAOYSA-N,,CACNA1F
3263,isradipine,Calcium channel blocker,CACNA1S,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23,QVGAECMHUSHDCG-UHFFFAOYSA-N,,CACNA1S
3264,isradipine,Calcium channel blocker,CACNA2D1,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23,QVGAECMHUSHDCG-UHFFFAOYSA-N,,CACNA2D1
3265,lacidipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C=CC(=O)OC(C)(C)C)C(=O)OCC,GKQPCPXONLDCMU-CCEZHUSRSA-N,,CACNA1C
3266,lacidipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C=CC(=O)OC(C)(C)C)C(=O)OCC,GKQPCPXONLDCMU-UHFFFAOYSA-N,,CACNA1C
3267,lacidipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C,BGYJFSXPRMOZJK-CCEZHUSRSA-N,,CACNA1C
3268,levetiracetam,Calcium channel blocker,CACNA1B,CC[C@H](N1CCCC1=O)C(N)=O,HPHUVLMMVZITSG-LURJTMIESA-N,,CACNA1B
3269,levetiracetam,Calcium channel blocker,SV2A,CC[C@H](N1CCCC1=O)C(N)=O,HPHUVLMMVZITSG-LURJTMIESA-N,,SV2A
3270,manidipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1,ANEBWFXPVPTEET-UHFFFAOYSA-N,,CACNA1C
3271,MRS-1845,Calcium channel blocker,ORAI1,COC(=O)C1=C(C)N(CC#C)C(=C(C1c2cccc(c2)n3oo3)C(=O)CCO)C,VNIMHBLANIQWNY-UHFFFAOYSA-N,,ORAI1
3272,nicardipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)N=C(C)C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1,UXVSDVSUISWXKD-UHFFFAOYSA-N,,CACNA1C
3273,nicardipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,,CACNA1C
3274,nifedipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,,CACNA1C
3275,nifedipine,Calcium channel blocker,CACNA1D,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,,CACNA1D
3276,nifedipine,Calcium channel blocker,CACNA1F,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,,CACNA1F
3277,nifedipine,Calcium channel blocker,CACNA1S,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,,CACNA1S
3278,nifedipine,Calcium channel blocker,CACNA2D1,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,,CACNA2D1
3279,nifedipine,Calcium channel blocker,CACNA1C,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-],OSUCQKNXQBPLDG-UHFFFAOYSA-N,,CACNA1C
3280,nifedipine,Calcium channel blocker,CACNA1D,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-],OSUCQKNXQBPLDG-UHFFFAOYSA-N,,CACNA1D
3281,nifedipine,Calcium channel blocker,CACNA1F,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-],OSUCQKNXQBPLDG-UHFFFAOYSA-N,,CACNA1F
3282,nifedipine,Calcium channel blocker,CACNA1S,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-],OSUCQKNXQBPLDG-UHFFFAOYSA-N,,CACNA1S
3283,nifedipine,Calcium channel blocker,CACNA2D1,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-],OSUCQKNXQBPLDG-UHFFFAOYSA-N,,CACNA2D1
3284,niguldipine,Calcium channel blocker,ADRA1A,CCCN1C(C)=C(C(c2cccc(c2)[N+]([O-])=O)C(C(=O)ON2CCC(CC2)(c2ccccc2)c2ccccc2)=C1C)C(=O)OC,SLTFTBXXKKDMPA-UHFFFAOYSA-N,,ADRA1A
3285,niguldipine,Calcium channel blocker,CACNA1C,CCCN1C(C)=C(C(c2cccc(c2)[N+]([O-])=O)C(C(=O)ON2CCC(CC2)(c2ccccc2)c2ccccc2)=C1C)C(=O)OC,SLTFTBXXKKDMPA-UHFFFAOYSA-N,,CACNA1C
3286,niguldipine,Calcium channel blocker,ADRA1A,COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C,SVJMLYUFVDMUHP-UHFFFAOYSA-N,,ADRA1A
3287,niguldipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C,SVJMLYUFVDMUHP-UHFFFAOYSA-N,,CACNA1C
3288,nilvadipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,,CACNA1C
3289,nilvadipine,Calcium channel blocker,CACNA1D,COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,,CACNA1D
3290,nimodipine,Calcium channel blocker,NR3C2,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,,NR3C2
3291,nimodipine,Calcium channel blocker,CACNA1C,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,,CACNA1C
3292,nimodipine,Calcium channel blocker,CACNA1D,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,,CACNA1D
3293,nimodipine,Calcium channel blocker,CACNA1F,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,,CACNA1F
3294,nimodipine,Calcium channel blocker,CACNA1S,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,,CACNA1S
3295,nimodipine,Calcium channel blocker,NR3C2,COCCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-],BAARDDGSQHXDDB-UHFFFAOYSA-N,,NR3C2
3296,nimodipine,Calcium channel blocker,CACNA1C,COCCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-],BAARDDGSQHXDDB-UHFFFAOYSA-N,,CACNA1C
3297,nimodipine,Calcium channel blocker,CACNA1D,COCCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-],BAARDDGSQHXDDB-UHFFFAOYSA-N,,CACNA1D
3298,nimodipine,Calcium channel blocker,CACNA1F,COCCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-],BAARDDGSQHXDDB-UHFFFAOYSA-N,,CACNA1F
3299,nimodipine,Calcium channel blocker,CACNA1S,COCCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-],BAARDDGSQHXDDB-UHFFFAOYSA-N,,CACNA1S
3300,nisoldipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,,CACNA1C
3301,nisoldipine,Calcium channel blocker,CACNA1D,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,,CACNA1D
3302,nisoldipine,Calcium channel blocker,CACNA1S,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,,CACNA1S
3303,nisoldipine,Calcium channel blocker,CACNA1C,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-],CMRUBVBRILWITQ-UHFFFAOYSA-N,,CACNA1C
3304,nisoldipine,Calcium channel blocker,CACNA1D,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-],CMRUBVBRILWITQ-UHFFFAOYSA-N,,CACNA1D
3305,nisoldipine,Calcium channel blocker,CACNA1S,COC(=O)C1C(C(=C(C)N=C1C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-],CMRUBVBRILWITQ-UHFFFAOYSA-N,,CACNA1S
3306,nitrendipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,,CACNA1C
3307,nitrendipine,Calcium channel blocker,CACNA1D,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,,CACNA1D
3308,nitrendipine,Calcium channel blocker,CACNA2D1,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,,CACNA2D1
3309,nitrendipine,Calcium channel blocker,CACNA1C,CCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-],NDYAXPIAEFCPMJ-UHFFFAOYSA-N,,CACNA1C
3310,nitrendipine,Calcium channel blocker,CACNA1D,CCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-],NDYAXPIAEFCPMJ-UHFFFAOYSA-N,,CACNA1D
3311,nitrendipine,Calcium channel blocker,CACNA2D1,CCOC(=O)C1C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-],NDYAXPIAEFCPMJ-UHFFFAOYSA-N,,CACNA2D1
3312,pranidipine,Calcium channel blocker,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCC=Cc1ccccc1,XTFPDGZNWTZCMF-DHZHZOJOSA-N,,CACNA1C
3313,ryanodine,Calcium channel blocker,RYR1,CC(C)[C@]1(O)[C@@H](OC(=O)c2ccc[nH]2)[C@]3(O)[C@]4(O)[C@]1(C)[C@]5(O)C[C@@]3(C)[C@@]6(O)CC[C@H](C)[C@@H](O)[C@]46O5,JJSYXNQGLHBRRK-RGPFZKLOSA-N,,RYR1
3314,SKF-96365,Calcium channel blocker,CYP3A4,COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1,HLMBXBGDBBCYII-UHFFFAOYSA-N,,CYP3A4
3315,SKF-96365,Calcium channel blocker,TRPC1,COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1,HLMBXBGDBBCYII-UHFFFAOYSA-N,,TRPC1
3316,verapamil,Calcium channel blocker,CACNA1C,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,SGTNSNPWRIOYBX-UHFFFAOYSA-N,,CACNA1C
3317,verapamil,Calcium channel blocker,CACNA1D,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,SGTNSNPWRIOYBX-UHFFFAOYSA-N,,CACNA1D
3318,verapamil,Calcium channel blocker,CACNA1S,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,SGTNSNPWRIOYBX-UHFFFAOYSA-N,,CACNA1S
3319,verapamil,Calcium channel blocker,CACNA1G,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,SGTNSNPWRIOYBX-UHFFFAOYSA-N,,CACNA1G
3320,VU-0413807-2,Calcium channel blocker,CACNA1I,CC(C)(C)CCN1C[C@H]2C(CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1,GSJIGYLGKSBYBC-ALOPSCKCSA-N,,CACNA1I
3321,VU-0413807-2,Calcium channel blocker,CACNA1H,CC(C)(C)CCN1C[C@H]2C(CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1,GSJIGYLGKSBYBC-ALOPSCKCSA-N,,CACNA1H
3322,VU-0413807-2,Calcium channel blocker,CACNA1G,CC(C)(C)CCN1C[C@H]2C(CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1,GSJIGYLGKSBYBC-ALOPSCKCSA-N,,CACNA1G
3323,cinnarizine,Calcium channel blocker,HRH1,C(/C=C/c1ccccc1)N2CCN(CC2)C(c3ccccc3)c4ccccc4,DERZBLKQOCDDDZ-JLHYYAGUSA-N,,HRH1
3324,CX-4945,Casein kinase inhibitor,CSNK2A1,OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21,MUOKSQABCJCOPU-UHFFFAOYSA-N,,CSNK2A1
3325,CX-4945,Casein kinase inhibitor,CSNK2A2,OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21,MUOKSQABCJCOPU-UHFFFAOYSA-N,,CSNK2A2
3326,EI-231,Casein kinase inhibitor,CSNK2A1,OC[C@H]1O[C@H](C(O)[C@H]1O)n2cnc3cc(Cl)c(Cl)cc23,XHSQDZXAVJRBMX-AYLPWXGPSA-N,,CSNK2A1
3327,LY-303511,Casein kinase inhibitor,BRD4,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD4
3328,LY-303511,Casein kinase inhibitor,BRD2,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD2
3329,LY-303511,Casein kinase inhibitor,BRD3,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,,BRD3
3330,artemisinin,DNA synthesis inhibitor,CYP2B6,C[C@@H]1CC[C@@H]2[C@@H](C)C(=O)O[C@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,BLUAFEHZUWYNDE-VCTNXPOSSA-N,,CYP2B6
3331,artemisinin,DNA synthesis inhibitor,CYP2B6,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,BLUAFEHZUWYNDE-NNWCWBAJSA-N,,CYP2B6
3332,capecitabine,DNA synthesis inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@@H]1O,GAGWJHPBXLXJQN-GMTLJSCSSA-N,,TYMS
3333,capecitabine,DNA synthesis inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,,TYMS
3334,capecitabine,DNA synthesis inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)C1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-LXGADPQPSA-N,,TYMS
3335,cisplatin,DNA synthesis inhibitor,XIAP,Cl[Pt]Cl,CLSUSRZJUQMOHH-UHFFFAOYSA-L,,XIAP
3336,estramustine-phosphate,DNA synthesis inhibitor,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR1
3337,estramustine-phosphate,DNA synthesis inhibitor,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR2
3338,estramustine-phosphate,DNA synthesis inhibitor,MAP1A,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP1A
3339,estramustine-phosphate,DNA synthesis inhibitor,MAP2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP2
3340,fludarabine,DNA synthesis inhibitor,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,,RRM1
3341,fludarabine,DNA synthesis inhibitor,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)C(O)C1O,HBUBKKRHXORPQB-VKJDSPIKSA-N,,RRM1
3342,fludarabine,DNA synthesis inhibitor,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O,HBUBKKRHXORPQB-UUOKFMHZSA-N,,RRM1
3343,fludarabine-phosphate,DNA synthesis inhibitor,POLA1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,POLA1
3344,fludarabine-phosphate,DNA synthesis inhibitor,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,RRM1
3345,methoxsalen,DNA synthesis inhibitor,CYP1A1,COc1c2occc2cc2ccc(=O)oc12,QXKHYNVANLEOEG-UHFFFAOYSA-N,,CYP1A1
3346,methoxsalen,DNA synthesis inhibitor,CYP1A2,COc1c2occc2cc2ccc(=O)oc12,QXKHYNVANLEOEG-UHFFFAOYSA-N,,CYP1A2
3347,methoxsalen,DNA synthesis inhibitor,CYP2A6,COc1c2occc2cc2ccc(=O)oc12,QXKHYNVANLEOEG-UHFFFAOYSA-N,,CYP2A6
3348,methoxsalen,DNA synthesis inhibitor,CYP2A13,COc1c2occc2cc2ccc(=O)oc12,QXKHYNVANLEOEG-UHFFFAOYSA-N,,CYP2A13
3349,methoxsalen,DNA synthesis inhibitor,CYP3A4,COc1c2occc2cc2ccc(=O)oc12,QXKHYNVANLEOEG-UHFFFAOYSA-N,,CYP3A4
3350,suramin,DNA synthesis inhibitor,FSHR,Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,,FSHR
3351,suramin,DNA synthesis inhibitor,P2RY2,Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,,P2RY2
3352,suramin,DNA synthesis inhibitor,RYR1,Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,,RYR1
3353,azathioprine,Dehydrogenase inhibitor,PPAT,Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O,LMEKQMALGUDUQG-UHFFFAOYSA-N,,PPAT
3354,mycophenolate-mofetil,Dehydrogenase inhibitor,IMPDH1,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH1
3355,mycophenolate-mofetil,Dehydrogenase inhibitor,IMPDH2,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH2
3356,racecadotril,Enkephalinase inhibitor,MME,CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1,ODUOJXZPIYUATO-UHFFFAOYSA-N,,MME
3357,LY-2183240,FAAH reuptake inhibitor,FAAH,CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1,GZNIYOXWFCDBBJ-UHFFFAOYSA-N,,FAAH
3358,etomidate,GABA receptor modulator,GABRA1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA1
3359,etomidate,GABA receptor modulator,GABRA2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA2
3360,etomidate,GABA receptor modulator,GABRA3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA3
3361,etomidate,GABA receptor modulator,GABRA4,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA4
3362,etomidate,GABA receptor modulator,GABRA5,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA5
3363,etomidate,GABA receptor modulator,GABRA6,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA6
3364,etomidate,GABA receptor modulator,GABRB1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB1
3365,etomidate,GABA receptor modulator,GABRB2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB2
3366,etomidate,GABA receptor modulator,GABRB3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB3
3367,etomidate,GABA receptor modulator,GABRD,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRD
3368,etomidate,GABA receptor modulator,GABRE,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRE
3369,etomidate,GABA receptor modulator,GABRG1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG1
3370,etomidate,GABA receptor modulator,GABRG2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG2
3371,etomidate,GABA receptor modulator,GABRG3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG3
3372,etomidate,GABA receptor modulator,GABRP,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRP
3373,etomidate,GABA receptor modulator,GABRQ,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRQ
3374,androstenol,GABA receptor modulator,NR1I3,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC=C2,KRVXMNNRSSQZJP-PHFHYRSDSA-N,,NR1I3
3375,CGP-13501,GABA receptor modulator,GABBR1,CC(C)(Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)C=O,XGWATTXMMMANFJ-UHFFFAOYSA-N,,GABBR1
3376,CGP-7930,GABA receptor modulator,GABBR1,CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,XLWJPQQFJNGUPA-UHFFFAOYSA-N,,GABBR1
3377,chlormezanone,GABA receptor modulator,GABRA1,CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O,WEQAYVWKMWHEJO-UHFFFAOYSA-N,,GABRA1
3378,clomethiazole,GABA receptor modulator,GABRA1,Cc1ncsc1CCCl,PCLITLDOTJTVDJ-UHFFFAOYSA-N,,GABRA1
3379,etomidate,GABA receptor modulator,GABRA1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA1
3380,etomidate,GABA receptor modulator,GABRA2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA2
3381,etomidate,GABA receptor modulator,GABRA3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA3
3382,etomidate,GABA receptor modulator,GABRA4,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA4
3383,etomidate,GABA receptor modulator,GABRA5,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA5
3384,etomidate,GABA receptor modulator,GABRA6,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA6
3385,etomidate,GABA receptor modulator,GABRB1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB1
3386,etomidate,GABA receptor modulator,GABRB2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB2
3387,etomidate,GABA receptor modulator,GABRB3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB3
3388,etomidate,GABA receptor modulator,GABRD,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRD
3389,etomidate,GABA receptor modulator,GABRE,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRE
3390,etomidate,GABA receptor modulator,GABRG1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG1
3391,etomidate,GABA receptor modulator,GABRG2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG2
3392,etomidate,GABA receptor modulator,GABRG3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG3
3393,etomidate,GABA receptor modulator,GABRP,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRP
3394,etomidate,GABA receptor modulator,GABRQ,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRQ
3395,GS-39783,GABA receptor modulator,GABBR1,CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O,GSGVDKOCBKBMGG-UHFFFAOYSA-N,,GABBR1
3396,metharbital,GABA receptor modulator,GABRA1,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA1
3397,metharbital,GABA receptor modulator,GABRA2,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA2
3398,metharbital,GABA receptor modulator,GABRA3,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA3
3399,metharbital,GABA receptor modulator,GABRA4,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA4
3400,metharbital,GABA receptor modulator,GABRA5,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA5
3401,metharbital,GABA receptor modulator,GABRA6,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRA6
3402,metharbital,GABA receptor modulator,GABRB1,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRB1
3403,metharbital,GABA receptor modulator,GABRB2,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRB2
3404,metharbital,GABA receptor modulator,GABRB3,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRB3
3405,metharbital,GABA receptor modulator,GABRD,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRD
3406,metharbital,GABA receptor modulator,GABRE,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRE
3407,metharbital,GABA receptor modulator,GABRG1,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRG1
3408,metharbital,GABA receptor modulator,GABRG2,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRG2
3409,metharbital,GABA receptor modulator,GABRG3,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRG3
3410,metharbital,GABA receptor modulator,GABRP,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRP
3411,metharbital,GABA receptor modulator,GABRQ,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,,GABRQ
3412,pentobarbital,GABA receptor modulator,GABRA1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA1
3413,pentobarbital,GABA receptor modulator,GABRA2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA2
3414,pentobarbital,GABA receptor modulator,GABRA3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA3
3415,pentobarbital,GABA receptor modulator,GABRA4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA4
3416,pentobarbital,GABA receptor modulator,GABRA5,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA5
3417,pentobarbital,GABA receptor modulator,GABRA6,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA6
3418,pentobarbital,GABA receptor modulator,GABRB1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB1
3419,pentobarbital,GABA receptor modulator,GABRB2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB2
3420,pentobarbital,GABA receptor modulator,GABRB3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB3
3421,pentobarbital,GABA receptor modulator,GABRD,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRD
3422,pentobarbital,GABA receptor modulator,GABRE,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRE
3423,pentobarbital,GABA receptor modulator,GABRG1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG1
3424,pentobarbital,GABA receptor modulator,GABRG2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG2
3425,pentobarbital,GABA receptor modulator,GABRG3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG3
3426,pentobarbital,GABA receptor modulator,GABRP,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRP
3427,pentobarbital,GABA receptor modulator,GABRQ,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRQ
3428,SB-205384,GABA receptor modulator,GABRA3,CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N,JDTZAGLGBRRCJT-UHFFFAOYSA-N,,GABRA3
3429,SB-205384,GABA receptor modulator,GABRA5,CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N,JDTZAGLGBRRCJT-UHFFFAOYSA-N,,GABRA5
3430,SB-205384,GABA receptor modulator,GABRA6,CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N,JDTZAGLGBRRCJT-UHFFFAOYSA-N,,GABRA6
3431,tracazolate,GABA receptor modulator,GABRA1,CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12,PCTRYMLLRKWXGF-UHFFFAOYSA-N,,GABRA1
3432,betulinic-acid,HIV integrase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
3433,betulinic-acid,HIV integrase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
3434,caffeic-acid,HIV integrase inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
3435,caffeic-acid,HIV integrase inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
3436,dolutegravir,HIV integrase inhibitor,CYP3A7,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,,CYP3A7
3437,dolutegravir,HIV integrase inhibitor,CYP3A4,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,,CYP3A4
3438,dolutegravir,HIV integrase inhibitor,CYP3A5,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,,CYP3A5
3439,dolutegravir,HIV integrase inhibitor,POU2F2,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,,POU2F2
3440,dolutegravir,HIV integrase inhibitor,UGT1A1,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,,UGT1A1
3441,ellagic-acid,HIV integrase inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
3442,ellagic-acid,HIV integrase inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
3443,ellagic-acid,HIV integrase inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
3444,ellagic-acid,HIV integrase inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
3445,ellagic-acid,HIV integrase inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
3446,ellagic-acid,HIV integrase inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
3447,ellagic-acid,HIV integrase inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
3448,ellagic-acid,HIV integrase inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
3449,ethotoin,Hydantoin antiepileptic,SCN5A,CCN1C(=O)NC(C1=O)c1ccccc1,SZQIFWWUIBRPBZ-UHFFFAOYSA-N,,SCN5A
3450,mephenytoin,Hydantoin antiepileptic,SCN5A,CCC1(NC(=O)N(C)C1=O)c1ccccc1,GMHKMTDVRCWUDX-UHFFFAOYSA-N,,SCN5A
3451,phenytoin,Hydantoin antiepileptic,SCN1A,O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1,CXOFVDLJLONNDW-UHFFFAOYSA-N,,SCN1A
3452,phenytoin,Hydantoin antiepileptic,SCN2A,O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1,CXOFVDLJLONNDW-UHFFFAOYSA-N,,SCN2A
3453,phenytoin,Hydantoin antiepileptic,SCN5A,O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1,CXOFVDLJLONNDW-UHFFFAOYSA-N,,SCN5A
3454,GSK-1904529A,Insulin receptor ligand,IGF1R,CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,MOSKATHMXWSZTQ-UHFFFAOYSA-N,,IGF1R
3455,GSK-1904529A,Insulin receptor ligand,INSR,CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,MOSKATHMXWSZTQ-UHFFFAOYSA-N,,INSR
3456,apocynin,NADPH oxidase inhibitor,NOX4,COc1cc(ccc1O)C(C)=O,DFYRUELUNQRZTB-UHFFFAOYSA-N,,NOX4
3457,BRD-K28452084,Opioid receptor agonist,OPRK1,O=C(NC1CCCCC1)C2(CCCCC2)N(Cc3cccs3)C(=O)c4ccccn4,FIFDVZFCMSONTO-UHFFFAOYSA-N,,OPRK1
3458,butorphanol-(+)-tartrate,Opioid receptor agonist,OPRD1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRD1
3459,butorphanol-(+)-tartrate,Opioid receptor agonist,OPRK1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRK1
3460,butorphanol-(+)-tartrate,Opioid receptor agonist,OPRM1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRM1
3461,BW-180C,Opioid receptor agonist,OPRD1,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O,ZHUJMSMQIPIPTF-IMNFJDCFSA-N,,OPRD1
3462,BW-373U86,Opioid receptor agonist,OPRD1,CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(O)c1,LBLDMHBSVIVJPM-YZIHRLCOSA-N,,OPRD1
3463,cebranopadol,Opioid receptor agonist,OPRL1,CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1,CSMVOZKEWSOFER-RQNOJGIXSA-N,,OPRL1
3464,cebranopadol,Opioid receptor agonist,OPRM1,CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1,CSMVOZKEWSOFER-RQNOJGIXSA-N,,OPRM1
3465,dalargin,Opioid receptor agonist,OPRM1,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O,GDPHPXYFLPDZGH-VSZNVKCOSA-N,,OPRM1
3466,diphenoxylate,Opioid receptor agonist,OPRM1,CCOC(=O)C1(CCN(CCC(C#N)(c2ccccc2)c3ccccc3)CC1)c4ccccc4,HYPPXZBJBPSRLK-UHFFFAOYSA-N,,OPRM1
3467,FK-33-824,Opioid receptor agonist,OPRM1,C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)CCS(C)=O,HYZHONGSQNXMPH-WFZMTUIASA-N,,OPRM1
3468,GR-89696,Opioid receptor agonist,OPRK1,COC(=O)N1CCN(C(CN2CCCC2)C1)C(=O)Cc3ccc(Cl)c(Cl)c3,HJUAKZYKCANOOZ-UHFFFAOYSA-N,,OPRK1
3469,ICI-199441,Opioid receptor agonist,OPRK1,CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccc(Cl)c(Cl)c1,AEJOEPSMZCEYJN-HXUWFJFHSA-N,,OPRK1
3470,ICI-204448,Opioid receptor agonist,OPRK1,CN(C(CN1CCCC1)c2cccc(OCC(=O)O)c2)C(=O)Cc3ccc(Cl)c(Cl)c3,JKYJSFISYHSNOE-UHFFFAOYSA-N,,OPRK1
3471,leu-enkephalin,Opioid receptor agonist,OPRD1,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc2ccc(O)cc2)C(=O)O,URLZCHNOLZSCCA-UHFFFAOYSA-N,,OPRD1
3472,leu-enkephalin,Opioid receptor agonist,OPRM1,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc2ccc(O)cc2)C(=O)O,URLZCHNOLZSCCA-UHFFFAOYSA-N,,OPRM1
3473,loperamide,Opioid receptor agonist,OPRD1,CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,RDOIQAHITMMDAJ-UHFFFAOYSA-N,,OPRD1
3474,loperamide,Opioid receptor agonist,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,RDOIQAHITMMDAJ-UHFFFAOYSA-N,,OPRM1
3475,matrine,Opioid receptor agonist,OPRK1,O=C1CCC[C@@H]2[C@@H]3CCCN4CCC[C@H](CN12)[C@@H]34,ZSBXGIUJOOQZMP-COMQUAJESA-N,,OPRK1
3476,metamizole,Opioid receptor agonist,PTGS1,CN(CS(O)(=O)=O)c1c(C)n(C)n(-c2ccccc2)c1=O,LVWZTYCIRDMTEY-UHFFFAOYSA-N,,PTGS1
3477,nalbuphine,Opioid receptor agonist,OPRD1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRD1
3478,nalbuphine,Opioid receptor agonist,OPRK1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRK1
3479,nalbuphine,Opioid receptor agonist,OPRM1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRM1
3480,nalbuphine,Opioid receptor agonist,OPRD1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRD1
3481,nalbuphine,Opioid receptor agonist,OPRK1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRK1
3482,nalbuphine,Opioid receptor agonist,OPRM1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRM1
3483,nalbuphine,Opioid receptor agonist,OPRD1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRD1
3484,nalbuphine,Opioid receptor agonist,OPRK1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRK1
3485,nalbuphine,Opioid receptor agonist,OPRM1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRM1
3486,NNC-63-0532,Opioid receptor agonist,OPRL1,COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O,AQMPIDSGLFVVPL-UHFFFAOYSA-N,,OPRL1
3487,NNC-63-0532,Opioid receptor agonist,OPRL1,COC(=O)CN1CN(c2ccccc2)C3(CCN(Cc4ccc5ccccc5c4)CC3)C1=O,DSEIKQVUTKGLGT-UHFFFAOYSA-N,,OPRL1
3488,salvinorin-a,Opioid receptor agonist,OPRK1,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1,OBSYBRPAKCASQB-AGQYDFLVSA-N,,OPRK1
3489,spiradoline,Opioid receptor agonist,OPRK1,CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1,NYKCGQQJNVPOLU-ONTIZHBOSA-N,,OPRK1
3490,tapentadol,Opioid receptor agonist,OPRM1,CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1,KWTWDQCKEHXFFR-FZMZJTMJSA-N,,OPRM1
3491,tapentadol,Opioid receptor agonist,SLC6A2,CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1,KWTWDQCKEHXFFR-FZMZJTMJSA-N,,SLC6A2
3492,tramadol,Opioid receptor agonist,OPRM1,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,OPRM1
3493,tramadol,Opioid receptor agonist,SLC6A2,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A2
3494,tramadol,Opioid receptor agonist,SLC6A4,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A4
3495,tramadol,Opioid receptor agonist,OPRM1,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,OPRM1
3496,tramadol,Opioid receptor agonist,SLC6A2,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A2
3497,tramadol,Opioid receptor agonist,SLC6A4,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A4
3498,trimebutine,Opioid receptor agonist,OPRD1,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1,LORDFXWUHHSAQU-UHFFFAOYSA-N,,OPRD1
3499,trimebutine,Opioid receptor agonist,OPRK1,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1,LORDFXWUHHSAQU-UHFFFAOYSA-N,,OPRK1
3500,trimebutine,Opioid receptor agonist,OPRM1,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1,LORDFXWUHHSAQU-UHFFFAOYSA-N,,OPRM1
3501,U-54494A,Opioid receptor agonist,OPRK1,CN([C@@H]1CCCC[C@@H]1N1CCCC1)C(=O)c1ccc(Cl)c(Cl)c1,JUBNVWGVNWIXMB-SJORKVTESA-N,,OPRK1
3502,caffeic-acid,PPAR receptor modulator,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
3503,caffeic-acid,PPAR receptor modulator,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
3504,prednicarbate,Phospholipase activator,NR3C1,CCOC(=O)O[C@@]1(CC[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC,FNPXMHRZILFCKX-FFCWRAGVSA-N,,NR3C1
3505,prednicarbate,Phospholipase activator,NR3C1,CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C)C(=O)COC(=O)CC,FNPXMHRZILFCKX-YKGOFRARSA-N,,NR3C1
3506,CAY-10594,Phospholipase inhibitor,PLD2,O=C(NCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc2ccccc2c1,FAIFAFUXFFWVNQ-UHFFFAOYSA-N,,PLD2
3507,darapladib,Phospholipase inhibitor,PLA2G7,CCN(CC)CCN(Cc1ccc(cc1)-c1ccc(cc1)C(F)(F)F)C(=O)Cn1c2CCCc2c(=O)nc1SCc1ccc(F)cc1,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,,PLA2G7
3508,loteprednol,Phospholipase inhibitor,NR3C1,CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl,DMKSVUSAATWOCU-HROMYWEYSA-N,,NR3C1
3509,OBAA,Phospholipase inhibitor,PLA2G1B,CCCCCCCCCCCCCCCCCCc1ccc(cc1)C(=O)/C=C/C(=O)O,ZBESASFHIWDSCJ-WCWDXBQESA-N,,PLA2G1B
3510,OBAA,Phospholipase inhibitor,PLA2G1B,CCCCCCCCCCCCCCCCCCc1ccc(cc1)C(=O)C=CC(=O)O,ZBESASFHIWDSCJ-UHFFFAOYSA-N,,PLA2G1B
3511,tagatose,Phosphorylase inhibitor,PYGL,OCC(O)C(O)C(O)C(=O)CO,BJHIKXHVCXFQLS-UHFFFAOYSA-N,,PYGL
3512,fluorouracil,RNA synthesis inhibitor,DPYD,Fc1c[nH]c(=O)[nH]c1=O,GHASVSINZRGABV-UHFFFAOYSA-N,,DPYD
3513,fluorouracil,RNA synthesis inhibitor,TYMS,Fc1c[nH]c(=O)[nH]c1=O,GHASVSINZRGABV-UHFFFAOYSA-N,,TYMS
3514,daunorubicin,RNA synthesis inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-INJOJONLSA-N,,TOP2A
3515,daunorubicin,RNA synthesis inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](C[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(O)=O,KNAGGICVJBKDDK-XUZKBGJLSA-N,,TOP2A
3516,daunorubicin,RNA synthesis inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-VGBVRHCVSA-N,,TOP2A
3517,daunorubicin,RNA synthesis inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-JYZNYWJRSA-N,,TOP2A
3518,daunorubicin,RNA synthesis inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)C,STQGQHZAVUOBTE-UHFFFAOYSA-N,,TOP2A
3519,rifaximin,RNA synthesis inhibitor,NR1I2,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)C(O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,NZCRJKRKKOLAOJ-HQDKJBBOSA-N,,NR1I2
3520,rifaximin,RNA synthesis inhibitor,NR1I2,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,NZCRJKRKKOLAOJ-LGPAXTBISA-N,,NR1I2
3521,amonafide,Topoisomerase inhibitor,TOP2A,CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23,UPALIKSFLSVKIS-UHFFFAOYSA-N,,TOP2A
3522,amsacrine,Topoisomerase inhibitor,TOP2A,COc1cc(NS(=O)(=O)C)ccc1Cc2c3ccccc3nc4ccccc24,JRNUZHHDXNSOMO-UHFFFAOYSA-N,,TOP2A
3523,amsacrine,Topoisomerase inhibitor,TOP2A,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,XCPGHVQEEXUHNC-UHFFFAOYSA-N,,TOP2A
3524,betulinic-acid,Topoisomerase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
3525,betulinic-acid,Topoisomerase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
3526,BRD-K52640952,Topoisomerase inhibitor,PLA2G1B,COc1cc(O)c2C(=O)C[C@@H](Oc2c1)c3ccccc3,ORJDDOBAOGKRJV-CQSZACIVSA-N,,PLA2G1B
3527,BRD-K85853281,Topoisomerase inhibitor,TOP2A,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@@H]1C[C@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O,XDXDZDZNSLXDNA-LGVQOGFTSA-N,,TOP2A
3528,camptothecin,Topoisomerase inhibitor,TOP1,CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O,VSJKWCGYPAHWDS-FQEVSTJZSA-N,,TOP1
3529,camptothecin,Topoisomerase inhibitor,TOP1,CCC1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O,VSJKWCGYPAHWDS-UHFFFAOYSA-N,,TOP1
3530,daunorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-INJOJONLSA-N,,TOP2A
3531,daunorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](C[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(O)=O,KNAGGICVJBKDDK-XUZKBGJLSA-N,,TOP2A
3532,daunorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-VGBVRHCVSA-N,,TOP2A
3533,daunorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O,STQGQHZAVUOBTE-JYZNYWJRSA-N,,TOP2A
3534,daunorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)C,STQGQHZAVUOBTE-UHFFFAOYSA-N,,TOP2A
3535,diminazene-aceturate,Topoisomerase inhibitor,AOC1,NC(=N)c1ccc(NN=Nc2ccc(cc2)C(N)=N)cc1,XNYZHCFCZNMTFY-UHFFFAOYSA-N,,AOC1
3536,doxorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-HEKDSCCBSA-N,,TOP2A
3537,doxorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-TZSSRYMLSA-N,,TOP2A
3538,doxorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-BLSUDJMZSA-N,,TOP2A
3539,doxorubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-UHFFFAOYSA-N,,TOP2A
3540,ellipticine,Topoisomerase inhibitor,TOP2A,Cc1c2[nH]c3ccccc3c2c(C)c4cnccc14,CTSPAMFJBXKSOY-UHFFFAOYSA-N,,TOP2A
3541,ellipticine,Topoisomerase inhibitor,TOP2B,Cc1c2[nH]c3ccccc3c2c(C)c4cnccc14,CTSPAMFJBXKSOY-UHFFFAOYSA-N,,TOP2B
3542,epirubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-SQGPBGNMSA-N,,TOP2A
3543,epirubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO,AOJJSUZBOXZQNB-SNFLSGHGSA-N,,TOP2A
3544,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-MRVIYFEKSA-N,,TOP2A
3545,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-MRVIYFEKSA-N,,TOP2B
3546,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(OC2O[C@@H]3COC(C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-GEGAHKOSSA-N,,TOP2A
3547,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(OC2O[C@@H]3COC(C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-GEGAHKOSSA-N,,TOP2B
3548,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]1[C@H]2[C@@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-GGDFOFTDSA-N,,TOP2A
3549,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)[C@H]1[C@H]2[C@@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,VJJPUSNTGOMMGY-GGDFOFTDSA-N,,TOP2B
3550,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26,VJJPUSNTGOMMGY-SEMSPOPGSA-N,,TOP2A
3551,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26,VJJPUSNTGOMMGY-SEMSPOPGSA-N,,TOP2B
3552,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(OCC3=O)C(OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26,SYKHAYBRYKMZLP-LTGYLHEKSA-N,,TOP2A
3553,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(OCC3=O)C(OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26,SYKHAYBRYKMZLP-LTGYLHEKSA-N,,TOP2B
3554,etoposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)C1C2C(COC2=O)C(OC2OC3COC(C)OC3C(O)C2O)C2C1=CC1=C2OCO1,DOXHGVQIEQIIIV-UHFFFAOYSA-N,,TOP2A
3555,etoposide,Topoisomerase inhibitor,TOP2B,COc1cc(cc(OC)c1O)C1C2C(COC2=O)C(OC2OC3COC(C)OC3C(O)C2O)C2C1=CC1=C2OCO1,DOXHGVQIEQIIIV-UHFFFAOYSA-N,,TOP2B
3556,idarubicin,Topoisomerase inhibitor,TOP2A,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O,XDXDZDZNSLXDNA-TZNDIEGXSA-N,,TOP2A
3557,idarubicin,Topoisomerase inhibitor,TOP2A,CC1OC(CC(N)C1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O,XDXDZDZNSLXDNA-YMYDAGKFSA-N,,TOP2A
3558,irinotecan,Topoisomerase inhibitor,TOP1,CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12,UWKQSNNFCGGAFS-XIFFEERXSA-N,,TOP1
3559,merbarone,Topoisomerase inhibitor,TOP2A,O=C(Nc1ccccc1)C1C(=O)NC(=S)NC1=O,JARCFMKMOFFIGZ-UHFFFAOYSA-N,,TOP2A
3560,mitoxantrone,Topoisomerase inhibitor,TOP2A,OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12,KKZJGLLVHKMTCM-UHFFFAOYSA-N,,TOP2A
3561,pirarubicin,Topoisomerase inhibitor,TOP2A,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,KMSKQZKKOZQFFG-YXRRJAAWSA-N,,TOP2A
3562,SN-38,Topoisomerase inhibitor,TOP1,CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12,FJHBVJOVLFPMQE-QFIPXVFZSA-N,,TOP1
3563,SN-38,Topoisomerase inhibitor,TOP1,CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc5ccc(O)cc15,FJHBVJOVLFPMQE-UHFFFAOYSA-N,,TOP1
3564,TAS-103,Topoisomerase inhibitor,TOP1,CN(C)CCNc1nc2cc(O)ccc2c2-c3ccccc3C(=O)c12,ROWSTIYZUWEOMM-UHFFFAOYSA-N,,TOP1
3565,teniposide,Topoisomerase inhibitor,TOP2A,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12,NRUKOCRGYNPUPR-OQMCATNJSA-N,,TOP2A
3566,topotecan,Topoisomerase inhibitor,TOP1,CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O,UCFGDBYHRUNTLO-QHCPKHFHSA-N,,TOP1
3567,topotecan,Topoisomerase inhibitor,TOP1,CCC1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O,UCFGDBYHRUNTLO-UHFFFAOYSA-N,,TOP1
3568,valrubicin,Topoisomerase inhibitor,TOP2A,CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,,TOP2A
3569,voreloxin,Topoisomerase inhibitor,TOP2A,CN[C@H]1CN(C[C@@H]1OC)c1ccc2c(n1)n(cc(C(O)=O)c2=O)-c1nccs1,XZAFZXJXZHRNAQ-STQMWFEESA-N,,TOP2A
3570,gambogic-acid,Topoisomerase inhibitor,BCL2,CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(CC=C(C)C(O)=O)OC6(C)C,GEZHEQNLKAOMCA-RRZNCOCZSA-N,,BCL2
3571,aclarubicin,Topoisomerase inhibitor,TOP1,,,,TOP1
3572,aclarubicin,Topoisomerase inhibitor,TOP2A,,,,TOP2A
3573,BRD-K67582595,Anti-amyloidogenic agent,DRD1,CCCN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,BTGAJCKRXPNBFI-HNNXBMFYSA-N,,DRD1
3574,BRD-K67582595,Anti-amyloidogenic agent,DRD2,CCCN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,BTGAJCKRXPNBFI-HNNXBMFYSA-N,,DRD2
3575,JLK-6,Anti-amyloidogenic agent,PSEN1,COc1oc(=O)c2cc(N)ccc2c1Cl,AMDGKLWVCUXONP-UHFFFAOYSA-N,,PSEN1
3576,compound-w,Beta secretase inhibitor,BACE1,OC(=O)c1cc(Oc2ccc(cc2)[N+]([O-])=O)cc(Oc2ccc(cc2)[N+]([O-])=O)c1,JOSXKPZXMVHRKU-UHFFFAOYSA-N,,BACE1
3577,ellagic-acid,Beta-secretase inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
3578,ellagic-acid,Beta-secretase inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
3579,ellagic-acid,Beta-secretase inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
3580,ellagic-acid,Beta-secretase inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
3581,ellagic-acid,Beta-secretase inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
3582,ellagic-acid,Beta-secretase inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
3583,ellagic-acid,Beta-secretase inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
3584,ellagic-acid,Beta-secretase inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
3585,ivacaftor,CFTR channel potentiator,CFTR,CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C,PURKAOJPTOLRMP-UHFFFAOYSA-N,,CFTR
3586,omecamtiv-mecarbil,Cardiac myosin activator,MYBPC3,COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,RFUBTTPMWSKEIW-UHFFFAOYSA-N,,MYBPC3
3587,alfaxalone,Chloride channel agonist,GABBR1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-OLVMNOGESA-N,,GABBR1
3588,alfaxalone,Chloride channel agonist,GABBR1,CC(=O)[C@H]1CC[C@H]2[C@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-KEGGPASISA-N,,GABBR1
3589,ambenonium,Cholinesterase inhibitor,ACHE,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,OMHBPUNFVFNHJK-UHFFFAOYSA-P,,ACHE
3590,mestinon,Cholinesterase inhibitor,ACHE,CN(C)C(=O)Oc1ccc[n+](C)c1,RVOLLAQWKVFTGE-UHFFFAOYSA-N,,ACHE
3591,physostigmine,Cholinesterase inhibitor,ACHE,CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1,PIJVFDBKTWXHHD-HIFRSBDPSA-N,,ACHE
3592,physostigmine,Cholinesterase inhibitor,ACHE,CNC(=O)Oc1ccc2N(C)C3N(C)CC[C@@]3(C)c2c1,PIJVFDBKTWXHHD-WUJWULDRSA-N,,ACHE
3593,indometacin,Cyclooxygenase inhibitor,PTGDR2,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1,CGIGDMFJXJATDK-UHFFFAOYSA-N,,PTGDR2
3594,indometacin,Cyclooxygenase inhibitor,PPARG,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1,CGIGDMFJXJATDK-UHFFFAOYSA-N,,PPARG
3595,indometacin,Cyclooxygenase inhibitor,PTGS1,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1,CGIGDMFJXJATDK-UHFFFAOYSA-N,,PTGS1
3596,indometacin,Cyclooxygenase inhibitor,PTGS2,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1,CGIGDMFJXJATDK-UHFFFAOYSA-N,,PTGS2
3597,aminosalicylic-acid,Cyclooxygenase inhibitor,PTGS1,Nc1ccc(C(O)=O)c(O)c1,WUBBRNOQWQTFEX-UHFFFAOYSA-N,,PTGS1
3598,aminosalicylic-acid,Cyclooxygenase inhibitor,PTGS2,Nc1ccc(C(O)=O)c(O)c1,WUBBRNOQWQTFEX-UHFFFAOYSA-N,,PTGS2
3599,acemetacin,Cyclooxygenase inhibitor,PTGS1,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1,FSQKKOOTNAMONP-UHFFFAOYSA-N,,PTGS1
3600,acemetacin,Cyclooxygenase inhibitor,PTGS2,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1,FSQKKOOTNAMONP-UHFFFAOYSA-N,,PTGS2
3601,AM-404,Cyclooxygenase inhibitor,TRPV1,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-DOFZRALJSA-N,,TRPV1
3602,AM-404,Cyclooxygenase inhibitor,TRPV1,CCCCCC=CCC=CCC=CCC=CCCCC(=O)Nc1ccc(O)cc1,IJBZOOZRAXHERC-UHFFFAOYSA-N,,TRPV1
3603,ampiroxicam,Cyclooxygenase inhibitor,PTGS1,CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1,LSNWBKACGXCGAJ-UHFFFAOYSA-N,,PTGS1
3604,ampiroxicam,Cyclooxygenase inhibitor,PTGS2,CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1,LSNWBKACGXCGAJ-UHFFFAOYSA-N,,PTGS2
3605,amtolmetin-guacil,Cyclooxygenase inhibitor,PTGS1,COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C,CWJNMKKMGIAGDK-UHFFFAOYSA-N,,PTGS1
3606,amtolmetin-guacil,Cyclooxygenase inhibitor,PTGS2,COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C,CWJNMKKMGIAGDK-UHFFFAOYSA-N,,PTGS2
3607,asaraldehyde,Cyclooxygenase inhibitor,PTGS2,COc1cc(OC)c(C=O)cc1OC,IAJBQAYHSQIQRE-UHFFFAOYSA-N,,PTGS2
3608,aspirin,Cyclooxygenase inhibitor,PTGS1,CC(=O)Oc1ccccc1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,,PTGS1
3609,aspirin,Cyclooxygenase inhibitor,PTGS2,CC(=O)Oc1ccccc1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,,PTGS2
3610,aspirin,Cyclooxygenase inhibitor,TP53,CC(=O)Oc1ccccc1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,,TP53
3611,azapropazone,Cyclooxygenase inhibitor,PTGS2,CCCC1C(=O)N2N(C1=O)c1cc(C)ccc1N=C2N(C)C,MPHPHYZQRGLTBO-UHFFFAOYSA-N,,PTGS2
3612,balsalazide,Cyclooxygenase inhibitor,PTGS1,OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O,IPOKCKJONYRRHP-UHFFFAOYSA-N,,PTGS1
3613,balsalazide,Cyclooxygenase inhibitor,PTGS2,OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O,IPOKCKJONYRRHP-UHFFFAOYSA-N,,PTGS2
3614,bromfenac,Cyclooxygenase inhibitor,PTGS1,Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,,PTGS1
3615,bromfenac,Cyclooxygenase inhibitor,PTGS2,Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,,PTGS2
3616,carprofen,Cyclooxygenase inhibitor,PTGS1,CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21,PUXBGTOOZJQSKH-UHFFFAOYSA-N,,PTGS1
3617,carprofen,Cyclooxygenase inhibitor,PTGS2,CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21,PUXBGTOOZJQSKH-UHFFFAOYSA-N,,PTGS2
3618,celecoxib,Cyclooxygenase inhibitor,PTGS2,Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F,RZEKVGVHFLEQIL-UHFFFAOYSA-N,,PTGS2
3619,curcumin,Cyclooxygenase inhibitor,PTGS1,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS1
3620,curcumin,Cyclooxygenase inhibitor,PTGS2,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS2
3621,curcumin,Cyclooxygenase inhibitor,PTGS1,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS1
3622,curcumin,Cyclooxygenase inhibitor,PTGS2,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS2
3623,curcumin,Cyclooxygenase inhibitor,PTGS1,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS1
3624,curcumin,Cyclooxygenase inhibitor,PTGS2,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS2
3625,deracoxib,Cyclooxygenase inhibitor,PTGS2,COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F,WAZQAZKAZLXFMK-UHFFFAOYSA-N,,PTGS2
3626,dexketoprofen,Cyclooxygenase inhibitor,PTGS1,C[C@H](C(=O)O)c1cccc(c1)C(=O)c2ccccc2,DKYWVDODHFEZIM-NSHDSACASA-N,,PTGS1
3627,dexketoprofen,Cyclooxygenase inhibitor,PTGS2,C[C@H](C(=O)O)c1cccc(c1)C(=O)c2ccccc2,DKYWVDODHFEZIM-NSHDSACASA-N,,PTGS2
3628,diclofenac,Cyclooxygenase inhibitor,PTGS1,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,,PTGS1
3629,diclofenac,Cyclooxygenase inhibitor,PTGS2,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,,PTGS2
3630,DUP-697,Cyclooxygenase inhibitor,PTGS2,CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1,AJFTZWGGHJXZOB-UHFFFAOYSA-N,,PTGS2
3631,eicosatetraynoic-acid,Cyclooxygenase inhibitor,ALOX12,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,ALOX12
3632,eicosatetraynoic-acid,Cyclooxygenase inhibitor,PPARA,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PPARA
3633,eicosatetraynoic-acid,Cyclooxygenase inhibitor,PPARG,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PPARG
3634,eicosatetraynoic-acid,Cyclooxygenase inhibitor,PTGS1,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,MGLDCXPLYOWQRP-UHFFFAOYSA-N,,PTGS1
3635,epirizole,Cyclooxygenase inhibitor,PTGS1,COc1cc(C)nn1-c1nc(C)cc(OC)n1,RHAXSHUQNIEUEY-UHFFFAOYSA-N,,PTGS1
3636,epirizole,Cyclooxygenase inhibitor,PTGS2,COc1cc(C)nn1-c1nc(C)cc(OC)n1,RHAXSHUQNIEUEY-UHFFFAOYSA-N,,PTGS2
3637,etodolac,Cyclooxygenase inhibitor,PTGS2,CCC1C=CC=C2C1=NC1=C2CCOC1(CC)CC(O)=O,YKHKOAOQAYXTKT-UHFFFAOYSA-N,,PTGS2
3638,etodolac,Cyclooxygenase inhibitor,PTGS2,CCc1cccc2c3CCO[C@](CC)(CC(O)=O)c3[nH]c12,NNYBQONXHNTVIJ-QGZVFWFLSA-N,,PTGS2
3639,etodolac,Cyclooxygenase inhibitor,PTGS2,CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12,NNYBQONXHNTVIJ-UHFFFAOYSA-N,,PTGS2
3640,etofenamate,Cyclooxygenase inhibitor,PTGS1,OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,XILVEPYQJIOVNB-UHFFFAOYSA-N,,PTGS1
3641,etofenamate,Cyclooxygenase inhibitor,PTGS2,OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,XILVEPYQJIOVNB-UHFFFAOYSA-N,,PTGS2
3642,etoricoxib,Cyclooxygenase inhibitor,PTGS2,Cc1ccc(cn1)-c1ncc(Cl)cc1-c1ccc(cc1)S(C)(=O)=O,MNJVRJDLRVPLFE-UHFFFAOYSA-N,,PTGS2
3643,fenbufen,Cyclooxygenase inhibitor,PTGS1,OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1,ZPAKPRAICRBAOD-UHFFFAOYSA-N,,PTGS1
3644,fenbufen,Cyclooxygenase inhibitor,PTGS2,OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1,ZPAKPRAICRBAOD-UHFFFAOYSA-N,,PTGS2
3645,fentiazac,Cyclooxygenase inhibitor,PTGS1,OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1,JIEKMACRVQTPRC-UHFFFAOYSA-N,,PTGS1
3646,fentiazac,Cyclooxygenase inhibitor,PTGS2,OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1,JIEKMACRVQTPRC-UHFFFAOYSA-N,,PTGS2
3647,hyperforin,Cyclooxygenase inhibitor,ALOX5,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,ALOX5
3648,hyperforin,Cyclooxygenase inhibitor,PTGS1,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,PTGS1
3649,hyperforin,Cyclooxygenase inhibitor,NR1I2,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,NR1I2
3650,ibuprofen,Cyclooxygenase inhibitor,PTGS1,CC(C)Cc1ccc(cc1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,,PTGS1
3651,ibuprofen,Cyclooxygenase inhibitor,PTGS2,CC(C)Cc1ccc(cc1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,,PTGS2
3652,ibuprofen-piconol,Cyclooxygenase inhibitor,PTGS1,CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1,ACEWLPOYLGNNHV-UHFFFAOYSA-N,,PTGS1
3653,ibuprofen-piconol,Cyclooxygenase inhibitor,PTGS2,CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1,ACEWLPOYLGNNHV-UHFFFAOYSA-N,,PTGS2
3654,iguratimod,Cyclooxygenase inhibitor,PTGS2,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,ANMATWQYLIFGOK-UHFFFAOYSA-N,,PTGS2
3655,indobufen,Cyclooxygenase inhibitor,PTGS1,CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N,,PTGS1
3656,indobufen,Cyclooxygenase inhibitor,PTGS2,CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N,,PTGS2
3657,indoprofen,Cyclooxygenase inhibitor,PTGS1,CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,,PTGS1
3658,indoprofen,Cyclooxygenase inhibitor,PTGS2,CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,,PTGS2
3659,isoniazid,Cyclooxygenase inhibitor,CYP1A2,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP1A2
3660,isoniazid,Cyclooxygenase inhibitor,CYP2C19,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2C19
3661,isoniazid,Cyclooxygenase inhibitor,CYP2C8,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2C8
3662,isoniazid,Cyclooxygenase inhibitor,CYP2E1,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2E1
3663,isoniazid,Cyclooxygenase inhibitor,CYP3A4,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP3A4
3664,isoxicam,Cyclooxygenase inhibitor,PTGS1,CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O,SPTMROWPYQRZSX-UHFFFAOYSA-N,,PTGS1
3665,isoxicam,Cyclooxygenase inhibitor,PTGS2,CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O,SPTMROWPYQRZSX-UHFFFAOYSA-N,,PTGS2
3666,ketoprofen,Cyclooxygenase inhibitor,PTGS1,CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1,DKYWVDODHFEZIM-UHFFFAOYSA-N,,PTGS1
3667,ketoprofen,Cyclooxygenase inhibitor,PTGS2,CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1,DKYWVDODHFEZIM-UHFFFAOYSA-N,,PTGS2
3668,ketorolac,Cyclooxygenase inhibitor,PTGS1,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1,OZWKMVRBQXNZKK-UHFFFAOYSA-N,,PTGS1
3669,ketorolac,Cyclooxygenase inhibitor,PTGS2,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1,OZWKMVRBQXNZKK-UHFFFAOYSA-N,,PTGS2
3670,LM-1685,Cyclooxygenase inhibitor,PTGS2,COC(=O)c1cc2cc(ccc2n1Cc1ccc(Cl)cc1)S(C)(=O)=O,UBZBOEWMQPWUKB-UHFFFAOYSA-N,,PTGS2
3671,lornoxicam,Cyclooxygenase inhibitor,PTGS1,CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O,QOFQTBTZCJVITI-UHFFFAOYSA-N,,PTGS1
3672,lornoxicam,Cyclooxygenase inhibitor,PTGS2,CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O,QOFQTBTZCJVITI-UHFFFAOYSA-N,,PTGS2
3673,lumiracoxib,Cyclooxygenase inhibitor,PTGS2,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1,KHPKQFYUPIUARC-UHFFFAOYSA-N,,PTGS2
3674,meclofenamic-acid,Cyclooxygenase inhibitor,PTGS1,Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl,SBDNJUWAMKYJOX-UHFFFAOYSA-N,,PTGS1
3675,meclofenamic-acid,Cyclooxygenase inhibitor,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl,SBDNJUWAMKYJOX-UHFFFAOYSA-N,,PTGS2
3676,mefenamic-acid,Cyclooxygenase inhibitor,PTGS1,Cc1cccc(Nc2ccccc2C(O)=O)c1C,HYYBABOKPJLUIN-UHFFFAOYSA-N,,PTGS1
3677,mefenamic-acid,Cyclooxygenase inhibitor,PTGS2,Cc1cccc(Nc2ccccc2C(O)=O)c1C,HYYBABOKPJLUIN-UHFFFAOYSA-N,,PTGS2
3678,meloxicam,Cyclooxygenase inhibitor,PTGS1,CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O,ZAHQBPYQBHTECE-UHFFFAOYSA-N,,PTGS1
3679,meloxicam,Cyclooxygenase inhibitor,PTGS2,CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O,ZAHQBPYQBHTECE-UHFFFAOYSA-N,,PTGS2
3680,mesalazine,Cyclooxygenase inhibitor,ALOX5,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,ALOX5
3681,mesalazine,Cyclooxygenase inhibitor,PPARG,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PPARG
3682,mesalazine,Cyclooxygenase inhibitor,PTGS1,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS1
3683,mesalazine,Cyclooxygenase inhibitor,PTGS2,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS2
3684,metamizole,Cyclooxygenase inhibitor,PTGS1,CN(CS(O)(=O)=O)c1c(C)n(C)n(-c2ccccc2)c1=O,LVWZTYCIRDMTEY-UHFFFAOYSA-N,,PTGS1
3685,metoxibutropate,Cyclooxygenase inhibitor,PTGS1,COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1,FVRWRGBTEHAPDI-UHFFFAOYSA-N,,PTGS1
3686,metoxibutropate,Cyclooxygenase inhibitor,PTGS2,COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1,FVRWRGBTEHAPDI-UHFFFAOYSA-N,,PTGS2
3687,nabumetone,Cyclooxygenase inhibitor,PTGS2,COc1ccc2cc(CCC(C)=O)ccc2c1,BLXXJMDCKKHMKV-UHFFFAOYSA-N,,PTGS2
3688,naproxen,Cyclooxygenase inhibitor,PTGS1,COc1ccc2cc(ccc2c1)[C@@H](C)C(=O)O,CMWTZPSULFXXJA-SECBINFHSA-N,,PTGS1
3689,naproxen,Cyclooxygenase inhibitor,PTGS2,COc1ccc2cc(ccc2c1)[C@@H](C)C(=O)O,CMWTZPSULFXXJA-SECBINFHSA-N,,PTGS2
3690,naproxen,Cyclooxygenase inhibitor,PTGS1,COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O,CMWTZPSULFXXJA-VIFPVBQESA-N,,PTGS1
3691,naproxen,Cyclooxygenase inhibitor,PTGS2,COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O,CMWTZPSULFXXJA-VIFPVBQESA-N,,PTGS2
3692,naproxen,Cyclooxygenase inhibitor,PTGS1,COc1ccc2cc(ccc2c1)C(C)C(=O)O,CMWTZPSULFXXJA-UHFFFAOYSA-N,,PTGS1
3693,naproxen,Cyclooxygenase inhibitor,PTGS2,COc1ccc2cc(ccc2c1)C(C)C(=O)O,CMWTZPSULFXXJA-UHFFFAOYSA-N,,PTGS2
3694,nepafenac,Cyclooxygenase inhibitor,PTGS1,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,QEFAQIPZVLVERP-UHFFFAOYSA-N,,PTGS1
3695,nepafenac,Cyclooxygenase inhibitor,PTGS2,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,QEFAQIPZVLVERP-UHFFFAOYSA-N,,PTGS2
3696,niflumic-acid,Cyclooxygenase inhibitor,CLCNKA,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F,JZFPYUNJRRFVQU-UHFFFAOYSA-N,,CLCNKA
3697,niflumic-acid,Cyclooxygenase inhibitor,PTGS2,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F,JZFPYUNJRRFVQU-UHFFFAOYSA-N,,PTGS2
3698,nimesulide,Cyclooxygenase inhibitor,LTF,CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O,HYWYRSMBCFDLJT-UHFFFAOYSA-N,,LTF
3699,nimesulide,Cyclooxygenase inhibitor,PTGS2,CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O,HYWYRSMBCFDLJT-UHFFFAOYSA-N,,PTGS2
3700,oxaprozin,Cyclooxygenase inhibitor,PTGS1,OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1,OFPXSFXSNFPTHF-UHFFFAOYSA-N,,PTGS1
3701,oxaprozin,Cyclooxygenase inhibitor,PTGS2,OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1,OFPXSFXSNFPTHF-UHFFFAOYSA-N,,PTGS2
3702,paracetamol,Cyclooxygenase inhibitor,PTGS1,CC(=O)Nc1ccc(O)cc1,RZVAJINKPMORJF-UHFFFAOYSA-N,,PTGS1
3703,paracetamol,Cyclooxygenase inhibitor,PTGS2,CC(=O)Nc1ccc(O)cc1,RZVAJINKPMORJF-UHFFFAOYSA-N,,PTGS2
3704,parecoxib,Cyclooxygenase inhibitor,LTF,CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,,LTF
3705,parecoxib,Cyclooxygenase inhibitor,PTGS2,CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,,PTGS2
3706,phenacetin,Cyclooxygenase inhibitor,PTGS1,CCOc1ccc(NC(C)=O)cc1,CPJSUEIXXCENMM-UHFFFAOYSA-N,,PTGS1
3707,phenylbutazone,Cyclooxygenase inhibitor,PTGS1,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,,PTGS1
3708,phenylbutazone,Cyclooxygenase inhibitor,PTGS2,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,,PTGS2
3709,piroxicam,Cyclooxygenase inhibitor,PTGS1,CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O,MNSCVRXKDINXEY-UHFFFAOYSA-N,,PTGS1
3710,piroxicam,Cyclooxygenase inhibitor,PTGS2,CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O,MNSCVRXKDINXEY-UHFFFAOYSA-N,,PTGS2
3711,pterostilbene,Cyclooxygenase inhibitor,PTGS2,COc1cc(OC)cc(/C=C/c2ccc(O)cc2)c1,VLEUZFDZJKSGMX-ONEGZZNKSA-N,,PTGS2
3712,pterostilbene,Cyclooxygenase inhibitor,PTGS2,COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1,VLEUZFDZJKSGMX-UHFFFAOYSA-N,,PTGS2
3713,rofecoxib,Cyclooxygenase inhibitor,PTGS2,CS(=O)(=O)c1ccc(cc1)C1=C(C(=O)OC1)c1ccccc1,RZJQGNCSTQAWON-UHFFFAOYSA-N,,PTGS2
3714,rutaecarpine,Cyclooxygenase inhibitor,PTGS2,O=c1n2CCc3c([nH]c4ccccc34)-c2nc2ccccc12,ACVGWSKVRYFWRP-UHFFFAOYSA-N,,PTGS2
3715,SC-560,Cyclooxygenase inhibitor,PTGS1,COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F,PQUGCKBLVKJMNT-UHFFFAOYSA-N,,PTGS1
3716,sulindac,Cyclooxygenase inhibitor,AKR1B1,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc3ccc(cc3)S(=O)C,MLKXDPUZXIRXEP-UHFFFAOYSA-N,,AKR1B1
3717,sulindac,Cyclooxygenase inhibitor,PTGS1,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc3ccc(cc3)S(=O)C,MLKXDPUZXIRXEP-UHFFFAOYSA-N,,PTGS1
3718,sulindac,Cyclooxygenase inhibitor,PTGS2,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc3ccc(cc3)S(=O)C,MLKXDPUZXIRXEP-UHFFFAOYSA-N,,PTGS2
3719,sulindac,Cyclooxygenase inhibitor,AKR1B1,CC1=C(CC(O)=O)c2cc(F)ccc2C1=C/c1ccc(cc1)S(C)=O,MLKXDPUZXIRXEP-MFOYZWKCSA-N,,AKR1B1
3720,sulindac,Cyclooxygenase inhibitor,PTGS1,CC1=C(CC(O)=O)c2cc(F)ccc2C1=C/c1ccc(cc1)S(C)=O,MLKXDPUZXIRXEP-MFOYZWKCSA-N,,PTGS1
3721,sulindac,Cyclooxygenase inhibitor,PTGS2,CC1=C(CC(O)=O)c2cc(F)ccc2C1=C/c1ccc(cc1)S(C)=O,MLKXDPUZXIRXEP-MFOYZWKCSA-N,,PTGS2
3722,sulindac,Cyclooxygenase inhibitor,AKR1B1,CSc1ccc(C=C2C(C)=C(CC(O)=O)c3cc(F)ccc23)cc1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,AKR1B1
3723,sulindac,Cyclooxygenase inhibitor,PTGS1,CSc1ccc(C=C2C(C)=C(CC(O)=O)c3cc(F)ccc23)cc1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,PTGS1
3724,sulindac,Cyclooxygenase inhibitor,PTGS2,CSc1ccc(C=C2C(C)=C(CC(O)=O)c3cc(F)ccc23)cc1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,PTGS2
3725,suprofen,Cyclooxygenase inhibitor,PTGS1,CC(C(O)=O)c1ccc(cc1)C(=O)c1cccs1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,,PTGS1
3726,suprofen,Cyclooxygenase inhibitor,PTGS2,CC(C(O)=O)c1ccc(cc1)C(=O)c1cccs1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,,PTGS2
3727,talniflumate,Cyclooxygenase inhibitor,CLCA1,FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,,CLCA1
3728,tenoxicam,Cyclooxygenase inhibitor,PTGS1,CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O,OTGJPAOGHQFBMI-UHFFFAOYSA-N,,PTGS1
3729,tenoxicam,Cyclooxygenase inhibitor,PTGS2,CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O,OTGJPAOGHQFBMI-UHFFFAOYSA-N,,PTGS2
3730,tiaprofenic-acid,Cyclooxygenase inhibitor,PTGS1,CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,,PTGS1
3731,tiaprofenic-acid,Cyclooxygenase inhibitor,PTGS2,CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,,PTGS2
3732,tolmetin,Cyclooxygenase inhibitor,PTGS1,Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C,UPSPUYADGBWSHF-UHFFFAOYSA-N,,PTGS1
3733,tolmetin,Cyclooxygenase inhibitor,PTGS2,Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C,UPSPUYADGBWSHF-UHFFFAOYSA-N,,PTGS2
3734,triflusal,Cyclooxygenase inhibitor,PDE10A,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PDE10A
3735,triflusal,Cyclooxygenase inhibitor,NFKB1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NFKB1
3736,triflusal,Cyclooxygenase inhibitor,NOS2,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NOS2
3737,triflusal,Cyclooxygenase inhibitor,PTGS1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PTGS1
3738,umbelliferone,Cyclooxygenase inhibitor,CA9,Oc1ccc2ccc(=O)oc2c1,ORHBXUUXSCNDEV-UHFFFAOYSA-N,,CA9
3739,valdecoxib,Cyclooxygenase inhibitor,PTGS2,Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1,LNPDTQAFDNKSHK-UHFFFAOYSA-N,,PTGS2
3740,glafenine,DeltaF508-CFTR Corrector,CFTR,OCC(O)COC(=O)c1ccccc1Nc1ccnc2cc(Cl)ccc12,GWOFUCIGLDBNKM-UHFFFAOYSA-N,,CFTR
3741,butalbital,GABA receptor antagonist,GABRA1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA1
3742,butalbital,GABA receptor antagonist,GABRA2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA2
3743,butalbital,GABA receptor antagonist,GABRA3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA3
3744,butalbital,GABA receptor antagonist,GABRA4,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA4
3745,butalbital,GABA receptor antagonist,GABRA5,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA5
3746,butalbital,GABA receptor antagonist,GABRA6,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRA6
3747,butalbital,GABA receptor antagonist,GABRB1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRB1
3748,butalbital,GABA receptor antagonist,GABRB2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRB2
3749,butalbital,GABA receptor antagonist,GABRB3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRB3
3750,butalbital,GABA receptor antagonist,GABRD,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRD
3751,butalbital,GABA receptor antagonist,GABRE,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRE
3752,butalbital,GABA receptor antagonist,GABRG1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRG1
3753,butalbital,GABA receptor antagonist,GABRG2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRG2
3754,butalbital,GABA receptor antagonist,GABRG3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRG3
3755,butalbital,GABA receptor antagonist,GABRP,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRP
3756,butalbital,GABA receptor antagonist,GABRQ,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,,GABRQ
3757,CGP-52432,GABA receptor antagonist,GABBR1,CCOC(OCC)P(=O)(O)CCCNCc1ccc(Cl)c(Cl)c1,GJZVQXWEIYRHBE-UHFFFAOYSA-N,,GABBR1
3758,CGP-54626,GABA receptor antagonist,GABBR1,CC(NCC(O)CP(=O)(O)CC1CCCCC1)c2ccc(Cl)c(Cl)c2,JGGVBBYJRQOPPA-UHFFFAOYSA-N,,GABBR1
3759,CGP-54626,GABA receptor antagonist,GABBR2,CC(NCC(O)CP(=O)(O)CC1CCCCC1)c2ccc(Cl)c(Cl)c2,JGGVBBYJRQOPPA-UHFFFAOYSA-N,,GABBR2
3760,CGP-55845,GABA receptor antagonist,GABBR1,C[C@H](NC[C@H](O)CP(O)(=O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1,ZODSPDOOCZZEIM-BBRMVZONSA-N,,GABBR1
3761,CGP-55845,GABA receptor antagonist,GABBR2,C[C@H](NC[C@H](O)CP(O)(=O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1,ZODSPDOOCZZEIM-BBRMVZONSA-N,,GABBR2
3762,clomethiazole,GABA receptor antagonist,GABRA1,Cc1ncsc1CCCl,PCLITLDOTJTVDJ-UHFFFAOYSA-N,,GABRA1
3763,gabazine,GABA receptor antagonist,GABRA1,COc1ccc(cc1)-c1ccc(=N)n(CCCC(O)=O)n1,ACVGNKYJVGNLIL-UHFFFAOYSA-N,,GABRA1
3764,gabazine,GABA receptor antagonist,GABRA1,COc1ccc(cc1)c2ccc(N)[n+](CCCC(=O)O)n2,ACVGNKYJVGNLIL-UHFFFAOYSA-O,,GABRA1
3765,ginkgolide-b,GABA receptor antagonist,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
3766,ginkgolide-b,GABA receptor antagonist,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
3767,ginkgolide-b,GABA receptor antagonist,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
3768,ginkgolide-b,GABA receptor antagonist,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
3769,ginkgolide-b,GABA receptor antagonist,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
3770,ginkgolide-b,GABA receptor antagonist,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
3771,NCS-382,GABA receptor antagonist,GABBR1,OC1C(=CC(=O)O)CCCc2ccccc12,UADPGHINQMWEAG-UHFFFAOYSA-N,,GABBR1
3772,NCS-382,GABA receptor antagonist,SLC52A2,OC1C(=CC(=O)O)CCCc2ccccc12,UADPGHINQMWEAG-UHFFFAOYSA-N,,SLC52A2
3773,NCS-382,GABA receptor antagonist,GABBR2,OC1C(=CC(=O)O)CCCc2ccccc12,UADPGHINQMWEAG-UHFFFAOYSA-N,,GABBR2
3774,NCS-382,GABA receptor antagonist,GABBR1,OC1c2ccccc2CCCC1=C/C(O)=O,UADPGHINQMWEAG-CSKARUKUSA-N,,GABBR1
3775,NCS-382,GABA receptor antagonist,SLC52A2,OC1c2ccccc2CCCC1=C/C(O)=O,UADPGHINQMWEAG-CSKARUKUSA-N,,SLC52A2
3776,NCS-382,GABA receptor antagonist,GABBR2,OC1c2ccccc2CCCC1=C/C(O)=O,UADPGHINQMWEAG-CSKARUKUSA-N,,GABBR2
3777,picrotin,GABA receptor antagonist,GLRA2,CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C,RYEFFICCPKWYML-UHFFFAOYSA-N,,GLRA2
3778,picrotin,GABA receptor antagonist,GLRB,CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C,RYEFFICCPKWYML-UHFFFAOYSA-N,,GLRB
3779,picrotin,GABA receptor antagonist,GLRA3,CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C,RYEFFICCPKWYML-UHFFFAOYSA-N,,GLRA3
3780,picrotoxin,GABA receptor antagonist,GABRA1,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C.CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C,VJKUPQSHOVKBCO-AHMKVGDJSA-N,,GABRA1
3781,picrotoxin,GABA receptor antagonist,GABRR1,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C.CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C,VJKUPQSHOVKBCO-AHMKVGDJSA-N,,GABRR1
3782,picrotoxin,GABA receptor antagonist,GLRA2,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C.CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C,VJKUPQSHOVKBCO-AHMKVGDJSA-N,,GLRA2
3783,picrotoxin,GABA receptor antagonist,GLRA3,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C.CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C,VJKUPQSHOVKBCO-AHMKVGDJSA-N,,GLRA3
3784,picrotoxin,GABA receptor antagonist,GABRA1,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]1(O)CC3O[C@]33C(=O)O[C@@H]2[C@]13C,PIMZUZSSNYHVCU-IGZCVCFJSA-N,,GABRA1
3785,picrotoxin,GABA receptor antagonist,GABRR1,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]1(O)CC3O[C@]33C(=O)O[C@@H]2[C@]13C,PIMZUZSSNYHVCU-IGZCVCFJSA-N,,GABRR1
3786,picrotoxin,GABA receptor antagonist,GLRA2,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]1(O)CC3O[C@]33C(=O)O[C@@H]2[C@]13C,PIMZUZSSNYHVCU-IGZCVCFJSA-N,,GLRA2
3787,picrotoxin,GABA receptor antagonist,GLRA3,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]1(O)CC3O[C@]33C(=O)O[C@@H]2[C@]13C,PIMZUZSSNYHVCU-IGZCVCFJSA-N,,GLRA3
3788,picrotoxin,GABA receptor antagonist,GABRA1,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]3(O)CC4O[C@]45C(=O)O[C@H]2[C@@]53C,PIMZUZSSNYHVCU-IQPPENEWSA-N,,GABRA1
3789,picrotoxin,GABA receptor antagonist,GABRR1,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]3(O)CC4O[C@]45C(=O)O[C@H]2[C@@]53C,PIMZUZSSNYHVCU-IQPPENEWSA-N,,GABRR1
3790,picrotoxin,GABA receptor antagonist,GLRA2,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]3(O)CC4O[C@]45C(=O)O[C@H]2[C@@]53C,PIMZUZSSNYHVCU-IQPPENEWSA-N,,GLRA2
3791,picrotoxin,GABA receptor antagonist,GLRA3,CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]3(O)CC4O[C@]45C(=O)O[C@H]2[C@@]53C,PIMZUZSSNYHVCU-IQPPENEWSA-N,,GLRA3
3792,primidone,GABA receptor antagonist,GABRA1,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA1
3793,primidone,GABA receptor antagonist,GABRA2,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA2
3794,primidone,GABA receptor antagonist,GABRA3,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA3
3795,primidone,GABA receptor antagonist,GABRA4,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA4
3796,primidone,GABA receptor antagonist,GABRA5,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA5
3797,primidone,GABA receptor antagonist,GABRA6,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRA6
3798,primidone,GABA receptor antagonist,GABRB1,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRB1
3799,primidone,GABA receptor antagonist,GABRB2,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRB2
3800,primidone,GABA receptor antagonist,GABRB3,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRB3
3801,primidone,GABA receptor antagonist,GABRD,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRD
3802,primidone,GABA receptor antagonist,GABRE,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRE
3803,primidone,GABA receptor antagonist,GABRG1,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRG1
3804,primidone,GABA receptor antagonist,GABRG2,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRG2
3805,primidone,GABA receptor antagonist,GABRG3,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRG3
3806,primidone,GABA receptor antagonist,GABRP,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRP
3807,primidone,GABA receptor antagonist,GABRQ,CCC1(C(=O)NCNC1=O)c1ccccc1,DQMZLTXERSFNPB-UHFFFAOYSA-N,,GABRQ
3808,scoulerine,GABA receptor antagonist,ADRA1D,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA1D
3809,scoulerine,GABA receptor antagonist,ADRA2A,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA2A
3810,scoulerine,GABA receptor antagonist,GABRA1,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,GABRA1
3811,securinine,GABA receptor antagonist,GABRA1,O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31,SWZMSZQQJRKFBP-WZRBSPASSA-N,,GABRA1
3812,securinine,GABA receptor antagonist,GABRA1,O=C1OC2(C[C@H]3C=CC2=C1)[C@H]4CCCCN34,SWZMSZQQJRKFBP-KKPNGEORSA-N,,GABRA1
3813,protoporphyrin-ix,Heme oxygenase inhibitor,HMOX1,Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(O)=O,KSFOVUSSGSKXFI-UHFFFAOYSA-N,,HMOX1
3814,gambogic-acid,MYC expression inhibitor,BCL2,CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(CC=C(C)C(O)=O)OC6(C)C,GEZHEQNLKAOMCA-RRZNCOCZSA-N,,BCL2
3815,camicinal,Motilin receptor agonist,MLNR,C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc3cccc(F)c3)cc2)CCN1,RZKDEGZIFSJVNA-IBGZPJMESA-N,,MLNR
3816,erythromycin-ethylsuccinate,Motilin receptor agonist,CYP3A4,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP3A4
3817,erythromycin-ethylsuccinate,Motilin receptor agonist,CYP51A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP51A1
3818,erythromycin-ethylsuccinate,Motilin receptor agonist,ALB,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ALB
3819,erythromycin-ethylsuccinate,Motilin receptor agonist,MLNR,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,MLNR
3820,erythromycin-ethylsuccinate,Motilin receptor agonist,KCNH2,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,KCNH2
3821,erythromycin-ethylsuccinate,Motilin receptor agonist,ABCB1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ABCB1
3822,erythromycin-ethylsuccinate,Motilin receptor agonist,SLC47A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,SLC47A1
3823,CHEMBL-1222381,Neural stem cell inducer,CAMK2A,O=C(NC1CC1)c2cc(on2)c3cccs3,SYENTKHGMVKGAQ-UHFFFAOYSA-N,,CAMK2A
3824,almitrine,Neurotransmitter agonist,ATP1A1,Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1,OBDOVFRMEYHSQB-UHFFFAOYSA-N,,ATP1A1
3825,amitriptyline,Norepinephrine inhibitor,CHRM1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM1
3826,amitriptyline,Norepinephrine inhibitor,CHRM2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM2
3827,amitriptyline,Norepinephrine inhibitor,CHRM3,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM3
3828,amitriptyline,Norepinephrine inhibitor,CHRM4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM4
3829,amitriptyline,Norepinephrine inhibitor,CHRM5,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM5
3830,amitriptyline,Norepinephrine inhibitor,HRH1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HRH1
3831,amitriptyline,Norepinephrine inhibitor,HTR6,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HTR6
3832,amitriptyline,Norepinephrine inhibitor,SLC6A2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A2
3833,amitriptyline,Norepinephrine inhibitor,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A4
3834,droxidopa,Norepinephrine precursor,ADRA1D,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA1D
3835,droxidopa,Norepinephrine precursor,ADRA1B,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA1B
3836,droxidopa,Norepinephrine precursor,ADRA1A,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA1A
3837,droxidopa,Norepinephrine precursor,ADRA2A,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA2A
3838,droxidopa,Norepinephrine precursor,ADRA2B,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA2B
3839,droxidopa,Norepinephrine precursor,ADRA2C,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRA2C
3840,droxidopa,Norepinephrine precursor,ADRB1,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRB1
3841,droxidopa,Norepinephrine precursor,ADRB2,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRB2
3842,droxidopa,Norepinephrine precursor,ADRB3,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,,ADRB3
3843,sufentanil,Opiod receptor modulator,OPRM1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,GGCSSNBKKAUURC-UHFFFAOYSA-N,,OPRM1
3844,elesclomol,Oxidative stress inducer,HSPA1A,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,BKJIXTWSNXCKJH-UHFFFAOYSA-N,,HSPA1A
3845,dofequidar,P-glycoprotein inhibitor,ABCC1,OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1,KLWUUPVJTLHYIM-UHFFFAOYSA-N,,ABCC1
3846,dofequidar,P-glycoprotein inhibitor,ABCB1,OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1,KLWUUPVJTLHYIM-UHFFFAOYSA-N,,ABCB1
3847,elacridar,P-glycoprotein inhibitor,ABCB1,COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC,OSFCMRGOZNQUSW-UHFFFAOYSA-N,,ABCB1
3848,NU-7441,P-glycoprotein inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1,JAMULYFATHSZJM-UHFFFAOYSA-N,,PRKDC
3849,tariquidar,P-glycoprotein inhibitor,ABCB1,COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cnc5ccccc5c4)cc3)Cc2cc1OC,LGGHDPFKSSRQNS-UHFFFAOYSA-N,,ABCB1
3850,valspodar,P-glycoprotein inhibitor,ABCB1,CC=CC[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C,YJDYDFNKCBANTM-QCWCSKBGSA-N,,ABCB1
3851,zosuquidar,P-glycoprotein inhibitor,ABCB1,O[C@@H](COc1cccc2ncccc12)CN1CCN(CC1)[C@@H]1c2ccccc2[C@@H]2[C@H](c3ccccc13)C2(F)F,IHOVFYSQUDPMCN-DBEBIPAYSA-N,,ABCB1
3852,GSK-0660,PPAR receptor antagonist,PPARD,COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC,NDFKBGWLUHKMFY-UHFFFAOYSA-N,,PPARD
3853,GW-6471,PPAR receptor antagonist,PPARA,CCOC(=O)NCC(Cc1ccc(OCCc2nc(oc2C)c3ccccc3)cc1)NC(=CC(=O)c4ccc(cc4)C(F)(F)F)C,UEPVEQWUZJXOKB-UHFFFAOYSA-N,,PPARA
3854,GW-9662,PPAR receptor antagonist,PPARG,[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccccc1,DNTSIBUQMRRYIU-UHFFFAOYSA-N,,PPARG
3855,mifobate,PPAR receptor antagonist,PPARG,COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC,VQHUQHAPWMNBLP-UHFFFAOYSA-N,,PPARG
3856,T-0070907,PPAR receptor antagonist,PPARG,[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccncc1,FRPJSHKMZHWJBE-UHFFFAOYSA-N,,PPARG
3857,SC-10,Protein kinase activator,PRKCA,CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12,MJMJERJFCHYXEM-UHFFFAOYSA-N,,PRKCA
3858,C-1,Protein kinase inhibitor,PRKCA,O=S(=O)(N1CCNCC1)c1cccc2cnccc12,UPTYCYWTFGTCCG-UHFFFAOYSA-N,,PRKCA
3859,AT-9283,Protein kinase inhibitor,JAK2,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK2
3860,AT-9283,Protein kinase inhibitor,JAK3,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,JAK3
3861,AT-9283,Protein kinase inhibitor,AURKA,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKA
3862,AT-9283,Protein kinase inhibitor,AURKB,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,,AURKB
3863,MLN-8054,Protein kinase inhibitor,AURKA,OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1,HHFBDROWDBDFBR-UHFFFAOYSA-N,,AURKA
3864,PD-0325901,Protein kinase inhibitor,MAP2K1,OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-SECBINFHSA-N,,MAP2K1
3865,PD-0325901,Protein kinase inhibitor,MAP2K1,OCC(O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-UHFFFAOYSA-N,,MAP2K1
3866,R-59022,Protein kinase inhibitor,DGKA,Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccccc1)c1ccc(F)cc1,MFVJXLPANKSLLD-UHFFFAOYSA-N,,DGKA
3867,rifampicin,RNA polymerase inhibitor,NR1I2,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,JQXXHWHPUNPDRT-YOPQJBRCSA-N,,NR1I2
3868,dactinomycin,RNA polymerase inhibitor,POLR2A,CC(C)[C@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O,RJURFGZVJUQBHK-IIXSONLDSA-N,,POLR2A
3869,dactinomycin,RNA polymerase inhibitor,POLR2A,CC(C)C1NC(=O)C(NC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O)C(C)OC(=O)c1ccc(C)c2oc3c(C)c(=O)c(N)c(C(=O)OC(C)C4NC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)c3nc12,QKRYGAZNLBVXHK-UHFFFAOYSA-N,,POLR2A
3870,rifampicin,RNA polymerase inhibitor,NR1I2,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,JQXXHWHPUNPDRT-YOPQJBRCSA-N,,NR1I2
3871,rifampicin,RNA polymerase inhibitor,NR1I2,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c4c(O)c(C=NN5CCN(C)CC5)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)C)c(O)c4c(O)c3C,JQXXHWHPUNPDRT-GHGVGPBWSA-N,,NR1I2
3872,rifapentine,RNA polymerase inhibitor,CYP2C8,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP2C8
3873,rifapentine,RNA polymerase inhibitor,CYP2C9,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP2C9
3874,rifapentine,RNA polymerase inhibitor,CYP3A4,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP3A4
3875,rifapentine,RNA polymerase inhibitor,CYP2C8,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP2C8
3876,rifapentine,RNA polymerase inhibitor,CYP2C9,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP2C9
3877,rifapentine,RNA polymerase inhibitor,CYP3A4,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(CC4)C4CCCC4)c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,WDZCUPBHRAEYDL-NAFQJNKLSA-N,,CYP3A4
3878,rifapentine,RNA polymerase inhibitor,CYP2C8,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c4c(O)c(C=NN5CCN(CC5)C6CCCC6)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)C)c(O)c4c(O)c3C,WDZCUPBHRAEYDL-HJTBMZGUSA-N,,CYP2C8
3879,rifapentine,RNA polymerase inhibitor,CYP2C9,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c4c(O)c(C=NN5CCN(CC5)C6CCCC6)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)C)c(O)c4c(O)c3C,WDZCUPBHRAEYDL-HJTBMZGUSA-N,,CYP2C9
3880,rifapentine,RNA polymerase inhibitor,CYP3A4,CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c4c(O)c(C=NN5CCN(CC5)C6CCCC6)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)C)c(O)c4c(O)c3C,WDZCUPBHRAEYDL-HJTBMZGUSA-N,,CYP3A4
3881,retinol,Retinoid receptor ligand,RXRA,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=C/CO,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,,RXRA
3882,retinol,Retinoid receptor ligand,RXRB,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=C/CO,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,,RXRB
3883,retinol,Retinoid receptor ligand,RXRG,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=C/CO,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,,RXRG
3884,retinol,Retinoid receptor ligand,RXRA,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,,RXRA
3885,retinol,Retinoid receptor ligand,RXRB,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,,RXRB
3886,retinol,Retinoid receptor ligand,RXRG,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,,RXRG
3887,tretinoin,Retinoid receptor ligand,RARA,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARA
3888,tretinoin,Retinoid receptor ligand,RARB,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARB
3889,tretinoin,Retinoid receptor ligand,RARG,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARG
3890,tretinoin,Retinoid receptor ligand,RORB,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RORB
3891,tretinoin,Retinoid receptor ligand,RARA,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARA
3892,tretinoin,Retinoid receptor ligand,RARB,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARB
3893,tretinoin,Retinoid receptor ligand,RARG,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARG
3894,tretinoin,Retinoid receptor ligand,RORB,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RORB
3895,tretinoin,Retinoid receptor ligand,RARA,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARA
3896,tretinoin,Retinoid receptor ligand,RARB,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARB
3897,tretinoin,Retinoid receptor ligand,RARG,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARG
3898,tretinoin,Retinoid receptor ligand,RORB,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RORB
3899,BRD-K63954456,TNF production inhibitor,MIF,COc1cc(cc(Br)c1OCC(=O)O)c2nc3ccccc3s2,VKGGBLHFFRIHKZ-UHFFFAOYSA-N,,MIF
3900,caffeic-acid,TNF production inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
3901,caffeic-acid,TNF production inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
3902,thalidomide,TNF production inhibitor,CRBN,O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12,UEJJHQNACJXSKW-UHFFFAOYSA-N,,CRBN
3903,thalidomide,TNF production inhibitor,TNF,O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12,UEJJHQNACJXSKW-UHFFFAOYSA-N,,TNF
3904,tafamidis-meglumine,Transthyretin stabilizer,TTR,OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1,TXEIIPDJKFWEEC-UHFFFAOYSA-N,,TTR
3905,desipramine,Tricyclic antidepressant,SLC6A2,CNCCCN1c2ccccc2CCc2ccccc12,HCYAFALTSJYZDH-UHFFFAOYSA-N,,SLC6A2
3906,desipramine,Tricyclic antidepressant,SLC6A4,CNCCCN1c2ccccc2CCc2ccccc12,HCYAFALTSJYZDH-UHFFFAOYSA-N,,SLC6A4
3907,dosulepin,Tricyclic antidepressant,SLC6A2,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A2
3908,dosulepin,Tricyclic antidepressant,SLC6A4,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A4
3909,maprotiline,Tricyclic antidepressant,SLC6A2,CNCCC[C@]1(CC[C@H]2c3ccccc31)c4ccccc24,QSLMDECMDJKHMQ-GSXCWMCISA-N,,SLC6A2
3910,maprotiline,Tricyclic antidepressant,SLC6A2,CNCCCC12CCC(c3ccccc13)c1ccccc21,QSLMDECMDJKHMQ-UHFFFAOYSA-N,,SLC6A2
3911,nortriptyline,Tricyclic antidepressant,KCNJ10,CNCCC=C1c2ccccc2CCc2ccccc12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,,KCNJ10
3912,nortriptyline,Tricyclic antidepressant,SLC6A2,CNCCC=C1c2ccccc2CCc2ccccc12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,,SLC6A2
3913,nortriptyline,Tricyclic antidepressant,SLC6A4,CNCCC=C1c2ccccc2CCc2ccccc12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,,SLC6A4
3914,protriptyline,Tricyclic antidepressant,SLC6A2,CNCCCC1c2ccccc2C=Cc2ccccc12,BWPIARFWQZKAIA-UHFFFAOYSA-N,,SLC6A2
3915,trimipramine,Tricyclic antidepressant,SLC6A2,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A2
3916,trimipramine,Tricyclic antidepressant,SLC6A3,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A3
3917,trimipramine,Tricyclic antidepressant,SLC6A4,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A4
3918,epitiostanol,Androgen receptor agonist,AR,C[C@]12CC[C@@H]3[C@@H](CC[C@@H]4CC5SC5C[C@]34C)[C@@H]1CC[C@@H]2O,OBMLHUPNRURLOK-VMLGWULXSA-N,,AR
3919,epitiostanol,Androgen receptor agonist,AR,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O,OBMLHUPNRURLOK-XGRAFVIBSA-N,,AR
3920,myricetin,Androgen receptor agonist,PIK3CG,Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O,IKMDFBPHZNJCSN-UHFFFAOYSA-N,,PIK3CG
3921,oxandrolone,Androgen receptor agonist,AR,C[C@]1(O)CC[C@@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@@H]3CC[C@]12C,QSLJIVKCVHQPLV-FXZUXNBISA-N,,AR
3922,oxandrolone,Androgen receptor agonist,AR,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C,QSLJIVKCVHQPLV-PEMPUTJUSA-N,,AR
3923,oxymetholone,Androgen receptor agonist,AR,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@H]3CC[C@]12C)C=O,DLZUBMGMHUNDLF-CVSXEEBHSA-N,,AR
3924,oxymetholone,Androgen receptor agonist,AR,CC1(O)CCC2C3CCC4CC(=O)C(CC4(C)C3CCC12C)C=O,DLZUBMGMHUNDLF-UHFFFAOYSA-N,,AR
3925,testosterone-enanthate,Androgen receptor agonist,AR,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,,AR
3926,testosterone-propionate,Androgen receptor agonist,AR,CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,PDMMFKSKQVNJMI-PPRDLICTSA-N,,AR
3927,tibolone,Androgen receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,ESR1
3928,tibolone,Androgen receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,AR
3929,tibolone,Androgen receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,PGR
3930,tibolone,Androgen receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,ESR1
3931,tibolone,Androgen receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,AR
3932,tibolone,Androgen receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,PGR
3933,pentobarbital,Barbiturate antiepileptic,GABRA1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA1
3934,pentobarbital,Barbiturate antiepileptic,GABRA2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA2
3935,pentobarbital,Barbiturate antiepileptic,GABRA3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA3
3936,pentobarbital,Barbiturate antiepileptic,GABRA4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA4
3937,pentobarbital,Barbiturate antiepileptic,GABRA5,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA5
3938,pentobarbital,Barbiturate antiepileptic,GABRA6,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRA6
3939,pentobarbital,Barbiturate antiepileptic,GABRB1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB1
3940,pentobarbital,Barbiturate antiepileptic,GABRB2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB2
3941,pentobarbital,Barbiturate antiepileptic,GABRB3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRB3
3942,pentobarbital,Barbiturate antiepileptic,GABRD,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRD
3943,pentobarbital,Barbiturate antiepileptic,GABRE,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRE
3944,pentobarbital,Barbiturate antiepileptic,GABRG1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG1
3945,pentobarbital,Barbiturate antiepileptic,GABRG2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG2
3946,pentobarbital,Barbiturate antiepileptic,GABRG3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRG3
3947,pentobarbital,Barbiturate antiepileptic,GABRP,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRP
3948,pentobarbital,Barbiturate antiepileptic,GABRQ,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,GABRQ
3949,alendronic-acid,Bone resorption inhibitor,FDPS,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,OGSPWJRAVKPPFI-UHFFFAOYSA-N,,FDPS
3950,alendronic-acid,Bone resorption inhibitor,PTPRS,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,OGSPWJRAVKPPFI-UHFFFAOYSA-N,,PTPRS
3951,clodronic-acid,Bone resorption inhibitor,SLC25A4,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,ACSIXWWBWUQEHA-UHFFFAOYSA-N,,SLC25A4
3952,etidronic-acid,Bone resorption inhibitor,PTPRS,CC(O)(P(O)(O)=O)P(O)(O)=O,DBVJJBKOTRCVKF-UHFFFAOYSA-N,,PTPRS
3953,minodronic-acid,Bone resorption inhibitor,FDPS,OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,,FDPS
3954,pamidronate,Bone resorption inhibitor,FDPS,NCCC(O)(P(O)(O)=O)P(O)(O)=O,WRUUGTRCQOWXEG-UHFFFAOYSA-N,,FDPS
3955,zoledronic-acid,Bone resorption inhibitor,FDPS,OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,,FDPS
3956,BAY-K8644,Calcium channel activator,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C(F)(F)F)[N+]([O-])=O,ZFLWDHHVRRZMEI-UHFFFAOYSA-N,,CACNA1C
3957,cinacalcet,Calcium channel activator,CASR,C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12,VDHAWDNDOKGFTD-MRXNPFEDSA-N,,CASR
3958,FPL-64176,Calcium channel activator,CACNA1C,COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1,MDMWHKZANMNXTF-UHFFFAOYSA-N,,CACNA1C
3959,NS-1619,Calcium channel activator,KCNMA1,Oc1ccc(cc1n2c(=O)[nH]c3cc(ccc23)C(F)(F)F)C(F)(F)F,YLFMCMWKHSDUCT-UHFFFAOYSA-N,,KCNMA1
3960,kavain,Calcium channel modulator,MTOR,COC1=CC(=O)OC(C1)/C=C/c2ccccc2,XEAQIWGXBXCYFX-BQYQJAHWSA-N,,MTOR
3961,kawain,Calcium channel modulator,MTOR,COC1=CC(=O)O[C@H](C1)/C=C/c2ccccc2,XEAQIWGXBXCYFX-GUOLPTJISA-N,,MTOR
3962,carbamazepine,Carboxamide antiepileptic,SCN1A,NC(=O)N1c2ccccc2C=Cc2ccccc12,FFGPTBGBLSHEPO-UHFFFAOYSA-N,,SCN1A
3963,carbamazepine,Carboxamide antiepileptic,SCN3A,NC(=O)N1c2ccccc2C=Cc2ccccc12,FFGPTBGBLSHEPO-UHFFFAOYSA-N,,SCN3A
3964,carbamazepine,Carboxamide antiepileptic,SCN5A,NC(=O)N1c2ccccc2C=Cc2ccccc12,FFGPTBGBLSHEPO-UHFFFAOYSA-N,,SCN5A
3965,androstenedione,Cytochrome P450 inhibitor,HSD3B1,C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CCC1=O,AEMFNILZOJDQLW-QAGGRKNESA-N,,HSD3B1
3966,androstenedione,Cytochrome P450 inhibitor,HSD17B1,C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CCC1=O,AEMFNILZOJDQLW-QAGGRKNESA-N,,HSD17B1
3967,androstenedione,Cytochrome P450 inhibitor,AKR1C3,C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CCC1=O,AEMFNILZOJDQLW-QAGGRKNESA-N,,AKR1C3
3968,arbidol,Cytochrome P450 inhibitor,CYP3A4,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,KCFYEAOKVJSACF-UHFFFAOYSA-N,,CYP3A4
3969,BRD-K76211160,Cytochrome P450 inhibitor,CYP11B2,Fc1ccc(cc1)C(=O)Nc2cccnc2,AILCVPMYLXWTCO-UHFFFAOYSA-N,,CYP11B2
3970,clotrimazole,Cytochrome P450 inhibitor,KCNN4,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,,KCNN4
3971,cobicistat,Cytochrome P450 inhibitor,CYP3A4,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,,CYP3A4
3972,dexamethasone-acetate,Cytochrome P450 inhibitor,NR3C1,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-HIBZCRSPSA-N,,NR3C1
3973,eplerenone,Cytochrome P450 inhibitor,NR3C2,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13,JUKPWJGBANNWMW-VWBFHTRKSA-N,,NR3C2
3974,eplerenone,Cytochrome P450 inhibitor,NR3C2,COC(=O)C1CC2=CC(=O)CCC2(C)C34OC4CC5(C)C(CCC65CCC(=O)O6)C13,JUKPWJGBANNWMW-UHFFFAOYSA-N,,NR3C2
3975,eriodictyol,Cytochrome P450 inhibitor,NFE2L2,Oc1cc(O)c2C(=O)CC(Oc2c1)c3ccc(O)c(O)c3,SBHXYTNGIZCORC-UHFFFAOYSA-N,,NFE2L2
3976,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,CYP3A4,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP3A4
3977,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,CYP51A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP51A1
3978,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,ALB,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ALB
3979,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,MLNR,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,MLNR
3980,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,KCNH2,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,KCNH2
3981,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,ABCB1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ABCB1
3982,erythromycin-ethylsuccinate,Cytochrome P450 inhibitor,SLC47A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,SLC47A1
3983,flunisolide,Cytochrome P450 inhibitor,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,XSFJVAJPIHIPKU-QYOXGAPUSA-N,,NR3C1
3984,flunisolide,Cytochrome P450 inhibitor,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,XSFJVAJPIHIPKU-BTUWQHORSA-N,,NR3C1
3985,flunisolide,Cytochrome P450 inhibitor,NR3C1,CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO,XSFJVAJPIHIPKU-CCRGDLLISA-N,,NR3C1
3986,metyrapone,Cytochrome P450 inhibitor,CYP11B1,CC(C)(C(=O)c1cccnc1)c1cccnc1,FJLBFSROUSIWMA-UHFFFAOYSA-N,,CYP11B1
3987,myricetin,Cytochrome P450 inhibitor,PIK3CG,Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O,IKMDFBPHZNJCSN-UHFFFAOYSA-N,,PIK3CG
3988,orteronel,Cytochrome P450 inhibitor,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12,OZPFIJIOIVJZMN-GOSISDBHSA-N,,CYP17A1
3989,orteronel,Cytochrome P450 inhibitor,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)C1(O)CCn2cncc12,OZPFIJIOIVJZMN-UHFFFAOYSA-N,,CYP17A1
3990,resveratrol,Cytochrome P450 inhibitor,SIRT1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,SIRT1
3991,resveratrol,Cytochrome P450 inhibitor,PTGS1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,PTGS1
3992,resveratrol,Cytochrome P450 inhibitor,PTGS2,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,LUKBXSAWLPMMSZ-UHFFFAOYSA-N,,PTGS2
3993,resveratrol,Cytochrome P450 inhibitor,SIRT1,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,SIRT1
3994,resveratrol,Cytochrome P450 inhibitor,PTGS1,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,PTGS1
3995,resveratrol,Cytochrome P450 inhibitor,PTGS2,Oc1ccc(cc1)C=Cc1cc(O)cc(O)c1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,,PTGS2
3996,RU-28318,Cytochrome P450 inhibitor,NR3C2,CCCC1CC2=CC(=O)CCC2(C)C3CCC4(C)C(CCC4(O)CCC(=O)O)C13,DNHCHRGCTVRAFT-UHFFFAOYSA-N,,NR3C2
3997,thiotepa,Cytochrome P450 inhibitor,CYP2B6,S=P(N1CC1)(N1CC1)N1CC1,FOCVUCIESVLUNU-UHFFFAOYSA-N,,CYP2B6
3998,thiotepa,Cytochrome P450 inhibitor,CYP3A4,S=P(N1CC1)(N1CC1)N1CC1,FOCVUCIESVLUNU-UHFFFAOYSA-N,,CYP3A4
3999,voriconazole,Cytochrome P450 inhibitor,CYP2C19,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-MGPLVRAMSA-N,,CYP2C19
4000,voriconazole,Cytochrome P450 inhibitor,CYP2C9,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-MGPLVRAMSA-N,,CYP2C9
4001,voriconazole,Cytochrome P450 inhibitor,CYP3A4,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-MGPLVRAMSA-N,,CYP3A4
4002,voriconazole,Cytochrome P450 inhibitor,CYP3A5,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-MGPLVRAMSA-N,,CYP3A5
4003,voriconazole,Cytochrome P450 inhibitor,PTGS1,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-MGPLVRAMSA-N,,PTGS1
4004,voriconazole,Cytochrome P450 inhibitor,CYP2C19,C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-QFYYESIMSA-N,,CYP2C19
4005,voriconazole,Cytochrome P450 inhibitor,CYP2C9,C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-QFYYESIMSA-N,,CYP2C9
4006,voriconazole,Cytochrome P450 inhibitor,CYP3A4,C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-QFYYESIMSA-N,,CYP3A4
4007,voriconazole,Cytochrome P450 inhibitor,CYP3A5,C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-QFYYESIMSA-N,,CYP3A5
4008,voriconazole,Cytochrome P450 inhibitor,PTGS1,C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F,BCEHBSKCWLPMDN-QFYYESIMSA-N,,PTGS1
4009,VT-464,Cytochrome P450 inhibitor,CYP17A1,CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1,ZBRAJOQFSNYJMF-SFHVURJKSA-N,,CYP17A1
4010,niclosamide,DNA replication inhibitor,STAT3,Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,,STAT3
4011,ABT-724,Dopamine receptor agonist,DRD4,C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1,FRPJGTNLZNXQEX-UHFFFAOYSA-N,,DRD4
4012,amineptine,Dopamine receptor agonist,SLC6A2,OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12,ONNOFKFOZAJDHT-UHFFFAOYSA-N,,SLC6A2
4013,amineptine,Dopamine receptor agonist,SLC6A4,OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12,ONNOFKFOZAJDHT-UHFFFAOYSA-N,,SLC6A4
4014,apomorphine,Dopamine receptor agonist,ADRA2A,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,ADRA2A
4015,apomorphine,Dopamine receptor agonist,ADRA2B,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,ADRA2B
4016,apomorphine,Dopamine receptor agonist,ADRA2C,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,ADRA2C
4017,apomorphine,Dopamine receptor agonist,DRD1,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,DRD1
4018,apomorphine,Dopamine receptor agonist,DRD2,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,DRD2
4019,apomorphine,Dopamine receptor agonist,DRD3,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,DRD3
4020,apomorphine,Dopamine receptor agonist,DRD4,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,DRD4
4021,apomorphine,Dopamine receptor agonist,DRD5,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,DRD5
4022,apomorphine,Dopamine receptor agonist,HTR1A,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,HTR1A
4023,apomorphine,Dopamine receptor agonist,HTR2A,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,HTR2A
4024,apomorphine,Dopamine receptor agonist,HTR2B,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,HTR2B
4025,apomorphine,Dopamine receptor agonist,HTR2C,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,HTR2C
4026,apomorphine,Dopamine receptor agonist,TRPA1,CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31.CN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,CFFNPVYFABROIZ-CHNGVTQJSA-N,,TRPA1
4027,BRD-K67582595,Dopamine receptor agonist,DRD1,CCCN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,BTGAJCKRXPNBFI-HNNXBMFYSA-N,,DRD1
4028,BRD-K67582595,Dopamine receptor agonist,DRD2,CCCN1CCc2cccc-3c2[C@@H]1Cc1ccc(O)c(O)c-31,BTGAJCKRXPNBFI-HNNXBMFYSA-N,,DRD2
4029,BRD-K84421793,Dopamine receptor agonist,DRD1,Oc1cc2[C@H](CNCCc2c(Cl)c1O)c3ccccc3,GHWJEDJMOVUXEC-CYBMUJFWSA-N,,DRD1
4030,bromocriptine,Dopamine receptor agonist,ADRA2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,ADRA2A
4031,bromocriptine,Dopamine receptor agonist,ADRA2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,ADRA2B
4032,bromocriptine,Dopamine receptor agonist,ADRA2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,ADRA2C
4033,bromocriptine,Dopamine receptor agonist,DRD1,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,DRD1
4034,bromocriptine,Dopamine receptor agonist,DRD2,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,DRD2
4035,bromocriptine,Dopamine receptor agonist,DRD3,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,DRD3
4036,bromocriptine,Dopamine receptor agonist,DRD4,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,DRD4
4037,bromocriptine,Dopamine receptor agonist,DRD5,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,DRD5
4038,bromocriptine,Dopamine receptor agonist,HTR1A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR1A
4039,bromocriptine,Dopamine receptor agonist,HTR1B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR1B
4040,bromocriptine,Dopamine receptor agonist,HTR1D,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR1D
4041,bromocriptine,Dopamine receptor agonist,HTR2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR2A
4042,bromocriptine,Dopamine receptor agonist,HTR2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR2B
4043,bromocriptine,Dopamine receptor agonist,HTR2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,,HTR2C
4044,bromocriptine,Dopamine receptor agonist,ADRA2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,ADRA2A
4045,bromocriptine,Dopamine receptor agonist,ADRA2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,ADRA2B
4046,bromocriptine,Dopamine receptor agonist,ADRA2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,ADRA2C
4047,bromocriptine,Dopamine receptor agonist,DRD1,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,DRD1
4048,bromocriptine,Dopamine receptor agonist,DRD2,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,DRD2
4049,bromocriptine,Dopamine receptor agonist,DRD3,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,DRD3
4050,bromocriptine,Dopamine receptor agonist,DRD4,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,DRD4
4051,bromocriptine,Dopamine receptor agonist,DRD5,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,DRD5
4052,bromocriptine,Dopamine receptor agonist,HTR1A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR1A
4053,bromocriptine,Dopamine receptor agonist,HTR1B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR1B
4054,bromocriptine,Dopamine receptor agonist,HTR1D,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR1D
4055,bromocriptine,Dopamine receptor agonist,HTR2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR2A
4056,bromocriptine,Dopamine receptor agonist,HTR2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR2B
4057,bromocriptine,Dopamine receptor agonist,HTR2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-JVOFPJAOSA-N,,HTR2C
4058,bromocriptine,Dopamine receptor agonist,ADRA2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,ADRA2A
4059,bromocriptine,Dopamine receptor agonist,ADRA2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,ADRA2B
4060,bromocriptine,Dopamine receptor agonist,ADRA2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,ADRA2C
4061,bromocriptine,Dopamine receptor agonist,DRD1,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,DRD1
4062,bromocriptine,Dopamine receptor agonist,DRD2,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,DRD2
4063,bromocriptine,Dopamine receptor agonist,DRD3,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,DRD3
4064,bromocriptine,Dopamine receptor agonist,DRD4,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,DRD4
4065,bromocriptine,Dopamine receptor agonist,DRD5,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,DRD5
4066,bromocriptine,Dopamine receptor agonist,HTR1A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR1A
4067,bromocriptine,Dopamine receptor agonist,HTR1B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR1B
4068,bromocriptine,Dopamine receptor agonist,HTR1D,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR1D
4069,bromocriptine,Dopamine receptor agonist,HTR2A,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR2A
4070,bromocriptine,Dopamine receptor agonist,HTR2B,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR2B
4071,bromocriptine,Dopamine receptor agonist,HTR2C,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-BGNMTYTCSA-N,,HTR2C
4072,bromocriptine,Dopamine receptor agonist,ADRA2A,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,ADRA2A
4073,bromocriptine,Dopamine receptor agonist,ADRA2B,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,ADRA2B
4074,bromocriptine,Dopamine receptor agonist,ADRA2C,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,ADRA2C
4075,bromocriptine,Dopamine receptor agonist,DRD1,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,DRD1
4076,bromocriptine,Dopamine receptor agonist,DRD2,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,DRD2
4077,bromocriptine,Dopamine receptor agonist,DRD3,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,DRD3
4078,bromocriptine,Dopamine receptor agonist,DRD4,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,DRD4
4079,bromocriptine,Dopamine receptor agonist,DRD5,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,DRD5
4080,bromocriptine,Dopamine receptor agonist,HTR1A,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR1A
4081,bromocriptine,Dopamine receptor agonist,HTR1B,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR1B
4082,bromocriptine,Dopamine receptor agonist,HTR1D,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR1D
4083,bromocriptine,Dopamine receptor agonist,HTR2A,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR2A
4084,bromocriptine,Dopamine receptor agonist,HTR2B,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR2B
4085,bromocriptine,Dopamine receptor agonist,HTR2C,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,OZVBMTJYIDMWIL-NXIPCUEUSA-N,,HTR2C
4086,bromocriptine,Dopamine receptor agonist,ADRA2A,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,ADRA2A
4087,bromocriptine,Dopamine receptor agonist,ADRA2B,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,ADRA2B
4088,bromocriptine,Dopamine receptor agonist,ADRA2C,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,ADRA2C
4089,bromocriptine,Dopamine receptor agonist,DRD1,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,DRD1
4090,bromocriptine,Dopamine receptor agonist,DRD2,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,DRD2
4091,bromocriptine,Dopamine receptor agonist,DRD3,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,DRD3
4092,bromocriptine,Dopamine receptor agonist,DRD4,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,DRD4
4093,bromocriptine,Dopamine receptor agonist,DRD5,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,DRD5
4094,bromocriptine,Dopamine receptor agonist,HTR1A,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR1A
4095,bromocriptine,Dopamine receptor agonist,HTR1B,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR1B
4096,bromocriptine,Dopamine receptor agonist,HTR1D,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR1D
4097,bromocriptine,Dopamine receptor agonist,HTR2A,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR2A
4098,bromocriptine,Dopamine receptor agonist,HTR2B,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR2B
4099,bromocriptine,Dopamine receptor agonist,HTR2C,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C,OZVBMTJYIDMWIL-UHFFFAOYSA-N,,HTR2C
4100,cabergoline,Dopamine receptor agonist,ADRA1A,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,ADRA1A
4101,cabergoline,Dopamine receptor agonist,ADRA2A,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,ADRA2A
4102,cabergoline,Dopamine receptor agonist,ADRA2B,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,ADRA2B
4103,cabergoline,Dopamine receptor agonist,ADRA2C,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,ADRA2C
4104,cabergoline,Dopamine receptor agonist,DRD1,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,DRD1
4105,cabergoline,Dopamine receptor agonist,DRD2,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,DRD2
4106,cabergoline,Dopamine receptor agonist,DRD3,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,DRD3
4107,cabergoline,Dopamine receptor agonist,DRD4,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,DRD4
4108,cabergoline,Dopamine receptor agonist,DRD5,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,DRD5
4109,cabergoline,Dopamine receptor agonist,HTR1A,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR1A
4110,cabergoline,Dopamine receptor agonist,HTR1B,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR1B
4111,cabergoline,Dopamine receptor agonist,HTR1D,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR1D
4112,cabergoline,Dopamine receptor agonist,HTR2A,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR2A
4113,cabergoline,Dopamine receptor agonist,HTR2B,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR2B
4114,cabergoline,Dopamine receptor agonist,HTR2C,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-KJXAQDMKSA-N,,HTR2C
4115,cabergoline,Dopamine receptor agonist,ADRA1A,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,ADRA1A
4116,cabergoline,Dopamine receptor agonist,ADRA2A,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,ADRA2A
4117,cabergoline,Dopamine receptor agonist,ADRA2B,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,ADRA2B
4118,cabergoline,Dopamine receptor agonist,ADRA2C,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,ADRA2C
4119,cabergoline,Dopamine receptor agonist,DRD1,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,DRD1
4120,cabergoline,Dopamine receptor agonist,DRD2,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,DRD2
4121,cabergoline,Dopamine receptor agonist,DRD3,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,DRD3
4122,cabergoline,Dopamine receptor agonist,DRD4,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,DRD4
4123,cabergoline,Dopamine receptor agonist,DRD5,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,DRD5
4124,cabergoline,Dopamine receptor agonist,HTR1A,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR1A
4125,cabergoline,Dopamine receptor agonist,HTR1B,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR1B
4126,cabergoline,Dopamine receptor agonist,HTR1D,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR1D
4127,cabergoline,Dopamine receptor agonist,HTR2A,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR2A
4128,cabergoline,Dopamine receptor agonist,HTR2B,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR2B
4129,cabergoline,Dopamine receptor agonist,HTR2C,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1,KORNTPPJEAJQIU-UHFFFAOYSA-N,,HTR2C
4130,carmoxirole,Dopamine receptor agonist,DRD2,OC(=O)c1ccc2[nH]cc(CCCCN3CCC(=CC3)c3ccccc3)c2c1,AFSOIHMEOKEZJF-UHFFFAOYSA-N,,DRD2
4131,dihydrexidine,Dopamine receptor agonist,DRD1,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,BGOQGUHWXBGXJW-RHSMWYFYSA-N,,DRD1
4132,dihydrexidine,Dopamine receptor agonist,DRD1,Oc1cc2CCC3NCc4ccccc4C3c2cc1O,BGOQGUHWXBGXJW-UHFFFAOYSA-N,,DRD1
4133,dopamine,Dopamine receptor agonist,DRD1,NCCC(=O)NCCc1ccc(O)c(O)c1,KGZWXTYWZFMLSQ-UHFFFAOYSA-N,,DRD1
4134,dopamine,Dopamine receptor agonist,DRD2,NCCC(=O)NCCc1ccc(O)c(O)c1,KGZWXTYWZFMLSQ-UHFFFAOYSA-N,,DRD2
4135,dopamine,Dopamine receptor agonist,DRD3,NCCC(=O)NCCc1ccc(O)c(O)c1,KGZWXTYWZFMLSQ-UHFFFAOYSA-N,,DRD3
4136,dopamine,Dopamine receptor agonist,DRD4,NCCC(=O)NCCc1ccc(O)c(O)c1,KGZWXTYWZFMLSQ-UHFFFAOYSA-N,,DRD4
4137,dopamine,Dopamine receptor agonist,DRD5,NCCC(=O)NCCc1ccc(O)c(O)c1,KGZWXTYWZFMLSQ-UHFFFAOYSA-N,,DRD5
4138,dopamine,Dopamine receptor agonist,DRD1,NCCc1ccc(O)c(O)c1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,DRD1
4139,dopamine,Dopamine receptor agonist,DRD2,NCCc1ccc(O)c(O)c1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,DRD2
4140,dopamine,Dopamine receptor agonist,DRD3,NCCc1ccc(O)c(O)c1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,DRD3
4141,dopamine,Dopamine receptor agonist,DRD4,NCCc1ccc(O)c(O)c1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,DRD4
4142,dopamine,Dopamine receptor agonist,DRD5,NCCc1ccc(O)c(O)c1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,DRD5
4143,dopamine,Dopamine receptor agonist,DRD1,NCCc1ccc(O)c(OS(O)(=O)=O)c1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,DRD1
4144,dopamine,Dopamine receptor agonist,DRD2,NCCc1ccc(O)c(OS(O)(=O)=O)c1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,DRD2
4145,dopamine,Dopamine receptor agonist,DRD3,NCCc1ccc(O)c(OS(O)(=O)=O)c1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,DRD3
4146,dopamine,Dopamine receptor agonist,DRD4,NCCc1ccc(O)c(OS(O)(=O)=O)c1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,DRD4
4147,dopamine,Dopamine receptor agonist,DRD5,NCCc1ccc(O)c(OS(O)(=O)=O)c1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,DRD5
4148,dopamine,Dopamine receptor agonist,DRD1,NCCc1ccc(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c(O)c1,CQASRCDNLNMIJY-ZAOAHOKWSA-N,,DRD1
4149,dopamine,Dopamine receptor agonist,DRD2,NCCc1ccc(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c(O)c1,CQASRCDNLNMIJY-ZAOAHOKWSA-N,,DRD2
4150,dopamine,Dopamine receptor agonist,DRD3,NCCc1ccc(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c(O)c1,CQASRCDNLNMIJY-ZAOAHOKWSA-N,,DRD3
4151,dopamine,Dopamine receptor agonist,DRD4,NCCc1ccc(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c(O)c1,CQASRCDNLNMIJY-ZAOAHOKWSA-N,,DRD4
4152,dopamine,Dopamine receptor agonist,DRD5,NCCc1ccc(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c(O)c1,CQASRCDNLNMIJY-ZAOAHOKWSA-N,,DRD5
4153,dopamine,Dopamine receptor agonist,DRD1,NCCc1ccc(OS(O)(=O)=O)c(O)c1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,DRD1
4154,dopamine,Dopamine receptor agonist,DRD2,NCCc1ccc(OS(O)(=O)=O)c(O)c1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,DRD2
4155,dopamine,Dopamine receptor agonist,DRD3,NCCc1ccc(OS(O)(=O)=O)c(O)c1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,DRD3
4156,dopamine,Dopamine receptor agonist,DRD4,NCCc1ccc(OS(O)(=O)=O)c(O)c1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,DRD4
4157,dopamine,Dopamine receptor agonist,DRD5,NCCc1ccc(OS(O)(=O)=O)c(O)c1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,DRD5
4158,ergocornine,Dopamine receptor agonist,DRD2,CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,UJYGDMFEEDNVBF-OGGGUQDZSA-N,,DRD2
4159,fenoldopam,Dopamine receptor agonist,DRD1,Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12,TVURRHSHRRELCG-UHFFFAOYSA-N,,DRD1
4160,lisuride,Dopamine receptor agonist,ADRA2A,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,ADRA2A
4161,lisuride,Dopamine receptor agonist,ADRA2B,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,ADRA2B
4162,lisuride,Dopamine receptor agonist,ADRA2C,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,ADRA2C
4163,lisuride,Dopamine receptor agonist,DRD1,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,DRD1
4164,lisuride,Dopamine receptor agonist,DRD2,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,DRD2
4165,lisuride,Dopamine receptor agonist,DRD3,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,DRD3
4166,lisuride,Dopamine receptor agonist,DRD4,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,DRD4
4167,lisuride,Dopamine receptor agonist,DRD5,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,DRD5
4168,lisuride,Dopamine receptor agonist,HTR1A,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR1A
4169,lisuride,Dopamine receptor agonist,HTR1B,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR1B
4170,lisuride,Dopamine receptor agonist,HTR1D,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR1D
4171,lisuride,Dopamine receptor agonist,HTR2A,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR2A
4172,lisuride,Dopamine receptor agonist,HTR2B,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR2B
4173,lisuride,Dopamine receptor agonist,HTR2C,CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-RDTXWAMCSA-N,,HTR2C
4174,mesulergine,Dopamine receptor agonist,HTR2A,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,JLVHTNZNKOSCNB-YSVLISHTSA-N,,HTR2A
4175,mesulergine,Dopamine receptor agonist,HTR2C,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,JLVHTNZNKOSCNB-YSVLISHTSA-N,,HTR2C
4176,mesulergine,Dopamine receptor agonist,HTR7,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,JLVHTNZNKOSCNB-YSVLISHTSA-N,,HTR7
4177,metergoline,Dopamine receptor agonist,HTR1A,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-QTGUNEKASA-N,,HTR1A
4178,metergoline,Dopamine receptor agonist,HTR2A,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-QTGUNEKASA-N,,HTR2A
4179,metergoline,Dopamine receptor agonist,HTR1A,CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-STDCAVTESA-N,,HTR1A
4180,metergoline,Dopamine receptor agonist,HTR2A,CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-STDCAVTESA-N,,HTR2A
4181,metergoline,Dopamine receptor agonist,HTR1A,CN1CC(CNC(=O)OCc2ccccc2)CC3C1Cc4cn(C)c5cccc3c45,WZHJKEUHNJHDLS-UHFFFAOYSA-N,,HTR1A
4182,metergoline,Dopamine receptor agonist,HTR2A,CN1CC(CNC(=O)OCc2ccccc2)CC3C1Cc4cn(C)c5cccc3c45,WZHJKEUHNJHDLS-UHFFFAOYSA-N,,HTR2A
4183,pergolide,Dopamine receptor agonist,ADRA2A,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,ADRA2A
4184,pergolide,Dopamine receptor agonist,ADRA2B,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,ADRA2B
4185,pergolide,Dopamine receptor agonist,ADRA2C,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,ADRA2C
4186,pergolide,Dopamine receptor agonist,DRD1,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,DRD1
4187,pergolide,Dopamine receptor agonist,DRD2,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,DRD2
4188,pergolide,Dopamine receptor agonist,DRD3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,DRD3
4189,pergolide,Dopamine receptor agonist,DRD4,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,DRD4
4190,pergolide,Dopamine receptor agonist,DRD5,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,DRD5
4191,pergolide,Dopamine receptor agonist,HTR1A,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR1A
4192,pergolide,Dopamine receptor agonist,HTR1B,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR1B
4193,pergolide,Dopamine receptor agonist,HTR1D,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR1D
4194,pergolide,Dopamine receptor agonist,HTR2A,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR2A
4195,pergolide,Dopamine receptor agonist,HTR2B,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR2B
4196,pergolide,Dopamine receptor agonist,HTR2C,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,YEHCICAEULNIGD-MZMPZRCHSA-N,,HTR2C
4197,piribedil,Dopamine receptor agonist,ADRA2A,C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,,ADRA2A
4198,piribedil,Dopamine receptor agonist,DRD2,C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,,DRD2
4199,piribedil,Dopamine receptor agonist,DRD3,C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,,DRD3
4200,pramipexole,Dopamine receptor agonist,DRD2,CCCN[C@H]1CCc2nc(N)sc2C1,FASDKYOPVNHBLU-ZETCQYMHSA-N,,DRD2
4201,pramipexole,Dopamine receptor agonist,DRD3,CCCN[C@H]1CCc2nc(N)sc2C1,FASDKYOPVNHBLU-ZETCQYMHSA-N,,DRD3
4202,quinpirole,Dopamine receptor agonist,DRD2,CCCN1CCCC2Cc3n[nH]cc3CC21,FTSUPYGMFAPCFZ-UHFFFAOYSA-N,,DRD2
4203,quinpirole,Dopamine receptor agonist,DRD3,CCCN1CCCC2Cc3n[nH]cc3CC21,FTSUPYGMFAPCFZ-UHFFFAOYSA-N,,DRD3
4204,quinpirole,Dopamine receptor agonist,DRD4,CCCN1CCCC2Cc3n[nH]cc3CC21,FTSUPYGMFAPCFZ-UHFFFAOYSA-N,,DRD4
4205,Ro-10-5824,Dopamine receptor agonist,DRD4,Cc1ncc(CN2CCC(=CC2)c2ccccc2)c(N)n1,KABDATZAOUSYES-UHFFFAOYSA-N,,DRD4
4206,ropinirole,Dopamine receptor agonist,DRD2,CCCN(CCC)CCc1cccc2NC(=O)Cc12,UHSKFQJFRQCDBE-UHFFFAOYSA-N,,DRD2
4207,ropinirole,Dopamine receptor agonist,DRD3,CCCN(CCC)CCc1cccc2NC(=O)Cc12,UHSKFQJFRQCDBE-UHFFFAOYSA-N,,DRD3
4208,rotigotine,Dopamine receptor agonist,DRD1,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,,DRD1
4209,rotigotine,Dopamine receptor agonist,DRD2,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,,DRD2
4210,rotigotine,Dopamine receptor agonist,DRD3,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,,DRD3
4211,rotigotine,Dopamine receptor agonist,DRD4,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,,DRD4
4212,rotigotine,Dopamine receptor agonist,DRD5,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,,DRD5
4213,SK-383933,Dopamine receptor agonist,DRD1,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,JUDKOGFHZYMDMF-CQSZACIVSA-N,,DRD1
4214,SK-383933,Dopamine receptor agonist,DRD5,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,JUDKOGFHZYMDMF-CQSZACIVSA-N,,DRD5
4215,SKF-38393,Dopamine receptor agonist,DRD1,Oc1cc2CCNCC(c3ccccc3)c2cc1O,JUDKOGFHZYMDMF-UHFFFAOYSA-N,,DRD1
4216,SKF-38393,Dopamine receptor agonist,DRD5,Oc1cc2CCNCC(c3ccccc3)c2cc1O,JUDKOGFHZYMDMF-UHFFFAOYSA-N,,DRD5
4217,SKF-77434,Dopamine receptor agonist,DRD1,Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O,QBUVZVXIRYFENV-UHFFFAOYSA-N,,DRD1
4218,SKF-81297,Dopamine receptor agonist,DRD1,Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1,GHWJEDJMOVUXEC-UHFFFAOYSA-N,,DRD1
4219,SKF-81297,Dopamine receptor agonist,DRD5,Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1,GHWJEDJMOVUXEC-UHFFFAOYSA-N,,DRD5
4220,talipexole,Dopamine receptor agonist,DRD2,Nc1nc2CCN(CC=C)CCc2s1,DHSSDEDRBUKTQY-UHFFFAOYSA-N,,DRD2
4221,terguride,Dopamine receptor agonist,DRD2,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,DRD2
4222,terguride,Dopamine receptor agonist,HTR2A,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,HTR2A
4223,terguride,Dopamine receptor agonist,HTR2B,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,HTR2B
4224,bupropion,Dopamine uptake inhibitor,SLC6A2,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,,SLC6A2
4225,bupropion,Dopamine uptake inhibitor,SLC6A3,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,,SLC6A3
4226,diphenylpyraline,Dopamine uptake inhibitor,HRH1,CN1CCC(CC1)OC(c1ccccc1)c1ccccc1,OWQUZNMMYNAXSL-UHFFFAOYSA-N,,HRH1
4227,diphenylpyraline,Dopamine uptake inhibitor,SLC6A3,CN1CCC(CC1)OC(c1ccccc1)c1ccccc1,OWQUZNMMYNAXSL-UHFFFAOYSA-N,,SLC6A3
4228,GBR-13069,Dopamine uptake inhibitor,SLC6A3,Fc1ccc(cc1)C(OCCN1CCN(CC=Cc2ccccc2)CC1)c1ccc(F)cc1,DASHZBBQOARCMQ-QPJJXVBHSA-N,,SLC6A3
4229,GBR-13069,Dopamine uptake inhibitor,SLC6A3,Fc1ccc(cc1)C(OCCN2CCN(CC=Cc3ccccc3)CC2)c4ccc(F)cc4,DASHZBBQOARCMQ-UHFFFAOYSA-N,,SLC6A3
4230,hyperforin,Dopamine uptake inhibitor,ALOX5,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,ALOX5
4231,hyperforin,Dopamine uptake inhibitor,PTGS1,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,PTGS1
4232,hyperforin,Dopamine uptake inhibitor,NR1I2,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,NR1I2
4233,nomifensine,Dopamine uptake inhibitor,SLC6A2,CN1CC(c2ccccc2)c2cccc(N)c2C1,XXPANQJNYNUNES-UHFFFAOYSA-N,,SLC6A2
4234,nomifensine,Dopamine uptake inhibitor,SLC6A3,CN1CC(c2ccccc2)c2cccc(N)c2C1,XXPANQJNYNUNES-UHFFFAOYSA-N,,SLC6A3
4235,phentermine,Dopamine uptake inhibitor,SLC6A2,CC(C)(N)Cc1ccccc1,DHHVAGZRUROJKS-UHFFFAOYSA-N,,SLC6A2
4236,safinamide,Dopamine uptake inhibitor,MAOB,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,MAOB
4237,safinamide,Dopamine uptake inhibitor,SLC6A3,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,SLC6A3
4238,safinamide,Dopamine uptake inhibitor,MAOB,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,MAOB
4239,safinamide,Dopamine uptake inhibitor,SLC6A3,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,SLC6A3
4240,vanoxerine,Dopamine uptake inhibitor,SLC6A3,Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1,NAUWTFJOPJWYOT-UHFFFAOYSA-N,,SLC6A3
4241,alpha-estradiol,Estrogen receptor agonist,ESR1,CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O,VOXZDWNPVJITMN-UHFFFAOYSA-N,,ESR1
4242,alpha-estradiol,Estrogen receptor agonist,ESR2,CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O,VOXZDWNPVJITMN-UHFFFAOYSA-N,,ESR2
4243,alpha-estradiol,Estrogen receptor agonist,NR1I2,CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O,VOXZDWNPVJITMN-UHFFFAOYSA-N,,NR1I2
4244,bisphenol-a,Estrogen receptor agonist,PPARG,CC(C)(c1ccc(O)cc1)c2ccc(O)cc2,IISBACLAFKSPIT-UHFFFAOYSA-N,,PPARG
4245,chlorotrianisene,Estrogen receptor agonist,ESR1,COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1,BFPSDSIWYFKGBC-UHFFFAOYSA-N,,ESR1
4246,coumestrol,Estrogen receptor agonist,ESR1,Oc1ccc2c(c1)oc3c2c(=O)oc4cc(O)ccc34,ZZIALNLLNHEQPJ-UHFFFAOYSA-N,,ESR1
4247,coumestrol,Estrogen receptor agonist,ESR2,Oc1ccc2c(c1)oc3c2c(=O)oc4cc(O)ccc34,ZZIALNLLNHEQPJ-UHFFFAOYSA-N,,ESR2
4248,dienestrol,Estrogen receptor agonist,ESR1,CC=C(c1ccc(O)cc1)C(c1ccc(O)cc1)=CC,NFDFQCUYFHCNBW-SCGPFSFSSA-N,,ESR1
4249,dienestrol,Estrogen receptor agonist,ESR1,CC=C(C(=CC)c1ccc(O)cc1)c1ccc(O)cc1,NFDFQCUYFHCNBW-UHFFFAOYSA-N,,ESR1
4250,DY-131,Estrogen receptor agonist,ESR2,CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1,WLKOCYWYAWBGKY-UHFFFAOYSA-N,,ESR2
4251,DY-131,Estrogen receptor agonist,ESRRG,CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1,WLKOCYWYAWBGKY-UHFFFAOYSA-N,,ESRRG
4252,equilin,Estrogen receptor agonist,HSD17B1,C[C@]12CC[C@@H]3C(=CCc4cc(O)ccc34)[C@H]1CCC2=O,WKRLQDKEXYKHJB-LESCRADOSA-N,,HSD17B1
4253,equilin,Estrogen receptor agonist,HSD17B1,C[C@@]12CC[C@H]3C(=CCc4cc(O)ccc34)[C@@H]2CCC1=O,WKRLQDKEXYKHJB-HFTRVMKXSA-N,,HSD17B1
4254,equilin,Estrogen receptor agonist,HSD17B1,CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O,WKRLQDKEXYKHJB-UHFFFAOYSA-N,,HSD17B1
4255,equol,Estrogen receptor agonist,ESR1,Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,,ESR1
4256,equol,Estrogen receptor agonist,ESR2,Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,,ESR2
4257,equol,Estrogen receptor agonist,ESR1,Oc1ccc(cc1)C2COc3cc(O)ccc3C2,ADFCQWZHKCXPAJ-UHFFFAOYSA-N,,ESR1
4258,equol,Estrogen receptor agonist,ESR2,Oc1ccc(cc1)C2COc3cc(O)ccc3C2,ADFCQWZHKCXPAJ-UHFFFAOYSA-N,,ESR2
4259,erteberel,Estrogen receptor agonist,ESR2,Oc1ccc(cc1)[C@@H]1Oc2ccc(O)cc2[C@@H]2CCC[C@H]12,XIESSJVMWNJCGZ-VKJFTORMSA-N,,ESR2
4260,estradiol,Estrogen receptor agonist,ESR1,C[C@]12CC[C@@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@H]2O,VOXZDWNPVJITMN-RZFLPCETSA-N,,ESR1
4261,estradiol,Estrogen receptor agonist,ESR2,C[C@]12CC[C@@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@H]2O,VOXZDWNPVJITMN-RZFLPCETSA-N,,ESR2
4262,estradiol,Estrogen receptor agonist,NR1I2,C[C@]12CC[C@@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@H]2O,VOXZDWNPVJITMN-RZFLPCETSA-N,,NR1I2
4263,estradiol,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,ESR1
4264,estradiol,Estrogen receptor agonist,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,ESR2
4265,estradiol,Estrogen receptor agonist,NR1I2,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,NR1I2
4266,estradiol,Estrogen receptor agonist,ESR1,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2O,VOXZDWNPVJITMN-PAOLREHBSA-N,,ESR1
4267,estradiol,Estrogen receptor agonist,ESR2,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2O,VOXZDWNPVJITMN-PAOLREHBSA-N,,ESR2
4268,estradiol,Estrogen receptor agonist,NR1I2,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2O,VOXZDWNPVJITMN-PAOLREHBSA-N,,NR1I2
4269,estradiol,Estrogen receptor agonist,ESR1,CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,QAHOQNJVHDHYRN-UHFFFAOYSA-N,,ESR1
4270,estradiol,Estrogen receptor agonist,ESR2,CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,QAHOQNJVHDHYRN-UHFFFAOYSA-N,,ESR2
4271,estradiol,Estrogen receptor agonist,NR1I2,CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,QAHOQNJVHDHYRN-UHFFFAOYSA-N,,NR1I2
4272,estradiol-cypionate,Estrogen receptor agonist,ESR1,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1,UOACKFBJUYNSLK-OCTSOESTSA-N,,ESR1
4273,estramustine-phosphate,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR1
4274,estramustine-phosphate,Estrogen receptor agonist,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,ESR2
4275,estramustine-phosphate,Estrogen receptor agonist,MAP1A,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP1A
4276,estramustine-phosphate,Estrogen receptor agonist,MAP2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,,MAP2
4277,estriol,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,ESR1
4278,estriol,Estrogen receptor agonist,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,ESR2
4279,estriol,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@H]1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-WJQMWINMSA-N,,ESR1
4280,estriol,Estrogen receptor agonist,ESR2,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@H]1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-WJQMWINMSA-N,,ESR2
4281,estriol,Estrogen receptor agonist,ESR1,C[C@]12CCC3C(CCc4cc(O)ccc34)C1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-YDGSGPMOSA-N,,ESR1
4282,estriol,Estrogen receptor agonist,ESR2,C[C@]12CCC3C(CCc4cc(O)ccc34)C1C[C@@H](O)[C@@H]2O,PROQIPRRNZUXQM-YDGSGPMOSA-N,,ESR2
4283,estriol,Estrogen receptor agonist,ESR1,CC12CCC3C(CCc4cc(O)ccc34)C2CC(O)C1O,PROQIPRRNZUXQM-UHFFFAOYSA-N,,ESR1
4284,estriol,Estrogen receptor agonist,ESR2,CC12CCC3C(CCc4cc(O)ccc34)C2CC(O)C1O,PROQIPRRNZUXQM-UHFFFAOYSA-N,,ESR2
4285,estriol,Estrogen receptor agonist,ESR1,COc1ccc2C3CCC4(C)C(O)[C@H](O)CC4C3CCc2c1,UHQGCIIQUZBJAE-JZJKZLICSA-N,,ESR1
4286,estriol,Estrogen receptor agonist,ESR2,COc1ccc2C3CCC4(C)C(O)[C@H](O)CC4C3CCc2c1,UHQGCIIQUZBJAE-JZJKZLICSA-N,,ESR2
4287,estrone,Estrogen receptor agonist,ESR1,C[C@]12CC[C@@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O,DNXHEGUUPJUMQT-DFGXFYAUSA-N,,ESR1
4288,estrone,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,ESR1
4289,estrone,Estrogen receptor agonist,ESR1,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@H]1CCC2=O,DNXHEGUUPJUMQT-KONPQCLYSA-N,,ESR1
4290,estrone,Estrogen receptor agonist,ESR1,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CCC2=O,DNXHEGUUPJUMQT-GUZDXLFXSA-N,,ESR1
4291,GR-235,Estrogen receptor agonist,NR1H4,CC=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-OSJVMJFVSA-N,,NR1H4
4292,guggulsterone,Estrogen receptor agonist,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
4293,guggulsterone,Estrogen receptor agonist,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
4294,guggulsterone,Estrogen receptor agonist,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
4295,guggulsterone,Estrogen receptor agonist,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
4296,guggulsterone,Estrogen receptor agonist,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
4297,guggulsterone,Estrogen receptor agonist,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
4298,guggulsterone,Estrogen receptor agonist,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
4299,guggulsterone,Estrogen receptor agonist,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
4300,guggulsterone,Estrogen receptor agonist,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
4301,guggulsterone,Estrogen receptor agonist,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
4302,hexestrol,Estrogen receptor agonist,ESR1,CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1,PBBGSZCBWVPOOL-HDICACEKSA-N,,ESR1
4303,hexestrol,Estrogen receptor agonist,ESR1,CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1,PBBGSZCBWVPOOL-UHFFFAOYSA-N,,ESR1
4304,levonorgestrel,Estrogen receptor agonist,PGR,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-XUDSTZEESA-N,,PGR
4305,levonorgestrel,Estrogen receptor agonist,PGR,CC[C@@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-ZWMUSQMVSA-N,,PGR
4306,mestranol,Estrogen receptor agonist,ESR1,COc1ccc2[C@@H]3CC[C@@]4(C)[C@@H](CC[C@]4(O)C#C)[C@@H]3CCc2c1,IMSSROKUHAOUJS-HGJUEJDCSA-N,,ESR1
4307,mestranol,Estrogen receptor agonist,ESR1,COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1,IMSSROKUHAOUJS-MJCUULBUSA-N,,ESR1
4308,mestranol,Estrogen receptor agonist,ESR1,COc1ccc2[C@H]3CC[C@@]4(C)[C@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1,IMSSROKUHAOUJS-XKRYSZRTSA-N,,ESR1
4309,mestranol,Estrogen receptor agonist,ESR1,COc1ccc2C3CC[C@@]4(C)C(CC[C@@]4(O)C#C)C3CCc2c1,IMSSROKUHAOUJS-VYJKVFMHSA-N,,ESR1
4310,MF-101,Estrogen receptor agonist,ESR2,Oc1ccc(cc1)[C@@H]1CC(=O)c2ccc(O)cc2O1,FURUXTVZLHCCNA-AWEZNQCLSA-N,,ESR2
4311,MF-101,Estrogen receptor agonist,XDH,Oc1ccc(cc1)[C@@H]1CC(=O)c2ccc(O)cc2O1,FURUXTVZLHCCNA-AWEZNQCLSA-N,,XDH
4312,propylpyrazole,Estrogen receptor agonist,ESR1,CCCc1cn(nc1-c1ccc(O)cc1)-c1ccc(O)cc1,HTMIOGNQDXQXAQ-UHFFFAOYSA-N,,ESR1
4313,tibolone,Estrogen receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,ESR1
4314,tibolone,Estrogen receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,AR
4315,tibolone,Estrogen receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,PGR
4316,tibolone,Estrogen receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,ESR1
4317,tibolone,Estrogen receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,AR
4318,tibolone,Estrogen receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,PGR
4319,JLK-6,Gamma secretase inhibitor,PSEN1,COc1oc(=O)c2cc(N)ccc2c1Cl,AMDGKLWVCUXONP-UHFFFAOYSA-N,,PSEN1
4320,benfluorex,Gluconeogenesis inhibitor,HMGCR,CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1,CJAVTWRYCDNHSM-UHFFFAOYSA-N,,HMGCR
4321,alimemazine,Histamine receptor ligand,HRH1,CC(CN(C)C)CN1c2ccccc2Sc2ccccc12,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,,HRH1
4322,alimemazine,Histamine receptor ligand,HRH1,CC(CN(C)C)CN1c2ccccc2Sc3ccccc13.CC(CN(C)C)CN1c2ccccc2Sc3ccccc13,QVKSGMJGGSXIQM-UHFFFAOYSA-N,,HRH1
4323,ketotifen,Histamine receptor ligand,HRH1,CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,,HRH1
4324,trimethadione,Oxazolidine antiepileptic,CACNA1G,CN1C(=O)OC(C)(C)C1=O,IRYJRGCIQBGHIV-UHFFFAOYSA-N,,CACNA1G
4325,carbetocin,Oxytocin receptor agonist,OXTR,CCC(C)[C@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(N)=O)C(C)(C)C,GOANGOSGGZAITB-SVCSGJSHSA-N,,OXTR
4326,amiodarone,Potassium channel blocker,KCNH2,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,,KCNH2
4327,amiodarone,Potassium channel blocker,KCNH2,CCCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,QMKSCTINHJSWPD-UHFFFAOYSA-N,,KCNH2
4328,AS-77,Potassium channel blocker,KCNA3,O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1,KINMYBBFQRSVLL-UHFFFAOYSA-N,,KCNA3
4329,azimilide,Potassium channel blocker,KCNH2,CN1CCN(CCCCN2C(=O)CN(N=Cc3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1,MREBEPTUUMTTIA-PCLIKHOPSA-N,,KCNH2
4330,azimilide,Potassium channel blocker,KCNQ1,CN1CCN(CCCCN2C(=O)CN(N=Cc3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1,MREBEPTUUMTTIA-PCLIKHOPSA-N,,KCNQ1
4331,CP-339818,Potassium channel blocker,KCNA3,CCCCCN=c1ccn(Cc2ccccc2)c2ccccc12,MMGAVKCAGQCFHS-UHFFFAOYSA-N,,KCNA3
4332,dalfampridine,Potassium channel blocker,KCNA1,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA1
4333,dalfampridine,Potassium channel blocker,KCNA2,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA2
4334,dalfampridine,Potassium channel blocker,KCNA3,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA3
4335,dalfampridine,Potassium channel blocker,KCNA4,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA4
4336,dalfampridine,Potassium channel blocker,KCNA5,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA5
4337,dalfampridine,Potassium channel blocker,KCNA6,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA6
4338,dalfampridine,Potassium channel blocker,KCNA7,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA7
4339,dalfampridine,Potassium channel blocker,KCNA10,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNA10
4340,dalfampridine,Potassium channel blocker,KCNB1,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNB1
4341,dalfampridine,Potassium channel blocker,KCNC1,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNC1
4342,dalfampridine,Potassium channel blocker,KCNC2,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNC2
4343,dalfampridine,Potassium channel blocker,KCNC3,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNC3
4344,dalfampridine,Potassium channel blocker,KCND1,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCND1
4345,dalfampridine,Potassium channel blocker,KCND2,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCND2
4346,dalfampridine,Potassium channel blocker,KCND3,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCND3
4347,dalfampridine,Potassium channel blocker,KCNB2,Nc1ccncc1,NUKYPUAOHBNCPY-UHFFFAOYSA-N,,KCNB2
4348,dofetilide,Potassium channel blocker,KCNH2,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IXTMWRCNAAVVAI-UHFFFAOYSA-N,,KCNH2
4349,doxapram,Potassium channel blocker,KCNK3,CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1,XFDJYSQDBULQSI-UHFFFAOYSA-N,,KCNK3
4350,doxapram,Potassium channel blocker,KCNK9,CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1,XFDJYSQDBULQSI-UHFFFAOYSA-N,,KCNK9
4351,DPO-1,Potassium channel blocker,KCNA5,CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1P(=O)(c1ccccc1)c1ccccc1,BPCNGVCAHAIZEE-COPCDDAFSA-N,,KCNA5
4352,E-4031,Potassium channel blocker,KCNH2,Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1,SRUISGSHWFJION-UHFFFAOYSA-N,,KCNH2
4353,ibutilide,Potassium channel blocker,KCNH2,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,ALOBUEHUHMBRLE-UHFFFAOYSA-N,,KCNH2
4354,ibutilide,Potassium channel blocker,CACNA1C,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,ALOBUEHUHMBRLE-UHFFFAOYSA-N,,CACNA1C
4355,ibutilide,Potassium channel blocker,KCNH2,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,HECQGWSAKVGEID-UHFFFAOYSA-N,,KCNH2
4356,ibutilide,Potassium channel blocker,CACNA1C,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,HECQGWSAKVGEID-UHFFFAOYSA-N,,CACNA1C
4357,ivabradine,Potassium channel blocker,HCN4,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN4
4358,ivabradine,Potassium channel blocker,HCN1,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN1
4359,ivabradine,Potassium channel blocker,HCN3,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,,HCN3
4360,linopirdine,Potassium channel blocker,KCNQ2,O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,,KCNQ2
4361,linopirdine,Potassium channel blocker,KCNQ3,O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,,KCNQ3
4362,oleoylethanolamide,Potassium channel blocker,GPR119,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,GPR119
4363,oleoylethanolamide,Potassium channel blocker,PPARA,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,PPARA
4364,oleylethanolamide,Potassium channel blocker,GPR119,CCCCCCCCC=CCCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-UHFFFAOYSA-N,,GPR119
4365,paxilline,Potassium channel blocker,KCNMA1,CC(C)(O)[C@H]1O[C@H]2CC[C@]3(C)[C@]4(C)[C@H](Cc5c4[nH]c6ccccc56)CC[C@@]3(O)C2=CC1=O,ACNHBCIZLNNLRS-UBGQALKQSA-N,,KCNMA1
4366,penitrem-a,Potassium channel blocker,KCNMA1,C[C@]12[C@@H](CC[C@@]3(O)[C@@]45O[C@@H]4[C@@H](O)[C@H](O[C@H]5CC[C@]13C)C(O)=O)[C@@H]1OC(C)(C)[C@H]3C[C@@H]4C(=C)Cc5c(Cl)cc6[nH]c2c1c6c5[C@]34O,UQZQZNKGIUPTGP-DNOATVEHSA-N,,KCNMA1
4367,penitrem-a,Potassium channel blocker,KCNMA1,CC(=C)[C@H]1O[C@H]2CC[C@]3(C)[C@]4(C)[C@@H](CC[C@@]3(O)[C@@]52O[C@@H]5[C@H]1O)[C@@H]6OC(C)(C)[C@H]7C[C@@H]8C(=C)Cc9c(Cl)cc%10[nH]c4c6c%10c9[C@@]87O,JDUWHZOLEDOQSR-JKPSMKLGSA-N,,KCNMA1
4368,vernakalant,Potassium channel blocker,KCNA5,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC,VBHQKCBVWWUUKN-KZNAEPCWSA-N,,KCNA5
4369,XE-991,Potassium channel blocker,KCNQ1,O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12,KHJFBUUFMUBONL-UHFFFAOYSA-N,,KCNQ1
4370,XE-991,Potassium channel blocker,KCNQ2,O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12,KHJFBUUFMUBONL-UHFFFAOYSA-N,,KCNQ2
4371,XE-991,Potassium channel blocker,KCNQ3,O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12,KHJFBUUFMUBONL-UHFFFAOYSA-N,,KCNQ3
4372,AC-55649,Retinoid receptor agonist,RARA,CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O,HXBKPYIEQLLNBK-UHFFFAOYSA-N,,RARA
4373,AC-55649,Retinoid receptor agonist,RARB,CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O,HXBKPYIEQLLNBK-UHFFFAOYSA-N,,RARB
4374,acitretin,Retinoid receptor agonist,RARA,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(O)=O)c(C)c1C,IHUNBGSDBOWDMA-AQFIFDHZSA-N,,RARA
4375,acitretin,Retinoid receptor agonist,RXRG,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(O)=O)c(C)c1C,IHUNBGSDBOWDMA-AQFIFDHZSA-N,,RXRG
4376,acitretin,Retinoid receptor agonist,RARA,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(O)=O)c(C)c1C,IHUNBGSDBOWDMA-UHFFFAOYSA-N,,RARA
4377,acitretin,Retinoid receptor agonist,RXRG,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(O)=O)c(C)c1C,IHUNBGSDBOWDMA-UHFFFAOYSA-N,,RXRG
4378,adapalene,Retinoid receptor agonist,RARA,COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O,LZCDAPDGXCYOEH-UHFFFAOYSA-N,,RARA
4379,adapalene,Retinoid receptor agonist,RARB,COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O,LZCDAPDGXCYOEH-UHFFFAOYSA-N,,RARB
4380,adapalene,Retinoid receptor agonist,RARG,COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O,LZCDAPDGXCYOEH-UHFFFAOYSA-N,,RARG
4381,adarotene,Retinoid receptor agonist,RARB,OC(=O)C=Cc1ccc(cc1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2,QAWBIEIZDDIEMW-FPYGCLRLSA-N,,RARB
4382,adarotene,Retinoid receptor agonist,RARG,OC(=O)C=Cc1ccc(cc1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2,QAWBIEIZDDIEMW-FPYGCLRLSA-N,,RARG
4383,alitretinoin,Retinoid receptor agonist,RARA,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RARA
4384,alitretinoin,Retinoid receptor agonist,RARB,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RARB
4385,alitretinoin,Retinoid receptor agonist,RARG,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RARG
4386,alitretinoin,Retinoid receptor agonist,RXRA,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RXRA
4387,alitretinoin,Retinoid receptor agonist,RXRB,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RXRB
4388,alitretinoin,Retinoid receptor agonist,RXRG,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,,RXRG
4389,AM-580,Retinoid receptor agonist,RARA,CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O,SZWKGOZKRMMLAJ-UHFFFAOYSA-N,,RARA
4390,bexarotene,Retinoid receptor agonist,RXRA,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,,RXRA
4391,bexarotene,Retinoid receptor agonist,RXRB,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,,RXRB
4392,bexarotene,Retinoid receptor agonist,RXRG,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,,RXRG
4393,CD-1530,Retinoid receptor agonist,RARG,OC(=O)c1ccc(cc1)-c1ccc2cc(O)c(cc2c1)C12CC3CC(CC(C3)C1)C2,VCQGNUWOMLYNNG-UHFFFAOYSA-N,,RARG
4394,CD-1530,Retinoid receptor agonist,RARG,OC(=O)c1ccc(cc1)c2ccc3cc(c(O)cc3c2)C4(CC5CC6CC(C5)C4)C6,YSGDXEKQTNMRQN-UHFFFAOYSA-N,,RARG
4395,CD-437,Retinoid receptor agonist,RARG,OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2,LDGIHZJOIQSHPB-UHFFFAOYSA-N,,RARG
4396,fenretinide,Retinoid receptor agonist,RARA,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1,AKJHMTWEGVYYSE-FXILSDISSA-N,,RARA
4397,fenretinide,Retinoid receptor agonist,RARA,CC(=CC=CC(=CC(=O)Nc1ccc(O)cc1)C)C=CC2=C(C)CCCC2(C)C,AKJHMTWEGVYYSE-UHFFFAOYSA-N,,RARA
4398,isotretinoin,Retinoid receptor agonist,RARA,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=C/C(O)=O,SHGAZHPCJJPHSC-XFYACQKRSA-N,,RARA
4399,isotretinoin,Retinoid receptor agonist,RARB,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=C/C(O)=O,SHGAZHPCJJPHSC-XFYACQKRSA-N,,RARB
4400,isotretinoin,Retinoid receptor agonist,RARG,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=C/C(O)=O,SHGAZHPCJJPHSC-XFYACQKRSA-N,,RARG
4401,LE-135,Retinoid receptor agonist,RARB,CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C,YZZAIQOVMHVWBS-UHFFFAOYSA-N,,RARB
4402,methoprene-acid,Retinoid receptor agonist,RXRA,COC(C)(C)CCCC(C)C/C=C/C(=C/C(=O)O)/C,MNYBEULOKRVZKY-TZOAMJEDSA-N,,RXRA
4403,palovarotene,Retinoid receptor agonist,RARG,CC1(C)CCC(C)(C)c2cc(C=Cc3ccc(cc3)C(O)=O)c(Cn3cccn3)cc12,YTFHCXIPDIHOIA-DHZHZOJOSA-N,,RARG
4404,SA-792709,Retinoid receptor agonist,RARA,CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)C=Cc2ccc(cc2)C(=O)O,FOUVTBKPJRMLPE-UHFFFAOYSA-N,,RARA
4405,SA-792709,Retinoid receptor agonist,RARB,CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)C=Cc2ccc(cc2)C(=O)O,FOUVTBKPJRMLPE-UHFFFAOYSA-N,,RARB
4406,tamibarotene,Retinoid receptor agonist,RARA,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12,MUTNCGKQJGXKEM-UHFFFAOYSA-N,,RARA
4407,tamibarotene,Retinoid receptor agonist,RARB,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12,MUTNCGKQJGXKEM-UHFFFAOYSA-N,,RARB
4408,tazarotene,Retinoid receptor agonist,RARA,CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1,OGQICQVSFDPSEI-UHFFFAOYSA-N,,RARA
4409,tazarotene,Retinoid receptor agonist,RARB,CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1,OGQICQVSFDPSEI-UHFFFAOYSA-N,,RARB
4410,tazarotene,Retinoid receptor agonist,RARG,CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1,OGQICQVSFDPSEI-UHFFFAOYSA-N,,RARG
4411,tretinoin,Retinoid receptor agonist,RARA,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARA
4412,tretinoin,Retinoid receptor agonist,RARB,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARB
4413,tretinoin,Retinoid receptor agonist,RARG,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RARG
4414,tretinoin,Retinoid receptor agonist,RORB,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,RORB
4415,tretinoin,Retinoid receptor agonist,RARA,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARA
4416,tretinoin,Retinoid receptor agonist,RARB,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARB
4417,tretinoin,Retinoid receptor agonist,RARG,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RARG
4418,tretinoin,Retinoid receptor agonist,RORB,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-N,,RORB
4419,tretinoin,Retinoid receptor agonist,RARA,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARA
4420,tretinoin,Retinoid receptor agonist,RARB,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARB
4421,tretinoin,Retinoid receptor agonist,RARG,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RARG
4422,tretinoin,Retinoid receptor agonist,RORB,CC(=CCO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-UHFFFAOYSA-N,,RORB
4423,TTNPB,Retinoid receptor agonist,RARB,CC(=C/c1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C,FOIVPCKZDPCJJY-JQIJEIRASA-N,,RARB
4424,TTNPB,Retinoid receptor agonist,RARB,CC(=Cc1ccc(cc1)C(=O)O)c2ccc3c(c2)C(C)(C)CCC3(C)C,FOIVPCKZDPCJJY-UHFFFAOYSA-N,,RARB
4425,dabigatran-etexilate,Serine protease inhibitor,F2,CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1,KSGXQBZTULBEEQ-UHFFFAOYSA-N,,F2
4426,gabexate,Serine protease inhibitor,PRSS1,CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1,YKGYIDJEEQRWQH-UHFFFAOYSA-N,,PRSS1
4427,API-001,Sigma receptor antagonist,SIGMAR1,Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1,DGPGXHRHNRYVDH-UHFFFAOYSA-N,,SIGMAR1
4428,BD-1063,Sigma receptor antagonist,SIGMAR1,CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1,SUIZRDJCBVPASY-UHFFFAOYSA-N,,SIGMAR1
4429,BMY-14802,Sigma receptor antagonist,HTR1A,OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1,ZXUYYZPJUGQHLQ-UHFFFAOYSA-N,,HTR1A
4430,L-693403,Sigma receptor antagonist,SIGMAR1,C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1,GSXJSGMDWKPVBY-UHFFFAOYSA-N,,SIGMAR1
4431,rimcazole,Sigma receptor antagonist,SIGMAR1,C[C@H]1CN(CCCn2c3ccccc3c3ccccc23)C[C@@H](C)N1,GUDVQJXODNJRIJ-CALCHBBNSA-N,,SIGMAR1
4432,rimcazole,Sigma receptor antagonist,SIGMAR1,CC1CN(CCCn2c3ccccc3c4ccccc24)CC(C)N1,GUDVQJXODNJRIJ-UHFFFAOYSA-N,,SIGMAR1
4433,SM-21,Sigma receptor antagonist,PGRMC1,CCC(Oc1ccc(Cl)cc1)C(=O)OC1CC2CCC(C1)N2C,WTPAXDRULIZRDJ-UHFFFAOYSA-N,,PGRMC1
4434,ethosuximide,Succinimide antiepileptic,CACNA1G,CCC1(C)CC(=O)NC1=O,HAPOVYFOVVWLRS-UHFFFAOYSA-N,,CACNA1G
4435,methylene-blue,Tau aggregation inhibitor,ACHE,CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,RBTBFTRPCNLSDE-UHFFFAOYSA-N,,ACHE
4436,BRD-A89049230,Thyroid hormone stimulant,TSHR,COc1ccc(cc1COc1ccc(NC(C)=O)cc1)C1Nc2cccc(O)c2C(=O)N1Cc1ccccc1,JRVXFGNCHKHBPA-UHFFFAOYSA-N,,TSHR
4437,levothyroxine,Thyroid hormone stimulant,THRA,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,,THRA
4438,levothyroxine,Thyroid hormone stimulant,THRB,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,,THRB
4439,liothyronine,Thyroid hormone stimulant,THRA,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,,THRA
4440,liothyronine,Thyroid hormone stimulant,THRB,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,,THRB
4441,tiratricol,Thyroid hormone stimulant,THRB,OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1,UOWZUVNAGUAEQC-UHFFFAOYSA-N,,THRB
4442,AG-494,Tyrosine kinase inhibitor,EGFR,Oc1ccc(C=C(C#N)C(=O)Nc2ccccc2)cc1O,HKHOVJYOELRGMV-UHFFFAOYSA-N,,EGFR
4443,AMG-208,Tyrosine kinase inhibitor,MET,COc1ccc2c(OCc3nnc4ccc(nn34)-c3ccccc3)ccnc2c1,HEAIZQNMNCHNFD-UHFFFAOYSA-N,,MET
4444,aminopurvalanol-a,Tyrosine kinase inhibitor,CDK2,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK2
4445,aminopurvalanol-a,Tyrosine kinase inhibitor,CDK5,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK5
4446,aminopurvalanol-a,Tyrosine kinase inhibitor,CDK1,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,RAMROQQYRRQPDL-HNNXBMFYSA-N,,CDK1
4447,BIBX-1382,Tyrosine kinase inhibitor,EGFR,CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,FTFRZXFNZVCRSK-UHFFFAOYSA-N,,EGFR
4448,BMS-777607,Tyrosine kinase inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
4449,BMS-777607,Tyrosine kinase inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
4450,BMS-777607,Tyrosine kinase inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
4451,BMS-777607,Tyrosine kinase inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
4452,BMS-777607,Tyrosine kinase inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
4453,CP-724714,Tyrosine kinase inhibitor,ERBB2,COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,LLVZBTWPGQVVLW-SNAWJCMRSA-N,,ERBB2
4454,dasatinib,Tyrosine kinase inhibitor,EPHA2,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,EPHA2
4455,dasatinib,Tyrosine kinase inhibitor,ABL1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,ABL1
4456,dasatinib,Tyrosine kinase inhibitor,FYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,FYN
4457,dasatinib,Tyrosine kinase inhibitor,KIT,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,KIT
4458,dasatinib,Tyrosine kinase inhibitor,LCK,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LCK
4459,dasatinib,Tyrosine kinase inhibitor,LYN,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,LYN
4460,dasatinib,Tyrosine kinase inhibitor,PDGFRB,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,PDGFRB
4461,dasatinib,Tyrosine kinase inhibitor,BCR,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,BCR
4462,dasatinib,Tyrosine kinase inhibitor,SRC,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,SRC
4463,dasatinib,Tyrosine kinase inhibitor,YES1,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,YES1
4464,erbstatin-analog,Tyrosine kinase inhibitor,EGFR,COC(=O)C=Cc1cc(O)ccc1O,BQCNSTFWSKOWMA-GORDUTHDSA-N,,EGFR
4465,genistein,Tyrosine kinase inhibitor,CFTR,Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O,TZBJGXHYKVUXJN-UHFFFAOYSA-N,,CFTR
4466,genistein,Tyrosine kinase inhibitor,ESR2,Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O,TZBJGXHYKVUXJN-UHFFFAOYSA-N,,ESR2
4467,genistein,Tyrosine kinase inhibitor,CFTR,OCC1OC(Oc2cc(O)c3c(=O)c(coc3c2)c4ccc(O)cc4)C(O)C(O)C1O,ZCOLJUOHXJRHDI-UHFFFAOYSA-N,,CFTR
4468,genistein,Tyrosine kinase inhibitor,ESR2,OCC1OC(Oc2cc(O)c3c(=O)c(coc3c2)c4ccc(O)cc4)C(O)C(O)C1O,ZCOLJUOHXJRHDI-UHFFFAOYSA-N,,ESR2
4469,GTP-14564,Tyrosine kinase inhibitor,FLT3,c1ccc(cc1)-c1n[nH]c2c1oc1ccccc21,DZQLVVLATXPWBK-UHFFFAOYSA-N,,FLT3
4470,JNJ-38877605,Tyrosine kinase inhibitor,MET,Cn1cc(cn1)-c1ccc2nnc(n2n1)C(F)(F)c1ccc2ncccc2c1,JRWCBEOAFGHNNU-UHFFFAOYSA-N,,MET
4471,purvalanol-b,Tyrosine kinase inhibitor,CDK2,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,,CDK2
4472,purvalanol-b,Tyrosine kinase inhibitor,CDK4,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,,CDK4
4473,purvalanol-b,Tyrosine kinase inhibitor,MAPK1,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,,MAPK1
4474,purvalanol-b,Tyrosine kinase inhibitor,MAPK3,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,,MAPK3
4475,SU-11274,Tyrosine kinase inhibitor,MET,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,FPYJSJDOHRDAMT-KQWNVCNZSA-N,,MET
4476,SU-11274,Tyrosine kinase inhibitor,MET,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)C(=Cc3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,FPYJSJDOHRDAMT-XQNSMLJCSA-N,,MET
4477,SU-11652,Tyrosine kinase inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C/2C(=O)Nc3ccc(Cl)cc23)c1C,XPLJEFSRINKZLC-ATVHPVEESA-N,,KDR
4478,SU-11652,Tyrosine kinase inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C/2C(=O)Nc3ccc(Cl)cc23)c1C,XPLJEFSRINKZLC-ATVHPVEESA-N,,PDGFRB
4479,SU-4312,Tyrosine kinase inhibitor,KDR,CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)cc1,UAKWLVYMKBWHMX-UHFFFAOYSA-N,,KDR
4480,SU-4312,Tyrosine kinase inhibitor,KDR,CN(C)c1ccc(cc1)C=C1/C(=O)Nc2ccccc12,UAKWLVYMKBWHMX-PTNGSMBKSA-N,,KDR
4481,tivantinib,Tyrosine kinase inhibitor,MET,O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23,UCEQXRCJXIVODC-PMACEKPBSA-N,,MET
4482,ABT-702,Adenosine kinase inhibitor,ADK,Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCOCC1,RQCXKDWOCUJWQZ-UHFFFAOYSA-N,,ADK
4483,acefylline,Adenosine receptor agonist,ADORA1,Cn1c2ncn(CC(O)=O)c2c(=O)n(C)c1=O,HCYFGRCYSCXKNQ-UHFFFAOYSA-N,,ADORA1
4484,adenosine,Adenosine receptor agonist,ADORA1,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,OIRDTQYFTABQOQ-KQYNXXCUSA-N,,ADORA1
4485,adenosine,Adenosine receptor agonist,ADORA2A,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,OIRDTQYFTABQOQ-KQYNXXCUSA-N,,ADORA2A
4486,adenosine,Adenosine receptor agonist,ADORA2B,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,OIRDTQYFTABQOQ-KQYNXXCUSA-N,,ADORA2B
4487,adenosine,Adenosine receptor agonist,ADORA3,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,OIRDTQYFTABQOQ-KQYNXXCUSA-N,,ADORA3
4488,BRD-A73929928,Adenosine receptor agonist,ADORA1,OC[C@H]1O[C@H]([C@@H](O)C1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12,GYWXTRVEUURNEW-QPIWWKSXSA-N,,ADORA1
4489,bucladesine,Adenosine receptor agonist,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC,CJGYSWNGNKCJSB-YVLZZHOMSA-N,,PRKACA
4490,bucladesine,Adenosine receptor agonist,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2OP(O)(=O)OC[C@@H]2[C@H]1OC(=O)CCC,ZKSUYDZTGVUZGX-BKCXMMJFSA-N,,PRKACA
4491,bucladesine,Adenosine receptor agonist,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]3O[C@@H]4OP(=O)(O)OC[C@H]4[C@H]3OC(=O)CCC,ZKSUYDZTGVUZGX-VBJMPTANSA-N,,PRKACA
4492,bucladesine,Adenosine receptor agonist,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC,CJGYSWNGNKCJSB-ZBSNKJFMSA-N,,PRKACA
4493,bucladesine,Adenosine receptor agonist,PRKACA,CCCC(=O)Nc1ncnc2n(cnc12)C3OC4COP(=O)(O)OC4C3OC(=O)CCC,CJGYSWNGNKCJSB-UHFFFAOYSA-N,,PRKACA
4494,CGS-21680,Adenosine receptor agonist,ADORA1,CCNC(=O)[C@H]1O[C@H](C(O)C1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12,PAOANWZGLPPROA-PNXXNBOHSA-N,,ADORA1
4495,CGS-21680,Adenosine receptor agonist,ADORA2A,CCNC(=O)[C@H]1O[C@H](C(O)C1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12,PAOANWZGLPPROA-PNXXNBOHSA-N,,ADORA2A
4496,CGS-21680,Adenosine receptor agonist,ADORA1,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23,PAOANWZGLPPROA-UHFFFAOYSA-N,,ADORA1
4497,CGS-21680,Adenosine receptor agonist,ADORA2A,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23,PAOANWZGLPPROA-UHFFFAOYSA-N,,ADORA2A
4498,CV-1808,Adenosine receptor agonist,ADORA2A,Nc1nc(Nc2ccccc2)nc3n(cnc13)C4OC(CO)C(O)C4O,SCNILGOVBBRMBK-UHFFFAOYSA-N,,ADORA2A
4499,GR-79236,Adenosine receptor agonist,ADORA1,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12,GYWXTRVEUURNEW-TVDBPQCTSA-N,,ADORA1
4500,hemado,Adenosine receptor agonist,ADORA3,CCCCC#Cc1nc(NC)c2ncn(C3OC(CO)C(O)C3O)c2n1,KOCIMZNSNPOGOP-UHFFFAOYSA-N,,ADORA3
4501,IB-MECA,Adenosine receptor agonist,ADORA3,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12,HUJXGQILHAUCCV-MOROJQBDSA-N,,ADORA3
4502,IB-MECA,Adenosine receptor agonist,ADORA3,CNC(=O)[C@H]1O[C@H](C(O)[C@H]1O)n2cnc3c(NCc4cccc(I)c4)ncnc23,HUJXGQILHAUCCV-FEWYLQRLSA-N,,ADORA3
4503,IB-MECA,Adenosine receptor agonist,ADORA3,CNC(=O)C1OC(C(O)C1O)n2cnc3c(NCc4cccc(I)c4)ncnc23,HUJXGQILHAUCCV-UHFFFAOYSA-N,,ADORA3
4504,NECA,Adenosine receptor agonist,ADORA1,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)ncnc23,JADDQZYHOWSFJD-UHFFFAOYSA-N,,ADORA1
4505,NECA,Adenosine receptor agonist,ADORA2A,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)ncnc23,JADDQZYHOWSFJD-UHFFFAOYSA-N,,ADORA2A
4506,NECA,Adenosine receptor agonist,ADORA2B,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)ncnc23,JADDQZYHOWSFJD-UHFFFAOYSA-N,,ADORA2B
4507,regadenoson,Adenosine receptor agonist,ADORA2A,CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1,LZPZPHGJDAGEJZ-SMDQVTJXSA-N,,ADORA2A
4508,SDZ-WAG-994,Adenosine receptor agonist,ADORA1,COC1C(O)C(CO)OC1n2cnc3c(NC4CCCCC4)ncnc23,JAKAFSGZUXCHLF-UHFFFAOYSA-N,,ADORA1
4509,colforsin,Adenylyl cyclase activator,ADCY2,CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C,OHCQJHSOBUTRHG-VDCUXWMXSA-N,,ADCY2
4510,colforsin,Adenylyl cyclase activator,ADCY5,CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C,OHCQJHSOBUTRHG-VDCUXWMXSA-N,,ADCY5
4511,forskolin,Adenylyl cyclase activator,ADCY2,CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C,OHCQJHSOBUTRHG-ZYIXGEAZSA-N,,ADCY2
4512,forskolin,Adenylyl cyclase activator,ADCY2,CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C,OHCQJHSOBUTRHG-KGGHGJDLSA-N,,ADCY2
4513,forskolin,Adenylyl cyclase activator,ADCY2,CC(=O)OC1C(O)C2C(C)(C)CCC(O)C2(C)C2(O)C(=O)CC(C)(OC12C)C=C,OHCQJHSOBUTRHG-UHFFFAOYSA-N,,ADCY2
4514,forskolin,Adenylyl cyclase activator,ADCY2,CN1CCN(CCCC(=O)O[C@H]2[C@@H](O)[C@H]3C(C)(C)CC[C@H](O)[C@]3(C)[C@@]4(O)C(=O)C[C@@](C)(O[C@]24C)C=C)CC1,PAYHDZDDAHVPDU-ZQVYKFDISA-N,,ADCY2
4515,SQ-22536,Adenylyl cyclase inhibitor,ADCY1,Nc1ncnc2n(cnc12)C1CCCO1,UKHMZCMKHPHFOT-UHFFFAOYSA-N,,ADCY1
4516,3-MPPI,Adrenergic receptor ligand,ADRA1A,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4ccccc4[nH]c3c2=O)CC1,AQASGOHUMGAWJJ-UHFFFAOYSA-N,,ADRA1A
4517,AD-5467,Aldose reductase inhibitor,AKR1B1,CC(C)C1Oc2c(cccc2N(CC(O)=O)C1=S)C(C)C,CLDJCRWXLDLJLO-UHFFFAOYSA-N,,AKR1B1
4518,alrestatin,Aldose reductase inhibitor,AKR1B1,OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23,GCUCIFQCGJIRNT-UHFFFAOYSA-N,,AKR1B1
4519,ellagic-acid,Aldose reductase inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
4520,ellagic-acid,Aldose reductase inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
4521,ellagic-acid,Aldose reductase inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
4522,ellagic-acid,Aldose reductase inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
4523,ellagic-acid,Aldose reductase inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
4524,ellagic-acid,Aldose reductase inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
4525,ellagic-acid,Aldose reductase inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
4526,ellagic-acid,Aldose reductase inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
4527,epalrestat,Aldose reductase inhibitor,AKR1B1,CC(C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1,CHNUOJQWGUIOLD-NFZZJPOKSA-N,,AKR1B1
4528,fidarestat,Aldose reductase inhibitor,AKR1B1,NC(=O)C1CC2(NC(=O)NC2=O)c2cc(F)ccc2O1,WAAPEIZFCHNLKK-UHFFFAOYSA-N,,AKR1B1
4529,hyperin,Aldose reductase inhibitor,AKR1B1,OCC1OC(Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)c(O)c2)C(O)C(O)C1O,OVSQVDMCBVZWGM-UHFFFAOYSA-N,,AKR1B1
4530,isoquercetin,Aldose reductase inhibitor,AKR1B1,OC[C@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O,OVSQVDMCBVZWGM-QSOFNFLRSA-N,,AKR1B1
4531,ponalrestat,Aldose reductase inhibitor,AKR1B1,OC(=O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c3ccccc13,LKBFFDOJUKLQNY-UHFFFAOYSA-N,,AKR1B1
4532,rhamnetin,Aldose reductase inhibitor,ALOX5,COc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3,JGUZGNYPMHHYRK-UHFFFAOYSA-N,,ALOX5
4533,sorbinil,Aldose reductase inhibitor,AKR1B1,Fc1ccc2OCCC3(NC(=O)NC3=O)c2c1,LXANPKRCLVQAOG-UHFFFAOYSA-N,,AKR1B1
4534,tolrestat,Aldose reductase inhibitor,AKR1B1,COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O,LUBHDINQXIHVLS-UHFFFAOYSA-N,,AKR1B1
4535,ASC-J9,Androgen receptor enhancer,AR,COc1ccc(cc1OC)C=CC(=O)CC(=O)C=Cc1ccc(OC)c(OC)c1,HMJSBVCDPKODEX-NXZHAISVSA-N,,AR
4536,BRD-K55186349,Apelin receptor antagonist,APLNR,[O-][N+](=O)c1ccc(cc1)C(=O)Oc1coc(CSc2ncccn2)cc1=O,UASIRTUMPRQVFY-UHFFFAOYSA-N,,APLNR
4537,cilastatin,Dehydropeptidase inhibitor,DPEP1,CC1(C)C[C@@H]1C(=O)N/C(=CCCCCSC[C@H](N)C(=O)O)/C(=O)O,DHSUYTOATWAVLW-WFVMDLQDSA-N,,DPEP1
4538,cilastatin,Dehydropeptidase inhibitor,DPEP1,CC1(C)CC1C(=O)NC(=CCCCCSCC(N)C(=O)O)C(=O)O,DHSUYTOATWAVLW-UHFFFAOYSA-N,,DPEP1
4539,cilastatin,Dehydropeptidase inhibitor,DPEP1,CC1(C)C[C@H]1C(=O)NC(C(O)=O)=C/CCCCSC[C@@H](N)C(O)=O,DHSUYTOATWAVLW-RXOUDOFYSA-N,,DPEP1
4540,L-glutamic-acid,Glutamate receptor agonist,GRM7,N[C@@H](CCC(O)=O)C(O)=O,WHUUTDBJXJRKMK-VKHMYHEASA-N,,GRM7
4541,L-glutamic-acid,Glutamate receptor agonist,GRM8,N[C@@H](CCC(O)=O)C(O)=O,WHUUTDBJXJRKMK-VKHMYHEASA-N,,GRM8
4542,ampalex,Glutamate receptor agonist,GRIA1,O=C(N1CCCCC1)c1ccc2nccnc2c1,ANDGGVOPIJEHOF-UHFFFAOYSA-N,,GRIA1
4543,aniracetam,Glutamate receptor agonist,DRD2,COc1ccc(cc1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,,DRD2
4544,aniracetam,Glutamate receptor agonist,GRIA1,COc1ccc(cc1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,,GRIA1
4545,aniracetam,Glutamate receptor agonist,GRIA2,COc1ccc(cc1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,,GRIA2
4546,aniracetam,Glutamate receptor agonist,GRIA3,COc1ccc(cc1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,,GRIA3
4547,aniracetam,Glutamate receptor agonist,HTR2A,COc1ccc(cc1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,,HTR2A
4548,dihydroxyphenylglycine,Glutamate receptor agonist,GRM1,NC(C(O)=O)c1cc(O)cc(O)c1,HOOWCUZPEFNHDT-UHFFFAOYSA-N,,GRM1
4549,dihydroxyphenylglycine,Glutamate receptor agonist,GRM5,NC(C(O)=O)c1cc(O)cc(O)c1,HOOWCUZPEFNHDT-UHFFFAOYSA-N,,GRM5
4550,eglumetad,Glutamate receptor agonist,GRM2,N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O,VTAARTQTOOYTES-RGDLXGNYSA-N,,GRM2
4551,eglumetad,Glutamate receptor agonist,GRM3,N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O,VTAARTQTOOYTES-RGDLXGNYSA-N,,GRM3
4552,LY-2140023,Glutamate receptor agonist,GRM3,N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O,AVDUGNCTZRCAHH-MDASVERJSA-N,,GRM3
4553,NMDA,Glutamate receptor agonist,GRIN1,CNC(CC(O)=O)C(O)=O,HOKKHZGPKSLGJE-UHFFFAOYSA-N,,GRIN1
4554,NMDA,Glutamate receptor agonist,GRIN2A,CNC(CC(O)=O)C(O)=O,HOKKHZGPKSLGJE-UHFFFAOYSA-N,,GRIN2A
4555,NMDA,Glutamate receptor agonist,GRIN2B,CNC(CC(O)=O)C(O)=O,HOKKHZGPKSLGJE-UHFFFAOYSA-N,,GRIN2B
4556,PHCCC,Glutamate receptor agonist,GRM1,ON=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1,FPXPIEZPAXSELW-CYVLTUHYSA-N,,GRM1
4557,PHCCC,Glutamate receptor agonist,GRM4,ON=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1,FPXPIEZPAXSELW-CYVLTUHYSA-N,,GRM4
4558,PHCCC,Glutamate receptor agonist,GRM1,ON=C1C2CC2(Oc3ccccc13)C(=O)Nc4ccccc4,FPXPIEZPAXSELW-UHFFFAOYSA-N,,GRM1
4559,PHCCC,Glutamate receptor agonist,GRM4,ON=C1C2CC2(Oc3ccccc13)C(=O)Nc4ccccc4,FPXPIEZPAXSELW-UHFFFAOYSA-N,,GRM4
4560,molsidomine,Guanylyl cyclase activator,GUCY1A1,CCOC(=O)/N=c1/c[n+]([n-]o1)N2CCOCC2,XLFWDASMENKTKL-UHFFFAOYSA-N,,GUCY1A1
4561,molsidomine,Guanylyl cyclase activator,GUCY1A1,CCOC(=O)Nc1c[n+](no1)N1CCOCC1,XLFWDASMENKTKL-UHFFFAOYSA-O,,GUCY1A1
4562,YC-1,Guanylyl cyclase activator,GUCY1A2,OCc1ccc(o1)c2nn(Cc3ccccc3)c4ccccc24,OQQVFCKUDYMWGV-UHFFFAOYSA-N,,GUCY1A2
4563,YC-1,Guanylyl cyclase activator,HIF1A,OCc1ccc(o1)c2nn(Cc3ccccc3)c4ccccc24,OQQVFCKUDYMWGV-UHFFFAOYSA-N,,HIF1A
4564,LY-83583,Guanylyl cyclase inhibitor,GUCY1A2,O=C1C=C(Nc2ccccc2)C(=O)c3cccnc13,GXIJYWUWLNHKNW-UHFFFAOYSA-N,,GUCY1A2
4565,methylene-blue,Guanylyl cyclase inhibitor,ACHE,CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,RBTBFTRPCNLSDE-UHFFFAOYSA-N,,ACHE
4566,vismodegib,Hedgehog pathway inhibitor,SMO,Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O,BPQMGSKTAYIVFO-UHFFFAOYSA-N,,SMO
4567,alimemazine,Histamine receptor agonist,HRH1,CC(CN(C)C)CN1c2ccccc2Sc2ccccc12,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,,HRH1
4568,alimemazine,Histamine receptor agonist,HRH1,CC(CN(C)C)CN1c2ccccc2Sc3ccccc13.CC(CN(C)C)CN1c2ccccc2Sc3ccccc13,QVKSGMJGGSXIQM-UHFFFAOYSA-N,,HRH1
4569,amodiaquine,Histamine receptor agonist,HNMT,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,OVCDSSHSILBFBN-UHFFFAOYSA-N,,HNMT
4570,betahistine,Histamine receptor agonist,HRH3,CNCCc1ccccn1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,,HRH3
4571,betahistine,Histamine receptor agonist,HRH1,CNCCc1ccccn1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,,HRH1
4572,betazole,Histamine receptor agonist,HRH2,NCCc1cc[nH]n1,JXDFEQONERDKSS-UHFFFAOYSA-N,,HRH2
4573,histamine,Histamine receptor agonist,HRH3,NCCc1c[nH]cn1,NTYJJOPFIAHURM-UHFFFAOYSA-N,,HRH3
4574,histamine,Histamine receptor agonist,HRH1,NCCc1c[nH]cn1,NTYJJOPFIAHURM-UHFFFAOYSA-N,,HRH1
4575,histamine,Histamine receptor agonist,HRH2,NCCc1c[nH]cn1,NTYJJOPFIAHURM-UHFFFAOYSA-N,,HRH2
4576,histamine,Histamine receptor agonist,HRH4,NCCc1c[nH]cn1,NTYJJOPFIAHURM-UHFFFAOYSA-N,,HRH4
4577,immepip,Histamine receptor agonist,HRH3,C(C1CCNCC1)c1c[nH]cn1,MCNGUYXRBCIGOV-UHFFFAOYSA-N,,HRH3
4578,immethridine,Histamine receptor agonist,HRH3,C(c1cnc[nH]1)c1ccncc1,DFVSGZHJSIEEQQ-UHFFFAOYSA-N,,HRH3
4579,ketotifen,Histamine receptor agonist,HRH1,CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,,HRH1
4580,lidocaine,Histamine receptor agonist,SCN5A,CCN(CC)CC(=O)Nc1c(C)cccc1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,,SCN5A
4581,lidocaine,Histamine receptor agonist,SCN9A,CCN(CC)CC(=O)Nc1c(C)cccc1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,,SCN9A
4582,lidocaine,Histamine receptor agonist,SCN10A,CCN(CC)CC(=O)Nc1c(C)cccc1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,,SCN10A
4583,anisodamine,Lipid peroxidase inhibitor,ADRA1A,CN1C2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1,WTQYWNWRJNXDEG-GZPFGDLZSA-N,,ADRA1A
4584,ursolic-acid,Lipid peroxidase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
4585,ursolic-acid,Lipid peroxidase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
4586,ursolic-acid,Lipid peroxidase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
4587,ursolic-acid,Lipid peroxidase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
4588,ER-27319,Mediator release inhibitor,SYK,Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O,CFPDEQBPNROZDC-UHFFFAOYSA-N,,SYK
4589,8-M-PDOT,Melatonin receptor agonist,MTNR1A,CCC(=O)NC1CCc2cccc(OC)c2C1,RVIGBTUDFAGRTQ-UHFFFAOYSA-N,,MTNR1A
4590,8-M-PDOT,Melatonin receptor agonist,MTNR1B,CCC(=O)NC1CCc2cccc(OC)c2C1,RVIGBTUDFAGRTQ-UHFFFAOYSA-N,,MTNR1B
4591,agomelatine,Melatonin receptor agonist,HTR2C,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,HTR2C
4592,agomelatine,Melatonin receptor agonist,MTNR1A,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,MTNR1A
4593,agomelatine,Melatonin receptor agonist,MTNR1B,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,MTNR1B
4594,melatonin,Melatonin receptor agonist,MTNR1A,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,DRLFMBDRBRZALE-UHFFFAOYSA-N,,MTNR1A
4595,melatonin,Melatonin receptor agonist,MTNR1B,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,DRLFMBDRBRZALE-UHFFFAOYSA-N,,MTNR1B
4596,ramelteon,Melatonin receptor agonist,MTNR1A,CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,,MTNR1A
4597,ramelteon,Melatonin receptor agonist,MTNR1B,CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,,MTNR1B
4598,alvimopan,Opioid receptor antagonist,OPRD1,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1,UPNUIXSCZBYVBB-JVFUWBCBSA-N,,OPRD1
4599,alvimopan,Opioid receptor antagonist,OPRK1,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1,UPNUIXSCZBYVBB-JVFUWBCBSA-N,,OPRK1
4600,alvimopan,Opioid receptor antagonist,OPRM1,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1,UPNUIXSCZBYVBB-JVFUWBCBSA-N,,OPRM1
4601,beta-funaltrexamine,Opioid receptor antagonist,OPRM1,COC(=O)C=CC(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45,PQKHESYTSKMWFP-WZJCLRDWSA-N,,OPRM1
4602,BRD-K18722736,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)C(C[C@@]35O)=Cc1ccccc1,WXOUFNFMPVMGFZ-BDQAUFNLSA-N,,OPRD1
4603,butorphanol-(+)-tartrate,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRD1
4604,butorphanol-(+)-tartrate,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRK1
4605,butorphanol-(+)-tartrate,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,,OPRM1
4606,JTC-801,Opioid receptor antagonist,OPRL1,CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1,VTGBZWHPJFMTKS-UHFFFAOYSA-N,,OPRL1
4607,lobelanidine,Opioid receptor antagonist,OPRM1,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,OPRM1
4608,lobelanidine,Opioid receptor antagonist,SLC18A2,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,SLC18A2
4609,methylnaltrexone,Opioid receptor antagonist,OPRK1,C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O,JVLBPIPGETUEET-RESYIPQXSA-O,,OPRK1
4610,methylnaltrexone,Opioid receptor antagonist,OPRM1,C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O,JVLBPIPGETUEET-RESYIPQXSA-O,,OPRM1
4611,nalbuphine,Opioid receptor antagonist,OPRD1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRD1
4612,nalbuphine,Opioid receptor antagonist,OPRK1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRK1
4613,nalbuphine,Opioid receptor antagonist,OPRM1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-CEDHKZHLSA-N,,OPRM1
4614,nalbuphine,Opioid receptor antagonist,OPRD1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRD1
4615,nalbuphine,Opioid receptor antagonist,OPRK1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRK1
4616,nalbuphine,Opioid receptor antagonist,OPRM1,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45,NETZHAKZCGBWSS-XDWDPSITSA-N,,OPRM1
4617,nalbuphine,Opioid receptor antagonist,OPRD1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRD1
4618,nalbuphine,Opioid receptor antagonist,OPRK1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRK1
4619,nalbuphine,Opioid receptor antagonist,OPRM1,OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54,NETZHAKZCGBWSS-OCKIPSRKSA-N,,OPRM1
4620,nalmefene,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O,WJBLNOPPDWQMCH-UHFFFAOYSA-N,,OPRD1
4621,nalmefene,Opioid receptor antagonist,OPRK1,Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O,WJBLNOPPDWQMCH-UHFFFAOYSA-N,,OPRK1
4622,nalmefene,Opioid receptor antagonist,OPRM1,Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O,WJBLNOPPDWQMCH-UHFFFAOYSA-N,,OPRM1
4623,naloxone,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC=C)CC[C@]4(C5Oc1c24)[C@@]3(O)CCC5=O,UZHSEJADLWPNLE-OGLQFSJHSA-N,,OPRD1
4624,naloxone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC=C)CC[C@]4(C5Oc1c24)[C@@]3(O)CCC5=O,UZHSEJADLWPNLE-OGLQFSJHSA-N,,OPRK1
4625,naloxone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC=C)CC[C@]4(C5Oc1c24)[C@@]3(O)CCC5=O,UZHSEJADLWPNLE-OGLQFSJHSA-N,,OPRM1
4626,naloxone,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,,OPRD1
4627,naloxone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,,OPRK1
4628,naloxone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,,OPRM1
4629,naloxone,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC=C)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-IPFLSCHISA-N,,OPRD1
4630,naloxone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC=C)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-IPFLSCHISA-N,,OPRK1
4631,naloxone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC=C)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-IPFLSCHISA-N,,OPRM1
4632,naloxone,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=NNC(=O)c6ccccc6,AKXCFAYOTIEFOH-UHFFFAOYSA-N,,OPRD1
4633,naloxone,Opioid receptor antagonist,OPRK1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=NNC(=O)c6ccccc6,AKXCFAYOTIEFOH-UHFFFAOYSA-N,,OPRK1
4634,naloxone,Opioid receptor antagonist,OPRM1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=NNC(=O)c6ccccc6,AKXCFAYOTIEFOH-UHFFFAOYSA-N,,OPRM1
4635,naloxone,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=O,UZHSEJADLWPNLE-UHFFFAOYSA-N,,OPRD1
4636,naloxone,Opioid receptor antagonist,OPRK1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=O,UZHSEJADLWPNLE-UHFFFAOYSA-N,,OPRK1
4637,naloxone,Opioid receptor antagonist,OPRM1,Oc1ccc2CC3N(CC=C)CCC4(C5Oc1c24)C3(O)CCC5=O,UZHSEJADLWPNLE-UHFFFAOYSA-N,,OPRM1
4638,naloxone-benzoylhydrazone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(CC[C@@]35O)=NNC(=O)c1ccccc1,AKXCFAYOTIEFOH-XTNAHFASSA-N,,OPRK1
4639,naloxone-benzoylhydrazone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(CC[C@@]35O)=NNC(=O)c1ccccc1,AKXCFAYOTIEFOH-XTNAHFASSA-N,,OPRM1
4640,naltrexone,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-XFWGSAIBSA-N,,OPRD1
4641,naltrexone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-XFWGSAIBSA-N,,OPRK1
4642,naltrexone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-XFWGSAIBSA-N,,OPRM1
4643,naltrexone,Opioid receptor antagonist,OPRD1,Oc1ccc2C[C@H]3N(CC4CC4)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-PODIIYFMSA-N,,OPRD1
4644,naltrexone,Opioid receptor antagonist,OPRK1,Oc1ccc2C[C@H]3N(CC4CC4)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-PODIIYFMSA-N,,OPRK1
4645,naltrexone,Opioid receptor antagonist,OPRM1,Oc1ccc2C[C@H]3N(CC4CC4)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O,DQCKKXVULJGBQN-PODIIYFMSA-N,,OPRM1
4646,naltrexone,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)CCC6=O,DQCKKXVULJGBQN-UHFFFAOYSA-N,,OPRD1
4647,naltrexone,Opioid receptor antagonist,OPRK1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)CCC6=O,DQCKKXVULJGBQN-UHFFFAOYSA-N,,OPRK1
4648,naltrexone,Opioid receptor antagonist,OPRM1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)CCC6=O,DQCKKXVULJGBQN-UHFFFAOYSA-N,,OPRM1
4649,naltriben,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1oc2ccccc2c1C[C@@]35O,ZHVWWEYETMPAMX-OOGIKFLQSA-N,,OPRD1
4650,naltriben,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)Cc7c6oc8ccccc78,ZHVWWEYETMPAMX-UHFFFAOYSA-N,,OPRD1
4651,naltrindole,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2ccccc2c1C[C@@]35O,WIYUZYBFCWCCQJ-OOGIKFLQSA-N,,OPRD1
4652,naltrindole,Opioid receptor antagonist,OPRD1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)Cc7c6[nH]c8ccccc78,WIYUZYBFCWCCQJ-UHFFFAOYSA-N,,OPRD1
4653,nor-binaltorphimine,Opioid receptor antagonist,OPRK1,Oc1ccc2CC3N(CC4CC4)CCC5(C6Oc1c25)C3(O)Cc7c8CC9(O)C%10Cc%11ccc(O)c%12OC(c8[nH]c67)C9(CCN%10CC%13CC%13)c%12%11,APSUXPSYBJVPPS-UHFFFAOYSA-N,,OPRK1
4654,SDM-25N,Opioid receptor antagonist,OPRD1,CC(=C)CN1CC[C@@]23[C@H]4Oc5c2c(CC1[C@]3(O)Cc1c4[nH]c2ccccc12)ccc5O,ZFMVWAWSKLAVOE-OOGIKFLQSA-N,,OPRD1
4655,taxifolin,Opioid receptor antagonist,ADIPOR2,O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1ccc(O)c(O)c1,CXQWRCVTCMQVQX-LSDHHAIUSA-N,,ADIPOR2
4656,taxifolin,Opioid receptor antagonist,ADIPOR2,O[C@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c3ccc(O)c(O)c3,CXQWRCVTCMQVQX-HUUCEWRRSA-N,,ADIPOR2
4657,almorexant,Orexin receptor antagonist,HCRTR1,CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1,DKMACHNQISHMDN-RPLLCQBOSA-N,,HCRTR1
4658,almorexant,Orexin receptor antagonist,HCRTR2,CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1,DKMACHNQISHMDN-RPLLCQBOSA-N,,HCRTR2
4659,SB-334867,Orexin receptor antagonist,HCRTR1,Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1,AKMNUCBQGHFICM-UHFFFAOYSA-N,,HCRTR1
4660,SB-408124,Orexin receptor antagonist,HCRTR1,CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1,JTARFZSNUAGHRB-UHFFFAOYSA-N,,HCRTR1
4661,suvorexant,Orexin receptor antagonist,HCRTR1,C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1,JYTNQNCOQXFQPK-MRXNPFEDSA-N,,HCRTR1
4662,suvorexant,Orexin receptor antagonist,HCRTR2,C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1,JYTNQNCOQXFQPK-MRXNPFEDSA-N,,HCRTR2
4663,myricitrin,Protein kinase C inhibitor,NOS1,C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1O,DCYOADKBABEMIQ-FLCVNNLFSA-N,,NOS1
4664,myricitrin,Protein kinase C inhibitor,PRKCA,C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1O,DCYOADKBABEMIQ-FLCVNNLFSA-N,,PRKCA
4665,adatanserin,Serotonin receptor agonist,HTR1A,O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2,HPFLVTSWRFCPCV-UHFFFAOYSA-N,,HTR1A
4666,adatanserin,Serotonin receptor agonist,HTR2A,O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2,HPFLVTSWRFCPCV-UHFFFAOYSA-N,,HTR2A
4667,adoprazine,Serotonin receptor agonist,DRD2,Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1,IUVSEUFHPNITEQ-UHFFFAOYSA-N,,DRD2
4668,adoprazine,Serotonin receptor agonist,HTR1A,Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1,IUVSEUFHPNITEQ-UHFFFAOYSA-N,,HTR1A
4669,almotriptan,Serotonin receptor agonist,HTR1B,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,,HTR1B
4670,almotriptan,Serotonin receptor agonist,HTR1D,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,,HTR1D
4671,anpirtoline,Serotonin receptor agonist,HTR1B,Clc1cccc(SC2CCNCC2)n1,GGALEXMXDMUMDM-UHFFFAOYSA-N,,HTR1B
4672,aripiprazole,Serotonin receptor agonist,DRD2,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,DRD2
4673,aripiprazole,Serotonin receptor agonist,HRH1,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HRH1
4674,aripiprazole,Serotonin receptor agonist,HTR1A,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1A
4675,aripiprazole,Serotonin receptor agonist,HTR1B,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1B
4676,aripiprazole,Serotonin receptor agonist,HTR1D,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1D
4677,aripiprazole,Serotonin receptor agonist,HTR2A,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR2A
4678,aripiprazole,Serotonin receptor agonist,HTR2C,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR2C
4679,BP-554,Serotonin receptor agonist,HTR1A,C(COc1ccc2OCOc2c1)CN1CCN(CC1)c1ccccc1,VUSNBQDZGKZEDL-UHFFFAOYSA-N,,HTR1A
4680,BRL-54443,Serotonin receptor agonist,HTR1E,CN1CCC(CC1)c1c[nH]c2ccc(O)cc12,WKNFADCGOAHBPG-UHFFFAOYSA-N,,HTR1E
4681,BRL-54443,Serotonin receptor agonist,HTR1F,CN1CCC(CC1)c1c[nH]c2ccc(O)cc12,WKNFADCGOAHBPG-UHFFFAOYSA-N,,HTR1F
4682,buspirone,Serotonin receptor agonist,HTR1A,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,,HTR1A
4683,BW-723C86,Serotonin receptor agonist,HTR2B,CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12,ALFGDCNSEBJYSP-UHFFFAOYSA-N,,HTR2B
4684,CGS-12066B,Serotonin receptor agonist,HTR1B,CN1CCN(CC1)c2nc3cc(ccc3n4cccc24)C(F)(F)F,LXFHSCDLMBZYKY-UHFFFAOYSA-N,,HTR1B
4685,cisapride,Serotonin receptor agonist,HTR4,CO[C@@H]1CN(CCCOc2ccc(F)cc2)CC[C@@H]1NC(=O)c3cc(Cl)c(N)cc3OC,DCSUBABJRXZOMT-RBBKRZOGSA-N,,HTR4
4686,cisapride,Serotonin receptor agonist,KCNH2,CO[C@@H]1CN(CCCOc2ccc(F)cc2)CC[C@@H]1NC(=O)c3cc(Cl)c(N)cc3OC,DCSUBABJRXZOMT-RBBKRZOGSA-N,,KCNH2
4687,cisapride,Serotonin receptor agonist,HTR4,CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c1cc(Cl)c(N)cc1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,,HTR4
4688,cisapride,Serotonin receptor agonist,KCNH2,CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c1cc(Cl)c(N)cc1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,,KCNH2
4689,cisapride,Serotonin receptor agonist,HTR4,COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC,DCSUBABJRXZOMT-UHFFFAOYSA-N,,HTR4
4690,cisapride,Serotonin receptor agonist,KCNH2,COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC,DCSUBABJRXZOMT-UHFFFAOYSA-N,,KCNH2
4691,CP-94253,Serotonin receptor agonist,HTR1B,CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1,KWQWBZIGHIOKIO-UHFFFAOYSA-N,,HTR1B
4692,cyclobenzaprine,Serotonin receptor agonist,HTR2A,CN(C)CCC=C1c2ccccc2C=Cc2ccccc12,JURKNVYFZMSNLP-UHFFFAOYSA-N,,HTR2A
4693,dexfenfluramine,Serotonin receptor agonist,SLC6A4,CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F,DBGIVFWFUFKIQN-VIFPVBQESA-N,,SLC6A4
4694,donitriptan,Serotonin receptor agonist,HTR1B,NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12,SOHCKWZVTCTQBG-UHFFFAOYSA-N,,HTR1B
4695,donitriptan,Serotonin receptor agonist,HTR1D,NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12,SOHCKWZVTCTQBG-UHFFFAOYSA-N,,HTR1D
4696,EMD-386088,Serotonin receptor agonist,HTR6,Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1,BPPGPYJBCVXILI-UHFFFAOYSA-N,,HTR6
4697,ergometrine,Serotonin receptor agonist,HTR2A,CC(CO)NC(=O)C1CN(C)C2Cc3c[nH]c4cccc(C2=C1)c34,WVVSZNPYNCNODU-UHFFFAOYSA-N,,HTR2A
4698,GR-46611,Serotonin receptor agonist,HTR1D,COc1ccc(CNC(=O)C=Cc2ccc3[nH]cc(CCN(C)C)c3c2)cc1,LBVZWEWTNUDWNS-YRNVUSSQSA-N,,HTR1D
4699,ipsapirone,Serotonin receptor agonist,HTR1A,O=C1N(CCCCN2CCN(CC2)c2ncccn2)S(=O)(=O)c2ccccc12,TZJUVVIWVWFLCD-UHFFFAOYSA-N,,HTR1A
4700,L-694247,Serotonin receptor agonist,HTR1D,CS(=O)(=O)Nc1ccc(Cc2noc(n2)-c2ccc3[nH]cc(CCN)c3c2)cc1,HKXMQLISPYELRD-UHFFFAOYSA-N,,HTR1D
4701,lorcaserin,Serotonin receptor agonist,HTR2C,C[C@H]1CNCCc2ccc(Cl)cc12,XTTZERNUQAFMOF-QMMMGPOBSA-N,,HTR2C
4702,LY-344864,Serotonin receptor agonist,HTR1F,CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1,GKWHICIUSVVNGX-MRXNPFEDSA-N,,HTR1F
4703,MDL-72832,Serotonin receptor agonist,HTR1A,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2O1,HCVRCHQFYYZPHT-UHFFFAOYSA-N,,HTR1A
4704,MK-212,Serotonin receptor agonist,HTR2C,Clc1cncc(n1)N2CCNCC2,CJAWPFJGFFNXQI-UHFFFAOYSA-N,,HTR2C
4705,mosapride,Serotonin receptor agonist,HTR4,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,YPELFRMCRYSPKZ-UHFFFAOYSA-N,,HTR4
4706,NAN-190,Serotonin receptor agonist,HTR1A,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1,SJDOMIRMMUGQQK-UHFFFAOYSA-N,,HTR1A
4707,PNU-22394,Serotonin receptor agonist,HTR2A,Cn1c2CCNCCc2c2ccccc12,ZBXDOQWPGBISAR-UHFFFAOYSA-N,,HTR2A
4708,PNU-22394,Serotonin receptor agonist,HTR2B,Cn1c2CCNCCc2c2ccccc12,ZBXDOQWPGBISAR-UHFFFAOYSA-N,,HTR2B
4709,PNU-22394,Serotonin receptor agonist,HTR2C,Cn1c2CCNCCc2c2ccccc12,ZBXDOQWPGBISAR-UHFFFAOYSA-N,,HTR2C
4710,rizatriptan,Serotonin receptor agonist,HTR1B,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,ULFRLSNUDGIQQP-UHFFFAOYSA-N,,HTR1B
4711,rizatriptan,Serotonin receptor agonist,HTR1D,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,ULFRLSNUDGIQQP-UHFFFAOYSA-N,,HTR1D
4712,rizatriptan,Serotonin receptor agonist,HTR1F,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,ULFRLSNUDGIQQP-UHFFFAOYSA-N,,HTR1F
4713,Ro-60-0175,Serotonin receptor agonist,HTR2A,CC(N)Cn1ccc2cc(F)c(Cl)cc12,XJJZQXUGLLXTHO-UHFFFAOYSA-N,,HTR2A
4714,Ro-60-0175,Serotonin receptor agonist,HTR2B,CC(N)Cn1ccc2cc(F)c(Cl)cc12,XJJZQXUGLLXTHO-UHFFFAOYSA-N,,HTR2B
4715,Ro-60-0175,Serotonin receptor agonist,HTR2C,CC(N)Cn1ccc2cc(F)c(Cl)cc12,XJJZQXUGLLXTHO-UHFFFAOYSA-N,,HTR2C
4716,rotundine,Serotonin receptor agonist,DRD1,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N,,DRD1
4717,rotundine,Serotonin receptor agonist,DRD2,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N,,DRD2
4718,rotundine,Serotonin receptor agonist,DRD3,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N,,DRD3
4719,rotundine,Serotonin receptor agonist,HTR1A,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N,,HTR1A
4720,RU-24969,Serotonin receptor agonist,HTR1A,COc1ccc2[nH]cc(C3=CCNCC3)c2c1,KRVMLPUDAOWOGN-UHFFFAOYSA-N,,HTR1A
4721,RU-24969,Serotonin receptor agonist,HTR1B,COc1ccc2[nH]cc(C3=CCNCC3)c2c1,KRVMLPUDAOWOGN-UHFFFAOYSA-N,,HTR1B
4722,RU-24969,Serotonin receptor agonist,HTR6,COc1ccc2[nH]cc(C3=CCNCC3)c2c1,KRVMLPUDAOWOGN-UHFFFAOYSA-N,,HTR6
4723,S-14506,Serotonin receptor agonist,HTR1A,COc1ccc2cccc(N3CCN(CCNC(=O)c4ccc(F)cc4)CC3)c2c1,IFMQODYDAUKKEN-UHFFFAOYSA-N,,HTR1A
4724,SR-57227A,Serotonin receptor agonist,HTR3A,NC1CCN(CC1)c1cccc(Cl)n1,WPVVMKYQOMJPIN-UHFFFAOYSA-N,,HTR3A
4725,sumatriptan,Serotonin receptor agonist,HTR1A,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,,HTR1A
4726,sumatriptan,Serotonin receptor agonist,HTR1B,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,,HTR1B
4727,sumatriptan,Serotonin receptor agonist,HTR1D,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,,HTR1D
4728,sumatriptan,Serotonin receptor agonist,HTR1F,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,,HTR1F
4729,vortioxetine,Serotonin receptor agonist,HTR1A,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1A
4730,vortioxetine,Serotonin receptor agonist,HTR1B,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1B
4731,vortioxetine,Serotonin receptor agonist,HTR1D,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1D
4732,vortioxetine,Serotonin receptor agonist,HTR7,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR7
4733,vortioxetine,Serotonin receptor agonist,SLC6A4,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,SLC6A4
4734,WAY-161503,Serotonin receptor agonist,HTR2C,Clc1cc2NC(=O)C3CNCCN3c2cc1Cl,PHGWDAICBXUJDU-UHFFFAOYSA-N,,HTR2C
4735,WAY-629,Serotonin receptor agonist,HTR2C,C1CCc2c(C1)n1CCNCc3cccc2c13,OIGHTPDWPMLMGT-UHFFFAOYSA-N,,HTR2C
4736,xaliproden,Serotonin receptor agonist,HTR1A,FC(F)(F)c1cccc(c1)C1=CCN(CCc2ccc3ccccc3c2)CC1,WJJYZXPHLSLMGE-UHFFFAOYSA-N,,HTR1A
4737,zolmitriptan,Serotonin receptor agonist,HTR1A,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,,HTR1A
4738,zolmitriptan,Serotonin receptor agonist,HTR1B,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,,HTR1B
4739,zolmitriptan,Serotonin receptor agonist,HTR1D,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,,HTR1D
4740,zolmitriptan,Serotonin receptor agonist,HTR1F,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,,HTR1F
4741,ursolic-acid,Steryl sulfatase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
4742,ursolic-acid,Steryl sulfatase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
4743,ursolic-acid,Steryl sulfatase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
4744,ursolic-acid,Steryl sulfatase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
4745,resiquimod,Toll-like receptor agonist,TLR7,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,,TLR7
4746,resiquimod,Toll-like receptor agonist,TLR8,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,,TLR8
4747,alfacalcidol,Vitamin D receptor agonist,VDR,CC(C)CCC[C@@H](C)[C@@H]1CC[C@H]2[C@@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,OFHCOWSQAMBJIW-FFVLKWEISA-N,,VDR
4748,alfacalcidol,Vitamin D receptor agonist,VDR,CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=CC=C1/C[C@@H](O)C[C@H](O)C1=C,OFHCOWSQAMBJIW-GITLSTMWSA-N,,VDR
4749,alfacalcidol,Vitamin D receptor agonist,VDR,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C1C[C@@H](O)C[C@H](O)C1=C,OFHCOWSQAMBJIW-HBHUAMBYSA-N,,VDR
4750,calcifediol,Vitamin D receptor agonist,VDR,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)CCC1=C,JWUBBDSIWDLEOM-DTOXIADCSA-N,,VDR
4751,calcifediol,Vitamin D receptor agonist,VDR,CC(CCCC(C)(C)O)C1CCC2C1(C)CCCC2=C/C=C1/CC(O)CCC1=C,JWUBBDSIWDLEOM-DWKIUPLPSA-N,,VDR
4752,calcipotriol,Vitamin D receptor agonist,VDR,C[C@H](C=C[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,LWQQLNNNIPYSNX-UROSTWAQSA-N,,VDR
4753,calcipotriol,Vitamin D receptor agonist,VDR,C[C@H](C=C[C@@H](O)C1CC1)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C1C[C@@H](O)C[C@H](O)C1=C,LWQQLNNNIPYSNX-KAOBTJPLSA-N,,VDR
4754,calcipotriol,Vitamin D receptor agonist,VDR,CC(C=CC(O)C1CC1)C1CCC2C1(C)CCCC2=C/C=C1CC(O)CC(O)C1=C,LWQQLNNNIPYSNX-NNEHDCEKSA-N,,VDR
4755,calcitriol,Vitamin D receptor agonist,VDR,C[C@H](CCCC(C)(C)O)[C@@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,GMRQFYUYWCNGIN-WEARQXOYSA-N,,VDR
4756,calcitriol,Vitamin D receptor agonist,VDR,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,GMRQFYUYWCNGIN-NKMMMXOESA-N,,VDR
4757,calcitriol,Vitamin D receptor agonist,VDR,CC(CCCC(C)(C)O)C1CCC2C(CCC[C@@]12C)=C/C=C1/CC(O)C[C@H](O)C1=C,GMRQFYUYWCNGIN-CSLIWIHMSA-N,,VDR
4758,calcitriol,Vitamin D receptor agonist,VDR,CC(CCCC(C)(C)O)C1CCC2C1(C)CCCC2=C/C=C1/CC(O)CC(O)C1=C,GMRQFYUYWCNGIN-KWJBEKLWSA-N,,VDR
4759,doxercalciferol,Vitamin D receptor agonist,VDR,CC(C)[C@@H](C)C=C[C@@H](C)[C@@H]1CC[C@H]2[C@@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,HKXBNHCUPKIYDM-MYVUTAQISA-N,,VDR
4760,ercalcitriol,Vitamin D receptor agonist,VDR,C[C@H](C=C[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,ZGLHBRQAEXKACO-XJRQOBMKSA-N,,VDR
4761,maxacalcitol,Vitamin D receptor agonist,VDR,[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H],DTXXSJZBSTYZKE-OXMAATCFSA-N,,VDR
4762,paricalcitol,Vitamin D receptor agonist,VDR,C[C@H](C=C[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1C[C@@H](O)C[C@H](O)C1,BPKAHTKRCLCHEA-UBFJEZKGSA-N,,VDR
4763,secalciferol,Vitamin D receptor agonist,VDR,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)CCC1=C,FCKJYANJHNLEEP-XRWYNYHCSA-N,,VDR
4764,seocalcitol,Vitamin D receptor agonist,VDR,CCC(O)(CC)C=CC=C[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,LVLLALCJVJNGQQ-SEODYNFXSA-N,,VDR
4765,tacalcitol,Vitamin D receptor agonist,VDR,CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,BJYLYJCXYAMOFT-RSFVBTMBSA-N,,VDR
4766,alfacalcidol,Vitamin D receptor agonist,VDR,CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCCC2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,OFHCOWSQAMBJIW-AVJTYSNKSA-N,,VDR
4767,allopurinol,Xanthine oxidase inhibitor,XDH,O=c1[nH]cnc2[nH]ncc12,OFCNXPDARWKPPY-UHFFFAOYSA-N,,XDH
4768,febuxostat,Xanthine oxidase inhibitor,XDH,CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O,BQSJTQLCZDPROO-UHFFFAOYSA-N,,XDH
4769,oxypurinol,Xanthine oxidase inhibitor,XDH,O=c1[nH]c2n[nH]cc2c(=O)[nH]1,HXNFUBHNUDHIGC-UHFFFAOYSA-N,,XDH
4770,topiroxostat,Xanthine oxidase inhibitor,XDH,N#Cc1cc(ccn1)-c1n[nH]c(n1)-c1ccncc1,UBVZQGOVTLIHLH-UHFFFAOYSA-N,,XDH
4771,acexamic-acid,5 alpha reductase inhibitor,GAST,CC(=O)NCCCCCC(O)=O,WDSCBUNMANHPFH-UHFFFAOYSA-N,,GAST
4772,dutasteride,5 alpha reductase inhibitor,SRD5A1,C[C@]12CC[C@@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-UUJLXMGASA-N,,SRD5A1
4773,dutasteride,5 alpha reductase inhibitor,SRD5A2,C[C@]12CC[C@@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-UUJLXMGASA-N,,SRD5A2
4774,finasteride,5 alpha reductase inhibitor,SRD5A1,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,,SRD5A1
4775,finasteride,5 alpha reductase inhibitor,SRD5A2,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,,SRD5A2
4776,finasteride,5 alpha reductase inhibitor,SRD5A1,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@@H]3CC[C@]12C,DBEPLOCGEIEOCV-CSSSSBCVSA-N,,SRD5A1
4777,finasteride,5 alpha reductase inhibitor,SRD5A2,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@@H]3CC[C@]12C,DBEPLOCGEIEOCV-CSSSSBCVSA-N,,SRD5A2
4778,finasteride,5 alpha reductase inhibitor,SRD5A1,CC(C)(C)NC(=O)[C@H]1CCC2C3CCC4NC(=O)C=C[C@]4(C)C3CC[C@]12C,DBEPLOCGEIEOCV-BYQKQGHSSA-N,,SRD5A1
4779,finasteride,5 alpha reductase inhibitor,SRD5A2,CC(C)(C)NC(=O)[C@H]1CCC2C3CCC4NC(=O)C=C[C@]4(C)C3CC[C@]12C,DBEPLOCGEIEOCV-BYQKQGHSSA-N,,SRD5A2
4780,CHEMBL-399379,ATP citrase lyase inhibitor,ACLY,COc1ccc(cc1NS(=O)(=O)c1cc(Cl)cc(Cl)c1O)-c1ccccc1,SIIPNDKXZOTLEA-UHFFFAOYSA-N,,ACLY
4781,orciprenaline,Adrenergic receptor agonist,ADRB2,CC(C)NCC(O)c1cc(O)cc(O)c1,LMOINURANNBYCM-UHFFFAOYSA-N,,ADRB2
4782,salbutamol,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,NDAUXUAQIAJITI-UHFFFAOYSA-N,,ADRB2
4783,amfepramone,Adrenergic receptor agonist,SLC6A2,CCN(CC)C(C)C(=O)c1ccccc1,XXEPPPIWZFICOJ-UHFFFAOYSA-N,,SLC6A2
4784,bambuterol,Adrenergic receptor agonist,ADRB2,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C,ANZXOIAKUNOVQU-UHFFFAOYSA-N,,ADRB2
4785,brimonidine,Adrenergic receptor agonist,ADRA2A,Brc1c(NC2=NCCN2)ccc2nccnc12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,,ADRA2A
4786,brimonidine,Adrenergic receptor agonist,ADRA2B,Brc1c(NC2=NCCN2)ccc2nccnc12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,,ADRA2B
4787,brimonidine,Adrenergic receptor agonist,ADRA2C,Brc1c(NC2=NCCN2)ccc2nccnc12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,,ADRA2C
4788,BRL-37344,Adrenergic receptor agonist,ADRB3,C[C@H](Cc1ccc(OCC(O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1,ZGGNJJJYUVRADP-ACJLOTCBSA-N,,ADRB3
4789,buphenine,Adrenergic receptor agonist,ADRB2,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,PTGXAUBQBSGPKF-UHFFFAOYSA-N,,ADRB2
4790,CGP-12177,Adrenergic receptor agonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12,ANAWRRAUQXSHKD-UHFFFAOYSA-N,,ADRB1
4791,CGP-12177,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12,ANAWRRAUQXSHKD-UHFFFAOYSA-N,,ADRB2
4792,CGP-12177,Adrenergic receptor agonist,ADRB3,CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12,ANAWRRAUQXSHKD-UHFFFAOYSA-N,,ADRB3
4793,CGP-12177,Adrenergic receptor agonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12,UMQUQWCJKFOUGV-UHFFFAOYSA-N,,ADRB1
4794,CGP-12177,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12,UMQUQWCJKFOUGV-UHFFFAOYSA-N,,ADRB2
4795,CGP-12177,Adrenergic receptor agonist,ADRB3,CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12,UMQUQWCJKFOUGV-UHFFFAOYSA-N,,ADRB3
4796,cimaterol,Adrenergic receptor agonist,ADRB1,CC(C)NCC(O)c1ccc(N)c(c1)C#N,BUXRLJCGHZZYNE-UHFFFAOYSA-N,,ADRB1
4797,cimaterol,Adrenergic receptor agonist,ADRB2,CC(C)NCC(O)c1ccc(N)c(c1)C#N,BUXRLJCGHZZYNE-UHFFFAOYSA-N,,ADRB2
4798,cimaterol,Adrenergic receptor agonist,ADRB3,CC(C)NCC(O)c1ccc(N)c(c1)C#N,BUXRLJCGHZZYNE-UHFFFAOYSA-N,,ADRB3
4799,cirazoline,Adrenergic receptor agonist,ADRA1A,C(Oc1ccccc1C1CC1)C1=NCCN1,YAORIDZYZDUZCM-UHFFFAOYSA-N,,ADRA1A
4800,clenbuterol,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,STJMRWALKKWQGH-UHFFFAOYSA-N,,ADRB2
4801,clonidine,Adrenergic receptor agonist,ADRA2A,Clc1cccc(Cl)c1N=C1NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,,ADRA2A
4802,clonidine,Adrenergic receptor agonist,ADRA2B,Clc1cccc(Cl)c1N=C1NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,,ADRA2B
4803,clonidine,Adrenergic receptor agonist,ADRA2C,Clc1cccc(Cl)c1N=C1NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,,ADRA2C
4804,cyclobenzaprine,Adrenergic receptor agonist,HTR2A,CN(C)CCC=C1c2ccccc2C=Cc2ccccc12,JURKNVYFZMSNLP-UHFFFAOYSA-N,,HTR2A
4805,dipivefrine,Adrenergic receptor agonist,ADRA1A,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,OCUJLLGVOUDECM-UHFFFAOYSA-N,,ADRA1A
4806,dobutamine,Adrenergic receptor agonist,ADRB1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,JRWZLRBJNMZMFE-UHFFFAOYSA-N,,ADRB1
4807,dobutamine,Adrenergic receptor agonist,ADRB2,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,JRWZLRBJNMZMFE-UHFFFAOYSA-N,,ADRB2
4808,epinephrine,Adrenergic receptor agonist,ADRA1D,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1D
4809,epinephrine,Adrenergic receptor agonist,ADRA1B,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1B
4810,epinephrine,Adrenergic receptor agonist,ADRA1A,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA1A
4811,epinephrine,Adrenergic receptor agonist,ADRA2A,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2A
4812,epinephrine,Adrenergic receptor agonist,ADRA2B,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2B
4813,epinephrine,Adrenergic receptor agonist,ADRA2C,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRA2C
4814,epinephrine,Adrenergic receptor agonist,ADRB1,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB1
4815,epinephrine,Adrenergic receptor agonist,ADRB2,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB2
4816,epinephrine,Adrenergic receptor agonist,ADRB3,CNC[C@H](O)c1ccc(O)c(O)c1,UCTWMZQNUQWSLP-VIFPVBQESA-N,,ADRB3
4817,ergometrine,Adrenergic receptor agonist,HTR2A,CC(CO)NC(=O)C1CN(C)C2Cc3c[nH]c4cccc(C2=C1)c34,WVVSZNPYNCNODU-UHFFFAOYSA-N,,HTR2A
4818,etilefrine,Adrenergic receptor agonist,ADRA1A,CCNCC(O)c1cccc(O)c1,SQVIAVUSQAWMKL-UHFFFAOYSA-N,,ADRA1A
4819,etilefrine,Adrenergic receptor agonist,ADRB1,CCNCC(O)c1cccc(O)c1,SQVIAVUSQAWMKL-UHFFFAOYSA-N,,ADRB1
4820,fenoterol,Adrenergic receptor agonist,ADRB2,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,LSLYOANBFKQKPT-UHFFFAOYSA-N,,ADRB2
4821,formoterol,Adrenergic receptor agonist,ADRB2,COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1,BPZSYCZIITTYBL-ORAYPTAESA-N,,ADRB2
4822,formoterol,Adrenergic receptor agonist,ADRB2,COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1,BPZSYCZIITTYBL-ORAYPTAESA-N,,ADRB2
4823,guanaben-acetate,Adrenergic receptor agonist,ADRA2A,NC(=N)NN=C/c1c(Cl)cccc1Cl,WDZVGELJXXEGPV-PQMHYQBVSA-N,,ADRA2A
4824,guanaben-acetate,Adrenergic receptor agonist,ADRA2B,NC(=N)NN=C/c1c(Cl)cccc1Cl,WDZVGELJXXEGPV-PQMHYQBVSA-N,,ADRA2B
4825,guanaben-acetate,Adrenergic receptor agonist,ADRA2A,NC(=N)NN=Cc1c(Cl)cccc1Cl,WDZVGELJXXEGPV-YIXHJXPBSA-N,,ADRA2A
4826,guanaben-acetate,Adrenergic receptor agonist,ADRA2B,NC(=N)NN=Cc1c(Cl)cccc1Cl,WDZVGELJXXEGPV-YIXHJXPBSA-N,,ADRA2B
4827,guanfacine,Adrenergic receptor agonist,ADRA2A,NC(=N)NC(=O)Cc1c(Cl)cccc1Cl,INJOMKTZOLKMBF-UHFFFAOYSA-N,,ADRA2A
4828,guanfacine,Adrenergic receptor agonist,ADRA2B,NC(=N)NC(=O)Cc1c(Cl)cccc1Cl,INJOMKTZOLKMBF-UHFFFAOYSA-N,,ADRA2B
4829,indacaterol,Adrenergic receptor agonist,ADRB2,CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,QZZUEBNBZAPZLX-QFIPXVFZSA-N,,ADRB2
4830,isoprenaline,Adrenergic receptor agonist,ADRB1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-NSHDSACASA-N,,ADRB1
4831,isoprenaline,Adrenergic receptor agonist,ADRB2,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-NSHDSACASA-N,,ADRB2
4832,isoprenaline,Adrenergic receptor agonist,ADRB3,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-NSHDSACASA-N,,ADRB3
4833,isoprenaline,Adrenergic receptor agonist,ADRB1,CC(C)NCC(O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-UHFFFAOYSA-N,,ADRB1
4834,isoprenaline,Adrenergic receptor agonist,ADRB2,CC(C)NCC(O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-UHFFFAOYSA-N,,ADRB2
4835,isoprenaline,Adrenergic receptor agonist,ADRB3,CC(C)NCC(O)c1ccc(O)c(O)c1,JWZZKOKVBUJMES-UHFFFAOYSA-N,,ADRB3
4836,isoxsuprine,Adrenergic receptor agonist,ADRB2,CC(COc1ccccc1)NC(C)[C@H](O)c1ccc(O)cc1,BMUKKTUHUDJSNZ-JRSKDTKFSA-N,,ADRB2
4837,isoxsuprine,Adrenergic receptor agonist,ADRB2,CC(COc1ccccc1)NC(C)C(O)c2ccc(O)cc2,BMUKKTUHUDJSNZ-UHFFFAOYSA-N,,ADRB2
4838,L-755507,Adrenergic receptor agonist,ADRB3,CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(CCNCC(O)COc3ccc(O)cc3)cc2,NYYJKMXNVNFOFQ-UHFFFAOYSA-N,,ADRB3
4839,levalbuterol,Adrenergic receptor agonist,ADRB2,CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1,NDAUXUAQIAJITI-LBPRGKRZSA-N,,ADRB2
4840,lofexidine,Adrenergic receptor agonist,ADRA2A,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,KSMAGQUYOIHWFS-UHFFFAOYSA-N,,ADRA2A
4841,medetomidine,Adrenergic receptor agonist,ADRA2A,CC(c1c[nH]cn1)c1cccc(C)c1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2A
4842,medetomidine,Adrenergic receptor agonist,ADRA2B,CC(c1c[nH]cn1)c1cccc(C)c1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2B
4843,medetomidine,Adrenergic receptor agonist,ADRA2C,CC(c1c[nH]cn1)c1cccc(C)c1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2C
4844,medetomidine,Adrenergic receptor agonist,ADRA2A,CC(c1cnc[nH]1)c2cccc(C)c2C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2A
4845,medetomidine,Adrenergic receptor agonist,ADRA2B,CC(c1cnc[nH]1)c2cccc(C)c2C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2B
4846,medetomidine,Adrenergic receptor agonist,ADRA2C,CC(c1cnc[nH]1)c2cccc(C)c2C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,,ADRA2C
4847,methoxamine,Adrenergic receptor agonist,ADRA1D,COc1ccc(OC)c(c1)C(O)C(C)N,WJAJPNHVVFWKKL-UHFFFAOYSA-N,,ADRA1D
4848,methoxamine,Adrenergic receptor agonist,ADRA1B,COc1ccc(OC)c(c1)C(O)C(C)N,WJAJPNHVVFWKKL-UHFFFAOYSA-N,,ADRA1B
4849,methoxamine,Adrenergic receptor agonist,ADRA1A,COc1ccc(OC)c(c1)C(O)C(C)N,WJAJPNHVVFWKKL-UHFFFAOYSA-N,,ADRA1A
4850,methyldopa,Adrenergic receptor agonist,ADRA2A,C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O,CJCSPKMFHVPWAR-JTQLQIEISA-N,,ADRA2A
4851,methyldopa,Adrenergic receptor agonist,DDC,C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O,CJCSPKMFHVPWAR-JTQLQIEISA-N,,DDC
4852,midodrine,Adrenergic receptor agonist,ADRA1D,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,PTKSEFOSCHHMPD-UHFFFAOYSA-N,,ADRA1D
4853,midodrine,Adrenergic receptor agonist,ADRA1B,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,PTKSEFOSCHHMPD-UHFFFAOYSA-N,,ADRA1B
4854,midodrine,Adrenergic receptor agonist,ADRA1A,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,PTKSEFOSCHHMPD-UHFFFAOYSA-N,,ADRA1A
4855,modafinil,Adrenergic receptor agonist,SLC6A3,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,,SLC6A3
4856,orciprenaline,Adrenergic receptor agonist,ADRB2,CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1,XNSAMYJBZOLTTD-UHFFFAOYSA-N,,ADRB2
4857,oxymetazoline,Adrenergic receptor agonist,ADRA1D,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA1D
4858,oxymetazoline,Adrenergic receptor agonist,ADRA1B,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA1B
4859,oxymetazoline,Adrenergic receptor agonist,ADRA1A,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA1A
4860,oxymetazoline,Adrenergic receptor agonist,ADRA2A,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA2A
4861,oxymetazoline,Adrenergic receptor agonist,ADRA2B,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA2B
4862,oxymetazoline,Adrenergic receptor agonist,ADRA2C,Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,,ADRA2C
4863,phenylephrine,Adrenergic receptor agonist,ADRA1B,CNC[C@H](O)c1cccc(O)c1,SONNWYBIRXJNDC-VIFPVBQESA-N,,ADRA1B
4864,phenylephrine,Adrenergic receptor agonist,ADRA1A,CNC[C@H](O)c1cccc(O)c1,SONNWYBIRXJNDC-VIFPVBQESA-N,,ADRA1A
4865,procaterol,Adrenergic receptor agonist,ADRB2,CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,FKNXQNWAXFXVNW-BLLLJJGKSA-N,,ADRB2
4866,procaterol,Adrenergic receptor agonist,ADRB2,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,FKNXQNWAXFXVNW-UHFFFAOYSA-N,,ADRB2
4867,rilmenidine,Adrenergic receptor agonist,NISCH,C1CC1C(NC1=NCCO1)C1CC1,CQXADFVORZEARL-UHFFFAOYSA-N,,NISCH
4868,rilmenidine,Adrenergic receptor agonist,ADRA2A,C1CC1C(NC1=NCCO1)C1CC1,CQXADFVORZEARL-UHFFFAOYSA-N,,ADRA2A
4869,rilmenidine,Adrenergic receptor agonist,NISCH,C1CC1C(NC2=NCCO2)C3CC3,CQXADFVORZEARL-UHFFFAOYSA-N,,NISCH
4870,rilmenidine,Adrenergic receptor agonist,ADRA2A,C1CC1C(NC2=NCCO2)C3CC3,CQXADFVORZEARL-UHFFFAOYSA-N,,ADRA2A
4871,ritodrine,Adrenergic receptor agonist,ADRB2,C[C@H](NCCc1ccc(O)cc1)[C@H](O)c2ccc(O)cc2,IOVGROKTTNBUGK-SJCJKPOMSA-N,,ADRB2
4872,ritodrine,Adrenergic receptor agonist,ADRB2,CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1,IOVGROKTTNBUGK-UHFFFAOYSA-N,,ADRB2
4873,salmeterol,Adrenergic receptor agonist,ADRB2,OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1,GIIZNNXWQWCKIB-UHFFFAOYSA-N,,ADRB2
4874,synephrine,Adrenergic receptor agonist,ADRA1A,CNCC(O)c1ccc(O)cc1,YRCWQPVGYLYSOX-UHFFFAOYSA-N,,ADRA1A
4875,talipexole,Adrenergic receptor agonist,DRD2,Nc1nc2CCN(CC=C)CCc2s1,DHSSDEDRBUKTQY-UHFFFAOYSA-N,,DRD2
4876,terbutaline,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,XWTYSIMOBUGWOL-UHFFFAOYSA-N,,ADRB2
4877,terbutaline,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1,BPZKHKAYOKSXAK-UHFFFAOYSA-N,,ADRB2
4878,tulobuterol,Adrenergic receptor agonist,ADRB2,CC(C)(C)NCC(O)c1ccccc1Cl,YREYLAVBNPACJM-UHFFFAOYSA-N,,ADRB2
4879,xamoterol,Adrenergic receptor agonist,ADRB1,OC(CNCCNC(=O)N1CCOCC1)COc1ccc(O)cc1,DXPOSRCHIDYWHW-UHFFFAOYSA-N,,ADRB1
4880,xamoterol,Adrenergic receptor agonist,ADRB1,OC(CNCCNC(=O)N1CCOCC1)COc2ccc(O)cc2.OC(CNCCNC(=O)N1CCOCC1)COc2ccc(O)cc2,PQQZHQGUKPKDBU-UHFFFAOYSA-N,,ADRB1
4881,xylometazoline,Adrenergic receptor agonist,ADRA2A,Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,,ADRA2A
4882,xylometazoline,Adrenergic receptor agonist,ADRA2B,Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,,ADRA2B
4883,xylometazoline,Adrenergic receptor agonist,ADRA2C,Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,,ADRA2C
4884,ZD-2079,Adrenergic receptor agonist,ADRB3,O[C@@H](CNCCOc1ccc(CC(O)=O)cc1)c1ccccc1,SRBPKVWITYPHQR-KRWDZBQOSA-N,,ADRB3
4885,ZD-7114,Adrenergic receptor agonist,ADRB3,COCCNC(=O)COc1ccc(OCCNC[C@@H](O)COc2ccccc2)cc1,RVMBDLSFFNKKLG-GOSISDBHSA-N,,ADRB3
4886,ZD-7114,Adrenergic receptor agonist,ADRB3,COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1,RVMBDLSFFNKKLG-SFHVURJKSA-N,,ADRB3
4887,andarine,Androgen receptor modulator,AR,CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc(c(c2)C(F)(F)F)[N+]([O-])=O)cc1,YVXVTLGIDOACBJ-SFHVURJKSA-N,,AR
4888,enobosarm,Androgen receptor modulator,AR,C[C@@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,JNGVJMBLXIUVRD-GOSISDBHSA-N,,AR
4889,galeterone,Androgen receptor modulator,CYP17A1,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1cnc2ccccc12,PAFKTGFSEFKSQG-BLYLLKCRSA-N,,CYP17A1
4890,galeterone,Androgen receptor modulator,AR,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1cnc2ccccc12,PAFKTGFSEFKSQG-BLYLLKCRSA-N,,AR
4891,MK-0773,Androgen receptor modulator,AR,CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCc5nc6cccnc6[nH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O,GBEUKTWTUSPHEE-JWJWXJQQSA-N,,AR
4892,ostarine,Androgen receptor modulator,AR,C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,JNGVJMBLXIUVRD-SFHVURJKSA-N,,AR
4893,diosmin,Capillary stabilizing agent,AHR,COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1,GZSOSUNBTXMUFQ-YFAPSIMESA-N,,AHR
4894,rutin,Capillary stabilizing agent,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-NVPNHPEKSA-N,,AKR1C3
4895,rutin,Capillary stabilizing agent,AKR1C3,C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-KUKMIBIMSA-N,,AKR1C3
4896,rutin,Capillary stabilizing agent,AKR1C3,CC1OC(OCC2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O,IKGXIBQEEMLURG-UHFFFAOYSA-N,,AKR1C3
4897,flufenamic-acid,Chloride channel antagonist,AR,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,,AR
4898,flufenamic-acid,Chloride channel antagonist,PTGS1,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,,PTGS1
4899,flufenamic-acid,Chloride channel antagonist,PTGS2,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,,PTGS2
4900,flufenamic-acid,Chloride channel antagonist,AKR1C3,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,,AKR1C3
4901,trichlormethiazide,Chloride channel antagonist,SLC12A1,NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl,LMJSLTNSBFUCMU-UHFFFAOYSA-N,,SLC12A1
4902,fludarabine-phosphate,DNA repair enzyme inhibitor,POLA1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,POLA1
4903,fludarabine-phosphate,DNA repair enzyme inhibitor,RRM1,Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,GIUYCYHIANZCFB-FJFJXFQQSA-N,,RRM1
4904,lobelanidine,Dopamine receptor modulator,OPRM1,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,OPRM1
4905,lobelanidine,Dopamine receptor modulator,SLC18A2,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,SLC18A2
4906,BTS-54505,Dopamine reuptake inhibitor,SLC6A2,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A2
4907,BTS-54505,Dopamine reuptake inhibitor,SLC6A3,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A3
4908,BTS-54505,Dopamine reuptake inhibitor,SLC6A4,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A4
4909,diclofensine,Dopamine reuptake inhibitor,DRD1,COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1,ZJDCGVDEEHWEIG-UHFFFAOYSA-N,,DRD1
4910,diclofensine,Dopamine reuptake inhibitor,MAOA,COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1,ZJDCGVDEEHWEIG-UHFFFAOYSA-N,,MAOA
4911,diclofensine,Dopamine reuptake inhibitor,MAOB,COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1,ZJDCGVDEEHWEIG-UHFFFAOYSA-N,,MAOB
4912,mazindol,Dopamine reuptake inhibitor,SLC6A2,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A2
4913,mazindol,Dopamine reuptake inhibitor,SLC6A3,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A3
4914,mazindol,Dopamine reuptake inhibitor,SLC6A4,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A4
4915,gelsemine,Glycine receptor antagonist,GLRA3,CN1C[C@@]2(C=C)C3CC4OC[C@@H]3[C@@H]1[C@H]2[C@@]45C(=O)Nc6ccccc65,NFYYATWFXNPTRM-KMXOBDGGSA-N,,GLRA3
4916,ginkgolide-b,Glycine receptor antagonist,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
4917,ginkgolide-b,Glycine receptor antagonist,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
4918,ginkgolide-b,Glycine receptor antagonist,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
4919,ginkgolide-b,Glycine receptor antagonist,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
4920,ginkgolide-b,Glycine receptor antagonist,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
4921,ginkgolide-b,Glycine receptor antagonist,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
4922,cinaciguat,Guanylate cyclase activator,GUCY1B1,OC(=O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(cc1)C(O)=O,WPYWMXNXEZFMAK-UHFFFAOYSA-N,,GUCY1B1
4923,isosorbide-dinitrate,Guanylate cyclase stimulant,GUCY1A1,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,MOYKHGMNXAOIAT-JGWLITMVSA-N,,GUCY1A1
4924,isosorbide-dinitrate,Guanylate cyclase stimulant,GUCY1B1,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,MOYKHGMNXAOIAT-JGWLITMVSA-N,,GUCY1B1
4925,riociguat,Guanylate cyclase stimulant,GUCY1A1,COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12,WXXSNCNJFUAIDG-UHFFFAOYSA-N,,GUCY1A1
4926,riociguat,Guanylate cyclase stimulant,GUCY1B1,COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12,WXXSNCNJFUAIDG-UHFFFAOYSA-N,,GUCY1B1
4927,polydatin,ICAM-1 expression inhibitor,ICAM1,OC[C@H]1O[C@@H](Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,HSTZMXCBWJGKHG-CUYWLFDKSA-N,,ICAM1
4928,AGN-192403,Imidazoline receptor ligand,NISCH,CC(C)C1C2CCC(C2)C1N,SHXVJSFOJHMEEQ-UHFFFAOYSA-N,,NISCH
4929,GYKI-52466,Kainate receptor antagonist,GRIA1,CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1,LFBZZHVSGAHQPP-UHFFFAOYSA-N,,GRIA1
4930,SYM-2081,Kainate receptor antagonist,GRIK1,C[C@H](C[C@H](N)C(O)=O)C(O)=O,KRKRAOXTGDJWNI-DMTCNVIQSA-N,,GRIK1
4931,SYM-2081,Kainate receptor antagonist,GRIK2,C[C@H](C[C@H](N)C(O)=O)C(O)=O,KRKRAOXTGDJWNI-DMTCNVIQSA-N,,GRIK2
4932,topiramate,Kainate receptor antagonist,GABRA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA1
4933,topiramate,Kainate receptor antagonist,GABRA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA2
4934,topiramate,Kainate receptor antagonist,GABRA3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA3
4935,topiramate,Kainate receptor antagonist,GABRA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA4
4936,topiramate,Kainate receptor antagonist,GABRA5,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA5
4937,topiramate,Kainate receptor antagonist,GABRA6,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA6
4938,topiramate,Kainate receptor antagonist,GABRB1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB1
4939,topiramate,Kainate receptor antagonist,GABRB2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB2
4940,topiramate,Kainate receptor antagonist,GABRB3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB3
4941,topiramate,Kainate receptor antagonist,GABRD,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRD
4942,topiramate,Kainate receptor antagonist,GABRE,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRE
4943,topiramate,Kainate receptor antagonist,GABRG1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG1
4944,topiramate,Kainate receptor antagonist,GABRG2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG2
4945,topiramate,Kainate receptor antagonist,GABRG3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG3
4946,topiramate,Kainate receptor antagonist,GABRP,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRP
4947,topiramate,Kainate receptor antagonist,GRIA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIA1
4948,topiramate,Kainate receptor antagonist,GRIK1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIK1
4949,topiramate,Kainate receptor antagonist,GABRQ,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRQ
4950,topiramate,Kainate receptor antagonist,SCN1A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN1A
4951,topiramate,Kainate receptor antagonist,SCN5A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN5A
4952,topiramate,Kainate receptor antagonist,CA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA2
4953,topiramate,Kainate receptor antagonist,CA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA4
4954,CL-82198,Metalloproteinase inhibitor,MMP13,O=C(NCCCCN1CCOCC1)c2cc3ccccc3o2,KUJQEQAVMNFFAO-UHFFFAOYSA-N,,MMP13
4955,CTS-1027,Metalloproteinase inhibitor,MMP2,ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,,MMP2
4956,CTS-1027,Metalloproteinase inhibitor,MMP3,ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,,MMP3
4957,CTS-1027,Metalloproteinase inhibitor,MMP9,ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,,MMP9
4958,CTS-1027,Metalloproteinase inhibitor,MMP13,ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,,MMP13
4959,doxycycline,Metalloproteinase inhibitor,MMP8,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12,VXVNYCRICCVPTD-MULYGRJNSA-N,,MMP8
4960,doxycycline,Metalloproteinase inhibitor,MMP8,CC1C2C(O)C3C(N(C)C)C(=O)C(C(N)=O)C(=O)C3(O)C(=O)C2C(=O)c2c(O)cccc12,VXVNYCRICCVPTD-UHFFFAOYSA-N,,MMP8
4961,PD-166793,Metalloproteinase inhibitor,MMP2,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP2
4962,PD-166793,Metalloproteinase inhibitor,MMP3,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP3
4963,PD-166793,Metalloproteinase inhibitor,MMP13,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,GJOCABIDMCKCEG-INIZCTEOSA-N,,MMP13
4964,PD-166793,Metalloproteinase inhibitor,MMP2,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP2
4965,PD-166793,Metalloproteinase inhibitor,MMP3,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP3
4966,PD-166793,Metalloproteinase inhibitor,MMP13,CC(C)C(NS(=O)(=O)c1ccc(cc1)c2ccc(Br)cc2)C(=O)O,GJOCABIDMCKCEG-UHFFFAOYSA-N,,MMP13
4967,UK-356618,Metalloproteinase inhibitor,MMP3,C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCc1ccc(c(C)c1)-c1ccccc1)CC(=O)NO)C(C)(C)C)c1ccccc1,JJHRUUKMPWUYIB-HVOSOHGQSA-N,,MMP3
4968,WAY-170523,Metalloproteinase inhibitor,MMP13,Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO,FARMEEAGJWMFSZ-UHFFFAOYSA-N,,MMP13
4969,zoledronic-acid,Metalloproteinase inhibitor,FDPS,OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,,FDPS
4970,clorgiline,Monoamine oxidase inhibitor,MAOA,CN(CCCOc1ccc(Cl)cc1Cl)CC#C,BTFHLQRNAMSNLC-UHFFFAOYSA-N,,MAOA
4971,desoxypeganine,Monoamine oxidase inhibitor,MAOA,C1CN2Cc3ccccc3N=C2C1,WUFQLZTXIWKION-UHFFFAOYSA-N,,MAOA
4972,desoxypeganine,Monoamine oxidase inhibitor,ACHE,C1CN2Cc3ccccc3N=C2C1,WUFQLZTXIWKION-UHFFFAOYSA-N,,ACHE
4973,eprobemide,Monoamine oxidase inhibitor,MAOA,Clc1ccc(cc1)C(=O)NCCCN1CCOCC1,YYFGRAGNYHYWEZ-UHFFFAOYSA-N,,MAOA
4974,harmane,Monoamine oxidase inhibitor,MAOA,Cc1nccc2c3ccccc3[nH]c12,PSFDQSOCUJVVGF-UHFFFAOYSA-N,,MAOA
4975,harmane,Monoamine oxidase inhibitor,MAOB,Cc1nccc2c3ccccc3[nH]c12,PSFDQSOCUJVVGF-UHFFFAOYSA-N,,MAOB
4976,hymecromone,Monoamine oxidase inhibitor,MAOA,Cc1cc(=O)oc2cc(O)ccc12,HSHNITRMYYLLCV-UHFFFAOYSA-N,,MAOA
4977,hymecromone,Monoamine oxidase inhibitor,MAOB,Cc1cc(=O)oc2cc(O)ccc12,HSHNITRMYYLLCV-UHFFFAOYSA-N,,MAOB
4978,isocarboxazid,Monoamine oxidase inhibitor,MAOA,Cc1cc(no1)C(=O)NNCc1ccccc1,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,,MAOA
4979,isocarboxazid,Monoamine oxidase inhibitor,MAOB,Cc1cc(no1)C(=O)NNCc1ccccc1,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,,MAOB
4980,lazabemide,Monoamine oxidase inhibitor,MAOB,NCCNC(=O)c1ccc(Cl)cn1,JZXRLKWWVNUZRB-UHFFFAOYSA-N,,MAOB
4981,methylene-blue,Monoamine oxidase inhibitor,ACHE,CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,RBTBFTRPCNLSDE-UHFFFAOYSA-N,,ACHE
4982,milacemide,Monoamine oxidase inhibitor,MAOB,CCCCCNCC(N)=O,GJNNXIYZWIZFRH-UHFFFAOYSA-N,,MAOB
4983,moclobemide,Monoamine oxidase inhibitor,MAOA,Clc1ccc(cc1)C(=O)NCCN1CCOCC1,YHXISWVBGDMDLQ-UHFFFAOYSA-N,,MAOA
4984,pargyline,Monoamine oxidase inhibitor,MAOB,CN(CC#C)Cc1ccccc1,DPWPWRLQFGFJFI-UHFFFAOYSA-N,,MAOB
4985,phenelzine,Monoamine oxidase inhibitor,MAOA,NNCCc1ccccc1,RMUCZJUITONUFY-UHFFFAOYSA-N,,MAOA
4986,phenelzine,Monoamine oxidase inhibitor,MAOB,NNCCc1ccccc1,RMUCZJUITONUFY-UHFFFAOYSA-N,,MAOB
4987,phenelzine,Monoamine oxidase inhibitor,AOC3,NNCCc1ccccc1,RMUCZJUITONUFY-UHFFFAOYSA-N,,AOC3
4988,piperine,Monoamine oxidase inhibitor,MAOA,O=C(C=CC=Cc1ccc2OCOc2c1)N1CCCCC1,MXXWOMGUGJBKIW-YPCIICBESA-N,,MAOA
4989,piperine,Monoamine oxidase inhibitor,MAOB,O=C(C=CC=Cc1ccc2OCOc2c1)N1CCCCC1,MXXWOMGUGJBKIW-YPCIICBESA-N,,MAOB
4990,pirlindole,Monoamine oxidase inhibitor,MAOA,Cc1ccc2n3CCNC4CCCc(c34)c2c1,IWVRVEIKCBFZNF-UHFFFAOYSA-N,,MAOA
4991,rasagiline,Monoamine oxidase inhibitor,MAOB,C#CCN[C@@H]1CCc2ccccc12,RUOKEQAAGRXIBM-GFCCVEGCSA-N,,MAOB
4992,safinamide,Monoamine oxidase inhibitor,MAOB,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,MAOB
4993,safinamide,Monoamine oxidase inhibitor,SLC6A3,C[C@@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-GFCCVEGCSA-N,,SLC6A3
4994,safinamide,Monoamine oxidase inhibitor,MAOB,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,MAOB
4995,safinamide,Monoamine oxidase inhibitor,SLC6A3,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,,SLC6A3
4996,selegiline,Monoamine oxidase inhibitor,MAOA,C[C@H](Cc1ccccc1)N(C)CC#C,MEZLKOACVSPNER-GFCCVEGCSA-N,,MAOA
4997,selegiline,Monoamine oxidase inhibitor,MAOB,C[C@H](Cc1ccccc1)N(C)CC#C,MEZLKOACVSPNER-GFCCVEGCSA-N,,MAOB
4998,selegiline,Monoamine oxidase inhibitor,MAOA,CC(Cc1ccccc1)N(C)CC#C,MEZLKOACVSPNER-UHFFFAOYSA-N,,MAOA
4999,selegiline,Monoamine oxidase inhibitor,MAOB,CC(Cc1ccccc1)N(C)CC#C,MEZLKOACVSPNER-UHFFFAOYSA-N,,MAOB
5000,tetrindole,Monoamine oxidase inhibitor,MAOA,C1CCC(CC1)c1ccc2n3CCNC4CCCc(c34)c2c1,AUXCHYJDVJZEPG-UHFFFAOYSA-N,,MAOA
5001,tranylcypromine,Monoamine oxidase inhibitor,KDM1A,N[C@@H]1C[C@H]1c1ccccc1,AELCINSCMGFISI-DTWKUNHWSA-N,,KDM1A
5002,tranylcypromine,Monoamine oxidase inhibitor,MAOA,N[C@@H]1C[C@H]1c1ccccc1,AELCINSCMGFISI-DTWKUNHWSA-N,,MAOA
5003,tranylcypromine,Monoamine oxidase inhibitor,MAOB,N[C@@H]1C[C@H]1c1ccccc1,AELCINSCMGFISI-DTWKUNHWSA-N,,MAOB
5004,tranylcypromine,Monoamine oxidase inhibitor,KDM1A,N[C@H]1C[C@@H]1c1ccccc1,AELCINSCMGFISI-BDAKNGLRSA-N,,KDM1A
5005,tranylcypromine,Monoamine oxidase inhibitor,MAOA,N[C@H]1C[C@@H]1c1ccccc1,AELCINSCMGFISI-BDAKNGLRSA-N,,MAOA
5006,tranylcypromine,Monoamine oxidase inhibitor,MAOB,N[C@H]1C[C@@H]1c1ccccc1,AELCINSCMGFISI-BDAKNGLRSA-N,,MAOB
5007,tranylcypromine,Monoamine oxidase inhibitor,KDM1A,NC1C[C@H]1c1ccccc1,AELCINSCMGFISI-IENPIDJESA-N,,KDM1A
5008,tranylcypromine,Monoamine oxidase inhibitor,MAOA,NC1C[C@H]1c1ccccc1,AELCINSCMGFISI-IENPIDJESA-N,,MAOA
5009,tranylcypromine,Monoamine oxidase inhibitor,MAOB,NC1C[C@H]1c1ccccc1,AELCINSCMGFISI-IENPIDJESA-N,,MAOB
5010,amrinone,Phosphodiesterase inhibitor,PDE3A,Nc1cc(c[nH]c1=O)-c1ccncc1,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,,PDE3A
5011,anagrelide,Phosphodiesterase inhibitor,PDE3A,Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,,PDE3A
5012,apremilast,Phosphodiesterase inhibitor,PDE4A,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,,PDE4A
5013,apremilast,Phosphodiesterase inhibitor,PDE4B,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,,PDE4B
5014,apremilast,Phosphodiesterase inhibitor,PDE4C,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,,PDE4C
5015,apremilast,Phosphodiesterase inhibitor,PDE4D,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,,PDE4D
5016,arofylline,Phosphodiesterase inhibitor,PDE4A,CCCn1c(=O)n(-c2ccc(Cl)cc2)c2[nH]cnc2c1=O,GVTLDPJNRVMCAL-UHFFFAOYSA-N,,PDE4A
5017,avanafil,Phosphodiesterase inhibitor,PDE5A,COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl,WEAJZXNPAWBCOA-INIZCTEOSA-N,,PDE5A
5018,caffeine,Phosphodiesterase inhibitor,ADORA1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA1
5019,caffeine,Phosphodiesterase inhibitor,ADORA2A,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA2A
5020,caffeine,Phosphodiesterase inhibitor,ADORA2B,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA2B
5021,caffeine,Phosphodiesterase inhibitor,ITPR1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ITPR1
5022,caffeine,Phosphodiesterase inhibitor,ATM,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ATM
5023,caffeine,Phosphodiesterase inhibitor,RYR1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,RYR1
5024,cilomilast,Phosphodiesterase inhibitor,PDE4A,COc1ccc(cc1OC1CCCC1)[C@@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-LDTOLXSISA-N,,PDE4A
5025,cilomilast,Phosphodiesterase inhibitor,PDE4B,COc1ccc(cc1OC1CCCC1)[C@@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-LDTOLXSISA-N,,PDE4B
5026,cilomilast,Phosphodiesterase inhibitor,PDE4D,COc1ccc(cc1OC1CCCC1)[C@@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-LDTOLXSISA-N,,PDE4D
5027,cilomilast,Phosphodiesterase inhibitor,PDE4A,COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-UHFFFAOYSA-N,,PDE4A
5028,cilomilast,Phosphodiesterase inhibitor,PDE4B,COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-UHFFFAOYSA-N,,PDE4B
5029,cilomilast,Phosphodiesterase inhibitor,PDE4D,COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-UHFFFAOYSA-N,,PDE4D
5030,cilostamide,Phosphodiesterase inhibitor,PDE3A,CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1,UIAYVIIHMORPSJ-UHFFFAOYSA-N,,PDE3A
5031,cilostamide,Phosphodiesterase inhibitor,PDE3B,CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1,UIAYVIIHMORPSJ-UHFFFAOYSA-N,,PDE3B
5032,cilostazol,Phosphodiesterase inhibitor,PDE3A,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,RRGUKTPIGVIEKM-UHFFFAOYSA-N,,PDE3A
5033,dipyridamole,Phosphodiesterase inhibitor,ADA,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,ADA
5034,dipyridamole,Phosphodiesterase inhibitor,PDE10A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE10A
5035,dipyridamole,Phosphodiesterase inhibitor,SLC29A1,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,SLC29A1
5036,dipyridamole,Phosphodiesterase inhibitor,PDE7B,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE7B
5037,dipyridamole,Phosphodiesterase inhibitor,PDE4A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE4A
5038,dipyridamole,Phosphodiesterase inhibitor,PDE8A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE8A
5039,dipyridamole,Phosphodiesterase inhibitor,PDE8B,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE8B
5040,dipyridamole,Phosphodiesterase inhibitor,PDE5A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,,PDE5A
5041,dyphylline,Phosphodiesterase inhibitor,PDE4A,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4A
5042,dyphylline,Phosphodiesterase inhibitor,PDE4B,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4B
5043,dyphylline,Phosphodiesterase inhibitor,PDE4C,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4C
5044,dyphylline,Phosphodiesterase inhibitor,PDE4D,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4D
5045,enprofylline,Phosphodiesterase inhibitor,ADORA2B,CCCn1c2nc[nH]c2c(=O)[nH]c1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,,ADORA2B
5046,enprofylline,Phosphodiesterase inhibitor,PDE4A,CCCn1c2nc[nH]c2c(=O)[nH]c1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,,PDE4A
5047,etazolate,Phosphodiesterase inhibitor,PDE4A,CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C,OPQRBXUBWHDHPQ-UHFFFAOYSA-N,,PDE4A
5048,fosfosal,Phosphodiesterase inhibitor,PTGS1,OC(=O)c1ccccc1OP(O)(O)=O,FFKUDWZICMJVPA-UHFFFAOYSA-N,,PTGS1
5049,fosfosal,Phosphodiesterase inhibitor,PTGS2,OC(=O)c1ccccc1OP(O)(O)=O,FFKUDWZICMJVPA-UHFFFAOYSA-N,,PTGS2
5050,ibudilast,Phosphodiesterase inhibitor,PDE10A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE10A
5051,ibudilast,Phosphodiesterase inhibitor,MIF,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,MIF
5052,ibudilast,Phosphodiesterase inhibitor,PDE3A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE3A
5053,ibudilast,Phosphodiesterase inhibitor,PDE4A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4A
5054,ibudilast,Phosphodiesterase inhibitor,PDE4B,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4B
5055,ibudilast,Phosphodiesterase inhibitor,PDE4C,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4C
5056,ibudilast,Phosphodiesterase inhibitor,PDE4D,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4D
5057,ibudilast,Phosphodiesterase inhibitor,TLR4,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,TLR4
5058,irsogladine,Phosphodiesterase inhibitor,PDE4A,Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl,ATCGGEJZONJOCL-UHFFFAOYSA-N,,PDE4A
5059,ketotifen,Phosphodiesterase inhibitor,HRH1,CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,,HRH1
5060,LY-294002,Phosphodiesterase inhibitor,MTOR,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,MTOR
5061,LY-294002,Phosphodiesterase inhibitor,PIK3CA,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CA
5062,LY-294002,Phosphodiesterase inhibitor,PIK3CB,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CB
5063,LY-294002,Phosphodiesterase inhibitor,PIK3CD,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CD
5064,LY-294002,Phosphodiesterase inhibitor,PIK3CG,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CG
5065,LY-294002,Phosphodiesterase inhibitor,PLK1,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PLK1
5066,LY-294002,Phosphodiesterase inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PRKDC
5067,milrinone,Phosphodiesterase inhibitor,PDE3A,Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N,PZRHRDRVRGEVNW-UHFFFAOYSA-N,,PDE3A
5068,mirodenafil,Phosphodiesterase inhibitor,PDE5A,CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1,MIJFNYMSCFYZNY-UHFFFAOYSA-N,,PDE5A
5069,MY-5445,Phosphodiesterase inhibitor,PDE5A,Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1,CEHQLKSLMFIHBF-UHFFFAOYSA-N,,PDE5A
5070,olprinone,Phosphodiesterase inhibitor,PDE3A,Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N,JPAWFIIYTJQOKW-UHFFFAOYSA-N,,PDE3A
5071,papaverine,Phosphodiesterase inhibitor,PDE10A,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,XQYZDYMELSJDRZ-UHFFFAOYSA-N,,PDE10A
5072,pentoxifylline,Phosphodiesterase inhibitor,ADORA2A,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,,ADORA2A
5073,pentoxifylline,Phosphodiesterase inhibitor,PDE4A,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,,PDE4A
5074,pentoxifylline,Phosphodiesterase inhibitor,PDE4B,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,,PDE4B
5075,pentoxifylline,Phosphodiesterase inhibitor,TNF,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,,TNF
5076,pentoxifylline,Phosphodiesterase inhibitor,PDE5A,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,,PDE5A
5077,PF-02545920,Phosphodiesterase inhibitor,PDE10A,Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1,AZEXWHKOMMASPA-UHFFFAOYSA-N,,PDE10A
5078,PF-04447943,Phosphodiesterase inhibitor,PDE9A,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2n(ncc2c(=O)[nH]1)C1CCOCC1,IWXUVYOOUMLUTQ-CZUORRHYSA-N,,PDE9A
5079,piclamilast,Phosphodiesterase inhibitor,PDE4A,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,,PDE4A
5080,piclamilast,Phosphodiesterase inhibitor,PDE4B,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,,PDE4B
5081,piclamilast,Phosphodiesterase inhibitor,PDE4C,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,,PDE4C
5082,piclamilast,Phosphodiesterase inhibitor,PDE4D,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,,PDE4D
5083,pimobendan,Phosphodiesterase inhibitor,PDE3A,COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C,GLBJJMFZWDBELO-UHFFFAOYSA-N,,PDE3A
5084,propentofylline,Phosphodiesterase inhibitor,PDE1A,CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12,RBQOQRRFDPXAGN-UHFFFAOYSA-N,,PDE1A
5085,Ro-20-1724,Phosphodiesterase inhibitor,PDE4A,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,PDMUULPVBYQBBK-UHFFFAOYSA-N,,PDE4A
5086,Ro-20-1724,Phosphodiesterase inhibitor,PDE4B,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,PDMUULPVBYQBBK-UHFFFAOYSA-N,,PDE4B
5087,Ro-20-1724,Phosphodiesterase inhibitor,PDE4D,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,PDMUULPVBYQBBK-UHFFFAOYSA-N,,PDE4D
5088,roflumilast,Phosphodiesterase inhibitor,PDE4A,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,,PDE4A
5089,roflumilast,Phosphodiesterase inhibitor,PDE4B,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,,PDE4B
5090,roflumilast,Phosphodiesterase inhibitor,PDE4C,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,,PDE4C
5091,roflumilast,Phosphodiesterase inhibitor,PDE4D,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,,PDE4D
5092,rolipram,Phosphodiesterase inhibitor,PDE4A,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,,PDE4A
5093,rolipram,Phosphodiesterase inhibitor,PDE4B,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,,PDE4B
5094,rolipram,Phosphodiesterase inhibitor,PDE4C,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,,PDE4C
5095,rolipram,Phosphodiesterase inhibitor,PDE4D,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,,PDE4D
5096,siguazodan,Phosphodiesterase inhibitor,PDE3A,CNC(NC#N)=N/c1ccc(cc1)C1=NNC(=O)CC1C,NUHPODZZKHQQET-UHFFFAOYSA-N,,PDE3A
5097,siguazodan,Phosphodiesterase inhibitor,PDE3A,CNC(=Nc1ccc(cc1)C2=NNC(=O)CC2C)NC#N,NUHPODZZKHQQET-UHFFFAOYSA-N,,PDE3A
5098,sildenafil,Phosphodiesterase inhibitor,PDE5A,CCCc1nn(C)c2c1[nH]c(nc2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1,BNRNXUUZRGQAQC-UHFFFAOYSA-N,,PDE5A
5099,sildenafil,Phosphodiesterase inhibitor,PDE5A,CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1,BNRNXUUZRGQAQC-UHFFFAOYSA-N,,PDE5A
5100,T-0156,Phosphodiesterase inhibitor,PDE5A,COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1,JEMJAABFSYOLAP-UHFFFAOYSA-N,,PDE5A
5101,tadalafil,Phosphodiesterase inhibitor,PDE11A,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O,WOXKDUGGOYFFRN-IIBYNOLFSA-N,,PDE11A
5102,tadalafil,Phosphodiesterase inhibitor,PDE5A,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O,WOXKDUGGOYFFRN-IIBYNOLFSA-N,,PDE5A
5103,vardenafil,Phosphodiesterase inhibitor,PDE5A,CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1,SECKRCOLJRRGGV-UHFFFAOYSA-N,,PDE5A
5104,vinpocetine,Phosphodiesterase inhibitor,PDE1A,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]23)n1c1ccccc41,DDNCQMVWWZOMLN-UNMCSNQZSA-N,,PDE1A
5105,vinpocetine,Phosphodiesterase inhibitor,PDE1A,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41,DDNCQMVWWZOMLN-IRLDBZIGSA-N,,PDE1A
5106,vinpocetine,Phosphodiesterase inhibitor,PDE1A,CCOC(=O)C1=CC2(CC)CCCN3CCc4c(C32)n1c5ccccc45,DDNCQMVWWZOMLN-UHFFFAOYSA-N,,PDE1A
5107,YM-976,Phosphodiesterase inhibitor,PDE4A,CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1,MNHXYNNKDDXKNP-UHFFFAOYSA-N,,PDE4A
5108,zaprinast,Phosphodiesterase inhibitor,PDE5A,CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1,REZGGXNDEMKIQB-UHFFFAOYSA-N,,PDE5A
5109,zaprinast,Phosphodiesterase inhibitor,PDE5A,CCCOc1ccccc1c2nc3nn[nH]c3c(=O)[nH]2,KFMVHONQQFRNNH-UHFFFAOYSA-N,,PDE5A
5110,zardaverine,Phosphodiesterase inhibitor,PDE4D,COc1cc(ccc1OC(F)F)-c1ccc(=O)[nH]n1,HJMQDJPMQIHLPB-UHFFFAOYSA-N,,PDE4D
5111,P-1075,Potassium channel activator,KCNJ11,CCC(C)(C)N=C(NC#N)Nc1cccnc1,HKZNADVVGXKQDL-UHFFFAOYSA-N,,KCNJ11
5112,P-1075,Potassium channel activator,KCNJ11,CCC(C)(C)NC(=NC#N)Nc1cccnc1,HKZNADVVGXKQDL-UHFFFAOYSA-N,,KCNJ11
5113,levcromakalim,Potassium channel activator,KCNJ8,CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N.CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N1CCCC1=O)C#N,BVMDRSUIADWFLV-PNSAJKJISA-N,,KCNJ8
5114,BMS-191011,Potassium channel activator,KCNMA1,Oc1ccc(Cl)cc1Cn1nc(oc1=O)-c1ccc(cc1)C(F)(F)F,QKOWACXSXTXRKA-UHFFFAOYSA-N,,KCNMA1
5115,cromakalim,Potassium channel activator,KCNJ8,CC1(C)Oc2ccc(C#N)cc2C(C1O)N3CCCC3=O,TVZCRIROJQEVOT-UHFFFAOYSA-N,,KCNJ8
5116,diazoxide,Potassium channel activator,KCNJ11,CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1,GDLBFKVLRPITMI-UHFFFAOYSA-N,,KCNJ11
5117,levcromakalim,Potassium channel activator,KCNJ8,CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N,TVZCRIROJQEVOT-CABCVRRESA-N,,KCNJ8
5118,minoxidil,Potassium channel activator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
5119,minoxidil,Potassium channel activator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
5120,minoxidil,Potassium channel activator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
5121,minoxidil,Potassium channel activator,ABCC9,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,ABCC9
5122,minoxidil,Potassium channel activator,KCNJ8,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ8
5123,minoxidil,Potassium channel activator,KCNJ11,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,ZFMITUMMTDLWHR-UHFFFAOYSA-N,,KCNJ11
5124,PCO-400,Potassium channel activator,KCNJ8,CC1(C)Oc2ccc(cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N,WJBHHTPFTVKZCV-CVEARBPZSA-N,,KCNJ8
5125,pinacidil,Potassium channel activator,ABCC9,CC(C(C)(C)C)N=C(/NC#N)Nc1ccncc1,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
5126,pinacidil,Potassium channel activator,ABCC8,CC(C(C)(C)C)N=C(/NC#N)Nc1ccncc1,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
5127,pinacidil,Potassium channel activator,ABCC9,CC(NC(Nc1ccncc1)=NC#N)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
5128,pinacidil,Potassium channel activator,ABCC8,CC(NC(Nc1ccncc1)=NC#N)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
5129,pinacidil,Potassium channel activator,ABCC9,CC(NC(=NC#N)Nc1ccncc1)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC9
5130,pinacidil,Potassium channel activator,ABCC8,CC(NC(=NC#N)Nc1ccncc1)C(C)(C)C,IVVNZDGDKPTYHK-UHFFFAOYSA-N,,ABCC8
5131,retigabine,Potassium channel activator,KCNQ2,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N,,KCNQ2
5132,retigabine,Potassium channel activator,KCNQ3,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N,,KCNQ3
5133,retigabine,Potassium channel activator,KCNQ5,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N,,KCNQ5
5134,retigabine,Potassium channel activator,KCNQ4,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N,,KCNQ4
5135,Y-26763,Potassium channel activator,KCNJ8,CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N,IWTCFIIOUXJOOV-OLZOCXBDSA-N,,KCNJ8
5136,Y-27152,Potassium channel activator,KCNJ8,CC(=O)N(OCc1ccccc1)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N,RHFUXPCCELGMFC-UXHICEINSA-N,,KCNJ8
5137,guggulsterone,Pregnane X receptor agonist,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
5138,guggulsterone,Pregnane X receptor agonist,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
5139,guggulsterone,Pregnane X receptor agonist,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
5140,guggulsterone,Pregnane X receptor agonist,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
5141,guggulsterone,Pregnane X receptor agonist,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
5142,guggulsterone,Pregnane X receptor agonist,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
5143,guggulsterone,Pregnane X receptor agonist,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
5144,guggulsterone,Pregnane X receptor agonist,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
5145,guggulsterone,Pregnane X receptor agonist,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
5146,guggulsterone,Pregnane X receptor agonist,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
5147,alprostadil,Prostanoid receptor agonist,PTGER1,CCCCC[C@H](O)C=C[C@@H]1[C@@H](O)CC(=O)[C@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-AIJKCLAYSA-N,,PTGER1
5148,alprostadil,Prostanoid receptor agonist,PTGER2,CCCCC[C@H](O)C=C[C@@H]1[C@@H](O)CC(=O)[C@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-AIJKCLAYSA-N,,PTGER2
5149,alprostadil,Prostanoid receptor agonist,PTGER1,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,,PTGER1
5150,alprostadil,Prostanoid receptor agonist,PTGER2,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,,PTGER2
5151,bimatoprost,Prostanoid receptor agonist,PTGFR,CCNC(=O)CCCC=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1C=CC(O)CCc1ccccc1,AQOKCDNYWBIDND-GCYMYIANSA-N,,PTGFR
5152,bimatoprost,Prostanoid receptor agonist,PTGFR,CCNC(=O)CCCC=C/CC1C(O)CC(O)[C@@H]1C=CC(O)CCc1ccccc1,AQOKCDNYWBIDND-NFTGKOCPSA-N,,PTGFR
5153,dinoprostone,Prostanoid receptor agonist,PTGER1,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CC=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,,PTGER1
5154,dinoprostone,Prostanoid receptor agonist,PTGER2,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CC=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,,PTGER2
5155,dinoprostone,Prostanoid receptor agonist,PTGER3,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CC=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,,PTGER3
5156,dinoprostone,Prostanoid receptor agonist,PTGER4,CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CC=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,,PTGER4
5157,iloprost,Prostanoid receptor agonist,PTGER1,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGER1
5158,iloprost,Prostanoid receptor agonist,PTGER2,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGER2
5159,iloprost,Prostanoid receptor agonist,PTGIR,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGIR
5160,iloprost,Prostanoid receptor agonist,PTGER1,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGER1
5161,iloprost,Prostanoid receptor agonist,PTGER2,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGER2
5162,iloprost,Prostanoid receptor agonist,PTGIR,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGIR
5163,latanoprost,Prostanoid receptor agonist,PTGFR,CC(C)OC(=O)CCCC=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,GGXICVAJURFBLW-CEYXHVGTSA-N,,PTGFR
5164,misoprostol,Prostanoid receptor agonist,PTGER2,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-LNQMSSPSSA-N,,PTGER2
5165,misoprostol,Prostanoid receptor agonist,PTGER3,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-LNQMSSPSSA-N,,PTGER3
5166,misoprostol,Prostanoid receptor agonist,PTGER4,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-LNQMSSPSSA-N,,PTGER4
5167,MRE-269,Prostanoid receptor agonist,PTGIR,CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(O)=O,PAJMKGZZBBTTOY-ZFORQUDYSA-N,,PTGIR
5168,travoprost,Prostanoid receptor agonist,PTGFR,CC(C)OC(=O)CCCC=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1C=C[C@@H](O)COc1cccc(c1)C(F)(F)F,MKPLKVHSHYCHOC-AHTXBMBWSA-N,,PTGFR
5169,misoprostol,Prostanoid receptor agonist,PTGER2,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,,PTGER2
5170,misoprostol,Prostanoid receptor agonist,PTGER3,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,,PTGER3
5171,misoprostol,Prostanoid receptor agonist,PTGER4,CCCCC(C)(O)CC=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,,PTGER4
5172,anguidine,Protein synthesis inhibitor,SLC5A1,CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1,AUGQEEXBDZWUJY-ZLJUKNTDSA-N,,SLC5A1
5173,cycloheximide,Protein synthesis inhibitor,RPL3,C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1,YPHMISFOHDHNIV-FSZOTQKASA-N,,RPL3
5174,cycloheximide,Protein synthesis inhibitor,RPL3,CC1CC(C)C(=O)C(C1)C(O)CC2CC(=O)NC(=O)C2,YPHMISFOHDHNIV-UHFFFAOYSA-N,,RPL3
5175,cycloheximide,Protein synthesis inhibitor,RPL3,CCOC(=O)CN1C(=O)CC(C[C@@H](O)C2C[C@@H](C)C[C@H](C)C2=O)CC1=O,KWCVNASRVVSXHH-LYUYJPIDSA-N,,RPL3
5176,emetine,Protein synthesis inhibitor,RPS2,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12,AUVVAXYIELKVAI-CKBKHPSWSA-N,,RPS2
5177,emetine,Protein synthesis inhibitor,RPS2,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc12,AUVVAXYIELKVAI-VXNUJMKFSA-N,,RPS2
5178,emetine,Protein synthesis inhibitor,RPS2,N[C@@H](CCl)C(=O)O,ASBJGPTTYPEMLP-REOHCLBHSA-N,,RPS2
5179,erythromycin-ethylsuccinate,Protein synthesis inhibitor,CYP3A4,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP3A4
5180,erythromycin-ethylsuccinate,Protein synthesis inhibitor,CYP51A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,CYP51A1
5181,erythromycin-ethylsuccinate,Protein synthesis inhibitor,ALB,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ALB
5182,erythromycin-ethylsuccinate,Protein synthesis inhibitor,MLNR,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,MLNR
5183,erythromycin-ethylsuccinate,Protein synthesis inhibitor,KCNH2,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,KCNH2
5184,erythromycin-ethylsuccinate,Protein synthesis inhibitor,ABCB1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,ABCB1
5185,erythromycin-ethylsuccinate,Protein synthesis inhibitor,SLC47A1,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,NSYZCCDSJNWWJL-YXOIYICCSA-N,,SLC47A1
5186,etretinate,Protein synthesis inhibitor,RARA,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,,RARA
5187,etretinate,Protein synthesis inhibitor,RXRG,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,,RXRG
5188,etretinate,Protein synthesis inhibitor,RARA,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,HQMNCQVAMBCHCO-UHFFFAOYSA-N,,RARA
5189,etretinate,Protein synthesis inhibitor,RXRG,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,HQMNCQVAMBCHCO-UHFFFAOYSA-N,,RXRG
5190,thiostrepton,Protein synthesis inhibitor,FOXM1,CCC(C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=CC)[C@@](C)(O)[C@@H](C)O)[C@H](C)O,NSFFHOGKXHRQEW-MWCLUCFNSA-N,,FOXM1
5191,thiostrepton,Protein synthesis inhibitor,FOXM1,CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O,NSFFHOGKXHRQEW-DVRIZHICSA-N,,FOXM1
5192,nicotinamide,Protein synthesis stimulant,PARP1,NC(=O)c1cccnc1,DFPAKSUCGFBDDF-UHFFFAOYSA-N,,PARP1
5193,BI-D1870,Ribosomal protein inhibitor,RPS6KA1,CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12,DTEKTGDVSARYDS-UHFFFAOYSA-N,,RPS6KA1
5194,BI-D1870,Ribosomal protein inhibitor,RPS6KA2,CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12,DTEKTGDVSARYDS-UHFFFAOYSA-N,,RPS6KA2
5195,BI-D1870,Ribosomal protein inhibitor,RPS6KA3,CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12,DTEKTGDVSARYDS-UHFFFAOYSA-N,,RPS6KA3
5196,BRD-K15107389,Ribosomal protein inhibitor,RPS6KA1,O=C1c2ccccc2-c3c(NCCc4ccccc4)c(=O)[nH]c5cccc1c35,XASCINRGTHLHGM-UHFFFAOYSA-N,,RPS6KA1
5197,BRD-K15107389,Ribosomal protein inhibitor,RPS6KA2,O=C1c2ccccc2-c3c(NCCc4ccccc4)c(=O)[nH]c5cccc1c35,XASCINRGTHLHGM-UHFFFAOYSA-N,,RPS6KA2
5198,BRD-K15107389,Ribosomal protein inhibitor,RPS6KA3,O=C1c2ccccc2-c3c(NCCc4ccccc4)c(=O)[nH]c5cccc1c35,XASCINRGTHLHGM-UHFFFAOYSA-N,,RPS6KA3
5199,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D,C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1,RFZPGNRLOKVZJY-AWEZNQCLSA-N,,INPP5D
5200,telotristat,Serotonin release inhibitor,TPH1,Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F,NCLGDOBQAWBXRA-PGRDOPGGSA-N,,TPH1
5201,purmorphamine,Smoothened receptor agonist,SMO,C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12,FYBHCRQFSFYWPY-UHFFFAOYSA-N,,SMO
5202,adaprev,TGF beta receptor inhibitor,M6PR,OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,NBSCHQHZLSJFNQ-GASJEMHNSA-N,,M6PR
5203,D-4476,TGF beta receptor inhibitor,CSNK1A1,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1,DPDZHVCKYBCJHW-UHFFFAOYSA-N,,CSNK1A1
5204,D-4476,TGF beta receptor inhibitor,TGFB1,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1,DPDZHVCKYBCJHW-UHFFFAOYSA-N,,TGFB1
5205,LY-364947,TGF beta receptor inhibitor,TGFBR1,c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1,IBCXZJCWDGCXQT-UHFFFAOYSA-N,,TGFBR1
5206,pirfenidone,TGF beta receptor inhibitor,TNF,Cc1ccc(=O)n(c1)-c1ccccc1,ISWRGOKTTBVCFA-UHFFFAOYSA-N,,TNF
5207,repsox,TGF beta receptor inhibitor,TGFBR1,Cc1cccc(n1)-c1n[nH]cc1-c1ccc2ncccc2n1,LBPKYPYHDKKRFS-UHFFFAOYSA-N,,TGFBR1
5208,SB-431542,TGF beta receptor inhibitor,ACVR1C,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1,FHYUGAJXYORMHI-UHFFFAOYSA-N,,ACVR1C
5209,SB-431542,TGF beta receptor inhibitor,TGFBR1,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1,FHYUGAJXYORMHI-UHFFFAOYSA-N,,TGFBR1
5210,SB-525334,TGF beta receptor inhibitor,TGFBR1,Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C,DKPQHFZUICCZHF-UHFFFAOYSA-N,,TGFBR1
5211,SD-208,TGF beta receptor inhibitor,TGFBR1,Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1,BERLXWPRSBJFHO-UHFFFAOYSA-N,,TGFBR1
5212,dilazep,Adenosine reuptake inhibitor,SLC29A1,COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1,QVZCXCJXTMIDME-UHFFFAOYSA-N,,SLC29A1
5213,propentofylline,Adenosine reuptake inhibitor,PDE1A,CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12,RBQOQRRFDPXAGN-UHFFFAOYSA-N,,PDE1A
5214,pyrvinium-pamoate,Androgen receptor antagonist,AR,CN(C)c1ccc2[n+](C)c(CCc3cc(C)n(c3C)-c3ccccc3)ccc2c1,JSZNAPGSRFTCQR-UHFFFAOYSA-N,,AR
5215,pyrvinium-pamoate,Androgen receptor antagonist,AR,CN(C)c1ccc2[n+](C)c(CCc3cc(C)n(c3C)-c3ccccc3)ccc2c1,JSZNAPGSRFTCQR-UHFFFAOYSA-N,,AR
5216,ARN-509,Androgen receptor antagonist,AR,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F,HJBWBFZLDZWPHF-UHFFFAOYSA-N,,AR
5217,bicalutamide,Androgen receptor antagonist,AR,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,LKJPYSCBVHEWIU-UHFFFAOYSA-N,,AR
5218,BMS-641988,Androgen receptor antagonist,AR,CCS(=O)(=O)N[C@@H]1C[C@@]2(C)O[C@]1(C)[C@H]1[C@@H]2C(=O)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F,HYNANJUKEMCYEQ-HIGHGGLBSA-N,,AR
5219,cyproterone,Androgen receptor antagonist,AR,CC(=O)O[C@@]1(CC[C@@H]2[C@@H]3C=C(Cl)C4=CC(=O)C5CC5[C@]4(C)[C@@H]3CC[C@]12C)C(C)=O,UWFYSQMTEOIJJG-PYAXFEBGSA-N,,AR
5220,cyproterone,Androgen receptor antagonist,AR,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)C5CC5[C@]4(C)[C@H]3CC[C@@]21C)C(=O)C,UWFYSQMTEOIJJG-NKGGGRBPSA-N,,AR
5221,enzalutamide,Androgen receptor antagonist,AR,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F,WXCXUHSOUPDCQV-UHFFFAOYSA-N,,AR
5222,flutamide,Androgen receptor antagonist,AR,CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O,MKXKFYHWDHIYRV-UHFFFAOYSA-N,,AR
5223,nilutamide,Androgen receptor antagonist,AR,CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O,XWXYUMMDTVBTOU-UHFFFAOYSA-N,,AR
5224,orteronel,Androgen receptor antagonist,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12,OZPFIJIOIVJZMN-GOSISDBHSA-N,,CYP17A1
5225,orteronel,Androgen receptor antagonist,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)C1(O)CCn2cncc12,OZPFIJIOIVJZMN-UHFFFAOYSA-N,,CYP17A1
5226,reichstein,Androgen receptor antagonist,AR,CC12CCC3C(CCC4=CC(=O)CCC34C)C2CCC1(O)C(=O)CO,WHBHBVVOGNECLV-UHFFFAOYSA-N,,AR
5227,RU-58841,Androgen receptor antagonist,AR,CC1(C)N(CCCCO)C(=O)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F,ARBYGDBJECGMGA-UHFFFAOYSA-N,,AR
5228,delivert,Angiotensin receptor agonist,AGTR1,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O,CZGUSIXMZVURDU-FCWOTDAASA-N,,AGTR1
5229,delivert,Angiotensin receptor agonist,AGTR2,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O,CZGUSIXMZVURDU-FCWOTDAASA-N,,AGTR2
5230,AM-1241,Cannabinoid receptor agonist,CNR2,CN1CCCCC1Cn1cc(C(=O)c2cc(ccc2I)[N+]([O-])=O)c2ccccc12,ZUHIXXCLLBMBDW-UHFFFAOYSA-N,,CNR2
5231,anandamide,Cannabinoid receptor agonist,CNR1,CCCCC/C=CC/C=CC/C=CCCCCCCC(=O)NCCO,ULQWKETUACYZLI-QNEBEIHSSA-N,,CNR1
5232,anandamide,Cannabinoid receptor agonist,CNR2,CCCCC/C=CC/C=CC/C=CCCCCCCC(=O)NCCO,ULQWKETUACYZLI-QNEBEIHSSA-N,,CNR2
5233,anandamide,Cannabinoid receptor agonist,TRPV1,CCCCC/C=CC/C=CC/C=CCCCCCCC(=O)NCCO,ULQWKETUACYZLI-QNEBEIHSSA-N,,TRPV1
5234,anandamide,Cannabinoid receptor agonist,CNR1,CCCCC/C=CC/C=CCCCCCCCC(=O)NCCO,KQXDGUVSAAQARU-HZJYTTRNSA-N,,CNR1
5235,anandamide,Cannabinoid receptor agonist,CNR2,CCCCC/C=CC/C=CCCCCCCCC(=O)NCCO,KQXDGUVSAAQARU-HZJYTTRNSA-N,,CNR2
5236,anandamide,Cannabinoid receptor agonist,TRPV1,CCCCC/C=CC/C=CCCCCCCCC(=O)NCCO,KQXDGUVSAAQARU-HZJYTTRNSA-N,,TRPV1
5237,anandamide,Cannabinoid receptor agonist,CNR1,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)NCCO,LGEQQWMQCRIYKG-DOFZRALJSA-N,,CNR1
5238,anandamide,Cannabinoid receptor agonist,CNR2,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)NCCO,LGEQQWMQCRIYKG-DOFZRALJSA-N,,CNR2
5239,anandamide,Cannabinoid receptor agonist,TRPV1,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)NCCO,LGEQQWMQCRIYKG-DOFZRALJSA-N,,TRPV1
5240,arachidonamide,Cannabinoid receptor agonist,CNR1,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)N,BNBSCAZCQDLUDU-DOFZRALJSA-N,,CNR1
5241,arachidonamide,Cannabinoid receptor agonist,CNR2,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)N,BNBSCAZCQDLUDU-DOFZRALJSA-N,,CNR2
5242,CP-55940,Cannabinoid receptor agonist,CNR1,CCCCCCC(C)(C)c1ccc(C2CC(O)CCC2CCCO)c(O)c1,YNZFFALZMRAPHQ-UHFFFAOYSA-N,,CNR1
5243,CP-55940,Cannabinoid receptor agonist,CNR2,CCCCCCC(C)(C)c1ccc(C2CC(O)CCC2CCCO)c(O)c1,YNZFFALZMRAPHQ-UHFFFAOYSA-N,,CNR2
5244,CP-55940,Cannabinoid receptor agonist,GPR55,CCCCCCC(C)(C)c1ccc(C2CC(O)CCC2CCCO)c(O)c1,YNZFFALZMRAPHQ-UHFFFAOYSA-N,,GPR55
5245,GW-405833,Cannabinoid receptor agonist,CNR2,COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1,FSFZRNZSZYDVLI-UHFFFAOYSA-N,,CNR2
5246,JWH-015,Cannabinoid receptor agonist,CNR2,CCCn1c(C)c(C(=O)c2cccc3ccccc23)c4ccccc14,LJSBBBWQTLXQEN-UHFFFAOYSA-N,,CNR2
5247,lylamine,Cannabinoid receptor agonist,CNR1,CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1,JVVXZOOGOGPDRZ-SLFFLAALSA-N,,CNR1
5248,oleamide,Cannabinoid receptor agonist,PLA2G2A,CCCCCCCCC=C/CCCCCCCC(N)=O,FATBGEAMYMYZAF-KTKRTIGZSA-N,,PLA2G2A
5249,oleoylethanolamide,Cannabinoid receptor agonist,GPR119,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,GPR119
5250,oleoylethanolamide,Cannabinoid receptor agonist,PPARA,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,PPARA
5251,oleylethanolamide,Cannabinoid receptor agonist,GPR119,CCCCCCCCC=CCCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-UHFFFAOYSA-N,,GPR119
5252,palmitoylethanolamide,Cannabinoid receptor agonist,CNR2,CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,,CNR2
5253,palmitoylethanolamide,Cannabinoid receptor agonist,GPR119,CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,,GPR119
5254,acetazolamide,Carbonic anhydrase inhibitor,CA14,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA14
5255,acetazolamide,Carbonic anhydrase inhibitor,CA1,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA1
5256,acetazolamide,Carbonic anhydrase inhibitor,CA2,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA2
5257,acetazolamide,Carbonic anhydrase inhibitor,CA4,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA4
5258,acetazolamide,Carbonic anhydrase inhibitor,CA7,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA7
5259,acetazolamide,Carbonic anhydrase inhibitor,CA12,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,,CA12
5260,benzthiazide,Carbonic anhydrase inhibitor,SLC12A3,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,NDTSRXAMMQDVSW-UHFFFAOYSA-N,,SLC12A3
5261,benzthiazide,Carbonic anhydrase inhibitor,CA2,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,NDTSRXAMMQDVSW-UHFFFAOYSA-N,,CA2
5262,brinzolamide,Carbonic anhydrase inhibitor,CA1,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,HCRKCZRJWPKOAR-JTQLQIEISA-N,,CA1
5263,brinzolamide,Carbonic anhydrase inhibitor,CA2,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,HCRKCZRJWPKOAR-JTQLQIEISA-N,,CA2
5264,brinzolamide,Carbonic anhydrase inhibitor,CA7,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,HCRKCZRJWPKOAR-JTQLQIEISA-N,,CA7
5265,diclofenamide,Carbonic anhydrase inhibitor,CA1,NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,,CA1
5266,diclofenamide,Carbonic anhydrase inhibitor,CA2,NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,,CA2
5267,diclofenamide,Carbonic anhydrase inhibitor,CA4,NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,,CA4
5268,diclofenamide,Carbonic anhydrase inhibitor,CA12,NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,,CA12
5269,dorzolamide,Carbonic anhydrase inhibitor,CA1,CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,IAVUPMFITXYVAF-POYBYMJQSA-N,,CA1
5270,dorzolamide,Carbonic anhydrase inhibitor,CA2,CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,IAVUPMFITXYVAF-POYBYMJQSA-N,,CA2
5271,dorzolamide,Carbonic anhydrase inhibitor,CA1,CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N,IAVUPMFITXYVAF-XPUUQOCRSA-N,,CA1
5272,dorzolamide,Carbonic anhydrase inhibitor,CA2,CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N,IAVUPMFITXYVAF-XPUUQOCRSA-N,,CA2
5273,fraxidin,Carbonic anhydrase inhibitor,CA12,COc1cc2ccc(=O)oc2c(OC)c1OC,RAYQKHLZHPFYEJ-UHFFFAOYSA-N,,CA12
5274,mafenide,Carbonic anhydrase inhibitor,CA6,NCc1ccc(cc1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,,CA6
5275,methazolamide,Carbonic anhydrase inhibitor,CA1,CC(=O)N=c1sc(nn1C)S(N)(=O)=O,FLOSMHQXBMRNHR-UHFFFAOYSA-N,,CA1
5276,methazolamide,Carbonic anhydrase inhibitor,CA2,CC(=O)N=c1sc(nn1C)S(N)(=O)=O,FLOSMHQXBMRNHR-UHFFFAOYSA-N,,CA2
5277,methazolamide,Carbonic anhydrase inhibitor,CA4,CC(=O)N=c1sc(nn1C)S(N)(=O)=O,FLOSMHQXBMRNHR-UHFFFAOYSA-N,,CA4
5278,methazolamide,Carbonic anhydrase inhibitor,CA7,CC(=O)N=c1sc(nn1C)S(N)(=O)=O,FLOSMHQXBMRNHR-UHFFFAOYSA-N,,CA7
5279,metolazone,Carbonic anhydrase inhibitor,SLC12A3,CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O,AQCHWTWZEMGIFD-UHFFFAOYSA-N,,SLC12A3
5280,topiramate,Carbonic anhydrase inhibitor,GABRA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA1
5281,topiramate,Carbonic anhydrase inhibitor,GABRA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA2
5282,topiramate,Carbonic anhydrase inhibitor,GABRA3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA3
5283,topiramate,Carbonic anhydrase inhibitor,GABRA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA4
5284,topiramate,Carbonic anhydrase inhibitor,GABRA5,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA5
5285,topiramate,Carbonic anhydrase inhibitor,GABRA6,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA6
5286,topiramate,Carbonic anhydrase inhibitor,GABRB1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB1
5287,topiramate,Carbonic anhydrase inhibitor,GABRB2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB2
5288,topiramate,Carbonic anhydrase inhibitor,GABRB3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB3
5289,topiramate,Carbonic anhydrase inhibitor,GABRD,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRD
5290,topiramate,Carbonic anhydrase inhibitor,GABRE,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRE
5291,topiramate,Carbonic anhydrase inhibitor,GABRG1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG1
5292,topiramate,Carbonic anhydrase inhibitor,GABRG2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG2
5293,topiramate,Carbonic anhydrase inhibitor,GABRG3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG3
5294,topiramate,Carbonic anhydrase inhibitor,GABRP,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRP
5295,topiramate,Carbonic anhydrase inhibitor,GRIA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIA1
5296,topiramate,Carbonic anhydrase inhibitor,GRIK1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIK1
5297,topiramate,Carbonic anhydrase inhibitor,GABRQ,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRQ
5298,topiramate,Carbonic anhydrase inhibitor,SCN1A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN1A
5299,topiramate,Carbonic anhydrase inhibitor,SCN5A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN5A
5300,topiramate,Carbonic anhydrase inhibitor,CA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA2
5301,topiramate,Carbonic anhydrase inhibitor,CA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA4
5302,carbachol,Cholinergic receptor agonist,CHRM1,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,,CHRM1
5303,carbachol,Cholinergic receptor agonist,CHRM2,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,,CHRM2
5304,carbachol,Cholinergic receptor agonist,CHRNA2,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,,CHRNA2
5305,oxotremorine-sesquifumarate,Cholinergic receptor agonist,CHRM2,O=C1CCCN1CC#CCN1CCCC1,RSDOPYMFZBJHRL-UHFFFAOYSA-N,,CHRM2
5306,PNU-282987,Cholinergic receptor agonist,CHRNA7,Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2,WECKJONDRAUFDD-ZDUSSCGKSA-N,,CHRNA7
5307,apixaban,Coagulation factor inhibitor,F10,COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O,QNZCBYKSOIHPEH-UHFFFAOYSA-N,,F10
5308,edoxaban,Coagulation factor inhibitor,F10,CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](C1)NC(=O)c1nc2CCN(C)Cc2s1,HGVDHZBSSITLCT-KMFMINBZSA-N,,F10
5309,otamixaban,Coagulation factor inhibitor,F10,COC(=O)[C@H](Cc1cccc(c1)C(N)=N)[C@@H](C)NC(=O)c1ccc(cc1)-c1cc[n+]([O-])cc1,PFGVNLZDWRZPJW-OPAMFIHVSA-N,,F10
5310,rivaroxaban,Coagulation factor inhibitor,F10,Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,,F10
5311,rivaroxaban,Coagulation factor inhibitor,F10,Clc1ccc(s1)C(=O)NCC1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O,KGFYHTZWPPHNLQ-UHFFFAOYSA-N,,F10
5312,tetrahydrouridine,Cytidine deaminase inhibitor,CDA,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O,UCKYOOZPSJFJIZ-XVKVHKPRSA-N,,CDA
5313,PIK-75,DNA protein kinase inhibitor,PIK3CA,CN(N=Cc1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,,PIK3CA
5314,PIK-75,DNA protein kinase inhibitor,PIK3CA,CN(N=Cc1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,,PIK3CA
5315,benserazide,DOPA decarboxylase inhibitor,DDC,NC(CO)C(=O)NNCc1ccc(O)c(O)c1O,BNQDCRGUHNALGH-UHFFFAOYSA-N,,DDC
5316,adoprazine,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1,IUVSEUFHPNITEQ-UHFFFAOYSA-N,,DRD2
5317,adoprazine,Dopamine receptor antagonist,HTR1A,Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1,IUVSEUFHPNITEQ-UHFFFAOYSA-N,,HTR1A
5318,alizapride,Dopamine receptor antagonist,DRD2,COc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C,KSEYRUGYKHXGFW-UHFFFAOYSA-N,,DRD2
5319,amisulpride,Dopamine receptor antagonist,DRD2,CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,,DRD2
5320,amisulpride,Dopamine receptor antagonist,DRD3,CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,,DRD3
5321,amperozide,Dopamine receptor antagonist,DRD2,CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,NNAIYOXJNVGUOM-UHFFFAOYSA-N,,DRD2
5322,amperozide,Dopamine receptor antagonist,HTR2A,CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,NNAIYOXJNVGUOM-UHFFFAOYSA-N,,HTR2A
5323,asenapine,Dopamine receptor antagonist,ADRB2,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,ADRB2
5324,asenapine,Dopamine receptor antagonist,DRD1,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,DRD1
5325,asenapine,Dopamine receptor antagonist,DRD2,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,DRD2
5326,asenapine,Dopamine receptor antagonist,HRH1,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HRH1
5327,asenapine,Dopamine receptor antagonist,HTR1A,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR1A
5328,asenapine,Dopamine receptor antagonist,HTR1B,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR1B
5329,asenapine,Dopamine receptor antagonist,HTR2A,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR2A
5330,asenapine,Dopamine receptor antagonist,ADRB2,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,ADRB2
5331,asenapine,Dopamine receptor antagonist,DRD1,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,DRD1
5332,asenapine,Dopamine receptor antagonist,DRD2,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,DRD2
5333,asenapine,Dopamine receptor antagonist,HRH1,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HRH1
5334,asenapine,Dopamine receptor antagonist,HTR1A,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR1A
5335,asenapine,Dopamine receptor antagonist,HTR1B,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR1B
5336,asenapine,Dopamine receptor antagonist,HTR2A,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR2A
5337,benperidol,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O,FEBOTPHFXYHVPL-UHFFFAOYSA-N,,DRD2
5338,blonanserin,Dopamine receptor antagonist,DRD2,CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1,XVGOZDAJGBALKS-UHFFFAOYSA-N,,DRD2
5339,blonanserin,Dopamine receptor antagonist,HTR2A,CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1,XVGOZDAJGBALKS-UHFFFAOYSA-N,,HTR2A
5340,bromopride,Dopamine receptor antagonist,DRD2,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC,GIYAQDDTCWHPPL-UHFFFAOYSA-N,,DRD2
5341,bromperidol,Dopamine receptor antagonist,DRD2,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Br)cc1,RKLNONIVDFXQRX-UHFFFAOYSA-N,,DRD2
5342,butaclamol,Dopamine receptor antagonist,DRD1,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34,ZZJYIKPMDIWRSN-TZBSWOFLSA-N,,DRD1
5343,butaclamol,Dopamine receptor antagonist,DRD2,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34,ZZJYIKPMDIWRSN-TZBSWOFLSA-N,,DRD2
5344,butaclamol,Dopamine receptor antagonist,DRD3,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34,ZZJYIKPMDIWRSN-TZBSWOFLSA-N,,DRD3
5345,cariprazine,Dopamine receptor antagonist,DRD2,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N,,DRD2
5346,cariprazine,Dopamine receptor antagonist,DRD3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N,,DRD3
5347,clebopride,Dopamine receptor antagonist,DRD2,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,BVPWJMCABCPUQY-UHFFFAOYSA-N,,DRD2
5348,clozapine,Dopamine receptor antagonist,CHRM1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM1
5349,clozapine,Dopamine receptor antagonist,CHRM2,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM2
5350,clozapine,Dopamine receptor antagonist,CHRM3,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM3
5351,clozapine,Dopamine receptor antagonist,CHRM4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM4
5352,clozapine,Dopamine receptor antagonist,ADRA1B,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,ADRA1B
5353,clozapine,Dopamine receptor antagonist,ADRA1A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,ADRA1A
5354,clozapine,Dopamine receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD1
5355,clozapine,Dopamine receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD2
5356,clozapine,Dopamine receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD3
5357,clozapine,Dopamine receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD4
5358,clozapine,Dopamine receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HRH1
5359,clozapine,Dopamine receptor antagonist,HTR1A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1A
5360,clozapine,Dopamine receptor antagonist,HTR1B,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1B
5361,clozapine,Dopamine receptor antagonist,HTR1D,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1D
5362,clozapine,Dopamine receptor antagonist,HTR1E,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1E
5363,clozapine,Dopamine receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR2A
5364,clozapine,Dopamine receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR2C
5365,clozapine,Dopamine receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR6
5366,clozapine,Dopamine receptor antagonist,HTR7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR7
5367,clozapine,Dopamine receptor antagonist,HRH4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HRH4
5368,domperidone,Dopamine receptor antagonist,DRD2,Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1,FGXWKSZFVQUSTL-UHFFFAOYSA-N,,DRD2
5369,domperidone,Dopamine receptor antagonist,DRD3,Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1,FGXWKSZFVQUSTL-UHFFFAOYSA-N,,DRD3
5370,droperidol,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O,RMEDXOLNCUSCGS-UHFFFAOYSA-N,,DRD2
5371,ecopipam,Dopamine receptor antagonist,DRD1,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4ccccc34,DMJWENQHWZZWDF-PKOBYXMFSA-N,,DRD1
5372,ecopipam,Dopamine receptor antagonist,DRD5,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4ccccc34,DMJWENQHWZZWDF-PKOBYXMFSA-N,,DRD5
5373,eticlopride,Dopamine receptor antagonist,DRD2,CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC,AADCDMQTJNYOSS-LBPRGKRZSA-N,,DRD2
5374,fananserin,Dopamine receptor antagonist,DRD4,Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,VGIGHGMPMUCLIQ-UHFFFAOYSA-N,,DRD4
5375,fananserin,Dopamine receptor antagonist,HTR2A,Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,VGIGHGMPMUCLIQ-UHFFFAOYSA-N,,HTR2A
5376,flupentixol,Dopamine receptor antagonist,DRD1,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,NJMYODHXAKYRHW-DVZOWYKESA-N,,DRD1
5377,flupentixol,Dopamine receptor antagonist,DRD2,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,NJMYODHXAKYRHW-DVZOWYKESA-N,,DRD2
5378,fluphenazine,Dopamine receptor antagonist,DRD1,FC(F)(F)c1ccc2Sc3ccccc3N(CCCN4CCN(CCCl)CC4)c2c1,WHVNGICQKYBDDP-UHFFFAOYSA-N,,DRD1
5379,fluphenazine,Dopamine receptor antagonist,DRD2,FC(F)(F)c1ccc2Sc3ccccc3N(CCCN4CCN(CCCl)CC4)c2c1,WHVNGICQKYBDDP-UHFFFAOYSA-N,,DRD2
5380,fluphenazine,Dopamine receptor antagonist,DRD1,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,,DRD1
5381,fluphenazine,Dopamine receptor antagonist,DRD2,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,,DRD2
5382,fluspirilene,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1,QOYHHIBFXOOADH-UHFFFAOYSA-N,,DRD2
5383,fluspirilene,Dopamine receptor antagonist,HTR2A,Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1,QOYHHIBFXOOADH-UHFFFAOYSA-N,,HTR2A
5384,GR-103691,Dopamine receptor antagonist,DRD3,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccc(cc2)C(C)=O)CC1,JARNORYOPMINDY-UHFFFAOYSA-N,,DRD3
5385,haloperidol,Dopamine receptor antagonist,DRD1,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,,DRD1
5386,haloperidol,Dopamine receptor antagonist,DRD2,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,,DRD2
5387,haloperidol,Dopamine receptor antagonist,DRD3,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,,DRD3
5388,haloperidol,Dopamine receptor antagonist,DRD4,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,,DRD4
5389,haloperidol,Dopamine receptor antagonist,HTR2A,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,,HTR2A
5390,iloperidone,Dopamine receptor antagonist,DRD2,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,DRD2
5391,iloperidone,Dopamine receptor antagonist,HTR1A,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR1A
5392,iloperidone,Dopamine receptor antagonist,HTR2A,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR2A
5393,iloperidone,Dopamine receptor antagonist,HTR6,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR6
5394,iloperidone,Dopamine receptor antagonist,HTR7,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR7
5395,itopride,Dopamine receptor antagonist,DRD2,COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,QQQIECGTIMUVDS-UHFFFAOYSA-N,,DRD2
5396,L-741626,Dopamine receptor antagonist,DRD2,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,LLBLNMUONVVVPG-UHFFFAOYSA-N,,DRD2
5397,L-741742,Dopamine receptor antagonist,DRD4,Cc1c(noc1-c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,QDMAKDIDFJTXEL-UHFFFAOYSA-N,,DRD4
5398,L-745870,Dopamine receptor antagonist,DRD4,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,OGJGQVFWEPNYSB-UHFFFAOYSA-N,,DRD4
5399,L-750667,Dopamine receptor antagonist,DRD4,Ic1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,OOEUHRGMLFVKQO-UHFFFAOYSA-N,,DRD4
5400,LE-300,Dopamine receptor antagonist,DRD5,CN1CCc2c(Cc3ccccc3CC1)[nH]c4ccccc24,YEWGIGCYIAMFMA-UHFFFAOYSA-N,,DRD5
5401,levomepromazine,Dopamine receptor antagonist,DRD2,COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1,VRQVVMDWGGWHTJ-CQSZACIVSA-N,,DRD2
5402,levomepromazine,Dopamine receptor antagonist,DRD3,COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1,VRQVVMDWGGWHTJ-CQSZACIVSA-N,,DRD3
5403,levomepromazine,Dopamine receptor antagonist,DRD4,COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1,VRQVVMDWGGWHTJ-CQSZACIVSA-N,,DRD4
5404,levosulpiride,Dopamine receptor antagonist,DRD2,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,BGRJTUBHPOOWDU-NSHDSACASA-N,,DRD2
5405,levosulpiride,Dopamine receptor antagonist,DRD3,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,BGRJTUBHPOOWDU-NSHDSACASA-N,,DRD3
5406,loxapine,Dopamine receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD1
5407,loxapine,Dopamine receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD2
5408,loxapine,Dopamine receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD3
5409,loxapine,Dopamine receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD4
5410,loxapine,Dopamine receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HRH1
5411,loxapine,Dopamine receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR2A
5412,loxapine,Dopamine receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR2C
5413,loxapine,Dopamine receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR6
5414,lurasidone,Dopamine receptor antagonist,ADRA2A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,ADRA2A
5415,lurasidone,Dopamine receptor antagonist,ADRA2C,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,ADRA2C
5416,lurasidone,Dopamine receptor antagonist,DRD2,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,DRD2
5417,lurasidone,Dopamine receptor antagonist,HTR1A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR1A
5418,lurasidone,Dopamine receptor antagonist,HTR2A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR2A
5419,lurasidone,Dopamine receptor antagonist,HTR7,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR7
5420,melperone,Dopamine receptor antagonist,DRD2,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,DKMFBWQBDIGMHM-UHFFFAOYSA-N,,DRD2
5421,melperone,Dopamine receptor antagonist,HTR2A,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,DKMFBWQBDIGMHM-UHFFFAOYSA-N,,HTR2A
5422,mesoridazine,Dopamine receptor antagonist,DRD2,CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O,SLVMESMUVMCQIY-UHFFFAOYSA-N,,DRD2
5423,mesoridazine,Dopamine receptor antagonist,HTR2A,CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O,SLVMESMUVMCQIY-UHFFFAOYSA-N,,HTR2A
5424,metoclopramide,Dopamine receptor antagonist,DRD2,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,DRD2
5425,metoclopramide,Dopamine receptor antagonist,HTR3A,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,HTR3A
5426,metoclopramide,Dopamine receptor antagonist,HTR4,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,HTR4
5427,molindone,Dopamine receptor antagonist,DRD2,CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,KLPWJLBORRMFGK-UHFFFAOYSA-N,,DRD2
5428,molindone,Dopamine receptor antagonist,HTR2A,CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,KLPWJLBORRMFGK-UHFFFAOYSA-N,,HTR2A
5429,nafadotride,Dopamine receptor antagonist,DRD3,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC,IDZASIQMRGPBCQ-UHFFFAOYSA-N,,DRD3
5430,nemonapride,Dopamine receptor antagonist,DRD2,CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C,QCYCDKUNJFKYEI-ZVWWNKPMSA-N,,DRD2
5431,nemonapride,Dopamine receptor antagonist,DRD3,CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C,QCYCDKUNJFKYEI-ZVWWNKPMSA-N,,DRD3
5432,nemonapride,Dopamine receptor antagonist,DRD2,CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]2CCN(Cc3ccccc3)[C@@H]2C,KRVOJOCLBAAKSJ-RDTXWAMCSA-N,,DRD2
5433,nemonapride,Dopamine receptor antagonist,DRD3,CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]2CCN(Cc3ccccc3)[C@@H]2C,KRVOJOCLBAAKSJ-RDTXWAMCSA-N,,DRD3
5434,nemonapride,Dopamine receptor antagonist,DRD2,CNc1cc(OC)c(cc1Cl)C(=O)NC2CCN(Cc3ccccc3)C2C,KRVOJOCLBAAKSJ-UHFFFAOYSA-N,,DRD2
5435,nemonapride,Dopamine receptor antagonist,DRD3,CNc1cc(OC)c(cc1Cl)C(=O)NC2CCN(Cc3ccccc3)C2C,KRVOJOCLBAAKSJ-UHFFFAOYSA-N,,DRD3
5436,NGB-2904,Dopamine receptor antagonist,DRD3,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl,YJPWVCIGSHWNON-UHFFFAOYSA-N,,DRD3
5437,olanzapine,Dopamine receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD1
5438,olanzapine,Dopamine receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD2
5439,olanzapine,Dopamine receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD3
5440,olanzapine,Dopamine receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD4
5441,olanzapine,Dopamine receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HRH1
5442,olanzapine,Dopamine receptor antagonist,HTR1A,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1A
5443,olanzapine,Dopamine receptor antagonist,HTR1B,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1B
5444,olanzapine,Dopamine receptor antagonist,HTR1D,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1D
5445,olanzapine,Dopamine receptor antagonist,HTR1E,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1E
5446,olanzapine,Dopamine receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR2A
5447,olanzapine,Dopamine receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR2C
5448,olanzapine,Dopamine receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR6
5449,olanzapine,Dopamine receptor antagonist,HTR7,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR7
5450,perospirone,Dopamine receptor antagonist,DRD2,O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12,FBVFZWUMDDXLLG-HDICACEKSA-N,,DRD2
5451,perospirone,Dopamine receptor antagonist,HTR2A,O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12,FBVFZWUMDDXLLG-HDICACEKSA-N,,HTR2A
5452,perphenazine,Dopamine receptor antagonist,DRD2,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,RGCVKNLCSQQDEP-UHFFFAOYSA-N,,DRD2
5453,pimozide,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,,DRD2
5454,pimozide,Dopamine receptor antagonist,DRD3,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,,DRD3
5455,pimozide,Dopamine receptor antagonist,HTR2A,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,,HTR2A
5456,pipamperone,Dopamine receptor antagonist,DRD2,NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1,AXKPFOAXAHJUAG-UHFFFAOYSA-N,,DRD2
5457,pipamperone,Dopamine receptor antagonist,HTR2A,NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1,AXKPFOAXAHJUAG-UHFFFAOYSA-N,,HTR2A
5458,prochlorperazine,Dopamine receptor antagonist,DRD2,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,WIKYUJGCLQQFNW-UHFFFAOYSA-N,,DRD2
5459,promazine,Dopamine receptor antagonist,CHRM5,CN(C)CCCN1c2ccccc2Sc2ccccc12,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,,CHRM5
5460,promazine,Dopamine receptor antagonist,DRD2,CN(C)CCCN1c2ccccc2Sc2ccccc12,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,,DRD2
5461,quetiapine,Dopamine receptor antagonist,DRD1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,DRD1
5462,quetiapine,Dopamine receptor antagonist,DRD2,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,DRD2
5463,quetiapine,Dopamine receptor antagonist,HRH1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HRH1
5464,quetiapine,Dopamine receptor antagonist,HTR1A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1A
5465,quetiapine,Dopamine receptor antagonist,HTR1D,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1D
5466,quetiapine,Dopamine receptor antagonist,HTR1E,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1E
5467,quetiapine,Dopamine receptor antagonist,HTR2A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR2A
5468,raclopride,Dopamine receptor antagonist,DRD2,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,WAOQONBSWFLFPE-VIFPVBQESA-N,,DRD2
5469,raclopride,Dopamine receptor antagonist,DRD3,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,WAOQONBSWFLFPE-VIFPVBQESA-N,,DRD3
5470,remoxipride,Dopamine receptor antagonist,DRD2,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,GUJRSXAPGDDABA-NSHDSACASA-N,,DRD2
5471,risperidone,Dopamine receptor antagonist,ADRA1B,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,ADRA1B
5472,risperidone,Dopamine receptor antagonist,ADRA1A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,ADRA1A
5473,risperidone,Dopamine receptor antagonist,DRD2,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD2
5474,risperidone,Dopamine receptor antagonist,DRD3,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD3
5475,risperidone,Dopamine receptor antagonist,DRD4,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD4
5476,risperidone,Dopamine receptor antagonist,HRH1,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HRH1
5477,risperidone,Dopamine receptor antagonist,HTR1A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR1A
5478,risperidone,Dopamine receptor antagonist,HTR1D,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR1D
5479,risperidone,Dopamine receptor antagonist,HTR2A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR2A
5480,risperidone,Dopamine receptor antagonist,HTR2C,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR2C
5481,SCH-23390,Dopamine receptor antagonist,DRD1,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1,GOTMKOSCLKVOGG-OAHLLOKOSA-N,,DRD1
5482,SCH-23390,Dopamine receptor antagonist,DRD5,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1,GOTMKOSCLKVOGG-OAHLLOKOSA-N,,DRD5
5483,SCH-23390,Dopamine receptor antagonist,HTR2C,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1,GOTMKOSCLKVOGG-OAHLLOKOSA-N,,HTR2C
5484,sertindole,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,DRD2
5485,sertindole,Dopamine receptor antagonist,HTR2A,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,HTR2A
5486,sertindole,Dopamine receptor antagonist,HTR2C,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,HTR2C
5487,spiperone,Dopamine receptor antagonist,ADRA1A,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,ADRA1A
5488,spiperone,Dopamine receptor antagonist,DRD2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,DRD2
5489,spiperone,Dopamine receptor antagonist,DRD3,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,DRD3
5490,spiperone,Dopamine receptor antagonist,DRD4,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,DRD4
5491,spiperone,Dopamine receptor antagonist,HTR1A,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,HTR1A
5492,spiperone,Dopamine receptor antagonist,HTR2A,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,HTR2A
5493,spiperone,Dopamine receptor antagonist,HTR7,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,,HTR7
5494,spiramide,Dopamine receptor antagonist,HTR1A,Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1,FJUKDAZEABGEIH-UHFFFAOYSA-N,,HTR1A
5495,spiramide,Dopamine receptor antagonist,HTR2A,Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1,FJUKDAZEABGEIH-UHFFFAOYSA-N,,HTR2A
5496,sulpiride,Dopamine receptor antagonist,DRD2,CCN1CCC(CNC(=O)c2cc(ccc2OC)S(=O)(=O)N)C1,IAGQNKXBDXVWPR-UHFFFAOYSA-N,,DRD2
5497,sulpiride,Dopamine receptor antagonist,DRD3,CCN1CCC(CNC(=O)c2cc(ccc2OC)S(=O)(=O)N)C1,IAGQNKXBDXVWPR-UHFFFAOYSA-N,,DRD3
5498,sulpiride,Dopamine receptor antagonist,CA7,CCN1CCC(CNC(=O)c2cc(ccc2OC)S(=O)(=O)N)C1,IAGQNKXBDXVWPR-UHFFFAOYSA-N,,CA7
5499,sulpiride,Dopamine receptor antagonist,DRD2,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,BGRJTUBHPOOWDU-UHFFFAOYSA-N,,DRD2
5500,sulpiride,Dopamine receptor antagonist,DRD3,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,BGRJTUBHPOOWDU-UHFFFAOYSA-N,,DRD3
5501,sulpiride,Dopamine receptor antagonist,CA7,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,BGRJTUBHPOOWDU-UHFFFAOYSA-N,,CA7
5502,thioridazine,Dopamine receptor antagonist,DRD1,CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1,KLBQZWRITKRQQV-UHFFFAOYSA-N,,DRD1
5503,thioridazine,Dopamine receptor antagonist,DRD2,CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1,KLBQZWRITKRQQV-UHFFFAOYSA-N,,DRD2
5504,thioridazine,Dopamine receptor antagonist,HTR2A,CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1,KLBQZWRITKRQQV-UHFFFAOYSA-N,,HTR2A
5505,thioridazine,Dopamine receptor antagonist,HTR2C,CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1,KLBQZWRITKRQQV-UHFFFAOYSA-N,,HTR2C
5506,thiothixene,Dopamine receptor antagonist,HTR2A,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3C(=C/CCN3CCN(C)CC3)c2c1,GFBKORZTTCHDGY-UFWORHAWSA-N,,HTR2A
5507,thiothixene,Dopamine receptor antagonist,HTR2A,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3C(=CCCN3CCNCC3)c2c1,NIOGWJDNUIUWFG-WSVATBPTSA-N,,HTR2A
5508,tiapride,Dopamine receptor antagonist,DRD2,CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,,DRD2
5509,tiapride,Dopamine receptor antagonist,DRD3,CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,,DRD3
5510,trifluoperazine,Dopamine receptor antagonist,DRD2,CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,,DRD2
5511,triflupromazine,Dopamine receptor antagonist,DRD2,CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,,DRD2
5512,triflupromazine,Dopamine receptor antagonist,HTR2B,CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,,HTR2B
5513,U-99194,Dopamine receptor antagonist,DRD3,CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1,UOLJKAPABHXFRE-UHFFFAOYSA-N,,DRD3
5514,YM-09151-2,Dopamine receptor antagonist,DRD2,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C,KRVOJOCLBAAKSJ-KSSFIOAISA-N,,DRD2
5515,YM-09151-2,Dopamine receptor antagonist,DRD3,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C,KRVOJOCLBAAKSJ-KSSFIOAISA-N,,DRD3
5516,ziprasidone,Dopamine receptor antagonist,DRD2,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,DRD2
5517,ziprasidone,Dopamine receptor antagonist,HRH1,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HRH1
5518,ziprasidone,Dopamine receptor antagonist,HTR1A,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1A
5519,ziprasidone,Dopamine receptor antagonist,HTR1B,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1B
5520,ziprasidone,Dopamine receptor antagonist,HTR1D,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1D
5521,ziprasidone,Dopamine receptor antagonist,HTR1E,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1E
5522,ziprasidone,Dopamine receptor antagonist,HTR2A,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR2A
5523,ziprasidone,Dopamine receptor antagonist,HTR2C,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR2C
5524,ziprasidone,Dopamine receptor antagonist,HTR7,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR7
5525,BRD-A83255679,Estrogen receptor antagonist,GPER1,Brc1cc2OCOc2cc1C3Nc4ccccc4C5C=CCC53,YOLTZIVRJAPVPH-UHFFFAOYSA-N,,GPER1
5526,clomifene,Estrogen receptor antagonist,ESR1,CCN(CC)CCOc1ccc(cc1)/C(=C(/Cl)c2ccccc2)/c3ccccc3,GKIRPKYJQBWNGO-OCEACIFDSA-N,,ESR1
5527,clomifene,Estrogen receptor antagonist,ESR1,CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)c1ccccc1,GKIRPKYJQBWNGO-QPLCGJKRSA-N,,ESR1
5528,clomifene,Estrogen receptor antagonist,ESR1,CCN(CC)CCOc1ccc(cc1)C(=C(Cl)c1ccccc1)c1ccccc1,GKIRPKYJQBWNGO-UHFFFAOYSA-N,,ESR1
5529,danazol,Estrogen receptor antagonist,ESR1,C[C@]12CC[C@@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@H]1CC[C@@]2(O)C#C,POZRVZJJTULAOH-AAPKDCIVSA-N,,ESR1
5530,danazol,Estrogen receptor antagonist,GNRHR,C[C@]12CC[C@@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@H]1CC[C@@]2(O)C#C,POZRVZJJTULAOH-AAPKDCIVSA-N,,GNRHR
5531,danazol,Estrogen receptor antagonist,ESR1,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,POZRVZJJTULAOH-GSQPBCFPSA-N,,ESR1
5532,danazol,Estrogen receptor antagonist,GNRHR,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,POZRVZJJTULAOH-GSQPBCFPSA-N,,GNRHR
5533,danazol,Estrogen receptor antagonist,ESR1,C[C@@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]2CC[C@@]1(O)C#C,POZRVZJJTULAOH-LHZXLZLDSA-N,,ESR1
5534,danazol,Estrogen receptor antagonist,GNRHR,C[C@@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]2CC[C@@]1(O)C#C,POZRVZJJTULAOH-LHZXLZLDSA-N,,GNRHR
5535,danazol,Estrogen receptor antagonist,ESR1,CC12CCC3C(CCC4=Cc5oncc5CC34C)C2CCC1(O)C#C,POZRVZJJTULAOH-UHFFFAOYSA-N,,ESR1
5536,danazol,Estrogen receptor antagonist,GNRHR,CC12CCC3C(CCC4=Cc5oncc5CC34C)C2CCC1(O)C#C,POZRVZJJTULAOH-UHFFFAOYSA-N,,GNRHR
5537,fulvestrant,Estrogen receptor antagonist,ESR1,C[C@]12CC[C@H]3[C@@H]([C@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,VWUXBMIQPBEWFH-OWGSCINVSA-N,,ESR1
5538,fulvestrant,Estrogen receptor antagonist,ESR1,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)C(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,VWUXBMIQPBEWFH-IOMDSJNNSA-N,,ESR1
5539,fulvestrant,Estrogen receptor antagonist,ESR1,C[C@]12CC[C@H]3C([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,VWUXBMIQPBEWFH-LQKBAPIOSA-N,,ESR1
5540,fulvestrant,Estrogen receptor antagonist,ESR1,CC12CCC3C(C2CCC1O)C(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc4cc(O)ccc34,VWUXBMIQPBEWFH-UHFFFAOYSA-N,,ESR1
5541,raloxifene,Estrogen receptor antagonist,ESR1,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,GZUITABIAKMVPG-UHFFFAOYSA-N,,ESR1
5542,raloxifene,Estrogen receptor antagonist,ESR2,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,GZUITABIAKMVPG-UHFFFAOYSA-N,,ESR2
5543,tamoxifen,Estrogen receptor antagonist,ESR1,CC/C(=C(c1ccc(O)cc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3,TXUZVZSFRXZGTL-QPLCGJKRSA-N,,ESR1
5544,tamoxifen,Estrogen receptor antagonist,ESR2,CC/C(=C(c1ccc(O)cc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3,TXUZVZSFRXZGTL-QPLCGJKRSA-N,,ESR2
5545,tamoxifen,Estrogen receptor antagonist,ESR1,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,NKANXQFJJICGDU-QPLCGJKRSA-N,,ESR1
5546,tamoxifen,Estrogen receptor antagonist,ESR2,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,NKANXQFJJICGDU-QPLCGJKRSA-N,,ESR2
5547,tamoxifen,Estrogen receptor antagonist,ESR1,CCC(=C(c1ccccc1)c2ccc(OCCN(C)C)cc2)c3ccccc3,NKANXQFJJICGDU-UHFFFAOYSA-N,,ESR1
5548,tamoxifen,Estrogen receptor antagonist,ESR2,CCC(=C(c1ccccc1)c2ccc(OCCN(C)C)cc2)c3ccccc3,NKANXQFJJICGDU-UHFFFAOYSA-N,,ESR2
5549,toremifene,Estrogen receptor antagonist,ESR1,CN(C)CCOc1ccc(cc1)C(c1ccccc1)=C(CCCl)c1ccccc1,XFCLJVABOIYOMF-QPLCGJKRSA-N,,ESR1
5550,toremifene,Estrogen receptor antagonist,ESR1,CN(C)CCOc1ccc(cc1)C(=C(/CCCl)c1ccccc1)c1ccccc1,XFCLJVABOIYOMF-OCEACIFDSA-N,,ESR1
5551,toremifene,Estrogen receptor antagonist,ESR1,CN(C)CCOc1ccc(cc1)C(=C(CCCl)c1ccccc1)c1ccccc1,XFCLJVABOIYOMF-UHFFFAOYSA-N,,ESR1
5552,Y-134,Estrogen receptor antagonist,ESR1,CC(C)N1CCN(CC1)c1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1,LQEOPHGPHCWOAC-UHFFFAOYSA-N,,ESR1
5553,Y-134,Estrogen receptor antagonist,ESR2,CC(C)N1CCN(CC1)c1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1,LQEOPHGPHCWOAC-UHFFFAOYSA-N,,ESR2
5554,fulvestrant,Estrogen receptor antagonist,ESR1,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,VWUXBMIQPBEWFH-WCCTWKNTSA-N,,ESR1
5555,L-168049,Glucagon receptor antagonist,GCGR,CCCOc1ccc(Br)cc1-c1cc([nH]c1-c1ccncc1)-c1ccc(Cl)cc1,HHBOWXZOLYQFNY-UHFFFAOYSA-N,,GCGR
5556,MK-0893,Glucagon receptor antagonist,GCGR,COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1,DNTVJEMGHBIUMW-IBGZPJMESA-N,,GCGR
5557,BRD-K06956503,Glucosylceramidase inhibitor,GBA,Clc1ccc(CN(CCCCNC(=S)NCCCc2c[nH]cn2)c2ccc(Br)cn2)cc1,ISTWZTLJICEOOO-UHFFFAOYSA-N,,GBA
5558,BRD-K73709114,Glucosylceramidase inhibitor,GBA,Cc1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1nc(nc2ccccc12)-c1cccs1,RGSRXYPOTJVNAZ-UHFFFAOYSA-N,,GBA
5559,BRD-K88761633,Glucosylceramidase inhibitor,GBA,CCOC(=O)c1ccccc1S(=O)(=O)N1CCN(CC1)c1nc(nc2ccccc12)-c1cccs1,UONYMHZUNCSOPQ-UHFFFAOYSA-N,,GBA
5560,BRD-K91691979,Glucosylceramidase inhibitor,GBA,CC(C)(C)Oc1ccccc1Nc2nc(NCCO)nc(n2)N3CCCC3,YLYZGVPSUIZOCY-UHFFFAOYSA-N,,GBA
5561,AMN-082,Glutamate receptor modulator,GRM7,C(CNC(c1ccccc1)c1ccccc1)NC(c1ccccc1)c1ccccc1,DTZDSNQYNPNCPK-UHFFFAOYSA-N,,GRM7
5562,cyclothiazide,Glutamate receptor modulator,SLC12A3,NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl,BOCUKUHCLICSIY-UHFFFAOYSA-N,,SLC12A3
5563,cyclothiazide,Glutamate receptor modulator,CA2,NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl,BOCUKUHCLICSIY-UHFFFAOYSA-N,,CA2
5564,DMeOB,Glutamate receptor modulator,GRM5,COc1cccc(C=NC=Nc2cccc(OC)c2)c1,CWHVUMNEZIBZFC-UHFFFAOYSA-N,,GRM5
5565,mibampator,Glutamate receptor modulator,GRIA1,CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)-c1ccc(CCNS(C)(=O)=O)cc1,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,,GRIA1
5566,VU-0366037-2,Glutamate receptor modulator,GRM4,Clc1ccccc1C(=O)Nc1ccc(NC(=O)c2ccccn2)cc1Cl,MTELUFOIWGSEFF-UHFFFAOYSA-N,,GRM4
5567,VU-0400071-3,Glutamate receptor modulator,GRM4,Clc1cc(NC(=O)c2ccccn2)ccc1N1C(=O)CC(C1=O)c1ccccc1,UYGDCIXFYIWDMR-UHFFFAOYSA-N,,GRM4
5568,VU-0400193-3,Glutamate receptor modulator,GRM4,Clc1cc(NC(=O)c2ccccn2)ccc1N1C(=O)CC2(CCCCC2)C1=O,YNDMAMUBWKKHPW-UHFFFAOYSA-N,,GRM4
5569,VU-0400195-3,Glutamate receptor modulator,GRM4,Clc1cc(NC(=O)c2ccccn2)ccc1N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O,LJUABYFUJVRUSJ-FRVJLOGJSA-N,,GRM4
5570,VU-0404997-2,Glutamate receptor modulator,GRM4,CC1(CC(=O)N(C1=O)c1ccc(NC(=O)c2ccccn2)cc1Cl)c1ccccc1,VVBFAZRDUJRAAU-UHFFFAOYSA-N,,GRM4
5571,VU-0415374-1,Glutamate receptor modulator,GRM4,COc1cc(NC(=O)c2ccccn2)ccc1NC(=O)c1ccccc1Cl,RZZCVJKQCRSTKD-UHFFFAOYSA-N,,GRM4
5572,cyclizine,Histamine receptor modulator,HRH1,CN1CCN(CC1)C(c1ccccc1)c1ccccc1,UVKZSORBKUEBAZ-UHFFFAOYSA-N,,HRH1
5573,proxyfan,Histamine receptor modulator,HRH3,C(COCc1ccccc1)Cc1cnc[nH]1,WNWALBVQAAIULR-UHFFFAOYSA-N,,HRH3
5574,moxonidine,Imidazoline receptor agonist,NISCH,COc1nc(C)nc(Cl)c1NC1=NCCN1,WPNJAUFVNXKLIM-UHFFFAOYSA-N,,NISCH
5575,nandrolone,Imidazoline receptor agonist,NISCH,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,NPAGDVCDWIYMMC-IZPLOLCNSA-N,,NISCH
5576,nandrolone,Imidazoline receptor agonist,CYP19A1,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,NPAGDVCDWIYMMC-IZPLOLCNSA-N,,CYP19A1
5577,nandrolone,Imidazoline receptor agonist,AR,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,NPAGDVCDWIYMMC-IZPLOLCNSA-N,,AR
5578,nandrolone,Imidazoline receptor agonist,MAOA,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,NPAGDVCDWIYMMC-IZPLOLCNSA-N,,MAOA
5579,nandrolone,Imidazoline receptor agonist,MAOB,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,NPAGDVCDWIYMMC-IZPLOLCNSA-N,,MAOB
5580,rilmenidine,Imidazoline receptor agonist,NISCH,C1CC1C(NC1=NCCO1)C1CC1,CQXADFVORZEARL-UHFFFAOYSA-N,,NISCH
5581,rilmenidine,Imidazoline receptor agonist,ADRA2A,C1CC1C(NC1=NCCO1)C1CC1,CQXADFVORZEARL-UHFFFAOYSA-N,,ADRA2A
5582,rilmenidine,Imidazoline receptor agonist,NISCH,C1CC1C(NC2=NCCO2)C3CC3,CQXADFVORZEARL-UHFFFAOYSA-N,,NISCH
5583,rilmenidine,Imidazoline receptor agonist,ADRA2A,C1CC1C(NC2=NCCO2)C3CC3,CQXADFVORZEARL-UHFFFAOYSA-N,,ADRA2A
5584,GW-311616,Leukocyte elastase inhibitor,ELANE,CC(C)C1[C@H]2[C@@H](CCN2C(=O)/C=C/CN3CCCCC3)N(C1=O)S(=O)(=O)C,NDNKNUMSTIMSHQ-PTJVQUAFSA-N,,ELANE
5585,SSR-69071,Leukocyte elastase inhibitor,ELANE,COc1cc2c(C(=O)N(COc3cc(=O)n4cccc(OCCN5CCCCC5)c4n3)S2(=O)=O)c(c1)C(C)C,DRZXDZYWZSKFDL-UHFFFAOYSA-N,,ELANE
5586,gemfibrozil,Lipoprotein lipase activator,CYP2C8,Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,,CYP2C8
5587,gemfibrozil,Lipoprotein lipase activator,LPL,Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,,LPL
5588,gemfibrozil,Lipoprotein lipase activator,PPARA,Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,,PPARA
5589,mirin,MRE11A exonuclease inhibitor,MRE11,NC1=NC(=O)C(S1)=Cc1ccc(O)cc1,YBHQCJILTOVLHD-YVMONPNESA-N,,MRE11
5590,etomidate,Membrane integrity inhibitor,GABRA1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA1
5591,etomidate,Membrane integrity inhibitor,GABRA2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA2
5592,etomidate,Membrane integrity inhibitor,GABRA3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA3
5593,etomidate,Membrane integrity inhibitor,GABRA4,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA4
5594,etomidate,Membrane integrity inhibitor,GABRA5,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA5
5595,etomidate,Membrane integrity inhibitor,GABRA6,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA6
5596,etomidate,Membrane integrity inhibitor,GABRB1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB1
5597,etomidate,Membrane integrity inhibitor,GABRB2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB2
5598,etomidate,Membrane integrity inhibitor,GABRB3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB3
5599,etomidate,Membrane integrity inhibitor,GABRD,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRD
5600,etomidate,Membrane integrity inhibitor,GABRE,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRE
5601,etomidate,Membrane integrity inhibitor,GABRG1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG1
5602,etomidate,Membrane integrity inhibitor,GABRG2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG2
5603,etomidate,Membrane integrity inhibitor,GABRG3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG3
5604,etomidate,Membrane integrity inhibitor,GABRP,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRP
5605,etomidate,Membrane integrity inhibitor,GABRQ,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRQ
5606,ciclopirox,Membrane integrity inhibitor,ATP1A1,Cc1cc(C2CCCCC2)n(O)c(=O)c1,SCKYRAXSEDYPSA-UHFFFAOYSA-N,,ATP1A1
5607,eltanolone,Membrane integrity inhibitor,GABRA1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,AURFZBICLPNKBZ-SYBPFIFISA-N,,GABRA1
5608,etomidate,Membrane integrity inhibitor,GABRA1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA1
5609,etomidate,Membrane integrity inhibitor,GABRA2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA2
5610,etomidate,Membrane integrity inhibitor,GABRA3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA3
5611,etomidate,Membrane integrity inhibitor,GABRA4,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA4
5612,etomidate,Membrane integrity inhibitor,GABRA5,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA5
5613,etomidate,Membrane integrity inhibitor,GABRA6,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA6
5614,etomidate,Membrane integrity inhibitor,GABRB1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB1
5615,etomidate,Membrane integrity inhibitor,GABRB2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB2
5616,etomidate,Membrane integrity inhibitor,GABRB3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB3
5617,etomidate,Membrane integrity inhibitor,GABRD,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRD
5618,etomidate,Membrane integrity inhibitor,GABRE,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRE
5619,etomidate,Membrane integrity inhibitor,GABRG1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG1
5620,etomidate,Membrane integrity inhibitor,GABRG2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG2
5621,etomidate,Membrane integrity inhibitor,GABRG3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG3
5622,etomidate,Membrane integrity inhibitor,GABRP,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRP
5623,etomidate,Membrane integrity inhibitor,GABRQ,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRQ
5624,tetracaine,Membrane integrity inhibitor,SCN9A,CCCCNc1ccc(cc1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,,SCN9A
5625,tetracaine,Membrane integrity inhibitor,SCN10A,CCCCNc1ccc(cc1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,,SCN10A
5626,BRD-K11757396,Neuropeptide receptor ligand,NPSR1,S=P(c1cn(Cc2ccccc2)c2cccc[n+]12)(c1ccccc1)c1ccccc1,YZFQKYMQJJRWSD-UHFFFAOYSA-N,,NPSR1
5627,L-368899,Oxytocin receptor antagonist,OXTR,Cc1ccccc1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C,MWIASLNTAGRGGA-WVJGRJQASA-N,,OXTR
5628,amitriptyline,Serotonin reuptake inhibitor,CHRM1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM1
5629,amitriptyline,Serotonin reuptake inhibitor,CHRM2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM2
5630,amitriptyline,Serotonin reuptake inhibitor,CHRM3,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM3
5631,amitriptyline,Serotonin reuptake inhibitor,CHRM4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM4
5632,amitriptyline,Serotonin reuptake inhibitor,CHRM5,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM5
5633,amitriptyline,Serotonin reuptake inhibitor,HRH1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HRH1
5634,amitriptyline,Serotonin reuptake inhibitor,HTR6,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HTR6
5635,amitriptyline,Serotonin reuptake inhibitor,SLC6A2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A2
5636,amitriptyline,Serotonin reuptake inhibitor,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A4
5637,BTS-54505,Serotonin reuptake inhibitor,SLC6A2,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A2
5638,BTS-54505,Serotonin reuptake inhibitor,SLC6A3,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A3
5639,BTS-54505,Serotonin reuptake inhibitor,SLC6A4,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A4
5640,citalopram,Serotonin reuptake inhibitor,SLC6A4,CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1,WSEQXVZVJXJVFP-UHFFFAOYSA-N,,SLC6A4
5641,desvenlafaxine,Serotonin reuptake inhibitor,SLC6A2,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,,SLC6A2
5642,desvenlafaxine,Serotonin reuptake inhibitor,SLC6A4,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,,SLC6A4
5643,dosulepin,Serotonin reuptake inhibitor,SLC6A2,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A2
5644,dosulepin,Serotonin reuptake inhibitor,SLC6A4,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A4
5645,duloxetine,Serotonin reuptake inhibitor,SLC6A2,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A2
5646,duloxetine,Serotonin reuptake inhibitor,SLC6A3,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A3
5647,duloxetine,Serotonin reuptake inhibitor,SLC6A4,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A4
5648,hyperforin,Serotonin reuptake inhibitor,ALOX5,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,ALOX5
5649,hyperforin,Serotonin reuptake inhibitor,PTGS1,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,PTGS1
5650,hyperforin,Serotonin reuptake inhibitor,NR1I2,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,NR1I2
5651,imipramine,Serotonin reuptake inhibitor,CHRM2,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,CHRM2
5652,imipramine,Serotonin reuptake inhibitor,SLC6A2,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,SLC6A2
5653,imipramine,Serotonin reuptake inhibitor,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,SLC6A4
5654,lofepramine,Serotonin reuptake inhibitor,SLC6A2,CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1,SAPNXPWPAUFAJU-UHFFFAOYSA-N,,SLC6A2
5655,lofepramine,Serotonin reuptake inhibitor,SLC6A4,CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1,SAPNXPWPAUFAJU-UHFFFAOYSA-N,,SLC6A4
5656,mazindol,Serotonin reuptake inhibitor,SLC6A2,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A2
5657,mazindol,Serotonin reuptake inhibitor,SLC6A3,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A3
5658,mazindol,Serotonin reuptake inhibitor,SLC6A4,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,,SLC6A4
5659,milnacipran,Serotonin reuptake inhibitor,SLC6A2,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c1ccccc1,GJJFMKBJSRMPLA-HIFRSBDPSA-N,,SLC6A2
5660,milnacipran,Serotonin reuptake inhibitor,SLC6A4,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c1ccccc1,GJJFMKBJSRMPLA-HIFRSBDPSA-N,,SLC6A4
5661,milnacipran,Serotonin reuptake inhibitor,SLC6A2,CCN(CC)C(=O)C1(CC1CN)c1ccccc1,GJJFMKBJSRMPLA-UHFFFAOYSA-N,,SLC6A2
5662,milnacipran,Serotonin reuptake inhibitor,SLC6A4,CCN(CC)C(=O)C1(CC1CN)c1ccccc1,GJJFMKBJSRMPLA-UHFFFAOYSA-N,,SLC6A4
5663,minaprine,Serotonin reuptake inhibitor,HTR2B,Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,,HTR2B
5664,minaprine,Serotonin reuptake inhibitor,SLC6A4,Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,,SLC6A4
5665,nefazodone,Serotonin reuptake inhibitor,HTR2A,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2A
5666,nefazodone,Serotonin reuptake inhibitor,HTR2C,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2C
5667,nefazodone,Serotonin reuptake inhibitor,SLC6A2,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A2
5668,nefazodone,Serotonin reuptake inhibitor,SLC6A4,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A4
5669,phentermine,Serotonin reuptake inhibitor,SLC6A2,CC(C)(N)Cc1ccccc1,DHHVAGZRUROJKS-UHFFFAOYSA-N,,SLC6A2
5670,sibutramine,Serotonin reuptake inhibitor,SLC6A2,CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1,UNAANXDKBXWMLN-UHFFFAOYSA-N,,SLC6A2
5671,sibutramine,Serotonin reuptake inhibitor,SLC6A3,CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1,UNAANXDKBXWMLN-UHFFFAOYSA-N,,SLC6A3
5672,sibutramine,Serotonin reuptake inhibitor,SLC6A4,CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1,UNAANXDKBXWMLN-UHFFFAOYSA-N,,SLC6A4
5673,tramadol,Serotonin reuptake inhibitor,OPRM1,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,OPRM1
5674,tramadol,Serotonin reuptake inhibitor,SLC6A2,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A2
5675,tramadol,Serotonin reuptake inhibitor,SLC6A4,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A4
5676,tramadol,Serotonin reuptake inhibitor,OPRM1,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,OPRM1
5677,tramadol,Serotonin reuptake inhibitor,SLC6A2,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A2
5678,tramadol,Serotonin reuptake inhibitor,SLC6A4,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A4
5679,trazodone,Serotonin reuptake inhibitor,HTR2A,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2A
5680,trazodone,Serotonin reuptake inhibitor,HTR2C,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2C
5681,trazodone,Serotonin reuptake inhibitor,SLC6A4,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,SLC6A4
5682,venlafaxine,Serotonin reuptake inhibitor,SLC6A2,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A2
5683,venlafaxine,Serotonin reuptake inhibitor,SLC6A4,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A4
5684,vilazodone,Serotonin reuptake inhibitor,HTR1A,NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1,SGEGOXDYSFKCPT-UHFFFAOYSA-N,,HTR1A
5685,vilazodone,Serotonin reuptake inhibitor,SLC6A4,NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1,SGEGOXDYSFKCPT-UHFFFAOYSA-N,,SLC6A4
5686,viloxazine,Serotonin reuptake inhibitor,SLC6A2,CCOc1ccccc1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,,SLC6A2
5687,zimelidine,Serotonin reuptake inhibitor,SLC6A4,CN(C)C/C=C(c1ccc(Br)cc1)/c2cccnc2,OYPPVKRFBIWMSX-CXUHLZMHSA-N,,SLC6A4
5688,zimelidine,Serotonin reuptake inhibitor,SLC6A4,CN(C)CC=C(c1ccc(Br)cc1)c2cccnc2,OYPPVKRFBIWMSX-UHFFFAOYSA-N,,SLC6A4
5689,ABC-294640,Sphingosine kinase inhibitor,SPHK2,Clc1ccc(cc1)C12CC3CC(CC(C3)(C1)C(=O)NCc1ccncc1)C2,CAOTVXGYTWCKQE-UHFFFAOYSA-N,,SPHK2
5690,PF-543,Sphingosine kinase inhibitor,SPHK1,Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1,NPUXORBZRBIOMQ-RUZDIDTESA-N,,SPHK1
5691,enilconazole,Sterol demethylase inhibitor,CYP1A2,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP1A2
5692,enilconazole,Sterol demethylase inhibitor,CYP2B6,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP2B6
5693,enilconazole,Sterol demethylase inhibitor,CYP2C9,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP2C9
5694,enilconazole,Sterol demethylase inhibitor,CYP2J2,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP2J2
5695,enilconazole,Sterol demethylase inhibitor,CYP3A4,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP3A4
5696,enilconazole,Sterol demethylase inhibitor,CYP3A5,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP3A5
5697,enilconazole,Sterol demethylase inhibitor,CYP19A1,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,CYP19A1
5698,enilconazole,Sterol demethylase inhibitor,PPARA,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,PPARA
5699,enilconazole,Sterol demethylase inhibitor,PTGER2,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,PTGER2
5700,enilconazole,Sterol demethylase inhibitor,NR1I2,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,,NR1I2
5701,fluconazole,Sterol demethylase inhibitor,CYP51A1,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,RFHAOTPXVQNOHP-UHFFFAOYSA-N,,CYP51A1
5702,ketoconazole,Sterol demethylase inhibitor,CYP19A1,CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1,XMAYWYJOQHXEEK-OZXSUGGESA-N,,CYP19A1
5703,ketoconazole,Sterol demethylase inhibitor,AR,CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1,XMAYWYJOQHXEEK-OZXSUGGESA-N,,AR
5704,ketoconazole,Sterol demethylase inhibitor,CYP19A1,CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1,XMAYWYJOQHXEEK-NASUQTAISA-N,,CYP19A1
5705,ketoconazole,Sterol demethylase inhibitor,AR,CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1,XMAYWYJOQHXEEK-NASUQTAISA-N,,AR
5706,ketoconazole,Sterol demethylase inhibitor,CYP19A1,CC(=O)N1CCN(CC1)c2ccc(OCC3COC(Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2,XMAYWYJOQHXEEK-UHFFFAOYSA-N,,CYP19A1
5707,ketoconazole,Sterol demethylase inhibitor,AR,CC(=O)N1CCN(CC1)c2ccc(OCC3COC(Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2,XMAYWYJOQHXEEK-UHFFFAOYSA-N,,AR
5708,propylthiouracil,Thyroid peroxidase inhibitor,DIO1,CCCc1cc(=O)[nH]c(=S)[nH]1,KNAHARQHSZJURB-UHFFFAOYSA-N,,DIO1
5709,propylthiouracil,Thyroid peroxidase inhibitor,TPO,CCCc1cc(=O)[nH]c(=S)[nH]1,KNAHARQHSZJURB-UHFFFAOYSA-N,,TPO
5710,desmopressin-acetate,Vasopressin receptor agonist,AVPR1A,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-UHFFFAOYSA-N,,AVPR1A
5711,desmopressin-acetate,Vasopressin receptor agonist,AVPR1B,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-UHFFFAOYSA-N,,AVPR1B
5712,desmopressin-acetate,Vasopressin receptor agonist,AVPR2,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-UHFFFAOYSA-N,,AVPR2
5713,lypressin,Vasopressin receptor agonist,AVPR1A,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,,AVPR1A
5714,lypressin,Vasopressin receptor agonist,AVPR1B,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,,AVPR1B
5715,lypressin,Vasopressin receptor agonist,AVPR2,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,,AVPR2
5716,cladribine,Adenosine deaminase inhibitor,ADA,Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1,PTOAARAWEBMLNO-KVQBGUIXSA-N,,ADA
5717,theophylline,Adenosine receptor antagonist,ADORA1,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,ADORA1
5718,theophylline,Adenosine receptor antagonist,ADORA2A,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,ADORA2A
5719,theophylline,Adenosine receptor antagonist,ADORA2B,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,ADORA2B
5720,theophylline,Adenosine receptor antagonist,ADORA3,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,ADORA3
5721,theophylline,Adenosine receptor antagonist,PDE3A,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,PDE3A
5722,theophylline,Adenosine receptor antagonist,PDE4A,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,PDE4A
5723,theophylline,Adenosine receptor antagonist,PDE4B,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,,PDE4B
5724,aminophylline,Adenosine receptor antagonist,ADORA1,Cn1c(=O)n(C)c2nc[nH]c2c1=O.Cn1c(=O)n(C)c2nc[nH]c2c1=O,NXSXRSNDUVSCRP-UHFFFAOYSA-N,,ADORA1
5725,aminophylline,Adenosine receptor antagonist,ADORA2A,Cn1c(=O)n(C)c2nc[nH]c2c1=O.Cn1c(=O)n(C)c2nc[nH]c2c1=O,NXSXRSNDUVSCRP-UHFFFAOYSA-N,,ADORA2A
5726,aminophylline,Adenosine receptor antagonist,ADORA2B,Cn1c(=O)n(C)c2nc[nH]c2c1=O.Cn1c(=O)n(C)c2nc[nH]c2c1=O,NXSXRSNDUVSCRP-UHFFFAOYSA-N,,ADORA2B
5727,aminophylline,Adenosine receptor antagonist,ADORA3,Cn1c(=O)n(C)c2nc[nH]c2c1=O.Cn1c(=O)n(C)c2nc[nH]c2c1=O,NXSXRSNDUVSCRP-UHFFFAOYSA-N,,ADORA3
5728,aminophylline,Adenosine receptor antagonist,PDE3A,Cn1c(=O)n(C)c2nc[nH]c2c1=O.Cn1c(=O)n(C)c2nc[nH]c2c1=O,NXSXRSNDUVSCRP-UHFFFAOYSA-N,,PDE3A
5729,caffeine,Adenosine receptor antagonist,ADORA1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA1
5730,caffeine,Adenosine receptor antagonist,ADORA2A,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA2A
5731,caffeine,Adenosine receptor antagonist,ADORA2B,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ADORA2B
5732,caffeine,Adenosine receptor antagonist,ITPR1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ITPR1
5733,caffeine,Adenosine receptor antagonist,ATM,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,ATM
5734,caffeine,Adenosine receptor antagonist,RYR1,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,RYR1
5735,CGS-15943,Adenosine receptor antagonist,ADORA1,Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1,MSJODEOZODDVGW-UHFFFAOYSA-N,,ADORA1
5736,CGS-15943,Adenosine receptor antagonist,ADORA2A,Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1,MSJODEOZODDVGW-UHFFFAOYSA-N,,ADORA2A
5737,CGS-15943,Adenosine receptor antagonist,ADORA2B,Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1,MSJODEOZODDVGW-UHFFFAOYSA-N,,ADORA2B
5738,doxofylline,Adenosine receptor antagonist,ADORA1,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,,ADORA1
5739,doxofylline,Adenosine receptor antagonist,PDE4A,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,,PDE4A
5740,doxofylline,Adenosine receptor antagonist,PDE4B,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,,PDE4B
5741,doxofylline,Adenosine receptor antagonist,PDE4C,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,,PDE4C
5742,doxofylline,Adenosine receptor antagonist,PDE4D,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,,PDE4D
5743,dyphylline,Adenosine receptor antagonist,PDE4A,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4A
5744,dyphylline,Adenosine receptor antagonist,PDE4B,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4B
5745,dyphylline,Adenosine receptor antagonist,PDE4C,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4C
5746,dyphylline,Adenosine receptor antagonist,PDE4D,Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,,PDE4D
5747,etofylline,Adenosine receptor antagonist,ADORA1,Cn1c2ncn(CCO)c2c(=O)n(C)c1=O,NWPRCRWQMGIBOT-UHFFFAOYSA-N,,ADORA1
5748,istradefylline,Adenosine receptor antagonist,ADORA1,CCn1c2nc(C=Cc3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O,IQVRBWUUXZMOPW-PKNBQFBNSA-N,,ADORA1
5749,istradefylline,Adenosine receptor antagonist,ADORA2A,CCn1c2nc(C=Cc3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O,IQVRBWUUXZMOPW-PKNBQFBNSA-N,,ADORA2A
5750,MRS-1220,Adenosine receptor antagonist,ADORA3,Clc1ccc2nc(NC(=O)Cc3ccccc3)n3nc(nc3c2c1)-c1ccco1,TWWFAXQOKNBUCR-UHFFFAOYSA-N,,ADORA3
5751,MRS-1334,Adenosine receptor antagonist,ADORA3,CCOC(=O)C1=C(C)NC(=C(C1C#Cc2ccccc2)C(=O)OCc3ccc(cc3)[N+](=O)[O-])c4ccccc4,QFLOJAMZLQXHFS-UHFFFAOYSA-N,,ADORA3
5752,MRS-1754,Adenosine receptor antagonist,ADORA2B,CCCn1c(=O)n(CCC)c2nc([nH]c2c1=O)c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3,AJBBEYXFRYFVNM-UHFFFAOYSA-N,,ADORA2B
5753,preladenant,Adenosine receptor antagonist,ADORA2A,COCCOc1ccc(cc1)N1CCN(CCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)CC1,DTYWJKSSUANMHD-UHFFFAOYSA-N,,ADORA2A
5754,PSB-11,Adenosine receptor antagonist,ADORA3,CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1,RGDHRCXUMURWBJ-LLVKDONJSA-N,,ADORA3
5755,PSB-1115,Adenosine receptor antagonist,ADORA1,CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O,UYDRRQPGDSIMNU-UHFFFAOYSA-N,,ADORA1
5756,PSB-1115,Adenosine receptor antagonist,ADORA2B,CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O,UYDRRQPGDSIMNU-UHFFFAOYSA-N,,ADORA2B
5757,PSB-36,Adenosine receptor antagonist,ADORA1,CCCCn1c(=O)n(CCCO)c2nc([nH]c2c1=O)C12CC3CC1CC(C2)C3,CIBIXJYFYPFMTN-UHFFFAOYSA-N,,ADORA1
5758,SAL-1,Adenosine receptor antagonist,ADORA2B,O=c1[nH]c(=O)c2nc3ccccc3nc2[nH]1,HAUGRYOERYOXHX-UHFFFAOYSA-N,,ADORA2B
5759,SCH-442416,Adenosine receptor antagonist,ADORA1,COc1ccc(CCCn2ncc3c4nc(nn4c(N)nc23)c5ccco5)cc1,AEULVFLPCJOBCE-UHFFFAOYSA-N,,ADORA1
5760,SCH-442416,Adenosine receptor antagonist,ADORA2A,COc1ccc(CCCn2ncc3c4nc(nn4c(N)nc23)c5ccco5)cc1,AEULVFLPCJOBCE-UHFFFAOYSA-N,,ADORA2A
5761,SCH-58261,Adenosine receptor antagonist,ADORA1,Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1,UTLPKQYUXOEJIL-UHFFFAOYSA-N,,ADORA1
5762,SCH-58261,Adenosine receptor antagonist,ADORA2A,Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1,UTLPKQYUXOEJIL-UHFFFAOYSA-N,,ADORA2A
5763,SLV-320,Adenosine receptor antagonist,ADORA1,O[C@H]1CC[C@@H](CC1)Nc1nc(nc2[nH]ccc12)-c1ccccc1,RBZNJGHIKXAKQE-HDJSIYSDSA-N,,ADORA1
5764,tozadenant,Adenosine receptor antagonist,ADORA2A,COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12,XNBRWUQWSKXMPW-UHFFFAOYSA-N,,ADORA2A
5765,ZM-241385,Adenosine receptor antagonist,ADORA1,Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,,ADORA1
5766,ZM-241385,Adenosine receptor antagonist,ADORA2A,Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,,ADORA2A
5767,ZM-241385,Adenosine receptor antagonist,ADORA2B,Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,,ADORA2B
5768,mepacrine,Cytokine production inhibitor,TP53,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,GPKJTRJOBQGKQK-UHFFFAOYSA-N,,TP53
5769,arglabin,Farnesyltransferase inhibitor,FNTA,CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13,UVJYAKBJSGRTHA-CUZKYEQNSA-N,,FNTA
5770,arglabin,Farnesyltransferase inhibitor,NFKB1,CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13,UVJYAKBJSGRTHA-CUZKYEQNSA-N,,NFKB1
5771,FTI-276,Farnesyltransferase inhibitor,FNTA,CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1)C(O)=O,ZIXDDEATQSBHHL-BEFAXECRSA-N,,FNTA
5772,lonafarnib,Farnesyltransferase inhibitor,FNTA,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1,DHMTURDWPRKSOA-RUZDIDTESA-N,,FNTA
5773,manumycin-a,Farnesyltransferase inhibitor,FNTA,CCCC[C@@H](C)/C=C(C)/C=C(C)/C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]3O[C@@H]3C1=O,XIZGHTZLVCHYJN-MVTGTTCWSA-N,,FNTA
5774,manumycin-a,Farnesyltransferase inhibitor,IKBKB,CCCC[C@@H](C)/C=C(C)/C=C(C)/C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]3O[C@@H]3C1=O,XIZGHTZLVCHYJN-MVTGTTCWSA-N,,IKBKB
5775,manumycin-a,Farnesyltransferase inhibitor,FNTA,CCCC[C@@H](C)C=C(C)C=C(/C)C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]2OC2C1=O,XIZGHTZLVCHYJN-YCWSEAROSA-N,,FNTA
5776,manumycin-a,Farnesyltransferase inhibitor,IKBKB,CCCC[C@@H](C)C=C(C)C=C(/C)C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]2OC2C1=O,XIZGHTZLVCHYJN-YCWSEAROSA-N,,IKBKB
5777,perillyl-alcohol,Farnesyltransferase inhibitor,FNTA,CC(=C)C1CCC(CO)=CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,,FNTA
5778,cerulenin,Fatty acid synthase inhibitor,FASN,CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,,FASN
5779,pyrazinamide,Fatty acid synthase inhibitor,FASN,NC(=O)c1cnccn1,IPEHBUMCGVEMRF-UHFFFAOYSA-N,,FASN
5780,L-655708,GABA receptor inverse agonist,GABRA5,CCOC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc-21,YKYOQIXTECBVBB-AWEZNQCLSA-N,,GABRA5
5781,L-655708,GABA receptor inverse agonist,GABRA5,CCOC(=O)c1ncn-2c1C3CCCN3C(=O)c4cc(OC)ccc42,YKYOQIXTECBVBB-UHFFFAOYSA-N,,GABRA5
5782,CPCCOEt,Glutamate receptor antagonist,GRM1,CCOC(=O)C12CC1C(=N/O)c1ccccc1O2,FXCTZFMSAHZQTR-KAMYIIQDSA-N,,GRM1
5783,dizocilpine,Glutamate receptor antagonist,GRIN1,C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21,LBOJYSIDWZQNJS-JKSUJKDBSA-N,,GRIN1
5784,dizocilpine,Glutamate receptor antagonist,GRIN2A,C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21,LBOJYSIDWZQNJS-JKSUJKDBSA-N,,GRIN2A
5785,dizocilpine,Glutamate receptor antagonist,GRIN2B,C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21,LBOJYSIDWZQNJS-JKSUJKDBSA-N,,GRIN2B
5786,aptiganel,Glutamate receptor antagonist,GRIN1,CCc1cccc(c1)N(C)C(=N)Nc1cccc2ccccc12,BFNCJMURTMZBTE-UHFFFAOYSA-N,,GRIN1
5787,basimglurant,Glutamate receptor antagonist,GRM5,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1,UPZWINBEAHDTLA-UHFFFAOYSA-N,,GRM5
5788,BAY-36-7620,Glutamate receptor antagonist,GRM1,C=C1C[C@@H]2COC(=O)[C@]2(Cc3ccc4ccccc4c3)C1,CVIRWLJKDBYYOG-MJGOQNOKSA-N,,GRM1
5789,BRD-A41630653,Glutamate receptor antagonist,SIGMAR1,COc1ccc2CC3C4CCCC[C@@]4(CCN3C)c2c1,MKXZASYAUGDDCJ-VJFUWPCTSA-N,,SIGMAR1
5790,BRD-A41630653,Glutamate receptor antagonist,SLC6A4,COc1ccc2CC3C4CCCC[C@@]4(CCN3C)c2c1,MKXZASYAUGDDCJ-VJFUWPCTSA-N,,SLC6A4
5791,budipine,Glutamate receptor antagonist,GRIN1,CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,,GRIN1
5792,CNQX,Glutamate receptor antagonist,GRIA1,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N,RPXVIAFEQBNEAX-UHFFFAOYSA-N,,GRIA1
5793,CNQX,Glutamate receptor antagonist,GRIA1,Oc1nc2cc(C#N)c(cc2nc1O)[N+](=O)[O-],RPXVIAFEQBNEAX-UHFFFAOYSA-N,,GRIA1
5794,dextrorphan,Glutamate receptor antagonist,OPRD1,CN1CC[C@]23CCCC[C@@H]3[C@@H]1Cc4ccc(O)cc42,JAQUASYNZVUNQP-PVAVHDDUSA-N,,OPRD1
5795,dextrorphan,Glutamate receptor antagonist,OPRK1,CN1CC[C@]23CCCC[C@@H]3[C@@H]1Cc4ccc(O)cc42,JAQUASYNZVUNQP-PVAVHDDUSA-N,,OPRK1
5796,dextrorphan,Glutamate receptor antagonist,OPRM1,CN1CC[C@]23CCCC[C@@H]3[C@@H]1Cc4ccc(O)cc42,JAQUASYNZVUNQP-PVAVHDDUSA-N,,OPRM1
5797,eliprodil,Glutamate receptor antagonist,GRIN1,OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1,GGUSQTSTQSHJAH-UHFFFAOYSA-N,,GRIN1
5798,eliprodil,Glutamate receptor antagonist,GRIN2B,OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1,GGUSQTSTQSHJAH-UHFFFAOYSA-N,,GRIN2B
5799,felbamate,Glutamate receptor antagonist,GRIN3A,NC(=O)OCC(COC(N)=O)c1ccccc1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,,GRIN3A
5800,felbamate,Glutamate receptor antagonist,GRIN2A,NC(=O)OCC(COC(N)=O)c1ccccc1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,,GRIN2A
5801,felbamate,Glutamate receptor antagonist,GRIN2B,NC(=O)OCC(COC(N)=O)c1ccccc1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,,GRIN2B
5802,fenobam,Glutamate receptor antagonist,GRM5,CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1,DWPQODZAOSWNHB-UHFFFAOYSA-N,,GRM5
5803,flupirtine,Glutamate receptor antagonist,KCNQ1,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N,JUUFBMODXQKSTD-UHFFFAOYSA-N,,KCNQ1
5804,flupirtine,Glutamate receptor antagonist,KCNQ2,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N,JUUFBMODXQKSTD-UHFFFAOYSA-N,,KCNQ2
5805,GYKI-52466,Glutamate receptor antagonist,GRIA1,CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1,LFBZZHVSGAHQPP-UHFFFAOYSA-N,,GRIA1
5806,HU-211,Glutamate receptor antagonist,CNR1,CCCCCCC(C)(C)c1cc(O)c2[C@H]3CC(CO)=CCC3C(C)(C)Oc2c1,SSQJFGMEZBFMNV-XJDOXCRVSA-N,,CNR1
5807,HU-211,Glutamate receptor antagonist,CNR2,CCCCCCC(C)(C)c1cc(O)c2[C@H]3CC(CO)=CCC3C(C)(C)Oc2c1,SSQJFGMEZBFMNV-XJDOXCRVSA-N,,CNR2
5808,HU-211,Glutamate receptor antagonist,GRIN1,CCCCCCC(C)(C)c1cc(O)c2[C@H]3CC(CO)=CCC3C(C)(C)Oc2c1,SSQJFGMEZBFMNV-XJDOXCRVSA-N,,GRIN1
5809,huperzine-a,Glutamate receptor antagonist,ACHE,C/C=C/1C2Cc3[nH]c(=O)ccc3C1(N)CC(=C2)C,ZRJBHWIHUMBLCN-QDEBKDIKSA-N,,ACHE
5810,huperzine-a,Glutamate receptor antagonist,ACHE,CC=C1/[C@H]2Cc3[nH]c(=O)ccc3[C@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-JRYCNTDSSA-N,,ACHE
5811,huperzine-a,Glutamate receptor antagonist,ACHE,CC=C1[C@@H]2Cc3nc(O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-SEQYCRGISA-N,,ACHE
5812,huperzine-a,Glutamate receptor antagonist,ACHE,CC=C1[C@@H]2Cc3nc(O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-ZUZCIYMTSA-N,,ACHE
5813,ifenprodil,Glutamate receptor antagonist,GRIN1,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,,GRIN1
5814,ifenprodil,Glutamate receptor antagonist,GRIN2B,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,,GRIN2B
5815,JNJ-16259685,Glutamate receptor antagonist,GRM1,COC1CCC(CC1)C(=O)c2ccc3nc4OCCCc4cc3c2,QOTAQTRFJWLFCR-UHFFFAOYSA-N,,GRM1
5816,L-701252,Glutamate receptor antagonist,GRIN1,Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12,MXEFWCFPCLDOOG-UHFFFAOYSA-N,,GRIN1
5817,L-701324,Glutamate receptor antagonist,GRIN1,Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12,FLVRDMUHUXVRET-UHFFFAOYSA-N,,GRIN1
5818,L-701324,Glutamate receptor antagonist,GRIN2A,Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12,FLVRDMUHUXVRET-UHFFFAOYSA-N,,GRIN2A
5819,L-701324,Glutamate receptor antagonist,GRIN2B,Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12,FLVRDMUHUXVRET-UHFFFAOYSA-N,,GRIN2B
5820,latrepirdine,Glutamate receptor antagonist,HTR6,CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1,JNODQFNWMXFMEV-UHFFFAOYSA-N,,HTR6
5821,LY-341495,Glutamate receptor antagonist,GRM2,N[C@@](CC1c2ccccc2Oc3ccccc13)([C@H]4C[C@@H]4C(=O)O)C(=O)O,VLZBRVJVCCNPRJ-KPHUOKFYSA-N,,GRM2
5822,LY-341495,Glutamate receptor antagonist,GRM3,N[C@@](CC1c2ccccc2Oc3ccccc13)([C@H]4C[C@@H]4C(=O)O)C(=O)O,VLZBRVJVCCNPRJ-KPHUOKFYSA-N,,GRM3
5823,LY-456236,Glutamate receptor antagonist,GRM1,COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1,XPJOMFBGKIABQW-UHFFFAOYSA-N,,GRM1
5824,MDL-29951,Glutamate receptor antagonist,FBP1,OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(=O)O,KNBSYZNKEAWABY-UHFFFAOYSA-N,,FBP1
5825,memantine,Glutamate receptor antagonist,GRIN1,C[C@@]1(C[C@@H]2C[C@]3(C)C1)C[C@](N)(C2)C3,BUGYDGFZZOZRHP-CDECOKDKSA-N,,GRIN1
5826,memantine,Glutamate receptor antagonist,GRIN1,CC12CC3CC(C)(C1)CC(N)(C3)C2,BUGYDGFZZOZRHP-UHFFFAOYSA-N,,GRIN1
5827,NBQX,Glutamate receptor antagonist,GRIA1,NS(=O)(=O)c1cccc2c1c(cc1[nH]c(=O)c(=O)[nH]c21)[N+]([O-])=O,UQNAFPHGVPVTAL-UHFFFAOYSA-N,,GRIA1
5828,NBQX,Glutamate receptor antagonist,GRIA1,NS(=O)(=O)c1cccc2c3nc(O)c(O)nc3cc([N+](=O)[O-])c12,UQNAFPHGVPVTAL-UHFFFAOYSA-N,,GRIA1
5829,norketamine,Glutamate receptor antagonist,CYP3A4,NC1(CCCCC1=O)c2ccccc2Cl,BEQZHFIKTBVCAU-UHFFFAOYSA-N,,CYP3A4
5830,NS-3694,Glutamate receptor antagonist,CASP9,OC(=O)c1ccc(Cl)cc1NC(=O)Nc2cccc(c2)C(F)(F)F,GNCZTZCPXFDPLI-UHFFFAOYSA-N,,CASP9
5831,perampanel,Glutamate receptor antagonist,GRIA1,O=c1c(cc(cn1-c1ccccc1)-c1ccccn1)-c1ccccc1C#N,PRMWGUBFXWROHD-UHFFFAOYSA-N,,GRIA1
5832,remacemide,Glutamate receptor antagonist,GRIN1,CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1,YSGASDXSLKIKOD-UHFFFAOYSA-N,,GRIN1
5833,Ro-04-5595,Glutamate receptor antagonist,GRIN2B,COc1cc2CCN(C)C(CCc3ccc(Cl)cc3)c2cc1O,DSTWURHEHMZWEI-UHFFFAOYSA-N,,GRIN2B
5834,SIB-1757,Glutamate receptor antagonist,GRM5,Cc1ccc(O)c(N=Nc2ccccc2)n1,LOCPVWIREQIGNQ-UHFFFAOYSA-N,,GRM5
5835,SIB-1893,Glutamate receptor antagonist,GRM5,Cc1cccc(C=Cc2ccccc2)n1,SISOFUCTXZKSOQ-UHFFFAOYSA-N,,GRM5
5836,SYM-2206,Glutamate receptor antagonist,GRIA1,CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C,OFUDZKKOKPGXOH-UHFFFAOYSA-N,,GRIA1
5837,SYM-2206,Glutamate receptor antagonist,GRIA2,CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C,OFUDZKKOKPGXOH-UHFFFAOYSA-N,,GRIA2
5838,SYM-2206,Glutamate receptor antagonist,GRIA3,CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C,OFUDZKKOKPGXOH-UHFFFAOYSA-N,,GRIA3
5839,SYM-2206,Glutamate receptor antagonist,GRIA4,CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C,OFUDZKKOKPGXOH-UHFFFAOYSA-N,,GRIA4
5840,thiamylal,Glutamate receptor antagonist,GABRA1,CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,,GABRA1
5841,topiramate,Glutamate receptor antagonist,GABRA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA1
5842,topiramate,Glutamate receptor antagonist,GABRA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA2
5843,topiramate,Glutamate receptor antagonist,GABRA3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA3
5844,topiramate,Glutamate receptor antagonist,GABRA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA4
5845,topiramate,Glutamate receptor antagonist,GABRA5,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA5
5846,topiramate,Glutamate receptor antagonist,GABRA6,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRA6
5847,topiramate,Glutamate receptor antagonist,GABRB1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB1
5848,topiramate,Glutamate receptor antagonist,GABRB2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB2
5849,topiramate,Glutamate receptor antagonist,GABRB3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRB3
5850,topiramate,Glutamate receptor antagonist,GABRD,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRD
5851,topiramate,Glutamate receptor antagonist,GABRE,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRE
5852,topiramate,Glutamate receptor antagonist,GABRG1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG1
5853,topiramate,Glutamate receptor antagonist,GABRG2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG2
5854,topiramate,Glutamate receptor antagonist,GABRG3,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRG3
5855,topiramate,Glutamate receptor antagonist,GABRP,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRP
5856,topiramate,Glutamate receptor antagonist,GRIA1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIA1
5857,topiramate,Glutamate receptor antagonist,GRIK1,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GRIK1
5858,topiramate,Glutamate receptor antagonist,GABRQ,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,GABRQ
5859,topiramate,Glutamate receptor antagonist,SCN1A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN1A
5860,topiramate,Glutamate receptor antagonist,SCN5A,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,SCN5A
5861,topiramate,Glutamate receptor antagonist,CA2,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA2
5862,topiramate,Glutamate receptor antagonist,CA4,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,KJADKKWYZYXHBB-XBWDGYHZSA-N,,CA4
5863,traxoprodil,Glutamate receptor antagonist,GRIN2B,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(CC1)c1ccccc1,QEMSVZNTSXPFJA-HNAYVOBHSA-N,,GRIN2B
5864,UBP-302,Glutamate receptor antagonist,GRIK1,NC(Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O,UUIYULWYHDSXHL-UHFFFAOYSA-N,,GRIK1
5865,YM-298198,Glutamate receptor antagonist,GRM1,Cc1c(sc2nc3ccc(N)cc3n12)C(=O)NC1CCCCC1,VWOMTTIMBHBPBI-UHFFFAOYSA-N,,GRM1
5866,YM-298198,Glutamate receptor antagonist,GRM1,CN(C1CCCCC1)C(=O)c1sc2nc3ccc(N)cc3n2c1C,KCBXOMYXOBVLED-UHFFFAOYSA-N,,GRM1
5867,huperzine-a,Glutamate receptor antagonist,ACHE,CC=C1/[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-YQEJDHNASA-N,,ACHE
5868,ALX-5407,Glycine transporter inhibitor,SLC6A9,CN(CC[C@@H](Oc1ccc(cc1)-c1ccccc1)c1ccc(F)cc1)CC(O)=O,FDORQEIHOKEJNX-HSZRJFAPSA-N,,SLC6A9
5869,bitopertin,Glycine transporter inhibitor,SLC6A9,C[C@H](Oc1ccc(cc1C(=O)N1CCN(CC1)c1ncc(cc1F)C(F)(F)F)S(C)(=O)=O)C(F)(F)F,YUUGYIUSCYNSQR-LBPRGKRZSA-N,,SLC6A9
5870,sarcosine,Glycine transporter inhibitor,SLC6A9,CNCC(O)=O,FSYKKLYZXJSNPZ-UHFFFAOYSA-N,,SLC6A9
5871,ABT-239,Histamine receptor antagonist,HRH3,C[C@@H]1CCCN1CCc1cc2cc(ccc2o1)-c1ccc(cc1)C#N,KFHYZKCRXNRKRC-MRXNPFEDSA-N,,HRH3
5872,acrivastine,Histamine receptor antagonist,HRH1,Cc1ccc(cc1)C(=C/CN1CCCC1)c1cccc(C=CC(O)=O)n1,PWACSDKDOHSSQD-IUTFFREVSA-N,,HRH1
5873,astemizole,Histamine receptor antagonist,HRH1,COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1,GXDALQBWZGODGZ-UHFFFAOYSA-N,,HRH1
5874,astemizole,Histamine receptor antagonist,KCNH2,COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1,GXDALQBWZGODGZ-UHFFFAOYSA-N,,KCNH2
5875,azelastine,Histamine receptor antagonist,HRH1,CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O,MBUVEWMHONZEQD-UHFFFAOYSA-N,,HRH1
5876,bavisant,Histamine receptor antagonist,HRH3,O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1,BGBVSGSIXIIREO-UHFFFAOYSA-N,,HRH3
5877,bepotastine,Histamine receptor antagonist,HRH1,OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1,YWGDOWXRIALTES-NRFANRHFSA-N,,HRH1
5878,betahistine,Histamine receptor antagonist,HRH3,CNCCc1ccccn1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,,HRH3
5879,betahistine,Histamine receptor antagonist,HRH1,CNCCc1ccccn1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,,HRH1
5880,brompheniramine,Histamine receptor antagonist,HRH1,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,ZDIGNSYAACHWNL-UHFFFAOYSA-N,,HRH1
5881,carbinoxamine,Histamine receptor antagonist,HRH1,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,OJFSXZCBGQGRNV-UHFFFAOYSA-N,,HRH1
5882,cetirizine,Histamine receptor antagonist,HRH1,OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,ZKLPARSLTMPFCP-UHFFFAOYSA-N,,HRH1
5883,chlorcyclizine,Histamine receptor antagonist,HRH1,CN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,WFNAKBGANONZEQ-UHFFFAOYSA-N,,HRH1
5884,chloropyramine,Histamine receptor antagonist,HRH1,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1,ICKFFNBDFNZJSX-UHFFFAOYSA-N,,HRH1
5885,cimetidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1nc[nH]c1C)=N/C#N,AQIXAKUUQRKLND-UHFFFAOYSA-N,,HRH2
5886,cimetidine,Histamine receptor antagonist,HRH2,CNC(=NC#N)NCCSCc1nc[nH]c1C,AQIXAKUUQRKLND-UHFFFAOYSA-N,,HRH2
5887,ciproxifan,Histamine receptor antagonist,HRH3,O=C(C1CC1)c1ccc(OCCCc2c[nH]cn2)cc1,ACQBHJXEAYTHCY-UHFFFAOYSA-N,,HRH3
5888,clemastine,Histamine receptor antagonist,HRH1,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,YNNUSGIPVFPVBX-NHCUHLMSSA-N,,HRH1
5889,clobenpropit,Histamine receptor antagonist,HRH3,Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1,UCAIEVHKDLMIFL-UHFFFAOYSA-N,,HRH3
5890,clobenpropit,Histamine receptor antagonist,HRH4,Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1,UCAIEVHKDLMIFL-UHFFFAOYSA-N,,HRH4
5891,cyproheptadine,Histamine receptor antagonist,HRH1,CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12,JJCFRYNCJDLXIK-UHFFFAOYSA-N,,HRH1
5892,deptropine,Histamine receptor antagonist,HRH1,CN1[C@H]2CC[C@@H]1CC(C2)OC1c2ccccc2CCc2ccccc12,ZWPODSUQWXAZNC-YOFSQIOKSA-N,,HRH1
5893,desloratadine,Histamine receptor antagonist,HRH1,Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1,JAUOIFJMECXRGI-UHFFFAOYSA-N,,HRH1
5894,dexbrompheniramine,Histamine receptor antagonist,HRH1,CN(C)CC[C@@H](c1ccc(Br)cc1)c2ccccn2,ZDIGNSYAACHWNL-HNNXBMFYSA-N,,HRH1
5895,dimenhydrinate,Histamine receptor antagonist,HRH1,Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1,NFLLKCVHYJRNRH-UHFFFAOYSA-N,,HRH1
5896,diphenhydramine,Histamine receptor antagonist,HRH1,CN(C)CCOC(c1ccccc1)c1ccccc1,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,,HRH1
5897,doxepin,Histamine receptor antagonist,HRH1,CN(C)CC/C=C/1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-GZTJUZNOSA-N,,HRH1
5898,doxepin,Histamine receptor antagonist,HRH2,CN(C)CC/C=C/1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-GZTJUZNOSA-N,,HRH2
5899,doxepin,Histamine receptor antagonist,SLC6A2,CN(C)CC/C=C/1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-GZTJUZNOSA-N,,SLC6A2
5900,doxepin,Histamine receptor antagonist,SLC6A4,CN(C)CC/C=C/1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-GZTJUZNOSA-N,,SLC6A4
5901,doxepin,Histamine receptor antagonist,HRH1,CN(C)CCC=C1c2ccccc2COc2ccccc12,ODQWQRRAPPTVAG-BOPFTXTBSA-N,,HRH1
5902,doxepin,Histamine receptor antagonist,HRH2,CN(C)CCC=C1c2ccccc2COc2ccccc12,ODQWQRRAPPTVAG-BOPFTXTBSA-N,,HRH2
5903,doxepin,Histamine receptor antagonist,SLC6A2,CN(C)CCC=C1c2ccccc2COc2ccccc12,ODQWQRRAPPTVAG-BOPFTXTBSA-N,,SLC6A2
5904,doxepin,Histamine receptor antagonist,SLC6A4,CN(C)CCC=C1c2ccccc2COc2ccccc12,ODQWQRRAPPTVAG-BOPFTXTBSA-N,,SLC6A4
5905,doxepin,Histamine receptor antagonist,HRH1,CN(C)CCC=C1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-UHFFFAOYSA-N,,HRH1
5906,doxepin,Histamine receptor antagonist,HRH2,CN(C)CCC=C1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-UHFFFAOYSA-N,,HRH2
5907,doxepin,Histamine receptor antagonist,SLC6A2,CN(C)CCC=C1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-UHFFFAOYSA-N,,SLC6A2
5908,doxepin,Histamine receptor antagonist,SLC6A4,CN(C)CCC=C1c2ccccc2COc3ccccc13,ODQWQRRAPPTVAG-UHFFFAOYSA-N,,SLC6A4
5909,doxylamine,Histamine receptor antagonist,HRH1,CN(C)CCOC(C)(c1ccccc1)c1ccccn1,HCFDWZZGGLSKEP-UHFFFAOYSA-N,,HRH1
5910,emedastine,Histamine receptor antagonist,HRH1,CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1,KBUZBQVCBVDWKX-UHFFFAOYSA-N,,HRH1
5911,epinastine,Histamine receptor antagonist,HRH1,NC1=NCC2N1c1ccccc1Cc1ccccc21,WHWZLSFABNNENI-UHFFFAOYSA-N,,HRH1
5912,epinastine,Histamine receptor antagonist,HRH2,NC1=NCC2N1c1ccccc1Cc1ccccc21,WHWZLSFABNNENI-UHFFFAOYSA-N,,HRH2
5913,famotidine,Histamine receptor antagonist,HRH2,NC(N)=Nc1nc(CSCCC(N)=N/S(N)(=O)=O)cs1,XUFQPHANEAPEMJ-UHFFFAOYSA-N,,HRH2
5914,fexofenadine,Histamine receptor antagonist,HRH1,CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,RWTNPBWLLIMQHL-UHFFFAOYSA-N,,HRH1
5915,ICI-162846,Histamine receptor antagonist,HRH2,NC(=O)CCCCn1ccc(N=C(N)NCC(F)(F)F)n1,ALCSGJCIESECFD-UHFFFAOYSA-N,,HRH2
5916,ICI-162846,Histamine receptor antagonist,HRH2,NC(=O)CCCCn1ccc(n1)N=C(/N)NCC(F)(F)F,ALCSGJCIESECFD-UHFFFAOYSA-N,,HRH2
5917,iodophenpropit,Histamine receptor antagonist,HRH3,Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1,UBHYDQAARZKHEZ-UHFFFAOYSA-N,,HRH3
5918,iodophenpropit,Histamine receptor antagonist,HRH4,Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1,UBHYDQAARZKHEZ-UHFFFAOYSA-N,,HRH4
5919,JNJ-10191584,Histamine receptor antagonist,HRH4,CN1CCN(CC1)C(=O)c1nc2ccc(Cl)cc2[nH]1,MOIWSUQWIOVGRH-UHFFFAOYSA-N,,HRH4
5920,lafutidine,Histamine receptor antagonist,HRH2,O=C(CS(=O)Cc1ccco1)NCC=C/COc1cc(CN2CCCCC2)ccn1,KMZQAVXSMUKBPD-DJWKRKHSSA-N,,HRH2
5921,levocabastine,Histamine receptor antagonist,NTSR2,C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1,ZCGOMHNNNFPNMX-KYTRFIICSA-N,,NTSR2
5922,levocabastine,Histamine receptor antagonist,HRH1,C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1,ZCGOMHNNNFPNMX-KYTRFIICSA-N,,HRH1
5923,levocetirizine,Histamine receptor antagonist,HRH1,OC(=O)COCCN1CCN(CC1)[C@H](c1ccccc1)c1ccc(Cl)cc1,ZKLPARSLTMPFCP-OAQYLSRUSA-N,,HRH1
5924,levomequitazine,Histamine receptor antagonist,HRH1,C(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12,HOKDBMAJZXIPGC-UHFFFAOYSA-N,,HRH1
5925,loratadine,Histamine receptor antagonist,HRH1,CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12,JCCNYMKQOSZNPW-UHFFFAOYSA-N,,HRH1
5926,mepyramine,Histamine receptor antagonist,HRH1,COc1ccc(cc1)CN(CCN(C)C)c1ccccn1,YECBIJXISLIIDS-UHFFFAOYSA-N,,HRH1
5927,methapyrilene,Histamine receptor antagonist,HRH1,CN(C)CCN(Cc1cccs1)c1ccccn1,HNJJXZKZRAWDPF-UHFFFAOYSA-N,,HRH1
5928,mizolastine,Histamine receptor antagonist,HRH1,CN(C1CCN(CC1)c1nc2ccccc2n1Cc1ccc(F)cc1)c1nccc(=O)[nH]1,PVLJETXTTWAYEW-UHFFFAOYSA-N,,HRH1
5929,nizatidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O,SGXXNSQHWDMGGP-IZZDOVSWSA-N,,HRH2
5930,nizatidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1csc(CN(C)C)n1)=C[N+]([O-])=O,SGXXNSQHWDMGGP-WDZFZDKYSA-N,,HRH2
5931,nizatidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1csc(CN(C)C)n1)=C[N+]([O-])=O,SGXXNSQHWDMGGP-UHFFFAOYSA-N,,HRH2
5932,olopatadine,Histamine receptor antagonist,HRH1,CN(C)CC/C=C1/c2ccccc2COc3ccc(CC(=O)O)cc13,JBIMVDZLSHOPLA-LSCVHKIXSA-N,,HRH1
5933,olopatadine,Histamine receptor antagonist,HRH1,CN(C)CCC=C1c2ccccc2COc2ccc(CC(O)=O)cc12,JBIMVDZLSHOPLA-UHFFFAOYSA-N,,HRH1
5934,oxatomide,Histamine receptor antagonist,HRH1,O=c1[nH]c2ccccc2n1CCCN1CCN(CC1)C(c1ccccc1)c1ccccc1,BAINIUMDFURPJM-UHFFFAOYSA-N,,HRH1
5935,pheniramine,Histamine receptor antagonist,HRH1,CN(C)CCC(c1ccccc1)c1ccccn1,IJHNSHDBIRRJRN-UHFFFAOYSA-N,,HRH1
5936,promethazine,Histamine receptor antagonist,HRH1,CC(CN1c2ccccc2Sc2ccccc12)N(C)C,PWWVAXIEGOYWEE-UHFFFAOYSA-N,,HRH1
5937,protopine,Histamine receptor antagonist,ACHE,CN1CCc2cc3OCOc3cc2C(=O)Cc4ccc5OCOc5c4C1,GPTFURBXHJWNHR-UHFFFAOYSA-N,,ACHE
5938,ranitidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O,VMXUWOKSQNHOCA-UKTHLTGXSA-N,,HRH2
5939,ranitidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1ccc(CN(C)C)o1)=C[N+]([O-])=O,VMXUWOKSQNHOCA-LCYFTJDESA-N,,HRH2
5940,ranitidine,Histamine receptor antagonist,HRH2,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,VMXUWOKSQNHOCA-UHFFFAOYSA-N,,HRH2
5941,rupatadine,Histamine receptor antagonist,HRH1,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,WUZYKBABMWJHDL-UHFFFAOYSA-N,,HRH1
5942,rupatadine,Histamine receptor antagonist,PTAFR,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,WUZYKBABMWJHDL-UHFFFAOYSA-N,,PTAFR
5943,tecastemizole,Histamine receptor antagonist,HRH1,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1,SFOVDSLXFUGAIV-UHFFFAOYSA-N,,HRH1
5944,terfenadine,Histamine receptor antagonist,HRH1,CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,GUGOEEXESWIERI-UHFFFAOYSA-N,,HRH1
5945,terfenadine,Histamine receptor antagonist,KCNH2,CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,GUGOEEXESWIERI-UHFFFAOYSA-N,,KCNH2
5946,thioperamide,Histamine receptor antagonist,HRH3,S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1,QKDDJDBFONZGBW-UHFFFAOYSA-N,,HRH3
5947,thioperamide,Histamine receptor antagonist,HRH4,S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1,QKDDJDBFONZGBW-UHFFFAOYSA-N,,HRH4
5948,thioperamide,Histamine receptor antagonist,HRH3,S=C(NC1CCCCC1)N2CCC(CC2)C3C=NC=N3,JFAYRTHYLOZRNL-UHFFFAOYSA-N,,HRH3
5949,thioperamide,Histamine receptor antagonist,HRH4,S=C(NC1CCCCC1)N2CCC(CC2)C3C=NC=N3,JFAYRTHYLOZRNL-UHFFFAOYSA-N,,HRH4
5950,tiotidine,Histamine receptor antagonist,HRH2,CNC(NCCSCc1csc(N=C(N)N)n1)=N/C#N,YDDXVAXDYKBWDX-UHFFFAOYSA-N,,HRH2
5951,tiotidine,Histamine receptor antagonist,HRH2,CNC(=NC#N)NCCSCc1csc(N=C(N)N)n1,YDDXVAXDYKBWDX-UHFFFAOYSA-N,,HRH2
5952,trimethobenzamide,Histamine receptor antagonist,DRD2,COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,FEZBIKUBAYAZIU-UHFFFAOYSA-N,,DRD2
5953,tripelennamine,Histamine receptor antagonist,HRH1,CN(C)CCN(Cc1ccccc1)c1ccccn1,UFLGIAIHIAPJJC-UHFFFAOYSA-N,,HRH1
5954,triprolidine,Histamine receptor antagonist,HRH1,Cc1ccc(cc1)C(=C/CN1CCCC1)c1ccccn1,CBEQULMOCCWAQT-WOJGMQOQSA-N,,HRH1
5955,triprolidine,Histamine receptor antagonist,HRH1,Cc1ccc(cc1)C(=CCN2CCCC2)c3ccccn3,CBEQULMOCCWAQT-UHFFFAOYSA-N,,HRH1
5956,VUF-5681,Histamine receptor antagonist,HRH3,C(CC1CCNCC1)Cc2c[nH]cn2,YPGRNKJNOSUCLY-UHFFFAOYSA-N,,HRH3
5957,4-P-PDOT,Melatonin receptor antagonist,MTNR1B,CCC(=O)NC1CC(c2ccccc2)c2ccccc2C1,RCYLUNPFECYGDW-UHFFFAOYSA-N,,MTNR1B
5958,luzindole,Melatonin receptor antagonist,MTNR1B,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12,WVVXBPKOIZGVNS-UHFFFAOYSA-N,,MTNR1B
5959,epothilone-b,Microtubule stabilizing agent,TUBB,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,QXRSDHAAWVKZLJ-AXCXJGFASA-N,,TUBB
5960,ixabepilone,Microtubule stabilizing agent,TUBB3,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,FABUFPQFXZVHFB-PVYNADRNSA-N,,TUBB3
5961,ixabepilone,Microtubule stabilizing agent,TUBB,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(C)=Cc1csc(C)n1,FABUFPQFXZVHFB-PVYNADRNSA-N,,TUBB
5962,farnesol,Monoamine oxidase B inhibitor,MAOB,CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C,CRDAMVZIKSXKFV-YFVJMOTDSA-N,,MAOB
5963,balaglitazone,PPAR receptor partial agonist,PPARG,Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O,IETKPTYAGKZLKY-UHFFFAOYSA-N,,PPARG
5964,norethindrone,Progesterone receptor agonist,PGR,CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@@]21C)C#C,IMONTRJLAWHYGT-FJMAIUEKSA-N,,PGR
5965,megestrol-acetate,Progesterone receptor agonist,PGR,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,,PGR
5966,danazol,Progesterone receptor agonist,ESR1,C[C@]12CC[C@@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@H]1CC[C@@]2(O)C#C,POZRVZJJTULAOH-AAPKDCIVSA-N,,ESR1
5967,danazol,Progesterone receptor agonist,GNRHR,C[C@]12CC[C@@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@H]1CC[C@@]2(O)C#C,POZRVZJJTULAOH-AAPKDCIVSA-N,,GNRHR
5968,danazol,Progesterone receptor agonist,ESR1,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,POZRVZJJTULAOH-GSQPBCFPSA-N,,ESR1
5969,danazol,Progesterone receptor agonist,GNRHR,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,POZRVZJJTULAOH-GSQPBCFPSA-N,,GNRHR
5970,danazol,Progesterone receptor agonist,ESR1,C[C@@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]2CC[C@@]1(O)C#C,POZRVZJJTULAOH-LHZXLZLDSA-N,,ESR1
5971,danazol,Progesterone receptor agonist,GNRHR,C[C@@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]2CC[C@@]1(O)C#C,POZRVZJJTULAOH-LHZXLZLDSA-N,,GNRHR
5972,danazol,Progesterone receptor agonist,ESR1,CC12CCC3C(CCC4=Cc5oncc5CC34C)C2CCC1(O)C#C,POZRVZJJTULAOH-UHFFFAOYSA-N,,ESR1
5973,danazol,Progesterone receptor agonist,GNRHR,CC12CCC3C(CCC4=Cc5oncc5CC34C)C2CCC1(O)C#C,POZRVZJJTULAOH-UHFFFAOYSA-N,,GNRHR
5974,dienogest,Progesterone receptor agonist,PGR,C[C@@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,AZFLJNIPTRTECV-IYWMVGAKSA-N,,PGR
5975,dydrogesterone,Progesterone receptor agonist,PGR,CC(=O)[C@H]1CC[C@@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,JGMOKGBVKVMRFX-WSBLSWJJSA-N,,PGR
5976,dydrogesterone,Progesterone receptor agonist,PGR,CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,JGMOKGBVKVMRFX-HQZYFCCVSA-N,,PGR
5977,ethylestrenol,Progesterone receptor agonist,AR,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C,AOXRBFRFYPMWLR-XGXHKTLJSA-N,,AR
5978,GR-235,Progesterone receptor agonist,NR1H4,CC=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-OSJVMJFVSA-N,,NR1H4
5979,guggulsterone,Progesterone receptor agonist,NR3C1,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C1
5980,guggulsterone,Progesterone receptor agonist,AR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,AR
5981,guggulsterone,Progesterone receptor agonist,NR3C2,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR3C2
5982,guggulsterone,Progesterone receptor agonist,PGR,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,PGR
5983,guggulsterone,Progesterone receptor agonist,NR1H4,CC=C1/C(=O)CC2C3CCC4=CC(=O)CC[C@@]4(C)C3CC[C@@]12C,WDXRGPWQVHZTQJ-SXMNTYMYSA-N,,NR1H4
5984,guggulsterone,Progesterone receptor agonist,NR3C1,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C1
5985,guggulsterone,Progesterone receptor agonist,AR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,AR
5986,guggulsterone,Progesterone receptor agonist,NR3C2,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR3C2
5987,guggulsterone,Progesterone receptor agonist,PGR,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,PGR
5988,guggulsterone,Progesterone receptor agonist,NR1H4,CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,WDXRGPWQVHZTQJ-UHFFFAOYSA-N,,NR1H4
5989,hydroxyprogesterone,Progesterone receptor agonist,PGR,CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,DBPWSSGDRRHUNT-AYUYWISESA-N,,PGR
5990,levonorgestrel,Progesterone receptor agonist,PGR,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-XUDSTZEESA-N,,PGR
5991,levonorgestrel,Progesterone receptor agonist,PGR,CC[C@@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-ZWMUSQMVSA-N,,PGR
5992,medroxyprogesterone-acetate,Progesterone receptor agonist,PGR,C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12,PSGAAPLEWMOORI-GDXVCIIOSA-N,,PGR
5993,megestrol-acetate,Progesterone receptor agonist,PGR,CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,RQZAXGRLVPAYTJ-VSUSFZLSSA-N,,PGR
5994,nomegestrol,Progesterone receptor agonist,PGR,CC(=O)O[C@@]1(CC[C@@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@@H]3CC[C@]12C)C(C)=O,IIVBFTNIGYRNQY-DQEDLLLISA-N,,PGR
5995,nomegestrol-acetate,Progesterone receptor agonist,PGR,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O,IIVBFTNIGYRNQY-YQLZSBIMSA-N,,PGR
5996,norethindrone,Progesterone receptor agonist,PGR,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@H]1CC[C@@]2(O)C#C,VIKNJXKGJWUCNN-SFUSBHMVSA-N,,PGR
5997,norethindrone,Progesterone receptor agonist,PGR,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,IMONTRJLAWHYGT-ZCPXKWAGSA-N,,PGR
5998,norgestimate,Progesterone receptor agonist,PGR,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(CC[C@H]34)=NO)[C@H]1CC[C@@]2(OC(C)=O)C#C,KIQQMECNKUGGKA-RSFSFSNISA-N,,PGR
5999,norgestimate,Progesterone receptor agonist,PGR,CC[C@]12CCC3C(CCC4=CC(CCC34)=NO)C1CC[C@@]2(OC(C)=O)C#C,KIQQMECNKUGGKA-OMEWWMGKSA-N,,PGR
6000,progesterone,Progesterone receptor agonist,CYP17A1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,,CYP17A1
6001,progesterone,Progesterone receptor agonist,NR3C2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,,NR3C2
6002,progesterone,Progesterone receptor agonist,PGR,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,,PGR
6003,progesterone,Progesterone receptor agonist,CYP17A1,CC(=O)[C@H]1CC[C@H]2[C@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C,RJKFOVLPORLFTN-OXZADQLBSA-N,,CYP17A1
6004,progesterone,Progesterone receptor agonist,NR3C2,CC(=O)[C@H]1CC[C@H]2[C@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C,RJKFOVLPORLFTN-OXZADQLBSA-N,,NR3C2
6005,progesterone,Progesterone receptor agonist,PGR,CC(=O)[C@H]1CC[C@H]2[C@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C,RJKFOVLPORLFTN-OXZADQLBSA-N,,PGR
6006,progesterone,Progesterone receptor agonist,CYP17A1,CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,RJKFOVLPORLFTN-OYEBDCLDSA-N,,CYP17A1
6007,progesterone,Progesterone receptor agonist,NR3C2,CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,RJKFOVLPORLFTN-OYEBDCLDSA-N,,NR3C2
6008,progesterone,Progesterone receptor agonist,PGR,CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,RJKFOVLPORLFTN-OYEBDCLDSA-N,,PGR
6009,tanaproget,Progesterone receptor agonist,PGR,Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N,PYVFWTPEBMRKSR-UHFFFAOYSA-N,,PGR
6010,tibolone,Progesterone receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,ESR1
6011,tibolone,Progesterone receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,AR
6012,tibolone,Progesterone receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,,PGR
6013,tibolone,Progesterone receptor agonist,ESR1,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,ESR1
6014,tibolone,Progesterone receptor agonist,AR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,AR
6015,tibolone,Progesterone receptor agonist,PGR,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,WZDGZWOAQTVYBX-XOINTXKNSA-N,,PGR
6016,z-guggulsterone,Progesterone receptor agonist,NR1H4,CC=C1C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-AUKWTSKRSA-N,,NR1H4
6017,calyculin,Protein phosphatase inhibitor,PPP1CA,COC[C@H]([C@@H](O)[C@@H](O)C(=O)NCC[C@@H](C)c1nc(/C=C/C[C@H]2OC3(C[C@H](O)[C@H]2C)OC([C@@H](C[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)/C=C(C)/C(=C/C=C/C(=CC#N)/C)/C)OC)[C@@H](OP(=O)(O)O)C3(C)C)co1)N(C)C,FKAWLXNLHHIHLA-OQLQHIBWSA-N,,PPP1CA
6018,calyculin,Protein phosphatase inhibitor,PPP2CA,COC[C@H]([C@@H](O)[C@@H](O)C(=O)NCC[C@@H](C)c1nc(/C=C/C[C@H]2OC3(C[C@H](O)[C@H]2C)OC([C@@H](C[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)/C=C(C)/C(=C/C=C/C(=CC#N)/C)/C)OC)[C@@H](OP(=O)(O)O)C3(C)C)co1)N(C)C,FKAWLXNLHHIHLA-OQLQHIBWSA-N,,PPP2CA
6019,amuvatinib,RET tyrosine kinase inhibitor,FLT3,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,FLT3
6020,amuvatinib,RET tyrosine kinase inhibitor,KIT,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,KIT
6021,amuvatinib,RET tyrosine kinase inhibitor,MET,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,MET
6022,amuvatinib,RET tyrosine kinase inhibitor,PDGFRA,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,FOFDIMHVKGYHRU-UHFFFAOYSA-N,,PDGFRA
6023,cabozantinib,RET tyrosine kinase inhibitor,FLT3,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,FLT3
6024,cabozantinib,RET tyrosine kinase inhibitor,KDR,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,KDR
6025,cabozantinib,RET tyrosine kinase inhibitor,KIT,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,KIT
6026,cabozantinib,RET tyrosine kinase inhibitor,MET,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,MET
6027,cabozantinib,RET tyrosine kinase inhibitor,RET,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,RET
6028,cabozantinib,RET tyrosine kinase inhibitor,TEK,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,ONIQOQHATWINJY-UHFFFAOYSA-N,,TEK
6029,regorafenib,RET tyrosine kinase inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR1
6030,regorafenib,RET tyrosine kinase inhibitor,FGFR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FGFR2
6031,regorafenib,RET tyrosine kinase inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT1
6032,regorafenib,RET tyrosine kinase inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FLT4
6033,regorafenib,RET tyrosine kinase inhibitor,FRK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,FRK
6034,regorafenib,RET tyrosine kinase inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,ABL1
6035,regorafenib,RET tyrosine kinase inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KDR
6036,regorafenib,RET tyrosine kinase inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,KIT
6037,regorafenib,RET tyrosine kinase inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,DDR2
6038,regorafenib,RET tyrosine kinase inhibitor,PDGFRA,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRA
6039,regorafenib,RET tyrosine kinase inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,PDGFRB
6040,regorafenib,RET tyrosine kinase inhibitor,MAPK11,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,MAPK11
6041,regorafenib,RET tyrosine kinase inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RAF1
6042,regorafenib,RET tyrosine kinase inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,RET
6043,regorafenib,RET tyrosine kinase inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,BRAF
6044,regorafenib,RET tyrosine kinase inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,,TEK
6045,sorafenib,RET tyrosine kinase inhibitor,FGFR1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FGFR1
6046,sorafenib,RET tyrosine kinase inhibitor,FLT1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT1
6047,sorafenib,RET tyrosine kinase inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT3
6048,sorafenib,RET tyrosine kinase inhibitor,FLT4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,FLT4
6049,sorafenib,RET tyrosine kinase inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KDR
6050,sorafenib,RET tyrosine kinase inhibitor,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,KIT
6051,sorafenib,RET tyrosine kinase inhibitor,DDR2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,DDR2
6052,sorafenib,RET tyrosine kinase inhibitor,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,PDGFRB
6053,sorafenib,RET tyrosine kinase inhibitor,RAF1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RAF1
6054,sorafenib,RET tyrosine kinase inhibitor,RET,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,RET
6055,sorafenib,RET tyrosine kinase inhibitor,BRAF,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,,BRAF
6056,sorafenib,RET tyrosine kinase inhibitor,FGFR1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FGFR1
6057,sorafenib,RET tyrosine kinase inhibitor,FLT1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT1
6058,sorafenib,RET tyrosine kinase inhibitor,FLT3,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT3
6059,sorafenib,RET tyrosine kinase inhibitor,FLT4,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,FLT4
6060,sorafenib,RET tyrosine kinase inhibitor,KDR,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KDR
6061,sorafenib,RET tyrosine kinase inhibitor,KIT,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,KIT
6062,sorafenib,RET tyrosine kinase inhibitor,DDR2,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,DDR2
6063,sorafenib,RET tyrosine kinase inhibitor,PDGFRB,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,PDGFRB
6064,sorafenib,RET tyrosine kinase inhibitor,RAF1,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RAF1
6065,sorafenib,RET tyrosine kinase inhibitor,RET,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,RET
6066,sorafenib,RET tyrosine kinase inhibitor,BRAF,CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)c1,CGFGJVMEGKQFPL-UHFFFAOYSA-N,,BRAF
6067,sunitinib,RET tyrosine kinase inhibitor,FLT1,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT1
6068,sunitinib,RET tyrosine kinase inhibitor,FLT3,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT3
6069,sunitinib,RET tyrosine kinase inhibitor,FLT4,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,FLT4
6070,sunitinib,RET tyrosine kinase inhibitor,KDR,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KDR
6071,sunitinib,RET tyrosine kinase inhibitor,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,KIT
6072,sunitinib,RET tyrosine kinase inhibitor,PDGFRA,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRA
6073,sunitinib,RET tyrosine kinase inhibitor,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,PDGFRB
6074,sunitinib,RET tyrosine kinase inhibitor,RET,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,WINHZLLDWRZWRT-ATVHPVEESA-N,,RET
6075,vandetanib,RET tyrosine kinase inhibitor,EGFR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,EGFR
6076,vandetanib,RET tyrosine kinase inhibitor,FLT1,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT1
6077,vandetanib,RET tyrosine kinase inhibitor,FLT4,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,FLT4
6078,vandetanib,RET tyrosine kinase inhibitor,KDR,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,KDR
6079,vandetanib,RET tyrosine kinase inhibitor,PTK6,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,PTK6
6080,vandetanib,RET tyrosine kinase inhibitor,RET,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,RET
6081,vandetanib,RET tyrosine kinase inhibitor,TEK,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,,TEK
6082,dolasetron,Serotonin receptor antagonist,HTR3A,O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12,UKTAZPQNNNJVKR-YXSUXZIUSA-N,,HTR3A
6083,adatanserin,Serotonin receptor antagonist,HTR1A,O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2,HPFLVTSWRFCPCV-UHFFFAOYSA-N,,HTR1A
6084,adatanserin,Serotonin receptor antagonist,HTR2A,O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2,HPFLVTSWRFCPCV-UHFFFAOYSA-N,,HTR2A
6085,agomelatine,Serotonin receptor antagonist,HTR2C,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,HTR2C
6086,agomelatine,Serotonin receptor antagonist,MTNR1A,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,MTNR1A
6087,agomelatine,Serotonin receptor antagonist,MTNR1B,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,,MTNR1B
6088,alaproclate,Serotonin receptor antagonist,SLC6A4,CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1,FZSPJBYOKQPKCD-UHFFFAOYSA-N,,SLC6A4
6089,alosetron,Serotonin receptor antagonist,HTR3A,Cc1[nH]cnc1CN1CCc2c(C1=O)c1ccccc1n2C,JSWZEAMFRNKZNL-UHFFFAOYSA-N,,HTR3A
6090,altanserin,Serotonin receptor antagonist,HTR2A,Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1,SMYALUSCZJXWHG-UHFFFAOYSA-N,,HTR2A
6091,amitriptyline,Serotonin receptor antagonist,CHRM1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM1
6092,amitriptyline,Serotonin receptor antagonist,CHRM2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM2
6093,amitriptyline,Serotonin receptor antagonist,CHRM3,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM3
6094,amitriptyline,Serotonin receptor antagonist,CHRM4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM4
6095,amitriptyline,Serotonin receptor antagonist,CHRM5,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM5
6096,amitriptyline,Serotonin receptor antagonist,HRH1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HRH1
6097,amitriptyline,Serotonin receptor antagonist,HTR6,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HTR6
6098,amitriptyline,Serotonin receptor antagonist,SLC6A2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A2
6099,amitriptyline,Serotonin receptor antagonist,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A4
6100,aripiprazole,Serotonin receptor antagonist,DRD2,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,DRD2
6101,aripiprazole,Serotonin receptor antagonist,HRH1,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HRH1
6102,aripiprazole,Serotonin receptor antagonist,HTR1A,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1A
6103,aripiprazole,Serotonin receptor antagonist,HTR1B,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1B
6104,aripiprazole,Serotonin receptor antagonist,HTR1D,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR1D
6105,aripiprazole,Serotonin receptor antagonist,HTR2A,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR2A
6106,aripiprazole,Serotonin receptor antagonist,HTR2C,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,,HTR2C
6107,asenapine,Serotonin receptor antagonist,ADRB2,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,ADRB2
6108,asenapine,Serotonin receptor antagonist,DRD1,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,DRD1
6109,asenapine,Serotonin receptor antagonist,DRD2,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,DRD2
6110,asenapine,Serotonin receptor antagonist,HRH1,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HRH1
6111,asenapine,Serotonin receptor antagonist,HTR1A,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR1A
6112,asenapine,Serotonin receptor antagonist,HTR1B,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR1B
6113,asenapine,Serotonin receptor antagonist,HTR2A,CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,,HTR2A
6114,asenapine,Serotonin receptor antagonist,ADRB2,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,ADRB2
6115,asenapine,Serotonin receptor antagonist,DRD1,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,DRD1
6116,asenapine,Serotonin receptor antagonist,DRD2,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,DRD2
6117,asenapine,Serotonin receptor antagonist,HRH1,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HRH1
6118,asenapine,Serotonin receptor antagonist,HTR1A,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR1A
6119,asenapine,Serotonin receptor antagonist,HTR1B,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR1B
6120,asenapine,Serotonin receptor antagonist,HTR2A,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,,HTR2A
6121,azasetron,Serotonin receptor antagonist,HTR3A,CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2,WUKZPHOXUVCQOR-UHFFFAOYSA-N,,HTR3A
6122,bemesetron,Serotonin receptor antagonist,HTR3A,CN1C2CCC1CC(C2)OC(=O)c1cc(Cl)cc(Cl)c1,MNJNPLVXBISNSX-UHFFFAOYSA-N,,HTR3A
6123,blonanserin,Serotonin receptor antagonist,DRD2,CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1,XVGOZDAJGBALKS-UHFFFAOYSA-N,,DRD2
6124,blonanserin,Serotonin receptor antagonist,HTR2A,CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1,XVGOZDAJGBALKS-UHFFFAOYSA-N,,HTR2A
6125,BMY-7378,Serotonin receptor antagonist,ADRA1D,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1D
6126,BMY-7378,Serotonin receptor antagonist,ADRA1B,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1B
6127,BMY-7378,Serotonin receptor antagonist,ADRA1A,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1A
6128,BMY-7378,Serotonin receptor antagonist,HTR1A,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,HTR1A
6129,BRL-15572,Serotonin receptor antagonist,HTR1D,OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1,QJHCTHPYUOXOGM-UHFFFAOYSA-N,,HTR1D
6130,clozapine,Serotonin receptor antagonist,CHRM1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM1
6131,clozapine,Serotonin receptor antagonist,CHRM2,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM2
6132,clozapine,Serotonin receptor antagonist,CHRM3,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM3
6133,clozapine,Serotonin receptor antagonist,CHRM4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,CHRM4
6134,clozapine,Serotonin receptor antagonist,ADRA1B,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,ADRA1B
6135,clozapine,Serotonin receptor antagonist,ADRA1A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,ADRA1A
6136,clozapine,Serotonin receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD1
6137,clozapine,Serotonin receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD2
6138,clozapine,Serotonin receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD3
6139,clozapine,Serotonin receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,DRD4
6140,clozapine,Serotonin receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HRH1
6141,clozapine,Serotonin receptor antagonist,HTR1A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1A
6142,clozapine,Serotonin receptor antagonist,HTR1B,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1B
6143,clozapine,Serotonin receptor antagonist,HTR1D,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1D
6144,clozapine,Serotonin receptor antagonist,HTR1E,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR1E
6145,clozapine,Serotonin receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR2A
6146,clozapine,Serotonin receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR2C
6147,clozapine,Serotonin receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR6
6148,clozapine,Serotonin receptor antagonist,HTR7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HTR7
6149,clozapine,Serotonin receptor antagonist,HRH4,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,,HRH4
6150,dolasetron,Serotonin receptor antagonist,HTR3A,O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12,UKTAZPQNNNJVKR-XDQVBPFNSA-N,,HTR3A
6151,dolasetron,Serotonin receptor antagonist,HTR3A,O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12,UKTAZPQNNNJVKR-YXSUXZIUSA-N,,HTR3A
6152,fananserin,Serotonin receptor antagonist,DRD4,Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,VGIGHGMPMUCLIQ-UHFFFAOYSA-N,,DRD4
6153,fananserin,Serotonin receptor antagonist,HTR2A,Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,VGIGHGMPMUCLIQ-UHFFFAOYSA-N,,HTR2A
6154,GR-113808,Serotonin receptor antagonist,HTR4,Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12,MOZPSIXKYJUTKI-UHFFFAOYSA-N,,HTR4
6155,GR-127935,Serotonin receptor antagonist,HTR1A,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N,,HTR1A
6156,GR-127935,Serotonin receptor antagonist,HTR1B,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N,,HTR1B
6157,GR-127935,Serotonin receptor antagonist,HTR1D,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N,,HTR1D
6158,GR-127935,Serotonin receptor antagonist,HTR2A,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N,,HTR2A
6159,GR-127935,Serotonin receptor antagonist,HTR2C,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N,,HTR2C
6160,GR-55562,Serotonin receptor antagonist,HTR1B,CN(C)CCCc1cc(ccc1O)C(=O)Nc2ccc(cc2)c3ccncc3,ZAGAUUVCYGSPBP-UHFFFAOYSA-N,,HTR1B
6161,granisetron,Serotonin receptor antagonist,HTR3A,CN1[C@H]2CCC[C@@H]1C[C@@H](C2)NC(=O)c3nn(C)c4ccccc34,MFWNKCLOYSRHCJ-BTTYYORXSA-N,,HTR3A
6162,granisetron,Serotonin receptor antagonist,HTR3A,CN1[C@H]2CCC[C@H]1C[C@H](C2)NC(=O)c1nn(C)c2ccccc12,MFWNKCLOYSRHCJ-KBPBESRZSA-N,,HTR3A
6163,granisetron,Serotonin receptor antagonist,HTR3A,CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,,HTR3A
6164,idalopirdine,Serotonin receptor antagonist,HTR6,FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,,HTR6
6165,iloperidone,Serotonin receptor antagonist,DRD2,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,DRD2
6166,iloperidone,Serotonin receptor antagonist,HTR1A,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR1A
6167,iloperidone,Serotonin receptor antagonist,HTR2A,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR2A
6168,iloperidone,Serotonin receptor antagonist,HTR6,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR6
6169,iloperidone,Serotonin receptor antagonist,HTR7,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,,HTR7
6170,ketanserin,Serotonin receptor antagonist,HTR2A,Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,FPCCSQOGAWCVBH-UHFFFAOYSA-N,,HTR2A
6171,ketanserin,Serotonin receptor antagonist,HTR2C,Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,FPCCSQOGAWCVBH-UHFFFAOYSA-N,,HTR2C
6172,lamotrigine,Serotonin receptor antagonist,SCN1A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN1A
6173,lamotrigine,Serotonin receptor antagonist,SCN2A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN2A
6174,lamotrigine,Serotonin receptor antagonist,SCN3A,Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl,PYZRQGJRPPTADH-UHFFFAOYSA-N,,SCN3A
6175,lerisetron,Serotonin receptor antagonist,HTR3A,C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1,PWWDCRQZITYKDV-UHFFFAOYSA-N,,HTR3A
6176,loxapine,Serotonin receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD1
6177,loxapine,Serotonin receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD2
6178,loxapine,Serotonin receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD3
6179,loxapine,Serotonin receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,DRD4
6180,loxapine,Serotonin receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HRH1
6181,loxapine,Serotonin receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR2A
6182,loxapine,Serotonin receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR2C
6183,loxapine,Serotonin receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,XJGVXQDUIWGIRW-UHFFFAOYSA-N,,HTR6
6184,lurasidone,Serotonin receptor antagonist,ADRA2A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,ADRA2A
6185,lurasidone,Serotonin receptor antagonist,ADRA2C,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,ADRA2C
6186,lurasidone,Serotonin receptor antagonist,DRD2,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,DRD2
6187,lurasidone,Serotonin receptor antagonist,HTR1A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR1A
6188,lurasidone,Serotonin receptor antagonist,HTR2A,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR2A
6189,lurasidone,Serotonin receptor antagonist,HTR7,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,,HTR7
6190,LY-165163,Serotonin receptor antagonist,HTR1A,Nc1ccc(CCN2CCN(CC2)c3cccc(c3)C(F)(F)F)cc1,GAAKALASJNGQKD-UHFFFAOYSA-N,,HTR1A
6191,LY-165163,Serotonin receptor antagonist,HTR1D,Nc1ccc(CCN2CCN(CC2)c3cccc(c3)C(F)(F)F)cc1,GAAKALASJNGQKD-UHFFFAOYSA-N,,HTR1D
6192,MDL-11939,Serotonin receptor antagonist,HTR2A,OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1,AXNGJCOYCMDPQG-UHFFFAOYSA-N,,HTR2A
6193,MDL-73005EF,Serotonin receptor antagonist,HTR1A,O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1,BVMYCHKQPGEOSI-UHFFFAOYSA-N,,HTR1A
6194,melperone,Serotonin receptor antagonist,DRD2,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,DKMFBWQBDIGMHM-UHFFFAOYSA-N,,DRD2
6195,melperone,Serotonin receptor antagonist,HTR2A,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,DKMFBWQBDIGMHM-UHFFFAOYSA-N,,HTR2A
6196,metergoline,Serotonin receptor antagonist,HTR1A,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-QTGUNEKASA-N,,HTR1A
6197,metergoline,Serotonin receptor antagonist,HTR2A,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-QTGUNEKASA-N,,HTR2A
6198,metergoline,Serotonin receptor antagonist,HTR1A,CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-STDCAVTESA-N,,HTR1A
6199,metergoline,Serotonin receptor antagonist,HTR2A,CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13,WZHJKEUHNJHDLS-STDCAVTESA-N,,HTR2A
6200,metergoline,Serotonin receptor antagonist,HTR1A,CN1CC(CNC(=O)OCc2ccccc2)CC3C1Cc4cn(C)c5cccc3c45,WZHJKEUHNJHDLS-UHFFFAOYSA-N,,HTR1A
6201,metergoline,Serotonin receptor antagonist,HTR2A,CN1CC(CNC(=O)OCc2ccccc2)CC3C1Cc4cn(C)c5cccc3c45,WZHJKEUHNJHDLS-UHFFFAOYSA-N,,HTR2A
6202,methysergide,Serotonin receptor antagonist,HTR1B,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR1B
6203,methysergide,Serotonin receptor antagonist,HTR1E,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR1E
6204,methysergide,Serotonin receptor antagonist,HTR1F,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR1F
6205,methysergide,Serotonin receptor antagonist,HTR2A,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR2A
6206,methysergide,Serotonin receptor antagonist,HTR2B,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR2B
6207,methysergide,Serotonin receptor antagonist,HTR2C,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR2C
6208,methysergide,Serotonin receptor antagonist,HTR7,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,,HTR7
6209,methysergide,Serotonin receptor antagonist,HTR1B,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR1B
6210,methysergide,Serotonin receptor antagonist,HTR1E,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR1E
6211,methysergide,Serotonin receptor antagonist,HTR1F,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR1F
6212,methysergide,Serotonin receptor antagonist,HTR2A,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR2A
6213,methysergide,Serotonin receptor antagonist,HTR2B,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR2B
6214,methysergide,Serotonin receptor antagonist,HTR2C,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR2C
6215,methysergide,Serotonin receptor antagonist,HTR7,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-UHFFFAOYSA-N,,HTR7
6216,metoclopramide,Serotonin receptor antagonist,DRD2,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,DRD2
6217,metoclopramide,Serotonin receptor antagonist,HTR3A,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,HTR3A
6218,metoclopramide,Serotonin receptor antagonist,HTR4,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,,HTR4
6219,mianserin,Serotonin receptor antagonist,ADRA1D,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,ADRA1D
6220,mianserin,Serotonin receptor antagonist,ADRA1B,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,ADRA1B
6221,mianserin,Serotonin receptor antagonist,ADRA1A,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,ADRA1A
6222,mianserin,Serotonin receptor antagonist,DRD2,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,DRD2
6223,mianserin,Serotonin receptor antagonist,HRH1,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HRH1
6224,mianserin,Serotonin receptor antagonist,HTR1A,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR1A
6225,mianserin,Serotonin receptor antagonist,HTR2A,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR2A
6226,mianserin,Serotonin receptor antagonist,HTR2B,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR2B
6227,mianserin,Serotonin receptor antagonist,HTR2C,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR2C
6228,mianserin,Serotonin receptor antagonist,HTR6,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR6
6229,mianserin,Serotonin receptor antagonist,HTR7,CN1CCN2C(C1)c1ccccc1Cc1ccccc21,UEQUQVLFIPOEMF-UHFFFAOYSA-N,,HTR7
6230,mirtazapine,Serotonin receptor antagonist,ADRA2A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2A
6231,mirtazapine,Serotonin receptor antagonist,ADRA2B,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2B
6232,mirtazapine,Serotonin receptor antagonist,ADRA2C,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2C
6233,mirtazapine,Serotonin receptor antagonist,HTR2A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR2A
6234,mirtazapine,Serotonin receptor antagonist,HTR2C,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR2C
6235,mirtazapine,Serotonin receptor antagonist,HTR3A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR3A
6236,mirtazapine,Serotonin receptor antagonist,ADRA2A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2A
6237,mirtazapine,Serotonin receptor antagonist,ADRA2B,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2B
6238,mirtazapine,Serotonin receptor antagonist,ADRA2C,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2C
6239,mirtazapine,Serotonin receptor antagonist,HTR2A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR2A
6240,mirtazapine,Serotonin receptor antagonist,HTR2C,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR2C
6241,mirtazapine,Serotonin receptor antagonist,HTR3A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR3A
6242,NAS-181,Serotonin receptor antagonist,HTR1B,C(Oc1cccc2C=C(CN3CCOCC3)COc12)C4CNCCO4,RTKDBEOSPDFLGD-UHFFFAOYSA-N,,HTR1B
6243,nefazodone,Serotonin receptor antagonist,HTR2A,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2A
6244,nefazodone,Serotonin receptor antagonist,HTR2C,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2C
6245,nefazodone,Serotonin receptor antagonist,SLC6A2,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A2
6246,nefazodone,Serotonin receptor antagonist,SLC6A4,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A4
6247,olanzapine,Serotonin receptor antagonist,DRD1,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD1
6248,olanzapine,Serotonin receptor antagonist,DRD2,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD2
6249,olanzapine,Serotonin receptor antagonist,DRD3,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD3
6250,olanzapine,Serotonin receptor antagonist,DRD4,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,DRD4
6251,olanzapine,Serotonin receptor antagonist,HRH1,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HRH1
6252,olanzapine,Serotonin receptor antagonist,HTR1A,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1A
6253,olanzapine,Serotonin receptor antagonist,HTR1B,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1B
6254,olanzapine,Serotonin receptor antagonist,HTR1D,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1D
6255,olanzapine,Serotonin receptor antagonist,HTR1E,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR1E
6256,olanzapine,Serotonin receptor antagonist,HTR2A,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR2A
6257,olanzapine,Serotonin receptor antagonist,HTR2C,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR2C
6258,olanzapine,Serotonin receptor antagonist,HTR6,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR6
6259,olanzapine,Serotonin receptor antagonist,HTR7,CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12,KVWDHTXUZHCGIO-UHFFFAOYSA-N,,HTR7
6260,ondansetron,Serotonin receptor antagonist,HTR3A,Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C,FELGMEQIXOGIFQ-UHFFFAOYSA-N,,HTR3A
6261,palonosetron,Serotonin receptor antagonist,HTR3A,O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]1CN2CCC1CC2,CPZBLNMUGSZIPR-NVXWUHKLSA-N,,HTR3A
6262,perospirone,Serotonin receptor antagonist,DRD2,O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12,FBVFZWUMDDXLLG-HDICACEKSA-N,,DRD2
6263,perospirone,Serotonin receptor antagonist,HTR2A,O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12,FBVFZWUMDDXLLG-HDICACEKSA-N,,HTR2A
6264,pirenperone,Serotonin receptor antagonist,HTR2A,Cc1nc2ccccn2c(=O)c1CCN1CCC(CC1)C(=O)c1ccc(F)cc1,HXCNRYXBZNHDNE-UHFFFAOYSA-N,,HTR2A
6265,pizotifen,Serotonin receptor antagonist,HTR2A,CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12,FIADGNVRKBPQEU-UHFFFAOYSA-N,,HTR2A
6266,pizotifen,Serotonin receptor antagonist,HTR2C,CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12,FIADGNVRKBPQEU-UHFFFAOYSA-N,,HTR2C
6267,PRX-08066,Serotonin receptor antagonist,HTR2B,Fc1ccc(CN2CCC(CC2)Nc2ncnc3sc(Cl)cc23)cc1C#N,IENZFHBNCRQMNP-UHFFFAOYSA-N,,HTR2B
6268,quetiapine,Serotonin receptor antagonist,DRD1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,DRD1
6269,quetiapine,Serotonin receptor antagonist,DRD2,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,DRD2
6270,quetiapine,Serotonin receptor antagonist,HRH1,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HRH1
6271,quetiapine,Serotonin receptor antagonist,HTR1A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1A
6272,quetiapine,Serotonin receptor antagonist,HTR1D,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1D
6273,quetiapine,Serotonin receptor antagonist,HTR1E,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR1E
6274,quetiapine,Serotonin receptor antagonist,HTR2A,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,URKOMYMAXPYINW-UHFFFAOYSA-N,,HTR2A
6275,R-96544,Serotonin receptor antagonist,HTR2A,COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1,AFZLABYDOCWQBQ-WOJBJXKFSA-N,,HTR2A
6276,risperidone,Serotonin receptor antagonist,ADRA1B,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,ADRA1B
6277,risperidone,Serotonin receptor antagonist,ADRA1A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,ADRA1A
6278,risperidone,Serotonin receptor antagonist,DRD2,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD2
6279,risperidone,Serotonin receptor antagonist,DRD3,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD3
6280,risperidone,Serotonin receptor antagonist,DRD4,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,DRD4
6281,risperidone,Serotonin receptor antagonist,HRH1,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HRH1
6282,risperidone,Serotonin receptor antagonist,HTR1A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR1A
6283,risperidone,Serotonin receptor antagonist,HTR1D,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR1D
6284,risperidone,Serotonin receptor antagonist,HTR2A,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR2A
6285,risperidone,Serotonin receptor antagonist,HTR2C,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,RAPZEAPATHNIPO-UHFFFAOYSA-N,,HTR2C
6286,ritanserin,Serotonin receptor antagonist,HTR2A,Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,,HTR2A
6287,ritanserin,Serotonin receptor antagonist,HTR2B,Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,,HTR2B
6288,ritanserin,Serotonin receptor antagonist,HTR2C,Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,,HTR2C
6289,Ro-04-6790,Serotonin receptor antagonist,HTR6,CNc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(NC)n1,JELFWSXQTXRMAJ-UHFFFAOYSA-N,,HTR6
6290,RS-102221,Serotonin receptor antagonist,HTR2C,COc1cc(OC)c(cc1NS(=O)(=O)c1ccc(cc1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O,HZZZZODVDSHQRG-UHFFFAOYSA-N,,HTR2C
6291,RS-127445,Serotonin receptor antagonist,HTR2B,CC(C)c1cc(nc(N)n1)-c1ccc(F)c2ccccc12,ZZZQXCUPAJFVBN-UHFFFAOYSA-N,,HTR2B
6292,RS-23597-190,Serotonin receptor antagonist,HTR4,COc1cc(N)c(Cl)cc1C(=O)OCCCN1CCCCC1,RLSGBCUXLRMTPF-UHFFFAOYSA-N,,HTR4
6293,RS-39604,Serotonin receptor antagonist,HTR4,COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1,BKVIWGRFRKLFIO-UHFFFAOYSA-N,,HTR4
6294,SB-200646,Serotonin receptor antagonist,HTR2B,Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12,OJZZJTLBYXHUSJ-UHFFFAOYSA-N,,HTR2B
6295,SB-200646,Serotonin receptor antagonist,HTR2C,Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12,OJZZJTLBYXHUSJ-UHFFFAOYSA-N,,HTR2C
6296,SB-203186,Serotonin receptor antagonist,HTR4,O=C(OCCN1CCCCC1)c1c[nH]c2ccccc12,YGKPIROTKVQCCU-UHFFFAOYSA-N,,HTR4
6297,SB-206553,Serotonin receptor antagonist,HTR2B,Cn1ccc2cc3N(CCc3cc12)C(=O)Nc1cccnc1,QJQORSLQNXDVGE-UHFFFAOYSA-N,,HTR2B
6298,SB-206553,Serotonin receptor antagonist,HTR2C,Cn1ccc2cc3N(CCc3cc12)C(=O)Nc1cccnc1,QJQORSLQNXDVGE-UHFFFAOYSA-N,,HTR2C
6299,SB-216641,Serotonin receptor antagonist,HTR1B,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1OCCN(C)C,JRNUKVFYILMMLX-UHFFFAOYSA-N,,HTR1B
6300,SB-216641,Serotonin receptor antagonist,HTR1D,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1OCCN(C)C,JRNUKVFYILMMLX-UHFFFAOYSA-N,,HTR1D
6301,SB-221284,Serotonin receptor antagonist,HTR2B,CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F,OQZOXHCRSXYSPM-UHFFFAOYSA-N,,HTR2B
6302,SB-221284,Serotonin receptor antagonist,HTR2C,CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F,OQZOXHCRSXYSPM-UHFFFAOYSA-N,,HTR2C
6303,SB-228357,Serotonin receptor antagonist,HTR2C,COc1cc2CCN(C(=O)Nc3cc(F)cc(c3)-c3cccnc3)c2cc1C(F)(F)F,RRJLJKRFFRZRAF-UHFFFAOYSA-N,,HTR2C
6304,SB-258585,Serotonin receptor antagonist,HTR6,COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1,BDHMSYNBSBZCAF-UHFFFAOYSA-N,,HTR6
6305,SB-269970,Serotonin receptor antagonist,HTR7,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1,HWKROQUZSKPIKQ-MRXNPFEDSA-N,,HTR7
6306,SB-271046,Serotonin receptor antagonist,HTR6,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1,LOCQRDBFWSXQQI-UHFFFAOYSA-N,,HTR6
6307,scoulerine,Serotonin receptor antagonist,ADRA1D,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA1D
6308,scoulerine,Serotonin receptor antagonist,ADRA2A,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA2A
6309,scoulerine,Serotonin receptor antagonist,GABRA1,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,GABRA1
6310,sertindole,Serotonin receptor antagonist,DRD2,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,DRD2
6311,sertindole,Serotonin receptor antagonist,HTR2A,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,HTR2A
6312,sertindole,Serotonin receptor antagonist,HTR2C,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,,HTR2C
6313,sertraline,Serotonin receptor antagonist,SLC6A4,CN[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12,VGKDLMBJGBXTGI-YVEFUNNKSA-N,,SLC6A4
6314,sertraline,Serotonin receptor antagonist,SLC6A4,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12,VGKDLMBJGBXTGI-SJCJKPOMSA-N,,SLC6A4
6315,sertraline,Serotonin receptor antagonist,SLC6A4,CN[C@H]1CC[C@H](c2ccc(Cl)c(Cl)c2)c2ccccc12,VGKDLMBJGBXTGI-PXAZEXFGSA-N,,SLC6A4
6316,spiramide,Serotonin receptor antagonist,HTR1A,Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1,FJUKDAZEABGEIH-UHFFFAOYSA-N,,HTR1A
6317,spiramide,Serotonin receptor antagonist,HTR2A,Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1,FJUKDAZEABGEIH-UHFFFAOYSA-N,,HTR2A
6318,spiroxatrine,Serotonin receptor antagonist,HTR1A,O=C1NCN(c2ccccc2)C11CCN(CC2COc3ccccc3O2)CC1,JVGBTTIJPBFLTE-UHFFFAOYSA-N,,HTR1A
6319,telotristat,Serotonin receptor antagonist,TPH1,Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F,NCLGDOBQAWBXRA-PGRDOPGGSA-N,,TPH1
6320,terguride,Serotonin receptor antagonist,DRD2,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,DRD2
6321,terguride,Serotonin receptor antagonist,HTR2A,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,HTR2A
6322,terguride,Serotonin receptor antagonist,HTR2B,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-QGPMSJSTSA-N,,HTR2B
6323,trazodone,Serotonin receptor antagonist,HTR2A,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2A
6324,trazodone,Serotonin receptor antagonist,HTR2C,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2C
6325,trazodone,Serotonin receptor antagonist,SLC6A4,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,SLC6A4
6326,tropisetron,Serotonin receptor antagonist,HTR3A,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c3c[nH]c4ccccc34,ZNRGQMMCGHDTEI-ITGUQSILSA-N,,HTR3A
6327,tropisetron,Serotonin receptor antagonist,HTR3A,CN1[C@H]2CC[C@@H]1CC(C2)OC(=O)C1C=Nc2ccccc12,RIJFNUHYNBVLOZ-DOOHLRMFSA-N,,HTR3A
6328,tropisetron,Serotonin receptor antagonist,HTR3A,CN1C2CCC1CC(C2)OC(=O)c3c[nH]c4ccccc34,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,,HTR3A
6329,vortioxetine,Serotonin receptor antagonist,HTR1A,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1A
6330,vortioxetine,Serotonin receptor antagonist,HTR1B,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1B
6331,vortioxetine,Serotonin receptor antagonist,HTR1D,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR1D
6332,vortioxetine,Serotonin receptor antagonist,HTR7,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,HTR7
6333,vortioxetine,Serotonin receptor antagonist,SLC6A4,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,,SLC6A4
6334,WAY-100635,Serotonin receptor antagonist,HTR1A,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1,SBPRIAGPYFYCRT-UHFFFAOYSA-N,,HTR1A
6335,zacopride,Serotonin receptor antagonist,HTR3A,COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2,FEROPKNOYKURCJ-UHFFFAOYSA-N,,HTR3A
6336,zacopride,Serotonin receptor antagonist,HTR4,COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2,FEROPKNOYKURCJ-UHFFFAOYSA-N,,HTR4
6337,ziprasidone,Serotonin receptor antagonist,DRD2,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,DRD2
6338,ziprasidone,Serotonin receptor antagonist,HRH1,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HRH1
6339,ziprasidone,Serotonin receptor antagonist,HTR1A,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1A
6340,ziprasidone,Serotonin receptor antagonist,HTR1B,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1B
6341,ziprasidone,Serotonin receptor antagonist,HTR1D,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1D
6342,ziprasidone,Serotonin receptor antagonist,HTR1E,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR1E
6343,ziprasidone,Serotonin receptor antagonist,HTR2A,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR2A
6344,ziprasidone,Serotonin receptor antagonist,HTR2C,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR2C
6345,ziprasidone,Serotonin receptor antagonist,HTR7,Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12,MVWVFYHBGMAFLY-UHFFFAOYSA-N,,HTR7
6346,BRD-K08438429,Somatostatin receptor agonist,GBA,Clc1ccc(CN(CCCNC(=S)NCCCc2c[nH]cn2)c3ccc(Br)cn3)cc1Cl,UREJDUPKGMFJRU-UHFFFAOYSA-N,,GBA
6347,BRD-K08438429,Somatostatin receptor agonist,SSTR4,Clc1ccc(CN(CCCNC(=S)NCCCc2c[nH]cn2)c3ccc(Br)cn3)cc1Cl,UREJDUPKGMFJRU-UHFFFAOYSA-N,,SSTR4
6348,L-803087,Somatostatin receptor agonist,SSTR4,COC(=O)C(CCCNC(=N)N)NC(=O)CCCc1c([nH]c2c(F)cc(F)cc12)c3ccccc3,OPNMQSFIGUSHDH-UHFFFAOYSA-N,,SSTR4
6349,pasireotide,Somatostatin receptor agonist,SSTR1,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,VMZMNAABQBOLAK-DBILLSOUSA-N,,SSTR1
6350,pasireotide,Somatostatin receptor agonist,SSTR2,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,VMZMNAABQBOLAK-DBILLSOUSA-N,,SSTR2
6351,pasireotide,Somatostatin receptor agonist,SSTR3,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,VMZMNAABQBOLAK-DBILLSOUSA-N,,SSTR3
6352,pasireotide,Somatostatin receptor agonist,SSTR5,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,VMZMNAABQBOLAK-DBILLSOUSA-N,,SSTR5
6353,somatostatin,Somatostatin receptor agonist,SSTR1,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,,SSTR1
6354,somatostatin,Somatostatin receptor agonist,SSTR2,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,,SSTR2
6355,somatostatin,Somatostatin receptor agonist,SSTR3,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,,SSTR3
6356,somatostatin,Somatostatin receptor agonist,SSTR4,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,,SSTR4
6357,somatostatin,Somatostatin receptor agonist,SSTR5,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,,SSTR5
6358,octreotide,Somatostatin receptor agonist,SSTR2,,,,SSTR2
6359,octreotide,Somatostatin receptor agonist,SSTR5,,,,SSTR5
6360,rebastinib,TIE tyrosine kinase inhibitor,FLT3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,FLT3
6361,rebastinib,TIE tyrosine kinase inhibitor,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,ABL1
6362,rebastinib,TIE tyrosine kinase inhibitor,KDR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,KDR
6363,rebastinib,TIE tyrosine kinase inhibitor,BCR,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,BCR
6364,rebastinib,TIE tyrosine kinase inhibitor,TEK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,,TEK
6365,resatorvid,Toll-like receptor antagonist,TLR4,CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl,LEEIJTHMHDMWLJ-CQSZACIVSA-N,,TLR4
6366,SB-657510,Urotensin receptor antagonist,UTS2R,COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(Cl)c(O[C@@H]2CCN(C)C2)c1,KQCZCINJGIRLCD-CYBMUJFWSA-N,,UTS2R
6367,aceclidine,Acetylcholine receptor agonist,CHRM1,CC(=O)OC1CN2CC[C@H]1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM1
6368,aceclidine,Acetylcholine receptor agonist,CHRM2,CC(=O)OC1CN2CC[C@H]1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM2
6369,aceclidine,Acetylcholine receptor agonist,CHRM3,CC(=O)OC1CN2CC[C@H]1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM3
6370,aceclidine,Acetylcholine receptor agonist,CHRM4,CC(=O)OC1CN2CC[C@H]1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM4
6371,aceclidine,Acetylcholine receptor agonist,CHRM5,CC(=O)OC1CN2CC[C@H]1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM5
6372,aceclidine,Acetylcholine receptor agonist,CHRM1,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM1
6373,aceclidine,Acetylcholine receptor agonist,CHRM2,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM2
6374,aceclidine,Acetylcholine receptor agonist,CHRM3,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM3
6375,aceclidine,Acetylcholine receptor agonist,CHRM4,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM4
6376,aceclidine,Acetylcholine receptor agonist,CHRM5,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,,CHRM5
6377,bethanechol,Acetylcholine receptor agonist,CHRM2,CC(C[N+](C)(C)C)OC(N)=O,NZUPCNDJBJXXRF-UHFFFAOYSA-O,,CHRM2
6378,BRD-K47448802,Acetylcholine receptor agonist,CHRM1,CCOC(=O)N1CCC(CC1)NCCNC(=O)c2ccccc2,VNRSRVXFGIQMBW-UHFFFAOYSA-N,,CHRM1
6379,cevimeline,Acetylcholine receptor agonist,CHRM1,C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1,YMMKDPCCYMGDHD-JWGPUQBJSA-N,,CHRM1
6380,cevimeline,Acetylcholine receptor agonist,CHRM3,C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1,YMMKDPCCYMGDHD-JWGPUQBJSA-N,,CHRM3
6381,cytisine,Acetylcholine receptor agonist,CHRNA2,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,,CHRNA2
6382,cytisine,Acetylcholine receptor agonist,CHRNA3,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,,CHRNA3
6383,cytisine,Acetylcholine receptor agonist,CHRNA4,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,,CHRNA4
6384,cytisine,Acetylcholine receptor agonist,CHRNA7,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,,CHRNA7
6385,cytisine,Acetylcholine receptor agonist,CHRNB2,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,,CHRNB2
6386,cytisine,Acetylcholine receptor agonist,CHRNA2,O=c1cccc2C3CNC[C@@H](C3)Cn12,ANJTVLIZGCUXLD-VEDVMXKPSA-N,,CHRNA2
6387,cytisine,Acetylcholine receptor agonist,CHRNA3,O=c1cccc2C3CNC[C@@H](C3)Cn12,ANJTVLIZGCUXLD-VEDVMXKPSA-N,,CHRNA3
6388,cytisine,Acetylcholine receptor agonist,CHRNA4,O=c1cccc2C3CNC[C@@H](C3)Cn12,ANJTVLIZGCUXLD-VEDVMXKPSA-N,,CHRNA4
6389,cytisine,Acetylcholine receptor agonist,CHRNA7,O=c1cccc2C3CNC[C@@H](C3)Cn12,ANJTVLIZGCUXLD-VEDVMXKPSA-N,,CHRNA7
6390,cytisine,Acetylcholine receptor agonist,CHRNB2,O=c1cccc2C3CNC[C@@H](C3)Cn12,ANJTVLIZGCUXLD-VEDVMXKPSA-N,,CHRNB2
6391,decamethonium,Acetylcholine receptor agonist,CHRNA2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,MTCUAOILFDZKCO-UHFFFAOYSA-N,,CHRNA2
6392,desmethylclozapine,Acetylcholine receptor agonist,CHRM1,Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,,CHRM1
6393,desmethylclozapine,Acetylcholine receptor agonist,DRD2,Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,,DRD2
6394,desmethylclozapine,Acetylcholine receptor agonist,DRD3,Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,,DRD3
6395,desmethylclozapine,Acetylcholine receptor agonist,HTR2A,Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,,HTR2A
6396,desmethylclozapine,Acetylcholine receptor agonist,HTR2C,Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,,HTR2C
6397,diphenidol,Acetylcholine receptor agonist,CHRM1,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,,CHRM1
6398,diphenidol,Acetylcholine receptor agonist,CHRM3,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,,CHRM3
6399,diphenidol,Acetylcholine receptor agonist,CHRM4,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,,CHRM4
6400,EVP-6124,Acetylcholine receptor agonist,CHRNA7,Clc1cccc2cc(sc12)C(=O)N[C@H]1CN2CCC1CC2,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,,CHRNA7
6401,nefiracetam,Acetylcholine receptor agonist,CHRM1,Cc1cccc(C)c1NC(=O)CN1CCCC1=O,NGHTXZCKLWZPGK-UHFFFAOYSA-N,,CHRM1
6402,nicotine,Acetylcholine receptor agonist,CHRNA4,CN1CCC[C@H]1c1cccnc1,SNICXCGAKADSCV-JTQLQIEISA-N,,CHRNA4
6403,nicotine,Acetylcholine receptor agonist,CHRNB2,CN1CCC[C@H]1c1cccnc1,SNICXCGAKADSCV-JTQLQIEISA-N,,CHRNB2
6404,nicotine,Acetylcholine receptor agonist,CHRNA9,CN1CCC[C@H]1c1cccnc1,SNICXCGAKADSCV-JTQLQIEISA-N,,CHRNA9
6405,nicotine,Acetylcholine receptor agonist,CHRNA10,CN1CCC[C@H]1c1cccnc1,SNICXCGAKADSCV-JTQLQIEISA-N,,CHRNA10
6406,pilocarpine,Acetylcholine receptor agonist,CHRM1,CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,,CHRM1
6407,pilocarpine,Acetylcholine receptor agonist,CHRM2,CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,,CHRM2
6408,pilocarpine,Acetylcholine receptor agonist,CHRM3,CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,,CHRM3
6409,PNU-120596,Acetylcholine receptor agonist,CHRNA7,COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl,CEIIEALEIHQDBX-UHFFFAOYSA-N,,CHRNA7
6410,SR-95639A,Acetylcholine receptor agonist,CHRM1,C(CN1CCOCC1)Nc1cc2CCCc3ccccc3-c2nn1,RUTYAHFAKWVMNH-UHFFFAOYSA-N,,CHRM1
6411,UB-165,Acetylcholine receptor agonist,CHRNA3,Clc1ccc(cn1)C1=CCCC2CCC1N2,TVSNVPGPFGAKPT-UHFFFAOYSA-N,,CHRNA3
6412,UB-165,Acetylcholine receptor agonist,CHRNA4,Clc1ccc(cn1)C1=CCCC2CCC1N2,TVSNVPGPFGAKPT-UHFFFAOYSA-N,,CHRNA4
6413,UB-165,Acetylcholine receptor agonist,CHRNB2,Clc1ccc(cn1)C1=CCCC2CCC1N2,TVSNVPGPFGAKPT-UHFFFAOYSA-N,,CHRNB2
6414,varenicline,Acetylcholine receptor agonist,CHRNA4,C1[C@H]2CNC[C@@H]1c1cc3nccnc3cc21,JQSHBVHOMNKWFT-DTORHVGOSA-N,,CHRNA4
6415,varenicline,Acetylcholine receptor agonist,CHRNA4,C1C2CNCC1c1cc3nccnc3cc21,JQSHBVHOMNKWFT-UHFFFAOYSA-N,,CHRNA4
6416,cryptotanshinone,Acetylcholinesterase inhibitor,STAT3,C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C,GVKKJJOMQCNPGB-JTQLQIEISA-N,,STAT3
6417,demecarium,Acetylcholinesterase inhibitor,ACHE,CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc1cccc(c1)[N+](C)(C)C,RWZVPVOZTJJMNU-UHFFFAOYSA-N,,ACHE
6418,desoxypeganine,Acetylcholinesterase inhibitor,MAOA,C1CN2Cc3ccccc3N=C2C1,WUFQLZTXIWKION-UHFFFAOYSA-N,,MAOA
6419,desoxypeganine,Acetylcholinesterase inhibitor,ACHE,C1CN2Cc3ccccc3N=C2C1,WUFQLZTXIWKION-UHFFFAOYSA-N,,ACHE
6420,dimpylate,Acetylcholinesterase inhibitor,ACHE,CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C,FHIVAFMUCKRCQO-UHFFFAOYSA-N,,ACHE
6421,donepezil,Acetylcholinesterase inhibitor,ACHE,COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC,ADEBPBSSDYVVLD-UHFFFAOYSA-N,,ACHE
6422,edrophonium,Acetylcholinesterase inhibitor,ACHE,CC[N+](C)(C)c1cccc(O)c1,VWLHWLSRQJQWRG-UHFFFAOYSA-O,,ACHE
6423,ethoprop,Acetylcholinesterase inhibitor,ACHE,CCCSP(=O)(OCC)SCCC,VJYFKVYYMZPMAB-UHFFFAOYSA-N,,ACHE
6424,galantamine,Acetylcholinesterase inhibitor,ACHE,COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24,ASUTZQLVASHGKV-JDFRZJQESA-N,,ACHE
6425,galantamine,Acetylcholinesterase inhibitor,BCHE,COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24,ASUTZQLVASHGKV-JDFRZJQESA-N,,BCHE
6426,galantamine,Acetylcholinesterase inhibitor,ACHE,COc1ccc2CN(C)CCC34C=CC(O)CC4Oc1c23,ASUTZQLVASHGKV-UHFFFAOYSA-N,,ACHE
6427,galantamine,Acetylcholinesterase inhibitor,BCHE,COc1ccc2CN(C)CCC34C=CC(O)CC4Oc1c23,ASUTZQLVASHGKV-UHFFFAOYSA-N,,BCHE
6428,harpagoside,Acetylcholinesterase inhibitor,NOS2,C[C@@]1(C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)OC(=O)/C=C/c4ccccc4,KVRQGMOSZKPBNS-FMHLWDFHSA-N,,NOS2
6429,harpagoside,Acetylcholinesterase inhibitor,PTGS2,C[C@@]1(C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)OC(=O)/C=C/c4ccccc4,KVRQGMOSZKPBNS-FMHLWDFHSA-N,,PTGS2
6430,huperzine-a,Acetylcholinesterase inhibitor,ACHE,C/C=C/1C2Cc3[nH]c(=O)ccc3C1(N)CC(=C2)C,ZRJBHWIHUMBLCN-QDEBKDIKSA-N,,ACHE
6431,huperzine-a,Acetylcholinesterase inhibitor,ACHE,CC=C1/[C@H]2Cc3[nH]c(=O)ccc3[C@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-JRYCNTDSSA-N,,ACHE
6432,huperzine-a,Acetylcholinesterase inhibitor,ACHE,CC=C1[C@@H]2Cc3nc(O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-SEQYCRGISA-N,,ACHE
6433,huperzine-a,Acetylcholinesterase inhibitor,ACHE,CC=C1[C@@H]2Cc3nc(O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-ZUZCIYMTSA-N,,ACHE
6434,ipidacrine,Acetylcholinesterase inhibitor,ACHE,Nc1c2CCCc2nc2CCCCc12,YLUSMKAJIQOXPV-UHFFFAOYSA-N,,ACHE
6435,metrifonate,Acetylcholinesterase inhibitor,ACHE,COP(=O)(OC)C(O)C(Cl)(Cl)Cl,NFACJZMKEDPNKN-UHFFFAOYSA-N,,ACHE
6436,neostigmine,Acetylcholinesterase inhibitor,ACHE,CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,ALWKGYPQUAPLQC-UHFFFAOYSA-N,,ACHE
6437,phenserine,Acetylcholinesterase inhibitor,APP,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,APP
6438,phenserine,Acetylcholinesterase inhibitor,ACHE,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,ACHE
6439,phenserine,Acetylcholinesterase inhibitor,BCHE,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,PBHFNBQPZCRWQP-QUCCMNQESA-N,,BCHE
6440,physostigmine,Acetylcholinesterase inhibitor,ACHE,CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1,PIJVFDBKTWXHHD-HIFRSBDPSA-N,,ACHE
6441,physostigmine,Acetylcholinesterase inhibitor,ACHE,CNC(=O)Oc1ccc2N(C)C3N(C)CC[C@@]3(C)c2c1,PIJVFDBKTWXHHD-WUJWULDRSA-N,,ACHE
6442,pralidoxime,Acetylcholinesterase inhibitor,ACHE,C[n+]1ccccc1C=NO,JBKPUQTUERUYQE-UHFFFAOYSA-O,,ACHE
6443,pralidoxime,Acetylcholinesterase inhibitor,ACHE,C[n+]1ccccc1C=NO,JBKPUQTUERUYQE-UHFFFAOYSA-O,,ACHE
6444,rivastigmine,Acetylcholinesterase inhibitor,ACHE,CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C,XSVMFMHYUFZWBK-NSHDSACASA-N,,ACHE
6445,rivastigmine,Acetylcholinesterase inhibitor,BCHE,CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C,XSVMFMHYUFZWBK-NSHDSACASA-N,,BCHE
6446,sanguinarium-chloride,Acetylcholinesterase inhibitor,CASP3,C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12,INVGWHRKADIJHF-UHFFFAOYSA-N,,CASP3
6447,tacrine,Acetylcholinesterase inhibitor,ACHE,Nc1c2CCCCc2nc2ccccc12,YLJREFDVOIBQDA-UHFFFAOYSA-N,,ACHE
6448,tacrine,Acetylcholinesterase inhibitor,BCHE,Nc1c2CCCCc2nc2ccccc12,YLJREFDVOIBQDA-UHFFFAOYSA-N,,BCHE
6449,ursolic-acid,Acetylcholinesterase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
6450,ursolic-acid,Acetylcholinesterase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
6451,ursolic-acid,Acetylcholinesterase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
6452,ursolic-acid,Acetylcholinesterase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
6453,vesamicol,Acetylcholinesterase inhibitor,SLC18A3,O[C@@H]1CCCC[C@H]1N1CCC(CC1)c1ccccc1,YSSBJODGIYRAMI-IAGOWNOFSA-N,,SLC18A3
6454,huperzine-a,Acetylcholinesterase inhibitor,ACHE,CC=C1/[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)CC(C)=C2,ZRJBHWIHUMBLCN-YQEJDHNASA-N,,ACHE
6455,CGP-20712,Adrenergic receptor antagonist,ADRB1,Cn1cc(nc1c2ccc(OCC(O)CNCCOc3ccc(O)c(c3)C(=O)N)cc2)C(F)(F)F,GKJZEKSHCJELPL-UHFFFAOYSA-N,,ADRB1
6456,atenolol,Adrenergic receptor antagonist,ADRB1,CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1,METKIMKYRPQLGS-LBPRGKRZSA-N,,ADRB1
6457,atenolol,Adrenergic receptor antagonist,ADRB2,CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1,METKIMKYRPQLGS-LBPRGKRZSA-N,,ADRB2
6458,levobunolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12,IXHBTMCLRNMKHZ-GFCCVEGCSA-N,,ADRB1
6459,levobunolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12,IXHBTMCLRNMKHZ-GFCCVEGCSA-N,,ADRB2
6460,yohimbine,Adrenergic receptor antagonist,ADRA2A,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,ADRA2A
6461,yohimbine,Adrenergic receptor antagonist,ADRA2B,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,ADRA2B
6462,yohimbine,Adrenergic receptor antagonist,ADRA2C,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,ADRA2C
6463,yohimbine,Adrenergic receptor antagonist,HTR1A,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,HTR1A
6464,yohimbine,Adrenergic receptor antagonist,HTR1B,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,HTR1B
6465,yohimbine,Adrenergic receptor antagonist,HTR1D,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,HTR1D
6466,yohimbine,Adrenergic receptor antagonist,HTR2B,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-DIRVCLHFSA-N,,HTR2B
6467,2-PMDQ,Adrenergic receptor antagonist,ADRA1A,O=C1Nc2ccccc2C2=NC(CN3CCN(CC3)c3ccccc3)CN12,ONSOQRPYFKDOEB-UHFFFAOYSA-N,,ADRA1A
6468,acebutolol,Adrenergic receptor antagonist,ADRB1,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O,GOEMGAFJFRBGGG-UHFFFAOYSA-N,,ADRB1
6469,alfuzosin,Adrenergic receptor antagonist,ADRA1D,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,,ADRA1D
6470,alfuzosin,Adrenergic receptor antagonist,ADRA1B,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,,ADRA1B
6471,alfuzosin,Adrenergic receptor antagonist,ADRA1A,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,,ADRA1A
6472,alprenolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1ccccc1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,,ADRB1
6473,alprenolol,Adrenergic receptor antagonist,ADRB2,CC(C)NCC(O)COc1ccccc1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,,ADRB2
6474,ARC-239,Adrenergic receptor antagonist,ADRA2B,COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1,JFNKXGOEOQCXDM-UHFFFAOYSA-N,,ADRA2B
6475,BD-1047,Adrenergic receptor antagonist,SIGMAR1,CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1,MGVRNMUKTZOQOW-UHFFFAOYSA-N,,SIGMAR1
6476,BE-2254,Adrenergic receptor antagonist,ADRA1A,Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1,PZZOEXPDTYIBPI-UHFFFAOYSA-N,,ADRA1A
6477,betaxolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,NWIUTZDMDHAVTP-UHFFFAOYSA-N,,ADRB1
6478,betaxolol,Adrenergic receptor antagonist,ADRB2,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,NWIUTZDMDHAVTP-UHFFFAOYSA-N,,ADRB2
6479,bisoprolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,VHYCDWMUTMEGQY-UHFFFAOYSA-N,,ADRB1
6480,BMY-7378,Adrenergic receptor antagonist,ADRA1D,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1D
6481,BMY-7378,Adrenergic receptor antagonist,ADRA1B,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1B
6482,BMY-7378,Adrenergic receptor antagonist,ADRA1A,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,ADRA1A
6483,BMY-7378,Adrenergic receptor antagonist,HTR1A,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,,HTR1A
6484,bopindolol,Adrenergic receptor antagonist,ADRB1,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,,ADRB1
6485,bopindolol,Adrenergic receptor antagonist,ADRB2,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,,ADRB2
6486,buflomedil,Adrenergic receptor antagonist,ADRA1A,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,OWYLAEYXIQKAOL-UHFFFAOYSA-N,,ADRA1A
6487,carteolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,LWAFSWPYPHEXKX-UHFFFAOYSA-N,,ADRB1
6488,carteolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,LWAFSWPYPHEXKX-UHFFFAOYSA-N,,ADRB2
6489,carvedilol,Adrenergic receptor antagonist,ADRA1D,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRA1D
6490,carvedilol,Adrenergic receptor antagonist,ADRA1B,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRA1B
6491,carvedilol,Adrenergic receptor antagonist,ADRA1A,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRA1A
6492,carvedilol,Adrenergic receptor antagonist,ADRB1,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRB1
6493,carvedilol,Adrenergic receptor antagonist,ADRB2,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRB2
6494,carvedilol,Adrenergic receptor antagonist,ADRB3,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,OGHNVEJMJSYVRP-UHFFFAOYSA-N,,ADRB3
6495,celiprolol,Adrenergic receptor antagonist,ADRA2A,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,,ADRA2A
6496,celiprolol,Adrenergic receptor antagonist,ADRB1,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,,ADRB1
6497,celiprolol,Adrenergic receptor antagonist,ADRB2,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,,ADRB2
6498,cyanopindolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NC[C@H](O)COc1cccc2[nH]c(C#N)cc12,QXIUMMLTJVHILT-LBPRGKRZSA-N,,ADRB1
6499,cyanopindolol,Adrenergic receptor antagonist,HTR1A,CC(C)(C)NC[C@H](O)COc1cccc2[nH]c(C#N)cc12,QXIUMMLTJVHILT-LBPRGKRZSA-N,,HTR1A
6500,cyanopindolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2[nH]c(cc12)C#N,QXIUMMLTJVHILT-UHFFFAOYSA-N,,ADRB1
6501,cyanopindolol,Adrenergic receptor antagonist,HTR1A,CC(C)(C)NCC(O)COc1cccc2[nH]c(cc12)C#N,QXIUMMLTJVHILT-UHFFFAOYSA-N,,HTR1A
6502,cyclazosin,Adrenergic receptor antagonist,ADRA1B,COc1cc2nc(nc(N)c2cc1OC)N1CCN(C2CCCCC12)C(=O)c1ccco1,XBRXTUGRUXGBPX-UHFFFAOYSA-N,,ADRA1B
6503,doxazosin,Adrenergic receptor antagonist,ADRA1D,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,,ADRA1D
6504,doxazosin,Adrenergic receptor antagonist,ADRA1B,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,,ADRA1B
6505,doxazosin,Adrenergic receptor antagonist,ADRA1A,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,,ADRA1A
6506,esmolol,Adrenergic receptor antagonist,ADRB1,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,AQNDDEOPVVGCPG-UHFFFAOYSA-N,,ADRB1
6507,ICI-118551,Adrenergic receptor antagonist,ADRB2,CC(C)NC(C)C(O)COc1ccc(C)c2CCCc21,VFIDUCMKNJIJTO-UHFFFAOYSA-N,,ADRB2
6508,ICI-89406,Adrenergic receptor antagonist,ADRB1,OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N,HTLWRKRZKFAAAH-UHFFFAOYSA-N,,ADRB1
6509,ICI-89406,Adrenergic receptor antagonist,ADRB2,OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N,HTLWRKRZKFAAAH-UHFFFAOYSA-N,,ADRB2
6510,idazoxan,Adrenergic receptor antagonist,ADRA2A,C1CN=C(N1)C1COc2ccccc2O1,HPMRFMKYPGXPEP-UHFFFAOYSA-N,,ADRA2A
6511,ifenprodil,Adrenergic receptor antagonist,GRIN1,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,,GRIN1
6512,ifenprodil,Adrenergic receptor antagonist,GRIN2B,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,,GRIN2B
6513,imiloxan,Adrenergic receptor antagonist,ADRA2A,CCn1ccnc1CC1COc2ccccc2O1,UXABARREKCJULM-UHFFFAOYSA-N,,ADRA2A
6514,imiloxan,Adrenergic receptor antagonist,ADRA2B,CCn1ccnc1CC1COc2ccccc2O1,UXABARREKCJULM-UHFFFAOYSA-N,,ADRA2B
6515,indoramin,Adrenergic receptor antagonist,ADRA1D,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,,ADRA1D
6516,indoramin,Adrenergic receptor antagonist,ADRA1A,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,,ADRA1A
6517,isamoltane,Adrenergic receptor antagonist,HTR1A,CC(C)NCC(O)COc1ccccc1-n1cccc1,XVTVPGKWYHWYAD-UHFFFAOYSA-N,,HTR1A
6518,isamoltane,Adrenergic receptor antagonist,HTR1B,CC(C)NCC(O)COc1ccccc1-n1cccc1,XVTVPGKWYHWYAD-UHFFFAOYSA-N,,HTR1B
6519,labetalol,Adrenergic receptor antagonist,ADRA1D,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-ACJLOTCBSA-N,,ADRA1D
6520,labetalol,Adrenergic receptor antagonist,ADRA1A,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-ACJLOTCBSA-N,,ADRA1A
6521,labetalol,Adrenergic receptor antagonist,ADRB1,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-ACJLOTCBSA-N,,ADRB1
6522,labetalol,Adrenergic receptor antagonist,ADRB2,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-ACJLOTCBSA-N,,ADRB2
6523,labetalol,Adrenergic receptor antagonist,ADRA1D,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N,,ADRA1D
6524,labetalol,Adrenergic receptor antagonist,ADRA1A,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N,,ADRA1A
6525,labetalol,Adrenergic receptor antagonist,ADRB1,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N,,ADRB1
6526,labetalol,Adrenergic receptor antagonist,ADRB2,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N,,ADRB2
6527,levobunolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,,ADRB1
6528,levobunolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,,ADRB2
6529,metoprolol,Adrenergic receptor antagonist,ADRB1,COCCc1ccc(OCC(O)CNC(C)C)cc1,IUBSYMUCCVWXPE-UHFFFAOYSA-N,,ADRB1
6530,metoprolol,Adrenergic receptor antagonist,ADRB2,COCCc1ccc(OCC(O)CNC(C)C)cc1,IUBSYMUCCVWXPE-UHFFFAOYSA-N,,ADRB2
6531,metoprolol,Adrenergic receptor antagonist,ADRB1,COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1,RAYDUSPLSJVROR-UHFFFAOYSA-N,,ADRB1
6532,metoprolol,Adrenergic receptor antagonist,ADRB2,COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1,RAYDUSPLSJVROR-UHFFFAOYSA-N,,ADRB2
6533,mirtazapine,Adrenergic receptor antagonist,ADRA2A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2A
6534,mirtazapine,Adrenergic receptor antagonist,ADRA2B,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2B
6535,mirtazapine,Adrenergic receptor antagonist,ADRA2C,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,ADRA2C
6536,mirtazapine,Adrenergic receptor antagonist,HTR2A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR2A
6537,mirtazapine,Adrenergic receptor antagonist,HTR2C,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR2C
6538,mirtazapine,Adrenergic receptor antagonist,HTR3A,CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24,RONZAEMNMFQXRA-INIZCTEOSA-N,,HTR3A
6539,mirtazapine,Adrenergic receptor antagonist,ADRA2A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2A
6540,mirtazapine,Adrenergic receptor antagonist,ADRA2B,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2B
6541,mirtazapine,Adrenergic receptor antagonist,ADRA2C,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,ADRA2C
6542,mirtazapine,Adrenergic receptor antagonist,HTR2A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR2A
6543,mirtazapine,Adrenergic receptor antagonist,HTR2C,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR2C
6544,mirtazapine,Adrenergic receptor antagonist,HTR3A,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,RONZAEMNMFQXRA-UHFFFAOYSA-N,,HTR3A
6545,nadolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,,ADRB1
6546,nadolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,,ADRB2
6547,nadolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12,VWPOSFSPZNDTMJ-UHFFFAOYSA-N,,ADRB1
6548,nadolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12,VWPOSFSPZNDTMJ-UHFFFAOYSA-N,,ADRB2
6549,nebivolol,Adrenergic receptor antagonist,ADRB1,O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1,KOHIRBRYDXPAMZ-YHBROIRLSA-N,,ADRB1
6550,nicergoline,Adrenergic receptor antagonist,ADRA1A,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,YSEXMKHXIOCEJA-FVFQAYNVSA-N,,ADRA1A
6551,nicergoline,Adrenergic receptor antagonist,ADRA1A,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@H]1Cc1cn(C)c3cccc2c13,YSEXMKHXIOCEJA-SJODRWRQSA-N,,ADRA1A
6552,niguldipine,Adrenergic receptor antagonist,ADRA1A,CCCN1C(C)=C(C(c2cccc(c2)[N+]([O-])=O)C(C(=O)ON2CCC(CC2)(c2ccccc2)c2ccccc2)=C1C)C(=O)OC,SLTFTBXXKKDMPA-UHFFFAOYSA-N,,ADRA1A
6553,niguldipine,Adrenergic receptor antagonist,CACNA1C,CCCN1C(C)=C(C(c2cccc(c2)[N+]([O-])=O)C(C(=O)ON2CCC(CC2)(c2ccccc2)c2ccccc2)=C1C)C(=O)OC,SLTFTBXXKKDMPA-UHFFFAOYSA-N,,CACNA1C
6554,niguldipine,Adrenergic receptor antagonist,ADRA1A,COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C,SVJMLYUFVDMUHP-UHFFFAOYSA-N,,ADRA1A
6555,niguldipine,Adrenergic receptor antagonist,CACNA1C,COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C,SVJMLYUFVDMUHP-UHFFFAOYSA-N,,CACNA1C
6556,oxprenolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1ccccc1OCC=C,CEMAWMOMDPGJMB-UHFFFAOYSA-N,,ADRB1
6557,penbutolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NCC(O)COc1ccccc1C2CCCC2.CC(C)(C)NCC(O)COc1ccccc1C2CCCC2,ZRBGRNFQUZAVDD-UHFFFAOYSA-N,,ADRB2
6558,phenoxybenzamine,Adrenergic receptor antagonist,ADRA2B,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,QZVCTJOXCFMACW-UHFFFAOYSA-N,,ADRA2B
6559,phentolamine,Adrenergic receptor antagonist,ADRA1A,Cc1ccc(cc1)N(CC1=NCCN1)c1ccc(O)cc1,LBXLJKWLYGGOTD-UHFFFAOYSA-N,,ADRA1A
6560,phentolamine,Adrenergic receptor antagonist,ADRA2A,Cc1ccc(cc1)N(CC1=NCCN1)c1ccc(O)cc1,LBXLJKWLYGGOTD-UHFFFAOYSA-N,,ADRA2A
6561,phentolamine,Adrenergic receptor antagonist,ADRA1A,Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1,MRBDMNSDAVCSSF-UHFFFAOYSA-N,,ADRA1A
6562,phentolamine,Adrenergic receptor antagonist,ADRA2A,Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1,MRBDMNSDAVCSSF-UHFFFAOYSA-N,,ADRA2A
6563,pindolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1cccc2[nH]ccc12,JZQKKSLKJUAGIC-UHFFFAOYSA-N,,ADRB1
6564,pindolol,Adrenergic receptor antagonist,ADRB2,CC(C)NCC(O)COc1cccc2[nH]ccc12,JZQKKSLKJUAGIC-UHFFFAOYSA-N,,ADRB2
6565,pindolol,Adrenergic receptor antagonist,HTR1A,CC(C)NCC(O)COc1cccc2[nH]ccc12,JZQKKSLKJUAGIC-UHFFFAOYSA-N,,HTR1A
6566,practolol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)COc1ccc(NC(C)=O)cc1,DURULFYMVIFBIR-UHFFFAOYSA-N,,ADRB1
6567,prazosin,Adrenergic receptor antagonist,ADRA1D,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA1D
6568,prazosin,Adrenergic receptor antagonist,ADRA1B,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA1B
6569,prazosin,Adrenergic receptor antagonist,ADRA1A,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA1A
6570,prazosin,Adrenergic receptor antagonist,ADRA2A,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA2A
6571,prazosin,Adrenergic receptor antagonist,ADRA2B,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA2B
6572,prazosin,Adrenergic receptor antagonist,ADRA2C,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,IENZQIKPVFGBNW-UHFFFAOYSA-N,,ADRA2C
6573,propranolol,Adrenergic receptor antagonist,ADRB2,CC(C)NCC(O)COc1cccc2ccccc12,AQHHHDLHHXJYJD-UHFFFAOYSA-N,,ADRB2
6574,propranolol,Adrenergic receptor antagonist,ADRB3,CC(C)NCC(O)COc1cccc2ccccc12,AQHHHDLHHXJYJD-UHFFFAOYSA-N,,ADRB3
6575,reboxetine,Adrenergic receptor antagonist,SLC6A2,CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1,XGSCYTRLSDKRRZ-JQDMTEHVSA-N,,SLC6A2
6576,reboxetine,Adrenergic receptor antagonist,SLC6A2,CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1,CBQGYUDMJHNJBX-OALUTQOASA-N,,SLC6A2
6577,reboxetine,Adrenergic receptor antagonist,SLC6A2,CCOc1ccccc1O[C@H]([C@H]1CNCCO1)c1ccccc1,CBQGYUDMJHNJBX-MOPGFXCFSA-N,,SLC6A2
6578,reboxetine,Adrenergic receptor antagonist,SLC6A2,CCOc1ccccc1OC(C2CNCCO2)c3ccccc3,CBQGYUDMJHNJBX-UHFFFAOYSA-N,,SLC6A2
6579,RS-100329,Adrenergic receptor antagonist,ADRA1A,Cc1c[nH]c(=O)n(CCCN2CCN(CC2)c2ccccc2OCC(F)(F)F)c1=O,RCOBWVAGWYRNHZ-UHFFFAOYSA-N,,ADRA1A
6580,RS-17053,Adrenergic receptor antagonist,ADRA1A,CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1,XLZHXAXXJVKTFM-UHFFFAOYSA-N,,ADRA1A
6581,RS-79948,Adrenergic receptor antagonist,ADRA2A,CCS(=O)(=O)N1CCC[C@@H]2CN3CCc4cc(OC)ccc4[C@@H]3C[C@H]12,UMGBFFAJXFXOIL-MNEFBYGVSA-N,,ADRA2A
6582,RX-821002,Adrenergic receptor antagonist,ADRA2A,COC1(COc2ccccc2O1)C1=NCCN1,HQGWKNGAKBPTBX-UHFFFAOYSA-N,,ADRA2A
6583,RX-821002,Adrenergic receptor antagonist,ADRA2B,COC1(COc2ccccc2O1)C1=NCCN1,HQGWKNGAKBPTBX-UHFFFAOYSA-N,,ADRA2B
6584,RX-821002,Adrenergic receptor antagonist,ADRA2C,COC1(COc2ccccc2O1)C1=NCCN1,HQGWKNGAKBPTBX-UHFFFAOYSA-N,,ADRA2C
6585,scoulerine,Adrenergic receptor antagonist,ADRA1D,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA1D
6586,scoulerine,Adrenergic receptor antagonist,ADRA2A,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,ADRA2A
6587,scoulerine,Adrenergic receptor antagonist,GABRA1,COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O,KNWVMRVOBAFFMH-HNNXBMFYSA-N,,GABRA1
6588,setiptiline,Adrenergic receptor antagonist,HRH1,CN1CCC2=C(C1)c1ccccc1Cc1ccccc21,GVPIXRLYKVFFMK-UHFFFAOYSA-N,,HRH1
6589,setiptiline,Adrenergic receptor antagonist,HTR2A,CN1CCC2=C(C1)c1ccccc1Cc1ccccc21,GVPIXRLYKVFFMK-UHFFFAOYSA-N,,HTR2A
6590,setiptiline,Adrenergic receptor antagonist,HTR2C,CN1CCC2=C(C1)c1ccccc1Cc1ccccc21,GVPIXRLYKVFFMK-UHFFFAOYSA-N,,HTR2C
6591,sotalol,Adrenergic receptor antagonist,ADRB1,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,,ADRB1
6592,sotalol,Adrenergic receptor antagonist,ADRB2,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,,ADRB2
6593,sotalol,Adrenergic receptor antagonist,KCNH2,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,,KCNH2
6594,SR-59230A,Adrenergic receptor antagonist,ADRB3,CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc12,VFDHMSXXELYMRW-ICSRJNTNSA-N,,ADRB3
6595,talinolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1,MXFWWQICDIZSOA-UHFFFAOYSA-N,,ADRB1
6596,tamsulosin,Adrenergic receptor antagonist,ADRA1D,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O,DRHKJLXJIQTDTD-OAHLLOKOSA-N,,ADRA1D
6597,tamsulosin,Adrenergic receptor antagonist,ADRA1B,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O,DRHKJLXJIQTDTD-OAHLLOKOSA-N,,ADRA1B
6598,tamsulosin,Adrenergic receptor antagonist,ADRA1A,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O,DRHKJLXJIQTDTD-OAHLLOKOSA-N,,ADRA1A
6599,terazosin,Adrenergic receptor antagonist,ADRA1D,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,,ADRA1D
6600,terazosin,Adrenergic receptor antagonist,ADRA1B,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,,ADRA1B
6601,terazosin,Adrenergic receptor antagonist,ADRA1A,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,,ADRA1A
6602,timolol,Adrenergic receptor antagonist,ADRB1,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,BLJRIMJGRPQVNF-JTQLQIEISA-N,,ADRB1
6603,timolol,Adrenergic receptor antagonist,ADRB2,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,BLJRIMJGRPQVNF-JTQLQIEISA-N,,ADRB2
6604,tolazoline,Adrenergic receptor antagonist,ADRA2A,C(C1=NCCN1)c1ccccc1,JIVZKJJQOZQXQB-UHFFFAOYSA-N,,ADRA2A
6605,tolazoline,Adrenergic receptor antagonist,ADRA2B,C(C1=NCCN1)c1ccccc1,JIVZKJJQOZQXQB-UHFFFAOYSA-N,,ADRA2B
6606,tolazoline,Adrenergic receptor antagonist,ADRA2C,C(C1=NCCN1)c1ccccc1,JIVZKJJQOZQXQB-UHFFFAOYSA-N,,ADRA2C
6607,trazodone,Adrenergic receptor antagonist,HTR2A,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2A
6608,trazodone,Adrenergic receptor antagonist,HTR2C,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,HTR2C
6609,trazodone,Adrenergic receptor antagonist,SLC6A4,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,,SLC6A4
6610,triacsin-c,Adrenergic receptor antagonist,ACSL1,CCCC=CCC=CC=CC=NN[NH2+][O-],DQMOSRDZWQSBHC-YLEPRARLSA-N,,ACSL1
6611,urapidil,Adrenergic receptor antagonist,HTR1A,COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1,ICMGLRUYEQNHPF-UHFFFAOYSA-N,,HTR1A
6612,WB-4101,Adrenergic receptor antagonist,ADRA1D,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA1D
6613,WB-4101,Adrenergic receptor antagonist,ADRA1B,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA1B
6614,WB-4101,Adrenergic receptor antagonist,ADRA1A,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA1A
6615,WB-4101,Adrenergic receptor antagonist,ADRA2A,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA2A
6616,WB-4101,Adrenergic receptor antagonist,ADRA2B,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA2B
6617,WB-4101,Adrenergic receptor antagonist,ADRA2C,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,GYSZUJHYXCZAKI-UHFFFAOYSA-N,,ADRA2C
6618,yohimbine,Adrenergic receptor antagonist,ADRA2A,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,ADRA2A
6619,yohimbine,Adrenergic receptor antagonist,ADRA2B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,ADRA2B
6620,yohimbine,Adrenergic receptor antagonist,ADRA2C,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,ADRA2C
6621,yohimbine,Adrenergic receptor antagonist,HTR1A,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,HTR1A
6622,yohimbine,Adrenergic receptor antagonist,HTR1B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,HTR1B
6623,yohimbine,Adrenergic receptor antagonist,HTR1D,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,HTR1D
6624,yohimbine,Adrenergic receptor antagonist,HTR2B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-SCYLSFHTSA-N,,HTR2B
6625,yohimbine,Adrenergic receptor antagonist,ADRA2A,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,ADRA2A
6626,yohimbine,Adrenergic receptor antagonist,ADRA2B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,ADRA2B
6627,yohimbine,Adrenergic receptor antagonist,ADRA2C,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,ADRA2C
6628,yohimbine,Adrenergic receptor antagonist,HTR1A,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,HTR1A
6629,yohimbine,Adrenergic receptor antagonist,HTR1B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,HTR1B
6630,yohimbine,Adrenergic receptor antagonist,HTR1D,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,HTR1D
6631,yohimbine,Adrenergic receptor antagonist,HTR2B,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]12,BLGXFZZNTVWLAY-KSOYODCDSA-N,,HTR2B
6632,yohimbine,Adrenergic receptor antagonist,ADRA2A,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,ADRA2A
6633,yohimbine,Adrenergic receptor antagonist,ADRA2B,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,ADRA2B
6634,yohimbine,Adrenergic receptor antagonist,ADRA2C,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,ADRA2C
6635,yohimbine,Adrenergic receptor antagonist,HTR1A,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,HTR1A
6636,yohimbine,Adrenergic receptor antagonist,HTR1B,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,HTR1B
6637,yohimbine,Adrenergic receptor antagonist,HTR1D,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,HTR1D
6638,yohimbine,Adrenergic receptor antagonist,HTR2B,COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,BLGXFZZNTVWLAY-AMZRAFDVSA-N,,HTR2B
6639,yohimbine,Adrenergic receptor antagonist,ADRA2A,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,ADRA2A
6640,yohimbine,Adrenergic receptor antagonist,ADRA2B,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,ADRA2B
6641,yohimbine,Adrenergic receptor antagonist,ADRA2C,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,ADRA2C
6642,yohimbine,Adrenergic receptor antagonist,HTR1A,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,HTR1A
6643,yohimbine,Adrenergic receptor antagonist,HTR1B,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,HTR1B
6644,yohimbine,Adrenergic receptor antagonist,HTR1D,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,HTR1D
6645,yohimbine,Adrenergic receptor antagonist,HTR2B,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12,BLGXFZZNTVWLAY-UHFFFAOYSA-N,,HTR2B
6646,BRD-K54331210,Alkaline phosphatase inhibitor,ALPL,OCCNC(=O)c1cc(n[nH]1)-c1ccc(Cl)c(Cl)c1Cl,NQORNRXANZIMLI-UHFFFAOYSA-N,,ALPL
6647,noscapine,Bradykinin receptor antagonist,SIGMAR1,COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-QZTJIDSGSA-N,,SIGMAR1
6648,noscapine,Bradykinin receptor antagonist,SIGMAR1,COc1ccc2[C@@H](OC(=O)c2c1OC)[C@H]1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-ZENAZSQFSA-N,,SIGMAR1
6649,noscapine,Bradykinin receptor antagonist,SIGMAR1,COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5c(OC)c34,AKNNEGZIBPJZJG-QNSVNVJESA-N,,SIGMAR1
6650,noscapine,Bradykinin receptor antagonist,SIGMAR1,COc1ccc2[C@H](OC(=O)c2c1OC)C1N(C)CCc2cc3OCOc3c(OC)c12,AKNNEGZIBPJZJG-ZVAWYAOSSA-N,,SIGMAR1
6651,SEP-227900,D-Amino Acid Oxidase Inhibitor,DAO,OC(=O)c1cc2occc2[nH]1,MMAIBGHDBYQYDI-UHFFFAOYSA-N,,DAO
6652,alogliptin,Dipeptidyl peptidase inhibitor,DPP4,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,,DPP4
6653,diprotin-a,Dipeptidyl peptidase inhibitor,DPP4,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,JNTMAZFVYNDPLB-PEDHHIEDSA-N,,DPP4
6654,linagliptin,Dipeptidyl peptidase inhibitor,DPP4,CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1,LTXREWYXXSTFRX-QGZVFWFLSA-N,,DPP4
6655,NVP-DPP728,Dipeptidyl peptidase inhibitor,DPP4,O=C(CNCCNc1ccc(cn1)C#N)N1CCC[C@H]1C#N,VFFZWMWTUSXDCB-ZDUSSCGKSA-N,,DPP4
6656,PT-630,Dipeptidyl peptidase inhibitor,DPP4,NC(CCC(O)=O)C(=O)N1CCC[C@H]1B(O)O,DMTPQYQQHYOTQM-MLWJPKLSSA-N,,DPP4
6657,saxagliptin,Dipeptidyl peptidase inhibitor,DPP4,N[C@H](C(=O)N1[C@@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2,QGJUIPDUBHWZPV-BBIKMUCQSA-N,,DPP4
6658,sitagliptin,Dipeptidyl peptidase inhibitor,DPP4,N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F,MFFMDFFZMYYVKS-SECBINFHSA-N,,DPP4
6659,teneligliptin,Dipeptidyl peptidase inhibitor,DPP4,Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1,WGRQANOPCQRCME-PMACEKPBSA-N,,DPP4
6660,trelagliptin,Dipeptidyl peptidase inhibitor,DPP4,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,IWYJYHUNXVAVAA-UHFFFAOYSA-N,,DPP4
6661,vildagliptin,Dipeptidyl peptidase inhibitor,DPP4,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,,DPP4
6662,saxagliptin,Dipeptidyl peptidase inhibitor,DPP4,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2,QGJUIPDUBHWZPV-SGTAVMJGSA-N,,DPP4
6663,ambrisentan,Endothelin receptor antagonist,EDNRA,COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1,OUJTZYPIHDYQMC-LJQANCHMSA-N,,EDNRA
6664,ambrisentan,Endothelin receptor antagonist,EDNRB,COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1,OUJTZYPIHDYQMC-LJQANCHMSA-N,,EDNRB
6665,ambrisentan,Endothelin receptor antagonist,EDNRA,COC(C(Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3,OUJTZYPIHDYQMC-UHFFFAOYSA-N,,EDNRA
6666,ambrisentan,Endothelin receptor antagonist,EDNRB,COC(C(Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3,OUJTZYPIHDYQMC-UHFFFAOYSA-N,,EDNRB
6667,atrasentan,Endothelin receptor antagonist,EDNRA,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(OC)cc1)C(O)=O)c1ccc2OCOc2c1,MOTJMGVDPWRKOC-QPVYNBJUSA-N,,EDNRA
6668,BMS-182874,Endothelin receptor antagonist,EDNRA,CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1onc(C)c1C,MJRGSRRZKSJHOE-UHFFFAOYSA-N,,EDNRA
6669,bosentan,Endothelin receptor antagonist,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1,GJPICJJJRGTNOD-UHFFFAOYSA-N,,EDNRA
6670,bosentan,Endothelin receptor antagonist,EDNRB,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1,GJPICJJJRGTNOD-UHFFFAOYSA-N,,EDNRB
6671,FR-139317,Endothelin receptor antagonist,EDNRA,CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(Cc2cn(C)c3ccccc23)C(=O)NC(Cc4ccccn4)C(=O)O,LIOKMIQQPDDTNO-UHFFFAOYSA-N,,EDNRA
6672,IRL-2500,Endothelin receptor antagonist,EDNRB,CN(C(Cc1ccc(cc1)c2ccccc2)C(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)C(=O)c5cc(C)cc(C)c5,UZDORQWMYRRLQV-UHFFFAOYSA-N,,EDNRB
6673,macitentan,Endothelin receptor antagonist,EDNRA,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,,EDNRA
6674,macitentan,Endothelin receptor antagonist,EDNRB,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,,EDNRB
6675,sitaxentan,Endothelin receptor antagonist,EDNRA,Cc1noc(NS(=O)(=O)c2ccsc2C(=O)Cc2cc3OCOc3cc2C)c1Cl,PHWXUGHIIBDVKD-UHFFFAOYSA-N,,EDNRA
6676,zibotentan,Endothelin receptor antagonist,EDNRA,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,,EDNRA
6677,CS-917,Fructose biphosphate inhibitor,FBP1,CC(C)Cc1sc(N)nc1-c1ccc(o1)P(O)(O)=O,XJMYIJPPDSZOPN-UHFFFAOYSA-N,,FBP1
6678,miglustat,Glycosyl transferase inhibitor,UGCG,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,UQRORFVVSGFNRO-UTINFBMNSA-N,,UGCG
6679,carbinoxamine,L-type calcium channel blocker,HRH1,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,OJFSXZCBGQGRNV-UHFFFAOYSA-N,,HRH1
6680,CGP-37157,L-type calcium channel blocker,SLC8A1,Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1,KQEPIRKXSUIUTH-UHFFFAOYSA-N,,SLC8A1
6681,Ro-25-6981,Monamine transporter modulator,GRIN2B,C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1,WVZSEUPGUDIELE-HTAPYJJXSA-N,,GRIN2B
6682,nomifensine,Noradrenaline uptake inhibitor,SLC6A2,CN1CC(c2ccccc2)c2cccc(N)c2C1,XXPANQJNYNUNES-UHFFFAOYSA-N,,SLC6A2
6683,nomifensine,Noradrenaline uptake inhibitor,SLC6A3,CN1CC(c2ccccc2)c2cccc(N)c2C1,XXPANQJNYNUNES-UHFFFAOYSA-N,,SLC6A3
6684,PF-03758309,P21 activated kinase inhibitor,PAK4,CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1,AYCPARAPKDAOEN-LJQANCHMSA-N,,PAK4
6685,eptifibatide,Platelet aggregation inhibitor,ITGA2B,NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,CZKPOZZJODAYPZ-UHFFFAOYSA-N,,ITGA2B
6686,eptifibatide,Platelet aggregation inhibitor,ITGB3,NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,CZKPOZZJODAYPZ-UHFFFAOYSA-N,,ITGB3
6687,etofylline-clofibrate,Platelet aggregation inhibitor,PPARA,Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O,KYAKGJDISSNVPZ-UHFFFAOYSA-N,,PPARA
6688,icosapent,Platelet aggregation inhibitor,PTGS1,CCC=C/CC=C/CC=C/CC=C/CC=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,,PTGS1
6689,icosapent,Platelet aggregation inhibitor,PTGS2,CCC=C/CC=C/CC=C/CC=C/CC=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,,PTGS2
6690,iloprost,Platelet aggregation inhibitor,PTGER1,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGER1
6691,iloprost,Platelet aggregation inhibitor,PTGER2,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGER2
6692,iloprost,Platelet aggregation inhibitor,PTGIR,CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,,PTGIR
6693,iloprost,Platelet aggregation inhibitor,PTGER1,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGER1
6694,iloprost,Platelet aggregation inhibitor,PTGER2,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGER2
6695,iloprost,Platelet aggregation inhibitor,PTGIR,CC#CCC(C)[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2CC(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,,PTGIR
6696,indobufen,Platelet aggregation inhibitor,PTGS1,CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N,,PTGS1
6697,indobufen,Platelet aggregation inhibitor,PTGS2,CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N,,PTGS2
6698,MRE-269,Platelet aggregation inhibitor,PTGIR,CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(O)=O,PAJMKGZZBBTTOY-ZFORQUDYSA-N,,PTGIR
6699,MY-5445,Platelet aggregation inhibitor,PDE5A,Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1,CEHQLKSLMFIHBF-UHFFFAOYSA-N,,PDE5A
6700,tirofiban,Platelet aggregation inhibitor,ITGA2B,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,,ITGA2B
6701,tirofiban,Platelet aggregation inhibitor,ITGB3,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,,ITGB3
6702,triflusal,Platelet aggregation inhibitor,PDE10A,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PDE10A
6703,triflusal,Platelet aggregation inhibitor,NFKB1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NFKB1
6704,triflusal,Platelet aggregation inhibitor,NOS2,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NOS2
6705,triflusal,Platelet aggregation inhibitor,PTGS1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PTGS1
6706,aceclofenac,Prostanoid receptor antagonist,PTGS2,OC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,,PTGS2
6707,DG-041,Prostanoid receptor antagonist,PTGER3,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(C=CC(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,BFBTVZNKWXWKNZ-HWKANZROSA-N,,PTGER3
6708,diflunisal,Prostanoid receptor antagonist,PTGS1,OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F,HUPFGZXOMWLGNK-UHFFFAOYSA-N,,PTGS1
6709,diflunisal,Prostanoid receptor antagonist,PTGS2,OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F,HUPFGZXOMWLGNK-UHFFFAOYSA-N,,PTGS2
6710,indoprofen,Prostanoid receptor antagonist,PTGS1,CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,,PTGS1
6711,indoprofen,Prostanoid receptor antagonist,PTGS2,CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,,PTGS2
6712,L-161982,Prostanoid receptor antagonist,PTGER4,CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C,MMDNKTXNUZFVKD-UHFFFAOYSA-N,,PTGER4
6713,laropiprant,Prostanoid receptor antagonist,PTGDR,CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12,NXFFJDQHYLNEJK-CYBMUJFWSA-N,,PTGDR
6714,meclofenamic-acid,Prostanoid receptor antagonist,PTGS1,Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl,SBDNJUWAMKYJOX-UHFFFAOYSA-N,,PTGS1
6715,meclofenamic-acid,Prostanoid receptor antagonist,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl,SBDNJUWAMKYJOX-UHFFFAOYSA-N,,PTGS2
6716,mesalazine,Prostanoid receptor antagonist,ALOX5,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,ALOX5
6717,mesalazine,Prostanoid receptor antagonist,PPARG,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PPARG
6718,mesalazine,Prostanoid receptor antagonist,PTGS1,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS1
6719,mesalazine,Prostanoid receptor antagonist,PTGS2,Nc1ccc(O)c(c1)C(O)=O,KBOPZPXVLCULAV-UHFFFAOYSA-N,,PTGS2
6720,phenylbutazone,Prostanoid receptor antagonist,PTGS1,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,,PTGS1
6721,phenylbutazone,Prostanoid receptor antagonist,PTGS2,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,,PTGS2
6722,prostaglandin,Prostanoid receptor antagonist,PTGDR2,CCCCC[C@H](O)C=C[C@H]1[C@H](CC=C/CCCC(O)=O)[C@@H](O)CC1=O,BHMBVRSPMRCCGG-SAIQCDIPSA-N,,PTGDR2
6723,prostaglandin,Prostanoid receptor antagonist,PTGDR,CCCCC[C@H](O)C=C[C@H]1[C@H](CC=C/CCCC(O)=O)[C@@H](O)CC1=O,BHMBVRSPMRCCGG-SAIQCDIPSA-N,,PTGDR
6724,ramatroban,Prostanoid receptor antagonist,PTGDR2,OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1,LDXDSHIEDAPSSA-OAHLLOKOSA-N,,PTGDR2
6725,ramatroban,Prostanoid receptor antagonist,TBXA2R,OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1,LDXDSHIEDAPSSA-OAHLLOKOSA-N,,TBXA2R
6726,SC-19220,Prostanoid receptor antagonist,PTGER1,CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc12,KNURFLJTOUGOOQ-UHFFFAOYSA-N,,PTGER1
6727,5-BDBD,Purinergic receptor antagonist,P2RX4,Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1ccccc21,NKYMVQPXXTZHSF-UHFFFAOYSA-N,,P2RX4
6728,clopidogrel,Purinergic receptor antagonist,P2RY12,COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl,GKTWGGQPFAXNFI-HNNXBMFYSA-N,,P2RY12
6729,clopidogrel,Purinergic receptor antagonist,P2RY12,COC(=O)C(N1CCc2sccc2C1)c3ccccc3Cl,GKTWGGQPFAXNFI-UHFFFAOYSA-N,,P2RY12
6730,KN-62,Purinergic receptor antagonist,P2RX7,CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67,RJVLFQBBRSMWHX-UHFFFAOYSA-N,,P2RX7
6731,KN-62,Purinergic receptor antagonist,CAMK2A,CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67,RJVLFQBBRSMWHX-UHFFFAOYSA-N,,CAMK2A
6732,NF-449,Purinergic receptor antagonist,P2RX1,OS(=O)(=O)c1ccc(NC(=O)c2cc(NC(=O)Nc3cc(cc(c3)C(=O)Nc3ccc(c(c3)S(O)(=O)=O)S(O)(=O)=O)C(=O)Nc3ccc(c(c3)S(O)(=O)=O)S(O)(=O)=O)cc(c2)C(=O)Nc2ccc(c(c2)S(O)(=O)=O)S(O)(=O)=O)cc1S(O)(=O)=O,CPISLWFLHGUZHF-UHFFFAOYSA-N,,P2RX1
6733,prasugrel,Purinergic receptor antagonist,P2RY12,CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F,DTGLZDAWLRGWQN-UHFFFAOYSA-N,,P2RY12
6734,ticagrelor,Purinergic receptor antagonist,P2RY12,CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1,OEKWJQXRCDYSHL-MGXMICMRSA-N,,P2RY12
6735,ticlopidine,Purinergic receptor antagonist,P2RY12,Clc1ccccc1CN1CCc2sccc2C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,,P2RY12
6736,cyclopamine,Smoothened receptor antagonist,SMO,C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@@]31CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C,QASFUMOKHFSJGL-LAFRSMQTSA-N,,SMO
6737,cyclopamine,Smoothened receptor antagonist,SMO,CC1C2NC[C@@H](C)C[C@H]2O[C@@]31CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C,QASFUMOKHFSJGL-ACLNMQFHSA-N,,SMO
6738,PF-5274857,Smoothened receptor antagonist,SMO,Cc1cnc(c(C)c1)-c1cc(ncc1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O,BBVNTTZIOTWDSV-UHFFFAOYSA-N,,SMO
6739,SANT-1,Smoothened receptor antagonist,SHH,Cc1nn(c(C)c1C=NN1CCN(Cc2ccccc2)CC1)-c1ccccc1,FOORCIAZMIWALX-JJIBRWJFSA-N,,SHH
6740,SANT-1,Smoothened receptor antagonist,SMO,Cc1nn(c(C)c1C=NN1CCN(Cc2ccccc2)CC1)-c1ccccc1,FOORCIAZMIWALX-JJIBRWJFSA-N,,SMO
6741,SANT-1,Smoothened receptor antagonist,SHH,Cc1nn(c(C)c1C=NN2CCN(Cc3ccccc3)CC2)c4ccccc4,FOORCIAZMIWALX-UHFFFAOYSA-N,,SHH
6742,SANT-1,Smoothened receptor antagonist,SMO,Cc1nn(c(C)c1C=NN2CCN(Cc3ccccc3)CC2)c4ccccc4,FOORCIAZMIWALX-UHFFFAOYSA-N,,SMO
6743,SANT-2,Smoothened receptor antagonist,SHH,CCOc1cc(cc(OCC)c1OCC)C(=O)Nc1ccc(Cl)c(c1)-c1nc2ccccc2[nH]1,VQOJFGFKIVFMDH-UHFFFAOYSA-N,,SHH
6744,SANT-2,Smoothened receptor antagonist,SMO,CCOc1cc(cc(OCC)c1OCC)C(=O)Nc1ccc(Cl)c(c1)-c1nc2ccccc2[nH]1,VQOJFGFKIVFMDH-UHFFFAOYSA-N,,SMO
6745,taladegib,Smoothened receptor antagonist,IHH,CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F,SZBGQDXLNMELTB-UHFFFAOYSA-N,,IHH
6746,taladegib,Smoothened receptor antagonist,DHH,CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F,SZBGQDXLNMELTB-UHFFFAOYSA-N,,DHH
6747,taladegib,Smoothened receptor antagonist,SMO,CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F,SZBGQDXLNMELTB-UHFFFAOYSA-N,,SMO
6748,vismodegib,Smoothened receptor antagonist,SMO,Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O,BPQMGSKTAYIVFO-UHFFFAOYSA-N,,SMO
6749,tetraethylenepentamine,Superoxide dismutase inhibitor,SOD1,NCCNCCNCCNCCN,FAGUFWYHJQFNRV-UHFFFAOYSA-N,,SOD1
6750,tetraethylenepentamine,Superoxide dismutase inhibitor,SOD2,NCCNCCNCCNCCN,FAGUFWYHJQFNRV-UHFFFAOYSA-N,,SOD2
6751,mibefradil,T-type calcium channel blocker,CACNA1C,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,,CACNA1C
6752,mibefradil,T-type calcium channel blocker,CACNA1I,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,,CACNA1I
6753,mibefradil,T-type calcium channel blocker,CACNA1H,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,,CACNA1H
6754,mibefradil,T-type calcium channel blocker,CACNA1G,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,,CACNA1G
6755,mibefradil,T-type calcium channel blocker,CACNA1C,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2C1C(C)C,HBNPJJILLOYFJU-UHFFFAOYSA-N,,CACNA1C
6756,mibefradil,T-type calcium channel blocker,CACNA1I,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2C1C(C)C,HBNPJJILLOYFJU-UHFFFAOYSA-N,,CACNA1I
6757,mibefradil,T-type calcium channel blocker,CACNA1H,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2C1C(C)C,HBNPJJILLOYFJU-UHFFFAOYSA-N,,CACNA1H
6758,mibefradil,T-type calcium channel blocker,CACNA1G,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2C1C(C)C,HBNPJJILLOYFJU-UHFFFAOYSA-N,,CACNA1G
6759,pinaverium,T-type calcium channel blocker,CACNA1C,COc1cc(Br)c(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)cc1OC,DDHUTBKXLWCZCO-GFUWAVFVSA-N,,CACNA1C
6760,zonisamide,T-type calcium channel blocker,SCN11A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN11A
6761,zonisamide,T-type calcium channel blocker,SCN1A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN1A
6762,zonisamide,T-type calcium channel blocker,SCN2A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN2A
6763,zonisamide,T-type calcium channel blocker,SCN3A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN3A
6764,zonisamide,T-type calcium channel blocker,SCN4A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN4A
6765,zonisamide,T-type calcium channel blocker,SCN5A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN5A
6766,zonisamide,T-type calcium channel blocker,SCN9A,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,SCN9A
6767,zonisamide,T-type calcium channel blocker,CA1,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA1
6768,zonisamide,T-type calcium channel blocker,CA7,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA7
6769,zonisamide,T-type calcium channel blocker,CA12,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N,KZFDKINRISJFCO-UHFFFAOYSA-N,,CA12
6770,zonisamide,T-type calcium channel blocker,SCN11A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN11A
6771,zonisamide,T-type calcium channel blocker,SCN1A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN1A
6772,zonisamide,T-type calcium channel blocker,SCN2A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN2A
6773,zonisamide,T-type calcium channel blocker,SCN3A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN3A
6774,zonisamide,T-type calcium channel blocker,SCN4A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN4A
6775,zonisamide,T-type calcium channel blocker,SCN5A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN5A
6776,zonisamide,T-type calcium channel blocker,SCN9A,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,SCN9A
6777,zonisamide,T-type calcium channel blocker,CA1,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA1
6778,zonisamide,T-type calcium channel blocker,CA7,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA7
6779,zonisamide,T-type calcium channel blocker,CA12,NS(=O)(=O)Cc1noc2ccccc12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,,CA12
6780,dazmegrel,Thromboxane synthase inhibitor,TBXAS1,Cc1c(Cn2ccnc2)c2ccccc2n1CCC(O)=O,DEQLGSOHGTZKFB-UHFFFAOYSA-N,,TBXAS1
6781,dazoxiben,Thromboxane synthase inhibitor,TBXAS1,OC(=O)c1ccc(OCCn2ccnc2)cc1,XQGZSYKGWHUSDH-UHFFFAOYSA-N,,TBXAS1
6782,ozagrel,Thromboxane synthase inhibitor,TBXAS1,OC(=O)C=Cc1ccc(Cn2ccnc2)cc1,SHZKQBHERIJWAO-AATRIKPKSA-N,,TBXAS1
6783,ozagrel,Thromboxane synthase inhibitor,TBXAS1,OC(=O)C=Cc1ccc(Cn2ccnc2)cc1,SHZKQBHERIJWAO-UHFFFAOYSA-N,,TBXAS1
6784,picotamide,Thromboxane synthase inhibitor,TBXA2R,COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1,KYWCWBXGRWWINE-UHFFFAOYSA-N,,TBXA2R
6785,triflusal,Thromboxane synthase inhibitor,PDE10A,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PDE10A
6786,triflusal,Thromboxane synthase inhibitor,NFKB1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NFKB1
6787,triflusal,Thromboxane synthase inhibitor,NOS2,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,NOS2
6788,triflusal,Thromboxane synthase inhibitor,PTGS1,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,RMWVZGDJPAKBDE-UHFFFAOYSA-N,,PTGS1
6789,fluorouracil,Thymidylate synthase inhibitor,DPYD,Fc1c[nH]c(=O)[nH]c1=O,GHASVSINZRGABV-UHFFFAOYSA-N,,DPYD
6790,fluorouracil,Thymidylate synthase inhibitor,TYMS,Fc1c[nH]c(=O)[nH]c1=O,GHASVSINZRGABV-UHFFFAOYSA-N,,TYMS
6791,5-FP,Thymidylate synthase inhibitor,TYMS,Oc1ncc(F)cn1,HPABFFGQPLJKBP-UHFFFAOYSA-N,,TYMS
6792,capecitabine,Thymidylate synthase inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@@H]1O,GAGWJHPBXLXJQN-GMTLJSCSSA-N,,TYMS
6793,capecitabine,Thymidylate synthase inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,,TYMS
6794,capecitabine,Thymidylate synthase inhibitor,TYMS,CCCCCOC(=O)Nc1nc(=O)n(cc1F)C1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-LXGADPQPSA-N,,TYMS
6795,carmofur,Thymidylate synthase inhibitor,TYMS,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,AOCCBINRVIKJHY-UHFFFAOYSA-N,,TYMS
6796,doxifluridine,Thymidylate synthase inhibitor,TYMS,C[C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O,ZWAOHEXOSAUJHY-YQHTUYAKSA-N,,TYMS
6797,doxifluridine,Thymidylate synthase inhibitor,TYMS,C[C@H]1OC(C(O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O,ZWAOHEXOSAUJHY-IRKUJEHTSA-N,,TYMS
6798,ftorafur,Thymidylate synthase inhibitor,TYMS,Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O,WFWLQNSHRPWKFK-ZCFIWIBFSA-N,,TYMS
6799,pemetrexed,Thymidylate synthase inhibitor,DHFR,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,DHFR
6800,pemetrexed,Thymidylate synthase inhibitor,GART,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,GART
6801,pemetrexed,Thymidylate synthase inhibitor,TYMS,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,TYMS
6802,pemetrexed,Thymidylate synthase inhibitor,DHFR,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,DHFR
6803,pemetrexed,Thymidylate synthase inhibitor,GART,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,GART
6804,pemetrexed,Thymidylate synthase inhibitor,TYMS,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,TYMS
6805,raltitrexed,Thymidylate synthase inhibitor,TYMS,CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,IVTVGDXNLFLDRM-HNNXBMFYSA-N,,TYMS
6806,tegafur,Thymidylate synthase inhibitor,TYMS,Fc1cn(C2CCCO2)c(=O)[nH]c1=O,WFWLQNSHRPWKFK-UHFFFAOYSA-N,,TYMS
6807,trifluridine,Thymidylate synthase inhibitor,TYMS,OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,,TYMS
6808,trifluridine,Thymidylate synthase inhibitor,TYMS,OC[C@H]1OC(C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F,VSQQQLOSPVPRAZ-GFCOJPQKSA-N,,TYMS
6809,doxifluridine,Thymidylate synthase inhibitor,TYMS,C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,,TYMS
6810,BRD-K86682249,Tyrosine phosphatase inhibitor,PTPN1,OC(=O)c1ccccc1c2ccc(C=c3sc4nc5cc(Br)cnc5n4c3=O)o2,NMLOLMOZTQCQJF-UHFFFAOYSA-N,,PTPN1
6811,BVT-948,Tyrosine phosphatase inhibitor,PTPN1,CC1(C)C2C(=NC1=O)c3ccccc3C(=O)C2=O,AJVXVYTVAAWZAP-UHFFFAOYSA-N,,PTPN1
6812,BVT-948,Tyrosine phosphatase inhibitor,PTPN2,CC1(C)C2C(=NC1=O)c3ccccc3C(=O)C2=O,AJVXVYTVAAWZAP-UHFFFAOYSA-N,,PTPN2
6813,BVT-948,Tyrosine phosphatase inhibitor,PTPN11,CC1(C)C2C(=NC1=O)c3ccccc3C(=O)C2=O,AJVXVYTVAAWZAP-UHFFFAOYSA-N,,PTPN11
6814,dephostatin,Tyrosine phosphatase inhibitor,PTPN1,CN([N+][O-])c1cc(O)ccc1O,HCJOLYFWJWJPTJ-UHFFFAOYSA-N,,PTPN1
6815,dephostatin,Tyrosine phosphatase inhibitor,PTPN6,CN([N+][O-])c1cc(O)ccc1O,HCJOLYFWJWJPTJ-UHFFFAOYSA-N,,PTPN6
6816,lobaric-acid,Tyrosine phosphatase inhibitor,PTPN1,CCCCCc1c(C(=O)O)c(O)cc2OC(=O)c3c(cc(OC)cc3Oc12)C(=O)CCCC,JHEWMLHQNRHTQX-UHFFFAOYSA-N,,PTPN1
6817,ursolic-acid,Tyrosine phosphatase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
6818,ursolic-acid,Tyrosine phosphatase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
6819,ursolic-acid,Tyrosine phosphatase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
6820,ursolic-acid,Tyrosine phosphatase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
6821,bifemelane,Acetylcholine release stimulant,MAOA,CNCCCCOc1ccccc1Cc1ccccc1,QSQQPMHPCBLLGX-UHFFFAOYSA-N,,MAOA
6822,bifemelane,Acetylcholine release stimulant,MAOB,CNCCCCOc1ccccc1Cc1ccccc1,QSQQPMHPCBLLGX-UHFFFAOYSA-N,,MAOB
6823,fomepizole,Alcohol dehydrogenase inhibitor,ADH1A,Cc1cn[nH]c1,RIKMMFOAQPJVMX-UHFFFAOYSA-N,,ADH1A
6824,fomepizole,Alcohol dehydrogenase inhibitor,ADH1B,Cc1cn[nH]c1,RIKMMFOAQPJVMX-UHFFFAOYSA-N,,ADH1B
6825,fomepizole,Alcohol dehydrogenase inhibitor,ADH1C,Cc1cn[nH]c1,RIKMMFOAQPJVMX-UHFFFAOYSA-N,,ADH1C
6826,formononetin,Alcohol dehydrogenase inhibitor,ADH1C,COc1ccc(cc1)-c1coc2cc(O)ccc2c1=O,HKQYGTCOTHHOMP-UHFFFAOYSA-N,,ADH1C
6827,abiraterone,Androgen biosynthesis inhibitor,CYP17A1,C[C@]12CC[C@@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]34C)[C@@H]1CC=C2c1cccnc1,GZOSMCIZMLWJML-CHCBBUOYSA-N,,CYP17A1
6828,orteronel,Androgen biosynthesis inhibitor,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12,OZPFIJIOIVJZMN-GOSISDBHSA-N,,CYP17A1
6829,orteronel,Androgen biosynthesis inhibitor,CYP17A1,CNC(=O)c1ccc2cc(ccc2c1)C1(O)CCn2cncc12,OZPFIJIOIVJZMN-UHFFFAOYSA-N,,CYP17A1
6830,abiraterone,Androgen biosynthesis inhibitor,CYP17A1,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1,GZOSMCIZMLWJML-VJLLXTKPSA-N,,CYP17A1
6831,azilsartan,Angiotensin receptor antagonist,AGTR1,CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,KGSXMPPBFPAXLY-UHFFFAOYSA-N,,AGTR1
6832,azilsartan,Angiotensin receptor antagonist,AGTR2,CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,KGSXMPPBFPAXLY-UHFFFAOYSA-N,,AGTR2
6833,azilsartan-medoxomil,Angiotensin receptor antagonist,AGTR2,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,QJFSABGVXDWMIW-UHFFFAOYSA-N,,AGTR2
6834,candesartan,Angiotensin receptor antagonist,AGTR1,CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,HTQMVQVXFRQIKW-UHFFFAOYSA-N,,AGTR1
6835,candesartan-cilextil,Angiotensin receptor antagonist,AGTR1,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,GHOSNRCGJFBJIB-UHFFFAOYSA-N,,AGTR1
6836,eprosartan,Angiotensin receptor antagonist,AGTR1,CCCCc1ncc(C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O,OROAFUQRIXKEMV-LDADJPATSA-N,,AGTR1
6837,irbesartan,Angiotensin receptor antagonist,AGTR1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,YOSHYTLCDANDAN-UHFFFAOYSA-N,,AGTR1
6838,losartan,Angiotensin receptor antagonist,AGTR1,CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,,AGTR1
6839,losartan,Angiotensin receptor antagonist,AGTR1,CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1C1=NNNN1,UAPLZGQBVVVUMU-UHFFFAOYSA-N,,AGTR1
6840,olmesartan-medoxomil,Angiotensin receptor antagonist,AGTR1,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1,UQGKUQLKSCSZGY-UHFFFAOYSA-N,,AGTR1
6841,telmisartan,Angiotensin receptor antagonist,AGTR1,CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C,RMMXLENWKUUMAY-UHFFFAOYSA-N,,AGTR1
6842,telmisartan,Angiotensin receptor antagonist,PPARG,CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C,RMMXLENWKUUMAY-UHFFFAOYSA-N,,PPARG
6843,valsartan,Angiotensin receptor antagonist,AGTR1,CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O,ACWBQPMHZXGDFX-QFIPXVFZSA-N,,AGTR1
6844,valsartan,Angiotensin receptor antagonist,AGTR1,CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C(C)C)C(O)=O,ACWBQPMHZXGDFX-UHFFFAOYSA-N,,AGTR1
6845,ZD-7155,Angiotensin receptor antagonist,AGTR1,CCc1cc2N(Cc3ccc(cc3)-c3ccccc3-c3nnn[nH]3)C(=O)CCc2c(CC)n1,BFVNEYDCFJNLGN-UHFFFAOYSA-N,,AGTR1
6846,alprazolam,Benzodiazepine receptor agonist,GABRA1,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA1
6847,alprazolam,Benzodiazepine receptor agonist,GABRA2,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA2
6848,alprazolam,Benzodiazepine receptor agonist,GABRA3,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA3
6849,alprazolam,Benzodiazepine receptor agonist,GABRA4,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA4
6850,alprazolam,Benzodiazepine receptor agonist,GABRA5,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA5
6851,alprazolam,Benzodiazepine receptor agonist,GABRA6,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRA6
6852,alprazolam,Benzodiazepine receptor agonist,GABRB1,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRB1
6853,alprazolam,Benzodiazepine receptor agonist,GABRB2,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRB2
6854,alprazolam,Benzodiazepine receptor agonist,GABRB3,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRB3
6855,alprazolam,Benzodiazepine receptor agonist,GABRD,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRD
6856,alprazolam,Benzodiazepine receptor agonist,GABRE,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRE
6857,alprazolam,Benzodiazepine receptor agonist,GABRG1,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRG1
6858,alprazolam,Benzodiazepine receptor agonist,GABRG2,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRG2
6859,alprazolam,Benzodiazepine receptor agonist,GABRG3,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRG3
6860,alprazolam,Benzodiazepine receptor agonist,GABRP,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRP
6861,alprazolam,Benzodiazepine receptor agonist,GABRQ,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,VREFGVBLTWBCJP-UHFFFAOYSA-N,,GABRQ
6862,CGS-20625,Benzodiazepine receptor agonist,GABRA1,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA1
6863,CGS-20625,Benzodiazepine receptor agonist,GABRA2,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA2
6864,CGS-20625,Benzodiazepine receptor agonist,GABRA3,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA3
6865,CGS-20625,Benzodiazepine receptor agonist,GABRA4,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA4
6866,CGS-20625,Benzodiazepine receptor agonist,GABRA5,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA5
6867,CGS-20625,Benzodiazepine receptor agonist,GABRA6,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,XRUUVUYJUULCBQ-UHFFFAOYSA-N,,GABRA6
6868,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA1,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA1
6869,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA2,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA2
6870,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA3,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA3
6871,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA4,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA4
6872,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA5,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA5
6873,chlordiazepoxide,Benzodiazepine receptor agonist,GABRA6,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRA6
6874,chlordiazepoxide,Benzodiazepine receptor agonist,GABRB1,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRB1
6875,chlordiazepoxide,Benzodiazepine receptor agonist,GABRB2,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRB2
6876,chlordiazepoxide,Benzodiazepine receptor agonist,GABRB3,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRB3
6877,chlordiazepoxide,Benzodiazepine receptor agonist,GABRD,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRD
6878,chlordiazepoxide,Benzodiazepine receptor agonist,GABRE,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRE
6879,chlordiazepoxide,Benzodiazepine receptor agonist,GABRG1,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRG1
6880,chlordiazepoxide,Benzodiazepine receptor agonist,GABRG2,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRG2
6881,chlordiazepoxide,Benzodiazepine receptor agonist,GABRG3,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRG3
6882,chlordiazepoxide,Benzodiazepine receptor agonist,GABRP,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRP
6883,chlordiazepoxide,Benzodiazepine receptor agonist,GABRQ,CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,ANTSCNMPPGJYLG-UHFFFAOYSA-N,,GABRQ
6884,diazepam,Benzodiazepine receptor agonist,GABRA1,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA1
6885,diazepam,Benzodiazepine receptor agonist,GABRA2,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA2
6886,diazepam,Benzodiazepine receptor agonist,GABRA3,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA3
6887,diazepam,Benzodiazepine receptor agonist,GABRA4,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA4
6888,diazepam,Benzodiazepine receptor agonist,GABRA5,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA5
6889,diazepam,Benzodiazepine receptor agonist,GABRA6,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRA6
6890,diazepam,Benzodiazepine receptor agonist,GABRB1,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRB1
6891,diazepam,Benzodiazepine receptor agonist,GABRB2,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRB2
6892,diazepam,Benzodiazepine receptor agonist,GABRB3,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRB3
6893,diazepam,Benzodiazepine receptor agonist,GABRD,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRD
6894,diazepam,Benzodiazepine receptor agonist,GABRE,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRE
6895,diazepam,Benzodiazepine receptor agonist,GABRG1,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRG1
6896,diazepam,Benzodiazepine receptor agonist,GABRG2,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRG2
6897,diazepam,Benzodiazepine receptor agonist,GABRG3,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRG3
6898,diazepam,Benzodiazepine receptor agonist,GABRP,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRP
6899,diazepam,Benzodiazepine receptor agonist,GABRQ,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,,GABRQ
6900,etizolam,Benzodiazepine receptor agonist,GABRA1,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,VMZUTJCNQWMAGF-UHFFFAOYSA-N,,GABRA1
6901,FGIN-1-43,Benzodiazepine receptor agonist,TSPO,CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccc(Cl)cc12)-c1ccc(Cl)cc1,XTZUPNNVXIMWAR-UHFFFAOYSA-N,,TSPO
6902,indiplon,Benzodiazepine receptor agonist,GABRA1,CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1,CBIAWPMZSFFRGN-UHFFFAOYSA-N,,GABRA1
6903,lorazepam,Benzodiazepine receptor agonist,GABRA1,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA1
6904,lorazepam,Benzodiazepine receptor agonist,GABRA2,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA2
6905,lorazepam,Benzodiazepine receptor agonist,GABRA3,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA3
6906,lorazepam,Benzodiazepine receptor agonist,GABRA4,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA4
6907,lorazepam,Benzodiazepine receptor agonist,GABRA5,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA5
6908,lorazepam,Benzodiazepine receptor agonist,GABRA6,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRA6
6909,lorazepam,Benzodiazepine receptor agonist,GABRB1,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRB1
6910,lorazepam,Benzodiazepine receptor agonist,GABRB2,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRB2
6911,lorazepam,Benzodiazepine receptor agonist,GABRB3,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRB3
6912,lorazepam,Benzodiazepine receptor agonist,GABRD,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRD
6913,lorazepam,Benzodiazepine receptor agonist,GABRE,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRE
6914,lorazepam,Benzodiazepine receptor agonist,GABRG1,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRG1
6915,lorazepam,Benzodiazepine receptor agonist,GABRG2,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRG2
6916,lorazepam,Benzodiazepine receptor agonist,GABRG3,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRG3
6917,lorazepam,Benzodiazepine receptor agonist,GABRP,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRP
6918,lorazepam,Benzodiazepine receptor agonist,GABRQ,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,,GABRQ
6919,nitrazepam,Benzodiazepine receptor agonist,GABRA1,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1,KJONHKAYOJNZEC-UHFFFAOYSA-N,,GABRA1
6920,zaleplon,Benzodiazepine receptor agonist,GABRA1,CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N,HUNXMJYCHXQEGX-UHFFFAOYSA-N,,GABRA1
6921,ZK-93423,Benzodiazepine receptor agonist,GABRA1,CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,,GABRA1
6922,ZK-93423,Benzodiazepine receptor agonist,GABRA2,CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,,GABRA2
6923,ZK-93423,Benzodiazepine receptor agonist,GABRA3,CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,,GABRA3
6924,ZK-93423,Benzodiazepine receptor agonist,GABRA5,CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,,GABRA5
6925,zolpidem,Benzodiazepine receptor agonist,GABRA1,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,,GABRA1
6926,zolpidem,Benzodiazepine receptor agonist,GABRA2,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,,GABRA2
6927,zolpidem,Benzodiazepine receptor agonist,GABRA3,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,,GABRA3
6928,profenamine,Butyrylcholinesterase inhibitor,CHRM1,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12,CDOZDBSBBXSXLB-UHFFFAOYSA-N,,CHRM1
6929,AM-251,Cannabinoid receptor antagonist,CNR1,Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1,BUZAJRPLUGXRAB-UHFFFAOYSA-N,,CNR1
6930,AM-281,Cannabinoid receptor antagonist,CNR1,Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCOCC1,AJFFBPZYXRNAIC-UHFFFAOYSA-N,,CNR1
6931,AM-630,Cannabinoid receptor antagonist,CNR1,COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12,JHOTYHDSLIUKCJ-UHFFFAOYSA-N,,CNR1
6932,AM-630,Cannabinoid receptor antagonist,CNR2,COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12,JHOTYHDSLIUKCJ-UHFFFAOYSA-N,,CNR2
6933,LY-320135,Cannabinoid receptor antagonist,CNR1,COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N,RYNSGDFWBJWWSZ-UHFFFAOYSA-N,,CNR1
6934,O-2050,Cannabinoid receptor antagonist,CNR1,CC1=CC[C@@H]2[C@@H](C1)c3c(O)cc(CC#CCCCNS(=O)(=O)C)cc3OC2(C)C,DJTGGIYZQHHLGJ-RTBURBONSA-N,,CNR1
6935,rimonabant,Cannabinoid receptor antagonist,CNR1,Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1,JZCPYUJPEARBJL-UHFFFAOYSA-N,,CNR1
6936,SR-147778,Cannabinoid receptor antagonist,CNR1,CCc1c(nn(c1-c1ccc(Br)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1,HMXDWDSNPRNUKI-UHFFFAOYSA-N,,CNR1
6937,nitrocaramiphen,Cholinergic receptor antagonist,CHRM1,CCN(CC)CCOC(=O)C1(CCCC1)c1ccc(cc1)[N+]([O-])=O,NSHMVLOWOAQFTP-UHFFFAOYSA-N,,CHRM1
6938,oxyphenonium,Cholinergic receptor antagonist,CHRM1,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,,CHRM1
6939,pipenzolate,Cholinergic receptor antagonist,CHRM1,CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,,CHRM1
6940,profenamine,Cholinergic receptor antagonist,CHRM1,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12,CDOZDBSBBXSXLB-UHFFFAOYSA-N,,CHRM1
6941,azacitidine,DNA methyltransferase inhibitor,DNMT1,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,NMUSYJAQQFHJEW-ARQDHWQXSA-N,,DNMT1
6942,azacitidine,DNA methyltransferase inhibitor,DNMT1,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,NMUSYJAQQFHJEW-KVTDHHQDSA-N,,DNMT1
6943,azacitidine,DNA methyltransferase inhibitor,DNMT1,Nc1ncn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,NMUSYJAQQFHJEW-JDJSBBGDSA-N,,DNMT1
6944,BIX-01294,DNA methyltransferase inhibitor,EHMT2,COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1,OSXFATOLZGZLSK-UHFFFAOYSA-N,,EHMT2
6945,decitabine,DNA methyltransferase inhibitor,DNMT1,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,XAUDJQYHKZQPEU-KVQBGUIXSA-N,,DNMT1
6946,disulfiram,DNA methyltransferase inhibitor,ALDH2,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,,ALDH2
6947,RG-108,DNA methyltransferase inhibitor,DNMT1,OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O,HPTXLHAHLXOAKV-INIZCTEOSA-N,,DNMT1
6948,SGI-1027,DNA methyltransferase inhibitor,DNMT1,Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1,QSYLKMKIVWJAAK-UHFFFAOYSA-N,,DNMT1
6949,SGI-1027,DNA methyltransferase inhibitor,DNMT3A,Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1,QSYLKMKIVWJAAK-UHFFFAOYSA-N,,DNMT3A
6950,SGI-1027,DNA methyltransferase inhibitor,DNMT3B,Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1,QSYLKMKIVWJAAK-UHFFFAOYSA-N,,DNMT3B
6951,zebularine,DNA methyltransferase inhibitor,DNMT1,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cccnc1=O,RPQZTTQVRYEKCR-WCTZXXKLSA-N,,DNMT1
6952,zebularine,DNA methyltransferase inhibitor,CDA,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cccnc1=O,RPQZTTQVRYEKCR-WCTZXXKLSA-N,,CDA
6953,zebularine,DNA methyltransferase inhibitor,DNMT1,OC[C@H]1O[C@H](C(O)[C@H]1O)n1cccnc1=O,RPQZTTQVRYEKCR-JJFBUQMESA-N,,DNMT1
6954,zebularine,DNA methyltransferase inhibitor,CDA,OC[C@H]1O[C@H](C(O)[C@H]1O)n1cccnc1=O,RPQZTTQVRYEKCR-JJFBUQMESA-N,,CDA
6955,SB-205607,Delta 1 opioid receptor agonist,OPRD1,CN1CC[C@@]2(Cc3nc4ccccc4cc3C[C@H]2C1)c1cccc(O)c1,LEPBHAAYNPPRRA-WMZHIEFXSA-N,,OPRD1
6956,SB-205607,Delta 1 opioid receptor agonist,OPRD1,CN1CCC2(Cc3nc4ccccc4cc3CC2C1)c5cccc(O)c5,LEPBHAAYNPPRRA-UHFFFAOYSA-N,,OPRD1
6957,R-59022,Diacylglycerol kinase inhibitor,DGKA,Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccccc1)c1ccc(F)cc1,MFVJXLPANKSLLD-UHFFFAOYSA-N,,DGKA
6958,defactinib,Focal adhesion kinase inhibitor,PTK2,CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1,FWLMVFUGMHIOAA-UHFFFAOYSA-N,,PTK2
6959,PF-562271,Focal adhesion kinase inhibitor,PTK2B,CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O,MZDKLVOWGIOKTN-UHFFFAOYSA-N,,PTK2B
6960,PF-562271,Focal adhesion kinase inhibitor,PTK2,CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O,MZDKLVOWGIOKTN-UHFFFAOYSA-N,,PTK2
6961,3-methyl-GABA,GABA aminotransferase activator,ABAT,CC(CN)CC(O)=O,CZGLBWZXGIAIBU-UHFFFAOYSA-N,,ABAT
6962,vigabatrin,GABA aminotransferase inhibitor,ABAT,NC(CCC(O)=O)C=C,PJDFLNIOAUIZSL-UHFFFAOYSA-N,,ABAT
6963,valproic-acid,GABAergic transmission enhancer,ABAT,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ABAT
6964,valproic-acid,GABAergic transmission enhancer,HDAC1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,HDAC1
6965,valproic-acid,GABAergic transmission enhancer,SCN1A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN1A
6966,valproic-acid,GABAergic transmission enhancer,SCN3A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN3A
6967,valproic-acid,GABAergic transmission enhancer,ALDH5A1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ALDH5A1
6968,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C,AKUJBENLRBOFTD-RPRRAYFGSA-N,,NR3C1
6969,mometasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5ccco5)C(=O)CCl,WOFMFGQZHJDGCX-ZULDAHANSA-N,,NR3C1
6970,flumetasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,WXURHACBFYSXBI-GQKYHHCASA-N,,NR3C1
6971,alclometasone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)CC2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@@]21C,DJHCCTTVDRAMEH-PEDQINGESA-N,,NR3C1
6972,alclometasone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@@H]3[C@@H](O)C[C@]12C,DJHCCTTVDRAMEH-BNMIAHSWSA-N,,NR3C1
6973,amcinonide,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,ILKJAFIWWBXGDU-KNPIAJNZSA-N,,NR3C1
6974,amcinonide,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,ILKJAFIWWBXGDU-ZYDCGBIBSA-N,,NR3C1
6975,amcinonide,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,ILKJAFIWWBXGDU-UHFFFAOYSA-N,,NR3C1
6976,beclometasone,Glucocorticoid receptor agonist,NR3C1,CC1CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(Cl)C(O)CC2(C)C1(O)C(=O)CO,NBMKJKDGKREAPL-WOOYFSPWSA-N,,NR3C1
6977,beclometasone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,KUVIULQEHSCUHY-YFYIJNNCSA-N,,NR3C1
6978,beclomethasone-dipropionate,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,KUVIULQEHSCUHY-XYWKZLDCSA-N,,NR3C1
6979,beclomethasone-dipropionate,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC12C,KUVIULQEHSCUHY-UHFFFAOYSA-N,,NR3C1
6980,betamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-DVTGEIKXSA-N,,NR3C1
6981,betamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-REKGUKDCSA-N,,NR3C1
6982,betamethasone-acetate,Glucocorticoid receptor agonist,NR3C1,C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-DKNQJTFPSA-N,,NR3C1
6983,betamethasone-valerate,Glucocorticoid receptor agonist,NR3C1,CCCCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(O)C[C@]12C)C(=O)CO,SNHRLVCMMWUAJD-FHOZUDJNSA-N,,NR3C1
6984,budesonide,Glucocorticoid receptor agonist,NR3C1,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,VOVIALXJUBGFJZ-KWVAZRHASA-N,,NR3C1
6985,budesonide,Glucocorticoid receptor agonist,NR3C1,CCCC1O[C@@H]2C[C@H]3[C@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,VOVIALXJUBGFJZ-JQDNLURHSA-N,,NR3C1
6986,budesonide,Glucocorticoid receptor agonist,NR3C1,CCCC1O[C@@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4[C@@H](O)CC3(C)[C@@]2(O1)C(=O)CO,VOVIALXJUBGFJZ-NECQTEFJSA-N,,NR3C1
6987,budesonide,Glucocorticoid receptor agonist,NR3C1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO,VOVIALXJUBGFJZ-UHFFFAOYSA-N,,NR3C1
6988,ciclesonide,Glucocorticoid receptor agonist,NR3C1,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1,LUKZNWIVRBCLON-GXOBDPJESA-N,,NR3C1
6989,clobetasol,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl,CBGUOGMQLZIXBE-XGQKBEPLSA-N,,NR3C1
6990,clobetasol,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl,CBGUOGMQLZIXBE-ZOQAIDMISA-N,,NR3C1
6991,clobetasol,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl,CBGUOGMQLZIXBE-BHPVMOEKSA-N,,NR3C1
6992,clobetasol,Glucocorticoid receptor agonist,NR3C1,CCC(=O)OC1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl,CBGUOGMQLZIXBE-DZLFUUCZSA-N,,NR3C1
6993,clocortolone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,SXYZQZLHAIHKKY-HLHNMYILSA-N,,NR3C1
6994,cortisol,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,ALEXXDVDDISNDU-FPNXCIAJSA-N,,NR3C1
6995,cortisone-acetate,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,ITRJWOMZKQRYTA-RFZYENFJSA-N,,NR3C1
6996,cortisone-acetate,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3C(=O)C[C@]12C,ITRJWOMZKQRYTA-XLSOAHDVSA-N,,NR3C1
6997,deflazacort,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C,FBHSPRKOSMHSIF-IXOLEQHTSA-N,,NR3C1
6998,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@]1(O)C(=O)CO,UREBDLICKHMUKA-UWJHKKLZSA-N,,NR3C1
6999,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-CXSFZGCWSA-N,,NR3C1
7000,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-ARBOEXFKSA-N,,NR3C1
7001,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-QCYOSJOCSA-N,,NR3C1
7002,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1CC2C3CCC4=CC(=O)C=CC4(C)[C@]3(F)[C@@H](O)CC2(C)[C@]1(O)C(=O)CO,UREBDLICKHMUKA-HIERVMNKSA-N,,NR3C1
7003,dexamethasone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-BGFPPJMDSA-N,,NR3C1
7004,dexamethasone,Glucocorticoid receptor agonist,NR3C1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,UREBDLICKHMUKA-UHFFFAOYSA-N,,NR3C1
7005,dexamethasone-acetate,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-HIBZCRSPSA-N,,NR3C1
7006,diflorasone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O,BOBLHFUVNSFZPJ-VPQUHHNCSA-N,,NR3C1
7007,diflorasone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)COC(=O)C,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,,NR3C1
7008,fludrocortisone-acetate,Glucocorticoid receptor agonist,NR3C2,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,SYWHXTATXSMDSB-JORUCDAYSA-N,,NR3C2
7009,flumetasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,WXURHACBFYSXBI-DRBBXQFKSA-N,,NR3C1
7010,fluocinolone-acetonide,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,WJOHZNCJWYWUJD-UUTDCOIBSA-N,,NR3C1
7011,fluocinolone-acetonide,Glucocorticoid receptor agonist,NR3C1,CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,FEBLZLNTKCEFIT-AHVBUMMWSA-N,,NR3C1
7012,fluticasone,Glucocorticoid receptor agonist,NR3C1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(CC(=O)CO)C(=O)SCF,RZXNVYCLMORIIB-UHFFFAOYSA-N,,NR3C1
7013,fluticasone,Glucocorticoid receptor agonist,PGR,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(CC(=O)CO)C(=O)SCF,RZXNVYCLMORIIB-UHFFFAOYSA-N,,PGR
7014,fluticasone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@]1([C@H](C)C[C@@H]2[C@H]3C[C@H](F)C4=CC(=O)C=C[C@@]4(C)[C@]3(F)[C@@H](O)C[C@@]12C)C(=O)SCF,WMWTYOKRWGGJOA-GFDKJMNNSA-N,,NR3C1
7015,fluticasone,Glucocorticoid receptor agonist,PGR,CCC(=O)O[C@]1([C@H](C)C[C@@H]2[C@H]3C[C@H](F)C4=CC(=O)C=C[C@@]4(C)[C@]3(F)[C@@H](O)C[C@@]12C)C(=O)SCF,WMWTYOKRWGGJOA-GFDKJMNNSA-N,,PGR
7016,fluticasone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@@]1([C@H](C)C[C@@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,WMWTYOKRWGGJOA-ZEVWSBCOSA-N,,NR3C1
7017,fluticasone,Glucocorticoid receptor agonist,PGR,CCC(=O)O[C@@]1([C@H](C)C[C@@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,WMWTYOKRWGGJOA-ZEVWSBCOSA-N,,PGR
7018,fluticasone-propionate,Glucocorticoid receptor agonist,NR3C1,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,WMWTYOKRWGGJOA-CENSZEJFSA-N,,NR3C1
7019,fluticasone-propionate,Glucocorticoid receptor agonist,PGR,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,WMWTYOKRWGGJOA-CENSZEJFSA-N,,PGR
7020,halcinonide,Glucocorticoid receptor agonist,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl,MUQNGPZZQDCDFT-JNQJZLCISA-N,,NR3C1
7021,halcinonide,Glucocorticoid receptor agonist,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl,MUQNGPZZQDCDFT-VDJZZIFASA-N,,NR3C1
7022,halcinonide,Glucocorticoid receptor agonist,NR3C1,CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl,MUQNGPZZQDCDFT-RLDTZFIDSA-N,,NR3C1
7023,halometasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)Cl,GGXMRPUKBWXVHE-MIHLVHIWSA-N,,NR3C1
7024,hydrocortisone,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO,JYGXADMDTFJGBT-YDAVOWJHSA-N,,NR3C1
7025,hydrocortisone,Glucocorticoid receptor agonist,NR3C1,C[C@@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@]1(O)C(=O)CO,JYGXADMDTFJGBT-JEFZWPMTSA-N,,NR3C1
7026,hydrocortisone,Glucocorticoid receptor agonist,NR3C1,C[C@@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@]1(O)C(=O)COC(=O)CCC(=O)O,VWQWXZAWFPZJDA-VDINROJTSA-N,,NR3C1
7027,hydrocortisone,Glucocorticoid receptor agonist,NR3C1,CC12CC(O)C3C(CCC4=CC(=O)CCC34C)C2CCC1(O)C(=O)CO,JYGXADMDTFJGBT-UHFFFAOYSA-N,,NR3C1
7028,hydrocortisone-acetate,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C,ALEXXDVDDISNDU-KPYZGQEZSA-N,,NR3C1
7029,hydrocortisone-hemisuccinate,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O,VWQWXZAWFPZJDA-PILPDLGISA-N,,NR3C1
7030,hydrocortisone-valerate,Glucocorticoid receptor agonist,NR3C1,CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO,FZCHYNWYXKICIO-BXLKFAEVSA-N,,NR3C1
7031,isoflupredone,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,ZOCUOMKMBMEYQV-YQKAUVFSSA-N,,NR3C1
7032,isoflupredone-acetate,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,ZOCUOMKMBMEYQV-GSLJADNHSA-N,,NR3C1
7033,loteprednol,Glucocorticoid receptor agonist,NR3C1,CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl,DMKSVUSAATWOCU-HROMYWEYSA-N,,NR3C1
7034,medrysone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14,GZENKSODFLBBHQ-XVDJYXIYSA-N,,NR3C1
7035,medrysone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@H]2[C@@]2(C)CCC(=O)C=C12,GZENKSODFLBBHQ-WXWRWIGRSA-N,,NR3C1
7036,medrysone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1CC2C3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CCC(=O)C=C12,GZENKSODFLBBHQ-IENIWFQZSA-N,,NR3C1
7037,methylprednisolone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14,VHRSUDSXCMQTMA-XRDLKPKISA-N,,NR3C1
7038,methylprednisolone,Glucocorticoid receptor agonist,NR3C1,C[C@H]1CC2C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12,VHRSUDSXCMQTMA-IETLARDKSA-N,,NR3C1
7039,mometasone,Glucocorticoid receptor agonist,NR3C1,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,WOFMFGQZHJDGCX-CLWZPKSSSA-N,,NR3C1
7040,piretanide,Glucocorticoid receptor agonist,SLC12A1,NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O,UJEWTUDSLQGTOA-UHFFFAOYSA-N,,SLC12A1
7041,piretanide,Glucocorticoid receptor agonist,SLC12A2,NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O,UJEWTUDSLQGTOA-UHFFFAOYSA-N,,SLC12A2
7042,prednisolone-acetate,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C,LRJOMUJRLNCICJ-AUGMLKDDSA-N,,NR3C1
7043,prednisolone-hemisuccinate,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O,APGDTXUMTIZLCJ-PILPDLGISA-N,,NR3C1
7044,prednisone,Glucocorticoid receptor agonist,NR3C1,C[C@]12CC(=O)[C@@H]3[C@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,XOFYZVNMUHMLCC-AGXRBINYSA-N,,NR3C1
7045,prednisone,Glucocorticoid receptor agonist,NR3C1,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,,NR3C1
7046,prednisone,Glucocorticoid receptor agonist,NR3C1,C[C@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO,XOFYZVNMUHMLCC-BDQMTFAOSA-N,,NR3C1
7047,rimexolone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)[C@@]1(C)[C@H](C)C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,QTTRZHGPGKRAFB-JSOPVXQKSA-N,,NR3C1
7048,rimexolone,Glucocorticoid receptor agonist,NR3C1,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,QTTRZHGPGKRAFB-OOKHYKNYSA-N,,NR3C1
7049,triamcinolone,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,GFNANZIMVAIWHM-OBYCQNJPSA-N,,NR3C1
7050,triamcinolone,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)[C@@]3(F)[C@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,GFNANZIMVAIWHM-YAQGJSIVSA-N,,NR3C1
7051,triamcinolone,Glucocorticoid receptor agonist,NR3C1,C[C@]12C[C@H](O)[C@@]3(F)C(CCC4=CC(=O)C=C[C@]34C)C1C[C@@H](O)[C@]2(O)C(=O)CO,GFNANZIMVAIWHM-MGVPRKGPSA-N,,NR3C1
7052,triamcinolone,Glucocorticoid receptor agonist,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@@H](CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)OC(=O)C,XGMPVBXKDAHORN-KUZKEXDLSA-N,,NR3C1
7053,triamcinolone,Glucocorticoid receptor agonist,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,YNDXUCZADRHECN-JNQJZLCISA-N,,NR3C1
7054,hyperforin,Interleukin receptor antagonist,ALOX5,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,ALOX5
7055,hyperforin,Interleukin receptor antagonist,PTGS1,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,PTGS1
7056,hyperforin,Interleukin receptor antagonist,NR1I2,CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,GQRREYKSPJMLAW-KZFONMTISA-N,,NR1I2
7057,STA-5326,Interleukin synthesis inhibitor,IL12A,Cc1cccc(C=NNc2cc(nc(OCCc3ccccn3)n2)N2CCOCC2)c1,HSKAZIJJKRAJAV-KOEQRZSOSA-N,,IL12A
7058,cinalukast,Leukotriene receptor antagonist,CYSLTR1,CCC(CC)(CC(=O)Nc1cccc(C=Cc2nc(cs2)C3CCC3)c1)C(=O)O,BZMKNPGKXJAIDV-UHFFFAOYSA-N,,CYSLTR1
7059,ibudilast,Leukotriene receptor antagonist,PDE10A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE10A
7060,ibudilast,Leukotriene receptor antagonist,MIF,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,MIF
7061,ibudilast,Leukotriene receptor antagonist,PDE3A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE3A
7062,ibudilast,Leukotriene receptor antagonist,PDE4A,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4A
7063,ibudilast,Leukotriene receptor antagonist,PDE4B,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4B
7064,ibudilast,Leukotriene receptor antagonist,PDE4C,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4C
7065,ibudilast,Leukotriene receptor antagonist,PDE4D,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,PDE4D
7066,ibudilast,Leukotriene receptor antagonist,TLR4,CC(C)C(=O)c1c(nn2ccccc12)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,,TLR4
7067,ketotifen,Leukotriene receptor antagonist,HRH1,CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,,HRH1
7068,montelukast,Leukotriene receptor antagonist,CYSLTR1,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,,CYSLTR1
7069,montelukast,Leukotriene receptor antagonist,CYSLTR1,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1,UCHDWCPVSPXUMX-JGCGQSQUSA-N,,CYSLTR1
7070,montelukast,Leukotriene receptor antagonist,CYSLTR1,CC(C)(O)c1ccccc1CCC(SCC1(CC(O)=O)CC1)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1,UCHDWCPVSPXUMX-XNTDXEJSSA-N,,CYSLTR1
7071,pranlukast,Leukotriene receptor antagonist,CYSLTR1,O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1,NBQKINXMPLXUET-UHFFFAOYSA-N,,CYSLTR1
7072,pranlukast,Leukotriene receptor antagonist,CYSLTR2,O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1,NBQKINXMPLXUET-UHFFFAOYSA-N,,CYSLTR2
7073,REV-5901,Leukotriene receptor antagonist,ALOX5,CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1,JRLOEMCOOZSCQP-UHFFFAOYSA-N,,ALOX5
7074,SR-2640,Leukotriene receptor antagonist,CYSLTR1,OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1,LMPZHLXYBWGGNT-UHFFFAOYSA-N,,CYSLTR1
7075,tomelukast,Leukotriene receptor antagonist,CYSLTR1,CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O,MWYHLEQJTQJHSS-UHFFFAOYSA-N,,CYSLTR1
7076,zafirlukast,Leukotriene receptor antagonist,CYSLTR1,COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C,YEEZWCHGZNKEEK-UHFFFAOYSA-N,,CYSLTR1
7077,etomidate,Membrane permeability inhibitor,GABRA1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA1
7078,etomidate,Membrane permeability inhibitor,GABRA2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA2
7079,etomidate,Membrane permeability inhibitor,GABRA3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA3
7080,etomidate,Membrane permeability inhibitor,GABRA4,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA4
7081,etomidate,Membrane permeability inhibitor,GABRA5,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA5
7082,etomidate,Membrane permeability inhibitor,GABRA6,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRA6
7083,etomidate,Membrane permeability inhibitor,GABRB1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB1
7084,etomidate,Membrane permeability inhibitor,GABRB2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB2
7085,etomidate,Membrane permeability inhibitor,GABRB3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRB3
7086,etomidate,Membrane permeability inhibitor,GABRD,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRD
7087,etomidate,Membrane permeability inhibitor,GABRE,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRE
7088,etomidate,Membrane permeability inhibitor,GABRG1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG1
7089,etomidate,Membrane permeability inhibitor,GABRG2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG2
7090,etomidate,Membrane permeability inhibitor,GABRG3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRG3
7091,etomidate,Membrane permeability inhibitor,GABRP,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRP
7092,etomidate,Membrane permeability inhibitor,GABRQ,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,NPUKDXXFDDZOKR-LLVKDONJSA-N,,GABRQ
7093,enflurane,Membrane permeability inhibitor,GABRA1,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA1
7094,enflurane,Membrane permeability inhibitor,GABRA2,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA2
7095,enflurane,Membrane permeability inhibitor,GABRA3,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA3
7096,enflurane,Membrane permeability inhibitor,GABRA4,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA4
7097,enflurane,Membrane permeability inhibitor,GABRA5,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA5
7098,enflurane,Membrane permeability inhibitor,GABRA6,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRA6
7099,enflurane,Membrane permeability inhibitor,GABRB1,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRB1
7100,enflurane,Membrane permeability inhibitor,GABRB2,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRB2
7101,enflurane,Membrane permeability inhibitor,GABRB3,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRB3
7102,enflurane,Membrane permeability inhibitor,GABRD,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRD
7103,enflurane,Membrane permeability inhibitor,GABRE,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRE
7104,enflurane,Membrane permeability inhibitor,GABRG1,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRG1
7105,enflurane,Membrane permeability inhibitor,GABRG2,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRG2
7106,enflurane,Membrane permeability inhibitor,GABRG3,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRG3
7107,enflurane,Membrane permeability inhibitor,GABRP,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRP
7108,enflurane,Membrane permeability inhibitor,GLRA1,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GLRA1
7109,enflurane,Membrane permeability inhibitor,GLRB,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GLRB
7110,enflurane,Membrane permeability inhibitor,GABRQ,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,,GABRQ
7111,etomidate,Membrane permeability inhibitor,GABRA1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA1
7112,etomidate,Membrane permeability inhibitor,GABRA2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA2
7113,etomidate,Membrane permeability inhibitor,GABRA3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA3
7114,etomidate,Membrane permeability inhibitor,GABRA4,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA4
7115,etomidate,Membrane permeability inhibitor,GABRA5,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA5
7116,etomidate,Membrane permeability inhibitor,GABRA6,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRA6
7117,etomidate,Membrane permeability inhibitor,GABRB1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB1
7118,etomidate,Membrane permeability inhibitor,GABRB2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB2
7119,etomidate,Membrane permeability inhibitor,GABRB3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRB3
7120,etomidate,Membrane permeability inhibitor,GABRD,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRD
7121,etomidate,Membrane permeability inhibitor,GABRE,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRE
7122,etomidate,Membrane permeability inhibitor,GABRG1,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG1
7123,etomidate,Membrane permeability inhibitor,GABRG2,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG2
7124,etomidate,Membrane permeability inhibitor,GABRG3,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRG3
7125,etomidate,Membrane permeability inhibitor,GABRP,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRP
7126,etomidate,Membrane permeability inhibitor,GABRQ,CCOC(=O)c1cncn1C(C)c1ccccc1,NPUKDXXFDDZOKR-UHFFFAOYSA-N,,GABRQ
7127,methoxyflurane,Membrane permeability inhibitor,GABRA1,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA1
7128,methoxyflurane,Membrane permeability inhibitor,GABRA2,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA2
7129,methoxyflurane,Membrane permeability inhibitor,GABRA3,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA3
7130,methoxyflurane,Membrane permeability inhibitor,GABRA4,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA4
7131,methoxyflurane,Membrane permeability inhibitor,GABRA5,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA5
7132,methoxyflurane,Membrane permeability inhibitor,GABRA6,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRA6
7133,methoxyflurane,Membrane permeability inhibitor,GABRB1,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRB1
7134,methoxyflurane,Membrane permeability inhibitor,GABRB2,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRB2
7135,methoxyflurane,Membrane permeability inhibitor,GABRB3,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRB3
7136,methoxyflurane,Membrane permeability inhibitor,GABRD,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRD
7137,methoxyflurane,Membrane permeability inhibitor,GABRE,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRE
7138,methoxyflurane,Membrane permeability inhibitor,GABRG1,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRG1
7139,methoxyflurane,Membrane permeability inhibitor,GABRG2,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRG2
7140,methoxyflurane,Membrane permeability inhibitor,GABRG3,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRG3
7141,methoxyflurane,Membrane permeability inhibitor,GABRP,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRP
7142,methoxyflurane,Membrane permeability inhibitor,GLRA1,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GLRA1
7143,methoxyflurane,Membrane permeability inhibitor,GABRQ,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,,GABRQ
7144,aminoguanidine,Nitric oxide synthase inhibitor,NOS2,NNC(N)=N,HAMNKKUPIHEESI-UHFFFAOYSA-N,,NOS2
7145,AR-C133057XX,Nitric oxide synthase inhibitor,NOS2,COc1ccnc(NC2CCN(CC2)C(=O)c2ccc(cc2)C#N)c1,SZUVGMCKKLJAFX-UHFFFAOYSA-N,,NOS2
7146,asymmetrical-dimethylarginine,Nitric oxide synthase inhibitor,NOS2,CN(C)C(=N)NCCC[C@H](N)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,,NOS2
7147,asymmetrical-dimethylarginine,Nitric oxide synthase inhibitor,NOS3,CN(C)C(=N)NCCC[C@H](N)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,,NOS3
7148,diphenyleneiodonium,Nitric oxide synthase inhibitor,NOS2,[I+]1c2ccccc2-c2ccccc12,QFXKXRXFBRLLPQ-UHFFFAOYSA-N,,NOS2
7149,diphenyleneiodonium,Nitric oxide synthase inhibitor,NOS3,[I+]1c2ccccc2-c2ccccc12,QFXKXRXFBRLLPQ-UHFFFAOYSA-N,,NOS3
7150,melatonin,Nitric oxide synthase inhibitor,MTNR1A,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,DRLFMBDRBRZALE-UHFFFAOYSA-N,,MTNR1A
7151,melatonin,Nitric oxide synthase inhibitor,MTNR1B,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,DRLFMBDRBRZALE-UHFFFAOYSA-N,,MTNR1B
7152,proadifen,Nitric oxide synthase inhibitor,NOS1,CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1,SNTQPLDRUZOSDP-UHFFFAOYSA-N,,NOS1
7153,tetrahydrobiopterin,Nitric oxide synthase stimulant,PAH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,PAH
7154,tetrahydrobiopterin,Nitric oxide synthase stimulant,TH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,TH
7155,aminocaproic-acid,Plasminogen activator inhibitor,PLAT,NCCCCCC(O)=O,SLXKOJJOQWFEFD-UHFFFAOYSA-N,,PLAT
7156,aminocaproic-acid,Plasminogen activator inhibitor,PLG,NCCCCCC(O)=O,SLXKOJJOQWFEFD-UHFFFAOYSA-N,,PLG
7157,tranexamic-acid,Plasminogen activator inhibitor,PLG,NC[C@H]1CC[C@@H](CC1)C(O)=O,GYDJEQRTZSCIOI-LJGSYFOKSA-N,,PLG
7158,quercetin,Polar auxin transport inhibitor,PIK3CG,Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O,REFJWTPEDVJJIY-UHFFFAOYSA-N,,PIK3CG
7159,ellagic-acid,Reverse transcriptase inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
7160,ellagic-acid,Reverse transcriptase inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
7161,ellagic-acid,Reverse transcriptase inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
7162,ellagic-acid,Reverse transcriptase inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
7163,ellagic-acid,Reverse transcriptase inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
7164,ellagic-acid,Reverse transcriptase inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
7165,ellagic-acid,Reverse transcriptase inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
7166,ellagic-acid,Reverse transcriptase inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
7167,nevirapine,Reverse transcriptase inhibitor,CYP1A2,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP1A2
7168,nevirapine,Reverse transcriptase inhibitor,CYP2A6,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP2A6
7169,nevirapine,Reverse transcriptase inhibitor,CYP2B6,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP2B6
7170,nevirapine,Reverse transcriptase inhibitor,CYP2C9,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP2C9
7171,nevirapine,Reverse transcriptase inhibitor,CYP2D6,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP2D6
7172,nevirapine,Reverse transcriptase inhibitor,CYP3A4,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP3A4
7173,nevirapine,Reverse transcriptase inhibitor,CYP3A5,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,,CYP3A5
7174,narciclasine,Rho associated kinase activator,RHOA,O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O,LZAZURSABQIKGB-AEKGRLRDSA-N,,RHOA
7175,fasudil,Rho associated kinase inhibitor,ROCK1,O=S(=O)(N1CCCNCC1)c1cccc2cnccc12,NGOGFTYYXHNFQH-UHFFFAOYSA-N,,ROCK1
7176,fasudil,Rho associated kinase inhibitor,ROCK2,O=S(=O)(N1CCCNCC1)c1cccc2cnccc12,NGOGFTYYXHNFQH-UHFFFAOYSA-N,,ROCK2
7177,GSK-429286A,Rho associated kinase inhibitor,ROCK1,CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F,OLIIUAHHAZEXEX-UHFFFAOYSA-N,,ROCK1
7178,hydroxyfasudil,Rho associated kinase inhibitor,ROCK1,Oc1nccc2c(cccc12)S(=O)(=O)N1CCCNCC1,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,,ROCK1
7179,KU-C103428N,Rho associated kinase inhibitor,NFE2,NS(=O)(=O)c1ccc(cc1)N1N=C(CC1c1cccc(Br)c1)c1ccccc1,YTYYWJOOCWVVKJ-UHFFFAOYSA-N,,NFE2
7180,ripasudil,Rho associated kinase inhibitor,ROCK1,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,QSKQVZWVLOIIEV-NSHDSACASA-N,,ROCK1
7181,ripasudil,Rho associated kinase inhibitor,ROCK2,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,QSKQVZWVLOIIEV-NSHDSACASA-N,,ROCK2
7182,RKI-1447,Rho associated kinase inhibitor,ROCK1,Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1,GDVRVPIXWXOKQO-UHFFFAOYSA-N,,ROCK1
7183,RKI-1447,Rho associated kinase inhibitor,ROCK2,Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1,GDVRVPIXWXOKQO-UHFFFAOYSA-N,,ROCK2
7184,sanguinarium-chloride,Rho associated kinase inhibitor,CASP3,C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12,INVGWHRKADIJHF-UHFFFAOYSA-N,,CASP3
7185,Y-27632,Rho associated kinase inhibitor,ROCK1,C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1,IYOZTVGMEWJPKR-IJLUTSLNSA-N,,ROCK1
7186,Y-27632,Rho associated kinase inhibitor,ROCK2,C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1,IYOZTVGMEWJPKR-IJLUTSLNSA-N,,ROCK2
7187,Y-27632,Rho associated kinase inhibitor,ROCK1,CC(N)C1CCC(CC1)C(=O)Nc2ccncc2,IYOZTVGMEWJPKR-UHFFFAOYSA-N,,ROCK1
7188,Y-27632,Rho associated kinase inhibitor,ROCK2,CC(N)C1CCC(CC1)C(=O)Nc2ccncc2,IYOZTVGMEWJPKR-UHFFFAOYSA-N,,ROCK2
7189,Y-39983,Rho associated kinase inhibitor,ROCK1,C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12,JTVBXQAYBIJXRP-SNVBAGLBSA-N,,ROCK1
7190,Y-39983,Rho associated kinase inhibitor,ROCK2,C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12,JTVBXQAYBIJXRP-SNVBAGLBSA-N,,ROCK2
7191,SID-7969543,Steroidogenic factor antagonist,NR5A1,CCOC(=O)C(C)Oc1cccc2c1ccn(CC(=O)Nc1ccc3OCCOc3c1)c2=O,KWMBIIQCLUIHDI-UHFFFAOYSA-N,,NR5A1
7192,BRD-A17664363,Steroidogenic factor antagonist,NR5A1,CCOC(=O)C(C)Oc1cccc2c1ccn(CC(=O)Nc1ccc(OC)cc1)c2=O,CFQXBSFRUQKYQA-UHFFFAOYSA-N,,NR5A1
7193,eltrombopag,Thrombopoietin receptor agonist,MPL,CC1=NN(C(=O)C1=NNc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1,XDXWLKQMMKQXPV-HPNDGRJYSA-N,,MPL
7194,GR-32191,Thromboxane receptor antagonist,TBXA2R,O[C@H]1C[C@H](OCc2ccc(cc2)c3ccccc3)[C@H](CC/C=CCCC(=O)O)[C@H]1N4CCCCC4,GQGRDYWMOPRROR-XUSMOFMBSA-N,,TBXA2R
7195,picotamide,Thromboxane receptor antagonist,TBXA2R,COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1,KYWCWBXGRWWINE-UHFFFAOYSA-N,,TBXA2R
7196,SQ-29548,Thromboxane receptor antagonist,TBXA2R,OC(=O)CCC/C=CCC1C(CNNC(=O)Nc2ccccc2)C3CCC1O3,RJNDVCNWVBWHLY-BHQIHCQQSA-N,,TBXA2R
7197,torasemide,Thromboxane receptor antagonist,SLC12A1,CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1,NGBFQHCMQULJNZ-UHFFFAOYSA-N,,SLC12A1
7198,tafamidis-meglumine,Transthyretin amyloid inhibitor,TTR,OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1,TXEIIPDJKFWEEC-UHFFFAOYSA-N,,TTR
7199,butabindide,Tripeptidyl peptidase inhibitor,TPP2,CCCCNC(=O)C1Cc2ccccc2N1C(=O)C(N)CC,HAQIRIMIVLFYIX-UHFFFAOYSA-N,,TPP2
7200,conivaptan,Vasopressin receptor antagonist,AVPR1A,Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1,IKENVDNFQMCRTR-UHFFFAOYSA-N,,AVPR1A
7201,conivaptan,Vasopressin receptor antagonist,AVPR2,Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1,IKENVDNFQMCRTR-UHFFFAOYSA-N,,AVPR2
7202,mozavaptan,Vasopressin receptor antagonist,AVPR1A,CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12,WRNXUQJJCIZICJ-UHFFFAOYSA-N,,AVPR1A
7203,mozavaptan,Vasopressin receptor antagonist,AVPR1B,CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12,WRNXUQJJCIZICJ-UHFFFAOYSA-N,,AVPR1B
7204,mozavaptan,Vasopressin receptor antagonist,AVPR2,CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12,WRNXUQJJCIZICJ-UHFFFAOYSA-N,,AVPR2
7205,relcovaptan,Vasopressin receptor antagonist,AVPR1A,COc1ccc(cc1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(c2cc(Cl)ccc12)c1ccccc1Cl,CEBYCSRFKCEUSW-NAYZPBBASA-N,,AVPR1A
7206,tolvaptan,Vasopressin receptor antagonist,AVPR1A,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1,GYHCTFXIZSNGJT-UHFFFAOYSA-N,,AVPR1A
7207,tolvaptan,Vasopressin receptor antagonist,AVPR2,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1,GYHCTFXIZSNGJT-UHFFFAOYSA-N,,AVPR2
7208,disulfiram,Aldehyde dehydrogenase inhibitor,ALDH2,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,,ALDH2
7209,GW-9508,Free fatty acid receptor agonist,FFAR1,OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1,DGENZVKCTGIDRZ-UHFFFAOYSA-N,,FFAR1
7210,GW-9508,Free fatty acid receptor agonist,FFAR4,OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1,DGENZVKCTGIDRZ-UHFFFAOYSA-N,,FFAR4
7211,CP-91149,Glycogen phosphorylase inhibitor,PYGL,CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1,HINJNZFCMLSBCI-PKOBYXMFSA-N,,PYGL
7212,dihydrodeoxygedunin,Growth factor receptor activator,NTRK2,CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5,QDBAUJQKYJXHPB-OMRKLITNSA-N,,NTRK2
7213,serotonin,Growth factor receptor activator,HTR1A,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR1A
7214,serotonin,Growth factor receptor activator,HTR1B,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR1B
7215,serotonin,Growth factor receptor activator,HTR1D,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR1D
7216,serotonin,Growth factor receptor activator,HTR2A,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR2A
7217,serotonin,Growth factor receptor activator,HTR2B,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR2B
7218,serotonin,Growth factor receptor activator,HTR2C,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR2C
7219,serotonin,Growth factor receptor activator,HTR3A,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR3A
7220,serotonin,Growth factor receptor activator,HTR4,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR4
7221,serotonin,Growth factor receptor activator,HTR5A,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR5A
7222,serotonin,Growth factor receptor activator,HTR6,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR6
7223,serotonin,Growth factor receptor activator,HTR7,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR7
7224,serotonin,Growth factor receptor activator,HTR3B,[2H]C([2H])([2H])C(=O)NC([2H])([2H])C([2H])([2H])c1c[nH]c2ccc(O)cc12,MVAWJSIDNICKHF-RDEKYTKOSA-N,,HTR3B
7225,serotonin,Growth factor receptor activator,HTR1A,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR1A
7226,serotonin,Growth factor receptor activator,HTR1B,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR1B
7227,serotonin,Growth factor receptor activator,HTR1D,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR1D
7228,serotonin,Growth factor receptor activator,HTR2A,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR2A
7229,serotonin,Growth factor receptor activator,HTR2B,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR2B
7230,serotonin,Growth factor receptor activator,HTR2C,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR2C
7231,serotonin,Growth factor receptor activator,HTR3A,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR3A
7232,serotonin,Growth factor receptor activator,HTR4,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR4
7233,serotonin,Growth factor receptor activator,HTR5A,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR5A
7234,serotonin,Growth factor receptor activator,HTR6,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR6
7235,serotonin,Growth factor receptor activator,HTR7,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR7
7236,serotonin,Growth factor receptor activator,HTR3B,CCCc1c[nH]c2ccc(CS(O)(=O)=O)cc12,WYFJNQLEVJHNQH-UHFFFAOYSA-N,,HTR3B
7237,serotonin,Growth factor receptor activator,HTR1A,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR1A
7238,serotonin,Growth factor receptor activator,HTR1B,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR1B
7239,serotonin,Growth factor receptor activator,HTR1D,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR1D
7240,serotonin,Growth factor receptor activator,HTR2A,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR2A
7241,serotonin,Growth factor receptor activator,HTR2B,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR2B
7242,serotonin,Growth factor receptor activator,HTR2C,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR2C
7243,serotonin,Growth factor receptor activator,HTR3A,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR3A
7244,serotonin,Growth factor receptor activator,HTR4,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR4
7245,serotonin,Growth factor receptor activator,HTR5A,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR5A
7246,serotonin,Growth factor receptor activator,HTR6,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR6
7247,serotonin,Growth factor receptor activator,HTR7,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR7
7248,serotonin,Growth factor receptor activator,HTR3B,NCCc1c[nH]c2ccc(O)cc12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,HTR3B
7249,serotonin,Growth factor receptor activator,HTR1A,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR1A
7250,serotonin,Growth factor receptor activator,HTR1B,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR1B
7251,serotonin,Growth factor receptor activator,HTR1D,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR1D
7252,serotonin,Growth factor receptor activator,HTR2A,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR2A
7253,serotonin,Growth factor receptor activator,HTR2B,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR2B
7254,serotonin,Growth factor receptor activator,HTR2C,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR2C
7255,serotonin,Growth factor receptor activator,HTR3A,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR3A
7256,serotonin,Growth factor receptor activator,HTR4,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR4
7257,serotonin,Growth factor receptor activator,HTR5A,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR5A
7258,serotonin,Growth factor receptor activator,HTR6,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR6
7259,serotonin,Growth factor receptor activator,HTR7,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR7
7260,serotonin,Growth factor receptor activator,HTR3B,NCCc1c[nH]c2ccc(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc12,QALKNDMLQRCLGT-AKFOCJAPSA-N,,HTR3B
7261,danusertib,Growth factor receptor inhibitor,FGFR1,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,FGFR1
7262,danusertib,Growth factor receptor inhibitor,NTRK1,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,NTRK1
7263,danusertib,Growth factor receptor inhibitor,RET,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,RET
7264,danusertib,Growth factor receptor inhibitor,AURKA,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKA
7265,danusertib,Growth factor receptor inhibitor,AURKC,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKC
7266,danusertib,Growth factor receptor inhibitor,AURKB,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,,AURKB
7267,GW-441756,Growth factor receptor inhibitor,NTRK1,Cn1cc(C=C2C(=O)Nc3cccnc23)c2ccccc12,NXNQLECPAXXYTR-UKTHLTGXSA-N,,NTRK1
7268,GW-441756,Growth factor receptor inhibitor,NTRK1,Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,NXNQLECPAXXYTR-UHFFFAOYSA-N,,NTRK1
7269,lestaurtinib,Growth factor receptor inhibitor,FLT3,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
7270,lestaurtinib,Growth factor receptor inhibitor,NTRK1,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
7271,lestaurtinib,Growth factor receptor inhibitor,FLT3,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,FLT3
7272,lestaurtinib,Growth factor receptor inhibitor,NTRK1,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,UIARLYUEJFELEN-DMVVYWCZSA-N,,NTRK1
7273,PHA-848125,Growth factor receptor inhibitor,CDK2,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK2
7274,PHA-848125,Growth factor receptor inhibitor,CDK4,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK4
7275,PHA-848125,Growth factor receptor inhibitor,NTRK1,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,NTRK1
7276,PHA-848125,Growth factor receptor inhibitor,CDK1,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,RXZMYLDMFYNEIM-UHFFFAOYSA-N,,CDK1
7277,BAY-K8644,L-type calcium channel activator,CACNA1C,COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C(F)(F)F)[N+]([O-])=O,ZFLWDHHVRRZMEI-UHFFFAOYSA-N,,CACNA1C
7278,clinofibrate,Lipase clearing factor inhibitor,LPL,CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(OC(C)(CC)C(O)=O)cc1)C(O)=O,BMOVQUBVGICXQN-UHFFFAOYSA-N,,LPL
7279,etofylline-clofibrate,Lipase clearing factor inhibitor,PPARA,Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O,KYAKGJDISSNVPZ-UHFFFAOYSA-N,,PPARA
7280,timofibrate,Lipase clearing factor inhibitor,LPL,CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(O)=O,QSNOWCXXECLALL-UHFFFAOYSA-N,,LPL
7281,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3,O=C1c2ccccc2C(NC2CCCCC2)C1=C/c1ccccc1,XJDKPLZUXCIMIS-HMMYKYKNSA-N,,MAPK3
7282,marimastat,Matrix metalloprotease inhibitor,MMP1,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,,MMP1
7283,marimastat,Matrix metalloprotease inhibitor,MMP2,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,,MMP2
7284,marimastat,Matrix metalloprotease inhibitor,MMP7,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,,MMP7
7285,NSC-405020,Matrix metalloprotease inhibitor,MMP1,CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1,ARDYECYBETXQFD-UHFFFAOYSA-N,,MMP1
7286,BRD-K36038115,Neuropeptide receptor antagonist,NPBWR1,COc1ccc(Oc2c(Cl)cnn(-c3cc(C)cc(C)c3)c2=O)cc1,RTIGBOQZDVBXCO-UHFFFAOYSA-N,,NPBWR1
7287,BRD-K37940862,Neuropeptide receptor antagonist,NPSR1,Cc1c(n2ccccc2[n+]1CC=Cc1ccccc1)P(=S)(c1ccccc1)c1ccccc1,VSWYSDPXUHVQCG-DTQAZKPQSA-N,,NPSR1
7288,BRD-K78883024,Neuropeptide receptor antagonist,NPSR1,Cc1c([n+]2ccccc2n1C)P(=S)(c3ccccc3)c4ccccc4,DHDHZKHTNUDMEA-UHFFFAOYSA-N,,NPSR1
7289,CGP-71683,Neuropeptide receptor antagonist,NPY5R,Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc5ccccc15,UULIGRNKXHCLQN-UHFFFAOYSA-N,,NPY5R
7290,L-152804,Neuropeptide receptor antagonist,NPY5R,CC1(C)CC(=O)C(C2c3ccccc3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1,XQDXIHYKAGHZRX-UHFFFAOYSA-N,,NPY5R
7291,NTNCB,Neuropeptide receptor antagonist,NPY5R,[O-][N+](=O)c1ccccc1S(=O)(=O)NCC2CCC(CNCC3CCc4ccccc4C3)CC2,ISSSVYKMIIAPTH-UHFFFAOYSA-N,,NPY5R
7292,PD-160170,Neuropeptide receptor antagonist,NPY1R,CC(C)c1ccccc1S(=O)(=O)c1cc(N)c2ncccc2c1[N+]([O-])=O,YUVNGBZROXQYQH-UHFFFAOYSA-N,,NPY1R
7293,gestrinone,Progesterone receptor antagonist,ESR1,CC[C@]1(O)CCC2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]12CC,OXHNQTSIKGHVBH-WVVQBRDUSA-N,,ESR1
7294,gestrinone,Progesterone receptor antagonist,AR,CC[C@]1(O)CCC2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]12CC,OXHNQTSIKGHVBH-WVVQBRDUSA-N,,AR
7295,gestrinone,Progesterone receptor antagonist,PGR,CC[C@]1(O)CCC2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]12CC,OXHNQTSIKGHVBH-WVVQBRDUSA-N,,PGR
7296,gestrinone,Progesterone receptor antagonist,ESR1,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-ANULTFPQSA-N,,ESR1
7297,gestrinone,Progesterone receptor antagonist,AR,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-ANULTFPQSA-N,,AR
7298,gestrinone,Progesterone receptor antagonist,PGR,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-ANULTFPQSA-N,,PGR
7299,gestrinone,Progesterone receptor antagonist,ESR1,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-CGXNFDGLSA-N,,ESR1
7300,gestrinone,Progesterone receptor antagonist,AR,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-CGXNFDGLSA-N,,AR
7301,gestrinone,Progesterone receptor antagonist,PGR,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-CGXNFDGLSA-N,,PGR
7302,levonorgestrel,Progesterone receptor antagonist,PGR,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-XUDSTZEESA-N,,PGR
7303,levonorgestrel,Progesterone receptor antagonist,PGR,CC[C@@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-ZWMUSQMVSA-N,,PGR
7304,mifepristone,Progesterone receptor antagonist,NR3C1,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,NR3C1
7305,mifepristone,Progesterone receptor antagonist,AR,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,AR
7306,mifepristone,Progesterone receptor antagonist,PGR,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,PGR
7307,mifepristone,Progesterone receptor antagonist,NR3C1,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,NR3C1
7308,mifepristone,Progesterone receptor antagonist,AR,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,AR
7309,mifepristone,Progesterone receptor antagonist,PGR,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,PGR
7310,mifepristone,Progesterone receptor antagonist,NR3C1,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,NR3C1
7311,mifepristone,Progesterone receptor antagonist,AR,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,AR
7312,mifepristone,Progesterone receptor antagonist,PGR,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,PGR
7313,ulipristal,Progesterone receptor antagonist,PGR,CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,OOLLAFOLCSJHRE-ONBAZCQBSA-N,,PGR
7314,CPI-613,Pyruvate dehydrogenase inhibitor,PDHA1,OC(=O)CCCCC(CCSCc1ccccc1)SCc1ccccc1,ZYRLHJIMTROTBO-UHFFFAOYSA-N,,PDHA1
7315,sobetirome,Thyroid hormone receptor agonist,THRA,CC(C)c1cc(Cc2c(C)cc(OCC(O)=O)cc2C)ccc1O,QNAZTOHXCZPOSA-UHFFFAOYSA-N,,THRA
7316,sobetirome,Thyroid hormone receptor agonist,THRB,CC(C)c1cc(Cc2c(C)cc(OCC(O)=O)cc2C)ccc1O,QNAZTOHXCZPOSA-UHFFFAOYSA-N,,THRB
7317,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2,COc1ccc(CN2CCNCC2)c(OC)c1OC,UHWVSEOVJBQKBE-UHFFFAOYSA-N,,ACAA2
7318,otenzepad,Acetylcholine receptor antagonist,CHRM1,CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12,UBRKDAVQCKZSPO-UHFFFAOYSA-N,,CHRM1
7319,otenzepad,Acetylcholine receptor antagonist,CHRM2,CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12,UBRKDAVQCKZSPO-UHFFFAOYSA-N,,CHRM2
7320,aclidinium,Acetylcholine receptor antagonist,CHRM1,OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1,ASMXXROZKSBQIH-VITNCHFBSA-N,,CHRM1
7321,aclidinium,Acetylcholine receptor antagonist,CHRM2,OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1,ASMXXROZKSBQIH-VITNCHFBSA-N,,CHRM2
7322,aclidinium,Acetylcholine receptor antagonist,CHRM3,OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1,ASMXXROZKSBQIH-VITNCHFBSA-N,,CHRM3
7323,adiphenine,Acetylcholine receptor antagonist,CHRNA1,CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1,JGOAIQNSOGZNBX-UHFFFAOYSA-N,,CHRNA1
7324,aminopentamide,Acetylcholine receptor antagonist,CHRM1,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,NARHAGIVSFTMIG-UHFFFAOYSA-N,,CHRM1
7325,AQ-RA741,Acetylcholine receptor antagonist,CHRM2,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1,BCUGCHZRMKTPMU-UHFFFAOYSA-N,,CHRM2
7326,atropine,Acetylcholine receptor antagonist,CHRM1,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1.CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,NBLUPZBTGKMBNV-BSNGCFTNSA-N,,CHRM1
7327,atropine,Acetylcholine receptor antagonist,CHRM2,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1.CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,NBLUPZBTGKMBNV-BSNGCFTNSA-N,,CHRM2
7328,atropine,Acetylcholine receptor antagonist,CHRM3,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1.CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,NBLUPZBTGKMBNV-BSNGCFTNSA-N,,CHRM3
7329,atropine,Acetylcholine receptor antagonist,CHRM4,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1.CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,NBLUPZBTGKMBNV-BSNGCFTNSA-N,,CHRM4
7330,atropine,Acetylcholine receptor antagonist,CHRM5,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1.CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,NBLUPZBTGKMBNV-BSNGCFTNSA-N,,CHRM5
7331,atropine,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-SPUOUPEWSA-N,,CHRM1
7332,atropine,Acetylcholine receptor antagonist,CHRM2,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-SPUOUPEWSA-N,,CHRM2
7333,atropine,Acetylcholine receptor antagonist,CHRM3,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-SPUOUPEWSA-N,,CHRM3
7334,atropine,Acetylcholine receptor antagonist,CHRM4,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-SPUOUPEWSA-N,,CHRM4
7335,atropine,Acetylcholine receptor antagonist,CHRM5,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-SPUOUPEWSA-N,,CHRM5
7336,atropine,Acetylcholine receptor antagonist,CHRM1,CN1C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-UHFFFAOYSA-N,,CHRM1
7337,atropine,Acetylcholine receptor antagonist,CHRM2,CN1C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-UHFFFAOYSA-N,,CHRM2
7338,atropine,Acetylcholine receptor antagonist,CHRM3,CN1C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-UHFFFAOYSA-N,,CHRM3
7339,atropine,Acetylcholine receptor antagonist,CHRM4,CN1C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-UHFFFAOYSA-N,,CHRM4
7340,atropine,Acetylcholine receptor antagonist,CHRM5,CN1C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,RKUNBYITZUJHSG-UHFFFAOYSA-N,,CHRM5
7341,benzatropine,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(c1ccccc1)c1ccccc1,GIJXKZJWITVLHI-PMOLBWCYSA-N,,CHRM1
7342,benzatropine,Acetylcholine receptor antagonist,CHRM1,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4,GIJXKZJWITVLHI-UHFFFAOYSA-N,,CHRM1
7343,biperiden,Acetylcholine receptor antagonist,CHRM1,OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1,YSXKPIUOCJLQIE-UHFFFAOYSA-N,,CHRM1
7344,biperiden,Acetylcholine receptor antagonist,CHRM1,OC(CCN1CCCCC1)(C2C[C@H]3C[C@@H]2C=C3)c4ccccc4,YSXKPIUOCJLQIE-BDWAOYLISA-N,,CHRM1
7345,BRD-A93048969,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2CC(C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4,STECJAGHUSJQJN-USLFZFAMSA-N,,CHRM1
7346,BRD-A93048969,Acetylcholine receptor antagonist,CHRM2,CN1[C@H]2CC(C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4,STECJAGHUSJQJN-USLFZFAMSA-N,,CHRM2
7347,BRD-A93048969,Acetylcholine receptor antagonist,CHRM3,CN1[C@H]2CC(C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4,STECJAGHUSJQJN-USLFZFAMSA-N,,CHRM3
7348,BRD-A93048969,Acetylcholine receptor antagonist,CHRM4,CN1[C@H]2CC(C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4,STECJAGHUSJQJN-USLFZFAMSA-N,,CHRM4
7349,BRD-K58033748,Acetylcholine receptor antagonist,CHRM1,O=C(CCNS(=O)(=O)c1cccc2nsnc12)N1CCN(CC1)c1ccncc1,WXDHQWPQLKGANZ-UHFFFAOYSA-N,,CHRM1
7350,carisoprodol,Acetylcholine receptor antagonist,CYP2C19,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,,CYP2C19
7351,clidinium,Acetylcholine receptor antagonist,CHRM1,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c1ccccc1)c1ccccc1,HOOSGZJRQIVJSZ-UHFFFAOYSA-N,,CHRM1
7352,darifenacin,Acetylcholine receptor antagonist,CHRM1,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,HXGBXQDTNZMWGS-RUZDIDTESA-N,,CHRM1
7353,darifenacin,Acetylcholine receptor antagonist,CHRM2,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,HXGBXQDTNZMWGS-RUZDIDTESA-N,,CHRM2
7354,darifenacin,Acetylcholine receptor antagonist,CHRM3,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,HXGBXQDTNZMWGS-RUZDIDTESA-N,,CHRM3
7355,darifenacin,Acetylcholine receptor antagonist,CHRM4,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,HXGBXQDTNZMWGS-RUZDIDTESA-N,,CHRM4
7356,darifenacin,Acetylcholine receptor antagonist,CHRM5,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,HXGBXQDTNZMWGS-RUZDIDTESA-N,,CHRM5
7357,DAU-5884,Acetylcholine receptor antagonist,CHRM3,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1Cc2ccccc2NC1=O,NWXCDQHBVVPPTL-WDNDVIMCSA-N,,CHRM3
7358,deltaline,Acetylcholine receptor antagonist,CHRNA7,CCN1C[C@]2(C)CC[C@H](OC)[C@@]34[C@@H]2[C@H](OC(=O)C)[C@@]5(OCO[C@]65C[C@H](OC)[C@H]7C[C@]4(O)[C@@H]6[C@H]7OC)C13,DTTPWCNKTMQMTE-DCRKHLHRSA-N,,CHRNA7
7359,dicycloverine,Acetylcholine receptor antagonist,CHRM1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,CURUTKGFNZGFSE-UHFFFAOYSA-N,,CHRM1
7360,dicycloverine,Acetylcholine receptor antagonist,CHRM2,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,CURUTKGFNZGFSE-UHFFFAOYSA-N,,CHRM2
7361,diphemanil,Acetylcholine receptor antagonist,CHRM3,C[N+]1(C)CCC(CC1)=C(c1ccccc1)c1ccccc1,LCTZPQRFOZKZNK-UHFFFAOYSA-N,,CHRM3
7362,gelsemine,Acetylcholine receptor antagonist,GLRA3,CN1C[C@@]2(C=C)C3CC4OC[C@@H]3[C@@H]1[C@H]2[C@@]45C(=O)Nc6ccccc65,NFYYATWFXNPTRM-KMXOBDGGSA-N,,GLRA3
7363,glycopyrrolate,Acetylcholine receptor antagonist,CHRM1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,,CHRM1
7364,glycopyrrolate,Acetylcholine receptor antagonist,CHRM2,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,,CHRM2
7365,glycopyrrolate,Acetylcholine receptor antagonist,CHRM3,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,,CHRM3
7366,homatropine,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c3ccccc3,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,,CHRM1
7367,homatropine,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1,ZTVIKZXZYLEVOL-QNIGDANOSA-N,,CHRM1
7368,homatropine,Acetylcholine receptor antagonist,CHRM1,CN1C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1,ZTVIKZXZYLEVOL-FGZQJIAISA-N,,CHRM1
7369,homatropine-methylbromide,Acetylcholine receptor antagonist,CHRM5,C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1,WKWOJBUWWZTUQV-JWMHWRSXSA-N,,CHRM5
7370,ipratropium,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+]1(C)[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-ZFWRPDKHSA-N,,CHRM1
7371,ipratropium,Acetylcholine receptor antagonist,CHRM2,CC(C)[N+]1(C)[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-ZFWRPDKHSA-N,,CHRM2
7372,ipratropium,Acetylcholine receptor antagonist,CHRM3,CC(C)[N+]1(C)[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-ZFWRPDKHSA-N,,CHRM3
7373,ipratropium,Acetylcholine receptor antagonist,CHRM4,CC(C)[N+]1(C)[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-ZFWRPDKHSA-N,,CHRM4
7374,ipratropium,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-RHRUOIOWSA-N,,CHRM1
7375,ipratropium,Acetylcholine receptor antagonist,CHRM2,CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-RHRUOIOWSA-N,,CHRM2
7376,ipratropium,Acetylcholine receptor antagonist,CHRM3,CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-RHRUOIOWSA-N,,CHRM3
7377,ipratropium,Acetylcholine receptor antagonist,CHRM4,CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,OEXHQOGQTVQTAT-RHRUOIOWSA-N,,CHRM4
7378,ipratropium,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-QQLIVEQCSA-N,,CHRM1
7379,ipratropium,Acetylcholine receptor antagonist,CHRM2,CC(C)[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-QQLIVEQCSA-N,,CHRM2
7380,ipratropium,Acetylcholine receptor antagonist,CHRM3,CC(C)[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-QQLIVEQCSA-N,,CHRM3
7381,ipratropium,Acetylcholine receptor antagonist,CHRM4,CC(C)[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-QQLIVEQCSA-N,,CHRM4
7382,ipratropium,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-UHFFFAOYSA-N,,CHRM1
7383,ipratropium,Acetylcholine receptor antagonist,CHRM2,CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-UHFFFAOYSA-N,,CHRM2
7384,ipratropium,Acetylcholine receptor antagonist,CHRM3,CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-UHFFFAOYSA-N,,CHRM3
7385,ipratropium,Acetylcholine receptor antagonist,CHRM4,CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1,OEXHQOGQTVQTAT-UHFFFAOYSA-N,,CHRM4
7386,J-104129,Acetylcholine receptor antagonist,CHRM3,CC(=CCCN1CCC(CC1)NC(=O)[C@@](O)(C2CCCC2)c3ccccc3)C,YECZUVJTDYORCB-DEOSSOPVSA-N,,CHRM3
7387,lobelanidine,Acetylcholine receptor antagonist,OPRM1,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,OPRM1
7388,lobelanidine,Acetylcholine receptor antagonist,SLC18A2,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,SLC18A2
7389,lobeline,Acetylcholine receptor antagonist,SLC18A2,CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1,MXYUKLILVYORSK-HBMCJLEFSA-N,,SLC18A2
7390,mebeverine,Acetylcholine receptor antagonist,CHRM1,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,VYVKHNNGDFVQGA-UHFFFAOYSA-N,,CHRM1
7391,mecamylamine,Acetylcholine receptor antagonist,CHRNA2,CNC1(C)C2CCC(C2)C1(C)C,IMYZQPCYWPFTAG-UHFFFAOYSA-N,,CHRNA2
7392,methscopolamine,Acetylcholine receptor antagonist,CHRM1,C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1,LZCOQTDXKCNBEE-RUTJIGONSA-N,,CHRM1
7393,methscopolamine,Acetylcholine receptor antagonist,CHRM2,C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1,LZCOQTDXKCNBEE-RUTJIGONSA-N,,CHRM2
7394,methscopolamine,Acetylcholine receptor antagonist,CHRM3,C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1,LZCOQTDXKCNBEE-RUTJIGONSA-N,,CHRM3
7395,methyllycaconitine,Acetylcholine receptor antagonist,CHRNA7,CCN1CC2(COC(=O)c3ccccc3N4C(=O)CC(C)C4=O)CCC(OC)C5(C6CC7C(OC)C6C(O)(CC7OC)C8(O)C(OC)C52)C18,XLTANAWLDBYGFU-UHFFFAOYSA-N,,CHRNA7
7396,metixene,Acetylcholine receptor antagonist,CHRM5,CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1,MJFJKKXQDNNUJF-UHFFFAOYSA-N,,CHRM5
7397,otilonium,Acetylcholine receptor antagonist,CACNA1C,CCCCCCCCOc1ccccc1C(=O)Nc1ccc(cc1)C(=O)OCC[N+](C)(CC)CC,NQHNLNLJPDMBFN-UHFFFAOYSA-O,,CACNA1C
7398,oxybutynin,Acetylcholine receptor antagonist,CHRM1,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,XIQVNETUBQGFHX-UHFFFAOYSA-N,,CHRM1
7399,oxybutynin,Acetylcholine receptor antagonist,CHRM2,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,XIQVNETUBQGFHX-UHFFFAOYSA-N,,CHRM2
7400,oxybutynin,Acetylcholine receptor antagonist,CHRM3,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,XIQVNETUBQGFHX-UHFFFAOYSA-N,,CHRM3
7401,PD-102807,Acetylcholine receptor antagonist,CHRM4,CCOC(=O)c1c(C)[nH]c2ccc3OC4N(CCc5cc(OC)ccc45)Cc3c12,VDDUJINYXKGZLV-UHFFFAOYSA-N,,CHRM4
7402,piperidolate,Acetylcholine receptor antagonist,CHRM1,CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,,CHRM1
7403,pirenzepine,Acetylcholine receptor antagonist,CHRM1,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1,RMHMFHUVIITRHF-UHFFFAOYSA-N,,CHRM1
7404,propantheline,Acetylcholine receptor antagonist,CHRM1,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc12)C(C)C,VVWYOYDLCMFIEM-UHFFFAOYSA-N,,CHRM1
7405,rocuronium,Acetylcholine receptor antagonist,CHRNA2,CC(=O)O[C@@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,YXRDKMPIGHSVRX-KKBURWSNSA-N,,CHRNA2
7406,scopolamine,Acetylcholine receptor antagonist,CHRM1,C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,GSYQNAMOFFWAPF-XIWXXBRKSA-N,,CHRM1
7407,scopolamine,Acetylcholine receptor antagonist,CHRM2,C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,GSYQNAMOFFWAPF-XIWXXBRKSA-N,,CHRM2
7408,scopolamine,Acetylcholine receptor antagonist,CHRM3,C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,GSYQNAMOFFWAPF-XIWXXBRKSA-N,,CHRM3
7409,scopolamine,Acetylcholine receptor antagonist,CHRM4,C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,GSYQNAMOFFWAPF-XIWXXBRKSA-N,,CHRM4
7410,scopolamine,Acetylcholine receptor antagonist,CHRM1,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-FWXGHANASA-N,,CHRM1
7411,scopolamine,Acetylcholine receptor antagonist,CHRM2,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-FWXGHANASA-N,,CHRM2
7412,scopolamine,Acetylcholine receptor antagonist,CHRM3,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-FWXGHANASA-N,,CHRM3
7413,scopolamine,Acetylcholine receptor antagonist,CHRM4,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-FWXGHANASA-N,,CHRM4
7414,scopolamine,Acetylcholine receptor antagonist,CHRM1,CN1C2C[C@@H](C[C@H]1[C@H]1OC21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-WLQVYHSDSA-N,,CHRM1
7415,scopolamine,Acetylcholine receptor antagonist,CHRM2,CN1C2C[C@@H](C[C@H]1[C@H]1OC21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-WLQVYHSDSA-N,,CHRM2
7416,scopolamine,Acetylcholine receptor antagonist,CHRM3,CN1C2C[C@@H](C[C@H]1[C@H]1OC21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-WLQVYHSDSA-N,,CHRM3
7417,scopolamine,Acetylcholine receptor antagonist,CHRM4,CN1C2C[C@@H](C[C@H]1[C@H]1OC21)OC(=O)[C@H](CO)c1ccccc1,STECJAGHUSJQJN-WLQVYHSDSA-N,,CHRM4
7418,scopolamine,Acetylcholine receptor antagonist,CHRM1,CN1C2CC(CC1C3OC32)OC(=O)C(CO)c4ccccc4,STECJAGHUSJQJN-UHFFFAOYSA-N,,CHRM1
7419,scopolamine,Acetylcholine receptor antagonist,CHRM2,CN1C2CC(CC1C3OC32)OC(=O)C(CO)c4ccccc4,STECJAGHUSJQJN-UHFFFAOYSA-N,,CHRM2
7420,scopolamine,Acetylcholine receptor antagonist,CHRM3,CN1C2CC(CC1C3OC32)OC(=O)C(CO)c4ccccc4,STECJAGHUSJQJN-UHFFFAOYSA-N,,CHRM3
7421,scopolamine,Acetylcholine receptor antagonist,CHRM4,CN1C2CC(CC1C3OC32)OC(=O)C(CO)c4ccccc4,STECJAGHUSJQJN-UHFFFAOYSA-N,,CHRM4
7422,solifenacin,Acetylcholine receptor antagonist,CHRM1,O=C(O[C@H]1CN2CCC1CC2)C1NCc2ccccc2[C@@H]1c1ccccc1,IGCKSKSSHBPKHO-LGTSYYJHSA-N,,CHRM1
7423,solifenacin,Acetylcholine receptor antagonist,CHRM2,O=C(O[C@H]1CN2CCC1CC2)C1NCc2ccccc2[C@@H]1c1ccccc1,IGCKSKSSHBPKHO-LGTSYYJHSA-N,,CHRM2
7424,solifenacin,Acetylcholine receptor antagonist,CHRM3,O=C(O[C@H]1CN2CCC1CC2)C1NCc2ccccc2[C@@H]1c1ccccc1,IGCKSKSSHBPKHO-LGTSYYJHSA-N,,CHRM3
7425,solifenacin-succinate,Acetylcholine receptor antagonist,CHRM1,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,FBOUYBDGKBSUES-VXKWHMMOSA-N,,CHRM1
7426,solifenacin-succinate,Acetylcholine receptor antagonist,CHRM2,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,FBOUYBDGKBSUES-VXKWHMMOSA-N,,CHRM2
7427,solifenacin-succinate,Acetylcholine receptor antagonist,CHRM3,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,FBOUYBDGKBSUES-VXKWHMMOSA-N,,CHRM3
7428,strychnine,Acetylcholine receptor antagonist,GLRA1,O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1c1ccccc61,QMGVPVSNSZLJIA-OFYMUHMXSA-N,,GLRA1
7429,telenzepine,Acetylcholine receptor antagonist,CHRM1,CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc3ccccc23)CC1,VSWPGAIWKHPTKX-UHFFFAOYSA-N,,CHRM1
7430,tiotropium,Acetylcholine receptor antagonist,CHRM3,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1,LERNTVKEWCAPOY-DZZGSBJMSA-N,,CHRM3
7431,tolterodine,Acetylcholine receptor antagonist,CHRM1,CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,,CHRM1
7432,tolterodine,Acetylcholine receptor antagonist,CHRM2,CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,,CHRM2
7433,tolterodine,Acetylcholine receptor antagonist,CHRM3,CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,,CHRM3
7434,tolterodine,Acetylcholine receptor antagonist,CHRM4,CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,,CHRM4
7435,trihexyphenidyl,Acetylcholine receptor antagonist,CHRM1,OC(CCN1CCCCC1)(C1CCCCC1)c1ccccc1,HWHLPVGTWGOCJO-UHFFFAOYSA-N,,CHRM1
7436,tropicamide,Acetylcholine receptor antagonist,CHRM3,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,BGDKAVGWHJFAGW-UHFFFAOYSA-N,,CHRM3
7437,tropicamide,Acetylcholine receptor antagonist,CHRM4,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,BGDKAVGWHJFAGW-UHFFFAOYSA-N,,CHRM4
7438,tubocurarine,Acetylcholine receptor antagonist,CHRNA2,COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7cccc(Oc(c1O)c32)c7)N(C)CCc6cc5OC)c4,MZTXBESCVZFFQE-XLTVJXRZSA-O,,CHRNA2
7439,tubocurarine,Acetylcholine receptor antagonist,HTR3A,COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7cccc(Oc(c1O)c32)c7)N(C)CCc6cc5OC)c4,MZTXBESCVZFFQE-XLTVJXRZSA-O,,HTR3A
7440,tubocurarine,Acetylcholine receptor antagonist,CHRNA2,COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4,JFJZZMVDLULRGK-URLMMPGGSA-O,,CHRNA2
7441,tubocurarine,Acetylcholine receptor antagonist,HTR3A,COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4,JFJZZMVDLULRGK-URLMMPGGSA-O,,HTR3A
7442,umeclidinium,Acetylcholine receptor antagonist,CHRM1,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,FVTWTVQXNAJTQP-UHFFFAOYSA-N,,CHRM1
7443,umeclidinium,Acetylcholine receptor antagonist,CHRM3,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,FVTWTVQXNAJTQP-UHFFFAOYSA-N,,CHRM3
7444,vecuronium,Acetylcholine receptor antagonist,CHRNA2,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@H]3CC[C@@H]4C[C@H](OC(C)=O)[C@H](C[C@@]4(C)[C@@H]3CC[C@@]12C)N1CCCCC1)[N+]1(C)CCCCC1,BGSZAXLLHYERSY-NGQATJDKSA-N,,CHRNA2
7445,vecuronium,Acetylcholine receptor antagonist,CHRNA2,CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(=O)C)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(C)CCCCC6,BGSZAXLLHYERSY-XQIGCQGXSA-N,,CHRNA2
7446,vecuronium,Acetylcholine receptor antagonist,CHRNA2,CC(=O)O[C@H]1[C@H](C[C@H]2[C@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,BGSZAXLLHYERSY-OLDKZTQHSA-N,,CHRNA2
7447,zamifenacin,Acetylcholine receptor antagonist,CHRM3,C(Cc1ccc2OCOc2c1)N1CCC[C@H](C1)OC(c1ccccc1)c1ccccc1,BDNFQGRSKSQXRI-XMMPIXPASA-N,,CHRM3
7448,BRD-K61463582,Aryl hydrocarbon receptor agonist,AHR,Cc1ccc2cc3c(ccc4ccccc43)c5CCc1c52,PPQNQXQZIWHJRB-UHFFFAOYSA-N,,AHR
7449,diosmin,Aryl hydrocarbon receptor agonist,AHR,COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1,GZSOSUNBTXMUFQ-YFAPSIMESA-N,,AHR
7450,methotrexate,Dihydrofolate reductase inhibitor,DHFR,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,,DHFR
7451,pemetrexed,Dihydrofolate reductase inhibitor,DHFR,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,DHFR
7452,pemetrexed,Dihydrofolate reductase inhibitor,GART,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,GART
7453,pemetrexed,Dihydrofolate reductase inhibitor,TYMS,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,TYMS
7454,pemetrexed,Dihydrofolate reductase inhibitor,DHFR,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,DHFR
7455,pemetrexed,Dihydrofolate reductase inhibitor,GART,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,GART
7456,pemetrexed,Dihydrofolate reductase inhibitor,TYMS,Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1,WBXPDJSOTKVWSJ-CYBMUJFWSA-N,,TYMS
7457,pralatrexate,Dihydrofolate reductase inhibitor,DHFR,Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1,OGSBUKJUDHAQEA-WMCAAGNKSA-N,,DHFR
7458,succinylsulfathiazole,Dihydrofolate reductase inhibitor,DHFR,OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1,SKVLYVHULOWXTD-UHFFFAOYSA-N,,DHFR
7459,brexpiprazole,Dopamine receptor partial agonist,DRD2,O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,,DRD2
7460,brexpiprazole,Dopamine receptor partial agonist,HTR1A,O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,,HTR1A
7461,brexpiprazole,Dopamine receptor partial agonist,HTR2A,O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,,HTR2A
7462,DY-131,Estrogen-related receptor agonist,ESR2,CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1,WLKOCYWYAWBGKY-UHFFFAOYSA-N,,ESR2
7463,DY-131,Estrogen-related receptor agonist,ESRRG,CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1,WLKOCYWYAWBGKY-UHFFFAOYSA-N,,ESRRG
7464,ellagic-acid,Glutathione transferase inhibitor,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
7465,ellagic-acid,Glutathione transferase inhibitor,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
7466,ellagic-acid,Glutathione transferase inhibitor,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
7467,ellagic-acid,Glutathione transferase inhibitor,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
7468,ellagic-acid,Glutathione transferase inhibitor,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
7469,ellagic-acid,Glutathione transferase inhibitor,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
7470,ellagic-acid,Glutathione transferase inhibitor,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
7471,ellagic-acid,Glutathione transferase inhibitor,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
7472,BRD-K12401458,Lysophospholipid receptor agonist,S1PR4,COCCN=C1/SC(=C/c2cc(C)n(c2C)-c2ccc(F)cc2F)C(=O)N1C,BKQZKTRCUAWRHT-ZGNGNRKCSA-N,,S1PR4
7473,BRD-K14048378,Lysophospholipid receptor agonist,S1PR3,CCCc1cc(no1)C(=O)N(C2CCCCC2)C3CCCCC3,XTUSMJNHGPASSE-UHFFFAOYSA-N,,S1PR3
7474,BRD-K14236372,Lysophospholipid receptor agonist,S1PR3,Clc1ccc(OCCOc2ccc(Br)nc2Br)c(Cl)c1,KMGUBUXDNOMSRM-UHFFFAOYSA-N,,S1PR3
7475,BRD-K16618170,Lysophospholipid receptor agonist,S1PR3,Cc1ccc(OCCOc2ccc(Cl)cc2Cl)c(Br)n1,AGOUWTBVEAKQIJ-UHFFFAOYSA-N,,S1PR3
7476,SEW-2871,Lysophospholipid receptor agonist,S1PR1,FC(F)(F)c1sc(cc1-c1ccccc1)-c1nc(no1)-c1cccc(c1)C(F)(F)F,OYMNPJXKQVTQTR-UHFFFAOYSA-N,,S1PR1
7477,CGP-57380,MAPK-interacting kinase inhibitor,MKNK1,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,UQPMANVRZYYQMD-UHFFFAOYSA-N,,MKNK1
7478,rotenone,Mitochondrial complex I inhibitor,ND1,COc1cc2OC[C@H]3Oc4c5C[C@@H](Oc5ccc4C(=O)[C@H]3c2cc1OC)C(=C)C,JUVIOZPCNVVQFO-HBGVWJBISA-N,,IVNS1ABP
7479,auraptene,Nitric oxide production inhibitor,MAOB,CC(=CCC/C(=C/COc1ccc2ccc(=O)oc2c1)/C)C,RSDDHGSKLOSQFK-RVDMUPIBSA-N,,MAOB
7480,caffeic-acid,Nitric oxide production inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
7481,caffeic-acid,Nitric oxide production inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
7482,methylene-blue,Nitric oxide production inhibitor,ACHE,CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,RBTBFTRPCNLSDE-UHFFFAOYSA-N,,ACHE
7483,amoxapine,Norepinephrine reputake inhibitor,DRD1,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,DRD1
7484,amoxapine,Norepinephrine reputake inhibitor,DRD2,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,DRD2
7485,amoxapine,Norepinephrine reputake inhibitor,DRD3,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,DRD3
7486,amoxapine,Norepinephrine reputake inhibitor,DRD4,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,DRD4
7487,amoxapine,Norepinephrine reputake inhibitor,HTR2A,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,HTR2A
7488,amoxapine,Norepinephrine reputake inhibitor,HTR6,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,HTR6
7489,amoxapine,Norepinephrine reputake inhibitor,SLC6A2,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,SLC6A2
7490,amoxapine,Norepinephrine reputake inhibitor,SLC6A4,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,QWGDMFLQWFTERH-UHFFFAOYSA-N,,SLC6A4
7491,BTS-54505,Norepinephrine reputake inhibitor,SLC6A2,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A2
7492,BTS-54505,Norepinephrine reputake inhibitor,SLC6A3,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A3
7493,BTS-54505,Norepinephrine reputake inhibitor,SLC6A4,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A4
7494,imipramine,Norepinephrine reputake inhibitor,CHRM2,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,CHRM2
7495,imipramine,Norepinephrine reputake inhibitor,SLC6A2,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,SLC6A2
7496,imipramine,Norepinephrine reputake inhibitor,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccccc12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,,SLC6A4
7497,maprotiline,Norepinephrine reputake inhibitor,SLC6A2,CNCCC[C@]1(CC[C@H]2c3ccccc31)c4ccccc24,QSLMDECMDJKHMQ-GSXCWMCISA-N,,SLC6A2
7498,maprotiline,Norepinephrine reputake inhibitor,SLC6A2,CNCCCC12CCC(c3ccccc13)c1ccccc21,QSLMDECMDJKHMQ-UHFFFAOYSA-N,,SLC6A2
7499,tramadol,Norepinephrine reputake inhibitor,OPRM1,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,OPRM1
7500,tramadol,Norepinephrine reputake inhibitor,SLC6A2,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A2
7501,tramadol,Norepinephrine reputake inhibitor,SLC6A4,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,,SLC6A4
7502,tramadol,Norepinephrine reputake inhibitor,OPRM1,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,OPRM1
7503,tramadol,Norepinephrine reputake inhibitor,SLC6A2,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A2
7504,tramadol,Norepinephrine reputake inhibitor,SLC6A4,COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,,SLC6A4
7505,trimipramine,Norepinephrine reputake inhibitor,SLC6A2,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A2
7506,trimipramine,Norepinephrine reputake inhibitor,SLC6A3,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A3
7507,trimipramine,Norepinephrine reputake inhibitor,SLC6A4,CC(CN(C)C)CN1c2ccccc2CCc2ccccc12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,,SLC6A4
7508,amitriptyline,Norepinephrine reuptake inhibitor,CHRM1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM1
7509,amitriptyline,Norepinephrine reuptake inhibitor,CHRM2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM2
7510,amitriptyline,Norepinephrine reuptake inhibitor,CHRM3,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM3
7511,amitriptyline,Norepinephrine reuptake inhibitor,CHRM4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM4
7512,amitriptyline,Norepinephrine reuptake inhibitor,CHRM5,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,CHRM5
7513,amitriptyline,Norepinephrine reuptake inhibitor,HRH1,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HRH1
7514,amitriptyline,Norepinephrine reuptake inhibitor,HTR6,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,HTR6
7515,amitriptyline,Norepinephrine reuptake inhibitor,SLC6A2,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A2
7516,amitriptyline,Norepinephrine reuptake inhibitor,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,,SLC6A4
7517,dosulepin,Norepinephrine reuptake inhibitor,SLC6A2,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A2
7518,dosulepin,Norepinephrine reuptake inhibitor,SLC6A4,CN(C)CCC=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,,SLC6A4
7519,duloxetine,Norepinephrine reuptake inhibitor,SLC6A2,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A2
7520,duloxetine,Norepinephrine reuptake inhibitor,SLC6A3,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A3
7521,duloxetine,Norepinephrine reuptake inhibitor,SLC6A4,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,,SLC6A4
7522,lofepramine,Norepinephrine reuptake inhibitor,SLC6A2,CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1,SAPNXPWPAUFAJU-UHFFFAOYSA-N,,SLC6A2
7523,lofepramine,Norepinephrine reuptake inhibitor,SLC6A4,CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1,SAPNXPWPAUFAJU-UHFFFAOYSA-N,,SLC6A4
7524,nefazodone,Norepinephrine reuptake inhibitor,HTR2A,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2A
7525,nefazodone,Norepinephrine reuptake inhibitor,HTR2C,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,HTR2C
7526,nefazodone,Norepinephrine reuptake inhibitor,SLC6A2,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A2
7527,nefazodone,Norepinephrine reuptake inhibitor,SLC6A4,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,,SLC6A4
7528,nisoxetine,Norepinephrine reuptake inhibitor,SLC6A2,CNCCC(Oc1ccccc1OC)c1ccccc1,ITJNARMNRKSWTA-UHFFFAOYSA-N,,SLC6A2
7529,venlafaxine,Norepinephrine reuptake inhibitor,SLC6A2,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A2
7530,venlafaxine,Norepinephrine reuptake inhibitor,SLC6A4,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,,SLC6A4
7531,eflornithine,Ornithine decarboxylase inhibitor,ODC1,NCCCC(N)(C(F)F)C(O)=O,VLCYCQAOQCDTCN-UHFFFAOYSA-N,,ODC1
7532,SC-9,Protein tyrosine kinase activator,PRKCA,Clc1cccc2c(cccc12)S(=O)(=O)NCCCCCCc1ccccc1,YUXMTDYHFPRPLG-UHFFFAOYSA-N,,PRKCA
7533,AG-957,Protein tyrosine kinase inhibitor,EGFR,COC(=O)c1ccc(NCc2cc(O)ccc2O)cc1,QSFREBZMBNRGOK-UHFFFAOYSA-N,,EGFR
7534,AG-957,Protein tyrosine kinase inhibitor,ABL1,COC(=O)c1ccc(NCc2cc(O)ccc2O)cc1,QSFREBZMBNRGOK-UHFFFAOYSA-N,,ABL1
7535,malonoben,Protein tyrosine kinase inhibitor,EGFR,CC(C)(C)c1cc(C=C(C#N)[N+]#[C-])cc(c1O)C(C)(C)C,MKUVGSJPVXTADZ-UHFFFAOYSA-N,,EGFR
7536,BRD-K61106942,Pyruvate kinase isozyme activator,PKM,Clc1cccc(NS(=O)(=O)c2ccc3NC(=O)CCc3c2)c1,KQHKZXBKJWOHHU-UHFFFAOYSA-N,,PKM
7537,BRD-K77690805,Pyruvate kinase isozyme activator,PKM,Cc1ccc(NS(=O)(=O)c2ccc3NC(=O)CCc3c2)cc1C,SNFROMRRGGKYTF-UHFFFAOYSA-N,,PKM
7538,varespladib,Secretory phospholipase inhibitor,PLA2G2A,CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1,BHLXTPHDSZUFHR-UHFFFAOYSA-N,,PLA2G2A
7539,LDN-193189,Serine/threonine kinase inhibitor,BMPR1A,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12,CDOVNWNANFFLFJ-UHFFFAOYSA-N,,BMPR1A
7540,LDN-193189,Serine/threonine kinase inhibitor,ACVR1,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12,CDOVNWNANFFLFJ-UHFFFAOYSA-N,,ACVR1
7541,CGP-37157,Sodium/calcium exchange inhibitor,SLC8A1,Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1,KQEPIRKXSUIUTH-UHFFFAOYSA-N,,SLC8A1
7542,KB-R7943,Sodium/calcium exchange inhibitor,SLC8A1,NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1,UMJUNUMSJDTYTM-UHFFFAOYSA-N,,SLC8A1
7543,MK-8245,Stearoyl-CoA desaturase inhibitor,SCD,OC(=O)Cn1nnc(n1)-c1cc(no1)N1CCC(CC1)Oc1cc(F)ccc1Br,UJEAABFSXKCSGI-UHFFFAOYSA-N,,SCD
7544,tipiracil,Thymidine phosphorylase inhibitor,TYMP,Clc1c(CN2CCCC2=N)[nH]c(=O)[nH]c1=O,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,,TYMP
7545,flumazenil,Benzodiazepine receptor antagonist,GABRA1,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA1
7546,flumazenil,Benzodiazepine receptor antagonist,GABRA2,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA2
7547,flumazenil,Benzodiazepine receptor antagonist,GABRA3,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA3
7548,flumazenil,Benzodiazepine receptor antagonist,GABRA4,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA4
7549,flumazenil,Benzodiazepine receptor antagonist,GABRA5,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA5
7550,flumazenil,Benzodiazepine receptor antagonist,GABRA6,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRA6
7551,flumazenil,Benzodiazepine receptor antagonist,GABRB1,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRB1
7552,flumazenil,Benzodiazepine receptor antagonist,GABRB2,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRB2
7553,flumazenil,Benzodiazepine receptor antagonist,GABRB3,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRB3
7554,flumazenil,Benzodiazepine receptor antagonist,GABRD,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRD
7555,flumazenil,Benzodiazepine receptor antagonist,GABRE,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRE
7556,flumazenil,Benzodiazepine receptor antagonist,GABRG1,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRG1
7557,flumazenil,Benzodiazepine receptor antagonist,GABRG2,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRG2
7558,flumazenil,Benzodiazepine receptor antagonist,GABRG3,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRG3
7559,flumazenil,Benzodiazepine receptor antagonist,GABRP,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRP
7560,flumazenil,Benzodiazepine receptor antagonist,GABRQ,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,OFBIFZUFASYYRE-UHFFFAOYSA-N,,GABRQ
7561,PK-11195,Benzodiazepine receptor antagonist,TSPO,CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)-c1ccccc1Cl,RAVIZVQZGXBOQO-UHFFFAOYSA-N,,TSPO
7562,ZK-93426,Benzodiazepine receptor antagonist,GABRA1,CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C,VMDUABMKBUKKPG-UHFFFAOYSA-N,,GABRA1
7563,LDN-212854,Bone morphogenic protein inhibitor,ABL1,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12,BBDGBGOVJPEFBT-UHFFFAOYSA-N,,ABL1
7564,LDN-212854,Bone morphogenic protein inhibitor,RIPK2,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12,BBDGBGOVJPEFBT-UHFFFAOYSA-N,,RIPK2
7565,LDN-212854,Bone morphogenic protein inhibitor,ACVR1,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12,BBDGBGOVJPEFBT-UHFFFAOYSA-N,,ACVR1
7566,torasemide,Electrolyte reabsorption inhibitor,SLC12A1,CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1,NGBFQHCMQULJNZ-UHFFFAOYSA-N,,SLC12A1
7567,taurocholic-acid,G protein-coupled receptor agonist,CEL,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,WBWWGRHZICKQGZ-IECFWMJSSA-N,,CEL
7568,GW-9508,G protein-coupled receptor agonist,FFAR1,OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1,DGENZVKCTGIDRZ-UHFFFAOYSA-N,,FFAR1
7569,GW-9508,G protein-coupled receptor agonist,FFAR4,OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1,DGENZVKCTGIDRZ-UHFFFAOYSA-N,,FFAR4
7570,SB-756050,G protein-coupled receptor agonist,GPBAR1,COc1ccc(cc1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc(OC)c(OC)c1,GJUFPAZNBPFNRI-UHFFFAOYSA-N,,GPBAR1
7571,aminoglutethimide,Glucocorticoid receptor antagonist,CYP11A1,CCC1(CCC(=O)NC1=O)c1ccc(N)cc1,ROBVIMPUHSLWNV-UHFFFAOYSA-N,,CYP11A1
7572,aminoglutethimide,Glucocorticoid receptor antagonist,CYP19A1,CCC1(CCC(=O)NC1=O)c1ccc(N)cc1,ROBVIMPUHSLWNV-UHFFFAOYSA-N,,CYP19A1
7573,levonorgestrel,Glucocorticoid receptor antagonist,PGR,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-XUDSTZEESA-N,,PGR
7574,levonorgestrel,Glucocorticoid receptor antagonist,PGR,CC[C@@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-ZWMUSQMVSA-N,,PGR
7575,mifepristone,Glucocorticoid receptor antagonist,NR3C1,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,NR3C1
7576,mifepristone,Glucocorticoid receptor antagonist,AR,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,AR
7577,mifepristone,Glucocorticoid receptor antagonist,PGR,CC#C[C@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-VBWGZTFCSA-N,,PGR
7578,mifepristone,Glucocorticoid receptor antagonist,NR3C1,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,NR3C1
7579,mifepristone,Glucocorticoid receptor antagonist,AR,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,AR
7580,mifepristone,Glucocorticoid receptor antagonist,PGR,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,VKHAHZOOUSRJNA-GCNJZUOMSA-N,,PGR
7581,mifepristone,Glucocorticoid receptor antagonist,NR3C1,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,NR3C1
7582,mifepristone,Glucocorticoid receptor antagonist,AR,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,AR
7583,mifepristone,Glucocorticoid receptor antagonist,PGR,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC21C)c5ccc(cc5)N(C)C,VKHAHZOOUSRJNA-UHFFFAOYSA-N,,PGR
7584,AGI-5198,Isocitrate dehydrogenase inhibitor,IDH1,Cc1nccn1CC(=O)N(C(C(=O)NC1CCCCC1)c1ccccc1C)c1cccc(F)c1,FNYGWXSATBUBER-UHFFFAOYSA-N,,IDH1
7585,AGI-6780,Isocitrate dehydrogenase inhibitor,IDH2,FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2-c2ccsc2)S(=O)(=O)NC2CC2)c1,CCAWRGNYALGPQH-UHFFFAOYSA-N,,IDH2
7586,oxalomalic-acid,Isocitrate dehydrogenase inhibitor,IDH1,OC(C(C(O)=O)C(=O)C(O)=O)C(O)=O,YILAUJBAPQXZGM-UHFFFAOYSA-N,,IDH1
7587,oxalomalic-acid,Isocitrate dehydrogenase inhibitor,ACO1,OC(C(C(O)=O)C(=O)C(O)=O)C(O)=O,YILAUJBAPQXZGM-UHFFFAOYSA-N,,ACO1
7588,cyanocobalamin,Methylmalonyl CoA mutase stimulant,MMUT,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12,FMCRMSOQAVOHRD-SBGISONWSA-M,,MMUT
7589,cyanocobalamin,Methylmalonyl CoA mutase stimulant,MMUT,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@@H]2N=C1C(C)=C1N=C(C=C3N=C(C(C)=C4[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12,RMRCNWBMXRMIRW-WDJKBINPSA-M,,MMUT
7590,desoxycortone,Mineralocorticoid receptor agonist,NR3C2,C[C@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO,ZESRJSPZRDMNHY-KBAFEORJSA-N,,NR3C2
7591,desoxycortone,Mineralocorticoid receptor agonist,NR3C2,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO,ZESRJSPZRDMNHY-YFWFAHHUSA-N,,NR3C2
7592,fludrocortisone-acetate,Mineralocorticoid receptor agonist,NR3C2,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,SYWHXTATXSMDSB-JORUCDAYSA-N,,NR3C2
7593,ellagic-acid,Quorum sensing signaling modulator,CA14,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA14
7594,ellagic-acid,Quorum sensing signaling modulator,SYK,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,SYK
7595,ellagic-acid,Quorum sensing signaling modulator,CA1,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA1
7596,ellagic-acid,Quorum sensing signaling modulator,CA2,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA2
7597,ellagic-acid,Quorum sensing signaling modulator,CA4,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA4
7598,ellagic-acid,Quorum sensing signaling modulator,CA6,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA6
7599,ellagic-acid,Quorum sensing signaling modulator,CA9,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA9
7600,ellagic-acid,Quorum sensing signaling modulator,CA12,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,AFSDNFLWKVMVRB-UHFFFAOYSA-N,,CA12
7601,ursolic-acid,Quorum sensing signaling modulator,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
7602,ursolic-acid,Quorum sensing signaling modulator,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
7603,ursolic-acid,Quorum sensing signaling modulator,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
7604,ursolic-acid,Quorum sensing signaling modulator,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
7605,cladribine,Ribonucleoside reductase inhibitor,ADA,Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1,PTOAARAWEBMLNO-KVQBGUIXSA-N,,ADA
7606,clofarabine,Ribonucleoside reductase inhibitor,POLA1,Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,WDDPHFBMKLOVOX-AYQXTPAHSA-N,,POLA1
7607,clofarabine,Ribonucleoside reductase inhibitor,RRM1,Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,WDDPHFBMKLOVOX-AYQXTPAHSA-N,,RRM1
7608,clofarabine,Ribonucleoside reductase inhibitor,RRM2,Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,WDDPHFBMKLOVOX-AYQXTPAHSA-N,,RRM2
7609,clofarabine,Ribonucleoside reductase inhibitor,POLA1,Nc1nc(Cl)nc2n(cnc12)C3OC(CO)C(O)C3F,WDDPHFBMKLOVOX-UHFFFAOYSA-N,,POLA1
7610,clofarabine,Ribonucleoside reductase inhibitor,RRM1,Nc1nc(Cl)nc2n(cnc12)C3OC(CO)C(O)C3F,WDDPHFBMKLOVOX-UHFFFAOYSA-N,,RRM1
7611,clofarabine,Ribonucleoside reductase inhibitor,RRM2,Nc1nc(Cl)nc2n(cnc12)C3OC(CO)C(O)C3F,WDDPHFBMKLOVOX-UHFFFAOYSA-N,,RRM2
7612,hydroxyurea,Ribonucleoside reductase inhibitor,RRM1,NC(=O)NO,VSNHCAURESNICA-UHFFFAOYSA-N,,RRM1
7613,hydroxyurea,Ribonucleoside reductase inhibitor,RRM2,NC(=O)NO,VSNHCAURESNICA-UHFFFAOYSA-N,,RRM2
7614,cytarabine,Ribonucleotide reductase inhibitor,POLA1,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,,POLA1
7615,cytarabine,Ribonucleotide reductase inhibitor,POLB,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,,POLB
7616,cytarabine,Ribonucleotide reductase inhibitor,POLA1,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,UHDGCWIWMRVCDJ-XVFCMESISA-N,,POLA1
7617,cytarabine,Ribonucleotide reductase inhibitor,POLB,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,UHDGCWIWMRVCDJ-XVFCMESISA-N,,POLB
7618,cytarabine,Ribonucleotide reductase inhibitor,POLA1,Nc1ccn(C2OC(CO)C(O)C2O)c(=O)n1,UHDGCWIWMRVCDJ-UHFFFAOYSA-N,,POLA1
7619,cytarabine,Ribonucleotide reductase inhibitor,POLB,Nc1ccn(C2OC(CO)C(O)C2O)c(=O)n1,UHDGCWIWMRVCDJ-UHFFFAOYSA-N,,POLB
7620,gemcitabine,Ribonucleotide reductase inhibitor,RRM1,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,SDUQYLNIPVEERB-QPPQHZFASA-N,,RRM1
7621,trimidox,Ribonucleotide reductase inhibitor,RRM1,ONC(=N)c1cc(O)c(O)c(O)c1,MSLJYSGFUMYUDX-UHFFFAOYSA-N,,RRM1
7622,pimavanserin,Serotonin receptor inverse agonist,HTR2A,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,RKEWSXXUOLRFBX-UHFFFAOYSA-N,,HTR2A
7623,RS-56812,Serotonin receptor partial agonist,HTR3A,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc12,ZNAPADWWBWFMCQ-HNNXBMFYSA-N,,HTR3A
7624,RS-67333,Serotonin receptor partial agonist,HTR4,CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1,JBHLYIVFFLNISJ-UHFFFAOYSA-N,,HTR4
7625,RS-67506,Serotonin receptor partial agonist,HTR4,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1,UATDVRSFFGFTAI-UHFFFAOYSA-N,,HTR4
7626,tegaserod,Serotonin receptor partial agonist,HTR2B,CCCCCN=C(/N)NN=Cc1c[nH]c2ccc(OC)cc12,IKBKZGMPCYNSLU-RGVLZGJSSA-N,,HTR2B
7627,tegaserod,Serotonin receptor partial agonist,HTR4,CCCCCN=C(/N)NN=Cc1c[nH]c2ccc(OC)cc12,IKBKZGMPCYNSLU-RGVLZGJSSA-N,,HTR4
7628,hexamethyleneamiloride,Sodium/hydrogen antiport inhibitor,GNRHR,NC(=N)NC(=O)c1nc(Cl)c(nc1N)N2CCCCCC2,RQQJJXVETXFINY-UHFFFAOYSA-N,,GNRHR
7629,hexamethyleneamiloride,Sodium/hydrogen antiport inhibitor,SLC9A1,NC(=N)NC(=O)c1nc(Cl)c(nc1N)N2CCCCCC2,RQQJJXVETXFINY-UHFFFAOYSA-N,,SLC9A1
7630,DU-728,Structural glycoprotein antagonist,ITGA2B,N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O,NNRFRJQMBSBXGO-CIUDSAMLSA-N,,ITGA2B
7631,DU-728,Structural glycoprotein antagonist,ITGB3,N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O,NNRFRJQMBSBXGO-CIUDSAMLSA-N,,ITGB3
7632,tirofiban,Structural glycoprotein antagonist,ITGA2B,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,,ITGA2B
7633,tirofiban,Structural glycoprotein antagonist,ITGB3,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,,ITGB3
7634,GW-3965,ABC transporter expression enhancer,NR1H3,OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,,NR1H3
7635,GW-3965,ABC transporter expression enhancer,NR1H2,OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,,NR1H2
7636,T-0901317,ABC transporter expression enhancer,NR1H3,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H3
7637,T-0901317,ABC transporter expression enhancer,NR1H2,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,SGIWFELWJPNFDH-UHFFFAOYSA-N,,NR1H2
7638,fusaric-acid,Dopamine beta hydroxylase inhibitor,DBH,CCCCc1ccc(nc1)C(=O)O,DGMPVYSXXIOGJY-UHFFFAOYSA-N,,DBH
7639,tunicamycin,GLCNAC phosphotransferase inhibitor,GNPTAB,CC(C)CC=C/C(=O)NC1C(OC2OC(C)C(O)C(O)C2NC(C)=O)OC(CC(O)C2OC(C(O)C2O)n2ccc(=O)[nH]c2=O)C(O)C1O,DBOBJBKGUAJFQX-ALCCZGGFSA-N,,GNPTAB
7640,tunicamycin,GLCNAC phosphotransferase inhibitor,GNPTAB,CC(C)CCCCCCCCC=CC(=O)N[C@H]1[C@H](O[C@@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2NC(C)=O)O[C@H](C[C@@H](O)[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O,YJQCOFNZVFGCAF-WPTOCQRYSA-N,,GNPTAB
7641,curcumin,Histone acetyltransferase inhibitor,PTGS1,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS1
7642,curcumin,Histone acetyltransferase inhibitor,PTGS2,COc1cc(ccc1O)C=CC(=O)CC(=O)C=Cc1ccc(O)c(OC)c1,VFLDPWHFBUODDF-FCXRPNKRSA-N,,PTGS2
7643,curcumin,Histone acetyltransferase inhibitor,PTGS1,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS1
7644,curcumin,Histone acetyltransferase inhibitor,PTGS2,COc1ccc(/C=C/C(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-OAMUUVBCSA-N,,PTGS2
7645,curcumin,Histone acetyltransferase inhibitor,PTGS1,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS1
7646,curcumin,Histone acetyltransferase inhibitor,PTGS2,COc1ccc(C=CC(=O)CC(=O)C=Cc2cccc(O)c2OC)cc1O,VZMSCIKIANDZNI-UHFFFAOYSA-N,,PTGS2
7647,TNP-470,Methionine aminopeptidase inhibitor,METAP2,CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl,MSHZHSPISPJWHW-MIQCOGSQSA-N,,METAP2
7648,fumagillin,Methionine aminopeptidase inhibitor,METAP2,CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)C=CC=CC=CC=CC(O)=O,NGGMYCMLYOUNGM-ZVVCMXCESA-N,,METAP2
7649,ML-7,Myosin light chain kinase inhibitor,MYLK,Ic1cccc2c(cccc12)S(=O)(=O)N3CCCNCC3,GEHJIACZUFWBTK-UHFFFAOYSA-N,,MYLK
7650,sulforaphane,Aryl hydrocarbon receptor antagonist,NFE2L2,CS(=O)CCCCN=C=S,SUVMJBTUFCVSAD-UHFFFAOYSA-N,,NFE2L2
7651,BML-190,Cannabinoid receptor inverse agonist,CNR2,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)N3CCOCC3)c2c1,BJSDNVVWJYDOLK-UHFFFAOYSA-N,,CNR2
7652,JTE-907,Cannabinoid receptor inverse agonist,CNR2,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12,GRAJFFFXJYFVOC-UHFFFAOYSA-N,,CNR2
7653,SR-144528,Cannabinoid receptor inverse agonist,CNR2,Cc1ccc(Cn2nc(cc2-c2ccc(Cl)c(C)c2)C(=O)N[C@H]2[C@]3(C)CC[C@H](C3)C2(C)C)cc1,SUGVYNSRNKFXQM-SGNYCRIWSA-N,,CNR2
7654,taranabant,Cannabinoid receptor inverse agonist,CNR1,C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc1ccc(Cl)cc1)c1cccc(c1)C#N,QLYKJCMUNUWAGO-GAJHUEQPSA-N,,CNR1
7655,BAY-59-3074,Cannabinoid receptor partial agonist,CNR1,FC(F)(F)CCCS(=O)(=O)Oc1cccc(Oc2cccc(c2C#N)C(F)(F)F)c1,LWUSZIVDPJPVBW-UHFFFAOYSA-N,,CNR1
7656,BAY-59-3074,Cannabinoid receptor partial agonist,CNR2,FC(F)(F)CCCS(=O)(=O)Oc1cccc(Oc2cccc(c2C#N)C(F)(F)F)c1,LWUSZIVDPJPVBW-UHFFFAOYSA-N,,CNR2
7657,narciclasine,Coflilin signaling pathway activator,RHOA,O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O,LZAZURSABQIKGB-AEKGRLRDSA-N,,RHOA
7658,sulfaphenazole,Dihydropteroate synthetase inhibitor,DHPS,Nc1ccc(cc1)S(=O)(=O)Nc1ccnn1-c1ccccc1,QWCJHSGMANYXCW-UHFFFAOYSA-N,,DHPS
7659,SCH-202676,G protein-coupled receptor modulator,CHRM1,CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1,FFUBTEITUNMMOK-UHFFFAOYSA-N,,CHRM1
7660,SCH-202676,G protein-coupled receptor modulator,CHRM2,CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1,FFUBTEITUNMMOK-UHFFFAOYSA-N,,CHRM2
7661,SCH-202676,G protein-coupled receptor modulator,DRD1,CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1,FFUBTEITUNMMOK-UHFFFAOYSA-N,,DRD1
7662,SCH-202676,G protein-coupled receptor modulator,DRD2,CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1,FFUBTEITUNMMOK-UHFFFAOYSA-N,,DRD2
7663,GSK-J4,Histone lysine demethylase inhibitor,KDM6B,CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1,WBKCKEHGXNWYMO-UHFFFAOYSA-N,,KDM6B
7664,GSK-J4,Histone lysine demethylase inhibitor,KDM6A,CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1,WBKCKEHGXNWYMO-UHFFFAOYSA-N,,KDM6A
7665,OG-L002,Histone lysine demethylase inhibitor,KDM1A,N[C@H]1C[C@@H]1c1ccc(cc1)-c1cccc(O)c1,DSOJSZXQRJGBCW-CABCVRRESA-N,,KDM1A
7666,XMD-1150,Leucine rich repeat kinase inhibitor,LRRK2,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1,IWMCPJZTADUIFX-UHFFFAOYSA-N,,LRRK2
7667,XMD-885,Leucine rich repeat kinase inhibitor,LRRK2,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,DDTPGANIPBKTNU-UHFFFAOYSA-N,,LRRK2
7668,XMD-885,Leucine rich repeat kinase inhibitor,MAPK7,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,DDTPGANIPBKTNU-UHFFFAOYSA-N,,MAPK7
7669,GW-5074,Leucine rich repeat kinase inhibitor,RAF1,Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br,LMXYVLFTZRPNRV-UHFFFAOYSA-N,,RAF1
7670,GW-5074,Leucine rich repeat kinase inhibitor,RAF1,Oc1c(Br)cc(cc1Br)C=C1/C(=O)Nc2ccc(I)cc12,LMXYVLFTZRPNRV-KMKOMSMNSA-N,,RAF1
7671,JTE-013,Lysophospholipid receptor antagonist,S1PR2,CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc2n(C)nc(C)c12,RNSLRQNDXRSASX-UHFFFAOYSA-N,,S1PR2
7672,atomoxetine,Norepinephrine transporter inhibitor,SLC6A2,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,VHGCDTVCOLNTBX-QGZVFWFLSA-N,,SLC6A2
7673,atomoxetine,Norepinephrine transporter inhibitor,SLC6A3,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,VHGCDTVCOLNTBX-QGZVFWFLSA-N,,SLC6A3
7674,atomoxetine,Norepinephrine transporter inhibitor,SLC6A4,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,VHGCDTVCOLNTBX-QGZVFWFLSA-N,,SLC6A4
7675,indatraline,Norepinephrine transporter inhibitor,MAOA,CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1,SVFXPTLYMIXFRX-XJKSGUPXSA-N,,MAOA
7676,indatraline,Norepinephrine transporter inhibitor,MAOB,CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1,SVFXPTLYMIXFRX-XJKSGUPXSA-N,,MAOB
7677,amoxicillin,Penicillin binding protein inhibitor,CYP2C19,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,,CYP2C19
7678,amoxicillin,Penicillin binding protein inhibitor,SLC15A1,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,,SLC15A1
7679,amoxicillin,Penicillin binding protein inhibitor,SLC15A2,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,,SLC15A2
7680,amoxicillin,Penicillin binding protein inhibitor,SLC22A6,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,,SLC22A6
7681,licarbazepine,Voltage-gated sodium channel blocker,SCN5A,NC(=O)N1c2ccccc2CC(O)c2ccccc12,BMPDWHIDQYTSHX-UHFFFAOYSA-N,,SCN5A
7682,rufinamide,Voltage-gated sodium channel blocker,SCN1A,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,POGQSBRIGCQNEG-UHFFFAOYSA-N,,SCN1A
7683,rufinamide,Voltage-gated sodium channel blocker,SCN3A,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,POGQSBRIGCQNEG-UHFFFAOYSA-N,,SCN3A
7684,rufinamide,Voltage-gated sodium channel blocker,SCN9A,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,POGQSBRIGCQNEG-UHFFFAOYSA-N,,SCN9A
7685,tolperisone,Voltage-gated sodium channel blocker,CYP2C19,CC(CN1CCCCC1)C(=O)c1ccc(C)cc1,FSKFPVLPFLJRQB-UHFFFAOYSA-N,,CYP2C19
7686,tolperisone,Voltage-gated sodium channel blocker,CYP2D6,CC(CN1CCCCC1)C(=O)c1ccc(C)cc1,FSKFPVLPFLJRQB-UHFFFAOYSA-N,,CYP2D6
7687,valproic-acid,Voltage-gated sodium channel blocker,ABAT,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ABAT
7688,valproic-acid,Voltage-gated sodium channel blocker,HDAC1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,HDAC1
7689,valproic-acid,Voltage-gated sodium channel blocker,SCN1A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN1A
7690,valproic-acid,Voltage-gated sodium channel blocker,SCN3A,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,SCN3A
7691,valproic-acid,Voltage-gated sodium channel blocker,ALDH5A1,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,,ALDH5A1
7692,mepireserpate,Catecholamine depleting sympatholytic,SLC18A1,COC1C(CC2CN3CCc4c([nH]c5cc(OC)ccc45)C3CC2C1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,QEVHRUUCFGRFIF-UHFFFAOYSA-N,,SLC18A1
7693,mepireserpate,Catecholamine depleting sympatholytic,SLC18A2,COC1C(CC2CN3CCc4c([nH]c5cc(OC)ccc45)C3CC2C1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,QEVHRUUCFGRFIF-UHFFFAOYSA-N,,SLC18A2
7694,trifluridine,DNA directed DNA polymerase inhibitor,TYMS,OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,,TYMS
7695,trifluridine,DNA directed DNA polymerase inhibitor,TYMS,OC[C@H]1OC(C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F,VSQQQLOSPVPRAZ-GFCOJPQKSA-N,,TYMS
7696,quinine,Hemozoin biocrystallization inhibitor,KCNN4,COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-AFHBHXEDSA-N,,KCNN4
7697,quinine,Hemozoin biocrystallization inhibitor,KCNN4,COc1ccc2nccc([C@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-FEBSWUBLSA-N,,KCNN4
7698,quinine,Hemozoin biocrystallization inhibitor,KCNN4,COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-WZBLMQSHSA-N,,KCNN4
7699,indoximod,"Indoleamine 2,3-dioxygenase inhibitor",IDO1,Cn1cc(C[C@@H](N)C(O)=O)c2ccccc12,ZADWXFSZEAPBJS-SNVBAGLBSA-N,,IDO1
7700,canrenone,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CC[C@@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@H]1CC[C@@]21CCC(=O)O1,UJVLDDZCTMKXJK-DHNHVGITSA-N,,NR3C2
7701,canrenone,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]21CCC(=O)O1,UJVLDDZCTMKXJK-GMTJQTPWSA-N,,NR3C2
7702,drospirenone,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,METQSPRSQINEEU-HXCATZOESA-N,,NR3C2
7703,drospirenone,Mineralocorticoid receptor antagonist,PGR,C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,METQSPRSQINEEU-HXCATZOESA-N,,PGR
7704,drospirenone,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CCC3C([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)C1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,METQSPRSQINEEU-GGORKCOASA-N,,NR3C2
7705,drospirenone,Mineralocorticoid receptor antagonist,PGR,C[C@]12CCC3C([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)C1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,METQSPRSQINEEU-GGORKCOASA-N,,PGR
7706,potassium-canrenoate,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O,PBKZPPIHUVSDNM-WNHSNXHDSA-N,,NR3C2
7707,potassium-canrenoate,Mineralocorticoid receptor antagonist,NR3C2,C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]2(O)CCC(O)=O,PBKZPPIHUVSDNM-GMTJQTPWSA-N,,NR3C2
7708,spironolactone,Mineralocorticoid receptor antagonist,NR3C2,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@H]2CC[C@@]3(C)[C@H](CC[C@@]33CCC(=O)O3)[C@H]12,LXMSZDCAJNLERA-WMSBGFBQSA-N,,NR3C2
7709,spironolactone,Mineralocorticoid receptor antagonist,NR3C2,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12,LXMSZDCAJNLERA-ZHYRCANASA-N,,NR3C2
7710,spironolactone,Mineralocorticoid receptor antagonist,NR3C2,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)C12,LXMSZDCAJNLERA-SRFJPPJVSA-N,,NR3C2
7711,sapropterin,Phenylalanine 4-hydroxylase stimulant,PAH,C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1,FNKQXYHWGSIFBK-RPDRRWSUSA-N,,PAH
7712,sapropterin,Phenylalanine 4-hydroxylase stimulant,TH,C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1,FNKQXYHWGSIFBK-RPDRRWSUSA-N,,TH
7713,tetrahydrobiopterin,Phenylalanine 4-hydroxylase stimulant,PAH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,PAH
7714,tetrahydrobiopterin,Phenylalanine 4-hydroxylase stimulant,TH,CC(O)[C@H](O)C1CNc2nc(N)[nH]c(=O)c2N1,FNKQXYHWGSIFBK-DGZDMUDUSA-N,,TH
7715,bazedoxifene,Selective estrogen receptor modulator,ESR1,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,UCJGJABZCDBEDK-UHFFFAOYSA-N,,ESR1
7716,raloxifene,Selective estrogen receptor modulator,ESR1,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,GZUITABIAKMVPG-UHFFFAOYSA-N,,ESR1
7717,raloxifene,Selective estrogen receptor modulator,ESR2,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,GZUITABIAKMVPG-UHFFFAOYSA-N,,ESR2
7718,tamoxifen,Selective estrogen receptor modulator,ESR1,CC/C(=C(c1ccc(O)cc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3,TXUZVZSFRXZGTL-QPLCGJKRSA-N,,ESR1
7719,tamoxifen,Selective estrogen receptor modulator,ESR2,CC/C(=C(c1ccc(O)cc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3,TXUZVZSFRXZGTL-QPLCGJKRSA-N,,ESR2
7720,tamoxifen,Selective estrogen receptor modulator,ESR1,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,NKANXQFJJICGDU-QPLCGJKRSA-N,,ESR1
7721,tamoxifen,Selective estrogen receptor modulator,ESR2,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,NKANXQFJJICGDU-QPLCGJKRSA-N,,ESR2
7722,tamoxifen,Selective estrogen receptor modulator,ESR1,CCC(=C(c1ccccc1)c2ccc(OCCN(C)C)cc2)c3ccccc3,NKANXQFJJICGDU-UHFFFAOYSA-N,,ESR1
7723,tamoxifen,Selective estrogen receptor modulator,ESR2,CCC(=C(c1ccccc1)c2ccc(OCCN(C)C)cc2)c3ccccc3,NKANXQFJJICGDU-UHFFFAOYSA-N,,ESR2
7724,toremifene,Selective estrogen receptor modulator,ESR1,CN(C)CCOc1ccc(cc1)C(c1ccccc1)=C(CCCl)c1ccccc1,XFCLJVABOIYOMF-QPLCGJKRSA-N,,ESR1
7725,toremifene,Selective estrogen receptor modulator,ESR1,CN(C)CCOc1ccc(cc1)C(=C(/CCCl)c1ccccc1)c1ccccc1,XFCLJVABOIYOMF-OCEACIFDSA-N,,ESR1
7726,toremifene,Selective estrogen receptor modulator,ESR1,CN(C)CCOc1ccc(cc1)C(=C(CCCl)c1ccccc1)c1ccccc1,XFCLJVABOIYOMF-UHFFFAOYSA-N,,ESR1
7727,tianeptine,Selective serotonin reuptake enhancer,OPRD1,CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,,OPRD1
7728,tianeptine,Selective serotonin reuptake enhancer,OPRK1,CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,,OPRK1
7729,tianeptine,Selective serotonin reuptake enhancer,OPRM1,CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,,OPRM1
7730,tianeptine,Selective serotonin reuptake enhancer,SLC6A4,CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,,SLC6A4
7731,NSC-632839,Ubiquitin specific protease inhibitor,SENP2,Cc1ccc(/C=C/2CNC/C(=C/c3ccc(C)cc3)/C2=O)cc1,PKCYYPHSCUSQDK-UHWBUFEVSA-N,,SENP2
7732,NSC-632839,Ubiquitin specific protease inhibitor,USP1,Cc1ccc(/C=C/2CNC/C(=C/c3ccc(C)cc3)/C2=O)cc1,PKCYYPHSCUSQDK-UHWBUFEVSA-N,,USP1
7733,NSC-632839,Ubiquitin specific protease inhibitor,USP7,Cc1ccc(/C=C/2CNC/C(=C/c3ccc(C)cc3)/C2=O)cc1,PKCYYPHSCUSQDK-UHWBUFEVSA-N,,USP7
7734,NSC-632839,Ubiquitin specific protease inhibitor,USP2,Cc1ccc(/C=C/2CNC/C(=C/c3ccc(C)cc3)/C2=O)cc1,PKCYYPHSCUSQDK-UHWBUFEVSA-N,,USP2
7735,NSC-632839,Ubiquitin specific protease inhibitor,SENP2,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,PKCYYPHSCUSQDK-UHFFFAOYSA-N,,SENP2
7736,NSC-632839,Ubiquitin specific protease inhibitor,USP1,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,PKCYYPHSCUSQDK-UHFFFAOYSA-N,,USP1
7737,NSC-632839,Ubiquitin specific protease inhibitor,USP7,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,PKCYYPHSCUSQDK-UHFFFAOYSA-N,,USP7
7738,NSC-632839,Ubiquitin specific protease inhibitor,USP2,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,PKCYYPHSCUSQDK-UHFFFAOYSA-N,,USP2
7739,NSC-632839,Ubiquitin specific protease inhibitor,SENP2,Cc1ccc(cc1)C=C1/CNCC(C1=O)=C/c1ccc(C)cc1,PKCYYPHSCUSQDK-AYKLPDECSA-N,,SENP2
7740,NSC-632839,Ubiquitin specific protease inhibitor,USP1,Cc1ccc(cc1)C=C1/CNCC(C1=O)=C/c1ccc(C)cc1,PKCYYPHSCUSQDK-AYKLPDECSA-N,,USP1
7741,NSC-632839,Ubiquitin specific protease inhibitor,USP7,Cc1ccc(cc1)C=C1/CNCC(C1=O)=C/c1ccc(C)cc1,PKCYYPHSCUSQDK-AYKLPDECSA-N,,USP7
7742,NSC-632839,Ubiquitin specific protease inhibitor,USP2,Cc1ccc(cc1)C=C1/CNCC(C1=O)=C/c1ccc(C)cc1,PKCYYPHSCUSQDK-AYKLPDECSA-N,,USP2
7743,omecamtiv-mecarbil,Unidentified pharmacological activity,MYBPC3,COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,RFUBTTPMWSKEIW-UHFFFAOYSA-N,,MYBPC3
7744,carglumic-acid,Carbamoyl phosphate synthase activator,CPS1,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,LCQLHJZYVOQKHU-VKHMYHEASA-N,,CPS1
7745,entacapone,Catechol O methyltransferase inhibitor,COMT,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c(c1)[N+]([O-])=O,JRURYQJSLYLRLN-BJMVGYQFSA-N,,COMT
7746,entacapone,Catechol O methyltransferase inhibitor,COMT,CCN(CC)C(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C#N,JRURYQJSLYLRLN-UHFFFAOYSA-N,,COMT
7747,purpurogallin,Catechol O methyltransferase inhibitor,BCL2L1,Oc1cc2cccc(O)c(=O)c2c(O)c1O,WDGFFVCWBZVLCE-UHFFFAOYSA-N,,BCL2L1
7748,tolcapone,Catechol O methyltransferase inhibitor,COMT,Cc1ccc(cc1)C(=O)c1cc(O)c(O)c(c1)[N+]([O-])=O,MIQPIUSUKVNLNT-UHFFFAOYSA-N,,COMT
7749,KU-0060648,DNA dependent protein kinase inhibitor,PIK3CA,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CA
7750,KU-0060648,DNA dependent protein kinase inhibitor,PIK3CB,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CB
7751,KU-0060648,DNA dependent protein kinase inhibitor,PIK3CD,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PIK3CD
7752,KU-0060648,DNA dependent protein kinase inhibitor,PRKDC,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1,AATCBLYHOUOCTO-UHFFFAOYSA-N,,PRKDC
7753,LY-294002,DNA dependent protein kinase inhibitor,MTOR,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,MTOR
7754,LY-294002,DNA dependent protein kinase inhibitor,PIK3CA,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CA
7755,LY-294002,DNA dependent protein kinase inhibitor,PIK3CB,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CB
7756,LY-294002,DNA dependent protein kinase inhibitor,PIK3CD,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CD
7757,LY-294002,DNA dependent protein kinase inhibitor,PIK3CG,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PIK3CG
7758,LY-294002,DNA dependent protein kinase inhibitor,PLK1,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PLK1
7759,LY-294002,DNA dependent protein kinase inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,PRKDC
7760,NU-1025,DNA dependent protein kinase inhibitor,PARP1,Cc1nc2c(O)cccc2c(=O)[nH]1,YJDAOHJWLUNFLX-UHFFFAOYSA-N,,PARP1
7761,NU-7026,DNA dependent protein kinase inhibitor,PRKDC,O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1,KKTZALUTXUZPSN-UHFFFAOYSA-N,,PRKDC
7762,NU-7441,DNA dependent protein kinase inhibitor,PRKDC,O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1,JAMULYFATHSZJM-UHFFFAOYSA-N,,PRKDC
7763,VAMA-37,DNA dependent protein kinase inhibitor,PRKDC,Oc1cc(ccc1C(=O)c2ccccc2)N3CCOCC3,FALILNHGILFDLC-UHFFFAOYSA-N,,PRKDC
7764,brequinar,Dihydroorotate dehydrogenase inhibitor,DHODH,Cc1c(nc2ccc(F)cc2c1C(O)=O)-c1ccc(cc1)-c1ccccc1F,PHEZJEYUWHETKO-UHFFFAOYSA-N,,DHODH
7765,leflunomide,Dihydroorotate dehydrogenase inhibitor,DHODH,Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F,VHOGYURTWQBHIL-UHFFFAOYSA-N,,DHODH
7766,SC-12267,Dihydroorotate dehydrogenase inhibitor,DHODH,COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1,XPRDUGXOWVXZLL-UHFFFAOYSA-N,,DHODH
7767,SC-12267,Dihydroorotate dehydrogenase inhibitor,IL17A,COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1,XPRDUGXOWVXZLL-UHFFFAOYSA-N,,IL17A
7768,teriflunomide,Dihydroorotate dehydrogenase inhibitor,DHODH,CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F,NABQBYDEMLGCEO-UHFFFAOYSA-N,,DHODH
7769,SB-743921,Kinesin-like spindle protein inhibitor,KIF11,CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1,PGXYIBJJCLWJST-MUUNZHRXSA-N,,KIF11
7770,escitalopram,Selective serotonin reuptake inhibitor,SLC6A4,CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1,WSEQXVZVJXJVFP-FQEVSTJZSA-N,,SLC6A4
7771,fluoxetine,Selective serotonin reuptake inhibitor,SLC6A4,CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,,SLC6A4
7772,fluvoxamine,Selective serotonin reuptake inhibitor,SLC6A4,COCCCCC(c1ccc(cc1)C(F)(F)F)=N/OCCN,CJOFXWAVKWHTFT-XSFVSMFZSA-N,,SLC6A4
7773,fluvoxamine,Selective serotonin reuptake inhibitor,SLC6A4,COCCCCC(c1ccc(cc1)C(F)(F)F)=NOCCN,CJOFXWAVKWHTFT-ZHZULCJRSA-N,,SLC6A4
7774,fluvoxamine,Selective serotonin reuptake inhibitor,SLC6A4,COCCCCC(=NOCCN)c1ccc(cc1)C(F)(F)F,CJOFXWAVKWHTFT-UHFFFAOYSA-N,,SLC6A4
7775,paroxetine,Selective serotonin reuptake inhibitor,SLC6A4,CN1CC[C@H]([C@H](COc2ccc3OCOc3c2)C1)c1ccc(F)cc1,MOJZPKOBKCXNKG-YJBOKZPZSA-N,,SLC6A4
7776,paroxetine,Selective serotonin reuptake inhibitor,SLC6A4,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1,AHOUBRCZNHFOSL-YOEHRIQHSA-N,,SLC6A4
7777,paroxetine,Selective serotonin reuptake inhibitor,SLC6A4,Fc1ccc(cc1)C2CCNCC2COc3ccc4OCOc4c3,AHOUBRCZNHFOSL-UHFFFAOYSA-N,,SLC6A4
7778,canagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A1,Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,,SLC5A1
7779,canagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A2,Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,,SLC5A2
7780,dapagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A2,CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc1,JVHXJTBJCFBINQ-MJCUULBUSA-N,,SLC5A2
7781,empagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A2,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1,OBWASQILIWPZMG-QZMOQZSNSA-N,,SLC5A2
7782,ertugliflozin,Sodium/glucose cotransporter inhibitor,SLC5A2,CCOc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1,MCIACXAZCBVDEE-VNXMGFANSA-N,,SLC5A2
7783,phlorizin,Sodium/glucose cotransporter inhibitor,SLC5A1,OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H](O)[C@@H]1O,IOUVKUPGCMBWBT-BVJIBDCISA-N,,SLC5A1
7784,phlorizin,Sodium/glucose cotransporter inhibitor,SLC5A2,OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H](O)[C@@H]1O,IOUVKUPGCMBWBT-BVJIBDCISA-N,,SLC5A2
7785,sotagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A1,CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1,QKDRXGFQVGOQKS-CRSSMBPESA-N,,SLC5A1
7786,sotagliflozin,Sodium/glucose cotransporter inhibitor,SLC5A2,CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1,QKDRXGFQVGOQKS-CRSSMBPESA-N,,SLC5A2
7787,bumetanide,Solute carrier family member inhibitor,SLC12A1,CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,,SLC12A1
7788,bumetanide,Solute carrier family member inhibitor,SLC12A2,CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,,SLC12A2
7789,NSC-697923,Ubiquitin-conjugating enzyme inhibitor,UBE2N,Cc1ccc(cc1)S(=O)(=O)c1ccc(o1)[N+]([O-])=O,GAUHIPWCDXOLCZ-UHFFFAOYSA-N,,UBE2N
7790,lobelanidine,Vesicular monoamine transporter ligand,OPRM1,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,OPRM1
7791,lobelanidine,Vesicular monoamine transporter ligand,SLC18A2,CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3,OWGJQNXIWMMDTH-UHFFFAOYSA-N,,SLC18A2
7792,BTS-54505,Adrenergic transmitter uptake inhibitor,SLC6A2,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A2
7793,BTS-54505,Adrenergic transmitter uptake inhibitor,SLC6A3,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A3
7794,BTS-54505,Adrenergic transmitter uptake inhibitor,SLC6A4,CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1,WQSACWZKKZPCHN-UHFFFAOYSA-N,,SLC6A4
7795,diminazene-aceturate,Angiotensin converting enzyme activator,AOC1,NC(=N)c1ccc(NN=Nc2ccc(cc2)C(N)=N)cc1,XNYZHCFCZNMTFY-UHFFFAOYSA-N,,AOC1
7796,benazepril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O,XPCFTKFZXHTYIP-PMACEKPBSA-N,,ACE
7797,benazepril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)C(CCc1ccccc1)NC2CCc3ccccc3N(CC(=O)O)C2=O,XPCFTKFZXHTYIP-UHFFFAOYSA-N,,ACE
7798,captopril,Angiotensin converting enzyme inhibitor,ACE,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,FAKRSMQSSFJEIM-RQJHMYQMSA-N,,ACE
7799,cilazapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O,HHHKFGXWKKUNCY-GBESFXJTSA-N,,ACE
7800,delapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(O)=O)C1Cc2ccccc2C1,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,,ACE
7801,deserpidine,Angiotensin converting enzyme inhibitor,SLC18A2,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1,CVBMAZKKCSYWQR-WCGOZPBSSA-N,,SLC18A2
7802,enalapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,GBXSMTUPTTWBMN-UAGQMJEPSA-N,,ACE
7803,enalapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,GBXSMTUPTTWBMN-XIRDDKMYSA-N,,ACE
7804,enalaprilat,Angiotensin converting enzyme inhibitor,ACE,C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,LZFZMUMEGBBDTC-QEJZJMRPSA-N,,ACE
7805,fosinopril,Angiotensin converting enzyme inhibitor,ACE,CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,BIDNLKIUORFRQP-AJTMIRJTSA-N,,ACE
7806,imidapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O,KLZWOWYOHUKJIG-CWRNSKLLSA-N,,ACE
7807,lisinopril,Angiotensin converting enzyme inhibitor,ACE,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,RLAWWYSOJDYHDC-BZSNNMDCSA-N,,ACE
7808,methiopril,Angiotensin converting enzyme inhibitor,ACE,CC1CCCC(N1C(=O)CCSC(C)=O)C(O)=O,JHFOAISYWJRTIM-UHFFFAOYSA-N,,ACE
7809,moexipril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O,UWWDHYUMIORJTA-HSQYWUDLSA-N,,ACE
7810,perindopril,Angiotensin converting enzyme inhibitor,ACE,CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O)C(=O)OCC,IPVQLZZIHOAWMC-QRJUGERDSA-N,,ACE
7811,perindopril,Angiotensin converting enzyme inhibitor,ACE,CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC,IPVQLZZIHOAWMC-QXKUPLGCSA-N,,ACE
7812,quinapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O,JSDRRTOADPPCHY-HSQYWUDLSA-N,,ACE
7813,ramipril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@@H]2C[C@H]1C(O)=O,HDACQVRGBOVJII-ZDNSCYFHSA-N,,ACE
7814,ramipril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O,HDACQVRGBOVJII-JBDAPHQKSA-N,,ACE
7815,ramipril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2C(C[C@@H]3CCC[C@@H]32)C(=O)O,HDACQVRGBOVJII-QJUJLUFUSA-N,,ACE
7816,rescinnamine,Angiotensin converting enzyme inhibitor,ACE,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)/C=C/c6cc(OC)c(OC)c(OC)c6,SZLZWPPUNLXJEA-QEGASFHISA-N,,ACE
7817,temocapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)c1cccs1,FIQOFIRCTOWDOW-BJLQDIEVSA-N,,ACE
7818,trandolapril,Angiotensin converting enzyme inhibitor,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O,VXFJYXUZANRPDJ-UPUXWEDPSA-N,,ACE
7819,zofenopril-calcium,Angiotensin converting enzyme inhibitor,ACE,C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@H](C[C@H]1C(O)=O)Sc1ccccc1,IAIDUHCBNLFXEF-MNEFBYGVSA-N,,ACE
7820,bacitracin,Bacterial cell wall synthesis inhibitor,IDE,CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC,CLKOFPXJLQSYAH-RNHDWVCBSA-N,,IDE
7821,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC15A1,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,,SLC15A1
7822,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC15A2,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,,SLC15A2
7823,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC22A6,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,,SLC22A6
7824,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC22A8,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,,SLC22A8
7825,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC15A1,CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O,BOEGTKLJZSQCCD-HUFXEGEASA-N,,SLC15A1
7826,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC15A2,CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O,BOEGTKLJZSQCCD-HUFXEGEASA-N,,SLC15A2
7827,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC22A6,CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O,BOEGTKLJZSQCCD-HUFXEGEASA-N,,SLC22A6
7828,cefadroxil,Bacterial cell wall synthesis inhibitor,SLC22A8,CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O,BOEGTKLJZSQCCD-HUFXEGEASA-N,,SLC22A8
7829,nafcillin,Bacterial cell wall synthesis inhibitor,CYP1A2,CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,,CYP1A2
7830,nafcillin,Bacterial cell wall synthesis inhibitor,CYP3A4,CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,,CYP3A4
7831,nafcillin,Bacterial cell wall synthesis inhibitor,SLC22A6,CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,,SLC22A6
7832,SKF-91488,Histamine N-methyltransferase inhibitor,HNMT,CN(C)CCCCSC(N)=N,UFYJLJINUGVUHO-UHFFFAOYSA-N,,HNMT
7833,IBC-293,Hydroxycarboxylic acid receptor agonist,HCAR3,CC(C)n1nnc2cc(ccc12)C(O)=O,RUTVRAJKELSHCC-UHFFFAOYSA-N,,HCAR3
7834,mycophenolate-mofetil,Hydroxycarboxylic acid receptor agonist,IMPDH1,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH1
7835,mycophenolate-mofetil,Hydroxycarboxylic acid receptor agonist,IMPDH2,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(=O)OCCN1CCOCC1,RTGDFNSFWBGLEC-SYZQJQIISA-N,,IMPDH2
7836,thiorphan,Membrane metalloendopeptidase inhibitor,MME,OC(=O)CNC(=O)C(CS)Cc1ccccc1,LJJKNPQAGWVLDQ-UHFFFAOYSA-N,,MME
7837,BX-912,Pyruvate dehydrogenase kinase inhibitor,PDK1,Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1,DMMILYKXNCVKOJ-UHFFFAOYSA-N,,PDK1
7838,BX-912,Pyruvate dehydrogenase kinase inhibitor,PDPK1,Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1,DMMILYKXNCVKOJ-UHFFFAOYSA-N,,PDPK1
7839,GSK-2334470,Pyruvate dehydrogenase kinase inhibitor,PDK1,CNc1nc(cc(n1)-c1ccc2c(N)n[nH]c2c1)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1,QLPHOXTXAKOFMU-WBVHZDCISA-N,,PDK1
7840,GSK-2334470,Pyruvate dehydrogenase kinase inhibitor,PDPK1,CNc1nc(cc(n1)-c1ccc2c(N)n[nH]c2c1)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1,QLPHOXTXAKOFMU-WBVHZDCISA-N,,PDPK1
7841,hydroxyamphetamine,Trace amine associated receptor agonist,TAAR1,CC(N)Cc1ccc(O)cc1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,TAAR1
7842,CPI-1189,Tumor necrosis factor release inhibitor,TNF,CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C,DJKNRCWSXSZACF-UHFFFAOYSA-N,,TNF
7843,glycitein,Tumor necrosis factor release inhibitor,TNF,COc1cc2c(cc1O)occ(-c1ccc(O)cc1)c2=O,DXYUAIFZCFRPTH-UHFFFAOYSA-N,,TNF
7844,sparfosic-acid,Aspartate carbamoyltransferase inhibitor,CAD,OC(=O)C[C@H](NC(=O)CP(O)(O)=O)C(O)=O,ZZKNRXZVGOYGJT-VKHMYHEASA-N,,CAD
7845,etomoxir,Carnitine palmitoyltransferase inhibitor,CPT1A,CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1,DZLOHEOHWICNIL-QGZVFWFLSA-N,,CPT1A
7846,etomoxir,Carnitine palmitoyltransferase inhibitor,CPT1A,CCOC(=O)C1(CCCCCCOc2ccc(Cl)cc2)CO1,DZLOHEOHWICNIL-UHFFFAOYSA-N,,CPT1A
7847,etomoxir,Carnitine palmitoyltransferase inhibitor,CPT1A,OC(=O)[C@]1(CCCCCCOc2ccc(Cl)cc2)CO1,NWSIRTXVYBEURF-HNNXBMFYSA-N,,CPT1A
7848,perhexiline,Carnitine palmitoyltransferase inhibitor,CPT1A,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,,CPT1A
7849,perhexiline,Carnitine palmitoyltransferase inhibitor,CPT2,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,,CPT2
7850,CO-101244,Ionotropic glutamate receptor antagonist,GRIN2B,Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1,VKMFDKYCIKEDMR-UHFFFAOYSA-N,,GRIN2B
7851,Ro-25-6981,Ionotropic glutamate receptor antagonist,GRIN2B,C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1,WVZSEUPGUDIELE-HTAPYJJXSA-N,,GRIN2B
7852,BRD-K93367411,Kelch-like ECH-associated protein ligand,KEAP1,OC(=O)[C@@H]1CCCC[C@@H]1C(=O)N1CCc2ccccc2[C@H]1CN1C(=O)c2ccccc2C1=O,LNENLABLFGGAFF-BHDDXSALSA-N,,KEAP1
7853,BRD-K98948170,Kelch-like ECH-associated protein ligand,KEAP1,OC(=O)[C@H]1CCCC[C@H]1C(=O)N1CCc2ccccc2[C@H]1CN1C(=O)c2ccccc2C1=O,LNENLABLFGGAFF-BHIFYINESA-N,,KEAP1
7854,dimethyl-fumarate,Kelch-like ECH-associated protein ligand,NFE2L2,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,NFE2L2
7855,dimethyl-fumarate,Kelch-like ECH-associated protein ligand,KEAP1,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,,KEAP1
7856,alexidine,Phosphatidylglycerophosphatase inhibitor,PTPMT1,CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC,LFVVNPBBFUSSHL-UHFFFAOYSA-N,,PTPMT1
7857,fingolimod,Sphingosine 1 phosphate receptor agonist,S1PR1,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR1
7858,fingolimod,Sphingosine 1 phosphate receptor agonist,S1PR3,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR3
7859,fingolimod,Sphingosine 1 phosphate receptor agonist,S1PR5,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR5
7860,fingolimod,Sphingosine 1 phosphate receptor agonist,S1PR4,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,KKGQTZUTZRNORY-UHFFFAOYSA-N,,S1PR4
7861,chlorzoxazone,Bacterial 30S ribosomal subunit inhibitor,KCNN4,Clc1ccc2oc(=O)[nH]c2c1,TZFWDZFKRBELIQ-UHFFFAOYSA-N,,KCNN4
7862,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,CYP3A4,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,CYP3A4
7863,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,CYP51A1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,CYP51A1
7864,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,ALB,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,ALB
7865,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,MLNR,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,MLNR
7866,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,KCNH2,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,KCNH2
7867,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,ABCB1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,ABCB1
7868,erythromycin-estolate,Bacterial 50S ribosomal subunit inhibitor,SLC47A1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,,SLC47A1
7869,linezolid,Bacterial 50S ribosomal subunit inhibitor,MAOA,CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1,TYZROVQLWOKYKF-ZDUSSCGKSA-N,,MAOA
7870,linezolid,Bacterial 50S ribosomal subunit inhibitor,MAOB,CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1,TYZROVQLWOKYKF-ZDUSSCGKSA-N,,MAOB
7871,gimeracil,Dihydropyrimidine dehydrogenase inhibitor,DPYD,Oc1cc(=O)[nH]cc1Cl,ZPLQIPFOCGIIHV-UHFFFAOYSA-N,,DPYD
7872,zoledronic-acid,Farnesyl pyrophosphate synthase inhibitor,FDPS,OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,,FDPS
7873,clonazepam,GABA benzodiazepine site receptor agonist,GABRA1,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA1
7874,clonazepam,GABA benzodiazepine site receptor agonist,GABRA2,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA2
7875,clonazepam,GABA benzodiazepine site receptor agonist,GABRA3,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA3
7876,clonazepam,GABA benzodiazepine site receptor agonist,GABRA4,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA4
7877,clonazepam,GABA benzodiazepine site receptor agonist,GABRA5,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA5
7878,clonazepam,GABA benzodiazepine site receptor agonist,GABRA6,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRA6
7879,clonazepam,GABA benzodiazepine site receptor agonist,GABRB1,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRB1
7880,clonazepam,GABA benzodiazepine site receptor agonist,GABRB2,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRB2
7881,clonazepam,GABA benzodiazepine site receptor agonist,GABRB3,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRB3
7882,clonazepam,GABA benzodiazepine site receptor agonist,GABRD,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRD
7883,clonazepam,GABA benzodiazepine site receptor agonist,GABRE,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRE
7884,clonazepam,GABA benzodiazepine site receptor agonist,GABRG1,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRG1
7885,clonazepam,GABA benzodiazepine site receptor agonist,GABRG2,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRG2
7886,clonazepam,GABA benzodiazepine site receptor agonist,GABRG3,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRG3
7887,clonazepam,GABA benzodiazepine site receptor agonist,GABRP,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRP
7888,clonazepam,GABA benzodiazepine site receptor agonist,GABRQ,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,,GABRQ
7889,KI-16425,Lysophosphatidic acid receptor antagonist,LPAR1,CC(OC(=O)Nc1c(C)noc1-c1ccc(CSCCC(O)=O)cc1)c1ccccc1Cl,LLIFMNUXGDHTRO-UHFFFAOYSA-N,,LPAR1
7890,KI-16425,Lysophosphatidic acid receptor antagonist,LPAR3,CC(OC(=O)Nc1c(C)noc1-c1ccc(CSCCC(O)=O)cc1)c1ccccc1Cl,LLIFMNUXGDHTRO-UHFFFAOYSA-N,,LPAR3
7891,niacin,NAD precursor with lipid lowering effects,HCAR2,OC(=O)c1cccnc1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,,HCAR2
7892,niacin,NAD precursor with lipid lowering effects,HCAR3,OC(=O)c1cccnc1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,,HCAR3
7893,niacin,NAD precursor with lipid lowering effects,HCAR2,OC(=O)c1cccnc1SCCc2ccccc2,UZERZZRWECLIKE-UHFFFAOYSA-N,,HCAR2
7894,niacin,NAD precursor with lipid lowering effects,HCAR3,OC(=O)c1cccnc1SCCc2ccccc2,UZERZZRWECLIKE-UHFFFAOYSA-N,,HCAR3
7895,ezetimibe,Niemann-Pick C1-like 1 protein antagonist,NPC1L1,O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1,OLNTVTPDXPETLC-XPWALMASSA-N,,NPC1L1
7896,ezetimibe,Niemann-Pick C1-like 1 protein antagonist,NPC1L1,OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1,OLNTVTPDXPETLC-OJVMETQDSA-N,,NPC1L1
7897,VGX-1027,Tumor necrosis factor receptor antagonist,TLR4,OC(=O)CC1CC(=NO1)c1ccccc1,MUFJHYRCIHHATF-UHFFFAOYSA-N,,TLR4
7898,isoreserpine,Vesicular monoamine transporter inhibitor,SLC18A1,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,QEVHRUUCFGRFIF-VPHNHGCZSA-N,,SLC18A1
7899,isoreserpine,Vesicular monoamine transporter inhibitor,SLC18A2,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,QEVHRUUCFGRFIF-VPHNHGCZSA-N,,SLC18A2
7900,reserpine,Vesicular monoamine transporter inhibitor,SLC18A1,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1,QEVHRUUCFGRFIF-UQJIOEFNSA-N,,SLC18A1
7901,reserpine,Vesicular monoamine transporter inhibitor,SLC18A2,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1,QEVHRUUCFGRFIF-UQJIOEFNSA-N,,SLC18A2
7902,reserpine,Vesicular monoamine transporter inhibitor,SLC18A1,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1,QEVHRUUCFGRFIF-MDEJGZGSSA-N,,SLC18A1
7903,reserpine,Vesicular monoamine transporter inhibitor,SLC18A2,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1,QEVHRUUCFGRFIF-MDEJGZGSSA-N,,SLC18A2
7904,tetrabenazine,Vesicular monoamine transporter inhibitor,SLC18A2,COc1cc2CCN3C[C@@H](CC(C)C)C(=O)C[C@@H]3c2cc1OC,MKJIEFSOBYUXJB-GDBMZVCRSA-N,,SLC18A2
7905,tetrabenazine,Vesicular monoamine transporter inhibitor,SLC18A2,COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC,MKJIEFSOBYUXJB-HOCLYGCPSA-N,,SLC18A2
7906,tetrabenazine,Vesicular monoamine transporter inhibitor,SLC18A2,COc1cc2CCN3CC(CC(C)C)C(=O)CC3c2cc1OC,MKJIEFSOBYUXJB-UHFFFAOYSA-N,,SLC18A2
7907,KO-143,Breast cancer resistance protein inhibitor,ABCG2,COc1ccc2c3C[C@@H]4N([C@@H](CC(C)C)c3[nH]c2c1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O,NXNRAECHCJZNRF-JBACZVJFSA-N,,ABCG2
7908,betulinic-acid,Diacylglycerol O acyltransferase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
7909,betulinic-acid,Diacylglycerol O acyltransferase inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
7910,PF-04620110,Diacylglycerol O acyltransferase inhibitor,DGAT1,Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12,GEVVQZHMFVFGLN-HDJSIYSDSA-N,,DGAT1
7911,methylphenidate,Dopamine-norepinephrine reuptake inhibitor,SLC6A2,COC(=O)C(C1CCCCN1)c1ccccc1,DUGOZIWVEXMGBE-UHFFFAOYSA-N,,SLC6A2
7912,methylphenidate,Dopamine-norepinephrine reuptake inhibitor,SLC6A3,COC(=O)C(C1CCCCN1)c1ccccc1,DUGOZIWVEXMGBE-UHFFFAOYSA-N,,SLC6A3
7913,QW-BI-011,Histone lysine methyltransferase inhibitor,EHMT2,COC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c4ccccc4)nc2c1,UCGWYCMPZXDHNR-UHFFFAOYSA-N,,EHMT2
7914,BIX-01294,Histone lysine methyltransferase inhibitor,EHMT2,COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1,OSXFATOLZGZLSK-UHFFFAOYSA-N,,EHMT2
7915,chaetocin,Histone lysine methyltransferase inhibitor,SUV39H1,CN1C(=O)C23CC4(C(Nc5ccccc54)N3C(=O)C1(CO)SS2)C67CC8(SSC9(CO)N(C)C8=O)N(C7Nc%10ccccc%106)C9=O,PZPPOCZWRGNKIR-UHFFFAOYSA-N,,SUV39H1
7916,ryuvidine,Histone lysine methyltransferase inhibitor,CDK4,Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O,HFPLHASLIOXVGS-UHFFFAOYSA-N,,CDK4
7917,UNC-0321,Histone lysine methyltransferase inhibitor,EHMT2,COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCOCCN(C)C)N1CCCN(C)CC1,AULLUGALUBVBDD-UHFFFAOYSA-N,,EHMT2
7918,importazole,Importin-beta transport receptor inhibitor,KPNB1,CC(Nc1nc(nc2ccccc12)N3CCCC3)c4ccccc4,HKGJEZIGDHFJFL-UHFFFAOYSA-N,,KPNB1
7919,didanosine,Nucleoside reverse transcriptase inhibitor,PNP,OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12,BXZVVICBKDXVGW-NKWVEPMBSA-N,,PNP
7920,AV-412,Receptor tyrosine protein kinase inhibitor,EGFR,CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C,ZAJXXUDARPGGOC-UHFFFAOYSA-N,,EGFR
7921,AV-412,Receptor tyrosine protein kinase inhibitor,ERBB2,CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C,ZAJXXUDARPGGOC-UHFFFAOYSA-N,,ERBB2
7922,BMS-599626,Receptor tyrosine protein kinase inhibitor,EGFR,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,EGFR
7923,BMS-599626,Receptor tyrosine protein kinase inhibitor,ERBB2,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,ERBB2
7924,BMS-599626,Receptor tyrosine protein kinase inhibitor,ERBB4,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12,LUJZZYWHBDHDQX-QFIPXVFZSA-N,,ERBB4
7925,GW-583340,Receptor tyrosine protein kinase inhibitor,EGFR,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,EGFR
7926,GW-583340,Receptor tyrosine protein kinase inhibitor,ERBB2,CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,MNNXRVSQOABRRP-UHFFFAOYSA-N,,ERBB2
7927,mubritinib,Receptor tyrosine protein kinase inhibitor,ERBB2,FC(F)(F)c1ccc(C=Cc2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,ZTFBIUXIQYRUNT-MDWZMJQESA-N,,ERBB2
7928,caffeic-acid,Tumor necrosis factor production inhibitor,ALOX5,OC(=O)C=Cc1ccc(O)c(O)c1,QAIPRVGONGVQAS-DUXPYHPUSA-N,,ALOX5
7929,caffeic-acid,Tumor necrosis factor production inhibitor,ALOX5,Oc1ccc(C=CC(=O)OCCc2ccccc2)cc1O,SWUARLUWKZWEBQ-UHFFFAOYSA-N,,ALOX5
7930,pomalidomide,Tumor necrosis factor production inhibitor,CRBN,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,UVSMNLNDYGZFPF-UHFFFAOYSA-N,,CRBN
7931,pomalidomide,Tumor necrosis factor production inhibitor,TNF,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,UVSMNLNDYGZFPF-UHFFFAOYSA-N,,TNF
7932,CCMI,Acetylcholine receptor allosteric modulator,CHRNA7,Cc1cc(on1)C(=C/Nc1ccc(Cl)cc1)C(=O)Nc1ccc(Cl)cc1,VMAKIACTLSBBIY-GZTJUZNOSA-N,,CHRNA7
7933,dalcetrapib,Cholesterylester transfer protein inhibitor,CETP,CCC(CC)CC1(CCCCC1)C(=O)Nc1ccccc1SC(=O)C(C)C,YZQLWPMZQVHJED-UHFFFAOYSA-N,,CETP
7934,DL-TBOA,Excitatory amino acid transporter inhibitor,SLC1A1,NC(C(OCc1ccccc1)C(=O)O)C(=O)O,BYOBCYXURWDEDS-UHFFFAOYSA-N,,SLC1A1
7935,DL-TBOA,Excitatory amino acid transporter inhibitor,SLC1A2,NC(C(OCc1ccccc1)C(=O)O)C(=O)O,BYOBCYXURWDEDS-UHFFFAOYSA-N,,SLC1A2
7936,DL-TBOA,Excitatory amino acid transporter inhibitor,SLC1A3,NC(C(OCc1ccccc1)C(=O)O)C(=O)O,BYOBCYXURWDEDS-UHFFFAOYSA-N,,SLC1A3
7937,CGP-7930,GABA receptor positive allosteric modulator,GABBR1,CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,XLWJPQQFJNGUPA-UHFFFAOYSA-N,,GABBR1
7938,BRD-K98404142,Glucose 6-phosphate dehydrogenase inhibitor,G6PD,C[C@@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]2C[C@H](Br)C1=O,CWVMWSZEMZOUPC-RWUIUEHLSA-N,,G6PD
7939,BMS-777607,Hepatocyte growth factor receptor inhibitor,MERTK,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MERTK
7940,BMS-777607,Hepatocyte growth factor receptor inhibitor,MET,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MET
7941,BMS-777607,Hepatocyte growth factor receptor inhibitor,MST1R,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,MST1R
7942,BMS-777607,Hepatocyte growth factor receptor inhibitor,AXL,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,AXL
7943,BMS-777607,Hepatocyte growth factor receptor inhibitor,TYRO3,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,,TYRO3
7944,EMD-1214063,Hepatocyte growth factor receptor inhibitor,MET,CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1,AHYMHWXQRWRBKT-UHFFFAOYSA-N,,MET
7945,SU-11274,Hepatocyte growth factor receptor inhibitor,MET,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,FPYJSJDOHRDAMT-KQWNVCNZSA-N,,MET
7946,SU-11274,Hepatocyte growth factor receptor inhibitor,MET,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)C(=Cc3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,FPYJSJDOHRDAMT-XQNSMLJCSA-N,,MET
7947,nitisinone,Hydroxyphenylpyruvate dioxygenase inhibitor,HPD,[O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F,OUBCNLGXQFSTLU-UHFFFAOYSA-N,,HPD
7948,CGP-37157,Mitochondrial Na+/Ca2+ exchanger antagonist,SLC8A1,Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1,KQEPIRKXSUIUTH-UHFFFAOYSA-N,,SLC8A1
7949,BRD-K19059335,Runt-related transcription factor inhibitor,RUNX1,Clc1ccc2NC(=O)CN=C(c3ccc[nH]3)c2c1,XWNMORIHKRROGW-UHFFFAOYSA-N,,RUNX1
7950,betulinic-acid,SARS coronavirus 3C-like protease inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,QGJZLNKBHJESQX-FZFNOLFKSA-N,,GPBAR1
7951,betulinic-acid,SARS coronavirus 3C-like protease inhibitor,GPBAR1,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,QGJZLNKBHJESQX-XNWPAUOFSA-N,,GPBAR1
7952,anacetrapib,Cholesteryl ester transfer protein inhibitor,CETP,COc1cc(F)c(cc1-c1ccc(cc1CN1[C@H](C)[C@H](OC1=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,MZZLGJHLQGUVPN-WZQKQDCOSA-N,,CETP
7953,torcetrapib,Cholesteryl ester transfer protein inhibitor,CETP,CCOC(=O)N1[C@H](CC)C[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c2cc(ccc12)C(F)(F)F,CMSGWTNRGKRWGS-WIYYLYMNSA-N,,CETP
7954,anamorelin,Growth hormone secretagogue receptor agonist,GHSR,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N,,GHSR
7955,bongkrek-acid,"Mitochondrial ADP, ATP translocase inhibitor",SLC25A4,COC(C/C=C/C=C/CCC=C/CC(C)C=C/C(=CC(=O)O)/CC(=O)O)/C(=CC=C(/C)C(=O)O)/C,SHCXABJSXUACKU-IPUKGTGASA-N,,SLC25A4
7956,carbidopa,Aromatic L-amino acid decarboxylase inhibitor,DDC,C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O,TZFNLOMSOLWIDK-JTQLQIEISA-N,,DDC
7957,carbidopa,Aromatic L-amino acid decarboxylase inhibitor,DDC,CC(Cc1ccc(O)c(O)c1)(NN)C(=O)O,TZFNLOMSOLWIDK-UHFFFAOYSA-N,,DDC
7958,lacosamide,Collapsin response mediator protein inhibitor,SCN1A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN1A
7959,lacosamide,Collapsin response mediator protein inhibitor,SCN3A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN3A
7960,lacosamide,Collapsin response mediator protein inhibitor,SCN9A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN9A
7961,lacosamide,Collapsin response mediator protein inhibitor,SCN10A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN10A
7962,lacosamide,Collapsin response mediator protein stimulant,SCN1A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN1A
7963,lacosamide,Collapsin response mediator protein stimulant,SCN3A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN3A
7964,lacosamide,Collapsin response mediator protein stimulant,SCN9A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN9A
7965,lacosamide,Collapsin response mediator protein stimulant,SCN10A,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,,SCN10A
7966,TER-14687,Inhibitor of translocation of PKCq in T cells,PRKCQ,CN(C)CC1Cc2ccccc2C1=O,IOXRKHWIYNWYFF-UHFFFAOYSA-N,,PRKCQ
7967,goserelin,Luteinizing hormone releasing hormone agonist,GNRHR,CC(C)CC(NC(=O)C(COC(C)(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-KJLMDEBVSA-N,,GNRHR
7968,ursolic-acid,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,HSD11B1
7969,ursolic-acid,11-beta hydroxysteroid dehydrogenase inhibitor,PTPN1,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,FZRIRHAXJWMMFP-PYQRESMBSA-N,,PTPN1
7970,ursolic-acid,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,HSD11B1
7971,ursolic-acid,11-beta hydroxysteroid dehydrogenase inhibitor,PTPN1,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O,WCGUUGGRBIKTOS-GPOJBZKASA-N,,PTPN1
7972,isoniazid,Enoyl-acyl-carrier protein reductase inhibitor,CYP1A2,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP1A2
7973,isoniazid,Enoyl-acyl-carrier protein reductase inhibitor,CYP2C19,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2C19
7974,isoniazid,Enoyl-acyl-carrier protein reductase inhibitor,CYP2C8,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2C8
7975,isoniazid,Enoyl-acyl-carrier protein reductase inhibitor,CYP2E1,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP2E1
7976,isoniazid,Enoyl-acyl-carrier protein reductase inhibitor,CYP3A4,NNC(=O)c1ccncc1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,,CYP3A4
7977,triclosan,Enoyl-acyl-carrier protein reductase inhibitor,DNMT1,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,XEFQLINVKFYRCS-UHFFFAOYSA-N,,DNMT1
7978,dapivirine,Non-nucleoside reverse transcriptase inhibitor,CYP3A4,Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1,ILAYIAGXTHKHNT-UHFFFAOYSA-N,,CYP3A4
7979,dapivirine,Non-nucleoside reverse transcriptase inhibitor,CYP3A5,Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1,ILAYIAGXTHKHNT-UHFFFAOYSA-N,,CYP3A5
7980,delavirdine,Non-nucleoside reverse transcriptase inhibitor,CYP3A4,CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1,WHBIGIKBNXZKFE-UHFFFAOYSA-N,,CYP3A4
7981,etravirine,Non-nucleoside reverse transcriptase inhibitor,CYP2C19,Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N,,CYP2C19
7982,etravirine,Non-nucleoside reverse transcriptase inhibitor,CYP2C9,Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N,,CYP2C9
7983,etravirine,Non-nucleoside reverse transcriptase inhibitor,CYP3A4,Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N,,CYP3A4
7984,ABT-491,Platelet activating factor receptor antagonist,PTAFR,CN(C)C(=O)n1cc(C(=O)c2ccc(Cn3c(C)nc4cnccc34)c(F)c2)c2c(cccc12)C#C,GDLNHSUSOZEAOR-UHFFFAOYSA-N,,PTAFR
7985,apafant,Platelet activating factor receptor antagonist,PTAFR,Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl,JGPJQFOROWSRRS-UHFFFAOYSA-N,,PTAFR
7986,ginkgolide-b,Platelet activating factor receptor antagonist,GLRA1,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRA1
7987,ginkgolide-b,Platelet activating factor receptor antagonist,GLRB,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,GLRB
7988,ginkgolide-b,Platelet activating factor receptor antagonist,PTAFR,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-IWNUMIARSA-N,,PTAFR
7989,ginkgolide-b,Platelet activating factor receptor antagonist,GLRA1,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRA1
7990,ginkgolide-b,Platelet activating factor receptor antagonist,GLRB,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,GLRB
7991,ginkgolide-b,Platelet activating factor receptor antagonist,PTAFR,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,SQOJOAFXDQDRGF-DJCNAJSISA-N,,PTAFR
7992,PCA-4248,Platelet activating factor receptor antagonist,PTAFR,COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1,DHCNAWNKZMNTIS-UHFFFAOYSA-N,,PTAFR
7993,rupatadine,Platelet activating factor receptor antagonist,HRH1,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,WUZYKBABMWJHDL-UHFFFAOYSA-N,,HRH1
7994,rupatadine,Platelet activating factor receptor antagonist,PTAFR,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,WUZYKBABMWJHDL-UHFFFAOYSA-N,,PTAFR
7995,protirelin,Thyrotropin releasing hormone receptor agonist,TRHR,NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1,XNSAINXGIQZQOO-UHFFFAOYSA-N,,TRHR
7996,taltirelin,Thyrotropin releasing hormone receptor agonist,TRHR,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O,LQZAIAZUDWIVPM-SRVKXCTJSA-N,,TRHR
7997,L-692585,Growth hormone releasing peptide ligand agonist,GHSR,C[C@@H](O)CNC(C)(C)CC(=O)N[C@@H]1CCc2ccccc2N(Cc3ccc(cc3)c4ccccc4c5nn[nH]n5)C1=O,AYBCFPXLXOLPIZ-JIPXPUAJSA-N,,GHSR
7998,FK-866,Niacinamide phosphoribosyltransferase inhibitor,NAMPT,O=C(NCCCCC1CCN(CC1)C(=O)c1ccccc1)C=Cc1cccnc1,KPBNHDGDUADAGP-VAWYXSNFSA-N,,NAMPT
7999,GSK-650394,Serum/glucocorticoid regulated kinase inhibitor,SGK1,OC(=O)c1ccc(cc1C1CCCC1)-c1c[nH]c2ncc(cc12)-c1ccccc1,WVSBGSNVCDAMCF-UHFFFAOYSA-N,,SGK1
8000,bendroflumethiazide,Sodium/potassium/chloride transporter inhibitor,SLC12A3,NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F,HDWIHXWEUNVBIY-UHFFFAOYSA-N,,SLC12A3
8001,etacrynic-acid,Sodium/potassium/chloride transporter inhibitor,SLC12A1,CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl,AVOLMBLBETYQHX-UHFFFAOYSA-N,,SLC12A1
8002,hydroflumethiazide,Sodium/potassium/chloride transporter inhibitor,SLC12A1,NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F,DMDGGSIALPNSEE-UHFFFAOYSA-N,,SLC12A1
8003,tienilic-acid,Sodium/potassium/chloride transporter inhibitor,CYP2C9,OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,AGHANLSBXUWXTB-UHFFFAOYSA-N,,CYP2C9
8004,tienilic-acid,Sodium/potassium/chloride transporter inhibitor,SLC12A1,OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,AGHANLSBXUWXTB-UHFFFAOYSA-N,,SLC12A1
8005,dipraglurant,Glutamate receptor negative allosteric modulator,GRM5,Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,,GRM5
8006,AMN-082,Glutamate receptor positive allosteric modulator,GRM7,C(CNC(c1ccccc1)c1ccccc1)NC(c1ccccc1)c1ccccc1,DTZDSNQYNPNCPK-UHFFFAOYSA-N,,GRM7
8007,asymmetrical-dimethylarginine,Dimethylarginine dimethylaminohydrolase inhibitor,NOS2,CN(C)C(=N)NCCC[C@H](N)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,,NOS2
8008,asymmetrical-dimethylarginine,Dimethylarginine dimethylaminohydrolase inhibitor,NOS3,CN(C)C(=N)NCCC[C@H](N)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,,NOS3
8009,Ro-15-4513,GABA benzodiazepine site receptor inverse agonist,GABRA1,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-],CFSOJZTUTOQNIA-UHFFFAOYSA-N,,GABRA1
8010,Ro-15-4513,GABA benzodiazepine site receptor inverse agonist,GABRA2,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-],CFSOJZTUTOQNIA-UHFFFAOYSA-N,,GABRA2
8011,Ro-15-4513,GABA benzodiazepine site receptor inverse agonist,GABRA3,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-],CFSOJZTUTOQNIA-UHFFFAOYSA-N,,GABRA3
8012,Ro-15-4513,GABA benzodiazepine site receptor inverse agonist,GABRA5,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-],CFSOJZTUTOQNIA-UHFFFAOYSA-N,,GABRA5
8013,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA1,CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21,LWUDDYHYYNNIQI-ZDUSSCGKSA-N,,GABRA1
8014,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA2,CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21,LWUDDYHYYNNIQI-ZDUSSCGKSA-N,,GABRA2
8015,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA3,CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21,LWUDDYHYYNNIQI-ZDUSSCGKSA-N,,GABRA3
8016,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA5,CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21,LWUDDYHYYNNIQI-ZDUSSCGKSA-N,,GABRA5
8017,MBX-2982,Glucose dependent insulinotropic receptor agonist,GPR119,CCc1cnc(nc1)N1CCC(CC1)c1nc(COc2ccc(cc2)-n2cnnn2)cs1,NFTMKHWBOINJGM-UHFFFAOYSA-N,,GPR119
8018,oleoylethanolamide,Glucose dependent insulinotropic receptor agonist,GPR119,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,GPR119
8019,oleoylethanolamide,Glucose dependent insulinotropic receptor agonist,PPARA,CCCCCCCCC=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,,PPARA
8020,oleylethanolamide,Glucose dependent insulinotropic receptor agonist,GPR119,CCCCCCCCC=CCCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-UHFFFAOYSA-N,,GPR119
8021,wiskostatin,Neural Wiskott-Aldrich syndrome protein inhibitor,WASL,CN(C)CC(O)Cn1c2ccc(Br)cc2c3cc(Br)ccc13,XUBJEDZHBUPBKL-UHFFFAOYSA-N,,WASL
8022,salubrinal,Eukaryotic translation initiation factor inhibitor,EIF2S1,ClC(Cl)(Cl)C(NC(=O)C=Cc1ccccc1)NC(=S)Nc1cccc2cccnc12,LCOIAYJMPKXARU-VAWYXSNFSA-N,,EIF2S1
8023,salubrinal,Eukaryotic translation initiation factor inhibitor,EIF2S1,ClC(Cl)(Cl)C(NC(=O)C=Cc1ccccc1)NC(=S)Nc2cccc3cccnc23,LCOIAYJMPKXARU-UHFFFAOYSA-N,,EIF2S1
8024,senicapoc,Intermediate conductance potassium channel blocker,KCNN4,NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1,SCTZUZTYRMOMKT-UHFFFAOYSA-N,,KCNN4
8025,lomitapide,Microsomal trigylceride transfer protein inhibitor,MTTP,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c2ccccc2-c2ccc(cc2)C(F)(F)F)c2ccccc2-c2ccccc12,MBBCVAKAJPKAKM-UHFFFAOYSA-N,,MTTP
8026,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR1,C[C@]12CC[C@@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@H]2O,RLQVKDVIBJCQGE-VWWPZJNLSA-N,,ESR1
8027,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR2,C[C@]12CC[C@@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@H]2O,RLQVKDVIBJCQGE-VWWPZJNLSA-N,,ESR2
8028,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,HSD3B2,C[C@]12CC[C@@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@H]2O,RLQVKDVIBJCQGE-VWWPZJNLSA-N,,HSD3B2
8029,deguelin,NADH-ubiquinone oxidoreductase (Complex I) inhibitor,AKT1,COc1cc2OC[C@H]3Oc4c5C=CC(C)(C)Oc5ccc4C(=O)[C@H]3c2cc1OC,ORDAZKGHSNRHTD-UXHICEINSA-N,,AKT1
8030,BRD-A61599461,Thyroid-stimulating hormone receptor inverse agonist,TSHR,COc1ccc(cc1COc1c(C)cccc1C)C1Nc2ccccc2C(=O)N1Cc1cccnc1,ODFGSMOTQLYMHU-UHFFFAOYSA-N,,TSHR
8031,KN-62,Calcium/calmodulin dependent protein kinase inhibitor,P2RX7,CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67,RJVLFQBBRSMWHX-UHFFFAOYSA-N,,P2RX7
8032,KN-62,Calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67,RJVLFQBBRSMWHX-UHFFFAOYSA-N,,CAMK2A
8033,KN-93,Calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,COc1ccc(cc1)S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c3ccc(Cl)cc3,LLLQTDSSHZREGW-AATRIKPKSA-N,,CAMK2A
8034,TAS-301,Calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,COc1ccc(cc1)C(=C2C(=O)Nc3ccccc23)c4ccc(OC)cc4,KUEYYIJXBRWZIB-UHFFFAOYSA-N,,CAMK2A
8035,gambogic-acid,Telomerase reverse transcriptase expression inhibitor,BCL2,CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(CC=C(C)C(O)=O)OC6(C)C,GEZHEQNLKAOMCA-RRZNCOCZSA-N,,BCL2
8036,goserelin-acetate,Gonadotropin releasing factor hormone receptor agonist,GNRHR,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-URPVMXJPSA-N,,GNRHR
8037,triptorelin,Gonadotropin releasing factor hormone receptor agonist,GNRHR,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,VXKHXGOKWPXYNA-PGBVPBMZSA-N,,GNRHR
8038,T-98475,Gonadotropin releasing factor hormone receptor antagonist,GNRHR,CC(C)OC(=O)c1cn(Cc2c(F)cccc2F)c3sc(c(CN(C)Cc4ccccc4)c3c1=O)c5ccc(NC(=O)C(C)C)cc5,RANJJVIMTOIWIN-UHFFFAOYSA-N,,GNRHR
8039,YK-4279,Binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor,DHX9,COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl,HLXSCTYHLQHQDJ-UHFFFAOYSA-N,,DHX9
8040,YK-4279,Binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor,FLI1,COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl,HLXSCTYHLQHQDJ-UHFFFAOYSA-N,,FLI1
8041,BI-2536,"PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor",PLK1,,,,PLK1
8042,BI-2536,"PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor",BRD4,,,,BRD4
8043,BI-2536,"PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor",PLK2,,,,PLK2
8044,BI-2536,"PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor",PLK3,,,,PLK3
8045,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",JAK2,,,,JAK2
8046,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",FLT3,,,,FLT3
8047,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",BRD4,,,,BRD4
8048,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",JAK1,,,,JAK1
8049,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",JAK3,,,,JAK3
8050,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",RET,,,,RET
8051,TG-101348,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor",TYK2,,,,TYK2
8052,PAC-1,caspase activator,CASP3,,,,CASP3
8053,XMD-1150,leucine rich repeat kinase inhibitor,LRRK2,,,,LRRK2
8054,apicidin,HDAC inhibitor,HDAC1,,,,HDAC1
8055,apicidin,HDAC inhibitor,HDAC10,,,,HDAC10
8056,apicidin,HDAC inhibitor,HDAC11,,,,HDAC11
8057,apicidin,HDAC inhibitor,HDAC2,,,,HDAC2
8058,apicidin,HDAC inhibitor,HDAC3,,,,HDAC3
8059,apicidin,HDAC inhibitor,HDAC4,,,,HDAC4
8060,apicidin,HDAC inhibitor,HDAC5,,,,HDAC5
8061,apicidin,HDAC inhibitor,HDAC6,,,,HDAC6
8062,apicidin,HDAC inhibitor,HDAC7,,,,HDAC7
8063,apicidin,HDAC inhibitor,HDAC8,,,,HDAC8
8064,apicidin,HDAC inhibitor,HDAC9,,,,HDAC9
8065,scriptaid,HDAC inhibitor,HDAC1,,,,HDAC1
8066,scriptaid,HDAC inhibitor,HDAC2,,,,HDAC2
8067,scriptaid,HDAC inhibitor,HDAC3,,,,HDAC3
8068,scriptaid,HDAC inhibitor,HDAC4,,,,HDAC4
8069,scriptaid,HDAC inhibitor,HDAC5,,,,HDAC5
8070,scriptaid,HDAC inhibitor,HDAC6,,,,HDAC6
8071,scriptaid,HDAC inhibitor,HDAC7,,,,HDAC7
8072,scriptaid,HDAC inhibitor,HDAC8,,,,HDAC8
8073,scriptaid,HDAC inhibitor,HDAC9,,,,HDAC9
8074,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
8075,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC2,,,,HDAC2
8076,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC3,,,,HDAC3
8077,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC6,,,,HDAC6
8078,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC8,,,,HDAC8
8079,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC10,,,,HDAC10
8080,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC11,,,,HDAC11
8081,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC5,,,,HDAC5
8082,vorinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC9,,,,HDAC9
8083,XMD-885,"leucine rich repeat kinase inhibitor, MAP kinase inhibitor",LRRK2,,,,LRRK2
8084,XMD-885,"leucine rich repeat kinase inhibitor, MAP kinase inhibitor",MAPK7,,,,MAPK7
8085,WT-171,HDAC inhibitor,HDAC6,,,,HDAC6
8086,TW-37,"BCL inhibitor, MCL1 inhibitor",BCL2,,,,BCL2
8087,TW-37,"BCL inhibitor, MCL1 inhibitor",BCL2L1,,,,BCL2L1
8088,TW-37,"BCL inhibitor, MCL1 inhibitor",MCL1,,,,MCL1
8089,KU-0060648,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
8090,KU-0060648,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PIK3CB,,,,PIK3CB
8091,KU-0060648,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PIK3CD,,,,PIK3CD
8092,KU-0060648,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PIK3CG,,,,PIK3CG
8093,KU-0060648,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PRKDC,,,,PRKDC
8094,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC1,,,,HDAC1
8095,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC2,,,,HDAC2
8096,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC3,,,,HDAC3
8097,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC4,,,,HDAC4
8098,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC6,,,,HDAC6
8099,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC7,,,,HDAC7
8100,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC8,,,,HDAC8
8101,panobinostat,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor",HDAC9,,,,HDAC9
8102,ISOX,HDAC inhibitor,HDAC6,,,,HDAC6
8103,JWE-035,Aurora kinase inhibitor,AURKA,,,,AURKA
8104,geldanamycin,HSP inhibitor,HSP90AA1,,,,HSP90AA1
8105,geldanamycin,HSP inhibitor,HSP90AB1,,,,HSP90AB1
8106,VU-0418946-1,hypoxia inducible factor activator,HIF1A,,,,HIF1A
8107,HC-toxin,HDAC inhibitor,HDAC1,,,,HDAC1
8108,PAC-1,caspase activator,CASP3,,,,CASP3
8109,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKA,,,,AURKA
8110,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKB,,,,AURKB
8111,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",ABL1,,,,ABL1
8112,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKC,,,,AURKC
8113,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",BCR,,,,BCR
8114,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",FLT3,,,,FLT3
8115,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",JAK2,,,,JAK2
8116,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",DDR2,,,,DDR2
8117,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",LCK,,,,LCK
8118,everolimus,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor",MTOR,,,,MTOR
8119,everolimus,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor",CYP3A5,,,,CYP3A5
8120,everolimus,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor",FKBP1A,,,,FKBP1A
8121,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",AKT1,,,,AKT1
8122,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",CHEK1,,,,CHEK1
8123,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",GSK3B,,,,GSK3B
8124,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",JAK2,,,,JAK2
8125,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",LCK,,,,LCK
8126,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K1,,,,MAP2K1
8127,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K2,,,,MAP2K2
8128,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K7,,,,MAP2K7
8129,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK1,,,,MAPK1
8130,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK11,,,,MAPK11
8131,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK12,,,,MAPK12
8132,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK14,,,,MAPK14
8133,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK8,,,,MAPK8
8134,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",PRKCA,,,,PRKCA
8135,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",RAF1,,,,RAF1
8136,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",ROCK1,,,,ROCK1
8137,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",RPS6KB1,,,,RPS6KB1
8138,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",SGK1,,,,SGK1
8139,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
8140,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC2,,,,HDAC2
8141,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC3,,,,HDAC3
8142,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC4,,,,HDAC4
8143,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC5,,,,HDAC5
8144,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC6,,,,HDAC6
8145,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC7,,,,HDAC7
8146,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC8,,,,HDAC8
8147,belinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC9,,,,HDAC9
8148,BIBU-1361,EGFR inhibitor,EGFR,,,,EGFR
8149,wiskostatin,neural Wiskott-Aldrich syndrome protein inhibitor,WAS,,,,WAS
8150,wiskostatin,neural Wiskott-Aldrich syndrome protein inhibitor,WASL,,,,WASL
8151,NVP-AUY922,HSP inhibitor,HSP90AA1,,,,HSP90AA1
8152,NVP-AUY922,HSP inhibitor,HSP90AA2,,,,HSP90AA2P
8153,NVP-AUY922,HSP inhibitor,HSP90AB1,,,,HSP90AB1
8154,NU-7441,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, P glycoprotein inhibitor",PRKDC,,,,PRKDC
8155,NU-7441,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, P glycoprotein inhibitor",ABCB1,,,,ABCB1
8156,BRD-K30351863,APEX inhibitor,APEX1,,,,APEX1
8157,BIX-01294,"DNA methyltransferase inhibitor, histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor",EHMT1,,,,EHMT1
8158,BIX-01294,"DNA methyltransferase inhibitor, histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor",EHMT2,,,,EHMT2
8159,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",ABL1,,,,ABL1
8160,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",SRC,,,,SRC
8161,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",BCR,,,,BCR
8162,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",CAMK2G,,,,CAMK2G
8163,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",LYN,,,,LYN
8164,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",CAMK1D,,,,CAMK1D
8165,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",CDK2,,,,CDK2
8166,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",FRK,,,,FRK
8167,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",FYN,,,,FYN
8168,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",HCK,,,,HCK
8169,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",MAP2K1,,,,MAP2K1
8170,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",MAP2K2,,,,MAP2K2
8171,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",MAP3K2,,,,MAP3K2
8172,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",MAP4K5,,,,MAP4K5
8173,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",STK10,,,,STK10
8174,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",STK24,,,,STK24
8175,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",STK4,,,,STK4
8176,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",TNK2,,,,TNK2
8177,bosutinib,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor",TXK,,,,TXK
8178,dacinostat,HDAC inhibitor,HDAC1,,,,HDAC1
8179,dacinostat,HDAC inhibitor,HDAC2,,,,HDAC2
8180,dacinostat,HDAC inhibitor,HDAC3,,,,HDAC3
8181,dacinostat,HDAC inhibitor,HDAC4,,,,HDAC4
8182,dacinostat,HDAC inhibitor,HDAC5,,,,HDAC5
8183,dacinostat,HDAC inhibitor,HDAC6,,,,HDAC6
8184,dacinostat,HDAC inhibitor,HDAC7,,,,HDAC7
8185,dacinostat,HDAC inhibitor,HDAC8,,,,HDAC8
8186,dacinostat,HDAC inhibitor,HDAC9,,,,HDAC9
8187,NCH-51,HDAC inhibitor,HDAC1,,,,HDAC1
8188,NCH-51,HDAC inhibitor,HDAC10,,,,HDAC10
8189,NCH-51,HDAC inhibitor,HDAC11,,,,HDAC11
8190,NCH-51,HDAC inhibitor,HDAC2,,,,HDAC2
8191,NCH-51,HDAC inhibitor,HDAC3,,,,HDAC3
8192,NCH-51,HDAC inhibitor,HDAC4,,,,HDAC4
8193,NCH-51,HDAC inhibitor,HDAC5,,,,HDAC5
8194,NCH-51,HDAC inhibitor,HDAC6,,,,HDAC6
8195,NCH-51,HDAC inhibitor,HDAC7,,,,HDAC7
8196,NCH-51,HDAC inhibitor,HDAC8,,,,HDAC8
8197,NCH-51,HDAC inhibitor,HDAC9,,,,HDAC9
8198,MST-312,telomerase inhibitor,TERT,,,,TERT
8199,WZ-3146,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor",EGFR,,,,EGFR
8200,QW-BI-011,histone lyinse methyltransferase inhibitor,EHMT2,,,,EHMT2
8201,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",ARF1,,,,ARF1
8202,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",ARFGEF1,,,,ARFGEF1
8203,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",ARFGEF2,,,,ARFGEF2
8204,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",CYTH2,,,,CYTH2
8205,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",GBF1,,,,GBF1
8206,brefeldin-a,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor",SAR1A,,,,SAR1A
8207,PD-0325901,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor",MAP2K1,,,,MAP2K1
8208,PD-0325901,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor",MAP2K2,,,,MAP2K2
8209,BRD-K00313977,APEX inhibitor,APEX1,,,,APEX1
8210,BRD-K37940862,neuropeptide receptor antagonist,NPSR1,,,,NPSR1
8211,iodophenpropit,"histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist",HRH3,,,,HRH3
8212,iodophenpropit,"histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist",HRH4,,,,HRH4
8213,iodophenpropit,"histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist",GRIN2B,,,,GRIN2B
8214,thiostrepton,"downregulates FOXM1 expression, FOXM1 expression inhibitor, protein synthesis inhibitor",FOXM1,,,,FOXM1
8215,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
8216,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM1,,,,CHRM1
8217,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM2,,,,CHRM2
8218,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM3,,,,CHRM3
8219,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM4,,,,CHRM4
8220,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM5,,,,CHRM5
8221,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",HTR2A,,,,HTR2A
8222,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
8223,alimemazine,histamine receptor ligand,HRH1,,,,HRH1
8224,WAY-170523,metalloproteinase inhibitor,MMP13,,,,MMP13
8225,perphenazine,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
8226,perphenazine,"dopamine receptor, dopamine receptor antagonist",CALM1,,,,CALM1
8227,perphenazine,"dopamine receptor, dopamine receptor antagonist",DRD1,,,,DRD1
8228,perphenazine,"dopamine receptor, dopamine receptor antagonist",HRH1,,,,HRH1
8229,perphenazine,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
8230,perphenazine,"dopamine receptor, dopamine receptor antagonist",HTR2C,,,,HTR2C
8231,perphenazine,"dopamine receptor, dopamine receptor antagonist",HTR6,,,,HTR6
8232,perphenazine,"dopamine receptor, dopamine receptor antagonist",HTR7,,,,HTR7
8233,MG-132,proteasome inhibitor,PSMB1,,,,PSMB1
8234,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
8235,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",KDR,,,,KDR
8236,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
8237,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",FLT1,,,,FLT1
8238,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",FLT3,,,,FLT3
8239,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",FLT4,,,,FLT4
8240,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",CSF1,,,,CSF1
8241,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",KIT,,,,KIT
8242,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
8243,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",RET,,,,RET
8244,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist",TEK,,,,TEK
8245,ispinesib,"kinesin family member inhibitor, kinesin inhibitor, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors",KIF11,,,,KIF11
8246,PD-0325901,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor",MAP2K1,,,,MAP2K1
8247,PD-0325901,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor",MAP2K2,,,,MAP2K2
8248,helveticoside,ATPase inhibitor,ATP1A1,,,,ATP1A1
8249,doxorubicin,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
8250,thiothixene,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
8251,thiothixene,"dopamine receptor, dopamine receptor antagonist",DRD1,,,,DRD1
8252,thiothixene,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
8253,thiothixene,"dopamine receptor, dopamine receptor antagonist",HRH1,,,,HRH1
8254,XMD-892,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor",MAPK7,,,,MAPK7
8255,XMD-892,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor",DCLK2,,,,DCLK2
8256,XMD-892,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
8257,XMD-892,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor",PLK4,,,,PLK4
8258,XMD-892,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor",TNK1,,,,TNK1
8259,GSK-1070916,Aurora kinase inhibitor,AURKB,,,,AURKB
8260,GSK-1070916,Aurora kinase inhibitor,AURKC,,,,AURKC
8261,GSK-1070916,Aurora kinase inhibitor,AURKA,,,,AURKA
8262,GSK-1070916,Aurora kinase inhibitor,CYP2D6,,,,CYP2D6
8263,GSK-1070916,Aurora kinase inhibitor,CYP3A4,,,,CYP3A4
8264,BNTX,opioid receptor antagonist,OPRD1,,,,OPRD1
8265,BNTX,opioid receptor antagonist,OPRK1,,,,OPRK1
8266,BNTX,opioid receptor antagonist,OPRM1,,,,OPRM1
8267,chaetocin,"histone lyinse methyltransferase inhibitor, histone lysine N methyltransferase inhibitor",EHMT2,,,,EHMT2
8268,chaetocin,"histone lyinse methyltransferase inhibitor, histone lysine N methyltransferase inhibitor",SUV39H1,,,,SUV39H1
8269,Y-134,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",ESR1,,,,ESR1
8270,Y-134,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",ESR2,,,,ESR2
8271,AS-703026,MEK inhibitor,MAP2K1,,,,MAP2K1
8272,AS-703026,MEK inhibitor,MAP2K2,,,,MAP2K2
8273,BIBX-1382,"EGFR inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
8274,BIBX-1382,"EGFR inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
8275,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
8276,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
8277,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
8278,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",ABCG2,,,,ABCG2
8279,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CA1,,,,CA1
8280,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1B,,,,CACNA1B
8281,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
8282,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA2D3,,,,CACNA2D3
8283,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNB1,,,,CACNB1
8284,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNB2,,,,CACNB2
8285,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",SMPD1,,,,SMPD1
8286,ZG-10,JNK inhibitor,MAPK8,,,,MAPK8
8287,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",ADIPOR2,,,,ADIPOR2
8288,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",IKBKB,,,,IKBKB
8289,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",RELA,,,,RELA
8290,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",EGFR,,,,EGFR
8291,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FGFR3,,,,FGFR3
8292,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
8293,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
8294,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
8295,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FGFR2,,,,FGFR2
8296,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FLT1,,,,FLT1
8297,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FLT3,,,,FLT3
8298,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",FLT4,,,,FLT4
8299,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",INSR,,,,INSR
8300,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",KDR,,,,KDR
8301,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",KIT,,,,KIT
8302,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
8303,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",PDPK1,,,,PDPK1
8304,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",CDK2,,,,CDK2
8305,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",CHEK1,,,,CHEK1
8306,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",GSK3B,,,,GSK3B
8307,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",IKBKE,,,,IKBKE
8308,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",KDR,,,,KDR
8309,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",PDK1,,,,PDK1
8310,BX-795,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor",TBK1,,,,TBK1
8311,AZD-7762,CHK inhibitor,CHEK1,,,,CHEK1
8312,AZD-7762,CHK inhibitor,CHEK2,,,,CHEK2
8313,BAPTA-AM,potassium channel blocker,KCNA3,,,,KCNA3
8314,BAPTA-AM,potassium channel blocker,KCNA5,,,,KCNA5
8315,BAPTA-AM,potassium channel blocker,KCNH2,,,,KCNH2
8316,alvespimycin,"HSP inhibitor, HSP antagonist",HSP90AA1,,,,HSP90AA1
8317,5-iodotubercidin,"adenosine kinase inhibitor, nucleoside transporter inhibitor",MAPK3,,,,MAPK3
8318,5-iodotubercidin,"adenosine kinase inhibitor, nucleoside transporter inhibitor",ADK,,,,ADK
8319,5-iodotubercidin,"adenosine kinase inhibitor, nucleoside transporter inhibitor",CSNK1G2,,,,CSNK1G2
8320,5-iodotubercidin,"adenosine kinase inhibitor, nucleoside transporter inhibitor",GSG2,,,,HASPIN
8321,5-iodotubercidin,"adenosine kinase inhibitor, nucleoside transporter inhibitor",LRRK2,,,,LRRK2
8322,T-98475,gonadotropin releasing factor hormone receptor antagonist,GNRH1,,,,GNRH1
8323,T-98475,gonadotropin releasing factor hormone receptor antagonist,GNRHR,,,,GNRHR
8324,PHA-793887,CDK inhibitor,CDK1,,,,CDK1
8325,PHA-793887,CDK inhibitor,CDK2,,,,CDK2
8326,PHA-793887,CDK inhibitor,CDK4,,,,CDK4
8327,PHA-793887,CDK inhibitor,CDK5,,,,CDK5
8328,PHA-793887,CDK inhibitor,CCND1,,,,CCND1
8329,PHA-793887,CDK inhibitor,CCNE1,,,,CCNE1
8330,PHA-793887,CDK inhibitor,CDK7,,,,CDK7
8331,PHA-793887,CDK inhibitor,CDK9,,,,CDK9
8332,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CA,,,,PIK3CA
8333,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CG,,,,PIK3CG
8334,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK1,,,,PLK1
8335,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATM,,,,ATM
8336,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATR,,,,ATR
8337,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",MTOR,,,,MTOR
8338,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KA,,,,PI4KA
8339,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KB,,,,PI4KB
8340,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CD,,,,PIK3CD
8341,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3R1,,,,PIK3R1
8342,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK3,,,,PLK3
8343,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PRKDC,,,,PRKDC
8344,hinokitiol,tyrosinase inhibitor,TYR,,,,TYR
8345,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",SMO,,,,SMO
8346,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",DHH,,,,DHH
8347,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",IHH,,,,IHH
8348,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",PTCH1,,,,PTCH1
8349,L-690488,nositol monophosphatase inhibitor,IMPA1,,,,IMPA1
8350,digitoxin,ATPase inhibitor,ATP1A1,,,,ATP1A1
8351,doxorubicin,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
8352,rimcazole,"sigma receptor antagonist, dopamine reuptake inhibitor",SIGMAR1,,,,SIGMAR1
8353,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK14,,,,MAPK14
8354,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",AKT1,,,,AKT1
8355,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",ALOX5,,,,ALOX5
8356,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",CHEK1,,,,CHEK1
8357,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",GSK3B,,,,GSK3B
8358,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",LCK,,,,LCK
8359,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK1,,,,MAPK1
8360,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK11,,,,MAPK11
8361,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK12,,,,MAPK12
8362,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK8,,,,MAPK8
8363,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",PRKCA,,,,PRKCA
8364,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",ROCK1,,,,ROCK1
8365,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",RPS6KB1,,,,RPS6KB1
8366,SB-202190,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor",SGK1,,,,SGK1
8367,malonoben,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
8368,PD-198306,"MAP kinase inhibitor, MEK inhibitor",MAP2K1,,,,MAP2K1
8369,PD-198306,"MAP kinase inhibitor, MEK inhibitor",MAP2K2,,,,MAP2K2
8370,PD-198306,"MAP kinase inhibitor, MEK inhibitor",MAPK1,,,,MAPK1
8371,PD-198306,"MAP kinase inhibitor, MEK inhibitor",MAPK3,,,,MAPK3
8372,fostamatinib,"syk inhibitor, FLT3 inhibitor",SYK,,,,SYK
8373,fostamatinib,"syk inhibitor, FLT3 inhibitor",FLT3,,,,FLT3
8374,fostamatinib,"syk inhibitor, FLT3 inhibitor",RET,,,,RET
8375,terreic-acid,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,,BTK
8376,niclosamide,"DNA replication inhibitor, STAT inhibitor",STAT3,,,,STAT3
8377,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP2,,,,USP2
8378,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP7,,,,USP7
8379,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",SENP2,,,,SENP2
8380,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP1,,,,USP1
8381,SU-11274,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET,,,,MET
8382,lylamine,cannabinoid receptor agonist,CNR1,,,,CNR1
8383,selumetinib,"MEK inhibitor, MAP kinase inhibitor",MAP2K1,,,,MAP2K1
8384,selumetinib,"MEK inhibitor, MAP kinase inhibitor",MAP2K2,,,,MAP2K2
8385,sertraline,"serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
8386,sertraline,"serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor",CYP2C19,,,,CYP2C19
8387,sertraline,"serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
8388,entinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
8389,entinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC2,,,,HDAC2
8390,entinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC3,,,,HDAC3
8391,entinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC9,,,,HDAC9
8392,L-733060,tachykinin antagonist,TACR1,,,,TACR1
8393,tetrindole,monoamine oxidase inhibitor,MAOA,,,,MAOA
8394,PF-562271,"focal adhesion kinase inhibitor, angiogenesis inhibitor, apoptosis stimulant",PTK2,,,,PTK2
8395,PF-562271,"focal adhesion kinase inhibitor, angiogenesis inhibitor, apoptosis stimulant",PTK2B,,,,PTK2B
8396,7b-cis,exportin antagonist,XPO1,,,,XPO1
8397,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",ACVR1,,,,ACVR1
8398,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",BMPR1A,,,,BMPR1A
8399,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",BMPR1B,,,,BMPR1B
8400,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",EPHA2,,,,EPHA2
8401,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",FKBP1A,,,,FKBP1A
8402,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",FLT1,,,,FLT1
8403,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",FLT3,,,,FLT3
8404,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",KDR,,,,KDR
8405,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",LCK,,,,LCK
8406,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",MKNK1,,,,MKNK1
8407,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",PRKAA1,,,,PRKAA1
8408,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",RPS6KA1,,,,RPS6KA1
8409,dorsomorphin,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor",SRC,,,,SRC
8410,digoxin,"ATPase inhibitor, ROR antagonist",ATP1A1,,,,ATP1A1
8411,digoxin,"ATPase inhibitor, ROR antagonist",ABCB1,,,,ABCB1
8412,digoxin,"ATPase inhibitor, ROR antagonist",RORC,,,,RORC
8413,digoxin,"ATPase inhibitor, ROR antagonist",SLCO1B3,,,,SLCO1B3
8414,berbamine,calmodulin antagonist,CALM1,,,,CALM1
8415,pirarubicin,topoisomerase inhibitor,TOP2A,,,,TOP2A
8416,digoxin,"ATPase inhibitor, ROR antagonist",ATP1A1,,,,ATP1A1
8417,digoxin,"ATPase inhibitor, ROR antagonist",ABCB1,,,,ABCB1
8418,digoxin,"ATPase inhibitor, ROR antagonist",RORC,,,,RORC
8419,digoxin,"ATPase inhibitor, ROR antagonist",SLCO1B3,,,,SLCO1B3
8420,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK2,,,,CDK2
8421,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK4,,,,CDK4
8422,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK1,,,,CDK1
8423,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK6,,,,CDK6
8424,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK7,,,,CDK7
8425,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK9,,,,CDK9
8426,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK5,,,,CDK5
8427,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CDK8,,,,CDK8
8428,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",EGFR,,,,EGFR
8429,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",PYGM,,,,PYGM
8430,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",BCL2,,,,BCL2
8431,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",BIRC5,,,,BIRC5
8432,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",CCNT1,,,,CCNT1
8433,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",MCL1,,,,MCL1
8434,alvocidib,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor",XIAP,,,,XIAP
8435,clomifene,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist",ESR1,,,,ESR1
8436,clomifene,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist",AR,,,,AR
8437,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",ACLY,,,,ACLY
8438,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",DLAT,,,,DLAT
8439,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",HSP90AB1,,,,HSP90AB1
8440,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",HSP90B1,,,,HSP90B1
8441,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",MAP3K7,,,,MAP3K7
8442,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",OPRM1,,,,OPRM1
8443,radicicol,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor",PDK3,,,,PDK3
8444,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP2C19,,,,CYP2C19
8445,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP3A5,,,,CYP3A5
8446,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP3A7,,,,CYP3A7
8447,droxinostat,HDAC inhibitor,HDAC6,,,,HDAC6
8448,droxinostat,HDAC inhibitor,HDAC8,,,,HDAC8
8449,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",KDR,,,,KDR
8450,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT1,,,,FLT1
8451,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT4,,,,FLT4
8452,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",KIT,,,,KIT
8453,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
8454,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
8455,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT3,,,,FLT3
8456,cediranib,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
8457,sarmentogenin,ATPase inhibitor,ATP1A1,,,,ATP1A1
8458,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK2,,,,CDK2
8459,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK5,,,,CDK5
8460,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK1,,,,CDK1
8461,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK4,,,,CDK4
8462,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK6,,,,CDK6
8463,AT-7519,"CDK inhibitor, cell cycle inhibitor",CDK9,,,,CDK9
8464,obatoclax,"BCL inhibitor, MCL1 inhibitor",BCL2,,,,BCL2
8465,obatoclax,"BCL inhibitor, MCL1 inhibitor",BCL2L1,,,,BCL2L1
8466,obatoclax,"BCL inhibitor, MCL1 inhibitor",MCL1,,,,MCL1
8467,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",AKT1,,,,AKT1
8468,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",CHEK1,,,,CHEK1
8469,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",GSK3B,,,,GSK3B
8470,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",JAK2,,,,JAK2
8471,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",LCK,,,,LCK
8472,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K1,,,,MAP2K1
8473,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K2,,,,MAP2K2
8474,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAP2K7,,,,MAP2K7
8475,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK1,,,,MAPK1
8476,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK11,,,,MAPK11
8477,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK12,,,,MAPK12
8478,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK14,,,,MAPK14
8479,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",MAPK8,,,,MAPK8
8480,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",PRKCA,,,,PRKCA
8481,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",RAF1,,,,RAF1
8482,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",ROCK1,,,,ROCK1
8483,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",RPS6KB1,,,,RPS6KB1
8484,U-0126,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor",SGK1,,,,SGK1
8485,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR,,,,PTGIR
8486,afatinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
8487,afatinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
8488,afatinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB4,,,,ERBB4
8489,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",DRD2,,,,DRD2
8490,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1A,,,,HTR1A
8491,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1B,,,,HTR1B
8492,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1D,,,,HTR1D
8493,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1E,,,,HTR1E
8494,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1F,,,,HTR1F
8495,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2A,,,,HTR2A
8496,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2B,,,,HTR2B
8497,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2C,,,,HTR2C
8498,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR5A,,,,HTR5A
8499,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR6,,,,HTR6
8500,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR7,,,,HTR7
8501,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",BDKRB2,,,,BDKRB2
8502,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",SIGMAR1,,,,SIGMAR1
8503,NVP-TAE684,"ALK tyrosine kinase receptor inhibitor, ALK tyrosine kinase receptor mutant inhibitor, leucine rich repeat kinase inhibitor",ALK,,,,ALK
8504,NVP-TAE684,"ALK tyrosine kinase receptor inhibitor, ALK tyrosine kinase receptor mutant inhibitor, leucine rich repeat kinase inhibitor",INSR,,,,INSR
8505,triptolide,RNA polymerase inhibitor,CYP2C19,,,,CYP2C19
8506,triptolide,RNA polymerase inhibitor,RELA,,,,RELA
8507,mitoxantrone,"topoisomerase inhibitor, DNA intercalating drug, HCV inhibitor, immunosuppressant, Pim kinase inhibitor",TOP2A,,,,TOP2A
8508,mitoxantrone,"topoisomerase inhibitor, DNA intercalating drug, HCV inhibitor, immunosuppressant, Pim kinase inhibitor",PIM1,,,,PIM1
8509,protriptyline,tricyclic antidepressant (TCA),SLC6A2,,,,SLC6A2
8510,NTNCB,neuropeptide receptor antagonist,NPY5R,,,,NPY5R
8511,dactinomycin,"DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor",POLR2A,,,,POLR2A
8512,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",MTOR,,,,MTOR
8513,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
8514,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",CCR5,,,,CCR5
8515,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FGF2,,,,FGF2
8516,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",ALOX5,,,,ALOX5
8517,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",MIF,,,,MIF
8518,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",RELA,,,,RELA
8519,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",TNF,,,,TNF
8520,pirlindole,monoamine oxidase inhibitor,MAOA,,,,MAOA
8521,pirlindole,monoamine oxidase inhibitor,SLC6A2,,,,SLC6A2
8522,pirlindole,monoamine oxidase inhibitor,SLC6A4,,,,SLC6A4
8523,NNC-55-0396,T-type calcium channel blocker,CATSPER1,,,,CATSPER1
8524,NNC-55-0396,T-type calcium channel blocker,CATSPER2,,,,CATSPER2
8525,NNC-55-0396,T-type calcium channel blocker,CATSPER3,,,,CATSPER3
8526,NNC-55-0396,T-type calcium channel blocker,CATSPER4,,,,CATSPER4
8527,H-9,"cAMP dependent protein kinase inhibitor, PKA inhibitor",PRKACA,,,,PRKACA
8528,digoxin,"ATPase inhibitor, ROR antagonist",ATP1A1,,,,ATP1A1
8529,digoxin,"ATPase inhibitor, ROR antagonist",ABCB1,,,,ABCB1
8530,digoxin,"ATPase inhibitor, ROR antagonist",RORC,,,,RORC
8531,digoxin,"ATPase inhibitor, ROR antagonist",SLCO1B3,,,,SLCO1B3
8532,floxuridine,"DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist",TYMS,,,,TYMS
8533,CGP-60474,"CDK inhibitor, PKC inhibitor",CDK1,,,,CDK1
8534,CGP-60474,"CDK inhibitor, PKC inhibitor",CDK2,,,,CDK2
8535,clocortolone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
8536,clocortolone,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
8537,LY-303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",CSNK2A1,,,,CSNK2A1
8538,LY-303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",CSNK2A2,,,,CSNK2A2
8539,LY-303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",CSNK2B,,,,CSNK2B
8540,LY-303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",MTOR,,,,MTOR
8541,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2A,,,,TOP2A
8542,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2B,,,,TOP2B
8543,JTE-907,cannabinoid receptor inverse agonist,CNR2,,,,CNR2
8544,UK-356618,metalloproteinase inhibitor,MMP3,,,,MMP3
8545,UK-356618,metalloproteinase inhibitor,MMP13,,,,MMP13
8546,UK-356618,metalloproteinase inhibitor,MMP14,,,,MMP14
8547,UK-356618,metalloproteinase inhibitor,MMP2,,,,MMP2
8548,UK-356618,metalloproteinase inhibitor,MMP9,,,,MMP9
8549,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor",CDK1,,,,CDK1
8550,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor",CDK2,,,,CDK2
8551,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor",CDK5,,,,CDK5
8552,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor",CDK6,,,,CDK6
8553,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
8554,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
8555,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",CALM1,,,,CALM1
8556,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",CHRNA7,,,,CHRNA7
8557,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD5,,,,DRD5
8558,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
8559,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
8560,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
8561,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
8562,ER-27319,"mediator release inhibitor, syk inhibitor",SYK,,,,SYK
8563,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",SLC6A2,,,,SLC6A2
8564,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",SLC6A4,,,,SLC6A4
8565,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",SLC6A3,,,,SLC6A3
8566,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRA1A,,,,ADRA1A
8567,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRA1B,,,,ADRA1B
8568,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRA2A,,,,ADRA2A
8569,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRA2B,,,,ADRA2B
8570,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRB1,,,,ADRB1
8571,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRB2,,,,ADRB2
8572,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",ADRB3,,,,ADRB3
8573,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",CHRM1,,,,CHRM1
8574,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",CHRM2,,,,CHRM2
8575,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",CHRM3,,,,CHRM3
8576,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",CHRM4,,,,CHRM4
8577,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",CHRM5,,,,CHRM5
8578,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",DRD1,,,,DRD1
8579,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",DRD2,,,,DRD2
8580,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",DRD5,,,,DRD5
8581,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HRH1,,,,HRH1
8582,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HTR1A,,,,HTR1A
8583,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HTR1D,,,,HTR1D
8584,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HTR2A,,,,HTR2A
8585,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HTR2C,,,,HTR2C
8586,trimipramine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)",HTR3A,,,,HTR3A
8587,roscovitine,"CDK inhibitor, apoptosis stimulant",CDK2,,,,CDK2
8588,roscovitine,"CDK inhibitor, apoptosis stimulant",CDK9,,,,CDK9
8589,roscovitine,"CDK inhibitor, apoptosis stimulant",CDK7,,,,CDK7
8590,roscovitine,"CDK inhibitor, apoptosis stimulant",CDK1,,,,CDK1
8591,roscovitine,"CDK inhibitor, apoptosis stimulant",CDK5,,,,CDK5
8592,flumetasone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
8593,flumetasone,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
8594,PD-184352,"MEK inhibitor, MAP kinase inhibitor",MAP2K1,,,,MAP2K1
8595,PD-184352,"MEK inhibitor, MAP kinase inhibitor",MAP2K2,,,,MAP2K2
8596,PD-184352,"MEK inhibitor, MAP kinase inhibitor",MAP3K1,,,,MAP3K1
8597,PD-184352,"MEK inhibitor, MAP kinase inhibitor",MAP3K2,,,,MAP3K2
8598,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1G,,,,CACNA1G
8599,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1H,,,,CACNA1H
8600,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1C,,,,CACNA1C
8601,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1I,,,,CACNA1I
8602,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",ANO1,,,,ANO1
8603,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1D,,,,CACNA1D
8604,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1F,,,,CACNA1F
8605,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1S,,,,CACNA1S
8606,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB1,,,,CACNB1
8607,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB2,,,,CACNB2
8608,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB3,,,,CACNB3
8609,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB4,,,,CACNB4
8610,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER1,,,,CATSPER1
8611,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER2,,,,CATSPER2
8612,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER3,,,,CATSPER3
8613,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER4,,,,CATSPER4
8614,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CYP3A5,,,,CYP3A5
8615,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CYP3A7,,,,CYP3A7
8616,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN2A,,,,SCN2A
8617,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN4A,,,,SCN4A
8618,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN5A,,,,SCN5A
8619,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN9A,,,,SCN9A
8620,dactinomycin,"DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor",POLR2A,,,,POLR2A
8621,RS-39604,serotonin receptor antagonist,HTR4,,,,HTR4
8622,canertinib,"EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
8623,canertinib,"EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
8624,canertinib,"EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB4,,,,ERBB4
8625,canertinib,"EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",AKT1,,,,AKT1
8626,triptolide,RNA polymerase inhibitor,CYP2C19,,,,CYP2C19
8627,triptolide,RNA polymerase inhibitor,RELA,,,,RELA
8628,AZ-628,RAF inhibitor,BRAF,,,,BRAF
8629,AZ-628,RAF inhibitor,RAF1,,,,RAF1
8630,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",HTR2B,,,,HTR2B
8631,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",CHRM1,,,,CHRM1
8632,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",CHRM2,,,,CHRM2
8633,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",CHRNA7,,,,CHRNA7
8634,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",DRD1,,,,DRD1
8635,triflupromazine,"acetylcholine receptor ligand, dopamine receptor",DRD2,,,,DRD2
8636,indatraline,"norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
8637,indatraline,"norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
8638,indatraline,"norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
8639,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1A,,,,ADRA1A
8640,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",CACNA1C,,,,CACNA1C
8641,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1B,,,,ADRA1B
8642,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1D,,,,ADRA1D
8643,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",KCNJ10,,,,KCNJ10
8644,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",SLC6A2,,,,SLC6A2
8645,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",SLC6A4,,,,SLC6A4
8646,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA1A,,,,ADRA1A
8647,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA1B,,,,ADRA1B
8648,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA1D,,,,ADRA1D
8649,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA2A,,,,ADRA2A
8650,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA2B,,,,ADRA2B
8651,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRA2C,,,,ADRA2C
8652,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRB1,,,,ADRB1
8653,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRB2,,,,ADRB2
8654,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",ADRB3,,,,ADRB3
8655,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CHRM1,,,,CHRM1
8656,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CHRM2,,,,CHRM2
8657,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CHRM3,,,,CHRM3
8658,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CHRM4,,,,CHRM4
8659,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CHRM5,,,,CHRM5
8660,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",CYP2C19,,,,CYP2C19
8661,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",DRD2,,,,DRD2
8662,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",HRH1,,,,HRH1
8663,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",HTR1A,,,,HTR1A
8664,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",HTR2A,,,,HTR2A
8665,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",HTR2C,,,,HTR2C
8666,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",HTR6,,,,HTR6
8667,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",PGRMC1,,,,PGRMC1
8668,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",PIK3CD,,,,PIK3CD
8669,nortriptyline,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)",SIGMAR1,,,,SIGMAR1
8670,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR1,,,,ESR1
8671,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR2,,,,ESR2
8672,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",CYP3A5,,,,CYP3A5
8673,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",EBP,,,,EBP
8674,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",GPER1,,,,GPER1
8675,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCA,,,,PRKCA
8676,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCB,,,,PRKCB
8677,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCD,,,,PRKCD
8678,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCE,,,,PRKCE
8679,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCG,,,,PRKCG
8680,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCI,,,,PRKCI
8681,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCQ,,,,PRKCQ
8682,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCZ,,,,PRKCZ
8683,PIK-75,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
8684,PIK-75,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CB,,,,PIK3CB
8685,PIK-75,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CD,,,,PIK3CD
8686,PIK-75,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CG,,,,PIK3CG
8687,PIK-75,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PRKDC,,,,PRKDC
8688,ICI-199441,opioid receptor agonist,OPRK1,,,,OPRK1
8689,ICI-199441,opioid receptor agonist,CYP2D6,,,,CYP2D6
8690,ICI-199441,opioid receptor agonist,OPRD1,,,,OPRD1
8691,ICI-199441,opioid receptor agonist,OPRM1,,,,OPRM1
8692,ICI-199441,opioid receptor agonist,UTS2R,,,,UTS2R
8693,eugenol,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator",AR,,,,AR
8694,eugenol,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator",MAOA,,,,MAOA
8695,bufalin,"ATPase inhibitor, chloride channel activator",ATP1A1,,,,ATP1A1
8696,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FGFR1,,,,FGFR1
8697,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FGFR3,,,,FGFR3
8698,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FGFR2,,,,FGFR2
8699,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FGFR4,,,,FGFR4
8700,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FLT1,,,,FLT1
8701,PD-173074,"FGFR inhibitor, VEGFR inhibitor",FLT4,,,,FLT4
8702,PD-173074,"FGFR inhibitor, VEGFR inhibitor",KDR,,,,KDR
8703,PD-173074,"FGFR inhibitor, VEGFR inhibitor",PDGFRA,,,,PDGFRA
8704,PD-173074,"FGFR inhibitor, VEGFR inhibitor",PDGFRB,,,,PDGFRB
8705,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP2,,,,USP2
8706,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP7,,,,USP7
8707,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",SENP2,,,,SENP2
8708,NSC-632839,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor",USP1,,,,USP1
8709,BMS-345541,IKK inhibitor,IKBKB,,,,IKBKB
8710,BMS-345541,IKK inhibitor,CHUK,,,,CHUK
8711,mephenytoin,cytochrome P450 substrate,SCN5A,,,,SCN5A
8712,mephenytoin,cytochrome P450 substrate,CYP2C19,,,,CYP2C19
8713,azithromycin,"50S ribosomal subunit inhibitor, protein synthesis inhibitor",MLNR,,,,MLNR
8714,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",MTOR,,,,MTOR
8715,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
8716,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",CCR5,,,,CCR5
8717,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FGF2,,,,FGF2
8718,BRD-K85853281,"radical formation stimulant, RNA synthesis inhibitor, topoisomerase inhibitor",TOP2A,,,,TOP2A
8719,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",NHP2L1,,,,SNU13
8720,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL10L,,,,RPL10L
8721,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL11,,,,RPL11
8722,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL13A,,,,RPL13A
8723,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL15,,,,RPL15
8724,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL19,,,,RPL19
8725,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL23,,,,RPL23
8726,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL23A,,,,RPL23A
8727,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL26L1,,,,RPL26L1
8728,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL3,,,,RPL3
8729,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL37,,,,RPL37
8730,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL8,,,,RPL8
8731,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RSL24D1,,,,RSL24D1
8732,AS-605240,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",MAOB,,,,MAOB
8733,AS-605240,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
8734,AS-605240,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CB,,,,PIK3CB
8735,AS-605240,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CD,,,,PIK3CD
8736,AS-605240,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CG,,,,PIK3CG
8737,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",NHP2L1,,,,SNU13
8738,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL10L,,,,RPL10L
8739,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL11,,,,RPL11
8740,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL13A,,,,RPL13A
8741,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL15,,,,RPL15
8742,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL19,,,,RPL19
8743,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL23,,,,RPL23
8744,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL23A,,,,RPL23A
8745,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL26L1,,,,RPL26L1
8746,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL3,,,,RPL3
8747,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL37,,,,RPL37
8748,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RPL8,,,,RPL8
8749,puromycin,"adenosine receptor agonist, protein synthesis inhibitor",RSL24D1,,,,RSL24D1
8750,clobetasol,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
8751,clobetasol,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
8752,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",ADA,,,,ADA
8753,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",DCK,,,,DCK
8754,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
8755,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
8756,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
8757,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",KDR,,,,KDR
8758,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",FLT1,,,,FLT1
8759,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",KIT,,,,KIT
8760,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
8761,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
8762,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",FLT3,,,,FLT3
8763,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",MET,,,,MET
8764,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
8765,semaxanib,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",RET,,,,RET
8766,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",FLT3,,,,FLT3
8767,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",KIT,,,,KIT
8768,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFRA,,,,PDGFRA
8769,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFRB,,,,PDGFRB
8770,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",CSF1R,,,,CSF1R
8771,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFD,,,,PDGFD
8772,SB-334867,orexin receptor antagonist,HCRTR1,,,,HCRTR1
8773,SB-334867,orexin receptor antagonist,HCRTR2,,,,HCRTR2
8774,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2A,,,,TOP2A
8775,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2B,,,,TOP2B
8776,hyperforin,"cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor",NR1I2,,,,NR1I2
8777,hyperforin,"cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor",ALOX5,,,,ALOX5
8778,hyperforin,"cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor",PTGS1,,,,PTGS1
8779,hyperforin,"cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor",TRPC6,,,,TRPC6
8780,CS-110266,dopamine receptor agonist,SLC6A3,,,,SLC6A3
8781,PHA-665752,"c-Met inhibitor, hepatocyte growth factor receptor inhibitor",MET,,,,MET
8782,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
8783,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA7,,,,CA7
8784,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",DRD3,,,,DRD3
8785,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA1,,,,CA1
8786,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA12,,,,CA12
8787,depudecin,HDAC inhibitor,HDAC1,,,,HDAC1
8788,depudecin,HDAC inhibitor,HDAC2,,,,HDAC2
8789,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",ABL1,,,,ABL1
8790,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",FYN,,,,FYN
8791,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",LCK,,,,LCK
8792,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",SRC,,,,SRC
8793,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",KIT,,,,KIT
8794,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",YES1,,,,YES1
8795,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",BCR,,,,BCR
8796,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",EPHA2,,,,EPHA2
8797,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",LYN,,,,LYN
8798,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",PDGFRB,,,,PDGFRB
8799,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",ABL2,,,,ABL2
8800,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",BTK,,,,BTK
8801,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",DDR1,,,,DDR1
8802,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",DDR2,,,,DDR2
8803,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",PDGFRA,,,,PDGFRA
8804,dasatinib,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor",STAT5B,,,,STAT5B
8805,homochlorcyclizine,antihistamine,HRH1,,,,HRH1
8806,PSB-36,adenosine receptor antagonist,ADORA1,,,,ADORA1
8807,PSB-36,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
8808,PSB-36,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
8809,PSB-36,adenosine receptor antagonist,ADORA3,,,,ADORA3
8810,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",AR,,,,AR
8811,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP19A1,,,,CYP19A1
8812,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP21A2,,,,CYP21A2
8813,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP2C19,,,,CYP2C19
8814,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP3A5,,,,CYP3A5
8815,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP3A7,,,,CYP3A7
8816,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",KCNA10,,,,KCNA10
8817,IKK-16,IKK inhibitor,IKBKB,,,,IKBKB
8818,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",ABL1,,,,ABL1
8819,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",BRAF,,,,BRAF
8820,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",CSF1R,,,,CSF1R
8821,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",EGFR,,,,EGFR
8822,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",FGFR1,,,,FGFR1
8823,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",FLT3,,,,FLT3
8824,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",KIT,,,,KIT
8825,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",MAPK11,,,,MAPK11
8826,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",PDGFRB,,,,PDGFRB
8827,HG-6-64-01,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor",RET,,,,RET
8828,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",DRD2,,,,DRD2
8829,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR1A,,,,HTR1A
8830,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR2A,,,,HTR2A
8831,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HRH1,,,,HRH1
8832,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR1B,,,,HTR1B
8833,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR1D,,,,HTR1D
8834,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR2C,,,,HTR2C
8835,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",ADRA1A,,,,ADRA1A
8836,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",ADRA1B,,,,ADRA1B
8837,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",ADRA2A,,,,ADRA2A
8838,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",ADRA2B,,,,ADRA2B
8839,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",ADRA2C,,,,ADRA2C
8840,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",CHRM1,,,,CHRM1
8841,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",CHRM2,,,,CHRM2
8842,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",CHRM3,,,,CHRM3
8843,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",CHRM4,,,,CHRM4
8844,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",CHRM5,,,,CHRM5
8845,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",DRD1,,,,DRD1
8846,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",DRD3,,,,DRD3
8847,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",DRD4,,,,DRD4
8848,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",DRD5,,,,DRD5
8849,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR1E,,,,HTR1E
8850,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR3A,,,,HTR3A
8851,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR6,,,,HTR6
8852,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist",HTR7,,,,HTR7
8853,dexbrompheniramine,histamine receptor antagonist,HRH1,,,,HRH1
8854,KB-R7943,sodium/calcium exchange inhibitor,SLC8A1,,,,SLC8A1
8855,KB-R7943,sodium/calcium exchange inhibitor,TRPC3,,,,TRPC3
8856,KB-R7943,sodium/calcium exchange inhibitor,TRPC5,,,,TRPC5
8857,KB-R7943,sodium/calcium exchange inhibitor,TRPC6,,,,TRPC6
8858,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",CAMK2A,,,,CAMK2A
8859,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",LCK,,,,LCK
8860,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",MAPK8,,,,MAPK8
8861,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",PRKACA,,,,PRKACA
8862,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",RIPK2,,,,RIPK2
8863,NM-PP1,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor",SRC,,,,SRC
8864,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",DRD2,,,,DRD2
8865,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1A,,,,HTR1A
8866,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1B,,,,HTR1B
8867,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1D,,,,HTR1D
8868,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1E,,,,HTR1E
8869,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR1F,,,,HTR1F
8870,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2A,,,,HTR2A
8871,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2B,,,,HTR2B
8872,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR2C,,,,HTR2C
8873,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR5A,,,,HTR5A
8874,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR6,,,,HTR6
8875,metergoline,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor",HTR7,,,,HTR7
8876,MBCQ,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
8877,MK-2206,AKT inhibitor,AKT1,,,,AKT1
8878,MK-2206,AKT inhibitor,AKT2,,,,AKT2
8879,MK-2206,AKT inhibitor,AKT3,,,,AKT3
8880,bis-tyrphostin,"EGFR inhibitor, dynamin GTPase inhibitor",DNM1,,,,DNM1
8881,bis-tyrphostin,"EGFR inhibitor, dynamin GTPase inhibitor",EGFR,,,,EGFR
8882,saracatinib,"src inhibitor, Abl kinase inhibitor",SRC,,,,SRC
8883,saracatinib,"src inhibitor, Abl kinase inhibitor",ABL1,,,,ABL1
8884,saracatinib,"src inhibitor, Abl kinase inhibitor",LCK,,,,LCK
8885,saracatinib,"src inhibitor, Abl kinase inhibitor",YES1,,,,YES1
8886,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2A,,,,TOP2A
8887,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant",TOP2B,,,,TOP2B
8888,clobetasol,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
8889,clobetasol,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
8890,JNJ-7706621,"CDK inhibitor, Aurora kinase inhibitor",CDK1,,,,CDK1
8891,JNJ-7706621,"CDK inhibitor, Aurora kinase inhibitor",CDK2,,,,CDK2
8892,JNJ-7706621,"CDK inhibitor, Aurora kinase inhibitor",AURKA,,,,AURKA
8893,JNJ-7706621,"CDK inhibitor, Aurora kinase inhibitor",AURKB,,,,AURKB
8894,benidipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
8895,benidipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1G,,,,CACNA1G
8896,benidipine,"calcium channel blocker, L-type calcium channel blocker",CYP3A5,,,,CYP3A5
8897,TAS-301,voltage-independent calcium influx blocker,CAMK2A,,,,CAMK2A
8898,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",PRKACA,,,,PRKACA
8899,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",GSG2,,,,HASPIN
8900,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNA2,,,,KCNA2
8901,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNA3,,,,KCNA3
8902,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNA5,,,,KCNA5
8903,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNAB2,,,,KCNAB2
8904,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNC1,,,,KCNC1
8905,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNC2,,,,KCNC2
8906,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNC3,,,,KCNC3
8907,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNE1,,,,KCNE1
8908,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNE2,,,,KCNE2
8909,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNE3,,,,KCNE3
8910,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNE4,,,,KCNE4
8911,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNH1,,,,KCNH1
8912,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNH2,,,,KCNH2
8913,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNQ1,,,,KCNQ1
8914,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNQ2,,,,KCNQ2
8915,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNQ3,,,,KCNQ3
8916,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNQ5,,,,KCNQ5
8917,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",KCNS3,,,,KCNS3
8918,H-89,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker",PKIA,,,,PKIA
8919,BRD-K97951054,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",AURKB,,,,AURKB
8920,BRD-K97951054,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",KDR,,,,KDR
8921,BRD-K97951054,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",PIM1,,,,PIM1
8922,retinol,RAR receptor binder,ALDH1A1,,,,ALDH1A1
8923,retinol,RAR receptor binder,ALDH1A2,,,,ALDH1A2
8924,retinol,RAR receptor binder,ALDH1A3,,,,ALDH1A3
8925,retinol,RAR receptor binder,DHRS3,,,,DHRS3
8926,retinol,RAR receptor binder,DHRS4,,,,DHRS4
8927,retinol,RAR receptor binder,LRAT,,,,LRAT
8928,retinol,RAR receptor binder,NR2C2,,,,NR2C2
8929,retinol,RAR receptor binder,RBP1,,,,RBP1
8930,retinol,RAR receptor binder,RBP3,,,,RBP3
8931,retinol,RAR receptor binder,RDH11,,,,RDH11
8932,retinol,RAR receptor binder,RDH12,,,,RDH12
8933,retinol,RAR receptor binder,RDH13,,,,RDH13
8934,retinol,RAR receptor binder,RDH14,,,,RDH14
8935,retinol,RAR receptor binder,RDH5,,,,RDH5
8936,retinol,RAR receptor binder,RDH8,,,,RDH8
8937,retinol,RAR receptor binder,RETSAT,,,,RETSAT
8938,retinol,RAR receptor binder,RHO,,,,RHO
8939,retinol,RAR receptor binder,RLBP1,,,,RLBP1
8940,retinol,RAR receptor binder,RXRA,,,,RXRA
8941,retinol,RAR receptor binder,RXRB,,,,RXRB
8942,retinol,RAR receptor binder,RXRG,,,,RXRG
8943,naftifine,"squalene epoxidase inhibitor, steroid sulfatase inhibitor",SQLE,,,,SQLE
8944,toremifene,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist",ESR1,,,,ESR1
8945,toremifene,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist",CYP3A5,,,,CYP3A5
8946,noretynodrel,progestogen steroid hormone,PGR,,,,PGR
8947,PD-160170,neuropeptide receptor antagonist,NPY1R,,,,NPY1R
8948,RS-17053,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
8949,RS-17053,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
8950,clemastine,histamine receptor antagonist,HRH1,,,,HRH1
8951,cyclophosphamide,"alkylating agrent, BCL inhibitor, galectin inhibitor",BCL2,,,,BCL2
8952,cyclophosphamide,"alkylating agrent, BCL inhibitor, galectin inhibitor",CYP2B6,,,,CYP2B6
8953,cyclophosphamide,"alkylating agrent, BCL inhibitor, galectin inhibitor",CYP2C19,,,,CYP2C19
8954,cyclophosphamide,"alkylating agrent, BCL inhibitor, galectin inhibitor",CYP3A5,,,,CYP3A5
8955,cyclophosphamide,"alkylating agrent, BCL inhibitor, galectin inhibitor",LGALS1,,,,LGALS1
8956,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",PTGS1,,,,PTGS1
8957,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",PTGS2,,,,PTGS2
8958,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",SIRT1,,,,SIRT1
8959,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",APOA1,,,,APOA1
8960,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",BACE1,,,,BACE1
8961,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",CSNK2A1,,,,CSNK2A1
8962,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",MAOA,,,,MAOA
8963,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",NQO2,,,,NQO2
8964,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",SCN5A,,,,SCN5A
8965,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",TXNRD1,,,,TXNRD1
8966,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",TXNRD2,,,,TXNRD2
8967,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
8968,WYE-354,mTOR inhibitor,MTOR,,,,MTOR
8969,tetrabenazine,vesicular monoamine transporter inhibitor,SLC18A2,,,,SLC18A2
8970,tetrabenazine,vesicular monoamine transporter inhibitor,DRD2,,,,DRD2
8971,tetrabenazine,vesicular monoamine transporter inhibitor,SLC18A1,,,,SLC18A1
8972,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",KCNH2,,,,KCNH2
8973,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",PRKCD,,,,PRKCD
8974,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",TGM2,,,,TGM2
8975,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MTOR,,,,MTOR
8976,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PIK3CD,,,,PIK3CD
8977,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PIK3CG,,,,PIK3CG
8978,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PIK3CA,,,,PIK3CA
8979,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PIK3CB,,,,PIK3CB
8980,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PLK1,,,,PLK1
8981,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PRKDC,,,,PRKDC
8982,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",AKT1,,,,AKT1
8983,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",CHEK1,,,,CHEK1
8984,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",GSK3B,,,,GSK3B
8985,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",LCK,,,,LCK
8986,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MAPK1,,,,MAPK1
8987,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MAPK11,,,,MAPK11
8988,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MAPK12,,,,MAPK12
8989,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MAPK14,,,,MAPK14
8990,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",MAPK8,,,,MAPK8
8991,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PDE2A,,,,PDE2A
8992,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",PRKCA,,,,PRKCA
8993,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",ROCK1,,,,ROCK1
8994,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",RPS6KB1,,,,RPS6KB1
8995,LY-294002,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor",SGK1,,,,SGK1
8996,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",ADIPOR2,,,,ADIPOR2
8997,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",IKBKB,,,,IKBKB
8998,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",RELA,,,,RELA
8999,naltrindole,opioid receptor antagonist,OPRD1,,,,OPRD1
9000,naltrindole,opioid receptor antagonist,OPRK1,,,,OPRK1
9001,naltrindole,opioid receptor antagonist,OPRM1,,,,OPRM1
9002,m-chlorophenylbiguanide,serotonin receptor agonist,HTR3A,,,,HTR3A
9003,m-chlorophenylbiguanide,serotonin receptor agonist,HTR3B,,,,HTR3B
9004,TPCA-1,IKK inhibitor,IKBKB,,,,IKBKB
9005,reserpine,vesicular monoamine transporter inhibitor,SLC18A2,,,,SLC18A2
9006,reserpine,vesicular monoamine transporter inhibitor,SLC18A1,,,,SLC18A1
9007,rabeprazole,"ATPase inhibitor, gastrin inhibitor",ATP4A,,,,ATP4A
9008,rabeprazole,"ATPase inhibitor, gastrin inhibitor",CYP2C19,,,,CYP2C19
9009,salbutamol,adrenergic receptor agonist,ADRB2,,,,ADRB2
9010,salbutamol,adrenergic receptor agonist,ADRB1,,,,ADRB1
9011,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",PDPK1,,,,PDPK1
9012,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",AKT2,,,,AKT2
9013,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",CDK2,,,,CDK2
9014,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",CHEK1,,,,CHEK1
9015,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",GSK3B,,,,GSK3B
9016,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",KDR,,,,KDR
9017,BX-912,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor",PDK1,,,,PDK1
9018,PSB-1115,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
9019,PSB-1115,adenosine receptor antagonist,ADORA1,,,,ADORA1
9020,PSB-1115,adenosine receptor antagonist,ADORA3,,,,ADORA3
9021,LE-300,"dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand",DRD5,,,,DRD5
9022,LE-300,"dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand",DRD1,,,,DRD1
9023,LE-300,"dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand",HTR2A,,,,HTR2A
9024,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",SIRT1,,,,SIRT1
9025,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",AKT1,,,,AKT1
9026,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",GSK3B,,,,GSK3B
9027,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",LCK,,,,LCK
9028,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",LRRK2,,,,LRRK2
9029,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",MAPK1,,,,MAPK1
9030,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",MAPK11,,,,MAPK11
9031,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",MAPK12,,,,MAPK12
9032,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",MAPK14,,,,MAPK14
9033,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",MAPK8,,,,MAPK8
9034,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",PRKCA,,,,PRKCA
9035,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",ROCK1,,,,ROCK1
9036,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",RPS6KB1,,,,RPS6KB1
9037,bisindolylmaleimide-ix,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor",SIRT2,,,,SIRT2
9038,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CA,,,,PIK3CA
9039,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CG,,,,PIK3CG
9040,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK1,,,,PLK1
9041,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATM,,,,ATM
9042,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATR,,,,ATR
9043,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",MTOR,,,,MTOR
9044,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KA,,,,PI4KA
9045,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KB,,,,PI4KB
9046,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CD,,,,PIK3CD
9047,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3R1,,,,PIK3R1
9048,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK3,,,,PLK3
9049,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PRKDC,,,,PRKDC
9050,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",FLT1,,,,FLT1
9051,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",FLT4,,,,FLT4
9052,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",KDR,,,,KDR
9053,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",KIT,,,,KIT
9054,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",PDGFRA,,,,PDGFRA
9055,tivozanib,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor",PDGFRB,,,,PDGFRB
9056,oligomycin-c,"ATP synthase inhibitor, regulatory volume decrease inhibitor",ATP5A1,,,,ATP5F1A
9057,BRD-K61463582,aryl hydrocarbon receptor agonist,AHR,,,,AHR
9058,BRD-K61463582,aryl hydrocarbon receptor agonist,CYP1A2,,,,CYP1A2
9059,profenamine,"butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist",CHRM1,,,,CHRM1
9060,profenamine,"butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist",BCHE,,,,BCHE
9061,profenamine,"butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist",CHRM2,,,,CHRM2
9062,profenamine,"butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist",GRIN3A,,,,GRIN3A
9063,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",IGF1R,,,,IGF1R
9064,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",AKT1,,,,AKT1
9065,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",CCNE1,,,,CCNE1
9066,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",CDK2,,,,CDK2
9067,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",CYP3A4,,,,CYP3A4
9068,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",ERBB2,,,,ERBB2
9069,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",INSR,,,,INSR
9070,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",KDR,,,,KDR
9071,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",LCK,,,,LCK
9072,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",MAPK1,,,,MAPK1
9073,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",MET,,,,MET
9074,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",PDGFRA,,,,PDGFRA
9075,BMS-536924,"insulin growth factor receptor inhibitor, insulin receptor ligand",PDGFRB,,,,PDGFRB
9076,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",AR,,,,AR
9077,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP19A1,,,,CYP19A1
9078,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP21A2,,,,CYP21A2
9079,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP2C19,,,,CYP2C19
9080,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP3A5,,,,CYP3A5
9081,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",CYP3A7,,,,CYP3A7
9082,ketoconazole,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor",KCNA10,,,,KCNA10
9083,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1G,,,,CACNA1G
9084,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1H,,,,CACNA1H
9085,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1I,,,,CACNA1I
9086,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CALM1,,,,CALM1
9087,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CYP2J2,,,,CYP2J2
9088,flunarizine,"calcium channel blocker, T-type calcium channel blocker",HRH1,,,,HRH1
9089,SA-792709,retinoid receptor agonist,RARA,,,,RARA
9090,SA-792709,retinoid receptor agonist,RARB,,,,RARB
9091,ODQ,"guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker",GUCY1A2,,,,GUCY1A2
9092,ODQ,"guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker",GUCY1A3,,,,GUCY1A1
9093,ODQ,"guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker",GUCY1B3,,,,GUCY1B1
9094,BRD-A89049230,thyroid-stimulating hormone receptor agonist,TSHR,,,,TSHR
9095,HG-5-88-01,protein kinase inhibitor,ADCK4,,,,COQ8B
9096,HG-5-88-01,protein kinase inhibitor,EGFR,,,,EGFR
9097,BRD-K91691979,glucosylceramidase inhibitor,GBA,,,,GBA
9098,CA-074-Me,"cathepsin inhibitor, antiamyloidogenic agent",CTSB,,,,CTSB
9099,strophanthidin,ATPase inhibitor,ATP1A1,,,,ATP1A1
9100,strophanthidin,ATPase inhibitor,ATP1A2,,,,ATP1A2
9101,strophanthidin,ATPase inhibitor,ATP1A3,,,,ATP1A3
9102,strophanthidin,ATPase inhibitor,ATP1A4,,,,ATP1A4
9103,strophanthidin,ATPase inhibitor,ATP1B1,,,,ATP1B1
9104,strophanthidin,ATPase inhibitor,ATP1B2,,,,ATP1B2
9105,strophanthidin,ATPase inhibitor,ATP1B3,,,,ATP1B3
9106,strophanthidin,ATPase inhibitor,ATP1B4,,,,ATP1B4
9107,strophanthidin,ATPase inhibitor,FXYD2,,,,FXYD2
9108,fluocinolone,"corticosteroid agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
9109,fluocinolone,"corticosteroid agonist, glucocorticoid receptor agonist",SERPINA6,,,,SERPINA6
9110,rifapentine,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor",CYP2C8,,,,CYP2C8
9111,rifapentine,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor",CYP3A4,,,,CYP3A4
9112,venlafaxine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
9113,venlafaxine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
9114,venlafaxine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor",CYP2C19,,,,CYP2C19
9115,venlafaxine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
9116,SB-206553,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR2B,,,,HTR2B
9117,SB-206553,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR2C,,,,HTR2C
9118,SB-206553,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR1A,,,,HTR1A
9119,SB-206553,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR2A,,,,HTR2A
9120,isoflupredone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
9121,GW-441756,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
9122,GW-441756,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor",NTRK1,,,,NTRK1
9123,ecopipam,dopamine receptor antagonist,DRD1,,,,DRD1
9124,ecopipam,dopamine receptor antagonist,DRD5,,,,DRD5
9125,ecopipam,dopamine receptor antagonist,DRD2,,,,DRD2
9126,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKA,,,,AURKA
9127,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKB,,,,AURKB
9128,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",ABL1,,,,ABL1
9129,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",BCR,,,,BCR
9130,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",FLT3,,,,FLT3
9131,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",JAK2,,,,JAK2
9132,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",JAK3,,,,JAK3
9133,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",RPS6KA6,,,,RPS6KA6
9134,AT-9283,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor",STK17A,,,,STK17A
9135,neratinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
9136,neratinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
9137,neratinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB4,,,,ERBB4
9138,neratinib,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",KDR,,,,KDR
9139,fluoxetine,"selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers",SLC6A4,,,,SLC6A4
9140,fluoxetine,"selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers",ANO1,,,,ANO1
9141,fluoxetine,"selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers",CYP2C19,,,,CYP2C19
9142,fluoxetine,"selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers",HTR2B,,,,HTR2B
9143,BCI-hydrochloride,"MAP kinase phosphatase inhibitor, protein phosphatase inhibitor",DUSP1,,,,DUSP1
9144,BCI-hydrochloride,"MAP kinase phosphatase inhibitor, protein phosphatase inhibitor",DUSP6,,,,DUSP6
9145,HG-5-113-01,protein kinase inhibitor,ABL1,,,,ABL1
9146,HG-5-113-01,protein kinase inhibitor,LTK,,,,LTK
9147,HG-5-113-01,protein kinase inhibitor,STK10,,,,STK10
9148,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",DRD1,,,,DRD1
9149,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",DRD2,,,,DRD2
9150,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HTR2A,,,,HTR2A
9151,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",ADRA1A,,,,ADRA1A
9152,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",ADRA1B,,,,ADRA1B
9153,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",CHRNA7,,,,CHRNA7
9154,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",DRD5,,,,DRD5
9155,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HRH1,,,,HRH1
9156,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HTR1A,,,,HTR1A
9157,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HTR2C,,,,HTR2C
9158,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HTR6,,,,HTR6
9159,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",HTR7,,,,HTR7
9160,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",KCNH2,,,,KCNH2
9161,thioridazine,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor",MALT1,,,,MALT1
9162,guanabenz,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
9163,guanabenz,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
9164,guanabenz,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
9165,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIA,,,,PPIA
9166,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",ABCB11,,,,ABCB11
9167,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CAMLG,,,,CAMLG
9168,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
9169,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
9170,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",FPR1,,,,FPR1
9171,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPID,,,,PPID
9172,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIF,,,,PPIF
9173,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3CA,,,,PPP3CA
9174,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3R2,,,,PPP3R2
9175,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLC10A1,,,,SLC10A1
9176,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B1,,,,SLCO1B1
9177,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B3,,,,SLCO1B3
9178,ZM-306416,"Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor",FLT1,,,,FLT1
9179,ZM-306416,"Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor",KDR,,,,KDR
9180,ZM-306416,"Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor",EGFR,,,,EGFR
9181,ZM-306416,"Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor",FLT4,,,,FLT4
9182,LE-135,retinoid receptor agonist,RARB,,,,RARB
9183,GDC-0879,RAF inhibitor,BRAF,,,,BRAF
9184,BRD-A54632525,lipoxygenase inhibitor,ALOX12,,,,ALOX12
9185,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",CYP2B6,,,,CYP2B6
9186,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",FAAH,,,,FAAH
9187,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA1,,,,GABRA1
9188,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA2,,,,GABRA2
9189,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA3,,,,GABRA3
9190,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA4,,,,GABRA4
9191,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA5,,,,GABRA5
9192,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRA6,,,,GABRA6
9193,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRB1,,,,GABRB1
9194,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRB2,,,,GABRB2
9195,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRB3,,,,GABRB3
9196,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRD,,,,GABRD
9197,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRE,,,,GABRE
9198,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRG1,,,,GABRG1
9199,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRG2,,,,GABRG2
9200,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRG3,,,,GABRG3
9201,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRP,,,,GABRP
9202,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",GABRQ,,,,GABRQ
9203,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",SCN2A,,,,SCN2A
9204,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",SCN4A,,,,SCN4A
9205,propofol,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist",TRPV1,,,,TRPV1
9206,AG-879,"angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor",ERBB2,,,,ERBB2
9207,AG-879,"angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor",KDR,,,,KDR
9208,AG-879,"angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor",NTRK1,,,,NTRK1
9209,ZM-323881,"vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor",KDR,,,,KDR
9210,U-46619,thromboxane receptor agonist,PTGDR,,,,PTGDR
9211,U-46619,thromboxane receptor agonist,PTGDR2,,,,PTGDR2
9212,U-46619,thromboxane receptor agonist,PTGER1,,,,PTGER1
9213,U-46619,thromboxane receptor agonist,PTGER2,,,,PTGER2
9214,U-46619,thromboxane receptor agonist,PTGER3,,,,PTGER3
9215,U-46619,thromboxane receptor agonist,PTGER4,,,,PTGER4
9216,U-46619,thromboxane receptor agonist,PTGFR,,,,PTGFR
9217,U-46619,thromboxane receptor agonist,PTGIR,,,,PTGIR
9218,U-46619,thromboxane receptor agonist,TBXA2R,,,,TBXA2R
9219,SEW-2871,lysophospholipid receptor agonist,S1PR1,,,,S1PR1
9220,L-741626,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
9221,L-741626,"dopamine receptor, dopamine receptor antagonist",DRD3,,,,DRD3
9222,L-741626,"dopamine receptor, dopamine receptor antagonist",DRD4,,,,DRD4
9223,L-741626,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
9224,L-741626,"dopamine receptor, dopamine receptor antagonist",HTR2B,,,,HTR2B
9225,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",BACE1,,,,BACE1
9226,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA1,,,,CA1
9227,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA12,,,,CA12
9228,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA14,,,,CA14
9229,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA2,,,,CA2
9230,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA4,,,,CA4
9231,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA6,,,,CA6
9232,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA9,,,,CA9
9233,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",FASN,,,,FASN
9234,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",PTGS1,,,,PTGS1
9235,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",SCN5A,,,,SCN5A
9236,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIA,,,,PPIA
9237,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",ABCB11,,,,ABCB11
9238,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CAMLG,,,,CAMLG
9239,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
9240,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
9241,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",FPR1,,,,FPR1
9242,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPID,,,,PPID
9243,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIF,,,,PPIF
9244,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3CA,,,,PPP3CA
9245,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3R2,,,,PPP3R2
9246,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLC10A1,,,,SLC10A1
9247,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B1,,,,SLCO1B1
9248,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B3,,,,SLCO1B3
9249,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",SLC6A4,,,,SLC6A4
9250,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",SLC6A2,,,,SLC6A2
9251,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",CYP2C19,,,,CYP2C19
9252,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",GSTP1,,,,GSTP1
9253,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",HTR2A,,,,HTR2A
9254,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",HTR2B,,,,HTR2B
9255,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",HTR2C,,,,HTR2C
9256,clomipramine,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor",SLC6A3,,,,SLC6A3
9257,strychnine,acetylcholine receptor antagonist,GLRA1,,,,GLRA1
9258,strychnine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
9259,strychnine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
9260,strychnine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
9261,strychnine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
9262,strychnine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
9263,strychnine,acetylcholine receptor antagonist,CHRNA10,,,,CHRNA10
9264,strychnine,acetylcholine receptor antagonist,CHRNA9,,,,CHRNA9
9265,strychnine,acetylcholine receptor antagonist,GLRA2,,,,GLRA2
9266,strychnine,acetylcholine receptor antagonist,GLRA3,,,,GLRA3
9267,strychnine,acetylcholine receptor antagonist,GLRB,,,,GLRB
9268,lomerizine,"calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor",ABCB1,,,,ABCB1
9269,lomerizine,"calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor",CACNA1B,,,,CACNA1B
9270,lomerizine,"calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor",SCN5A,,,,SCN5A
9271,CAY-10618,"NAMPT inhibitor, niacinamide phosphoribosyltransferase inhibitor",NAMPT,,,,NAMPT
9272,PU-H71,HSP inhibitor,HSP90AA1,,,,HSP90AA1
9273,huperzine-a,"acetylcholinesterase inhibitor, glutamate receptor antagonist",ACHE,,,,ACHE
9274,trimebutine,"opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers",CHRM1,,,,CHRM1
9275,trimebutine,"opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers",CHRM2,,,,CHRM2
9276,trimebutine,"opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers",CHRM3,,,,CHRM3
9277,trimebutine,"opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers",CHRM4,,,,CHRM4
9278,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1A,,,,ADRA1A
9279,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",CACNA1C,,,,CACNA1C
9280,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1B,,,,ADRA1B
9281,niguldipine,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor",ADRA1D,,,,ADRA1D
9282,deguelin,"NADH-ubiquinone oxidoreductase (Complex I) inhibitor, AKT inhibitor, cyclooxygenase inhibitor, NFkB pathway inhibitor, phorbol ester-induced ornithine decarboxylase (ODC) activity suppressor, PI3K inhibitor",AKT1,,,,AKT1
9283,deguelin,"NADH-ubiquinone oxidoreductase (Complex I) inhibitor, AKT inhibitor, cyclooxygenase inhibitor, NFkB pathway inhibitor, phorbol ester-induced ornithine decarboxylase (ODC) activity suppressor, PI3K inhibitor",PTGS2,,,,PTGS2
9284,pyroxamide,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
9285,carprofen,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
9286,carprofen,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
9287,AS-601245,JNK inhibitor,GSK3B,,,,GSK3B
9288,AS-601245,JNK inhibitor,MAPK10,,,,MAPK10
9289,AS-601245,JNK inhibitor,MAPK8,,,,MAPK8
9290,AS-601245,JNK inhibitor,MAPK9,,,,MAPK9
9291,AS-601245,JNK inhibitor,PIM1,,,,PIM1
9292,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A1,,,,ATP1A1
9293,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A2,,,,ATP1A2
9294,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A3,,,,ATP1A3
9295,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A4,,,,ATP1A4
9296,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B1,,,,ATP1B1
9297,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B2,,,,ATP1B2
9298,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B3,,,,ATP1B3
9299,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B4,,,,ATP1B4
9300,ouabain,"ATPase inhibitor, alpha subunit binder",FXYD2,,,,FXYD2
9301,terfenadine,histamine receptor antagonist,HRH1,,,,HRH1
9302,terfenadine,histamine receptor antagonist,KCNH2,,,,KCNH2
9303,terfenadine,histamine receptor antagonist,CHRM1,,,,CHRM1
9304,terfenadine,histamine receptor antagonist,CHRM2,,,,CHRM2
9305,terfenadine,histamine receptor antagonist,CHRM3,,,,CHRM3
9306,terfenadine,histamine receptor antagonist,CHRM4,,,,CHRM4
9307,terfenadine,histamine receptor antagonist,CHRM5,,,,CHRM5
9308,terfenadine,histamine receptor antagonist,KCNH1,,,,KCNH1
9309,herniarin,acetylcholinesterase inhibitor,ACHE,,,,ACHE
9310,herniarin,acetylcholinesterase inhibitor,CA1,,,,CA1
9311,herniarin,acetylcholinesterase inhibitor,CA12,,,,CA12
9312,herniarin,acetylcholinesterase inhibitor,CA14,,,,CA14
9313,herniarin,acetylcholinesterase inhibitor,CA4,,,,CA4
9314,herniarin,acetylcholinesterase inhibitor,CA6,,,,CA6
9315,herniarin,acetylcholinesterase inhibitor,CA9,,,,CA9
9316,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT3,,,,FLT3
9317,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",KDR,,,,KDR
9318,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",KIT,,,,KIT
9319,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT4,,,,FLT4
9320,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT1,,,,FLT1
9321,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
9322,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
9323,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",RET,,,,RET
9324,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
9325,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
9326,captopril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
9327,captopril,angiotensin converting enzyme inhibitor,LTA4H,,,,LTA4H
9328,captopril,angiotensin converting enzyme inhibitor,MMP2,,,,MMP2
9329,captopril,angiotensin converting enzyme inhibitor,MMP9,,,,MMP9
9330,amcinonide,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
9331,amcinonide,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",ANXA1,,,,ANXA1
9332,ZM-39923,JAK inhibitor,JAK1,,,,JAK1
9333,ZM-39923,JAK inhibitor,JAK3,,,,JAK3
9334,mycophenolate-mofetil,"dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",IMPDH1,,,,IMPDH1
9335,mycophenolate-mofetil,"dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",IMPDH2,,,,IMPDH2
9336,mycophenolate-mofetil,"dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",HCAR2,,,,HCAR2
9337,eticlopride,dopamine receptor antagonist,DRD2,,,,DRD2
9338,eticlopride,dopamine receptor antagonist,DRD3,,,,DRD3
9339,eticlopride,dopamine receptor antagonist,DRD4,,,,DRD4
9340,triciribine,AKT inhibitor,AKT1,,,,AKT1
9341,triciribine,AKT inhibitor,AKT2,,,,AKT2
9342,triciribine,AKT inhibitor,AKT3,,,,AKT3
9343,deforolimus,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, serine/threonine kinase inhibitor, VEGFR antagonist",MTOR,,,,MTOR
9344,SB-216641,serotonin receptor antagonist,HTR1B,,,,HTR1B
9345,SB-216641,serotonin receptor antagonist,HTR1D,,,,HTR1D
9346,SB-216641,serotonin receptor antagonist,HTR1A,,,,HTR1A
9347,SB-216641,serotonin receptor antagonist,HTR2A,,,,HTR2A
9348,SB-216641,serotonin receptor antagonist,HTR2B,,,,HTR2B
9349,SB-216641,serotonin receptor antagonist,HTR2C,,,,HTR2C
9350,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",NR3C1,,,,NR3C1
9351,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A5,,,,CYP3A5
9352,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A7,,,,CYP3A7
9353,SCH-28080,"ATPase inhibitor, potassium-competitive acid antagonist",ATP4A,,,,ATP4A
9354,mepireserpate,catecholamine depleting sympatholytic,SLC18A2,,,,SLC18A2
9355,mepireserpate,catecholamine depleting sympatholytic,SLC18A1,,,,SLC18A1
9356,talniflumate,"cyclooxygenase inhibitor, calcium channel blocker, calcium-activated chloride channel blocker, mucin production inhibitor",CLCA1,,,,CLCA1
9357,purvalanol-b,tyrosine kinase inhibitor,CDK2,,,,CDK2
9358,purvalanol-b,tyrosine kinase inhibitor,CDK4,,,,CDK4
9359,purvalanol-b,tyrosine kinase inhibitor,MAPK1,,,,MAPK1
9360,purvalanol-b,tyrosine kinase inhibitor,MAPK3,,,,MAPK3
9361,purvalanol-b,tyrosine kinase inhibitor,CDK5,,,,CDK5
9362,purvalanol-b,tyrosine kinase inhibitor,SRPK2,,,,SRPK2
9363,gabazine,GABA receptor antagonist,GABRA1,,,,GABRA1
9364,gabazine,GABA receptor antagonist,GABRA2,,,,GABRA2
9365,gabazine,GABA receptor antagonist,GABRA3,,,,GABRA3
9366,gabazine,GABA receptor antagonist,GABRA4,,,,GABRA4
9367,gabazine,GABA receptor antagonist,GABRA5,,,,GABRA5
9368,gabazine,GABA receptor antagonist,GABRA6,,,,GABRA6
9369,gabazine,GABA receptor antagonist,GABRG2,,,,GABRG2
9370,idarubicin,"topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor",TOP2A,,,,TOP2A
9371,IRL-2500,endothelin receptor antagonist,EDNRB,,,,EDNRB
9372,amonafide,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
9373,amonafide,"topoisomerase inhibitor, DNA intercalating drug",TOP2B,,,,TOP2B
9374,PF-543,sphingosine kinase inhibitor,SPHK1,,,,SPHK1
9375,PLX-4720,RAF inhibitor,BRAF,,,,BRAF
9376,PLX-4720,RAF inhibitor,KDR,,,,KDR
9377,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA1,,,,GABRA1
9378,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA2,,,,GABRA2
9379,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA3,,,,GABRA3
9380,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA5,,,,GABRA5
9381,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",CYP3A5,,,,CYP3A5
9382,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA4,,,,GABRA4
9383,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRA6,,,,GABRA6
9384,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRB1,,,,GABRB1
9385,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRB2,,,,GABRB2
9386,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRB3,,,,GABRB3
9387,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRD,,,,GABRD
9388,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRE,,,,GABRE
9389,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRG1,,,,GABRG1
9390,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRG2,,,,GABRG2
9391,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRG3,,,,GABRG3
9392,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRP,,,,GABRP
9393,alprazolam,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist",GABRQ,,,,GABRQ
9394,amcinonide,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
9395,amcinonide,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",ANXA1,,,,ANXA1
9396,KU-55933,ATM kinase inhibitor,ATM,,,,ATM
9397,KU-55933,ATM kinase inhibitor,PRKDC,,,,PRKDC
9398,proscillaridin,ATPase inhibitor,ATP1A1,,,,ATP1A1
9399,icilin,"TRPA1 agonist, TRPM8 agonist",TRPA1,,,,TRPA1
9400,icilin,"TRPA1 agonist, TRPM8 agonist",TRPM8,,,,TRPM8
9401,AG-494,"epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
9402,pifithrin-mu,HSP inhibitor,HSPA1A,,,,HSPA1A
9403,pifithrin-mu,HSP inhibitor,TP53,,,,TP53
9404,GDC-0941,PI3K inhibitor,PIK3CG,,,,PIK3CG
9405,GDC-0941,PI3K inhibitor,PIK3CA,,,,PIK3CA
9406,GDC-0941,PI3K inhibitor,PIK3CB,,,,PIK3CB
9407,GDC-0941,PI3K inhibitor,PIK3CD,,,,PIK3CD
9408,toremifene,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist",ESR1,,,,ESR1
9409,toremifene,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist",CYP3A5,,,,CYP3A5
9410,ellipticine,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
9411,ellipticine,"topoisomerase inhibitor, DNA intercalating drug",TOP2B,,,,TOP2B
9412,RG-14620,EGFR inhibitor,EGFR,,,,EGFR
9413,amperozide,"dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist",HTR2A,,,,HTR2A
9414,amperozide,"dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist",DRD2,,,,DRD2
9415,amperozide,"dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist",FAAH,,,,FAAH
9416,HTMT,histamine receptor agonist,HRH4,,,,HRH4
9417,MLN-4924,nedd activating enzyme inhibitor,NAE1,,,,NAE1
9418,MLN-4924,nedd activating enzyme inhibitor,UBA3,,,,UBA3
9419,epicatechin,"beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor",FASN,,,,FASN
9420,epicatechin,"beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor",APP,,,,APP
9421,epicatechin,"beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor",BACE1,,,,BACE1
9422,epicatechin,"beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor",SLC5A1,,,,SLC5A1
9423,ketorolac,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
9424,ketorolac,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
9425,ITE,"aryl hydrocarbon receptor agonist, aryl hydrocarbon receptor ligand",AHR,,,,AHR
9426,CGP-71683,neuropeptide receptor antagonist,NPY5R,,,,NPY5R
9427,piperine,"monoamine oxidase inhibitor, ACAT inhibitor",MAOA,,,,MAOA
9428,piperine,"monoamine oxidase inhibitor, ACAT inhibitor",MAOB,,,,MAOB
9429,piperine,"monoamine oxidase inhibitor, ACAT inhibitor",TRPV1,,,,TRPV1
9430,linoleamide,ACAT inhibitor,SOAT1,,,,SOAT1
9431,linoleamide,ACAT inhibitor,SOAT2,,,,SOAT2
9432,loteprednol,"corticosteroid agonist, phospholipase inhibitor",NR3C1,,,,NR3C1
9433,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",SLC6A2,,,,SLC6A2
9434,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1A,,,,ADRA1A
9435,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1B,,,,ADRA1B
9436,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1D,,,,ADRA1D
9437,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2A,,,,ADRA2A
9438,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2B,,,,ADRA2B
9439,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2C,,,,ADRA2C
9440,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM1,,,,CHRM1
9441,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM2,,,,CHRM2
9442,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM3,,,,CHRM3
9443,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM4,,,,CHRM4
9444,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM5,,,,CHRM5
9445,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",DRD2,,,,DRD2
9446,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HRH1,,,,HRH1
9447,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR2A,,,,HTR2A
9448,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR2C,,,,HTR2C
9449,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR7,,,,HTR7
9450,alaproclate,"serotonin receptor antagonist, serotonin reuptake inhibitor",SLC6A4,,,,SLC6A4
9451,GBR-12935,dopamine uptake inhibitor,AGTR1,,,,AGTR1
9452,GBR-12935,dopamine uptake inhibitor,SLC6A3,,,,SLC6A3
9453,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",PNLIP,,,,PNLIP
9454,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",DAGLA,,,,DAGLA
9455,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",FASN,,,,FASN
9456,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",LIPF,,,,LIPF
9457,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",CNR1,,,,CNR1
9458,orlistat,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor",DAGLB,,,,DAGLB
9459,GR-127935,serotonin receptor antagonist,HTR1B,,,,HTR1B
9460,GR-127935,serotonin receptor antagonist,HTR1D,,,,HTR1D
9461,GR-127935,serotonin receptor antagonist,HTR1A,,,,HTR1A
9462,GR-127935,serotonin receptor antagonist,HTR2A,,,,HTR2A
9463,GR-127935,serotonin receptor antagonist,HTR2C,,,,HTR2C
9464,GR-127935,serotonin receptor antagonist,HTR1E,,,,HTR1E
9465,GR-127935,serotonin receptor antagonist,HTR1F,,,,HTR1F
9466,GR-127935,serotonin receptor antagonist,HTR2B,,,,HTR2B
9467,GR-127935,serotonin receptor antagonist,HTR6,,,,HTR6
9468,PD-158780,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor",EGFR,,,,EGFR
9469,norcyclobenzaprine,"adrenergic receptor ligand, serotonin receptor ligand",HTR2A,,,,HTR2A
9470,amodiaquine,histamine N-methyltransferase inhibitor,HNMT,,,,HNMT
9471,amodiaquine,histamine N-methyltransferase inhibitor,CYP2C8,,,,CYP2C8
9472,ZD-7114,adrenergic receptor agonist,ADRB3,,,,ADRB3
9473,reversine,"Aurora kinase inhibitor, adenosine receptor antagonist",AURKB,,,,AURKB
9474,reversine,"Aurora kinase inhibitor, adenosine receptor antagonist",ADORA3,,,,ADORA3
9475,reversine,"Aurora kinase inhibitor, adenosine receptor antagonist",AURKA,,,,AURKA
9476,reversine,"Aurora kinase inhibitor, adenosine receptor antagonist",INCENP,,,,INCENP
9477,reversine,"Aurora kinase inhibitor, adenosine receptor antagonist",MAP2K1,,,,MAP2K1
9478,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",RET,,,,RET
9479,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",BRAF,,,,BRAF
9480,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT3,,,,FLT3
9481,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",KDR,,,,KDR
9482,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",RAF1,,,,RAF1
9483,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT1,,,,FLT1
9484,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT4,,,,FLT4
9485,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",KIT,,,,KIT
9486,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",DDR2,,,,DDR2
9487,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
9488,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
9489,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP2B6,,,,CYP2B6
9490,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP2C8,,,,CYP2C8
9491,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP3A5,,,,CYP3A5
9492,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFB,,,,PDGFB
9493,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",SLCO1B3,,,,SLCO1B3
9494,linsitinib,"insulin growth factor receptor inhibitor, insulin receptor antagonist",IGF1R,,,,IGF1R
9495,linsitinib,"insulin growth factor receptor inhibitor, insulin receptor antagonist",INSR,,,,INSR
9496,linsitinib,"insulin growth factor receptor inhibitor, insulin receptor antagonist",INSRR,,,,INSRR
9497,ZM-447439,Aurora kinase inhibitor,AURKA,,,,AURKA
9498,ZM-447439,Aurora kinase inhibitor,AURKB,,,,AURKB
9499,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",FLT3,,,,FLT3
9500,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",KIT,,,,KIT
9501,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",CCNB1,,,,CCNB1
9502,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",FLT1,,,,FLT1
9503,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",KDR,,,,KDR
9504,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",PDGFRB,,,,PDGFRB
9505,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",PRKCA,,,,PRKCA
9506,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",PRKCG,,,,PRKCG
9507,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor",VEGFA,,,,VEGFA
9508,necrostatin-1,"RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor",IDO1,,,,IDO1
9509,necrostatin-1,"RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor",KRR1,,,,KRR1
9510,necrostatin-1,"RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor",RIPK1,,,,RIPK1
9511,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY2,,,,ADCY2
9512,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY5,,,,ADCY5
9513,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",GNAS,,,,GNAS
9514,bumetanide,"diuretic, solute carrier family member inhibitor",SLC12A1,,,,SLC12A1
9515,bumetanide,"diuretic, solute carrier family member inhibitor",SLC12A2,,,,SLC12A2
9516,bumetanide,"diuretic, solute carrier family member inhibitor",CFTR,,,,CFTR
9517,bumetanide,"diuretic, solute carrier family member inhibitor",GPR35,,,,GPR35
9518,bumetanide,"diuretic, solute carrier family member inhibitor",SLC12A4,,,,SLC12A4
9519,bumetanide,"diuretic, solute carrier family member inhibitor",SLC12A5,,,,SLC12A5
9520,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
9521,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
9522,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
9523,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",ABCG2,,,,ABCG2
9524,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CA1,,,,CA1
9525,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1B,,,,CACNA1B
9526,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
9527,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNA2D3,,,,CACNA2D3
9528,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNB1,,,,CACNB1
9529,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",CACNB2,,,,CACNB2
9530,amlodipine,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker",SMPD1,,,,SMPD1
9531,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR3A,,,,HTR3A
9532,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA1,,,,GLRA1
9533,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA2,,,,GLRA2
9534,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRB,,,,GLRB
9535,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR4,,,,HTR4
9536,tunicamycin,GLCNAC phosphotransferase inhibitor,GNPTAB,,,,GNPTAB
9537,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR2A,,,,HTR2A
9538,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR2C,,,,HTR2C
9539,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA1A,,,,ADRA1A
9540,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA1B,,,,ADRA1B
9541,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA1D,,,,ADRA1D
9542,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HRH1,,,,HRH1
9543,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR2B,,,,HTR2B
9544,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR6,,,,HTR6
9545,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR7,,,,HTR7
9546,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA2A,,,,ADRA2A
9547,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA2B,,,,ADRA2B
9548,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",ADRA2C,,,,ADRA2C
9549,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",DRD1,,,,DRD1
9550,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",DRD2,,,,DRD2
9551,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",DRD3,,,,DRD3
9552,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",DRD5,,,,DRD5
9553,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HRH2,,,,HRH2
9554,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HRH4,,,,HRH4
9555,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR1A,,,,HTR1A
9556,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",HTR1F,,,,HTR1F
9557,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",OPRK1,,,,OPRK1
9558,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",SLC6A2,,,,SLC6A2
9559,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",SLC6A3,,,,SLC6A3
9560,mianserin,"serotonin receptor antagonist, tetracyclic antidepressant",SLC6A4,,,,SLC6A4
9561,itopride,"dopamine receptor antagonist, acetylcholinesterase inhibitor",DRD2,,,,DRD2
9562,itopride,"dopamine receptor antagonist, acetylcholinesterase inhibitor",ACHE,,,,ACHE
9563,itopride,"dopamine receptor antagonist, acetylcholinesterase inhibitor",CHRM3,,,,CHRM3
9564,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",CYP3A4,,,,CYP3A4
9565,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",MLNR,,,,MLNR
9566,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1G,,,,CACNA1G
9567,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1H,,,,CACNA1H
9568,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CACNA1I,,,,CACNA1I
9569,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CALM1,,,,CALM1
9570,flunarizine,"calcium channel blocker, T-type calcium channel blocker",CYP2J2,,,,CYP2J2
9571,flunarizine,"calcium channel blocker, T-type calcium channel blocker",HRH1,,,,HRH1
9572,fluvastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
9573,fluvastatin,HMGCR inhibitor,CYP2C8,,,,CYP2C8
9574,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",HMGCR,,,,HMGCR
9575,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",DPP4,,,,DPP4
9576,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",AHR,,,,AHR
9577,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",CYP3A5,,,,CYP3A5
9578,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",FASLG,,,,FASLG
9579,nafadotride,dopamine receptor antagonist,DRD3,,,,DRD3
9580,nafadotride,dopamine receptor antagonist,DRD2,,,,DRD2
9581,nafadotride,dopamine receptor antagonist,HTR1A,,,,HTR1A
9582,NSC-3852,HDAC inhibitor,HDAC1,,,,HDAC1
9583,daidzein,estrogen receptor agonist,ESRRA,,,,ESRRA
9584,daidzein,estrogen receptor agonist,ESRRB,,,,ESRRB
9585,daidzein,estrogen receptor agonist,ESRRG,,,,ESRRG
9586,daidzein,estrogen receptor agonist,TRPC5,,,,TRPC5
9587,BW-723C86,serotonin receptor agonist,HTR2B,,,,HTR2B
9588,BW-723C86,serotonin receptor agonist,HTR2A,,,,HTR2A
9589,BW-723C86,serotonin receptor agonist,HTR2C,,,,HTR2C
9590,doxorubicin,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
9591,syrosingopine,vesicular monoamine transporter inhibitor,SLC18A2,,,,SLC18A2
9592,syrosingopine,vesicular monoamine transporter inhibitor,SLC18A1,,,,SLC18A1
9593,sulforaphane,"anticancer agent, aryl hydrocarbon receptor antagonist, nuclear factor erythroid derived, like (NRF2) activator",NFE2L2,,,,NFE2L2
9594,GW-441756,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
9595,GW-441756,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor",NTRK1,,,,NTRK1
9596,PD-102807,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
9597,zamifenacin,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
9598,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD2,,,,DRD2
9599,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2A,,,,ADRA2A
9600,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2B,,,,ADRA2B
9601,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2C,,,,ADRA2C
9602,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD1,,,,DRD1
9603,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD3,,,,DRD3
9604,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD4,,,,DRD4
9605,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD5,,,,DRD5
9606,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1A,,,,HTR1A
9607,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1B,,,,HTR1B
9608,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1D,,,,HTR1D
9609,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2A,,,,HTR2A
9610,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2B,,,,HTR2B
9611,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2C,,,,HTR2C
9612,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1A,,,,ADRA1A
9613,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1B,,,,ADRA1B
9614,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1D,,,,ADRA1D
9615,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR6,,,,HTR6
9616,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR7,,,,HTR7
9617,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",PRL,,,,PRL
9618,glycopyrrolate,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
9619,glycopyrrolate,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
9620,glycopyrrolate,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
9621,glycopyrrolate,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
9622,glycopyrrolate,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
9623,KN-93,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,,,,CAMK2A
9624,BRD-K47448802,acetylcholine receptor allosteric modulator,CHRM1,,,,CHRM1
9625,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
9626,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
9627,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR2A,,,,HTR2A
9628,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR6,,,,HTR6
9629,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA1A,,,,ADRA1A
9630,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA1B,,,,ADRA1B
9631,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA1D,,,,ADRA1D
9632,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA2A,,,,ADRA2A
9633,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA2B,,,,ADRA2B
9634,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",ADRA2C,,,,ADRA2C
9635,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM1,,,,CHRM1
9636,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM2,,,,CHRM2
9637,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM3,,,,CHRM3
9638,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM4,,,,CHRM4
9639,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM5,,,,CHRM5
9640,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",DRD1,,,,DRD1
9641,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",DRD2,,,,DRD2
9642,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",DRD3,,,,DRD3
9643,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",DRD4,,,,DRD4
9644,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA1,,,,GABRA1
9645,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA2,,,,GABRA2
9646,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA3,,,,GABRA3
9647,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA4,,,,GABRA4
9648,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA5,,,,GABRA5
9649,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRA6,,,,GABRA6
9650,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRB1,,,,GABRB1
9651,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRB2,,,,GABRB2
9652,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRB3,,,,GABRB3
9653,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRD,,,,GABRD
9654,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRE,,,,GABRE
9655,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRG1,,,,GABRG1
9656,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRG2,,,,GABRG2
9657,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRG3,,,,GABRG3
9658,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRP,,,,GABRP
9659,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",GABRQ,,,,GABRQ
9660,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HRH1,,,,HRH1
9661,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HRH4,,,,HRH4
9662,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR1A,,,,HTR1A
9663,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR1B,,,,HTR1B
9664,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR2B,,,,HTR2B
9665,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR2C,,,,HTR2C
9666,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR3A,,,,HTR3A
9667,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HTR7,,,,HTR7
9668,amoxapine,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A3,,,,SLC6A3
9669,kawain,"calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers",MTOR,,,,MTOR
9670,FR-139317,endothelin receptor antagonist,EDNRA,,,,EDNRA
9671,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",DRD2,,,,DRD2
9672,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR1A,,,,HTR1A
9673,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR2A,,,,HTR2A
9674,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",DRD1,,,,DRD1
9675,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HRH1,,,,HRH1
9676,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR1D,,,,HTR1D
9677,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR1E,,,,HTR1E
9678,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA1A,,,,ADRA1A
9679,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA1B,,,,ADRA1B
9680,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA1D,,,,ADRA1D
9681,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA2A,,,,ADRA2A
9682,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA2B,,,,ADRA2B
9683,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",ADRA2C,,,,ADRA2C
9684,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",CHRM1,,,,CHRM1
9685,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",CHRM2,,,,CHRM2
9686,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",CHRM3,,,,CHRM3
9687,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",CHRM4,,,,CHRM4
9688,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",CHRM5,,,,CHRM5
9689,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",DRD3,,,,DRD3
9690,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",DRD4,,,,DRD4
9691,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",DRD5,,,,DRD5
9692,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR1B,,,,HTR1B
9693,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR1F,,,,HTR1F
9694,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR2C,,,,HTR2C
9695,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR3A,,,,HTR3A
9696,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR6,,,,HTR6
9697,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",HTR7,,,,HTR7
9698,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist",SLC6A2,,,,SLC6A2
9699,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIA,,,,PPIA
9700,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",ABCB11,,,,ABCB11
9701,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CAMLG,,,,CAMLG
9702,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
9703,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
9704,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",FPR1,,,,FPR1
9705,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPID,,,,PPID
9706,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIF,,,,PPIF
9707,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3CA,,,,PPP3CA
9708,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3R2,,,,PPP3R2
9709,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLC10A1,,,,SLC10A1
9710,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B1,,,,SLCO1B1
9711,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B3,,,,SLCO1B3
9712,GW-4064,FXR agonist,NR1H4,,,,NR1H4
9713,pitavastatin,"HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor",HMGCR,,,,HMGCR
9714,pitavastatin,"HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor",APOA1,,,,APOA1
9715,pitavastatin,"HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor",CYP2C8,,,,CYP2C8
9716,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
9717,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
9718,MDL-73005EF,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR1A,,,,HTR1A
9719,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
9720,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
9721,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",CACNA1I,,,,CACNA1I
9722,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",CALM1,,,,CALM1
9723,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
9724,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
9725,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
9726,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",KCNA10,,,,KCNA10
9727,pimozide,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist",KCNH2,,,,KCNH2
9728,BRD-A61599461,thyroid-stimulating hormone receptor inverse agonist,TSHR,,,,TSHR
9729,ranitidine,histamine receptor antagonist,HRH2,,,,HRH2
9730,ranitidine,histamine receptor antagonist,SLC22A2,,,,SLC22A2
9731,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIA,,,,PPIA
9732,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",ABCB11,,,,ABCB11
9733,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CAMLG,,,,CAMLG
9734,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
9735,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
9736,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",FPR1,,,,FPR1
9737,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPID,,,,PPID
9738,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPIF,,,,PPIF
9739,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3CA,,,,PPP3CA
9740,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",PPP3R2,,,,PPP3R2
9741,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLC10A1,,,,SLC10A1
9742,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B1,,,,SLCO1B1
9743,cyclosporin-a,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor",SLCO1B3,,,,SLCO1B3
9744,BRD-A61189834,XIAP inhibitor,XIAP,,,,XIAP
9745,dicyclohexylurea,epoxide hydolase inhibitor,EPHX2,,,,EPHX2
9746,bucladesine,"adenosine receptor agonist, cAMP stimulant, vasodilator",PRKACA,,,,PRKACA
9747,lovastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
9748,lovastatin,HMGCR inhibitor,CYP3A5,,,,CYP3A5
9749,lovastatin,HMGCR inhibitor,HDAC2,,,,HDAC2
9750,lovastatin,HMGCR inhibitor,ITGAL,,,,ITGAL
9751,lovastatin,HMGCR inhibitor,NR1I2,,,,NR1I2
9752,TWS-119,glycogen synthase kinase inhibitor,GSK3B,,,,GSK3B
9753,TWS-119,glycogen synthase kinase inhibitor,JUN,,,,JUN
9754,TWS-119,glycogen synthase kinase inhibitor,MYC,,,,MYC
9755,oxprenolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
9756,oxprenolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
9757,Merck60,HDAC inhibitor,HDAC1,,,,HDAC1
9758,Merck60,HDAC inhibitor,HDAC2,,,,HDAC2
9759,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",AURKA,,,,AURKA
9760,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",AURKB,,,,AURKB
9761,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",AURKC,,,,AURKC
9762,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",FGFR1,,,,FGFR1
9763,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",NTRK1,,,,NTRK1
9764,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",RET,,,,RET
9765,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",BCR,,,,BCR
9766,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor",SLK,,,,SLK
9767,thioproperazine,dopamine receptor antagonist,ADRA1A,,,,ADRA1A
9768,thioproperazine,dopamine receptor antagonist,ADRA1B,,,,ADRA1B
9769,thioproperazine,dopamine receptor antagonist,DRD1,,,,DRD1
9770,thioproperazine,dopamine receptor antagonist,DRD2,,,,DRD2
9771,thioproperazine,dopamine receptor antagonist,HTR1A,,,,HTR1A
9772,thioproperazine,dopamine receptor antagonist,HTR2A,,,,HTR2A
9773,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
9774,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
9775,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",CALM1,,,,CALM1
9776,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",CHRNA7,,,,CHRNA7
9777,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",DRD5,,,,DRD5
9778,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
9779,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
9780,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
9781,fluphenazine,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
9782,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",CHRM1,,,,CHRM1
9783,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",CHRM2,,,,CHRM2
9784,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",CHRM3,,,,CHRM3
9785,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",CHRM4,,,,CHRM4
9786,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",CHRM5,,,,CHRM5
9787,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HRH1,,,,HRH1
9788,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR6,,,,HTR6
9789,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",SLC6A2,,,,SLC6A2
9790,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",SLC6A4,,,,SLC6A4
9791,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRA1A,,,,ADRA1A
9792,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRA1B,,,,ADRA1B
9793,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRA1D,,,,ADRA1D
9794,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRA2A,,,,ADRA2A
9795,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRB1,,,,ADRB1
9796,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRB2,,,,ADRB2
9797,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",ADRB3,,,,ADRB3
9798,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HRH2,,,,HRH2
9799,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HRH4,,,,HRH4
9800,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR1A,,,,HTR1A
9801,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR1B,,,,HTR1B
9802,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR1D,,,,HTR1D
9803,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR2A,,,,HTR2A
9804,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR2C,,,,HTR2C
9805,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",HTR7,,,,HTR7
9806,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",KCNA1,,,,KCNA1
9807,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",KCND2,,,,KCND2
9808,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",KCND3,,,,KCND3
9809,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",KCNQ2,,,,KCNQ2
9810,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",KCNQ3,,,,KCNQ3
9811,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",NTRK1,,,,NTRK1
9812,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",NTRK2,,,,NTRK2
9813,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",OPRD1,,,,OPRD1
9814,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",OPRK1,,,,OPRK1
9815,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",OPRM1,,,,OPRM1
9816,amitriptyline,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor",SIGMAR1,,,,SIGMAR1
9817,GBR-13069,dopamine uptake inhibitor,SLC6A3,,,,SLC6A3
9818,VAMA-37,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor",PRKDC,,,,PRKDC
9819,thapsigargin,"ATPase inhibitor, calcium channel blocker, PKC activator",ATP2A1,,,,ATP2A1
9820,BMS-754807,insulin growth factor receptor inhibitor,IGF1R,,,,IGF1R
9821,BMS-754807,insulin growth factor receptor inhibitor,AKT1,,,,AKT1
9822,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7,,,,CHRNA7
9823,prochlorperazine,"dopamine receptor antagonist, dopamine receptor",DRD2,,,,DRD2
9824,prochlorperazine,"dopamine receptor antagonist, dopamine receptor",DRD1,,,,DRD1
9825,prochlorperazine,"dopamine receptor antagonist, dopamine receptor",DRD3,,,,DRD3
9826,prochlorperazine,"dopamine receptor antagonist, dopamine receptor",DRD4,,,,DRD4
9827,MK-5108,Aurora kinase inhibitor,AURKA,,,,AURKA
9828,MK-5108,Aurora kinase inhibitor,AURKB,,,,AURKB
9829,MK-5108,Aurora kinase inhibitor,AURKC,,,,AURKC
9830,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",ADRA2A,,,,ADRA2A
9831,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",ADRA2B,,,,ADRA2B
9832,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",ADRA2C,,,,ADRA2C
9833,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",CYP3A5,,,,CYP3A5
9834,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",HCN1,,,,HCN1
9835,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",HCN2,,,,HCN2
9836,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",HCN3,,,,HCN3
9837,guanfacine,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker",HCN4,,,,HCN4
9838,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",ALDH1A2,,,,ALDH1A2
9839,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",ALDH2,,,,ALDH2
9840,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",ALDH5A1,,,,ALDH5A1
9841,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",ALDH7A1,,,,ALDH7A1
9842,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",NOX3,,,,NOX3
9843,diphenyleneiodonium,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
9844,varenicline,acetylcholine receptor partial agonist,CHRNA4,,,,CHRNA4
9845,varenicline,acetylcholine receptor partial agonist,CHRNA3,,,,CHRNA3
9846,varenicline,acetylcholine receptor partial agonist,CHRNA6,,,,CHRNA6
9847,varenicline,acetylcholine receptor partial agonist,CHRNA7,,,,CHRNA7
9848,varenicline,acetylcholine receptor partial agonist,CHRNB2,,,,CHRNB2
9849,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",ESR1,,,,ESR1
9850,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR,,,,GNRHR
9851,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",AR,,,,AR
9852,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CCL2,,,,CCL2
9853,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CYP2C8,,,,CYP2C8
9854,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR2,,,,GNRHR2
9855,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",PGR,,,,PGR
9856,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",TNF,,,,TNF
9857,ethylestrenol,"anabolic steroid, has some progesterone-like activity",AR,,,,AR
9858,equilin,estrogen receptor agonist,HSD17B1,,,,HSD17B1
9859,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CNR1,,,,CNR1
9860,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CNR2,,,,CNR2
9861,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",TRPV1,,,,TRPV1
9862,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1G,,,,CACNA1G
9863,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1H,,,,CACNA1H
9864,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1I,,,,CACNA1I
9865,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GLRA1,,,,GLRA1
9866,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR119,,,,GPR119
9867,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR18,,,,GPR18
9868,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR55,,,,GPR55
9869,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNA2,,,,KCNA2
9870,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCND3,,,,KCND3
9871,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNK3,,,,KCNK3
9872,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNK9,,,,KCNK9
9873,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",TRPM8,,,,TRPM8
9874,BML-257,"AKT inhibitor, HCV NS5B RdRp inhibitor",AKT1,,,,AKT1
9875,GBR-13069,dopamine uptake inhibitor,SLC6A3,,,,SLC6A3
9876,colforsin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY2,,,,ADCY2
9877,colforsin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY5,,,,ADCY5
9878,colforsin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",GNAS,,,,GNAS
9879,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",ESR1,,,,ESR1
9880,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR,,,,GNRHR
9881,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",AR,,,,AR
9882,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CCL2,,,,CCL2
9883,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CYP2C8,,,,CYP2C8
9884,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR2,,,,GNRHR2
9885,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",PGR,,,,PGR
9886,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",TNF,,,,TNF
9887,bicuculline,GABA receptor antagonist,GABRA1,,,,GABRA1
9888,bicuculline,GABA receptor antagonist,GABRA2,,,,GABRA2
9889,bicuculline,GABA receptor antagonist,GABRA3,,,,GABRA3
9890,bicuculline,GABA receptor antagonist,GABRA4,,,,GABRA4
9891,bicuculline,GABA receptor antagonist,GABRA5,,,,GABRA5
9892,bicuculline,GABA receptor antagonist,GABRA6,,,,GABRA6
9893,bicuculline,GABA receptor antagonist,KCNN1,,,,KCNN1
9894,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR4,,,,HTR4
9895,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",KCNH2,,,,KCNH2
9896,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP2B6,,,,CYP2B6
9897,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP2C8,,,,CYP2C8
9898,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP3A5,,,,CYP3A5
9899,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP3A7,,,,CYP3A7
9900,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR2A,,,,HTR2A
9901,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR3A,,,,HTR3A
9902,PF-3845,FAAH inhibitor,FAAH,,,,FAAH
9903,tofacitinib,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor",JAK3,,,,JAK3
9904,tofacitinib,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor",JAK1,,,,JAK1
9905,tofacitinib,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor",JAK2,,,,JAK2
9906,tofacitinib,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor",CYP2C19,,,,CYP2C19
9907,tofacitinib,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor",TYK2,,,,TYK2
9908,guanabenz,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
9909,guanabenz,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
9910,guanabenz,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
9911,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",SLC6A2,,,,SLC6A2
9912,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",SLC6A4,,,,SLC6A4
9913,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA1A,,,,ADRA1A
9914,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA1B,,,,ADRA1B
9915,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA1D,,,,ADRA1D
9916,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA2A,,,,ADRA2A
9917,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA2B,,,,ADRA2B
9918,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRA2C,,,,ADRA2C
9919,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRB1,,,,ADRB1
9920,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",ADRB2,,,,ADRB2
9921,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",CHRM1,,,,CHRM1
9922,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",CHRM2,,,,CHRM2
9923,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",CHRM3,,,,CHRM3
9924,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",CHRM4,,,,CHRM4
9925,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",CHRM5,,,,CHRM5
9926,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",DRD2,,,,DRD2
9927,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",HRH1,,,,HRH1
9928,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",HTR1A,,,,HTR1A
9929,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",HTR2A,,,,HTR2A
9930,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",HTR2C,,,,HTR2C
9931,desipramine,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)",SMPD1,,,,SMPD1
9932,REV-5901,"leukotriene receptor antagonist, lipoxygenase inhibitor",ALOX5,,,,ALOX5
9933,BRD-K20401833,ROR inverse agonist,RORA,,,,RORA
9934,desmethylclozapine,"acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist",CHRM1,,,,CHRM1
9935,desmethylclozapine,"acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist",DRD2,,,,DRD2
9936,desmethylclozapine,"acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist",DRD3,,,,DRD3
9937,desmethylclozapine,"acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist",HTR2A,,,,HTR2A
9938,nadolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
9939,nadolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
9940,nadolol,adrenergic receptor antagonist,ADRB3,,,,ADRB3
9941,SKF-81297,dopamine receptor agonist,DRD1,,,,DRD1
9942,SKF-81297,dopamine receptor agonist,DRD5,,,,DRD5
9943,BRD-K78883024,neuropeptide receptor antagonist,NPSR1,,,,NPSR1
9944,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY2,,,,ADCY2
9945,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY5,,,,ADCY5
9946,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",GNAS,,,,GNAS
9947,digoxigenin,ATPase inhibitor,ATP1A1,,,,ATP1A1
9948,SB-590885,RAF inhibitor,BRAF,,,,BRAF
9949,BRD-K63784565,"beta amyloid synthesis inhibitor, topoisomerase inhibitor",TOP1,,,,TOP1
9950,L-745870,dopamine receptor antagonist,DRD4,,,,DRD4
9951,L-745870,dopamine receptor antagonist,DRD1,,,,DRD1
9952,L-745870,dopamine receptor antagonist,DRD2,,,,DRD2
9953,L-745870,dopamine receptor antagonist,DRD3,,,,DRD3
9954,L-745870,dopamine receptor antagonist,HTR1A,,,,HTR1A
9955,L-745870,dopamine receptor antagonist,HTR2A,,,,HTR2A
9956,L-745870,dopamine receptor antagonist,HTR6,,,,HTR6
9957,L-745870,dopamine receptor antagonist,HTR7,,,,HTR7
9958,PQ-401,insulin growth factor receptor inhibitor,IGF1R,,,,IGF1R
9959,bupropion,"dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor",SLC6A2,,,,SLC6A2
9960,bupropion,"dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor",SLC6A3,,,,SLC6A3
9961,bupropion,"dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor",CHRNA3,,,,CHRNA3
9962,bupropion,"dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor",CYP2B6,,,,CYP2B6
9963,naltrindole,opioid receptor antagonist,OPRD1,,,,OPRD1
9964,naltrindole,opioid receptor antagonist,OPRK1,,,,OPRK1
9965,naltrindole,opioid receptor antagonist,OPRM1,,,,OPRM1
9966,olmesartan,"angiotensin receptor antagonist, angiotensin antagonist",AGTR1,,,,AGTR1
9967,VER-155008,HSP inhibitor,HSPA1A,,,,HSPA1A
9968,fenofibrate,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor",PPARA,,,,PPARA
9969,fenofibrate,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor",APOA1,,,,APOA1
9970,fenofibrate,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor",CYP2C19,,,,CYP2C19
9971,fenofibrate,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor",CYP2C8,,,,CYP2C8
9972,fenofibrate,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor",MMP25,,,,MMP25
9973,VU-0415374-1,glutamate receptor modulator,GRM4,,,,GRM4
9974,rosuvastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
9975,doxylamine,histamine receptor antagonist,HRH1,,,,HRH1
9976,doxylamine,histamine receptor antagonist,CHRM1,,,,CHRM1
9977,mevastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
9978,phylloquinone,"antifibrinolytic agent, gamma carboxylase enzyme",BGLAP,,,,BGLAP
9979,phylloquinone,"antifibrinolytic agent, gamma carboxylase enzyme",GGCX,,,,GGCX
9980,T-0070907,"PPAR receptor anatagonist, PPAR receptor antagonist",PPARG,,,,PPARG
9981,gefitinib,EGFR inhibitor,EGFR,,,,EGFR
9982,gefitinib,EGFR inhibitor,CYP2C19,,,,CYP2C19
9983,rescinnamine,angiotensin converting enzyme inhibitor,ACE,,,,ACE
9984,DPO-1,potassium channel blocker,KCNA5,,,,KCNA5
9985,SB-222200,tachykinin antagonist,TACR3,,,,TACR3
9986,metronidazole,DNA inhibitor,CYP2C8,,,,CYP2C8
9987,metronidazole,DNA inhibitor,CYP2E1,,,,CYP2E1
9988,metronidazole,DNA inhibitor,CYP3A5,,,,CYP3A5
9989,metronidazole,DNA inhibitor,CYP3A7,,,,CYP3A7
9990,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",JAK2,,,,JAK2
9991,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",JAK3,,,,JAK3
9992,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",EGFR,,,,EGFR
9993,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",STAT3,,,,STAT3
9994,BML-190,cannabinoid receptor inverse agonist,CNR2,,,,CNR2
9995,AZ-10417808,caspase inhibitor,CASP3,,,,CASP3
9996,oxaprozin,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
9997,oxaprozin,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
9998,MRS-1754,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
9999,MRS-1754,adenosine receptor antagonist,ADORA1,,,,ADORA1
10000,MRS-1754,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
10001,MRS-1754,adenosine receptor antagonist,ADORA3,,,,ADORA3
10002,DUP-697,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
10003,olaparib,"PARP inhibitor, DNA repair enzyme inhibitor",PARP1,,,,PARP1
10004,olaparib,"PARP inhibitor, DNA repair enzyme inhibitor",PARP2,,,,PARP2
10005,olaparib,"PARP inhibitor, DNA repair enzyme inhibitor",PARP3,,,,PARP3
10006,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",ACHE,,,,ACHE
10007,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",BCHE,,,,BCHE
10008,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA1,,,,CHRNA1
10009,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA10,,,,CHRNA10
10010,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA2,,,,CHRNA2
10011,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA3,,,,CHRNA3
10012,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA4,,,,CHRNA4
10013,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA5,,,,CHRNA5
10014,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA6,,,,CHRNA6
10015,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA7,,,,CHRNA7
10016,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA9,,,,CHRNA9
10017,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB1,,,,CHRNB1
10018,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB2,,,,CHRNB2
10019,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB3,,,,CHRNB3
10020,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB4,,,,CHRNB4
10021,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRND,,,,CHRND
10022,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNE,,,,CHRNE
10023,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNG,,,,CHRNG
10024,fluspirilene,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
10025,fluspirilene,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
10026,fluspirilene,"dopamine receptor, dopamine receptor antagonist",CACNG1,,,,CACNG1
10027,fluspirilene,"dopamine receptor, dopamine receptor antagonist",HRH1,,,,HRH1
10028,fluspirilene,"dopamine receptor, dopamine receptor antagonist",HTR1A,,,,HTR1A
10029,fluspirilene,"dopamine receptor, dopamine receptor antagonist",HTR1D,,,,HTR1D
10030,fluspirilene,"dopamine receptor, dopamine receptor antagonist",HTR1E,,,,HTR1E
10031,oleoylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist",CNR1,,,,CNR1
10032,oleoylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist",GPR119,,,,GPR119
10033,oleoylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist",GPR55,,,,GPR55
10034,oleoylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist",KCND3,,,,KCND3
10035,oleoylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist",PPARA,,,,PPARA
10036,triprolidine,histamine receptor antagonist,HRH1,,,,HRH1
10037,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
10038,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
10039,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
10040,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
10041,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKA,,,,AURKA
10042,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKB,,,,AURKB
10043,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",ABL1,,,,ABL1
10044,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",AURKC,,,,AURKC
10045,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",BCR,,,,BCR
10046,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",FLT3,,,,FLT3
10047,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",JAK2,,,,JAK2
10048,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",DDR2,,,,DDR2
10049,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor",LCK,,,,LCK
10050,salmeterol,adrenergic receptor agonist,ADRB2,,,,ADRB2
10051,sotalol,"adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist",ADRB1,,,,ADRB1
10052,sotalol,"adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist",ADRB2,,,,ADRB2
10053,sotalol,"adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist",KCNH2,,,,KCNH2
10054,montelukast,leukotriene receptor antagonist,CYSLTR1,,,,CYSLTR1
10055,montelukast,leukotriene receptor antagonist,ALOX5,,,,ALOX5
10056,montelukast,leukotriene receptor antagonist,CYP2C8,,,,CYP2C8
10057,GW-7647,PPAR receptor agonist,PPARA,,,,PPARA
10058,BRD-K71726959,CDK inhibitor,CDK1,,,,CDK1
10059,BRD-K71726959,CDK inhibitor,CDK5,,,,CDK5
10060,NNC-05-2090,"GABA uptake inhibitor, GAT inhibitor",SLC6A11,,,,SLC6A11
10061,NNC-05-2090,"GABA uptake inhibitor, GAT inhibitor",SLC6A12,,,,SLC6A12
10062,NNC-05-2090,"GABA uptake inhibitor, GAT inhibitor",SLC6A13,,,,SLC6A13
10063,megestrol,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor",PGR,,,,PGR
10064,BRD-K28452084,opioid receptor agonist,OPRK1,,,,OPRK1
10065,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",TP53,,,,TP53
10066,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",AKT1,,,,AKT1
10067,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",MTOR,,,,MTOR
10068,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",NFKB1,,,,NFKB1
10069,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLA2G1B,,,,PLA2G1B
10070,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLA2G2A,,,,PLA2G2A
10071,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLA2G2D,,,,PLA2G2D
10072,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLA2G4A,,,,PLA2G4A
10073,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLA2G6,,,,PLA2G6
10074,mepacrine,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator",PLCL1,,,,PLCL1
10075,UNC-0321,"histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor",EHMT2,,,,EHMT2
10076,paxilline,"ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist",ABCA1,,,,ABCA1
10077,paxilline,"ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist",KCNMA1,,,,KCNMA1
10078,paxilline,"ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist",NR1H3,,,,NR1H3
10079,azelastine,"histamine receptor antagonist, histamine release inhibitor, immunosuppressant",HRH1,,,,HRH1
10080,azelastine,"histamine receptor antagonist, histamine release inhibitor, immunosuppressant",CYP2C19,,,,CYP2C19
10081,rizatriptan,serotonin receptor agonist,HTR1D,,,,HTR1D
10082,rizatriptan,serotonin receptor agonist,HTR1B,,,,HTR1B
10083,rizatriptan,serotonin receptor agonist,HTR1F,,,,HTR1F
10084,rizatriptan,serotonin receptor agonist,HTR1A,,,,HTR1A
10085,rizatriptan,serotonin receptor agonist,HTR1E,,,,HTR1E
10086,ICI-204448,opioid receptor agonist,OPRK1,,,,OPRK1
10087,nizatidine,histamine receptor antagonist,HRH2,,,,HRH2
10088,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",FLT1,,,,FLT1
10089,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",FLT4,,,,FLT4
10090,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",KDR,,,,KDR
10091,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",KIT,,,,KIT
10092,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
10093,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist",RET,,,,RET
10094,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
10095,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
10096,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
10097,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
10098,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
10099,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
10100,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
10101,mestranol,estrogen receptor agonist,ESR1,,,,ESR1
10102,bergenin,anti-arthritic compound that modulates Th1/Th2 cytokine balance,PTPN1,,,,PTPN1
10103,PCO-400,"potassium channel activator, potassium channel agonist",ABCC9,,,,ABCC9
10104,PCO-400,"potassium channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
10105,JNJ-16259685,glutamate receptor antagonist,GRM1,,,,GRM1
10106,ticlopidine,"purinergic receptor antagonist, platelet aggregation inhibitor",P2RY12,,,,P2RY12
10107,ticlopidine,"purinergic receptor antagonist, platelet aggregation inhibitor",CYP2B6,,,,CYP2B6
10108,ticlopidine,"purinergic receptor antagonist, platelet aggregation inhibitor",CYP2C19,,,,CYP2C19
10109,trimethobenzamide,histamine receptor antagonist,DRD2,,,,DRD2
10110,VU-0404997-2,glutamate receptor modulator,GRM4,,,,GRM4
10111,1-monopalmitin,P glycoprotein inhibitor,ABCB1,,,,ABCB1
10112,QX-314,sodium channel blocker,MAPK14,,,,MAPK14
10113,QX-314,sodium channel blocker,TGFBR1,,,,TGFBR1
10114,benzbromarone,"calcium-activated chloride channel blocker, uric acid diuretic",ABCC1,,,,ABCC1
10115,benzbromarone,"calcium-activated chloride channel blocker, uric acid diuretic",SLC22A12,,,,SLC22A12
10116,irbesartan,"angiotensin receptor antagonist, liver bile acid transporter inhibitor",AGTR1,,,,AGTR1
10117,irbesartan,"angiotensin receptor antagonist, liver bile acid transporter inhibitor",JUN,,,,JUN
10118,irbesartan,"angiotensin receptor antagonist, liver bile acid transporter inhibitor",SLC10A1,,,,SLC10A1
10119,SKF-89976A,GABA uptake inhibitor,SLC6A1,,,,SLC6A1
10120,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",PTGS1,,,,PTGS1
10121,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",PTGS2,,,,PTGS2
10122,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",ACSL3,,,,ACSL3
10123,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",ACSL4,,,,ACSL4
10124,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",FADS1,,,,FADS1
10125,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",FFAR1,,,,FFAR1
10126,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",PPARD,,,,PPARD
10127,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",PPARG,,,,PPARG
10128,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",SLC8A1,,,,SLC8A1
10129,icosapent,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties",TRPV1,,,,TRPV1
10130,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",KCNH2,,,,KCNH2
10131,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
10132,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",ADRB1,,,,ADRB1
10133,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",ADRB2,,,,ADRB2
10134,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",KCNA5,,,,KCNA5
10135,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",KCNK2,,,,KCNK2
10136,propafenone,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker",KCNK3,,,,KCNK3
10137,telmisartan,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist",AGTR1,,,,AGTR1
10138,telmisartan,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist",PPARG,,,,PPARG
10139,telmisartan,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist",CYP2C19,,,,CYP2C19
10140,telmisartan,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist",CYP2J2,,,,CYP2J2
10141,telmisartan,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist",PPARA,,,,PPARA
10142,promazine,"dopamine receptor, dopamine receptor antagonist",CHRM5,,,,CHRM5
10143,promazine,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
10144,promazine,"dopamine receptor, dopamine receptor antagonist",ADRA1A,,,,ADRA1A
10145,promazine,"dopamine receptor, dopamine receptor antagonist",ADRA1B,,,,ADRA1B
10146,promazine,"dopamine receptor, dopamine receptor antagonist",ADRA1D,,,,ADRA1D
10147,promazine,"dopamine receptor, dopamine receptor antagonist",CHRM1,,,,CHRM1
10148,promazine,"dopamine receptor, dopamine receptor antagonist",CHRM2,,,,CHRM2
10149,promazine,"dopamine receptor, dopamine receptor antagonist",CHRM3,,,,CHRM3
10150,promazine,"dopamine receptor, dopamine receptor antagonist",CHRM4,,,,CHRM4
10151,promazine,"dopamine receptor, dopamine receptor antagonist",DRD1,,,,DRD1
10152,promazine,"dopamine receptor, dopamine receptor antagonist",DRD3,,,,DRD3
10153,promazine,"dopamine receptor, dopamine receptor antagonist",DRD4,,,,DRD4
10154,promazine,"dopamine receptor, dopamine receptor antagonist",HRH1,,,,HRH1
10155,promazine,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
10156,promazine,"dopamine receptor, dopamine receptor antagonist",HTR2C,,,,HTR2C
10157,NSC-94258,antitumor agent,AKR1B1,,,,AKR1B1
10158,NSC-94258,antitumor agent,CYP19A1,,,,CYP19A1
10159,NSC-94258,antitumor agent,HSD17B1,,,,HSD17B1
10160,phenazone,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
10161,phenazone,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
10162,W-9,calmodulin antagonist,CALM2,,,,CALM2
10163,hyoscyamine,acetylcholine receptor inhibitor,CHRM1,,,,CHRM1
10164,hyoscyamine,acetylcholine receptor inhibitor,CHRM2,,,,CHRM2
10165,hyoscyamine,acetylcholine receptor inhibitor,CHRM3,,,,CHRM3
10166,hyoscyamine,acetylcholine receptor inhibitor,CHRM4,,,,CHRM4
10167,BRD-K06956503,glucosylceramidase inhibitor,GBA,,,,GBA
10168,doxapram,potassium channel blocker,KCNK3,,,,KCNK3
10169,doxapram,potassium channel blocker,KCNK9,,,,KCNK9
10170,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR1,,,,ESR1
10171,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR2,,,,ESR2
10172,BMS-182874,endothelin receptor antagonist,EDNRA,,,,EDNRA
10173,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",DRD1,,,,DRD1
10174,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",DRD2,,,,DRD2
10175,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA2A,,,,ADRA2A
10176,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA2B,,,,ADRA2B
10177,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA2C,,,,ADRA2C
10178,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",DRD3,,,,DRD3
10179,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",DRD4,,,,DRD4
10180,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",DRD5,,,,DRD5
10181,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR1A,,,,HTR1A
10182,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR1B,,,,HTR1B
10183,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR1D,,,,HTR1D
10184,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR2A,,,,HTR2A
10185,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR2B,,,,HTR2B
10186,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",HTR2C,,,,HTR2C
10187,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA1A,,,,ADRA1A
10188,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA1B,,,,ADRA1B
10189,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",ADRA1D,,,,ADRA1D
10190,pergolide,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor",KCNA5,,,,KCNA5
10191,loxoprofen,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
10192,yohimbine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
10193,yohimbine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
10194,yohimbine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
10195,yohimbine,adrenergic receptor antagonist,HTR1A,,,,HTR1A
10196,yohimbine,adrenergic receptor antagonist,HTR1B,,,,HTR1B
10197,yohimbine,adrenergic receptor antagonist,HTR1D,,,,HTR1D
10198,yohimbine,adrenergic receptor antagonist,HTR2B,,,,HTR2B
10199,yohimbine,adrenergic receptor antagonist,DRD2,,,,DRD2
10200,yohimbine,adrenergic receptor antagonist,DRD3,,,,DRD3
10201,yohimbine,adrenergic receptor antagonist,HTR1E,,,,HTR1E
10202,yohimbine,adrenergic receptor antagonist,HTR1F,,,,HTR1F
10203,yohimbine,adrenergic receptor antagonist,HTR2A,,,,HTR2A
10204,yohimbine,adrenergic receptor antagonist,HTR2C,,,,HTR2C
10205,yohimbine,adrenergic receptor antagonist,HTR5A,,,,HTR5A
10206,yohimbine,adrenergic receptor antagonist,HTR7,,,,HTR7
10207,yohimbine,adrenergic receptor antagonist,KCNJ1,,,,KCNJ1
10208,yohimbine,adrenergic receptor antagonist,KCNJ10,,,,KCNJ10
10209,yohimbine,adrenergic receptor antagonist,KCNJ11,,,,KCNJ11
10210,yohimbine,adrenergic receptor antagonist,KCNJ12,,,,KCNJ12
10211,yohimbine,adrenergic receptor antagonist,KCNJ14,,,,KCNJ14
10212,yohimbine,adrenergic receptor antagonist,KCNJ15,,,,KCNJ15
10213,yohimbine,adrenergic receptor antagonist,KCNJ8,,,,KCNJ8
10214,TCS-359,FLT3 inhibitor,FLT3,,,,FLT3
10215,liothyronine,thyroid hormone function stimulant,THRA,,,,THRA
10216,liothyronine,thyroid hormone function stimulant,THRB,,,,THRB
10217,topotecan,topoisomerase inhibitor,TOP1,,,,TOP1
10218,topotecan,topoisomerase inhibitor,TOP1MT,,,,TOP1MT
10219,ranitidine,histamine receptor antagonist,HRH2,,,,HRH2
10220,ranitidine,histamine receptor antagonist,SLC22A2,,,,SLC22A2
10221,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",ACE,,,,ACE
10222,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",CXCL8,,,,CXCL8
10223,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",IL6,,,,IL6
10224,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",SIRT1,,,,SIRT1
10225,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",SRD5A1,,,,SRD5A1
10226,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",SRD5A2,,,,SRD5A2
10227,butein,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
10228,BRD-A94297859,XIAP inhibitor,XIAP,,,,XIAP
10229,naloxone,opioid receptor antagonist,OPRM1,,,,OPRM1
10230,naloxone,opioid receptor antagonist,OPRK1,,,,OPRK1
10231,naloxone,opioid receptor antagonist,OPRD1,,,,OPRD1
10232,naloxone,opioid receptor antagonist,CREB1,,,,CREB1
10233,naloxone,opioid receptor antagonist,ESR1,,,,ESR1
10234,naloxone,opioid receptor antagonist,TLR4,,,,TLR4
10235,megestrol,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor",PGR,,,,PGR
10236,prednisolone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
10237,prednisolone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
10238,prednisolone,glucocorticoid receptor agonist,SERPINA6,,,,SERPINA6
10239,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",PIK3CG,,,,PIK3CG
10240,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",AKR1B1,,,,AKR1B1
10241,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",ATP5A1,,,,ATP5F1A
10242,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",ATP5B,,,,ATP5F1B
10243,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",ATP5C1,,,,ATP5F1C
10244,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",CYP2C8,,,,CYP2C8
10245,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",EGFR,,,,EGFR
10246,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",GAA,,,,GAA
10247,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",HCK,,,,HCK
10248,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",HIBCH,,,,HIBCH
10249,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",MAOA,,,,MAOA
10250,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",PIM1,,,,PIM1
10251,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",PTPN1,,,,PTPN1
10252,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",SCN5A,,,,SCN5A
10253,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",SIRT1,,,,SIRT1
10254,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",STK17B,,,,STK17B
10255,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",UGT3A1,,,,UGT3A1
10256,quercetin,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
10257,PETCM,caspase activator,CASP3,,,,CASP3
10258,methoprene-acid,RXR agonist,NCOA2,,,,NCOA2
10259,methoprene-acid,RXR agonist,NR1H3,,,,NR1H3
10260,methoprene-acid,RXR agonist,RXRA,,,,RXRA
10261,methoprene-acid,RXR agonist,RXRB,,,,RXRB
10262,UB-165,acetylcholine receptor agonist,CHRNA3,,,,CHRNA3
10263,UB-165,acetylcholine receptor agonist,CHRNA4,,,,CHRNA4
10264,UB-165,acetylcholine receptor agonist,CHRNB2,,,,CHRNB2
10265,AZD-6482,PI3K inhibitor,PIK3CD,,,,PIK3CD
10266,AZD-6482,PI3K inhibitor,PIK3CG,,,,PIK3CG
10267,AZD-6482,PI3K inhibitor,PIK3CA,,,,PIK3CA
10268,AZD-6482,PI3K inhibitor,PIK3CB,,,,PIK3CB
10269,isorotenone,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor",MT-ND1,,,,MT-ND1
10270,NPC-15199,"ICAM 1 antagonist, increases intracellular calcium levels",ICAM1,,,,ICAM1
10271,NPC-15199,"ICAM 1 antagonist, increases intracellular calcium levels",PPARG,,,,PPARG
10272,milrinone,phosphodiesterase inhibitor,PDE3A,,,,PDE3A
10273,milrinone,phosphodiesterase inhibitor,PDE2A,,,,PDE2A
10274,milrinone,phosphodiesterase inhibitor,PDE3B,,,,PDE3B
10275,milrinone,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
10276,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",KCNH2,,,,KCNH2
10277,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",PRKCD,,,,PRKCD
10278,rottlerin,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor",TGM2,,,,TGM2
10279,amlexanox,"histamine release inhibitor, mediator release inhibitor",FGF1,,,,FGF1
10280,amlexanox,"histamine release inhibitor, mediator release inhibitor",IL3,,,,IL3
10281,amlexanox,"histamine release inhibitor, mediator release inhibitor",S100A12,,,,S100A12
10282,amlexanox,"histamine release inhibitor, mediator release inhibitor",S100A13,,,,S100A13
10283,BH3I-1,BCL inhibitor,BCL2,,,,BCL2
10284,valsartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
10285,luzindole,melatonin receptor antagonist,MTNR1B,,,,MTNR1B
10286,luzindole,melatonin receptor antagonist,MTNR1A,,,,MTNR1A
10287,OMDM-2,FAAH reuptake inhibitor,GPR119,,,,GPR119
10288,BRD-K36038115,neuropeptide receptor antagonist,NPBWR1,,,,NPBWR1
10289,ilomastat,matrix metalloprotease inhibitor,ACAN,,,,ACAN
10290,ilomastat,matrix metalloprotease inhibitor,ADAM28,,,,ADAM28
10291,ilomastat,matrix metalloprotease inhibitor,MMP1,,,,MMP1
10292,ilomastat,matrix metalloprotease inhibitor,MMP12,,,,MMP12
10293,ilomastat,matrix metalloprotease inhibitor,MMP13,,,,MMP13
10294,ilomastat,matrix metalloprotease inhibitor,MMP14,,,,MMP14
10295,ilomastat,matrix metalloprotease inhibitor,MMP2,,,,MMP2
10296,ilomastat,matrix metalloprotease inhibitor,MMP3,,,,MMP3
10297,ilomastat,matrix metalloprotease inhibitor,MMP8,,,,MMP8
10298,ilomastat,matrix metalloprotease inhibitor,MMP9,,,,MMP9
10299,levetiracetam,"acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand",SV2A,,,,SV2A
10300,levetiracetam,"acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand",CACNA1B,,,,CACNA1B
10301,levetiracetam,"acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand",SCN1A,,,,SCN1A
10302,bisphenol-a,synthetic compound with hormone-like properties,AR,,,,AR
10303,bisphenol-a,synthetic compound with hormone-like properties,ESR2,,,,ESR2
10304,bisphenol-a,synthetic compound with hormone-like properties,ESRRG,,,,ESRRG
10305,bisphenol-a,synthetic compound with hormone-like properties,PPARG,,,,PPARG
10306,diflorasone,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
10307,diflorasone,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",PLA2G1B,,,,PLA2G1B
10308,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",ADORA1,,,,ADORA1
10309,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",ADORA2A,,,,ADORA2A
10310,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",ADORA2B,,,,ADORA2B
10311,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",ADORA3,,,,ADORA3
10312,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",CHIA,,,,CHIA
10313,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",CYP2E1,,,,CYP2E1
10314,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",CYP3A4,,,,CYP3A4
10315,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",HDAC2,,,,HDAC2
10316,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",PDE3A,,,,PDE3A
10317,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",PDE4A,,,,PDE4A
10318,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",PDE4B,,,,PDE4B
10319,theophylline,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor",PDE5A,,,,PDE5A
10320,donepezil,acetylcholinesterase inhibitor,ACHE,,,,ACHE
10321,donepezil,acetylcholinesterase inhibitor,HTR2A,,,,HTR2A
10322,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",CYP3A4,,,,CYP3A4
10323,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",MLNR,,,,MLNR
10324,pizotifen,serotonin receptor antagonist,HTR2A,,,,HTR2A
10325,pizotifen,serotonin receptor antagonist,HTR1A,,,,HTR1A
10326,pizotifen,serotonin receptor antagonist,HTR2C,,,,HTR2C
10327,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",AR,,,,AR
10328,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP19A1,,,,CYP19A1
10329,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C19,,,,CYP2C19
10330,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C8,,,,CYP2C8
10331,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP3A5,,,,CYP3A5
10332,medrysone,"corticosteroid hormone receptor agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
10333,CGS-15943,adenosine receptor antagonist,ADORA1,,,,ADORA1
10334,CGS-15943,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
10335,CGS-15943,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
10336,CGS-15943,adenosine receptor antagonist,ADORA3,,,,ADORA3
10337,chloroquine,antimalarial agent,CYP2C8,,,,CYP2C8
10338,chloroquine,antimalarial agent,GSTA2,,,,GSTA2
10339,chloroquine,antimalarial agent,MRGPRX1,,,,MRGPRX1
10340,chloroquine,antimalarial agent,TLR9,,,,TLR9
10341,chloroquine,antimalarial agent,TNF,,,,TNF
10342,proxymetacaine,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker",SCN10A,,,,SCN10A
10343,proxymetacaine,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker",SCN5A,,,,SCN5A
10344,proxymetacaine,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker",SCN9A,,,,SCN9A
10345,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",NR3C1,,,,NR3C1
10346,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A5,,,,CYP3A5
10347,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A7,,,,CYP3A7
10348,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",SERPINA6,,,,SERPINA6
10349,YM-298198,glutamate receptor antagonist,GRM1,,,,GRM1
10350,GW-311616,leukocyte elastase inhibitor,ELANE,,,,ELANE
10351,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",SLC18A2,,,,SLC18A2
10352,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA10,,,,CHRNA10
10353,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA4,,,,CHRNA4
10354,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA9,,,,CHRNA9
10355,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNB2,,,,CHRNB2
10356,lobelanidine,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",OPRM1,,,,OPRM1
10357,ciprofibrate,"PPAR receptor agonist, lipase clearing factor inhibitor",PPARA,,,,PPARA
10358,ciprofibrate,"PPAR receptor agonist, lipase clearing factor inhibitor",LPL,,,,LPL
10359,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
10360,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
10361,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
10362,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",HTR2A,,,,HTR2A
10363,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",HTR2C,,,,HTR2C
10364,duloxetine,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor",HTR6,,,,HTR6
10365,SR-57227A,"serotonin receptor agonist, serotonin release enhancer",HTR3A,,,,HTR3A
10366,itraconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor",CYP3A5,,,,CYP3A5
10367,itraconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor",CYP3A7,,,,CYP3A7
10368,itraconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor",CYP51A1,,,,CYP51A1
10369,itraconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor",KDR,,,,KDR
10370,pinacidil,"ATP channel activator, potassium channel agonist",ABCC9,,,,ABCC9
10371,pinacidil,"ATP channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
10372,dexketoprofen,cyclooxygenase inhibitor,CXCR1,,,,CXCR1
10373,dexketoprofen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
10374,dexketoprofen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
10375,dexketoprofen,cyclooxygenase inhibitor,SLC5A8,,,,SLC5A8
10376,loratadine,histamine receptor antagonist,HRH1,,,,HRH1
10377,loratadine,histamine receptor antagonist,CYP2C19,,,,CYP2C19
10378,loratadine,histamine receptor antagonist,CYP3A5,,,,CYP3A5
10379,withaferin-a,"acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor",ACHE,,,,ACHE
10380,withaferin-a,"acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor",BCHE,,,,BCHE
10381,withaferin-a,"acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor",IKBKB,,,,IKBKB
10382,losartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
10383,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",ABCC8,,,,ABCC8
10384,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",KCNJ11,,,,KCNJ11
10385,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",KCNJ1,,,,KCNJ1
10386,erlotinib,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
10387,erlotinib,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor",NR1I2,,,,NR1I2
10388,Y-27152,"potassium channel activator, potassium channel agonist",ABCC9,,,,ABCC9
10389,Y-27152,"potassium channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
10390,GW-3965,"LXR agonist, ABC transporter expression enhancer",NR1H2,,,,NR1H2
10391,GW-3965,"LXR agonist, ABC transporter expression enhancer",NR1H3,,,,NR1H3
10392,GW-3965,"LXR agonist, ABC transporter expression enhancer",ABCA1,,,,ABCA1
10393,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CA,,,,PIK3CA
10394,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CG,,,,PIK3CG
10395,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK1,,,,PLK1
10396,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATM,,,,ATM
10397,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",ATR,,,,ATR
10398,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",MTOR,,,,MTOR
10399,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KA,,,,PI4KA
10400,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PI4KB,,,,PI4KB
10401,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3CD,,,,PIK3CD
10402,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PIK3R1,,,,PIK3R1
10403,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PLK3,,,,PLK3
10404,wortmannin,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor",PRKDC,,,,PRKDC
10405,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CA2,,,,CA2
10406,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CA4,,,,CA4
10407,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GRIK1,,,,GRIK1
10408,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CA1,,,,CA1
10409,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CA12,,,,CA12
10410,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CA7,,,,CA7
10411,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CYP2C19,,,,CYP2C19
10412,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CYP3A4,,,,CYP3A4
10413,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA1,,,,GABRA1
10414,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA2,,,,GABRA2
10415,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA3,,,,GABRA3
10416,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA4,,,,GABRA4
10417,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA5,,,,GABRA5
10418,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRA6,,,,GABRA6
10419,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRB1,,,,GABRB1
10420,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRB2,,,,GABRB2
10421,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRB3,,,,GABRB3
10422,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRD,,,,GABRD
10423,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRE,,,,GABRE
10424,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRG1,,,,GABRG1
10425,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRG2,,,,GABRG2
10426,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRG3,,,,GABRG3
10427,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRP,,,,GABRP
10428,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GABRQ,,,,GABRQ
10429,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",GRIA1,,,,GRIA1
10430,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",SCN1A,,,,SCN1A
10431,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
10432,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS2,,,,PTGS2
10433,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS1,,,,PTGS1
10434,etodolac,"cyclooxygenase inhibitor, TRPV agonist",RXRA,,,,RXRA
10435,etodolac,"cyclooxygenase inhibitor, TRPV agonist",TRPV1,,,,TRPV1
10436,spiramide,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
10437,spiramide,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
10438,spiramide,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
10439,spiramide,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2B,,,,HTR2B
10440,spiramide,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
10441,mepivacaine,"potassium channel antagonist, voltage-gated sodium channel blocker",SCN10A,,,,SCN10A
10442,mepivacaine,"potassium channel antagonist, voltage-gated sodium channel blocker",SCN9A,,,,SCN9A
10443,nemonapride,"dopamine receptor antagonist, serotonin receptor agonist",DRD2,,,,DRD2
10444,nemonapride,"dopamine receptor antagonist, serotonin receptor agonist",DRD3,,,,DRD3
10445,nemonapride,"dopamine receptor antagonist, serotonin receptor agonist",DRD4,,,,DRD4
10446,NAN-190,serotonin receptor agonist,HTR1A,,,,HTR1A
10447,NAN-190,serotonin receptor agonist,ADRA1A,,,,ADRA1A
10448,NAN-190,serotonin receptor agonist,ADRA1B,,,,ADRA1B
10449,NAN-190,serotonin receptor agonist,ADRA1D,,,,ADRA1D
10450,NAN-190,serotonin receptor agonist,HTR1F,,,,HTR1F
10451,yohimbine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
10452,yohimbine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
10453,yohimbine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
10454,yohimbine,adrenergic receptor antagonist,HTR1A,,,,HTR1A
10455,yohimbine,adrenergic receptor antagonist,HTR1B,,,,HTR1B
10456,yohimbine,adrenergic receptor antagonist,HTR1D,,,,HTR1D
10457,yohimbine,adrenergic receptor antagonist,HTR2B,,,,HTR2B
10458,yohimbine,adrenergic receptor antagonist,DRD2,,,,DRD2
10459,yohimbine,adrenergic receptor antagonist,DRD3,,,,DRD3
10460,yohimbine,adrenergic receptor antagonist,HTR1E,,,,HTR1E
10461,yohimbine,adrenergic receptor antagonist,HTR1F,,,,HTR1F
10462,yohimbine,adrenergic receptor antagonist,HTR2A,,,,HTR2A
10463,yohimbine,adrenergic receptor antagonist,HTR2C,,,,HTR2C
10464,yohimbine,adrenergic receptor antagonist,HTR5A,,,,HTR5A
10465,yohimbine,adrenergic receptor antagonist,HTR7,,,,HTR7
10466,yohimbine,adrenergic receptor antagonist,KCNJ1,,,,KCNJ1
10467,yohimbine,adrenergic receptor antagonist,KCNJ10,,,,KCNJ10
10468,yohimbine,adrenergic receptor antagonist,KCNJ11,,,,KCNJ11
10469,yohimbine,adrenergic receptor antagonist,KCNJ12,,,,KCNJ12
10470,yohimbine,adrenergic receptor antagonist,KCNJ14,,,,KCNJ14
10471,yohimbine,adrenergic receptor antagonist,KCNJ15,,,,KCNJ15
10472,yohimbine,adrenergic receptor antagonist,KCNJ8,,,,KCNJ8
10473,amoxicillin,"cell wall synthesis inhibitor, PBPA inhibitor",SLC15A1,,,,SLC15A1
10474,ML-7,myosin light chain kinase inhibitor,MYLK,,,,MYLK
10475,lavendustin-c,epidermal growth factor receptor (EGFR) inhibitor,CAMK2A,,,,CAMK2A
10476,lavendustin-c,epidermal growth factor receptor (EGFR) inhibitor,EGFR,,,,EGFR
10477,lavendustin-c,epidermal growth factor receptor (EGFR) inhibitor,SRC,,,,SRC
10478,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",JAK2,,,,JAK2
10479,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",JAK3,,,,JAK3
10480,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",EGFR,,,,EGFR
10481,AG-490,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor",STAT3,,,,STAT3
10482,R-96544,serotonin receptor antagonist,HTR2A,,,,HTR2A
10483,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5A1,,,,ATP5F1A
10484,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5B,,,,ATP5F1B
10485,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5C1,,,,ATP5F1C
10486,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",IRF3,,,,IRF3
10487,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",PTGS2,,,,PTGS2
10488,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",SIRT1,,,,SIRT1
10489,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",SYK,,,,SYK
10490,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",TYR,,,,TYR
10491,AM-251,"ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist",CNR1,,,,CNR1
10492,AM-251,"ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist",GPR18,,,,GPR18
10493,AM-251,"ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist",GPR55,,,,GPR55
10494,ZSTK-474,PI3K inhibitor,PIK3CG,,,,PIK3CG
10495,ZSTK-474,PI3K inhibitor,PIK3CA,,,,PIK3CA
10496,ZSTK-474,PI3K inhibitor,PIK3CB,,,,PIK3CB
10497,ZSTK-474,PI3K inhibitor,PIK3CD,,,,PIK3CD
10498,phenacetin,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
10499,flavokavain-b,"carcinoma cell growth inhibitor, hypoxia inducible factor inhibitor",HIF1A,,,,HIF1A
10500,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",TRPV1,,,,TRPV1
10501,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",CNR1,,,,CNR1
10502,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",CNR2,,,,CNR2
10503,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",FAAH,,,,FAAH
10504,vanoxerine,"dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor",SLC6A3,,,,SLC6A3
10505,vanoxerine,"dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor",MAOA,,,,MAOA
10506,vanoxerine,"dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor",MAOB,,,,MAOB
10507,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",SRD5A2,,,,SRD5A2
10508,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",SRD5A1,,,,SRD5A1
10509,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",AKR1D1,,,,AKR1D1
10510,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",AR,,,,AR
10511,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK14,,,,MAPK14
10512,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK1,,,,MAPK1
10513,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK11,,,,MAPK11
10514,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",AKT1,,,,AKT1
10515,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",ALOX5,,,,ALOX5
10516,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CHEK1,,,,CHEK1
10517,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CYP2D6,,,,CYP2D6
10518,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CYP3A4,,,,CYP3A4
10519,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",GAK,,,,GAK
10520,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",GSK3B,,,,GSK3B
10521,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",LCK,,,,LCK
10522,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK10,,,,MAPK10
10523,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK12,,,,MAPK12
10524,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK8,,,,MAPK8
10525,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK9,,,,MAPK9
10526,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",PRKCA,,,,PRKCA
10527,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RAF1,,,,RAF1
10528,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RIPK2,,,,RIPK2
10529,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",ROCK1,,,,ROCK1
10530,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RPS6KB1,,,,RPS6KB1
10531,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",SGK1,,,,SGK1
10532,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",SRC,,,,SRC
10533,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",TNF,,,,TNF
10534,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",DHODH,,,,DHODH
10535,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",AHR,,,,AHR
10536,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",CYP2C19,,,,CYP2C19
10537,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",JAK3,,,,JAK3
10538,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",PTK2B,,,,PTK2B
10539,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor",STAT6,,,,STAT6
10540,FPL-64176,"calcium channel agonist, L-type calcium channel activator",CACNA1C,,,,CACNA1C
10541,FPL-64176,"calcium channel agonist, L-type calcium channel activator",CACNA1S,,,,CACNA1S
10542,deracoxib,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
10543,raltitrexed,"thymidylate synthase inhibitor, pyrimidine antagonist",TYMS,,,,TYMS
10544,raltitrexed,"thymidylate synthase inhibitor, pyrimidine antagonist",FPGS,,,,FPGS
10545,phentermine,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor",MAOA,,,,MAOA
10546,phentermine,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor",MAOB,,,,MAOB
10547,phentermine,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
10548,phentermine,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
10549,phentermine,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
10550,NS-1619,"calcium channel activator, large conductance potassium channel activator",KCNMA1,,,,KCNMA1
10551,NS-1619,"calcium channel activator, large conductance potassium channel activator",KCNT1,,,,KCNT1
10552,NS-1619,"calcium channel activator, large conductance potassium channel activator",KCNT2,,,,KCNT2
10553,NS-1619,"calcium channel activator, large conductance potassium channel activator",KCNU1,,,,KCNU1
10554,thiorphan,membrane metalloendopeptidase inhibitor,MME,,,,MME
10555,efavirenz,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP2B6,,,,CYP2B6
10556,efavirenz,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP2C19,,,,CYP2C19
10557,efavirenz,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP2C8,,,,CYP2C8
10558,efavirenz,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP3A4,,,,CYP3A4
10559,efavirenz,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP3A5,,,,CYP3A5
10560,PK-11195,"benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist",TSPO,,,,TSPO
10561,PK-11195,"benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist",NR1I2,,,,NR1I2
10562,PK-11195,"benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist",NR1I3,,,,NR1I3
10563,oxindole-I,"protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor",AKT1,,,,AKT1
10564,oxindole-I,"protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor",KDR,,,,KDR
10565,oxindole-I,"protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor",PDPK1,,,,PDPK1
10566,oxindole-I,"protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor",RET,,,,RET
10567,picotamide,"prostanoid receptor antagonist, thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXA2R,,,,TBXA2R
10568,picotamide,"prostanoid receptor antagonist, thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXAS1,,,,TBXAS1
10569,clobetasol,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
10570,clobetasol,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
10571,famotidine,histamine receptor antagonist,HRH2,,,,HRH2
10572,tolbutamide,ATP channel blocker,ABCC8,,,,ABCC8
10573,tolbutamide,ATP channel blocker,CYP2B6,,,,CYP2B6
10574,tolbutamide,ATP channel blocker,CYP2C19,,,,CYP2C19
10575,tolbutamide,ATP channel blocker,CYP2C8,,,,CYP2C8
10576,tolbutamide,ATP channel blocker,KCNJ1,,,,KCNJ1
10577,tolbutamide,ATP channel blocker,KCNJ11,,,,KCNJ11
10578,tolbutamide,ATP channel blocker,KCNJ8,,,,KCNJ8
10579,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",KCNN4,,,,KCNN4
10580,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",CYP3A4,,,,CYP3A4
10581,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",CYP51A1,,,,CYP51A1
10582,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",NR1I2,,,,NR1I2
10583,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",NR1I3,,,,NR1I3
10584,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",TRPM2,,,,TRPM2
10585,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",TRPM4,,,,TRPM4
10586,clotrimazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor",TRPM8,,,,TRPM8
10587,diphenhydramine,histamine receptor antagonist,HRH1,,,,HRH1
10588,SRT-1720,SIRT activator,SIRT1,,,,SIRT1
10589,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",MTOR,,,,MTOR
10590,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
10591,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",CCR5,,,,CCR5
10592,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FGF2,,,,FGF2
10593,pirenperone,serotonin receptor antagonist,HTR2A,,,,HTR2A
10594,pirenperone,serotonin receptor antagonist,HTR7,,,,HTR7
10595,altanserin,"serotonin receptor antagonist, collagen stimulant",HTR2A,,,,HTR2A
10596,altanserin,"serotonin receptor antagonist, collagen stimulant",HTR2C,,,,HTR2C
10597,NU-7026,"DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",PRKDC,,,,PRKDC
10598,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
10599,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
10600,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
10601,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
10602,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",HTR1B,,,,HTR1B
10603,pipamperone,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist",HTR1D,,,,HTR1D
10604,nicergoline,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
10605,H-8,PKA inhibitor,PKIA,,,,PKIA
10606,H-8,PKA inhibitor,PRKACA,,,,PRKACA
10607,atracurium,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
10608,gliquidone,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",ABCC8,,,,ABCC8
10609,gliquidone,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",KCNJ10,,,,KCNJ10
10610,gliquidone,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",KCNJ11,,,,KCNJ11
10611,gliquidone,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",KCNJ8,,,,KCNJ8
10612,PPT,estrogen receptor agonist,ESR1,,,,ESR1
10613,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1C,,,,CACNA1C
10614,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1S,,,,CACNA1S
10615,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA2D1,,,,CACNA2D1
10616,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNG1,,,,CACNG1
10617,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A5,,,,CYP3A5
10618,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A7,,,,CYP3A7
10619,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",HTR3A,,,,HTR3A
10620,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",KCNA5,,,,KCNA5
10621,dilazep,"adenosine reuptake inhibitor, calcium channel antagonist, platelet aggregation inhibitor",SLC29A1,,,,SLC29A1
10622,dilazep,"adenosine reuptake inhibitor, calcium channel antagonist, platelet aggregation inhibitor",CACNA1C,,,,CACNA1C
10623,olvanil,TRPV agonist,TRPV1,,,,TRPV1
10624,olvanil,TRPV agonist,CNR1,,,,CNR1
10625,olvanil,TRPV agonist,GPR119,,,,GPR119
10626,betamethasone,"corticosteroid agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
10627,5-methoxytryptamine,serotonin receptor agonist,HTR2A,,,,HTR2A
10628,5-methoxytryptamine,serotonin receptor agonist,HTR6,,,,HTR6
10629,5-methoxytryptamine,serotonin receptor agonist,HTR1B,,,,HTR1B
10630,5-methoxytryptamine,serotonin receptor agonist,HTR1D,,,,HTR1D
10631,5-methoxytryptamine,serotonin receptor agonist,HTR1E,,,,HTR1E
10632,5-methoxytryptamine,serotonin receptor agonist,HTR1F,,,,HTR1F
10633,5-methoxytryptamine,serotonin receptor agonist,HTR2C,,,,HTR2C
10634,5-methoxytryptamine,serotonin receptor agonist,HTR4,,,,HTR4
10635,5-methoxytryptamine,serotonin receptor agonist,HTR7,,,,HTR7
10636,5-methoxytryptamine,serotonin receptor agonist,TRPM8,,,,TRPM8
10637,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2A,,,,ADRA2A
10638,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
10639,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
10640,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2C,,,,ADRA2C
10641,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
10642,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
10643,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1B,,,,ADRA1B
10644,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1D,,,,ADRA1D
10645,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2B,,,,ADRA2B
10646,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRB1,,,,ADRB1
10647,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRB2,,,,ADRB2
10648,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
10649,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
10650,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
10651,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD5,,,,DRD5
10652,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
10653,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HRH3,,,,HRH3
10654,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2B,,,,HTR2B
10655,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
10656,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",OPRK1,,,,OPRK1
10657,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A2,,,,SLC6A2
10658,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A3,,,,SLC6A3
10659,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A4,,,,SLC6A4
10660,ditolylguanidine,sigma receptor agonist,GRIN1,,,,GRIN1
10661,ditolylguanidine,sigma receptor agonist,GRIN2A,,,,GRIN2A
10662,ditolylguanidine,sigma receptor agonist,GRIN2B,,,,GRIN2B
10663,ditolylguanidine,sigma receptor agonist,SIGMAR1,,,,SIGMAR1
10664,carteolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
10665,carteolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
10666,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",ABL1,,,,ABL1
10667,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",KIT,,,,KIT
10668,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",PDGFRA,,,,PDGFRA
10669,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",BCR,,,,BCR
10670,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",CSF1R,,,,CSF1R
10671,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",PDGFRB,,,,PDGFRB
10672,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",ABCG2,,,,ABCG2
10673,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",CYP2C19,,,,CYP2C19
10674,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",CYP2C8,,,,CYP2C8
10675,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",CYP3A5,,,,CYP3A5
10676,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",DDR1,,,,DDR1
10677,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",NTRK1,,,,NTRK1
10678,imatinib,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor",RET,,,,RET
10679,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
10680,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
10681,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM1,,,,CHRM1
10682,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM2,,,,CHRM2
10683,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM3,,,,CHRM3
10684,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM4,,,,CHRM4
10685,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CHRM5,,,,CHRM5
10686,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",CYP2C19,,,,CYP2C19
10687,dosulepin,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",HRH1,,,,HRH1
10688,alprenolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
10689,alprenolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
10690,alprenolol,adrenergic receptor antagonist,HTR1A,,,,HTR1A
10691,levomepromazine,dopamine receptor,ADRA1A,,,,ADRA1A
10692,levomepromazine,dopamine receptor,ADRA1B,,,,ADRA1B
10693,levomepromazine,dopamine receptor,ADRA1D,,,,ADRA1D
10694,levomepromazine,dopamine receptor,ADRA2A,,,,ADRA2A
10695,levomepromazine,dopamine receptor,ADRA2B,,,,ADRA2B
10696,levomepromazine,dopamine receptor,ADRA2C,,,,ADRA2C
10697,levomepromazine,dopamine receptor,CHRM1,,,,CHRM1
10698,levomepromazine,dopamine receptor,CHRM2,,,,CHRM2
10699,levomepromazine,dopamine receptor,CHRM3,,,,CHRM3
10700,levomepromazine,dopamine receptor,CHRM4,,,,CHRM4
10701,levomepromazine,dopamine receptor,CHRM5,,,,CHRM5
10702,levomepromazine,dopamine receptor,DRD1,,,,DRD1
10703,levomepromazine,dopamine receptor,DRD2,,,,DRD2
10704,levomepromazine,dopamine receptor,DRD3,,,,DRD3
10705,levomepromazine,dopamine receptor,DRD4,,,,DRD4
10706,levomepromazine,dopamine receptor,DRD5,,,,DRD5
10707,levomepromazine,dopamine receptor,HRH1,,,,HRH1
10708,levomepromazine,dopamine receptor,HTR2A,,,,HTR2A
10709,levomepromazine,dopamine receptor,HTR2C,,,,HTR2C
10710,bepridil,"calcium channel blocker, L-type calcium channel blocker",ATP1A1,,,,ATP1A1
10711,bepridil,"calcium channel blocker, L-type calcium channel blocker",CACNA1A,,,,CACNA1A
10712,bepridil,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
10713,bepridil,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
10714,bepridil,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
10715,bepridil,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
10716,bepridil,"calcium channel blocker, L-type calcium channel blocker",KCNQ1,,,,KCNQ1
10717,bepridil,"calcium channel blocker, L-type calcium channel blocker",KCNQ4,,,,KCNQ4
10718,bepridil,"calcium channel blocker, L-type calcium channel blocker",PDE1A,,,,PDE1A
10719,bepridil,"calcium channel blocker, L-type calcium channel blocker",PDE1B,,,,PDE1B
10720,bepridil,"calcium channel blocker, L-type calcium channel blocker",SCN5A,,,,SCN5A
10721,bepridil,"calcium channel blocker, L-type calcium channel blocker",TNNC1,,,,TNNC1
10722,tubocurarine,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
10723,tubocurarine,acetylcholine receptor antagonist,HTR3A,,,,HTR3A
10724,tubocurarine,acetylcholine receptor antagonist,ACHE,,,,ACHE
10725,tubocurarine,acetylcholine receptor antagonist,HTR3B,,,,HTR3B
10726,tubocurarine,acetylcholine receptor antagonist,KCNN1,,,,KCNN1
10727,tubocurarine,acetylcholine receptor antagonist,KCNN2,,,,KCNN2
10728,tubocurarine,acetylcholine receptor antagonist,KCNN3,,,,KCNN3
10729,tubocurarine,acetylcholine receptor antagonist,ZACN,,,,ZACN
10730,betaxolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
10731,betaxolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
10732,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist",ESR1,,,,ESR1
10733,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist",ESR2,,,,ESR2
10734,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist",ACVRL1,,,,ACVRL1
10735,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist",ENG,,,,ENG
10736,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
10737,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",CYP3A5,,,,CYP3A5
10738,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",GPR97,,,,ADGRG3
10739,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",SERPINA6,,,,SERPINA6
10740,ABT-737,BCL inhibitor,BCL2,,,,BCL2
10741,ABT-737,BCL inhibitor,BCL2L1,,,,BCL2L1
10742,ABT-737,BCL inhibitor,BCL2L2,,,,BCL2L2
10743,miglitol,"glucosidase inhibitor, sodium/glucose cotransporter activator",GAA,,,,GAA
10744,miglitol,"glucosidase inhibitor, sodium/glucose cotransporter activator",MGAM,,,,MGAM
10745,miglitol,"glucosidase inhibitor, sodium/glucose cotransporter activator",GANAB,,,,GANAB
10746,miglitol,"glucosidase inhibitor, sodium/glucose cotransporter activator",GANC,,,,GANC
10747,miglitol,"glucosidase inhibitor, sodium/glucose cotransporter activator",SLC5A4,,,,SLC5A4
10748,papaverine,phosphodiesterase inhibitor,PDE10A,,,,PDE10A
10749,papaverine,phosphodiesterase inhibitor,PDE4B,,,,PDE4B
10750,papaverine,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
10751,tomelukast,leukotriene receptor antagonist,CYSLTR1,,,,CYSLTR1
10752,saquinavir,"HIV protease inhibitor, peptidase inhibitor",CYP3A4,,,,CYP3A4
10753,saquinavir,"HIV protease inhibitor, peptidase inhibitor",CYP3A5,,,,CYP3A5
10754,spiperone,dopamine receptor antagonist,ADRA1A,,,,ADRA1A
10755,spiperone,dopamine receptor antagonist,DRD2,,,,DRD2
10756,spiperone,dopamine receptor antagonist,DRD3,,,,DRD3
10757,spiperone,dopamine receptor antagonist,DRD4,,,,DRD4
10758,spiperone,dopamine receptor antagonist,HTR1A,,,,HTR1A
10759,spiperone,dopamine receptor antagonist,HTR2A,,,,HTR2A
10760,spiperone,dopamine receptor antagonist,HTR7,,,,HTR7
10761,spiperone,dopamine receptor antagonist,ADRA1B,,,,ADRA1B
10762,spiperone,dopamine receptor antagonist,ADRA1D,,,,ADRA1D
10763,spiperone,dopamine receptor antagonist,DRD1,,,,DRD1
10764,spiperone,dopamine receptor antagonist,DRD5,,,,DRD5
10765,spiperone,dopamine receptor antagonist,HTR1D,,,,HTR1D
10766,spiperone,dopamine receptor antagonist,HTR2B,,,,HTR2B
10767,spiperone,dopamine receptor antagonist,HTR2C,,,,HTR2C
10768,spiperone,dopamine receptor antagonist,HTR6,,,,HTR6
10769,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",HPGDS,,,,HPGDS
10770,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",HRH1,,,,HRH1
10771,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IDO1,,,,IDO1
10772,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IFNG,,,,IFNG
10773,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL10,,,,IL10
10774,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL2,,,,IL2
10775,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL4,,,,IL4
10776,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",SLC22A12,,,,SLC22A12
10777,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TGFB1,,,,TGFB1
10778,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TNF,,,,TNF
10779,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TRPV2,,,,TRPV2
10780,DH-97,melatonin receptor antagonist,MTNR1B,,,,MTNR1B
10781,simvastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
10782,simvastatin,HMGCR inhibitor,CYP2C8,,,,CYP2C8
10783,simvastatin,HMGCR inhibitor,CYP3A4,,,,CYP3A4
10784,simvastatin,HMGCR inhibitor,CYP3A5,,,,CYP3A5
10785,simvastatin,HMGCR inhibitor,ITGB2,,,,ITGB2
10786,phenoxybenzamine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
10787,phenoxybenzamine,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
10788,phenoxybenzamine,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
10789,phenoxybenzamine,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
10790,phenoxybenzamine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
10791,phenoxybenzamine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
10792,phenoxybenzamine,adrenergic receptor antagonist,ADRB2,,,,ADRB2
10793,phenoxybenzamine,adrenergic receptor antagonist,CALM1,,,,CALM1
10794,manumycin-a,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor",FNTA,,,,FNTA
10795,manumycin-a,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor",IKBKB,,,,IKBKB
10796,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",DRD2,,,,DRD2
10797,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",DRD4,,,,DRD4
10798,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA1A,,,,ADRA1A
10799,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA1B,,,,ADRA1B
10800,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CHRM1,,,,CHRM1
10801,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",DRD1,,,,DRD1
10802,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",DRD3,,,,DRD3
10803,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HRH1,,,,HRH1
10804,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HRH4,,,,HRH4
10805,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR1A,,,,HTR1A
10806,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR1B,,,,HTR1B
10807,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR1D,,,,HTR1D
10808,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR1E,,,,HTR1E
10809,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR2A,,,,HTR2A
10810,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR2C,,,,HTR2C
10811,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR6,,,,HTR6
10812,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR7,,,,HTR7
10813,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA1D,,,,ADRA1D
10814,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA2A,,,,ADRA2A
10815,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA2B,,,,ADRA2B
10816,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",ADRA2C,,,,ADRA2C
10817,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CALY,,,,CALY
10818,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CHRM2,,,,CHRM2
10819,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CHRM3,,,,CHRM3
10820,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CHRM4,,,,CHRM4
10821,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CHRM5,,,,CHRM5
10822,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",CYP2C19,,,,CYP2C19
10823,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",DRD5,,,,DRD5
10824,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR1F,,,,HTR1F
10825,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR2B,,,,HTR2B
10826,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR3A,,,,HTR3A
10827,clozapine,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist",HTR5A,,,,HTR5A
10828,thioperamide,"histamine receptor antagonist, histamine receptor inverse agonist",HRH3,,,,HRH3
10829,thioperamide,"histamine receptor antagonist, histamine receptor inverse agonist",HRH4,,,,HRH4
10830,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
10831,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
10832,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
10833,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",ADRA2A,,,,ADRA2A
10834,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",ADRA2B,,,,ADRA2B
10835,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",ADRA2C,,,,ADRA2C
10836,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",HTR2A,,,,HTR2A
10837,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",MAOA,,,,MAOA
10838,noreleagnine,"imidazoline receptor ligand, serotonin receptor ligand",MAOB,,,,MAOB
10839,terazosin,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
10840,terazosin,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
10841,terazosin,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
10842,terazosin,adrenergic receptor antagonist,KCNH2,,,,KCNH2
10843,terazosin,adrenergic receptor antagonist,KCNH6,,,,KCNH6
10844,terazosin,adrenergic receptor antagonist,KCNH7,,,,KCNH7
10845,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",DRD2,,,,DRD2
10846,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",DRD3,,,,DRD3
10847,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",ADRA2A,,,,ADRA2A
10848,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",ADRA2B,,,,ADRA2B
10849,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",ADRA2C,,,,ADRA2C
10850,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",DRD1,,,,DRD1
10851,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",DRD4,,,,DRD4
10852,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",DRD5,,,,DRD5
10853,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR1A,,,,HTR1A
10854,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR1B,,,,HTR1B
10855,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR1D,,,,HTR1D
10856,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR2A,,,,HTR2A
10857,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR2B,,,,HTR2B
10858,ropinirole,"dopamine receptor agonist, dopamine receptor modulator",HTR2C,,,,HTR2C
10859,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",SLC6A2,,,,SLC6A2
10860,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",SLC6A4,,,,SLC6A4
10861,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CHRM2,,,,CHRM2
10862,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",ADRA1A,,,,ADRA1A
10863,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",ADRA1B,,,,ADRA1B
10864,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",ADRA1D,,,,ADRA1D
10865,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CHRM1,,,,CHRM1
10866,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CHRM3,,,,CHRM3
10867,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CHRM4,,,,CHRM4
10868,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CHRM5,,,,CHRM5
10869,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",CYP2C19,,,,CYP2C19
10870,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",DRD1,,,,DRD1
10871,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",DRD2,,,,DRD2
10872,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",DRD5,,,,DRD5
10873,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HRH1,,,,HRH1
10874,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HTR1A,,,,HTR1A
10875,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HTR2A,,,,HTR2A
10876,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HTR2C,,,,HTR2C
10877,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HTR6,,,,HTR6
10878,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",HTR7,,,,HTR7
10879,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",KCND2,,,,KCND2
10880,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",KCND3,,,,KCND3
10881,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",KCNH1,,,,KCNH1
10882,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",KCNH2,,,,KCNH2
10883,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers",SLC6A3,,,,SLC6A3
10884,gabazine,GABA receptor antagonist,GABRA1,,,,GABRA1
10885,gabazine,GABA receptor antagonist,GABRA2,,,,GABRA2
10886,gabazine,GABA receptor antagonist,GABRA3,,,,GABRA3
10887,gabazine,GABA receptor antagonist,GABRA4,,,,GABRA4
10888,gabazine,GABA receptor antagonist,GABRA5,,,,GABRA5
10889,gabazine,GABA receptor antagonist,GABRA6,,,,GABRA6
10890,gabazine,GABA receptor antagonist,GABRG2,,,,GABRG2
10891,azasetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
10892,azasetron,serotonin receptor antagonist,HTR3B,,,,HTR3B
10893,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR1,,,,ESR1
10894,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR2,,,,ESR2
10895,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",CYP3A5,,,,CYP3A5
10896,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",EBP,,,,EBP
10897,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",GPER1,,,,GPER1
10898,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCA,,,,PRKCA
10899,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCB,,,,PRKCB
10900,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCD,,,,PRKCD
10901,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCE,,,,PRKCE
10902,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCG,,,,PRKCG
10903,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCI,,,,PRKCI
10904,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCQ,,,,PRKCQ
10905,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCZ,,,,PRKCZ
10906,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",NR1H3,,,,NR1H3
10907,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",NR1H2,,,,NR1H2
10908,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",ABCA1,,,,ABCA1
10909,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",NCOA1,,,,NCOA1
10910,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",NCOA2,,,,NCOA2
10911,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",NR1I2,,,,NR1I2
10912,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",RORA,,,,RORA
10913,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",RORC,,,,RORC
10914,T-0901317,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist",RXRB,,,,RXRB
10915,DMBI,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor",PDGFRB,,,,PDGFRB
10916,CGS-12066B,serotonin receptor agonist,HTR1B,,,,HTR1B
10917,CGS-12066B,serotonin receptor agonist,HTR1A,,,,HTR1A
10918,CGS-12066B,serotonin receptor agonist,HTR1D,,,,HTR1D
10919,CGS-12066B,serotonin receptor agonist,HTR2A,,,,HTR2A
10920,CGS-12066B,serotonin receptor agonist,HTR2B,,,,HTR2B
10921,CGS-12066B,serotonin receptor agonist,HTR2C,,,,HTR2C
10922,cytarabine,"antimetabolite, DNA polymerase inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",POLB,,,,POLB
10923,cytarabine,"antimetabolite, DNA polymerase inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
10924,BRD-K70693222,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CLK1,,,,CLK1
10925,BRD-K70693222,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CLK4,,,,CLK4
10926,BRD-K70693222,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",DYRK1A,,,,DYRK1A
10927,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",DRD2,,,,DRD2
10928,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",ABCG2,,,,ABCG2
10929,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",ADRA1A,,,,ADRA1A
10930,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",CALM1,,,,CALM1
10931,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",CALY,,,,CALY
10932,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",CAMK2A,,,,CAMK2A
10933,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",DRD4,,,,DRD4
10934,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",HRH1,,,,HRH1
10935,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",HTR2A,,,,HTR2A
10936,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",HTR2C,,,,HTR2C
10937,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",S100A4,,,,S100A4
10938,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",SCN4A,,,,SCN4A
10939,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",SCN9A,,,,SCN9A
10940,trifluoperazine,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker",TNNC1,,,,TNNC1
10941,desloratadine,histamine receptor antagonist,HRH1,,,,HRH1
10942,triamterene,sodium channel blocker,SCNN1A,,,,SCNN1A
10943,triamterene,sodium channel blocker,SCNN1B,,,,SCNN1B
10944,triamterene,sodium channel blocker,SCNN1G,,,,SCNN1G
10945,triamterene,sodium channel blocker,SCNN1D,,,,SCNN1D
10946,pyrimethamine,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor",DHFR,,,,DHFR
10947,pyrimethamine,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor",DHFRP1,,,,DHFRP1
10948,pyrimethamine,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor",HEXA,,,,HEXA
10949,pyrimethamine,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor",SLC47A1,,,,SLC47A1
10950,pyrimethamine,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor",STAT3,,,,STAT3
10951,penitrem-a,potassium channel blocker,KCNMA1,,,,KCNMA1
10952,GW-9508,"Free Fatty Acid Receptor 1 (FFAR1;  GPR40) Agonists, G protein coupled receptor agonist, G-protein coupled receptor agonist",FFAR4,,,,FFAR4
10953,GW-9508,"Free Fatty Acid Receptor 1 (FFAR1;  GPR40) Agonists, G protein coupled receptor agonist, G-protein coupled receptor agonist",FFAR1,,,,FFAR1
10954,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH1,,,,HRH1
10955,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH2,,,,HRH2
10956,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
10957,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
10958,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1A,,,,ADRA1A
10959,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1B,,,,ADRA1B
10960,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1D,,,,ADRA1D
10961,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2A,,,,ADRA2A
10962,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2B,,,,ADRA2B
10963,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2C,,,,ADRA2C
10964,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM1,,,,CHRM1
10965,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM2,,,,CHRM2
10966,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM3,,,,CHRM3
10967,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM4,,,,CHRM4
10968,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM5,,,,CHRM5
10969,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CYP2C19,,,,CYP2C19
10970,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",DRD2,,,,DRD2
10971,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH4,,,,HRH4
10972,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR1A,,,,HTR1A
10973,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2A,,,,HTR2A
10974,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2B,,,,HTR2B
10975,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2C,,,,HTR2C
10976,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR6,,,,HTR6
10977,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",KCNH2,,,,KCNH2
10978,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A3,,,,SLC6A3
10979,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",AKR1C3,,,,AKR1C3
10980,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",AKR1B1,,,,AKR1B1
10981,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",F10,,,,F10
10982,diflunisal,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
10983,diflunisal,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
10984,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",PGR,,,,PGR
10985,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",AR,,,,AR
10986,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",CYP2E1,,,,CYP2E1
10987,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",ESR1,,,,ESR1
10988,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",SRD5A1,,,,SRD5A1
10989,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",HTR2A,,,,HTR2A
10990,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
10991,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",HTR2C,,,,HTR2C
10992,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
10993,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",ADRA1A,,,,ADRA1A
10994,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",ADRA1B,,,,ADRA1B
10995,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",ADRA2A,,,,ADRA2A
10996,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",CYP3A4,,,,CYP3A4
10997,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",CYP3A5,,,,CYP3A5
10998,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",CYP3A7,,,,CYP3A7
10999,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",HTR1A,,,,HTR1A
11000,nefazodone,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
11001,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
11002,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
11003,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
11004,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
11005,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
11006,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
11007,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
11008,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNG1,,,,CACNG1
11009,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",KCNN4,,,,KCNN4
11010,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH1,,,,HRH1
11011,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH2,,,,HRH2
11012,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
11013,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
11014,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1A,,,,ADRA1A
11015,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1B,,,,ADRA1B
11016,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1D,,,,ADRA1D
11017,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2A,,,,ADRA2A
11018,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2B,,,,ADRA2B
11019,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2C,,,,ADRA2C
11020,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM1,,,,CHRM1
11021,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM2,,,,CHRM2
11022,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM3,,,,CHRM3
11023,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM4,,,,CHRM4
11024,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM5,,,,CHRM5
11025,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CYP2C19,,,,CYP2C19
11026,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",DRD2,,,,DRD2
11027,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH4,,,,HRH4
11028,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR1A,,,,HTR1A
11029,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2A,,,,HTR2A
11030,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2B,,,,HTR2B
11031,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2C,,,,HTR2C
11032,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR6,,,,HTR6
11033,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",KCNH2,,,,KCNH2
11034,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A3,,,,SLC6A3
11035,procainamide,"sodium channel blocker, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
11036,procainamide,"sodium channel blocker, voltage-gated sodium channel blocker",DNMT1,,,,DNMT1
11037,AM-580,"RAR agonist, retinoid receptor agonist",RARA,,,,RARA
11038,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAP2K1,,,,MAP2K1
11039,PD-98059,"MEK inhibitor, MAP kinase inhibitor",AKT1,,,,AKT1
11040,PD-98059,"MEK inhibitor, MAP kinase inhibitor",CHEK1,,,,CHEK1
11041,PD-98059,"MEK inhibitor, MAP kinase inhibitor",GSK3B,,,,GSK3B
11042,PD-98059,"MEK inhibitor, MAP kinase inhibitor",LCK,,,,LCK
11043,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAP2K2,,,,MAP2K2
11044,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK1,,,,MAPK1
11045,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK11,,,,MAPK11
11046,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK12,,,,MAPK12
11047,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK14,,,,MAPK14
11048,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK3,,,,MAPK3
11049,PD-98059,"MEK inhibitor, MAP kinase inhibitor",MAPK8,,,,MAPK8
11050,PD-98059,"MEK inhibitor, MAP kinase inhibitor",PRKCA,,,,PRKCA
11051,PD-98059,"MEK inhibitor, MAP kinase inhibitor",RAF1,,,,RAF1
11052,PD-98059,"MEK inhibitor, MAP kinase inhibitor",ROCK1,,,,ROCK1
11053,PD-98059,"MEK inhibitor, MAP kinase inhibitor",RPS6KB1,,,,RPS6KB1
11054,PD-98059,"MEK inhibitor, MAP kinase inhibitor",SGK1,,,,SGK1
11055,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",NR3C2,,,,NR3C2
11056,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",AR,,,,AR
11057,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1A,,,,CACNA1A
11058,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1B,,,,CACNA1B
11059,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1C,,,,CACNA1C
11060,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1D,,,,CACNA1D
11061,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1F,,,,CACNA1F
11062,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1G,,,,CACNA1G
11063,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1H,,,,CACNA1H
11064,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1I,,,,CACNA1I
11065,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA1S,,,,CACNA1S
11066,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA2D1,,,,CACNA2D1
11067,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA2D2,,,,CACNA2D2
11068,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNA2D3,,,,CACNA2D3
11069,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNB1,,,,CACNB1
11070,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNB2,,,,CACNB2
11071,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNB3,,,,CACNB3
11072,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNB4,,,,CACNB4
11073,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CACNG1,,,,CACNG1
11074,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",CYP11B2,,,,CYP11B2
11075,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",KCNA5,,,,KCNA5
11076,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",KCND3,,,,KCND3
11077,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",NR3C1,,,,NR3C1
11078,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",PGR,,,,PGR
11079,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",SCNN1A,,,,SCNN1A
11080,spironolactone,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker",SHBG,,,,SHBG
11081,valdecoxib,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
11082,valdecoxib,cyclooxygenase inhibitor,CA12,,,,CA12
11083,valdecoxib,cyclooxygenase inhibitor,CYP2C19,,,,CYP2C19
11084,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",PGR,,,,PGR
11085,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",NR3C1,,,,NR3C1
11086,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",AR,,,,AR
11087,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP2B6,,,,CYP2B6
11088,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP2C8,,,,CYP2C8
11089,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP3A5,,,,CYP3A5
11090,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP3A7,,,,CYP3A7
11091,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",NR1I2,,,,NR1I2
11092,droperidol,"dopamine receptor antagonist, dopamine receptor",DRD2,,,,DRD2
11093,droperidol,"dopamine receptor antagonist, dopamine receptor",ADRA1A,,,,ADRA1A
11094,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,,BTK
11095,brimonidine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
11096,brimonidine,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
11097,brimonidine,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
11098,brimonidine,adrenergic receptor agonist,AOX1,,,,AOX1
11099,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",AOX1,,,,AOX1
11100,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",BGLAP,,,,BGLAP
11101,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",F10,,,,F10
11102,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",F2,,,,F2
11103,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",F7,,,,F7
11104,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",F9,,,,F9
11105,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",GGCX,,,,GGCX
11106,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",NQO1,,,,NQO1
11107,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",NQO2,,,,NQO2
11108,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",PKM,,,,PKM
11109,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",PROC,,,,PROC
11110,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",PROS1,,,,PROS1
11111,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",PROZ,,,,PROZ
11112,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",VKORC1,,,,VKORC1
11113,menadione,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor",VKORC1L1,,,,VKORC1L1
11114,pifithrin-alpha,TP53 inhibitor,TP53,,,,TP53
11115,montelukast,leukotriene receptor antagonist,CYSLTR1,,,,CYSLTR1
11116,montelukast,leukotriene receptor antagonist,ALOX5,,,,ALOX5
11117,montelukast,leukotriene receptor antagonist,CYP2C8,,,,CYP2C8
11118,tetrahydrobiopterin,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator",PAH,,,,PAH
11119,tetrahydrobiopterin,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator",TH,,,,TH
11120,tetrahydrobiopterin,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator",DBH,,,,DBH
11121,tetrahydrobiopterin,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator",NOS3,,,,NOS3
11122,tetrahydrobiopterin,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator",TPH1,,,,TPH1
11123,ascorbic-acid,"vitamin C, antioxidant",AKR1B1,,,,AKR1B1
11124,calyculin,protein phosphatase inhibitor,PPP1CA,,,,PPP1CA
11125,calyculin,protein phosphatase inhibitor,PPP1CC,,,,PPP1CC
11126,calyculin,protein phosphatase inhibitor,PPP2CA,,,,PPP2CA
11127,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",PGR,,,,PGR
11128,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",AR,,,,AR
11129,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",CYP2E1,,,,CYP2E1
11130,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",ESR1,,,,ESR1
11131,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist",SRD5A1,,,,SRD5A1
11132,norethindrone,"ovulation inhibitor, progesterone receptor agonist",PGR,,,,PGR
11133,idarubicin,"topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor",TOP2A,,,,TOP2A
11134,cefazolin,cell wall synthesis inhibitor,PON1,,,,PON1
11135,cefazolin,cell wall synthesis inhibitor,SLC22A8,,,,SLC22A8
11136,cortisone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
11137,flurbiprofen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
11138,flurbiprofen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
11139,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
11140,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
11141,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
11142,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
11143,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
11144,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
11145,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
11146,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
11147,naloxone,opioid receptor antagonist,OPRM1,,,,OPRM1
11148,naloxone,opioid receptor antagonist,OPRK1,,,,OPRK1
11149,naloxone,opioid receptor antagonist,OPRD1,,,,OPRD1
11150,naloxone,opioid receptor antagonist,CREB1,,,,CREB1
11151,naloxone,opioid receptor antagonist,ESR1,,,,ESR1
11152,naloxone,opioid receptor antagonist,TLR4,,,,TLR4
11153,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA1,,,,GABRA1
11154,primidone,"GABA receptor antagonist, unidentified pharmacological activity",CHRNA4,,,,CHRNA4
11155,primidone,"GABA receptor antagonist, unidentified pharmacological activity",CHRNA7,,,,CHRNA7
11156,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA2,,,,GABRA2
11157,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA3,,,,GABRA3
11158,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA4,,,,GABRA4
11159,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA5,,,,GABRA5
11160,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRA6,,,,GABRA6
11161,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRB1,,,,GABRB1
11162,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRB2,,,,GABRB2
11163,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRB3,,,,GABRB3
11164,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRD,,,,GABRD
11165,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRE,,,,GABRE
11166,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRG1,,,,GABRG1
11167,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRG2,,,,GABRG2
11168,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRG3,,,,GABRG3
11169,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRP,,,,GABRP
11170,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GABRQ,,,,GABRQ
11171,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GRIA2,,,,GRIA2
11172,primidone,"GABA receptor antagonist, unidentified pharmacological activity",GRIK2,,,,GRIK2
11173,propantheline,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
11174,propantheline,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
11175,propantheline,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
11176,propantheline,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
11177,sulfinpyrazone,platelet aggregation inhibitor,ABCC1,,,,ABCC1
11178,sulfinpyrazone,platelet aggregation inhibitor,ABCC2,,,,ABCC2
11179,sulfinpyrazone,platelet aggregation inhibitor,FPR1,,,,FPR1
11180,sulfinpyrazone,platelet aggregation inhibitor,SLC22A12,,,,SLC22A12
11181,bimatoprost,prostanoid receptor agonist,PTGFR,,,,PTGFR
11182,bimatoprost,prostanoid receptor agonist,AKR1C3,,,,AKR1C3
11183,bimatoprost,prostanoid receptor agonist,PTGER1,,,,PTGER1
11184,bimatoprost,prostanoid receptor agonist,PTGER3,,,,PTGER3
11185,megestrol,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor",PGR,,,,PGR
11186,edaravone,free radical scavenger,BCL2,,,,BCL2
11187,LY-2140023,glutamate receptor agonist,GRM3,,,,GRM3
11188,LY-2140023,glutamate receptor agonist,GRM2,,,,GRM2
11189,L-690330,inositol monophophatase inhibitor,IMPA1,,,,IMPA1
11190,velnacrine,calcium channel activator,ACHE,,,,ACHE
11191,doxazosin,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
11192,doxazosin,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
11193,doxazosin,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
11194,doxazosin,adrenergic receptor antagonist,CYP2C19,,,,CYP2C19
11195,doxazosin,adrenergic receptor antagonist,KCNH2,,,,KCNH2
11196,doxazosin,adrenergic receptor antagonist,KCNH6,,,,KCNH6
11197,doxazosin,adrenergic receptor antagonist,KCNH7,,,,KCNH7
11198,enalapril,"angiotensin converting enzyme inhibitor, angiotensin receptor blocker",ACE,,,,ACE
11199,griseofulvin,"microtubule inhibitor, microtubule stabilizing agent, mitosis inhibitor",KRT12,,,,KRT12
11200,ipratropium,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
11201,ipratropium,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
11202,ipratropium,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
11203,ipratropium,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
11204,ipratropium,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
11205,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN1,,,,GRIN1
11206,memantine,"glutamate receptor antagonist, glutamate release inhibitor",CHRFAM7A,,,,CHRFAM7A
11207,memantine,"glutamate receptor antagonist, glutamate release inhibitor",CYP2E1,,,,CYP2E1
11208,memantine,"glutamate receptor antagonist, glutamate release inhibitor",DRD2,,,,DRD2
11209,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN2A,,,,GRIN2A
11210,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN2B,,,,GRIN2B
11211,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN3A,,,,GRIN3A
11212,memantine,"glutamate receptor antagonist, glutamate release inhibitor",HTR3A,,,,HTR3A
11213,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2A,,,,ADRA2A
11214,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
11215,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
11216,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2C,,,,ADRA2C
11217,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
11218,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
11219,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1B,,,,ADRA1B
11220,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA1D,,,,ADRA1D
11221,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRA2B,,,,ADRA2B
11222,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRB1,,,,ADRB1
11223,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",ADRB2,,,,ADRB2
11224,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
11225,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
11226,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
11227,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",DRD5,,,,DRD5
11228,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
11229,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HRH3,,,,HRH3
11230,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR2B,,,,HTR2B
11231,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
11232,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",OPRK1,,,,OPRK1
11233,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A2,,,,SLC6A2
11234,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A3,,,,SLC6A3
11235,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist",SLC6A4,,,,SLC6A4
11236,ramipril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
11237,timolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
11238,timolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
11239,losartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
11240,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PTGS1,,,,PTGS1
11241,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PTGS2,,,,PTGS2
11242,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",TP53,,,,TP53
11243,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",AKR1C1,,,,AKR1C1
11244,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",ASIC3,,,,ASIC3
11245,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",EDNRA,,,,EDNRA
11246,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",HSPA5,,,,HSPA5
11247,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",IKBKB,,,,IKBKB
11248,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",NFKB1,,,,NFKB1
11249,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",NFKB2,,,,NFKB2
11250,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",NFKBIA,,,,NFKBIA
11251,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAA1,,,,PRKAA1
11252,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAA2,,,,PRKAA2
11253,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAB1,,,,PRKAB1
11254,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAB2,,,,PRKAB2
11255,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAG1,,,,PRKAG1
11256,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAG2,,,,PRKAG2
11257,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",PRKAG3,,,,PRKAG3
11258,aspirin,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer",RPS6KA3,,,,RPS6KA3
11259,phenylbutyrate,"HDAC inhibitor, cell cycle inhibitor, pharmacological chaperone, pyruvate dehydrogenase kinase inhibitor",CYP3A5,,,,CYP3A5
11260,phenylbutyrate,"HDAC inhibitor, cell cycle inhibitor, pharmacological chaperone, pyruvate dehydrogenase kinase inhibitor",HDAC1,,,,HDAC1
11261,medrysone,"corticosteroid hormone receptor agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
11262,aminolevulinic-acid,oxidizing agent,ALAD,,,,ALAD
11263,eliprodil,glutamate receptor antagonist,GRIN1,,,,GRIN1
11264,eliprodil,glutamate receptor antagonist,GRIN2B,,,,GRIN2B
11265,nicotine,acetylcholine receptor agonist,CHRNA10,,,,CHRNA10
11266,nicotine,acetylcholine receptor agonist,CHRNA9,,,,CHRNA9
11267,nicotine,acetylcholine receptor agonist,AOX1,,,,AOX1
11268,nicotine,acetylcholine receptor agonist,CHAT,,,,CHAT
11269,nicotine,acetylcholine receptor agonist,CHRNA2,,,,CHRNA2
11270,nicotine,acetylcholine receptor agonist,CHRNA3,,,,CHRNA3
11271,nicotine,acetylcholine receptor agonist,CHRNA4,,,,CHRNA4
11272,nicotine,acetylcholine receptor agonist,CHRNA5,,,,CHRNA5
11273,nicotine,acetylcholine receptor agonist,CHRNA6,,,,CHRNA6
11274,nicotine,acetylcholine receptor agonist,CHRNA7,,,,CHRNA7
11275,nicotine,acetylcholine receptor agonist,CHRNB2,,,,CHRNB2
11276,nicotine,acetylcholine receptor agonist,CHRNB3,,,,CHRNB3
11277,nicotine,acetylcholine receptor agonist,CHRNB4,,,,CHRNB4
11278,nicotine,acetylcholine receptor agonist,CYP19A1,,,,CYP19A1
11279,nicotine,acetylcholine receptor agonist,CYP2B6,,,,CYP2B6
11280,nicotine,acetylcholine receptor agonist,TBXAS1,,,,TBXAS1
11281,nicotine,acetylcholine receptor agonist,TRPA1,,,,TRPA1
11282,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",MTOR,,,,MTOR
11283,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",PIK3CA,,,,PIK3CA
11284,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",PIK3CG,,,,PIK3CG
11285,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",PIK3CD,,,,PIK3CD
11286,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",ATR,,,,ATR
11287,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor",PIK3CB,,,,PIK3CB
11288,bethanechol,acetylcholine receptor agonist,CHRM2,,,,CHRM2
11289,bethanechol,acetylcholine receptor agonist,CHRM1,,,,CHRM1
11290,bethanechol,acetylcholine receptor agonist,CHRM3,,,,CHRM3
11291,bethanechol,acetylcholine receptor agonist,CHRM4,,,,CHRM4
11292,zidovudine,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",TERT,,,,TERT
11293,fosinopril,"angiotensin converting enzyme inhibitor, breast cancer resistance protein inhibitor",ACE,,,,ACE
11294,fosinopril,"angiotensin converting enzyme inhibitor, breast cancer resistance protein inhibitor",ABCG2,,,,ABCG2
11295,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",ALOX5,,,,ALOX5
11296,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",MIF,,,,MIF
11297,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",RELA,,,,RELA
11298,caffeic-acid,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor",TNF,,,,TNF
11299,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",PTGS1,,,,PTGS1
11300,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",PTGS2,,,,PTGS2
11301,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",SIRT1,,,,SIRT1
11302,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",APOA1,,,,APOA1
11303,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",BACE1,,,,BACE1
11304,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",CSNK2A1,,,,CSNK2A1
11305,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",MAOA,,,,MAOA
11306,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",NQO2,,,,NQO2
11307,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",SCN5A,,,,SCN5A
11308,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",TXNRD1,,,,TXNRD1
11309,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",TXNRD2,,,,TXNRD2
11310,resveratrol,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
11311,bosentan,endothelin receptor antagonist,EDNRB,,,,EDNRB
11312,bosentan,endothelin receptor antagonist,EDNRA,,,,EDNRA
11313,bosentan,endothelin receptor antagonist,ABCB1,,,,ABCB1
11314,bosentan,endothelin receptor antagonist,CYP2C19,,,,CYP2C19
11315,bosentan,endothelin receptor antagonist,CYP3A4,,,,CYP3A4
11316,ataluren,"CFTR channel agonist, coagulation stimulant, dystrophin stimulant",CFTR,,,,CFTR
11317,ataluren,"CFTR channel agonist, coagulation stimulant, dystrophin stimulant",DMD,,,,DMD
11318,ataluren,"CFTR channel agonist, coagulation stimulant, dystrophin stimulant",F8,,,,F8
11319,ataluren,"CFTR channel agonist, coagulation stimulant, dystrophin stimulant",F9,,,,F9
11320,atenolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
11321,atenolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
11322,sildenafil,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
11323,sildenafil,phosphodiesterase inhibitor,PDE6G,,,,PDE6G
11324,sildenafil,phosphodiesterase inhibitor,PDE6H,,,,PDE6H
11325,sildenafil,phosphodiesterase inhibitor,SLCO1B1,,,,SLCO1B1
11326,sildenafil,phosphodiesterase inhibitor,SLCO1B3,,,,SLCO1B3
11327,benzatropine,anticholinergic,CHRM1,,,,CHRM1
11328,benzatropine,anticholinergic,HRH1,,,,HRH1
11329,benzatropine,anticholinergic,SLC6A3,,,,SLC6A3
11330,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
11331,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
11332,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
11333,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
11334,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
11335,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
11336,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
11337,phloretin,"VCAM expression inhibitor, ICAM1 expression inhibitor",AQP9,,,,AQP9
11338,phloretin,"VCAM expression inhibitor, ICAM1 expression inhibitor",CLCN3,,,,CLCN3
11339,phloretin,"VCAM expression inhibitor, ICAM1 expression inhibitor",SLC23A1,,,,SLC23A1
11340,doxycycline,"metalloproteinase inhibitor, 30S ribosomal protein inhibitor, matrix metalloprotease inhibitor, protein arginine deiminase inhibitor",MMP8,,,,MMP8
11341,doxycycline,"metalloproteinase inhibitor, 30S ribosomal protein inhibitor, matrix metalloprotease inhibitor, protein arginine deiminase inhibitor",MMP1,,,,MMP1
11342,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1C,,,,CACNA1C
11343,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1D,,,,CACNA1D
11344,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1G,,,,CACNA1G
11345,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1S,,,,CACNA1S
11346,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1A,,,,CACNA1A
11347,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1B,,,,CACNA1B
11348,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1F,,,,CACNA1F
11349,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNA1I,,,,CACNA1I
11350,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNB1,,,,CACNB1
11351,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNB2,,,,CACNB2
11352,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNB3,,,,CACNB3
11353,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CACNB4,,,,CACNB4
11354,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CYP2C8,,,,CYP2C8
11355,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CYP2E1,,,,CYP2E1
11356,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CYP3A4,,,,CYP3A4
11357,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CYP3A5,,,,CYP3A5
11358,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",CYP3A7,,,,CYP3A7
11359,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",DRD2,,,,DRD2
11360,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",KCNA10,,,,KCNA10
11361,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",KCNA7,,,,KCNA7
11362,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",KCNH2,,,,KCNH2
11363,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",KCNJ11,,,,KCNJ11
11364,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",NALCN,,,,NALCN
11365,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",SCN5A,,,,SCN5A
11366,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",SLC29A4,,,,SLC29A4
11367,verapamil,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist",SLC6A4,,,,SLC6A4
11368,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",AKR1B1,,,,AKR1B1
11369,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS1,,,,PTGS1
11370,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS2,,,,PTGS2
11371,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",MAPK3,,,,MAPK3
11372,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",PPARD,,,,PPARD
11373,sulindac,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGDR2,,,,PTGDR2
11374,tizanidine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
11375,tizanidine,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
11376,tizanidine,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
11377,tizanidine,adrenergic receptor agonist,CYP1A2,,,,CYP1A2
11378,tizanidine,adrenergic receptor agonist,NISCH,,,,NISCH
11379,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",HMGCR,,,,HMGCR
11380,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",DPP4,,,,DPP4
11381,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",AHR,,,,AHR
11382,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",CYP3A5,,,,CYP3A5
11383,atorvastatin,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor",FASLG,,,,FASLG
11384,JNJ-38877605,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET,,,,MET
11385,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
11386,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
11387,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
11388,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
11389,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
11390,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
11391,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
11392,floxuridine,"DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist",TYMS,,,,TYMS
11393,fluconazole,"cell wall synthesis inhibitor, sterol demethylase inhibitor",CYP3A5,,,,CYP3A5
11394,fluconazole,"cell wall synthesis inhibitor, sterol demethylase inhibitor",CYP3A7,,,,CYP3A7
11395,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",OPRM1,,,,OPRM1
11396,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",OPRD1,,,,OPRD1
11397,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",CACNA1A,,,,CACNA1A
11398,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",CALM1,,,,CALM1
11399,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",CYP2B6,,,,CYP2B6
11400,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",CYP2C8,,,,CYP2C8
11401,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",NPR2,,,,NPR2
11402,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",OPRK1,,,,OPRK1
11403,loperamide,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist",POMC,,,,POMC
11404,acetylcholine,neurotransmitter of the peripheral and central nervous systems,ACHE,,,,ACHE
11405,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRM1,,,,CHRM1
11406,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRM2,,,,CHRM2
11407,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRM3,,,,CHRM3
11408,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRM4,,,,CHRM4
11409,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRM5,,,,CHRM5
11410,acetylcholine,neurotransmitter of the peripheral and central nervous systems,CHRNA2,,,,CHRNA2
11411,erastin,"anion channel modulator, ion channel antagonist",VDAC2,,,,VDAC2
11412,ofloxacin,"antibiotic that inhibits DNA gyrase, topoisomerase inhibitor",TOP2A,,,,TOP2A
11413,gemcitabine,"cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
11414,gemcitabine,"cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor",CMPK1,,,,CMPK1
11415,gemcitabine,"cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
11416,gemcitabine,"cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor",TYMS,,,,TYMS
11417,gestrinone,"progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant",PGR,,,,PGR
11418,gestrinone,"progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant",AR,,,,AR
11419,gestrinone,"progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant",ESR1,,,,ESR1
11420,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",KCNH2,,,,KCNH2
11421,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",ADRB1,,,,ADRB1
11422,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CACNA1H,,,,CACNA1H
11423,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CACNA2D2,,,,CACNA2D2
11424,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CHRM3,,,,CHRM3
11425,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CYP2C8,,,,CYP2C8
11426,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",KCNA7,,,,KCNA7
11427,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
11428,alfacalcidol,"hypercalcaemic agent, vitamin D receptor agonist",VDR,,,,VDR
11429,alfacalcidol,"hypercalcaemic agent, vitamin D receptor agonist",CYP27B1,,,,CYP27B1
11430,alfacalcidol,"hypercalcaemic agent, vitamin D receptor agonist",CYP3A5,,,,CYP3A5
11431,etacrynic-acid,"not applicable, sodium/potassium/chloride transporter inhibitor",SLC12A1,,,,SLC12A1
11432,etacrynic-acid,"not applicable, sodium/potassium/chloride transporter inhibitor",ATP1A1,,,,ATP1A1
11433,etacrynic-acid,"not applicable, sodium/potassium/chloride transporter inhibitor",SLC12A2,,,,SLC12A2
11434,BRD-K59222562,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK1,,,,CLK1
11435,BRD-K59222562,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK4,,,,CLK4
11436,BRD-K59222562,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1A,,,,DYRK1A
11437,BRD-K59222562,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1B,,,,DYRK1B
11438,dopamine,dopamine receptor agonist,DRD2,,,,DRD2
11439,dopamine,dopamine receptor agonist,DRD1,,,,DRD1
11440,dopamine,dopamine receptor agonist,DRD3,,,,DRD3
11441,dopamine,dopamine receptor agonist,DRD4,,,,DRD4
11442,dopamine,dopamine receptor agonist,DRD5,,,,DRD5
11443,dopamine,dopamine receptor agonist,DBH,,,,DBH
11444,dopamine,dopamine receptor agonist,HTR1A,,,,HTR1A
11445,dopamine,dopamine receptor agonist,HTR7,,,,HTR7
11446,dopamine,dopamine receptor agonist,SLC6A2,,,,SLC6A2
11447,dopamine,dopamine receptor agonist,SLC6A3,,,,SLC6A3
11448,dopamine,dopamine receptor agonist,SLC6A4,,,,SLC6A4
11449,procyclidine,anticholinergic,CHRM1,,,,CHRM1
11450,procyclidine,anticholinergic,CHRM2,,,,CHRM2
11451,procyclidine,anticholinergic,CHRM3,,,,CHRM3
11452,procyclidine,anticholinergic,CHRM4,,,,CHRM4
11453,BRD-A38793261,ROR antagonist,RORC,,,,RORC
11454,prilocaine,anesthetic,SCN5A,,,,SCN5A
11455,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",BCL2,,,,BCL2
11456,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",BCL2L1,,,,BCL2L1
11457,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",MCL1,,,,MCL1
11458,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",BCL2L2,,,,BCL2L2
11459,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",CTGF,,,,CCN2
11460,gossypol,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor",EGF,,,,EGF
11461,dobutamine,adrenergic receptor agonist,ADRB1,,,,ADRB1
11462,dobutamine,adrenergic receptor agonist,ADRB2,,,,ADRB2
11463,dobutamine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
11464,ethotoin,anticonvulsant,SCN5A,,,,SCN5A
11465,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARG,,,,RARG
11466,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RORB,,,,RORB
11467,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",ALDH1A1,,,,ALDH1A1
11468,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",ALDH1A2,,,,ALDH1A2
11469,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",GPRC5A,,,,GPRC5A
11470,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",NR0B1,,,,NR0B1
11471,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",NR2C2,,,,NR2C2
11472,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",PPARD,,,,PPARD
11473,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARA,,,,RARA
11474,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARB,,,,RARB
11475,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARRES1,,,,RARRES1
11476,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RORC,,,,RORC
11477,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RXRB,,,,RXRB
11478,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RXRG,,,,RXRG
11479,naphazoline,"adrenergic receptor agonist, peptide agonist",ADRA1A,,,,ADRA1A
11480,naphazoline,"adrenergic receptor agonist, peptide agonist",ADRA2A,,,,ADRA2A
11481,pindolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
11482,pindolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
11483,pindolol,adrenergic receptor antagonist,HTR1A,,,,HTR1A
11484,pindolol,adrenergic receptor antagonist,HTR1B,,,,HTR1B
11485,pindolol,adrenergic receptor antagonist,HTR2A,,,,HTR2A
11486,pindolol,adrenergic receptor antagonist,HTR2B,,,,HTR2B
11487,pioglitazone,"PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione",PPARG,,,,PPARG
11488,pioglitazone,"PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione",INS,,,,INS
11489,pioglitazone,"PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione",TRPM3,,,,TRPM3
11490,acyclovir,"DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor",PNP,,,,PNP
11491,azacyclonol,ataractive drug used to diminish hallucinations,HRH1,,,,HRH1
11492,FR-180204,MAP kinase inhibitor,MAPK1,,,,MAPK1
11493,FR-180204,MAP kinase inhibitor,MAPK3,,,,MAPK3
11494,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA6,,,,CA6
11495,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA12,,,,CA12
11496,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA14,,,,CA14
11497,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA2,,,,CA2
11498,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA4,,,,CA4
11499,mafenide,"carbonic anhydrase inhibitor, unidentified pharmacological activity",CA9,,,,CA9
11500,VU-0366037-2,glutamate receptor modulator,GRM4,,,,GRM4
11501,dicycloverine,"acetylcholine receptor antagonist, anticholinergic",CHRM1,,,,CHRM1
11502,dicycloverine,"acetylcholine receptor antagonist, anticholinergic",CHRM2,,,,CHRM2
11503,dicycloverine,"acetylcholine receptor antagonist, anticholinergic",CHRM3,,,,CHRM3
11504,diphenidol,acetylcholine receptor ligand,CHRM1,,,,CHRM1
11505,diphenidol,acetylcholine receptor ligand,CHRM3,,,,CHRM3
11506,diphenidol,acetylcholine receptor ligand,CHRM4,,,,CHRM4
11507,diphenidol,acetylcholine receptor ligand,CHRM2,,,,CHRM2
11508,AGK-2,"SIRT inhibitor, SIRT pathway",SIRT2,,,,SIRT2
11509,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",KCNJ11,,,,KCNJ11
11510,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",ABCC8,,,,ABCC8
11511,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",CFTR,,,,CFTR
11512,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",KCNJ5,,,,KCNJ5
11513,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",KCNJ8,,,,KCNJ8
11514,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",ABCA1,,,,ABCA1
11515,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",ABCB11,,,,ABCB11
11516,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",ABCC9,,,,ABCC9
11517,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",CPT1A,,,,CPT1A
11518,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",KCNJ1,,,,KCNJ1
11519,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",SLCO2B1,,,,SLCO2B1
11520,glibenclamide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist",TRPA1,,,,TRPA1
11521,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
11522,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
11523,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
11524,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
11525,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
11526,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
11527,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
11528,flavoxate,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
11529,flavoxate,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
11530,aminoglutethimide,"antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor",CYP19A1,,,,CYP19A1
11531,aminoglutethimide,"antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor",CYP11A1,,,,CYP11A1
11532,aminoglutethimide,"antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor",NR3C1,,,,NR3C1
11533,carbidopa,"aromatic L-amino acid decarboxylase inhibitor, dopa decarboxylase (aromatic L-amino acid decarboxylase) inhibitor",DDC,,,,DDC
11534,ketoprofen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
11535,ketoprofen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
11536,ketoprofen,cyclooxygenase inhibitor,CXCR1,,,,CXCR1
11537,ketoprofen,cyclooxygenase inhibitor,SLC5A8,,,,SLC5A8
11538,mefenamic-acid,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
11539,mefenamic-acid,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
11540,mefenamic-acid,cyclooxygenase inhibitor,KCNQ1,,,,KCNQ1
11541,mefenamic-acid,cyclooxygenase inhibitor,TRPM3,,,,TRPM3
11542,moclobemide,monoamine oxidase inhibitor,MAOA,,,,MAOA
11543,moclobemide,monoamine oxidase inhibitor,CYP2C19,,,,CYP2C19
11544,moclobemide,monoamine oxidase inhibitor,MAOB,,,,MAOB
11545,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
11546,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADORA3,,,,ADORA3
11547,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1A,,,,ADRA1A
11548,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1B,,,,ADRA1B
11549,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1D,,,,ADRA1D
11550,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
11551,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
11552,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
11553,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
11554,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM1,,,,CHRM1
11555,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM2,,,,CHRM2
11556,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM3,,,,CHRM3
11557,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM4,,,,CHRM4
11558,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM5,,,,CHRM5
11559,nicardipine,"calcium channel blocker, L-type calcium channel blocker",PDE1A,,,,PDE1A
11560,nicardipine,"calcium channel blocker, L-type calcium channel blocker",PDE1B,,,,PDE1B
11561,celecoxib,"cyclooxygenase inhibitor, caspase activator",PTGS2,,,,PTGS2
11562,celecoxib,"cyclooxygenase inhibitor, caspase activator",CA12,,,,CA12
11563,celecoxib,"cyclooxygenase inhibitor, caspase activator",CASP3,,,,CASP3
11564,celecoxib,"cyclooxygenase inhibitor, caspase activator",CYP2C19,,,,CYP2C19
11565,celecoxib,"cyclooxygenase inhibitor, caspase activator",PDPK1,,,,PDPK1
11566,cetirizine,histamine receptor antagonist,HRH1,,,,HRH1
11567,pheniramine,acetylcholine receptor antagonist,HRH1,,,,HRH1
11568,citalopram,"serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
11569,citalopram,"serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
11570,ranitidine,histamine receptor antagonist,HRH2,,,,HRH2
11571,ranitidine,histamine receptor antagonist,SLC22A2,,,,SLC22A2
11572,alisertib,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKA,,,,AURKA
11573,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH1,,,,HRH1
11574,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH2,,,,HRH2
11575,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
11576,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
11577,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1A,,,,ADRA1A
11578,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1B,,,,ADRA1B
11579,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA1D,,,,ADRA1D
11580,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2A,,,,ADRA2A
11581,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2B,,,,ADRA2B
11582,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",ADRA2C,,,,ADRA2C
11583,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM1,,,,CHRM1
11584,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM2,,,,CHRM2
11585,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM3,,,,CHRM3
11586,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM4,,,,CHRM4
11587,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CHRM5,,,,CHRM5
11588,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",CYP2C19,,,,CYP2C19
11589,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",DRD2,,,,DRD2
11590,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HRH4,,,,HRH4
11591,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR1A,,,,HTR1A
11592,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2A,,,,HTR2A
11593,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2B,,,,HTR2B
11594,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR2C,,,,HTR2C
11595,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",HTR6,,,,HTR6
11596,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",KCNH2,,,,KCNH2
11597,doxepin,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant",SLC6A3,,,,SLC6A3
11598,methocarbamol,muscle relaxant,CA1,,,,CA1
11599,clopidogrel,"purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor",P2RY12,,,,P2RY12
11600,clopidogrel,"purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor",CYP2B6,,,,CYP2B6
11601,clopidogrel,"purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor",CYP2C19,,,,CYP2C19
11602,clopidogrel,"purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor",CYP3A5,,,,CYP3A5
11603,benperidol,dopamine receptor antagonist,DRD2,,,,DRD2
11604,linezolid,"50S ribosomal subunit inhibitor, protein synthesis inhibitor, monoamine oxidase inhibitor",MAOA,,,,MAOA
11605,MK-1775,wee1 kinase inhibitor,WEE1,,,,WEE1
11606,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",PARP1,,,,PARP1
11607,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",AOX1,,,,AOX1
11608,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",BST1,,,,BST1
11609,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",CYP2E1,,,,CYP2E1
11610,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",LDHA,,,,LDHA
11611,nicotinamide,"oxidoreductase stimulant, protein synthesis stimulant",SIRT5,,,,SIRT5
11612,pepstatin,aspartic protease inhibitor,CTSB,,,,CTSB
11613,pepstatin,aspartic protease inhibitor,CTSD,,,,CTSD
11614,pepstatin,aspartic protease inhibitor,CTSL,,,,CTSL
11615,pepstatin,aspartic protease inhibitor,REN,,,,REN
11616,pilocarpine,acetylcholine receptor agonist,CHRM3,,,,CHRM3
11617,pilocarpine,acetylcholine receptor agonist,CHRM1,,,,CHRM1
11618,pilocarpine,acetylcholine receptor agonist,CHRM2,,,,CHRM2
11619,pilocarpine,acetylcholine receptor agonist,CHRM4,,,,CHRM4
11620,pilocarpine,acetylcholine receptor agonist,CHRM5,,,,CHRM5
11621,racecadotril,"enkephalinase inhibitor, membrane metalloendopeptidase inhibitor, neprilysin inhibitor",MME,,,,MME
11622,sumatriptan,serotonin receptor agonist,HTR1D,,,,HTR1D
11623,sumatriptan,serotonin receptor agonist,HTR1B,,,,HTR1B
11624,sumatriptan,serotonin receptor agonist,HTR1A,,,,HTR1A
11625,sumatriptan,serotonin receptor agonist,HTR1F,,,,HTR1F
11626,sumatriptan,serotonin receptor agonist,HTR1E,,,,HTR1E
11627,sumatriptan,serotonin receptor agonist,HTR5A,,,,HTR5A
11628,sumatriptan,serotonin receptor agonist,HTR6,,,,HTR6
11629,sumatriptan,serotonin receptor agonist,HTR7,,,,HTR7
11630,tolazamide,ATP channel blocker,KCNJ1,,,,KCNJ1
11631,tolazamide,ATP channel blocker,KCNJ10,,,,KCNJ10
11632,BRD-K98948170,kelch-like ECH-associated protein ligand,KEAP1,,,,KEAP1
11633,amisulpride,dopamine receptor antagonist,DRD2,,,,DRD2
11634,amisulpride,dopamine receptor antagonist,DRD3,,,,DRD3
11635,amisulpride,dopamine receptor antagonist,HTR2A,,,,HTR2A
11636,amisulpride,dopamine receptor antagonist,HTR7,,,,HTR7
11637,brompheniramine,histamine receptor antagonist,HRH1,,,,HRH1
11638,brompheniramine,histamine receptor antagonist,CHRM1,,,,CHRM1
11639,brompheniramine,histamine receptor antagonist,CHRM2,,,,CHRM2
11640,brompheniramine,histamine receptor antagonist,CHRM3,,,,CHRM3
11641,brompheniramine,histamine receptor antagonist,CHRM4,,,,CHRM4
11642,brompheniramine,histamine receptor antagonist,CHRM5,,,,CHRM5
11643,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS2,,,,PTGS2
11644,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS1,,,,PTGS1
11645,etodolac,"cyclooxygenase inhibitor, TRPV agonist",RXRA,,,,RXRA
11646,etodolac,"cyclooxygenase inhibitor, TRPV agonist",TRPV1,,,,TRPV1
11647,phenazopyridine,unidentified pharmacological activity,SCN1A,,,,SCN1A
11648,equol,estrogen receptor agonist,ESR2,,,,ESR2
11649,equol,estrogen receptor agonist,ESR1,,,,ESR1
11650,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",AURKA,,,,AURKA
11651,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",FLT3,,,,FLT3
11652,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",KDR,,,,KDR
11653,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",PDGFRA,,,,PDGFRA
11654,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",SRC,,,,SRC
11655,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",CSF1R,,,,CSF1R
11656,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",EPHA1,,,,EPHA1
11657,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",FGFR1,,,,FGFR1
11658,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",FGFR2,,,,FGFR2
11659,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",FGFR3,,,,FGFR3
11660,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",FLT4,,,,FLT4
11661,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",KIT,,,,KIT
11662,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor",PTK2,,,,PTK2
11663,vidarabine,"adenylyl cyclase inhibitor, DNA directed DNA polymerase inhibitor, viral DNA synthesis inhibitor",ADCY5,,,,ADCY5
11664,thiothixene,"dopamine receptor, dopamine receptor antagonist",HTR2A,,,,HTR2A
11665,thiothixene,"dopamine receptor, dopamine receptor antagonist",DRD1,,,,DRD1
11666,thiothixene,"dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
11667,thiothixene,"dopamine receptor, dopamine receptor antagonist",HRH1,,,,HRH1
11668,quipazine,serotonin receptor agonist,HTR2A,,,,HTR2A
11669,quipazine,serotonin receptor agonist,HTR3A,,,,HTR3A
11670,quipazine,serotonin receptor agonist,HTR3B,,,,HTR3B
11671,quipazine,serotonin receptor agonist,HTR1A,,,,HTR1A
11672,quipazine,serotonin receptor agonist,HTR1D,,,,HTR1D
11673,quipazine,serotonin receptor agonist,HTR2B,,,,HTR2B
11674,quipazine,serotonin receptor agonist,HTR2C,,,,HTR2C
11675,quipazine,serotonin receptor agonist,HTR6,,,,HTR6
11676,quipazine,serotonin receptor agonist,SLC6A4,,,,SLC6A4
11677,clofibric-acid,PPAR receptor agonist,PPARA,,,,PPARA
11678,molsidomine,"activator of soluble guanylyl cyclase, nitric oxide donor, nitric oxide stimulant",GUCY1A3,,,,GUCY1A1
11679,bemegride,chemoreceptor agonist,GABRA1,,,,GABRA1
11680,benzthiazide,carbonic anhydrase inhibitor,CA2,,,,CA2
11681,benzthiazide,carbonic anhydrase inhibitor,CA1,,,,CA1
11682,benzthiazide,carbonic anhydrase inhibitor,CA12,,,,CA12
11683,benzthiazide,carbonic anhydrase inhibitor,CA4,,,,CA4
11684,benzthiazide,carbonic anhydrase inhibitor,CA9,,,,CA9
11685,benzthiazide,carbonic anhydrase inhibitor,SLC12A3,,,,SLC12A3
11686,cyclopentolate,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
11687,balsalazide,"cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PTGS1,,,,PTGS1
11688,balsalazide,"cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PTGS2,,,,PTGS2
11689,balsalazide,"cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",ALOX5,,,,ALOX5
11690,balsalazide,"cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PPARG,,,,PPARG
11691,etilefrine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
11692,etilefrine,adrenergic receptor agonist,ADRB1,,,,ADRB1
11693,fexofenadine,histamine receptor antagonist,HRH1,,,,HRH1
11694,haloperidol,dopamine receptor antagonist,DRD2,,,,DRD2
11695,haloperidol,dopamine receptor antagonist,DRD1,,,,DRD1
11696,haloperidol,dopamine receptor antagonist,DRD3,,,,DRD3
11697,haloperidol,dopamine receptor antagonist,HTR2A,,,,HTR2A
11698,haloperidol,dopamine receptor antagonist,CYP3A7,,,,CYP3A7
11699,haloperidol,dopamine receptor antagonist,DRD4,,,,DRD4
11700,haloperidol,dopamine receptor antagonist,DRD5,,,,DRD5
11701,haloperidol,dopamine receptor antagonist,GRIN2B,,,,GRIN2B
11702,haloperidol,dopamine receptor antagonist,HRH1,,,,HRH1
11703,haloperidol,dopamine receptor antagonist,HTR1A,,,,HTR1A
11704,haloperidol,dopamine receptor antagonist,HTR1D,,,,HTR1D
11705,haloperidol,dopamine receptor antagonist,HTR2B,,,,HTR2B
11706,haloperidol,dopamine receptor antagonist,HTR7,,,,HTR7
11707,haloperidol,dopamine receptor antagonist,KCNH1,,,,KCNH1
11708,hymecromone,monoamine oxidase inhibitor,MAOA,,,,MAOA
11709,indoprofen,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
11710,indoprofen,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
11711,indoprofen,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",CXCR1,,,,CXCR1
11712,indoprofen,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",CXCR2,,,,CXCR2
11713,adipiodone,serum albumin binder,ALB,,,,ALB
11714,levocabastine,histamine receptor antagonist,HRH1,,,,HRH1
11715,levocabastine,histamine receptor antagonist,NTSR2,,,,NTSR2
11716,nialamide,monoamine oxidase inhibitor,COMT,,,,COMT
11717,nialamide,monoamine oxidase inhibitor,MAOA,,,,MAOA
11718,nialamide,monoamine oxidase inhibitor,MAOB,,,,MAOB
11719,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",HRH1,,,,HRH1
11720,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",S100A1,,,,S100A1
11721,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",S100A12,,,,S100A12
11722,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",S100A13,,,,S100A13
11723,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",S100A2,,,,S100A2
11724,olopatadine,"histamine receptor antagonist, histamine blocker, mediator release inhibitor",S100B,,,,S100B
11725,letrozole,"aromatase inhibitor, estrogen receptor antagonist",CYP19A1,,,,CYP19A1
11726,remacemide,"glutamate receptor antagonist, glutamate receptor agonist",GRIN1,,,,GRIN1
11727,AICA-ribonucleotide,"adenosine release stimulant, AMPK stimulant",ATIC,,,,ATIC
11728,AICA-ribonucleotide,"adenosine release stimulant, AMPK stimulant",PRKAA1,,,,PRKAA1
11729,pramipexole,dopamine receptor agonist,DRD3,,,,DRD3
11730,pramipexole,dopamine receptor agonist,DRD2,,,,DRD2
11731,pramipexole,dopamine receptor agonist,ADRA2A,,,,ADRA2A
11732,pramipexole,dopamine receptor agonist,ADRA2B,,,,ADRA2B
11733,pramipexole,dopamine receptor agonist,ADRA2C,,,,ADRA2C
11734,pramipexole,dopamine receptor agonist,DRD1,,,,DRD1
11735,pramipexole,dopamine receptor agonist,DRD4,,,,DRD4
11736,pramipexole,dopamine receptor agonist,DRD5,,,,DRD5
11737,pramipexole,dopamine receptor agonist,HTR1A,,,,HTR1A
11738,pramipexole,dopamine receptor agonist,HTR1B,,,,HTR1B
11739,pramipexole,dopamine receptor agonist,HTR1D,,,,HTR1D
11740,pramipexole,dopamine receptor agonist,HTR2A,,,,HTR2A
11741,pramipexole,dopamine receptor agonist,HTR2B,,,,HTR2B
11742,pramipexole,dopamine receptor agonist,HTR2C,,,,HTR2C
11743,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA1A,,,,ADRA1A
11744,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA1B,,,,ADRA1B
11745,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA1D,,,,ADRA1D
11746,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA2A,,,,ADRA2A
11747,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA2B,,,,ADRA2B
11748,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",ADRA2C,,,,ADRA2C
11749,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",CDK1,,,,CDK1
11750,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",KCNH2,,,,KCNH2
11751,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",KCNH6,,,,KCNH6
11752,prazosin,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor",KCNH7,,,,KCNH7
11753,proguanil,dihydrofolate reductase inhibitor,CYP2C19,,,,CYP2C19
11754,proguanil,dihydrofolate reductase inhibitor,DHFR,,,,DHFR
11755,CAY-10470,NFKB pathway inhibitor,NFKB1,,,,NFKB1
11756,CAY-10470,NFKB pathway inhibitor,TNF,,,,TNF
11757,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA1A,,,,ADRA1A
11758,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA1B,,,,ADRA1B
11759,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA1D,,,,ADRA1D
11760,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA2A,,,,ADRA2A
11761,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA2B,,,,ADRA2B
11762,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRA2C,,,,ADRA2C
11763,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRB1,,,,ADRB1
11764,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRB2,,,,ADRB2
11765,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",ADRB3,,,,ADRB3
11766,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",PAH,,,,PAH
11767,epinephrine,"carbonic anhydrase activator, hormone, neurotransmitter",TNF,,,,TNF
11768,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",TOP2A,,,,TOP2A
11769,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",CYP2E1,,,,CYP2E1
11770,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",CYP3A5,,,,CYP3A5
11771,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",TOP2B,,,,TOP2B
11772,scopolamine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
11773,scopolamine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
11774,scopolamine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
11775,scopolamine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
11776,scopolamine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
11777,scopolamine,acetylcholine receptor antagonist,SI,,,,SI
11778,tocainide,"sodium channel blocker, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
11779,urapidil,"adrenergic receptor antagonist, serotonin receptor agonist",HTR1A,,,,HTR1A
11780,antimycin-a,"antibiotic, electron transfer inhibitor",CYCS,,,,CYCS
11781,tacedinaline,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
11782,DL-PDMP,"ceramide glucosyltransferase inhibitor, glucosyltransferase inhibitor",ASAH1,,,,ASAH1
11783,DL-PDMP,"ceramide glucosyltransferase inhibitor, glucosyltransferase inhibitor",UGCG,,,,UGCG
11784,emetine,protein synthesis inhibitor,RPS2,,,,RPS2
11785,HDAC3-selective,HDAC inhibitor,HDAC3,,,,HDAC3
11786,tubastatin-a,HDAC inhibitor,HDAC6,,,,HDAC6
11787,BRD-K87426499,caspase inhibitor,CASP3,,,,CASP3
11788,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",ADIPOR2,,,,ADIPOR2
11789,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",IKBKB,,,,IKBKB
11790,parthenolide,"NFkB pathway inhibitor, adiponectin receptor agonist",RELA,,,,RELA
11791,decitabine,"DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor",DNMT1,,,,DNMT1
11792,cytochalasin-d,"actin polymerization inhibitor, actin stabilizer",ACTB,,,,ACTB
11793,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",FLT3,,,,FLT3
11794,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",CSF1R,,,,CSF1R
11795,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",KIT,,,,KIT
11796,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",RET,,,,RET
11797,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",PDGFRA,,,,PDGFRA
11798,quizartinib,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor",PDGFRB,,,,PDGFRB
11799,ALW-II-38-3,ephrin inhibitor,DDR1,,,,DDR1
11800,ALW-II-38-3,ephrin inhibitor,EPHA2,,,,EPHA2
11801,ALW-II-38-3,ephrin inhibitor,EPHA4,,,,EPHA4
11802,ALW-II-38-3,ephrin inhibitor,EPHB2,,,,EPHB2
11803,ALW-II-38-3,ephrin inhibitor,EPHB4,,,,EPHB4
11804,ALW-II-38-3,ephrin inhibitor,EPHB6,,,,EPHB6
11805,minaprine,serotonin uptake inhibitor,HTR2B,,,,HTR2B
11806,minaprine,serotonin uptake inhibitor,SLC6A4,,,,SLC6A4
11807,minaprine,serotonin uptake inhibitor,ACHE,,,,ACHE
11808,minaprine,serotonin uptake inhibitor,CHRM1,,,,CHRM1
11809,minaprine,serotonin uptake inhibitor,DRD1,,,,DRD1
11810,minaprine,serotonin uptake inhibitor,DRD2,,,,DRD2
11811,minaprine,serotonin uptake inhibitor,HTR2A,,,,HTR2A
11812,minaprine,serotonin uptake inhibitor,HTR2C,,,,HTR2C
11813,minaprine,serotonin uptake inhibitor,MAOA,,,,MAOA
11814,AZD-8055,mTOR inhibitor,MTOR,,,,MTOR
11815,Y-26763,"potassium channel activator, potassium channel agonist",ABCC9,,,,ABCC9
11816,Y-26763,"potassium channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
11817,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",CDK1,,,,CDK1
11818,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",FLT1,,,,FLT1
11819,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",FYN,,,,FYN
11820,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",MCL1,,,,MCL1
11821,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",PDGFRA,,,,PDGFRA
11822,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",PLK1,,,,PLK1
11823,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",PLK2,,,,PLK2
11824,ON-01910,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor",SRC,,,,SRC
11825,GSK-429286A,ROCK inhibitor,ROCK1,,,,ROCK1
11826,GSK-461364,PLK inhibitor,PLK1,,,,PLK1
11827,KIN001-055,"EGFR inhibitor, JAK inhibitor, leukotriene synthesis inhibitor, mediator release inhibitor",EGFR,,,,EGFR
11828,KIN001-055,"EGFR inhibitor, JAK inhibitor, leukotriene synthesis inhibitor, mediator release inhibitor",JAK3,,,,JAK3
11829,KIN001-127,ITK inhibitor,ITK,,,,ITK
11830,KU-0063794,mTOR inhibitor,MTOR,,,,MTOR
11831,MLN-8054,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKA,,,,AURKA
11832,OSI-027,mTOR inhibitor,MTOR,,,,MTOR
11833,palbociclib,CDK inhibitor,CDK4,,,,CDK4
11834,palbociclib,CDK inhibitor,CDK6,,,,CDK6
11835,palbociclib,CDK inhibitor,CCND3,,,,CCND3
11836,zibotentan,endothelin receptor antagonist,EDNRA,,,,EDNRA
11837,WYE-125132,"mTOR inhibitor, PI3K inhibitor",MTOR,,,,MTOR
11838,WYE-125132,"mTOR inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
11839,sitagliptin,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor",DPP4,,,,DPP4
11840,sitagliptin,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor",CYP2C8,,,,CYP2C8
11841,sitagliptin,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor",FASLG,,,,FASLG
11842,sitagliptin,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor",HMGCR,,,,HMGCR
11843,sitagliptin,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor",SLC22A8,,,,SLC22A8
11844,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGIR,,,,PTGIR
11845,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGER1,,,,PTGER1
11846,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGER2,,,,PTGER2
11847,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PDE4A,,,,PDE4A
11848,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PDE4B,,,,PDE4B
11849,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PDE4C,,,,PDE4C
11850,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PDE4D,,,,PDE4D
11851,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PLAT,,,,PLAT
11852,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGDR,,,,PTGDR
11853,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGER3,,,,PTGER3
11854,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGER4,,,,PTGER4
11855,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",PTGFR,,,,PTGFR
11856,iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog",TBXA2R,,,,TBXA2R
11857,oligomycin-a,"ATP synthase inhibitor, ATPase inhibitor",ATP5A1,,,,ATP5F1A
11858,molindone,dopamine receptor antagonist,DRD2,,,,DRD2
11859,molindone,dopamine receptor antagonist,HTR2A,,,,HTR2A
11860,molindone,dopamine receptor antagonist,CHRM1,,,,CHRM1
11861,molindone,dopamine receptor antagonist,DRD5,,,,DRD5
11862,molindone,dopamine receptor antagonist,HRH1,,,,HRH1
11863,molindone,dopamine receptor antagonist,HTR1A,,,,HTR1A
11864,moracizine,sodium channel blocker,SCN5A,,,,SCN5A
11865,carbetocin,analogue of oxytocin,OXTR,,,,OXTR
11866,PJ-34,PARP inhibitor,EEF2,,,,EEF2
11867,PJ-34,PARP inhibitor,PARP1,,,,PARP1
11868,PJ-34,PARP inhibitor,PARP15,,,,PARP15
11869,PJ-34,PARP inhibitor,PARP3,,,,PARP3
11870,PTB1,"AMPK activator, tyrosine phosphatase inhibitor",PTPN1,,,,PTPN1
11871,SNS-314,Aurora kinase inhibitor,AURKA,,,,AURKA
11872,SNS-314,Aurora kinase inhibitor,AURKB,,,,AURKB
11873,SNS-314,Aurora kinase inhibitor,AURKC,,,,AURKC
11874,calcifediol,vitamin D receptor agonist,VDR,,,,VDR
11875,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",TNF,,,,TNF
11876,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",CRBN,,,,CRBN
11877,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",CYP1A2,,,,CYP1A2
11878,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",CYP2B6,,,,CYP2B6
11879,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",CYP2C19,,,,CYP2C19
11880,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",CYP3A5,,,,CYP3A5
11881,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",FGFR2,,,,FGFR2
11882,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",NFKB1,,,,NFKB1
11883,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",ORM1,,,,ORM1
11884,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",ORM2,,,,ORM2
11885,thalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor",PTGS2,,,,PTGS2
11886,androstenol,GABA receptor modulator,NR1I3,,,,NR1I3
11887,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRK1,,,,OPRK1
11888,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRM1,,,,OPRM1
11889,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRD1,,,,OPRD1
11890,naltrexone,"opioid receptor antagonist, opioid receptor ligand",SIGMAR1,,,,SIGMAR1
11891,eicosatetraynoic-acid,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX12,,,,ALOX12
11892,eicosatetraynoic-acid,"cyclooxygenase inhibitor, lipoxygenase inhibitor",PPARA,,,,PPARA
11893,eicosatetraynoic-acid,"cyclooxygenase inhibitor, lipoxygenase inhibitor",PPARG,,,,PPARG
11894,eicosatetraynoic-acid,"cyclooxygenase inhibitor, lipoxygenase inhibitor",PTGS1,,,,PTGS1
11895,ondansetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
11896,ondansetron,serotonin receptor antagonist,CYP2D6,,,,CYP2D6
11897,ondansetron,serotonin receptor antagonist,CYP3A5,,,,CYP3A5
11898,ondansetron,serotonin receptor antagonist,HTR1A,,,,HTR1A
11899,ondansetron,serotonin receptor antagonist,HTR1B,,,,HTR1B
11900,ondansetron,serotonin receptor antagonist,HTR3B,,,,HTR3B
11901,ondansetron,serotonin receptor antagonist,HTR4,,,,HTR4
11902,ondansetron,serotonin receptor antagonist,OPRM1,,,,OPRM1
11903,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",PPARA,,,,PPARA
11904,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",CYP2C8,,,,CYP2C8
11905,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",LPL,,,,LPL
11906,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",SLCO1B1,,,,SLCO1B1
11907,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",SLCO1B3,,,,SLCO1B3
11908,gemfibrozil,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist",SLCO2B1,,,,SLCO2B1
11909,teniposide,"topoisomerase inhibitor, DNA inhibitor, DNA repair enzyme inhibitor, mitotic inhibitor",TOP2A,,,,TOP2A
11910,teniposide,"topoisomerase inhibitor, DNA inhibitor, DNA repair enzyme inhibitor, mitotic inhibitor",CYP3A5,,,,CYP3A5
11911,quinethazone,diuretic,SLC12A3,,,,SLC12A3
11912,quinpirole,dopamine receptor agonist,DRD2,,,,DRD2
11913,quinpirole,dopamine receptor agonist,DRD3,,,,DRD3
11914,quinpirole,dopamine receptor agonist,DRD4,,,,DRD4
11915,quinpirole,dopamine receptor agonist,DRD1,,,,DRD1
11916,quinpirole,dopamine receptor agonist,HTR1A,,,,HTR1A
11917,quinpirole,dopamine receptor agonist,HTR2A,,,,HTR2A
11918,quinpirole,dopamine receptor agonist,HTR2B,,,,HTR2B
11919,quinpirole,dopamine receptor agonist,HTR2C,,,,HTR2C
11920,AG-957,"Abl kinase inhibitor, protein tyrosine kinase inhibitor",ABL1,,,,ABL1
11921,AG-957,"Abl kinase inhibitor, protein tyrosine kinase inhibitor",EGFR,,,,EGFR
11922,AG-99,tyrosine kinase inhibitor,EGFR,,,,EGFR
11923,altrenogest,progestogen steroid hormone,PGR,,,,PGR
11924,AMG-9810,TRPV antagonist,TRPV1,,,,TRPV1
11925,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",KCNH2,,,,KCNH2
11926,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",ADRB1,,,,ADRB1
11927,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CACNA1H,,,,CACNA1H
11928,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CACNA2D2,,,,CACNA2D2
11929,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CHRM3,,,,CHRM3
11930,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",CYP2C8,,,,CYP2C8
11931,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",KCNA7,,,,KCNA7
11932,amiodarone,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
11933,amsacrine,"topoisomerase inhibitor, DNA intercalating drug",TOP2A,,,,TOP2A
11934,amsacrine,"topoisomerase inhibitor, DNA intercalating drug",KCNH2,,,,KCNH2
11935,anagrelide,phosphodiesterase inhibitor,PDE3A,,,,PDE3A
11936,ARC-239,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
11937,ARC-239,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
11938,ARC-239,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
11939,ambroxol,"glucosylceramidase inhibitor, mucolytic agent, sodium channel blocker",GBA,,,,GBA
11940,CS-1657,PARP inhibitor,PARP1,,,,PARP1
11941,KIN001-244,phosphoinositide dependent kinase inhibitor,PDPK1,,,,PDPK1
11942,anpirtoline,"serotonin receptor agonist, serotonin receptor antagonist",HTR1B,,,,HTR1B
11943,anpirtoline,"serotonin receptor agonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
11944,arcyriaflavin-a,CDK inhibitor,CCND1,,,,CCND1
11945,arcyriaflavin-a,CDK inhibitor,CCNE1,,,,CCNE1
11946,arcyriaflavin-a,CDK inhibitor,CDK2,,,,CDK2
11947,arcyriaflavin-a,CDK inhibitor,CDK4,,,,CDK4
11948,atovaquone,"cytochrome b-c1 complex inhibitor, dihydroorotate dehydrogenase inhibitor, mitochondrial electron transport inhibitor",DHODH,,,,DHODH
11949,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",SLC12A3,,,,SLC12A3
11950,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",CA1,,,,CA1
11951,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",CA2,,,,CA2
11952,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",CA4,,,,CA4
11953,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",KCNMA1,,,,KCNMA1
11954,bendroflumethiazide,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic",SLC12A1,,,,SLC12A1
11955,betamethasone,"corticosteroid agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
11956,BH3I-1,BCL inhibitor,BCL2,,,,BCL2
11957,biperiden,anticholinergic,CHRM1,,,,CHRM1
11958,biperiden,anticholinergic,CHRM2,,,,CHRM2
11959,biperiden,anticholinergic,CHRM3,,,,CHRM3
11960,biperiden,anticholinergic,CHRM4,,,,CHRM4
11961,biperiden,anticholinergic,CHRM5,,,,CHRM5
11962,biperiden,anticholinergic,CHRNA2,,,,CHRNA2
11963,bisoprolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
11964,bisoprolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
11965,bithionol,autotaxin inhibitor,ESR1,,,,ESR1
11966,bithionol,autotaxin inhibitor,ESR2,,,,ESR2
11967,bithionol,autotaxin inhibitor,MCL1,,,,MCL1
11968,BRL-52537,opioid receptor agonist,OPRK1,,,,OPRK1
11969,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD2,,,,DRD2
11970,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2A,,,,ADRA2A
11971,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2B,,,,ADRA2B
11972,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2C,,,,ADRA2C
11973,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD1,,,,DRD1
11974,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD3,,,,DRD3
11975,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD4,,,,DRD4
11976,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD5,,,,DRD5
11977,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1A,,,,HTR1A
11978,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1B,,,,HTR1B
11979,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1D,,,,HTR1D
11980,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2A,,,,HTR2A
11981,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2B,,,,HTR2B
11982,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2C,,,,HTR2C
11983,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1A,,,,ADRA1A
11984,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1B,,,,ADRA1B
11985,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1D,,,,ADRA1D
11986,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR6,,,,HTR6
11987,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR7,,,,HTR7
11988,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",PRL,,,,PRL
11989,BU-224,imidazoline receptor ligand,MAOA,,,,MAOA
11990,BU-224,imidazoline receptor ligand,MAOB,,,,MAOB
11991,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",NR3C1,,,,NR3C1
11992,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A5,,,,CYP3A5
11993,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A7,,,,CYP3A7
11994,BVT-948,tyrosine phosphatase inhibitor,PTPN1,,,,PTPN1
11995,BVT-948,tyrosine phosphatase inhibitor,PTPN11,,,,PTPN11
11996,BVT-948,tyrosine phosphatase inhibitor,PTPN2,,,,PTPN2
11997,BW-B70C,lipoxygenase inhibitor,ALOX5,,,,ALOX5
11998,benazepril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
11999,benzamil,epithelial sodium channel blocker,PKD2L1,,,,PKD2L1
12000,benzamil,epithelial sodium channel blocker,SCNN1A,,,,SCNN1A
12001,benzamil,epithelial sodium channel blocker,SCNN1B,,,,SCNN1B
12002,benzamil,epithelial sodium channel blocker,SCNN1G,,,,SCNN1G
12003,benzamil,epithelial sodium channel blocker,ASIC1,,,,ASIC1
12004,benzamil,epithelial sodium channel blocker,SCNN1D,,,,SCNN1D
12005,benzamil,epithelial sodium channel blocker,SLC8A1,,,,SLC8A1
12006,calmidazolium,"calcium channel blocker, calmodulin antagonist",ATP2B1,,,,ATP2B1
12007,calmidazolium,"calcium channel blocker, calmodulin antagonist",PDE1A,,,,PDE1A
12008,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ADORA1,,,,ADORA1
12009,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ADORA2A,,,,ADORA2A
12010,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ADORA2B,,,,ADORA2B
12011,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ATM,,,,ATM
12012,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ITPR1,,,,ITPR1
12013,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",RYR1,,,,RYR1
12014,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ADORA3,,,,ADORA3
12015,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ATR,,,,ATR
12016,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ITPR2,,,,ITPR2
12017,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",ITPR3,,,,ITPR3
12018,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE10A,,,,PDE10A
12019,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE11A,,,,PDE11A
12020,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE1A,,,,PDE1A
12021,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE1B,,,,PDE1B
12022,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE1C,,,,PDE1C
12023,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE2A,,,,PDE2A
12024,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE3A,,,,PDE3A
12025,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE3B,,,,PDE3B
12026,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE4A,,,,PDE4A
12027,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE4B,,,,PDE4B
12028,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE4C,,,,PDE4C
12029,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE4D,,,,PDE4D
12030,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE5A,,,,PDE5A
12031,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE6A,,,,PDE6A
12032,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE6B,,,,PDE6B
12033,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE6C,,,,PDE6C
12034,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE7A,,,,PDE7A
12035,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE7B,,,,PDE7B
12036,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE8A,,,,PDE8A
12037,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE8B,,,,PDE8B
12038,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PDE9A,,,,PDE9A
12039,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PIK3CA,,,,PIK3CA
12040,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PIK3CB,,,,PIK3CB
12041,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PIK3CD,,,,PIK3CD
12042,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",PRKDC,,,,PRKDC
12043,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",RYR2,,,,RYR2
12044,caffeine,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor",RYR3,,,,RYR3
12045,candesartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
12046,candesartan,angiotensin receptor antagonist,AGTR2,,,,AGTR2
12047,carbinoxamine,"histamine receptor antagonist, L-type calcium channel blocker",HRH1,,,,HRH1
12048,CGP-54626,GABA receptor antagonist,GABBR1,,,,GABBR1
12049,CGP-54626,GABA receptor antagonist,GABBR2,,,,GABBR2
12050,CGP-54626,GABA receptor antagonist,KCTD12,,,,KCTD12
12051,CGP-54626,GABA receptor antagonist,KCTD16,,,,KCTD16
12052,CGP-54626,GABA receptor antagonist,KCTD8,,,,KCTD8
12053,chlormadinone,progesterone receptor agonist,PGR,,,,PGR
12054,chloroxine,opioid receptor inhibitor,OPRK1,,,,OPRK1
12055,cilostazol,"phosphodiesterase inhibitor, platelet aggregation inhibitor",PDE3A,,,,PDE3A
12056,cilostazol,"phosphodiesterase inhibitor, platelet aggregation inhibitor",CYP2C19,,,,CYP2C19
12057,cilostazol,"phosphodiesterase inhibitor, platelet aggregation inhibitor",CYP3A5,,,,CYP3A5
12058,cilostazol,"phosphodiesterase inhibitor, platelet aggregation inhibitor",PDE3B,,,,PDE3B
12059,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",HRH2,,,,HRH2
12060,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC29A4,,,,SLC29A4
12061,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC47A1,,,,SLC47A1
12062,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC47A2,,,,SLC47A2
12063,cinchonine,antimalarial agent,CYP2D6,,,,CYP2D6
12064,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3,,,,NR1I3
12065,clofibrate,PPAR receptor agonist,PPARA,,,,PPARA
12066,clofibrate,PPAR receptor agonist,LPL,,,,LPL
12067,CMPD-1,p38 MAPK inhibitor,GNRHR,,,,GNRHR
12068,CMPD-1,p38 MAPK inhibitor,MAPK14,,,,MAPK14
12069,CNQX,"glutamate receptor antagonist, unidentified pharmacological activity",GRIA1,,,,GRIA1
12070,CNQX,"glutamate receptor antagonist, unidentified pharmacological activity",GRIA2,,,,GRIA2
12071,CNQX,"glutamate receptor antagonist, unidentified pharmacological activity",GRIA3,,,,GRIA3
12072,CNQX,"glutamate receptor antagonist, unidentified pharmacological activity",GRIA4,,,,GRIA4
12073,cortisone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
12074,CV-1808,adenosine receptor agonist,ADORA2A,,,,ADORA2A
12075,CV-1808,adenosine receptor agonist,ADORA2B,,,,ADORA2B
12076,cyanopindolol,adrenergic receptor antagonist,HTR1D,,,,HTR1D
12077,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",GSK3B,,,,GSK3B
12078,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",RPL3,,,,RPL3
12079,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,,,,ATP2A1
12080,calcipotriol,vitamin D receptor agonist,VDR,,,,VDR
12081,cyclazosin,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
12082,cyclazosin,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
12083,cyclazosin,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
12084,clioquinol,"chelating agent, antiamyloidogenic agent, beta amyloid antagonist, carbonic anhydrase inhibitor",OPRK1,,,,OPRK1
12085,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",GSK3B,,,,GSK3B
12086,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",RPL3,,,,RPL3
12087,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",ESR1,,,,ESR1
12088,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR,,,,GNRHR
12089,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",AR,,,,AR
12090,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CCL2,,,,CCL2
12091,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",CYP2C8,,,,CYP2C8
12092,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",GNRHR2,,,,GNRHR2
12093,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",PGR,,,,PGR
12094,danazol,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator",TNF,,,,TNF
12095,gedunin,HSP inhibitor,HSP90AA1,,,,HSP90AA1
12096,desoxypeganine,"acetylcholinesterase inhibitor, monoamine oxidase inhibitor",ACHE,,,,ACHE
12097,desoxypeganine,"acetylcholinesterase inhibitor, monoamine oxidase inhibitor",MAOA,,,,MAOA
12098,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
12099,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
12100,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
12101,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
12102,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
12103,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
12104,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
12105,diclofenac,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
12106,diclofenac,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
12107,diclofenac,cyclooxygenase inhibitor,AKR1C3,,,,AKR1C3
12108,diclofenac,cyclooxygenase inhibitor,ALOX5,,,,ALOX5
12109,diclofenac,cyclooxygenase inhibitor,ASIC1,,,,ASIC1
12110,diclofenac,cyclooxygenase inhibitor,ASIC3,,,,ASIC3
12111,diclofenac,cyclooxygenase inhibitor,CYP2C8,,,,CYP2C8
12112,diclofenac,cyclooxygenase inhibitor,KCNQ2,,,,KCNQ2
12113,diclofenac,cyclooxygenase inhibitor,KCNQ3,,,,KCNQ3
12114,diclofenac,cyclooxygenase inhibitor,PLA2G2A,,,,PLA2G2A
12115,diclofenac,cyclooxygenase inhibitor,PPARG,,,,PPARG
12116,diclofenac,cyclooxygenase inhibitor,SCN4A,,,,SCN4A
12117,dienestrol,estrogen receptor agonist,ESR1,,,,ESR1
12118,diethylcarbamazine,lipoxygenase inhibitor,ALOX5,,,,ALOX5
12119,diethylcarbamazine,lipoxygenase inhibitor,PTGS1,,,,PTGS1
12120,dihydrodeoxygedunin,growth factor receptor activator,NTRK2,,,,NTRK2
12121,bucladesine,"adenosine receptor agonist, cAMP stimulant, vasodilator",PRKACA,,,,PRKACA
12122,digitoxigenin,ATPase inhibitor,ATP1A1,,,,ATP1A1
12123,dihydrexidine,dopamine receptor agonist,DRD1,,,,DRD1
12124,dihydrexidine,dopamine receptor agonist,DRD2,,,,DRD2
12125,dihydrexidine,dopamine receptor agonist,DRD3,,,,DRD3
12126,dihydrexidine,dopamine receptor agonist,DRD4,,,,DRD4
12127,dihydrexidine,dopamine receptor agonist,DRD5,,,,DRD5
12128,diphemanil,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
12129,streptozotocin,DNA alkylating drug,SLC2A2,,,,SLC2A2
12130,E-4031,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNH2,,,,KCNH2
12131,E-4031,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNH1,,,,KCNH1
12132,nomifensine,norepinephrine-dopamine reuptake inhibitor,SLC6A2,,,,SLC6A2
12133,nomifensine,norepinephrine-dopamine reuptake inhibitor,SLC6A3,,,,SLC6A3
12134,nomifensine,norepinephrine-dopamine reuptake inhibitor,DRD2,,,,DRD2
12135,nomifensine,norepinephrine-dopamine reuptake inhibitor,MAOA,,,,MAOA
12136,nomifensine,norepinephrine-dopamine reuptake inhibitor,MAOB,,,,MAOB
12137,nomifensine,norepinephrine-dopamine reuptake inhibitor,MPO,,,,MPO
12138,EMD-386088,serotonin receptor agonist,HTR6,,,,HTR6
12139,emetine,protein synthesis inhibitor,RPS2,,,,RPS2
12140,ephedrine,adrenergic receptor agonist,ACHE,,,,ACHE
12141,ephedrine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
12142,ephedrine,adrenergic receptor agonist,ADRB2,,,,ADRB2
12143,ephedrine,adrenergic receptor agonist,SLC18A2,,,,SLC18A2
12144,ephedrine,adrenergic receptor agonist,SLC6A2,,,,SLC6A2
12145,estradiol,estrogen receptor agonist,ESR1,,,,ESR1
12146,estradiol,estrogen receptor agonist,ESR2,,,,ESR2
12147,estradiol,estrogen receptor agonist,NR1I2,,,,NR1I2
12148,estradiol,estrogen receptor agonist,CYP2B6,,,,CYP2B6
12149,estradiol,estrogen receptor agonist,CYP2C19,,,,CYP2C19
12150,estradiol,estrogen receptor agonist,CYP2C8,,,,CYP2C8
12151,estradiol,estrogen receptor agonist,CYP2E1,,,,CYP2E1
12152,estradiol,estrogen receptor agonist,CYP3A5,,,,CYP3A5
12153,estradiol,estrogen receptor agonist,CYP3A7,,,,CYP3A7
12154,estradiol,estrogen receptor agonist,GPER1,,,,GPER1
12155,estradiol,estrogen receptor agonist,KCNMA1,,,,KCNMA1
12156,estradiol-cypionate,estrogen receptor agonist,ESR1,,,,ESR1
12157,estrone,"estrogen receptor agonist, estrogenic hormone",ESR1,,,,ESR1
12158,estrone,"estrogen receptor agonist, estrogenic hormone",ESR2,,,,ESR2
12159,estropipate,estrogen receptor agonist,ESR1,,,,ESR1
12160,estropipate,estrogen receptor agonist,ESR2,,,,ESR2
12161,exemestane,aromatase inhibitor,CYP19A1,,,,CYP19A1
12162,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",NPC1L1,,,,NPC1L1
12163,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",ANPEP,,,,ANPEP
12164,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",SOAT1,,,,SOAT1
12165,estropipate,estrogen receptor agonist,ESR1,,,,ESR1
12166,estropipate,estrogen receptor agonist,ESR2,,,,ESR2
12167,etazolate,"phosphodiesterase inhibitor, alpha secretase activator, GABA receptor modulator",GABRB3,,,,GABRB3
12168,etazolate,"phosphodiesterase inhibitor, alpha secretase activator, GABA receptor modulator",PDE4A,,,,PDE4A
12169,fenoterol,adrenergic receptor agonist,ADRB2,,,,ADRB2
12170,fenoterol,adrenergic receptor agonist,ADRB1,,,,ADRB1
12171,fenoterol,adrenergic receptor agonist,ADRB3,,,,ADRB3
12172,FGIN-1-43,benzodiazepine receptor ligand,TSPO,,,,TSPO
12173,fluocinolone,"corticosteroid agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
12174,fluocinolone,"corticosteroid agonist, glucocorticoid receptor agonist",SERPINA6,,,,SERPINA6
12175,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",NR3C1,,,,NR3C1
12176,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",SERPINA6,,,,SERPINA6
12177,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",SMO,,,,SMO
12178,flutamide,androgen receptor antagonist,AR,,,,AR
12179,flutamide,androgen receptor antagonist,AHR,,,,AHR
12180,flutamide,androgen receptor antagonist,CYP2C19,,,,CYP2C19
12181,gitoxigenin,ATPase inhibitor,ATP1A1,,,,ATP1A1
12182,GR-113808,serotonin receptor antagonist,HTR4,,,,HTR4
12183,GW-1929,"PPAR receptor agonist, insulin sensitizer",INS,,,,INS
12184,GW-1929,"PPAR receptor agonist, insulin sensitizer",PPARG,,,,PPARG
12185,triacsin-c,adrenergic receptor antagonist,ACSL1,,,,ACSL1
12186,gelsemine,"acetylcholine receptor antagonist, glycine receptor antagonist",GLRA3,,,,GLRA3
12187,glycocholic-acid,cholesterol inhibitor,FABP6,,,,FABP6
12188,guanabenz,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
12189,guanabenz,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
12190,guanabenz,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
12191,hydroxyfasudil,ROCK inhibitor,ROCK1,,,,ROCK1
12192,hydroxyfasudil,ROCK inhibitor,PKIA,,,,PKIA
12193,hydroxyfasudil,ROCK inhibitor,PRKACA,,,,PRKACA
12194,hydroxyfasudil,ROCK inhibitor,ROCK2,,,,ROCK2
12195,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
12196,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
12197,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
12198,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
12199,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
12200,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
12201,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
12202,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
12203,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
12204,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
12205,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
12206,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
12207,INCA-6,"calcineurin inhibitor, Inhibitor of interaction between calcineurin and its substrate nuclear factor of activated T cells (NFAT)",NFATC1,,,,NFATC1
12208,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK1,,,,CDK1
12209,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5,,,,CDK5
12210,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CCNE1,,,,CCNE1
12211,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK2,,,,CDK2
12212,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK4,,,,CDK4
12213,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5R1,,,,CDK5R1
12214,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK9,,,,CDK9
12215,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3A,,,,GSK3A
12216,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3B,,,,GSK3B
12217,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LCK,,,,LCK
12218,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK1,,,,LRRK1
12219,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK2,,,,LRRK2
12220,indometacin,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
12221,indometacin,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
12222,indometacin,cyclooxygenase inhibitor,PPARG,,,,PPARG
12223,indometacin,cyclooxygenase inhibitor,PTGDR2,,,,PTGDR2
12224,indometacin,cyclooxygenase inhibitor,GLO1,,,,GLO1
12225,indometacin,cyclooxygenase inhibitor,PLA2G2A,,,,PLA2G2A
12226,indometacin,cyclooxygenase inhibitor,PPARA,,,,PPARA
12227,indometacin,cyclooxygenase inhibitor,PTGR2,,,,PTGR2
12228,indometacin,cyclooxygenase inhibitor,SLC46A1,,,,SLC46A1
12229,imiloxan,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
12230,immethridine,histamine receptor agonist,HRH3,,,,HRH3
12231,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK1,,,,CDK1
12232,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5,,,,CDK5
12233,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CCNE1,,,,CCNE1
12234,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK2,,,,CDK2
12235,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK4,,,,CDK4
12236,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5R1,,,,CDK5R1
12237,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK9,,,,CDK9
12238,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3A,,,,GSK3A
12239,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3B,,,,GSK3B
12240,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LCK,,,,LCK
12241,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK1,,,,LRRK1
12242,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK2,,,,LRRK2
12243,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK1,,,,CDK1
12244,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5,,,,CDK5
12245,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CCNE1,,,,CCNE1
12246,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK2,,,,CDK2
12247,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK4,,,,CDK4
12248,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK5R1,,,,CDK5R1
12249,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",CDK9,,,,CDK9
12250,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3A,,,,GSK3A
12251,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",GSK3B,,,,GSK3B
12252,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LCK,,,,LCK
12253,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK1,,,,LRRK1
12254,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor",LRRK2,,,,LRRK2
12255,ipratropium,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
12256,ipratropium,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
12257,ipratropium,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
12258,ipratropium,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
12259,ipratropium,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
12260,KI-8751,"PDGFR alpha and c-Kit inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor",KDR,,,,KDR
12261,L-161982,"prostanoid receptor antagonist, angiotensin receptor antagonist",PTGER4,,,,PTGER4
12262,L-755507,"adrenergic receptor agonist, adrenergic receptor partial agonist",ADRB3,,,,ADRB3
12263,L-755507,"adrenergic receptor agonist, adrenergic receptor partial agonist",ADRB1,,,,ADRB1
12264,L-755507,"adrenergic receptor agonist, adrenergic receptor partial agonist",ADRB2,,,,ADRB2
12265,L-168049,"glucagon receptor antagonist, human glucagon receptor antagonist",GCGR,,,,GCGR
12266,L-701324,glutamate receptor antagonist,GRIN1,,,,GRIN1
12267,L-701324,glutamate receptor antagonist,GRIN2A,,,,GRIN2A
12268,L-701324,glutamate receptor antagonist,GRIN2B,,,,GRIN2B
12269,L-701324,glutamate receptor antagonist,GRIN2C,,,,GRIN2C
12270,L-701324,glutamate receptor antagonist,GRIN2D,,,,GRIN2D
12271,leu-enkephalin,opioid receptor agonist,OPRD1,,,,OPRD1
12272,leu-enkephalin,opioid receptor agonist,OPRM1,,,,OPRM1
12273,lobaric-acid,tyrosine phosphatase inhibitor,PTPN1,,,,PTPN1
12274,LY-344864,serotonin receptor agonist,HTR1F,,,,HTR1F
12275,LY-344864,serotonin receptor agonist,HTR1A,,,,HTR1A
12276,LY-344864,serotonin receptor agonist,HTR1B,,,,HTR1B
12277,LY-344864,serotonin receptor agonist,HTR1D,,,,HTR1D
12278,LY-344864,serotonin receptor agonist,HTR1E,,,,HTR1E
12279,LY-344864,serotonin receptor agonist,HTR2A,,,,HTR2A
12280,LY-344864,serotonin receptor agonist,HTR2B,,,,HTR2B
12281,LY-344864,serotonin receptor agonist,HTR2C,,,,HTR2C
12282,LY-344864,serotonin receptor agonist,HTR7,,,,HTR7
12283,LY-83583,"inhibitor of soluble guanylyl cyclase, leukotriene synthesis inhibitor",GUCY1A2,,,,GUCY1A2
12284,linopirdine,"acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker",KCNQ2,,,,KCNQ2
12285,linopirdine,"acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker",KCNQ3,,,,KCNQ3
12286,linopirdine,"acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker",KCNQ4,,,,KCNQ4
12287,linopirdine,"acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker",KCNQ5,,,,KCNQ5
12288,MDL-11939,serotonin receptor antagonist,HTR2A,,,,HTR2A
12289,MDL-11939,serotonin receptor antagonist,HTR2B,,,,HTR2B
12290,MDL-11939,serotonin receptor antagonist,HTR2C,,,,HTR2C
12291,MDL-29951,"glutamate receptor antagonist, fructose biphosphate inhibitor, UDP/CysLT (GPR17, P2Y-like) Agonists",FBP1,,,,FBP1
12292,MDL-29951,"glutamate receptor antagonist, fructose biphosphate inhibitor, UDP/CysLT (GPR17, P2Y-like) Agonists",GPR17,,,,GPR17
12293,mebeverine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
12294,mebeverine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
12295,mebeverine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
12296,mebeverine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
12297,mephentermine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
12298,mephentermine,adrenergic receptor agonist,ADRA1B,,,,ADRA1B
12299,mephentermine,adrenergic receptor agonist,ADRA1D,,,,ADRA1D
12300,mephentermine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
12301,mephentermine,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
12302,mephentermine,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
12303,mephentermine,adrenergic receptor agonist,ADRB1,,,,ADRB1
12304,mephentermine,adrenergic receptor agonist,ADRB2,,,,ADRB2
12305,mephentermine,adrenergic receptor agonist,ADRB3,,,,ADRB3
12306,mesulergine,dopamine receptor agonist,HTR2A,,,,HTR2A
12307,mesulergine,dopamine receptor agonist,HTR2C,,,,HTR2C
12308,mesulergine,dopamine receptor agonist,HTR7,,,,HTR7
12309,mesulergine,dopamine receptor agonist,HTR2B,,,,HTR2B
12310,mesulergine,dopamine receptor agonist,HTR3A,,,,HTR3A
12311,mesulergine,dopamine receptor agonist,HTR3B,,,,HTR3B
12312,mesulergine,dopamine receptor agonist,HTR6,,,,HTR6
12313,methysergide,serotonin receptor antagonist,HTR2C,,,,HTR2C
12314,methysergide,serotonin receptor antagonist,HTR1B,,,,HTR1B
12315,methysergide,serotonin receptor antagonist,HTR1E,,,,HTR1E
12316,methysergide,serotonin receptor antagonist,HTR1F,,,,HTR1F
12317,methysergide,serotonin receptor antagonist,HTR2A,,,,HTR2A
12318,methysergide,serotonin receptor antagonist,HTR2B,,,,HTR2B
12319,methysergide,serotonin receptor antagonist,HTR7,,,,HTR7
12320,methysergide,serotonin receptor antagonist,HTR1A,,,,HTR1A
12321,methysergide,serotonin receptor antagonist,HTR1D,,,,HTR1D
12322,methysergide,serotonin receptor antagonist,HTR5A,,,,HTR5A
12323,methysergide,serotonin receptor antagonist,HTR6,,,,HTR6
12324,metolazone,"carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters",SLC12A3,,,,SLC12A3
12325,metolazone,"carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters",CA2,,,,CA2
12326,metolazone,"carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters",CA7,,,,CA7
12327,midodrine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
12328,midodrine,adrenergic receptor agonist,ADRA1B,,,,ADRA1B
12329,midodrine,adrenergic receptor agonist,ADRA1D,,,,ADRA1D
12330,mitotane,antineoplastic agent,CYP11B1,,,,CYP11B1
12331,mitotane,antineoplastic agent,CYP11A1,,,,CYP11A1
12332,mitotane,antineoplastic agent,CYP3A4,,,,CYP3A4
12333,mitotane,antineoplastic agent,ESR1,,,,ESR1
12334,mitotane,antineoplastic agent,FDX1,,,,FDX1
12335,ML-9,myosin light chain kinase inhibitor,MLCK,,,,MYLK
12336,ML-9,myosin light chain kinase inhibitor,TRPC6,,,,TRPC6
12337,ML-9,myosin light chain kinase inhibitor,PKA,,,,
12338,ML-9,myosin light chain kinase inhibitor,PKC,,,,PRRT2
12339,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",SLC6A2,,,,SLC6A2
12340,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1A,,,,ADRA1A
12341,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1B,,,,ADRA1B
12342,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA1D,,,,ADRA1D
12343,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2A,,,,ADRA2A
12344,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2B,,,,ADRA2B
12345,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",ADRA2C,,,,ADRA2C
12346,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM1,,,,CHRM1
12347,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM2,,,,CHRM2
12348,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM3,,,,CHRM3
12349,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM4,,,,CHRM4
12350,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",CHRM5,,,,CHRM5
12351,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",DRD2,,,,DRD2
12352,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HRH1,,,,HRH1
12353,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR2A,,,,HTR2A
12354,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR2C,,,,HTR2C
12355,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)",HTR7,,,,HTR7
12356,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA2A,,,,ADRA2A
12357,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA2B,,,,ADRA2B
12358,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA2C,,,,ADRA2C
12359,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA1A,,,,ADRA1A
12360,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA1B,,,,ADRA1B
12361,medetomidine,"adrenergic receptor agonist, MAP kinase inhibitor",ADRA1D,,,,ADRA1D
12362,labetalol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
12363,labetalol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
12364,labetalol,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
12365,labetalol,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
12366,labetalol,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
12367,metixene,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
12368,metixene,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
12369,metixene,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
12370,metixene,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
12371,metixene,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
12372,metyrapone,"cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist",CYP11B1,,,,CYP11B1
12373,metyrapone,"cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist",HSD11B1,,,,HSD11B1
12374,metyrapone,"cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist",NR3C2,,,,NR3C2
12375,BRD-K51557114,GlyT-2 inhibitor,GPR18,,,,GPR18
12376,BRD-K51557114,GlyT-2 inhibitor,LPAR5,,,,LPAR5
12377,BRD-K51557114,GlyT-2 inhibitor,SLC6A5,,,,SLC6A5
12378,BRD-K98297262,"1,3-beta-glucan synthase inhibitor",CLC,,,,CLC
12379,tolcapone,"catechol O methyltransferase inhibitor, transthyretin amyloid inhibitor",COMT,,,,COMT
12380,tolcapone,"catechol O methyltransferase inhibitor, transthyretin amyloid inhibitor",TTR,,,,TTR
12381,nevirapine,"non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP2B6,,,,CYP2B6
12382,nevirapine,"non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP2C19,,,,CYP2C19
12383,nevirapine,"non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",CYP3A4,,,,CYP3A4
12384,naproxol,antiinflammatory agent,PTGS1,,,,PTGS1
12385,naproxol,antiinflammatory agent,PTGS2,,,,PTGS2
12386,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIA1,,,,GRIA1
12387,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIA2,,,,GRIA2
12388,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIA3,,,,GRIA3
12389,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIA4,,,,GRIA4
12390,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIK1,,,,GRIK1
12391,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIN1,,,,GRIN1
12392,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIN2A,,,,GRIN2A
12393,NBQX,"glutamate receptor antagonist, kainate receptor antagonist",GRIN2B,,,,GRIN2B
12394,norethindrone,"ovulation inhibitor, progesterone receptor agonist",PGR,,,,PGR
12395,norgestimate,progesterone receptor agonist,PGR,,,,PGR
12396,norgestimate,progesterone receptor agonist,ESR1,,,,ESR1
12397,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRD1,,,,OPRD1
12398,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRK1,,,,OPRK1
12399,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRM1,,,,OPRM1
12400,naloxone,opioid receptor antagonist,OPRM1,,,,OPRM1
12401,naloxone,opioid receptor antagonist,OPRK1,,,,OPRK1
12402,naloxone,opioid receptor antagonist,OPRD1,,,,OPRD1
12403,naloxone,opioid receptor antagonist,CREB1,,,,CREB1
12404,naloxone,opioid receptor antagonist,ESR1,,,,ESR1
12405,naloxone,opioid receptor antagonist,TLR4,,,,TLR4
12406,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRK1,,,,OPRK1
12407,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRM1,,,,OPRM1
12408,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRD1,,,,OPRD1
12409,naltrexone,"opioid receptor antagonist, opioid receptor ligand",SIGMAR1,,,,SIGMAR1
12410,naringenin,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist",CYP19A1,,,,CYP19A1
12411,naringenin,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist",ESR2,,,,ESR2
12412,naringenin,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist",CYP1B1,,,,CYP1B1
12413,naringenin,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist",GLO1,,,,GLO1
12414,naringenin,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist",HSD17B1,,,,HSD17B1
12415,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A1,,,,ATP1A1
12416,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A2,,,,ATP1A2
12417,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A3,,,,ATP1A3
12418,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A4,,,,ATP1A4
12419,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B1,,,,ATP1B1
12420,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B2,,,,ATP1B2
12421,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B3,,,,ATP1B3
12422,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B4,,,,ATP1B4
12423,ouabain,"ATPase inhibitor, alpha subunit binder",FXYD2,,,,FXYD2
12424,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A1,,,,ATP1A1
12425,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A2,,,,ATP1A2
12426,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A3,,,,ATP1A3
12427,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1A4,,,,ATP1A4
12428,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B1,,,,ATP1B1
12429,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B2,,,,ATP1B2
12430,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B3,,,,ATP1B3
12431,ouabain,"ATPase inhibitor, alpha subunit binder",ATP1B4,,,,ATP1B4
12432,ouabain,"ATPase inhibitor, alpha subunit binder",FXYD2,,,,FXYD2
12433,pentobarbital,GABA receptor modulator,GABRA1,,,,GABRA1
12434,pentobarbital,GABA receptor modulator,CHRNA4,,,,CHRNA4
12435,pentobarbital,GABA receptor modulator,CHRNA7,,,,CHRNA7
12436,pentobarbital,GABA receptor modulator,GABRA2,,,,GABRA2
12437,pentobarbital,GABA receptor modulator,GABRA3,,,,GABRA3
12438,pentobarbital,GABA receptor modulator,GABRA4,,,,GABRA4
12439,pentobarbital,GABA receptor modulator,GABRA5,,,,GABRA5
12440,pentobarbital,GABA receptor modulator,GABRA6,,,,GABRA6
12441,pentobarbital,GABA receptor modulator,GABRB1,,,,GABRB1
12442,pentobarbital,GABA receptor modulator,GABRB2,,,,GABRB2
12443,pentobarbital,GABA receptor modulator,GABRB3,,,,GABRB3
12444,pentobarbital,GABA receptor modulator,GABRD,,,,GABRD
12445,pentobarbital,GABA receptor modulator,GABRE,,,,GABRE
12446,pentobarbital,GABA receptor modulator,GABRG1,,,,GABRG1
12447,pentobarbital,GABA receptor modulator,GABRG2,,,,GABRG2
12448,pentobarbital,GABA receptor modulator,GABRG3,,,,GABRG3
12449,pentobarbital,GABA receptor modulator,GABRP,,,,GABRP
12450,pentobarbital,GABA receptor modulator,GABRQ,,,,GABRQ
12451,pentobarbital,GABA receptor modulator,GRIA2,,,,GRIA2
12452,pentobarbital,GABA receptor modulator,GRIK2,,,,GRIK2
12453,pentobarbital,GABA receptor modulator,GRIN1,,,,GRIN1
12454,pentobarbital,GABA receptor modulator,GRIN2A,,,,GRIN2A
12455,pentobarbital,GABA receptor modulator,GRIN2B,,,,GRIN2B
12456,pentobarbital,GABA receptor modulator,GRIN2C,,,,GRIN2C
12457,pentobarbital,GABA receptor modulator,GRIN2D,,,,GRIN2D
12458,pentobarbital,GABA receptor modulator,GRIN3A,,,,GRIN3A
12459,pentobarbital,GABA receptor modulator,GRIN3B,,,,GRIN3B
12460,perindopril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
12461,PHCCC,"glutamate receptor agonist, glutamate receptor modulator",GRM1,,,,GRM1
12462,PHCCC,"glutamate receptor agonist, glutamate receptor modulator",GRM4,,,,GRM4
12463,tienilic-acid,"sodium/potassium/chloride transporter inhibitor, uric acid diuretic",CYP2C9,,,,CYP2C9
12464,tienilic-acid,"sodium/potassium/chloride transporter inhibitor, uric acid diuretic",SLC12A1,,,,SLC12A1
12465,tienilic-acid,"sodium/potassium/chloride transporter inhibitor, uric acid diuretic",SLC22A12,,,,SLC22A12
12466,physostigmine,"acetylcholinesterase inhibitor, cholinesterase inhibitor",ACHE,,,,ACHE
12467,physostigmine,"acetylcholinesterase inhibitor, cholinesterase inhibitor",BCHE,,,,BCHE
12468,piceid,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor",GAA,,,,GAA
12469,piceid,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
12470,piperidolate,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
12471,piroxicam,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
12472,piroxicam,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
12473,PRE-084,"alpha receptor agonist, sigma receptor agonist",SIGMAR1,,,,SIGMAR1
12474,prednisolone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
12475,prednisolone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
12476,prednisolone,glucocorticoid receptor agonist,SERPINA6,,,,SERPINA6
12477,prednisolone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
12478,prednisolone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
12479,prednisolone,glucocorticoid receptor agonist,SERPINA6,,,,SERPINA6
12480,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",CYP17A1,,,,CYP17A1
12481,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",PGR,,,,PGR
12482,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",SULT2B1,,,,SULT2B1
12483,primaquine,"antimalarial agent, DNA inhibitor",KRT7,,,,KRT7
12484,primaquine,"antimalarial agent, DNA inhibitor",NQO2,,,,NQO2
12485,progesterone,progesterone receptor agonist,PGR,,,,PGR
12486,progesterone,progesterone receptor agonist,CYP17A1,,,,CYP17A1
12487,progesterone,progesterone receptor agonist,NR3C2,,,,NR3C2
12488,progesterone,progesterone receptor agonist,CATSPER1,,,,CATSPER1
12489,progesterone,progesterone receptor agonist,CATSPER2,,,,CATSPER2
12490,progesterone,progesterone receptor agonist,CATSPER3,,,,CATSPER3
12491,progesterone,progesterone receptor agonist,CATSPER4,,,,CATSPER4
12492,progesterone,progesterone receptor agonist,CYP2C19,,,,CYP2C19
12493,progesterone,progesterone receptor agonist,ESR1,,,,ESR1
12494,progesterone,progesterone receptor agonist,OPRK1,,,,OPRK1
12495,progesterone,progesterone receptor agonist,TRPC5,,,,TRPC5
12496,PSB-06126,NTPDase inhibitor,ENTPD3,,,,ENTPD3
12497,PSB-069,NTPDase inhibitor,ENTPD1,,,,ENTPD1
12498,PSB-069,NTPDase inhibitor,ENTPD2,,,,ENTPD2
12499,PSB-069,NTPDase inhibitor,ENTPD3,,,,ENTPD3
12500,practolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
12501,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CDK1,,,,CDK1
12502,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CDK2,,,,CDK2
12503,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CDK4,,,,CDK4
12504,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CDK5,,,,CDK5
12505,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CCND1,,,,CCND1
12506,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CCNE1,,,,CCNE1
12507,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CSNK1G3,,,,CSNK1G3
12508,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",RPS6KA1,,,,RPS6KA1
12509,purvalanol-a,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",SRC,,,,SRC
12510,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA,,,,DGKA
12511,rhamnetin,"aldose reductase inhibitor, JNK inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, p38 MAPK inhibitor",ALOX5,,,,ALOX5
12512,rhamnetin,"aldose reductase inhibitor, JNK inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, p38 MAPK inhibitor",MAPK8,,,,MAPK8
12513,ritanserin,serotonin receptor antagonist,HTR2A,,,,HTR2A
12514,ritanserin,serotonin receptor antagonist,HTR2C,,,,HTR2C
12515,ritanserin,serotonin receptor antagonist,HTR2B,,,,HTR2B
12516,ritanserin,serotonin receptor antagonist,ADRA1A,,,,ADRA1A
12517,ritanserin,serotonin receptor antagonist,ADRA1B,,,,ADRA1B
12518,ritanserin,serotonin receptor antagonist,ADRA1D,,,,ADRA1D
12519,ritanserin,serotonin receptor antagonist,HTR1A,,,,HTR1A
12520,ritanserin,serotonin receptor antagonist,HTR1B,,,,HTR1B
12521,ritanserin,serotonin receptor antagonist,HTR1D,,,,HTR1D
12522,ritanserin,serotonin receptor antagonist,HTR5A,,,,HTR5A
12523,ritanserin,serotonin receptor antagonist,HTR6,,,,HTR6
12524,ritanserin,serotonin receptor antagonist,HTR7,,,,HTR7
12525,RK-682,"heparanase inhibitor, tyrosine phosphatase inhibitor",HPSE,,,,HPSE
12526,RK-682,"heparanase inhibitor, tyrosine phosphatase inhibitor",PTPN1,,,,PTPN1
12527,Ro-04-6790,"serotonin receptor antagonist, serotonin receptor inhibitor",HTR6,,,,HTR6
12528,rolipram,"phosphodiesterase inhibitor, interleukin receptor antagonist",PDE4A,,,,PDE4A
12529,rolipram,"phosphodiesterase inhibitor, interleukin receptor antagonist",PDE4B,,,,PDE4B
12530,rolipram,"phosphodiesterase inhibitor, interleukin receptor antagonist",PDE4D,,,,PDE4D
12531,rolipram,"phosphodiesterase inhibitor, interleukin receptor antagonist",PDE4C,,,,PDE4C
12532,rolipram,"phosphodiesterase inhibitor, interleukin receptor antagonist",PDE5A,,,,PDE5A
12533,RU-28318,cytochrome P450 antagonist,NR3C2,,,,NR3C2
12534,RS-102895,"CC chemokine receptor antagonist, CCR antagonist",CCR2,,,,CCR2
12535,RX-821002,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
12536,RX-821002,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
12537,RX-821002,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
12538,RX-821002,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
12539,RX-821002,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
12540,RX-821002,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
12541,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",ABCC8,,,,ABCC8
12542,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",CYP2C8,,,,CYP2C8
12543,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",CYP3A5,,,,CYP3A5
12544,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",INS,,,,INS
12545,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",KCNJ11,,,,KCNJ11
12546,repaglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide",PPARG,,,,PPARG
12547,ritodrine,adrenergic receptor agonist,ADRB2,,,,ADRB2
12548,SB-218078,"CHK inhibitor, PKC inhibitor",CHEK1,,,,CHEK1
12549,SB-258585,serotonin receptor antagonist,HTR6,,,,HTR6
12550,SC-19220,prostanoid receptor antagonist,PTGER1,,,,PTGER1
12551,SD-169,p38 MAPK inhibitor,MAPK14,,,,MAPK14
12552,SIB-1893,glutamate receptor antagonist,GRM5,,,,GRM5
12553,SIB-1893,glutamate receptor antagonist,GRM4,,,,GRM4
12554,sildenafil,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
12555,sildenafil,phosphodiesterase inhibitor,PDE6G,,,,PDE6G
12556,sildenafil,phosphodiesterase inhibitor,PDE6H,,,,PDE6H
12557,sildenafil,phosphodiesterase inhibitor,SLCO1B1,,,,SLCO1B1
12558,sildenafil,phosphodiesterase inhibitor,SLCO1B3,,,,SLCO1B3
12559,mifobate,"cholesterol inhibitor, PPAR receptor antagonist, renin inhibitor",PPARG,,,,PPARG
12560,mifobate,"cholesterol inhibitor, PPAR receptor antagonist, renin inhibitor",REN,,,,REN
12561,salubrinal,"eukaryotic translation initiation factor inhibitor, GlyT-1 inhibitor",EIF2S1,,,,EIF2S1
12562,salubrinal,"eukaryotic translation initiation factor inhibitor, GlyT-1 inhibitor",SLC6A9,,,,SLC6A9
12563,simvastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
12564,simvastatin,HMGCR inhibitor,CYP2C8,,,,CYP2C8
12565,simvastatin,HMGCR inhibitor,CYP3A4,,,,CYP3A4
12566,simvastatin,HMGCR inhibitor,CYP3A5,,,,CYP3A5
12567,simvastatin,HMGCR inhibitor,ITGB2,,,,ITGB2
12568,spiroxatrine,serotonin receptor antagonist,HTR1A,,,,HTR1A
12569,spiroxatrine,serotonin receptor antagonist,ADRA1A,,,,ADRA1A
12570,spiroxatrine,serotonin receptor antagonist,ADRA1B,,,,ADRA1B
12571,spiroxatrine,serotonin receptor antagonist,ADRA1D,,,,ADRA1D
12572,spiroxatrine,serotonin receptor antagonist,ADRA2A,,,,ADRA2A
12573,spiroxatrine,serotonin receptor antagonist,ADRA2B,,,,ADRA2B
12574,spiroxatrine,serotonin receptor antagonist,ADRA2C,,,,ADRA2C
12575,spiroxatrine,serotonin receptor antagonist,HTR2B,,,,HTR2B
12576,splitomycin,SIRT inhibitor,SIRT1,,,,SIRT1
12577,splitomycin,SIRT inhibitor,SIRT2,,,,SIRT2
12578,tenoxicam,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
12579,tenoxicam,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
12580,thapsigargin,"ATPase inhibitor, calcium channel blocker, PKC activator",ATP2A1,,,,ATP2A1
12581,tolmetin,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
12582,tolmetin,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
12583,tranylcypromine,"cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor",MAOA,,,,MAOA
12584,tranylcypromine,"cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor",MAOB,,,,MAOB
12585,tranylcypromine,"cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor",KDM1A,,,,KDM1A
12586,tranylcypromine,"cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor",CYP2A6,,,,CYP2A6
12587,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",HTR2A,,,,HTR2A
12588,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",HTR2C,,,,HTR2C
12589,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
12590,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",ADRA1A,,,,ADRA1A
12591,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",ADRA2A,,,,ADRA2A
12592,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",HRH1,,,,HRH1
12593,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",HTR1A,,,,HTR1A
12594,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor",HTR2B,,,,HTR2B
12595,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",NR3C1,,,,NR3C1
12596,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A5,,,,CYP3A5
12597,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A7,,,,CYP3A7
12598,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",SERPINA6,,,,SERPINA6
12599,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",NR3C1,,,,NR3C1
12600,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A5,,,,CYP3A5
12601,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A7,,,,CYP3A7
12602,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",SERPINA6,,,,SERPINA6
12603,thiethylperazine,dopamine receptor antagonist,DRD1,,,,DRD1
12604,thiethylperazine,dopamine receptor antagonist,DRD2,,,,DRD2
12605,thiethylperazine,dopamine receptor antagonist,DRD4,,,,DRD4
12606,tianeptine,"selective serotonin reuptake enhancer (SSRE), serotonin reuptake enhancer, serotonin uptake enhancer",SLC6A4,,,,SLC6A4
12607,torasemide,"cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist",SLC12A1,,,,SLC12A1
12608,torasemide,"cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist",CYP2C8,,,,CYP2C8
12609,torasemide,"cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist",SLC12A2,,,,SLC12A2
12610,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PDE4A,,,,PDE4A
12611,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PDE4B,,,,PDE4B
12612,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PDE4C,,,,PDE4C
12613,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PDE4D,,,,PDE4D
12614,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PDE5A,,,,PDE5A
12615,trequinsin,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker",PTGIR,,,,PTGIR
12616,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR3A,,,,HTR3A
12617,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA1,,,,GLRA1
12618,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA2,,,,GLRA2
12619,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRB,,,,GLRB
12620,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR4,,,,HTR4
12621,MAZ-51,VEGFR inhibitor,FLT4,,,,FLT4
12622,WAY-161503,serotonin receptor agonist,HTR2C,,,,HTR2C
12623,WAY-629,serotonin receptor agonist,HTR2C,,,,HTR2C
12624,bromfenac,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
12625,bromfenac,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
12626,XE-991,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker",KCNQ1,,,,KCNQ1
12627,XE-991,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker",KCNQ2,,,,KCNQ2
12628,XE-991,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker",KCNQ3,,,,KCNQ3
12629,XE-991,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker",KCNQ4,,,,KCNQ4
12630,XE-991,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker",KCNQ5,,,,KCNQ5
12631,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",ROCK1,,,,ROCK1
12632,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",ROCK2,,,,ROCK2
12633,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
12634,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PKIA,,,,PKIA
12635,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PKN2,,,,PKN2
12636,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PRKACA,,,,PRKACA
12637,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PRKCE,,,,PRKCE
12638,abiraterone,"17,20 lyase inhibitor, androgen biosynthesis inhibitor, cytochrome P450 inhibitor, steroid sulfatase inhibitor",CYP17A1,,,,CYP17A1
12639,abiraterone,"17,20 lyase inhibitor, androgen biosynthesis inhibitor, cytochrome P450 inhibitor, steroid sulfatase inhibitor",CYP11B1,,,,CYP11B1
12640,yohimbine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
12641,yohimbine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
12642,yohimbine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
12643,yohimbine,adrenergic receptor antagonist,HTR1A,,,,HTR1A
12644,yohimbine,adrenergic receptor antagonist,HTR1B,,,,HTR1B
12645,yohimbine,adrenergic receptor antagonist,HTR1D,,,,HTR1D
12646,yohimbine,adrenergic receptor antagonist,HTR2B,,,,HTR2B
12647,yohimbine,adrenergic receptor antagonist,DRD2,,,,DRD2
12648,yohimbine,adrenergic receptor antagonist,DRD3,,,,DRD3
12649,yohimbine,adrenergic receptor antagonist,HTR1E,,,,HTR1E
12650,yohimbine,adrenergic receptor antagonist,HTR1F,,,,HTR1F
12651,yohimbine,adrenergic receptor antagonist,HTR2A,,,,HTR2A
12652,yohimbine,adrenergic receptor antagonist,HTR2C,,,,HTR2C
12653,yohimbine,adrenergic receptor antagonist,HTR5A,,,,HTR5A
12654,yohimbine,adrenergic receptor antagonist,HTR7,,,,HTR7
12655,yohimbine,adrenergic receptor antagonist,KCNJ1,,,,KCNJ1
12656,yohimbine,adrenergic receptor antagonist,KCNJ10,,,,KCNJ10
12657,yohimbine,adrenergic receptor antagonist,KCNJ11,,,,KCNJ11
12658,yohimbine,adrenergic receptor antagonist,KCNJ12,,,,KCNJ12
12659,yohimbine,adrenergic receptor antagonist,KCNJ14,,,,KCNJ14
12660,yohimbine,adrenergic receptor antagonist,KCNJ15,,,,KCNJ15
12661,yohimbine,adrenergic receptor antagonist,KCNJ8,,,,KCNJ8
12662,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA1,,,,CA1
12663,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA12,,,,CA12
12664,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA7,,,,CA7
12665,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN1A,,,,SCN1A
12666,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA10,,,,CA10
12667,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA11,,,,CA11
12668,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA13,,,,CA13
12669,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA14,,,,CA14
12670,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA2,,,,CA2
12671,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA3,,,,CA3
12672,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA4,,,,CA4
12673,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA5A,,,,CA5A
12674,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA5B,,,,CA5B
12675,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA6,,,,CA6
12676,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA8,,,,CA8
12677,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CA9,,,,CA9
12678,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CACNA1G,,,,CACNA1G
12679,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CACNA1H,,,,CACNA1H
12680,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",CACNA1I,,,,CACNA1I
12681,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",MAOA,,,,MAOA
12682,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",MAOB,,,,MAOB
12683,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN11A,,,,SCN11A
12684,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN1B,,,,SCN1B
12685,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN2A,,,,SCN2A
12686,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN2B,,,,SCN2B
12687,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN3A,,,,SCN3A
12688,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN3B,,,,SCN3B
12689,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN4A,,,,SCN4A
12690,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN4B,,,,SCN4B
12691,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN5A,,,,SCN5A
12692,zonisamide,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker",SCN9A,,,,SCN9A
12693,epibatidine,acetylcholine receptor agonist,CHRFAM7A,,,,CHRFAM7A
12694,epibatidine,acetylcholine receptor agonist,CHRNA2,,,,CHRNA2
12695,epibatidine,acetylcholine receptor agonist,CHRNA3,,,,CHRNA3
12696,epibatidine,acetylcholine receptor agonist,CHRNA4,,,,CHRNA4
12697,epibatidine,acetylcholine receptor agonist,CHRNA7,,,,CHRNA7
12698,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY2,,,,ADCY2
12699,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY5,,,,ADCY5
12700,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",GNAS,,,,GNAS
12701,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",ESR1,,,,ESR1
12702,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",EPHX2,,,,EPHX2
12703,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",ESR2,,,,ESR2
12704,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",GPER1,,,,GPER1
12705,quinpirole,dopamine receptor agonist,DRD2,,,,DRD2
12706,quinpirole,dopamine receptor agonist,DRD3,,,,DRD3
12707,quinpirole,dopamine receptor agonist,DRD4,,,,DRD4
12708,quinpirole,dopamine receptor agonist,DRD1,,,,DRD1
12709,quinpirole,dopamine receptor agonist,HTR1A,,,,HTR1A
12710,quinpirole,dopamine receptor agonist,HTR2A,,,,HTR2A
12711,quinpirole,dopamine receptor agonist,HTR2B,,,,HTR2B
12712,quinpirole,dopamine receptor agonist,HTR2C,,,,HTR2C
12713,maackiain,"interleukin synthesis inhibitor, sodium/glucose cotransporter inhibitor",SLC5A2,,,,SLC5A2
12714,cephaeline,protein synthesis inhibitor,RPS2,,,,RPS2
12715,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",BDKRB2,,,,BDKRB2
12716,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",SIGMAR1,,,,SIGMAR1
12717,tyrphostin,"epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor",ERBB2,,,,ERBB2
12718,AG-370,"PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor",PDGFRB,,,,PDGFRB
12719,alverine,smooth muscle relaxant,HTR1A,,,,HTR1A
12720,AM-630,"cannabinoid receptor antagonist, cannabinoid receptor inverse agonist",CNR2,,,,CNR2
12721,AM-630,"cannabinoid receptor antagonist, cannabinoid receptor inverse agonist",CNR1,,,,CNR1
12722,AM-92016,"glutamate receptor antagonist, ionotropic glutamate receptor antagonist, time-dependent delayed rectifier potassium current blocker",GRIN1,,,,GRIN1
12723,AM-92016,"glutamate receptor antagonist, ionotropic glutamate receptor antagonist, time-dependent delayed rectifier potassium current blocker",GRIN2B,,,,GRIN2B
12724,AMN-082,glutamate receptor positive allosteric modulator,GRM7,,,,GRM7
12725,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2,,,,NOS2
12726,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CNR1,,,,CNR1
12727,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CNR2,,,,CNR2
12728,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",TRPV1,,,,TRPV1
12729,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1G,,,,CACNA1G
12730,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1H,,,,CACNA1H
12731,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",CACNA1I,,,,CACNA1I
12732,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GLRA1,,,,GLRA1
12733,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR119,,,,GPR119
12734,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR18,,,,GPR18
12735,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",GPR55,,,,GPR55
12736,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNA2,,,,KCNA2
12737,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCND3,,,,KCND3
12738,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNK3,,,,KCNK3
12739,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",KCNK9,,,,KCNK9
12740,anandamide,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist",TRPM8,,,,TRPM8
12741,triciribine,AKT inhibitor,AKT1,,,,AKT1
12742,triciribine,AKT inhibitor,AKT2,,,,AKT2
12743,triciribine,AKT inhibitor,AKT3,,,,AKT3
12744,arachidonamide,cannabinoid receptor agonist,CNR1,,,,CNR1
12745,arachidonamide,cannabinoid receptor agonist,CNR2,,,,CNR2
12746,auraptene,"lipoxygenase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, nitric oxide synthase expression inhibitor",MAOB,,,,MAOB
12747,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",ADA,,,,ADA
12748,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",DCK,,,,DCK
12749,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
12750,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
12751,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
12752,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK2,,,,CDK2
12753,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK5,,,,CDK5
12754,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK1,,,,CDK1
12755,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK5R1,,,,CDK5R1
12756,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CFTR,,,,CFTR
12757,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",PTK2B,,,,PTK2B
12758,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",ZAP70,,,,ZAP70
12759,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK2,,,,CDK2
12760,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK5,,,,CDK5
12761,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK1,,,,CDK1
12762,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CDK5R1,,,,CDK5R1
12763,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",CFTR,,,,CFTR
12764,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",PTK2B,,,,PTK2B
12765,aloisine,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor",ZAP70,,,,ZAP70
12766,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",SCNN1A,,,,SCNN1A
12767,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",ASIC1,,,,ASIC1
12768,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",ASIC2,,,,ASIC2
12769,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",SCNN1B,,,,SCNN1B
12770,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",SCNN1G,,,,SCNN1G
12771,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",AOC1,,,,AOC1
12772,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",ASIC3,,,,ASIC3
12773,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",PKD2,,,,PKD2
12774,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",PKD2L1,,,,PKD2L1
12775,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",PLAU,,,,PLAU
12776,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",SCNN1D,,,,SCNN1D
12777,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",SLC9A1,,,,SLC9A1
12778,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",TRPC7,,,,TRPC7
12779,amiloride,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor",TRPV2,,,,TRPV2
12780,aminogenistein,"PKC inhibitor, src inhibitor",LCK,,,,LCK
12781,amthamine,histamine receptor agonist,HRH2,,,,HRH2
12782,angiogenesis-inhibitor,angiogenesis inhibitor,EGFR,,,,EGFR
12783,aniracetam,glutamate receptor agonist,DRD2,,,,DRD2
12784,aniracetam,glutamate receptor agonist,GRIA1,,,,GRIA1
12785,aniracetam,glutamate receptor agonist,GRIA2,,,,GRIA2
12786,aniracetam,glutamate receptor agonist,GRIA3,,,,GRIA3
12787,aniracetam,glutamate receptor agonist,HTR2A,,,,HTR2A
12788,aniracetam,glutamate receptor agonist,GRIA4,,,,GRIA4
12789,anisomycin,DNA synthesis inhibitor,NHP2L1,,,,SNU13
12790,anisomycin,DNA synthesis inhibitor,RPL10L,,,,RPL10L
12791,anisomycin,DNA synthesis inhibitor,RPL11,,,,RPL11
12792,anisomycin,DNA synthesis inhibitor,RPL13A,,,,RPL13A
12793,anisomycin,DNA synthesis inhibitor,RPL15,,,,RPL15
12794,anisomycin,DNA synthesis inhibitor,RPL19,,,,RPL19
12795,anisomycin,DNA synthesis inhibitor,RPL23,,,,RPL23
12796,anisomycin,DNA synthesis inhibitor,RPL23A,,,,RPL23A
12797,anisomycin,DNA synthesis inhibitor,RPL26L1,,,,RPL26L1
12798,anisomycin,DNA synthesis inhibitor,RPL3,,,,RPL3
12799,anisomycin,DNA synthesis inhibitor,RPL37,,,,RPL37
12800,anisomycin,DNA synthesis inhibitor,RPL8,,,,RPL8
12801,anisomycin,DNA synthesis inhibitor,RSL24D1,,,,RSL24D1
12802,arctigenin,"adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor",ADIPOR1,,,,ADIPOR1
12803,arctigenin,"adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor",AHR,,,,AHR
12804,arctigenin,"adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor",CHUK,,,,CHUK
12805,arctigenin,"adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor",MAP2K1,,,,MAP2K1
12806,arvanil,"TRPV agonist, cannabinoid receptor agonist",CNR1,,,,CNR1
12807,arvanil,"TRPV agonist, cannabinoid receptor agonist",TRPV1,,,,TRPV1
12808,talipexole,"adrenergic receptor agonist, dopamine receptor agonist, dopamine autoreceptor agonist, serotonin receptor antagonist",DRD2,,,,DRD2
12809,talipexole,"adrenergic receptor agonist, dopamine receptor agonist, dopamine autoreceptor agonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
12810,BAY-36-7620,glutamate receptor antagonist,GRM1,,,,GRM1
12811,BAY-59-3074,cannabinoid receptor partial agonist,CNR1,,,,CNR1
12812,BAY-59-3074,cannabinoid receptor partial agonist,CNR2,,,,CNR2
12813,BD-1047,"alpha receptor antagonist, sigma receptor antagonist",SIGMAR1,,,,SIGMAR1
12814,BD-1063,sigma receptor antagonist,SIGMAR1,,,,SIGMAR1
12815,benzamil,epithelial sodium channel blocker,PKD2L1,,,,PKD2L1
12816,benzamil,epithelial sodium channel blocker,SCNN1A,,,,SCNN1A
12817,benzamil,epithelial sodium channel blocker,SCNN1B,,,,SCNN1B
12818,benzamil,epithelial sodium channel blocker,SCNN1G,,,,SCNN1G
12819,benzamil,epithelial sodium channel blocker,ASIC1,,,,ASIC1
12820,benzamil,epithelial sodium channel blocker,SCNN1D,,,,SCNN1D
12821,benzamil,epithelial sodium channel blocker,SLC8A1,,,,SLC8A1
12822,betahistine,"histamine receptor agonist, histamine receptor antagonist",HRH3,,,,HRH3
12823,betahistine,"histamine receptor agonist, histamine receptor antagonist",HRH1,,,,HRH1
12824,bezafibrate,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor",PPARA,,,,PPARA
12825,bezafibrate,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor",PPARD,,,,PPARD
12826,bezafibrate,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor",PPARG,,,,PPARG
12827,bezafibrate,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor",HSD11B1,,,,HSD11B1
12828,bezafibrate,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor",LPL,,,,LPL
12829,BMY-14802,"sigma receptor antagonist, glutamate receptor antagonist, serotonin receptor agonist",HTR1A,,,,HTR1A
12830,BMY-14802,"sigma receptor antagonist, glutamate receptor antagonist, serotonin receptor agonist",SIGMAR1,,,,SIGMAR1
12831,BMY-7378,"serotonin receptor antagonist, adrenergic receptor antagonist",HTR1A,,,,HTR1A
12832,BMY-7378,"serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1D,,,,ADRA1D
12833,BMY-7378,"serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1A,,,,ADRA1A
12834,BMY-7378,"serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1B,,,,ADRA1B
12835,BP-554,serotonin receptor agonist,HTR1A,,,,HTR1A
12836,BRL-15572,serotonin receptor antagonist,HTR1D,,,,HTR1D
12837,BRL-15572,serotonin receptor antagonist,HTR1A,,,,HTR1A
12838,BRL-15572,serotonin receptor antagonist,HTR1B,,,,HTR1B
12839,BRL-15572,serotonin receptor antagonist,HTR1E,,,,HTR1E
12840,BRL-15572,serotonin receptor antagonist,HTR1F,,,,HTR1F
12841,BRL-15572,serotonin receptor antagonist,HTR2A,,,,HTR2A
12842,BRL-15572,serotonin receptor antagonist,HTR2B,,,,HTR2B
12843,BRL-15572,serotonin receptor antagonist,HTR2C,,,,HTR2C
12844,BRL-15572,serotonin receptor antagonist,HTR6,,,,HTR6
12845,BRL-37344,adrenergic receptor agonist,ADRB3,,,,ADRB3
12846,BRL-37344,adrenergic receptor agonist,ADRB1,,,,ADRB1
12847,BRL-37344,adrenergic receptor agonist,ADRB2,,,,ADRB2
12848,BRL-50481,phosphodiesterase inhibitor,PDE7A,,,,PDE7A
12849,BRL-50481,phosphodiesterase inhibitor,PDE7B,,,,PDE7B
12850,BRL-54443,serotonin receptor agonist,HTR1E,,,,HTR1E
12851,BRL-54443,serotonin receptor agonist,HTR1F,,,,HTR1F
12852,bucladesine,"adenosine receptor agonist, cAMP stimulant, vasodilator",PRKACA,,,,PRKACA
12853,BW-B70C,lipoxygenase inhibitor,ALOX5,,,,ALOX5
12854,BCL2-inhibitor,BCL inhibitor,BCL2,,,,BCL2
12855,ubenimex,"leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor",LTA4H,,,,LTA4H
12856,ubenimex,"leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor",ANPEP,,,,ANPEP
12857,ubenimex,"leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor",RNPEP,,,,RNPEP
12858,betamethasone,"corticosteroid agonist, glucocorticoid receptor agonist",NR3C1,,,,NR3C1
12859,bifemelane,"acetylcholine release stimulant, adrenergic transmitter uptake inhibitor, reducing agent",SLC6A2,,,,SLC6A2
12860,biperiden,anticholinergic,CHRM1,,,,CHRM1
12861,biperiden,anticholinergic,CHRM2,,,,CHRM2
12862,biperiden,anticholinergic,CHRM3,,,,CHRM3
12863,biperiden,anticholinergic,CHRM4,,,,CHRM4
12864,biperiden,anticholinergic,CHRM5,,,,CHRM5
12865,biperiden,anticholinergic,CHRNA2,,,,CHRNA2
12866,boldine,"acetylcholine receptor inhibitor, dopamine receptor antagonist",CHRNA4,,,,CHRNA4
12867,boldine,"acetylcholine receptor inhibitor, dopamine receptor antagonist",CHRNB2,,,,CHRNB2
12868,boldine,"acetylcholine receptor inhibitor, dopamine receptor antagonist",DRD1,,,,DRD1
12869,boldine,"acetylcholine receptor inhibitor, dopamine receptor antagonist",DRD2,,,,DRD2
12870,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD2,,,,DRD2
12871,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2A,,,,ADRA2A
12872,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2B,,,,ADRA2B
12873,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA2C,,,,ADRA2C
12874,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD1,,,,DRD1
12875,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD3,,,,DRD3
12876,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD4,,,,DRD4
12877,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",DRD5,,,,DRD5
12878,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1A,,,,HTR1A
12879,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1B,,,,HTR1B
12880,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR1D,,,,HTR1D
12881,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2A,,,,HTR2A
12882,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2B,,,,HTR2B
12883,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR2C,,,,HTR2C
12884,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1A,,,,ADRA1A
12885,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1B,,,,ADRA1B
12886,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",ADRA1D,,,,ADRA1D
12887,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR6,,,,HTR6
12888,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",HTR7,,,,HTR7
12889,bromocriptine,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor",PRL,,,,PRL
12890,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PPARD,,,,PPARD
12891,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGDR,,,,PTGDR
12892,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGER1,,,,PTGER1
12893,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGER2,,,,PTGER2
12894,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGER3,,,,PTGER3
12895,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGER4,,,,PTGER4
12896,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGFR,,,,PTGFR
12897,carbacyclin,"IP receptor activator, PPARbeta receptor activator",PTGIR,,,,PTGIR
12898,carbacyclin,"IP receptor activator, PPARbeta receptor activator",TBXA2R,,,,TBXA2R
12899,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,,,,HSD11B1
12900,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1,,,,GJA1
12901,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA10,,,,GJA10
12902,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA3,,,,GJA3
12903,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA4,,,,GJA4
12904,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA5,,,,GJA5
12905,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA8,,,,GJA8
12906,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA9,,,,GJA9
12907,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB1,,,,GJB1
12908,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB2,,,,GJB2
12909,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB3,,,,GJB3
12910,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB4,,,,GJB4
12911,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB5,,,,GJB5
12912,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB6,,,,GJB6
12913,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB7,,,,GJB7
12914,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC1,,,,GJC1
12915,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC2,,,,GJC2
12916,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC3,,,,GJC3
12917,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD2,,,,GJD2
12918,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD3,,,,GJD3
12919,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD4,,,,GJD4
12920,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJE1,,,,GJE1
12921,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX1,,,,PANX1
12922,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX2,,,,PANX2
12923,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX3,,,,PANX3
12924,CDC,lipoxygenase inhibitor,ALOX12,,,,ALOX12
12925,CDC,lipoxygenase inhibitor,ALOX5,,,,ALOX5
12926,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor",ATM,,,,ATM
12927,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor",ATR,,,,ATR
12928,CGP-12177,adrenergic receptor agonist,ADRB1,,,,ADRB1
12929,CGP-12177,adrenergic receptor agonist,ADRB2,,,,ADRB2
12930,CGP-12177,adrenergic receptor agonist,ADRB3,,,,ADRB3
12931,CGP-52432,GABA receptor antagonist,GABBR1,,,,GABBR1
12932,CGP-52432,GABA receptor antagonist,GABBR2,,,,GABBR2
12933,CGP-53353,"EGFR inhibitor, PKC inhibitor",EGFR,,,,EGFR
12934,CGP-53353,"EGFR inhibitor, PKC inhibitor",PRKCB,,,,PRKCB
12935,CGP-55845,GABA receptor antagonist,GABBR1,,,,GABBR1
12936,CGP-55845,GABA receptor antagonist,GABBR2,,,,GABBR2
12937,CGP-55845,GABA receptor antagonist,KCTD12,,,,KCTD12
12938,CGP-55845,GABA receptor antagonist,KCTD16,,,,KCTD16
12939,CGP-55845,GABA receptor antagonist,KCTD8,,,,KCTD8
12940,CGP-7930,"GABA receptor modulator, GABA receptor positive allosteric modulator",GABBR1,,,,GABBR1
12941,CGS-21680,adenosine receptor agonist,ADORA2A,,,,ADORA2A
12942,CGS-21680,adenosine receptor agonist,ADORA1,,,,ADORA1
12943,CGS-21680,adenosine receptor agonist,ADORA2B,,,,ADORA2B
12944,CGS-21680,adenosine receptor agonist,ADORA3,,,,ADORA3
12945,zaldaride,"calmodulin antagonist, calmodulin inhibitor",CALM1,,,,CALM1
12946,ciglitazone,"PPAR receptor agonist, insulin sensitizer",PPARG,,,,PPARG
12947,ciglitazone,"PPAR receptor agonist, insulin sensitizer",INS,,,,INS
12948,CL-218872,GABA receptor agonist,GABRA1,,,,GABRA1
12949,CL-218872,GABA receptor agonist,GABRA2,,,,GABRA2
12950,CL-218872,GABA receptor agonist,GABRA3,,,,GABRA3
12951,CL-218872,GABA receptor agonist,GABRA5,,,,GABRA5
12952,CL-218872,GABA receptor agonist,GABRB2,,,,GABRB2
12953,CL-218872,GABA receptor agonist,GABRG2,,,,GABRG2
12954,CL-82198,metalloproteinase inhibitor,MMP13,,,,MMP13
12955,CP-93129,serotonin receptor agonist,HTR1A,,,,HTR1A
12956,CP-93129,serotonin receptor agonist,HTR1B,,,,HTR1B
12957,CP-94253,serotonin receptor agonist,HTR1B,,,,HTR1B
12958,CPCCOEt,glutamate receptor antagonist,GRM1,,,,GRM1
12959,irinotecan,topoisomerase inhibitor,TOP1,,,,TOP1
12960,irinotecan,topoisomerase inhibitor,CYP3A5,,,,CYP3A5
12961,irinotecan,topoisomerase inhibitor,TOP1MT,,,,TOP1MT
12962,indolophenanthridine,"CALY activator, dopamine receptor agonist",CALY,,,,CALY
12963,indolophenanthridine,"CALY activator, dopamine receptor agonist",DRD1,,,,DRD1
12964,cymarin,ATPase inhibitor,ATP1A1,,,,ATP1A1
12965,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD2,,,,DRD2
12966,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1A,,,,ADRA1A
12967,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2A,,,,ADRA2A
12968,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2B,,,,ADRA2B
12969,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2C,,,,ADRA2C
12970,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD1,,,,DRD1
12971,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD3,,,,DRD3
12972,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD4,,,,DRD4
12973,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD5,,,,DRD5
12974,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1A,,,,HTR1A
12975,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1B,,,,HTR1B
12976,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1D,,,,HTR1D
12977,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2A,,,,HTR2A
12978,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2B,,,,HTR2B
12979,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2C,,,,HTR2C
12980,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1B,,,,ADRA1B
12981,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1D,,,,ADRA1D
12982,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRB1,,,,ADRB1
12983,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRB2,,,,ADRB2
12984,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR7,,,,HTR7
12985,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",PRL,,,,PRL
12986,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD2,,,,DRD2
12987,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1A,,,,ADRA1A
12988,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2A,,,,ADRA2A
12989,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2B,,,,ADRA2B
12990,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA2C,,,,ADRA2C
12991,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD1,,,,DRD1
12992,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD3,,,,DRD3
12993,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD4,,,,DRD4
12994,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",DRD5,,,,DRD5
12995,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1A,,,,HTR1A
12996,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1B,,,,HTR1B
12997,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR1D,,,,HTR1D
12998,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2A,,,,HTR2A
12999,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2B,,,,HTR2B
13000,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR2C,,,,HTR2C
13001,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1B,,,,ADRA1B
13002,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRA1D,,,,ADRA1D
13003,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRB1,,,,ADRB1
13004,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",ADRB2,,,,ADRB2
13005,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",HTR7,,,,HTR7
13006,cabergoline,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor",PRL,,,,PRL
13007,ramipril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
13008,camptothecin,"topoisomerase inhibitor, beta amyloid synthesis inhibitor, hypoxia inducible factor inhibitor",TOP1,,,,TOP1
13009,camptothecin,"topoisomerase inhibitor, beta amyloid synthesis inhibitor, hypoxia inducible factor inhibitor",HIF1A,,,,HIF1A
13010,capsazepine,"TRPV agonist, TRPV antagonist",TRPV1,,,,TRPV1
13011,capsazepine,"TRPV agonist, TRPV antagonist",TRPV4,,,,TRPV4
13012,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,,,,HSD11B1
13013,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1,,,,GJA1
13014,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA10,,,,GJA10
13015,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA3,,,,GJA3
13016,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA4,,,,GJA4
13017,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA5,,,,GJA5
13018,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA8,,,,GJA8
13019,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA9,,,,GJA9
13020,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB1,,,,GJB1
13021,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB2,,,,GJB2
13022,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB3,,,,GJB3
13023,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB4,,,,GJB4
13024,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB5,,,,GJB5
13025,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB6,,,,GJB6
13026,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJB7,,,,GJB7
13027,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC1,,,,GJC1
13028,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC2,,,,GJC2
13029,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJC3,,,,GJC3
13030,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD2,,,,GJD2
13031,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD3,,,,GJD3
13032,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJD4,,,,GJD4
13033,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJE1,,,,GJE1
13034,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX1,,,,PANX1
13035,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX2,,,,PANX2
13036,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,PANX3,,,,PANX3
13037,carmoxirole,dopamine receptor agonist,DRD2,,,,DRD2
13038,clomethiazole,"GABA receptor agonist, GABA receptor antagonist, GABA receptor modulator, p38 MAPK inhibitor",GABRA1,,,,GABRA1
13039,cilastatin,dehydropeptidase inhibitor,DPEP1,,,,DPEP1
13040,cilnidipine,"calcium channel blocker, L-type calcium channel blocker, N-type calcium channel blocker",CACNA1B,,,,CACNA1B
13041,cilnidipine,"calcium channel blocker, L-type calcium channel blocker, N-type calcium channel blocker",CACNA1C,,,,CACNA1C
13042,cilostamide,phosphodiesterase inhibitor,PDE3A,,,,PDE3A
13043,cilostamide,phosphodiesterase inhibitor,PDE3B,,,,PDE3B
13044,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",HRH2,,,,HRH2
13045,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC29A4,,,,SLC29A4
13046,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC47A1,,,,SLC47A1
13047,cimetidine,"histamine receptor antagonist, histamine receptor inhibitor",SLC47A2,,,,SLC47A2
13048,cinanserin,serotonin receptor antagonist,HTR2A,,,,HTR2A
13049,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",HRH1,,,,HRH1
13050,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1C,,,,CACNA1C
13051,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1D,,,,CACNA1D
13052,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1F,,,,CACNA1F
13053,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1G,,,,CACNA1G
13054,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1H,,,,CACNA1H
13055,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1I,,,,CACNA1I
13056,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CACNA1S,,,,CACNA1S
13057,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CHRM1,,,,CHRM1
13058,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CHRM2,,,,CHRM2
13059,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CHRM3,,,,CHRM3
13060,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CHRM4,,,,CHRM4
13061,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",CHRM5,,,,CHRM5
13062,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",DRD1,,,,DRD1
13063,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",DRD2,,,,DRD2
13064,cinnarizine,"calcium ion channel antagonist, histamine receptor antagonist",DRD5,,,,DRD5
13065,cirazoline,alpha receptor agonist,ADRA1A,,,,ADRA1A
13066,clobenpropit,"histamine receptor antagonist, histamine receptor inverse agonist",HRH3,,,,HRH3
13067,clobenpropit,"histamine receptor antagonist, histamine receptor inverse agonist",HRH4,,,,HRH4
13068,clobenpropit,"histamine receptor antagonist, histamine receptor inverse agonist",HRH1,,,,HRH1
13069,clobenpropit,"histamine receptor antagonist, histamine receptor inverse agonist",HRH2,,,,HRH2
13070,clofarabine,"ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
13071,clofarabine,"ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
13072,clofarabine,"ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
13073,clofarabine,"ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor",SLC22A8,,,,SLC22A8
13074,CO-102862,sodium channel blocker,SCN2A,,,,SCN2A
13075,CO-102862,sodium channel blocker,SCN4A,,,,SCN4A
13076,CO-102862,sodium channel blocker,SCN9A,,,,SCN9A
13077,cromakalim,"ATP channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
13078,cromakalim,"ATP channel activator, potassium channel agonist",ABCC9,,,,ABCC9
13079,cromakalim,"ATP channel activator, potassium channel agonist",KCNJ5,,,,KCNJ5
13080,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,,,,ATP2A1
13081,cyproterone,"androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist",AR,,,,AR
13082,cyproterone,"androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist",ADORA1,,,,ADORA1
13083,cyproterone,"androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist",ESR1,,,,ESR1
13084,D-4476,"casein kinase inhibitor, TGF beta receptor inhibitor",CSNK1A1,,,,CSNK1A1
13085,D-4476,"casein kinase inhibitor, TGF beta receptor inhibitor",CSNK1D,,,,CSNK1D
13086,D-4476,"casein kinase inhibitor, TGF beta receptor inhibitor",TGFB1,,,,TGFB1
13087,tacrine,"acetylcholinesterase inhibitor, acetylcholine release stimulant, butyrylcholinesterase inhibitors, potassium channel antagonist",ACHE,,,,ACHE
13088,tacrine,"acetylcholinesterase inhibitor, acetylcholine release stimulant, butyrylcholinesterase inhibitors, potassium channel antagonist",BCHE,,,,BCHE
13089,DAU-5884,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
13090,DAU-5884,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
13091,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",ADA,,,,ADA
13092,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",PNP,,,,PNP
13093,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
13094,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",POLE,,,,POLE
13095,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",POLE2,,,,POLE2
13096,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",POLE3,,,,POLE3
13097,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",POLE4,,,,POLE4
13098,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
13099,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
13100,cladribine,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor",RRM2B,,,,RRM2B
13101,benzydamine,"membrane integrity inhibitor, prostanoid receptor inhibitor",PRSS1,,,,PRSS1
13102,benzydamine,"membrane integrity inhibitor, prostanoid receptor inhibitor",PRSS2,,,,PRSS2
13103,tubaic-acid,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor",MT-ND1,,,,MT-ND1
13104,dipropyl-5ct,serotonin receptor agonist,HTR1B,,,,HTR1B
13105,dipropyl-5ct,serotonin receptor agonist,HTR1D,,,,HTR1D
13106,dipropyl-5ct,serotonin receptor agonist,HTR1F,,,,HTR1F
13107,dipropyl-5ct,serotonin receptor agonist,HTR7,,,,HTR7
13108,DMAB-anabaseine,alpha receptor partial agonist,CHRNA7,,,,CHRNA7
13109,DNQX,glutamate receptor antagonist,GRIA1,,,,GRIA1
13110,DNQX,glutamate receptor antagonist,GRIA2,,,,GRIA2
13111,DNQX,glutamate receptor antagonist,GRIK1,,,,GRIK1
13112,DNQX,glutamate receptor antagonist,GRIN1,,,,GRIN1
13113,DNQX,glutamate receptor antagonist,GRIN2A,,,,GRIN2A
13114,DNQX,glutamate receptor antagonist,GRIN2B,,,,GRIN2B
13115,doconexent,"PPAR receptor agonist, unidentified pharmacological activity",FFAR1,,,,FFAR1
13116,doconexent,"PPAR receptor agonist, unidentified pharmacological activity",PPARA,,,,PPARA
13117,doconexent,"PPAR receptor agonist, unidentified pharmacological activity",PTGS1,,,,PTGS1
13118,doconexent,"PPAR receptor agonist, unidentified pharmacological activity",PTGS2,,,,PTGS2
13119,DPPE,histamine receptor antagonist,ABCB1,,,,ABCB1
13120,DPPE,histamine receptor antagonist,HRH1,,,,HRH1
13121,DY-131,estrogen-related receptor agonist,ESR2,,,,ESR2
13122,DY-131,estrogen-related receptor agonist,ESRRB,,,,ESRRB
13123,DY-131,estrogen-related receptor agonist,ESRRG,,,,ESRRG
13124,denbufylline,phosphodiesterase inhibitor,PDE4A,,,,PDE4A
13125,denbufylline,phosphodiesterase inhibitor,PDE4B,,,,PDE4B
13126,denbufylline,phosphodiesterase inhibitor,PDE4D,,,,PDE4D
13127,desoxycortone,mineralocorticoid receptor agonist,NR3C1,,,,NR3C1
13128,desoxycortone,mineralocorticoid receptor agonist,NR3C2,,,,NR3C2
13129,devazepide,"CCK receptor antagonist, gastrin inhibitor",CCKAR,,,,CCKAR
13130,devazepide,"CCK receptor antagonist, gastrin inhibitor",CCKBR,,,,CCKBR
13131,devazepide,"CCK receptor antagonist, gastrin inhibitor",GAST,,,,GAST
13132,diclofenamide,carbonic anhydrase inhibitor,CA1,,,,CA1
13133,diclofenamide,carbonic anhydrase inhibitor,CA2,,,,CA2
13134,diclofenamide,carbonic anhydrase inhibitor,CA4,,,,CA4
13135,diclofenamide,carbonic anhydrase inhibitor,CA12,,,,CA12
13136,diclofenamide,carbonic anhydrase inhibitor,CA7,,,,CA7
13137,EHNA,adenosine deaminase inhibitor,ADA,,,,ADA
13138,EHNA,adenosine deaminase inhibitor,PDE2A,,,,PDE2A
13139,EHNA,adenosine deaminase inhibitor,ADORA2A,,,,ADORA2A
13140,EO-1428,p38 MAPK inhibitor,MAPK11,,,,MAPK11
13141,EO-1428,p38 MAPK inhibitor,MAPK14,,,,MAPK14
13142,ergocornine,dopamine receptor agonist,DRD2,,,,DRD2
13143,ergometrine,"adrenergic receptor stimulatant, serotonin receptor stimulant",ADRA1A,,,,ADRA1A
13144,ergometrine,"adrenergic receptor stimulatant, serotonin receptor stimulant",HTR1E,,,,HTR1E
13145,ergometrine,"adrenergic receptor stimulatant, serotonin receptor stimulant",HTR2A,,,,HTR2A
13146,eriodictyol,"cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor",CYP1B1,,,,CYP1B1
13147,eriodictyol,"cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor",NFE2L2,,,,NFE2L2
13148,eriodictyol,"cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor",XDH,,,,XDH
13149,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR1,,,,ESR1
13150,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR2,,,,ESR2
13151,BRD-K49061529,GABA benzodiazepine site receptor inverse agonist,GABRA1,,,,GABRA1
13152,BRD-K49061529,GABA benzodiazepine site receptor inverse agonist,GABRG2,,,,GABRG2
13153,eugenitol,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator",AR,,,,AR
13154,eugenitol,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator",MAOA,,,,MAOA
13155,eplerenone,"cytochrome P450 antagonist, mineralocorticoid receptor antagonist",NR3C2,,,,NR3C2
13156,eplerenone,"cytochrome P450 antagonist, mineralocorticoid receptor antagonist",CYP3A5,,,,CYP3A5
13157,equilin,estrogen receptor agonist,HSD17B1,,,,HSD17B1
13158,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR1,,,,ESR1
13159,estriol,"estrogen receptor agonist, estrogen receptor antagonist",ESR2,,,,ESR2
13160,estrone,"estrogen receptor agonist, estrogenic hormone",ESR1,,,,ESR1
13161,estrone,"estrogen receptor agonist, estrogenic hormone",ESR2,,,,ESR2
13162,ethisterone,androgen receptor agonist,TYR,,,,TYR
13163,febuxostat,xanthine oxidase inhibitor,XDH,,,,XDH
13164,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",SRD5A2,,,,SRD5A2
13165,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",SRD5A1,,,,SRD5A1
13166,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",AKR1D1,,,,AKR1D1
13167,finasteride,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor",AR,,,,AR
13168,FIT,opioid receptor agonist,OPRD1,,,,OPRD1
13169,FK-888,tachykinin antagonist,TACR1,,,,TACR1
13170,FK-888,tachykinin antagonist,TACR2,,,,TACR2
13171,flumetasone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
13172,flumetasone,glucocorticoid receptor agonist,PLA2G1B,,,,PLA2G1B
13173,fluperlapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
13174,fluperlapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
13175,fluperlapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
13176,fluperlapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
13177,fluprostenol,prostaglandin F receptor agonist,PTGER3,,,,PTGER3
13178,fluprostenol,prostaglandin F receptor agonist,PTGFR,,,,PTGFR
13179,fluprostenol,prostaglandin F receptor agonist,TBXA2R,,,,TBXA2R
13180,niflumic-acid,cyclooxgenase inhibitor,CLCNKA,,,,CLCNKA
13181,niflumic-acid,cyclooxgenase inhibitor,PTGS2,,,,PTGS2
13182,niflumic-acid,cyclooxgenase inhibitor,ANO1,,,,ANO1
13183,niflumic-acid,cyclooxgenase inhibitor,CLCN1,,,,CLCN1
13184,niflumic-acid,cyclooxgenase inhibitor,CLCNKB,,,,CLCNKB
13185,niflumic-acid,cyclooxgenase inhibitor,KCNQ1,,,,KCNQ1
13186,niflumic-acid,cyclooxgenase inhibitor,PLA2G1B,,,,PLA2G1B
13187,niflumic-acid,cyclooxgenase inhibitor,PLA2G4A,,,,PLA2G4A
13188,niflumic-acid,cyclooxgenase inhibitor,PTGS1,,,,PTGS1
13189,niflumic-acid,cyclooxgenase inhibitor,UGT1A9,,,,UGT1A9
13190,fraxidin,carbonic anhydrase inhibitor,CA1,,,,CA1
13191,fananserin,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
13192,fananserin,"dopamine receptor antagonist, serotonin receptor antagonist",DRD4,,,,DRD4
13193,felbamate,"carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker",GRIN2A,,,,GRIN2A
13194,felbamate,"carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker",GRIN2B,,,,GRIN2B
13195,felbamate,"carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker",GRIN3A,,,,GRIN3A
13196,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
13197,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
13198,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
13199,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
13200,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
13201,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
13202,felodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
13203,felodipine,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
13204,felodipine,"calcium channel blocker, L-type calcium channel blocker",CFTR,,,,CFTR
13205,felodipine,"calcium channel blocker, L-type calcium channel blocker",NR3C2,,,,NR3C2
13206,felodipine,"calcium channel blocker, L-type calcium channel blocker",PDE1A,,,,PDE1A
13207,felodipine,"calcium channel blocker, L-type calcium channel blocker",PDE1B,,,,PDE1B
13208,felodipine,"calcium channel blocker, L-type calcium channel blocker",TNNC1,,,,TNNC1
13209,felodipine,"calcium channel blocker, L-type calcium channel blocker",TNNC2,,,,TNNC2
13210,fenobam,glutamate receptor antagonist,GRM5,,,,GRM5
13211,fenoldopam,dopamine receptor agonist,DRD1,,,,DRD1
13212,fenoldopam,dopamine receptor agonist,ADRA1A,,,,ADRA1A
13213,fenoldopam,dopamine receptor agonist,ADRA1B,,,,ADRA1B
13214,fenoldopam,dopamine receptor agonist,ADRA1D,,,,ADRA1D
13215,fenoldopam,dopamine receptor agonist,ADRA2A,,,,ADRA2A
13216,fenoldopam,dopamine receptor agonist,ADRA2B,,,,ADRA2B
13217,fenoldopam,dopamine receptor agonist,ADRA2C,,,,ADRA2C
13218,fenoldopam,dopamine receptor agonist,DRD4,,,,DRD4
13219,fenoldopam,dopamine receptor agonist,DRD5,,,,DRD5
13220,fexaramine,FXR agonist,NR1H4,,,,NR1H4
13221,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA1,,,,GABRA1
13222,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA2,,,,GABRA2
13223,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA3,,,,GABRA3
13224,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA5,,,,GABRA5
13225,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA4,,,,GABRA4
13226,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA6,,,,GABRA6
13227,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRB1,,,,GABRB1
13228,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRB2,,,,GABRB2
13229,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRB3,,,,GABRB3
13230,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRD,,,,GABRD
13231,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRE,,,,GABRE
13232,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRG1,,,,GABRG1
13233,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRG2,,,,GABRG2
13234,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRG3,,,,GABRG3
13235,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRP,,,,GABRP
13236,flumazenil,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRQ,,,,GABRQ
13237,flunisolide,"cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
13238,fluticasone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
13239,fluticasone,glucocorticoid receptor agonist,CYP3A5,,,,CYP3A5
13240,fluticasone,glucocorticoid receptor agonist,CYP3A7,,,,CYP3A7
13241,fluticasone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
13242,fluticasone,glucocorticoid receptor agonist,PGR,,,,PGR
13243,fluticasone,glucocorticoid receptor agonist,PLA2G4A,,,,PLA2G4A
13244,fluticasone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
13245,fluticasone,glucocorticoid receptor agonist,CYP3A5,,,,CYP3A5
13246,fluticasone,glucocorticoid receptor agonist,CYP3A7,,,,CYP3A7
13247,fluticasone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
13248,fluticasone,glucocorticoid receptor agonist,PGR,,,,PGR
13249,fluticasone,glucocorticoid receptor agonist,PLA2G4A,,,,PLA2G4A
13250,fluvoxamine,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
13251,fluvoxamine,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CYP2C19,,,,CYP2C19
13252,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY2,,,,ADCY2
13253,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",ADCY5,,,,ADCY5
13254,forskolin,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant",GNAS,,,,GNAS
13255,fusaric-acid,"chelating agent, dopamine beta hydroxylase inhibitor",DBH,,,,DBH
13256,GR-144053,integrin antagonist,ITGB3,,,,ITGB3
13257,GR-144053,integrin antagonist,ITGA2B,,,,ITGA2B
13258,GR-159897,tachykinin antagonist,TACR2,,,,TACR2
13259,GR-159897,tachykinin antagonist,TAC1,,,,TAC1
13260,GR-32191,"thromboxane receptor antagonist, prostanoid receptor antagonist",TBXA2R,,,,TBXA2R
13261,GR-46611,serotonin receptor agonist,HTR1D,,,,HTR1D
13262,GR-55562,serotonin receptor antagonist,HTR1B,,,,HTR1B
13263,GR-55562,serotonin receptor antagonist,HTR1D,,,,HTR1D
13264,GR-79236,adenosine receptor agonist,ADORA1,,,,ADORA1
13265,GR-79236,adenosine receptor agonist,ADORA2A,,,,ADORA2A
13266,GR-89696,opioid receptor agonist,OPRK1,,,,OPRK1
13267,GS-39783,"GABA receptor modulator, GABA receptor positive allosteric modulator",GABBR1,,,,GABBR1
13268,AR-A014418,glycogen synthase kinase inhibitor,GSK3B,,,,GSK3B
13269,GTP-14564,"FLT3 inhibitor, tyrosine kinase receptor inhibitor",FLT3,,,,FLT3
13270,GTP-14564,"FLT3 inhibitor, tyrosine kinase receptor inhibitor",CSF1R,,,,CSF1R
13271,GTP-14564,"FLT3 inhibitor, tyrosine kinase receptor inhibitor",KIT,,,,KIT
13272,GTP-14564,"FLT3 inhibitor, tyrosine kinase receptor inhibitor",PDGFRB,,,,PDGFRB
13273,GW-0742,"PPAR receptor agonist, insulin sensitizer",INS,,,,INS
13274,GW-0742,"PPAR receptor agonist, insulin sensitizer",PPARD,,,,PPARD
13275,GW-583340,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, ErbB2 tyrosine kinase inhibitor, receptor tyrosine protein kinase inhibitor",EGFR,,,,EGFR
13276,GW-583340,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, ErbB2 tyrosine kinase inhibitor, receptor tyrosine protein kinase inhibitor",ERBB2,,,,ERBB2
13277,GW-6471,PPAR receptor antagonist,PPARA,,,,PPARA
13278,GW-9662,PPAR receptor antagonist,PPARG,,,,PPARG
13279,GW-9662,PPAR receptor antagonist,NCOA2,,,,NCOA2
13280,GW-9662,PPAR receptor antagonist,RXRA,,,,RXRA
13281,GYKI-52466,"glutamate receptor antagonist, kainate receptor antagonist",GRIA1,,,,GRIA1
13282,GYKI-52466,"glutamate receptor antagonist, kainate receptor antagonist",GRIA2,,,,GRIA2
13283,GYKI-52466,"glutamate receptor antagonist, kainate receptor antagonist",GRIA3,,,,GRIA3
13284,GYKI-52466,"glutamate receptor antagonist, kainate receptor antagonist",GRIA4,,,,GRIA4
13285,gabexate,"serine protease inhibitor, AP inhibitor, NFkB pathway inhibitor, peptidase inhibitor, protease inhibitor",PRSS1,,,,PRSS1
13286,gabexate,"serine protease inhibitor, AP inhibitor, NFkB pathway inhibitor, peptidase inhibitor, protease inhibitor",TPSAB1,,,,TPSAB1
13287,gavestinel,"glutamate receptor antagonist, glycine receptor antagonist",GLRB,,,,GLRB
13288,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",CFTR,,,,CFTR
13289,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESR2,,,,ESR2
13290,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",EGFR,,,,EGFR
13291,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESR1,,,,ESR1
13292,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRA,,,,ESRRA
13293,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRB,,,,ESRRB
13294,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRG,,,,ESRRG
13295,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",NCOA1,,,,NCOA1
13296,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",NCOA2,,,,NCOA2
13297,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",PPARG,,,,PPARG
13298,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",PTK2B,,,,PTK2B
13299,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",TOP2A,,,,TOP2A
13300,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",TRPC5,,,,TRPC5
13301,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR1H4,,,,NR1H4
13302,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",PGR,,,,PGR
13303,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",AR,,,,AR
13304,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",ESR1,,,,ESR1
13305,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",IKBKB,,,,IKBKB
13306,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR1I2,,,,NR1I2
13307,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR3C1,,,,NR3C1
13308,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR3C2,,,,NR3C2
13309,azacitidine,"DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor, DNA synthesis inhibitor, RNA synthesis inhibitor",DNMT1,,,,DNMT1
13310,acebutolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
13311,acebutolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
13312,hemado,adenosine receptor agonist,ADORA3,,,,ADORA3
13313,hemado,adenosine receptor agonist,ADORA1,,,,ADORA1
13314,hemado,adenosine receptor agonist,ADORA2A,,,,ADORA2A
13315,hemado,adenosine receptor agonist,ADORA2B,,,,ADORA2B
13316,quercetagetin,Pim kinase inhibitor,PIM1,,,,PIM1
13317,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",ANXA1,,,,ANXA1
13318,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NOS2,,,,NOS2
13319,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C1,,,,NR3C1
13320,hydrocortisone,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist",NR3C2,,,,NR3C2
13321,halcinonide,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
13322,harpagoside,acetylcholinesterase inhibitor,ACHE,,,,ACHE
13323,hesperidin,free radical scavenger,CACNA1B,,,,CACNA1B
13324,hispidin,"beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor",PREP,,,,PREP
13325,hispidin,"beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor",PRKCB,,,,PRKCB
13326,hispidin,"beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor",PTGS2,,,,PTGS2
13327,hispidin,"beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
13328,bisbenzimide,"BCL inhibitor, DNA binding, topoisomerase inhibitor",BCL2L1,,,,BCL2L1
13329,bisbenzimide,"BCL inhibitor, DNA binding, topoisomerase inhibitor",TOP1,,,,TOP1
13330,hydralazine,smooth muscle relaxant,AOC3,,,,AOC3
13331,hydralazine,smooth muscle relaxant,P4HA1,,,,P4HA1
13332,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA3,,,,ADORA3
13333,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA1,,,,ADORA1
13334,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA2A,,,,ADORA2A
13335,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA2B,,,,ADORA2B
13336,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3,,,,HCAR3
13337,ICI-89406,adrenergic receptor antagonist,ADRB1,,,,ADRB1
13338,ICI-89406,adrenergic receptor antagonist,ADRB2,,,,ADRB2
13339,imperatorin,"acetylcholinesterase inhibitor, nitric oxide production inhibitor, Sodium Channel  Blockers",ACHE,,,,ACHE
13340,imperatorin,"acetylcholinesterase inhibitor, nitric oxide production inhibitor, Sodium Channel  Blockers",HTR7,,,,HTR7
13341,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",ABCB1,,,,ABCB1
13342,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",CYP1A2,,,,CYP1A2
13343,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",CYP3A4,,,,CYP3A4
13344,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN1A,,,,SCN1A
13345,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN3A,,,,SCN3A
13346,carbamazepine,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
13347,ipratropium,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
13348,ipratropium,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
13349,ipratropium,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
13350,ipratropium,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
13351,ipratropium,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
13352,isoreserpine,vesicular monoamine transporter inhibitor,SLC18A2,,,,SLC18A2
13353,isoreserpine,vesicular monoamine transporter inhibitor,SLC18A1,,,,SLC18A1
13354,isoreserpine,vesicular monoamine transporter inhibitor,SIAH1,,,,SIAH1
13355,ivermectin,"GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator",CHRNA7,,,,CHRNA7
13356,ivermectin,"GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator",GABRB3,,,,GABRB3
13357,ivermectin,"GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator",GLRA3,,,,GLRA3
13358,ivermectin,"GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator",P2RX7,,,,P2RX7
13359,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE4A,,,,PDE4A
13360,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE4B,,,,PDE4B
13361,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE4C,,,,PDE4C
13362,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",MIF,,,,MIF
13363,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE10A,,,,PDE10A
13364,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE3A,,,,PDE3A
13365,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE4D,,,,PDE4D
13366,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",TLR4,,,,TLR4
13367,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",CYSLTR1,,,,CYSLTR1
13368,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",IL1B,,,,IL1B
13369,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",IL6,,,,IL6
13370,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE11A,,,,PDE11A
13371,ibudilast,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor",PDE5A,,,,PDE5A
13372,immepip,histamine receptor agonist,HRH3,,,,HRH3
13373,immepip,histamine receptor agonist,HRH4,,,,HRH4
13374,irsogladine,"diuretic, phosphodiesterase inhibitor",PDE4A,,,,PDE4A
13375,isoxsuprine,adrenergic receptor agonist,ADRB2,,,,ADRB2
13376,ivachtin,caspase inhibitor,CASP3,,,,CASP3
13377,J-104129,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
13378,JLK-6,"gamma secretase inhibitor, antiamyloidogenic agent",PSEN1,,,,PSEN1
13379,JNJ-10191584,"histamine receptor antagonist, histamine receptor silent antagonist",HRH4,,,,HRH4
13380,JTE-013,lysophospholipid receptor antagonist,S1PR2,,,,S1PR2
13381,JTE-013,lysophospholipid receptor antagonist,P2RY10,,,,P2RY10
13382,JWH-015,cannabinoid receptor agonist,CNR2,,,,CNR2
13383,JWH-015,cannabinoid receptor agonist,GPR55,,,,GPR55
13384,kavain,"calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers",MTOR,,,,MTOR
13385,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",AKT1,,,,AKT1
13386,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",CAMK2A,,,,CAMK2A
13387,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",CHEK1,,,,CHEK1
13388,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",LCK,,,,LCK
13389,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",MAPK1,,,,MAPK1
13390,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",MAPK11,,,,MAPK11
13391,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",MAPK12,,,,MAPK12
13392,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",MAPK14,,,,MAPK14
13393,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",MAPK8,,,,MAPK8
13394,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",P2RX7,,,,P2RX7
13395,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",PRKCA,,,,PRKCA
13396,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",ROCK1,,,,ROCK1
13397,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",RPS6KB1,,,,RPS6KB1
13398,KN-62,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist",SGK1,,,,SGK1
13399,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",GSK3B,,,,GSK3B
13400,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",CDK1,,,,CDK1
13401,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",CDK5,,,,CDK5
13402,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",CCNB1,,,,CCNB1
13403,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",CDK2,,,,CDK2
13404,kenpaullone,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor",LCK,,,,LCK
13405,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR2A,,,,HTR2A
13406,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR2C,,,,HTR2C
13407,ketanserin,"serotonin receptor antagonist, collagen stimulant",ADRA1A,,,,ADRA1A
13408,ketanserin,"serotonin receptor antagonist, collagen stimulant",ADRA1B,,,,ADRA1B
13409,ketanserin,"serotonin receptor antagonist, collagen stimulant",ADRA1D,,,,ADRA1D
13410,ketanserin,"serotonin receptor antagonist, collagen stimulant",DRD1,,,,DRD1
13411,ketanserin,"serotonin receptor antagonist, collagen stimulant",DRD5,,,,DRD5
13412,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR1A,,,,HTR1A
13413,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR1B,,,,HTR1B
13414,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR1D,,,,HTR1D
13415,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR2B,,,,HTR2B
13416,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR5A,,,,HTR5A
13417,ketanserin,"serotonin receptor antagonist, collagen stimulant",HTR7,,,,HTR7
13418,ketanserin,"serotonin receptor antagonist, collagen stimulant",SLC18A1,,,,SLC18A1
13419,ketanserin,"serotonin receptor antagonist, collagen stimulant",SLC18A2,,,,SLC18A2
13420,L-368899,oxytocin receptor antagonist,OXTR,,,,OXTR
13421,L-368899,oxytocin receptor antagonist,AVPR1A,,,,AVPR1A
13422,L-368899,oxytocin receptor antagonist,AVPR2,,,,AVPR2
13423,L-368899,oxytocin receptor antagonist,OXT,,,,OXT
13424,L-655240,"platelet aggregation inhibitor, prostanoid receptor antagonist, thromboxane receptor antagonist",PTGES,,,,PTGES
13425,vesamicol,acetylcholine transport inhibitor,SLC18A3,,,,SLC18A3
13426,L-152804,neuropeptide receptor antagonist,NPY5R,,,,NPY5R
13427,L-165041,PPAR receptor agonist,PPARD,,,,PPARD
13428,L-689560,glutamate receptor antagonist,GRIN1,,,,GRIN1
13429,L-689560,glutamate receptor antagonist,GRIN2A,,,,GRIN2A
13430,L-689560,glutamate receptor antagonist,GRIN2B,,,,GRIN2B
13431,L-689560,glutamate receptor antagonist,GRIN2C,,,,GRIN2C
13432,L-689560,glutamate receptor antagonist,GRIN2D,,,,GRIN2D
13433,L-689560,glutamate receptor antagonist,GRIN1,,,,GRIN1
13434,L-689560,glutamate receptor antagonist,GRIN2A,,,,GRIN2A
13435,L-689560,glutamate receptor antagonist,GRIN2B,,,,GRIN2B
13436,L-689560,glutamate receptor antagonist,GRIN2C,,,,GRIN2C
13437,L-689560,glutamate receptor antagonist,GRIN2D,,,,GRIN2D
13438,L-692585,"growth hormone releasing peptide ligand agonist, growth hormone secretagogue",GH1,,,,GH1
13439,L-692585,"growth hormone releasing peptide ligand agonist, growth hormone secretagogue",GHSR,,,,GHSR
13440,L-693403,"sigma receptor antagonist, sigma receptor ligand",SIGMAR1,,,,SIGMAR1
13441,L-701252,glutamate receptor antagonist,GRIN1,,,,GRIN1
13442,L-732138,tachykinin antagonist,TACR1,,,,TACR1
13443,L-732138,tachykinin antagonist,TACR2,,,,TACR2
13444,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1C,,,,CACNA1C
13445,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1S,,,,CACNA1S
13446,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA2D1,,,,CACNA2D1
13447,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNG1,,,,CACNG1
13448,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A5,,,,CYP3A5
13449,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A7,,,,CYP3A7
13450,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",HTR3A,,,,HTR3A
13451,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",KCNA5,,,,KCNA5
13452,lavendustin-a,"EGFR inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
13453,lavendustin-a,"EGFR inhibitor, tyrosine kinase inhibitor",LCK,,,,LCK
13454,LFM-A12,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor",EGFR,,,,EGFR
13455,lonidamine,"glucokinase inhibitor, protein synthesis inhibitor",GCK,,,,GCK
13456,LY-288513,CCK receptor antagonist,CCKBR,,,,CCKBR
13457,LY-320135,cannabinoid receptor antagonist,CNR1,,,,CNR1
13458,LY-341495,glutamate receptor antagonist,GRM2,,,,GRM2
13459,LY-341495,glutamate receptor antagonist,GRM3,,,,GRM3
13460,LY-364947,"TGF beta receptor inhibitor, p38 MAPK inhibitor",TGFBR1,,,,TGFBR1
13461,LY-16350,"dopamine receptor agonist, dopamine receptor antagonist",DRD2,,,,DRD2
13462,LY-16350,"dopamine receptor agonist, dopamine receptor antagonist",DRD3,,,,DRD3
13463,LY-165163,serotonin receptor antagonist,HTR1A,,,,HTR1A
13464,LY-165163,serotonin receptor antagonist,HTR1D,,,,HTR1D
13465,LY-278584,serotonin receptor antagonist,HTR3A,,,,HTR3A
13466,LY-255283,leukotriene receptor antagonist,LTB4R,,,,LTB4R
13467,LY-255283,leukotriene receptor antagonist,LTB4R2,,,,LTB4R2
13468,lamotrigine,"glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN1A,,,,SCN1A
13469,lamotrigine,"glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN2A,,,,SCN2A
13470,lamotrigine,"glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker",SCN3A,,,,SCN3A
13471,levcromakalim,"potassium channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
13472,levcromakalim,"potassium channel activator, potassium channel agonist",ABCC9,,,,ABCC9
13473,levcromakalim,"potassium channel activator, potassium channel agonist",KCNJ5,,,,KCNJ5
13474,lidoflazine,calcium channel antagonist,SCN1A,,,,SCN1A
13475,lidoflazine,calcium channel antagonist,SCN3A,,,,SCN3A
13476,lidoflazine,calcium channel antagonist,SLC29A1,,,,SLC29A1
13477,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",NR3C1,,,,NR3C1
13478,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A5,,,,CYP3A5
13479,budesonide,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant",CYP3A7,,,,CYP3A7
13480,loreclezole,GABA receptor agonist,GABRB2,,,,GABRB2
13481,loreclezole,GABA receptor agonist,GABRB3,,,,GABRB3
13482,lysergol,ergoline alkaloid,HTR1B,,,,HTR1B
13483,lysergol,ergoline alkaloid,HTR1D,,,,HTR1D
13484,lysergol,ergoline alkaloid,HTR1E,,,,HTR1E
13485,bemesetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
13486,bemesetron,serotonin receptor antagonist,HTR3B,,,,HTR3B
13487,MDL-72832,serotonin receptor agonist,HTR1A,,,,HTR1A
13488,MDL-28170,"calpain inhibitor, cathepsin inhibitor",CAPN1,,,,CAPN1
13489,MDL-28170,"calpain inhibitor, cathepsin inhibitor",CTSB,,,,CTSB
13490,MDL-28170,"calpain inhibitor, cathepsin inhibitor",CTSL,,,,CTSL
13491,MDM2-inhibitor,MDM inhibitor,MDM2,,,,MDM2
13492,mesoridazine,dopamine receptor antagonist,DRD2,,,,DRD2
13493,mesoridazine,dopamine receptor antagonist,HTR2A,,,,HTR2A
13494,BRD-K14844937,GABA benzodiazepine site receptor inverse agonist,GABRA1,,,,GABRA1
13495,BRD-K14844937,GABA benzodiazepine site receptor inverse agonist,GABRA2,,,,GABRA2
13496,BRD-K14844937,GABA benzodiazepine site receptor inverse agonist,GABRA3,,,,GABRA3
13497,BRD-K14844937,GABA benzodiazepine site receptor inverse agonist,GABRA5,,,,GABRA5
13498,BRD-K28680267,CCK receptor antagonist,CCKAR,,,,CCKAR
13499,BRD-K28680267,CCK receptor antagonist,GABRA1,,,,GABRA1
13500,BRD-K28680267,CCK receptor antagonist,GABRB2,,,,GABRB2
13501,BRD-K28680267,CCK receptor antagonist,GABRG2,,,,GABRG2
13502,metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist",DRD2,,,,DRD2
13503,metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist",HTR3A,,,,HTR3A
13504,metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist",HTR4,,,,HTR4
13505,metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist",CHRM1,,,,CHRM1
13506,metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist",HTR3B,,,,HTR3B
13507,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ8,,,,KCNJ8
13508,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",ABCC9,,,,ABCC9
13509,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ1,,,,KCNJ1
13510,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ10,,,,KCNJ10
13511,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ11,,,,KCNJ11
13512,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",PTGS1,,,,PTGS1
13513,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",REN,,,,REN
13514,ML-3163,p38 MAPK inhibitor,CYP2D6,,,,CYP2D6
13515,ML-3163,p38 MAPK inhibitor,CYP3A4,,,,CYP3A4
13516,ML-3163,p38 MAPK inhibitor,MAPK11,,,,MAPK11
13517,ML-3163,p38 MAPK inhibitor,MAPK12,,,,MAPK12
13518,ML-3163,p38 MAPK inhibitor,MAPK14,,,,MAPK14
13519,LY-456236,glutamate receptor antagonist,GRM1,,,,GRM1
13520,MRS-1220,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
13521,MRS-1220,adenosine receptor antagonist,ADORA3,,,,ADORA3
13522,buspirone,"serotonin receptor agonist, serotonin receptor partial agonist",HTR1A,,,,HTR1A
13523,buspirone,"serotonin receptor agonist, serotonin receptor partial agonist",DRD2,,,,DRD2
13524,MY-5445,"phosphodiesterase inhibitor, platelet aggregation inhibitor",PDE5A,,,,PDE5A
13525,melperone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
13526,melperone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
13527,melperone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
13528,methantheline,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
13529,methantheline,acetylcholine receptor antagonist,HRH2,,,,HRH2
13530,methysergide,serotonin receptor antagonist,HTR2C,,,,HTR2C
13531,methysergide,serotonin receptor antagonist,HTR1B,,,,HTR1B
13532,methysergide,serotonin receptor antagonist,HTR1E,,,,HTR1E
13533,methysergide,serotonin receptor antagonist,HTR1F,,,,HTR1F
13534,methysergide,serotonin receptor antagonist,HTR2A,,,,HTR2A
13535,methysergide,serotonin receptor antagonist,HTR2B,,,,HTR2B
13536,methysergide,serotonin receptor antagonist,HTR7,,,,HTR7
13537,methysergide,serotonin receptor antagonist,HTR1A,,,,HTR1A
13538,methysergide,serotonin receptor antagonist,HTR1D,,,,HTR1D
13539,methysergide,serotonin receptor antagonist,HTR5A,,,,HTR5A
13540,methysergide,serotonin receptor antagonist,HTR6,,,,HTR6
13541,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",PGR,,,,PGR
13542,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",NR3C1,,,,NR3C1
13543,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",AR,,,,AR
13544,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP2B6,,,,CYP2B6
13545,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP2C8,,,,CYP2C8
13546,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP3A5,,,,CYP3A5
13547,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",CYP3A7,,,,CYP3A7
13548,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor",NR1I2,,,,NR1I2
13549,moexipril,"angiotensin converting enzyme inhibitor, phosphodiesterase inhibitor",ACE,,,,ACE
13550,moexipril,"angiotensin converting enzyme inhibitor, phosphodiesterase inhibitor",ACE2,,,,ACE2
13551,mometasone,"glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
13552,monastrol,kinesin-like spindle protein inhibitor,KIF11,,,,KIF11
13553,moxonidine,"imidazoline receptor agonist, adrenergic receptor agonist",NISCH,,,,NISCH
13554,moxonidine,"imidazoline receptor agonist, adrenergic receptor agonist",ADRA2A,,,,ADRA2A
13555,moxonidine,"imidazoline receptor agonist, adrenergic receptor agonist",ADRA2B,,,,ADRA2B
13556,moxonidine,"imidazoline receptor agonist, adrenergic receptor agonist",ADRA2C,,,,ADRA2C
13557,hexamethyleneamiloride,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor",GNRHR,,,,GNRHR
13558,hexamethyleneamiloride,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor",ADRA2A,,,,ADRA2A
13559,hexamethyleneamiloride,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor",GNRH1,,,,GNRH1
13560,hexamethyleneamiloride,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor",PLAU,,,,PLAU
13561,hexamethyleneamiloride,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor",SLC9A1,,,,SLC9A1
13562,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRD1,,,,OPRD1
13563,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRK1,,,,OPRK1
13564,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRM1,,,,OPRM1
13565,naloxone,opioid receptor antagonist,OPRM1,,,,OPRM1
13566,naloxone,opioid receptor antagonist,OPRK1,,,,OPRK1
13567,naloxone,opioid receptor antagonist,OPRD1,,,,OPRD1
13568,naloxone,opioid receptor antagonist,CREB1,,,,CREB1
13569,naloxone,opioid receptor antagonist,ESR1,,,,ESR1
13570,naloxone,opioid receptor antagonist,TLR4,,,,TLR4
13571,NAS-181,serotonin receptor antagonist,HTR1B,,,,HTR1B
13572,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",ABCC8,,,,ABCC8
13573,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",KCNJ11,,,,KCNJ11
13574,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",CYP3A4,,,,CYP3A4
13575,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",INS,,,,INS
13576,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",KCNJ10,,,,KCNJ10
13577,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",PPARG,,,,PPARG
13578,NBI-27914,CRF receptor antagonist,CRHR1,,,,CRHR1
13579,NGB-2904,dopamine receptor antagonist,DRD3,,,,DRD3
13580,nilutamide,"androgen receptor antagonist, RNA directed RNA polymerase inhibitor",AR,,,,AR
13581,nilutamide,"androgen receptor antagonist, RNA directed RNA polymerase inhibitor",CYP2C19,,,,CYP2C19
13582,nizatidine,histamine receptor antagonist,HRH2,,,,HRH2
13583,BRD-K08438429,"glucosylceramidase inhibitor, somatostatin receptor agonist",GBA,,,,GBA
13584,BRD-K08438429,"glucosylceramidase inhibitor, somatostatin receptor agonist",SSTR4,,,,SSTR4
13585,NNC-63-0532,opioid receptor agonist,OPRL1,,,,OPRL1
13586,NNC-711,GAT inhibitor,SLC6A1,,,,SLC6A1
13587,NNC-711,GAT inhibitor,SIGMAR1,,,,SIGMAR1
13588,nobiletin,"MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor",ABCB1,,,,ABCB1
13589,nobiletin,"MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor",MAP2K1,,,,MAP2K1
13590,nobiletin,"MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor",TYR,,,,TYR
13591,noretynodrel,progestogen steroid hormone,PGR,,,,PGR
13592,norgestrel,progesterone receptor agonist,CYP2E1,,,,CYP2E1
13593,norgestrel,progesterone receptor agonist,PGR,,,,PGR
13594,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",BDKRB2,,,,BDKRB2
13595,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",SIGMAR1,,,,SIGMAR1
13596,SB-203186,serotonin receptor antagonist,HTR4,,,,HTR4
13597,nadolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
13598,nadolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
13599,nadolol,adrenergic receptor antagonist,ADRB3,,,,ADRB3
13600,naltriben,opioid receptor antagonist,OPRD1,,,,OPRD1
13601,naltriben,opioid receptor antagonist,OPRK1,,,,OPRK1
13602,naltriben,opioid receptor antagonist,OPRM1,,,,OPRM1
13603,naproxen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
13604,naproxen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
13605,nisoxetine,"dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",SLC6A2,,,,SLC6A2
13606,nisoxetine,"dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",SLC6A3,,,,SLC6A3
13607,nisoxetine,"dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",SLC6A4,,,,SLC6A4
13608,cromoglicic-acid,immunosuppressant,KCNMA1,,,,KCNMA1
13609,cromoglicic-acid,immunosuppressant,S100P,,,,S100P
13610,norketamine,glutamate receptor antagonist,CYP2B6,,,,CYP2B6
13611,norketamine,glutamate receptor antagonist,CYP2C19,,,,CYP2C19
13612,norketamine,glutamate receptor antagonist,CYP3A5,,,,CYP3A5
13613,norketamine,glutamate receptor antagonist,GRIN1,,,,GRIN1
13614,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",BDKRB2,,,,BDKRB2
13615,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor",SIGMAR1,,,,SIGMAR1
13616,O-2050,cannabinoid receptor antagonist,CNR1,,,,CNR1
13617,OBAA,phospholipase inhibitor,PLA2G1B,,,,PLA2G1B
13618,OBAA,phospholipase inhibitor,PLA2G1B,,,,PLA2G1B
13619,orphenadrine,acetylcholine receptor antagonist,CYP2B6,,,,CYP2B6
13620,orphenadrine,acetylcholine receptor antagonist,GRIN1,,,,GRIN1
13621,orphenadrine,acetylcholine receptor antagonist,GRIN2D,,,,GRIN2D
13622,orphenadrine,acetylcholine receptor antagonist,GRIN3A,,,,GRIN3A
13623,orphenadrine,acetylcholine receptor antagonist,GRIN3B,,,,GRIN3B
13624,orphenadrine,acetylcholine receptor antagonist,HRH1,,,,HRH1
13625,orphenadrine,acetylcholine receptor antagonist,SCN10A,,,,SCN10A
13626,orphenadrine,acetylcholine receptor antagonist,SLC6A2,,,,SLC6A2
13627,oxybenzone,lipase inhibitor,LIPE,,,,LIPE
13628,olomoucine,CDK inhibitor,CDK1,,,,CDK1
13629,olomoucine,CDK inhibitor,CDK2,,,,CDK2
13630,olomoucine,CDK inhibitor,CDK5,,,,CDK5
13631,olomoucine,CDK inhibitor,MAPK1,,,,MAPK1
13632,ozagrel,"thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor",TBXAS1,,,,TBXAS1
13633,P-1075,"ATP channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
13634,pantoprazole,ATPase inhibitor,ATP4A,,,,ATP4A
13635,pantoprazole,ATPase inhibitor,CYP2C19,,,,CYP2C19
13636,pantoprazole,ATPase inhibitor,CYP3A4,,,,CYP3A4
13637,pargyline,monoamine oxidase inhibitor,MAOB,,,,MAOB
13638,pargyline,monoamine oxidase inhibitor,MAOA,,,,MAOA
13639,PCA-4248,platelet activating factor receptor antagonist,PTAFR,,,,PTAFR
13640,PD-166793,"collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor",MMP13,,,,MMP13
13641,PD-166793,"collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor",MMP2,,,,MMP2
13642,PD-166793,"collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor",MMP3,,,,MMP3
13643,PD-169316,p38 MAPK inhibitor,ALOX5,,,,ALOX5
13644,D-64406,PDGFR tyrosine kinase receptor inhibitor,FLT3,,,,FLT3
13645,D-64406,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,,,,PDGFRA
13646,D-64406,PDGFR tyrosine kinase receptor inhibitor,PDGFRB,,,,PDGFRB
13647,penfluridol,"dopamine receptor antagonist, T-type calcium channel blocker",CACNA1G,,,,CACNA1G
13648,penfluridol,"dopamine receptor antagonist, T-type calcium channel blocker",DRD1,,,,DRD1
13649,penfluridol,"dopamine receptor antagonist, T-type calcium channel blocker",DRD2,,,,DRD2
13650,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
13651,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",ACHE,,,,ACHE
13652,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",ADORA1,,,,ADORA1
13653,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",ADORA2A,,,,ADORA2A
13654,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",ADRA2B,,,,ADRA2B
13655,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",CHIA,,,,CHIA
13656,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",NT5E,,,,NT5E
13657,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",PDE4A,,,,PDE4A
13658,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",PDE4B,,,,PDE4B
13659,pentoxifylline,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor",PDE5A,,,,PDE5A
13660,phentolamine,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
13661,phentolamine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
13662,phentolamine,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
13663,phentolamine,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
13664,phentolamine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
13665,phentolamine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
13666,phenylbutazone,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
13667,phenylbutazone,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
13668,phenylbutazone,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor",PTGIS,,,,PTGIS
13669,pinacidil,"ATP channel activator, potassium channel agonist",ABCC9,,,,ABCC9
13670,pinacidil,"ATP channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
13671,pinocembrin,"androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor",AR,,,,AR
13672,pinocembrin,"androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor",CYP1B1,,,,CYP1B1
13673,pinocembrin,"androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor",SRD5A1,,,,SRD5A1
13674,pinocembrin,"androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor",SRD5A2,,,,SRD5A2
13675,pirenzepine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
13676,pirenzepine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
13677,pirenzepine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
13678,pirenzepine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
13679,pirenzepine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
13680,PIT,purinergic receptor antagonist,P2RY1,,,,P2RY1
13681,PNU-120596,"acetylcholine receptor modulator, acetylcholine receptor positive allosteric modulator",CHRNA7,,,,CHRNA7
13682,PNU-22394,serotonin receptor agonist,MAOA,,,,MAOA
13683,PNU-22394,serotonin receptor agonist,MAOB,,,,MAOB
13684,PNU-282987,acetylcholine receptor antagonist,CHRNA7,,,,CHRNA7
13685,PP-1,"src inhibitor, Abl kinase inhibitor",HCK,,,,HCK
13686,PP-1,"src inhibitor, Abl kinase inhibitor",RET,,,,RET
13687,PP-1,"src inhibitor, Abl kinase inhibitor",SRC,,,,SRC
13688,PP-2,src inhibitor,SRC,,,,SRC
13689,PP-2,src inhibitor,LCK,,,,LCK
13690,PP-2,src inhibitor,ABL1,,,,ABL1
13691,PP-2,src inhibitor,LYN,,,,LYN
13692,PP-2,src inhibitor,RIPK2,,,,RIPK2
13693,beta-CCP,"indoleamine 2,3-dioxygenase inhibitor",GABRA1,,,,GABRA1
13694,beta-CCP,"indoleamine 2,3-dioxygenase inhibitor",GABRG2,,,,GABRG2
13695,beta-CCP,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,,,IDO1
13696,PSB-11,adenosine receptor antagonist,ADORA3,,,,ADORA3
13697,PSB-11,adenosine receptor antagonist,ADORA1,,,,ADORA1
13698,PSB-11,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
13699,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ADRA1A,,,,ADRA1A
13700,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ADRA2A,,,,ADRA2A
13701,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ADRB1,,,,ADRB1
13702,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ADRB2,,,,ADRB2
13703,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF1,,,,ATF1
13704,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF2,,,,ATF2
13705,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF3,,,,ATF3
13706,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF4,,,,ATF4
13707,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF5,,,,ATF5
13708,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF6,,,,ATF6
13709,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",ATF7,,,,ATF7
13710,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",CXCL8,,,,CXCL8
13711,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",FOS,,,,FOS
13712,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",HRH1,,,,HRH1
13713,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",IL2,,,,IL2
13714,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",JDP2,,,,JDP2
13715,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",JUN,,,,JUN
13716,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",NFATC1,,,,NFATC1
13717,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",SLC6A2,,,,SLC6A2
13718,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",SLC6A3,,,,SLC6A3
13719,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",SLC6A4,,,,SLC6A4
13720,pseudoephedrine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",TNF,,,,TNF
13721,mepyramine,histamine receptor antagonist,HRH1,,,,HRH1
13722,palmitoylethanolamide,"cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity",CNR2,,,,CNR2
13723,palmitoylethanolamide,"cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity",GPR119,,,,GPR119
13724,palmitoylethanolamide,"cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity",GPR55,,,,GPR55
13725,phenanthridone,PARP inhibitor,PARP1,,,,PARP1
13726,phenformin,AMPK activator,KCNJ8,,,,KCNJ8
13727,phenformin,AMPK activator,PRKAA1,,,,PRKAA1
13728,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5A1,,,,ATP5F1A
13729,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5B,,,,ATP5F1B
13730,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",ATP5C1,,,,ATP5F1C
13731,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",IRF3,,,,IRF3
13732,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",PTGS2,,,,PTGS2
13733,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",SIRT1,,,,SIRT1
13734,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",SYK,,,,SYK
13735,piceatannol,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor",TYR,,,,TYR
13736,picrotoxin,GABA receptor antagonist,GABRA1,,,,GABRA1
13737,picrotoxin,GABA receptor antagonist,GLRA2,,,,GLRA2
13738,picrotoxin,GABA receptor antagonist,GLRA3,,,,GLRA3
13739,picrotoxin,GABA receptor antagonist,GABRR1,,,,GABRR1
13740,picrotoxin,GABA receptor antagonist,GLRA1,,,,GLRA1
13741,picrotoxin,GABA receptor antagonist,GLRB,,,,GLRB
13742,picrotoxin,GABA receptor antagonist,HTR3A,,,,HTR3A
13743,picrotoxin,GABA receptor antagonist,HTR3B,,,,HTR3B
13744,cycloserine,"glutamate receptor agonist, glutamate receptor modulator",GRIN1,,,,GRIN1
13745,pinacidil,"ATP channel activator, potassium channel agonist",ABCC9,,,,ABCC9
13746,pinacidil,"ATP channel activator, potassium channel agonist",KCNJ8,,,,KCNJ8
13747,piretanide,"diuretic, glucocorticoid receptor agonist",SLC12A1,,,,SLC12A1
13748,piretanide,"diuretic, glucocorticoid receptor agonist",SLC12A2,,,,SLC12A2
13749,pirfenidone,"FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",TNF,,,,TNF
13750,pirfenidone,"FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",FURIN,,,,FURIN
13751,pirfenidone,"FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",MAPK14,,,,MAPK14
13752,pirfenidone,"FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",TNFRSF1A,,,,TNFRSF1A
13753,pravastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
13754,pravastatin,HMGCR inhibitor,SLCO1B1,,,,SLCO1B1
13755,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",CYP17A1,,,,CYP17A1
13756,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",PGR,,,,PGR
13757,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",SULT2B1,,,,SULT2B1
13758,procaterol,adrenergic receptor agonist,ADRB2,,,,ADRB2
13759,progesterone,progesterone receptor agonist,PGR,,,,PGR
13760,progesterone,progesterone receptor agonist,CYP17A1,,,,CYP17A1
13761,progesterone,progesterone receptor agonist,NR3C2,,,,NR3C2
13762,progesterone,progesterone receptor agonist,CATSPER1,,,,CATSPER1
13763,progesterone,progesterone receptor agonist,CATSPER2,,,,CATSPER2
13764,progesterone,progesterone receptor agonist,CATSPER3,,,,CATSPER3
13765,progesterone,progesterone receptor agonist,CATSPER4,,,,CATSPER4
13766,progesterone,progesterone receptor agonist,CYP2C19,,,,CYP2C19
13767,progesterone,progesterone receptor agonist,ESR1,,,,ESR1
13768,progesterone,progesterone receptor agonist,OPRK1,,,,OPRK1
13769,progesterone,progesterone receptor agonist,TRPC5,,,,TRPC5
13770,proxyfan,histamine receptor modulator,HRH3,,,,HRH3
13771,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SCN5A,,,,SCN5A
13772,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",ABCB1,,,,ABCB1
13773,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",CYP2D6,,,,CYP2D6
13774,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA5,,,,KCNA5
13775,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA7,,,,KCNA7
13776,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH1,,,,KCNH1
13777,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH2,,,,KCNH2
13778,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH5,,,,KCNH5
13779,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK1,,,,KCNK1
13780,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK6,,,,KCNK6
13781,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SLC29A4,,,,SLC29A4
13782,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SCN5A,,,,SCN5A
13783,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",ABCB1,,,,ABCB1
13784,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",CYP2D6,,,,CYP2D6
13785,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA5,,,,KCNA5
13786,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA7,,,,KCNA7
13787,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH1,,,,KCNH1
13788,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH2,,,,KCNH2
13789,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH5,,,,KCNH5
13790,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK1,,,,KCNK1
13791,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK6,,,,KCNK6
13792,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SLC29A4,,,,SLC29A4
13793,BRD-K84421793,dopamine receptor agonist,DRD1,,,,DRD1
13794,dapsone,"dihydrofolate reductase inhibitor, dihydropteroate synthase inhibitor, FOLP inhibitor",DHFR,,,,DHFR
13795,edrophonium,acetylcholinesterase inhibitor,ACHE,,,,ACHE
13796,edrophonium,acetylcholinesterase inhibitor,BCHE,,,,BCHE
13797,siguazodan,"histamine receptor antagonist, phosphodiesterase inhibitor",PDE3A,,,,PDE3A
13798,RG-13022,"EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor",EGFR,,,,EGFR
13799,RG-13022,"EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFRA,,,,PDGFRA
13800,RG-13022,"EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFRB,,,,PDGFRB
13801,ritodrine,adrenergic receptor agonist,ADRB2,,,,ADRB2
13802,RS-100329,adrenoceptor antagonist,ADRA1A,,,,ADRA1A
13803,RS-100329,adrenoceptor antagonist,ADRA1D,,,,ADRA1D
13804,RS-504393,CC chemokine receptor antagonist,CCR2,,,,CCR2
13805,RS-504393,CC chemokine receptor antagonist,CCL2,,,,CCL2
13806,RS-56812,"serotonin receptor antagonist, serotonin receptor partial agonist",HTR3A,,,,HTR3A
13807,RS-67506,serotonin receptor partial agonist,HTR4,,,,HTR4
13808,RWJ-21757,toll-like receptor ligand,TLR7,,,,TLR7
13809,ryanodine,calcium channel inhibitor,RYR1,,,,RYR1
13810,ryanodine,calcium channel inhibitor,RYR2,,,,RYR2
13811,ryanodine,calcium channel inhibitor,RYR3,,,,RYR3
13812,raclopride,dopamine receptor antagonist,DRD2,,,,DRD2
13813,raclopride,dopamine receptor antagonist,DRD3,,,,DRD3
13814,raclopride,dopamine receptor antagonist,HTR1A,,,,HTR1A
13815,reboxetine,"adrenergic receptor antagonist, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine transporter inhibitor",SLC6A2,,,,SLC6A2
13816,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",NISCH,,,,NISCH
13817,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",KCND3,,,,KCND3
13818,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",KCNK10,,,,KCNK10
13819,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",KCNK2,,,,KCNK2
13820,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",KCNK4,,,,KCNK4
13821,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",KCNN4,,,,KCNN4
13822,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",SCN5A,,,,SCN5A
13823,riluzole,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker",SLC7A11,,,,SLC7A11
13824,rosmarinic-acid,antioxidant,MCL1,,,,MCL1
13825,rosmarinic-acid,antioxidant,TYR,,,,TYR
13826,ryuvidine,histone lyinse methyltransferase inhibitor,CDK4,,,,CDK4
13827,ryuvidine,histone lyinse methyltransferase inhibitor,CDK2,,,,CDK2
13828,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",DRD2,,,,DRD2
13829,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR2A,,,,HTR2A
13830,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR2B,,,,HTR2B
13831,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
13832,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",ADRA2A,,,,ADRA2A
13833,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",ADRA2B,,,,ADRA2B
13834,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",ADRA2C,,,,ADRA2C
13835,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",DRD3,,,,DRD3
13836,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",DRD4,,,,DRD4
13837,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR1A,,,,HTR1A
13838,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR1B,,,,HTR1B
13839,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR1D,,,,HTR1D
13840,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",HTR2C,,,,HTR2C
13841,terguride,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist",PRL,,,,PRL
13842,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",DRD2,,,,DRD2
13843,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR2B,,,,HTR2B
13844,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR2C,,,,HTR2C
13845,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",ADRA2A,,,,ADRA2A
13846,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",ADRA2B,,,,ADRA2B
13847,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",ADRA2C,,,,ADRA2C
13848,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",DRD1,,,,DRD1
13849,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",DRD3,,,,DRD3
13850,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",DRD4,,,,DRD4
13851,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",DRD5,,,,DRD5
13852,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR1A,,,,HTR1A
13853,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR1B,,,,HTR1B
13854,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR1D,,,,HTR1D
13855,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR2A,,,,HTR2A
13856,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",ADRA1A,,,,ADRA1A
13857,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HRH1,,,,HRH1
13858,lisuride,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand",HTR6,,,,HTR6
13859,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS2,,,,PTGS2
13860,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS1,,,,PTGS1
13861,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",ASIC1,,,,ASIC1
13862,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",BCL2,,,,BCL2
13863,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",CFTR,,,,CFTR
13864,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",CYP2C8,,,,CYP2C8
13865,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",FABP2,,,,FABP2
13866,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PLAT,,,,PLAT
13867,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PPARG,,,,PPARG
13868,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",SLC5A8,,,,SLC5A8
13869,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",THBD,,,,THBD
13870,salvinorin-a,opioid receptor agonist,OPRK1,,,,OPRK1
13871,salvinorin-a,opioid receptor agonist,OPRD1,,,,OPRD1
13872,salvinorin-a,opioid receptor agonist,OPRM1,,,,OPRM1
13873,SANT-1,smoothened receptor antagonist,DHH,,,,DHH
13874,SANT-1,smoothened receptor antagonist,IHH,,,,IHH
13875,SANT-1,smoothened receptor antagonist,PTCH1,,,,PTCH1
13876,SANT-1,smoothened receptor antagonist,SMO,,,,SMO
13877,SB-200646,serotonin receptor antagonist,HTR2B,,,,HTR2B
13878,SB-200646,serotonin receptor antagonist,HTR2C,,,,HTR2C
13879,flecainide,"sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
13880,flecainide,"sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker",KCNA5,,,,KCNA5
13881,flecainide,"sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker",KCNA7,,,,KCNA7
13882,flecainide,"sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker",SCN4A,,,,SCN4A
13883,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK14,,,,MAPK14
13884,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK1,,,,MAPK1
13885,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK11,,,,MAPK11
13886,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",AKT1,,,,AKT1
13887,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",ALOX5,,,,ALOX5
13888,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CHEK1,,,,CHEK1
13889,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CYP2D6,,,,CYP2D6
13890,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",CYP3A4,,,,CYP3A4
13891,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",GAK,,,,GAK
13892,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",GSK3B,,,,GSK3B
13893,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",LCK,,,,LCK
13894,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK10,,,,MAPK10
13895,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK12,,,,MAPK12
13896,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK8,,,,MAPK8
13897,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",MAPK9,,,,MAPK9
13898,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",PRKCA,,,,PRKCA
13899,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RAF1,,,,RAF1
13900,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RIPK2,,,,RIPK2
13901,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",ROCK1,,,,ROCK1
13902,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",RPS6KB1,,,,RPS6KB1
13903,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",SGK1,,,,SGK1
13904,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",SRC,,,,SRC
13905,SB-203580,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor",TNF,,,,TNF
13906,SB-205384,GABA receptor modulator,GABRA3,,,,GABRA3
13907,SB-205384,GABA receptor modulator,GABRA5,,,,GABRA5
13908,SB-205384,GABA receptor modulator,GABRA6,,,,GABRA6
13909,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRD1,,,,OPRD1
13910,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRK1,,,,OPRK1
13911,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRM1,,,,OPRM1
13912,SB-218795,tachykinin antagonist,TACR3,,,,TACR3
13913,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",MAPK11,,,,MAPK11
13914,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",MAPK14,,,,MAPK14
13915,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",PTGS2,,,,PTGS2
13916,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
13917,SB-269970,serotonin receptor antagonist,HTR7,,,,HTR7
13918,SB-366791,TRPV antagonist,TRPV1,,,,TRPV1
13919,SB-431542,"TGF beta receptor inhibitor, ALK inhibitor",TGFBR1,,,,TGFBR1
13920,SB-431542,"TGF beta receptor inhibitor, ALK inhibitor",ACVR1C,,,,ACVR1C
13921,SB-431542,"TGF beta receptor inhibitor, ALK inhibitor",ACVR1B,,,,ACVR1B
13922,SC-560,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
13923,SC-68376,p38 MAPK inhibitor,MAPK14,,,,MAPK14
13924,SCH-23390,dopamine receptor antagonist,DRD1,,,,DRD1
13925,SCH-23390,dopamine receptor antagonist,DRD5,,,,DRD5
13926,SCH-23390,dopamine receptor antagonist,HTR2C,,,,HTR2C
13927,SCH-23390,dopamine receptor antagonist,KCNJ4,,,,KCNJ4
13928,SCH-23390,dopamine receptor antagonist,KCNJ6,,,,KCNJ6
13929,SCH-442416,adenosine receptor antagonist,ADORA1,,,,ADORA1
13930,SCH-442416,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
13931,SCH-442416,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
13932,SCH-442416,adenosine receptor antagonist,ADORA3,,,,ADORA3
13933,SCH-58261,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
13934,SCH-58261,adenosine receptor antagonist,ADORA1,,,,ADORA1
13935,SCH-58261,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
13936,SCH-58261,adenosine receptor antagonist,ADORA3,,,,ADORA3
13937,SDZ-205-557,serotonin receptor antagonist,HTR3A,,,,HTR3A
13938,SDZ-205-557,serotonin receptor antagonist,HTR3B,,,,HTR3B
13939,SDZ-205-557,serotonin receptor antagonist,HTR4,,,,HTR4
13940,SDZ-NKT-343,tachykinin antagonist,TACR1,,,,TACR1
13941,SDZ-WAG-994,adenosine receptor agonist,ADORA1,,,,ADORA1
13942,skatole,thrombin inhibitor,F2,,,,F2
13943,SKF-77434,"dopamine receptor agonist, dopamine receptor partial agonist",DRD1,,,,DRD1
13944,SKF-86002,p38 MAPK inhibitor,ALOX5,,,,ALOX5
13945,SKF-86002,p38 MAPK inhibitor,MAPK14,,,,MAPK14
13946,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",MAPK10,,,,MAPK10
13947,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",MAPK8,,,,MAPK8
13948,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",MAPK9,,,,MAPK9
13949,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",TTK,,,,TTK
13950,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
13951,pyrazolanthrone,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor",MAPK8IP1,,,,MAPK8IP1
13952,SQ-22536,adenylyl cyclase inhibitor,ADCY1,,,,ADCY1
13953,SQ-22536,adenylyl cyclase inhibitor,ADCY5,,,,ADCY5
13954,SR-27897,CCK receptor antagonist,CCKAR,,,,CCKAR
13955,relcovaptan,vasopressin receptor antagonist,AVPR1A,,,,AVPR1A
13956,relcovaptan,vasopressin receptor antagonist,AVPR1B,,,,AVPR1B
13957,relcovaptan,vasopressin receptor antagonist,AVPR2,,,,AVPR2
13958,relcovaptan,vasopressin receptor antagonist,OXTR,,,,OXTR
13959,SR-59230A,adrenergic receptor antagonist,ADRB3,,,,ADRB3
13960,SR-59230A,adrenergic receptor antagonist,ADRB1,,,,ADRB1
13961,SR-59230A,adrenergic receptor antagonist,ADRB2,,,,ADRB2
13962,STO-609,"calcium/calmodulin dependent protein kinase inhibitor, calmodulin inhibitor",CAMKK1,,,,CAMKK1
13963,STO-609,"calcium/calmodulin dependent protein kinase inhibitor, calmodulin inhibitor",CAMKK2,,,,CAMKK2
13964,SU-4312,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor",KDR,,,,KDR
13965,SU-4312,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor",PDGFRB,,,,PDGFRB
13966,SU-4312,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor",KDR,,,,KDR
13967,SU-4312,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor",PDGFRB,,,,PDGFRB
13968,SU-1498,"receptor tyrosine protein kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor",ERBB2,,,,ERBB2
13969,SU-1498,"receptor tyrosine protein kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor",KDR,,,,KDR
13970,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",DRD2,,,,DRD2
13971,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA7,,,,CA7
13972,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",DRD3,,,,DRD3
13973,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA1,,,,CA1
13974,sulpiride,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist",CA12,,,,CA12
13975,saclofen,GABA receptor antagonist,GABBR1,,,,GABBR1
13976,saclofen,GABA receptor antagonist,GABBR2,,,,GABBR2
13977,saclofen,GABA receptor antagonist,KCTD12,,,,KCTD12
13978,saclofen,GABA receptor antagonist,KCTD16,,,,KCTD16
13979,saclofen,GABA receptor antagonist,KCTD8,,,,KCTD8
13980,scopolamine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
13981,scopolamine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
13982,scopolamine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
13983,scopolamine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
13984,scopolamine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
13985,scopolamine,acetylcholine receptor antagonist,SI,,,,SI
13986,securinine,"GABA receptor antagonist, TP53 activator",GABRA1,,,,GABRA1
13987,T-0156,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
13988,TC-2559,"acetylcholine receptor agonist, acetylcholine receptor ligand",CHRNA4,,,,CHRNA4
13989,TCB2,serotonin receptor agonist,HTR2A,,,,HTR2A
13990,TER-14687,inhibitor of translocation of PKCq in T cells,PRKCQ,,,,PRKCQ
13991,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS2,,,,PTGS2
13992,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS1,,,,PTGS1
13993,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",ASIC1,,,,ASIC1
13994,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",BCL2,,,,BCL2
13995,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",CFTR,,,,CFTR
13996,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",CYP2C8,,,,CYP2C8
13997,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",FABP2,,,,FABP2
13998,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PLAT,,,,PLAT
13999,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PPARG,,,,PPARG
14000,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",SLC5A8,,,,SLC5A8
14001,ibuprofen,"cyclooxygenase inhibitor, NFkB pathway inhibitor",THBD,,,,THBD
14002,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRM1,,,,OPRM1
14003,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
14004,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
14005,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CHRFAM7A,,,,CHRFAM7A
14006,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CHRM3,,,,CHRM3
14007,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CYP2B6,,,,CYP2B6
14008,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",GRIN3A,,,,GRIN3A
14009,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",HTR2C,,,,HTR2C
14010,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRD1,,,,OPRD1
14011,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRK1,,,,OPRK1
14012,tripelennamine,histamine receptor antagonist,HRH1,,,,HRH1
14013,thenoyltrifluoroacetone,PPAR receptor ligand,CES1,,,,CES1
14014,thenoyltrifluoroacetone,PPAR receptor ligand,PPARA,,,,PPARA
14015,thenoyltrifluoroacetone,PPAR receptor ligand,SDHA,,,,SDHA
14016,TTNPB,"RAR agonist, retinoid receptor agonist",RARB,,,,RARB
14017,TTNPB,"RAR agonist, retinoid receptor agonist",RARA,,,,RARA
14018,TTNPB,"RAR agonist, retinoid receptor agonist",RARG,,,,RARG
14019,tubaic-acid,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor",MT-ND1,,,,MT-ND1
14020,tyrphostin-47,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor",EGFR,,,,EGFR
14021,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR1,,,,ESR1
14022,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",ESR2,,,,ESR2
14023,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",CYP3A5,,,,CYP3A5
14024,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",EBP,,,,EBP
14025,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",GPER1,,,,GPER1
14026,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCA,,,,PRKCA
14027,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCB,,,,PRKCB
14028,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCD,,,,PRKCD
14029,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCE,,,,PRKCE
14030,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCG,,,,PRKCG
14031,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCI,,,,PRKCI
14032,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCQ,,,,PRKCQ
14033,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor",PRKCZ,,,,PRKCZ
14034,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TUBB,,,,TUBB
14035,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",NR1I2,,,,NR1I2
14036,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",ABCB1,,,,ABCB1
14037,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",BCL2,,,,BCL2
14038,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",CYP2C8,,,,CYP2C8
14039,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAP2,,,,MAP2
14040,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAP4,,,,MAP4
14041,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAPT,,,,MAPT
14042,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TLR4,,,,TLR4
14043,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TUBB1,,,,TUBB1
14044,tenidap,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist",ALOX5,,,,ALOX5
14045,tenidap,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist",KCNJ4,,,,KCNJ4
14046,tenidap,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist",PTGS1,,,,PTGS1
14047,homatropine,acetylcholine receptor antagonist,CES1,,,,CES1
14048,homatropine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
14049,tiotidine,histamine receptor antagonist,HRH2,,,,HRH2
14050,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",SLC6A2,,,,SLC6A2
14051,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",SLC6A3,,,,SLC6A3
14052,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",SLC6A4,,,,SLC6A4
14053,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN1,,,,GRIN1
14054,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN2A,,,,GRIN2A
14055,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN2B,,,,GRIN2B
14056,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN2C,,,,GRIN2C
14057,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN2D,,,,GRIN2D
14058,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN3A,,,,GRIN3A
14059,atomoxetine,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor",GRIN3B,,,,GRIN3B
14060,tracazolate,"GABA receptor agonist, GABA receptor modulator",GABRA1,,,,GABRA1
14061,trap-101,"nociceptin/orphanin FQ (NOP) receptor antagonist, opioid receptor antagonist",OPRL1,,,,OPRL1
14062,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",NR3C1,,,,NR3C1
14063,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A5,,,,CYP3A5
14064,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A7,,,,CYP3A7
14065,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",SERPINA6,,,,SERPINA6
14066,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR3A,,,,HTR3A
14067,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA1,,,,GLRA1
14068,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRA2,,,,GLRA2
14069,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",GLRB,,,,GLRB
14070,tropisetron,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker",HTR4,,,,HTR4
14071,tubocurarine,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
14072,tubocurarine,acetylcholine receptor antagonist,HTR3A,,,,HTR3A
14073,tubocurarine,acetylcholine receptor antagonist,ACHE,,,,ACHE
14074,tubocurarine,acetylcholine receptor antagonist,HTR3B,,,,HTR3B
14075,tubocurarine,acetylcholine receptor antagonist,KCNN1,,,,KCNN1
14076,tubocurarine,acetylcholine receptor antagonist,KCNN2,,,,KCNN2
14077,tubocurarine,acetylcholine receptor antagonist,KCNN3,,,,KCNN3
14078,tubocurarine,acetylcholine receptor antagonist,ZACN,,,,ZACN
14079,U-99194,dopamine receptor antagonist,DRD3,,,,DRD3
14080,UBP-302,glutamate receptor antagonist,GRIK1,,,,GRIK1
14081,vardenafil,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
14082,vardenafil,phosphodiesterase inhibitor,CYP2C19,,,,CYP2C19
14083,vardenafil,phosphodiesterase inhibitor,CYP2C8,,,,CYP2C8
14084,vardenafil,phosphodiesterase inhibitor,CYP3A5,,,,CYP3A5
14085,vardenafil,phosphodiesterase inhibitor,PDE6G,,,,PDE6G
14086,vardenafil,phosphodiesterase inhibitor,PDE6H,,,,PDE6H
14087,veratridine,sodium channel activator,SCN1A,,,,SCN1A
14088,veratridine,sodium channel activator,SCN3A,,,,SCN3A
14089,veratridine,sodium channel activator,SCN8A,,,,SCN8A
14090,veratridine,sodium channel activator,SCN9A,,,,SCN9A
14091,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBB,,,,TUBB
14092,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",JUN,,,,JUN
14093,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBA1A,,,,TUBA1A
14094,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBD1,,,,TUBD1
14095,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBE1,,,,TUBE1
14096,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBG1,,,,TUBG1
14097,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBB,,,,TUBB
14098,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBA4A,,,,TUBA4A
14099,VUF-5681,histamine receptor antagonist,HRH3,,,,HRH3
14100,vincamine,adrenergic receptor antagonist,CHRM1,,,,CHRM1
14101,vincamine,adrenergic receptor antagonist,CHRM2,,,,CHRM2
14102,vincamine,adrenergic receptor antagonist,CHRM3,,,,CHRM3
14103,vincamine,adrenergic receptor antagonist,CHRM4,,,,CHRM4
14104,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBB,,,,TUBB
14105,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBA4A,,,,TUBA4A
14106,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",PDE1A,,,,PDE1A
14107,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",PDE1C,,,,PDE1C
14108,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",SCN10A,,,,SCN10A
14109,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",PDE1A,,,,PDE1A
14110,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",PDE1C,,,,PDE1C
14111,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor",SCN10A,,,,SCN10A
14112,W-13,calmodulin antagonist,CALM1,,,,CALM1
14113,W-13,calmodulin antagonist,MYLK,,,,MYLK
14114,W-13,calmodulin antagonist,PDE1A,,,,PDE1A
14115,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",CALM1,,,,CALM1
14116,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",CALM2,,,,CALM2
14117,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",KCNA5,,,,KCNA5
14118,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",KCNH2,,,,KCNH2
14119,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",TNNC1,,,,TNNC1
14120,W-7,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker",TNNI3,,,,TNNI3
14121,WAY-213613,glutamate transporter inhibitor,SLC1A2,,,,SLC1A2
14122,apafant,platelet activating factor receptor antagonist,PTAFR,,,,PTAFR
14123,pirinixic-acid,PPAR receptor agonist,PPARA,,,,PPARA
14124,xylazine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
14125,xylazine,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
14126,xylazine,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
14127,xaliproden,"serotonin receptor agonist, nerve growth factor agonist, neurotrophic factor enhancer",HTR1A,,,,HTR1A
14128,YC-1,"activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor",HIF1A,,,,HIF1A
14129,YC-1,"activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor",GUCY1A2,,,,GUCY1A2
14130,YC-1,"activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor",GUCY1A3,,,,GUCY1A1
14131,YC-1,"activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor",GUCY1B3,,,,GUCY1B1
14132,YM-298198,glutamate receptor antagonist,GRM1,,,,GRM1
14133,YM-976,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor",PDE4A,,,,PDE4A
14134,YM-976,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor",PDE4B,,,,PDE4B
14135,YM-976,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor",PDE4C,,,,PDE4C
14136,YM-976,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor",PDE4D,,,,PDE4D
14137,YM-976,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
14138,ZD-2079,"adrenergic receptor agonist, insulin sensitizer",ADRB3,,,,ADRB3
14139,ZD-7155,angiotensin receptor antagonist,AGTR1,,,,AGTR1
14140,ZD-7288,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN1,,,,HCN1
14141,ZD-7288,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN2,,,,HCN2
14142,ZD-7288,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN3,,,,HCN3
14143,ZD-7288,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN4,,,,HCN4
14144,ZK-164015,estrogen receptor antagonist,ESR1,,,,ESR1
14145,ZK-164015,estrogen receptor antagonist,ESR2,,,,ESR2
14146,ZK-93423,benzodiazepine receptor agonist,GABRA1,,,,GABRA1
14147,ZK-93423,benzodiazepine receptor agonist,GABRA2,,,,GABRA2
14148,ZK-93423,benzodiazepine receptor agonist,GABRA3,,,,GABRA3
14149,ZK-93423,benzodiazepine receptor agonist,GABRA5,,,,GABRA5
14150,ZK-93423,benzodiazepine receptor agonist,GABRB2,,,,GABRB2
14151,ZK-93423,benzodiazepine receptor agonist,GABRG2,,,,GABRG2
14152,ZK-93426,"benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA1,,,,GABRA1
14153,ZK-93426,"benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA2,,,,GABRA2
14154,ZK-93426,"benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA3,,,,GABRA3
14155,ZK-93426,"benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist",GABRA5,,,,GABRA5
14156,labetalol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
14157,labetalol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
14158,labetalol,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
14159,labetalol,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
14160,labetalol,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
14161,zaprinast,"phosphodiesterase inhibitor, histamine release inhibitor",PDE5A,,,,PDE5A
14162,zaprinast,"phosphodiesterase inhibitor, histamine release inhibitor",GPR35,,,,GPR35
14163,zaprinast,"phosphodiesterase inhibitor, histamine release inhibitor",PDE1A,,,,PDE1A
14164,zaprinast,"phosphodiesterase inhibitor, histamine release inhibitor",PDE4D,,,,PDE4D
14165,zaprinast,"phosphodiesterase inhibitor, histamine release inhibitor",PDE9A,,,,PDE9A
14166,zardaverine,phosphodiesterase inhibitor,PDE4D,,,,PDE4D
14167,zardaverine,phosphodiesterase inhibitor,PDE3A,,,,PDE3A
14168,zardaverine,phosphodiesterase inhibitor,PDE4A,,,,PDE4A
14169,zardaverine,phosphodiesterase inhibitor,PDE4B,,,,PDE4B
14170,zardaverine,phosphodiesterase inhibitor,PDE4C,,,,PDE4C
14171,zatebradine,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN1,,,,HCN1
14172,zatebradine,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN2,,,,HCN2
14173,zatebradine,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN3,,,,HCN3
14174,zatebradine,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker",HCN4,,,,HCN4
14175,betulinic-acid,"apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor",CASP3,,,,CASP3
14176,betulinic-acid,"apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor",CASP8,,,,CASP8
14177,betulinic-acid,"apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor",GPBAR1,,,,GPBAR1
14178,betulinic-acid,"apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor",TOP1,,,,TOP1
14179,bongkrek-acid,"mitochondrial ADP, ATP translocase inhibitor",SLC25A4,,,,SLC25A4
14180,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1A1,,,,ATP1A1
14181,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1A2,,,,ATP1A2
14182,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1A3,,,,ATP1A3
14183,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1A4,,,,ATP1A4
14184,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1B1,,,,ATP1B1
14185,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1B2,,,,ATP1B2
14186,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1B3,,,,ATP1B3
14187,cinobufagin,"ATPase inhibitor, chloride channel activator",ATP1B4,,,,ATP1B4
14188,cinobufagin,"ATPase inhibitor, chloride channel activator",FXYD2,,,,FXYD2
14189,flupentixol,dopamine receptor antagonist,DRD2,,,,DRD2
14190,flupentixol,dopamine receptor antagonist,DRD1,,,,DRD1
14191,flupentixol,dopamine receptor antagonist,ADRA1A,,,,ADRA1A
14192,flupentixol,dopamine receptor antagonist,CHRM1,,,,CHRM1
14193,flupentixol,dopamine receptor antagonist,DRD3,,,,DRD3
14194,flupentixol,dopamine receptor antagonist,DRD5,,,,DRD5
14195,flupentixol,dopamine receptor antagonist,HTR2A,,,,HTR2A
14196,coumestrol,"AGE inhibitor, estrogen receptor agonist, estrogen receptor ligand",ESR1,,,,ESR1
14197,coumestrol,"AGE inhibitor, estrogen receptor agonist, estrogen receptor ligand",ESR2,,,,ESR2
14198,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",GSK3B,,,,GSK3B
14199,cycloheximide,"glycogen synthase kinase inhibitor, protein synthesis inhibitor",RPL3,,,,RPL3
14200,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",SMO,,,,SMO
14201,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",DHH,,,,DHH
14202,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",IHH,,,,IHH
14203,cyclopamine,"smoothened receptor antagonist, hedgehog pathway inhibitor",PTCH1,,,,PTCH1
14204,bucladesine,"adenosine receptor agonist, cAMP stimulant, vasodilator",PRKACA,,,,PRKACA
14205,estradiol,estrogen receptor agonist,ESR1,,,,ESR1
14206,estradiol,estrogen receptor agonist,ESR2,,,,ESR2
14207,estradiol,estrogen receptor agonist,NR1I2,,,,NR1I2
14208,estradiol,estrogen receptor agonist,CYP2B6,,,,CYP2B6
14209,estradiol,estrogen receptor agonist,CYP2C19,,,,CYP2C19
14210,estradiol,estrogen receptor agonist,CYP2C8,,,,CYP2C8
14211,estradiol,estrogen receptor agonist,CYP2E1,,,,CYP2E1
14212,estradiol,estrogen receptor agonist,CYP3A5,,,,CYP3A5
14213,estradiol,estrogen receptor agonist,CYP3A7,,,,CYP3A7
14214,estradiol,estrogen receptor agonist,GPER1,,,,GPER1
14215,estradiol,estrogen receptor agonist,KCNMA1,,,,KCNMA1
14216,formestane,aromatase inhibitor,CYP19A1,,,,CYP19A1
14217,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",AKR1C3,,,,AKR1C3
14218,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",AKR1B1,,,,AKR1B1
14219,rutin,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor",F10,,,,F10
14220,siguazodan,"histamine receptor antagonist, phosphodiesterase inhibitor",PDE3A,,,,PDE3A
14221,alpha-estradiol,estrogen receptor agonist,ESR1,,,,ESR1
14222,alpha-estradiol,estrogen receptor agonist,ESR2,,,,ESR2
14223,alpha-estradiol,estrogen receptor agonist,NR1I2,,,,NR1I2
14224,alpha-estradiol,estrogen receptor agonist,CYP2B6,,,,CYP2B6
14225,alpha-estradiol,estrogen receptor agonist,CYP2C19,,,,CYP2C19
14226,alpha-estradiol,estrogen receptor agonist,CYP2C8,,,,CYP2C8
14227,alpha-estradiol,estrogen receptor agonist,CYP2E1,,,,CYP2E1
14228,alpha-estradiol,estrogen receptor agonist,CYP3A5,,,,CYP3A5
14229,alpha-estradiol,estrogen receptor agonist,CYP3A7,,,,CYP3A7
14230,alpha-estradiol,estrogen receptor agonist,GPER1,,,,GPER1
14231,alpha-estradiol,estrogen receptor agonist,KCNMA1,,,,KCNMA1
14232,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",CFTR,,,,CFTR
14233,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESR2,,,,ESR2
14234,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",EGFR,,,,EGFR
14235,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESR1,,,,ESR1
14236,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRA,,,,ESRRA
14237,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRB,,,,ESRRB
14238,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",ESRRG,,,,ESRRG
14239,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",NCOA1,,,,NCOA1
14240,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",NCOA2,,,,NCOA2
14241,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",PPARG,,,,PPARG
14242,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",PTK2B,,,,PTK2B
14243,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",TOP2A,,,,TOP2A
14244,genistein,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor",TRPC5,,,,TRPC5
14245,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARG,,,,RARG
14246,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RORB,,,,RORB
14247,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",ALDH1A1,,,,ALDH1A1
14248,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",ALDH1A2,,,,ALDH1A2
14249,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",GPRC5A,,,,GPRC5A
14250,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",NR0B1,,,,NR0B1
14251,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",NR2C2,,,,NR2C2
14252,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",PPARD,,,,PPARD
14253,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARA,,,,RARA
14254,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARB,,,,RARB
14255,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RARRES1,,,,RARRES1
14256,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RORC,,,,RORC
14257,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RXRB,,,,RXRB
14258,tretinoin,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand",RXRG,,,,RXRG
14259,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",ABAT,,,,ABAT
14260,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",HDAC1,,,,HDAC1
14261,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN1A,,,,SCN1A
14262,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN3A,,,,SCN3A
14263,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",ACADSB,,,,ACADSB
14264,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",ALDH5A1,,,,ALDH5A1
14265,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",HDAC2,,,,HDAC2
14266,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",HDAC9,,,,HDAC9
14267,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",OGDH,,,,OGDH
14268,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN10A,,,,SCN10A
14269,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN11A,,,,SCN11A
14270,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN1B,,,,SCN1B
14271,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN2A,,,,SCN2A
14272,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN2B,,,,SCN2B
14273,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN3B,,,,SCN3B
14274,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN4A,,,,SCN4A
14275,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN4B,,,,SCN4B
14276,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN5A,,,,SCN5A
14277,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN7A,,,,SCN7A
14278,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN8A,,,,SCN8A
14279,valproic-acid,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker",SCN9A,,,,SCN9A
14280,JTC-801,opioid receptor antagonist,OPRL1,,,,OPRL1
14281,BAY-K8644,L-type calcium channel activator,CACNA1C,,,,CACNA1C
14282,SN-38,topoisomerase inhibitor,TOP1,,,,TOP1
14283,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist",HPRT1,,,,HPRT1
14284,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist",IMPDH1,,,,IMPDH1
14285,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist",IMPDH2,,,,IMPDH2
14286,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist",PPAT,,,,PPAT
14287,SCH-79797,proteinase activated receptor antagonist,F2R,,,,F2R
14288,CD-437,"RAR agonist, retinoid receptor agonist",RARG,,,,RARG
14289,serdemetan,"MDM inhibitor, angiogenesis stimulant, apoptosis stimulant, oncogene inhibitor",MDM2,,,,MDM2
14290,SJ-172550,MDM inhibitor,MDM4,,,,MDM4
14291,BRD-K98404142,"glucose 6 phosphate dehydrogenase inhibitor, immunostimulant",G6PD,,,,G6PD
14292,veliparib,"PARP inhibitor, DNA repair enzyme inhibitor",PARP1,,,,PARP1
14293,veliparib,"PARP inhibitor, DNA repair enzyme inhibitor",PARP2,,,,PARP2
14294,AG-14361,PARP inhibitor,PARP1,,,,PARP1
14295,pyrvinium-pamoate,"AKT inhibitor, androgen receptor (AR) inhibitor, androgen receptor antagonist",AR,,,,AR
14296,BMS-641988,androgen receptor antagonist,AR,,,,AR
14297,AR-C133057XX,nitric oxide synthase inhibitor,NOS2,,,,NOS2
14298,AR-C133057XX,nitric oxide synthase inhibitor,NOS1,,,,NOS1
14299,importazole,importin-beta transport receptor inhibitor,KPNB1,,,,KPNB1
14300,ingenol,PKC activator,PRKCD,,,,PRKCD
14301,ingenol,PKC activator,PRKCE,,,,PRKCE
14302,NF-449,purinergic receptor antagonist,P2RX1,,,,P2RX1
14303,narciclasine,"coflilin signaling pathway activator, LIM kinase activator, ROCK activator",RHOA,,,,RHOA
14304,perhexiline,"carnitine palmitoyltransferase binder, carnitine palmitoyltransferase inhibitor",CPT1A,,,,CPT1A
14305,perhexiline,"carnitine palmitoyltransferase binder, carnitine palmitoyltransferase inhibitor",CPT2,,,,CPT2
14306,PI-103,"PI3K inhibitor, mTOR inhibitor",PIK3CA,,,,PIK3CA
14307,PI-103,"PI3K inhibitor, mTOR inhibitor",PIK3CG,,,,PIK3CG
14308,PI-103,"PI3K inhibitor, mTOR inhibitor",MTOR,,,,MTOR
14309,PI-103,"PI3K inhibitor, mTOR inhibitor",PIK3CB,,,,PIK3CB
14310,PI-103,"PI3K inhibitor, mTOR inhibitor",PIK3CD,,,,PIK3CD
14311,PI-103,"PI3K inhibitor, mTOR inhibitor",PRKDC,,,,PRKDC
14312,PT-630,"dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor",DPP4,,,,DPP4
14313,PT-630,"dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor",FAP,,,,FAP
14314,SID-26681509,cathepsin inhibitor,CTSL,,,,CTSL
14315,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",KDR,,,,KDR
14316,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",PDGFRB,,,,PDGFRB
14317,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",CAMK1G,,,,CAMK1G
14318,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",FGF2,,,,FGF2
14319,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",FGFR1,,,,FGFR1
14320,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",FLT1,,,,FLT1
14321,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",KIT,,,,KIT
14322,SU-11652,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor",PDGFRA,,,,PDGFRA
14323,temozolomide,"DNA alkylating drug, DNA damage inducer, DNA inhibitor, topoisomerase inhibitor",TOP2A,,,,TOP2A
14324,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",ROCK1,,,,ROCK1
14325,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",ROCK2,,,,ROCK2
14326,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
14327,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PKIA,,,,PKIA
14328,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PKN2,,,,PKN2
14329,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PRKACA,,,,PRKACA
14330,Y-27632,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor",PRKCE,,,,PRKCE
14331,auranofin,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor",IKBKB,,,,IKBKB
14332,auranofin,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor",PRDX5,,,,PRDX5
14333,auranofin,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor",TRPA1,,,,TRPA1
14334,auranofin,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor",TXNRD1,,,,TXNRD1
14335,auranofin,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor",TXNRD2,,,,TXNRD2
14336,manumycin-a,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor",FNTA,,,,FNTA
14337,manumycin-a,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor",IKBKB,,,,IKBKB
14338,myriocin,sphingolipid biosynthesis inhibitor,AKT1,,,,AKT1
14339,myriocin,sphingolipid biosynthesis inhibitor,SPTLC1,,,,SPTLC1
14340,myriocin,sphingolipid biosynthesis inhibitor,SPTLC2,,,,SPTLC2
14341,myriocin,sphingolipid biosynthesis inhibitor,SPTLC3,,,,SPTLC3
14342,temsirolimus,"mTOR inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor",MTOR,,,,MTOR
14343,temsirolimus,"mTOR inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor",PTEN,,,,PTEN
14344,LDN-193189,"ALK inhibitor, serine/threonine protein kinase inhibitor",ACVR1,,,,ACVR1
14345,LDN-193189,"ALK inhibitor, serine/threonine protein kinase inhibitor",BMPR1A,,,,BMPR1A
14346,BRD-K19059335,"runt-related transcription factor inhibitor, tyrosine aminotransferase inhibitor",RUNX1,,,,RUNX1
14347,BRD-K14609189,PPAR receptor partial agonist,PPARG,,,,PPARG
14348,BRD-K77690805,pyruvate kinase isozyme activator,PKM,,,,PKM
14349,BRD-K58033748,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
14350,BRD-K58033748,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
14351,BRD-K58033748,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
14352,BRD-K58033748,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
14353,BRD-K58033748,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
14354,BRD-K11757396,neuropeptide receptor ligand,NPSR1,,,,NPSR1
14355,BRD-K12401458,lysophospholipid receptor agonist,S1PR4,,,,S1PR4
14356,BRD-K14048378,lysophospholipid receptor agonist,S1PR3,,,,S1PR3
14357,BRD-K14236372,lysophospholipid receptor agonist,S1PR4,,,,S1PR4
14358,BRD-K16618170,lysophospholipid receptor agonist,S1PR4,,,,S1PR4
14359,KU-C103871,GSP agonist,SMAD3,,,,SMAD3
14360,BRD-K73709114,glucosylceramidase inhibitor,GBA,,,,GBA
14361,BRD-K76211160,cytochrome P450 inhibitor,CYP11B2,,,,CYP11B2
14362,5-nonyloxytryptamine,serotonin receptor agonist,HTR1B,,,,HTR1B
14363,5-nonyloxytryptamine,serotonin receptor agonist,HTR1D,,,,HTR1D
14364,emetine,protein synthesis inhibitor,RPS2,,,,RPS2
14365,KU-C103428N,"CDC inhibitor, rho GTPase inhibitor",NFE2,,,,NFE2
14366,BRD-A69470004,XIAP inhibitor,XIAP,,,,XIAP
14367,BRD-A05680309,"caspase activator, XIAP inhibitor",CASP8,,,,CASP8
14368,BRD-A05680309,"caspase activator, XIAP inhibitor",XIAP,,,,XIAP
14369,BRD-K55186349,apelin receptor antagonist,APLNR,,,,APLNR
14370,myricetin,"androgen receptor ligand, cytochrome P450 inhibitor",PIK3CG,,,,PIK3CG
14371,myricetin,"androgen receptor ligand, cytochrome P450 inhibitor",AR,,,,AR
14372,myricetin,"androgen receptor ligand, cytochrome P450 inhibitor",CYP3A4,,,,CYP3A4
14373,latrepirdine,"glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
14374,latrepirdine,"glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist",GRIN2B,,,,GRIN2B
14375,latrepirdine,"glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
14376,BRD-K68783079,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CLK1,,,,CLK1
14377,BRD-K68783079,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",CLK4,,,,CLK4
14378,BRD-K68783079,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor",DYRK1A,,,,DYRK1A
14379,BRD-A32917072,ROR antagonist,RORC,,,,RORC
14380,BRD-A81377415,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK1,,,,CLK1
14381,BRD-A81377415,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK4,,,,CLK4
14382,BRD-A81377415,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1A,,,,DYRK1A
14383,BRD-A81377415,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1B,,,,DYRK1B
14384,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",SIGMAR1,,,,SIGMAR1
14385,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNA2,,,,CHRNA2
14386,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNA3,,,,CHRNA3
14387,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNA4,,,,CHRNA4
14388,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNA7,,,,CHRNA7
14389,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNB2,,,,CHRNB2
14390,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CHRNB4,,,,CHRNB4
14391,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CYBA,,,,CYBA
14392,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CYBB,,,,CYBB
14393,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",CYP3A5,,,,CYP3A5
14394,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",GRIN1,,,,GRIN1
14395,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",GRIN3A,,,,GRIN3A
14396,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",NCF1,,,,NCF1
14397,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",NCF2,,,,NCF2
14398,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",NCF4,,,,NCF4
14399,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",OPRD1,,,,OPRD1
14400,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",OPRK1,,,,OPRK1
14401,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",OPRM1,,,,OPRM1
14402,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",PGRMC1,,,,PGRMC1
14403,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",RAC1,,,,RAC1
14404,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",RAC2,,,,RAC2
14405,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",SLC6A2,,,,SLC6A2
14406,BRD-A41630653,"glutamate receptor antagonist, sigma receptor agonist",SLC6A4,,,,SLC6A4
14407,VU-0400071-3,glutamate receptor modulator,GRM4,,,,GRM4
14408,VU-0400193-3,glutamate receptor modulator,GRM4,,,,GRM4
14409,VU-0400195-3,glutamate receptor modulator,GRM4,,,,GRM4
14410,VU-0413807-2,calcium channel blocker,CACNA1G,,,,CACNA1G
14411,VU-0413807-2,calcium channel blocker,CACNA1H,,,,CACNA1H
14412,VU-0413807-2,calcium channel blocker,CACNA1I,,,,CACNA1I
14413,propranolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
14414,propranolol,adrenergic receptor antagonist,ADRB3,,,,ADRB3
14415,propranolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
14416,propranolol,adrenergic receptor antagonist,CYP2C19,,,,CYP2C19
14417,propranolol,adrenergic receptor antagonist,HTR1A,,,,HTR1A
14418,propranolol,adrenergic receptor antagonist,HTR1B,,,,HTR1B
14419,methylprednisolone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
14420,phenelzine,monoamine oxidase inhibitor,MAOB,,,,MAOB
14421,phenelzine,monoamine oxidase inhibitor,AOC3,,,,AOC3
14422,phenelzine,monoamine oxidase inhibitor,MAOA,,,,MAOA
14423,phenelzine,monoamine oxidase inhibitor,ABAT,,,,ABAT
14424,phenelzine,monoamine oxidase inhibitor,GAD2,,,,GAD2
14425,phenelzine,monoamine oxidase inhibitor,GPT,,,,GPT
14426,phenelzine,monoamine oxidase inhibitor,GPT2,,,,GPT2
14427,phenelzine,monoamine oxidase inhibitor,SLC6A2,,,,SLC6A2
14428,phenelzine,monoamine oxidase inhibitor,SLC6A3,,,,SLC6A3
14429,phenelzine,monoamine oxidase inhibitor,SLC6A4,,,,SLC6A4
14430,ribavirin,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",IMPDH1,,,,IMPDH1
14431,ribavirin,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",ADK,,,,ADK
14432,ribavirin,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",ENPP1,,,,ENPP1
14433,ribavirin,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",IMPDH2,,,,IMPDH2
14434,ribavirin,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor",NT5C2,,,,NT5C2
14435,rifapentine,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor",CYP2C8,,,,CYP2C8
14436,rifapentine,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor",CYP3A4,,,,CYP3A4
14437,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRD1,,,,OPRD1
14438,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRK1,,,,OPRK1
14439,SB-205607,"delta 1 opioid receptor agonist, opioid receptor agonist",OPRM1,,,,OPRM1
14440,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",OPRM1,,,,OPRM1
14441,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",OPRK1,,,,OPRK1
14442,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",OPRD1,,,,OPRD1
14443,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",GRIN1,,,,GRIN1
14444,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
14445,dextrorphan,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist",SLC6A2,,,,SLC6A2
14446,BRD-A17664363,steroidogenic factor antagonist,NR5A1,,,,NR5A1
14447,BRD-A93048969,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
14448,BRD-A93048969,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
14449,BRD-A93048969,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
14450,BRD-A93048969,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
14451,BRD-A93048969,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
14452,BRD-A93048969,acetylcholine receptor antagonist,SI,,,,SI
14453,BRD-K01265221,BCL inhibitor,BCL2,,,,BCL2
14454,BRD-K06217810,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK1,,,,CLK1
14455,BRD-K06217810,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",CLK4,,,,CLK4
14456,BRD-K06217810,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1A,,,,DYRK1A
14457,BRD-K06217810,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor",DYRK1B,,,,DYRK1B
14458,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC2,,,,HDAC2
14459,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC1,,,,HDAC1
14460,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC3,,,,HDAC3
14461,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC4,,,,HDAC4
14462,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC5,,,,HDAC5
14463,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC6,,,,HDAC6
14464,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC7,,,,HDAC7
14465,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC8,,,,HDAC8
14466,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",HDAC9,,,,HDAC9
14467,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",IL1B,,,,IL1B
14468,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",IL1R2,,,,IL1R2
14469,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",IL6R,,,,IL6R
14470,givinostat,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor",TNF,,,,TNF
14471,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
14472,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
14473,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",ADRA1B,,,,ADRA1B
14474,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",ADRA1D,,,,ADRA1D
14475,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",CHRM1,,,,CHRM1
14476,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",CHRM2,,,,CHRM2
14477,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",CHRM3,,,,CHRM3
14478,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
14479,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HTR2B,,,,HTR2B
14480,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
14481,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
14482,cyproheptadine,"histamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
14483,disopyramide,voltage-gated sodium channel blocker,SCN5A,,,,SCN5A
14484,disopyramide,voltage-gated sodium channel blocker,CHRM1,,,,CHRM1
14485,disopyramide,voltage-gated sodium channel blocker,CHRM2,,,,CHRM2
14486,disopyramide,voltage-gated sodium channel blocker,CHRM3,,,,CHRM3
14487,disopyramide,voltage-gated sodium channel blocker,KCND2,,,,KCND2
14488,disopyramide,voltage-gated sodium channel blocker,KCND3,,,,KCND3
14489,disopyramide,voltage-gated sodium channel blocker,KCNH2,,,,KCNH2
14490,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",TOP2A,,,,TOP2A
14491,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",CYP2E1,,,,CYP2E1
14492,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",CYP3A5,,,,CYP3A5
14493,etoposide,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor",TOP2B,,,,TOP2B
14494,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",NISCH,,,,NISCH
14495,BRD-K61106942,pyruvate kinase isozyme activator,PKM,,,,PKM
14496,oxybutynin,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
14497,oxybutynin,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
14498,oxybutynin,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
14499,oxybutynin,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
14500,JW-7-24-1,LCK Inhibitor,LCK,,,,LCK
14501,1-benzylimidazole,thromboxane synthase inhibitor,CYP11B1,,,,CYP11B1
14502,1-benzylimidazole,thromboxane synthase inhibitor,QPCT,,,,QPCT
14503,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",CNR1,,,,CNR1
14504,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",CNR2,,,,CNR2
14505,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",GLRA1,,,,GLRA1
14506,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",GLRA2,,,,GLRA2
14507,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",GLRA3,,,,GLRA3
14508,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",GPR55,,,,GPR55
14509,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",GRIN1,,,,GRIN1
14510,HU-211,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent",NFKB1,,,,NFKB1
14511,propylpyrazole,estrogen receptor agonist,ESR1,,,,ESR1
14512,BRD-K20168484,"lipoxygenase inhibitor, leukotriene synthesis inhibitor, PPAR receptor modulator",ALOX5AP,,,,ALOX5AP
14513,didanosine,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor",PNP,,,,PNP
14514,niacin,vitamin agonist,HCAR2,,,,HCAR2
14515,niacin,vitamin agonist,HCAR3,,,,HCAR3
14516,niacin,vitamin agonist,ACHE,,,,ACHE
14517,niacin,vitamin agonist,DGAT2,,,,DGAT2
14518,niacin,vitamin agonist,HCAR1,,,,HCAR1
14519,niacin,vitamin agonist,NNMT,,,,NNMT
14520,niacin,vitamin agonist,PTGDR,,,,PTGDR
14521,niacin,vitamin agonist,QPRT,,,,QPRT
14522,BRD-K79511609,adenosine receptor agonist,ADORA1,,,,ADORA1
14523,BRD-K79511609,adenosine receptor agonist,ADORA2A,,,,ADORA2A
14524,BRD-K79511609,adenosine receptor agonist,ADORA2B,,,,ADORA2B
14525,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
14526,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM1,,,,CHRM1
14527,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM2,,,,CHRM2
14528,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM3,,,,CHRM3
14529,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM4,,,,CHRM4
14530,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM5,,,,CHRM5
14531,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",HTR2A,,,,HTR2A
14532,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
14533,deferiprone,"chelating agent, cytochrome P450 inhibitor, iron absorption inhibitor, reducing agent",CYP4F2,,,,CYP4F2
14534,GANT-61,GLI antagonist,DHH,,,,DHH
14535,GANT-61,GLI antagonist,IHH,,,,IHH
14536,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",PTGS1,,,,PTGS1
14537,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",PPARG,,,,PPARG
14538,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",PTGS2,,,,PTGS2
14539,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",ALOX5,,,,ALOX5
14540,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",CHUK,,,,CHUK
14541,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",CTNNB1,,,,CTNNB1
14542,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",IKBKB,,,,IKBKB
14543,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",MPO,,,,MPO
14544,mesalazine,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor",NAT1,,,,NAT1
14545,flucytosine,"pyrimidine analog, inhibits fungal DNA synthesis",DNMT1,,,,DNMT1
14546,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",NR1I2,,,,NR1I2
14547,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",ABCB1,,,,ABCB1
14548,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2B6,,,,CYP2B6
14549,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2C19,,,,CYP2C19
14550,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2C8,,,,CYP2C8
14551,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP3A4,,,,CYP3A4
14552,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP3A5,,,,CYP3A5
14553,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1A2,,,,SLCO1A2
14554,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1B1,,,,SLCO1B1
14555,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1B3,,,,SLCO1B3
14556,BRD-K63954456,"macrophage migration inhibiting factor inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor",MIF,,,,MIF
14557,BRD-K63954456,"macrophage migration inhibiting factor inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
14558,doxercalciferol,vitamin D receptor agonist,VDR,,,,VDR
14559,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
14560,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
14561,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
14562,fluticasone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
14563,fluticasone,glucocorticoid receptor agonist,CYP3A5,,,,CYP3A5
14564,fluticasone,glucocorticoid receptor agonist,CYP3A7,,,,CYP3A7
14565,fluticasone,glucocorticoid receptor agonist,NR3C2,,,,NR3C2
14566,fluticasone,glucocorticoid receptor agonist,PGR,,,,PGR
14567,fluticasone,glucocorticoid receptor agonist,PLA2G4A,,,,PLA2G4A
14568,huperzine-a,"acetylcholinesterase inhibitor, glutamate receptor antagonist",ACHE,,,,ACHE
14569,CP-724714,"receptor tyrosine protein kinase inhibitor, EGFR inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
14570,BRD-K54331210,alkaline phosphatase inhibitor,ALPL,,,,ALPL
14571,BRD-K71427192,XIAP inhibitor,XIAP,,,,XIAP
14572,BRD-K52640952,topoisomerase inhibitor,TOP1,,,,TOP1
14573,PD-168077,dopamine receptor agonist,DRD2,,,,DRD2
14574,PD-168077,dopamine receptor agonist,DRD4,,,,DRD4
14575,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",AR,,,,AR
14576,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP19A1,,,,CYP19A1
14577,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C19,,,,CYP2C19
14578,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C8,,,,CYP2C8
14579,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP3A5,,,,CYP3A5
14580,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",RET,,,,RET
14581,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",BRAF,,,,BRAF
14582,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT3,,,,FLT3
14583,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",KDR,,,,KDR
14584,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",RAF1,,,,RAF1
14585,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT1,,,,FLT1
14586,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FLT4,,,,FLT4
14587,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",KIT,,,,KIT
14588,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",DDR2,,,,DDR2
14589,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
14590,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
14591,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP2B6,,,,CYP2B6
14592,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP2C8,,,,CYP2C8
14593,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",CYP3A5,,,,CYP3A5
14594,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",PDGFB,,,,PDGFB
14595,sorafenib,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist",SLCO1B3,,,,SLCO1B3
14596,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",KDR,,,,KDR
14597,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",FLT1,,,,FLT1
14598,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",FLT4,,,,FLT4
14599,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",CSF1,,,,CSF1
14600,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",CYP2C19,,,,CYP2C19
14601,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",CYP3A5,,,,CYP3A5
14602,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",KIT,,,,KIT
14603,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
14604,axitinib,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist",PLK4,,,,PLK4
14605,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
14606,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
14607,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",CYP3A5,,,,CYP3A5
14608,lenalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",CRBN,,,,CRBN
14609,lenalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",TNF,,,,TNF
14610,lenalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",CDH5,,,,CDH5
14611,lenalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",PTGS2,,,,PTGS2
14612,lenalidomide,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist",TNFSF11,,,,TNFSF11
14613,HA-14-1,BCL inhibitor,BCL2,,,,BCL2
14614,GSK-1904529A,"insulin growth factor receptor inhibitor, insulin receptor ligand",IGF1R,,,,IGF1R
14615,GSK-1904529A,"insulin growth factor receptor inhibitor, insulin receptor ligand",INSR,,,,INSR
14616,YM-155,"survivin inhibitor, XIAP expression inhibitor",BIRC5,,,,BIRC5
14617,andarine,androgen receptor modulator,AR,,,,AR
14618,barasertib,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKB,,,,AURKB
14619,barasertib,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor",AURKC,,,,AURKC
14620,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",TUBB,,,,TUBB
14621,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",BCL2,,,,BCL2
14622,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAP2,,,,MAP2
14623,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAP4,,,,MAP4
14624,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAPT,,,,MAPT
14625,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",NR1I2,,,,NR1I2
14626,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",TUBB1,,,,TUBB1
14627,enobosarm,"androgen receptor modulator, androgen receptor agonist",AR,,,,AR
14628,KI-16425,lysophosphatidic acid receptor antagonist,LPAR1,,,,LPAR1
14629,KI-16425,lysophosphatidic acid receptor antagonist,LPAR3,,,,LPAR3
14630,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA1A,,,,TUBA1A
14631,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA1B,,,,TUBA1B
14632,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA1C,,,,TUBA1C
14633,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA3C,,,,TUBA3C
14634,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA4A,,,,TUBA4A
14635,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBA8,,,,TUBA8
14636,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBB,,,,TUBB
14637,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBB1,,,,TUBB1
14638,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBB3,,,,TUBB3
14639,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBB4A,,,,TUBB4A
14640,epothilone,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor",TUBB4B,,,,TUBB4B
14641,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",PDE4A,,,,PDE4A
14642,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",PDE4B,,,,PDE4B
14643,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",PDE4D,,,,PDE4D
14644,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",IL12A,,,,IL12A
14645,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",IL12B,,,,IL12B
14646,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",IL1B,,,,IL1B
14647,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",PDE4C,,,,PDE4C
14648,cilomilast,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
14649,topotecan,topoisomerase inhibitor,TOP1,,,,TOP1
14650,topotecan,topoisomerase inhibitor,TOP1MT,,,,TOP1MT
14651,acarbose,glucosidase inhibitor,GAA,,,,GAA
14652,acarbose,glucosidase inhibitor,MGAM,,,,MGAM
14653,acarbose,glucosidase inhibitor,AMY2A,,,,AMY2A
14654,acarbose,glucosidase inhibitor,SI,,,,SI
14655,BRD-A73929928,adenosine receptor agonist,ADORA1,,,,ADORA1
14656,BRD-A73929928,adenosine receptor agonist,ADORA2A,,,,ADORA2A
14657,alosetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
14658,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",TRPV1,,,,TRPV1
14659,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",CNR1,,,,CNR1
14660,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",CNR2,,,,CNR2
14661,AM-404,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist",FAAH,,,,FAAH
14662,ampiroxicam,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
14663,ampiroxicam,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
14664,anastrozole,aromatase inhibitor,CYP19A1,,,,CYP19A1
14665,argatroban,"thrombin inhibitor, peptidase inhibitor, protease inhibitor",F2,,,,F2
14666,argatroban,"thrombin inhibitor, peptidase inhibitor, protease inhibitor",CYP3A5,,,,CYP3A5
14667,artemether,"antimalarial, interacts with heme and with COX3",ATP1A1,,,,ATP1A1
14668,artemether,"antimalarial, interacts with heme and with COX3",CYP2B6,,,,CYP2B6
14669,artemether,"antimalarial, interacts with heme and with COX3",CYP2C19,,,,CYP2C19
14670,artemether,"antimalarial, interacts with heme and with COX3",CYP3A5,,,,CYP3A5
14671,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
14672,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",CYP3A5,,,,CYP3A5
14673,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",GPR97,,,,ADGRG3
14674,beclometasone,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant",SERPINA6,,,,SERPINA6
14675,benazepril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
14676,bifonazole,"cell wall synthesis inhibitor, sterol demethylase inhibitor",CYP2B6,,,,CYP2B6
14677,brucine,glycine receptor antagonist,CHRM1,,,,CHRM1
14678,brucine,glycine receptor antagonist,CHRM2,,,,CHRM2
14679,brucine,glycine receptor antagonist,CHRM3,,,,CHRM3
14680,brucine,glycine receptor antagonist,CHRM4,,,,CHRM4
14681,brucine,glycine receptor antagonist,CHRM5,,,,CHRM5
14682,capsaicin,"TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor",TRPV1,,,,TRPV1
14683,capsaicin,"TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor",CFTR,,,,CFTR
14684,capsaicin,"TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor",ENOX2,,,,ENOX2
14685,cerivastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
14686,cerivastatin,HMGCR inhibitor,CYP2C8,,,,CYP2C8
14687,cerivastatin,HMGCR inhibitor,CYP3A5,,,,CYP3A5
14688,cetraxate,"gastrin inhibitor, mucus protecting agent",GAST,,,,GAST
14689,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA1,,,,GABRA1
14690,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA2,,,,GABRA2
14691,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA3,,,,GABRA3
14692,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA4,,,,GABRA4
14693,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA5,,,,GABRA5
14694,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRA6,,,,GABRA6
14695,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRB1,,,,GABRB1
14696,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRB2,,,,GABRB2
14697,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRB3,,,,GABRB3
14698,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRD,,,,GABRD
14699,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRE,,,,GABRE
14700,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRG1,,,,GABRG1
14701,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRG2,,,,GABRG2
14702,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRG3,,,,GABRG3
14703,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRP,,,,GABRP
14704,chlordiazepoxide,GABA benzodiazepine site receptor agonist,GABRQ,,,,GABRQ
14705,cilastatin,dehydropeptidase inhibitor,DPEP1,,,,DPEP1
14706,triprolidine,histamine receptor antagonist,HRH1,,,,HRH1
14707,diphenoxylate,opoid receptor agonist,OPRM1,,,,OPRM1
14708,diphenoxylate,opoid receptor agonist,OPRD1,,,,OPRD1
14709,tropicamide,"acetylcholine receptor antagonist, anticholinergic",CHRM3,,,,CHRM3
14710,tropicamide,"acetylcholine receptor antagonist, anticholinergic",CHRM4,,,,CHRM4
14711,tropicamide,"acetylcholine receptor antagonist, anticholinergic",CHRM1,,,,CHRM1
14712,tropicamide,"acetylcholine receptor antagonist, anticholinergic",CHRM2,,,,CHRM2
14713,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",TUBB,,,,TUBB
14714,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",BCL2,,,,BCL2
14715,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAP2,,,,MAP2
14716,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAP4,,,,MAP4
14717,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",MAPT,,,,MAPT
14718,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",NR1I2,,,,NR1I2
14719,docetaxel,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane",TUBB1,,,,TUBB1
14720,dofetilide,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNH2,,,,KCNH2
14721,dofetilide,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNH1,,,,KCNH1
14722,dofetilide,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNJ12,,,,KCNJ12
14723,dofetilide,"polarization inhibitor, potassium channel antagonist, potassium channel blocker",KCNK2,,,,KCNK2
14724,esmolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
14725,esomeprazole,"ATPase inhibitor, ABC transporter expression enhancer",ATP4A,,,,ATP4A
14726,esomeprazole,"ATPase inhibitor, ABC transporter expression enhancer",CYP2C19,,,,CYP2C19
14727,esomeprazole,"ATPase inhibitor, ABC transporter expression enhancer",CYP3A4,,,,CYP3A4
14728,exemestane,aromatase inhibitor,CYP19A1,,,,CYP19A1
14729,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",NPC1L1,,,,NPC1L1
14730,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",ANPEP,,,,ANPEP
14731,ezetimibe,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior",SOAT1,,,,SOAT1
14732,fluvoxamine,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
14733,fluvoxamine,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CYP2C19,,,,CYP2C19
14734,formoterol,adrenergic receptor agonist,ADRB2,,,,ADRB2
14735,formoterol,adrenergic receptor agonist,CYP2C19,,,,CYP2C19
14736,tegafur,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS,,,,TYMS
14737,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",ACHE,,,,ACHE
14738,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",BCHE,,,,BCHE
14739,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA1,,,,CHRNA1
14740,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA10,,,,CHRNA10
14741,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA2,,,,CHRNA2
14742,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA3,,,,CHRNA3
14743,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA4,,,,CHRNA4
14744,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA5,,,,CHRNA5
14745,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA6,,,,CHRNA6
14746,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA7,,,,CHRNA7
14747,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNA9,,,,CHRNA9
14748,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB1,,,,CHRNB1
14749,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB2,,,,CHRNB2
14750,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB3,,,,CHRNB3
14751,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNB4,,,,CHRNB4
14752,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRND,,,,CHRND
14753,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNE,,,,CHRNE
14754,galantamine,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors",CHRNG,,,,CHRNG
14755,granisetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
14756,granisetron,serotonin receptor antagonist,CYP3A5,,,,CYP3A5
14757,halometasone,"cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
14758,honokiol,"AKT inhibitor, neurotrophic agent",ALOX5,,,,ALOX5
14759,honokiol,"AKT inhibitor, neurotrophic agent",PTGS1,,,,PTGS1
14760,honokiol,"AKT inhibitor, neurotrophic agent",PTGS2,,,,PTGS2
14761,huperzine-a,"acetylcholinesterase inhibitor, glutamate receptor antagonist",ACHE,,,,ACHE
14762,hyperoside,"glucosidase inhibitor, free radical scavenger",ACE,,,,ACE
14763,hyperoside,"glucosidase inhibitor, free radical scavenger",AKR1B1,,,,AKR1B1
14764,hyperoside,"glucosidase inhibitor, free radical scavenger",GAA,,,,GAA
14765,indinavir,HIV protease inhibitor,CYP3A5,,,,CYP3A5
14766,isoquercetin,"aldose reductase inhibitor, falcipain inhibitor",AKR1B1,,,,AKR1B1
14767,isoquercetin,"aldose reductase inhibitor, falcipain inhibitor",ACE,,,,ACE
14768,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
14769,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
14770,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
14771,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
14772,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
14773,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
14774,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
14775,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
14776,methotrexate,"dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor",DHFR,,,,DHFR
14777,methotrexate,"dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor",AOX1,,,,AOX1
14778,methotrexate,"dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor",FOLR1,,,,FOLR1
14779,methotrexate,"dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor",TYMS,,,,TYMS
14780,targinine,nitric oxide synthase inhibitor,NOS2,,,,NOS2
14781,targinine,nitric oxide synthase inhibitor,NOS3,,,,NOS3
14782,lacidipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
14783,lansoprazole,ATPase inhibitor,ATP4A,,,,ATP4A
14784,lansoprazole,ATPase inhibitor,CYP2C19,,,,CYP2C19
14785,lansoprazole,ATPase inhibitor,CYP3A4,,,,CYP3A4
14786,lansoprazole,ATPase inhibitor,CYP3A5,,,,CYP3A5
14787,latanoprost,prostanoid receptor agonist,PTGFR,,,,PTGFR
14788,levocetirizine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",HRH1,,,,HRH1
14789,levocetirizine,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor",CXCL8,,,,CXCL8
14790,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",SLC18A2,,,,SLC18A2
14791,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA10,,,,CHRNA10
14792,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA4,,,,CHRNA4
14793,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNA9,,,,CHRNA9
14794,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",CHRNB2,,,,CHRNB2
14795,lobeline,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand",OPRM1,,,,OPRM1
14796,lofepramine,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A2,,,,SLC6A2
14797,lofepramine,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant",SLC6A4,,,,SLC6A4
14798,lofexidine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
14799,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA1,,,,GABRA1
14800,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA2,,,,GABRA2
14801,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA3,,,,GABRA3
14802,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA5,,,,GABRA5
14803,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA4,,,,GABRA4
14804,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRA6,,,,GABRA6
14805,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRB1,,,,GABRB1
14806,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRB2,,,,GABRB2
14807,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRB3,,,,GABRB3
14808,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRD,,,,GABRD
14809,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRE,,,,GABRE
14810,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRG1,,,,GABRG1
14811,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRG2,,,,GABRG2
14812,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRG3,,,,GABRG3
14813,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRP,,,,GABRP
14814,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",GABRQ,,,,GABRQ
14815,lorazepam,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist",TSPO,,,,TSPO
14816,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",CYP3A4,,,,CYP3A4
14817,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",MLNR,,,,MLNR
14818,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN1,,,,GRIN1
14819,memantine,"glutamate receptor antagonist, glutamate release inhibitor",CHRFAM7A,,,,CHRFAM7A
14820,memantine,"glutamate receptor antagonist, glutamate release inhibitor",CYP2E1,,,,CYP2E1
14821,memantine,"glutamate receptor antagonist, glutamate release inhibitor",DRD2,,,,DRD2
14822,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN2A,,,,GRIN2A
14823,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN2B,,,,GRIN2B
14824,memantine,"glutamate receptor antagonist, glutamate release inhibitor",GRIN3A,,,,GRIN3A
14825,memantine,"glutamate receptor antagonist, glutamate release inhibitor",HTR3A,,,,HTR3A
14826,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",AR,,,,AR
14827,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP19A1,,,,CYP19A1
14828,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C19,,,,CYP2C19
14829,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C8,,,,CYP2C8
14830,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP3A5,,,,CYP3A5
14831,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",CYP3A5,,,,CYP3A5
14832,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",CYP3A7,,,,CYP3A7
14833,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA1,,,,GABRA1
14834,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA2,,,,GABRA2
14835,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA3,,,,GABRA3
14836,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA4,,,,GABRA4
14837,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA5,,,,GABRA5
14838,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA6,,,,GABRA6
14839,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB1,,,,GABRB1
14840,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB2,,,,GABRB2
14841,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB3,,,,GABRB3
14842,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRD,,,,GABRD
14843,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRE,,,,GABRE
14844,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG1,,,,GABRG1
14845,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG2,,,,GABRG2
14846,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG3,,,,GABRG3
14847,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRP,,,,GABRP
14848,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRQ,,,,GABRQ
14849,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR1,,,,GABRR1
14850,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR2,,,,GABRR2
14851,midazolam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR3,,,,GABRR3
14852,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
14853,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
14854,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN1,,,,GRIN1
14855,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN2A,,,,GRIN2A
14856,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN2B,,,,GRIN2B
14857,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN2C,,,,GRIN2C
14858,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN2D,,,,GRIN2D
14859,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN3A,,,,GRIN3A
14860,milnacipran,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor",GRIN3B,,,,GRIN3B
14861,mosapride,"serotonin receptor agonist, serotonin receptor antagonist",HTR4,,,,HTR4
14862,mosapride,"serotonin receptor agonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
14863,naftopidil,"adrenergic receptor antagonist, calcium channel antagonist",ADRA1A,,,,ADRA1A
14864,naftopidil,"adrenergic receptor antagonist, calcium channel antagonist",ADRA1D,,,,ADRA1D
14865,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRD1,,,,OPRD1
14866,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRK1,,,,OPRK1
14867,nalbuphine,"opioid receptor agonist, opioid receptor antagonist",OPRM1,,,,OPRM1
14868,naproxen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
14869,naproxen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
14870,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",ABCC8,,,,ABCC8
14871,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",KCNJ11,,,,KCNJ11
14872,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",CYP3A4,,,,CYP3A4
14873,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",INS,,,,INS
14874,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",KCNJ10,,,,KCNJ10
14875,nateglinide,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator",PPARG,,,,PPARG
14876,nimetazepam,"chloride channel agonist, GABA receptor agonist, potassium channel agonist",GABRA1,,,,GABRA1
14877,nimetazepam,"chloride channel agonist, GABA receptor agonist, potassium channel agonist",GABRA2,,,,GABRA2
14878,nimetazepam,"chloride channel agonist, GABA receptor agonist, potassium channel agonist",GABRA3,,,,GABRA3
14879,nimetazepam,"chloride channel agonist, GABA receptor agonist, potassium channel agonist",GABRA5,,,,GABRA5
14880,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
14881,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
14882,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
14883,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
14884,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
14885,nisoldipine,"calcium channel blocker, L-type calcium channel blocker",CYP3A5,,,,CYP3A5
14886,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA1,,,,GABRA1
14887,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA2,,,,GABRA2
14888,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA3,,,,GABRA3
14889,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA4,,,,GABRA4
14890,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA5,,,,GABRA5
14891,nitrazepam,GABA benzodiazepine site receptor agonist,GABRA6,,,,GABRA6
14892,nitrazepam,GABA benzodiazepine site receptor agonist,GABRB1,,,,GABRB1
14893,nitrazepam,GABA benzodiazepine site receptor agonist,GABRB2,,,,GABRB2
14894,nitrazepam,GABA benzodiazepine site receptor agonist,GABRB3,,,,GABRB3
14895,nitrazepam,GABA benzodiazepine site receptor agonist,GABRD,,,,GABRD
14896,nitrazepam,GABA benzodiazepine site receptor agonist,GABRE,,,,GABRE
14897,nitrazepam,GABA benzodiazepine site receptor agonist,GABRG1,,,,GABRG1
14898,nitrazepam,GABA benzodiazepine site receptor agonist,GABRG2,,,,GABRG2
14899,nitrazepam,GABA benzodiazepine site receptor agonist,GABRG3,,,,GABRG3
14900,nitrazepam,GABA benzodiazepine site receptor agonist,GABRP,,,,GABRP
14901,nitrazepam,GABA benzodiazepine site receptor agonist,GABRQ,,,,GABRQ
14902,nitrazepam,GABA benzodiazepine site receptor agonist,GABRR1,,,,GABRR1
14903,nitrazepam,GABA benzodiazepine site receptor agonist,GABRR2,,,,GABRR2
14904,nitrazepam,GABA benzodiazepine site receptor agonist,GABRR3,,,,GABRR3
14905,nitrazepam,GABA benzodiazepine site receptor agonist,SCN1A,,,,SCN1A
14906,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
14907,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
14908,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
14909,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
14910,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
14911,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
14912,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
14913,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",CACNG1,,,,CACNG1
14914,nitrendipine,"calcium channel blocker, L-type calcium channel blocker",KCNN4,,,,KCNN4
14915,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
14916,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
14917,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
14918,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
14919,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
14920,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD4,,,,DRD4
14921,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
14922,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
14923,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1B,,,,HTR1B
14924,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1D,,,,HTR1D
14925,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1E,,,,HTR1E
14926,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
14927,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
14928,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
14929,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA1B,,,,ADRA1B
14930,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA2A,,,,ADRA2A
14931,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA2B,,,,ADRA2B
14932,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA2C,,,,ADRA2C
14933,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRB1,,,,ADRB1
14934,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRB2,,,,ADRB2
14935,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",ADRB3,,,,ADRB3
14936,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CHRM1,,,,CHRM1
14937,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CHRM2,,,,CHRM2
14938,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CHRM3,,,,CHRM3
14939,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CHRM4,,,,CHRM4
14940,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CHRM5,,,,CHRM5
14941,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",CYP2C8,,,,CYP2C8
14942,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",DRD5,,,,DRD5
14943,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA1,,,,GABRA1
14944,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA2,,,,GABRA2
14945,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA3,,,,GABRA3
14946,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA4,,,,GABRA4
14947,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA5,,,,GABRA5
14948,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRA6,,,,GABRA6
14949,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRB1,,,,GABRB1
14950,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRB2,,,,GABRB2
14951,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRB3,,,,GABRB3
14952,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRD,,,,GABRD
14953,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRE,,,,GABRE
14954,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRG1,,,,GABRG1
14955,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRG2,,,,GABRG2
14956,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRG3,,,,GABRG3
14957,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRP,,,,GABRP
14958,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",GABRQ,,,,GABRQ
14959,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HRH2,,,,HRH2
14960,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HRH4,,,,HRH4
14961,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1F,,,,HTR1F
14962,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2B,,,,HTR2B
14963,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR3A,,,,HTR3A
14964,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist",HTR5A,,,,HTR5A
14965,olmesartan,"angiotensin receptor antagonist, angiotensin antagonist",AGTR1,,,,AGTR1
14966,etomoxir,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor",CPT1A,,,,CPT1A
14967,etomoxir,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor",CPT1B,,,,CPT1B
14968,oxymetholone,"androgen receptor agonist, synthetic hormone with anabolic and androgenic properties",AR,,,,AR
14969,oxyphenonium,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
14970,palonosetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
14971,pancuronium,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
14972,pancuronium,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
14973,pancuronium,acetylcholine receptor antagonist,CHRNA1,,,,CHRNA1
14974,pancuronium,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
14975,parecoxib,cyclooxygenase inhibitor,LTF,,,,LTF
14976,parecoxib,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
14977,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
14978,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM1,,,,CHRM1
14979,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM2,,,,CHRM2
14980,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM3,,,,CHRM3
14981,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM4,,,,CHRM4
14982,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",CHRM5,,,,CHRM5
14983,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",HTR2A,,,,HTR2A
14984,paroxetine,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
14985,rucaparib,PARP inhibitor,PARP1,,,,PARP1
14986,rucaparib,PARP inhibitor,PARP2,,,,PARP2
14987,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
14988,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
14989,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
14990,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD4,,,,DRD4
14991,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2C,,,,HTR2C
14992,physostigmine,"acetylcholinesterase inhibitor, cholinesterase inhibitor",ACHE,,,,ACHE
14993,physostigmine,"acetylcholinesterase inhibitor, cholinesterase inhibitor",BCHE,,,,BCHE
14994,piceid,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor",GAA,,,,GAA
14995,piceid,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
14996,picrotoxin,GABA receptor antagonist,GABRA1,,,,GABRA1
14997,picrotoxin,GABA receptor antagonist,GLRA2,,,,GLRA2
14998,picrotoxin,GABA receptor antagonist,GLRA3,,,,GLRA3
14999,picrotoxin,GABA receptor antagonist,GABRR1,,,,GABRR1
15000,picrotoxin,GABA receptor antagonist,GLRA1,,,,GLRA1
15001,picrotoxin,GABA receptor antagonist,GLRB,,,,GLRB
15002,picrotoxin,GABA receptor antagonist,HTR3A,,,,HTR3A
15003,picrotoxin,GABA receptor antagonist,HTR3B,,,,HTR3B
15004,pterostilbene,"cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist",FAAH,,,,FAAH
15005,pterostilbene,"cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist",PPARA,,,,PPARA
15006,pterostilbene,"cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist",PTGS1,,,,PTGS1
15007,pterostilbene,"cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist",PTGS2,,,,PTGS2
15008,reichstein,androgen receptor antagonist,AR,,,,AR
15009,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",CYP3A4,,,,CYP3A4
15010,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",HSP90AA1,,,,HSP90AA1
15011,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",HSP90B1,,,,HSP90B1
15012,rifaximin,"50S ribosomal subunit inhibitor, DNA directed DNA polymerase inhibitor, PXR agonist, RNA synthesis inhibitor",NR1I2,,,,NR1I2
15013,rifaximin,"50S ribosomal subunit inhibitor, DNA directed DNA polymerase inhibitor, PXR agonist, RNA synthesis inhibitor",CYP3A4,,,,CYP3A4
15014,rimcazole,"sigma receptor antagonist, dopamine reuptake inhibitor",SIGMAR1,,,,SIGMAR1
15015,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A4,,,,CYP3A4
15016,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP1A2,,,,CYP1A2
15017,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP2B6,,,,CYP2B6
15018,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP2C19,,,,CYP2C19
15019,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A5,,,,CYP3A5
15020,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A7,,,,CYP3A7
15021,ropivacaine,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker",SCN10A,,,,SCN10A
15022,ropivacaine,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker",SCN9A,,,,SCN9A
15023,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
15024,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
15025,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",SLC6A3,,,,SLC6A3
15026,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",CYP2B6,,,,CYP2B6
15027,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",CYP2C19,,,,CYP2C19
15028,sibutramine,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor",CYP3A5,,,,CYP3A5
15029,stiripentol,"GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker",ABAT,,,,ABAT
15030,stiripentol,"GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker",SCN1A,,,,SCN1A
15031,stiripentol,"GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker",SCN3A,,,,SCN3A
15032,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PTGS1,,,,PTGS1
15033,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PTGS2,,,,PTGS2
15034,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",ACAT1,,,,ACAT1
15035,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",ALOX5,,,,ALOX5
15036,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",CHUK,,,,CHUK
15037,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",IKBKB,,,,IKBKB
15038,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PLA2G1B,,,,PLA2G1B
15039,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",PPARG,,,,PPARG
15040,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",SLC46A1,,,,SLC46A1
15041,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",SLC7A11,,,,SLC7A11
15042,sulfasalazine,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist",TBXAS1,,,,TBXAS1
15043,synephrine,"adrenergic receptor agonist, L-type calcium channel activator",ADRA1A,,,,ADRA1A
15044,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
15045,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A5,,,,CYP3A5
15046,tacrolimus,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor",CYP3A7,,,,CYP3A7
15047,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",APOB,,,,APOB
15048,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",APP,,,,APP
15049,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",HMGCR,,,,HMGCR
15050,tegaserod,"serotonin receptor partial agonist, serotonin receptor agonist",HTR4,,,,HTR4
15051,tegaserod,"serotonin receptor partial agonist, serotonin receptor agonist",HTR2B,,,,HTR2B
15052,tegaserod,"serotonin receptor partial agonist, serotonin receptor agonist",HTR2A,,,,HTR2A
15053,tegaserod,"serotonin receptor partial agonist, serotonin receptor agonist",HTR2C,,,,HTR2C
15054,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",ALDH2,,,,ALDH2
15055,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",ALDH1A2,,,,ALDH1A2
15056,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",ALDH5A1,,,,ALDH5A1
15057,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",ALDH7A1,,,,ALDH7A1
15058,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",CYP2E1,,,,CYP2E1
15059,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",DBH,,,,DBH
15060,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",DNMT1,,,,DNMT1
15061,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist",TRPA1,,,,TRPA1
15062,propylthiouracil,thyroperoxidase inhibitor,TPO,,,,TPO
15063,propylthiouracil,thyroperoxidase inhibitor,DIO1,,,,DIO1
15064,tiagabine,"GABA uptake inhibitor, GAT inhibitor",SLC6A1,,,,SLC6A1
15065,tiagabine,"GABA uptake inhibitor, GAT inhibitor",CYP2C19,,,,CYP2C19
15066,tibolone,"estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor",AR,,,,AR
15067,tibolone,"estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor",ESR1,,,,ESR1
15068,tibolone,"estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor",PGR,,,,PGR
15069,tibolone,"estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor",STS,,,,STS
15070,tolterodine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
15071,tolterodine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
15072,tolterodine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
15073,tolterodine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
15074,tolterodine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
15075,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRM1,,,,OPRM1
15076,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",SLC6A2,,,,SLC6A2
15077,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",SLC6A4,,,,SLC6A4
15078,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CHRFAM7A,,,,CHRFAM7A
15079,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CHRM3,,,,CHRM3
15080,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",CYP2B6,,,,CYP2B6
15081,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",GRIN3A,,,,GRIN3A
15082,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",HTR2C,,,,HTR2C
15083,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRD1,,,,OPRD1
15084,tramadol,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor",OPRK1,,,,OPRK1
15085,triclabendazole,"acetylcholinesterase inhibitor, DNA methyltransferase inhibitor, microtubule inhibitor",DNMT1,,,,DNMT1
15086,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",CYP2C19,,,,CYP2C19
15087,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",CYP3A4,,,,CYP3A4
15088,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",CYP3A5,,,,CYP3A5
15089,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",SCN1A,,,,SCN1A
15090,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",SCN3A,,,,SCN3A
15091,oxcarbazepine,"voltage-gated sodium channel blocker, Sodium Channel  Blockers",SCN5A,,,,SCN5A
15092,vecuronium,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
15093,vinorelbine,"tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBB,,,,TUBB
15094,voriconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor",CYP2C19,,,,CYP2C19
15095,voriconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor",CYP51A1,,,,CYP51A1
15096,zolpidem,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic",GABRA1,,,,GABRA1
15097,zolpidem,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic",GABRA2,,,,GABRA2
15098,zolpidem,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic",GABRA3,,,,GABRA3
15099,JNK-9L,JNK inhibitor,MAPK8,,,,MAPK8
15100,KIN001-242,protein kinase inhiibor,RPS6KA3,,,,RPS6KA3
15101,torin-1,"mTOR inhibitor, PI3K inhibitor",MTOR,,,,MTOR
15102,torin-1,"mTOR inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
15103,torin-2,mTOR inhibitor,MTOR,,,,MTOR
15104,WZ-4002,EGFR inhibitor,EGFR,,,,EGFR
15105,WZ-4002,EGFR inhibitor,ERBB2,,,,ERBB2
15106,CG-930,JNK inhibitor,MAPK8,,,,MAPK8
15107,WZ-4-145,EGFR inhibitor,CSF1R,,,,CSF1R
15108,WZ-4-145,EGFR inhibitor,DDR1,,,,DDR1
15109,WZ-4-145,EGFR inhibitor,EGFR,,,,EGFR
15110,WZ-4-145,EGFR inhibitor,PDGFRA,,,,PDGFRA
15111,WZ-4-145,EGFR inhibitor,TIE1,,,,TIE1
15112,QL-X-138,mTOR inhibitor,BTK,,,,BTK
15113,QL-X-138,mTOR inhibitor,JAK3,,,,JAK3
15114,QL-X-138,mTOR inhibitor,MKNK2,,,,MKNK2
15115,QL-X-138,mTOR inhibitor,MTOR,,,,MTOR
15116,QL-X-138,mTOR inhibitor,PRKDC,,,,PRKDC
15117,WH-4023,src inhibitor,ABL1,,,,ABL1
15118,WH-4023,src inhibitor,LCK,,,,LCK
15119,WH-4023,src inhibitor,SRC,,,,SRC
15120,QL-XI-92,DDR1 inhibitor,DDR1,,,,DDR1
15121,QL-XII-47,"BMX inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, bruton's tyrosine kinase inhibitor, cytoplasmic tyrosine protein kinase BMX inhibitor",BMX,,,,BMX
15122,QL-XII-47,"BMX inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, bruton's tyrosine kinase inhibitor, cytoplasmic tyrosine protein kinase BMX inhibitor",BTK,,,,BTK
15123,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",SSTR1,,,,SSTR1
15124,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",SSTR2,,,,SSTR2
15125,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",SSTR3,,,,SSTR3
15126,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",SSTR4,,,,SSTR4
15127,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",SSTR5,,,,SSTR5
15128,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",GH1,,,,GH1
15129,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",GHR,,,,GHR
15130,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",OPRD1,,,,OPRD1
15131,somatostatin,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand",OPRM1,,,,OPRM1
15132,AS-604850,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CG,,,,PIK3CG
15133,AS-604850,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
15134,CAY-10585,hypoxia inducible factor inhibitor,HIF1A,,,,HIF1A
15135,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",CYP3A4,,,,CYP3A4
15136,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",HSP90AA1,,,,HSP90AA1
15137,rifabutin,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor",HSP90B1,,,,HSP90B1
15138,HNHA,HDAC inhibitor,HDAC1,,,,HDAC1
15139,oxalomalic-acid,isocitrate dehydrogenase inhibitor,ACO1,,,,ACO1
15140,oxalomalic-acid,isocitrate dehydrogenase inhibitor,IDH1,,,,IDH1
15141,celastrol,"anti-inflammatory agent, antioxidant, HSP90 Inhibitor, NFKB pathway inhibitor, topoisomerase inhibitor",IL1B,,,,IL1B
15142,celastrol,"anti-inflammatory agent, antioxidant, HSP90 Inhibitor, NFKB pathway inhibitor, topoisomerase inhibitor",TNF,,,,TNF
15143,ochratoxin-a,phenylalanyl tRNA synthetase inhibitor,SLC22A6,,,,SLC22A6
15144,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",ADA,,,,ADA
15145,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",DCK,,,,DCK
15146,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",POLA1,,,,POLA1
15147,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
15148,fludarabine,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor",RRM2,,,,RRM2
15149,tenovins,"SIRT inhibitor, TP53 activator",SIRT1,,,,SIRT1
15150,tenovins,"SIRT inhibitor, TP53 activator",SIRT2,,,,SIRT2
15151,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR1H4,,,,NR1H4
15152,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",PGR,,,,PGR
15153,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",AR,,,,AR
15154,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",ESR1,,,,ESR1
15155,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",IKBKB,,,,IKBKB
15156,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR1I2,,,,NR1I2
15157,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR3C1,,,,NR3C1
15158,guggulsterone,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist",NR3C2,,,,NR3C2
15159,calcitriol,"vitamin D receptor agonist, hypercalcaemic agent",VDR,,,,VDR
15160,calcitriol,"vitamin D receptor agonist, hypercalcaemic agent",CYP3A5,,,,CYP3A5
15161,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",MTOR,,,,MTOR
15162,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
15163,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",CCR5,,,,CCR5
15164,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FGF2,,,,FGF2
15165,antimycin-a,"antibiotic, electron transfer inhibitor",CYCS,,,,CYCS
15166,BI-78D3,JNK inhibitor,MAPK8,,,,MAPK8
15167,retinol,RAR receptor binder,ALDH1A1,,,,ALDH1A1
15168,retinol,RAR receptor binder,ALDH1A2,,,,ALDH1A2
15169,retinol,RAR receptor binder,ALDH1A3,,,,ALDH1A3
15170,retinol,RAR receptor binder,DHRS3,,,,DHRS3
15171,retinol,RAR receptor binder,DHRS4,,,,DHRS4
15172,retinol,RAR receptor binder,LRAT,,,,LRAT
15173,retinol,RAR receptor binder,NR2C2,,,,NR2C2
15174,retinol,RAR receptor binder,RBP1,,,,RBP1
15175,retinol,RAR receptor binder,RBP3,,,,RBP3
15176,retinol,RAR receptor binder,RDH11,,,,RDH11
15177,retinol,RAR receptor binder,RDH12,,,,RDH12
15178,retinol,RAR receptor binder,RDH13,,,,RDH13
15179,retinol,RAR receptor binder,RDH14,,,,RDH14
15180,retinol,RAR receptor binder,RDH5,,,,RDH5
15181,retinol,RAR receptor binder,RDH8,,,,RDH8
15182,retinol,RAR receptor binder,RETSAT,,,,RETSAT
15183,retinol,RAR receptor binder,RHO,,,,RHO
15184,retinol,RAR receptor binder,RLBP1,,,,RLBP1
15185,retinol,RAR receptor binder,RXRA,,,,RXRA
15186,retinol,RAR receptor binder,RXRB,,,,RXRB
15187,retinol,RAR receptor binder,RXRG,,,,RXRG
15188,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",CES1,,,,CES1
15189,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",FECH,,,,FECH
15190,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",PLA2G1B,,,,PLA2G1B
15191,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",ADH1C,,,,ADH1C
15192,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX4I1,,,,COX4I1
15193,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX5A,,,,COX5A
15194,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX5B,,,,COX5B
15195,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX6A2,,,,COX6A2
15196,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX6B1,,,,COX6B1
15197,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX6C,,,,COX6C
15198,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX7A1,,,,COX7A1
15199,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX7B,,,,COX7B
15200,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX7C,,,,COX7C
15201,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",COX8A,,,,COX8A
15202,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",ESRRG,,,,ESRRG
15203,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",FABP6,,,,FABP6
15204,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",GPBAR1,,,,GPBAR1
15205,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",MT-CO1,,,,MT-CO1
15206,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",MT-CO2,,,,MT-CO2
15207,cholic-acid,"ferrochelatase inhibitor, unidentified pharmacological activity",MT-CO3,,,,MT-CO3
15208,taurocholic-acid,bile acid,CEL,,,,CEL
15209,taurocholic-acid,bile acid,NR1H4,,,,NR1H4
15210,taurocholic-acid,bile acid,FABP6,,,,FABP6
15211,taurocholic-acid,bile acid,SLCO1C1,,,,SLCO1C1
15212,TCPOBOP,constitutive androstane receptor (CAR) agonist,NR1I3,,,,NR1I3
15213,farnesol,"amine oxidase B inhibitor, FXR agonist",MAOB,,,,MAOB
15214,farnesol,"amine oxidase B inhibitor, FXR agonist",MVK,,,,MVK
15215,farnesol,"amine oxidase B inhibitor, FXR agonist",NR1H4,,,,NR1H4
15216,androstanol,constitutive androstane receptor (CAR) inhibitor,NR1I3,,,,NR1I3
15217,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",CYP17A1,,,,CYP17A1
15218,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",PGR,,,,PGR
15219,pregnenolone,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1",SULT2B1,,,,SULT2B1
15220,androstenedione,cytochrome P450 inhibitor,AKR1C3,,,,AKR1C3
15221,androstenedione,cytochrome P450 inhibitor,HSD17B1,,,,HSD17B1
15222,androstenedione,cytochrome P450 inhibitor,HSD3B1,,,,HSD3B1
15223,ruxolitinib,"JAK inhibitor, tyrosine kinase inhibitor",JAK1,,,,JAK1
15224,ruxolitinib,"JAK inhibitor, tyrosine kinase inhibitor",JAK2,,,,JAK2
15225,ruxolitinib,"JAK inhibitor, tyrosine kinase inhibitor",TYK2,,,,TYK2
15226,ruxolitinib,"JAK inhibitor, tyrosine kinase inhibitor",JAK3,,,,JAK3
15227,ebelactone-b,pancreatic lipase inhibitor,PNLIP,,,,PNLIP
15228,etomoxir,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor",CPT1A,,,,CPT1A
15229,etomoxir,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor",CPT1B,,,,CPT1B
15230,H-7,PKA inhibitor,PKIA,,,,PKIA
15231,H-7,PKA inhibitor,PRKACA,,,,PRKACA
15232,H-7,PKA inhibitor,PRKAR1A,,,,PRKAR1A
15233,sphingosine,ceramidase inhibitor,GLTP,,,,GLTP
15234,sphingosine,ceramidase inhibitor,PVR,,,,PVR
15235,sphingosine,ceramidase inhibitor,TRPM3,,,,TRPM3
15236,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK2,,,,CDK2
15237,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",GSK3B,,,,GSK3B
15238,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CAMK2B,,,,CAMK2B
15239,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK1,,,,CDK1
15240,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK5,,,,CDK5
15241,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHEK1,,,,CHEK1
15242,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM1,,,,CHRM1
15243,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM2,,,,CHRM2
15244,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM4,,,,CHRM4
15245,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CSK,,,,CSK
15246,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",DAPK1,,,,DAPK1
15247,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",GPR35,,,,GPR35
15248,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",IKBKB,,,,IKBKB
15249,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",ITK,,,,ITK
15250,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",LCK,,,,LCK
15251,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",LRRK2,,,,LRRK2
15252,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAP2K4,,,,MAP2K4
15253,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAP2K6,,,,MAP2K6
15254,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAPKAPK2,,,,MAPKAPK2
15255,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PAK2,,,,PAK2
15256,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PDPK1,,,,PDPK1
15257,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PHKG2,,,,PHKG2
15258,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PIK3CG,,,,PIK3CG
15259,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PIM1,,,,PIM1
15260,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PKN1,,,,PKN1
15261,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKACB,,,,PRKACB
15262,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKCI,,,,PRKCI
15263,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKCQ,,,,PRKCQ
15264,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",RPS6KA1,,,,RPS6KA1
15265,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",STK3,,,,STK3
15266,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",SYK,,,,SYK
15267,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",TNIK,,,,TNIK
15268,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",ZAP70,,,,ZAP70
15269,H-9,"cAMP dependent protein kinase inhibitor, PKA inhibitor",PRKACA,,,,PRKACA
15270,EI-231,casein kinase inhibitor,CSNK2A1,,,,CSNK2A1
15271,EI-231,casein kinase inhibitor,CSNK2A2,,,,CSNK2A2
15272,EI-231,casein kinase inhibitor,CSNK2B,,,,CSNK2B
15273,EI-247,insulin growth factor receptor inhibitor,INSR,,,,INSR
15274,EI-273,PKC inhibitor,PRKCA,,,,PRKCA
15275,EI-273,PKC inhibitor,PRKCG,,,,PRKCG
15276,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1G,,,,CACNA1G
15277,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1H,,,,CACNA1H
15278,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1C,,,,CACNA1C
15279,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1I,,,,CACNA1I
15280,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",ANO1,,,,ANO1
15281,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1D,,,,CACNA1D
15282,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1F,,,,CACNA1F
15283,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNA1S,,,,CACNA1S
15284,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB1,,,,CACNB1
15285,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB2,,,,CACNB2
15286,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB3,,,,CACNB3
15287,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CACNB4,,,,CACNB4
15288,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER1,,,,CATSPER1
15289,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER2,,,,CATSPER2
15290,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER3,,,,CATSPER3
15291,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CATSPER4,,,,CATSPER4
15292,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CYP3A5,,,,CYP3A5
15293,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",CYP3A7,,,,CYP3A7
15294,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN2A,,,,SCN2A
15295,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN4A,,,,SCN4A
15296,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN5A,,,,SCN5A
15297,mibefradil,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker",SCN9A,,,,SCN9A
15298,flupirtine,"glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist",KCNQ2,,,,KCNQ2
15299,flupirtine,"glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist",ADRA2A,,,,ADRA2A
15300,flupirtine,"glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist",KCNQ1,,,,KCNQ1
15301,flupirtine,"glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist",KCNQ3,,,,KCNQ3
15302,GSK-0660,PPAR receptor inhibitor,PPARD,,,,PPARD
15303,epoxycholesterol,LXR agonist,NR1H2,,,,NR1H2
15304,epoxycholesterol,LXR agonist,NR1H3,,,,NR1H3
15305,GR-235,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist",ESR1,,,,ESR1
15306,GR-235,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist",IKBKB,,,,IKBKB
15307,GR-235,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist",NR1H4,,,,NR1H4
15308,GR-235,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist",NR1I2,,,,NR1I2
15309,GR-235,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist",PGR,,,,PGR
15310,HO-013,PPAR receptor agonist,PPARG,,,,PPARG
15311,TAK-715,"p38 MAPK inhibitor, tumor necrosis factor production inhibitor",MAPK14,,,,MAPK14
15312,TAK-715,"p38 MAPK inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
15313,trimidox,"antimetabolite, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor",RRM1,,,,RRM1
15314,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",MAPK11,,,,MAPK11
15315,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",MAPK14,,,,MAPK14
15316,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",PTGS2,,,,PTGS2
15317,SB-239063,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor",TNF,,,,TNF
15318,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",ALK,,,,ALK
15319,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET,,,,MET
15320,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",CYP2B6,,,,CYP2B6
15321,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",CYP3A5,,,,CYP3A5
15322,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MST1R,,,,MST1R
15323,crizotinib,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",ROS1,,,,ROS1
15324,terbinafine,"fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor",CYP2C19,,,,CYP2C19
15325,terbinafine,"fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor",CYP2C8,,,,CYP2C8
15326,terbinafine,"fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor",SQLE,,,,SQLE
15327,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
15328,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",ERBB2,,,,ERBB2
15329,lapatinib,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor",CYP3A5,,,,CYP3A5
15330,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant",FLT3,,,,FLT3
15331,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant",NTRK1,,,,NTRK1
15332,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant",JAK2,,,,JAK2
15333,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant",NTRK2,,,,NTRK2
15334,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant",NTRK3,,,,NTRK3
15335,L-2167,PPAR receptor agonist,PPARD,,,,PPARD
15336,mirin,inhibitor of MRE11A exonuclease activity,MRE11A,,,,MRE11
15337,prostaglandin,prostanoid receptor antagonist,AKR1C3,,,,AKR1C3
15338,prostaglandin,prostanoid receptor antagonist,PTGDR,,,,PTGDR
15339,prostaglandin,prostanoid receptor antagonist,PTGDR2,,,,PTGDR2
15340,prostaglandin,prostanoid receptor antagonist,PTGER1,,,,PTGER1
15341,prostaglandin,prostanoid receptor antagonist,PTGER2,,,,PTGER2
15342,prostaglandin,prostanoid receptor antagonist,PTGER4,,,,PTGER4
15343,prostaglandin,prostanoid receptor antagonist,PTGFR,,,,PTGFR
15344,voriconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor",CYP2C19,,,,CYP2C19
15345,voriconazole,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor",CYP51A1,,,,CYP51A1
15346,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP2C19,,,,CYP2C19
15347,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP3A5,,,,CYP3A5
15348,nelfinavir,"HIV protease inhibitor, proteasome inhibitor",CYP3A7,,,,CYP3A7
15349,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",NR3C1,,,,NR3C1
15350,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",SERPINA6,,,,SERPINA6
15351,fluocinonide,"corticosteroid agonist, corticosteroid hormone receptor agonist",SMO,,,,SMO
15352,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",KDR,,,,KDR
15353,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",KIT,,,,KIT
15354,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",FLT1,,,,FLT1
15355,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",FLT4,,,,FLT4
15356,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
15357,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
15358,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",BRAF,,,,BRAF
15359,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
15360,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",CYP2B6,,,,CYP2B6
15361,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",CYP2C8,,,,CYP2C8
15362,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",CYP2E1,,,,CYP2E1
15363,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",DDR2,,,,DDR2
15364,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",FGF1,,,,FGF1
15365,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
15366,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",FGFR3,,,,FGFR3
15367,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",ITK,,,,ITK
15368,pazopanib,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist",SH2B3,,,,SH2B3
15369,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor",KIT,,,,KIT
15370,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor",FGFR3,,,,FGFR3
15371,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor",LYN,,,,LYN
15372,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor",PDGFRA,,,,PDGFRA
15373,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor",PDGFRB,,,,PDGFRB
15374,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",FGFR1,,,,FGFR1
15375,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",KDR,,,,KDR
15376,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",FLT1,,,,FLT1
15377,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",CYP3A4,,,,CYP3A4
15378,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",FGFR2,,,,FGFR2
15379,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",FGFR3,,,,FGFR3
15380,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",FLT4,,,,FLT4
15381,brivanib,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor",KCNH2,,,,KCNH2
15382,XL-147,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CA,,,,PIK3CA
15383,XL-147,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CD,,,,PIK3CD
15384,XL-147,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor",PIK3CG,,,,PIK3CG
15385,mocetinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC1,,,,HDAC1
15386,mocetinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC2,,,,HDAC2
15387,mocetinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC3,,,,HDAC3
15388,mocetinostat,"HDAC inhibitor, cell cycle inhibitor",HDAC11,,,,HDAC11
15389,TGX-221,PI3K inhibitor,PIK3CB,,,,PIK3CB
15390,TGX-221,PI3K inhibitor,PIK3CD,,,,PIK3CD
15391,aprepitant,tachykinin antagonist,TACR1,,,,TACR1
15392,aprepitant,tachykinin antagonist,CYP2C19,,,,CYP2C19
15393,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS2,,,,PTGS2
15394,etodolac,"cyclooxygenase inhibitor, TRPV agonist",PTGS1,,,,PTGS1
15395,etodolac,"cyclooxygenase inhibitor, TRPV agonist",RXRA,,,,RXRA
15396,etodolac,"cyclooxygenase inhibitor, TRPV agonist",TRPV1,,,,TRPV1
15397,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
15398,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",AURKA,,,,AURKA
15399,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",AURKB,,,,AURKB
15400,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",KDR,,,,KDR
15401,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",EGFR,,,,EGFR
15402,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
15403,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FGFR2,,,,FGFR2
15404,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
15405,orantinib,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",TBK1,,,,TBK1
15406,safinamide,"dopamine reuptake inhibitor, glutamate release inhibitor, monoamine oxidase inhibitor, calcium channel antagonist, calcium channel modulator, Sodium Channel  Blockers, sodium channel blocker",MAOB,,,,MAOB
15407,safinamide,"dopamine reuptake inhibitor, glutamate release inhibitor, monoamine oxidase inhibitor, calcium channel antagonist, calcium channel modulator, Sodium Channel  Blockers, sodium channel blocker",SLC6A3,,,,SLC6A3
15408,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD2,,,,DRD2
15409,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A,,,,HTR2A
15410,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR1A,,,,HTR1A
15411,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR6,,,,HTR6
15412,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",HTR7,,,,HTR7
15413,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA1A,,,,ADRA1A
15414,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",ADRA2C,,,,ADRA2C
15415,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD1,,,,DRD1
15416,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD3,,,,DRD3
15417,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",DRD4,,,,DRD4
15418,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist",HRH1,,,,HRH1
15419,vinorelbine,"tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBB,,,,TUBB
15420,vicriviroc,"CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist",CCR5,,,,CCR5
15421,rivaroxaban,"coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor",F10,,,,F10
15422,rivaroxaban,"coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor",CYP2J2,,,,CYP2J2
15423,rivaroxaban,"coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor",CYP3A5,,,,CYP3A5
15424,SB-525334,TGF beta receptor inhibitor,TGFBR1,,,,TGFBR1
15425,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",VKORC1,,,,VKORC1
15426,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP2C19,,,,CYP2C19
15427,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP2C8,,,,CYP2C8
15428,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP4F2,,,,CYP4F2
15429,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",DRD2,,,,DRD2
15430,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR2A,,,,HTR2A
15431,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR1A,,,,HTR1A
15432,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR1D,,,,HTR1D
15433,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HRH1,,,,HRH1
15434,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR1B,,,,HTR1B
15435,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR1E,,,,HTR1E
15436,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR2C,,,,HTR2C
15437,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR7,,,,HTR7
15438,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",ADRA1A,,,,ADRA1A
15439,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",ADRA1B,,,,ADRA1B
15440,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",ADRA2A,,,,ADRA2A
15441,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",ADRA2B,,,,ADRA2B
15442,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",ADRA2C,,,,ADRA2C
15443,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",CHRM1,,,,CHRM1
15444,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",CHRM2,,,,CHRM2
15445,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",CHRM3,,,,CHRM3
15446,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",CHRM4,,,,CHRM4
15447,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",CHRM5,,,,CHRM5
15448,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",DRD1,,,,DRD1
15449,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",DRD3,,,,DRD3
15450,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",DRD4,,,,DRD4
15451,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",DRD5,,,,DRD5
15452,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR3A,,,,HTR3A
15453,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",HTR6,,,,HTR6
15454,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor",SLC6A4,,,,SLC6A4
15455,calmidazolium,"calcium channel blocker, calmodulin antagonist",ATP2B1,,,,ATP2B1
15456,calmidazolium,"calcium channel blocker, calmodulin antagonist",PDE1A,,,,PDE1A
15457,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A4,,,,CYP3A4
15458,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP1A2,,,,CYP1A2
15459,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP2B6,,,,CYP2B6
15460,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP2C19,,,,CYP2C19
15461,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A5,,,,CYP3A5
15462,ritonavir,"HIV protease inhibitor, cytochrome P450 inhibitor",CYP3A7,,,,CYP3A7
15463,pravastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
15464,pravastatin,HMGCR inhibitor,SLCO1B1,,,,SLCO1B1
15465,valsartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
15466,BRD-A80383043,"glutamate receptor agonist, glutamate receptor antagonist",GRM1,,,,GRM1
15467,BRD-A80383043,"glutamate receptor agonist, glutamate receptor antagonist",GRM2,,,,GRM2
15468,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",NR1I2,,,,NR1I2
15469,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",ABCB1,,,,ABCB1
15470,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2B6,,,,CYP2B6
15471,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2C19,,,,CYP2C19
15472,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP2C8,,,,CYP2C8
15473,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP3A4,,,,CYP3A4
15474,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",CYP3A5,,,,CYP3A5
15475,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1A2,,,,SLCO1A2
15476,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1B1,,,,SLCO1B1
15477,rifampicin,"DNA directed RNA polymerase inhibitor, enzyme inducer",SLCO1B3,,,,SLCO1B3
15478,3-matida,glutamate receptor antagonist,GRM1,,,,GRM1
15479,GSK-1059615,"PI3K inhibitor, mTOR inhibitor",PIK3CA,,,,PIK3CA
15480,GSK-1059615,"PI3K inhibitor, mTOR inhibitor",PIK3CG,,,,PIK3CG
15481,BRD-K06817181,JAK inhibitor,JAK2,,,,JAK2
15482,mefloquine,"acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor",ADORA2A,,,,ADORA2A
15483,mefloquine,"acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor",HBA1,,,,HBA1
15484,mefloquine,"acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor",PANX1,,,,PANX1
15485,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK2,,,,CDK2
15486,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",GSK3B,,,,GSK3B
15487,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CAMK2B,,,,CAMK2B
15488,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK1,,,,CDK1
15489,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CDK5,,,,CDK5
15490,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHEK1,,,,CHEK1
15491,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM1,,,,CHRM1
15492,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM2,,,,CHRM2
15493,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CHRM4,,,,CHRM4
15494,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",CSK,,,,CSK
15495,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",DAPK1,,,,DAPK1
15496,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",GPR35,,,,GPR35
15497,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",IKBKB,,,,IKBKB
15498,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",ITK,,,,ITK
15499,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",LCK,,,,LCK
15500,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",LRRK2,,,,LRRK2
15501,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAP2K4,,,,MAP2K4
15502,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAP2K6,,,,MAP2K6
15503,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",MAPKAPK2,,,,MAPKAPK2
15504,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PAK2,,,,PAK2
15505,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PDPK1,,,,PDPK1
15506,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PHKG2,,,,PHKG2
15507,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PIK3CG,,,,PIK3CG
15508,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PIM1,,,,PIM1
15509,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PKN1,,,,PKN1
15510,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKACB,,,,PRKACB
15511,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKCI,,,,PRKCI
15512,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",PRKCQ,,,,PRKCQ
15513,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",RPS6KA1,,,,RPS6KA1
15514,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",STK3,,,,STK3
15515,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",SYK,,,,SYK
15516,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",TNIK,,,,TNIK
15517,staurosporine,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor",ZAP70,,,,ZAP70
15518,SA-94315,caspase inhibitor,CASP3,,,,CASP3
15519,1-phenylbiguanide,serotonin receptor agonist,HTR3A,,,,HTR3A
15520,1-phenylbiguanide,serotonin receptor agonist,HTR3B,,,,HTR3B
15521,acepromazine,dopamine receptor antagonist,ADRA1A,,,,ADRA1A
15522,acepromazine,dopamine receptor antagonist,ADRA1B,,,,ADRA1B
15523,acepromazine,dopamine receptor antagonist,DRD1,,,,DRD1
15524,acepromazine,dopamine receptor antagonist,DRD2,,,,DRD2
15525,acepromazine,dopamine receptor antagonist,HTR1A,,,,HTR1A
15526,acepromazine,dopamine receptor antagonist,HTR2A,,,,HTR2A
15527,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",NR3C1,,,,NR3C1
15528,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A5,,,,CYP3A5
15529,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",CYP3A7,,,,CYP3A7
15530,triamcinolone,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent",SERPINA6,,,,SERPINA6
15531,MPEP,glutamate receptor antagonist,GRM5,,,,GRM5
15532,MPEP,glutamate receptor antagonist,GRM1,,,,GRM1
15533,MPEP,glutamate receptor antagonist,GRM4,,,,GRM4
15534,eprosartan,angiotensin receptor antagonist,AGTR1,,,,AGTR1
15535,entacapone,catechol O methyltransferase inhibitor,COMT,,,,COMT
15536,prostratin,"NFkB pathway activator, PKC activator",PRKCA,,,,PRKCA
15537,prostratin,"NFkB pathway activator, PKC activator",PRKCB,,,,PRKCB
15538,prostratin,"NFkB pathway activator, PKC activator",PRKCD,,,,PRKCD
15539,prostratin,"NFkB pathway activator, PKC activator",PRKCE,,,,PRKCE
15540,prostratin,"NFkB pathway activator, PKC activator",PRKCG,,,,PRKCG
15541,prostratin,"NFkB pathway activator, PKC activator",PRKCH,,,,PRKCH
15542,prostratin,"NFkB pathway activator, PKC activator",PRKCQ,,,,PRKCQ
15543,BRD-K91781484,"nuclear factor erythroid derived, like (NRF2) activator",NFE2L2,,,,NFE2L2
15544,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
15545,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADORA3,,,,ADORA3
15546,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1A,,,,ADRA1A
15547,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1B,,,,ADRA1B
15548,nicardipine,"calcium channel blocker, L-type calcium channel blocker",ADRA1D,,,,ADRA1D
15549,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
15550,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
15551,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
15552,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
15553,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM1,,,,CHRM1
15554,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM2,,,,CHRM2
15555,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM3,,,,CHRM3
15556,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM4,,,,CHRM4
15557,nicardipine,"calcium channel blocker, L-type calcium channel blocker",CHRM5,,,,CHRM5
15558,nicardipine,"calcium channel blocker, L-type calcium channel blocker",PDE1A,,,,PDE1A
15559,nicardipine,"calcium channel blocker, L-type calcium channel blocker",PDE1B,,,,PDE1B
15560,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA1,,,,CA1
15561,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA2,,,,CA2
15562,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA4,,,,CA4
15563,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA7,,,,CA7
15564,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA12,,,,CA12
15565,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",CA14,,,,CA14
15566,methazolamide,"carbonic anhydrase inhibitor, insulin sensitizer",INS,,,,INS
15567,methimazole,antithyroid Drugs,TPO,,,,TPO
15568,pyrazinamide,fatty acid synthase inhibitor,FASN,,,,FASN
15569,tetracycline,"30S ribosomal protein inhibitor, 30S ribosomal subunit inhibitor, protein arginine deiminase inhibitor",PRNP,,,,PRNP
15570,mestinon,cholinesterase inhibitor,ACHE,,,,ACHE
15571,mestinon,cholinesterase inhibitor,BCHE,,,,BCHE
15572,XAV-939,"PARP inhibitor, TNKS inhibitor",TNKS,,,,TNKS
15573,XAV-939,"PARP inhibitor, TNKS inhibitor",TNKS2,,,,TNKS2
15574,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,SLC12A1,,,,SLC12A1
15575,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,ATP1A1,,,,ATP1A1
15576,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA1,,,,CA1
15577,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA12,,,,CA12
15578,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA2,,,,CA2
15579,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA4,,,,CA4
15580,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA9,,,,CA9
15581,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,KCNMA1,,,,KCNMA1
15582,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",SLC22A6,,,,SLC22A6
15583,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",ABCC1,,,,ABCC1
15584,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",PANX1,,,,PANX1
15585,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",SLC22A11,,,,SLC22A11
15586,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",SLC22A8,,,,SLC22A8
15587,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",SLCO1C1,,,,SLCO1C1
15588,probenecid,"MRP inhibitor, TRPV agonist, uricosuric blocker",TRPV2,,,,TRPV2
15589,zimelidine,serotonin uptake inhibitor,SLC6A4,,,,SLC6A4
15590,zimelidine,serotonin uptake inhibitor,MAOA,,,,MAOA
15591,zimelidine,serotonin uptake inhibitor,MAOB,,,,MAOB
15592,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",DRD2,,,,DRD2
15593,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR2A,,,,HTR2A
15594,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1A,,,,ADRA1A
15595,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1B,,,,ADRA1B
15596,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",DRD3,,,,DRD3
15597,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HRH1,,,,HRH1
15598,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR1A,,,,HTR1A
15599,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR1D,,,,HTR1D
15600,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR2C,,,,HTR2C
15601,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA1D,,,,ADRA1D
15602,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA2A,,,,ADRA2A
15603,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA2B,,,,ADRA2B
15604,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",ADRA2C,,,,ADRA2C
15605,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",CYP3A5,,,,CYP3A5
15606,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",DRD1,,,,DRD1
15607,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",DRD4,,,,DRD4
15608,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR1B,,,,HTR1B
15609,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR1E,,,,HTR1E
15610,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR1F,,,,HTR1F
15611,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR6,,,,HTR6
15612,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist",HTR7,,,,HTR7
15613,icariin,"neuromedin receptor agonist, sorbitol dehydrogenase inhibitor",NMUR2,,,,NMUR2
15614,icariin,"neuromedin receptor agonist, sorbitol dehydrogenase inhibitor",PDE5A,,,,PDE5A
15615,icariin,"neuromedin receptor agonist, sorbitol dehydrogenase inhibitor",SORD,,,,SORD
15616,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",PRKCB,,,,PRKCB
15617,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",AKT1,,,,AKT1
15618,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",GSK3B,,,,GSK3B
15619,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",PRKCA,,,,PRKCA
15620,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",PRKCD,,,,PRKCD
15621,enzastaurin,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor",PRKCG,,,,PRKCG
15622,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",PPARG,,,,PPARG
15623,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",ACSL4,,,,ACSL4
15624,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",CYP2C8,,,,CYP2C8
15625,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",FFAR1,,,,FFAR1
15626,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",INS,,,,INS
15627,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",TRPC5,,,,TRPC5
15628,rosiglitazone,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione",TRPM3,,,,TRPM3
15629,RU-24969,serotonin receptor agonist,HTR1A,,,,HTR1A
15630,RU-24969,serotonin receptor agonist,HTR1B,,,,HTR1B
15631,RU-24969,serotonin receptor agonist,HTR6,,,,HTR6
15632,RU-24969,serotonin receptor agonist,HTR1D,,,,HTR1D
15633,RU-24969,serotonin receptor agonist,HTR2A,,,,HTR2A
15634,RU-24969,serotonin receptor agonist,HTR2B,,,,HTR2B
15635,RU-24969,serotonin receptor agonist,HTR2C,,,,HTR2C
15636,RU-24969,serotonin receptor agonist,HTR5A,,,,HTR5A
15637,GW-405833,cannabinoid receptor agonist,CNR2,,,,CNR2
15638,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
15639,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
15640,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
15641,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
15642,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
15643,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
15644,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
15645,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
15646,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CYP3A5,,,,CYP3A5
15647,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRA1,,,,GLRA1
15648,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRA3,,,,GLRA3
15649,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRB,,,,GLRB
15650,nifedipine,"calcium channel blocker, L-type calcium channel blocker",KCNA1,,,,KCNA1
15651,nifedipine,"calcium channel blocker, L-type calcium channel blocker",KCNA5,,,,KCNA5
15652,nifedipine,"calcium channel blocker, L-type calcium channel blocker",NR1I2,,,,NR1I2
15653,nifedipine,"calcium channel blocker, L-type calcium channel blocker",TRPM3,,,,TRPM3
15654,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",ADA,,,,ADA
15655,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE5A,,,,PDE5A
15656,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE10A,,,,PDE10A
15657,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE4A,,,,PDE4A
15658,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE7B,,,,PDE7B
15659,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE8A,,,,PDE8A
15660,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",PDE8B,,,,PDE8B
15661,dipyridamole,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor",SLC29A1,,,,SLC29A1
15662,tyrphostin-1,epidermal growth factor receptor (EGFR) inhibitor,EGFR,,,,EGFR
15663,moxifloxacin,"DNA gyrase inhibitor, topoisomerase inhibitor",TOP2A,,,,TOP2A
15664,epirizole,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
15665,epirizole,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
15666,cortisone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
15667,zileuton,"leukotriene synthesis inhibitor, lipoxygenase inhibitor",ALOX5,,,,ALOX5
15668,FGIN-1-27,"benzodiazepine receptor agonist, inositol monophosphatase inhibitor",TSPO,,,,TSPO
15669,propentofylline,"acetylcholinesterase inhibitor, adenosine reuptake inhibitor, adenosine uptake inhibitor, phosphodiesterase inhibitor",ACHE,,,,ACHE
15670,BRD-A83255679,estrogen receptor antagonist,GPER1,,,,GPER1
15671,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRB1,,,,ADRB1
15672,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRB2,,,,ADRB2
15673,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA1A,,,,ADRA1A
15674,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA1B,,,,ADRA1B
15675,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA1D,,,,ADRA1D
15676,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA2A,,,,ADRA2A
15677,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA2B,,,,ADRA2B
15678,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRA2C,,,,ADRA2C
15679,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",ADRB3,,,,ADRB3
15680,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",CYP2C19,,,,CYP2C19
15681,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",CYP2E1,,,,CYP2E1
15682,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",GJA1,,,,GJA1
15683,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",HIF1A,,,,HIF1A
15684,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",KCNH2,,,,KCNH2
15685,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",NDUFC2,,,,NDUFC2
15686,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",NPPB,,,,NPPB
15687,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",RYR2,,,,RYR2
15688,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",SELE,,,,SELE
15689,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",VCAM1,,,,VCAM1
15690,carvedilol,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator",VEGFA,,,,VEGFA
15691,lidocaine,"histamine receptor agonist, voltage-gated sodium channel modulator",SCN5A,,,,SCN5A
15692,lidocaine,"histamine receptor agonist, voltage-gated sodium channel modulator",EGFR,,,,EGFR
15693,lidocaine,"histamine receptor agonist, voltage-gated sodium channel modulator",SCN10A,,,,SCN10A
15694,lidocaine,"histamine receptor agonist, voltage-gated sodium channel modulator",SCN9A,,,,SCN9A
15695,nafcillin,antibiotic,CYP3A4,,,,CYP3A4
15696,diazoxide,"ATP channel activator, potassium channel activator",ATP1A1,,,,ATP1A1
15697,diazoxide,"ATP channel activator, potassium channel activator",CA1,,,,CA1
15698,diazoxide,"ATP channel activator, potassium channel activator",CA2,,,,CA2
15699,diazoxide,"ATP channel activator, potassium channel activator",KCNJ11,,,,KCNJ11
15700,diazoxide,"ATP channel activator, potassium channel activator",KCNMA1,,,,KCNMA1
15701,diazoxide,"ATP channel activator, potassium channel activator",SLC12A3,,,,SLC12A3
15702,EMF-BCA1-64,caspase inhibitor,CASP3,,,,CASP3
15703,prednicarbate,"corticosteroid agonist, immunosuppressant, phospholipase activator",NR3C1,,,,NR3C1
15704,prednicarbate,"corticosteroid agonist, immunosuppressant, phospholipase activator",PLA2G1B,,,,PLA2G1B
15705,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",SLC6A4,,,,SLC6A4
15706,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",ADRA1A,,,,ADRA1A
15707,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",CHRM1,,,,CHRM1
15708,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",CYP2C19,,,,CYP2C19
15709,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",HRH1,,,,HRH1
15710,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",SLC6A2,,,,SLC6A2
15711,escitalopram,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor",SLC6A3,,,,SLC6A3
15712,remoxipride,dopamine receptor antagonist,DRD2,,,,DRD2
15713,remoxipride,dopamine receptor antagonist,DRD3,,,,DRD3
15714,remoxipride,dopamine receptor antagonist,DRD4,,,,DRD4
15715,remoxipride,dopamine receptor antagonist,HTR2A,,,,HTR2A
15716,remoxipride,dopamine receptor antagonist,SIGMAR1,,,,SIGMAR1
15717,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",CYP3A4,,,,CYP3A4
15718,erythromycin,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor",MLNR,,,,MLNR
15719,dolasetron,serotonin receptor antagonist,HTR3A,,,,HTR3A
15720,SR-95639A,acetylcholine receptor agonist,CHRM1,,,,CHRM1
15721,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",CYP2C8,,,,CYP2C8
15722,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",CYP3A5,,,,CYP3A5
15723,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",RARA,,,,RARA
15724,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",RARG,,,,RARG
15725,CGP-57380,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor",AURKB,,,,AURKB
15726,CGP-57380,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor",LCK,,,,LCK
15727,CGP-57380,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor",MKNK1,,,,MKNK1
15728,CGP-57380,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor",MKNK2,,,,MKNK2
15729,CGP-57380,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor",SGK1,,,,SGK1
15730,proadifen,"nitric oxide synthase inhibitor, cytochrome P450 inhibitor, potassium channel blocker",NOS1,,,,NOS1
15731,meloxicam,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
15732,meloxicam,"cyclooxygenase inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
15733,SKF-83566,dopamine receptor antagonist,DRD1,,,,DRD1
15734,SKF-83566,dopamine receptor antagonist,DRD5,,,,DRD5
15735,L-694247,serotonin receptor agonist,HTR1D,,,,HTR1D
15736,L-694247,serotonin receptor agonist,HTR1A,,,,HTR1A
15737,L-694247,serotonin receptor agonist,HTR1B,,,,HTR1B
15738,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",ADRA1B,,,,ADRA1B
15739,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",CYP1A2,,,,CYP1A2
15740,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",CYP2B6,,,,CYP2B6
15741,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",CYP2C19,,,,CYP2C19
15742,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",CYP3A4,,,,CYP3A4
15743,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",CYP3A5,,,,CYP3A5
15744,modafinil,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor",SLC6A3,,,,SLC6A3
15745,prednisone,glucocorticoid receptor agonist,NR3C1,,,,NR3C1
15746,prednisone,glucocorticoid receptor agonist,HSD11B1,,,,HSD11B1
15747,YM-90709,"IL5 inhibitor, interleukin receptor antagonist",CSF2RB,,,,CSF2RB
15748,YM-90709,"IL5 inhibitor, interleukin receptor antagonist",IL5RA,,,,IL5RA
15749,cinanserin,serotonin receptor antagonist,HTR2A,,,,HTR2A
15750,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",AKR1B1,,,,AKR1B1
15751,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",AR,,,,AR
15752,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CDK6,,,,CDK6
15753,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CFTR,,,,CFTR
15754,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP19A1,,,,CYP19A1
15755,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP1A2,,,,CYP1A2
15756,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP1B1,,,,CYP1B1
15757,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",HSD17B1,,,,HSD17B1
15758,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",MAOA,,,,MAOA
15759,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",ODC1,,,,ODC1
15760,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
15761,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",DRD2,,,,DRD2
15762,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",DRD3,,,,DRD3
15763,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",DRD4,,,,DRD4
15764,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",DRD1,,,,DRD1
15765,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HRH1,,,,HRH1
15766,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR2A,,,,HTR2A
15767,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR2C,,,,HTR2C
15768,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR6,,,,HTR6
15769,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRA1A,,,,ADRA1A
15770,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRA1B,,,,ADRA1B
15771,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRA2A,,,,ADRA2A
15772,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRA2B,,,,ADRA2B
15773,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRA2C,,,,ADRA2C
15774,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",ADRB1,,,,ADRB1
15775,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",CHRM1,,,,CHRM1
15776,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",CHRM2,,,,CHRM2
15777,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",CHRM3,,,,CHRM3
15778,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",CHRM4,,,,CHRM4
15779,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",CHRM5,,,,CHRM5
15780,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",DRD5,,,,DRD5
15781,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HRH2,,,,HRH2
15782,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HRH4,,,,HRH4
15783,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR1A,,,,HTR1A
15784,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR1B,,,,HTR1B
15785,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR1D,,,,HTR1D
15786,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR1E,,,,HTR1E
15787,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR3A,,,,HTR3A
15788,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR5A,,,,HTR5A
15789,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",HTR7,,,,HTR7
15790,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",SLC6A2,,,,SLC6A2
15791,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",SLC6A3,,,,SLC6A3
15792,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand",SLC6A4,,,,SLC6A4
15793,zacopride,"serotonin receptor antagonist, serotonin receptor agonist",HTR3A,,,,HTR3A
15794,zacopride,"serotonin receptor antagonist, serotonin receptor agonist",HTR4,,,,HTR4
15795,zacopride,"serotonin receptor antagonist, serotonin receptor agonist",HTR3B,,,,HTR3B
15796,zacopride,"serotonin receptor antagonist, serotonin receptor agonist",HTR5A,,,,HTR5A
15797,omeprazole,"ATPase inhibitor, ABC transporter expression enhancer",ATP4A,,,,ATP4A
15798,omeprazole,"ATPase inhibitor, ABC transporter expression enhancer",CLCN2,,,,CLCN2
15799,omeprazole,"ATPase inhibitor, ABC transporter expression enhancer",CYP1A2,,,,CYP1A2
15800,omeprazole,"ATPase inhibitor, ABC transporter expression enhancer",CYP2C19,,,,CYP2C19
15801,alfuzosin,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
15802,alfuzosin,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
15803,alfuzosin,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
15804,alfuzosin,adrenergic receptor antagonist,KCNH2,,,,KCNH2
15805,ebselen,"COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent",ALB,,,,ALB
15806,ebselen,"COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent",LTB4R,,,,LTB4R
15807,ebselen,"COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent",NOX3,,,,NOX3
15808,alclometasone,"glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
15809,alclometasone,"glucocorticoid receptor agonist, immunosuppressant",SERPINA6,,,,SERPINA6
15810,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TUBB,,,,TUBB
15811,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",NR1I2,,,,NR1I2
15812,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",ABCB1,,,,ABCB1
15813,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",BCL2,,,,BCL2
15814,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",CYP2C8,,,,CYP2C8
15815,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAP2,,,,MAP2
15816,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAP4,,,,MAP4
15817,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",MAPT,,,,MAPT
15818,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TLR4,,,,TLR4
15819,paclitaxel,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane",TUBB1,,,,TUBB1
15820,isocarboxazid,monoamine oxidase inhibitor,MAOA,,,,MAOA
15821,isocarboxazid,monoamine oxidase inhibitor,MAOB,,,,MAOB
15822,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ8,,,,KCNJ8
15823,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",ABCC9,,,,ABCC9
15824,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ1,,,,KCNJ1
15825,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ10,,,,KCNJ10
15826,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",KCNJ11,,,,KCNJ11
15827,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",PTGS1,,,,PTGS1
15828,minoxidil,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant",REN,,,,REN
15829,hexylcaine,sodium channel blocker,SCN5A,,,,SCN5A
15830,hexylcaine,sodium channel blocker,SCN10A,,,,SCN10A
15831,asiatic-acid,antioxidant and antiinflammatory agent,PYGM,,,,PYGM
15832,acarbose,glucosidase inhibitor,GAA,,,,GAA
15833,acarbose,glucosidase inhibitor,MGAM,,,,MGAM
15834,acarbose,glucosidase inhibitor,AMY2A,,,,AMY2A
15835,acarbose,glucosidase inhibitor,SI,,,,SI
15836,mexiletine,"sodium channel blocker, potassium channel blocker",SCN5A,,,,SCN5A
15837,mexiletine,"sodium channel blocker, potassium channel blocker",AHR,,,,AHR
15838,mexiletine,"sodium channel blocker, potassium channel blocker",CYP2B6,,,,CYP2B6
15839,mexiletine,"sodium channel blocker, potassium channel blocker",CYP2E1,,,,CYP2E1
15840,mexiletine,"sodium channel blocker, potassium channel blocker",KCNK2,,,,KCNK2
15841,mexiletine,"sodium channel blocker, potassium channel blocker",KCNK3,,,,KCNK3
15842,mexiletine,"sodium channel blocker, potassium channel blocker",SCN4A,,,,SCN4A
15843,nicorandil,"ATP channel activator, nitric oxide donor, potassium channel agonist",ABCC9,,,,ABCC9
15844,nicorandil,"ATP channel activator, nitric oxide donor, potassium channel agonist",KCNJ11,,,,KCNJ11
15845,nicorandil,"ATP channel activator, nitric oxide donor, potassium channel agonist",KCNJ8,,,,KCNJ8
15846,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist",GRIN1,,,,GRIN1
15847,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist",GRIN2B,,,,GRIN2B
15848,triclosan,"DNA methyltransferase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor",DNMT1,,,,DNMT1
15849,brinzolamide,carbonic anhydrase inhibitor,CA2,,,,CA2
15850,brinzolamide,carbonic anhydrase inhibitor,CA1,,,,CA1
15851,brinzolamide,carbonic anhydrase inhibitor,CA7,,,,CA7
15852,brinzolamide,carbonic anhydrase inhibitor,CA12,,,,CA12
15853,brinzolamide,carbonic anhydrase inhibitor,CA14,,,,CA14
15854,brinzolamide,carbonic anhydrase inhibitor,CA4,,,,CA4
15855,brinzolamide,carbonic anhydrase inhibitor,CA5A,,,,CA5A
15856,brinzolamide,carbonic anhydrase inhibitor,CYP2B6,,,,CYP2B6
15857,brinzolamide,carbonic anhydrase inhibitor,CYP2C8,,,,CYP2C8
15858,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",CYP2B6,,,,CYP2B6
15859,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",CYP2C19,,,,CYP2C19
15860,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",CYP2C8,,,,CYP2C8
15861,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",CYP3A5,,,,CYP3A5
15862,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",CYP3A7,,,,CYP3A7
15863,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",NR2C2,,,,NR2C2
15864,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",PPARD,,,,PPARD
15865,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",RARA,,,,RARA
15866,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",RARB,,,,RARB
15867,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",RARG,,,,RARG
15868,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",RORB,,,,RORB
15869,isotretinoin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist",RORC,,,,RORC
15870,benzonatate,non-narcotic cough suppressant thought to act as a local anesthetic,SCN5A,,,,SCN5A
15871,alrestatin,aldose reductase inhibitor,AKR1B1,,,,AKR1B1
15872,tadalafil,phosphodiesterase inhibitor,PDE5A,,,,PDE5A
15873,tadalafil,phosphodiesterase inhibitor,PDE11A,,,,PDE11A
15874,L-803087,somatostatin receptor agonist,SSTR4,,,,SSTR4
15875,ranolazine,"fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker",SCN9A,,,,SCN9A
15876,ranolazine,"fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker",SCN10A,,,,SCN10A
15877,ranolazine,"fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker",SCN5A,,,,SCN5A
15878,ranolazine,"fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker",SLC22A2,,,,SLC22A2
15879,clonidine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
15880,clonidine,adrenergic receptor agonist,ADRA2B,,,,ADRA2B
15881,clonidine,adrenergic receptor agonist,ADRA2C,,,,ADRA2C
15882,clonidine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
15883,clonidine,adrenergic receptor agonist,ADRA1B,,,,ADRA1B
15884,clonidine,adrenergic receptor agonist,ADRA1D,,,,ADRA1D
15885,CGP-20712,adrenergic receptor antagonist,ADRB1,,,,ADRB1
15886,CGP-20712,adrenergic receptor antagonist,ADRB3,,,,ADRB3
15887,thioperamide,"histamine receptor antagonist, histamine receptor inverse agonist",HRH3,,,,HRH3
15888,thioperamide,"histamine receptor antagonist, histamine receptor inverse agonist",HRH4,,,,HRH4
15889,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",PTGS2,,,,PTGS2
15890,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",AKR1C3,,,,AKR1C3
15891,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",CYP2B6,,,,CYP2B6
15892,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",CYP2C19,,,,CYP2C19
15893,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",CYP2E1,,,,CYP2E1
15894,nabumetone,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor",PTGS1,,,,PTGS1
15895,BMS-191011,"large conductance calcium activated potassium channel opener, large conductance potassium channel activator",KCNMA1,,,,KCNMA1
15896,levofloxacin,"topoisomerase inhibitor, DNA gyrase inhibitor",TOP2A,,,,TOP2A
15897,telenzepine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
15898,quinapril,angiotensin converting enzyme inhibitor,ACE,,,,ACE
15899,aliskiren,"renin inhibitor, peptidase inhibitor, protease inhibitor",REN,,,,REN
15900,DCEBIO,intermediate conductance potassium channel activator,KCNN2,,,,KCNN2
15901,DCEBIO,intermediate conductance potassium channel activator,KCNN3,,,,KCNN3
15902,DCEBIO,intermediate conductance potassium channel activator,KCNN4,,,,KCNN4
15903,LY-225910,CCK receptor antagonist,CCKBR,,,,CCKBR
15904,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA1,,,,GABRA1
15905,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA2,,,,GABRA2
15906,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA3,,,,GABRA3
15907,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA5,,,,GABRA5
15908,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",ADRA1A,,,,ADRA1A
15909,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",CYP2C19,,,,CYP2C19
15910,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA4,,,,GABRA4
15911,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRA6,,,,GABRA6
15912,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB1,,,,GABRB1
15913,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB2,,,,GABRB2
15914,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRB3,,,,GABRB3
15915,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRD,,,,GABRD
15916,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRE,,,,GABRE
15917,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG1,,,,GABRG1
15918,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG2,,,,GABRG2
15919,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRG3,,,,GABRG3
15920,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRP,,,,GABRP
15921,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRQ,,,,GABRQ
15922,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR1,,,,GABRR1
15923,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR2,,,,GABRR2
15924,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",GABRR3,,,,GABRR3
15925,diazepam,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist",TSPO,,,,TSPO
15926,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",AKR1B1,,,,AKR1B1
15927,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",AR,,,,AR
15928,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CDK6,,,,CDK6
15929,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CFTR,,,,CFTR
15930,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP19A1,,,,CYP19A1
15931,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP1A2,,,,CYP1A2
15932,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",CYP1B1,,,,CYP1B1
15933,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",HSD17B1,,,,HSD17B1
15934,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",MAOA,,,,MAOA
15935,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",ODC1,,,,ODC1
15936,apigenin,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor",XDH,,,,XDH
15937,zolmitriptan,serotonin receptor agonist,HTR1B,,,,HTR1B
15938,zolmitriptan,serotonin receptor agonist,HTR1D,,,,HTR1D
15939,zolmitriptan,serotonin receptor agonist,HTR1A,,,,HTR1A
15940,zolmitriptan,serotonin receptor agonist,HTR1F,,,,HTR1F
15941,zolmitriptan,serotonin receptor agonist,HTR1E,,,,HTR1E
15942,pravastatin,HMGCR inhibitor,HMGCR,,,,HMGCR
15943,pravastatin,HMGCR inhibitor,SLCO1B1,,,,SLCO1B1
15944,azaperone,dopamine receptor antagonist,DRD2,,,,DRD2
15945,azaperone,dopamine receptor antagonist,DRD3,,,,DRD3
15946,cefdinir,cell wall synthesis inhibitor,MPO,,,,MPO
15947,salsolinol,"monoamine oxidase inhibitor, tyrosine hydroxylase inhibitor",DRD2,,,,DRD2
15948,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",ABL1,,,,ABL1
15949,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",KIT,,,,KIT
15950,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",BCR,,,,BCR
15951,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",CYP2B6,,,,CYP2B6
15952,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",CYP2C8,,,,CYP2C8
15953,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",DDR1,,,,DDR1
15954,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",DDR2,,,,DDR2
15955,nilotinib,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",PDGFRA,,,,PDGFRA
15956,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
15957,nimodipine,"calcium channel blocker, L-type calcium channel blocker",NR3C2,,,,NR3C2
15958,nimodipine,"calcium channel blocker, L-type calcium channel blocker",AHR,,,,AHR
15959,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
15960,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
15961,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
15962,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB1,,,,CACNB1
15963,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
15964,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB3,,,,CACNB3
15965,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB4,,,,CACNB4
15966,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CFTR,,,,CFTR
15967,BRD-A89208012,"prostanoid receptor antagonist, thromboxane receptor antagonist",TBXA2R,,,,TBXA2R
15968,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,HSD11B1,,,,HSD11B1
15969,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,RELA,,,,RELA
15970,L-750667,dopamine receptor antagonist,DRD4,,,,DRD4
15971,glipizide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",ABCC8,,,,ABCC8
15972,glipizide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",KCNJ10,,,,KCNJ10
15973,glipizide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",KCNJ11,,,,KCNJ11
15974,glipizide,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue",PPARG,,,,PPARG
15975,vemurafenib,"RAF inhibitor, protein kinase inhibitor",BRAF,,,,BRAF
15976,vemurafenib,"RAF inhibitor, protein kinase inhibitor",CYP2C19,,,,CYP2C19
15977,vemurafenib,"RAF inhibitor, protein kinase inhibitor",CYP3A4,,,,CYP3A4
15978,vemurafenib,"RAF inhibitor, protein kinase inhibitor",CYP3A5,,,,CYP3A5
15979,vemurafenib,"RAF inhibitor, protein kinase inhibitor",RAF1,,,,RAF1
15980,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",APOB,,,,APOB
15981,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",APP,,,,APP
15982,taxifolin,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor",HMGCR,,,,HMGCR
15983,RHC-80267,triacylglycerol lipase inhibitor,DAGLA,,,,DAGLA
15984,RHC-80267,triacylglycerol lipase inhibitor,DAGLB,,,,DAGLB
15985,RHC-80267,triacylglycerol lipase inhibitor,LIPC,,,,LIPC
15986,RHC-80267,triacylglycerol lipase inhibitor,LIPE,,,,LIPE
15987,RHC-80267,triacylglycerol lipase inhibitor,LIPG,,,,LIPG
15988,brucine,glycine receptor antagonist,CHRM1,,,,CHRM1
15989,brucine,glycine receptor antagonist,CHRM2,,,,CHRM2
15990,brucine,glycine receptor antagonist,CHRM3,,,,CHRM3
15991,brucine,glycine receptor antagonist,CHRM4,,,,CHRM4
15992,brucine,glycine receptor antagonist,CHRM5,,,,CHRM5
15993,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
15994,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
15995,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
15996,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
15997,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
15998,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
15999,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D2,,,,CACNA2D2
16000,isradipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
16001,capecitabine,"dihydropyrimidine dehydrogenase inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, RNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS,,,,TYMS
16002,capecitabine,"dihydropyrimidine dehydrogenase inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, RNA synthesis inhibitor, thymidylate synthase inhibitor",DPYD,,,,DPYD
16003,fenbufen,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
16004,fenbufen,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
16005,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS1,,,,PTGS1
16006,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2,,,,PTGS2
16007,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",ALOX5,,,,ALOX5
16008,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",CNR1,,,,CNR1
16009,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",KCNQ2,,,,KCNQ2
16010,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",KCNQ3,,,,KCNQ3
16011,RS-67333,serotonin receptor partial agonist,HTR4,,,,HTR4
16012,thiotepa,cytochrome P450 inhibitor,CYP2B6,,,,CYP2B6
16013,selegiline,"monoamine oxidase inhibitor, superoxide dismutase stimulant",MAOB,,,,MAOB
16014,selegiline,"monoamine oxidase inhibitor, superoxide dismutase stimulant",MAOA,,,,MAOA
16015,selegiline,"monoamine oxidase inhibitor, superoxide dismutase stimulant",CYP2B6,,,,CYP2B6
16016,selegiline,"monoamine oxidase inhibitor, superoxide dismutase stimulant",CYP2C19,,,,CYP2C19
16017,domperidone,"dopamine receptor antagonist, breast cancer resistance protein inhibitor",DRD2,,,,DRD2
16018,domperidone,"dopamine receptor antagonist, breast cancer resistance protein inhibitor",DRD3,,,,DRD3
16019,domperidone,"dopamine receptor antagonist, breast cancer resistance protein inhibitor",ABCG2,,,,ABCG2
16020,domperidone,"dopamine receptor antagonist, breast cancer resistance protein inhibitor",CYP3A5,,,,CYP3A5
16021,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",CA7,,,,CA7
16022,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",CA1,,,,CA1
16023,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",CA12,,,,CA12
16024,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",CA14,,,,CA14
16025,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",CA4,,,,CA4
16026,chlortalidone,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor",SLC12A1,,,,SLC12A1
16027,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",ANO1,,,,ANO1
16028,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",CLCN6,,,,CLCN6
16029,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",CLCN7,,,,CLCN7
16030,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",CLCNKA,,,,CLCNKA
16031,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",CLCNKB,,,,CLCNKB
16032,BRD-K13872703,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist",P2RY2,,,,P2RY2
16033,ozagrel,"thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor",TBXAS1,,,,TBXAS1
16034,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",DRD2,,,,DRD2
16035,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN1,,,,GRIN1
16036,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN2A,,,,GRIN2A
16037,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN2B,,,,GRIN2B
16038,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN2C,,,,GRIN2C
16039,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN2D,,,,GRIN2D
16040,amantadine,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist",GRIN3A,,,,GRIN3A
16041,tamibarotene,"retinoid receptor agonist, RAR agonist",RARA,,,,RARA
16042,tamibarotene,"retinoid receptor agonist, RAR agonist",RARB,,,,RARB
16043,tipifarnib-P2,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant",FNTA,,,,FNTA
16044,tipifarnib-P2,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant",FNTB,,,,FNTB
16045,enalaprilat,angiotensin converting enzyme inhibitor,ACE,,,,ACE
16046,CI-966,"GABA uptake inhibitor, GAT inhibitor",SLC6A1,,,,SLC6A1
16047,nimesulide,"cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor",PTGS2,,,,PTGS2
16048,nimesulide,"cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor",LTF,,,,LTF
16049,nimesulide,"cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor",PLA2G2E,,,,PLA2G2E
16050,nimesulide,"cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor",PTGS1,,,,PTGS1
16051,GW-501516,"PPAR receptor agonist, insulin sensitizer",PPARD,,,,PPARD
16052,GW-501516,"PPAR receptor agonist, insulin sensitizer",INS,,,,INS
16053,GW-501516,"PPAR receptor agonist, insulin sensitizer",PPARA,,,,PPARA
16054,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA1,,,,GABRA1
16055,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",ADRA2B,,,,ADRA2B
16056,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA2,,,,GABRA2
16057,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA3,,,,GABRA3
16058,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA4,,,,GABRA4
16059,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA5,,,,GABRA5
16060,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRA6,,,,GABRA6
16061,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRB1,,,,GABRB1
16062,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRB2,,,,GABRB2
16063,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRB3,,,,GABRB3
16064,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRD,,,,GABRD
16065,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRE,,,,GABRE
16066,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRG1,,,,GABRG1
16067,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRG2,,,,GABRG2
16068,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRG3,,,,GABRG3
16069,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRP,,,,GABRP
16070,etomidate,"membrane integrity inhibitor, membrane permeability inhibitor",GABRQ,,,,GABRQ
16071,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",PPARG,,,,PPARG
16072,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",ACSL4,,,,ACSL4
16073,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",AKR1B1,,,,AKR1B1
16074,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",CCL2,,,,CCL2
16075,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",CYP3A4,,,,CYP3A4
16076,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",ESRRA,,,,ESRRA
16077,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",ESRRG,,,,ESRRG
16078,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",INS,,,,INS
16079,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",SERPINE1,,,,SERPINE1
16080,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",SLC29A1,,,,SLC29A1
16081,troglitazone,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant",TRPM3,,,,TRPM3
16082,mebendazole,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor",TUBA1A,,,,TUBA1A
16083,mebendazole,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor",TUBB,,,,TUBB
16084,mebendazole,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor",TUBB4B,,,,TUBB4B
16085,azathioprine,"dehydrogenase inhibitor, immunosuppressant, purine antagonist",HPRT1,,,,HPRT1
16086,azathioprine,"dehydrogenase inhibitor, immunosuppressant, purine antagonist",IMPDH1,,,,IMPDH1
16087,azathioprine,"dehydrogenase inhibitor, immunosuppressant, purine antagonist",PPAT,,,,PPAT
16088,dihydrexidine,dopamine receptor agonist,DRD1,,,,DRD1
16089,dihydrexidine,dopamine receptor agonist,DRD2,,,,DRD2
16090,dihydrexidine,dopamine receptor agonist,DRD3,,,,DRD3
16091,dihydrexidine,dopamine receptor agonist,DRD4,,,,DRD4
16092,dihydrexidine,dopamine receptor agonist,DRD5,,,,DRD5
16093,methoxsalen,"acetylcholinesterase inhibitor, cytochrome P450 inhibitor, DNA damaging, DNA synthesis inhibitor, immunosuppressant",ACHE,,,,ACHE
16094,methoxsalen,"acetylcholinesterase inhibitor, cytochrome P450 inhibitor, DNA damaging, DNA synthesis inhibitor, immunosuppressant",CYP1A2,,,,CYP1A2
16095,dydrogesterone,progesterone receptor agonist,PGR,,,,PGR
16096,isoxicam,cyclooxygenase inhibitor,PTGS1,,,,PTGS1
16097,isoxicam,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
16098,buflomedil,"adrenergic receptor antagonist, calcium channel antagonist",CACNA1C,,,,CACNA1C
16099,SR-142948,neurotensin receptor antagonist,NTSR1,,,,NTSR1
16100,dantrolene,calcium channel antagonist,RYR1,,,,RYR1
16101,dantrolene,calcium channel antagonist,RYR3,,,,RYR3
16102,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA1,,,,GABRA1
16103,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA2,,,,GABRA2
16104,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA3,,,,GABRA3
16105,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA4,,,,GABRA4
16106,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA5,,,,GABRA5
16107,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRA6,,,,GABRA6
16108,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRB1,,,,GABRB1
16109,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRB2,,,,GABRB2
16110,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRB3,,,,GABRB3
16111,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRD,,,,GABRD
16112,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRE,,,,GABRE
16113,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRG1,,,,GABRG1
16114,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRG2,,,,GABRG2
16115,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRG3,,,,GABRG3
16116,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRP,,,,GABRP
16117,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GABRQ,,,,GABRQ
16118,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN1,,,,GRIN1
16119,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN2A,,,,GRIN2A
16120,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN2B,,,,GRIN2B
16121,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN2C,,,,GRIN2C
16122,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN2D,,,,GRIN2D
16123,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN3A,,,,GRIN3A
16124,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRIN3B,,,,GRIN3B
16125,acamprosate,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator",GRM5,,,,GRM5
16126,JZL-184,monoacylglucerol lipase inhibitor,MGLL,,,,MGLL
16127,zafirlukast,leukotriene receptor antagonist,CYSLTR1,,,,CYSLTR1
16128,zafirlukast,leukotriene receptor antagonist,CYSLTR2,,,,CYSLTR2
16129,oxybuprocaine,anesthetic,SCN10A,,,,SCN10A
16130,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",HRH1,,,,HRH1
16131,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE4A,,,,PDE4A
16132,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE4B,,,,PDE4B
16133,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE4C,,,,PDE4C
16134,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE4D,,,,PDE4D
16135,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE7A,,,,PDE7A
16136,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE7B,,,,PDE7B
16137,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE8A,,,,PDE8A
16138,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PDE8B,,,,PDE8B
16139,ketotifen,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor",PGD,,,,PGD
16140,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",DRD2,,,,DRD2
16141,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",DRD3,,,,DRD3
16142,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",ADRA1A,,,,ADRA1A
16143,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",ADRA2A,,,,ADRA2A
16144,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",ADRA2C,,,,ADRA2C
16145,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",DRD4,,,,DRD4
16146,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",HTR1A,,,,HTR1A
16147,piribedil,"dopamine receptor agonist, adrenergic receptor antagonist",HTR2B,,,,HTR2B
16148,bicalutamide,androgen receptor antagonist,AR,,,,AR
16149,bicalutamide,androgen receptor antagonist,CYP2C19,,,,CYP2C19
16150,FTI-276,farnesyltransferase inhibitor,FNTA,,,,FNTA
16151,FTI-276,farnesyltransferase inhibitor,FNTB,,,,FNTB
16152,ponalrestat,"aldose reductase inhibitor, reductase inhibitor",AKR1B1,,,,AKR1B1
16153,rofecoxib,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
16154,rofecoxib,cyclooxygenase inhibitor,CYP3A4,,,,CYP3A4
16155,rofecoxib,cyclooxygenase inhibitor,ELN,,,,ELN
16156,MRS-1845,calcium channel blocker,ORAI1,,,,ORAI1
16157,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",AR,,,,AR
16158,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP19A1,,,,CYP19A1
16159,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C19,,,,CYP2C19
16160,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C8,,,,CYP2C8
16161,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP3A5,,,,CYP3A5
16162,CGS-20625,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist",GABRA1,,,,GABRA1
16163,CGS-20625,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist",GABRA2,,,,GABRA2
16164,CGS-20625,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist",GABRA3,,,,GABRA3
16165,CGS-20625,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist",GABRA5,,,,GABRA5
16166,DR-2313,PARP inhibitor,PARP1,,,,PARP1
16167,DR-2313,PARP inhibitor,PARP3,,,,PARP3
16168,econazole,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor",CYP51A1,,,,CYP51A1
16169,econazole,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor",NPY1R,,,,NPY1R
16170,econazole,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor",NPY2R,,,,NPY2R
16171,econazole,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor",TRPM2,,,,TRPM2
16172,econazole,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor",TRPV5,,,,TRPV5
16173,purmorphamine,smoothened receptor agonist,SMO,,,,SMO
16174,purmorphamine,smoothened receptor agonist,DHH,,,,DHH
16175,purmorphamine,smoothened receptor agonist,IHH,,,,IHH
16176,purmorphamine,smoothened receptor agonist,PTCH1,,,,PTCH1
16177,metoprolol,adrenergic receptor antagonist,ADRB1,,,,ADRB1
16178,metoprolol,adrenergic receptor antagonist,ADRB2,,,,ADRB2
16179,zebularine,"DNA methyltransferase inhibitor, cytidine deaminase inhibitor",CDA,,,,CDA
16180,zebularine,"DNA methyltransferase inhibitor, cytidine deaminase inhibitor",DNMT1,,,,DNMT1
16181,SAL-1,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
16182,SAL-1,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
16183,calcitriol,"vitamin D receptor agonist, hypercalcaemic agent",VDR,,,,VDR
16184,calcitriol,"vitamin D receptor agonist, hypercalcaemic agent",CYP3A5,,,,CYP3A5
16185,VX-702,p38 MAPK inhibitor,MAPK14,,,,MAPK14
16186,VX-702,p38 MAPK inhibitor,MAPK11,,,,MAPK11
16187,VX-702,p38 MAPK inhibitor,MAPK12,,,,MAPK12
16188,CGP-13501,GABA receptor modulator,GABBR1,,,,GABBR1
16189,triciribine,AKT inhibitor,AKT1,,,,AKT1
16190,triciribine,AKT inhibitor,AKT2,,,,AKT2
16191,triciribine,AKT inhibitor,AKT3,,,,AKT3
16192,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",ANXA1,,,,ANXA1
16193,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A4,,,,CYP3A4
16194,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",CYP3A5,,,,CYP3A5
16195,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NOS2,,,,NOS2
16196,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR0B1,,,,NR0B1
16197,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C1,,,,NR3C1
16198,dexamethasone,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant",NR3C2,,,,NR3C2
16199,tipifarnib,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant",FNTA,,,,FNTA
16200,tipifarnib,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant",FNTB,,,,FNTB
16201,SB-221284,serotonin receptor antagonist,HTR2B,,,,HTR2B
16202,SB-221284,serotonin receptor antagonist,HTR2C,,,,HTR2C
16203,SB-221284,serotonin receptor antagonist,HTR2A,,,,HTR2A
16204,trapidil,"calcium channel antagonist, PDGFR tyrosine kinase receptor inhibitor, platelet aggregation inhibitor, protein kinase activator",PDGFRA,,,,PDGFRA
16205,fasudil,"ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor",ROCK1,,,,ROCK1
16206,fasudil,"ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor",ROCK2,,,,ROCK2
16207,fasudil,"ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor",PKIA,,,,PKIA
16208,fasudil,"ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor",PRKACA,,,,PRKACA
16209,scopolamine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
16210,scopolamine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
16211,scopolamine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
16212,scopolamine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
16213,scopolamine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
16214,scopolamine,acetylcholine receptor antagonist,SI,,,,SI
16215,meptazinol,opioid receptor agonist,BCHE,,,,BCHE
16216,lypressin,vasopressin receptor agonist,AVPR1A,,,,AVPR1A
16217,lypressin,vasopressin receptor agonist,AVPR1B,,,,AVPR1B
16218,lypressin,vasopressin receptor agonist,AVPR2,,,,AVPR2
16219,EBPC,aldose reductase inhibitor,AKR1B1,,,,AKR1B1
16220,xanthohumol,"aromatase inhibitor, diacylglycerol O acyltransferase inhibitor, valosin containing protein inhibitor",CYP19A1,,,,CYP19A1
16221,xanthohumol,"aromatase inhibitor, diacylglycerol O acyltransferase inhibitor, valosin containing protein inhibitor",VCP,,,,VCP
16222,PHTPP,estrogen receptor antagonist,ESR2,,,,ESR2
16223,flufenamic-acid,calcium activated chloride channel inhibitor,AKR1C3,,,,AKR1C3
16224,flufenamic-acid,calcium activated chloride channel inhibitor,AR,,,,AR
16225,flufenamic-acid,calcium activated chloride channel inhibitor,PTGS1,,,,PTGS1
16226,flufenamic-acid,calcium activated chloride channel inhibitor,PTGS2,,,,PTGS2
16227,flufenamic-acid,calcium activated chloride channel inhibitor,ANO1,,,,ANO1
16228,flufenamic-acid,calcium activated chloride channel inhibitor,GJA1,,,,GJA1
16229,flufenamic-acid,calcium activated chloride channel inhibitor,GJA10,,,,GJA10
16230,flufenamic-acid,calcium activated chloride channel inhibitor,GJA3,,,,GJA3
16231,flufenamic-acid,calcium activated chloride channel inhibitor,GJA4,,,,GJA4
16232,flufenamic-acid,calcium activated chloride channel inhibitor,GJA5,,,,GJA5
16233,flufenamic-acid,calcium activated chloride channel inhibitor,GJA8,,,,GJA8
16234,flufenamic-acid,calcium activated chloride channel inhibitor,GJA9,,,,GJA9
16235,flufenamic-acid,calcium activated chloride channel inhibitor,GJB1,,,,GJB1
16236,flufenamic-acid,calcium activated chloride channel inhibitor,GJB2,,,,GJB2
16237,flufenamic-acid,calcium activated chloride channel inhibitor,GJB3,,,,GJB3
16238,flufenamic-acid,calcium activated chloride channel inhibitor,GJB4,,,,GJB4
16239,flufenamic-acid,calcium activated chloride channel inhibitor,GJB5,,,,GJB5
16240,flufenamic-acid,calcium activated chloride channel inhibitor,GJB6,,,,GJB6
16241,flufenamic-acid,calcium activated chloride channel inhibitor,GJB7,,,,GJB7
16242,flufenamic-acid,calcium activated chloride channel inhibitor,GJC1,,,,GJC1
16243,flufenamic-acid,calcium activated chloride channel inhibitor,GJC2,,,,GJC2
16244,flufenamic-acid,calcium activated chloride channel inhibitor,GJC3,,,,GJC3
16245,flufenamic-acid,calcium activated chloride channel inhibitor,GJD2,,,,GJD2
16246,flufenamic-acid,calcium activated chloride channel inhibitor,GJD3,,,,GJD3
16247,flufenamic-acid,calcium activated chloride channel inhibitor,GJD4,,,,GJD4
16248,flufenamic-acid,calcium activated chloride channel inhibitor,GJE1,,,,GJE1
16249,flufenamic-acid,calcium activated chloride channel inhibitor,PANX1,,,,PANX1
16250,flufenamic-acid,calcium activated chloride channel inhibitor,PANX2,,,,PANX2
16251,flufenamic-acid,calcium activated chloride channel inhibitor,PANX3,,,,PANX3
16252,flufenamic-acid,calcium activated chloride channel inhibitor,PKD2L1,,,,PKD2L1
16253,flufenamic-acid,calcium activated chloride channel inhibitor,TRPC5,,,,TRPC5
16254,flufenamic-acid,calcium activated chloride channel inhibitor,TRPM2,,,,TRPM2
16255,flufenamic-acid,calcium activated chloride channel inhibitor,TRPM5,,,,TRPM5
16256,ALW-II-49-7,ephrin inhibitor,DDR1,,,,DDR1
16257,ALW-II-49-7,ephrin inhibitor,EPHA2,,,,EPHA2
16258,ALW-II-49-7,ephrin inhibitor,EPHA4,,,,EPHA4
16259,ALW-II-49-7,ephrin inhibitor,EPHA7,,,,EPHA7
16260,ALW-II-49-7,ephrin inhibitor,EPHB2,,,,EPHB2
16261,ALW-II-49-7,ephrin inhibitor,EPHB4,,,,EPHB4
16262,ALW-II-49-7,ephrin inhibitor,EPHB6,,,,EPHB6
16263,pefloxacin,topoisomerase inhibitor,TOP2A,,,,TOP2A
16264,methylnorlichexanthone,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",AURKB,,,,AURKB
16265,methylnorlichexanthone,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",KDR,,,,KDR
16266,methylnorlichexanthone,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor",PIM1,,,,PIM1
16267,flunisolide,"cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant",NR3C1,,,,NR3C1
16268,SU-6656,src inhibitor,LYN,,,,LYN
16269,SU-6656,src inhibitor,AURKB,,,,AURKB
16270,SU-6656,src inhibitor,AURKC,,,,AURKC
16271,SU-6656,src inhibitor,BRSK2,,,,BRSK2
16272,SU-6656,src inhibitor,CALM1,,,,CALM1
16273,SU-6656,src inhibitor,CAMK2D,,,,CAMK2D
16274,SU-6656,src inhibitor,LCK,,,,LCK
16275,SU-6656,src inhibitor,RET,,,,RET
16276,SU-6656,src inhibitor,SRC,,,,SRC
16277,SU-6656,src inhibitor,YES1,,,,YES1
16278,deltaline,acetylcholine receptor antagonist,CHRNA7,,,,CHRNA7
16279,JX-401,p38 MAPK inhibitor,MAPK14,,,,MAPK14
16280,hyoscyamine,acetylcholine receptor inhibitor,CHRM1,,,,CHRM1
16281,hyoscyamine,acetylcholine receptor inhibitor,CHRM2,,,,CHRM2
16282,hyoscyamine,acetylcholine receptor inhibitor,CHRM3,,,,CHRM3
16283,hyoscyamine,acetylcholine receptor inhibitor,CHRM4,,,,CHRM4
16284,NCS-382,GABA receptor antagonist,GABBR1,,,,GABBR1
16285,NCS-382,GABA receptor antagonist,GABBR2,,,,GABBR2
16286,NCS-382,GABA receptor antagonist,SLC52A2,,,,SLC52A2
16287,clomifene,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist",ESR1,,,,ESR1
16288,clomifene,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist",AR,,,,AR
16289,methyl-angolensate,apoptosis inhibitor,HTR2B,,,,HTR2B
16290,dihydroxyphenylglycine,glutamate receptor agonist,GRM1,,,,GRM1
16291,zosuquidar,"P glycoprotein inhibitor, P glycoprotein modulator",ABCB1,,,,ABCB1
16292,zosuquidar,"P glycoprotein inhibitor, P glycoprotein modulator",ABCB4,,,,ABCB4
16293,rimexolone,"glucocorticoid receptor agonist, immunosuppressant, mineralocorticoid receptor agonist",NR3C1,,,,NR3C1
16294,rimexolone,"glucocorticoid receptor agonist, immunosuppressant, mineralocorticoid receptor agonist",SERPINA6,,,,SERPINA6
16295,L-741742,dopamine receptor antagonist,DRD4,,,,DRD4
16296,L-741742,dopamine receptor antagonist,DRD3,,,,DRD3
16297,L-741742,dopamine receptor antagonist,SCN1A,,,,SCN1A
16298,L-741742,dopamine receptor antagonist,SCN3A,,,,SCN3A
16299,NU-1025,"PARP inhibitor, DNA dependent protein kinase inhibitor",PARP1,,,,PARP1
16300,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",MTOR,,,,MTOR
16301,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FKBP1A,,,,FKBP1A
16302,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",CCR5,,,,CCR5
16303,sirolimus,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor",FGF2,,,,FGF2
16304,buphenine,adrenergic receptor agonist,ADRB2,,,,ADRB2
16305,alfaxalone,"11-beta hydroxysteroid dehydrogenase inhibitor, chloride channel agonist, general pump inhibitor",HSD11B1,,,,HSD11B1
16306,dephostatin,tyrosine phosphatase inhibitor,PTPN1,,,,PTPN1
16307,dephostatin,tyrosine phosphatase inhibitor,PTPN6,,,,PTPN6
16308,probucol,"atherogenesis inhibitor, cholesterol inhibitor, reducing agent",ABCA1,,,,ABCA1
16309,probucol,"atherogenesis inhibitor, cholesterol inhibitor, reducing agent",ABCB11,,,,ABCB11
16310,probucol,"atherogenesis inhibitor, cholesterol inhibitor, reducing agent",CES1,,,,CES1
16311,7-nitroindazole,nitric oxide synthase inhibitor,NOS1,,,,NOS1
16312,7-nitroindazole,nitric oxide synthase inhibitor,NOS2,,,,NOS2
16313,7-nitroindazole,nitric oxide synthase inhibitor,NOS3,,,,NOS3
16314,indapamide,"carbonic anhydrase inhibitor, thiazide diuretic",KCNQ1,,,,KCNQ1
16315,indapamide,"carbonic anhydrase inhibitor, thiazide diuretic",CA7,,,,CA7
16316,indapamide,"carbonic anhydrase inhibitor, thiazide diuretic",KCNE1,,,,KCNE1
16317,indapamide,"carbonic anhydrase inhibitor, thiazide diuretic",SLC12A3,,,,SLC12A3
16318,solifenacin,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
16319,solifenacin,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
16320,solifenacin,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
16321,solifenacin,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
16322,solifenacin,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
16323,nomegestrol,progesterone receptor agonist,PGR,,,,PGR
16324,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",ABCC8,,,,ABCC8
16325,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",KCNJ11,,,,KCNJ11
16326,glimepiride,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea",KCNJ1,,,,KCNJ1
16327,nTZDpa,PPAR receptor partial agonist,PPARG,,,,PPARG
16328,CP-55940,"cannabinoid receptor agonist, CC chemokine receptor antagonist",CNR1,,,,CNR1
16329,CP-55940,"cannabinoid receptor agonist, CC chemokine receptor antagonist",CNR2,,,,CNR2
16330,CP-55940,"cannabinoid receptor agonist, CC chemokine receptor antagonist",CXCR4,,,,CXCR4
16331,CP-55940,"cannabinoid receptor agonist, CC chemokine receptor antagonist",GPR55,,,,GPR55
16332,MT-21,"adenine nucleotide translocase inhibitor, caspase activator, neurotrophic agent",CYCS,,,,CYCS
16333,MT-21,"adenine nucleotide translocase inhibitor, caspase activator, neurotrophic agent",SLC25A4,,,,SLC25A4
16334,metformin,"insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor",ACACB,,,,ACACB
16335,metformin,"insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor",INS,,,,INS
16336,metformin,"insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor",PRKAB1,,,,PRKAB1
16337,coumarin,vitamin antagonist,CA1,,,,CA1
16338,coumarin,vitamin antagonist,CA12,,,,CA12
16339,coumarin,vitamin antagonist,CA14,,,,CA14
16340,coumarin,vitamin antagonist,CA2,,,,CA2
16341,coumarin,vitamin antagonist,CA4,,,,CA4
16342,coumarin,vitamin antagonist,CA6,,,,CA6
16343,coumarin,vitamin antagonist,CA9,,,,CA9
16344,coumarin,vitamin antagonist,CYP2A6,,,,CYP2A6
16345,oleylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker",GPR119,,,,GPR119
16346,oleylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker",CNR1,,,,CNR1
16347,oleylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker",GPR55,,,,GPR55
16348,oleylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker",KCND3,,,,KCND3
16349,oleylethanolamide,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker",PPARA,,,,PPARA
16350,roxatidine,histamine receptor antagonist,HRH2,,,,HRH2
16351,DCPIB,"chloride channel blocker, gap junction modulator, glutamate transporter inhibitor, membrane permeability inhibitor",SLC1A2,,,,SLC1A2
16352,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SCN5A,,,,SCN5A
16353,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",ABCB1,,,,ABCB1
16354,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",CYP2D6,,,,CYP2D6
16355,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA5,,,,KCNA5
16356,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNA7,,,,KCNA7
16357,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH1,,,,KCNH1
16358,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH2,,,,KCNH2
16359,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNH5,,,,KCNH5
16360,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK1,,,,KCNK1
16361,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",KCNK6,,,,KCNK6
16362,quinidine,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker",SLC29A4,,,,SLC29A4
16363,lupanine,"ATP channel blocker, insulin secretagogue, Sodium Channel  Blockers, sodium channel blocker",INS,,,,INS
16364,NSC-693868,"CDK inhibitor, glycogen synthase kinase inhibitor",CDK1,,,,CDK1
16365,NSC-693868,"CDK inhibitor, glycogen synthase kinase inhibitor",CDK5,,,,CDK5
16366,NSC-693868,"CDK inhibitor, glycogen synthase kinase inhibitor",GSK3A,,,,GSK3A
16367,NSC-693868,"CDK inhibitor, glycogen synthase kinase inhibitor",GSK3B,,,,GSK3B
16368,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBB,,,,TUBB
16369,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",JUN,,,,JUN
16370,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBA1A,,,,TUBA1A
16371,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBD1,,,,TUBD1
16372,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBE1,,,,TUBE1
16373,vinblastine,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor",TUBG1,,,,TUBG1
16374,cinacalcet,calcimimetic that activates calcium-sensing receptors,CASR,,,,CASR
16375,vinburnine,adrenergic receptor antagonist,CHRM1,,,,CHRM1
16376,vinburnine,adrenergic receptor antagonist,CHRM2,,,,CHRM2
16377,vinburnine,adrenergic receptor antagonist,CHRM3,,,,CHRM3
16378,vinburnine,adrenergic receptor antagonist,CHRM4,,,,CHRM4
16379,tolazoline,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
16380,tolazoline,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
16381,tolazoline,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
16382,tolazoline,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
16383,tolazoline,adrenergic receptor antagonist,HRH1,,,,HRH1
16384,tolazoline,adrenergic receptor antagonist,HRH2,,,,HRH2
16385,razoxane,"topoisomerase inhibitor, chelating agent",TOP2A,,,,TOP2A
16386,razoxane,"topoisomerase inhibitor, chelating agent",TOP2B,,,,TOP2B
16387,umbelliferone,"carbonic anhydrase inhibitor, cyclooxygenase inhibitor",CA9,,,,CA9
16388,umbelliferone,"carbonic anhydrase inhibitor, cyclooxygenase inhibitor",CA12,,,,CA12
16389,umbelliferone,"carbonic anhydrase inhibitor, cyclooxygenase inhibitor",PTGS2,,,,PTGS2
16390,carmofur,"thymidylate synthase inhibitor, pyrimidine antagonist",TYMS,,,,TYMS
16391,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RARA,,,,RARA
16392,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RARB,,,,RARB
16393,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RARG,,,,RARG
16394,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RBP1,,,,RBP1
16395,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RXRA,,,,RXRA
16396,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RXRB,,,,RXRB
16397,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",RXRG,,,,RXRG
16398,acitretin,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor",STAT3,,,,STAT3
16399,BRD-A97035593,XIAP inhibitor,XIAP,,,,XIAP
16400,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
16401,nimodipine,"calcium channel blocker, L-type calcium channel blocker",NR3C2,,,,NR3C2
16402,nimodipine,"calcium channel blocker, L-type calcium channel blocker",AHR,,,,AHR
16403,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
16404,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
16405,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
16406,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB1,,,,CACNB1
16407,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
16408,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB3,,,,CACNB3
16409,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CACNB4,,,,CACNB4
16410,nimodipine,"calcium channel blocker, L-type calcium channel blocker",CFTR,,,,CFTR
16411,oligomycin-a,"ATP synthase inhibitor, ATPase inhibitor",ATP5A1,,,,ATP5F1A
16412,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1C,,,,CACNA1C
16413,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1D,,,,CACNA1D
16414,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1S,,,,CACNA1S
16415,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA2D1,,,,CACNA2D1
16416,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1F,,,,CACNA1F
16417,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNA1H,,,,CACNA1H
16418,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CACNB2,,,,CACNB2
16419,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CALM1,,,,CALM1
16420,nifedipine,"calcium channel blocker, L-type calcium channel blocker",CYP3A5,,,,CYP3A5
16421,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRA1,,,,GLRA1
16422,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRA3,,,,GLRA3
16423,nifedipine,"calcium channel blocker, L-type calcium channel blocker",GLRB,,,,GLRB
16424,nifedipine,"calcium channel blocker, L-type calcium channel blocker",KCNA1,,,,KCNA1
16425,nifedipine,"calcium channel blocker, L-type calcium channel blocker",KCNA5,,,,KCNA5
16426,nifedipine,"calcium channel blocker, L-type calcium channel blocker",NR1I2,,,,NR1I2
16427,nifedipine,"calcium channel blocker, L-type calcium channel blocker",TRPM3,,,,TRPM3
16428,AC-55649,"RAR agonist, retinoid receptor agonist",RARB,,,,RARB
16429,AC-55649,"RAR agonist, retinoid receptor agonist",RARA,,,,RARA
16430,imiquimod,"interferon inducer, toll-like receptor agonist, immunostimulant",TLR7,,,,TLR7
16431,imiquimod,"interferon inducer, toll-like receptor agonist, immunostimulant",TLR8,,,,TLR8
16432,SB-408124,"orexin receptor antagonist, orexin type 1 receptor antagonist",HCRTR1,,,,HCRTR1
16433,SB-408124,"orexin receptor antagonist, orexin type 1 receptor antagonist",HCRTR2,,,,HCRTR2
16434,embelin,"HCV inhibitor, XIAP inhibitor",XIAP,,,,XIAP
16435,protopine,"acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",ACHE,,,,ACHE
16436,protopine,"acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",SLC6A2,,,,SLC6A2
16437,protopine,"acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor",SLC6A4,,,,SLC6A4
16438,KF-38789,P selectin inhibitor,SELP,,,,SELP
16439,ethoprop,acetylcholinesterase inhibitor,ACHE,,,,ACHE
16440,PP-30,RAF inhibitor,RAF1,,,,RAF1
16441,methylene-blue,"guanylate cyclase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, tau aggregation inhibitor",ACHE,,,,ACHE
16442,methylene-blue,"guanylate cyclase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, tau aggregation inhibitor",MAPT,,,,MAPT
16443,AM-281,"cannabinoid receptor antagonist, cannabinoid receptor inhibitor",CNR1,,,,CNR1
16444,AM-281,"cannabinoid receptor antagonist, cannabinoid receptor inhibitor",CNR2,,,,CNR2
16445,AM-281,"cannabinoid receptor antagonist, cannabinoid receptor inhibitor",GPR55,,,,GPR55
16446,NECA,adenosine receptor agonist,ADORA1,,,,ADORA1
16447,NECA,adenosine receptor agonist,ADORA2A,,,,ADORA2A
16448,NECA,adenosine receptor agonist,ADORA2B,,,,ADORA2B
16449,NECA,adenosine receptor agonist,ADORA3,,,,ADORA3
16450,NECA,adenosine receptor agonist,HSP90B1,,,,HSP90B1
16451,quipazine,serotonin receptor agonist,HTR2A,,,,HTR2A
16452,quipazine,serotonin receptor agonist,HTR3A,,,,HTR3A
16453,quipazine,serotonin receptor agonist,HTR3B,,,,HTR3B
16454,quipazine,serotonin receptor agonist,HTR1A,,,,HTR1A
16455,quipazine,serotonin receptor agonist,HTR1D,,,,HTR1D
16456,quipazine,serotonin receptor agonist,HTR2B,,,,HTR2B
16457,quipazine,serotonin receptor agonist,HTR2C,,,,HTR2C
16458,quipazine,serotonin receptor agonist,HTR6,,,,HTR6
16459,quipazine,serotonin receptor agonist,SLC6A4,,,,SLC6A4
16460,BRD-K75430629,PI3K inhibitor,PIK3CD,,,,PIK3CD
16461,navitoclax,"BCL inhibitor, apoptosis stimulant",BCL2,,,,BCL2
16462,navitoclax,"BCL inhibitor, apoptosis stimulant",BCL2L1,,,,BCL2L1
16463,navitoclax,"BCL inhibitor, apoptosis stimulant",BCL2L2,,,,BCL2L2
16464,flavanone,11-beta hydroxysteroid dehydrogenase inhibitor,ADORA3,,,,ADORA3
16465,flavanone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,,,,HSD11B1
16466,S-14506,serotonin receptor agonist,HTR1A,,,,HTR1A
16467,S-14506,serotonin receptor agonist,DRD2,,,,DRD2
16468,S-14506,serotonin receptor agonist,HTR2C,,,,HTR2C
16469,NCS-382,GABA receptor antagonist,GABBR1,,,,GABBR1
16470,NCS-382,GABA receptor antagonist,GABBR2,,,,GABBR2
16471,NCS-382,GABA receptor antagonist,SLC52A2,,,,SLC52A2
16472,ipsapirone,serotonin receptor agonist,HTR1A,,,,HTR1A
16473,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",NISCH,,,,NISCH
16474,naringin,cytochrome P450 inhibitor,SLCO1A2,,,,SLCO1A2
16475,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",HPGDS,,,,HPGDS
16476,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",HRH1,,,,HRH1
16477,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IDO1,,,,IDO1
16478,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IFNG,,,,IFNG
16479,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL10,,,,IL10
16480,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL2,,,,IL2
16481,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",IL4,,,,IL4
16482,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",SLC22A12,,,,SLC22A12
16483,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TGFB1,,,,TGFB1
16484,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TNF,,,,TNF
16485,tranilast,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor",TRPV2,,,,TRPV2
16486,estradiol,estrogen receptor agonist,ESR1,,,,ESR1
16487,estradiol,estrogen receptor agonist,ESR2,,,,ESR2
16488,estradiol,estrogen receptor agonist,NR1I2,,,,NR1I2
16489,estradiol,estrogen receptor agonist,CYP2B6,,,,CYP2B6
16490,estradiol,estrogen receptor agonist,CYP2C19,,,,CYP2C19
16491,estradiol,estrogen receptor agonist,CYP2C8,,,,CYP2C8
16492,estradiol,estrogen receptor agonist,CYP2E1,,,,CYP2E1
16493,estradiol,estrogen receptor agonist,CYP3A5,,,,CYP3A5
16494,estradiol,estrogen receptor agonist,CYP3A7,,,,CYP3A7
16495,estradiol,estrogen receptor agonist,GPER1,,,,GPER1
16496,estradiol,estrogen receptor agonist,KCNMA1,,,,KCNMA1
16497,maraviroc,"CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist, reverse transcriptase inhibitor",CCR5,,,,CCR5
16498,maraviroc,"CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist, reverse transcriptase inhibitor",CYP3A5,,,,CYP3A5
16499,BRD-K30064966,caspase activator,CASP3,,,,CASP3
16500,albendazole,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor",CYP1A2,,,,CYP1A2
16501,albendazole,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor",CYP2J2,,,,CYP2J2
16502,albendazole,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor",TUBA1A,,,,TUBA1A
16503,albendazole,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor",TUBB,,,,TUBB
16504,albendazole,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor",TUBB4B,,,,TUBB4B
16505,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA3,,,,ADORA3
16506,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA1,,,,ADORA1
16507,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA2A,,,,ADORA2A
16508,IB-MECA,"adenosine receptor agonist, granulocyte colony stimulating factor agonist",ADORA2B,,,,ADORA2B
16509,SYK-inhibitor,syk inhibitor,SYK,,,,SYK
16510,ZM-241385,adenosine receptor antagonist,ADORA2A,,,,ADORA2A
16511,ZM-241385,adenosine receptor antagonist,ADORA2B,,,,ADORA2B
16512,ZM-241385,adenosine receptor antagonist,ADORA1,,,,ADORA1
16513,ZM-241385,adenosine receptor antagonist,ADORA3,,,,ADORA3
16514,diprotin-a,dipeptidyl peptidase inhibitor,DPP4,,,,DPP4
16515,ATPA,glutamate receptor agonist,GRIK1,,,,GRIK1
16516,ATPA,glutamate receptor agonist,GRIA2,,,,GRIA2
16517,NSC-663284,CDC inhibitor,CDC25A,,,,CDC25A
16518,NSC-663284,CDC inhibitor,CDC25B,,,,CDC25B
16519,NSC-663284,CDC inhibitor,CDC25C,,,,CDC25C
16520,BRD-K26947839,NADPH oxidase inhibitor,NOX1,,,,NOX1
16521,BRD-K86682249,tyrosine phosphatase inhibitor,PTPN1,,,,PTPN1
16522,BRD-K86682249,tyrosine phosphatase inhibitor,PTPN11,,,,PTPN11
16523,CGP-37157,"L-type calcium channel blocker, mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor",SLC8A1,,,,SLC8A1
16524,MK-212,serotonin receptor agonist,HTR2A,,,,HTR2A
16525,MK-212,serotonin receptor agonist,HTR2B,,,,HTR2B
16526,MK-212,serotonin receptor agonist,HTR2C,,,,HTR2C
16527,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1C,,,,CACNA1C
16528,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA1S,,,,CACNA1S
16529,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNA2D1,,,,CACNA2D1
16530,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CACNG1,,,,CACNG1
16531,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A5,,,,CYP3A5
16532,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",CYP3A7,,,,CYP3A7
16533,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",HTR3A,,,,HTR3A
16534,diltiazem,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker",KCNA5,,,,KCNA5
16535,resorcinol,phosphodiesterase inhibitor,CA12,,,,CA12
16536,resorcinol,phosphodiesterase inhibitor,CA14,,,,CA14
16537,resorcinol,phosphodiesterase inhibitor,CA2,,,,CA2
16538,resorcinol,phosphodiesterase inhibitor,PTGS1,,,,PTGS1
16539,butabindide,tripeptidyl peptidase inhibitor,TPP2,,,,TPP2
16540,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",AR,,,,AR
16541,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP19A1,,,,CYP19A1
16542,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C19,,,,CYP2C19
16543,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP2C8,,,,CYP2C8
16544,testosterone,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist",CYP3A5,,,,CYP3A5
16545,fatostatin,sterol regulatory element binding protein (SREBP) inhibitor,SREBF1,,,,SREBF1
16546,fatostatin,sterol regulatory element binding protein (SREBP) inhibitor,SREBF2,,,,SREBF2
16547,tubacin,HDAC inhibitor,HDAC6,,,,HDAC6
16548,goserelin,"gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist",GNRHR,,,,GNRHR
16549,goserelin,"gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist",GNRH1,,,,GNRH1
16550,goserelin,"gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist",LHCGR,,,,LHCGR
16551,elesclomol,"apoptosis stimulant, HSP agonist, HSP inducer, oxidative stress inducer, topoisomerase inhibitor",TOP2A,,,,TOP2A
16552,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",KCNN4,,,,KCNN4
16553,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",ABCB1,,,,ABCB1
16554,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",CYP2D6,,,,CYP2D6
16555,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",GP9,,,,GP9
16556,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",KCNB2,,,,KCNB2
16557,quinine,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor",SLC29A4,,,,SLC29A4
16558,PD-123319,angiotensin antagonist,AGTR2,,,,AGTR2
16559,scopolamine,acetylcholine receptor antagonist,CHRM2,,,,CHRM2
16560,scopolamine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
16561,scopolamine,acetylcholine receptor antagonist,CHRM3,,,,CHRM3
16562,scopolamine,acetylcholine receptor antagonist,CHRM4,,,,CHRM4
16563,scopolamine,acetylcholine receptor antagonist,CHRM5,,,,CHRM5
16564,scopolamine,acetylcholine receptor antagonist,SI,,,,SI
16565,isoxsuprine,adrenergic receptor agonist,ADRB2,,,,ADRB2
16566,dipivefrine,adrenergic receptor agonist,ADRA1A,,,,ADRA1A
16567,dipivefrine,adrenergic receptor agonist,ACHE,,,,ACHE
16568,dipivefrine,adrenergic receptor agonist,ADRA2A,,,,ADRA2A
16569,dipivefrine,adrenergic receptor agonist,ADRB2,,,,ADRB2
16570,dipivefrine,adrenergic receptor agonist,BCHE,,,,BCHE
16571,terbutaline,adrenergic receptor agonist,ADRB2,,,,ADRB2
16572,enalapril,"angiotensin converting enzyme inhibitor, angiotensin receptor blocker",ACE,,,,ACE
16573,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRK1,,,,OPRK1
16574,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRM1,,,,OPRM1
16575,naltrexone,"opioid receptor antagonist, opioid receptor ligand",OPRD1,,,,OPRD1
16576,naltrexone,"opioid receptor antagonist, opioid receptor ligand",SIGMAR1,,,,SIGMAR1
16577,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA1A,,,,ADRA1A
16578,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA2A,,,,ADRA2A
16579,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA1B,,,,ADRA1B
16580,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA1D,,,,ADRA1D
16581,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA2B,,,,ADRA2B
16582,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",ADRA2C,,,,ADRA2C
16583,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",CYP2C19,,,,CYP2C19
16584,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",HTR1B,,,,HTR1B
16585,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",HTR1D,,,,HTR1D
16586,oxymetazoline,"adrenergic receptor agonist, unidentified pharmacological activity",HTR2C,,,,HTR2C
16587,iproniazid,monoamine oxidase inhibitor,MAOA,,,,MAOA
16588,iproniazid,monoamine oxidase inhibitor,MAOB,,,,MAOB
16589,ZK-756326,CC chemokine receptor ligand,CCR8,,,,CCR8
16590,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",LRRK1,,,,LRRK1
16591,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
16592,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",NTRK1,,,,NTRK1
16593,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",RAF1,,,,RAF1
16594,RITA,"MDM inhibitor, thioredoxin reductase inhibitor",MDM2,,,,MDM2
16595,RITA,"MDM inhibitor, thioredoxin reductase inhibitor",TXNRD1,,,,TXNRD1
16596,RITA,"MDM inhibitor, thioredoxin reductase inhibitor",TXNRD2,,,,TXNRD2
16597,formoterol,adrenergic receptor agonist,ADRB2,,,,ADRB2
16598,formoterol,adrenergic receptor agonist,CYP2C19,,,,CYP2C19
16599,homatropine,acetylcholine receptor antagonist,CES1,,,,CES1
16600,homatropine,acetylcholine receptor antagonist,CHRM1,,,,CHRM1
16601,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",CYP3A4,,,,CYP3A4
16602,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",TRPC1,,,,TRPC1
16603,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",PKD2,,,,PKD2
16604,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",TRPC3,,,,TRPC3
16605,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",TRPC4,,,,TRPC4
16606,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",TRPC5,,,,TRPC5
16607,SKF-96365,"calcium channel blocker, cytochrome P450 inhibitor",TRPV2,,,,TRPV2
16608,dichloroacetic-acid,"pyruvate dehydrogenase kinase inhibitor, pyruvate dehydrogenase stimulant",PDK1,,,,PDK1
16609,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",LRRK1,,,,LRRK1
16610,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",LRRK2,,,,LRRK2
16611,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",NTRK1,,,,NTRK1
16612,GW-5074,"RAF inhibitor, leucine rich repeat kinase inhibitor",RAF1,,,,RAF1
16613,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",CYP2C8,,,,CYP2C8
16614,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",CYP3A5,,,,CYP3A5
16615,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",RARA,,,,RARA
16616,fenretinide,"apoptosis stimulant, retinoid receptor agonist, RAR agonist",RARG,,,,RARG
16617,hexylresorcinol,polyphenol oxidase inhibitor,TYR,,,,TYR
16618,QS-11,ARFGAP inhibitor,ARFGAP1,,,,ARFGAP1
16619,CO-101244,ionotropic glutamate receptor antagonist,GRIN2B,,,,GRIN2B
16620,prunetin,breast cancer resistance protein inhibitor,ABCG2,,,,ABCG2
16621,prunetin,breast cancer resistance protein inhibitor,ALDH2,,,,ALDH2
16622,SSR-69071,leukocyte elastase inhibitor,ELANE,,,,ELANE
16623,LY-2183240,"FAAH inhibitor, FAAH reuptake inhibitor",FAAH,,,,FAAH
16624,PF-04217903,"c-Met inhibitor, hepatocyte growth factor receptor inhibitor",MET,,,,MET
16625,ALX-5407,"glycine transporter inhibitor, GlyT-1 inhibitor",SLC6A9,,,,SLC6A9
16626,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1,,,,TRPV1
16627,cinalukast,leukotriene receptor antagonist,CYSLTR1,,,,CYSLTR1
16628,vecuronium,acetylcholine receptor antagonist,CHRNA2,,,,CHRNA2
16629,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBB,,,,TUBB
16630,vincristine,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid",TUBA4A,,,,TUBA4A
16631,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR4,,,,HTR4
16632,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",KCNH2,,,,KCNH2
16633,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP2B6,,,,CYP2B6
16634,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP2C8,,,,CYP2C8
16635,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP3A5,,,,CYP3A5
16636,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",CYP3A7,,,,CYP3A7
16637,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR2A,,,,HTR2A
16638,cisapride,"acetylcholine receptor agonist, serotonin receptor agonist",HTR3A,,,,HTR3A
16639,PKCbeta-inhibitor,PKC inhibitor,PRKCB,,,,PRKCB
16640,SIB-1757,glutamate receptor antagonist,GRM5,,,,GRM5
16641,BRD-K56658166,"N-type calcium channel blocker, Sodium Channel  Blockers",CACNA1B,,,,CACNA1B
16642,orciprenaline,adrenergic receptor agonist,ADRB2,,,,ADRB2
16643,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",VKORC1,,,,VKORC1
16644,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP2C19,,,,CYP2C19
16645,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP2C8,,,,CYP2C8
16646,warfarin,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor",CYP4F2,,,,CYP4F2
16647,NS-3694,glutamate receptor antagonist,GRIK1,,,,GRIK1
16648,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",BACE1,,,,BACE1
16649,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA1,,,,CA1
16650,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA12,,,,CA12
16651,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA14,,,,CA14
16652,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA2,,,,CA2
16653,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA4,,,,CA4
16654,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA6,,,,CA6
16655,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",CA9,,,,CA9
16656,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",FASN,,,,FASN
16657,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",PTGS1,,,,PTGS1
16658,catechin,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker",SCN5A,,,,SCN5A
16659,BRD-K48969316,caspase inhibitor,CASP1,,,,CASP1
16660,phenytoin,sodium channel blocker,ABCB1,,,,ABCB1
16661,phenytoin,sodium channel blocker,CYP2B6,,,,CYP2B6
16662,phenytoin,sodium channel blocker,CYP2C19,,,,CYP2C19
16663,phenytoin,sodium channel blocker,CYP3A4,,,,CYP3A4
16664,phenytoin,sodium channel blocker,SCN1A,,,,SCN1A
16665,phenytoin,sodium channel blocker,SCN2A,,,,SCN2A
16666,phenytoin,sodium channel blocker,SCN5A,,,,SCN5A
16667,dinoprostone,prostanoid receptor agonist,PTGER2,,,,PTGER2
16668,dinoprostone,prostanoid receptor agonist,PTGER1,,,,PTGER1
16669,dinoprostone,prostanoid receptor agonist,PTGER3,,,,PTGER3
16670,dinoprostone,prostanoid receptor agonist,PTGER4,,,,PTGER4
16671,dinoprostone,prostanoid receptor agonist,CATSPER1,,,,CATSPER1
16672,dinoprostone,prostanoid receptor agonist,CATSPER2,,,,CATSPER2
16673,dinoprostone,prostanoid receptor agonist,CATSPER3,,,,CATSPER3
16674,dinoprostone,prostanoid receptor agonist,CATSPER4,,,,CATSPER4
16675,dinoprostone,prostanoid receptor agonist,PTGDR,,,,PTGDR
16676,dinoprostone,prostanoid receptor agonist,PTGDR2,,,,PTGDR2
16677,dinoprostone,prostanoid receptor agonist,PTGFR,,,,PTGFR
16678,dinoprostone,prostanoid receptor agonist,TBXA2R,,,,TBXA2R
16679,phentolamine,adrenergic receptor antagonist,ADRA1A,,,,ADRA1A
16680,phentolamine,adrenergic receptor antagonist,ADRA2A,,,,ADRA2A
16681,phentolamine,adrenergic receptor antagonist,ADRA1B,,,,ADRA1B
16682,phentolamine,adrenergic receptor antagonist,ADRA1D,,,,ADRA1D
16683,phentolamine,adrenergic receptor antagonist,ADRA2B,,,,ADRA2B
16684,phentolamine,adrenergic receptor antagonist,ADRA2C,,,,ADRA2C
16685,HLI-373,MDM inhibitor,MDM2,,,,MDM2
16686,cytosporone-b,HMR receptor agonist,NR4A1,,,,NR4A1
16687,biotin,vitamin cofactor for many metabolic reactions,ACACA,,,,ACACA
16688,biotin,vitamin cofactor for many metabolic reactions,ACACB,,,,ACACB
16689,biotin,vitamin cofactor for many metabolic reactions,HLCS,,,,HLCS
16690,biotin,vitamin cofactor for many metabolic reactions,MCCC1,,,,MCCC1
16691,biotin,vitamin cofactor for many metabolic reactions,MCCC2,,,,MCCC2
16692,biotin,vitamin cofactor for many metabolic reactions,PC,,,,PC
16693,biotin,vitamin cofactor for many metabolic reactions,PCCA,,,,PCCA
16694,biotin,vitamin cofactor for many metabolic reactions,PCCB,,,,PCCB
16695,biotin,vitamin cofactor for many metabolic reactions,SLC5A6,,,,SLC5A6
16696,mestranol,estrogen receptor agonist,ESR1,,,,ESR1
16697,prima-1-met,"thioredoxin inhibitor, TP53 activator",TP53,,,,TP53
16698,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT3,,,,FLT3
16699,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",KDR,,,,KDR
16700,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",KIT,,,,KIT
16701,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT4,,,,FLT4
16702,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FLT1,,,,FLT1
16703,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRA,,,,PDGFRA
16704,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",PDGFRB,,,,PDGFRB
16705,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",RET,,,,RET
16706,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",CSF1R,,,,CSF1R
16707,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist",FGFR1,,,,FGFR1
16708,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RARG,,,,RARG
16709,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RARA,,,,RARA
16710,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RARB,,,,RARB
16711,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RXRA,,,,RXRA
16712,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RXRG,,,,RXRG
16713,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",ABCA1,,,,ABCA1
16714,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",CYP2C8,,,,CYP2C8
16715,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",CYP3A7,,,,CYP3A7
16716,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",RXRB,,,,RXRB
16717,alitretinoin,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist",VKORC1,,,,VKORC1
16718,oxibendazole,"DNA polymerase inhibitor, tubulin inhibitor",TUBB,,,,TUBB
16719,oxibendazole,"DNA polymerase inhibitor, tubulin inhibitor",TUBB4B,,,,TUBB4B
16720,GANT-58,GLI antagonist,DHH,,,,DHH
16721,GANT-58,GLI antagonist,GLI1,,,,GLI1
16722,GANT-58,GLI antagonist,IHH,,,,IHH
16723,treprostinil,prostacyclin analog,PTGIR,,,,PTGIR
16724,treprostinil,prostacyclin analog,CYP2C8,,,,CYP2C8
16725,treprostinil,prostacyclin analog,P2RY12,,,,P2RY12
16726,treprostinil,prostacyclin analog,PPARD,,,,PPARD
16727,treprostinil,prostacyclin analog,PTGDR,,,,PTGDR
16728,treprostinil,prostacyclin analog,PTGER1,,,,PTGER1
16729,treprostinil,prostacyclin analog,PTGER2,,,,PTGER2
16730,treprostinil,prostacyclin analog,PTGER3,,,,PTGER3
16731,treprostinil,prostacyclin analog,PTGER4,,,,PTGER4
16732,erbstatin-analog,"EGFR inhibitor, tyrosine kinase inhibitor",EGFR,,,,EGFR
16733,linoleic-acid,oxidative stress inducer,FABP4,,,,FABP4
16734,linoleic-acid,oxidative stress inducer,FFAR1,,,,FFAR1
16735,linoleic-acid,oxidative stress inducer,FFAR4,,,,FFAR4
16736,linoleic-acid,oxidative stress inducer,HNF4A,,,,HNF4A
16737,linoleic-acid,oxidative stress inducer,KCNB1,,,,KCNB1
16738,linoleic-acid,oxidative stress inducer,PPARG,,,,PPARG
16739,linoleic-acid,oxidative stress inducer,TRPM8,,,,TRPM8
16740,SB-225002,"CC chemokine receptor antagonist, Chemokine CXCR2  (IL-8 beta Receptor) Antagonists",CXCR2,,,,CXCR2
16741,CAY-10415,insulin sensitizer,INS,,,,INS
16742,SB-415286,glycogen synthase kinase inhibitor,GSK3B,,,,GSK3B
16743,SB-415286,glycogen synthase kinase inhibitor,GSK3A,,,,GSK3A
16744,SB-415286,glycogen synthase kinase inhibitor,RPS6KB1,,,,RPS6KB1
16745,SB-216763,glycogen synthase kinase inhibitor,GSK3B,,,,GSK3B
16746,SB-216763,glycogen synthase kinase inhibitor,CCNA2,,,,CCNA2
16747,SB-216763,glycogen synthase kinase inhibitor,CDK2,,,,CDK2
16748,SB-216763,glycogen synthase kinase inhibitor,GSK3A,,,,GSK3A
16749,BRD-K15107389,ribosomal protein inhibitor,RPS6KA1,,,,RPS6KA1
16750,BRD-K15107389,ribosomal protein inhibitor,RPS6KA2,,,,RPS6KA2
16751,BRD-K15107389,ribosomal protein inhibitor,RPS6KA3,,,,RPS6KA3
16752,clebopride,dopamine receptor antagonist,DRD2,,,,DRD2
16753,clebopride,dopamine receptor antagonist,ACHE,,,,ACHE
16754,L-655708,GABA receptor inverse agonist,GABRA5,,,,GABRA5
16755,L-655708,GABA receptor inverse agonist,GABRA1,,,,GABRA1
16756,L-655708,GABA receptor inverse agonist,GABRA2,,,,GABRA2
16757,L-655708,GABA receptor inverse agonist,GABRA3,,,,GABRA3
16758,L-655708,GABA receptor inverse agonist,GABRG2,,,,GABRG2
16759,RS-102221,serotonin receptor antagonist,HTR2C,,,,HTR2C
16760,RS-102221,serotonin receptor antagonist,HTR2A,,,,HTR2A
16761,RS-102221,serotonin receptor antagonist,HTR2B,,,,HTR2B
16762,flubendazole,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor",TUBB,,,,TUBB
16763,phenethyl-isothiocyanate,"cancer cell growth inhibitor, unidentified pharmacological activity",CYP2E1,,,,CYP2E1
16764,LM-1685,cyclooxygenase inhibitor,PTGS2,,,,PTGS2
16765,ampicillin,cell wall synthesis inhibitor,SLC15A1,,,,SLC15A1
16766,vindesine,"tubulin inhibitor, microtubule inhibitor, vinca alkaloid",TUBB,,,,TUBB
16767,vindesine,"tubulin inhibitor, microtubule inhibitor, vinca alkaloid",TUBB1,,,,TUBB1
16768,nocodazole,"tubulin inhibitor, Tubulin Polymerization Inhibitors",HPGDS,,,,HPGDS
16769,YK-4279,"apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor",DHX9,,,,DHX9
16770,YK-4279,"apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor",EWSR1,,,,EWSR1
16771,YK-4279,"apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor",FLI1,,,,FLI1
16772,GW-843682X,PLK inhibitor,PLK1,,,,PLK1
16773,GW-843682X,PLK inhibitor,PLK3,,,,PLK3
16774,VX-745,p38 MAPK inhibitor,MAPK14,,,,MAPK14
16775,VX-745,p38 MAPK inhibitor,MAPK11,,,,MAPK11
16776,VX-745,p38 MAPK inhibitor,MAPK12,,,,MAPK12
16777,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",ESR1,,,,ESR1
16778,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",EPHX2,,,,EPHX2
16779,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",ESR2,,,,ESR2
16780,fulvestrant,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor",GPER1,,,,GPER1
16781,TTNPB,"RAR agonist, retinoid receptor agonist",RARB,,,,RARB
16782,TTNPB,"RAR agonist, retinoid receptor agonist",RARA,,,,RARA
16783,TTNPB,"RAR agonist, retinoid receptor agonist",RARG,,,,RARG
16784,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",PTGS1,,,,PTGS1
16785,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",PTGS2,,,,PTGS2
16786,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",APP,,,,APP
16787,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA1,,,,CA1
16788,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA12,,,,CA12
16789,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA14,,,,CA14
16790,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA2,,,,CA2
16791,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA4,,,,CA4
16792,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA6,,,,CA6
16793,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CA9,,,,CA9
16794,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CCND1,,,,CCND1
16795,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",CYP3A4,,,,CYP3A4
16796,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",DNMT1,,,,DNMT1
16797,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",DNMT3B,,,,DNMT3B
16798,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",EP300,,,,EP300
16799,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",G6PC,,,,G6PC
16800,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",MAPT,,,,MAPT
16801,curcumin,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity",MMP13,,,,MMP13
